PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	GUVAKOVA, MA; YAKUBOV, LA; VLODAVSKY, I; TONKINSON, JL; STEIN, CA				GUVAKOVA, MA; YAKUBOV, LA; VLODAVSKY, I; TONKINSON, JL; STEIN, CA			PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES BIND TO BASIC FIBROBLAST GROWTH-FACTOR, INHIBIT ITS BINDING TO CELL-SURFACE RECEPTORS, AND REMOVE IT FROM LOW-AFFINITY BINDING-SITES OIL EXTRACELLULAR-MATRIX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL STRUCTURE; ENDOTHELIAL-CELLS; SURAMIN; HEPARIN; OLIGONUCLEOTIDES; TRANSFORMATION; STIMULATION; MECHANISM; MEMBRANE; REVERSAL	We studied the interactions of phosphorothioate oligodeoxynucleotides and heparin-binding growth factors. By means of a gel mobility shift assay, we demonstrated that phosphodiester and phosphorothioate homopolymers bound to basic fibroblast growth factor (bFGF). Binding of a probe phosphodiester oligodeoxynucleotide could also be shown for other proteins of the FGF family, including acidic fibroblast growth factor (aFGF), Kaposi's growth factor (FGF-4) as well as for the bFGF-related vascular endothelial growth factor, VEGF. No binding to epidermal growth factor (EGF) was observed. In addition, using a radioreceptor assay, we have shown that phosphorothioate homopolymers of cytidine and thymidine blocked binding of not only I-125-bFGF, but also of I-125-PDGF to NIH 3T3 cells, whereas phosphodiester oligodeoxynucleotides were ineffective. The extent of blockade of binding was dependent on the chain length of the phosphorothioate oligodeoxynucleotide. Furthermore, we have examined the effects of 18-mer phosphorothioate oligodeoxynucleotides of different sequences on I-125-bFGF binding to low and high affinity sites on both NIR 3T3 fibroblasts and DU-145 prostate cancer cells. Despite the fact that we have observed inhibition of bFGF binding by the 18-mer phosphorothioate oligodeoxynucleotides for both the high and low affinity classes of bFGF receptor, the inhibition was sequence-selective only for the high affinity receptors. We have also demonstrated that phosphorothioate homopolymers of cytidine and thymidine release bFGF bound to low affinity receptors in extracellular matrix (ECM). Finally, the most potent phosphorothioate oligodeoxynucleotides used in these experiments (e.g. SdC28) were inhibitors of bFGF-induced DNA synthesis in NIH 3T3 cells.	COLUMBIA UNIV,COLL PHYS & SURG,DEPT MED,NEW YORK,NY 10032; RUSSIAN ACAD SCI,INST CYTOL & GENET,NOVOSIBIRSK 630090,RUSSIA; RUSSIAN ACAD SCI,INST BIOORGAN CHEM,NOVOSIBIRSK 630090,RUSSIA; HADASSAH UNIV HOSP,DEPT ONCOL,IL-91120 JERUSALEM,ISRAEL	Columbia University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Hebrew University of Jerusalem								AMALRIC F, 1994, BIOCHEM PHARMACOL, V47, P111, DOI 10.1016/0006-2952(94)90443-X; BASHKIN P, 1989, BIOCHEMISTRY-US, V28, P1737, DOI 10.1021/bi00430a047; BIKFALVI A, 1991, J CELL PHYSIOL, V149, P50, DOI 10.1002/jcp.1041490108; CARDONCARDO C, 1990, LAB INVEST, V63, P832; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; COFFEY RJ, 1987, J CELL PHYSIOL, V132, P143, DOI 10.1002/jcp.1041320120; EISENBERGER MA, 1993, J NATL CANCER I, V85, P611, DOI 10.1093/jnci/85.8.611; ERIKSSON AE, 1991, P NATL ACAD SCI USA, V88, P3441, DOI 10.1073/pnas.88.8.3441; FOLKMAN J, 1988, AM J PATHOL, V130, P393; GONZALEZ AM, 1990, J CELL BIOL, V110, P753, DOI 10.1083/jcb.110.3.753; GOSPODAROWICZ D, 1977, EXP EYE RES, V25, P75, DOI 10.1016/0014-4835(77)90248-2; ISHAIMICHAELI R, 1992, BIOCHEMISTRY-US, V31, P2080, DOI 10.1021/bi00122a027; JELLINEK D, 1993, P NATL ACAD SCI USA, V90, P11227, DOI 10.1073/pnas.90.23.11227; KAJIO T, 1992, FEBS LETT, V306, P243, DOI 10.1016/0014-5793(92)81009-B; KNORRE DG, 1985, ADV ENZYME REGUL, V24, P277, DOI 10.1016/0065-2571(85)90082-2; MACIAG T, 1994, RECENT PROG HORM RES, V49, P105; MOSCATELLI D, 1989, J CELL BIOL, V109, P2519, DOI 10.1083/jcb.109.5.2519; MOSCATELLI D, 1987, J CELL PHYSIOL, V131, P123, DOI 10.1002/jcp.1041310118; PRESTRELSKI SJ, 1992, ARCH BIOCHEM BIOPHYS, V293, P314, DOI 10.1016/0003-9861(92)90401-H; ROGHANI M, 1994, J BIOL CHEM, V269, P3976; Sambrook J, 1989, MOL CLONING LABORATO; SIMONS M, 1992, NATURE, V359, P67, DOI 10.1038/359067a0; Stein C A, 1993, Antisense Res Dev, V3, P19; STEIN CA, 1988, NUCLEIC ACIDS RES, V16, P3209, DOI 10.1093/nar/16.8.3209; STEIN CA, 1993, SCIENCE, V261, P1004, DOI 10.1126/science.8351515; STEIN CA, 1993, CANCER RES, V53, P2239; STEIN CA, 1989, J CLIN ONCOL, V7, P499, DOI 10.1200/JCO.1989.7.4.499; STEIN CA, 1994, ANTISENSE RES DEV, V4, P67, DOI 10.1089/ard.1994.4.67; Vlasov V V, 1993, Biokhimiia, V58, P1247; VLODAVSKY I, 1987, P NATL ACAD SCI USA, V84, P2292, DOI 10.1073/pnas.84.8.2292; VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2; WEINER HL, 1989, P NATL ACAD SCI USA, V86, P2683, DOI 10.1073/pnas.86.8.2683; WELLSTEIN A, 1991, JNCI-J NATL CANCER I, V83, P716, DOI 10.1093/jnci/83.10.716; WILLIAMS LT, 1984, J BIOL CHEM, V259, P5287; YAKUBOV L, 1993, J BIOL CHEM, V268, P18818; YAYON A, 1990, P NATL ACAD SCI USA, V87, P5346, DOI 10.1073/pnas.87.14.5346; ZHANG JD, 1991, P NATL ACAD SCI USA, V88, P3446, DOI 10.1073/pnas.88.8.3446; ZUGMAIER G, 1991, J NATL CANCER I, V84, P1716	38	289	302	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2620	2627		10.1074/jbc.270.6.2620	http://dx.doi.org/10.1074/jbc.270.6.2620			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852327	hybrid			2022-12-27	WOS:A1995QF53500035
J	LAMBETH, JD; KWAK, JY; BOWMAN, EP; PERRY, D; UHLINGER, DJ; LOPEZ, I				LAMBETH, JD; KWAK, JY; BOWMAN, EP; PERRY, D; UHLINGER, DJ; LOPEZ, I			ADP-RIBOSYLATION FACTOR FUNCTIONS SYNERGISTICALLY WITH A 50-KDA CYTOSOLIC FACTOR IN CELL-FREE ACTIVATION OF HUMAN NEUTROPHIL PHOSPHOLIPASE-D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PHOSPHATIDIC-ACID; BINDING PROTEIN; GTP; MEMBRANE; CALCIUM; PHOSPHOHYDROLASE; STIMULATION; INVOLVEMENT; HYDROLYSIS; BRAIN	Proteins in both the cytosol and plasma membrane are needed to reconstitute cell-free phospholipase D activity from phagocytes (Olson, S., Bowman, E. P., and Lambeth, J. D. (1991) J. Biol. Chem. 266, 17236-17242); membrane factors include a small GTP-binding protein in the Rho family (Bowman, E., Uhlinger, D. J., and Lambeth, J. D. (1993) J. Biol. Chem. 268, 21509-21512), ADP-ribosylation factor (ARF) was recently implicated as the cytosolic factor, as it activates phospholipase D in HL-60 membranes, Herein, we show that ion exchange chromatography separates ARF from the major phospholipase D-stimulating cytosolic factor, Both bovine brain ARF and recombinant human ARF-1 stimulated a small amount of phospholipase D activity in the absence of cytosol (about 10% of the response seen with cytosol), With a high concentration of ARF-depleted cytosol, ARF did not further activate, However, at low cytosol, ARF caused marked activation. Thus, ARF synergizes with the cytosolic factor in phospholipase D activation.			LAMBETH, JD (corresponding author), EMORY UNIV, SCH MED, DEPT BIOCHEM, ATLANTA, GA 30322 USA.				NATIONAL CANCER INSTITUTE [R01CA046508] Funding Source: NIH RePORTER; NCI NIH HHS [CA46508] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANTHES JC, 1989, BIOCHEM BIOPH RES CO, V163, P657, DOI 10.1016/0006-291X(89)92187-6; ANTHES JC, 1991, BIOCHEM BIOPH RES CO, V175, P236, DOI 10.1016/S0006-291X(05)81225-2; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BALSINDE J, 1989, EUR J BIOCHEM, V186, P717, DOI 10.1111/j.1432-1033.1989.tb15265.x; BILLAH MM, 1989, J BIOL CHEM, V264, P17069; BOCCKINO SB, 1987, FEBS LETT, V225, P201, DOI 10.1016/0014-5793(87)81157-2; BOWMAN EP, 1993, J BIOL CHEM, V268, P21509; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; CONRICODE KM, 1992, J BIOL CHEM, V267, P7199; DEMATTELS MA, 1994, NATURE, V364, P818; HORWITZ J, 1992, J NEUROCHEM, V59, P1474, DOI 10.1111/j.1471-4159.1992.tb08463.x; KAHN RA, 1991, METHOD ENZYMOL, V195, P233; KATER LA, 1976, J CLIN INVEST, V57, P1173, DOI 10.1172/JCI108385; KROLL MH, 1989, J CELL PHYSIOL, V139, P558, DOI 10.1002/jcp.1041390315; MALCOLM KC, 1994, J BIOL CHEM, V269, P25951; MELANCON P, 1987, CELL, V51, P1053, DOI 10.1016/0092-8674(87)90591-5; MOOLENAAR WH, 1991, ADV CANCER RES, V57, P87; MOOLENAAR WH, 1986, NATURE, V323, P171, DOI 10.1038/323171a0; NELSON DH, 1986, BIOCHEM BIOPH RES CO, V138, P463, DOI 10.1016/0006-291X(86)90303-7; NODA M, 1989, BIOCHEMISTRY-US, V28, P7936, DOI 10.1021/bi00445a057; OHSAKO S, 1981, J BIOL CHEM, V256, P945; OLSON SC, 1991, J BIOL CHEM, V266, P17236; PERRY DK, 1992, J IMMUNOL, V149, P2749; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; SAITO M, 1975, ARCH BIOCHEM BIOPHYS, V169, P318, DOI 10.1016/0003-9861(75)90346-X; SCHMID PC, 1983, J BIOL CHEM, V258, P9302; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; TEAL SB, 1994, J BIOL CHEM, V269, P3135; TSAI SC, 1987, P NATL ACAD SCI USA, V84, P5139, DOI 10.1073/pnas.84.15.5139; TSAI SC, 1988, J BIOL CHEM, V263, P1768	31	63	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2431	2434		10.1074/jbc.270.6.2431	http://dx.doi.org/10.1074/jbc.270.6.2431			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852301	hybrid			2022-12-27	WOS:A1995QF53500006
J	GAVALAS, A; ZALKIN, H				GAVALAS, A; ZALKIN, H			ANALYSIS OF THE CHICKEN GPAT AIRC BIDIRECTIONAL PROMOTER FOR DE-NOVO PURINE NUCLEOTIDE SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROFOLATE-REDUCTASE GENE; DIVERGENT TRANSCRIPTS; BINDING PROTEINS; EXPRESSION; INITIATOR; SEQUENCE; IDENTIFICATION; EFFICIENT; COLLAGEN; UPSTREAM	GPAT and AIRC encode two enzymes that catalyze steps 1 and 6 plus 7, respectively, of the de novo purine biosynthetic pathway. The chicken genes are closely linked and divergently transcribed from an similar to 230-base pair intergenic region, The promoter was scanned by deletion mutagenesis in a bireporter vector that allowed assay of transcriptional activity in both directions in transfected HepG2 and chicken LMH cells, Three classes of deletions were obtained: those affecting bidirectional transcription, those predominantly affecting GPAT transcription, and those predominantly affecting AIRC transcription, Defects in bidirectional transcription resulted from removal of an initiator-like element overlapping the AIRC transcription start site, as well as deletions removing a series of GC and CCAAT boxes from the AIRC proximal half of the promoter and a CCAAT-containing segment from the GPAT side. Several regions in the GPAT proximal half of the promoter, including an octamer-like motif downstream from the transcription start site, were required predominantly for GPAT expression. Evidence for interaction of HeLa nuclear proteins with some of these sites was obtained by gel retardation, DNase I, and methylation interference assays. Overall, the results showed that the intergenic region is an integrated bidirectional promoter and that a novel initiator-like element plays a central role in coordinating expression of the divergently transcribed AIRC and GPAT genes.	PURDUE UNIV, DEPT BIOCHEM, W LAFAYETTE, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus			Gavalas, Anthony/F-5817-2015	Gavalas, Anthony/0000-0003-4897-0359	NIDDK NIH HHS [DK20524] Funding Source: Medline; NIGMS NIH HHS [GM46466] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; BARTON JW, 1991, GENOMICS, V9, P314, DOI 10.1016/0888-7543(91)90259-H; BEAUPAIN D, 1990, NUCLEIC ACIDS RES, V18, P6509, DOI 10.1093/nar/18.22.6509; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAYTON KA, 1994, J BIOL CHEM, V269, P5313; BURATOWSKI S, 1994, CELL, V77, P1, DOI 10.1016/0092-8674(94)90226-7; CHANG Y, 1991, ONCOGENE, V6, P1979; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; COLOMBO P, 1992, P NATL ACAD SCI USA, V89, P6358, DOI 10.1073/pnas.89.14.6358; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FUJII H, 1992, FEBS LETT, V314, P33, DOI 10.1016/0014-5793(92)81455-U; GAVALAS A, 1993, MOL CELL BIOL, V13, P4784, DOI 10.1128/MCB.13.8.4784; HEIKKILA P, 1993, J BIOL CHEM, V268, P24677; HENTSCHEL CC, 1981, CELL, V25, P301, DOI 10.1016/0092-8674(81)90048-9; HERR W, 1992, TRANSCRIPTIONAL REGU, V1, P1103; HUANG A, 1990, SCIENCE, V250, P991, DOI 10.1126/science.2173145; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAVIA P, 1987, EMBO J, V6, P2773, DOI 10.1002/j.1460-2075.1987.tb02572.x; LINTON JP, 1989, MOL CELL BIOL, V9, P3058, DOI 10.1128/MCB.9.7.3058; NGUYEN QT, 1991, NUCLEIC ACIDS RES, V19, P5339, DOI 10.1093/nar/19.19.5339; RIZZO MG, 1990, EXP CELL RES, V188, P286, DOI 10.1016/0014-4827(90)90172-7; SAFFER JD, 1984, NUCLEIC ACIDS RES, V12, P4769, DOI 10.1093/nar/12.11.4769; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHILLING LJ, 1989, MOL CELL BIOL, V9, P4568, DOI 10.1128/MCB.9.10.4568; SCHOLER HR, 1991, TRENDS GENET, V7, P323, DOI 10.1016/0168-9525(91)90422-M; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; SETO E, 1991, NATURE, V354, P241, DOI 10.1038/354241a0; SHIMADA T, 1989, J BIOL CHEM, V264, P20171; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SOININEN R, 1988, J BIOL CHEM, V263, P17217; TSUI HW, 1993, GENE, V131, P201, DOI 10.1016/0378-1119(93)90294-D; WEIS L, 1992, FASEB J, V6, P3300, DOI 10.1096/fasebj.6.14.1426767; WINGENDER E, 1990, Critical Reviews in Eukaryotic Gene Expression, V1, P11	35	35	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2403	2410		10.1074/jbc.270.5.2403	http://dx.doi.org/10.1074/jbc.270.5.2403			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836476	hybrid			2022-12-27	WOS:A1995QE49300064
J	MOLINARI, M; ANAGLI, J; CARAFOLI, E				MOLINARI, M; ANAGLI, J; CARAFOLI, E			PEST SEQUENCES DO NOT INFLUENCE SUBSTRATE SUSCEPTIBILITY TO CALPAIN PROTEOLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ERYTHROCYTES; DOMAIN; ENZYME; PUMP; PROTEINS; SITE	Mutations lowering the PEST score of domains surrounding the calmodulin (CaM)-binding region of the plasma membrane Ca2+-ATPase failed to influence the susceptibility of the enzyme to mu-calpain (mu-CANP). Synthetic peptides corresponding to the high PEST score C-terminal sequences A18 and B28 had no effect on the rate of pump proteolysis by mu-CANP, i,e, the peptides did not compete for a putative high PEST score recognition site for mu-CANP in the pump molecule. An accessible CaM-binding region appears to be critical for substrate (i.e, the Ca2+ pump) proteolysis and probably also for its recognition by mu-CANP; phosphorylation of the CaM-binding domain of the pump or its occupation by CaM significantly decreased the rate of proteolysis.	ETH ZURICH, INST BIOCHEM 3, CH-8092 ZURICH, SWITZERLAND	Swiss Federal Institutes of Technology Domain; ETH Zurich			Molinari, Maurizio/N-2587-2019; Carafoli, Ernesto/K-5192-2016	Molinari, Maurizio/0000-0002-7636-5829; Carafoli, Ernesto/0000-0002-7826-0094				CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; CONG JY, 1989, J BIOL CHEM, V264, P10096; CONG JY, 1993, J BIOL CHEM, V268, P25740; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209; HOFMANN F, 1993, J BIOL CHEM, V268, P10252; HOFMANN F, 1994, J BIOL CHEM, V269, P24298; JAMES P, 1989, J BIOL CHEM, V264, P8289; JAMES PH, 1989, BIOCHEMISTRY-US, V28, P4253, DOI 10.1021/bi00436a020; MELLONI E, 1982, BIOCHEM BIOPH RES CO, V106, P731, DOI 10.1016/0006-291X(82)91772-7; MOLINARI M, 1994, J BIOL CHEM, V269, P27992; PONTREMOLI S, 1988, BIOCHEM BIOPH RES CO, V157, P867, DOI 10.1016/S0006-291X(88)80955-0; PONTREMOLI S, 1985, BIOCHEM INT, V11, P35; Rechsteiner M, 1990, Semin Cell Biol, V1, P433; RECHSTEINER M, 1988, ADV ENZYME REGUL, V27, P135; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; SALAMINO F, 1994, CELL CALCIUM, V15, P28, DOI 10.1016/0143-4160(94)90101-5; SUZUKI K, 1987, TRENDS BIOCHEM SCI, V12, P103, DOI 10.1016/0968-0004(87)90048-X; VORHERR T, 1990, BIOCHEMISTRY-US, V29, P355, DOI 10.1021/bi00454a008; WANG KKW, 1991, J BIOL CHEM, V266, P9078; WANG KKW, 1989, BIOCHEM J, V262, P693, DOI 10.1042/bj2620693	21	59	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2032	2035		10.1074/jbc.270.5.2032	http://dx.doi.org/10.1074/jbc.270.5.2032			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836429	hybrid			2022-12-27	WOS:A1995QE49300010
J	WO, ZGL; OSWALD, RE				WO, ZGL; OSWALD, RE			A TOPOLOGICAL ANALYSIS OF GOLDFISH KAINATE RECEPTORS PREDICTS 3 TRANSMEMBRANE SEGMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; PROTEIN ANTIGENIC DETERMINANTS; CENTRAL-NERVOUS-SYSTEM; AMINO-ACID-SEQUENCES; GLUTAMATE-RECEPTOR; RAT-BRAIN; BIOCHEMICAL-CHARACTERIZATION; MOLECULAR-CLONING; MEMBRANE-PROTEINS; BINDING-PROTEINS	Glutamate receptors are the most abundant excitatory neurotransmitter receptors in vertebrate brain, We have previously cloned cDNAs encoding two homologous kainate receptors (GFKAR alpha, 45 kDa, and GFKAR beta, 41 kDa) from goldfish brain and proposed a topology with three transmembrane domains (Wo, Z, G,, and Oswald, R, E, (1994) Proc, Natl, Acad, Sci, U, S, A. 91, 7154-7158), These studies have been extended using an in vitro translation/translocation system in conjunction with site-specific antibodies and point and deletion mutations, We report here that the entire region between the previously proposed third and fourth transmembrane segments is translocated and likely to be extracellular in mature receptors, This was based on the following results, 1) The entire segment was protected from Proteinase K and trypsin digestion and could be immunoprecipitated by a site specific antibody, 2) Functional sites for N-glycosylation are present in the C-terminal half of the segment, and 3) a mutation, constructed with an additional consensus site for N-glycosylation in the N-terminal half of the segment, was found to be glycosylated at that site, Given the fact that the N terminus of the protein is likely to be extracellular, this would place an even number of transmembrane segments between the extracellular N terminus and the glycosylated segment, In addition, results of N-glycosylation and proteolysis protection assays of GFRAR alpha mutations indicated that the previously proposed second transmembrane segment is not a true transmembrane domain, These results provide further evidence in support of a topology with three transmembrane domains that has important implications for the relationship of structure to function in ionotropic glutamate receptors.	CORNELL UNIV, COLL VET MED, DEPT PHARMACOL, ITHACA, NY 14853 USA	Cornell University					NIGMS NIH HHS [T32-GM08210] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008210] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKIYAMA Y, 1987, EMBO J, V6, P3465, DOI 10.1002/j.1460-2075.1987.tb02670.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARUFFO A, 1987, EMBO J, V6, P3313, DOI 10.1002/j.1460-2075.1987.tb02651.x; Ausubel FM., 2006, ENZYMATIC MANIPULATI; BAMBERG K, 1994, J BIOL CHEM, V269, P16909; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; CHANGEUX JP, 1992, Q REV BIOPHYS, V25, P395, DOI 10.1017/S0033583500004352; CHAVEZ RA, 1992, J CELL BIOL, V116, P385, DOI 10.1083/jcb.116.2.385; CHAVEZ RA, 1991, J BIOL CHEM, V266, P15532; COLEMAN J, 1985, CELL, V43, P351, DOI 10.1016/0092-8674(85)90040-6; DINGLEDINE R, 1992, J NEUROSCI, V12, P4080; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; EWALT KL, 1994, BIOCHEMISTRY-US, V33, P5077, DOI 10.1021/bi00183a011; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; GREGOR P, 1989, NATURE, V342, P689, DOI 10.1038/342689a0; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HIGH S, 1992, Current Opinion in Cell Biology, V4, P581, DOI 10.1016/0955-0674(92)90075-N; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HOPP TP, 1983, MOL IMMUNOL, V20, P483, DOI 10.1016/0161-5890(83)90029-9; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; HULLEBROECK MF, 1992, BRAIN RES, V590, P187, DOI 10.1016/0006-8993(92)91094-U; HUNG AY, 1994, EMBO J, V13, P534, DOI 10.1002/j.1460-2075.1994.tb06291.x; JENNINGS ML, 1989, ANNU REV BIOCHEM, V58, P999; KERRY CJ, 1993, MOL PHARMACOL, V44, P142; KIMURA N, 1993, MOL BRAIN RES, V17, P351, DOI 10.1016/0169-328X(93)90022-H; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; KOHR G, 1994, NEURON, V12, P1031, DOI 10.1016/0896-6273(94)90311-5; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANDOLTMARTICORENA C, 1994, BIOCHEM J, V302, P253, DOI 10.1042/bj3020253; LIPP J, 1989, J CELL BIOL, V109, P2013, DOI 10.1083/jcb.109.5.2013; MARTIN LJ, 1993, NEUROSCIENCE, V53, P327, DOI 10.1016/0306-4522(93)90199-P; MOLNAR E, 1994, J NEUROCHEM, V63, P683; MOLNAR E, 1993, NEUROSCIENCE, V53, P307, DOI 10.1016/0306-4522(93)90198-O; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; MORI H, 1993, NEUROREPORT, V4, P519, DOI 10.1097/00001756-199305000-00014; NAKAHARA DH, 1994, J BIOL CHEM, V269, P7617; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; NAKANISHI S, 1994, ANNU REV BIOPH BIOM, V23, P319, DOI 10.1146/annurev.bb.23.060194.001535; NILSSON I, 1993, J BIOL CHEM, V268, P5798; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; POSNETT DN, 1988, J BIOL CHEM, V263, P1719; RAYMOND LA, 1993, NATURE, V361, P637, DOI 10.1038/361637a0; ROCHE KW, 1994, J BIOL CHEM, V269, P11679; ROGERS SW, 1991, J NEUROSCI, V11, P2713; ROTHMAN JE, 1977, NATURE, V269, P775, DOI 10.1038/269775a0; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; TAVERNA FA, 1994, J BIOL CHEM, V269, P14159; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; UCHINO S, 1992, FEBS LETT, V308, P253, DOI 10.1016/0014-5793(92)81286-U; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; WADA K, 1989, NATURE, V342, P684, DOI 10.1038/342684a0; WANG LY, 1993, SCIENCE, V259, P1173, DOI 10.1126/science.8382377; WESSELS HP, 1988, CELL, V55, P61, DOI 10.1016/0092-8674(88)90009-8; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0; ZHENG X, 1994, NEURON, V12, P811; ZIEGRA CJ, 1992, MOL PHARMACOL, V42, P203	63	54	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2000	2009		10.1074/jbc.270.5.2000	http://dx.doi.org/10.1074/jbc.270.5.2000			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836426	hybrid			2022-12-27	WOS:A1995QE49300006
J	ZHANG, JT; LEE, CH; DUTHIE, M; LING, V				ZHANG, JT; LEE, CH; DUTHIE, M; LING, V			TOPOLOGICAL DETERMINANTS OF INTERNAL TRANSMEMBRANE SEGMENTS IN P-GLYCOPROTEIN SEQUENCES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL TRANSPORT PROTEINS; MULTIDRUG-RESISTANCE; MEMBRANE-PROTEINS; CHARGED RESIDUES; ORIENTATION; GENE; HOMOLOGY; CHANNEL	P-glycoprotein (Pgp) is a polytopic membrane protein responsible for multidrug resistance in cancer cells, Previously, we have used a coupled cell-free translation/translocation system to investigate the membrane orientation of Pgp sequences and have made the unexpected observation that predicted transmembrane (TM) segments from both the NH2-terminal and COOH-terminal halves inserted in microsomal membranes in two different orientations (Zhang, J.-T., Duthie, M., and Ling, V. (1993) J. Biol, Chem, 268, 15101-15110). How these topological forms of Pgp are regulated is not known, In the present study, we have used site-directed mutagenesis to investigate if the amino acids surrounding the internal TM segments of Pgp may affect their orientation, We discovered that the charged amino acids flanking TM4 are important in determining the membrane orientation of the NH2-terminal half molecule of Pgp, This is a novel observation demonstrating the existence of internal topogenic sequences in a mammalian polytopic membrane protein, These findings thus suggest A) that the topological structure of a mammalian polytopic membrane protein does not integrate into the membrane simply by following the lead of the first inserted TM segment but that internal TMs may have independent topogenic information and B) that the TM segments in a multi-spanning membrane protein may be more dynamic than have been previously anticipated, i.e. mutations in the amino acids surrounding internal TMs could drastically change the overall topology of the molecule.	UNIV TORONTO,ONTARIO CANC INST,DEPT MED BIOPHYS,DIV MOLEC & STRUCT BIOL,TORONTO,ON M4X 1K9,CANADA	University of Toronto; University Toronto Affiliates; University Health Network Toronto			Zhang, Jian-Ting/L-8334-2015					ABRAHAM EH, 1993, P NATL ACAD SCI USA, V90, P312, DOI 10.1073/pnas.90.1.312; ALTENBERG GA, 1994, J BIOL CHEM, V269, P7145; ANDREWS D, 1989, BIOTECHNIQUES, V7, P960; BELTZER JP, 1991, J BIOL CHEM, V266, P973; BOYD D, 1990, CELL, V62, P1031, DOI 10.1016/0092-8674(90)90378-R; BOYD D, 1989, P NATL ACAD SCI USA, V86, P9446, DOI 10.1073/pnas.86.23.9446; CHAN HSL, 1991, NEW ENGL J MED, V325, P1608, DOI 10.1056/NEJM199112053252304; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Childs S, 1994, Important Adv Oncol, P21; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; GERLACH JH, 1986, NATURE, V324, P458; GILL DR, 1992, CELL, V71, P23, DOI 10.1016/0092-8674(92)90263-C; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; JURANKA PF, 1989, FASEB J, V3, P2583, DOI 10.1096/fasebj.3.14.2574119; PARKS GD, 1990, CELL, V64, P777; SKACH WR, 1993, J BIOL CHEM, V268, P6903; VALVERDE MA, 1992, NATURE, V355, P830, DOI 10.1038/355830a0; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; WESSELS HP, 1988, CELL, V55, P61, DOI 10.1016/0092-8674(88)90009-8; ZHANG JT, 1991, J BIOL CHEM, V266, P18224; ZHANG JT, 1993, J BIOL CHEM, V268, P15101; ZHANG JT, 1993, BIOCHIM BIOPHYS ACTA, V1153, P191, DOI 10.1016/0005-2736(93)90405-O	26	39	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1742	1746		10.1074/jbc.270.4.1742	http://dx.doi.org/10.1074/jbc.270.4.1742			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829509	hybrid			2022-12-27	WOS:A1995QD20400042
J	CHIONO, M; MAHEY, R; TATE, G; COOPER, DMF				CHIONO, M; MAHEY, R; TATE, G; COOPER, DMF			CAPACITATIVE CA2+ ENTRY EXCLUSIVELY INHIBITS CAMP SYNTHESIS IN C6-2B GLIOMA-CELLS - EVIDENCE THAT PHYSIOLOGICALLY EVOKED CA2+ ENTRY REGULATES CA2+-INHIBITABLE ADENYLYL-CYCLASE IN NONEXCITABLE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP ACCUMULATION; INTRACELLULAR CALCIUM; NCB-20 CELLS; PROTEIN-KINASE; RELEASE; MOBILIZATION; RECEPTORS; CHANNELS; CLONING; VI	Elevation of cytosolic free Ca2+ inhibits the type VI adenylyl cyclase that predominates in C6-2B cells, However, it is not known whether there is any selective requirement for Ca2+ entry or release for inhibition of cAMP accumulation to occur, In the present study, the effectiveness of intracellular Ca2+ release evoked by three independent methods (thapsigargin, ionomycin, and UTP) was compared with the capacitative Ca2+ entry that was triggered by these treatments. In each situation, only Ca2+ entry could inhibit cAMP accumulation (La3+ ions blocked the effect); Ca2+ release, which was substantial in some cases, was without effect, A moderate inhibition, as was elicited by a modest degree of Ca2+ entry, could be rendered substantial in the absence of phosphodiesterase inhibitors. Such conditions more closely mimic the physiological situation of normal cells. These results are particularly significant, in demonstrating not only that Ca2+ entry mediates the inhibitory effects of Ca2+ on cAMP accumulation, but also that diffuse elevations in [Ca2+](i) are ineffective in modulating cAMP synthesis, This property suggests that, as with certain Ca2+-sensitive ion channels, Ca2+-sensitive adenylyl cyclases may be functionally colocalized with Ca2+ entry channels.	UNIV COLORADO,HLTH SCI CTR,DEPT PHARMACOL,DENVER,CO 80262	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver					NIGMS NIH HHS [GM 07063, GM 32483] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032483, T32GM007063] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AAKERLUND L, 1990, FEBS LETT, V260, P73, DOI 10.1016/0014-5793(90)80069-U; ALBERT PR, 1986, AM J PHYSIOL, V251, pC887, DOI 10.1152/ajpcell.1986.251.6.C887; ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; ALTIOK N, 1993, CELL SIGNAL, V5, P279, DOI 10.1016/0898-6568(93)90018-H; BOYAJIAN CL, 1991, J BIOL CHEM, V266, P4995; BURNSTOCK G, 1990, ANN NY ACAD SCI, V603, P1; CHARPENTIER N, 1993, J BIOL CHEM, V268, P8980; COLVIN RA, 1991, CELL CALCIUM, V12, P19, DOI 10.1016/0143-4160(91)90081-O; COOPER DMF, 1994, BIOCHEM J, V297, P437, DOI 10.1042/bj2970437; COOPER DMF, 1993, TRENDS PHARMACOL SCI, V14, P34, DOI 10.1016/0165-6147(93)90027-H; DEBERNARDI MA, 1993, BIOCHEM J, V293, P325, DOI 10.1042/bj2930325; DEBERNARDI MA, 1991, P NATL ACAD SCI USA, V88, P9257, DOI 10.1073/pnas.88.20.9257; DEBERNARDI MA, 1993, MOL PHARMACOL, V43, P451; DORFLINGER LJ, 1984, ENDOCRINOLOGY, V114, P1208, DOI 10.1210/endo-114-4-1208; ERNEUX C, 1985, MOL CELL ENDOCRINOL, V43, P123, DOI 10.1016/0303-7207(85)90075-9; EVANS T, 1984, MOL PHARMACOL, V26, P395; GARRITSEN A, 1992, J NEUROCHEM, V59, P1630, DOI 10.1111/j.1471-4159.1992.tb10992.x; GARRITSEN A, 1992, J NEUROCHEM, V59, P190, DOI 10.1111/j.1471-4159.1992.tb08890.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HONNOR RC, 1985, J BIOL CHEM, V260, P5130; ISHIKAWA Y, 1992, J BIOL CHEM, V267, P13553; IYENGAR R, 1993, FASEB J, V7, P768, DOI 10.1096/fasebj.7.9.8330684; KATSUSHIKA S, 1992, P NATL ACAD SCI USA, V89, P8774, DOI 10.1073/pnas.89.18.8774; KRUPINSKI J, 1992, J BIOL CHEM, V267, P24858; LIN WW, 1992, J NEUROSCI, V12, P1077; LIN WW, 1993, MOL PHARMACOL, V44, P158; LIU CM, 1978, J BIOL CHEM, V253, P5892; MARUYAMA Y, 1993, EMBO J, V12, P3017, DOI 10.1002/j.1460-2075.1993.tb05970.x; MEEKER RB, 1982, MOL PHARMACOL, V22, P310; MONS N, 1994, MOL BRAIN RES, V22, P236, DOI 10.1016/0169-328X(94)90052-3; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; MUNSHI R, 1993, MOL PHARMACOL, V44, P1185; Newsholme EA, 1973, REGULATION METABOLIS; PEREIRA ME, 1988, ENDOCRINOLOGY, V122, P2232, DOI 10.1210/endo-122-5-2232; PIANET I, 1989, BIOCHEM BIOPH RES CO, V163, P1150, DOI 10.1016/0006-291X(89)92341-3; PREMONT RT, 1992, P NATL ACAD SCI USA, V89, P9809, DOI 10.1073/pnas.89.20.9809; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SIHRA TS, 1992, J BIOL CHEM, V267, P1983; TANG WJ, 1992, CELL, V70, P869, DOI 10.1016/0092-8674(92)90236-6; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; WALLACH J, 1994, FEBS LETT, V338, P257, DOI 10.1016/0014-5793(94)80279-3; YOSHIMURA M, 1992, P NATL ACAD SCI USA, V89, P6716, DOI 10.1073/pnas.89.15.6716; YU HJ, 1993, MOL PHARMACOL, V44, P689; ZGOMBICK JM, 1993, MOL PHARMACOL, V44, P575; ZUFALL F, 1993, P NATL ACAD SCI USA, V90, P9335, DOI 10.1073/pnas.90.20.9335	49	157	159	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1149	1155		10.1074/jbc.270.3.1149	http://dx.doi.org/10.1074/jbc.270.3.1149			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836373	hybrid			2022-12-27	WOS:A1995QB15600028
J	DEBIE, I; SAVARIA, D; ROEBROEK, AJM; DAY, R; LAZURE, C; VANDEVEN, WJM; SEIDAH, NG				DEBIE, I; SAVARIA, D; ROEBROEK, AJM; DAY, R; LAZURE, C; VANDEVEN, WJM; SEIDAH, NG			PROCESSING SPECIFICITY AND BIOSYNTHESIS OF THE DROSOPHILA-MELANOGASTER CONVERTASES DFURIN1, DFURIN1-CRR, DFURIN1-X, AND DFURIN2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; PROHORMONE CONVERTASES; SUBTILISIN FAMILY; CDNA SEQUENCE; KEX2-LIKE ENDOPROTEASE; PROPROTEIN CONVERTASE; FUNCTIONAL EXPRESSION; PRO-PROTEIN; YEAST KEX2; IDENTIFICATION	Pro-protein and pro-hormone convertases are subtilisin/kexin-like enzymes implicated in the activation of numerous precursors by cleavage at sites mostly composed of pairs of basic amino acids. Six members of this family of enzymes have been identified in mammals and named furin (also called PACE), PC1 (also called PC3), PC2, PACE4, PC4, and PC5 (also called PC6), Multiple transcripts are produced for all the mammalian convertases, but only in the cases of PC4, PACE4, and PC5 does differential splicing result in the modification of the C-terminal sequence of these enzymes. A similar molecular diversity is also observed for the convertases of Hydra vulgaris, Caenorhabditis elegans, and Drosophila melanogaster. In the third species, two genes homologous to human furin called Dfur1 and Dfur2 have been identified. The Dfur1 gene undergoes differential splicing to generate three type I membrane-bound proteins called dfurin1, dfurin1-CRR, and dfurin1-X, which differ only in their C-terminal sequence. By using recombinant vaccinia viruses that express each of the dfurin proteins, we investigated the potential effect of the C-terminal domain on their catalytic specificities. For this purpose, these enzymes were coexpressed with the precursors pro-7B2, pro-opiomelanocortin, and pro-dynorphin in a number of cell lines, and the processed products obtained were characterized. Our studies demonstrate that these proteases display cleavage specificities similar to that of mammalian furin but not to that of PC2. In contrast, we noted significant differences in the biosynthetic fates of these convertases. Al dfurins undergo rapid removal of their transmembrane domain within the endoplasmic reticulum, resulting in the release of several truncated soluble forms. However, in the media of cells containing secretory granules, such as GH4C1 and AtT-20, dfurin1-CRR and dfurin2 predominate over dfurin1, whereas dfurin1-X is never detected. While pro-segment removal occurs predominantly in the trans-Golgi network for ah the dfurins, in the presence of brefeldin A, only dfurin1-CRR and dfurin2 can undergo partial zymogen cleavage. The conclusions drawn from the results of this study may well be applicable to the mammalian convertases PC4, PACE4, and PC5, which also display C-terminal sequence heterogeneity.	CLIN RES INST MONTREAL,JA DESEVE LAB BIOCHEM NEUROENDOCRINOL,MONTREAL,PQ H2W 1R7,CANADA; CLIN RES INST MONTREAL,JA DESEVE LAB NEUROPEPTIDES STRUCT & METAB,MONTREAL,PQ H2W 1R7,CANADA; CATHOLIC UNIV LEUVEN,CTR HUMAN GENET,MOLEC ONCOL LAB,B-3000 LOUVAIN,BELGIUM	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; KU Leuven			Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342				BENJANNET S, 1993, BIOCHEM J, V294, P735, DOI 10.1042/bj2940735; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; BENJANNET S, 1992, J BIOL CHEM, V267, P11417; BRESNAHAN PA, 1992, MECHANISMS INTRACELL, P225; CHAN SJ, 1992, P NATL ACAD SCI USA, V89, P6678, DOI 10.1073/pnas.89.15.6678; CHUN JY, 1994, NEURON, V12, P831, DOI 10.1016/0896-6273(94)90336-0; DAVISON AJ, 1990, NUCLEIC ACIDS RES, V18, P4285, DOI 10.1093/nar/18.14.4285; DAY R, 1989, ENDOCRINOLOGY, V124, P2392, DOI 10.1210/endo-124-5-2392; DAY R, 1992, P NATL ACAD SCI USA, V88, P1320; DUPUY A, 1994, FEBS LETT, V337, P60, DOI 10.1016/0014-5793(94)80630-6; EIPPER BA, 1987, MOL ENDOCRINOL, V1, P777, DOI 10.1210/mend-1-11-777; FRICKER LD, 1986, NATURE, V323, P461, DOI 10.1038/323461a0; GOMEZSALADIN E, 1994, CELL MOL NEUROBIOL, V14, P9, DOI 10.1007/BF02088586; HATSUZAWA K, 1992, J BIOCHEM-TOKYO, V111, P296, DOI 10.1093/oxfordjournals.jbchem.a123753; HAYFLICK JS, 1992, J NEUROSCI, V12, P705; Hruby D E, 1986, Methods Enzymol, V124, P295; KIEFER MC, 1991, DNA CELL BIOL, V10, P757, DOI 10.1089/dna.1991.10.757; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KORNER J, 1991, P NATL ACAD SCI USA, V88, P11393, DOI 10.1073/pnas.88.24.11393; LAZURE C, 1983, CAN J BIOCHEM CELL B, V61, P501, DOI 10.1139/o83-066; LUSSON J, 1993, P NATL ACAD SCI USA, V90, P6691, DOI 10.1073/pnas.90.14.6691; MAINS RE, 1990, FRONT NEUROENDOCRIN, V11, P52; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; MBIKAY M, 1989, INT J PEPT PROT RES, V33, P39; MBIKAY M, 1994, GENOMICS, V20, P231, DOI 10.1006/geno.1994.1158; MILGRAM SL, 1994, J CELL BIOL, V124, P33, DOI 10.1083/jcb.124.1.33; MISUMI Y, 1990, NUCLEIC ACIDS RES, V18, P6719, DOI 10.1093/nar/18.22.6719; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; NAKAGAWA T, 1993, J BIOCHEM-TOKYO, V113, P132, DOI 10.1093/oxfordjournals.jbchem.a124015; NAKAGAWA T, 1993, FEBS LETT, V327, P165, DOI 10.1016/0014-5793(93)80163-O; NAKAYAMA K, 1992, J BIOL CHEM, V267, P5897; NISHIDA Y, 1986, BIOCHEM BIOPH RES CO, V141, P474, DOI 10.1016/S0006-291X(86)80197-8; OUIMET T, 1993, FEBS LETT, V330, P343, DOI 10.1016/0014-5793(93)80901-6; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; PAQUET L, 1994, J BIOL CHEM, V269, P19279; PAQUET L, 1991, FEBS LETT, V294, P23, DOI 10.1016/0014-5793(91)81334-5; PETERS K, 1991, WORM BREEDERS GAZETT, V11, P28; ROEBROEK AJM, 1986, EMBO J, V5, P2197, DOI 10.1002/j.1460-2075.1986.tb04484.x; ROEBROEK AJM, 1992, J BIOL CHEM, V267, P17208; ROEBROEK AJM, 1993, EMBO J, V12, P1853, DOI 10.1002/j.1460-2075.1993.tb05834.x; ROEBROEK AJM, 1991, FEBS LETT, V289, P133, DOI 10.1016/0014-5793(91)81052-A; ROTH WW, 1993, ENDOCRINOL J, V1, P131; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; SEIDAH NG, 1991, ENZYME, V45, P271, DOI 10.1159/000468901; SEIDAH NG, 1992, TRENDS ENDOCRIN MET, V3, P133, DOI 10.1016/1043-2760(92)90102-7; SEIDAH NG, 1993, BIOCHEM SOC T, V21, P685, DOI 10.1042/bst0210685; SEIDAH NG, 1983, ARCH BIOCHEM BIOPHYS, V225, P525, DOI 10.1016/0003-9861(83)90063-2; SEIDAH NG, 1992, MOL ENDOCRINOL, V6, P1559, DOI 10.1210/me.6.10.1559; SEIDAH NG, 1991, MOL ENDOCRINOL, V5, P111, DOI 10.1210/mend-5-1-111; SEIDAH NG, 1990, DNA CELL BIOL, V9, P415, DOI 10.1089/dna.1990.9.415; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; SMEEKENS SP, 1990, J BIOL CHEM, V265, P2997; SMIT AB, 1992, FEBS LETT, V312, P213, DOI 10.1016/0014-5793(92)80938-D; STEINER DF, 1992, J BIOL CHEM, V267, P23435; TAKAHASHI S, 1993, BIOCHEM BIOPH RES CO, V195, P1019, DOI 10.1006/bbrc.1993.2146; TSUJI A, 1994, BIOCHEM BIOPH RES CO, V200, P943, DOI 10.1006/bbrc.1994.1541; VANDENOUWELAND AMW, 1990, NUCLEIC ACIDS RES, V18, P664, DOI 10.1093/nar/18.3.664; VANDEVEN WJM, 1993, CRIT REV ONCOGENESIS, V4, P115; VIDRICAIRE G, 1993, BIOCHEM BIOPH RES CO, V195, P1011, DOI 10.1006/bbrc.1993.2145; WEHRLI M, 1993, MECH DEVELOP, V43, P21, DOI 10.1016/0925-4773(93)90020-X	60	41	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1020	1028		10.1074/jbc.270.3.1020	http://dx.doi.org/10.1074/jbc.270.3.1020			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836354	hybrid			2022-12-27	WOS:A1995QB15600009
J	DESILVA, DM; ASKWITH, CC; EIDE, D; KAPLAN, J				DESILVA, DM; ASKWITH, CC; EIDE, D; KAPLAN, J			THE FET3 GENE-PRODUCT REQUIRED FOR HIGH-AFFINITY IRON TRANSPORT IN YEAST IS A CELL-SURFACE FERROXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; LACCASE	The yeast FET3 gene is required for high affinity iron transport (Askwith, C., Eide, D., Ho, A. V., Bernard, P. S., Li, L., Davis-Kaplan, S., Sipe, D. M., and Kaplan, J. (1994) Cell 76, 403-410). The gene has extensive sequence homology to the family of multi-copper oxidases. In this communication, we demonstrate that the gene product is a cell surface ferroxidase involved in iron transport. Cells that contain a functional FET3 gene product exhibited an iron-dependent non-mitochondrial increase in oxygen consumption, Comparison of the rate of iron oxidation to O-2, consumption yielded an approximate value of 4:1, as predicted for a ferroxidase. Spheroplasts obtained from cells grown under low iron conditions also displayed an iron-dependent increase in O-2 consumption. Treatment of spheroplasts with trypsin or affinity-purified antibodies directed against the putative external ferroxidase domain of Fet3 had no effect on basal O-2 consumption but inhibited the iron-dependent increase in O-2 consumption. Anti-peptide antibodies directed against the cytosolic domain of Fet3 had no effect on O-2 consumption. These studies indicate that Fets is a plasma membrane ferroxidase required for high affinity iron uptake, in which the ferroxidase-containing domain is localized on the external cell surface.	UNIV UTAH,COLL MED,SCH MED,DEPT PATHOL,DIV CELL BIOL & IMMUNOL,SALT LAKE CITY,UT 84132; UNIV MINNESOTA,COLL MED,DEPT BIOCHEM & MOLEC BIOL,DULUTH,MN 55812	Utah System of Higher Education; University of Utah; University of Minnesota System; University of Minnesota Duluth					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007115] Funding Source: NIH RePORTER; NIDDK NIH HHS [NIDDK-5-30534, T32 DK07115] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; BAO W, 1993, SCIENCE, V260, P672, DOI 10.1126/science.260.5108.672; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1990, MOL CELL BIOL, V10, P2294, DOI 10.1128/MCB.10.5.2294; EIDE D, 1992, J BIOL CHEM, V267, P20774; EIDE D, 1992, J GEN MICROBIOL, V138, P34; FOX TD, 1981, METHOD ENZYMOL, V194, P149; GEORGATSOU E, 1994, MOL CELL BIOL, V14, P3065, DOI 10.1128/MCB.14.5.3065; HARLOW E, 1988, ANTIBODIES LABORATOR; KOJIMA Y, 1990, J BIOL CHEM, V265, P15224; LEE RL, 1968, J CLIN INVEST, V47, P2958; LESUISSE E, 1989, J GEN MICROBIOL, V135, P257; MESSERSCHMIDT A, 1990, EUR J BIOCHEM, V187, P341, DOI 10.1111/j.1432-1033.1990.tb15311.x; OSAKI S, 1971, J BIOL CHEM, V246, P3018; RYDEN L, 1981, COPPER PROTEINS COPP, V3, P37; SMITH JW, 1990, BIOCHEMISTRY-US, V29, P8950, DOI 10.1021/bi00490a010; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17	17	195	199	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1098	1101		10.1074/jbc.270.3.1098	http://dx.doi.org/10.1074/jbc.270.3.1098			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836366	hybrid			2022-12-27	WOS:A1995QB15600021
J	LOBELLO, M; BATTISTONI, A; MAZZETTI, AP; BOARD, PG; MURAMATSU, M; FEDERICI, G; RICCI, G				LOBELLO, M; BATTISTONI, A; MAZZETTI, AP; BOARD, PG; MURAMATSU, M; FEDERICI, G; RICCI, G			SITE-DIRECTED MUTAGENESIS OF HUMAN GLUTATHIONE TRANSFERASE P1-1 - SPECTRAL, KINETIC, AND STRUCTURAL-PROPERTIES OF CYS-47 AND LYS-54 MUTANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-TRANSFERASE; CLASS-PI; ESCHERICHIA-COLI; 3-DIMENSIONAL STRUCTURE; CONFERS RESISTANCE; ACID-RESIDUES; EXPRESSION; IDENTIFICATION; INACTIVATION; RESOLUTION	In the human placental glutathione transferase, Cys 47 possesses, at physiological pH values, a pK(a) value of 4.2 and may exist as an ion pair with the protonated epsilon-amino group of Lys-54, Using site directed mutagenesis we investigate spectral, kinetic, and structural properties of Cys-47 and Lys-54 mutants. The results shown indicate that the thiolate ion detected at 229 nm should be assigned exclusively to Cys-47. The contribution of Lys-54 to the activation of Cys-47 is assessed by the spectral properties of the K54A mutant enzyme. The induced cooperativity toward glutathione, as a consequence of mutation of Lys-54 to alanine, clearly parallels that observed for the Cys-47 mutant enzymes (see the preceding paper (Ricci, G., Lo Bello, M., Caccuri, A. M., Pastore, A., Nuccetelli, M., Parker, M. W,, and Federici, G, (1995) J. Biol. Chem. 270, 1243-1248) and points out the importance of this electrostatic interaction in shaping the correct spatial arrangement for the binding of glutathione and in anchoring the flexible helix alpha 2. When this ion pair is disrupted, by mutation of either residue, the flexibility of this region could be greatly increased, causing helix alpha 2 to come in contact with the other subunit and generating a structural communication, which is the basis of the observed cooperativity.	UNIV ROMA TOR VERGATA,DEPT BIOL,I-00133 ROME,ITALY; AUSTRALIAN NATL UNIV,JOHN CURTIN SCH MED RES,CANBERRA,ACT 2601,AUSTRALIA; SAITAMA MED SCH,DEPT BIOCHEM,MOROYAMA,SAITAMA 35004,JAPAN	University of Rome Tor Vergata; Australian National University; John Curtin School of Medical Research; Saitama Medical University			Battistoni, Andrea/A-4778-2016	Battistoni, Andrea/0000-0003-4085-7917; Ricci, Giorgio/0000-0002-7108-2846				BAKER RT, 1994, J BIOL CHEM, V269, P25381; BATIST G, 1986, J BIOL CHEM, V261, P5544; BLACK SM, 1990, BIOCHEM J, V268, P309, DOI 10.1042/bj2680309; BOARD PG, 1987, BIOCHEM J, V248, P937, DOI 10.1042/bj2480937; BOARD PG, 1994, J BIOL CHEM, V268, P15655; DENTE L, 1985, DNA CLONING PRACTICA, V1, P101; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Habig W H, 1981, Methods Enzymol, V77, P398; JAKOBY WB, 1980, ENZYMATIC BASIS DETO, V2, P63; KANO T, 1987, CANCER RES, V47, P5626; KONG KH, 1992, J BIOCHEM-TOKYO, V112, P725, DOI 10.1093/oxfordjournals.jbchem.a123965; KONG KH, 1993, PROTEIN ENG, V6, P93, DOI 10.1093/protein/6.1.93; KONG KH, 1991, BIOCHEM BIOPH RES CO, V181, P748, DOI 10.1016/0006-291X(91)91254-A; KRAMER B, 1984, CELL, V38, P879, DOI 10.1016/0092-8674(84)90283-6; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBELLO M, 1993, BIOCHEM BIOPH RES CO, V194, P804; LOBELLO M, 1990, FEBS LETT, V263, P389, DOI 10.1016/0014-5793(90)81421-J; LOBELLO M, 1993, J BIOL CHEM, V268, P19033; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANNERVIK B, 1985, P NATL ACAD SCI USA, V82, P7202, DOI 10.1073/pnas.82.21.7202; MANNERVIK B, 1992, BIOCHEM J, V282, P305, DOI 10.1042/bj2820305; MANOHARAN TH, 1992, J MOL BIOL, V226, P319, DOI 10.1016/0022-2836(92)90949-K; MESSING J, 1977, P NATL ACAD SCI USA, V74, P3642, DOI 10.1073/pnas.74.9.3642; MEYER DJ, 1991, BIOCHEM J, V274, P409, DOI 10.1042/bj2740409; PHILLIPS MF, 1993, BIOCHEM J, V294, P57, DOI 10.1042/bj2940057; PUCHALSKI RB, 1990, P NATL ACAD SCI USA, V87, P2443, DOI 10.1073/pnas.87.7.2443; REINEMER P, 1992, J MOL BIOL, V227, P214, DOI 10.1016/0022-2836(92)90692-D; RICCI G, 1995, J BIOL CHEM, V270, P1243, DOI 10.1074/jbc.270.3.1243; RICCI G, 1989, J BIOL CHEM, V264, P5462; SCHAGGER H, 1987, ANAL BIOCHEM, V155, P83; SIMMONS PC, 1977, ANAL BIOCHEM, V82, P334; TAMAI K, 1990, BIOCHEM BIOPH RES CO, V167, P331, DOI 10.1016/0006-291X(90)91769-O; TAMAI K, 1991, BIOCHEM BIOPH RES CO, V179, P790, DOI 10.1016/0006-291X(91)91886-H; TSUCHIDA S, 1989, CANCER RES, V49, P5225; VANOMMEN B, 1990, BIOCHEM J, V269, P609, DOI 10.1042/bj2690609; WIDERSTEIN M, 1992, BIOCHEM J, V285, P377, DOI 10.1042/bj2850377; WILCE MCJ, 1994, BBA-PROTEIN STRUCT M, V1205, P1, DOI 10.1016/0167-4838(94)90086-8; YAMAGUCHI H, 1993, J MOL BIOL, V229, P1083, DOI 10.1006/jmbi.1993.1106	40	78	78	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1249	1253						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836387				2022-12-27	WOS:A1995QB15600042
J	MIURA, Y; KAWABATA, S; WAKAMIYA, Y; NAKAMURA, T; IWANAGA, S				MIURA, Y; KAWABATA, S; WAKAMIYA, Y; NAKAMURA, T; IWANAGA, S			A LIMULUS INTRACELLULAR COAGULATION INHIBITOR TYPE-2 - PURIFICATION, CHARACTERIZATION, CDNA CLONING, AND TISSUE LOCALIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TACHYPLEUS-TRIDENTATUS HEMOCYTES; SERINE-PROTEASE ZYMOGEN; PLASMINOGEN-ACTIVATOR INHIBITOR; AMINO-ACID-SEQUENCE; BINDING PROTEIN; FACTOR-C; MOLECULAR CHARACTERIZATION; NUCLEOTIDE-SEQUENCE; PROCLOTTING ENZYME; ELASTASE INHIBITOR	We described in a foregoing report findings on serpin, a serine protease inhibitor, newly identified in horseshoe crab (Tachypleus tridentatus) hemocytes and we name it limulus intracellular coagulation inhibitor. LICI (Miura, Y., Kawabata, S., and Iwanaga, S. (1994) J. Biol. Chem. 269, 542-547). This serpin specifically inhibits limulus lipopolysaccharide-sensitive serine protease, factor ($) over bar C. In ongoing studies on limulus serpin, we have found another inhibitor, LICI type-2 (LICI-2), which inhibits not only factor ($) over bar C (k(1) = 7.1 x 10(4) M(-1) s(-1)) but also limulus clotting enzyme (k(1) = 4.3 x 10(5) M(-1) s(-1)). LICI-2 inhibits mammalian serine proteases, including alpha-thrombin, salivary kallikrein, plasmin, and tissue plasminogen activator. The inactivation of plasmin is the most rapid (k(1) = 1.2 x 10(6) M(-1) s(-1)). The purified LICI-2 is a single chain glycoprotein with an apparent M(r) = 42,000. A cDNA for LICI-2 was isolated and the open reading frame coded for a mature protein of 386 amino acids, of which 160 residues were confirmed by peptide sequencing. Although LICI-2 shows significant sequence similarity to the previous limulus serpin, LTCI-1 (42% identity), LICI-2 contains a unique putative reactive site, -Lys-Ser-, distinct from that of LICI-1 (-Arg-Ser-). Northern blotting revealed expression of LICI-2 mRNA only in hemocytes, and not in heart, brain, stomach, intestine, coral gland, and skeletal muscle. The immunoblot of large and small granule components with antiserum against purified LICI-2 suggests that LICI-2 is stored specifically in large granules, as in the case of LICI-1, and is released in response to external stimuli. We propose that the LICIs be classified into a new subfamily of intracellular serpins, regulated secretory serpins.	KYUSHU UNIV 33,FAC SCI,DEPT BIOL,HIGASHI KU,FUKUOKA 812,JAPAN	Kyushu University			Miura, Yoshiki/U-8875-2019	Miura, Yoshiki/0000-0002-7596-0482				AKETAGAWA J, 1986, J BIOL CHEM, V261, P7357; ARMSTRONG PB, 1990, BIOL BULL, V178, P137, DOI 10.2307/1541972; BELIN D, 1989, EMBO J, V8, P3287, DOI 10.1002/j.1460-2075.1989.tb08489.x; CARRELL RW, 1982, NATURE, V298, P329, DOI 10.1038/298329a0; CHAI KX, 1991, J BIOL CHEM, V266, P16029; CHASE T, 1970, METHOD ENZYMOL, V19, P20; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COUGHLIN P, 1993, P NATL ACAD SCI USA, V90, P9417, DOI 10.1073/pnas.90.20.9417; DUBIN A, 1992, J BIOL CHEM, V267, P6576; DUMONT JN, 1966, J MORPHOL, V119, P181, DOI 10.1002/jmor.1051190206; EHRLICH HJ, 1990, J BIOL CHEM, V265, P13029; HARLOW E, 1989, ANTIBODIES LABORATOR, P471; HEUSSEN C, 1984, J BIOL CHEM, V259, P1635; HJORK I, 1986, PROTEASE INHIBITORS, P489; IWANAGA S, 1993, CURR OPIN IMMUNOL, V5, P74, DOI 10.1016/0952-7915(93)90084-6; IWANAGA S, 1992, THROMB RES, V68, P1, DOI 10.1016/0049-3848(92)90124-S; KANOST MR, 1989, J BIOL CHEM, V264, P965; KATO H, 1987, J BIOCHEM, V102, P1389, DOI 10.1093/oxfordjournals.jbchem.a122185; KATO H, 1980, J BIOCHEM-TOKYO, V88, P183; KAWABATA S, 1985, J BIOCHEM, V97, P1073, DOI 10.1093/oxfordjournals.jbchem.a135150; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE DA, 1990, J BIOL CHEM, V265, P20293; LEVIN J, 1964, B JOHNS HOPKINS HOSP, V115, P265; MINETTI CASA, 1991, J BIOL CHEM, V266, P20773; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; MIURA Y, 1992, J BIOCHEM-TOKYO, V112, P476, DOI 10.1093/oxfordjournals.jbchem.a123924; MIURA Y, 1994, J BIOL CHEM, V269, P542; MIYATA T, 1984, J BIOL CHEM, V259, P8924; MORGENSTERN KA, 1993, J BIOL CHEM, V268, P21560; MULLER EH, 1975, J CELL PHYSL, V86, P533; MUTA T, 1991, J BIOL CHEM, V266, P6554; MUTA T, 1993, J BIOL CHEM, V268, P21384; MUTA T, 1990, J BIOL CHEM, V265, P22426; MUTA T, 1995, IN PRESS J BIOL CHEM, V270; NAKAMURA H, 1993, EUR J BIOCHEM, V214, P181; NAKAMURA T, 1986, EUR J BIOCHEM, V154, P511, DOI 10.1111/j.1432-1033.1986.tb09427.x; NAKAMURA T, 1986, J BIOCHEM, V99, P847, DOI 10.1093/oxfordjournals.jbchem.a135545; NAKAMURA T, 1985, J BIOCHEM, V97, P1561, DOI 10.1093/oxfordjournals.jbchem.a135213; Nei M., 1987, MOL EVOLUT GENET, P293; ORNBERG RL, 1981, J CELL BIOL, V90, P40, DOI 10.1083/jcb.90.1.40; PANNEKOEK H, 1987, EMBO J, V5, P25339; REMOLDODONNELL E, 1992, P NATL ACAD SCI USA, V89, P5635, DOI 10.1073/pnas.89.12.5635; Sambrook J, 1989, MOL CLONING LABORATO; SEKI N, 1994, J BIOL CHEM, V269, P1370; SHIGENAGA T, 1993, J BIOCHEM-TOKYO, V114, P307, DOI 10.1093/oxfordjournals.jbchem.a124173; TAKAGI H, 1990, J BIOCHEM, V108, P372, DOI 10.1093/oxfordjournals.jbchem.a123208; TESCHAUER WF, 1993, EUR J BIOCHEM, V217, P519, DOI 10.1111/j.1432-1033.1993.tb18272.x; TOLLEFSEN DM, 1983, J BIOL CHEM, V258, P6713; VONHEIJNE G, 1991, J BIOL CHEM, V266, P15240; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; WOO SLC, 1981, BIOCHEMISTRY-US, V20, P6437, DOI 10.1021/bi00525a024; YE RD, 1987, J BIOL CHEM, V262, P3718; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	53	66	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					558	565		10.1074/jbc.270.2.558	http://dx.doi.org/10.1074/jbc.270.2.558			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822280	hybrid			2022-12-27	WOS:A1995QB81600012
J	NAGPAL, S; ATHANIKAR, J; CHANDRARATNA, RAS				NAGPAL, S; ATHANIKAR, J; CHANDRARATNA, RAS			SEPARATION OF TRANSACTIVATION AND AP1 ANTAGONISM FUNCTIONS OF RETINOIC ACID RECEPTOR-ALPHA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X RECEPTOR; PROMOTER; CELLS; GENE; AP-1; DIFFERENTIATION; INTERLEUKIN-6; COLLAGENASE; SITE; FOS	Retinoic acid receptors (RARs) regulate gene expression either by directly binding to the RAR-responsive elements or by antagonizing the action of c-Jun/c-Fos (AP1). AP1 is involved in the expression of metalloproteases, cytokines and other factors which play critical roles in the turnover of extracellular matrix, inflammation and hyperproliferation in diseases such as psoriasis, rheumatoid arthritis and in tumor metastases. We demonstrate here that synthetic retinoids inhibit 12-O-tetradecanoylphorbol-14-acetate-induced transcription from the stromelysin AP1 motif through RAR alpha, -beta, and -gamma. Interestingly, these diaryl acetylenic retinoids, which are potent agonists only for RAR beta and -beta, but not for RAR alpha, in transactivation assays, are able to in hibit AP1-dependent gene expression through RAR alpha. Thus these analogs can differentially affect the transactivation and AP1 antagonistic functions of RAR alpha. These results demonstrate that the transactivation and AP1 antagonistic functions are separable, and it should be possible to develop retinoids that are completely specific for AP1 antagonism through all RARs. Furthermore, using an RAR-selective ligand, we also demonstrate the separation of ligand binding and API antagonism functions of RARs.	ALLERGAN PHARMACEUT INC,DEPT CHEM,RETINOID RES,IRVINE,CA 92713	AbbVie; Allergan	NAGPAL, S (corresponding author), ALLERGAN PHARMACEUT INC,DEPT BIOL,RETINOID RES,IRVINE,CA 92713, USA.		Nagpal, Sunil/A-8007-2009					ABERGEL RP, 1985, ARCH DERMATOL, V121, P632, DOI 10.1001/archderm.121.5.632; ALLEGRETTO EA, 1993, J BIOL CHEM, V268, P26625; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; BAILLY C, 1990, J INVEST DERMATOL, V94, P47, DOI 10.1111/1523-1747.ep12873342; BARTSCH D, 1992, EMBO J, V11, P2283, DOI 10.1002/j.1460-2075.1992.tb05287.x; BEARD RL, 1994, BIOORG MED CHEM LETT, V4, P1447, DOI 10.1016/S0960-894X(01)80511-4; Chambon Pierre, 1994, Seminars in Cell Biology, V5, P115, DOI 10.1006/scel.1994.1015; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; DE LUCA LM, 1991, FASEB J, V5, P2924; ESGLEYESRIBOT T, 1994, J AM ACAD DERMATOL, V30, P581, DOI 10.1016/S0190-9622(94)70066-4; GILLARD EF, 1993, CURR BIOL, V3, P185, DOI 10.1016/0960-9822(93)90269-T; GRAUPNER G, 1991, BIOCHEM BIOPH RES CO, V179, P1554, DOI 10.1016/0006-291X(91)91750-7; GRIFFITHS CEM, 1993, NEW ENGL J MED, V329, P530, DOI 10.1056/NEJM199308193290803; GROSSMAN RM, 1989, P NATL ACAD SCI USA, V86, P6367, DOI 10.1073/pnas.86.16.6367; GUDAS LJ, 1992, CELL GROWTH DIFFER, V3, P655; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; LAFYATIS R, 1990, MOL ENDOCRINOL, V4, P973, DOI 10.1210/mend-4-7-973; LOTAN R, 1991, CANCER BIOL, V2, P197; Mangelsdorf David J., 1994, P319; MEYSKENS FL, 1986, J AM ACAD DERMATOL, V15, P826, DOI 10.1016/S0190-9622(86)70240-5; Mitsuyasu Ronald T., 1993, Current Opinion in Oncology, V5, P835, DOI 10.1097/00001622-199309000-00011; NAGPAL S, 1993, EMBO J, V12, P2349, DOI 10.1002/j.1460-2075.1993.tb05889.x; NAGPAL S, 1992, CELL, V70, P1007, DOI 10.1016/0092-8674(92)90250-G; NICHOLSON RC, 1990, EMBO J, V9, P4443, DOI 10.1002/j.1460-2075.1990.tb07895.x; OBRIEN TG, 1975, CANCER RES, V35, P1662; OHTA A, 1987, ANN RHEUM DIS, V46, P357, DOI 10.1136/ard.46.5.357; PFAHL M, 1993, ENDOCR REV, V14, P651, DOI 10.1210/er.14.5.651; RAY A, 1990, MOL CELL BIOL, V10, P5736, DOI 10.1128/MCB.10.11.5736; ROMNEY SL, 1981, AM J OBSTET GYNECOL, V141, P890; SALBERT G, 1993, MOL ENDOCRINOL, V7, P1347, DOI 10.1210/me.7.10.1347; SCHULE R, 1991, P NATL ACAD SCI USA, V88, P6092, DOI 10.1073/pnas.88.14.6092; TEELMANN K, 1989, PHARMACOL THERAPEUT, V40, P29, DOI 10.1016/0163-7258(89)90072-7; WRIGHTON C, 1993, MOL CELL BIOL, V13, P4657, DOI 10.1128/MCB.13.8.4657; YANGYEN HF, 1991, NEW BIOL, V3, P1206	36	155	183	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					923	927		10.1074/jbc.270.2.923	http://dx.doi.org/10.1074/jbc.270.2.923			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822331	hybrid			2022-12-27	WOS:A1995QB81600066
J	BORNER, C; UEFFING, M; JAKEN, S; PARKER, PJ; WEINSTEIN, IB				BORNER, C; UEFFING, M; JAKEN, S; PARKER, PJ; WEINSTEIN, IB			2 CLOSELY-RELATED ISOFORMS OF PROTEIN-KINASE-C PRODUCE RECIPROCAL EFFECTS ON THE GROWTH OF RAT FIBROBLASTS - POSSIBLE MOLECULAR MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTING PHORBOL ESTERS; NIH 3T3 CELLS; SUBCELLULAR-DISTRIBUTION; TUMOR PROMOTION; ACTIVATION; PHOSPHORYLATION; GENE; RECEPTOR; OVEREXPRESSION; EXPRESSION	We have previously reported that two closely related protein kinase C (PKC) isoforms, PKC alpha and PKC beta I, had divergent effects on the growth and transformation of the same parental R6 rat embryo fibroblast cell line (Housey, G. M., Johnson, M. D., Hsiao, W.-L. W., O'Brian, C. A., Murphey, J. P., Kirschmeier, P., and Weinstein, I. B. (1988) Cell 52, 343-354; Borner, C., Filipuzzi, I., Weinstein, I. B., and Imber, R. (1991) Nature 353, 78-80). Whereas cells that overexpress PKC beta I lost anchorage dependence, grew to higher saturation densities, and generated small tumors when injected into nude mice, none of these properties were seen with cells that overexpress PKC alpha. In fact, the latter cells grew even slower and to lower saturation densities as compared to control cells. Here we investigate possible molecular mechanisms underlying the reciprocal effects of PKC alpha and PKC beta I. Overexpression of both isoforms enhanced 12-O-tetradecanoyl phorbol-13 acetate-induced expression of the growth regulatory genes c-jun, c-myc, and collagenase and enhanced feedback inhibition of epidermal growth factor receptor binding and cellular levels of diacylglycerol. However, the cells overexpressing PKC beta I differed from those overexpressing PKC alpha by displaying a decreased requirement for growth factors and by the production of a mitogenic factor. Thus, the basis for enhanced growth and transformation of cells overexpressing PKC beta I may be the establishment of an autocrine growth factor loop. These findings may be relevant to the roles of specific isoforms of PKC in carcinogenesis and tumor growth.	COLUMBIA UNIV,CANC RES INST,NEW YORK,NY 10032; UNIV FRIBOURG,INST BIOCHEM,CH-1700 FRIBOURG,SWITZERLAND; INST CLIN MOLEC BIOL & TUMORIGENET,W-8000 MUNICH,GERMANY; W ALTON JONES SCI CTR,NEW YORK,NY 12946; IMPERIAL CANC RES FUND,LONDON WC2A 3PX,ENGLAND	Columbia University; University of Fribourg; Cancer Research UK	BORNER, C (corresponding author), COLUMBIA UNIV,COLUMBIA PRESBYTERIAN MED CTR,NEW YORK,NY 10032, USA.		Parker, Peter j/D-5192-2013	parker, peter/0000-0002-6218-2933	NCI NIH HHS [CA 02111] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALESSANDRINI A, 1992, P NATL ACAD SCI USA, V89, P8200, DOI 10.1073/pnas.89.17.8200; AMES BN, 1964, METHOD ENZYMOL, V8, P115; ANDERSON WB, 1985, ADV CYCLIC NUCL PROT, V19, P287; ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; BAUERLE PA, 1988, CELL, V53, P211; BAZZI MD, 1988, BIOCHEMISTRY-US, V27, P7589, DOI 10.1021/bi00420a003; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BORNER C, 1990, CELL GROWTH DIFFER, V1, P653; BORNER C, 1992, J BIOL CHEM, V267, P12892; BORNER C, 1991, NATURE, V353, P78, DOI 10.1038/353078a0; BORNER C, 1992, PROTEIN KINASE C CUR, P297; CACACE AM, 1993, ONCOGENE, V8, P2095; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; CEPKO CL, 1984, CELL, V37, P1053, DOI 10.1016/0092-8674(84)90440-9; CHOI PM, 1990, MOL CELL BIOL, V10, P4650, DOI 10.1128/MCB.10.9.4650; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; DRINKWATER NR, 1990, CANCER CELL-MON REV, V2, P8; HERSCHMAN HR, 1989, TRENDS BIOCHEM SCI, V14, P455, DOI 10.1016/0968-0004(89)90105-9; Hinrichs Reimer, 1992, Biological Chemistry Hoppe-Seyler, V373, P776; HOCEVAR BA, 1991, J BIOL CHEM, V266, P28; HOSHINA S, 1990, J CELL PHYSIOL, V145, P262, DOI 10.1002/jcp.1041450210; HOUSEY GM, 1988, CELL, V52, P343, DOI 10.1016/S0092-8674(88)80027-8; HUANG CL, 1987, NATURE, V329, P849, DOI 10.1038/329849a0; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; JAKEN S, 1989, J CELL BIOL, V109, P697, DOI 10.1083/jcb.109.2.697; KARIN M, 1992, FASEB J, V6, P2581, DOI 10.1096/fasebj.6.8.1317309; KARIN M, 1990, MOL ASPECTS CELLULAR, V6, P236; KIKKAWA U, 1983, J BIOL CHEM, V258, P1442; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; KRAUSS RS, 1989, ONCOGENE, V4, P991; LEACH KL, 1989, J CELL BIOL, V109, P685, DOI 10.1083/jcb.109.2.685; LISKOVITCH M, 1991, BIOCHEM SOC T, V19, P402; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; MURRAY AW, 1987, TRENDS BIOCHEM SCI, V12, P53, DOI 10.1016/0968-0004(87)90026-0; MURRAY AW, 1989, SCIENCE, V246, P614, DOI 10.1126/science.2683077; NICHOLS SG, 1992, J BIOL CHEM, V267, P2697; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NORI M, 1992, MOL CELL BIOL, V12, P936, DOI 10.1128/MCB.12.3.936; PAI JK, 1991, P NATL ACAD SCI USA, V88, P598, DOI 10.1073/pnas.88.2.598; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PARKER PJ, 1986, SCIENCE, V233, P853, DOI 10.1126/science.3755547; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; RHEE SG, 1992, J BIOL CHEM, V267, P12393; ROGUE P, 1990, J BIOL CHEM, V265, P4161; SOZERI O, 1992, ONCOGENE, V7, P2259; STANTON LW, 1983, NATURE, V308, P401; SUSA M, 1989, CELL, V57, P817, DOI 10.1016/0092-8674(89)90796-4; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; UEFFING M, 1991, J CELL BIOCHEM, V37, P168; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; WEINBERG RA, 1990, TRENDS BIOCHEM SCI, V15, P199, DOI 10.1016/0968-0004(90)90162-5; WEINSTEIN IB, 1988, CANCER RES, V48, P4135; WETSEL WC, 1992, J CELL BIOL, V117, P121, DOI 10.1083/jcb.117.1.121; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; Woodgett JR., 1987, CELL MEMBRANES, P215, DOI [10.1007/978-1-4613-1915-3_6, DOI 10.1007/978-1-4613-1915-3_6]	57	113	113	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					78	86		10.1074/jbc.270.1.78	http://dx.doi.org/10.1074/jbc.270.1.78			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814423	hybrid			2022-12-27	WOS:A1995QA28700018
J	CHAKRAVARTI, S; HORCHAR, T; JEFFERSON, B; LAURIE, GW; HASSELL, JR				CHAKRAVARTI, S; HORCHAR, T; JEFFERSON, B; LAURIE, GW; HASSELL, JR			RECOMBINANT DOMAIN-III OF PERLECAN PROMOTES CELL ATTACHMENT THROUGH ITS RGDS SEQUENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; DENSITY-LIPOPROTEIN-RECEPTOR; LAMININ-A CHAIN; BASEMENT-MEMBRANE; CORE PROTEIN; EXTRACELLULAR-MATRIX; IDENTIFICATION; BINDING; VISUALIZATION; FIBRONECTIN	Perlecan has been previously been shown to support attachment of a wide variety of cells through interactions of its core protein with the cell surface. The core protein domains involved in cell adhesion are, however, unknown. The laminin-like domain III of murine perlecan can contains an RGDS sequence and is a likely candidate for supporting integrin-mediated cell attachment. We made a cDNA construct corresponding to domain III and containing an in frame signal peptide at the 5' end as well as in frame a stop codon at the 3' end by using cDNA clones to perlecan. The construct was inserted into the pRC/CMV vector and transfected into HT1080 cells, and the secreted recombinant domain III, a 130-kDa protein, was purified from the medium. The size of proteolytic fragments produced by digestion with V8 protease as well as analysis of the rotary shadowed image of the recombinant protein indicated it was produced in a native conformation. Recombinant domain III coated on tissue culture dishes, supports adhesion of an epithelial-like mouse mammary tumor cell line MMT 060562 in a dose-dependent manner. This interaction was inhibited specifically by the RGDS synthetic peptide and intact perlecan, but not laminin. This domain III RGD-dependent cell attachment activity indicates a role for perlecan in integrin-mediated signaling.	UNIV PITTSBURGH,SCH MED,INST EYE & EAR,DEPT OPHTHALMOL,PITTSBURGH,PA 15213; CASE WESTERN RESERVE UNIV,SCH MED,DEPT GENET,CLEVELAND,OH 44106; UNIV VIRGINIA,DEPT CELL BIOL,CHARLOTTESVILLE,VA 22908	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Case Western Reserve University; University of Virginia			Laurie, Gordon W/A-5244-2008	Laurie, Gordon W/0000-0002-5311-2650	NEI NIH HHS [R01 EY009747-08, P30 EY08098] Funding Source: Medline; NIGMS NIH HHS [GM45380] Funding Source: Medline; PHS HHS [FY09747] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009747, P30EY008098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045380] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUMAILLEY M, 1990, FEBS LETT, V262, P82, DOI 10.1016/0014-5793(90)80159-G; BATTAGLIA C, 1992, EUR J BIOCHEM, V208, P359, DOI 10.1111/j.1432-1033.1992.tb17195.x; CHAKRAVARTI S, 1990, J BIOL CHEM, V265, P10597; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEMENT B, 1990, EXP CELL RES, V187, P320, DOI 10.1016/0014-4827(90)90098-U; CLEMENT B, 1989, J BIOL CHEM, V264, P12467; DEUTZMANN R, 1990, EUR J BIOCHEM, V191, P512; Farquhar M. G., 1981, CELL BIOL EXTRACELLU, V1981, P335; GRAF J, 1987, CELL, V48, P989, DOI 10.1016/0092-8674(87)90707-0; HASSELL JR, 1993, ADV MOL CELL BIOL, V6, P69; HAYASHI K, 1992, J CELL BIOL, V119, P945, DOI 10.1083/jcb.119.4.945; HEREMANS A, 1990, J BIOL CHEM, V265, P8716; HEUSER J, 1989, J ELECTRON MICR TECH, V13, P244, DOI 10.1002/jemt.1060130310; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; KALLUNKI P, 1992, J CELL BIOL, V116, P59; KLEIN DJ, 1988, J CELL BIOL, V106, P963, DOI 10.1083/jcb.106.3.963; LAURIE GW, 1986, J MOL BIOL, V189, P205, DOI 10.1016/0022-2836(86)90391-8; LAURIE GW, 1988, AM J ANAT, V181, P320, DOI 10.1002/aja.1001810308; LAURIE GW, 1985, DEV BIOL, V108, P299, DOI 10.1016/0012-1606(85)90034-X; LEDBETTER SR, 1985, J BIOL CHEM, V260, P8106; LEDBETTER SR, 1987, BIOCHEMISTRY-US, V26, P988, DOI 10.1021/bi00378a003; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; MURDOCH AD, 1992, J BIOL CHEM, V267, P8544; NOONAN DM, 1991, J BIOL CHEM, V266, P22939; NOONAN DM, 1988, J BIOL CHEM, V263, P16379; PATTHY L, 1994, NEUROCHEM INT, V24, P301, DOI 10.1016/0197-0186(94)90108-2; PAULSSON M, 1987, J MOL BIOL, V197, P297, DOI 10.1016/0022-2836(87)90125-2; ROGALSKI TM, 1993, GENE DEV, V7, P1471, DOI 10.1101/gad.7.8.1471; Sambrook J, 1989, MOL CLONING LABORATO; TIMPL R, 1993, EXPERIENTIA, V49, P417, DOI 10.1007/BF01923586; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; YURCHENCO PD, 1987, J BIOL CHEM, V262, P17668	32	55	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					404	409		10.1074/jbc.270.1.404	http://dx.doi.org/10.1074/jbc.270.1.404			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814401	hybrid			2022-12-27	WOS:A1995QA28700064
J	GROEBE, DR; ABRAMSON, SN				GROEBE, DR; ABRAMSON, SN			LOPHOTOXIN IS A SLOW BINDING IRREVERSIBLE INHIBITOR OF NICOTINIC ACETYLCHOLINE-RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC RECEPTORS; NUMERICAL-INTEGRATION; CHOLINERGIC RECEPTOR; LIGAND-BINDING; ALPHA-SUBUNIT; AGONIST SITES; KINETICS; ANTAGONISTS; AFFINITY; TRANSITIONS	Lophotoxin and the bipinnatins are members of the lophotoxin family of marine neurotoxins, which covalently react with Tyr(190) in the alpha-subunits of the nicotinic acetylcholine receptor. Bipinnatin-A, -B, and -C are protoxins that have been shown to spontaneously convert from inactive to active toxins during preincubation in buffer. However, in this report, we show that preincubation of lophotoxin did not result in an increase in the subsequent rate of irreversible inhibition of nicotinic receptors, Thus, unlike the bipinnatins, lophotoxin does not appear to be an inactive protoxin. Lophotoxin preferentially inhibited one of the two acetylcholine-binding sites on the receptor, and this preference resulted from both a higher reversible affinity and a faster rate of irreversible inhibition at this site. Association of I-125-alpha-bungarotoxin in the presence of lophotoxin was analyzed to obtain the apparent reversible association and dissociation rate constants for lophotoxin. The apparent association rate constant of lophotoxin was approximately 10(6)-fold slower than expected for a diffusion-limited interaction, indicating that lophotoxin is a slow binding irreversible inhibitor. The kinetic constants that describe the interaction of lophotoxin with the receptor did not change in the presence of dibucaine, suggesting that, unlike agonists, the slow apparent association of lophotoxin does not result from a slow transition of the receptor to a desensitized conformation.	UNIV PITTSBURGH, SCH MED, DEPT PHARMACOL, PITTSBURGH, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R55NS029951, R29NS029951] Funding Source: NIH RePORTER; NINDS NIH HHS [NS29951] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAMSON SN, 1991, J MED CHEM, V34, P1798, DOI 10.1021/jm00110a007; ABRAMSON SN, 1989, J BIOL CHEM, V264, P12666; ABRAMSON SN, 1988, J BIOL CHEM, V263, P18568; ALLEN KN, 1989, BIOCHEMISTRY-US, V28, P8466, DOI 10.1021/bi00447a029; BERMAN HA, 1989, J BIOL CHEM, V264, P3942; BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; BOYD ND, 1980, BIOCHEMISTRY-US, V19, P5344, DOI 10.1021/bi00564a031; CHANDLER JP, 1972, COMPUT BIOMED RES, V5, P515, DOI 10.1016/0010-4809(72)90058-4; CONTRERAS ML, 1986, J PHARMACOL EXP THER, V239, P136; CULVER P, 1985, MOL PHARMACOL, V28, P436; CULVER P, 1984, J BIOL CHEM, V259, P3763; FENICAL W, 1981, SCIENCE, V212, P1512, DOI 10.1126/science.6112796; FRIEDEN C, 1993, TRENDS BIOCHEM SCI, V18, P58, DOI 10.1016/0968-0004(93)90056-S; GROEBE DR, 1994, J BIOL CHEM, V269, P8885; HAWKINSON JE, 1992, MOL PHARMACOL, V42, P1069; JACKSON MB, 1989, P NATL ACAD SCI USA, V86, P2199, DOI 10.1073/pnas.86.7.2199; KARLIN A, 1967, J THEOR BIOL, V16, P306, DOI 10.1016/0022-5193(67)90011-2; KITZ R, 1962, J BIOL CHEM, V237, P3245; KRANTZ A, 1991, BIOCHEMISTRY-US, V30, P4678, DOI 10.1021/bi00233a007; LEJCZAK B, 1989, BIOCHEMISTRY-US, V28, P3549, DOI 10.1021/bi00434a060; LIUCHEN LY, 1990, MOL PHARMACOL, V37, P243; MAIN AR, 1964, SCIENCE, V144, P992, DOI 10.1126/science.144.3621.992; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MOTULSKY HJ, 1984, MOL PHARMACOL, V25, P1; RAKITZIS ET, 1984, BIOCHEM J, V217, P341, DOI 10.1042/bj2170341; SAMAMA P, 1994, MOL PHARMACOL, V45, P390; SINE SM, 1982, J BIOL CHEM, V257, P8106; SINE SM, 1991, J BIOL CHEM, V266, P19369; SINE SM, 1991, J BIOL CHEM, V266, P13679; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; VAUQUELIN G, 1980, MOL PHARMACOL, V17, P163; WEILAND G, 1976, MOL PHARMACOL, V12, P1091; WEILAND G, 1977, J BIOL CHEM, V252, P7648; WILLIAMS JW, 1979, BIOCHEMISTRY-US, V18, P2567, DOI 10.1021/bi00579a021; WRIGHT AE, 1989, TETRAHEDRON LETT, V30, P3491, DOI 10.1016/S0040-4039(00)99421-8; ZIMMERLE CT, 1989, BIOCHEM J, V258, P381, DOI 10.1042/bj2580381	36	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					281	286		10.1074/jbc.270.1.281	http://dx.doi.org/10.1074/jbc.270.1.281			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814387	hybrid			2022-12-27	WOS:A1995QA28700045
J	MA, JX; YANG, ZR; CHAO, J; CHAO, L				MA, JX; YANG, ZR; CHAO, J; CHAO, L			INTRAMUSCULAR DELIVERY OF RAT KALLIKREIN-BINDING PROTEIN GENE REVERSES HYPOTENSION IN TRANSGENIC MICE EXPRESSING HUMAN TISSUE KALLIKREIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPONTANEOUSLY HYPERTENSIVE RATS; URINARY KALLIKREIN; MUSCLE INVIVO; SYSTEMIC DELIVERY; DIRECT INJECTION; BLOOD-PRESSURE; EXCRETION; PURIFICATION; STABILITY; MYOBLASTS	The tissue kallikrein-kinin system has been postulated to play a role in blood pressure regulation. The activity of tissue kallikrein is controlled by a number of factors in vivo. Rat kallikrein-binding protein (RKBP) is a serine proteinase inhibitor which binds to and inhibits tissue kallikrein's activity in vitro. We have recently developed several hypotensive transgenic mouse Lines which express human tissue kallikrein. In order to investigate the role of RKBP in blood pressure regulation, we delivered the RKBP to these transgenic mice by intramuscular injection. Expression of the RKBP was detected in skeletal muscle by reverse transcription-polymerase chain reaction and Southern blot analysis at 10, 20, 30, and 40 days post-injection. Immunoreactive RKBP levels in the muscle and serum of these mice were quantified by a RKBP-specific enzyme-linked immunosorbent assay and Western blot analysis. The levels of RKBP mRNA and immunoreactive protein were detectable at 10 days post-injection and increased significantly at 20 and 30 days, During this period, RKBP delivery significantly increased systemic blood pressure in the kallikrein transgenic mice to a level comparable to that of normotensive control mice. The RKBP and vector DNA delivery had no effect on the blood pressure of normotensive control mice. No serum antibodies to RKBP or its DNA were detected in the mice 40 days post injection. These results suggest that the increase of systemic blood pressure by RKBP delivery in these hypotensive transgenic mice may be mediated by inhibiting tissue kallikrein activity.	MED UNIV S CAROLINA,DEPT BIOCHEM & MOLEC BIOL,CHARLESTON,SC 29425	Medical University of South Carolina					NHLBI NIH HHS [HL 44083, HL 29397] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL029397, R01HL044083] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADER JL, 1985, AM J PHYSIOL, V248, pF396, DOI 10.1152/ajprenal.1985.248.3.F396; BARR E, 1991, SCIENCE, V254, P1507, DOI 10.1126/science.1962212; BERRY TD, 1989, HYPERTENSION, V13, P3, DOI 10.1161/01.HYP.13.1.3; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; CHAI KX, 1991, J BIOL CHEM, V266, P16029; CHAO J, 1990, J BIOL CHEM, V265, P16394; CHAO J, 1986, BIOCHEM J, V239, P325, DOI 10.1042/bj2390325; CHEN LM, 1990, BIOCHEM J, V267, P79, DOI 10.1042/bj2670079; DAVIS HL, 1993, HUM GENE THER, V4, P151, DOI 10.1089/hum.1993.4.2-151; DHAWAN J, 1991, SCIENCE, V254, P1509, DOI 10.1126/science.1962213; ELLIOT R, 1934, ENDOCRINOLOGY, V18, P462; GEIGER R, 1981, HOPPESEYLERS Z PHYSL, V365, pS27; GELLER RG, 1975, CIRC RES, V36, P103, DOI 10.1161/01.RES.36.6.103; GILKESON GS, 1993, J IMMUNOL, V151, P1353; GLANVILLE N, 1981, NATURE, V292, P267, DOI 10.1038/292267a0; GUESDON JL, 1979, J HISTOCHEM CYTOCHEM, V27, P1131, DOI 10.1177/27.8.90074; HANSEN E, 1991, FEBS LETT, V290, P73, DOI 10.1016/0014-5793(91)81229-2; LIN H, 1990, CIRCULATION, V82, P2217, DOI 10.1161/01.CIR.82.6.2217; LINDPAINTNER K, 1994, J HYPERTENSION S3, V12, pS66; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MA JX, 1993, BIOCHEM J, V292, P825, DOI 10.1042/bj2920825; MARGOLIUS HS, 1989, ANNU REV PHARMACOL, V29, P343; MARGOLIUS HS, 1971, LANCET, V2, P1063; MARGOLIUS HS, 1974, CIRC RES, V35, P820, DOI 10.1161/01.RES.35.6.820; PRAVENEC M, 1991, HYPERTENSION, V17, P242, DOI 10.1161/01.HYP.17.2.242; Sambrook J, 1989, MOL CLONING LABORATO; WANG J, 1994, HYPERTENSION, V23, P236, DOI 10.1161/01.HYP.23.2.236; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; WOLFF JA, 1991, BIOTECHNIQUES, V11, P474; ZHOU GX, 1992, J BIOL CHEM, V267, P25873; ZINNER SH, 1978, CIRCULATION, V58, P908, DOI 10.1161/01.CIR.58.5.908	31	46	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					451	455		10.1074/jbc.270.1.451	http://dx.doi.org/10.1074/jbc.270.1.451			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814410	hybrid			2022-12-27	WOS:A1995QA28700071
J	PARLATI, F; DOMINGUEZ, M; BERGERON, JJM; THOMAS, DY				PARLATI, F; DOMINGUEZ, M; BERGERON, JJM; THOMAS, DY			SACCHAROMYCES-CEREVISIAE CNE1 ENCODES AN ENDOPLASMIC-RETICULUM (ER) MEMBRANE-PROTEIN WITH SEQUENCE SIMILARITY TO CALNEXIN AND CALRETICULIN AND FUNCTIONS AS A CONSTITUENT OF THE ER QUALITY-CONTROL APPARATUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST; CHAPERONE; HOMOLOG; BIOGENESIS; SEPARATION; MOLECULES; VECTORS; GROWTH; CELLS	We have used a polymerase chain reaction strategy to identify in the yeast Saccharomyces cerevisiae genes of the mammalian calnexin/calreticulin family, and we have identified and isolated a single gene, CNE1, The protein predicted from the CNE1 DNA sequence shares some of the motifs with calnexin and calreticulin, and it is 24% identical and 31% similar at the amino acid level with mammalian calnexin, On the basis of its solubility in detergents and its lack of extraction from membranes by 2.5 M urea, high salt, and sodium carbonate at pH 11.5, we have established that Cne1p is an integral membrane protein, However, unlike calnexins, the predicted carboxyl-terminal membrane-spanning domain of Cne1p terminates directly, Furthermore, based on its changed mobility from 76 to 60 kDa after endoglycosidase H digestion Cne1p was shown to be N-glycosylated, Localization of the Cne1p protein by differential and analytical subcellular fractionation as well as by confocal immunofluorescence microscopy showed that it was exclusively located in the endoplasmic reticulum (ER), despite the lack of known ER retention motifs, Although six Ca2+-binding proteins were detected in the ER fractions, they were all soluble proteins, and Ca2+ binding activity has not been detected for Cne1p, Disruption of the CNE1 gene did not lead to inviable cells or to gross effects on the levels of secreted proteins such as alpha-pheromone or acid phosphatase. However, in CNE1 disrupted cells, there was an increase of cell surface expression of an ER retained temperature sensitive mutant of the alpha-pheromone receptor, ste2-3p, and also an increase in the secretion of heterologously expressed mammalian alpha(1)-antitrypsin. Hence, Cne1p appears to function as a constituent of the S, cerevisiae ER protein quality control apparatus.	MCGILL UNIV, DEPT ANAT & CELL BIOL, MONTREAL, PQ H3A 2B2, CANADA; NATL RES COUNCIL CANADA, BIOTECHNOL RES INST, GENET GRP, MONTREAL, PQ H4P 2R2, CANADA	McGill University; National Research Council Canada	PARLATI, F (corresponding author), MCGILL UNIV, DEPT BIOL, 3640 UNIV ST, MONTREAL, PQ H3A 2B2, CANADA.		Bergeron, John/AAW-1893-2021; Thomas, David/M-7661-2017	Thomas, David/0000-0002-8854-762X				ABEIJON C, 1989, P NATL ACAD SCI USA, V86, P6935, DOI 10.1073/pnas.86.18.6935; AHLUWALIA N, 1992, J BIOL CHEM, V267, P10914; ANDERSON KS, 1994, EMBO J, V13, P675, DOI 10.1002/j.1460-2075.1994.tb06306.x; ARGOS P, 1982, EUR J BIOCHEM, V128, P565; BANDLOW W, 1972, BIOCHIM BIOPHYS ACTA, V282, P105, DOI 10.1016/0005-2736(72)90315-X; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BOWMAN BJ, 1979, J BIOL CHEM, V254, P2928; COSTIGAN C, 1992, MOL CELL BIOL, V12, P1162, DOI 10.1128/MCB.12.3.1162; DAVID V, 1993, J BIOL CHEM, V268, P9585; DEGEN E, 1992, J EXP MED, V175, P1653, DOI 10.1084/jem.175.6.1653; DEGEN E, 1991, J CELL BIOL, V112, P1099, DOI 10.1083/jcb.112.6.1099; DEVIRGILIO C, 1993, YEAST, V9, P185, DOI 10.1002/yea.320090209; DUVE CD, 1975, SCIENCE, V189, P186, DOI 10.1126/science.1138375; FELDHEIM D, 1992, MOL CELL BIOL, V12, P3288, DOI 10.1128/MCB.12.7.3288; GALVIN K, 1992, P NATL ACAD SCI USA, V89, P8452, DOI 10.1073/pnas.89.18.8452; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HANN BC, 1989, J CELL BIOL, V109, P3223, DOI 10.1083/jcb.109.6.3223; HERSCOVICS A, 1993, FASEB J, V7, P540, DOI 10.1096/fasebj.7.6.8472892; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; HUANG LQ, 1993, J BIOL CHEM, V268, P6560; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JACKSON MR, 1994, SCIENCE, V263, P384, DOI 10.1126/science.8278813; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JONES JS, 1990, YEAST, V6, P363, DOI 10.1002/yea.320060502; KUBOTA S, 1977, J BIOCHEM-TOKYO, V81, P187, DOI 10.1093/oxfordjournals.jbchem.a131434; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LE AQ, 1994, J BIOL CHEM, V269, P7514; LENTER M, 1994, J BIOL CHEM, V269, P12263; Maniatis T., 1982, MOL CLONING; MCCRACKEN AA, 1993, MOL BIOL CELL, V4, P729, DOI 10.1091/mbc.4.7.729; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; PIND S, 1994, J BIOL CHEM, V269, P12784; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; RAJAGOPALAN S, 1994, SCIENCE, V263, P387, DOI 10.1126/science.8278814; RILES L, 1993, GENETICS, V134, P81; SCHULZE E, 1986, J CELL BIOL, V102, P1020, DOI 10.1083/jcb.102.3.1020; Sherman F, 1979, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SPRAGUE GF, 1991, METHOD ENZYMOL, V194, P77; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; TOHE A, 1973, J BACTERIOL, V113, P727, DOI 10.1128/JB.113.2.727-738.1973; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WADA I, 1994, J BIOL CHEM, V269, P7464; WADA I, 1991, J BIOL CHEM, V266, P19599; WISE JA, 1991, METHOD ENZYMOL, V194, P405	48	132	137	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					244	253		10.1074/jbc.270.1.244	http://dx.doi.org/10.1074/jbc.270.1.244			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814381	hybrid			2022-12-27	WOS:A1995QA28700040
J	VISAI, L; BOZZINI, S; RAUCCI, G; TONIOLO, A; SPEZIALE, P				VISAI, L; BOZZINI, S; RAUCCI, G; TONIOLO, A; SPEZIALE, P			ISOLATION AND CHARACTERIZATION OF A NOVEL COLLAGEN-BINDING PROTEIN FROM STREPTOCOCCUS-PYOGENES STRAIN-6414	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS; FIBRONECTIN RECEPTOR; MEDIATES ADHESION; MEMBRANES; CHROMATOGRAPHY; ATTACHMENT; CARTILAGE; SEQUENCE; AFFINITY; COWAN-1	In this report we have analyzed the binding of collagen to Streptococcus pyogenes strain 6414. This binding was rapid, specific, and involved a limited number of receptor molecules (11,600 copies per cell). When the proteins in a streptococcal lysate were blotted onto a nitrocellulose filter and probed with I-125-labeled collagen, a prominent collagen-binding protein of 57 kDa was identified as well as minor 130-150-kDa components. The major 57-kDa protein was isolated by affinity chromatography on collagen-Sepharose followed by gel filtration chromatography. The 57-kDa protein purified from S. pyogenes was used to raise a monospecific antibody which also reacted with a collagen-binding protein of similar molecular size isolated from Streptococcus zooepidemicus. The two collagen-binding proteins from streptococci have a similar amino acid composition and isoelectric points. Isolated collagen-binding protein was specifically recognized by I-125-collagen in a solid-phase binding assay and displayed an affinity for the ligand quite similar to that exhibited by intact bacteria (K-d = 3.1 versus 3.5 x 10(-9) M, respectively). Surface-labeled bacteria attached to microtiter wells coated with different collagen types and the 57-kDa protein blocked the adhesion to collagen substrate. We propose that the 57-kDa protein is an adhesin involved in the attachment of streptococci to host tissues.	UNIV PAVIA,DEPT BIOCHEM,I-27100 PAVIA,ITALY; MENARINI SUD,I-00040 POMEZIA,ITALY; UNIV PAVIA,INST MED & PUBL HLTH,I-21100 VARESE,ITALY	University of Pavia; Menarini Group; University of Pavia			Toniolo, Antonio/AAA-2845-2021; Visai, Livia/R-7397-2017; Toniolo, Antonio Q./B-4103-2015	Visai, Livia/0000-0003-1181-3632; Toniolo, Antonio Q./0000-0003-3008-2126				ADAMSON ED, 1983, COLLAGEN HLTH DISEAS, P218; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; BRILES EB, 1982, EXP CELL RES, V138, P436, DOI 10.1016/0014-4827(82)90194-X; COHEN SA, 1993, ANAL BIOCHEM, V211, P279, DOI 10.1006/abio.1993.1270; DEDHAR S, 1987, J CELL BIOL, V104, P585, DOI 10.1083/jcb.104.3.585; EMODY L, 1989, J BACTERIOL, V171, P6674; FROMAN G, 1987, J BIOL CHEM, V262, P6564; GULLBERG D, 1989, J BIOL CHEM, V264, P12686; Hay E.D., 1991, CELL BIOL EXTRACELLU, P419; HOLDERBAUM D, 1987, J CLIN MICROBIOL, V25, P2258, DOI 10.1128/JCM.25.12.2258-2261.1987; KIRCHHOFER D, 1990, J BIOL CHEM, V265, P615; KOSTRZYNSKA M, 1989, FEMS MICROBIOL LETT, V59, P229; LANTZ MS, 1986, INFECT IMMUN, V54, P654, DOI 10.1128/IAI.54.3.654-658.1986; LOHLER J, 1984, CELL, V38, P597, DOI 10.1016/0092-8674(84)90514-2; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MOLLENHAUER J, 1983, EMBO J, V2, P45, DOI 10.1002/j.1460-2075.1983.tb01378.x; PATTI JM, 1992, J BIOL CHEM, V267, P4766; RAJA RH, 1990, INFECT IMMUN, V58, P2593, DOI 10.1128/IAI.58.8.2593-2598.1990; RUBIN K, 1981, CELL, V24, P463, DOI 10.1016/0092-8674(81)90337-8; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SPEZIALE P, 1987, FEMS MICROBIOL LETT, V48, P47, DOI 10.1016/0378-1097(87)90133-9; SPEZIALE P, 1986, J BACTERIOL, V167, P77, DOI 10.1128/jb.167.1.77-81.1986; STAATZ WD, 1989, J CELL BIOL, P1917; STRAWICH E, 1971, BIOCHEMISTRY-US, V10, P3905, DOI 10.1021/bi00797a017; SWITALSKI LM, 1984, J BIOL CHEM, V259, P3734; SWITALSKI LM, 1993, INFECT IMMUN, V61, P4119, DOI 10.1128/IAI.61.10.4119-4125.1993; SWITALSKI LM, 1989, J BIOL CHEM, V264, P21080; SWITALSKI LM, 1993, MOL MICROBIOL, V7, P99, DOI 10.1111/j.1365-2958.1993.tb01101.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VUENTO M, 1979, BIOCHEM J, V183, P331, DOI 10.1042/bj1830331; WESTERLUND B, 1989, MOL MICROBIOL, V3, P329, DOI 10.1111/j.1365-2958.1989.tb00178.x	31	32	32	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					347	353		10.1074/jbc.270.1.347	http://dx.doi.org/10.1074/jbc.270.1.347			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814395	hybrid			2022-12-27	WOS:A1995QA28700055
J	WATANABE, Y; PERRINO, BA; CHANG, BH; SODERLING, TR				WATANABE, Y; PERRINO, BA; CHANG, BH; SODERLING, TR			IDENTIFICATION IN THE CALCINEURIN A SUBUNIT OF THE DOMAIN THAT BINDS THE REGULATORY B-SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN PHOSPHATASE; ELECTROPHORETIC TRANSFER; POLYACRYLAMIDE GELS; CALMODULIN; DEPHOSPHORYLATION; NITROCELLULOSE; ANTIBODY; KINASE	Calcineurin (CaN) is the serine/threonine protein phosphatase (phosphatase 2B) that is activated by binding of Ca2+ to its B subunit and to calmodulin (CaM). This paper identifies residues between the catalytic region and the CaM-binding domain of the A subunit as the domain that binds the regulatory B subunit. A purified fusion protein containing residues 328-390 of the A subunit 1) binds CaN B subunit, and 2) inhibits (IC50 = 0.1 mu M) the in vitro stimulation of CaN A phosphatase activity by purified CaN B subunit. A synthetic peptide corresponding to residues 341-360 blocked the binding of CaN B to residues 328-390 in the fusion protein, so 4 hydrophobic residues within this region (Val(349)-Phe(350) and Phe(356)-Val(357)) were mutated to either Glu (E mutant) or Gin (Q mutant). The wild-type and mutant A subunits were expressed individually or coexpressed with B subunit in Sf9 cells, purified and characterized. The mutant A subunits were similar to wildtype A subunit in terms of basal phosphatase activity (1-3 nmol/min/mg) and activation by Mn2+/CaM. Addition of purified B subunit to purified wild-type A subunit at a 1:1 molar ratio gave a 40-fold increase in phosphatase activity whereas addition of B subunit to either of the mutant A subunits had no effect on phosphatase activity, even at a 3:1 molar excess of B subunit. Furthermore, when wild-type or mutant A subunits were coexpressed with B subunit and purified on CaM-Sepharose, the B subunit co-eluted with the wild-type A subunit but not with either mutant A subunit. These results demonstrate that residues 328-390 in the A subunit bind B subunit and that the mutated hydrophobic residues are essential.	OREGON HLTH SCI UNIV,VOLLUM INST,PORTLAND,OR 97201	Oregon Health & Science University				Watanabe, Yasuo/0000-0003-2232-0091; Chang, Bill/0000-0003-3783-1820	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041292] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41292] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLUMENTHAL DK, 1986, J BIOL CHEM, V261, P8140; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COHEN P, 1989, J BIOL CHEM, V264, P21435; ENSLEN H, 1994, J BIOL CHEM, V269, P20872; HASHIMOTO Y, 1990, J BIOL CHEM, V265, P1924; HASHIMOTO Y, 1987, ARCH BIOCHEM BIOPHYS, V257, P418; HUBBARD MJ, 1989, EUR J BIOCHEM, V185, P411, DOI 10.1111/j.1432-1033.1989.tb15130.x; HUBBARD MJ, 1989, BIOCHEMISTRY-US, V28, P1868, DOI 10.1021/bi00430a066; KINCAID RL, 1988, P NATL ACAD SCI USA, V85, P8983, DOI 10.1073/pnas.85.23.8983; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MERAT DL, 1985, J BIOL CHEM, V260, P1053; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MURPHY BJ, 1993, J BIOL CHEM, V268, P27355; PERRINO BA, 1992, J BIOL CHEM, V267, P15965; SAITOH Y, 1991, BIOMED RES-TOKYO, V12, P215, DOI 10.2220/biomedres.12.215; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWANINGER M, 1993, J BIOL CHEM, V268, P23111; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	22	44	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					456	460		10.1074/jbc.270.1.456	http://dx.doi.org/10.1074/jbc.270.1.456			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814411	hybrid			2022-12-27	WOS:A1995QA28700072
J	LILJELUND, P; GHOSH, P; VANDENPOL, AN				LILJELUND, P; GHOSH, P; VANDENPOL, AN			EXPRESSION OF THE NEURAL AXON ADHESION MOLECULE L1 IN THE DEVELOPING AND ADULT-RAT BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTERNAL NILE GLYCOPROTEIN; CEREBELLAR GRANULE CELLS; X-LINKED HYDROCEPHALUS; 2ND MESSENGER SYSTEMS; NEURITE OUTGROWTH; N-CAM; BIOCHEMICAL-CHARACTERIZATION; NERVOUS-SYSTEM; IMMUNOGLOBULIN SUPERFAMILY; POSTNATAL-DEVELOPMENT	L1 is a developmentally regulated adhesion molecule that may play a role in some aspects of axonal guidance. With Northern blots we find peak expression of L1 RNA at postnatal day 1 (P1) in the developing rat brain. Western blots show a peak of protein on P15. The major form of L1 is 200 kDa, but lower molecular mass forms are found including 140 and 80 kDa, representing, respectively, the extracellular and intracellular regions of L1. Ah molecular mass forms of L1 change during development. Although expressed at lower levels than during development, L1 is found in all brain regions in the adult rat. Different regions of the brain show differential expression and regulation of L1 and its peptide fragments. For instance, the hypothalamus showed an enhanced L1-80/L1-200 ratio at P10 and P15 relative to that expressed by cerebellum and hippocampus. Cerebellar granule cells in culture showed strong L1-200 and almost no L1-60, 80, or -140, in contrast to the intact cerebellum at the same age, which showed weaker L1-200 and strong L1-60, -80, and -140. Control experiments indicated that the L1 proteolytic cleavage found in different developing brain regions occurred in vivo and was not a result of sample preparation. The amount of L1-200 in cultured granule cells was proportional to the measured length of the growing axon. Neuronal activity (increased with 25 mM K+, 100 mu m N-methyl-D-aspartate, and 100 mu m 4-aminopyridine) enhanced L1 transcription and translation. Together, these data suggest differential regulation of L1 expression and proteolytic cleavage specific for developmental ages and brain regions.	YALE UNIV,SCH MED,NEUROSURG SECT,NEW HAVEN,CT 06510	Yale University					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS010174, R01NS016296] Funding Source: NIH RePORTER; NINDS NIH HHS [NS16296, NS10174] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1972, J COMP NEUROL, V145, P399, DOI 10.1002/cne.901450402; ALTMAN J, 1982, EXP BRAIN RES S, V6, P8; APPEL F, 1993, J NEUROSCI, V13, P4764; ASOU H, 1992, NEUROREPORT, V3, P481, DOI 10.1097/00001756-199206000-00006; ASOU H, 1992, J CELL PHYSIOL, V153, P313, DOI 10.1002/jcp.1041530211; ATASHI JR, 1992, NEURON, V8, P831, DOI 10.1016/0896-6273(92)90197-L; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BALAZS R, 1988, NEUROSCIENCE, V27, P437, DOI 10.1016/0306-4522(88)90279-5; BALAZS R, 1990, NEUROSCIENCE, V37, P251, DOI 10.1016/0306-4522(90)90211-L; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; BRUMMENDORF T, 1993, NEURON, V10, P711; BURGOON MP, 1991, J CELL BIOL, V112, P1017, DOI 10.1083/jcb.112.5.1017; BUYUKUYSAL RL, 1990, J NEUROCHEM, V54, P1302, DOI 10.1111/j.1471-4159.1990.tb01963.x; CHUONG CM, 1984, J NEUROSCI, V4, P2354; COVAULT J, 1985, P NATL ACAD SCI USA, V82, P4544, DOI 10.1073/pnas.82.13.4544; DOHERTY P, 1992, J NEUROCHEM, V58, P2338, DOI 10.1111/j.1471-4159.1992.tb10984.x; EDELMAN GM, 1982, P NATL ACAD SCI-BIOL, V79, P7036, DOI 10.1073/pnas.79.22.7036; FAISSNER A, 1985, EMBO J, V4, P3105, DOI 10.1002/j.1460-2075.1985.tb04052.x; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FELSENFELD DP, 1994, NEURON, V12, P675, DOI 10.1016/0896-6273(94)90222-4; FISCHER G, 1986, J NEUROSCI, V6, P605; GAARDSVOLL H, 1991, FEBS LETT, V294, P94, DOI 10.1016/0014-5793(91)81350-H; GALLO V, 1987, J NEUROSCI, V7, P2203; GRUMET M, 1993, CELL ADHES COMMUN, V1, P177, DOI 10.3109/15419069309095693; GRUMET M, 1991, J CELL BIOL, V113, P1399, DOI 10.1083/jcb.113.6.1399; GRUMET M, 1984, P NATL ACAD SCI-BIOL, V81, P267, DOI 10.1073/pnas.81.1.267; HLAVIN ML, 1991, GENOMICS, V11, P416, DOI 10.1016/0888-7543(91)90150-D; HOFFMAN S, 1983, P NATL ACAD SCI-BIOL, V80, P5762, DOI 10.1073/pnas.80.18.5762; JAFFE SH, 1990, P NATL ACAD SCI USA, V87, P3589, DOI 10.1073/pnas.87.9.3589; JOUET M, 1994, NAT GENET, V7, P402, DOI 10.1038/ng0794-402; JOUET M, 1993, NAT GENET, V4, P331, DOI 10.1038/ng0893-331; KADMON G, 1990, J CELL BIOL, V110, P193, DOI 10.1083/jcb.110.1.193; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KOBAYASHI M, 1991, BIOCHIM BIOPHYS ACTA, V1090, P238, DOI 10.1016/0167-4781(91)90108-X; LASHER RS, 1972, BRAIN RES, V41, P482, DOI 10.1016/0006-8993(72)90521-5; LEGIUS E, 1994, CLIN GENET, V45, P165; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; LEMMON V, 1986, J NEUROSCI, V6, P2987; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; LINNEMANN D, 1988, DEV NEUROSCI-BASEL, V10, P34, DOI 10.1159/000111953; MCGUIRE JC, 1978, CELL, V15, P357, DOI 10.1016/0092-8674(78)90004-1; MIURA M, 1991, FEBS LETT, V289, P91, DOI 10.1016/0014-5793(91)80915-P; MIURA M, 1992, J BIOL CHEM, V267, P10752; MOGENSEN NW, 1990, DEV BRAIN RES, V54, P81, DOI 10.1016/0165-3806(90)90067-9; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; MURRAY BA, 1986, J CELL BIOL, V103, P1431, DOI 10.1083/jcb.103.4.1431; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; NYBROE O, 1990, INT J DEV NEUROSCI, V8, P273, DOI 10.1016/0736-5748(90)90033-X; PERIDES G, 1993, J BIOL CHEM, V268, P25197; PERIDES G, 1994, J BIOL CHEM, V269, P765; PERSOHN E, 1987, J CELL BIOL, V105, P569, DOI 10.1083/jcb.105.1.569; PERSOHN E, 1990, J NEUROCYTOL, V19, P807, DOI 10.1007/BF01186812; PRATTIS SM, 1994, J COMP PATHOL, V110, P253, DOI 10.1016/S0021-9975(08)80278-2; PRINCE JT, 1991, J NEUROSCI RES, V30, P567, DOI 10.1002/jnr.490300315; RATHJEN FG, 1984, EMBO J, V3, P1; RATHJEN FG, 1988, TRENDS NEUROSCI, V11, P183, DOI 10.1016/0166-2236(88)90116-6; REID RA, 1992, J MOL NEUROSCI, V3, P127, DOI 10.1007/BF02919404; RICHTERLANDSBER.C, 1988, CELL TISSUE RES, V252, P181; ROSENTHAL A, 1992, NAT GENET, V2, P107, DOI 10.1038/ng1092-107; ROTHBARD JB, 1982, J BIOL CHEM, V257, P1064; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SADOUL K, 1988, J NEUROCHEM, V50, P510, DOI 10.1111/j.1471-4159.1988.tb02941.x; SALTON SRJ, 1983, J NEUROSCI, V3, P441; SALTON SRJ, 1983, J NEUROSCI, V3, P2420; SALZER JL, 1989, DEV NEUROSCI-BASEL, V11, P377, DOI 10.1159/000111914; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; STALLCUP WB, 1985, P NATL ACAD SCI USA, V82, P1276, DOI 10.1073/pnas.82.4.1276; STALLCUP WB, 1985, J NEUROSCI, V5, P1090; SUCHER NJ, 1993, J BIOL CHEM, V268, P22299; TIBBS GR, 1989, J NEUROCHEM, V52, P201, DOI 10.1111/j.1471-4159.1989.tb10917.x; VACCARINO FM, 1992, MOL BRAIN RES, V12, P233, DOI 10.1016/0169-328X(92)90089-T; VANDENPOL AN, 1985, SCIENCE, V228, P332, DOI 10.1126/science.2858916; VANDENPOL AN, 1993, J COMP NEUROL, V332, P237, DOI 10.1002/cne.903320208; VANDENPOL AN, 1994, J NEUROSCI, V14, P3816; VONBOHLEN F, 1992, EUR J NEUROSCI, V4, P896; WALLACE DR, 1993, NEUROCHEM RES, V18, P1271, DOI 10.1007/BF00975047; WILLE W, 1981, J NEUROCHEM, V37, P443, DOI 10.1111/j.1471-4159.1981.tb00475.x; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883; WOLFF JM, 1988, J BIOL CHEM, V263, P11943; WOLFF JM, 1987, EUR J BIOCHEM, V168, P551, DOI 10.1111/j.1432-1033.1987.tb13453.x	81	55	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					32886	32895						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806515				2022-12-27	WOS:A1994QA63800028
J	ARENDT, CW; OSTERGAARD, HL				ARENDT, CW; OSTERGAARD, HL			CD45 PROTEIN-TYROSINE-PHOSPHATASE IS SPECIFICALLY ASSOCIATED WITH A 116-KDA TYROSINE-PHOSPHORYLATED GLYCOPROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL ANTIGEN RECEPTOR; HUMAN LYMPHOCYTES-T; LEUKOCYTE-COMMON ANTIGEN; PHOSPHOTYROSINE PHOSPHATASE; SIGNAL TRANSDUCTION; CYTOPLASMIC DOMAIN; ZETA-CHAIN; KINASE; ACTIVATION; TRANSMEMBRANE	CD45 is a protein-tyrosine phosphatase expressed on all cells of hematopoietic origin. In an attempt to further characterize CD45 function, we set out to identify molecule(s) that specifically associate with CD45. A 116-kDa protein was detected in immunoprecipitates from CD45(+) cells but not CD45(-) cells. The association between CD45 and this 116-kDa protein can be reconstituted by mixing lysates from CD45(-) cell lines with purified CD45. p116 appears to associate with CD45 through the external, transmembrane, or membrane-proximal region of CD45 since p116 is associated with a mutant form of CD45 possessing a truncated cytoplasmic domain. The association of p116 with CD45 is not isoform-specific as p116 associates equally well with various CD45 isoforms. We have determined that p116 is a tyrosine-phosphorylated glycoprotein and that it is associated with CD45 in all hematopoietic cells examined, Because of its broad distribution, it is possible that identification of pile will provide additional insight into the function of CD45 in lymphoid as well as non-lymphoid hematopoietic cells.	UNIV ALBERTA,DEPT IMMUNOL,EDMONTON,AB T6G 2H7,CANADA	University of Alberta								CHARBONNEAU H, 1988, P NATL ACAD SCI USA, V85, P7182, DOI 10.1073/pnas.85.19.7182; DESAI DM, 1993, CELL, V73, P541, DOI 10.1016/0092-8674(93)90141-C; DIANZANI U, 1992, EUR J IMMUNOL, V22, P365, DOI 10.1002/eji.1830220212; DIANZANI U, 1990, EUR J IMMUNOL, V20, P2249, DOI 10.1002/eji.1830201014; HOVIS RR, 1993, SCIENCE, V260, P544, DOI 10.1126/science.8475387; HYMAN R, 1982, IMMUNOGENETICS, V15, P413, DOI 10.1007/BF00364264; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; JOHNSON P, 1989, J EXP MED, V169, P1179, DOI 10.1084/jem.169.3.1179; JUSTEMENT LB, 1991, SCIENCE, V252, P1839, DOI 10.1126/science.1648262; KANE KP, 1989, MOL IMMUNOL, V26, P759, DOI 10.1016/0161-5890(89)90036-9; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOKESHWAR VB, 1992, J BIOL CHEM, V267, P21551; MCFARLAND EDC, 1993, P NATL ACAD SCI USA, V90, P1402, DOI 10.1073/pnas.90.4.1402; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; MUSTELIN T, 1992, EUR J IMMUNOL, V22, P1173, DOI 10.1002/eji.1830220510; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; PEYRON JF, 1991, INT IMMUNOL, V3, P1357, DOI 10.1093/intimm/3.12.1357; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; SCHRAVEN B, 1990, NATURE, V345, P71, DOI 10.1038/345071a0; SHIROO M, 1992, EMBO J, V11, P4887, DOI 10.1002/j.1460-2075.1992.tb05595.x; SIEH M, 1993, EMBO J, V12, P315, DOI 10.1002/j.1460-2075.1993.tb05659.x; TAKEDA A, 1992, J BIOL CHEM, V267, P16651; TAKEDA A, 1994, J BIOL CHEM, V269, P2357; TONKS N K, 1988, Biochemistry, V27, P8695, DOI 10.1021/bi00424a001; TORIMOTO Y, 1991, J IMMUNOL, V147, P2514; TROWBRIDGE IS, 1978, J EXP MED, V148, P313, DOI 10.1084/jem.148.1.313; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; VOLAREVIC S, 1993, SCIENCE, V260, P541, DOI 10.1126/science.8475386; VOLAREVIC S, 1990, P NATL ACAD SCI USA, V87, P7085, DOI 10.1073/pnas.87.18.7085; VOLAREVIC S, 1992, J EXP MED, V176, P835, DOI 10.1084/jem.176.3.835; WEAVER CT, 1991, MOL CELL BIOL, V11, P4415, DOI 10.1128/MCB.11.9.4415; WEISSMAN AM, 1988, SCIENCE, V239, P1018, DOI 10.1126/science.3278377	34	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2313	2319						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836464				2022-12-27	WOS:A1995QE49300052
J	MORRISON, BW; MOORMAN, JR; KOWDLEY, GC; KOBAYASHI, YM; JONES, LR; LEDER, P				MORRISON, BW; MOORMAN, JR; KOWDLEY, GC; KOBAYASHI, YM; JONES, LR; LEDER, P			MAT-8, A NOVEL PHOSPHOLEMMAN-LIKE PROTEIN EXPRESSED IN HUMAN BREAST-TUMORS, INDUCES A CHLORIDE CONDUCTANCE IN XENOPUS OOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; CHANNEL; MUTATIONS; CELLS; ACID; ISK; K+	We recently identified a novel 8-kDa transmembrane protein, Mat-8, that is expressed in a subset of murine breast tumors. We have now cloned a cDNA encoding the human version of Mat-8 and show that it is expressed both in primary human breast tumors and in human breast tumor cell lines. The extracellular and transmembrane domains of Mat-8 are homologous to those of phospholemman (PLM), the major plasmalemmal substrate for cAMP-dependent protein kinase and protein kinase C in several different tissues, PLM, which induces chloride currents when expressed in Xenopus oocytes, contains consensus phosphorylation sites for both cAMP-dependent protein kinase A and protein kinase C in its cytoplasmic domain. In contrast, the cytoplasmic domain of Mat-8 contains no such consensus phosphorylation sites and is, in fact, unrelated to the cytoplasmic domain of PLM, RNA blot analysis reveals that Mat-8 and PLM exhibit distinct tissue-specific patterns of expression. We show that expression of Mat-8 in Xenopus oocytes induces hyperpolarization-activated chloride currents similar to those induced by PLM expression, These findings suggest that Mat-8 and PLM, the products of distinct genes, are related proteins that serve as Cl- channels or Cl- channel regulators but have different roles in cell and organ physiology.	HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,BOSTON,MA 02115; UNIV VIRGINIA,HLTH SCI CTR,DEPT INTERNAL MED,DIV CARDIOVASC,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,HLTH SCI CTR,DEPT MOLEC PHYSIOL & BIOPHYS,CHARLOTTESVILLE,VA 22908; INDIANA UNIV,SCH MED,KRANNERT INST CARDIOL,DEPT INTERNAL MED,INDIANAPOLIS,IN 46202; INDIANA UNIV,SCH MED,KRANNERT INST CARDIOL,DEPT BIOCHEM,INDIANAPOLIS,IN 46202	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Virginia; University of Virginia; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis			Moorman, J Randall/ABG-9946-2020					ACKERMAN SJ, 1994, BIOPHYS J, V66, pA216; Almers W, 1978, Rev Physiol Biochem Pharmacol, V82, P96, DOI 10.1007/BFb0030498; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ATTALI B, 1993, NATURE, V365, P850, DOI 10.1038/365850a0; BLATZ AL, 1985, BIOPHYS J, V47, P119, DOI 10.1016/S0006-3495(85)83884-4; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DURIEUX ME, 1992, AM J PHYSIOL, V263, pC896, DOI 10.1152/ajpcell.1992.263.4.C896; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRANCIOLINI F, 1987, J GEN PHYSIOL, V90, P453, DOI 10.1085/jgp.90.4.453; GOLDSTEIN SAN, 1991, NEURON, V7, P403, DOI 10.1016/0896-6273(91)90292-8; Hille B., 1992, IONIC CHANNELS EXCIT; HOLLYWOOD DP, 1993, EMBO J, V12, P2369, DOI 10.1002/j.1460-2075.1993.tb05891.x; KOWDLEY GC, 1994, J GEN PHYSIOL, V103, P217, DOI 10.1085/jgp.103.2.217; KOWDLEY GC, 1994, BIOPHYS J, V66, pA216; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KREIG PA, 1984, NUCLEIC ACIDS RES, V12, P7057; MERCER RW, 1993, J CELL BIOL, V121, P579, DOI 10.1083/jcb.121.3.579; MOORMAN JR, 1992, J BIOL CHEM, V267, P14551; MORRISON BW, 1994, ONCOGENE, V9, P3417; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; Sambrook J, 1989, MOL CLONING LABORATO; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCOTT GK, 1993, MOL CELL BIOL, V13, P2247, DOI 10.1128/MCB.13.4.2247; SHEN MM, 1992, P NATL ACAD SCI USA, V89, P8240, DOI 10.1073/pnas.89.17.8240; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; TAKUMI T, 1991, J BIOL CHEM, V266, P22192; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; THOMAS P, 1981, P NATL ACAD SCI USA, V77, P5201; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683	31	139	152	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2176	2182		10.1074/jbc.270.5.2176	http://dx.doi.org/10.1074/jbc.270.5.2176			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836447	hybrid			2022-12-27	WOS:A1995QE49300032
J	PARADA, CA; YOON, JB; ROEDER, RG				PARADA, CA; YOON, JB; ROEDER, RG			A NOVEL LBP-1-MEDIATED RESTRICTION OF HIV-1 TRANSCRIPTION AT THE LEVEL OF ELONGATION IN-VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-II; LONG TERMINAL REPEAT; VIRUS TYPE-1 PROMOTER; NF-KAPPA-B; TAT PROTEIN; ACTIVATES TRANSCRIPTION; COOPERATIVE INTERACTION; XENOPUS-OOCYTES; GENE-EXPRESSION; MESSENGER-RNA	The cellular factor, LBP-1, can repress HIV-1 transcription by preventing the binding of TFIID to the promoter. Here we have analyzed the effect of recombinant LBP-1 on HIV-1 transcription in vitro by using a ''pulse-chase'' assay. LBP-1 had no effect on initiation from a preformed preinitiation complex and elongation to position +13 (''pulse''). However, addition of LBP-1 after RNA polymerase was stalled at +13 strongly inhibited further elongation (''chase'') by reducing RNA polymerase processivity, Severe mutations of the high affinity LBP-1 binding sites between -4 and +21 did not relieve the LBP-1-dependent block. However, LBP-1 could bind independently to upstream low affinity sites (-80 to -4), suggesting that these sites mediate the effect of LBP-1 on elongation. These results demonstrate a novel function of LBP-1, restricting HIV-1 transcription at the level of elongation. In addition, Tat was found to suppress the antiprocessivity effect of LBP-1 on HIV-1 transcription in nuclear extracts. These findings strongly suggest that LBP-1 may provide a natural mechanism for restricting the elongation of HIV-1 transcripts and that this may be a target for the action of Tat in enhancing transcription.			PARADA, CA (corresponding author), ROCKEFELLER UNIV, BIOCHEM & MOLEC BIOL LAB, NEW YORK, NY 10021 USA.			Yoon, Jong-Bok/0000-0002-3563-0702	NIAID NIH HHS [AI27397] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI027397] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BENGAL E, 1991, MOL CELL BIOL, V11, P1195, DOI 10.1128/MCB.11.3.1195; BENGAL E, 1991, J VIROL, V65, P4910, DOI 10.1128/JVI.65.9.4910-4918.1991; BERKHOUT B, 1992, J VIROL, V66, P139, DOI 10.1128/JVI.66.1.139-149.1992; BERKHOUT B, 1990, CELL, V62, P757, DOI 10.1016/0092-8674(90)90120-4; BIELINSKA A, 1989, J VIROL, V63, P4097, DOI 10.1128/JVI.63.9.4097-4100.1989; Bohan Cindy A., 1992, Gene Expression, V2, P391; BRADDOCK M, 1993, FASEB J, V7, P214, DOI 10.1096/fasebj.7.1.8422967; BRADSHER JN, 1993, J BIOL CHEM, V268, P25594; CULLEN BR, 1993, CELL, V73, P417, DOI 10.1016/0092-8674(93)90126-B; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FASHANACHI F, 1994, NATURE, V367, P295; GENTZ R, 1989, P NATL ACAD SCI USA, V86, P821, DOI 10.1073/pnas.86.3.821; GIARDINA C, 1992, GENE DEV, V6, P2190, DOI 10.1101/gad.6.11.2190; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; GRAEBLE MA, 1993, P NATL ACAD SCI USA, V90, P6184, DOI 10.1073/pnas.90.13.6184; GREENBLATT J, 1993, NATURE, V364, P401, DOI 10.1038/364401a0; HAN P, 1991, NUCLEIC ACIDS RES, V19, P7225, DOI 10.1093/nar/19.25.7225; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; JEANG KT, 1993, J BIOL CHEM, V268, P24940; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; JONES KA, 1988, GENE DEV, V2, P1101, DOI 10.1101/gad.2.9.1101; KAMINE J, 1992, J VIROL, V66, P3932, DOI 10.1128/JVI.66.6.3932-3936.1992; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; KATO H, 1992, GENE DEV, V6, P655, DOI 10.1101/gad.6.4.655; KATO H, 1991, SCIENCE, V251, P1476, DOI 10.1126/science.2006421; KEPHART DD, 1992, MOL CELL BIOL, V12, P2067, DOI 10.1128/MCB.12.5.2067; KESSLER M, 1992, J VIROL, V66, P4488, DOI 10.1128/JVI.66.7.4488-4496.1992; KESSLER M, 1991, P NATL ACAD SCI USA, V88, P10018, DOI 10.1073/pnas.88.22.10018; KREUZER KN, 1984, J BIOL CHEM, V259, P5339; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; LASPIA MF, 1990, GENE DEV, V4, P2397, DOI 10.1101/gad.4.12b.2397; LASPIA MF, 1989, CELL, V59, P283, DOI 10.1016/0092-8674(89)90290-0; LEE HS, 1992, GENE DEV, V6, P284, DOI 10.1101/gad.6.2.284; LU XB, 1993, J VIROL, V67, P1752, DOI 10.1128/JVI.67.4.1752-1760.1993; MADORE SJ, 1993, J VIROL, V67, P3703, DOI 10.1128/JVI.67.7.3703-3711.1993; MALIM MH, 1989, J VIROL, V63, P3213, DOI 10.1128/JVI.63.8.3213-3219.1989; MARCINIAK RA, 1990, CELL, V63, P791, DOI 10.1016/0092-8674(90)90145-5; MARCINIAK RA, 1991, EMBO J, V10, P4189, DOI 10.1002/j.1460-2075.1991.tb04997.x; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; MEISTERERNST M, 1991, CELL, V66, P981, DOI 10.1016/0092-8674(91)90443-3; MEULIA T, 1993, MOL CELL BIOL, V13, P5647, DOI 10.1128/MCB.13.9.5647; OLSEN HS, 1992, J VIROL, V66, P5594, DOI 10.1128/JVI.66.9.5594-5597.1992; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; RATNASABAPATHY R, 1990, GENE DEV, V4, P2061, DOI 10.1101/gad.4.12a.2061; REINES D, 1992, J BIOL CHEM, V267, P3795; ROSEN CA, 1985, CELL, V41, P813, DOI 10.1016/S0092-8674(85)80062-3; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; SELBY MJ, 1989, GENE DEV, V3, P547, DOI 10.1101/gad.3.4.547; SHARP PA, 1989, CELL, V59, P229, DOI 10.1016/0092-8674(89)90279-1; SHELDON M, 1993, MOL CELL BIOL, V13, P1251, DOI 10.1128/MCB.13.2.1251; SOUTHGATE CD, 1991, GENE DEV, V5, P2496, DOI 10.1101/gad.5.12b.2496; SPENCER CA, 1990, ONCOGENE, V5, P777; STROBL LJ, 1992, EMBO J, V11, P3307, DOI 10.1002/j.1460-2075.1992.tb05409.x; TOOHEY MG, 1989, GENE DEV, V3, P265, DOI 10.1101/gad.3.3.265; WRIGHT S, 1993, MOL BIOL CELL, V4, P661, DOI 10.1091/mbc.4.7.661; WU FK, 1988, EMBO J, V7, P2117, DOI 10.1002/j.1460-2075.1988.tb03051.x; YANKULOV K, 1994, CELL, V77, P749, DOI 10.1016/0092-8674(94)90058-2; YARNELL WS, 1992, CELL, V69, P1181, DOI 10.1016/0092-8674(92)90639-T; YOON JB, 1994, MOL CELL BIOL, V14, P176; ZENZIEGREGORY B, 1992, J BIOL CHEM, V267, P2823	63	38	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2274	2283		10.1074/jbc.270.5.2274	http://dx.doi.org/10.1074/jbc.270.5.2274			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836461	hybrid			2022-12-27	WOS:A1995QE49300047
J	LESSARD, M; ZHAO, CQ; SINGH, SM; POULIN, R				LESSARD, M; ZHAO, CQ; SINGH, SM; POULIN, R			HORMONAL AND FEEDBACK-REGULATION OF PUTRESCINE AND SPERMIDINE TRANSPORT IN HUMAN BREAST-CANCER CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L1210 LEUKEMIA-CELLS; POLYAMINE TRANSPORT; ORNITHINE DECARBOXYLASE; MAMMALIAN-CELLS; GENE-EXPRESSION; GROWTH-FACTOR; METHYLGLYOXAL BIS(GUANYLHYDRAZONE); GASTROINTESTINAL-TRACT; PROGESTERONE-RECEPTOR; CARCINOMA-CELLS	The properties and regulation of the mammalian polyamine transport system are still poorly understood, In estrogen-responsive ZR-75-1 human breast cancer cells, which display low polyamine biosynthetic activity, putrescine and spermidine were internalized with high affinity (K-m = 3.7 and 0.5 mu M, respectively) via a single class of saturable transporter shared by both substrate types, or via distinct but closely similar carriers, The V-max, but not the K-m of polyamine transport was rapidly and synergistically up-regulated by estrogens and insulin, The steady decay in transport activity observed in hormone deprived cells was accelerated by retinoic acid, The enhancement of uptake activity resulting from polyamine depletion was amplified 3-fold by estrogens and insulin despite profound growth inhibition, indicating that the cooperative hormonal induction of polyamine transport is dissociated from cell growth status, Polyamine uptake was under feedback inhibition by at least three distinct mechanisms in these cells, namely (i) the induction of a short-lived protein not actively synthesized without ongoing uptake or upon polyamine deletion; (ii) a more latent, protein synthesis-independent ''trans-inhibition'' mechanism; and (iii) a post-carrier, cycloheximide-sensitive mechanism limiting substrate accumulation. The complexity of these multiple levels of feedback transport inhibition is in keeping with the cytotoxicity of excessive polyamine content.	UNIV LAVAL,MED RES CTR,DEPT PHYSIOL,MOLEC ENDOCRINOL LAB,ST FOY,PQ G1V 4G2,CANADA	Laval University								ALHONENHONGISTO L, 1980, BIOCHEM J, V192, P941, DOI 10.1042/bj1920941; ASK A, 1992, CANCER LETT, V66, P29, DOI 10.1016/0304-3835(92)90276-2; BERGERON RJ, 1986, BIOORG CHEM, V14, P345, DOI 10.1016/0045-2068(86)90001-5; Bey P., 1987, INHIBITION POLYAMINE, P1; BOGLE RG, 1994, AM J PHYSIOL, V266, pC776, DOI 10.1152/ajpcell.1994.266.3.C776; BRUNTON VG, 1991, BIOCHEM J, V280, P193, DOI 10.1042/bj2800193; BYERS TL, 1987, AM J PHYSIOL, V252, pC663, DOI 10.1152/ajpcell.1987.252.6.C663; BYERS TL, 1989, AM J PHYSIOL, V257, pC545, DOI 10.1152/ajpcell.1989.257.3.C545; BYERS TL, 1990, J CELL PHYSIOL, V143, P460, DOI 10.1002/jcp.1041430309; BYERS TL, 1992, BIOCHEM J, V287, P697; CASARA P, 1989, J AM CHEM SOC, V111, P9111, DOI 10.1021/ja00207a024; CASERO RA, 1993, FASEB J, V7, P653, DOI 10.1096/fasebj.7.8.8500690; CELANO P, 1989, J BIOL CHEM, V264, P8922; CHANEY JE, 1983, LIFE SCI, V32, P1237, DOI 10.1016/0024-3205(83)90193-5; CHEN N, 1992, BIOCHEM PHARMACOL, V44, P1029, DOI 10.1016/0006-2952(92)90364-O; CLARKE CL, 1991, J BIOL CHEM, V266, P18969; DAVIS RH, 1991, ARCH BIOCHEM BIOPHYS, V285, P297, DOI 10.1016/0003-9861(91)90363-N; DICKSON RB, 1988, BREAST CANCER CELLUL, P119; Dixon M., 1979, Enzymes.; FONTANA JA, 1992, CANCER RES, V52, P3938; GAWELTHOMPSON KJ, 1989, J CELL PHYSIOL, V140, P359, DOI 10.1002/jcp.1041400222; GLIKMAN P, 1989, CANCER RES, V49, P1369; GORDONSMITH RH, 1983, BIOCHEM PHARMACOL, V32, P3701, DOI 10.1016/0006-2952(83)90138-7; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; HE Y, 1994, BIOCHEM BIOPH RES CO, V203, P608, DOI 10.1006/bbrc.1994.2226; HEATON MA, 1988, J CELL PHYSIOL, V136, P133, DOI 10.1002/jcp.1041360117; HEBY O, 1990, TRENDS BIOCHEM SCI, V15, P153, DOI 10.1016/0968-0004(90)90216-X; HESSELS J, 1989, INT J CANCER, V43, P1155, DOI 10.1002/ijc.2910430632; HUBER M, 1995, IN PRESS CANCER RES, V55; HYVONEN T, 1994, BBA-MOL CELL RES, V1221, P279, DOI 10.1016/0167-4889(94)90251-8; ISSINGER OG, 1993, PHARMACOL THERAPEUT, V59, P1, DOI 10.1016/0163-7258(93)90039-G; KAKINUMA Y, 1988, EUR J BIOCHEM, V176, P409, DOI 10.1111/j.1432-1033.1988.tb14297.x; KANO K, 1976, J BIOL CHEM, V251, P2795; KENDRA KL, 1987, J STEROID BIOCHEM, V28, P123, DOI 10.1016/0022-4731(87)90367-0; KILLBERG MS, 1994, FASEB J, V8, P13; KINGSNORTH AN, 1985, EUR J CANCER CLIN ON, V21, P1057, DOI 10.1016/0277-5379(85)90291-3; KUMAGAI J, 1989, AM J PHYSIOL, V256, pG905, DOI 10.1152/ajpgi.1989.256.5.G905; LAKANEN JR, 1992, J MED CHEM, V35, P724, DOI 10.1021/jm00082a013; LIMA G, 1985, CANCER RES, V45, P2466; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTIN RL, 1991, HEPATOLOGY, V14, P1243, DOI 10.1002/hep.1840140646; Marton LJ, 1987, INHIB POLYAM METABOL, P79; MATSUFUJI S, 1990, J BIOCHEM-TOKYO, V108, P365, DOI 10.1093/oxfordjournals.jbchem.a123207; MINCHIN RF, 1989, BIOCHEM J, V262, P391, DOI 10.1042/bj2620391; MITCHELL JLA, 1992, BIOCHEM BIOPH RES CO, V186, P81, DOI 10.1016/S0006-291X(05)80778-8; MITCHELL JLA, 1994, BIOCHEM J, V299, P19, DOI 10.1042/bj2990019; MITCHELL JLA, 1992, BIOCHIM BIOPHYS ACTA, V1136, P136, DOI 10.1016/0167-4889(92)90248-A; MURAKAMI Y, 1992, J BIOL CHEM, V267, P13138; NICOLET T, 1991, INT J CANCER, V49, P577, DOI 10.1002/ijc.2910490418; NORMAN JC, 1988, EUR J CANCER CLIN ON, V24, P603, DOI 10.1016/0277-5379(88)90288-X; Oka T., 1981, Advances in Polyamine Research, V3, P309; OSBORNE DL, 1990, AM J PHYSIOL, V258, pG576, DOI 10.1152/ajpgi.1990.258.4.G576; PARK MH, 1993, TRENDS BIOCHEM SCI, V18, P475, DOI 10.1016/0968-0004(93)90010-K; PEGG AE, 1989, BIOCHEMISTRY-US, V28, P8446, DOI 10.1021/bi00447a026; PEGG AE, 1988, CANCER RES, V48, P759; PERSSON L, 1988, CANCER RES, V48, P4807; PHILIPS A, 1993, J BIOL CHEM, V268, P14103; POHJANPELTO P, 1976, J CELL BIOL, V68, P512, DOI 10.1083/jcb.68.3.512; PORTER CW, 1985, CANCER RES, V45, P2050; PORTER CW, 1984, CANCER RES, V44, P126; POULIN R, 1995, J BIOL CHEM, V270, P1695, DOI 10.1074/jbc.270.4.1695; POULIN R, 1991, J BIOL CHEM, V266, P6142; POULIN R, 1993, J BIOL CHEM, V268, P4690; POULIN R, 1989, ENDOCRINOLOGY, V125, P392, DOI 10.1210/endo-125-1-392; RINEHART CA, 1984, J BIOL CHEM, V259, P4750; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; ROMAN SD, 1992, CANCER RES, V52, P2236; ROSE MS, 1974, NATURE, V252, P314, DOI 10.1038/252314b0; SARHAN S, 1989, ANTICANCER RES, V9, P215; SAUNDERS NA, 1989, J CELL PHYSIOL, V139, P624, DOI 10.1002/jcp.1041390324; SEILER N, 1990, CANCER RES, V50, P5077; SEILER N, 1990, INT J BIOCHEM, V22, P211, DOI 10.1016/0020-711X(90)90332-W; SIMARD J, 1990, ENDOCRINOLOGY, V126, P3223, DOI 10.1210/endo-126-6-3223; SPORN MB, 1995, MOL ENDOCRINOL, V5, P3; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; THOMAS T, 1989, CANCER RES, V49, P5852; THOMAS T, 1994, CANCER RES, V54, P1077; TOME ME, 1994, J CELL PHYSIOL, V158, P237, DOI 10.1002/jcp.1041580205; VANDERBURG B, 1990, MOL ENDOCRINOL, V4, P1720, DOI 10.1210/mend-4-11-1720; VOLKOW N, 1983, SCIENCE, V221, P673, DOI 10.1126/science.6603020	80	49	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1685	1694		10.1074/jbc.270.4.1685	http://dx.doi.org/10.1074/jbc.270.4.1685			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829504	hybrid			2022-12-27	WOS:A1995QD20400034
J	NAGAI, M; KAMINAKA, S; OHBA, Y; NAGAI, Y; MIZUTANI, Y; KITAGAWA, T				NAGAI, M; KAMINAKA, S; OHBA, Y; NAGAI, Y; MIZUTANI, Y; KITAGAWA, T			ULTRAVIOLET RESONANCE RAMAN STUDIES OF QUATERNARY STRUCTURE OF HEMOGLOBIN USING A TRYPTOPHAN BETA-37 MUTANT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; RESOLUTION; SPECTROSCOPY; PROTEINS; SPECTRA; DEOXYHEMOGLOBIN; INTERSUBUNIT; EXCHANGE; TYROSINE; KINETICS	Environmental changes of tyrosine and tryptophan residues of hemoglobin (Hb) upon its T to R transition of quaternary structure were investigated with ultraviolet resonance Raman (UVRR) spectroscopy excited at 235 nm, DeoxyHb A (T-form) showed a UVRR spectrum distinctly different from those of the ligated Hbs (R-form) including oxyHb, COHb, and metHb G whereas the ligated Hbs exhibited similar UVRR spectra irrespective of the ligand species and the oxidation state of the heme, To characterize the spectral change of Trp-beta 37 at the alpha(1) beta(2) interface due to the quaternary structure transition, the UVRR spectra of Hb A were compared with the corresponding spectra of Hb Hirose (Trp-beta 37 --> Ser), A difference spectrum between deoxyHb A and deoxyHb Hirose showed only Trp resonance Raman (RR) bands, which were reasonably ascribed to Trp-beta 37 in deoxyHb A. RR bands at 873 cm(-1) (W17) and at 1360 and 1343 cm(-1) (W7, Fermi doublet) indicated that the indole ring of Trp-beta 37 in deoxyHb A formed a strong hydrogen bond at the N1H site in hydrophobic environments, Tyr residues in deoxyHb Hirose seemed to be in the same environments as those of deoxyHb A. In contrast, the difference spectrum between Hb A and Hb Hirose in the ligated state displayed peaks for RR bands of both Trp and Tyr, The difference spectra were unaltered by the addition of 5 mM inositol hexaphosphate, This means that the differences were not caused by the tetramer to dimer dissociation but by a conformation change within a tetramer, Comparison of the Hb A-Hb Hirose difference spectra in the oxy and deoxy states revealed that the oxygenation-induced changes of Trp RR bands arose mostly from Trp-beta 37 with the small portion of remaining changes coming from Trp-beta 15, demonstrating that Trp-beta 37 plays a pivotal role in the quaternary structural change in Hb A.	OKAZAKI NATL RES INST,INST MOLEC SCI,OKAZAKI,AICHI 444,JAPAN; KANAZAWA UNIV,SCH ALLIED MED PROFESS,BIOL LAB,KANAZAWA,ISHIKAWA 920,JAPAN; YAMAGUCHI UNIV,SCH MED,DEPT CLIN SCI,UBE,YAMAGUCHI 755,JAPAN; FUKUI MED SCH,BIOL LAB,FUKUI 91011,JAPAN	National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Okazaki Institute for Integrative Bioscience (OIIB); Kanazawa University; Yamaguchi University; University of Fukui			Mizutani, Yasuhisa/B-3809-2009					[Anonymous], 1968, J CRYST GROWTH, DOI [rg/10.1016/00220248(68)900717, DOI 10.1016/0022-0248(68)90071-7]; ASAKURA T, 1976, J MOL BIOL, V104, P185, DOI 10.1016/0022-2836(76)90008-5; Austin J. C., 1993, BIOMOLECULAR SPECT A, P55; BALDWIN J, 1979, J MOL BIOL, V129, P175, DOI 10.1016/0022-2836(79)90277-8; BALDWIN JM, 1980, J MOL BIOL, V136, P103, DOI 10.1016/0022-2836(80)90308-3; CHO NJ, 1994, BIOCHEMISTRY-US, V33, P5932, DOI 10.1021/bi00185a034; COPELAND RA, 1985, BIOCHEMISTRY-US, V24, P4960, DOI 10.1021/bi00339a035; FERMI G, 1984, J MOL BIOL, V175, P159, DOI 10.1016/0022-2836(84)90472-8; FERMI G, 1981, ATLAS MOL STRUCTURES, V2, P3; FUNG LWM, 1975, BIOCHEMISTRY-US, V14, P2526, DOI 10.1021/bi00682a036; HARADA I, 1986, SPECTROCHIM ACTA A, V42, P307, DOI 10.1016/0584-8539(86)80193-3; Harada I, 1986, SPECTROSCOPY BIOL SY, P113; HILDEBRANDT PG, 1988, BIOCHEMISTRY-US, V27, P5426, DOI 10.1021/bi00415a007; HO C, 1992, ADV PROTEIN CHEM, V43, P153, DOI 10.1016/S0065-3233(08)60555-0; HUDSON B, 1987, BIOL APPLICATIONS RA, V2, P181; ISHIMORI K, 1992, BIOCHEMISTRY-US, V31, P3256, DOI 10.1021/bi00127a030; JAYARAMAN V, 1993, BIOCHEMISTRY-US, V32, P4547, DOI 10.1021/bi00068a009; KAMINAKA S, 1992, APPL SPECTROSC, V46, P1804, DOI 10.1366/0003702924123485; KAVANAUGH JS, 1992, BIOCHEMISTRY-US, V31, P4111, DOI 10.1021/bi00131a030; KITAGAWA T, 1992, PROG BIOPHYS MOL BIO, V58, P1, DOI 10.1016/0079-6107(92)90009-U; LADNER RC, 1977, J MOL BIOL, V114, P385, DOI 10.1016/0022-2836(77)90256-X; LIU GY, 1989, BIOCHEMISTRY-US, V28, P5046, DOI 10.1021/bi00438a022; MIURA T, 1989, J RAMAN SPECTROSC, V20, P667, DOI 10.1002/jrs.1250201007; MIURA T, 1988, BIOCHEMISTRY-US, V27, P88, DOI 10.1021/bi00401a015; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; RAVA RP, 1985, J PHYS CHEM-US, V89, P1856, DOI 10.1021/j100256a007; RODGERS KR, 1992, J AM CHEM SOC, V114, P3697, DOI 10.1021/ja00036a019; SASAKI J, 1978, J BIOL CHEM, V253, P87; SHAANAN B, 1983, J MOL BIOL, V171, P31, DOI 10.1016/S0022-2836(83)80313-1; SILVA MM, 1992, J BIOL CHEM, V267, P17248; SONG S, 1991, BIOCHEMISTRY-US, V30, P1199, DOI 10.1021/bi00219a006; YAMAOKA K, 1971, BLOOD-J HEMATOL, V38, P730, DOI 10.1182/blood.V38.6.730.730	32	53	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1636	1642		10.1074/jbc.270.4.1636	http://dx.doi.org/10.1074/jbc.270.4.1636			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829496	hybrid			2022-12-27	WOS:A1995QD20400026
J	KULIK, VP; KAVSAN, VM; VANSCHAIK, FMA; NOLTEN, LA; STEENBERGH, PH; SUSSENBACH, JS				KULIK, VP; KAVSAN, VM; VANSCHAIK, FMA; NOLTEN, LA; STEENBERGH, PH; SUSSENBACH, JS			THE PROMOTER OF THE SALMON INSULIN-LIKE GROWTH-FACTOR-I GENE IS ACTIVATED BY HEPATOCYTE NUCLEAR FACTOR-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IGF-I; INVITRO TRANSCRIPTION; MESSENGER-RNA; NUCLEOTIDE-SEQUENCE; TISSUE DISTRIBUTION; MOLECULAR-CLONING; XENOPUS-LAEVIS; ADULT-RAT; EXPRESSION; LIVER	Hepatocyte nuclear factor 1 (HNF-1) was found to have a potent stimulatory action on the activity of the promoter of the salmon insulin-like growth factor I (IGF-I) gene in transient transfection experiments. This liver-enriched transcription factor was shown to bind to an element in the proximal region of the promoter with distinct nucleotide sequence homology to the HNF-1 consensus binding sequence. Mutating this sequence to a variant no longer capable of HNF-1 binding resulted in the loss of the stimulatory effect. Since the sequence of the HNF-1 binding site is conserved in all mammalian, avian, and amphibian species from which the IGF-I promoter sequences have been derived to date, we propose that HNF-1 may be an important regulator of IGF-I gene expression in all of these species.	UNIV UTRECHT,PHYSIOL CHEM LAB,3508 TA UTRECHT,NETHERLANDS; UKRAINIAN ACAD SCI,INST MOLEC BIOL & GENET,DEPT BIOSYNTH NUCLEIC ACIDS,KIEV 252627,UKRAINE	Utrecht University; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU								ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; BARTKOWSKI S, 1993, MOL CELL BIOL, V13, P421, DOI 10.1128/MCB.13.1.421; BAUMHUETER S, 1990, GENE DEV, V49, P372; BICHELL DP, 1992, MOL ENDOCRINOL, V6, P1899, DOI 10.1210/me.6.11.1899; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; CAO QP, 1989, MOL ENDOCRINOL, V3, P2005, DOI 10.1210/mend-3-12-2005; COURTOIS G, 1988, P NATL ACAD SCI USA, V85, P7937, DOI 10.1073/pnas.85.21.7937; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DUGUAY SJ, 1994, J MOL ENDOCRINOL, V12, P25, DOI 10.1677/jme.0.0120025; ELSHOLTZ HP, 1992, MOL ENDOCRINOL, V6, P515, DOI 10.1210/me.6.4.515; FRAIN M, 1989, CELL, V59, P145, DOI 10.1016/0092-8674(89)90877-5; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hoerlein Andreas, 1993, Biological Chemistry Hoppe-Seyler, V374, P419; JANSEN E, 1991, MOL CELL ENDOCRINOL, V78, P115, DOI 10.1016/0303-7207(91)90192-U; JANSEN E, 1992, BIOCHEM BIOPH RES CO, V187, P1219, DOI 10.1016/0006-291X(92)90433-L; KAJIMOTO Y, 1990, MOL ENDOCRINOL, V4, P217, DOI 10.1210/mend-4-2-217; KAJIMOTO Y, 1989, MOL ENDOCRINOL, V3, P1907, DOI 10.1210/mend-3-12-1907; KAJIMOTO Y, 1991, J BIOL CHEM, V266, P9724; KAVSAN VM, 1994, DNA CELL BIOL, V13, P555, DOI 10.1089/dna.1994.13.555; KAVSAN VM, 1993, DNA CELL BIOL, V12, P729, DOI 10.1089/dna.1993.12.729; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; KOVAL A, 1994, DNA CELL BIOL, V13, P1057, DOI 10.1089/dna.1994.13.1057; KUO CJ, 1990, P NATL ACAD SCI USA, V87, P9838, DOI 10.1073/pnas.87.24.9838; KUSHNER PJ, 1994, MOL ENDOCRINOL, V8, P405, DOI 10.1210/me.8.4.405; LI Y, 1988, MOL CELL BIOL, V8, P4362, DOI 10.1128/MCB.8.10.4362; LI YC, 1994, GENE, V138, P257, DOI 10.1016/0378-1119(94)90819-2; LI YC, 1991, MOL CELL BIOL, V11, P1883, DOI 10.1128/MCB.11.4.1883; MENDEL DB, 1991, J BIOL CHEM, V266, P677; MONACI P, 1988, EMBO J, V7, P2075, DOI 10.1002/j.1460-2075.1988.tb03047.x; MURPHY LJ, 1987, ENDOCRINOLOGY, V120, P1279, DOI 10.1210/endo-120-4-1279; NICOSIA A, 1990, CELL, V61, P1225, DOI 10.1016/0092-8674(90)90687-A; ONO M, 1992, GENE, V226, P275; PRUIJN GJM, 1987, EMBO J, V6, P3771, DOI 10.1002/j.1460-2075.1987.tb02712.x; ROBERTS CT, 1987, BIOCHEM BIOPH RES CO, V146, P1154, DOI 10.1016/0006-291X(87)90768-6; ROBERTS CT, 1986, J BIOL CHEM, V261, P25; ROLS MP, 1994, NUCLEIC ACIDS RES, V22, P540, DOI 10.1093/nar/22.3.540; ROTWEIN P, 1986, J BIOL CHEM, V261, P4828; Sambrook J, 1989, MOL CLONING LABORATO; SAWADAISHI K, 1988, MOL CELL BIOL, V8, P5179, DOI 10.1128/MCB.8.12.5179; SCHORPP M, 1988, J MOL BIOL, V202, P307, DOI 10.1016/0022-2836(88)90460-3; STEENBERGH PH, 1991, BIOCHEM BIOPH RES CO, V175, P507, DOI 10.1016/0006-291X(91)91593-2; WARD A, 1992, INSULIN LIKE GROWTH, P45; WONG EA, 1989, DNA-J MOLEC CELL BIO, V8, P649, DOI 10.1089/dna.1.1989.8.649; YAMADA S, 1993, J BIOL CHEM, V268, P24361	45	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1068	1073		10.1074/jbc.270.3.1068	http://dx.doi.org/10.1074/jbc.270.3.1068			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836361	hybrid			2022-12-27	WOS:A1995QB15600016
J	SANCHEZ, HB; YIEH, L; OSBORNE, TF				SANCHEZ, HB; YIEH, L; OSBORNE, TF			COOPERATION BY STEROL REGULATORY ELEMENT-BINDING PROTEIN AND SP1 IN STEROL REGULATION OF LOW-DENSITY-LIPOPROTEIN RECEPTOR GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SP1; POLYMERASE-II TRANSCRIPTION; NF-KAPPA-B; DNA-BINDING; 3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE; SYNERGISTIC ACTIVATION; PROMOTER; SEQUENCE; IDENTIFICATION; EXPRESSION	Regulation of the low density lipoprotein (LDL) receptor promoter by cholesterol requires a well defined sterol regulatory site and an adjacent binding site for the universal transcription factor Sp1. These elements are located in repeats 2 and 3 of the wild type promoter, respectively, The experiments reported here demon strate that Sp1 participates in sterol regulation of the LDL receptor in an orientation-specific fashion. We pre sent data which suggest that sterol regulatory element binding protein (SREBP) increases the binding of Sp1 to the adjacent repeat 3 sequence. We also demonstrate that SREBP and Sp1 synergistically activate expression from the LDL receptor promoter inside the cell by cotransfecting expression vectors encoding each protein into Drosophila tissue culture cells that are devoid of endogenous Sp1. In addition, other transcription factor sites were unable to substitute for Sp1 in sterol regulation when placed next to the SREBP-binding site, These studies together with recent data from others provide the basis of a working model for sterol regulation of the LDL receptor promoter, The presence of Sp1 sites in several other regulated promoters suggests that this universal transcription factor has been recruited to participate in many regulatory responses possibly by a similar mechanism.			SANCHEZ, HB (corresponding author), UNIV CALIF IRVINE,DEPT MOLEC BIOL & BIOCHEM,IRVINE,CA 92717, USA.							BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAEUERLE PA, 1989, SCIENCE, V242, P540; BEGEOT M, 1993, J BIOL CHEM, V268, P17317; BRIGGS MR, 1993, J BIOL CHEM, V268, P14490; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; COURNEY AJ, 1988, CELL, V59, P827; DAWSON PA, 1988, J BIOL CHEM, V263, P3372; DYNAN WS, 1993, CELL, V35, P79; GEGONNE A, 1993, EMBO J, V12, P1169, DOI 10.1002/j.1460-2075.1993.tb05758.x; GIL G, 1988, J BIOL CHEM, V263, P19009; GILL G, 1994, P NATL ACAD SCI USA, P192; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; JACKSON SP, 1989, P NATL ACAD SCI USA, V86, P1781, DOI 10.1073/pnas.86.6.1781; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KAGEYAMA R, 1989, CELL, V59, P815, DOI 10.1016/0092-8674(89)90605-3; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; KUROKAWA R, 1993, GENE DEV, V7, P1423, DOI 10.1101/gad.7.7b.1423; KUWAHARA J, 1993, BIOCHEMISTRY-US, V32, P5994, DOI 10.1021/bi00074a010; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LEE YH, 1994, MOL CELL BIOL, V14, P1383, DOI 10.1128/MCB.14.2.1383; Maxam A M, 1980, Methods Enzymol, V65, P499; MCKNIGHT SL, 1982, CELL, V31, P355, DOI 10.1016/0092-8674(82)90129-5; MERMOD N, 1988, NATURE, V332, P557, DOI 10.1038/332557a0; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; NARDELLI J, 1991, NATURE, V349, P175, DOI 10.1038/349175a0; NISHIO Y, 1993, MOL CELL BIOL, V13, P1854, DOI 10.1128/MCB.13.3.1854; OSBORNE TF, 1992, J BIOL CHEM, V267, P18973; OSBORNE TF, 1987, P NATL ACAD SCI USA, V84, P3614, DOI 10.1073/pnas.84.11.3614; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; PTASHNE M, 1992, GENETIC SWITCH, P143; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; Sambrook J, 1989, MOL CLONING LABORATO; SATO R, 1994, J BIOL CHEM, V209, P17267; SCHEIDEREIT C, 1987, CELL, V51, P783, DOI 10.1016/0092-8674(87)90101-2; SMITH JR, 1990, J BIOL CHEM, V265, P2306; SMITH JR, 1988, J BIOL CHEM, V263, P18480; SMITH JR, 1990, THESIS U TEXAS SW ME; STUART GW, 1985, NATURE, V317, P828, DOI 10.1038/317828a0; SUDHOF TC, 1987, CELL, V48, P1061, DOI 10.1016/0092-8674(87)90713-6; SUDHOF TC, 1987, J BIOL CHEM, V262, P10773; TANESE N, 1991, GENE DEV, V5, P2212, DOI 10.1101/gad.5.12a.2212; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; WAGNER S, 1993, SCIENCE, V262, P395, DOI 10.1126/science.8211160; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; YOKOYAMA C, 1993, CELL, V75, P1	52	276	276	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1161	1169		10.1074/jbc.270.3.1161	http://dx.doi.org/10.1074/jbc.270.3.1161			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836375	hybrid			2022-12-27	WOS:A1995QB15600030
J	HANAKAM, F; ECKERSKORN, C; LOTTSPEICH, F; MULLERTAUBENBERGER, A; SCHAFER, W; GERISCH, G				HANAKAM, F; ECKERSKORN, C; LOTTSPEICH, F; MULLERTAUBENBERGER, A; SCHAFER, W; GERISCH, G			THE PH-SENSITIVE ACTIN-BINDING PROTEIN HISACTOPHILIN OF DICTYOSTELIUM EXISTS IN 2 ISOFORMS WHICH BOTH ARE MYRISTOYLATED AND DISTRIBUTED BETWEEN PLASMA-MEMBRANE AND CYTOPLASM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C SUBSTRATE; GROWTH-FACTOR; DISCOIDEUM	The histidine-rich protein hisactophilin is known to be associated with the inner surface of the plasma membrane and to be present as a soluble protein in the cytoplasm of Dictyostelium discoideum cells. Mass spectrometry of hisactophilin from the cytosol or extracted from a membrane fraction showed that none of the hisactophilin purified from D. discoideum cells had the mass predicted from the known cDNA-derived amino acid sequence of the protein. Electrospray mass spectrometry and Liquid secondary ion mass spectrometry of tryptic fragments separated by reversed-phase high performance liquid chromatography (HPLC) identified the most hydrophobic peptide as a myristoylated fragment from the N terminus of hisactophilin, Taken together the analytical data, it is concluded that all hisactophilin in D. discoideum cells is N terminally modified by myristoylation. By reversed-phase HPLC, two isoforms of hisactophilin, HsI and HsII, were recovered from the cytosolic as well as the membrane fraction of D. discoideum cells. Whereas the masses of HsI fragments produced by trypsin fit into the previously published sequence of hisactophilin (myristoylation considered), HsII is another protein distinguished from HsI by several amino acid exchanges. HsI and HsII can form homo- and heterodimers by disulfide bridges. Hisactophilin is phosphorylated in vivo. Both isoforms proved to be substrates of membrane-associated threonine/serine kinase from D. discoideum, which may regulate the interaction of hisactophilin with the plasma membrane.			HANAKAM, F (corresponding author), MAX PLANCK INST BIOCHEM,KLOPFERSPITZ 18A,D-82152 MARTINSRIED,GERMANY.		Müller-Taubenberger, Annette/AAM-3671-2021	Muller-Taubenberger, Annette/0000-0003-1163-9232				BARTH A, 1994, J CELL BIOL, V124, P205, DOI 10.1083/jcb.124.1.205; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; DAVIES L, 1993, CELL, V75, P321, DOI 10.1016/0092-8674(93)80073-N; GERISCH G, 1993, SYM SOC EXP BIOL, V47, P297; HABAZETTL J, 1992, NATURE, V359, P855, DOI 10.1038/359855a0; HITT AL, 1994, J CELL BIOL, V126, P1433, DOI 10.1083/jcb.126.6.1433; HITT AL, 1994, J CELL BIOL, V126, P1421, DOI 10.1083/jcb.126.6.1421; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; LESSEL J, 1990, THESIS U BONN; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; MALCHOW D, 1972, EUR J BIOCHEM, V28, P136, DOI 10.1111/j.1432-1033.1972.tb01894.x; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; SCHEEL J, 1989, J BIOL CHEM, V264, P2832; SCHLEICHER M, 1992, NEW BIOL, V4, P461; SCHULTZ AM, 1988, ANNU REV CELL BIOL, V4, P611, DOI 10.1146/annurev.cb.04.110188.003143; STADLER J, 1989, EMBO J, V8, P371, DOI 10.1002/j.1460-2075.1989.tb03387.x; SWEELEY CC, 1963, J AM CHEM SOC, V85, P2497, DOI 10.1021/ja00899a032; TANIGUCHI H, 1993, J BIOL CHEM, V268, P9960; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; URBAN MB, 1989, THESIS U TUBINGEN; WALKER F, 1993, J BIOL CHEM, V268, P19552; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; ZHOU WJ, 1994, J VIROL, V68, P2556, DOI 10.1128/JVI.68.4.2556-2569.1994	25	30	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					596	602		10.1074/jbc.270.2.596	http://dx.doi.org/10.1074/jbc.270.2.596			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822284	hybrid			2022-12-27	WOS:A1995QB81600017
J	SUPAKAR, PC; JUNG, MH; SONG, CS; CHATTERJEE, B; ROY, AK				SUPAKAR, PC; JUNG, MH; SONG, CS; CHATTERJEE, B; ROY, AK			NUCLEAR FACTOR KAPPA-B FUNCTIONS AS A NEGATIVE REGULATOR FOR THE RAT ANDROGEN RECEPTOR GENE AND NF-KAPPA-B ACTIVITY INCREASES DURING THE AGE-DEPENDENT DESENSITIZATION OF THE LIVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; P65 SUBUNIT; PROMOTER; ACTIVATION; ENHANCER; EXPRESSION; SUPERFAMILY; SEQUENCES; PROTEIN	Transcriptional regulation of the steroid hormone receptor genes plays a central role in temporal changes of target cell sensitivity during development, maturation, and aging, Sequence-specific DNA-protein interactions mediate these regulatory functions, Progressive 5' deletion of the rat androgen receptor (rAR) gene immediately beyond the -572 base pair (bp) region causes a marked increase in its promoter activity. DNase I footprinting with nuclear proteins revealed a protected area encompassing -574- to -554-bp positions that begins with a perfectly palindromic nuclear factor kappa B (NF-kappa B) motif. Electrophoretic mobility shift analyses (EMSA) showed that the decameric rAR NF-kappa B site at positions -574 to -565 cross-competes with the authentic kappa immunoglobulin light chain enhancer for specific protein binding, Supershift with specific antibodies to NP-kappa B subunits confirmed that the two retarded bands observed in the EMSA with the labeled rAR probe are due to p50/p65 and p50/p50 dimers of the NF-kappa B/Rel proteins, Fragments of rAR promoter with either deletion or point mutation of the NF-kappa B site are found to be about 2- to S-fold more effective as compared to the wild type control in driving a heterologous reporter gene in cellulo. Thus, unlike most other known cases, NF-kappa B acts as a negative regulator for the rAR gene, The physiological relevance of this repressor function is evident from a 10-fold increase in the p50/p50 form of the NF-kappa B activity in the liver of aged rats exhibiting hepatic androgen desensitization. The newly identified repressor element is a rare example of a naturally occurring perfect palindromic binding motif for the NF-kappa B/Rel family of transcription factors, This repressor factor and the positively acting age-dependent factor, ADF, described earlier (Supakar, P. C., Song C. S., Jung, M., H., Slomczynska, M. A., Kim, J.-M., Vellanoweth, R. L., Chatterjee, B. & Poy, A. K. (1993) J. Biol. Chem. 268, 26400-26408) function to coordinate the tissue-specific down-regulation of the rAR gene during aging.	UNIV TEXAS,HLTH SCI CTR,DEPT CELLULAR & STRUCT BIOL,SAN ANTONIO,TX 78284	University of Texas System; University of Texas Health San Antonio					NIA NIH HHS [P01 AG06872, R01 AG10486] Funding Source: Medline; NIDDK NIH HHS [R-37 DK14744] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK014744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG006872, R01AG010486] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAARENDS WM, 1990, MOL CELL ENDOCRINOL, V74, P75, DOI 10.1016/0303-7207(90)90207-O; BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; BALLARD DW, 1990, CELL, V63, P803, DOI 10.1016/0092-8674(90)90146-6; BROWN AM, 1994, MOL CELL BIOL, V14, P2926, DOI 10.1128/MCB.14.5.2926; CAULEY K, 1994, P NATL ACAD SCI USA, V91, P390, DOI 10.1073/pnas.91.1.390; DEWET JR, 1987, MOL CELL BIOL, V2, P1044; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FABER PW, 1993, J BIOL CHEM, V268, P9296; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777; JIANG J, 1993, EMBO J, V12, P3201, DOI 10.1002/j.1460-2075.1993.tb05989.x; KIMURA A, 1986, CELL, V44, P261, DOI 10.1016/0092-8674(86)90760-9; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LERNBECHER T, 1993, NATURE, V365, P767, DOI 10.1038/365767a0; LINDZEY J, 1993, MOL ENDOCRINOL, V7, P1530, DOI 10.1210/me.7.12.1530; Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H; LIU JK, 1991, MOL CELL BIOL, V11, P773, DOI 10.1128/MCB.11.2.773; MIZOKAMI A, 1994, MOL ENDOCRINOL, V8, P77, DOI 10.1210/me.8.1.77; NAKAYAMA K, 1992, MOL CELL BIOL, V12, P1736, DOI 10.1128/MCB.12.4.1736; OMALLEY B, 1990, MOL ENDOCRINOL, V4, P363, DOI 10.1210/mend-4-3-363; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; POST DJ, 1991, ANN NY ACAD SCI, V621, P66; ROY AK, 1983, ANNU REV PHYSIOL, V45, P37, DOI 10.1146/annurev.ph.45.030183.000345; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SONG CS, 1993, BIOCHEM J, V294, P779, DOI 10.1042/bj2940779; SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400; TILLEY WD, 1990, J BIOL CHEM, V265, P13776; URBAN MB, 1991, EMBO J, V10, P1817, DOI 10.1002/j.1460-2075.1991.tb07707.x	31	137	138	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					837	842		10.1074/jbc.270.2.837	http://dx.doi.org/10.1074/jbc.270.2.837			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822319	hybrid			2022-12-27	WOS:A1995QB81600053
J	GERHARDINGER, C; MARION, MS; ROVNER, A; GLOMB, M; MONNIER, VM				GERHARDINGER, C; MARION, MS; ROVNER, A; GLOMB, M; MONNIER, VM			NOVEL DEGRADATION PATHWAY OF GLYCATED AMINO-ACIDS INTO FREE FRUCTOSAMINE BY A PSEUDOMONAS SP SOIL STRAIN EXTRACT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL DIABETES-MELLITUS; VASCULAR DYSFUNCTION; AMINOGUANIDINE; COMPLICATIONS; GLYCOSYLATION; PURIFICATION; INCREASE; PROTEINS; GLUCOSE; OXIDASE	A Pseudomonas sp, soil strain, selected for its ability to grow on epsilon-(1-deoxyfructosyl) aminocaproic acid, was induced to express a membrane bound enzymatic activity which oxidatively degrades Amadori products into free fructosamine, Apparent K-m values for fructosyl aminocaproate, epsilon-fructosyl lysine, fructosyl glycine, and ribated lysine were 0.21 mM, 2.73 mM, 3.52 mM, and 1.57 mM, respectively, The enzyme was also active against alpha-fructosyl lysine and borohydride-reduced Amadori product, weakly active with ribated and glycated polylysine, and inactive with reducing sugars, amino acids, and glycated proteins, The enzymatic activity was highest at pH 6.5 and 25 degrees C in 0.1 M sodium phosphate, while over 80% of the activity was lost above 65 degrees C, Complete inhibition was observed by HgCl2, NaN3, and NaCN suggesting a role for SH groups and copper in the enzymatic activity. The reaction products were characterized by H-1 NMR, C-13 NMR, and GC/MS and found to correspond to 1-deoxy-1-aminofructose, i,e, free ''fructosamine,'' and adipic acid, Confirmation of the free fructosamine structure was based on the complete spectroscopic identity of the borohydride reduction product with commercially available glucamine (1-amino-1-deoxyglucitol). The new enzyme is provisorily classified as fructosyl N-alkyl amino acid oxidase (EC 1.5.3) (fructosyl-amino acid:oxygen oxidoreductase) and may thus belong to a novel class of ''Amadoriases'' which deglycate Amadori products oxidatively, In contrast, however, the new enzyme acts on the alkylamine bond rather than the ketoamine bond of the Amadori product.	CASE WESTERN RESERVE UNIV,SCH MED,INST PATHOL,CLEVELAND,OH 44106	Case Western Reserve University			Monnier, Vincent M/B-1371-2009		NEI NIH HHS [EY 07099] Funding Source: Medline; NIA NIH HHS [AG 05601] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005601] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; BENSON JR, 1975, P NATL ACAD SCI USA, V72, P619, DOI 10.1073/pnas.72.2.619; Bergmeyer H.U., 1983, METHOD ENZYMAT AN, V2, P201; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWNLEE M, 1986, SCIENCE, V232, P1629, DOI 10.1126/science.3487117; CAGLIERO E, 1991, J BIOL CHEM, V266, P14244; CERAMI A, 1979, METABOLISM, V28, P431, DOI 10.1016/0026-0495(79)90051-9; CORBETT JA, 1992, DIABETES, V41, P552, DOI 10.2337/diabetes.41.4.552; CRAVEN PA, 1990, DIABETES, V39, P667, DOI 10.2337/diabetes.39.6.667; ELLIS EN, 1991, METABOLISM, V40, P1016, DOI 10.1016/0026-0495(91)90122-D; FINOT PA, 1986, HELV CHIM ACTA, V52, P1488; GERHARDINGER C, 1994, J BIOL CHEM, V269, P27297; GREENE DA, 1988, DIABETES METAB REV, V4, P202; HAMMES HP, 1992, P NATL ACAD SCI USA, V88, P11555; HORIUCHI T, 1991, AGR BIOL CHEM TOKYO, V55, P333, DOI 10.1080/00021369.1991.10870584; HORIUCHI T, 1989, AGR BIOL CHEM TOKYO, V53, P103, DOI 10.1080/00021369.1989.10869245; JANAUER GA, 1978, J CHROMATOGR, V153, P539, DOI 10.1016/S0021-9673(00)95518-3; KUMURI K, 1991, DIABETES, V40, P1079; Malmstrom B.G., 1975, ENZYMES B, V12, P507, DOI DOI 10.1016/S1874-6047(08)60231-0; MORTENSEN HB, 1982, BIOCHIM BIOPHYS ACTA, V707, P154, DOI 10.1016/0167-4838(82)90409-5; NAGARAJ RH, 1993, DIABETES S, V142, pA240; OXLUND H, 1992, DIABETOLOGIA, V35, P19, DOI 10.1007/BF00400847; ROBINSON J, 1970, ANAL BIOCHEM, V33, P390, DOI 10.1016/0003-2697(70)90310-6; SCHLEICHER E, 1986, BIOCHIM BIOPHYS ACTA, V884, P199, DOI 10.1016/0304-4165(86)90244-8; SCHWARTZ BA, 1977, ARCH BIOCHEM BIOPHYS, V181, P542, DOI 10.1016/0003-9861(77)90261-2; SELL DR, 1992, DIABETES, V41, P1286, DOI 10.2337/diabetes.41.10.1286; SOULISLIPAROTA T, 1991, DIABETES, V40, P1328, DOI 10.2337/diabetes.40.10.1328; Stryer L., 1988, BIOCHEMISTRY-US; VLASSARA H, 1992, P NATL ACAD SCI USA, V89, P12043, DOI 10.1073/pnas.89.24.12043; YAGIHASHI S, 1992, DIABETES, V41, P47, DOI 10.2337/diabetes.41.1.47; 1993, NEW ENGL J MED, V329, P977	31	41	46	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					218	224		10.1074/jbc.270.1.218	http://dx.doi.org/10.1074/jbc.270.1.218			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814378	hybrid			2022-12-27	WOS:A1995QA28700037
J	RYE, KA; HIME, NJ; BARTER, PJ				RYE, KA; HIME, NJ; BARTER, PJ			THE INFLUENCE OF CHOLESTERYL ESTER TRANSFER PROTEIN ON THE COMPOSITION, SIZE, AND STRUCTURE OF SPHERICAL, RECONSTITUTED HIGH-DENSITY-LIPOPROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; HUMAN-PLASMA-LIPOPROTEINS; EGG PHOSPHATIDYLCHOLINE; GEL-ELECTROPHORESIS; CONVERSION FACTOR; TRANSGENIC MICE; LIPID-TRANSFER; TRIGLYCERIDE; CHARGE; ATHEROSCLEROSIS	The effect of cholesteryl ester transfer protein (CETP) on the size, composition, and structure of spherical, reconstituted HDL (rHDL) which contain apolipoprotein (ape) A-I as their sole apolipoprotein has been studied. Spherical rHDL were incubated with CETP and Intralipid for up to 24 h, During this time CETP promoted transfers of cholesteryl esters (CE) and triglyceride (TG) between rHDL and Intralipid, As a result, the rHDL became depleted of CE and enriched in TG, However, as the loss of CE from the rHDL was greater than the gain of TG, the concentration of core lipids in the rHDL decreased, The decrease in the concentration of rHDL core lipids, which was evident throughout the incubation, was accompanied by a reduction in rHDL diameter from 9.2 to 8.0 nm, the dissociation of apoA-I hom rHDL and a decrease in the number of apoA-I molecules, from three/particle in the 9.2-nm rHDL, to two/particle in the 8.0 nm rHDL, Spectroscopic studies showed that the lipid-water interface and phospholipid packing of the 8,0-nm rHDL were, respectively, more polar and less ordered than those of the 9,2-nm rHDL, Quenching studies with KI revealed that the number of exposed apoA-I Trp residues in the 9.2- and 8,0-nm rHDL was two and three, respectively, Circular dichroism established that the 9.2- and 8,0-nm rHDL had identical apoA-I alpha-helical contents, The 9.2- and 8.0 nm rHDL also had identical surface charges as determined by agarose gel electrophoresis, Denaturation studies with guanidine hydrochloride demonstrated that apoA-I is more stable in 8.0 nm rHDL than in 9,2-nm rHDL, It is concluded that CETP converts rHDL to small, TG-enriched, apoA-I-depleted particles with increased lipid-water interfacial hydration and less ordered phospholipid packing, These changes are associated with enhanced stability and minor changes to the conformation of the apoA-I which remains associated with the rHDL.	ROYAL ADELAIDE HOSP, DIV CARDIOVASC SCI, ADELAIDE, SA 5000, AUSTRALIA; UNIV ADELAIDE, ROYAL ADELAIDE HOSP, DEPT MED, ADELAIDE, SA, AUSTRALIA	Royal Adelaide Hospital; Royal Adelaide Hospital; University of Adelaide								AGELLON LB, 1991, J BIOL CHEM, V266, P10796; BARTER PJ, 1990, ATHEROSCLEROSIS, V84, P13, DOI 10.1016/0021-9150(90)90003-2; BARTER PJ, 1988, BIOCHEM J, V254, P179, DOI 10.1042/bj2540179; BARTER PJ, 1982, ATHEROSCLEROSIS, V44, P27, DOI 10.1016/0021-9150(82)90050-8; BARTER PJ, 1990, BIOCHIM BIOPHYS ACTA, V1045, P81, DOI 10.1016/0005-2760(90)90206-D; BARTER PJ, 1979, ATHEROSCLEROSIS, V34, P67, DOI 10.1016/0021-9150(79)90107-2; BARTER PJ, 1980, J LIPID RES, V21, P238; BENYASHAR V, 1991, CHEM PHYS LIPIDS, V60, P1, DOI 10.1016/0009-3084(91)90009-Z; BISGAIER CL, 1991, J LIPID RES, V32, P21; BLANCHE PJ, 1981, BIOCHIM BIOPHYS ACTA, V665, P408, DOI 10.1016/0005-2760(81)90253-8; BREWER HB, 1978, BIOCHEM BIOPH RES CO, V80, P623, DOI 10.1016/0006-291X(78)91614-5; BURSTEIN M, 1970, J LIPID RES, V11, P583; DALTON MB, 1993, J BIOL CHEM, V268, P19274; HOPKINS GJ, 1989, ATHEROSCLEROSIS, V75, P73, DOI 10.1016/0021-9150(89)90209-8; HOPKINS GJ, 1982, METABOLISM, V31, P78, DOI 10.1016/0026-0495(82)90048-8; HOPKINS GJ, 1982, METAB CLIN BIOL, V29, P546; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; JONAS A, 1990, J BIOL CHEM, V265, P22123; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; LEROY A, 1993, J BIOL CHEM, V268, P4798; LIANG HQ, 1994, J LIPID RES, V35, P1187; MAHADEVAN V, 1983, BIOCHIM BIOPHYS ACTA, V752, P89, DOI 10.1016/0005-2760(83)90236-9; MARCEL YL, 1991, J BIOL CHEM, V266, P3644; MAROTTI KR, 1993, NATURE, V364, P73, DOI 10.1038/364073a0; MATZ CE, 1982, J BIOL CHEM, V257, P4535; MORTON RE, 1983, J BIOL CHEM, V258, P1751; OSBORNE JC, 1986, METHOD ENZYMOL, V128, P213; PAIGEN B, 1987, P NATL ACAD SCI USA, V84, P3763, DOI 10.1073/pnas.84.11.3763; PATTNAIK NM, 1978, BIOCHIM BIOPHYS ACTA, V530, P428, DOI 10.1016/0005-2760(78)90163-7; PIRAN U, 1979, J LIPID RES, V20, P1040; PRENDERGAST FG, 1981, BIOCHEMISTRY-US, V20, P7333, DOI 10.1021/bi00529a002; RAJARAM OV, 1985, BIOCHIM BIOPHYS ACTA, V835, P41, DOI 10.1016/0005-2760(85)90028-1; RYE KA, 1990, BIOCHIM BIOPHYS ACTA, V1042, P227, DOI 10.1016/0005-2760(90)90013-N; RYE KA, 1989, J LIPID RES, V30, P335; RYE KA, 1994, J BIOL CHEM, V269, P10298; RYE KA, 1993, BIOCHIM BIOPHYS ACTA, V1167, P316, DOI 10.1016/0005-2760(93)90235-2; SATA T, 1972, J LIPID RES, V13, P757; SEGREST JP, 1992, J LIPID RES, V33, P141; SHENG J, 1990, METABOLISM, V39, P155, DOI 10.1016/0026-0495(90)90069-O; SPARKS DL, 1992, J LIPID RES, V33, P123; SPARKS DL, 1993, J BIOL CHEM, V268, P23250; SPARKS DL, 1992, J BIOL CHEM, V267, P25839; STAROS JV, 1982, BIOCHEMISTRY-US, V21, P3950, DOI 10.1021/bi00260a008; TOLLEFSON JH, 1988, AM J PHYSIOL, V255, pE894, DOI 10.1152/ajpendo.1988.255.6.E894; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025; WEISWEILER P, 1987, CLIN CHIM ACTA, V169, P249, DOI 10.1016/0009-8981(87)90325-1	46	60	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					189	196		10.1074/jbc.270.1.189	http://dx.doi.org/10.1074/jbc.270.1.189			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814372	hybrid			2022-12-27	WOS:A1995QA28700032
J	GETTEMANS, J; DEVILLE, Y; WAELKENS, E; VANDEKERCKHOVE, J				GETTEMANS, J; DEVILLE, Y; WAELKENS, E; VANDEKERCKHOVE, J			THE ACTIN-BINDING PROPERTIES OF THE PHYSARUM ACTIN-FRAGMIN COMPLEX - REGULATION OF CALCIUM, PHOSPHOLIPIDS, AND PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; MODULATING PROTEIN; PLASMA GELSOLIN; POLYCEPHALUM; FILAMENTS; DOMAIN; PROFILIN; SEQUENCE; IDENTIFICATION	The actin-binding properties of the actin-fragmin complex hom Physarum polycephalum microplasmodia were investigated with respect to regulation by Ca2+, phospholipids, and phosphorylation of the actin subunit by the endogenous actin-fragmin kinase. Fragmin possesses two high affinity actin-binding sites and probably also a third, low affinity site. Its nucleating and F-actin severing activities are inhibited by phosphatidylinositol 4,5-bisphosphate (PIP2). Actin-fragmin specifically binds PIP2 which competes with actin for the Ca2+-sensitive site. However, PIP2, cannot dissociate the actin-fragmin complex nor the actin(2)-fragmin trimer. Efficient F-actin nucleating activity by actin-fragmin is only observed with unphosphorylated actin-fragmin, in the absence of PIP2 and at high Ca2+ (> mu M) concentrations. In the presence of PIP2, actin-fragmin only caps actin filaments when unphosphorylated. The results suggest that in the cell, hydrolysis of PIP2, concomitant with the increase of cytosolic Ca2+, could promote subcortical actin polymerization.	KATHOLIEKE UNIV LEUVEN,DIV BIOCHEM,B-3000 LOUVAIN,BELGIUM	KU Leuven	GETTEMANS, J (corresponding author), STATE UNIV GHENT,DEPT BIOCHEM,PHYSIOL CHEM LAB,LEDEGANCKSTR 35,B-9000 GHENT,BELGIUM.							AMPE C, 1987, EMBO J, V6, P4149, DOI 10.1002/j.1460-2075.1987.tb02761.x; ARPIN M, 1988, J CELL BIOL, V107, P1759, DOI 10.1083/jcb.107.5.1759; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER SL, 1983, J BIOL CHEM, V258, P5013; BRYAN J, 1986, J CELL BIOL, V102, P1439, DOI 10.1083/jcb.102.4.1439; BRYAN J, 1986, J CELL BIOL, V106, P1553; CHAPONNIER C, 1986, J CELL BIOL, V103, P1473, DOI 10.1083/jcb.103.4.1473; COUE M, 1985, J BIOL CHEM, V260, P5033; DITSCH A, 1994, EUR J BIOCHEM, V224, P223, DOI 10.1111/j.1432-1033.1994.tb20015.x; EICHINGER L, 1992, BIOCHEMISTRY-US, V31, P4779, DOI 10.1021/bi00135a006; FURUHASHI K, 1990, J CELL BIOL, V111, P1081, DOI 10.1083/jcb.111.3.1081; GETTEMANS J, 1993, EUR J BIOCHEM, V214, P111, DOI 10.1111/j.1432-1033.1993.tb17902.x; GETTEMANS J, 1992, EMBO J, V11, P3185, DOI 10.1002/j.1460-2075.1992.tb05395.x; GOLDSCHMIDTCLER.PJ, 1991, SCIENCE, V251, P1231; HARTWIG JH, 1989, J CELL BIOL, V108, P467, DOI 10.1083/jcb.108.2.467; Hartwig JH, 1991, CURR OPIN CELL BIOL, V3, P87, DOI 10.1016/0955-0674(91)90170-4; HASEGAWA T, 1980, BIOCHEMISTRY-US, V19, P2677, DOI 10.1021/bi00553a021; HINSSEN H, 1981, EUR J CELL BIOL, V23, P234; HINSSEN H, 1981, EUR J CELL BIOL, V23, P225; HOFMANN A, 1992, CELL MOTIL CYTOSKEL, V23, P133, DOI 10.1002/cm.970230206; HOLMES KC, 1990, NATURE, V347, P37; JANMEY PA, 1987, J BIOL CHEM, V262, P12228; JANMEY PA, 1992, J BIOL CHEM, V267, P11818; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; KWIATKOWSKI DJ, 1985, J BIOL CHEM, V260, P5232; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAHAM LE, 1993, J BIOL CHEM, V268, P14202; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; LIND SE, 1987, J CELL BIOL, V105, P833, DOI 10.1083/jcb.105.2.833; MARKUS MA, 1994, PROTEIN SCI, V3, P70; MARUTA H, 1983, J BIOL CHEM, V258, P151; MATSUDAIRA PT, 1978, ANAL BIOCHEM, V87, P386, DOI 10.1016/0003-2697(78)90688-7; MCLAUGHLIN PJ, 1993, NATURE, V364, P677; OHNUMA M, 1993, J BIOCHEM-TOKYO, V114, P718, DOI 10.1093/oxfordjournals.jbchem.a124243; OHNUMA M, 1988, ZOOL SCI, V5, P691; ONODA K, 1993, J BIOL CHEM, V268, P4106; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; SELVE N, 1987, EUR J BIOCHEM, V168, P111, DOI 10.1111/j.1432-1033.1987.tb13394.x; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STOSSEL TP, 1989, J BIOL CHEM, V264, P18261; SUN HQ, 1994, J BIOL CHEM, V269, P9473; VANDEKERCKHOVE J, 1992, Current Opinion in Cell Biology, V4, P36, DOI 10.1016/0955-0674(92)90056-I; Weeds A, 1993, CURR OPIN CELL BIOL, V5, P63, DOI 10.1016/S0955-0674(05)80009-2; YIN HL, 1988, J CELL BIOL, V106, P805, DOI 10.1083/jcb.106.3.805; YIN HL, 1979, NATURE, V281, P581; YU FX, 1992, J BIOL CHEM, V267, P14616	46	37	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2644	2651		10.1074/jbc.270.6.2644	http://dx.doi.org/10.1074/jbc.270.6.2644			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852332	hybrid			2022-12-27	WOS:A1995QF53500040
J	SATO, A; NISHINO, T; NODA, K; AMAYA, Y; NISHINO, T				SATO, A; NISHINO, T; NODA, K; AMAYA, Y; NISHINO, T			THE STRUCTURE OF CHICKEN LIVER XANTHINE DEHYDROGENASE - CDNA CLONING AND THE DOMAIN-STRUCTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DINUCLEOTIDE-BINDING-SITE; DROSOPHILA-MELANOGASTER; O-2-DEPENDENT TYPES; CALLIPHORA-VICINA; ROSY LOCUS; OXIDASE; PROTEIN; SEQUENCE; GENE; PURIFICATION	The amino acid sequence of chicken Liver xanthine dehydrogenase (EC 1.1.1.204) was determined by cDNA cloning and partial amino acid sequencing of the purified enzyme. The enzyme consisted of 1358 amino acids with calculated molecular mass of 149,633 Da. In order to compare the structure of the chicken and rat enzymes, limited proteolysis was performed with the purified chicken Liver xanthine dehydrogenase. When the enzyme was digested with subtilisin, it was not converted fi om the NAD-dependent dehydrogenase type to the O-2-dependent oxidase type, in contrast with the mammalian enzyme. However, the enzyme was cleaved mainly into three fragments in a manner similar to that for the rat enzyme at pH 8.2 (20, 37, and 84 kDa) and retaining a full complement of redox centers. The cleavage sites were identified by determination of aminoterminal sequences of the produced fragments. It was concluded that the 20-kDa fragment was amino-terminal, the 84-kDa fragment carboxyl-terminal, and the 37-kDa fragment an intermediate portion in the enzyme protein. On the other hand, when the enzyme was digested with the same protease at pH 10.5, the sample contained only the 20- and 84-kDa portions and lacked the 37-kDa portion. The resultant sample possessed xanthine dichlorophenol indophenol reductase activity, indicating that the molybdenum center remained intact. The absorption spectrum showed the sample was very similar to deflavo-enzyme. From these results and sequence analyses, the domain structure of the enzyme is discussed.	NIPPON MED COLL, DEPT BIOCHEM & MOLEC BIOL, BUNKYO KU, TOKYO 113, JAPAN; YOKOHAMA CITY UNIV, SCH MED, DEPT BIOCHEM, KANAZAWA KU, YOKOHAMA, KANAGAWA 236, JAPAN	Nippon Medical School; Yokohama City University								AMAYA Y, 1990, J BIOL CHEM, V265, P14170; BAIROCH A, 1992, NUCLEIC ACIDS RES, V20, P2013, DOI 10.1093/nar/20.suppl.2013; Bray RC., 1975, ENZYMES, V12, P299, DOI DOI 10.1016/S1874-6047(08)60229-2; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHOW CW, 1994, NUCLEIC ACIDS RES, V22, P1846, DOI 10.1093/nar/22.10.1846; COUGHLAN MP, 1979, J BIOL CHEM, V254, P694; COUGHLAN MP, 1986, IRCS MED SCI-BIOCHEM, V14, P736; Della Corte E, 1968, Biochem J, V108, P349; Eger BT, 1994, FLAVINS AND FLAVOPROTEINS 1993, P727; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; Hille R., 1985, Metal Ions in Biology, V7, P443; HOUDE M, 1989, GENE, V85, P391, DOI 10.1016/0378-1119(89)90432-0; HUNT J, 1992, J BIOL CHEM, V267, P21479; ICHIDA K, 1993, GENE, V133, P279; KEITH TP, 1987, GENETICS, V116, P67; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CS, 1987, GENETICS, V116, P55; Maniatis T., 1982, MOL CLONING; MASSEY V, 1989, J BIOL CHEM, V264, P10567; NAGLER LG, 1976, BIOCHIM BIOPHYS ACTA, V427, P78, DOI 10.1016/0005-2795(76)90287-7; NAKAMURA M, 1982, J BIOCHEM-TOKYO, V92, P1279, DOI 10.1093/oxfordjournals.jbchem.a134046; NISHINO T, 1974, BIOCHIM BIOPHYS ACTA, V341, P93, DOI 10.1016/0005-2744(74)90069-2; NISHINO T, 1989, J BIOL CHEM, V264, P5468; NISHINO T, 1989, J BIOL CHEM, V264, P2518; NISHINO T, 1982, J BIOL CHEM, V257, P7348; NISHINO T, 1987, BIOCHEMISTRY-US, V26, P3068, DOI 10.1021/bi00385a018; Nishino T, 1994, FLAVINS AND FLAVOPROTEINS 1993, P699; RAJAGOPALAN KV, 1967, J BIOL CHEM, V242, P4097; ROCHERCHAMBONNET C, 1987, GENE, V59, P201, DOI 10.1016/0378-1119(87)90328-3; SAITO T, 1989, J BIOL CHEM, V264, P10015; SAITO T, 1989, J BIOL CHEM, V264, P15930; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOPFER LM, 1988, J BIOL CHEM, V263, P13528; STIRPE F, 1969, J BIOL CHEM, V244, P3855; TERAO M, 1992, BIOCHEM J, V283, P863, DOI 10.1042/bj2830863; WOOTTON JC, 1991, BIOCHIM BIOPHYS ACTA, V1057, P157, DOI 10.1016/S0005-2728(05)80100-8; WRIGHT RM, 1993, P NATL ACAD SCI USA, V90, P10690, DOI 10.1073/pnas.90.22.10690	37	71	72	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2818	2826		10.1074/jbc.270.6.2818	http://dx.doi.org/10.1074/jbc.270.6.2818			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852355	hybrid			2022-12-27	WOS:A1995QF53500065
J	SWAMY, N; BRISSON, M; RAY, R				SWAMY, N; BRISSON, M; RAY, R			TRP-145 IS ESSENTIAL FOR THE BINDING OF 25-HYDROXYVITAMIN-D-3 TO HUMAN SERUM VITAMIN-D BINDING-PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-SPECIFIC COMPONENT; ALPHA-FETOPROTEIN; GC-GLOBULIN; ALBUMIN; LYMPHOCYTES; MEMBER; FAMILY; ACTIN	Chemical modification of specific amino acid residues in a protein has been a valuable tool in identifying amino acid residues that are responsible for ligand binding of a protein. In the present investigation, we targeted Trp and His residues in human serum vitamin D-binding protein (hDBP) by modifying them with specific chemical modifiers. We also evaluated the results of these modifications in the binding of 25-hydroxy[26(27)-H-3]vitamin D-3 ([H-3]25-OH-D-3) to hDBP. We observed a dose dependent loss of binding activity by N-bromosuccinimide (specific for Trp). Similar results were observed with diethylpyrocarbonate (specific for His). Furthermore, loss of [H-3]25-OH-D-3-binding was protected by preincubation of hDBP samples with an excess of 25-hydroxyvitamin D-3. These results strongly emphasized the importance of Trp (single residue at position 145) and 1 His residue (out of a total of 6) in the vitamin D sterol-binding by vitamin D-binding protein.	BOSTON UNIV,SCH MED,DEPT BIOORGAN & PROT CHEM,VITAMIN D LAB,BOSTON,MA 02118	Boston University				Ray, Rahul/0000-0002-2078-2201	NIDDK NIH HHS [DK 44337, DK 47418] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044337, R01DK047418] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		COOKE NE, 1985, J CLIN INVEST, V76, P2420, DOI 10.1172/JCI112256; COOKE NE, 1989, ENDOCR REV, V10, P294, DOI 10.1210/edrv-10-3-294; HADDAD JG, 1982, ARCH BIOCHEM BIOPHYS, V213, P538, DOI 10.1016/0003-9861(82)90581-1; MILES EW, 1972, METHOD ENZYMOL, V25, P431; OVADI J, 1969, ACTA BIOCHIMICA B A, V4, P365; PETRINI M, 1985, J BIOL CHEM, V260, P1804; PETRINI M, 1983, NATURE, V306, P73, DOI 10.1038/306073a0; RAY R, 1991, BIOCHEMISTRY-US, V30, P4809, DOI 10.1021/bi00233a024; RAY R, 1991, BIOCHEMISTRY-US, V30, P7638, DOI 10.1021/bi00244a036; RAY R, 1986, BIOCHEMISTRY-US, V25, P4729, DOI 10.1021/bi00365a001; SCHOENTGEN F, 1986, BIOCHIM BIOPHYS ACTA, V871, P189, DOI 10.1016/0167-4838(86)90173-1; SPANDE TF, 1966, BIOCHEMISTRY-US, V5, P1926, DOI 10.1021/bi00870a020; VANBAELEN H, 1980, J BIOL CHEM, V255, P2270; YAMAMOTO N, 1991, P NATL ACAD SCI USA, V88, P8539, DOI 10.1073/pnas.88.19.8539; YANG F, 1985, P NATL ACAD SCI USA, V82, P7994, DOI 10.1073/pnas.82.23.7994; [No title captured]	16	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2636	2639		10.1074/jbc.270.6.2636	http://dx.doi.org/10.1074/jbc.270.6.2636			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852330	hybrid			2022-12-27	WOS:A1995QF53500038
J	TAYLOR, JM; DAVIES, JD; PETERSON, CA				TAYLOR, JM; DAVIES, JD; PETERSON, CA			REGULATION OF THE MYOBLAST-SPECIFIC EXPRESSION OF THE HUMAN BETA-ENOLASE GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-SPECIFIC ENOLASE; SATELLITE CELLS; GROWTH-FACTOR; VIMENTIN PROMOTER; EARLY MYOGENESIS; BINDING-FACTOR; DNA-BINDING; ENHANCER; TRANSCRIPTION; SEQUENCE	The muscle-specific beta-enolase gene is expressed in proliferating adult myoblasts as well as in differentiated myotubes. Through deletion-transfection analysis, we identified a 79-base pair enhancer from the beta-enolase gene that leads to high level expression of a reporter gene in myoblasts, but not in fibroblasts. Following myoblast differentiation into myotubes, the activity of the enhancer declined, indicating that beta-enolase gene expression in myotubes is mediated by other regulators, possibly the myogenic helix-loop-helix family of transcription factors. Electrophoretic mobility shift assays indicated that proteins present in myoblast nuclear extracts specifically bind to the 3' half of the 79-base pair enhancer. This region contains an ets DNA-binding motif which is required not only for high level activity in myoblasts, but also for repressing activity in fibroblasts. Furthermore, the beta-enolase myoblast-specific enhancer shows limited similarity to the myoblast-specific enhancer associated with the human desmin gene, suggesting that gene expression in adult myoblasts may be coordinately regulated.	UNIV ARKANSAS MED SCI HOSP,DEPT MED,LITTLE ROCK,AR 72205; UNIV ARKANSAS MED SCI HOSP,DEPT BIOCHEM & MOLEC BIOL,LITTLE ROCK,AR 72205; JOHN L MCCLELLAN MEM VET ADM MED CTR,CTR GERIATR RES EDUC & CLIN,LITTLE ROCK,AR 72205	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Geriatric Research Education & Clinical Center					NIA NIH HHS [AG10523] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R29AG010523] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BARBIERI G, 1990, DIFFERENTIATION, V45, P179, DOI 10.1111/j.1432-0436.1990.tb00471.x; BORRAS T, 1988, DEV BIOL, V127, P209, DOI 10.1016/0012-1606(88)90202-3; BRENNAN TJ, 1991, P NATL ACAD SCI USA, V88, P3822, DOI 10.1073/pnas.88.9.3822; CAREY J, 1991, METHOD ENZYMOL, V208, P103; CHURCH GM, 1985, NATURE, V313, P798, DOI 10.1038/313798a0; COSSU G, 1987, CURR TOP DEV BIOL, V23, P185; COSSU G, 1985, EXP CELL RES, V160, P403, DOI 10.1016/0014-4827(85)90187-9; COSSU G, 1987, DEV BIOL, V123, P43, DOI 10.1016/0012-1606(87)90425-8; DARVILLE MI, 1992, NUCLEIC ACIDS RES, V20, P3575, DOI 10.1093/nar/20.14.3575; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DONOGHUE M, 1988, GENE DEV, V2, P1779, DOI 10.1101/gad.2.12b.1779; EDMONDSON DG, 1993, J BIOL CHEM, V268, P755; FARRELL FX, 1990, MOL CELL BIOL, V10, P2349, DOI 10.1128/MCB.10.5.2349; FELDMAN JL, 1991, DEV BIOL, V143, P320, DOI 10.1016/0012-1606(91)90083-F; FELDMAN JL, 1992, DEV BIOL, V153, P217, DOI 10.1016/0012-1606(92)90107-R; GIALLONGO A, 1993, EUR J BIOCHEM, V214, P367, DOI 10.1111/j.1432-1033.1993.tb17932.x; GIOVANE A, 1994, GENE DEV, V8, P1502, DOI 10.1101/gad.8.13.1502; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; HARTLEY RS, 1992, DEV BIOL, V153, P206, DOI 10.1016/0012-1606(92)90106-Q; HARTLEY RS, 1991, DEV BIOL, V148, P249, DOI 10.1016/0012-1606(91)90334-Y; HO IC, 1990, SCIENCE, V250, P814, DOI 10.1126/science.2237431; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KAUFMAN SJ, 1988, P NATL ACAD SCI USA, V85, P9606, DOI 10.1073/pnas.85.24.9606; KELLER A, 1992, MECH DEVELOP, V38, P41, DOI 10.1016/0925-4773(92)90037-K; LAMANDE N, 1989, P NATL ACAD SCI USA, V86, P4445, DOI 10.1073/pnas.86.12.4445; LI ZL, 1993, J BIOL CHEM, V268, P10403; LI ZL, 1991, J BIOL CHEM, V266, P6562; LILLIE JW, 1989, CURR TOP MICROBIOL, V144, P191; LUCAS M, 1992, DIFFERENTIATION, V51, P1, DOI 10.1111/j.1432-0436.1992.tb00674.x; MAR JH, 1990, MOL CELL BIOL, V10, P4271, DOI 10.1128/MCB.10.8.4271; MINTY A, 1986, MOL CELL BIOL, V6, P2125, DOI 10.1128/MCB.6.6.2125; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; ORKIN SH, 1992, BLOOD, V80, P575; PESHAVARIA M, 1991, BIOCHEM J, V275, P427, DOI 10.1042/bj2750427; PETERSON CA, 1992, DEV BIOL, V151, P626, DOI 10.1016/0012-1606(92)90201-Q; RITTLING SR, 1989, NUCLEIC ACIDS RES, V17, P1619, DOI 10.1093/nar/17.4.1619; SAX CM, 1989, GENE, V78, P235, DOI 10.1016/0378-1119(89)90226-6; SHACKELFORD JE, 1981, J BIOL CHEM, V256, P6423; SONG WK, 1992, J CELL BIOL, V117, P643, DOI 10.1083/jcb.117.3.643; STERNBERG EA, 1988, MOL CELL BIOL, V8, P2896, DOI 10.1128/MCB.8.7.2896; TAPSCOTT SJ, 1992, MOL CELL BIOL, V12, P4994, DOI 10.1128/MCB.12.11.4994; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; TWEEDIE S, 1991, SOMAT CELL MOLEC GEN, V17, P215, DOI 10.1007/BF01232818; VAIDYA TB, 1989, MOL CELL BIOL, V9, P3576, DOI 10.1128/MCB.9.8.3576; VANDEKLUNDERT FAJM, 1992, GENE, V122, P337, DOI 10.1016/0378-1119(92)90223-C; WASYLYK B, 1993, EUR J BIOCHEM, V221, P7; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; WENTWORTH BM, 1991, P NATL ACAD SCI USA, V88, P1242, DOI 10.1073/pnas.88.4.1242; YABLONKAREUVENI Z, 1993, DEV BIOL, V156, P307, DOI 10.1006/dbio.1993.1079; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277	53	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2535	2540		10.1074/jbc.270.6.2535	http://dx.doi.org/10.1074/jbc.270.6.2535			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852315	hybrid			2022-12-27	WOS:A1995QF53500023
J	DIRKX, R; THOMAS, A; LI, LS; LERNMARK, A; SHERWIN, RS; DECAMILLI, P; SOLIMENA, M				DIRKX, R; THOMAS, A; LI, LS; LERNMARK, A; SHERWIN, RS; DECAMILLI, P; SOLIMENA, M			TARGETING OF THE 67-KDA ISOFORM OF GLUTAMIC-ACID DECARBOXYLASE TO INTRACELLULAR ORGANELLES IS MEDIATED BY ITS INTERACTION WITH THE NH2-TERMINAL REGION OF THE 65-KDA ISOFORM OF GLUTAMIC-ACID DECARBOXYLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; STIFF-MAN SYNDROME; TERMINAL-SPECIFIC PHOSPHOPROTEIN; SYNAPTIC-LIKE MICROVESICLES; I PROTEIN-I; COFACTOR INTERACTIONS; AUTOANTIBODIES; FORMS; GAD-65; BRAIN	The two isoforms of glutamic acid decarboxylase (GAD), GAD67 and GAD65, synthesize the neurotransmitter gamma-aminobutyric acid in neurons and pancreatic beta-cells. Previous studies suggest that GAD67 is a soluble cytosolic protein, whereas GAD65 is membrane-associated. Here, we study the intracellular distribution of GAD67 in neurons, pancreatic beta-cells, and fibroblasts transfected either with GAD65 and GAD67 together or with GAD67 alone. Neuronal GAD67 is partially recovered with GAD65 in membrane-containing pellet fractions and Triton X-114 detergent phases. The two proteins co-immunoprecipitate from extracts of brain and GAD65-GAD67 co-transfected fibroblasts, but not when extracts of GAD65 and GAD67 transfected fibroblasts were mixed and used as a starting material for immunoprecipitation, GAD67 is concentrated in the Golgi complex region in GAD65-GAD67 co-transfected fibroblasts, but not in fibroblasts transfected with GAD67 alone. A pool of neuronal GAD67 co-localizes with GAD65 in the Golgi complex region and in many synapses. The two proteins also co-localize in the perinuclear region of some pancreatic beta-cells. GAD67 interacts with the NH2-terminal region of GAD65, even in the absence of palmitoylation of this region of GAD65. Taken together, our results indicate that GAD65-GAD67 association occurs in vivo and is required for the targeting of GAD67 to membranes.	YALE UNIV, SCH MED, DEPT INTERNAL MED, ENDOCRINOL SECT, NEW HAVEN, CT 06520 USA; YALE UNIV, SCH MED, DEPT CELL BIOL, NEW HAVEN, CT 06520 USA; YALE UNIV, SCH MED, HOWARD HUGHES MED INST, NEW HAVEN, CT 06520 USA; UNIV WASHINGTON, DEPT MED, SEATTLE, WA 98195 USA; KAROLINSKA INST, KAROLINSKA HOSP, DEPT ENDOCRINOL, S-17176 STOCKHOLM, SWEDEN	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; University of Washington; University of Washington Seattle; Karolinska Institutet; Karolinska University Hospital			Solimena, Michele/GVS-5990-2022; Lernmark, Åke/F-8140-2015; Solimena, Michele/E-1275-2011	Lernmark, Åke/0000-0003-1735-0499; 	NIDDK NIH HHS [DK-45735, DK-43078, R01 DK026190] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026190, P30DK045735, P01DK043078] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; BAEKKESKOV S, 1988, DIABETOLOGIA, V31, pA466; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BUTLER MH, 1993, J EXP MED, V178, P2097, DOI 10.1084/jem.178.6.2097; CAMERON PL, 1991, J CELL BIOL, V115, P151, DOI 10.1083/jcb.115.1.151; CHANG YC, 1988, J NEUROSCI, V8, P2123; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHRISTGAU S, 1991, J BIOL CHEM, V266, P21257; CHRISTGAU S, 1992, J CELL BIOL, V118, P309, DOI 10.1083/jcb.118.2.309; DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337; ERLANDER MG, 1991, NEUROCHEM RES, V16, P215, DOI 10.1007/BF00966084; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; KARLSEN AE, 1992, DIABETES, V41, P1355, DOI 10.2337/diabetes.41.10.1355; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; KOBAYASHI Y, 1987, J NEUROSCI, V7, P2768; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEGAY F, 1987, J NEUROCHEM, V48, P1022, DOI 10.1111/j.1471-4159.1987.tb05620.x; LI LS, 1994, J IMMUNOL, V152, P930; MARTIN DL, 1991, J NEUROSCI, V11, P2725; MARTIN DL, 1991, NEUROCHEM RES, V16, P243, DOI 10.1007/BF00966087; MAYCOX PR, 1990, TRENDS NEUROSCI, V13, P83, DOI 10.1016/0166-2236(90)90178-D; MCLAUGHLIN BJ, 1975, BRAIN RES, V85, P355, DOI 10.1016/0006-8993(75)90813-6; MUNDIGL O, 1994, CURR OPIN CELL BIOL, V6, P561, DOI 10.1016/0955-0674(94)90077-9; OERTEL WH, 1981, NEUROSCIENCE, V6, P2689, DOI 10.1016/0306-4522(81)90113-5; REETZ A, 1991, EMBO J, V10, P1275, DOI 10.1002/j.1460-2075.1991.tb08069.x; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; SHI YG, 1994, J CELL BIOL, V124, P927, DOI 10.1083/jcb.124.6.927; SOLIMENA M, 1988, NEW ENGL J MED, V318, P1012, DOI 10.1056/NEJM198804213181602; SOLIMENA M, 1993, P NATL ACAD SCI USA, V90, P3073, DOI 10.1073/pnas.90.7.3073; SOLIMENA M, 1994, J CELL BIOL, V126, P331, DOI 10.1083/jcb.126.2.331; SOLIMENA M, 1990, NEW ENGL J MED, V322, P1555, DOI 10.1056/NEJM199005313222202; SOLIMENA M, 1994, IN PRESS J ENDOCRINO; SORENSON RL, 1991, DIABETES, V40, P1365, DOI 10.2337/diabetes.40.11.1365; THOMASREETZ A, 1993, P NATL ACAD SCI USA, V90, P5317, DOI 10.1073/pnas.90.11.5317; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VELLOSO LA, 1993, J CLIN INVEST, V91, P2084, DOI 10.1172/JCI116431; WYBORSKI RJ, 1990, MOL BRAIN RES, V8, P193, DOI 10.1016/0169-328X(90)90016-7; XU T, 1992, DEVELOPMENT, V115, P913	41	74	77	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2241	2246		10.1074/jbc.270.5.2241	http://dx.doi.org/10.1074/jbc.270.5.2241			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836456				2022-12-27	WOS:A1995QE49300041
J	KODANDAPANI, R; VEERAPANDIAN, B; KUNICKI, TJ; ELY, KR				KODANDAPANI, R; VEERAPANDIAN, B; KUNICKI, TJ; ELY, KR			CRYSTAL-STRUCTURE OF THE OPG2 FAB - AN ANTIRECEPTOR ANTIBODY THAT MIMICS AN RGD CELL-ADHESION SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB-IIIA; PLATELET-AGGREGATION INHIBITOR; NUCLEAR-MAGNETIC-RESONANCE; 3-DIMENSIONAL STRUCTURE; CRYSTALLOGRAPHIC REFINEMENT; MONOCLONAL-ANTIBODY; SECONDARY STRUCTURE; MACROMOLECULAR STRUCTURES; ALPHA-5-BETA-1 INTEGRIN; SURFACE GLYCOPROTEIN	Cell surface receptors called integrins mediate di verse cell adhesion phenomena through recognition of the sequence arginine glycine aspartic acid (RGD) present in proteins such as fibronectin and fibrinogen. Platelet aggregation in hemostasis is mediated by the binding of fibrinogen to the gpIIb/IIIa integrin. The OPG2 antibody binds the gpIIb/IIIa receptor and acts as a ligand mimic due to the presence of an arginine-tyrosine-aspartic acid (RYD) sequence in the CDR3 loop of the heavy chain. The RYD loop and side chains are ordered in the 2.0-Angstrom resolution crystal structure of the Fab fragment from this antireceptor antibody, Moreover, the RYD loop assumes two clearly defined conformations that may correspond to the orientations of the loop in the free state or bound to integrin, This molecule will serve as a tool for understanding protein-integrin recognition in platelet aggregation and other RGD-mediated cell adhesion interactions.	LA JOLLA CANC RES FDN, CTR CANC RES, LA JOLLA, CA 92037 USA; SCRIPPS RES INST, LA JOLLA, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Scripps Research Institute					NHLBI NIH HHS [HL46979] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046979] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADLER M, 1991, SCIENCE, V253, P445, DOI 10.1126/science.1862345; AUMAILLEY M, 1991, FEBS LETT, V291, P50, DOI 10.1016/0014-5793(91)81101-D; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BHAT TN, 1984, J APPL CRYSTALLOGR, V17, P244, DOI 10.1107/S0021889884011456; BOGUSKY MJ, 1992, INT J PEPT PROT RES, V39, P63; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P585, DOI 10.1107/S0108767390002355; BRUNGER AT, 1988, J MOL BIOL, V203, P803, DOI 10.1016/0022-2836(88)90211-2; BRUNGER AT, 1992, XPLOR MANUAL VERSION; BUSK M, 1992, J BIOL CHEM, V267, P5790; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; CELIKEL R, 1993, ACTA CRYSTALLOGR D, V49, P421, DOI 10.1107/S0907444993002501; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; COOKE RM, 1991, EUR J BIOCHEM, V202, P323, DOI 10.1111/j.1432-1033.1991.tb16379.x; DALVIT C, 1991, EUR J BIOCHEM, V202, P315, DOI 10.1111/j.1432-1033.1991.tb16378.x; DICKINSON CD, 1994, J MOL BIOL, V236, P1079, DOI 10.1016/0022-2836(94)90013-2; FAN ZC, 1992, J MOL BIOL, V228, P188, DOI 10.1016/0022-2836(92)90500-J; FAUCHERE JL, 1993, INT J PEPT PROT RES, V42, P440; FUREY W, 1990, 40TH ACA ANN M NEW O, P33; GINSBERG M, 1985, J BIOL CHEM, V260, P3931; GINSBERG MH, 1991, CHEM IMMUNOL, V50, P75; GURRATH M, 1992, EUR J BIOCHEM, V210, P911, DOI 10.1111/j.1432-1033.1992.tb17495.x; HE XM, 1992, P NATL ACAD SCI USA, V89, P7154, DOI 10.1073/pnas.89.15.7154; HENDRICKSON WA, 1985, METHOD ENZYMOL, V115, P252; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KOIVUNEN E, 1993, J BIOL CHEM, V268, P20205; KREZEL AM, 1994, SCIENCE, V264, P1944, DOI 10.1126/science.8009227; LASCOMBE MB, 1989, P NATL ACAD SCI USA, V86, P607, DOI 10.1073/pnas.86.2.607; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; LOFTUS JC, 1990, SCIENCE, V249, P915, DOI 10.1126/science.2392682; LOGAN D, 1993, NATURE, V362, P566, DOI 10.1038/362566a0; LU XJ, 1993, BIOCHEM J, V296, P21, DOI 10.1042/bj2960021; MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H; MARQUART M, 1980, J MOL BIOL, V141, P369, DOI 10.1016/0022-2836(80)90252-1; MCDOWELL RS, 1992, BIOCHEMISTRY-US, V31, P4766, DOI 10.1021/bi00135a004; NIIYA K, 1987, BLOOD, V70, P475; NISHIMURA SL, 1993, MOL BIOL CELL S, V4, P285; NOWLIN DM, 1993, J BIOL CHEM, V268, P20352; OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6; ONEIL KT, 1992, PROTEINS, V14, P509, DOI 10.1002/prot.340140411; PADLAN EA, 1989, P NATL ACAD SCI USA, V86, P5938, DOI 10.1073/pnas.86.15.5938; Pflugrath J. W., 1984, Methods and Applications in Crystallographic Computing. International Summer School on Crystallographic Computing, P404; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8; ROSSMANN MG, 1972, MOL REPLACEMENT METH, V13; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SAUDEK V, 1991, BIOCHEMISTRY-US, V30, P7369, DOI 10.1021/bi00244a003; SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1066; SCHULZEGAHMEN U, 1993, J MOL BIOL, V234, P1098, DOI 10.1006/jmbi.1993.1663; SENN H, 1993, J MOL BIOL, V232, P907, DOI 10.1006/jmbi.1993.1439; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; SOTERIADOU KP, 1992, J BIOL CHEM, V267, P13980; TAUB R, 1989, J BIOL CHEM, V264, P259; TAUB R, 1992, BIOCHEMISTRY-US, V31, P7431, DOI 10.1021/bi00148a001; TOMIYAMA Y, 1992, J BIOL CHEM, V267, P18085; TOMIYAMA Y, 1992, BLOOD, V79, P2303; TSCHOPP JF, 1993, CORONARY ARTERY DIS, V4, P1; VIX O, 1993, PROTEINS, V15, P339, DOI 10.1002/prot.340150402; VOGEL BE, 1993, J CELL BIOL, V121, P461, DOI 10.1083/jcb.121.2.461	62	37	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2268	2273		10.1074/jbc.270.5.2268	http://dx.doi.org/10.1074/jbc.270.5.2268			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836460	hybrid			2022-12-27	WOS:A1995QE49300046
J	HU, Q; DAVIDSON, D; SCHWARTZBERG, PL; MACCHIARINI, F; LENARDO, MJ; BLUESTONE, JA; MATIS, LA				HU, Q; DAVIDSON, D; SCHWARTZBERG, PL; MACCHIARINI, F; LENARDO, MJ; BLUESTONE, JA; MATIS, LA			IDENTIFICATION OF RLK, A NOVEL PROTEIN-TYROSINE KINASE WITH PREDOMINANT EXPRESSION IN THE T-CELL LINEAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED AGAMMAGLOBULINEMIA; MICE LACKING; GENE; RECEPTOR; DOMAINS; PHOSPHORYLATION; INTERLEUKIN-2; DEFICIENCY; P56LCK; FAMILY	The control of phosphorylation by protein tyrosine kinases represents an important regulatory mechanism in T cell growth, function, and differentiation. We have identified a 62-kDa murine protein tyrosine kinase predominantly expressed within the T cell lineage, which we have termed Rlk (for Resting lymphocyte kinase), rlk mRNA was found to be expressed in the fetal thymus as early as day 13 of embryonic development as well as in adult thymus and mature resting peripheral T cells, The sequence of rlk showed that it is most closely related to the subfamily of cytoplasmic tyrosine kinases that includes the Btk, Itk, and Tec proteins. However, Rlk differs from these kinases by virtue of its unique aminoterminal domain, which lacks a region of pleckstrin homology common to the other members of this protein subfamily. Examination of rlk abundance within different T cell subpopulations revealed preferential expression in Th1 relative to Th2 T cell clones, suggesting a possible role in signal transduction pathways that selectively regulate cytokine production in mature CD4(+) T cell subsets. Rlk thus represents a novel cytoplasmic tyrosine kinase with potential functions in intrathymic T cell development and mature T cell signaling.	ALEX PHARMACEUT,IMMUNOBIOL PROGRAM,NEW HAVEN,CT 06511; NCI,FREDERICK CANC RES & DEV CTR,BIOL RESPONSE MODIFIERS PROGRAM,FREDERICK,MD 21702; UNIV CHICAGO,DEPT ENDOCRINOL,CHICAGO,IL 60637; UNIV CHICAGO,DEPT PATHOL,CHICAGO,IL 60637; NIAID,IMMUNOL LAB,BETHESDA,MD 20098; PRI DYNCORP,BIOL CARCINOGENESIS & DEV PROGRAM,FREDERICK,MD 21702	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Chicago; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)			Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007011] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK07011] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; BIERER BE, 1989, ANNU REV IMMUNOL, V7, P579, DOI 10.1146/annurev.immunol.7.1.579; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; CHOW LML, 1994, P NATL ACAD SCI USA, V91, P4975, DOI 10.1073/pnas.91.11.4975; COLIGAN JE, 1992, CURRENT PROTOCOLS IM; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; GAUEN LKT, 1994, MOL CELL BIOL, V14, P3729, DOI 10.1128/MCB.14.6.3729; HAIRE RN, 1994, HUM MOL GENET, V3, P897, DOI 10.1093/hmg/3.6.897; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HEYECK SD, 1993, P NATL ACAD SCI USA, V90, P669, DOI 10.1073/pnas.90.2.669; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; KAPLAN JM, 1988, MOL CELL BIOL, V57, P69; KARNITZ L, 1992, MOL CELL BIOL, V12, P4521, DOI 10.1128/MCB.12.10.4521; KLAUSNER RD, 1991, CELL, V64, P85; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; MANO H, 1990, ONCOGENE, V5, P1781; MANO H, 1993, ONCOGENE, V8, P417; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; MUNRO S, 1984, EMBO J, V3, P3087, DOI 10.1002/j.1460-2075.1984.tb02263.x; OSBORNE WRA, 1990, HUM GENE THER, V1, P31, DOI 10.1089/hum.1990.1.1-31; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PERLMUTTER RM, 1993, ANNU REV IMMUNOL, V11, P451, DOI 10.1146/annurev.iy.11.040193.002315; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; SHAW G, 1993, BIOCHEM BIOPH RES CO, V195, P1145, DOI 10.1006/bbrc.1993.2164; SILICIANO JD, 1992, P NATL ACAD SCI USA, V89, P11194, DOI 10.1073/pnas.89.23.11194; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; TANAKA N, 1993, FEBS LETT, V324, P1, DOI 10.1016/0014-5793(93)81520-A; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; VANDENBERGHE P, 1992, J EXP MED, V175, P951, DOI 10.1084/jem.175.4.951; VANOERS NSC, 1992, ADV EXP MED BIOL, V323, P89; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WICKER LS, 1986, CURR TOP MICROBIOL, V124, P87; Yokoyama W M, 1989, Year Immunol, V4, P110	44	76	80	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1928	1934		10.1074/jbc.270.4.1928	http://dx.doi.org/10.1074/jbc.270.4.1928			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829530	hybrid			2022-12-27	WOS:A1995QD20400067
J	FRANCO, M; CHARDIN, P; CHABRE, M; PARIS, S				FRANCO, M; CHARDIN, P; CHABRE, M; PARIS, S			MYRISTOYLATION OF ADP-RIBOSYLATION FACTOR-1 FACILITATES NUCLEOTIDE EXCHANGE AT PHYSIOLOGICAL MG2+ LEVELS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-DEPENDENT BINDING; COP-COATED VESICLES; GOLGI MEMBRANES; BREFELDIN-A; FACTOR ARF; GUANINE-NUCLEOTIDE; ESCHERICHIA-COLI; PHOSPHOLIPASE-D; CHOLERA-TOXIN; PROTEIN	Recombinant N-myristoylated bovine ADP-ribosylation factor 1 (myr-rARF1) has been expressed in bacteria and purified to near homogeneity with a high (85%) myristoylation efficiency. Myr-rARF1 and nonmyristoylated rARF1 have been compared with respect to their kinetics of guanine nucleotide exchange and their interactions with phospholipids. Myristoylation is shown to allow the release of bound GDP at physiological (mM) concentrations of Mg2+. GDP dissociation is slow in the absence of phospholipids but is accelerated a-fold in the presence of phospholipid vesicles. On the contrary, myristoylation decreases 10-fold the rate of dissociation of GTP or guanosine 5'-O-(thiotriphosphate) (GTP gamma S) in the presence of phospholipids. As a result, myr-ARF1 can be spontaneously activated by GTP or GTP gamma S (t1/2 similar to 30 min at 37 degrees C) at 1 mM Mg2+, in the sole presence of phospholipid membranes without the need for a nucleotide exchange factor. In contrast to the nonacylated protein, the GDP-bound form of myr-ARF1 interacts with phospholipids, as demonstrated by its cosedimentation with phospholipid vesicles and its comigration with phospholipid/cholate micelles on gel filtration. The interaction is, however, weaker than for the GTP-bound form, suggesting that only the myristate in myr-ARF1(GDP) interacts with phospholipids, whereas both the myristate and the amino-terminal hydrophobic residues in myr-ARF1(GTP) bind to phospholipids.	CNRS,INST PHARMACOL MOLEC & CELLULAIRE,F-06560 VALBONNE,FRANCE	Centre National de la Recherche Scientifique (CNRS)			Franco, Michel/ABH-4993-2020; FRANCO, michel/AAA-9735-2021	Franco, Michel/0000-0003-1853-8661; 				BALCH WE, 1992, J BIOL CHEM, V267, P13053; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; CLARK J, 1993, P NATL ACAD SCI USA, V90, P8952, DOI 10.1073/pnas.90.19.8952; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; FRANCO M, 1993, J BIOL CHEM, V268, P24531; HAUN RS, 1993, J BIOL CHEM, V268, P7064; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; HELMS JB, 1993, J CELL BIOL, V121, P751, DOI 10.1083/jcb.121.4.751; KAHN RA, 1984, J BIOL CHEM, V259, P6228; KAHN RA, 1992, J BIOL CHEM, V267, P13039; KAHN RA, 1993, CELL, V75, P1045, DOI 10.1016/0092-8674(93)90314-G; LENHARD JM, 1992, J BIOL CHEM, V267, P13047; PALMER DJ, 1993, J BIOL CHEM, V268, P12083; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; RANDAZZO PA, 1993, J BIOL CHEM, V268, P9555; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; TAYLOR TC, 1992, CELL, V70, P69, DOI 10.1016/0092-8674(92)90534-J; TSAI SC, 1994, P NATL ACAD SCI USA, V91, P3063, DOI 10.1073/pnas.91.8.3063; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; WALKER MW, 1992, J BIOL CHEM, V267, P3230; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569	26	147	148	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1337	1341		10.1074/jbc.270.3.1337	http://dx.doi.org/10.1074/jbc.270.3.1337			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836400	hybrid			2022-12-27	WOS:A1995QB15600055
J	KIM, K; NAMGOONG, SY; JAYARAM, M; HARSHEY, RM				KIM, K; NAMGOONG, SY; JAYARAM, M; HARSHEY, RM			STEP-ARREST MUTANTS OF PHAGE MU-TRANSPOSASE - IMPLICATIONS IN DNA-PROTEIN ASSEMBLY, MU-END CLEAVAGE, AND STRAND TRANSFER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC RECOMBINATION; FLP RECOMBINASE; INVITRO TRANSPOSITION; REACTION-MECHANISM; 3'-5' EXONUCLEASE; ESCHERICHIA-COLI; ION CATALYSIS; POLYMERASE-I; ACTIVE-SITE; AMINO-ACID	We describe the isolation and characterization of Mu A variants arrested at specific steps of transposition. Mutations at 13 residues within the Mu A protein were analyzed for precise excision of Mu DNA in vivo. A subset of the defective variants (altered at Asp(269), Asp(294), Gly(348), and Glu(392)) were tested in specific steps of transposition in vitro. It is possible that at least some residues of the Asp(269)-Asp(294)-Glu(392) triad may have functional similarities to those of the conserved Asp-Asp-Glu motif found in several transposases and retroviral integrases. Mu A(D269V) is defective in high-order DNA-protein assembly, Mu end cleavage, and strand transfer. The assembly defect, but not the catalytic defect, can be overcome by precleavage of Mu ends, Mu A(E392A) can assemble the synaptic complex, but cannot cleave Mu ends, A mutation of Gly(348) to aspartic acid within Mu A permits the uncoupling of cleavage and strand transfer activities. This mutant is completely defective in synaptic assembly and Mu end cleavage in presence of Mg2+. The assembly defect is alleviated by replacing Mg2+ with Ca2+. Some Mu end cleavage is observed with this mutant in the presence of Mn2+. When presented with precleaved Mu ends, Mu A(G348D) exhibits efficient strand transfer activity.	UNIV TEXAS,DEPT MICROBIOL,AUSTIN,TX 78712	University of Texas System; University of Texas Austin								BAKER TA, 1993, CELL, V74, P723, DOI 10.1016/0092-8674(93)90519-V; BAKER TA, 1991, CELL, V65, P1003, DOI 10.1016/0092-8674(91)90552-A; BAKER TA, 1994, P NATL ACAD SCI USA, V91, P6645; Barik S, 1993, Methods Mol Biol, V15, P277, DOI 10.1385/0-89603-244-2:277; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BETERMIER M, 1989, MOL MICROBIOL, V3, P1159, DOI 10.1111/j.1365-2958.1989.tb00266.x; BREMER E, 1988, GENE, V71, P177, DOI 10.1016/0378-1119(88)90089-3; BUKHARI AI, 1975, J MOL BIOL, V96, P87, DOI 10.1016/0022-2836(75)90183-7; CHEN JW, 1992, CELL, V69, P647, DOI 10.1016/0092-8674(92)90228-5; DERBYSHIRE V, 1991, EMBO J, V10, P17, DOI 10.1002/j.1460-2075.1991.tb07916.x; ENGELMAN A, 1992, J VIROL, V66, P6361, DOI 10.1128/JVI.66.11.6361-6369.1992; FAYET O, 1990, MOL MICROBIOL, V4, P1771, DOI 10.1111/j.1365-2958.1990.tb00555.x; HARSHEY RM, 1985, P NATL ACAD SCI USA, V82, P7676, DOI 10.1073/pnas.82.22.7676; HARSHEY RM, 1986, J GENET, V65, P159, DOI 10.1007/BF02931149; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; KRAMER W, 1993, NUCLEIC ACIDS RES, V12, P9441; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; KUO CF, 1991, EMBO J, V10, P1585, DOI 10.1002/j.1460-2075.1991.tb07679.x; LAVOIE BD, 1991, EMBO J, V10, P3051, DOI 10.1002/j.1460-2075.1991.tb07856.x; LEAVITT AD, 1993, J BIOL CHEM, V268, P2113; LEE J, 1993, J BIOL CHEM, V268, P17564; LEUNG PC, 1989, NATURE, V338, P656, DOI 10.1038/338656a0; LEUNG PC, 1991, J MOL BIOL, V219, P189, DOI 10.1016/0022-2836(91)90561-J; Maniatis T., 1982, MOL CLONING; MIZUUCHI K, 1992, ANNU REV BIOCHEM, V61, P1011; MIZUUCHI M, 1992, CELL, V70, P303, DOI 10.1016/0092-8674(92)90104-K; MIZUUCHI M, 1989, CELL, V58, P399, DOI 10.1016/0092-8674(89)90854-4; NAKAYAMA C, 1987, P NATL ACAD SCI USA, V84, P1809, DOI 10.1073/pnas.84.7.1809; NAMGOONG S, 1994, J MOL BIOL, V238, P514, DOI 10.1006/jmbi.1994.1311; PARSONS RL, 1988, MOL CELL BIOL, V8, P3303, DOI 10.1128/MCB.8.8.3303; PARSONS RL, 1990, J BIOL CHEM, V265, P4527; PICCIRILLI JA, 1993, NATURE, V361, P85, DOI 10.1038/361085a0; PRIESS H, 1987, PHAGE MU, P277; QIAN XH, 1990, J BIOL CHEM, V265, P21779; RADSTROM P, 1994, J BACTERIOL, V176, P3257, DOI 10.1128/jb.176.11.3257-3268.1994; ROWLAND SJ, 1990, MOL MICROBIOL, V4, P961, DOI 10.1111/j.1365-2958.1990.tb00669.x; SMITH D, 1993, BIOCHEMISTRY-US, V32, P5273, DOI 10.1021/bi00071a001; Suck D, 1992, CURR OPIN STRUC BIOL, V2, P84; SURETTE MG, 1987, CELL, V49, P253, DOI 10.1016/0092-8674(87)90566-6; SURETTE MG, 1991, J BIOL CHEM, V266, P3118; VANGENT DC, 1993, NUCLEIC ACIDS RES, V21, P3373, DOI 10.1093/nar/21.15.3373	41	57	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1472	1479		10.1074/jbc.270.3.1472	http://dx.doi.org/10.1074/jbc.270.3.1472			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836417	hybrid			2022-12-27	WOS:A1995QB15600074
J	KWAK, SP; DIXON, JE				KWAK, SP; DIXON, JE			MULTIPLE DUAL-SPECIFICITY PROTEIN-TYROSINE PHOSPHATASES ARE EXPRESSED AND REGULATED DIFFERENTIALLY IN LIVER-CELL LINES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMEDIATE-EARLY GENE; VACCINIA VIRUS VH1; GROWTH-FACTOR; SEQUENCE; KINASE	An emerging subclass of protein-tyrosine phosphatases (PTPases) exhibits sequence identity to the vaccinia H-1 (VH-1) gene product. These VH-1-like PTPases possess the canonical HCXAGXXR(S/T) sequence common to all PTPases, but unlike other PTPases they exhibit dual catalytic activity toward phosphotyrosine and nearby phosphothreonine residues in substrate proteins. We have isolated a novel VH-1-like PTPase, hVH-3, from the human placenta and compared various aspects of its expression with previously isolated members of this subfamily. The mammalian members of this subfamily including hVH-3 commonly localize to the nucleus and exhibit catalytic activity toward phosphorylated extracellular signal-regulated kinase. However, while the expression of some VH-1-like PTPases is extremely transient and independent of protein synthesis, hVH-3 expression is sustained over 3 h after being cell stimulated. Tissue-specific expression of hVH-3 is also distinct from other VH-1-like PTPases. Although VH-1-like PTPases have overlapping substrate specificity, there are differences in their mRNA regulation, response to extracellular stimuli, and tissue-specific expression, suggesting they serve specific roles in cellular function.	UNIV MICHIGAN, DEPT BIOL CHEM, ANN ARBOR, MI 48109 USA	University of Michigan System; University of Michigan					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018024, R37DK018024] Funding Source: NIH RePORTER; NIDDK NIH HHS [NIDDK 18024] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; CHARLES CH, 1992, ONCOGENE, V7, P187; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; DENU JM, 1995, IN PRESS J BIOL CHEM, V270; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DOI K, 1994, EMBO J, V13, P61, DOI 10.1002/j.1460-2075.1994.tb06235.x; Errede B, 1993, CURR OPIN CELL BIOL, V5, P254, DOI 10.1016/0955-0674(93)90112-4; GUAN K, 1992, P NATL ACAD SCI USA, V89, P12175, DOI 10.1073/pnas.89.24.12175; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; HAKES DJ, 1993, P NATL ACAD SCI USA, V90, P4017, DOI 10.1073/pnas.90.9.4017; HAKES DJ, 1992, ANAL BIOCHEM, V202, P293, DOI 10.1016/0003-2697(92)90108-J; ISHIBASHI T, 1992, P NATL ACAD SCI USA, V89, P12170, DOI 10.1073/pnas.89.24.12170; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; KEYSE SM, 1993, TRENDS BIOCHEM SCI, V18, P377, DOI 10.1016/0968-0004(93)90092-2; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; KWAK SP, 1994, J BIOL CHEM, V269, P3596; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MARTELL KJ, 1994, GENOMICS, V22, P462, DOI 10.1006/geno.1994.1411; NOGUCHI T, 1993, MOL CELL BIOL, V13, P5195, DOI 10.1128/MCB.13.9.5195; PERALDI P, 1993, ENDOCRINOLOGY, V132, P2578, DOI 10.1210/en.132.6.2578; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; STUCKEY JA, 1994, NATURE, V370, P571, DOI 10.1038/370571a0; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; WALTON KM, 1993, NEURON, V11, P387, DOI 10.1016/0896-6273(93)90193-U; WARD Y, 1994, NATURE, V367, P651, DOI 10.1038/367651a0; ZHENG CF, 1993, J BIOL CHEM, V268, P16114	30	115	117	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1156	1160		10.1074/jbc.270.3.1156	http://dx.doi.org/10.1074/jbc.270.3.1156			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836374	hybrid			2022-12-27	WOS:A1995QB15600029
J	LOO, TW; CLARKE, DM				LOO, TW; CLARKE, DM			MEMBRANE TOPOLOGY OF A CYSTEINE-LESS MUTANT OF HUMAN P-GLYCOPROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; MULTIDRUG TRANSPORTER; FUNCTIONAL CONSEQUENCES; RESISTANCE; ORIENTATION; EXPRESSION; ANTIBODIES; MUTATIONS; SEQUENCE; PROTEINS	A human P-glycoprotein devoid of cysteine residues was constructed by site-directed mutagenesis for studying its topology, The cDNA for human P-glycoprotein-A52 in which codons for cysteines 137, 431, 717, 956, 1074, 1125, 1227, 1288, and 1304 were changed to Ala, was transfected into NIH 3T3 cells and analyzed with respect to its ability to confer resistance to various drugs, The cysteine-less P-glycoprotein-A52 retained the ability to confer resistance to vinblastine, colchicine, doxorubicin, and actinomycin D with only a small decrease in efficiency relative to wild-type enzyme, Cysteine residues were then reintroduced into predicted extracellular or cytoplasmic loops of the cysteine less P-glycoprotein-A52, and the topology of the protein was determined using membrane-permeant and impermeant thiol-specific reagents, It was found that 8 of 15 cysteine residues introduced into P-glycoprotein-A52 could be biotinylated, when cells expressing the mutant P-glycoprotein were incubated with membrane-permeant biotin maleimide, Biotinylation of a cysteine residue placed in predicted extracellular loops between transmembrane segment (TM) 5 and TM6, TM7 and TM8, or TM11 and TM12 was blocked by pretreatment of the cells with a membrane impermeant maleimide, suggesting that these residues have an extracellular location, By contrast, biotinylation of cysteine residues located in the predicted cytoplasmic loops between TM2 and TM3, TM4 and TM5, TM8 and TM9, or TM10 and TM11 were not blocked by pretreatment with membrane impermeant maleimide, suggesting that these residues were in the cytoplasm. These results are consistent with the model of P-glycoprotein, which predicts six transmembrane segments in each of the two homologous halves of the molecule.	UNIV TORONTO,DEPT MED,MRC,MEMBRANE BIOL GRP,TORONTO,ON M5S 1A8,CANADA; UNIV TORONTO,DEPT BIOCHEM,TORONTO,ON M5S 1A8,CANADA	University of Toronto; University of Toronto			Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188				ALLEY MC, 1988, CANCER RES, V48, P589; ALSHAWI MK, 1994, J BIOL CHEM, V269, P8986; BAYER EA, 1985, ANAL BIOCHEM, V149, P529, DOI 10.1016/0003-2697(85)90609-8; BELL GI, 1986, NUCLEIC ACIDS RES, V14, P8427, DOI 10.1093/nar/14.21.8427; BRUGGEMANN EP, 1989, J BIOL CHEM, V264, P15483; CLARKE DM, 1989, J BIOL CHEM, V264, P11246; GEORGES E, 1993, J BIOL CHEM, V268, P1792; GOTTESMAN MM, 1988, J BIOL CHEM, V263, P12163; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; JURANKA PF, 1989, FASEB J, V3, P2583, DOI 10.1096/fasebj.3.14.2574119; LOO TW, 1993, J BIOL CHEM, V268, P3143; LOO TW, 1994, J BIOL CHEM, V269, P7243; LOO TW, 1994, J BIOL CHEM, V269, P7750; LOO TW, 1994, J BIOL CHEM, V269, P28683; MARUYAMA K, 1989, CELL MOTIL CYTOSKEL, V14, P26, DOI 10.1002/cm.970140107; RONINSON IBE, 1991, MOL CELLULAR BIOL MU; SCHINKEL AH, 1993, J BIOL CHEM, V268, P7474; SKACH WR, 1994, CANCER RES, V54, P3202; SKACH WR, 1993, J BIOL CHEM, V268, P6903; VANIWAARDEN PR, 1991, BIOCHEMISTRY-US, V30, P9595, DOI 10.1021/bi00104a005; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; YOSHIMURA A, 1989, J BIOL CHEM, V264, P16282; ZHANG JT, 1991, J BIOL CHEM, V266, P18224; ZUBRZYCKAGAARN E, 1984, J BIOENERG BIOMEMBR, V16, P441, DOI 10.1007/BF00743238	25	263	269	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					843	848		10.1074/jbc.270.2.843	http://dx.doi.org/10.1074/jbc.270.2.843			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822320	hybrid			2022-12-27	WOS:A1995QB81600054
J	KAZAMA, Y; HAMAMOTO, T; FOSTER, DC; KISIEL, W				KAZAMA, Y; HAMAMOTO, T; FOSTER, DC; KISIEL, W			HEPSIN, A PUTATIVE MEMBRANE-ASSOCIATED SERINE-PROTEASE, ACTIVATES HUMAN FACTOR-VII AND INITIATES A PATHWAY OF BLOOD-COAGULATION ON THE CELL-SURFACE LEADING TO THROMBIN FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-FACTOR; FACTOR-X; TRANSMEMBRANE DOMAIN; EXTRINSIC PATHWAY; FACTOR-IX; PLASMA; PHOSPHOLIPIDS; PURIFICATION; INHIBITOR; CANCER	Previous studies have shown that hepsin is a putative membrane-associated serine protease that is required for cell growth (Torres-Rosado, A., O'Shea, K. S., Tsuji, A., Chou, S.-H., and Kurachi, K. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 7181 7185). In the present study, we have transfected baby hamster kidney (BHK) cells with a plasmid containing the cDNA for human hepsin and examined these cells for their ability to activate several blood coagulation factors including factors X, IX, VII, prothrombin, and protein C. Little, if any, proteolytic activation of factors X, IX, prothrombin, or protein C was observed when these clotting factors were incubated with hepsin-transfected cells. On the other hand, hepsin-transfected cells proteolytically activated significant concentrations of human factor VII in a time- and calcium-dependent manner, whereas essentially no activation of factor VII was observed in BHK cells transfected with plasmid lacking the cDNA for hepsin. The factor VII activating activity in the hepsin-transfected BHK cell line was confined exclusively to the total membrane fraction and was inhibited >95% by antibody raised against a fusion protein consisting of maltose-binding protein and the extracellular domain of human hepsin. An active site factor VII mutant, S344A factor VII, was cleaved as readily as plasma-derived factor VII by hepsin-transfected cells, indicating that factor VII was not converted to factor Wa autocatalytically on the cell surface. In contrast, an activation cleavage site factor VII mutant, R152E factor VII, was not cleaved by hepsin-transfected cells, suggesting that factor VII and S344A factor VII were activated on these cells by cleavage of the Arg(152)-Ile(153) peptide bond. In the copresence of factor VII and factor X, hepsin-transfected BHK cells supported the formation of factor Xa. In addition, in the copresence of factor VII, factor X, and prothrombin, hepsin-transfected BHK cells supported the formation of thrombin. These results strongly suggest that membrane associated hepsin converts zymogen factor VII to factor VIIa, which in turn, is capable of initiating a coagulation pathway on the cell surface that ultimately leads to thrombin formation.	UNIV NEW MEXICO, SCH MED, DEPT PATHOL, ALBUQUERQUE, NM 87131 USA; ZYMOGENET INC, SEATTLE, WA 98102 USA	University of New Mexico; Zymogenet Inc.					NHLBI NIH HHS [HL35246] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035246] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BELL WN, 1954, NATURE, V174, P880, DOI 10.1038/174880a0; BOM VJJ, 1990, BIOCHEM J, V265, P327, DOI 10.1042/bj2650327; BOND JS, 1991, BIOMED BIOCHIM ACTA, V50, P775; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COSTANTINI V, 1993, THROMB HAEMOSTASIS, V69, P406; DUNBAR BS, 1990, METHOD ENZYMOL, V182, P663; EDWARDS RL, 1993, THROMB HAEMOSTASIS, V69, P205; FALANGA A, 1985, BIOCHEMISTRY-US, V24, P5558, DOI 10.1021/bi00341a041; FOSTER DC, 1991, BIOCHEMISTRY-US, V30, P367, DOI 10.1021/bi00216a009; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GUAN C, 1988, GENE, V67, P21; HAGEN FS, 1986, P NATL ACAD SCI USA, V83, P2412, DOI 10.1073/pnas.83.8.2412; HOFFMAN M, 1994, BLOOD, V83, P38; KAZAMA Y, 1993, J BIOL CHEM, V268, P16231; KISIEL W, 1979, J CLIN INVEST, V64, P761, DOI 10.1172/JCI109521; KISIEL W, 1973, BIOCHIM BIOPHYS ACTA, V304, P103, DOI 10.1016/0304-4165(73)90119-0; KOMIYAMA Y, 1990, BIOCHEMISTRY-US, V29, P9418, DOI 10.1021/bi00492a016; KONDO S, 1987, BLOOD, V70, P1947; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWSON JH, 1993, METHOD ENZYMOL, V222, P177; LEYTUS SP, 1988, BIOCHEMISTRY-US, V27, P1067, DOI 10.1021/bi00403a032; MAHONEY WC, 1980, EUR J BIOCHEM, V105, P545, DOI 10.1111/j.1432-1033.1980.tb04531.x; MORGENSTERN KA, 1993, J BIOL CHEM, V268, P21560; MURRAY JC, 1991, BRIT J CANCER, V64, P422, DOI 10.1038/bjc.1991.325; NAKAGAKI T, 1991, BIOCHEMISTRY-US, V30, P10819, DOI 10.1021/bi00109a001; NICOLAISEN EM, 1992, FEBS LETT, V306, P157, DOI 10.1016/0014-5793(92)80989-T; NORDFANG O, 1991, BIOCHEMISTRY-US, V30, P10371, DOI 10.1021/bi00107a002; OSTERUD B, 1983, HAEMOSTASIS, V13, P161; OSTERUD B, 1977, P NATL ACAD SCI USA, V74, P5260, DOI 10.1073/pnas.74.12.5260; PABORSKY LR, 1991, J BIOL CHEM, V266, P21911; QUICK AJ, 1966, HEMORRHAGIC DISEASE, P438; RAO LVM, 1990, BLOOD, V75, P1069; RUF W, 1991, J BIOL CHEM, V266, P2158; SAKAI T, 1990, HAEMOSTASIS, V20, P125; Sambrook J, 1989, MOL CLONING LABORATO; THIM L, 1988, BIOCHEMISTRY-US, V27, P7785, DOI 10.1021/bi00420a030; TORRESROSADO A, 1993, P NATL ACAD SCI USA, V90, P7181, DOI 10.1073/pnas.90.15.7181; TSUJI A, 1991, J BIOL CHEM, V266, P16948; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615; WILDGOOSE P, 1990, BIOCHEMISTRY-US, V29, P3413, DOI 10.1021/bi00465a039; WILDGOOSE P, 1989, BLOOD, V73, P1888; WILDGOOSE P, 1992, THROMB HAEMOSTASIS, V67, P679; WILDGOOSE P, 1992, BLOOD, V80, P25; WOJTUKIEWICZ MZ, 1990, ANTICANCER RES, V10, P579; ZACHARSKI LR, 1991, THROMB HAEMOSTASIS, V65, P545	46	93	124	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					66	72		10.1074/jbc.270.1.66	http://dx.doi.org/10.1074/jbc.270.1.66			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814421	hybrid			2022-12-27	WOS:A1995QA28700016
J	MU, D; PARK, CH; MATSUNAGA, T; HSU, DS; REARDON, JT; SANCAR, A				MU, D; PARK, CH; MATSUNAGA, T; HSU, DS; REARDON, JT; SANCAR, A			RECONSTITUTION OF HUMAN DNA-REPAIR EXCISION NUCLEASE IN A HIGHLY DEFINED SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RNA POLYMERASE-II; TRANSCRIPTION; HELICASE; EXTRACT; PROTEIN; ERCC1	Xeroderma pigmentosum is a hereditary disease caused by defective DNA repair. Somatic cell genetics and biochemical studies with cell-free extracts indicate that at least 16 polypeptides are required to carry out the repair reaction proper, i.e. the removal of the lesion from the DNA by the dual incisions of the damaged strand. To find out if these proteins are necessary and sufficient for excision repair, they were obtained at a high level of purity in five fractions. The mixture of these five fractions reconstituted the excision nuclease (excinuclease) activity. Using the reconstituted excinuclease, we found that the excised fragment remains associated with the post-incision DNA-protein complex, suggesting that accessory proteins are needed to release the excised oligomer.	UNIV N CAROLINA,SCH MED,DEPT BIOCHEM & BIOPHYS,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine			Mu, David/E-8933-2011	Mu, David/0000-0002-7762-0182	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32833] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARDWELL AJ, 1994, MOL CELL BIOL, V14, P3569, DOI 10.1128/MCB.14.6.3569; BIGGERSTAFF M, 1992, EMBO J, V12, P3685; BUSCH D, 1994, MUTAGENESIS, V9, P301, DOI 10.1093/mutage/9.4.301; Cleaver J. E., 1989, METABOLIC BASIS INHE, V2, P2949; CLEAVER JE, 1968, NATURE, V218, P652, DOI 10.1038/218652a0; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; COVERLEY D, 1992, NUCLEIC ACIDS RES, V20, P3873, DOI 10.1093/nar/20.15.3873; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; DRAPKIN R, 1994, TRENDS BIOCHEM SCI, V19, P504, DOI 10.1016/0968-0004(94)90139-2; FLORES O, 1992, J BIOL CHEM, V267, P2786; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; HOEIJMAKERS JHJ, 1994, NATURE, V371, P654, DOI 10.1038/371654a0; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P12213, DOI 10.1073/pnas.91.25.12213; MA LB, 1994, NUCLEIC ACIDS RES, V22, P4095, DOI 10.1093/nar/22.20.4095; MANLEY JL, 1980, P NATL ACAD SCI-BIOL, V77, P3855, DOI 10.1073/pnas.77.7.3855; MASUTANI C, 1994, EMBO J, V13, P1831, DOI 10.1002/j.1460-2075.1994.tb06452.x; NICHOLS AF, 1992, NUCLEIC ACIDS RES, V20, P2441, DOI 10.1093/nar/20.10.2441; PARK CH, 1994, P NATL ACAD SCI USA, V91, P5017, DOI 10.1073/pnas.91.11.5017; PARK CH, 1993, NUCLEIC ACIDS RES, V21, P5110, DOI 10.1093/nar/21.22.5110; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; REARDON JT, 1993, COLD SPRING HARB SYM, V58, P605, DOI 10.1101/SQB.1993.058.01.067; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; STEFANINI M, 1991, CANCER RES, V51, P3965; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; SVOBODA DL, 1993, J BIOL CHEM, V268, P1931; TANAKA K, 1994, TRENDS BIOCHEM SCI, V19, P83, DOI 10.1016/0968-0004(94)90040-X; THOMPSON LH, 1989, ENVIRON MOL MUTAGEN, V14, P264, DOI 10.1002/em.2850140409; VANVUUREN AJ, 1993, EMBO J, V12, P3693, DOI 10.1002/j.1460-2075.1993.tb06044.x; ZAWEL L, 1993, PROG NUCLEIC ACID RE, V44, P67, DOI 10.1016/S0079-6603(08)60217-2	31	406	415	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2415	2418		10.1074/jbc.270.6.2415	http://dx.doi.org/10.1074/jbc.270.6.2415			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852297	Green Published, hybrid			2022-12-27	WOS:A1995QF53500002
J	RANI, CSS; ABE, A; CHANG, Y; ROSENZWEIG, N; SALTIEL, AR; RADIN, NS; SHAYMAN, JA				RANI, CSS; ABE, A; CHANG, Y; ROSENZWEIG, N; SALTIEL, AR; RADIN, NS; SHAYMAN, JA			CELL-CYCLE ARREST INDUCED BY ALL INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE - CORRELATION WITH CYCLIN-DEPENDENT KINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GANGLIOSIDE-MEDIATED MODULATION; PROTEIN-KINASE; GROWTH; PHOSPHORYLATION; RECEPTOR; DNA; CERAMIDE; INSULIN; CDC2; SPHINGOLIPIDS	In an attempt to define the basis for sphingolipid regulation of cell proliferation, we studied the effects of glucosylceramide (GlcCer) synthase inhibition by three-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) on NIH 3T3 cells overexpressing insulin-like growth factor-1 (IGF-1) receptors, PDMP treatment resulted in a time-dependent decrease in GlcCer levels and an increase in cellular ceramide levels, PDMP abolished serum and IGF-1-stimulated cell proliferation, as measured by a reduction in [H-3]thymidine incorporation, protein, and DNA levels, However it did not affect IGF-1-mediated early signaling events, including receptor tyrosine kinase, MAP kinase, and phosphatidylinositol 3-kinase activities, Two-color flow cytometry with propidium iodide and 5-bromo-2'-deoxyuridine monophosphate labeling revealed an arrest of the cell cycle at G(1)/S and G(2)/M transitions in an asynchronous population of cells, These changes were time dependent, with maximal effects seen by 12-24 h. Removal of PDMP from the cell medium resulted in reversal of the cell cycle changes, with cells re-entering the S phase. The cell cycle arrest at the G(1)/S and G(2)/M transitions was confirmed in cells synchronized by pretreatment with nocodazole, aphidicolin, or hydroxyurea, and released from blockade in the presence of PDMP, A decrease in the activities of two cyclin-dependent kinases, p34(edc2) kinase and cdk2 kinase, was observed with PDMP treatment, When cell ceramide levels were increased by N-acetylsphingosine, comparable changes in the cell cycle distribution were seen, However, sphingomyelinase treatment was without effect, Therefore, it appears that ceramide mediates in part the inhibitory effect of GlcCer synthase inhibition on IGF-1-induced cell proliferation in 3T3 cells, The rapid production of decreased cyclin-dependent kinase activities by PDMP suggests that one of the crucial sites of action of the inhibitor lies in this area.	UNIV MICHIGAN,DEPT INTERNAL MED,DIV NEPHROL,ANN ARBOR,MI 48109; WARNER LAMBERT PARKE DAVIS,PARKE DAVIS PHARMACEUT RES DIV,DEPT SIGNAL TRANSDUCT,ANN ARBOR,MI 48105	University of Michigan System; University of Michigan; Pfizer			Saltiel, Alan/L-3632-2019	Saltiel, Alan/0000-0002-9726-9828	NIDDK NIH HHS [DK41487, DK39255] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK039255, R01DK041487] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABE A, 1992, EUR J BIOCHEM, V210, P765, DOI 10.1111/j.1432-1033.1992.tb17479.x; ABE A, 1994, IN PRESS J LIPID RES; BORCHARDT RA, 1994, BBA-LIPID LIPID MET, V1212, P327, DOI 10.1016/0005-2760(94)90207-0; BREMER EG, 1984, J BIOL CHEM, V259, P6818; BREMER EG, 1986, J BIOL CHEM, V261, P2434; CARSON KG, 1994, TETRAHEDRON LETT, V35, P2659, DOI 10.1016/S0040-4039(00)76999-1; COHEN P, 1993, BIOCHEM SOC T, V21, P555, DOI 10.1042/bst0210555; DEVOTO SH, 1992, CELL, V68, P167, DOI 10.1016/0092-8674(92)90215-X; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; ELLEDGE SJ, 1992, P NATL ACAD SCI USA, V89, P2907, DOI 10.1073/pnas.89.7.2907; FELDINGHABERMANN B, 1990, BIOCHEMISTRY-US, V29, P6314, DOI 10.1021/bi00478a028; HAKOMORI SI, 1990, J BIOL CHEM, V265, P18713; HANNUN YA, 1989, CLIN CHIM ACTA, V185, P333, DOI 10.1016/0009-8981(89)90224-6; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HANNUN YA, 1993, ADV LIPID RES, V25, P43; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HOY CA, 1989, CYTOMETRY, V10, P718, DOI 10.1002/cyto.990100608; INOKUCHI J, 1990, CANCER RES, V50, P6731; KASTAN MB, 1991, CANCER RES, V51, P6304; KATO H, 1993, J BIOL CHEM, V268, P2655; LEE KJ, 1985, CARBOHYD RES, V144, P148, DOI 10.1016/0008-6215(85)85015-1; LEE MG, 1987, NATURE, V327, P31, DOI 10.1038/327031a0; LEE TH, 1991, CELL, V64, P415, DOI 10.1016/0092-8674(91)90649-J; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARSHAK DR, 1991, J CELL BIOCHEM, V45, P391, DOI 10.1002/jcb.240450413; MASTICK CC, 1994, ENDOCRINOLOGY, V135, P214, DOI 10.1210/en.135.1.214; MIYASAKA T, 1990, J BIOL CHEM, V265, P4730; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; NOJIRI H, 1991, J BIOL CHEM, V266, P4531; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; PANG L, 1994, J BIOL CHEM, V269, P10604; PINES J, 1993, TRENDS BIOCHEM SCI, V18, P195, DOI 10.1016/0968-0004(93)90185-P; RADIN NS, 1993, ADV LIPID RES, V26, P183; RAPPOLEE DA, 1989, J CELL BIOCHEM, V39, P1, DOI 10.1002/jcb.240390102; ROSENBLATT J, 1992, P NATL ACAD SCI USA, V89, P2824, DOI 10.1073/pnas.89.7.2824; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; SHAYMAN JA, 1991, J BIOL CHEM, V266, P22968; SHAYMAN JA, 1990, J BIOL CHEM, V265, P12135; SHAYMAN JA, 1994, IN PRESS LIPOBIOLOGY; SHIRODKAR S, 1992, CELL, V68, P157, DOI 10.1016/0092-8674(92)90214-W; SUNDARAM KS, 1984, J NEUROCHEM, V42, P577, DOI 10.1111/j.1471-4159.1984.tb02716.x; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TOUCHSTONE JC, 1983, CLIN CHEM, V29, P1951; WANG E, 1991, J BIOL CHEM, V266, P14486; YANAGA F, 1994, BIOCHEM J, V298, P733, DOI 10.1042/bj2980733; ZADOR IZ, 1993, J CLIN INVEST, V91, P797, DOI 10.1172/JCI116299; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155	48	153	158	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2859	2867		10.1074/jbc.270.6.2859	http://dx.doi.org/10.1074/jbc.270.6.2859			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852361	hybrid			2022-12-27	WOS:A1995QF53500071
J	SWOBODA, I; JILEK, A; FERREIRA, F; ENGEL, E; HOFFMANNSOMMERGRUBER, K; SCHEINER, O; KRAFT, D; BREITENEDER, H; PITTENAUER, E; SCHMID, E; VICENTE, O; HEBERLEBORS, E; AHORN, H; BREITENBACH, M				SWOBODA, I; JILEK, A; FERREIRA, F; ENGEL, E; HOFFMANNSOMMERGRUBER, K; SCHEINER, O; KRAFT, D; BREITENEDER, H; PITTENAUER, E; SCHMID, E; VICENTE, O; HEBERLEBORS, E; AHORN, H; BREITENBACH, M			ISOFORMS OF BET-V-1, THE MAJOR BIRCH POLLEN ALLERGEN, ANALYZED BY LIQUID-CHROMATOGRAPHY, MASS-SPECTROMETRY, AND CDNA CLONING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PR PROTEINS; GENE; PURIFICATION; LOCALIZATION; TRANSCRIPTS; EXPRESSION; ANTIBODIES; VERRUCOSA; HORNBEAM; ALDER	Bet v 1, the major allergen of birch pollen, displays a considerable degree of heterogeneity. Several charge variants have been detected by two-dimensional IgE immunoblots and isoelectric focusing techniques. This heterogeneity has been attributed to glycosylation (or other post-translational modifications) or to isogenes coding for Bet vl isoforms and/or allelic variants. However, until now, only limited structural data for Bet v 1 have been published, Recently, we described the expression, purification, and immunological properties of recombinant Bet v 1 (rBet v 1) produced in Escherichia coli as a non-fusion protein (Ferreira, F. D., Hoffmann-Sommergruber, K., Breiteneder, H., Pettenburger, K., Ebner, C., Sammergruber, W., Steiner, R., Bohle, B., Sperr, W. R., Valent, P., Kungl, A. J., Breitenbach, Ri., Kraft, D,, and Scheiner, O. (1993) J. Biol. Chem. 268, 19574-19580). Here, we present a more detailed structural characterization of Bet v 1 by both cDNA cloning and mass spectrometry. Thirteen different cDNA clones coding for Bet v 1 isoforms were obtained by polymerase chain reaction amplification of birch pollen cDNA with a sequence specific 5'-terminal primer and a nonspecific S'-terminal primer or by immunological screening of a birch pollen cDNA Library. These isoforms are referred to as Bet v Ib to Bet v In, whereas the previously isolated Bet v 1 cDNA (Breiteneder, H., Pettenburger, K., Bite, A., Valenta, R., Kraft, D., Rumpold, H., Scheiner, O., and Breitenbach, M. (1989) EMBO J. 8, 1935-1938) is now referred to as Bet v la. High performance liquid chromatography and plasma desorption mass spectrometry of proteolytic fragments of purified natural Bet v 1 (nBet v 1) and rBet v la were used to (i) confirm the primary structure of all Bet v 1 isoforms and (ii) to investigate any possible postsynthetic modifications on rBet v la or on the natural mixture of isoallergens obtained from birch pollen. Except for the cleavage of initiating methionine, no postsynthetic modifications were found in either nBet v 1 or rBet v 1a.	SALZBURG UNIV,INST GENET & ALLGEMEINE BIOL,A-5020 SALZBURG,AUSTRIA; UNIV VIENNA,INST ALLGEMEINE & EXPTL PATHOL,A-1090 VIENNA,AUSTRIA; UNIV VIENNA,INST MIKROBIOL & GENET,A-1030 VIENNA,AUSTRIA; UNIV VIENNA,INST ANALYT CHEM,A-1090 VIENNA,AUSTRIA; ERNST BOHRINGER INST ARZNEIMITTELFORSCH,A-1120 VIENNA,AUSTRIA	Salzburg University; University of Vienna; University of Vienna; University of Vienna			Ferreira, Fatima/AAB-4321-2019; ENGEL, Erwan/HHC-1529-2022; Ferreira, Fatima/E-4889-2011; Vicente, Oscar/A-3858-2009	Ferreira, Fatima/0000-0003-0989-2335; Ferreira, Fatima/0000-0003-0989-2335; Vicente, Oscar/0000-0001-5076-3784; Hoffmann-Sommergruber, Karin/0000-0002-8830-058X; Swoboda, Ines/0000-0002-9164-1721				BATANERO E, 1994, MOL IMMUNOL, V31, P31, DOI 10.1016/0161-5890(94)90135-X; BOWLES DJ, 1990, ANNU REV BIOCHEM, V59, P873, DOI 10.1146/annurev.bi.59.070190.004301; BREITENEDER H, 1992, J ALLERGY CLIN IMMUN, V90, P909, DOI 10.1016/0091-6749(92)90463-C; BREITENEDER H, 1993, EUR J BIOCHEM, V212, P355, DOI 10.1111/j.1432-1033.1993.tb17669.x; BREITENEDER H, 1989, EMBO J, V8, P1935, DOI 10.1002/j.1460-2075.1989.tb03597.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CRAIG AG, 1991, BIOL MASS SPECTROM, V20, P565, DOI 10.1002/bms.1200200910; CROWELL DN, 1992, PLANT MOL BIOL, V18, P459, DOI 10.1007/BF00040662; FERREIRA FD, 1993, J BIOL CHEM, V268, P19574; FRISTENSKY B, 1988, PLANT MOL BIOL, V11, P713, DOI 10.1007/BF00017470; GROTE M, 1991, J HISTOCHEM CYTOCHEM, V39, P1395, DOI 10.1177/39.10.1940310; HIRSCHBERG CB, 1987, ANNU REV BIOCHEM, V56, P63, DOI 10.1146/annurev.bi.56.070187.000431; IPSEN H, 1983, J ALLERGY CLIN IMMUN, V72, P150, DOI 10.1016/0091-6749(83)90523-7; IPSEN H, 1989, EPITOPES ATOPIC ALLE, P3; JACOBS S, 1959, NATURE, V183, P262, DOI 10.1038/183262a0; JAROLIM E, 1989, ALLERGY, V44, P385, DOI 10.1111/j.1398-9995.1989.tb04169.x; JAROLIM E, 1989, INT ARCH ALLER A IMM, V90, P54, DOI 10.1159/000235000; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSEN JN, 1992, MOL IMMUNOL, V29, P703, DOI 10.1016/0161-5890(92)90180-6; MATTON DP, 1989, MOL PLANT MICROBE IN, V2, P325, DOI 10.1094/MPMI-2-325; NIELSEN PF, 1988, BIOMED ENVIRON MASS, V17, P355, DOI 10.1002/bms.1200170503; NILSEN BM, 1991, J BIOL CHEM, V266, P2660; PEDERSEN J, 1993, BIOCHIM BIOPHYS ACTA, V1202, P13, DOI 10.1016/0167-4838(93)90057-X; ROHAC M, 1991, MOL IMMUNOL, V28, P897, DOI 10.1016/0161-5890(91)90054-N; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SOMSSICH IE, 1988, MOL GEN GENET, V213, P93, DOI 10.1007/BF00333403; TSARBOPOULOS A, 1988, ANAL BIOCHEM, V171, P113, DOI 10.1016/0003-2697(88)90131-5; VALENTA R, 1991, J ALLERGY CLIN IMMUN, V87, P677, DOI 10.1016/0091-6749(91)90388-5; VESTLING MM, 1990, ANAL CHEM, V62, P2391, DOI 10.1021/ac00220a025; WALTER MH, 1990, MOL GEN GENET, V222, P353, DOI 10.1007/BF00633840; WARNER SAJ, 1992, PLANT MOL BIOL, V19, P555, DOI 10.1007/BF00026782	31	173	191	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2607	2613		10.1074/jbc.270.6.2607	http://dx.doi.org/10.1074/jbc.270.6.2607			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852325	hybrid			2022-12-27	WOS:A1995QF53500033
J	BERNARD, MT; MACDONALD, GM; NGUYEN, AP; DEBUS, RJ; BARRY, BA				BERNARD, MT; MACDONALD, GM; NGUYEN, AP; DEBUS, RJ; BARRY, BA			A DIFFERENCE INFRARED STUDY OF HYDROGEN-BONDING TO THE Z-CENTER-DOT TYROSYL RADICAL OF PHOTOSYSTEM-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-EVOLVING COMPLEX; SITE-DIRECTED MUTANTS; RIBONUCLEOTIDE REDUCTASE; ELECTRON-DONOR; EPR SPECTROSCOPY; D1 POLYPEPTIDE; MANGANESE; SYNECHOCYSTIS-6803; TYROSINE-161; PARTICLES	Photosystem II, the photosynthetic water oxidizing complex, contains two well characterized redox active tyrosines, D and Z. D forms a stable radical of unknown function. Z is an electron carrier between the primary chlorophyll donor and the manganese catalytic site. The vibrational difference spectra associated with the oxidation of tyrosines Z and D have been obtained through the use of infrared spectroscopy (MacDonald, G. M., Bixby, K. A., and Barry, B. A. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 11024-11028), Here, we examine the effect of deuterium exchange on these vibrational difference spectra, While the putative C-O vibration of stable tyrosine radical D-. downshifts in (H2O)-H-2, the putative C-O vibration of tyrosine radical Z(.) does not. This result is consistent with the existence of a hydrogen bond to the phenol oxygen of the D-. radical; we conclude that a hydrogen bond is not formed to the Z(.) radical. In an effort to identify the amino acid residue that is the proton acceptor for Z, we have performed global N-15 labeling, While significant N-15 shifts are observed in the vibrational difference spectrum, substitution of a glutamine for a histidine that is predicted to lie in the environment of tyrosine Z has little or no effect on the difference infrared spectrum, There is also no significant change in the yield or lineshape of the Z(.) EPR signal under continuous illumination in this mutant. Our results are inconsistent with the possibility that this residue, histidine 190 of the D1 polypeptide, acts as the sole proton acceptor for tyrosine Z.	UNIV MINNESOTA,DEPT BIOCHEM,ST PAUL,MN 55108; UNIV CALIF RIVERSIDE,DEPT BIOCHEM,RIVERSIDE,CA 92521	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Riverside					NIGMS NIH HHS [GM 43496, GM 43273] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043273, R01GM043496] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACKES G, 1989, BIOCHEMISTRY-US, V28, P1923, DOI 10.1021/bi00430a074; BARRY BA, 1987, P NATL ACAD SCI USA, V84, P7099, DOI 10.1073/pnas.84.20.7099; BARRY BA, 1993, PHOTOCHEM PHOTOBIOL, V57, P179, DOI 10.1111/j.1751-1097.1993.tb02275.x; BARRY BA, 1994, MOL BIOL CYANOBACTER, P217; BERTHOMIEU C, 1990, FEBS LETT, V269, P363, DOI 10.1016/0014-5793(90)81194-S; BOERNER RJ, 1993, J BIOL CHEM, V268, P1817; BOERNER RJ, 1993, J BIOL CHEM, V268, P17151; BOERNER RJ, 1994, J BIOL CHEM, V269, P134; BROK M, 1985, BIOCHIM BIOPHYS ACTA, V809, P421, DOI 10.1016/0005-2728(85)90193-8; CHU HA, 1994, BIOCHEMISTRY-US, V33, P6137, DOI 10.1021/bi00186a013; DEBUS RJ, 1988, BIOCHEMISTRY-US, V27, P9071, DOI 10.1021/bi00426a001; DEBUS RJ, 1988, P NATL ACAD SCI USA, V85, P427, DOI 10.1073/pnas.85.2.427; DEBUS RJ, 1992, BIOCHIM BIOPHYS ACTA, V1102, P269, DOI 10.1016/0005-2728(92)90133-M; DEISENHOFER J, 1989, SCIENCE, V245, P1463, DOI 10.1126/science.245.4925.1463; DEROSE VJ, 1991, BIOCHEMISTRY-US, V30, P1335, DOI 10.1021/bi00219a025; Diner BA, 1991, CURR OPIN STRUC BIOL, V1, P546, DOI 10.1016/S0959-440X(05)80076-4; EARNEST TN, 1990, BIOPHYS J, V58, P1539, DOI 10.1016/S0006-3495(90)82498-X; ERICKSON JM, 1992, TOPICS PHOTOSYNTHESI, V11, P101; EVELO RG, 1989, CHEM PHYS LETT, V161, P479, DOI 10.1016/0009-2614(89)87024-1; EVELO RG, 1989, CHEM PHYS LETT, V157, P25, DOI 10.1016/0009-2614(89)87201-X; FERSHT A, 1977, ENZYME STRUCTURE MEC, P170; GERFEN GJ, 1993, J AM CHEM SOC, V115, P6420, DOI 10.1021/ja00067a071; GHANOTAKIS DF, 1982, BIOCHIM BIOPHYS ACTA, V682, P21, DOI 10.1016/0005-2728(82)90115-3; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; MACDONALD GM, 1992, BIOCHEMISTRY-US, V31, P9848, DOI 10.1021/bi00155a043; MACDONALD GM, 1993, P NATL ACAD SCI USA, V90, P11024, DOI 10.1073/pnas.90.23.11024; MAJOUBE M, 1992, J MOL STRUCT, V266, P345, DOI 10.1016/0022-2860(92)80090-5; METZ JG, 1989, BIOCHEMISTRY-US, V28, P6960, DOI 10.1021/bi00443a028; MILLER AF, 1991, BIOCHIM BIOPHYS ACTA, V1056, P1, DOI 10.1016/S0005-2728(05)80067-2; NANBA O, 1987, P NATL ACAD SCI USA, V84, P109, DOI 10.1073/pnas.84.1.109; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; NOREN GH, 1991, BIOCHEMISTRY-US, V30, P3943, DOI 10.1021/bi00230a020; NOREN GH, 1992, BIOCHEMISTRY-US, V31, P3335, DOI 10.1021/bi00128a005; PAKRASI HB, 1992, CURRENT TOPICS PHOTO, V11, P231; PEIFFER WE, 1990, BIOCHEMISTRY-US, V29, P8696, DOI 10.1021/bi00489a027; RODRIGUEZ ID, 1987, PROGR PHOTOSYNTHESIS, V1, P471; ROFFEY RA, 1994, J BIOL CHEM, V269, P5115; RUFFLE SV, 1992, PHOTOSYNTH RES, V34, P287, DOI 10.1007/BF00033446; SVENSSON B, 1990, EMBO J, V7, P2051; TAKEUCHI H, 1989, J RAMAN SPECTROSC, V20, P233, DOI 10.1002/jrs.1250200407; TANG XS, 1993, BIOCHEMISTRY-US, V32, P13742, DOI 10.1021/bi00212a045; TOMMOS C, 1993, BIOCHEMISTRY-US, V32, P5436, DOI 10.1021/bi00071a020; TRIPATHI GNR, 1984, J CHEM PHYS, V81, P113, DOI 10.1063/1.447373; VERMAAS WFJ, 1988, P NATL ACAD SCI USA, V85, P8477, DOI 10.1073/pnas.85.22.8477	44	56	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1589	1594		10.1074/jbc.270.4.1589	http://dx.doi.org/10.1074/jbc.270.4.1589			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829489	hybrid			2022-12-27	WOS:A1995QD20400019
J	BROCK, IW; MILLS, JD; ROBINSON, D; ROBINSON, C				BROCK, IW; MILLS, JD; ROBINSON, D; ROBINSON, C			THE DELTA-PH-DRIVEN, ATP-INDEPENDENT PROTEIN TRANSLOCATION MECHANISM IN THE CHLOROPLAST THYLAKOID MEMBRANE - KINETICS AND ENERGETICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PROTONMOTIVE FORCE; PRECURSOR PROTEINS; TRANSPORT; ENERGY; IMPORT; LUMEN; MITOCHONDRIAL; PLASTOCYANIN; REQUIREMENTS	Previous studies have shown that proteins are transported across the chloroplast thylakoid membrane by two very different mechanisms, one of which requires stromal factors and ATP, whereas the other mechanism is ATP independent but completely reliant on the thylakoidal Delta pH. We have examined the role of the Delta pH in the latter mechanism by simultaneously monitoring the magnitude of Delta pH (by 9-aminoacridine fluorescence quenching) and the rate of import of the 23-kDa photosystem II protein into isolated pea thylakoids. We show that protein import can take place, at low but significant rates, at very low values of Delta pH (in the region of 1.2-1.4), and that plots of the rate of protein import against proton concentration gradient are probably hyperbolic in nature. There is no evidence for a threshold level of Delta pH which is required to drive translocation of the 23-kDa protein, Addition of uncouplers midway during import incubations results in a rapid and complete inhibition of translocation, showing that the continuous presence of the Delta pH is required for translocation to take place, During import into intact chloroplasts, the intermediate-size 23-kDa protein substrate for the thylakoidal protein transport machinery is found only in the stromal fraction at all values of Delta pH, suggesting that the initial interaction with the machinery is relatively weak, reversible and Delta pH-independent. We therefore propose that the Delta pH is required for both the initiation and completion of translocation; these roles are in marked contrast to the roles of protonmotive force in mitochondrial and sec-dependent bacterial protein transport.	UNIV WARWICK, DEPT BIOL SCI, COVENTRY CV4 7AL, W MIDLANDS, ENGLAND; UNIV KEELE, DEPT BIOL SCI, KEELE ST5 5BG, STAFFS, ENGLAND	University of Warwick; Keele University								BAKKER EP, 1984, EMBO J, V3, P895, DOI 10.1002/j.1460-2075.1984.tb01902.x; BASSHAM DC, 1991, J BIOL CHEM, V266, P23606; BIZOUARN T, 1991, BIOCHEMISTRY-US, V30, P6847, DOI 10.1021/bi00242a007; BRIGGS LM, 1990, PLANT MOL BIOL, V15, P633, DOI 10.1007/BF00017837; BROCK IW, 1993, PLANT MOL BIOL, V23, P717, DOI 10.1007/BF00021527; CASADIO R, 1985, ARCH BIOCHEM BIOPHYS, V238, P219, DOI 10.1016/0003-9861(85)90159-6; CLINE K, 1992, J BIOL CHEM, V267, P2688; CLINE K, 1993, EMBO J, V12, P4105, DOI 10.1002/j.1460-2075.1993.tb06094.x; DESHAIES RJ, 1988, TRENDS BIOCHEM SCI, V13, P384, DOI 10.1016/0968-0004(88)90180-6; DRIESSEN AJM, 1992, TRENDS BIOCHEM SCI, V17, P219, DOI 10.1016/0968-0004(92)90381-I; GRZESIEK S, 1988, BIOCHIM BIOPHYS ACTA, V938, P411, DOI 10.1016/0005-2736(88)90139-3; HAGEMAN J, 1986, NATURE, V324, P567, DOI 10.1038/324567a0; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; HENRY R, 1994, J BIOL CHEM, V269, P10189; HULFORD A, 1994, J BIOL CHEM, V269, P3251; JUNESCH U, 1987, BIOCHIM BIOPHYS ACTA, V893, P275, DOI 10.1016/0005-2728(87)90049-1; KLOSGEN RB, 1992, PLANT MOL BIOL, V18, P1031, DOI 10.1007/BF00019226; KNOTT TG, 1994, J BIOL CHEM, V269, P7843; KO K, 1989, EMBO J, V8, P3187, DOI 10.1002/j.1460-2075.1989.tb08477.x; KRAAYENHOF R, 1974, DYNAMICS ENERGY TRAN, P355; KUWABARA T, 1987, P NATL ACAD SCI USA, V84, P8230, DOI 10.1073/pnas.84.23.8230; MARTIN J, 1991, J BIOL CHEM, V266, P18051; MEYER DI, 1988, TRENDS BIOCHEM SCI, V13, P471, DOI 10.1016/0968-0004(88)90233-2; Mills J. D., 1986, Photosynthesis: energy transduction: a practical approach, P143; MOULD RM, 1991, J BIOL CHEM, V266, P17286; MOULD RM, 1991, J BIOL CHEM, V266, P12189; NIELSEN VS, 1994, J BIOL CHEM, V269, P3762; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; OLSEN LJ, 1989, J BIOL CHEM, V264, P6724; PFANNER N, 1985, EMBO J, V4, P2819, DOI 10.1002/j.1460-2075.1985.tb04009.x; QUICK WP, 1987, BIOCHIM BIOPHYS ACTA, V893, P197, DOI 10.1016/0005-2728(87)90040-5; ROBINSON C, 1994, EMBO J, V13, P279, DOI 10.1002/j.1460-2075.1994.tb06260.x; Rumberg B., 1984, H PLUS ATPASE STRUCT, P421; SCHULDINER S, 1972, EUR J BIOCHEM, V25, P64, DOI 10.1111/j.1432-1033.1972.tb01667.x; SHIOZUKA K, 1990, J BIOL CHEM, V265, P18843; SUTTON A, 1987, EUR J BIOCHEM, V164, P571, DOI 10.1111/j.1432-1033.1987.tb11165.x; THEG SM, 1989, J BIOL CHEM, V264, P6730; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; WICKNER W, 1989, TRENDS BIOCHEM SCI, V14, P280, DOI 10.1016/0968-0004(89)90064-9; WICKNER W, 1991, ANNU REV BIOCHEM, V60, P1165	40	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1657	1662		10.1074/jbc.270.4.1657	http://dx.doi.org/10.1074/jbc.270.4.1657			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829499	hybrid			2022-12-27	WOS:A1995QD20400029
J	MELY, Y; DEROCQUIGNY, H; SORINASJIMENO, M; KEITH, G; ROQUES, BP; MARQUET, R; GERARD, D				MELY, Y; DEROCQUIGNY, H; SORINASJIMENO, M; KEITH, G; ROQUES, BP; MARQUET, R; GERARD, D			BINDING OF THE HIV-1 NUCLEOCAPSID PROTEIN TO THE PRIMER TRNA(3)(LYS), IN-VITRO, IS ESSENTIALLY NOT SPECIFIC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NUCLEIC-ACID INTERACTIONS; REVERSE-TRANSCRIPTASE; LAC REPRESSOR; ZINC FINGERS; REPLICATION PRIMER; TRANSFER-RNAS; VIRAL-RNA; DOMAINS; SITE	The nucleocapsid protein NCp7 of human immunodeficiency virus, type 1, is a key component in the viral life cycle, Since, the first common step of all reported NCp7 activities corresponds to a nucleic acid-binding step, the NCp7 binding parameters to the natural primer tRNA(3)(Lys) were investigated. Using NCp7 intrinsic fluorescence, we found that (i) in 0.1 hr NaCl, NCp7 bound noncooperatively to tRNA(3)(Lys) with a K-obs = 3.2 x 10(6) M(-1) association constant and a n = 6 binding site size, (ii) four ionic interactions were formed in the NCp7.tRNA(3)(Lys) complex, and (iii) nonelectrostatic factors provided about 60% of the binding energy. These binding parameters were not significantly altered when the natural tRNA(3)(Lys) was replaced by either an in vitro synthetic tRNA(3)(Lys) transcript, the heterologous yeast tRNA(Phe) or the structurally unrelated 5 S RNA from Escherichia coli. Moreover, the environment of the intrinsic fluorescent reporters (Trp(37) and Trp(61)) was similar in the various complexes. Finally, experiments performed at low protein concentration provide no evidence of high affinity binding sites. Taken together, our data strongly suggested an essentially nonspecific binding of NCp7 to tRNA(3)(Lys) and thus did not seem to support a direct role of NCp7, per se, in the selection of tRNA(3)(Lys) from the pool of cellular tRNAs.	INST BIOL MOLEC & CELLULAIRE, CNRS, UPR 9002, F-67084 STRASBOURG, FRANCE; UFR SCI PHARMACEUT & BIOL, DEPT CHIM ORGAN, CNRS, INSERM, U266, F-75270 PARIS 06, FRANCE	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	MELY, Y (corresponding author), UNIV LOUIS PASTEUR STRASBOURG 1, FAC PHARM,BIOPHYS LAB,CNRS,URA 491, BP 24, F-67401 ILLKIRCH GRAFFENSTADEN, FRANCE.			Marquet, Roland/0000-0002-4209-3976				ARNOLD E, 1991, ADV VIRUS RES, V39, P1; BARAT C, 1993, J MOL BIOL, V231, P185, DOI 10.1006/jmbi.1993.1273; BARAT C, 1991, NUCLEIC ACIDS RES, V19, P751, DOI 10.1093/nar/19.4.751; BARAT C, 1989, EMBO J, V8, P3279, DOI 10.1002/j.1460-2075.1989.tb08488.x; BARKLEY MD, 1981, BIOCHEMISTRY-US, V20, P3842, DOI 10.1021/bi00516a027; BERG JM, 1986, SCIENCE, V232, P485, DOI 10.1126/science.2421409; BESS JW, 1992, J VIROL, V66, P840, DOI 10.1128/JVI.66.2.840-847.1992; BRUNEL C, 1991, J MOL BIOL, V221, P293; BUJALOWSKI W, 1987, BIOCHEMISTRY-US, V26, P3099, DOI 10.1021/bi00385a023; DANNULL J, 1994, EMBO J, V13, P1525, DOI 10.1002/j.1460-2075.1994.tb06414.x; DARLIX JL, 1990, J MOL BIOL, V216, P689, DOI 10.1016/0022-2836(90)90392-Y; DARLIX JL, 1991, B I PASTEUR, V89, P211; DEHASETH PL, 1977, BIOCHEMISTRY-US, V16, P4783, DOI 10.1021/bi00641a004; DEROCQUIGNY H, 1991, BIOCHEM BIOPH RES CO, V180, P1010, DOI 10.1016/S0006-291X(05)81166-0; DEROCQUIGNY H, 1992, P NATL ACAD SCI USA, V89, P6472, DOI 10.1073/pnas.89.14.6472; DIBHAJJ F, 1993, PROTEIN SCI, V2, P231; GELFAND CA, 1993, J BIOL CHEM, V268, P18450; HELENE C, 1971, J MOL BIOL, V58, P349, DOI 10.1016/0022-2836(71)90251-8; ISEL C, 1993, J BIOL CHEM, V268, P25269; JIANG M, 1993, J VIROL, V67, P3246, DOI 10.1128/JVI.67.6.3246-3253.1993; KARPEL RL, 1987, J BIOL CHEM, V262, P4961; KEITH G, 1983, BIOCHIMIE, V65, P661; KHAN R, 1992, J BIOL CHEM, V267, P6689; KHAN R, 1994, J BIOL CHEM, V269, P22538; KOWALCZYKOWSKI SC, 1986, BIOCHEMISTRY-US, V25, P1226, DOI 10.1021/bi00354a006; LAPADATTAPOLSKY M, 1993, NUCLEIC ACIDS RES, V21, P831, DOI 10.1093/nar/21.4.831; LEIS J, 1983, J VIROL, V48, P361, DOI 10.1128/JVI.48.2.361-369.1983; MAK J, 1994, J VIROL, V68, P2065, DOI 10.1128/JVI.68.4.2065-2072.1994; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; MELY Y, 1993, BIOPHYS J, V65, P1513, DOI 10.1016/S0006-3495(93)81222-0; MORELLET N, 1992, EMBO J, V11, P3059, DOI 10.1002/j.1460-2075.1992.tb05377.x; OMICHINSKI JG, 1991, FEBS LETT, V292, P25, DOI 10.1016/0014-5793(91)80825-N; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; RECORD MT, 1977, BIOCHEMISTRY-US, V16, P4791, DOI 10.1021/bi00641a005; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; SAKAGUCHI K, 1993, P NATL ACAD SCI USA, V90, P5219, DOI 10.1073/pnas.90.11.5219; SARIHCOTTIN L, 1992, J MOL BIOL, V226, P1, DOI 10.1016/0022-2836(92)90117-3; SOUTH TL, 1993, PROTEIN SCI, V2, P3; SUMMERS MF, 1992, PROTEIN SCI, V1, P563, DOI 10.1002/pro.5560010502; SUROVOY A, 1993, J MOL BIOL, V229, P94, DOI 10.1006/jmbi.1993.1011; VERONESE FD, 1987, AIDS RES HUM RETROV, V3, P253, DOI 10.1089/aid.1987.3.253; WONDRAK EM, 1993, FEBS LETT, V333, P21, DOI 10.1016/0014-5793(93)80367-4	42	75	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1650	1656		10.1074/jbc.270.4.1650	http://dx.doi.org/10.1074/jbc.270.4.1650			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829498	hybrid			2022-12-27	WOS:A1995QD20400028
J	SABERANDJONEIDI, D; MAREYSEMPER, I; PICART, R; STUDLER, JM; TOUGARD, C; GLOWINSKI, J; LEVISTRAUSS, M				SABERANDJONEIDI, D; MAREYSEMPER, I; PICART, R; STUDLER, JM; TOUGARD, C; GLOWINSKI, J; LEVISTRAUSS, M			A 19-KDA PROTEIN BELONGING TO A NEW FAMILY IS EXPRESSED IN THE GOLGI-APPARATUS OF NEURAL CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCEPHALIC DOPAMINERGIC-NEURONS; MESSENGER-RNA; SEQUENCES; COMPONENT; PEPTIDES; VESICLES; PRODUCT; SITE	The mouse 8.5 mRNA encodes a 171-residue novel protein which displays a highly significant similarity with the product of the previously characterized neuronal p1A75 cDNA (Sutcliffe, J. G., Milner, R. J., Shinnick, T. M., and Bloom, F. E. (1983) Cell 33, 671-682). Northern blot and in situ hybridization experiments indicated that the 8.5 mRNA is specifically expressed in neural and neuroendocrine tissues. An affinity-purified antibody directed against the recombinant 8.5 protein demonstrated the existence of the 19-kDa natural protein in brain and evidenced its prominent juxtanuclear Golgi-like localization in cultured neurons. Ultrastructural analysis of the same preparation revealed a specific labeling of all the Golgi saccules and of some vesicles in the Golgi zone. In transfected COS cells, the exogenous protein was also detected in the Golgi area, indicating, therefore, the presence of a Golgi targeting signal in its primary sequence.	COLL FRANCE, INSERM, U114, CHAIRE NEUROPHARMACOL, F-75005 PARIS, FRANCE; COLL FRANCE, BIOL CELLULE NEUROENDOCRINE GRP, CNRS, URA 1115, F-75005 PARIS, FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France			Saberan-Djoneidi, Delara/AAD-7820-2022	Saberan-Djoneidi, Delara/0000-0002-2757-6419				ANSON DS, 1984, EMBO J, V3, P1053, DOI 10.1002/j.1460-2075.1984.tb01926.x; APPELLA E, 1988, FEBS LETT, V231, P1, DOI 10.1016/0014-5793(88)80690-2; BRINKLEY BR, 1967, J CELL BIOL, V35, P279, DOI 10.1083/jcb.35.1.279; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DALE RMK, 1985, PLASMID, V13, P31, DOI 10.1016/0147-619X(85)90053-8; DENISDONINI S, 1984, NATURE, V307, P641, DOI 10.1038/307641a0; DESSEN P, 1990, COMPUT APPL BIOSCI, V6, P355; DIPORZIO U, 1980, NATURE, V288, P370, DOI 10.1038/288370a0; DIRIONG S, 1994, HUM GENET, V93, P703; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GIRAULT JA, 1989, ANAL BIOCHEM, V182, P193, DOI 10.1016/0003-2697(89)90741-0; HOCHULI E, 1987, J CHROMATOGR, V411, P177, DOI 10.1016/S0021-9673(00)93969-4; HUTTNER WB, 1991, TRENDS BIOCHEM SCI, V16, P27, DOI 10.1016/0968-0004(91)90012-K; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; KANZAKI T, 1990, CELL, V61, P1051, DOI 10.1016/0092-8674(90)90069-Q; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; OTTIGER HP, 1990, J NEUROSCI, V10, P3135; PARTON RG, 1992, J CELL BIOL, V119, P123, DOI 10.1083/jcb.119.1.123; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STUDLER JM, 1993, EUR J NEUROSCI, V5, P614, DOI 10.1111/j.1460-9568.1993.tb00527.x; SUTCLIFFE JG, 1983, CELL, V33, P671, DOI 10.1016/0092-8674(83)90010-7; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TOUGARD C, 1986, AM J ANAT, V175, P161, DOI 10.1002/aja.1001750206; TOWBIN H, 1984, J IMMUNOL METHODS, V72, P313, DOI 10.1016/0022-1759(84)90001-2; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0	34	24	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1888	1893		10.1074/jbc.270.4.1888	http://dx.doi.org/10.1074/jbc.270.4.1888			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829526	hybrid			2022-12-27	WOS:A1995QD20400061
J	ZIEROLD, C; DARWISH, HM; DELUCA, HF				ZIEROLD, C; DARWISH, HM; DELUCA, HF			2 VITAMIN-D RESPONSE ELEMENTS FUNCTION IN THE RAT 1,25-DIHYDROXYVITAMIN-D-24-HYDROXYLASE PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOCALCIN GENE; EXPRESSION; RECEPTOR; BINDING; IDENTIFICATION; METABOLISM; INTESTINE; SEQUENCES; HORMONE; KIDNEY	The interaction between the two vitamin D response elements (DRE) located at -154 to -134 base pairs (bp) and -262 to -238 bp from the transcription initiation site has been studied using reporter gene assays and binding assays by electrophoretic gel shift measurements. 3 half-sites separated by 3 bp were found necessary for transactivation by the -154 to -125 DRE, while 2 half-sites separated by 3 bp were needed for the DRE at -262 to -238 to function. However, the two DREs together provided maximal activity. The 93-bp fragment separating the two DREs was not required and could be deleted. The most effective binding by receptor was found with the two complete DREs (dissociation constant (K-d) = 13.7 pM), although each DRE bound to the receptor and nuclear accessory factor with about 5 nM K-d. The two DREs (a total of 5 half-sites) apparently account for most if not all of the transactivation of the rat 24-hydroxylase by 1,25-dihydroxyvitamin D-3. This system represents the most powerful of the DREs reported to date.	UNIV WISCONSIN, DEPT BIOCHEM, MADISON, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK014881] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-14881] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARMBRECHT HJ, 1991, FEBS LETT, V292, P17, DOI 10.1016/0014-5793(91)80823-L; BURCH JBE, 1988, MOL CELL BIOL, V8, P1123, DOI 10.1128/MCB.8.3.1123; Darwish Hisham, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P89; DARWISH HM, 1992, P NATL ACAD SCI USA, V89, P603, DOI 10.1073/pnas.89.2.603; DELUCA HF, 1988, FASEB J, V2, P224, DOI 10.1096/fasebj.2.3.3280376; DELUCA HF, 1991, J BONE MINE METAB, V9, P17; DEMAY MB, 1990, P NATL ACAD SCI USA, V87, P369, DOI 10.1073/pnas.87.1.369; ENGSTROM GW, 1986, ARCH BIOCHEM BIOPHYS, V250, P86, DOI 10.1016/0003-9861(86)90704-6; GRAY RW, 1990, STEROIDS, V55, P395, DOI 10.1016/0039-128X(90)90097-U; KERNER SA, 1989, P NATL ACAD SCI USA, V86, P4455, DOI 10.1073/pnas.86.12.4455; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MACDONALD PN, 1992, DNA CELL BIOL, V11, P377, DOI 10.1089/dna.1992.11.377; MORRISON NA, 1989, SCIENCE, V246, P1158, DOI 10.1126/science.2588000; NODA M, 1990, P NATL ACAD SCI USA, V87, P9995, DOI 10.1073/pnas.87.24.9995; OHYAMA Y, 1994, J BIOL CHEM, V269, P10545; OHYAMA Y, 1991, FEBS LETT, V278, P195, DOI 10.1016/0014-5793(91)80115-J; REDDY GS, 1989, BIOCHEMISTRY-US, V28, P1763, DOI 10.1021/bi00430a051; REICHEL H, 1986, ARCH BIOCHEM BIOPHYS, V251, P222, DOI 10.1016/0003-9861(86)90069-X; ROSS TK, 1992, P NATL ACAD SCI USA, V89, P256, DOI 10.1073/pnas.89.1.256; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHEIDEREIT C, 1983, NATURE, V304, P749, DOI 10.1038/304749a0; SHINKI T, 1992, J BIOL CHEM, V267, P13757; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; ZIEROLD C, 1994, P NATL ACAD SCI USA, V91, P900, DOI 10.1073/pnas.91.3.900	24	151	157	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1675	1678		10.1074/jbc.270.4.1675	http://dx.doi.org/10.1074/jbc.270.4.1675			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829502	hybrid			2022-12-27	WOS:A1995QD20400032
J	MITAMURA, T; HIGASHIYAMA, S; TANIGUCHI, N; KLAGSBRUN, M; MEKADA, E				MITAMURA, T; HIGASHIYAMA, S; TANIGUCHI, N; KLAGSBRUN, M; MEKADA, E			DIPHTHERIA-TOXIN BINDS TO THE EPIDERMAL GROWTH-FACTOR (EGF)-LIKE DOMAIN OF HUMAN HEPARIN-BINDING EGF-LIKE GROWTH-FACTOR DIPHTHERIA-TOXIN RECEPTOR AND INHIBITS SPECIFICALLY ITS MITOGENIC ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERO CELLS; CD9 ANTIGEN; LOW PH; FRAGMENT; MUTANTS; PROTEIN; IDENTIFICATION; PURIFICATION; EXPRESSION; MEMBRANE	The membrane anchored form of human heparin-binding epidermal growth factor-like growth factor (HB-EGF) acts as the diphtheria toxin (DT) receptor. Transfection of human HE-EGF cDNA into mouse LC cells, L cells stably expressing DRAP27, conferred sensitivity to DT, but transfection of mouse HB-EGF cDNA did not. To define the essential regions of HB-EGF that serve as the functional DT receptor, we examined the sensitivity to DT and DT binding of cells expressing several human/mouse HB-EGF chimeras. It was found that DT binds to the EGF-like domain of the human HB-EGF, However, mouse HB-EGF does not serve as a functional DT receptor due to non-conserved amino acid substitutions in this domain, In addition, CRM197, a non-toxic mutant of DT, inhibited strongly the mitogenic activity of the secreted form of human HB-EGF, but not of mouse HB-EGF and other EGF receptor-binding growth factors. These results confirmed further that DT interacts with the EGF-like domain of HB-EGF and that this interaction is specific for human HB-EGF.	KURUME UNIV, INST LIFE SCI, DIV CELL BIOL, KURUME, FUKUOKA 830, JAPAN; OSAKA UNIV, SCH MED, DEPT BIOCHEM, SUITA, OSAKA 565, JAPAN; CHILDRENS HOSP, DEPT SURG, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA	Kurume University; Osaka University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School			Ibrahim, Essam Hassan/G-1960-2018; Taniguchi, Naoyuki/A-7086-2016; Taniguchi, Naoyuki/I-4182-2014	Ibrahim, Essam Hassan/0000-0003-0130-2257; Taniguchi, Naoyuki/0000-0001-5889-5968; Mekada, Eisuke/0000-0001-8858-4781	NCI NIH HHS [CA37392] Funding Source: Medline; NIGMS NIH HHS [GM47397] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA037392, R37CA037392, R56CA037392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047397] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAM JA, 1993, BIOCHEM BIOPH RES CO, V190, P125, DOI 10.1006/bbrc.1993.1020; BESNER G, 1990, CELL REGUL, V1, P811, DOI 10.1091/mbc.1.11.811; BLONTNICK S, 1994, P NATL ACAD SCI USA, V91, P2890; BROWN JG, 1993, P NATL ACAD SCI USA, V90, P8184, DOI 10.1073/pnas.90.17.8184; CAMPION SR, 1990, BIOCHEMISTRY-US, V29, P9988, DOI 10.1021/bi00494a032; CAMPION SR, 1993, J BIOL CHEM, V268, P1742; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; CIEPLAK W, 1987, J BIOL CHEM, V262, P13246; COLLIER RJ, 1975, BACTERIOL REV, V39, P54, DOI 10.1128/MMBR.39.1.54-85.1975; ENGLER DA, 1988, J BIOL CHEM, V263, P12384; GABLIKS J, 1962, J IMMUNOL, V88, P505; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HIGASHIYAMA S, 1992, J BIOL CHEM, V267, P6205; IHLE JN, 1982, J IMMUNOL, V129, P2431; IWAMOTO R, 1994, EMBO J, V13, P2322, DOI 10.1002/j.1460-2075.1994.tb06516.x; KOHNO K, 1985, SOMAT CELL MOLEC GEN, V11, P421, DOI 10.1007/BF01534836; LENNOX ES, 1957, P SOC EXP BIOL MED, V95, P700, DOI 10.3181/00379727-95-23335; MEKADA E, 1991, J BIOL CHEM, V266, P20457; MEKADA E, 1985, J BIOL CHEM, V260, P2148; MEKADA E, 1988, J CELL BIOL, V107, P511, DOI 10.1083/jcb.107.2.511; MEKADA E, 1982, BIOCHEM BIOPH RES CO, V109, P792, DOI 10.1016/0006-291X(82)92009-5; MIDDLEBROOK JL, 1978, J BIOL CHEM, V253, P7325; MIDDLEBROOK JL, 1977, CAN J MICROBIOL, V23, P183, DOI 10.1139/m77-026; MITAMURA T, 1992, J CELL BIOL, V118, P1389, DOI 10.1083/jcb.118.6.1389; MOSKAUG JO, 1991, J BIOL CHEM, V266, P2652; MOSKAUG JO, 1988, J BIOL CHEM, V263, P2518; MOYA M, 1985, J CELL BIOL, V101, P548, DOI 10.1083/jcb.101.2.548; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; PAPPENHEIMER AM, 1977, ANNU REV BIOCHEM, V46, P69, DOI 10.1146/annurev.bi.46.070177.000441; PIERCE JH, 1988, SCIENCE, V239, P628, DOI 10.1126/science.3257584; SOUSA CP, 1957, BRIT J EXP PATHOL, V38, P644; THOMPSON SA, 1994, J BIOL CHEM, V269, P2541; UCHIDA T, 1973, J BIOL CHEM, V248, P3838; UMATA T, 1990, J BIOL CHEM, V265, P21940	34	246	271	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1015	1019		10.1074/jbc.270.3.1015	http://dx.doi.org/10.1074/jbc.270.3.1015			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836353	hybrid			2022-12-27	WOS:A1995QB15600008
J	LEDEBUR, HC; PARKS, TP				LEDEBUR, HC; PARKS, TP			TRANSCRIPTIONAL REGULATION OF THE INTERCELLULAR-ADHESION MOLECULE-1 GENE BY INFLAMMATORY CYTOKINES IN HUMAN ENDOTHELIAL-CELLS - ESSENTIAL ROLES OF A VARIANT NF-KAPPA-B SITE AND P65 HOMODIMERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; STIMULATING FACTOR GENE; NUCLEAR FACTOR; DIFFERENTIAL REGULATION; INTERLEUKIN-8 GENE; ONCOPROTEIN BCL-3; FAMILY MEMBERS; PHORBOL ESTER; C/EBP FAMILY; ICAM-1 GENE	Intercellular adhesion molecule-1 (ICAM-1) is greatly up-regulated on endothelial cells at sites of inflammation and is involved in leukocyte attachment and extravasation. Previously, we had shown that the ICAM-1 gene expression in human umbilical vein endothelial cells (HUVECs) was transcriptionally regulated by tumor necrosis factor-alpha (TNF-alpha) (Wertheimer, S. J., Myers, C. L., Wallace, R. W., and Parks, T. P. (1992) J. Biol. Chem. 267, 12030-12035). In the present investigation, TNF-alpha-induced transcription was found to be initiated exclusively at two sites, 40 and 41 base pairs upstream of the translation start site, Deletion analysis of the 5' regulatory region of the ICAM-1 gene revealed a 92-base pair sequence which was both necessary and sufficient to confer TNF-alpha responsiveness to a linked luciferase reporter gene in transient transfection assays, This TNF-alpha-responsive region contained a variant NF-kappa P site at -187 to -178, which when mutated, completely abolished ICAM-1 promoter activation by TNF-alpha, interleukin-1 beta, and lipopolysaccharide. Two inducible nuclear protein complexes bound to the ICAM-1 kappa B site and were identified as the NF-kappa D p65 homodimer and p65/p50 heterodimer. Overexpression of p65, but not p50, transactivated the ICAM-1 promoter in a kappa B site-dependent manner in HUVECs. In addition, p65-mediated transactivation was suppressed by co-expression of p50. Our results suggest that cytokine activation of the ICAM-1 promoter in HUVECs may critically depend on p65 homodimers binding to a variant kappa B site.	BOEHRINGER INGELHEIM PHARMACEUT INC,DEPT INFLAMMATORY DIS,RIDGEFIELD,CT 06877	Boehringer Ingelheim				Ledebur, Harry/0000-0001-8011-8655				AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; BALLARD DW, 1992, P NATL ACAD SCI USA, V89, P1875, DOI 10.1073/pnas.89.5.1875; BLANK V, 1992, TRENDS BIOCHEM SCI, V17, P135, DOI 10.1016/0968-0004(92)90321-Y; BULL P, 1990, MOL CELL BIOL, V10, P5473, DOI 10.1128/MCB.10.10.5473; CORNELIUS LA, 1993, J INVEST DERMATOL, V100, P753, DOI 10.1111/1523-1747.ep12476300; DEGITZ K, 1991, J BIOL CHEM, V266, P14024; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DUSTIN ML, 1986, J IMMUNOL, V137, P245; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; ENTMAN ML, 1992, J CLIN INVEST, V90, P1335, DOI 10.1172/JCI115999; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; FRANZOSO G, 1993, EMBO J, V12, P3893, DOI 10.1002/j.1460-2075.1993.tb06067.x; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7; GUNDEL RH, 1991, J CLIN INVEST, V88, P1407, DOI 10.1172/JCI115447; HANSEN SK, 1992, EMBO J, V11, P205, DOI 10.1002/j.1460-2075.1992.tb05043.x; IADEMARCO MF, 1992, J BIOL CHEM, V267, P16323; INOUE J, 1991, P NATL ACAD SCI USA, V88, P3715, DOI 10.1073/pnas.88.9.3715; KASZUBSKA W, 1993, MOL CELL BIOL, V13, P7180, DOI 10.1128/MCB.13.11.7180; Kishimoto T K, 1994, Adv Pharmacol, V25, P117, DOI 10.1016/S1054-3589(08)60431-7; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; KUNSCH C, 1993, MOL CELL BIOL, V13, P6137, DOI 10.1128/MCB.13.10.6137; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE TA, 1989, BIOCHEM BIOPH RES CO, V161, P945, DOI 10.1016/0006-291X(89)91334-X; LECLAIR KP, 1992, P NATL ACAD SCI USA, V89, P8145, DOI 10.1073/pnas.89.17.8145; LEWIS H, 1994, MOL CELL BIOL, V14, P5701, DOI 10.1128/MCB.14.9.5701; Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H; LOOK DC, 1994, J BIOL CHEM, V269, P8952; MACKMAN N, 1991, J EXP MED, V174, P1517, DOI 10.1084/jem.174.6.1517; MACLEOD K, 1992, TRENDS BIOCHEM SCI, V17, P251, DOI 10.1016/0968-0004(92)90404-W; MANIATIS T, 1989, MOL CLONING, V3; MENTZER SJ, 1988, J CELL PHYSIOL, V137, P173, DOI 10.1002/jcp.1041370121; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; MYERS CL, 1992, AM J PHYSIOL, V262, pC865; NEISH AS, 1992, J EXP MED, V176, P1583, DOI 10.1084/jem.176.6.1583; NISHIZAWA M, 1990, MOL CELL BIOL, V10, P2002, DOI 10.1128/MCB.10.5.2002; PARRY GCN, 1994, J BIOL CHEM, V269, P20823; PERKINS ND, 1992, P NATL ACAD SCI USA, V89, P1529, DOI 10.1073/pnas.89.5.1529; POBER JS, 1987, J IMMUNOL, V138, P3319; POBER JS, 1986, J IMMUNOL, V137, P1893; READ MA, 1994, J EXP MED, V179, P503, DOI 10.1084/jem.179.2.503; ROOS E, 1987, J CELL BIOL, V105, P553, DOI 10.1083/jcb.105.1.553; RUBEN SM, 1992, MOL CELL BIOL, V12, P444, DOI 10.1128/MCB.12.2.444; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; SCHRECK R, 1990, MOL CELL BIOL, V10, P1281, DOI 10.1128/MCB.10.3.1281; SHU HB, 1993, MOL CELL BIOL, V13, P6283, DOI 10.1128/MCB.13.10.6283; SIMMONS D, 1988, NATURE, V331, P624, DOI 10.1038/331624a0; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; STADE BG, 1990, IMMUNOBIOLOGY, V182, P79, DOI 10.1016/S0171-2985(11)80585-1; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; STEIN B, 1993, MOL CELL BIOL, V13, P7191, DOI 10.1128/MCB.13.11.7191; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; VANDESTOLPE A, 1994, J BIOL CHEM, V269, P6185; VANHUIJSDUIJNEN RH, 1992, J BIOL CHEM, V267, P22385; VORABERGER G, 1991, J IMMUNOL, V147, P2777; WAWRYK SO, 1991, INT IMMUNOL, V3, P83, DOI 10.1093/intimm/3.1.83; WERTHEIMER SJ, 1992, J BIOL CHEM, V267, P12030; WHELAN J, 1991, NUCLEIC ACIDS RES, V19, P2645, DOI 10.1093/nar/19.10.2645; WHITLEY MZ, 1994, MOL CELL BIOL, V14, P6464, DOI 10.1128/MCB.14.10.6464	64	522	532	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					933	943		10.1074/jbc.270.2.933	http://dx.doi.org/10.1074/jbc.270.2.933			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822333	hybrid			2022-12-27	WOS:A1995QB81600068
J	LEE, CC; YAMADA, KM				LEE, CC; YAMADA, KM			ALTERNATIVELY SPLICED JUXTAMEMBRANE DOMAIN OF A TYROSINE KINASE RECEPTOR IS A MULTIFUNCTIONAL REGULATORY SITE - DELETION ALTERS CELLULAR TYROSINE PHOSPHORYLATION PATTERN AND FACILITATES BINDING OF PHOSPHATIDYLINOSITOL-3-OH KINASE TO THE HEPATOCYTE GROWTH-FACTOR RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SCATTER FACTOR-RECEPTOR; 3-KINASE	The hepatocyte growth factor (HGF) receptor is a tyrosine kinase receptor that mediates signal transduction upon ligand stimulation, This receptor is present in mouse tissues as two major isoforms differing by a 47-amino acid segment in the juxtamembrane domain, an alternatively spliced cytoplasmic region adjacent to the transmembrane domain of the receptor. We report here that the juxtamembrane domain of the receptor is involved in the regulation of downstream signal transduction, The two receptor isoforms were transiently expressed in COS-7 cells, Both exogenous receptors underwent autophosphorylation and subsequently stimulated a set of protein tyrosine phosphorylations that were not present in control cells. Comparisons of phosphotyrosine profiles of transfected cell lysates induced by receptor isoforms demonstrated that at least three phosphorylated proteins of similar to 62, similar to 35, and similar to 30 kDa were differentially induced by the receptor isoforms, suggesting that the juxtamembrane domain of a kinase receptor can play a role in selective signal transduction, Furthermore, the p85 subunit of phosphatidylinositol-3-OH kinase (PI3 kinase) co-precipitated with the small isoform of the HGF receptor, and this association was dramatically inhibited by treatment with 12-O-tetradecanoylphorbol-13-acetate. Since removal of the juxtamembrane domain facilitates the binding of p85 to the receptor, it is likely that the juxtamembrane region plays a role in negative regulation of the binding of PI3 kinase to the HGF receptor, Our study establishes novel molecular sequelae of alternative splicing of an intracellular domain of the HGF receptor.	NIDR,DEV BIOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)				Yamada, Kenneth/0000-0003-1512-6805				BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; CHAN AML, 1988, ONCOGENE, V2, P593; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DIFIORE PP, 1992, EMBO J, V11, P3927, DOI 10.1002/j.1460-2075.1992.tb05486.x; GANDINO L, 1994, J BIOL CHEM, V269, P1815; GRAZIANI A, 1991, J BIOL CHEM, V266, P22087; GRAZIANI A, 1993, J BIOL CHEM, V268, P9165; HARTMANN G, 1994, J BIOL CHEM, V269, P21936; LEE CC, 1994, J BIOL CHEM, V269, P19457; MCGLADE CJ, 1992, MOL CELL BIOL, V12, P991, DOI 10.1128/MCB.12.3.991; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; PARK M, 1987, P NATL ACAD SCI USA, V84, P6379, DOI 10.1073/pnas.84.18.6379; PONZETTO C, 1993, MOL CELL BIOL, V13, P4600, DOI 10.1128/MCB.13.8.4600; POWIS G, 1994, CANCER METAST REV, V13, P91, DOI 10.1007/BF00690420; RODRIGUEZVICIAN.P, 1994, NATURE, V370, P527; RUBIN JS, 1991, P NATL ACAD SCI USA, V88, P415, DOI 10.1073/pnas.88.2.415; SAMBROOK J, 1989, MOL CLONING LABORATO, V1; SEGATTO O, 1991, MOL CELL BIOL, V11, P3191, DOI 10.1128/MCB.11.6.3191; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; WHITELEY B, 1986, J CELL BIOL, V103, P1355, DOI 10.1083/jcb.103.4.1355; ZHEN Z, 1994, ONCOGENE, V9, P1691	22	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					507	510		10.1074/jbc.270.2.507	http://dx.doi.org/10.1074/jbc.270.2.507			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822270	hybrid			2022-12-27	WOS:A1995QB81600002
J	TAKADA, T; IIDA, K; MOSS, J				TAKADA, T; IIDA, K; MOSS, J			CONSERVATION OF A COMMON MOTIF IN ENZYMES CATALYZING ADP-RIBOSE TRANSFER - IDENTIFICATION OF DOMAINS IN MAMMALIAN TRANSFERASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-LABILE ENTEROTOXIN; NAD-BINDING-SITE; ESCHERICHIA-COLI; NUCLEOTIDE-SEQUENCE; DIPHTHERIA-TOXIN; SKELETAL-MUSCLE; POLY(ADP-RIBOSE) POLYMERASE; RIBOSYLTRANSFERASE ACTIVITY; CRYSTAL-STRUCTURE; CHOLERA-TOXIN	Bacterial toxin ADP-ribosyltransferases, e.g. diphtheria toxin (DT) and pertussis toxin, have in common consensus sequences involved in catalytic activity, which are localized to three regions, Region I is notable for a histidine or arginine; region II, similar to 50-75 amino acids downstream, is rich in aromatic/hydrophobic amino acids; and region III, further downstream has a glutamate and other acidic amino acids, A similar motif was observed in the sequence of the glycosylphosphatidylinositol-linked muscle ADP-ribosyltransferase. Site-directed mutagenesis was performed to verify the role of this motif, Proteins were expressed in rat adenocarcinoma cells, released from the cell with phosphatidylinositol-specific phospholipase C, and quantified with polyclonal antibodies, Transferase His(114) in region I aligned with His(21) of DT; as with DT, the H114N mutant was active. Aromatic/hydrophobic amino acids (region II) were found similar to 30-50 amino acids downstream of this histidine, Although transferase has a Glu(278)-Tyr-Ile sequence characteristic of region III in DT, Glu(278) was not critical for activity, In an alternative region III containing Glu(238)-Glu(239)-Glu(240), Glu(238) and Glu(240) but not Glu(239) were critical, Glu(240) aligned with critical glutamates in DT, Pseudomonas exotoxin, and C3 transferase. Thus, the mammalian ADP-ribosyltransferases have motifs similar to toxin ADP-ribosyltransferases, suggesting that these sequences are important in ADP-ribose transfer reactions.			TAKADA, T (corresponding author), NHLBI, PULM & CRIT CARE MED BRANCH, RM 5N-307, BLDG 10, BETHESDA, MD 20892 USA.							ANTOINE R, 1994, J BIOL CHEM, V269, P6450; Ausubel F, 1990, CURRENT PROTOCOLS MO, V1; BLANKE SR, 1994, BIOCHEMISTRY-US, V33, P5155, DOI 10.1021/bi00183a019; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; DOMENIGHINI M, 1991, MOL MICROBIOL, V5, P23, DOI 10.1111/j.1365-2958.1991.tb01822.x; GRAY GL, 1984, P NATL ACAD SCI-BIOL, V81, P2645, DOI 10.1073/pnas.81.9.2645; GREENFIELD L, 1983, P NATL ACAD SCI-BIOL, V80, P6853, DOI 10.1073/pnas.80.22.6853; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; JOHNSON VG, 1994, J BIOL CHEM, V269, P4349; JUNG M, 1993, J BIOL CHEM, V268, P23215; KOCH F, 1990, P NATL ACAD SCI USA, V87, P964, DOI 10.1073/pnas.87.3.964; KUROSAKI T, 1987, J BIOL CHEM, V262, P15990; LOBET Y, 1991, INFECT IMMUN, V59, P2870, DOI 10.1128/IAI.59.9.2870-2879.1991; LOCHT C, 1986, SCIENCE, V232, P1258, DOI 10.1126/science.3704651; LOWERY RG, 1990, ADP RIBOSYLATING TOX, P459; MARSISCHKY GT, 1991, ADP RIBOSYLATION REA, P47; MOSS J, 1992, J BIOL CHEM, V267, P10481; NEMOTO Y, 1991, J BIOL CHEM, V266, P19312; OKAZAKI IJ, 1994, BIOCHEMISTRY-US, V33, P12828, DOI 10.1021/bi00209a014; PETERSON JE, 1990, J BIOL CHEM, V265, P17062; POPOFF MR, 1991, INFECT IMMUN, V59, P3673, DOI 10.1128/IAI.59.10.3673-3679.1991; SIMONIN F, 1993, J BIOL CHEM, V268, P8529; SIXMA TK, 1991, NATURE, V351, P371, DOI 10.1038/351371a0; SIXMA TK, 1993, J MOL BIOL, V230, P890, DOI 10.1006/jmbi.1993.1209; STATES DJ, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90337-9; STEIN PE, 1994, STRUCTURE, V2, P45, DOI 10.1016/S0969-2126(00)00007-1; TAKADA T, 1994, J BIOL CHEM, V269, P9420; TAKADA T, 1993, J BIOL CHEM, V268, P17837; TWETEN RK, 1985, J BIOL CHEM, V260, P392; UCHIDA K, 1987, BIOCHEM BIOPH RES CO, V148, P617, DOI 10.1016/0006-291X(87)90921-1; YAMAMOTO T, 1984, J BIOL CHEM, V259, P5037; ZOLKIEWSKA A, 1993, J BIOL CHEM, V268, P25273; ZOLKIEWSKA A, 1992, P NATL ACAD SCI USA, V89, P11352, DOI 10.1073/pnas.89.23.11352; [No title captured]	34	61	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					541	544		10.1074/jbc.270.2.541	http://dx.doi.org/10.1074/jbc.270.2.541			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822277	hybrid			2022-12-27	WOS:A1995QB81600009
J	HODGESGARCIA, Y; HAGERMAN, PJ				HODGESGARCIA, Y; HAGERMAN, PJ			INVESTIGATION OF THE INFLUENCE OF CYTOSINE METHYLATION ON DNA FLEXIBILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RING-CLOSURE PROBABILITIES; HELICAL REPEAT; CURVATURE; CYCLIZATION; DEPENDENCE; FRAGMENTS	To test the influence of pyrimidine methyl groups on DNA flexibility and helix repeat, two sets of 14 mixed sequence DNA molecules, spanning a range of lengths from 158 to 180 base pairs, were cyclized with T4 DNA ligase. The two sets differed only in that the Cyt-5 positions of all cytosines (80-90 cytosine residues per molecule) were fully methylated in the members of one set. Determination of the molar cyclization factors, persistence lengths, helix repeats, and torsional elastic constants revealed no significant differences between the two sets. These results imply that, at least for mixed sequence DNA the biological consequences of cytosine methylation are likely to derive from either local structural distortions in the helix, which do not propagate as altered twist, or from direct protein-methyl cytosine interactions.	UNIV COLORADO,HLTH SCI CTR,DEPT BIOCHEM BIOPHYS & GENET,DENVER,CO 80262	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver					NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NCI NIH HHS [CA46934-06] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARNHEIM N, 1992, ANNU REV BIOCHEM, V61, P131, DOI 10.1146/annurev.bi.61.070192.001023; BRUKNER I, 1993, NUCLEIC ACIDS RES, V21, P1025, DOI 10.1093/nar/21.4.1025; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; CEDAR H, 1990, BIOCHIM BIOPHYS ACTA, V1049, P1, DOI 10.1016/0167-4781(90)90076-E; COLASANTI J, 1991, NUCLEIC ACIDS RES, V19, P391, DOI 10.1093/nar/19.2.391; CROTHERS DM, 1992, METHOD ENZYMOL, V212, P3; DIEKMANN S, 1987, EMBO J, V6, P4213, DOI 10.1002/j.1460-2075.1987.tb02769.x; HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265; HAGERMAN PJ, 1984, P NATL ACAD SCI-BIOL, V81, P4632, DOI 10.1073/pnas.81.15.4632; HAGERMAN PJ, 1990, J MOL BIOL, V212, P351, DOI 10.1016/0022-2836(90)90130-E; HAGERMAN PJ, 1985, BIOCHEMISTRY-US, V24, P7033, DOI 10.1021/bi00346a001; HAGERMAN PJ, 1990, BIOCHEMISTRY-US, V29, P1980, DOI 10.1021/bi00460a003; HAGERMAN RJ, 1994, AM J MED GENET, V51, P298, DOI 10.1002/ajmg.1320510404; HAGERMAN RJ, 1991, FRAGILE X SYNDROME; HEINEMANN U, 1992, J BIOL CHEM, V267, P7332; HODGESGARCIA Y, 1992, BIOCHEMISTRY-US, V31, P7595, DOI 10.1021/bi00148a022; KAHN JD, 1992, P NATL ACAD SCI USA, V89, P6343, DOI 10.1073/pnas.89.14.6343; KAHN JD, 1994, NATURE, V368, P163, DOI 10.1038/368163a0; LEVENE SD, 1986, J MOL BIOL, V189, P61, DOI 10.1016/0022-2836(86)90381-5; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; MCCONKIEROSELL A, 1993, AM J HUM GENET, V53, P800; MIGEON B, 1993, AM J MED GENET, V47, P685; MURCHIE AI, 1993, J MOL BIOL, V205, P593; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SHIMADA J, 1984, MACROMOLECULES, V17, P689, DOI 10.1021/ma00134a028; SHORE D, 1983, J MOL BIOL, V170, P957, DOI 10.1016/S0022-2836(83)80198-3; SHORE D, 1981, P NATL ACAD SCI-BIOL, V78, P4833, DOI 10.1073/pnas.78.8.4833; SONG L, 1990, BIOPOLYMERS, V30, P229, DOI 10.1002/bip.360300302; STROBEL SA, 1993, NATURE, V350, P172; TAYLOR WH, 1990, J MOL BIOL, V212, P363, DOI 10.1016/0022-2836(90)90131-5; Trifonov E. N., 1987, DNA BENDING CURVATUR, P243; VINCENT A, 1991, NATURE, V349, P624, DOI 10.1038/349624a0; XODO LE, 1991, NUCLEIC ACIDS RES, V19, P5625, DOI 10.1093/nar/19.20.5625; ZACHARIAS W, 1993, DNA METHYLATION MOL, P27; ZHURKIN VB, 1991, P NATL ACAD SCI USA, V88, P7046, DOI 10.1073/pnas.88.16.7046	35	30	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					197	201		10.1074/jbc.270.1.197	http://dx.doi.org/10.1074/jbc.270.1.197			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814373	hybrid			2022-12-27	WOS:A1995QA28700033
J	LIU, RC; ZHU, J; JOSPE, N; FURLANETTO, RW; BASTIAN, W; LIVINGSTON, JN				LIU, RC; ZHU, J; JOSPE, N; FURLANETTO, RW; BASTIAN, W; LIVINGSTON, JN			DELETION OF LYSINE-121 CREATES A TEMPERATURE-SENSITIVE ALTERATION IN INSULIN BINDING BY THE INSULIN-RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; NEGATIVE COOPERATIVITY; ALPHA-SUBUNIT; SPECIFICITY; REGION; SITE; CELLS	Recently we reported the deletion of Lys-121 in one allele of the insulin receptor gene from a child with severe insulin resistance, In the present work, this mutant receptor (M121) was shown to have an abnormal sensitivity to temperature and an alteration in ''negative cooperativity.'' In contrast to the wild-type receptor (HIRC), insulin binding by the M121 receptor was rapidly and irreversibly lost at temperatures above 30 degrees C with the phosphorylated form of the receptor being more temperature-sensitive than the nonphosphorylated form, Although insulin binding activity was lost, Western analysis and other studies showed that the mutant receptor remained intact, Measurements of I-125-insulin dissociation at 21 degrees C in the presence of native insulin (an estimate of negative cooperativity) demonstrated a difference between the mutant and wild-type receptor, Insulin dissociation from the mutant receptor was not as pronounced as that found with the wild-type receptor, Thus, an abnormality in insulin binding by the mutation was evident at lower ''permissive'' temperatures, The results of these and other studies argue that Lys-121 occupies an important position for the regulation of insulin receptor conformation, This regulation apparently influences negative cooperative interactions with insulin and modulates signal transduction.	UNIV ROCHESTER,SCH MED & DENT,DEPT BIOCHEM,ROCHESTER,NY 14642; UNIV ROCHESTER,SCH MED & DENT,DEPT PEDIAT,DIV PEDIAT ENDOCRINOL,ROCHESTER,NY 14642; MILES PHARMACEUT DIV,W HAVEN,CT 06515	University of Rochester; University of Rochester					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040394] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK40394] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSEN AS, 1990, BIOCHEMISTRY-US, V29, P7363, DOI 10.1021/bi00484a002; ARNER P, 1987, DIABETOLOGIA, V30, P437, DOI 10.1007/BF00292549; BASTIAN W, 1993, DIABETES, V42, P966, DOI 10.2337/diabetes.42.7.966; DEMEYTS P, 1990, MOL ENDOCRINOL, V4, P409, DOI 10.1210/mend-4-3-409; DEMEYTS P, 1978, NATURE, V273, P504; DEMEYTS P, 1976, J BIOL CHEM, V251, P1877; DEVRIES CP, 1990, DIABETES METAB, V16, P70; GUSTAFSON TA, 1990, J BIOL CHEM, V265, P18663; HAIGLER HT, 1980, J BIOL CHEM, V255, P1239; HARRISON LC, 1980, J BIOL CHEM, V255, P2066; JOSPE N, 1994, IN PRESS J CLIN ENDO; KADOWAKI H, 1990, J BIOL CHEM, V265, P21285; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; LECONTE I, 1992, J BIOL CHEM, V267, P17415; PILCH P, 1981, SERONO S, V41, P255; POLLET RJ, 1977, J BIOL CHEM, V252, P5828; RAFAELOFF R, 1989, J BIOL CHEM, V264, P15900; SCHUMACHER R, 1991, J BIOL CHEM, V266, P19288; SHAPIRO DL, 1986, BIOCHIM BIOPHYS ACTA, V885, P216, DOI 10.1016/0167-4889(86)90091-1; SHOELSON SE, 1993, J BIOL CHEM, V268, P4085; TAYLOR S, 1990, DIABETES CARE, V18, P257; TAYLOR SI, 1981, P NATL ACAD SCI-BIOL, V78, P7157, DOI 10.1073/pnas.78.11.7157; WEDEKIND F, 1989, BIOL CHEM H-S, V370, P251, DOI 10.1515/bchm3.1989.370.1.251; YIP CC, 1978, J BIOL CHEM, V253, P1743; YIP CC, 1992, J CELL BIOCHEM, V48, P19, DOI 10.1002/jcb.240480105; YIP CC, 1988, BIOCHEM BIOPH RES CO, V157, P321, DOI 10.1016/S0006-291X(88)80050-0; ZHANG B, 1992, J BIOL CHEM, V267, P18320	27	7	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					476	482		10.1074/jbc.270.1.476	http://dx.doi.org/10.1074/jbc.270.1.476			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814414	hybrid			2022-12-27	WOS:A1995QA28700075
J	THOMPSON, DK; GARBERS, DL				THOMPSON, DK; GARBERS, DL			DOMINANT-NEGATIVE MUTATIONS OF THE GUANYLYL CYCLASE-A RECEPTOR - EXTRACELLULAR DOMAIN DELETION AND CATALYTIC DOMAIN POINT MUTATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATRIURETIC-PEPTIDE RECEPTOR; ADENYLYL CYCLASE; SIGNAL TRANSDUCTION; MOLECULAR-CLONING; ACTIVITY REQUIRES; ENZYME SUBUNITS; LIGAND-BINDING; EXPRESSION; IDENTIFICATION; MESODERM	Guanylyl cyclase-A (GC-A), a receptor for A-type natriuretic peptide (ANP), contains an extracellular ligand-binding domain, a single transmembrane domain, and intracellular protein kinase-like and cyclase catalytic domains. Expression of the putative cyclase catalytic region (HCAT) resulted in the formation of an active enzyme that migrated as a homodimer on gel filtration columns; treatment with sodium trichloroacetate caused dissociation of the dimer and a loss of cyclase activity. Co-transfection of HCAT and full-length GC-A led to elevated basal intact cell cGMP concentrations and increased cell homogenate guanylyl cyclase activity. However, atrial natriuretic peptide-induced elevations of cGMP and cyclase activity were inhibited by the introduction of HCAT. Alanine scanning mutagenesis of highly conserved residues within HCAT identified one mutation (D893A) that destroyed enzyme activity but not the ability of the mutant subunit to form homodimers. The mutant subunit inhibited the cyclase activity of wild-type HCAT (approximately 70%) as well as that of full-length GC-A (approximately 85%) in co-expression studies where the amount of wild-type HCAT or full-length GC-A was not altered. Unlike co-transfection with wild-type HCAT, co-transfection of HCATD893A and GC-A did not result in elevated basal intact cell cGMP concentrations. For the first time we describe deletion and point mutations within the plasma membrane family of guanylyl cyclase receptors that result in the formation of effective dominant negative proteins.	UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT PHARMACOL,DALLAS,TX 75235; VANDERBILT UNIV,MED CTR,DEPT MOLEC PHYSIOL & BIOPHYS,NASHVILLE,TN 37232	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Vanderbilt University					NICHD NIH HHS [HD10254] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD010254] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUECHLER WA, 1991, BIOCHEM BIOPH RES CO, V174, P351, DOI 10.1016/0006-291X(91)90527-E; CHINKERS M, 1992, J BIOL CHEM, V267, P18589; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; FEINSTEIN PG, 1991, P NATL ACAD SCI USA, V88, P10173, DOI 10.1073/pnas.88.22.10173; GAO BN, 1991, P NATL ACAD SCI USA, V88, P10178, DOI 10.1073/pnas.88.22.10178; HANSBROUGH JR, 1981, J BIOL CHEM, V256, P2235; HARTENECK C, 1990, FEBS LETT, V272, P221, DOI 10.1016/0014-5793(90)80489-6; ISHIKAWA Y, 1992, J BIOL CHEM, V26, P13553; IWATA T, 1991, J BIOCHEM-TOKYO, V110, P35, DOI 10.1093/oxfordjournals.jbchem.a123539; KASHLES O, 1991, MOL CELL BIOL, V11, P1454, DOI 10.1128/MCB.11.3.1454; KOCH KW, 1990, J BIOL CHEM, V265, P9659; KOESLING D, 1990, FEBS LETT, V266, P128, DOI 10.1016/0014-5793(90)81523-Q; KOESLING D, 1988, FEBS LETT, V239, P29, DOI 10.1016/0014-5793(88)80539-8; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LOWE DG, 1992, BIOCHEMISTRY-US, V31, P10421, DOI 10.1021/bi00158a001; MACNICOL AM, 1993, CELL, V73, P571, DOI 10.1016/0092-8674(93)90143-E; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NAKANE M, 1990, J BIOL CHEM, V265, P16841; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; PREMONT RT, 1992, P NATL ACAD SCI USA, V89, P9809, DOI 10.1073/pnas.89.20.9809; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; TAKAYANAGI R, 1987, J BIOL CHEM, V262, P12104; TANG WJ, 1991, J BIOL CHEM, V266, P8595; UENO H, 1991, SCIENCE, V252, P844, DOI 10.1126/science.1851331; UENO H, 1992, J BIOL CHEM, V267, P1470; YUEN PST, 1994, J BIOL CHEM, V269, P791	31	61	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					425	430		10.1074/jbc.270.1.425	http://dx.doi.org/10.1074/jbc.270.1.425			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814405	hybrid			2022-12-27	WOS:A1995QA28700067
J	FURLAN, M; STEINMANN, C; JUNGO, M; BOGLI, C; BAUDO, F; REDAELLI, R; FEDELI, F; LAMMLE, B				FURLAN, M; STEINMANN, C; JUNGO, M; BOGLI, C; BAUDO, F; REDAELLI, R; FEDELI, F; LAMMLE, B			A FRAMESHIFT MUTATION IN EXON V OF THE A-ALPHA-CHAIN GENE LEADING TO TRUNCATED A-ALPHA-CHAINS IN THE HOMOZYGOUS DYSFIBRINOGEN MILANO-III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRIN GEL FORMATION; MONOCLONAL-ANTIBODIES; POLYMERIZATION; DNA; SUBSTITUTION; INVOLVEMENT; FRAGMENTS; COMPLEXES; FORM; CLOT	An inherited dysfunctional fibrinogen variant, de noted as fibrinogen Milano III, was found in a 13-year-old girl suffering from recurrent venous thrombosis, Plasma of the patient exhibited prolonged thrombin time and Reptilase time, Polymerization of fibrin monomers in the presence and absence of calcium ions was strongly impaired, SDS-polyacrylamide gel electrophoresis of reduced fibrinogen showed normal B beta- and gamma-chains, whereas no normal A alpha-chain was detected in the proposita. Immunoblot analysis with the monoclonal antibody Y18, detecting an epitope within the stretch of amino acids A alpha 1-51, revealed an A alpha-chain of about 50 kDa with an intact amino terminus. Immunoblotting with antibodies directed against serum albumin demonstrated the presence of albumin covalently linked to fibrinogen via a disulfide bridge, The structural defect of fibrinogen Milano III was determined by sequence analysis of a single-stranded fragment of genomic DNA amplified by polymerase chain reaction. An insertion of a thymine in the exon V of the A alpha-chain gene after the triplet ATT coding for Ile(A alpha 451) altered the reading frame and caused premature termination of the protein synthesis (Trp(452)(TGG)-Ser(453)(TCC)-Stop(454)(TGA)). In both parents, normal and mutant alleles were established, leading to duplication of the sequence pattern after the thymine insertion site, whereas the proposita is homozygous for the new mutation in the fibrinogen A alpha-chain gene.	OSPED MAGGIORE NIGUARDA,DEPT HEMATOL,I-20162 MILAN,ITALY; OSPED MAGGIORE NIGUARDA,DEPT PEDIAT,I-20162 MILAN,ITALY		FURLAN, M (corresponding author), UNIV BERN,INSELSPITAL,CENT HEMATOL LAB,CH-3010 BERN,SWITZERLAND.		Laemmle, Bernhard/AAJ-1216-2020	Laemmle, Bernhard/0000-0003-4538-5154				BOGLI C, 1987, THROMB HAEMOSTASIS, V58, P515; BUFFONE GJ, 1985, CLIN CHEM, V31, P164; CIERNIEWSKI CS, 1992, BIOCHEMISTRY-US, V31, P4248, DOI 10.1021/bi00132a014; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; CORDELL JL, 1984, J HISTOCHEM CYTOCHEM, V32, P219, DOI 10.1177/32.2.6198355; EBERT RF, 1993, THROMB HAEMOSTASIS, V69, P1296; FURLAN M, 1982, THROMB HAEMOSTASIS, V47, P118; GALANAKIS DK, 1978, J LAB CLIN MED, V92, P376; GOTTLIEB M, 1987, ANAL BIOCHEM, V165, P33, DOI 10.1016/0003-2697(87)90197-7; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; HASEGAWA N, 1990, THROMB RES, V57, P183, DOI 10.1016/0049-3848(90)90318-7; HOLM B, 1985, THROMB RES, V39, P595, DOI 10.1016/0049-3848(85)90239-7; KEHL M, 1981, HOPPESEYLERS Z PHYSL, V363, P1161; KOOPMAN J, 1992, P NATL ACAD SCI USA, V89, P3478, DOI 10.1073/pnas.89.8.3478; KOOPMAN J, 1993, J CLIN INVEST, V91, P1637, DOI 10.1172/JCI116371; KOOPMAN J, 1992, BLOOD, V80, P1972; KOPPERT PW, 1985, BLOOD, V66, P503; LAEMMLE B, 1986, ANAL BIOCHEM, V156, P118; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAU HKF, 1993, BLOOD, V81, P3277; LAURELL CB, 1966, ANAL BIOCHEM, V15, P45, DOI 10.1016/0003-2697(66)90246-6; MAEKAWA H, 1991, J BIOL CHEM, V266, P11575; MAEKAWA H, 1992, J CLIN INVEST, V90, P67, DOI 10.1172/JCI115857; MARDER VJ, 1969, J BIOL CHEM, V244, P2111; MEDVED LV, 1985, FEBS LETT, V181, P109, DOI 10.1016/0014-5793(85)81123-6; MOSESSON MW, 1966, BIOCHEMISTRY-US, V5, P2829, DOI 10.1021/bi00873a008; NAKASHIMA A, 1992, BLOOD COAGUL FIBRIN, V3, P361, DOI 10.1097/00001721-199203040-00002; REBER P, 1986, BLOOD, V67, P1751; RIXON MW, 1983, BIOCHEMISTRY-US, V22, P3237, DOI 10.1021/bi00282a031; RUPP C, 1984, VARIANTS HUMAN FIBRI, P65; SOUTHAN C, 1988, FIBRINOGEN FIBRIN ST, P65; STEINMANN C, 1994, BLOOD, V84, P1874; VEKLICH YI, 1993, J BIOL CHEM, V268, P13577; WEISEL JW, 1987, THROMB RES, V47, P155, DOI 10.1016/0049-3848(87)90372-0	34	43	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					33129	33134						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806542				2022-12-27	WOS:A1994QA63800060
J	MATSUDA, K; KASAMA, T; ISHIZUKA, I; HANDA, S; YAMAMOTO, N; TAKI, T				MATSUDA, K; KASAMA, T; ISHIZUKA, I; HANDA, S; YAMAMOTO, N; TAKI, T			STRUCTURE OF A NOVEL PHOSPHOCHOLINE-CONTAINING GLYCOGLYCEROLIPID FROM MYCOPLASMA-FERMENTANS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HTLV-I; LIPOTEICHOIC ACID; CHOLINE PHOSPHATE; APLYSIA-KURODAI; CELL-LINES; HIV-1; LYMPHOCYTES; INCOGNITUS; INFECTION; AIDS	Mycoplasma fermentans is thought to be a pathogen of rheumatoid arthritis or cofactor of AIDS. A novel phosphocholine-containing glycoglycerophospholipid named GGPL-I was isolated from a M. fermentans infected human helper T-cell culture. It was revealed that GGPL-I is a lipid component of the M. fermentans and a major immunological determinant. The GGPL-I was purified by DEAE-Sephadex column chromatography and repeated Iatrobeads column chromatography. The purified glycophospholipid was subjected to structural characterization by thin-layer chromatography, Fourier-transform infrared spectrometry, liquid secondary ion mass spectrometry, and nuclear magnetic resonance spectroscopy. Its structure was determined to be as follows: 6'-O-phosphocholine-alpha-glucopyranosyl-(1'-3)-1,2-diacyl-sn-glycerol. This glycoglycerophospholipid is unique in containing phosphocholine, which is attached to C-6 of glucose. The stereospecific numbering (an) of naturally occurring GGPL-I was determined through comparison with chemically synthesized compounds.	TOKYO MED & DENT UNIV,FAC MED,DEPT BIOCHEM,BUNKYO KU,TOKYO 113,JAPAN; TOKYO MED & DENT UNIV,BIOMED ANAL LAB,BUNKYO KU,TOKYO 113,JAPAN; TEIKYO UNIV,SCH MED,DEPT BIOCHEM,ITABASHI KU,TOKYO 173,JAPAN	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Teikyo University	MATSUDA, K (corresponding author), TOKYO MED & DENT UNIV,DEPT MICROBIOL,BUNKYO KU,5-45 YUSHIMA 1 CHOME,TOKYO 113,JAPAN.							ABE S, 1991, J BIOL CHEM, V266, P9939; [Anonymous], 1977, EUR J BIOCHEM, V79, P11; ARAKI S, 1986, J BIOL CHEM, V261, P5138; BEBEAR C, 1993, LANCET, V341, P758, DOI 10.1016/0140-6736(93)90531-K; BEHR T, 1992, EUR J BIOCHEM, V207, P1063, DOI 10.1111/j.1432-1033.1992.tb17143.x; DAWSON MS, 1993, ARCH PATHOL LAB MED, V117, P511; DITTMER JC, 1964, J LIPID RES, V5, P126; HAUSER H, 1980, J MOL BIOL, V137, P265, DOI 10.1016/0022-2836(80)90316-2; KAGAN GY, 1982, ZH MIKROBIOL EPIDEMI, V3, P107; KAPLAN MH, 1974, J IMMUNOL, V112, P283; Kates M, 1986, LAB TECHNIQUES BIOCH, V3; KOCHANOWSKI B, 1993, EUR J BIOCHEM, V214, P747, DOI 10.1111/j.1432-1033.1993.tb17976.x; LEMAITRE M, 1990, RES VIROLOGY, V141, P5, DOI 10.1016/0923-2516(90)90052-K; LEMAITRE M, 1992, INFECT IMMUN, V60, P742; LO SC, 1989, AM J TROP MED HYG, V41, P586, DOI 10.4269/ajtmh.1989.41.586; LO SC, 1989, AM J TROP MED HYG, V41, P601, DOI 10.4269/ajtmh.1989.41.601; LO SC, 1991, SCIENCE, V251, P1074, DOI 10.1126/science.1705362; MANNOCK DA, 1990, CHEM PHYS LIPIDS, V55, P309, DOI 10.1016/0009-3084(90)90169-R; MARINETTI GV, 1962, J LIPID RES, V3, P1; MATSUBARA T, 1994, IN PRESS BIOCH BIOPH; MATSUDA K, 1993, BIOCHIM BIOPHYS ACTA, V1168, P123; MATSUDA K, 1993, GLYCOCONJUGATE J, V10, P340, DOI 10.1007/BF01210178; MIYOSHI I, 1980, GANN, V71, P155; NISHIDA Y, 1994, IN PRESS TETRAHEDRON; PHILLIPS DM, 1992, AIDS RES HUM RETROV, V8, P1863, DOI 10.1089/aid.1992.8.1863; SIMS RPA, 1962, J AM OIL CHEM SOC, V39, P232, DOI 10.1007/BF02635828; SUGITA M, 1992, J BIOL CHEM, V267, P22595; SVENNERHOLM L, 1956, J NEUROCHEM, V1, P42, DOI 10.1111/j.1471-4159.1956.tb12053.x; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; SVENNERHOLM L, 1963, J NEUROCHEM, V10, P613, DOI 10.1111/j.1471-4159.1963.tb08933.x; TATE SI, 1992, J MAGN RESON, V96, P635, DOI 10.1016/0022-2364(92)90352-8; VOLANAKI.JE, 1971, P SOC EXP BIOL MED, V136, P612; WILLIAMS MH, 1970, LANCET, V2, P277; WILLIAMS MH, 1971, ANN RHEUM DIS, V30, P271, DOI 10.1136/ard.30.3.271	34	33	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					33123	33128						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806541				2022-12-27	WOS:A1994QA63800059
J	PERLMAN, RK; ROSNER, MR				PERLMAN, RK; ROSNER, MR			IDENTIFICATION OF ZINC LIGANDS OF THE INSULIN-DEGRADING ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; RAT-LIVER; METALLOENDOPROTEASE INHIBITORS; DEGRADATION PRODUCTS; PROTEASE-III; FACTOR-ALPHA; ACTIVE-SITE; BINDING; HEPATOCYTES; PROTEINS	The insulin degrading enzyme (IDE), a nonlysosomal enzyme involved in the metabolism of internalized insulin, is a member of a new family of metalloproteases which has an HXXEH active site motif. We have previously shown that both His(108) and Glu(111) within the HX-CEH domain of human IDE are necessary for catalytic activity. Comparison to the prototypic zinc metalloprotease thermolysin, which contains an inversion of this motif, would predict that His(112), as well as a downstream glutamate, serves as the second and third zinc Ligands of IDE. To examine the role of His(112), we mutated this residue to glutamine, leucine, or arginine. To identify a downstream zinc ligand, we substituted a glutamine for glutamate at either Glu(182) or Glu(189), both of which are conserved in human, rat, and Drosophila IDE. Vectors containing wild type or mutant IDE genes were transfected into COS cells, and the enzymes were analyzed for insulin degradation, insulin cross-linking, and zinc binding. Our results suggest that His(108), His(112), and Glu(189) are the zinc ligands of human IDE, and Glu(182) can influence zinc binding. In addition to a catalytic role, zinc binding to these residues appears to play a role in stabilizing the structure of the enzyme.	UNIV CHICAGO, BEN MAY INST, CHICAGO, IL 60637 USA; UNIV CHICAGO, DEPT MOLEC GENET & CELL BIOL, CHICAGO, IL 60637 USA; UNIV CHICAGO, DEPT PHARMACOL & PHYSIOL SCI, CHICAGO, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007151] Funding Source: NIH RePORTER; NIGMS NIH HHS [2T32 GM07151-17] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AFFHOLTER JA, 1988, SCIENCE, V242, P1415, DOI 10.1126/science.3059494; ALI M, 1989, J BIOL CHEM, V264, P20992; BAUMEISTER H, 1993, FEBS LETT, V317, P250, DOI 10.1016/0014-5793(93)81286-9; BECKER AB, 1993, BIOCHEM J, V292, P137, DOI 10.1042/bj2920137; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHRISTIANSON DW, 1991, ADV PROTEIN CHEM, V42, P281; DELSAL G, 1989, BIOTECHNIQUES, V7, P514; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DUCKWORTH WC, 1988, J BIOL CHEM, V263, P1826; EBRAHIM A, 1991, BIOCHEM BIOPH RES CO, V181, P1398, DOI 10.1016/0006-291X(91)92094-Z; FAGAN JM, 1991, BIOCHEM J, V277, P779, DOI 10.1042/bj2770779; FINCH PW, 1986, NUCLEIC ACIDS RES, V14, P7695, DOI 10.1093/nar/14.19.7695; GARCIA JV, 1987, J CELL BIOL, V105, P449, DOI 10.1083/jcb.105.1.449; GARCIA JV, 1989, J CELL BIOL, V109, P1301, DOI 10.1083/jcb.109.3.1301; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GEHM BD, 1991, ENDOCRINOLOGY, V128, P1603, DOI 10.1210/endo-128-3-1603; GEHM BD, 1993, J BIOL CHEM, V268, P7943; HAMEL FG, 1988, J BIOL CHEM, V263, P6703; HIGAKI JN, 1992, TRENDS BIOCHEM SCI, V17, P100, DOI 10.1016/0968-0004(92)90245-5; JONGENEEL CV, 1989, FEBS LETT, V242, P211, DOI 10.1016/0014-5793(89)80471-5; KAYALAR C, 1989, J BIOL CHEM, V264, P8928; KAYALAR C, 1990, J CELL BIOCHEM, V44, P137, DOI 10.1002/jcb.240440303; KOZAK M, 1983, CELL, V34, P971, DOI 10.1016/0092-8674(83)90554-8; KUO WL, 1990, MOL ENDOCRINOL, V4, P1580, DOI 10.1210/mend-4-10-1580; KUO WL, 1991, MOL ENDOCRINOL, V5, P1467, DOI 10.1210/mend-5-10-1467; KUO WL, 1993, ENDOCRINOLOGY, V132, P604, DOI 10.1210/en.132.2.604; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI D, 1992, J BIOL CHEM, V267, P2414; MATTHEWS BW, 1972, NATURE-NEW BIOL, V238, P37, DOI 10.1038/newbio238037a0; MATTHEWS BW, 1972, NATURE-NEW BIOL, V238, P41, DOI 10.1038/newbio238041a0; MULLER D, 1992, BIOCHEMISTRY-US, V31, P11138; NEURATH H, 1989, PROTEOLYTIC ENZYMES, P1; ODELL BL, 1992, NUTR REV, V50, P48, DOI 10.1111/j.1753-4887.1992.tb02513.x; OGAWA W, 1992, J BIOL CHEM, V267, P1310; PERLMAN RK, 1993, J BIOL CHEM, V268, P21538; ROTH RA, 1984, ENDOCR RES, V10, P101, DOI 10.3109/07435808409035411; Sambrook J, 1989, MOL CLONING LABORATO; SHII K, 1986, P NATL ACAD SCI USA, V83, P4147, DOI 10.1073/pnas.83.12.4147; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; VALLEE BL, 1990, P NATL ACAD SCI USA, V87, P220, DOI 10.1073/pnas.87.1.220; WARD WF, 1985, DIABETES, V34, P446, DOI 10.2337/diabetes.34.5.446	41	54	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					33140	33145						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806544				2022-12-27	WOS:A1994QA63800062
J	ARUNACHALAM, B; CRESSWELL, P				ARUNACHALAM, B; CRESSWELL, P			MOLECULAR REQUIREMENTS FOR THE INTERACTION OF CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX-MOLECULES AND INVARIANT CHAIN WITH CALNEXIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; INTRACELLULAR-TRANSPORT; MONOCLONAL-ANTIBODIES; ESCHERICHIA-COLI; ALPHA-CHAIN; BETA-CHAIN; PROTEIN; BINDING; GLYCOPROTEINS; CHAPERONE	Molecular chaperones are believed to retain misfolded and incompletely assembled oligomeric proteins in the endoplasmic reticulum (ER). Here, we have further analyzed the association of one such chaperone, calnexin, with human major histocompatibility complex class II alpha and beta subunits and the invariant chain. Calnexin associates with transport-competent invariant chain trimers (p33 or p41), as well as ER-retained trimers (p35/33 or p43/41), suggesting that ER retention of the latter is not because of calnexin association. Neither the replacement of the transmembrane segment of the DR beta subunit with a glycosyl phosphatidylinositol anchor nor deglycosylation of any of these proteins with tunicamycin or endoglycosidase H treatment abolished calnexin association. Using a cell-permeabilization system, we were unable to observe association of newly synthesized glycopeptides with calnexin, arguing that calnexin may not act Like a simple lectin for association with glycoproteins. The results indicate that neither transmembrane regions nor N-linked glycans are exclusively responsible for calnexin association. Based on our data and the observations of others, we suggest that these features may have varying significance for different glycoproteins in determining their interaction with calnexin.	YALE UNIV,SCH MED,HOWARD HUGHES MED INST,IMMUNOBIOL SECT,NEW HAVEN,CT 06510	Howard Hughes Medical Institute; Yale University				Arunachalam, Arun/0000-0001-6486-5722	NIAID NIH HHS [AI23081] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023081, R01AI023081] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHLUWALIA N, 1992, J BIOL CHEM, V267, P10914; ALTMAN JD, 1993, P NATL ACAD SCI USA, V90, P10330, DOI 10.1073/pnas.90.21.10330; ANDERSON KS, 1994, EMBO J, V13, P675, DOI 10.1002/j.1460-2075.1994.tb06306.x; ANDROLEWICZ MJ, 1994, IMMUNITY, V1, P7, DOI 10.1016/1074-7613(94)90004-3; ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; ARUNACHALAM B, 1994, INT IMMUNOL, V6, P439, DOI 10.1093/intimm/6.3.439; AUBRY JP, 1994, J IMMUNOL, V152, P5806; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; DAVID V, 1993, J BIOL CHEM, V268, P9585; DEGEN E, 1991, J CELL BIOL, V112, P1099, DOI 10.1083/jcb.112.6.1099; DRICKAMER K, 1981, J BIOL CHEM, V256, P5827; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; FUERST TR, 1986, P NATL ACAD SCI USA, V8, P8122; GALVIN K, 1992, P NATL ACAD SCI USA, V89, P8452, DOI 10.1073/pnas.89.18.8452; GETHING MJ, 1986, CELL, V46, P939, DOI 10.1016/0092-8674(86)90076-0; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GUY K, 1982, EUR J IMMUNOL, V12, P942, DOI 10.1002/eji.1830121109; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HAYERHARTL MK, 1994, EMBO J, V13, P3192, DOI 10.1002/j.1460-2075.1994.tb06618.x; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; JACKSON MR, 1994, SCIENCE, V263, P384, DOI 10.1126/science.8278813; KEARSE KP, 1994, EMBO J, V13, P3678, DOI 10.1002/j.1460-2075.1994.tb06677.x; Kelley William L., 1992, Current Opinion in Cell Biology, V4, P984, DOI 10.1016/0955-0674(92)90130-5; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAMB CA, 1991, P NATL ACAD SCI USA, V88, P5998, DOI 10.1073/pnas.88.14.5998; LAMB CA, 1992, J IMMUNOL, V148, P3478; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; LEE JS, 1982, NATURE, V299, P750, DOI 10.1038/299750a0; LOEB JA, 1987, J BIOL CHEM, V262, P3022; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MARGOLESE L, 1993, J BIOL CHEM, V268, P17959; MARKS MS, 1990, J CELL BIOL, V111, P839, DOI 10.1083/jcb.111.3.839; MARTIN J, 1993, NATURE, V366, P228, DOI 10.1038/366228a0; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; OSULLIVAN DM, 1987, J EXP MED, V166, P444, DOI 10.1084/jem.166.2.444; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; RADKA SF, 1984, HUM IMMUNOL, V10, P177, DOI 10.1016/0198-8859(84)90038-7; RAJAGOPALAN S, 1994, SCIENCE, V263, P387, DOI 10.1126/science.8278814; RAJAGOPALAN S, 1994, J EXP MED, V180, P407, DOI 10.1084/jem.180.1.407; RANDALL LL, 1986, CELL, V46, P921, DOI 10.1016/0092-8674(86)90074-7; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; SCREIBER KL, 1994, INT IMMUNOL, V6, P101; STRUBIN M, 1984, EMBO J, V3, P869, DOI 10.1002/j.1460-2075.1984.tb01898.x; STRUBIN M, 1986, EMBO J, V5, P3483, DOI 10.1002/j.1460-2075.1986.tb04673.x; TONNELLE C, 1985, EMBO J, V4, P2839, DOI 10.1002/j.1460-2075.1985.tb04012.x; WADA I, 1991, J BIOL CHEM, V266, P19599	52	84	85	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2784	2790		10.1074/jbc.270.6.2784	http://dx.doi.org/10.1074/jbc.270.6.2784			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852350	hybrid			2022-12-27	WOS:A1995QF53500060
J	CATASTI, P; FONTENOT, JD; BRADBURY, E; GUPTA, G				CATASTI, P; FONTENOT, JD; BRADBURY, E; GUPTA, G			LOCAL AND GLOBAL STRUCTURAL-PROPERTIES OF THE HIV-MN V3 LOOP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PRINCIPAL NEUTRALIZING DETERMINANT; ENVELOPE GLYCOPROTEIN; CELL TROPISM; TYPE-1; ANTIBODIES; SEQUENCE; DOMAIN; GP120; IDENTIFICATION	Studies of the feasibility of a subunit vaccine to protect against human immunodeficiency virus (HIV) infection have principally focused on the third variable (V3) loop, The principal neutralizing determinant (PND) of HIV-1 is located inside the V3 loop of the surface envelope glycoprotein, gp120. However, progress toward a PND-based vaccine has been impeded by the amino acid sequence variability in the V3 loops of different HN isolates, Theoretical studies revealed that the variability in sequence and structure of the V3 loop is confined to the N- and C-terminal sides of the conserved GPG crest, This leaves three regions of the V3 loop conserved both in sequence and secondary structure, We present the results of NMR studies that test the validity of our theoretical predictions. Structural studies are reported for the HIV-V3 loop (HIV-MN) in the linear and cyclic (S-S-bridged) forms. For the V3 loop sequence of the HIV-MN isolate, the three conserved secondary structural elements are as underlined below: CTRPNYNKRKRIHIGPGRAFYTTKNIIGTIROAHC(turns, turn helix) Finally, the conformational requirement of the PND in the V3 loop-antibody interaction is tested by monitoring the monoclonal antibody binding to the HIV-MN V3 loop in the linear and cyclic forms by enzyme-linked immunosorbent assay, The binding data reveal that the cyclic V3 loop is a better ligand for the monoclonal antibodies than the linear form although the latter has the same sequence. This means that the monoclonal antibodies recognize the PNDs as conformational epitopes.	LOS ALAMOS NATL LAB,THEORET BIOL & BIOPHYS GRP,LOS ALAMOS,NM 87545; LOS ALAMOS NATL LAB,DIV LS,LOS ALAMOS,NM 87545; UNIV CALIF DAVIS,SCH MED,DEPT BIOL CHEM,DAVIS,CA 95616	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California Davis					NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR004795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032891] Funding Source: NIH RePORTER; NCRR NIH HHS [RR04795] Funding Source: Medline; NIAID NIH HHS [R01 AI32891-01A2] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHANDRASEKHAR K, 1991, BIOCHEMISTRY-US, V30, P9187, DOI 10.1021/bi00102a009; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; DELEAGE G, 1989, PREDICTION PROTEIN S, P587; FREED EO, 1991, J VIROL, V65, P190, DOI 10.1128/JVI.65.1.190-194.1991; FREED EO, 1991, J VIROL, V65, P333; GEYER H, 1988, J BIOL CHEM, V263, P11760; GORNY MK, 1991, P NATL ACAD SCI USA, V88, P3238, DOI 10.1073/pnas.88.8.3238; GOUDSMIT J, 1988, P NATL ACAD SCI USA, V85, P4478, DOI 10.1073/pnas.85.12.4478; GUPTA G, 1993, J BIOMOL STRUCT DYN, V11, P345, DOI 10.1080/07391102.1993.10508731; GUPTA G, 1988, BIOCHEMISTRY-US, V27, P3423; GUPTA G, 1990, 5 C CENT GARD PAR, P99; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; JAVAHERIAN K, 1989, P NATL ACAD SCI USA, V86, P6768, DOI 10.1073/pnas.86.17.6768; LAROSA GJ, 1990, SCIENCE, V249, P932, DOI 10.1126/science.2392685; PUTNEY SD, 1986, SCIENCE, V234, P1392, DOI 10.1126/science.2431482; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; RINI JM, 1993, P NATL ACAD SCI USA, V90, P6325, DOI 10.1073/pnas.90.13.6325; ROSE GD, 1985, ADV PROTEIN CHEM, V37, P1, DOI 10.1016/S0065-3233(08)60063-7; ROTERMAN IK, 1989, J BIOMOL STRUCT DYN, V7, P1; RUSCHE JR, 1988, P NATL ACAD SCI USA, V85, P3198, DOI 10.1073/pnas.85.9.3198; SKLENAR V, 1987, J MAGN RESON, V74, P469, DOI 10.1016/0022-2364(87)90269-1; VERONESE FD, 1993, J BIOL CHEM, V268, P25894; WUTHRICH K, 1984, J MOL BIOL, V180, P715, DOI 10.1016/0022-2836(84)90034-2; Wuthrich K., 1986, NMR PROTEINS NUCL AC; WYATT R, 1992, J VIROL, V66, P6997, DOI 10.1128/JVI.66.12.6997-7004.1992; ZVI A, 1992, BIOCHEMISTRY-US, V31, P6972, DOI 10.1021/bi00145a015	26	86	90	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2224	2232		10.1074/jbc.270.5.2224	http://dx.doi.org/10.1074/jbc.270.5.2224			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836454	hybrid			2022-12-27	WOS:A1995QE49300039
J	QUITTERER, U; SCHRODER, C; MULLERESTERL, W; REHM, H				QUITTERER, U; SCHRODER, C; MULLERESTERL, W; REHM, H			EFFECTS OF BRADYKININ AND ENDOTHELIN-1 ON THE CALCIUM HOMEOSTASIS OF MAMMALIAN-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; CULTURED HUMAN-FIBROBLASTS; VASOCONSTRICTOR PEPTIDE; INTRACELLULAR CA2+; LYS-BRADYKININ; DNA-SYNTHESIS; RECEPTOR; CLONING; RELEASE; POTENT	Ca2+ mobilization from intracellular stores is a major event in the signaling cascade triggered by peptide hormone receptors. The transient rise in intracellular free Ca2+ concentration ([Ca2+](i)) is well characterized, but little is known about alterations of total cell Ca. Therefore we established a technique to determine changes in total cell Ca during hormone stimulation of Ca-45-loaded cells. Bradykinin and endothelin-l reduced total cell Ca by up to 56% in HF-15 cells, COS-7 cells, and CHO K1 cells transfected with the rat B2 receptor cDNA. In Rat-1 cells and PC-12 cells, stimulation with endothelin-l or bradykinin did not result in a net decrease in total cell Ca at physiological extracellular Ca2+ concentration. Decrease in total cell Ca was preceded by an increase in [Ca2+](i) and blunting of the transient rise in [Ca2+](i) by a Ca2+ chelator prevented the hormone-induced decrease in total cell Ca. Previous reduction of total cell Ca by one hormone suppressed the transient rise in [Ca2+](i) induced by another. The data present evidence that the hormones bradykinin and endothelin-l are capable of switching off the Ca2+-mobilizing signal transduction pathway in a cell by depleting intracellular Ca stores. This process is accompanied by a significant reduction of total cell Ca.			QUITTERER, U (corresponding author), INST PHYSIOL CHEM & PATHOBIOCHEM, DUESBERGWEG 6, D-55099 MAINZ, GERMANY.							ABDALLA S, 1993, J BIOL CHEM, V268, P17277; ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; ARAMORI I, 1992, J BIOL CHEM, V267, P12468; ARMSTRONG D, 1954, NATURE, V174, P791, DOI 10.1038/174791a0; BAUMGARTEN LB, 1992, J BIOL CHEM, V267, P10524; CUTHBERT AW, 1982, BRIT J PHARMACOL, V75, P587, DOI 10.1111/j.1476-5381.1982.tb09178.x; EGUCHI S, 1992, FEBS LETT, V302, P243, DOI 10.1016/0014-5793(92)80451-L; FARMER SG, 1992, ANNU REV PHARMACOL, V32, P511; FASOLATO C, 1988, J BIOL CHEM, V263, P17350; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; GAUDREAU P, 1981, CAN J PHYSIOL PHARM, V59, P371, DOI 10.1139/y81-059; GREENBAUM LM, 1963, BIOCHEM PHARMACOL, V12, P325, DOI 10.1016/0006-2952(63)90057-1; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HIRATA Y, 1989, ATHEROSCLEROSIS, V78, P225, DOI 10.1016/0021-9150(89)90227-X; HIRATA Y, 1988, BIOCHEM BIOPH RES CO, V154, P868, DOI 10.1016/0006-291X(88)90220-3; HOCK FJ, 1991, BRIT J PHARMACOL, V102, P769, DOI 10.1111/j.1476-5381.1991.tb12248.x; ITOH Y, 1988, FEBS LETT, V231, P440, DOI 10.1016/0014-5793(88)80867-6; KAUFMANN J, 1993, J BIOL CHEM, V268, P9079; LAGNADO L, 1994, NATURE, V367, P273, DOI 10.1038/367273a0; MARSDEN PA, 1989, BIOCHEM BIOPH RES CO, V158, P86, DOI 10.1016/S0006-291X(89)80180-9; MATTHEWS HR, 1988, NATURE, V334, P67, DOI 10.1038/334067a0; MCEACHERN AE, 1991, P NATL ACAD SCI USA, V88, P7724, DOI 10.1073/pnas.88.17.7724; MCPHERSON GA, 1985, J PHARMACOL METHOD, V14, P213, DOI 10.1016/0160-5402(85)90034-8; MIASIRO N, 1988, BIOCHEM BIOPH RES CO, V156, P312, DOI 10.1016/S0006-291X(88)80841-6; MILLER RC, 1993, TRENDS PHARMACOL SCI, V14, P54, DOI 10.1016/0165-6147(93)90031-E; MULDOON LL, 1989, J BIOL CHEM, V264, P8529; MULDOON LL, 1991, AM J PHYSIOL, V260, pC1273, DOI 10.1152/ajpcell.1991.260.6.C1273; NAKADE S, 1991, BIOCHEM J, V277, P125, DOI 10.1042/bj2770125; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; OWEN NE, 1983, J CELL PHYSIOL, V117, P23, DOI 10.1002/jcp.1041170105; OWEN NE, 1983, CELL, V32, P979, DOI 10.1016/0092-8674(83)90082-X; REISER G, 1992, EXP CELL RES, V202, P440, DOI 10.1016/0014-4827(92)90097-R; ROSCHER AA, 1983, J CLIN INVEST, V72, P626, DOI 10.1172/JCI111012; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; SAWUTZ DG, 1992, EUR J PHARM-MOLEC PH, V227, P309, DOI 10.1016/0922-4106(92)90009-K; SHORT AD, 1993, P NATL ACAD SCI USA, V90, P4986, DOI 10.1073/pnas.90.11.4986; SILVA MRE, 1949, AM J PHYSIOL, V156, P261, DOI 10.1152/ajplegacy.1949.156.2.261; TEPIKIN AV, 1992, J BIOL CHEM, V267, P14073; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; Weil A, 1914, H-S Z PHYSIOL CHEM, V89, P349, DOI 10.1515/bchm2.1914.89.5.349; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	41	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					1992	1999		10.1074/jbc.270.5.1992	http://dx.doi.org/10.1074/jbc.270.5.1992			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836425	hybrid			2022-12-27	WOS:A1995QE49300005
J	SHI, W; OSAWA, S; DICKERSON, CD; WEISS, ER				SHI, W; OSAWA, S; DICKERSON, CD; WEISS, ER			RHODOPSIN MUTANTS DISCRIMINATE SITES IMPORTANT FOR THE ACTIVATION OF RHODOPSIN KINASE AND G(T)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTOR KINASES; AMINO-ACID; TRANSDUCIN; PHOSPHORYLATION; BOVINE; PROTEINS; BINDING; ROD; ANTIBODIES; MEMBRANES	The cytoplasmic loops of rhodopsin, the rod cell photoreceptor, play important regulatory roles in the activation of both rhodopsin kinase and the rod cell G protein, G(t). A number of studies have identified domains in rhodopsin that are important for the activation of G(t). However, less is known concerning the cytoplasmic regions that regulate phosphorylation of the photoreceptor by rhodopsin kinase, To identify regions that participate in these processes, a series of alanine mutations were generated in the three cytoplasmic loops of rhodopsin and transiently expressed in HEK-293 cells, Membranes prepared from these cells were reconstituted with the opsin chromophore, Il-cis-retinal, and characterized for their ability to undergo light dependent phosphorylation by rhodopsin kinase and to catalyze GTP gamma S (guanosine 5'-O-(3-thiotriphosphate)) binding to G(t). We have identified mutants that fall into three distinct categories: 1) those that show altered phosphorylation but normal C-t activation, such as T62A/V63A/Q64A and R147A/F148A/G149A in Loops I and II, respectively; 2) mutants that have reduced ability to activate G(t) but are phosphorylated normally, including T242A/T243A and V250A/T251A/R252A in Loop III; and 3) mutants that affect both phosphorylation and G(t) activation, including A233G/A234G/A235G and A233N/A234N/A235N in Loop III, The use of these two assays in parallel have allowed us to distinguish the presence of distinct functional domains within the cytoplasmic loops which are specific for interaction with rhodopsin kinase or G(t).	UNIV N CAROLINA,DEPT CELL BIOL & ANAT,CHAPEL HILL,NC 27599; UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,CHAPEL HILL,NC 27599; UNIV N CAROLINA,CURRICULUM GENET & MOLEC BIOL,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill			Weiss, Ellen/AAK-9868-2020		NIGMS NIH HHS [GM47438, GM43582] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043582, R29GM043582, R55GM047438, R29GM047438] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERLOT CH, 1992, CELL, V68, P911, DOI 10.1016/0092-8674(92)90034-A; BHATTACHARYA S, 1992, J BIOL CHEM, V267, P6763; BORJIGIN J, 1994, J BIOL CHEM, V269, P14715; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN NG, 1992, EUR J BIOCHEM, V208, P659, DOI 10.1111/j.1432-1033.1992.tb17232.x; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; FOWLES C, 1988, FEBS LETT, V238, P56, DOI 10.1016/0014-5793(88)80224-2; FRANKE RR, 1988, J BIOL CHEM, V263, P2119; FRANKE RR, 1990, SCIENCE, V250, P123, DOI 10.1126/science.2218504; FRANKE RR, 1992, J BIOL CHEM, V267, P14767; HARGRAVE PA, 1992, FASEB J, V6, P2323, DOI 10.1096/fasebj.6.6.1544542; HAWES BE, 1994, J BIOL CHEM, V269, P15776; HICKS D, 1986, EXP EYE RES, V42, P55, DOI 10.1016/0014-4835(86)90017-5; INGLESE J, 1993, J BIOL CHEM, V268, P23735; KELLEHER DJ, 1990, J BIOL CHEM, V265, P2632; KELLEHER DJ, 1988, MOL PHARMACOL, V34, P452; KLAPPER MH, 1977, BIOCHEM BIOPH RES CO, V78, P1018, DOI 10.1016/0006-291X(77)90523-X; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; KRUPNICK JG, 1994, J BIOL CHEM, V269, P3226; KUHN H, 1981, BIOCHEMISTRY-US, V20, P2410; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MIN KC, 1993, J BIOL CHEM, V268, P9400; MORO O, 1993, J BIOL CHEM, V268, P22273; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; OSAWA S, 1994, MOL PHARMACOL, V46, P1036; PALCZEWSKI K, 1988, BIOCHEMISTRY-US, V27, P2306, DOI 10.1021/bi00407a010; PALCZEWSKI K, 1991, TRENDS BIOCHEM SCI, V16, P387, DOI 10.1016/0968-0004(91)90157-Q; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P21249; PHILLIPS WJ, 1992, J BIOL CHEM, V267, P17032; PHILLIPS WJ, 1994, BIOCHEM J, V299, P351, DOI 10.1042/bj2990351; PIN JP, 1994, EMBO J, V13, P342, DOI 10.1002/j.1460-2075.1994.tb06267.x; PISTORIUS AMA, 1994, BIOCHEM BIOPH RES CO, V198, P1040, DOI 10.1006/bbrc.1994.1148; PULVERMULLER A, 1993, BIOCHEMISTRY-US, V32, P14082, DOI 10.1021/bi00214a002; ROBINSON PR, 1994, P NATL ACAD SCI USA, V91, P5411, DOI 10.1073/pnas.91.12.5411; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; Schulz G. E., 1979, PRINCIPLES PROTEIN S; SITARAMAYYA A, 1986, BIOCHEMISTRY-US, V25, P5460, DOI 10.1021/bi00367a017; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; WEISS ER, 1988, J BIOL CHEM, V263, P6150; WEISS ER, 1994, BIOCHEMISTRY-US, V33, P7587, DOI 10.1021/bi00190a011; WONG SKF, 1994, J BIOL CHEM, V269, P18968	44	72	72	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2112	2119		10.1074/jbc.270.5.2112	http://dx.doi.org/10.1074/jbc.270.5.2112			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836439	hybrid			2022-12-27	WOS:A1995QE49300022
J	BEYLOT, M; SOLOVIEV, MV; DAVID, F; LANDAU, BR; BRUNENGRABER, H				BEYLOT, M; SOLOVIEV, MV; DAVID, F; LANDAU, BR; BRUNENGRABER, H			TRACING HEPATIC GLUCONEOGENESIS RELATIVE TO CITRIC-ACID CYCLE ACTIVITY IN-VITRO AND IN-VIVO - COMPARISONS IN THE USE OF [3-C-13]LACTATE, [2-C-13]ACETATE, AND ALPHA-KETO[3-C-13]ISOCAPROATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATOGRAPHY MASS-SPECTROMETRY; PERFUSED RAT-LIVER; KREBS CYCLE; C-13-LABELING PATTERN; QUANTITATIVE-ANALYSIS; GLUCOSE-PRODUCTION; ISOTOPE-DILUTION; AMINO-ACIDS; C-14 ATOMS; FATTY-ACID	The validity of the use of a carbon tracer for investigating liver intermediary metabolism in vivo requires that the labeling pattern of liver metabolites not be influenced by metabolism of the tracer in other tissues. To identify such specific tracer, livers from 48-h starved rats were perfused with recirculating buffer containing [3-C-13]lactate, [2-C-13]acetate, or alpha-keto[3-C-13]isocaproate. Conscious 48-h starved rats were infused with the same tracers for 5 h. The labeling patterns of liver glutamate and extracellular glucose were assayed by gas chromatography-mass spectrometry. In vivo data were corrected for (CO2)-C-13 reincorporation into C-1 of glutamate and C-3 and C-4 of glucose, using data from control rats infused with (NaHCO3)-C-13. With [3-C-13]lactate the labeling pattern of liver glutamate was the same in perfused organs and in vivo. In contrast, with [2-C-13]acetate and alpha-keto[3-C-13]isocaproate the labeling pattern of liver glutamate in vivo was clearly influenced by the expected labeling pattern of citric acid cycle intermediates formed in non gluconeogenic organs, presumably glutamine made in muscle. Indeed, the labeling pattern of plasma glutamine and liver glutamate were similar in experiments with [3-C-13]lactate but different in experiments with [2-C-13]acetate and alpha-keto[3-C-13]isocaproate. Similar conclusions were drawn from the labeling patterns of glucose. Therefore, labeled lactate appears as the best tracer for studies of liver intermediary metabolism in vivo. Our data also show that a substantial fraction of alpha-ketoisocaproate metabolism occurs in peripheral tissues.	CASE WESTERN RESERVE UNIV, DEPT NUTR, CLEVELAND, OH 44106 USA; CASE WESTERN RESERVE UNIV, DEPT MED, CLEVELAND, OH 44106 USA; CASE WESTERN RESERVE UNIV, DEPT BIOCHEM, CLEVELAND, OH 44106 USA; INSERM, U197, F-69008 LYON, FRANCE	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Institut National de la Sante et de la Recherche Medicale (Inserm)					NIDDK NIH HHS [DK35543, DK14507] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035543, R37DK014507, R01DK014507] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEYLOT M, 1993, ANAL BIOCHEM, V212, P532, DOI 10.1006/abio.1993.1364; BEYLOT M, 1994, BIOL MASS SPECTROM, V23, P510, DOI 10.1002/bms.1200230808; BEYLOT M, 1993, ANAL BIOCHEM, V212, P526, DOI 10.1006/abio.1993.1363; BRUNENGRABER H, 1978, EUR J BIOCHEM, V82, P373, DOI 10.1111/j.1432-1033.1978.tb12032.x; BRUNENGRABER H, 1973, J BIOL CHEM, V248, P2656; CONSOLI A, 1989, DIABETES, V38, P550, DOI 10.2337/diabetes.38.5.550; CONSOLI A, 1987, J CLIN INVEST, V80, P1303, DOI 10.1172/JCI113206; CRABTREE B, 1989, BIOCHEM J, V257, P673, DOI 10.1042/bj2570673; DAVIS EJ, 1980, EUR J BIOCHEM, V110, P255, DOI 10.1111/j.1432-1033.1980.tb04863.x; DESROSIERS C, 1990, AM J PHYSIOL, V258, pE519, DOI 10.1152/ajpendo.1990.258.3.E519; DIDONATO L, 1993, J BIOL CHEM, V268, P4170; DUGELAY S, 1994, ANAL BIOCHEM, V221, P368, DOI 10.1006/abio.1994.1427; ESENMO E, 1992, AM J PHYSIOL, V263, pE36, DOI 10.1152/ajpendo.1992.263.1.E36; FINK G, 1988, J BIOL CHEM, V263, P18036; GAVINO VC, 1987, J BIOL CHEM, V262, P6735; GRUNNET N, 1978, BIOCHEM J, V172, P595, DOI 10.1042/bj1720595; HARPER AE, 1984, ANNU REV NUTR, V4, P409, DOI 10.1146/annurev.nu.04.070184.002205; HETENYI G, 1979, CAN J PHYSIOL PHARM, V57, P767, DOI 10.1139/y79-119; HETENYI G, 1982, FED PROC, V41, P104; HETENYI G, 1982, CAN J PHYSIOL PHARM, V60, P1603, DOI 10.1139/y82-237; HILL RJ, 1958, J BIOL CHEM, V230, P169; JUNGERMANN K, 1986, ENZYME, V35, P161, DOI 10.1159/000469338; KATZ J, 1993, J BIOL CHEM, V268, P25509; KATZ J, 1985, AM J PHYSIOL, V248, pR391, DOI 10.1152/ajpregu.1985.248.4.R391; KELLEHER JK, 1985, AM J PHYSIOL, V248, pE252, DOI 10.1152/ajpendo.1985.248.2.E252; KELLEHER JK, 1986, AM J PHYSIOL, V250, pE296, DOI 10.1152/ajpendo.1986.250.3.E296; KREBS HA, 1966, BIOCHEM J, V101, P242, DOI 10.1042/bj1010242; LANDAU BR, 1993, AM J PHYSIOL, V265, pE636, DOI 10.1152/ajpendo.1993.265.4.E636; LANDAU BR, 1993, METABOLISM, V42, P264, DOI 10.1016/0026-0495(93)90048-S; LANDAU BR, 1993, ADV EXP MED BIOL, V334, P209; MAGNUSSON I, 1991, J BIOL CHEM, V266, P6975; MALLOY CR, 1988, J BIOL CHEM, V263, P6964; MAMER OA, 1986, BIOMED ENVIRON MASS, V13, P553, DOI 10.1002/bms.1200131007; MARSOLAIS C, 1989, J BIOL CHEM, V264, P19761; MARTIN C, 1991, METABOLISM, V40, P420, DOI 10.1016/0026-0495(91)90154-O; MAY ME, 1989, DIABETES METAB REV, V5, P227, DOI 10.1002/dmr.5610050303; MILES JM, 1984, ANAL BIOCHEM, V141, P110, DOI 10.1016/0003-2697(84)90432-9; PEUHKURINEN KJ, 1982, BIOCHEM J, V202, P67, DOI 10.1042/bj2020067; PRASS RL, 1980, J BIOL CHEM, V255, P5215; RABKIN M, 1985, BIOCHEM J, V225, P761, DOI 10.1042/bj2250761; RADZIUK J, 1989, AM J PHYSIOL, V257, pE158, DOI 10.1152/ajpendo.1989.257.2.E158; ROGNSTAD R, 1988, Medical Science Research, V16, P293; ROSIERS CD, 1988, ANAL BIOCHEM, V173, P96, DOI 10.1016/0003-2697(88)90165-0; ROSIERS CD, 1991, J BIOL CHEM, V266, P1574; RUSSELL RR, 1991, AM J PHYSIOL, V261, pH1756, DOI 10.1152/ajpheart.1991.261.6.H1756; RYAN C, 1993, J APPL PHYSIOL, V74, P2404, DOI 10.1152/jappl.1993.74.5.2404; SAHLIN K, 1987, AM J PHYSIOL, V252, pE439, DOI 10.1152/ajpendo.1987.252.3.E439; SCHUMANN WC, 1991, J BIOL CHEM, V266, P6985; SCHWENK WF, 1984, ANAL BIOCHEM, V141, P101; SCRUTTON MC, 1969, METHOD ENZYMOL, V13, P235; SHULMAN GI, 1987, J CLIN INVEST, V80, P387, DOI 10.1172/JCI113084; STRISOWER EH, 1952, J BIOL CHEM, V198, P115; TAPPY L, 1992, AM J PHYSIOL, V262, pE826, DOI 10.1152/ajpendo.1992.262.6.E826; WEBSTER LT, 1976, J BIOL CHEM, V251, P3352; WOLFE RR, 1990, ANN MED, V22, P163, DOI 10.3109/07853899009147263; YANG DW, 1993, ANAL BIOCHEM, V212, P277, DOI 10.1006/abio.1993.1323; ZHANG Y, 1994, J BIOL CHEM, V269, P11025	57	44	44	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1509	1514		10.1074/jbc.270.4.1509	http://dx.doi.org/10.1074/jbc.270.4.1509			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829478	hybrid			2022-12-27	WOS:A1995QD20400007
J	BILLY, D; SPEIJER, H; WILLEMS, G; HEMKER, HC; LINDHOUT, T				BILLY, D; SPEIJER, H; WILLEMS, G; HEMKER, HC; LINDHOUT, T			PROTHROMBIN ACTIVATION BY PROTHROMBINASE IN A TUBULAR FLOW REACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE FACTOR-V; BLOOD-COAGULATION; TISSUE FACTOR; FACTOR-XA; COMPLEX; SURFACE; BINDING	Thrombin production by the phospholipid-bound complex of blood clotting factors Xa and Va (prothrombinase) was studied in a tubular flow reactor. The inner wall of a glass capillary was coated with a phospholipid bilayer of 25% phosphatidylserine and 75% phosphatidylcholine. Prothrombinase was assembled on this bilayer by perfusion with a mixture containing an excess of factor Va (2 nM) and a limiting amount of factor Xa (1-100 pM), either in the absence or presence of prothrombin. The rate of assembly of prothrombinase in the presence of prothrombin appeared to be limited by the transfer rate of factor Xa to the phospholipid surface. A good agreement was found between the predicted mass transfer coefficient for factor Xa and the observed pre-steady state rate of thrombin production. The eventually obtained steady state rates of thrombin production were proportional to the prothrombin concentration and independent of the surface density of prothrombinase. The observed rate of thrombin production conversion was observed for prothrombinase densities exceeding 1 fmol/cm(2), which corresponds to 0.05% occupation of available binding sites. The kinetic parameters of the reaction were determined at low prothrombinase densities (0.02-0.04 fmol/cm(2)). Even in this situation the Michaelis-Menten equation had to be corrected for substrate depletion near the catalytic surface. We hereto employed an accurate approximation of the mass transfer coefficient. The kinetic parameter k(cat) was 60 s(-1) and the intrinsic K-m had a surprisingly low value of 3 nM. Both parameters were not influenced by the wall shear rate.	UNIV LIMBURG, CARDIOVASC RES INST MAASTRICHT, DEPT BIOCHEM, 6200 MD MAASTRICHT, NETHERLANDS	Hasselt University; Maastricht University				Hemker, Coen/0000-0003-1669-2358				ANDREE HAM, 1994, BIOCHEMISTRY-US, V33, P4368, DOI 10.1021/bi00180a034; BEVERS EM, 1982, EUR J BIOCHEM, V122, P429, DOI 10.1111/j.1432-1033.1982.tb05898.x; BROWN GM, 1960, AICHE J, V6, P179, DOI 10.1002/aic.690060204; CONTINO P, 1991, THROMB HAEMOSTASIS, V66, P138; GEMMELL CH, 1990, MICROVASC RES, V40, P327, DOI 10.1016/0026-2862(90)90031-L; GEMMELL CH, 1988, BLOOD, V72, P1404; GIESEN PLA, 1991, J BIOL CHEM, V266, P1379; HIGGINS DL, 1983, J BIOL CHEM, V258, P6503; JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001; KOBAYASHI T, 1974, BIOTECHNOL BIOENG, V66, P99; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; Leveque M. A., 1928, ANN MINES, V13, P201; Levich VG, 1962, PHYSICOCHEMICAL HYDR, P112; LIM TK, 1977, BIOCHEMISTRY-US, V16, P4177, DOI 10.1021/bi00638a007; MANN KG, 1990, BLOOD, V76, P1; MANN KG, 1987, TRENDS BIOCHEM SCI, V12, P229, DOI 10.1016/0968-0004(87)90115-0; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; PUSEY ML, 1982, BIOCHEMISTRY-US, V21, P5262, DOI 10.1021/bi00264a022; RODGERS GM, 1983, P NATL ACAD SCI-BIOL, V80, P7001, DOI 10.1073/pnas.80.22.7001; ROSING J, 1993, J BIOL CHEM, V268, P21130; ROSING J, 1980, J BIOL CHEM, V255, P274; SCHOEN P, 1990, THROMB HAEMOSTASIS, V64, P542; TRACY PB, 1981, J BIOL CHEM, V256, P743; WILLEMS GM, 1993, BLOOD, V82, P497, DOI 10.1182/blood.V82.2.497.bloodjournal822497	24	36	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1029	1034		10.1074/jbc.270.3.1029	http://dx.doi.org/10.1074/jbc.270.3.1029			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836355	hybrid			2022-12-27	WOS:A1995QB15600010
J	ITO, K; SHINOMURA, T; ZAKO, M; UJITA, M; KIMATA, K				ITO, K; SHINOMURA, T; ZAKO, M; UJITA, M; KIMATA, K			MULTIPLE FORMS OF MOUSE PG-M, A LARGE CHONDROITIN SULFATE PROTEOGLYCAN GENERATED BY ALTERNATIVE SPLICING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHICK-EMBRYO; CELLS; VERSICAN; CHONDROGENESIS; HYALURONATE; FIBRONECTIN; SEQUENCES; ADHESION; BINDING; MATRIX	We have isolated and sequenced cDNA clones that encode the core protein of PG-M-like proteoglycan produced by cultured mouse aortic endothelial cells (Morita, H., Takeuchi, T., Suzuki, S., Maeda, R., Yamada, R., Eguchi, G., and Kimata, R. (1990) Biochem. J. 265, 61-68). A homology search of the cDNA sequence has suggested that the core protein is a mouse equivalent of chick PG-M(V1), one of the alternatively spliced forms of the PG-M core protein, which may correspond to human versican. Northern blot analysis revealed three mRNA species of 10, 9, and 8 kilobases (kb) in size, The analysis of PG-M mRNA species in embryonic limb buds and adult brain revealed the presence of other mRNA species with different sizes; the one with the largest size (12 kb) was found in embryonic limb buds, and the ones with smaller sizes of 7.5 and 6.5 kb were in adult brain. Sequencing of cDNA clones for the smaller forms in the adult brain showed that they were different from PG-M(V1) in encoding the second chondroitin sulfate attachment domain (CS alpha) alone, Occurrence of the PCR products striding over the junction of the first and second chondroitin sulfate attachment domains suggested that a mRNA of 12 kb in size corresponded to a transcript without the alternative splicing (PG-M(V0)). It is likely, therefore, that multiforms of the PG-M core protein may be generated by alternative usage of either or both of the two different chondroitin sulfate attachment domains (alpha and beta) and that molecular forms of PG-M may vary from tissue to tissue by such an alternative splicing.	AICHI MED UNIV,INST MOLEC SCI MED,NAGAKUTE,AICHI 48011,JAPAN	Aichi Medical University								BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; BIGNAMI A, 1993, J NEUROSCI RES, V34, P97, DOI 10.1002/jnr.490340110; Bourdon M. A., 1990, EXTRACELLULAR MATRIX, P166; BOYD CD, 1993, MATRIX, V13, P457, DOI 10.1016/S0934-8832(11)80112-5; CHANG Y, 1983, J BIOL CHEM, V258, P5679; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; FERNANDEZ MS, 1991, DEV BIOL, V147, P46; FULOP C, 1993, J BIOL CHEM, V268, P17377; GOOLEY AA, 1991, BIOCHEM BIOPH RES CO, V178, P1194, DOI 10.1016/0006-291X(91)91019-9; GUAN JL, 1990, CELL, V60, P53, DOI 10.1016/0092-8674(90)90715-Q; KAPOOR R, 1986, BIOCHEM J, V240, P575, DOI 10.1042/bj2400575; KARASAWA K, 1979, DEV BIOL, V70, P287, DOI 10.1016/0012-1606(79)90029-0; KIMATA K, 1986, J BIOL CHEM, V261, P3517; KITAMURA K, 1976, FEBS LETT, V71, P337, DOI 10.1016/0014-5793(76)80965-9; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRUSIUS T, 1987, J BIOL CHEM, V262, P13120; LARK MW, 1988, J HISTOCHEM CYTOCHEM, V36, P1211, DOI 10.1177/36.10.3047228; MORITA H, 1990, BIOCHEM J, V265, P61, DOI 10.1042/bj2650061; OKAYAMA M, 1976, P NATL ACAD SCI USA, V73, P3224, DOI 10.1073/pnas.73.9.3224; RAUCH U, 1992, J BIOL CHEM, V267, P19536; ROYAL PD, 1980, J BIOL CHEM, V255, P9870; SALISBURY BGJ, 1981, J BIOL CHEM, V256, P8050; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWARZBAUER JE, 1989, J CELL BIOL, V109, P3445, DOI 10.1083/jcb.109.6.3445; SHINOMURA T, 1990, ANAT EMBRYOL, V181, P227; SHINOMURA T, 1993, J BIOL CHEM, V268, P14461; STAMENKOVIC I, 1991, EMBO J, V10, P343, DOI 10.1002/j.1460-2075.1991.tb07955.x; VONHEIJNE G, 1984, J MOL BIOL, V173, P243, DOI 10.1016/0022-2836(84)90192-X; WILSON CL, 1992, J CELL BIOL, V119, P923, DOI 10.1083/jcb.119.4.923; YAMADA H, 1994, J BIOL CHEM, V269, P10119; YAMAGATA M, 1993, J CELL SCI, V106, P55; YAMAGATA M, 1993, ANAT EMBRYOL, V187, P433; YAMAGATA M, 1989, J BIOL CHEM, V264, P8012; YAMAGATA M, 1986, J BIOL CHEM, V261, P3526; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	35	149	153	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					958	965		10.1074/jbc.270.2.958	http://dx.doi.org/10.1074/jbc.270.2.958			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822336	hybrid			2022-12-27	WOS:A1995QB81600071
J	WONG, VV; PEARSALL, D; ARRIAGA, R; IP, NY; STAHL, N; LINDSAY, RM				WONG, VV; PEARSALL, D; ARRIAGA, R; IP, NY; STAHL, N; LINDSAY, RM			BINDING CHARACTERISTICS OF CILIARY NEUROTROPHIC FACTOR TO SYMPATHETIC NEURONS AND NEURONAL CELL-LINES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-6 SIGNAL TRANSDUCER; CNTF RECEPTOR; MOTOR-NEURONS; MOLECULAR-CLONING; ALPHA COMPONENT; SENSORY NEURONS; FACTOR PREVENTS; GROWTH-FACTOR; GP130; EXPRESSION	Ciliary neurotrophic factor (CNTF) is a cytokine whose actions are largely restricted to the nervous system because of the predominant neuronal distribution of its receptor, CNTFR alpha. In this study, we sought to define the binding characteristics of CNTF to cultured sympathetic neurons and cell lines of neuronal origin. We report that I-125-CNTF binds to cultured sympathetic neurons, MAH, PC12, and EW-1 cells via high and low affinity receptors that can be distinguished on the basis of their dissociation constants (K(D1 similar to)10(-12) M and K(D2)similar to 10(-9) M). Competition experiments showed that the IC50 for rat and human CNTF were, respectively, 65 pM and 5 an for sympathetic neurons and 75 pM. and 1.2 nM for EW-1 cells. Interestingly, leukemia inhibitory factor (LIF) did not compete for CNTF binding even at 100 nM concentration. The binding of I-125-CNTF to sympathetic neurons involved all three components of the CNTF receptor complex, namely CNTFR alpha; LIFR, and gp130, as shown by cross-linking experiments. CNTF and LIF treatments down-regulated CNTF binding to sympathetic neurons and EW-1 cells, suggesting that heterologous ligands can regulate CNTF receptor levels, which may in turn modulate the efficacy of CNTF in vitro and in vivo.			WONG, VV (corresponding author), REGENERON PHARMACEUT INC, TARRYTOWN, NY 10591 USA.		Lindsay, Ronald/GQP-8001-2022					ADLER R, 1979, SCIENCE, V204, P1434, DOI 10.1126/science.451576; ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; BARINAGA M, 1994, SCIENCE, V264, P772, DOI 10.1126/science.8171331; BIRREN SJ, 1990, NEURON, V4, P189, DOI 10.1016/0896-6273(90)90094-V; CURTIS R, 1993, NATURE, V365, P253, DOI 10.1038/365253a0; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DAVIS S, 1993, SCIENCE, V259, P1736, DOI 10.1126/science.7681218; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; Davis S, 1993, Curr Opin Neurobiol, V3, P20, DOI 10.1016/0959-4388(93)90030-3; DISTEFANO PS, 1992, NEURON, V8, P983, DOI 10.1016/0896-6273(92)90213-W; ERNSBERGER U, 1989, NEURON, V2, P1275, DOI 10.1016/0896-6273(89)90312-7; FORGER NG, 1993, J NEUROSCI, V13, P4720; GEARING DP, 1994, P NATL ACAD SCI USA, V91, P1119, DOI 10.1073/pnas.91.3.1119; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; GURNEY ME, 1992, J NEUROSCI, V12, P3241, DOI 10.1523/JNEUROSCI.12-08-03241.1992; HELGREN ME, 1994, CELL, V76, P493, DOI 10.1016/0092-8674(94)90113-9; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Ip Nancy Y., 1992, Progress in Growth Factor Research, V4, P139, DOI 10.1016/0955-2235(92)90028-G; IP NY, 1991, J NEUROSCI, V11, P3124; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; IP NY, 1993, NEURON, V10, P89, DOI 10.1016/0896-6273(93)90245-M; IP NY, 1993, SEMIN NEUROSCI, V5, P249; KESSLER JA, 1984, DEV BIOL, V106, P61, DOI 10.1016/0012-1606(84)90061-7; KOTZBAUER PT, 1994, NEURON, V12, P763, DOI 10.1016/0896-6273(94)90329-8; LARKFORS L, 1994, EUR J NEUROSCI, V6, P1015, DOI 10.1111/j.1460-9568.1994.tb00596.x; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; MARCHALONIS JJ, 1969, BIOCHEM J, V113, P299, DOI 10.1042/bj1130299; MASIAKOWSKI P, 1991, J NEUROCHEM, V57, P1003, DOI 10.1111/j.1471-4159.1991.tb08250.x; MITSUMOTO H, 1994, SCIENCE, V265, P1107, DOI 10.1126/science.8066451; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; PANAYOTATOS N, 1993, J BIOL CHEM, V268, P19000; SAADAT S, 1989, J CELL BIOL, V108, P1807, DOI 10.1083/jcb.108.5.1807; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SKAPER SD, 1986, DEV BRAIN RES, V24, P39, DOI 10.1016/0165-3806(86)90171-9; SQUINTO SP, 1990, NEURON, V5, P757, DOI 10.1016/0896-6273(90)90334-C; STAHL N, 1993, J BIOL CHEM, V268, P7628; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; STAHL N, 1993, CELL, V74, P587, DOI 10.1016/0092-8674(93)90506-L; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; VERGE VMK, 1992, J NEUROSCI, V12, P4011; WONG V, 1993, EUR J NEUROSCI, V5, P466, DOI 10.1111/j.1460-9568.1993.tb00513.x	47	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					313	318		10.1074/jbc.270.1.313	http://dx.doi.org/10.1074/jbc.270.1.313			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814393	hybrid			2022-12-27	WOS:A1995QA28700050
J	ALLEN, PG; JANMEY, PA				ALLEN, PG; JANMEY, PA			GELSOLIN DISPLACES PHALLOIDIN FROM ACTIN-FILAMENTS - A NEW FLUORESCENCE METHOD SHOWS THAT BOTH CA2+ AND MG2+ AFFECT THE RATE AT WHICH GELSOLIN SEVERS F-ACTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA GELSOLIN; BINDING-SITES; POLYMORPHONUCLEAR LEUKOCYTES; REGULATORY PROTEIN; COMPLEX; POLYMERIZATION; CELLS; STABILIZATION; PURIFICATION; TROPOMYOSIN	We describe an assay for measuring both the extent and kinetics of the severing of F-actin, based on the enhanced fluorescence emission of tetramethylrhodamine-phalloidin bound to F-actin, The enhanced fluorescence is lost after exposure to active gelsolin by displacement of the phalloidin from actin during severing. This assay requires small amounts of actin and gelsolin, can be used to measure reaction times ranging from 1 to 10(3) s, and does not require covalent modification of either protein. The rate of fluorescence loss is linearly related to the concentrations of both actin and gelsolin, However, the apparent rate constant of the reaction is highly dependent on the divalent cation concentration, varying between 10(4) and 10(6) M(-1) s(-1) when the [Ca2+] varies between 20 and 200 mu M. Addition of Mg2+ increases the apparent rate constant at equivalent Ca2+ concentration. These results suggest that in vitro the rate limiting step in the severing process is the activation of gelsolin by the binding of Ca2+ and Mg2+ to several low affinity (K-d approximate to 100 mu M) sites on gelsolin. While activation of gelsolin by Ca2+ is a slow process, the binding and severing of actin occurs at a rate approaching the diffusion limit,	HARVARD UNIV,SCH MED,PROGRAM BIOL & BIOMED SCI,BOSTON,MA 02115	Harvard University; Harvard Medical School	ALLEN, PG (corresponding author), BRIGHAM & WOMENS HOSP,DIV EXPTL MED,LMRC 301,221 LONGWOOD AVE,BOSTON,MA 02115, USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038910, R29AR038910] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 38910] Funding Source: Medline; PHS HHS [AL 07680] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BARDEN JA, 1987, EUR J BIOCHEM, V162, P583, DOI 10.1111/j.1432-1033.1987.tb10679.x; BEARER EL, 1991, J CELL BIOL, V115, P1629, DOI 10.1083/jcb.115.6.1629; BRYAN J, 1984, J BIOL CHEM, V259, P7480; BRYAN J, 1985, J CELL BIOL, V101, P1236, DOI 10.1083/jcb.101.4.1236; CANO ML, 1992, CELL MOTIL CYTOSKEL, V21, P147, DOI 10.1002/cm.970210208; CANO ML, 1992, J CELL BIOL, V116, P1123, DOI 10.1083/jcb.116.5.1123; COLUCCIO LM, 1984, J CELL BIOL, V99, P529, DOI 10.1083/jcb.99.2.529; COOPER JA, 1987, J CELL BIOL, V104, P491, DOI 10.1083/jcb.104.3.491; CUNNINGHAM CC, 1991, SCIENCE, V251, P1233, DOI 10.1126/science.1848726; DANCKER P, 1975, BIOCHIM BIOPHYS ACTA, V400, P407, DOI 10.1016/0005-2795(75)90196-8; DOI Y, 1990, BIOCHEMISTRY-US, V29, P1392, DOI 10.1021/bi00458a008; DRUBIN DG, 1993, MOL BIOL CELL, V4, P1277, DOI 10.1091/mbc.4.12.1277; ESTES JE, 1981, BIOCHEMISTRY-US, V20, P708, DOI 10.1021/bi00507a006; HARRIS HE, 1984, FEBS LETT, V177, P184, DOI 10.1016/0014-5793(84)81280-6; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; HESTERKAMP T, 1993, EUR J BIOCHEM, V218, P507, DOI 10.1111/j.1432-1033.1993.tb18403.x; HOWARD T, 1990, J CELL BIOL, V110, P1983, DOI 10.1083/jcb.110.6.1983; HUANG ZJ, 1992, ANAL BIOCHEM, V200, P199, DOI 10.1016/0003-2697(92)90299-M; HUCKRIEDE A, 1990, CELL MOTIL CYTOSKEL, V16, P229, DOI 10.1002/cm.970160403; ILLNER H, 1992, PFLUG ARCH EUR J PHY, V422, P179, DOI 10.1007/BF00370418; JANMEY PA, 1987, J BIOL CHEM, V262, P12228; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; KANNO K, 1989, J CELL PHYSIOL, V139, P58, DOI 10.1002/jcp.1041390110; KILHOFFER MC, 1985, BIOCHEM BIOPH RES CO, V131, P1132, DOI 10.1016/0006-291X(85)90208-6; KUROKAWA H, 1990, BIOCHEM BIOPH RES CO, V168, P451, DOI 10.1016/0006-291X(90)92342-W; KURTH MC, 1984, J BIOL CHEM, V259, P7473; KWIATKOWSKI DJ, 1988, J BIOL CHEM, V263, P13857; KWIATKOWSKI DJ, 1989, J CELL BIOL, V108, P1717, DOI 10.1083/jcb.108.5.1717; LAHAM LE, 1993, J BIOL CHEM, V268, P14202; LAMB JA, 1993, J BIOL CHEM, V268, P8999; LIND SE, 1987, J CELL BIOL, V105, P833, DOI 10.1083/jcb.105.2.833; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; LOEW I, 1975, Febs Letters, V54, P263; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; MACIVER SK, 1991, J CELL BIOL, V115, P1611, DOI 10.1083/jcb.115.6.1611; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; Moore WJ, 1972, PHYS CHEM, V4th, P977; NISHIDA E, 1987, P NATL ACAD SCI USA, V84, P5262, DOI 10.1073/pnas.84.15.5262; RINK TJ, 1990, ANNU REV PHYSIOL, V52, P431, DOI 10.1146/annurev.ph.52.030190.002243; SCHOEPPER B, 1992, J BIOL CHEM, V267, P13924; SELVE N, 1987, EUR J BIOCHEM, V168, P111, DOI 10.1111/j.1432-1033.1987.tb13394.x; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; TELLAM RL, 1991, ARCH BIOCHEM BIOPHYS, V288, P185, DOI 10.1016/0003-9861(91)90182-I; VANDEKERCKHOVE J, 1985, EMBO J, V4, P2815, DOI 10.1002/j.1460-2075.1985.tb04008.x; VERKHOVSKY AB, 1984, BIOCHEM BIOPH RES CO, V123, P596, DOI 10.1016/0006-291X(84)90271-7; WATTS RG, 1992, CELL MOTIL CYTOSKEL, V21, P25, DOI 10.1002/cm.970210104; YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0; YIN HL, 1981, J BIOL CHEM, V256, P9693; YIN HL, 1980, J BIOL CHEM, V255, P9490; YONEZAWA N, 1988, BIOCHEM J, V251, P121, DOI 10.1042/bj2510121	51	65	67	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					32916	32923						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806519				2022-12-27	WOS:A1994QA63800032
J	LIN, HY; MOUSTAKAS, A; KNAUS, P; WELLS, RG; HENIS, YI; LODISH, HF				LIN, HY; MOUSTAKAS, A; KNAUS, P; WELLS, RG; HENIS, YI; LODISH, HF			THE SOLUBLE EXOPLASMIC DOMAIN OF THE TYPE-II TRANSFORMING GROWTH-FACTOR (TGF)-BETA RECEPTOR - A HETEROGENEOUSLY GLYCOSYLATED PROTEIN WITH HIGH-AFFINITY AND SELECTIVITY FOR TGF-BETA LIGANDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOGLYCAN BETAGLYCAN; MEMBRANE PROTEOGLYCAN; EXPRESSION CLONING; CRYSTAL-STRUCTURE; CELL-LINES; KINASE; COMPLEX; ACTIVIN; GROWTH-FACTOR-BETA-2; PURIFICATION	The transforming growth factor (TGF)-beta type II receptor is a transmembrane serine/threonine kinase which is essential for all TGF-beta induced signals. In several cell types TGF-beta 2 is as potent as TGF-beta 1 or TGF-beta 3 in inducing cellular responses, yet TGF-beta 2 does not bind to the majority of expressed type II receptors. Here we characterized the properties of the soluble extracellular domain of the human TGF-beta type II receptor synthesized in COS-7 cells, Like the membrane-attached type II receptor, the soluble receptor contains complex N-linked oligosaccharides as well as additional sialic acid residues that cause it to migrate heterogenously upon SDS-polyacrylamide gel electrophoresis. I-125-TGF-beta 1 binds to and is chemically cross-linked to this protein. Unlabeled TGF-beta 1 inhibits the binding of I-125-TGF-beta 1 with an apparent dissociation constant (K-d) of similar to 200 pM, similar to the apparent K-d (similar to 50 pM) of the cell-surface type II receptor. TGF-beta 3 inhibits the binding of I-125-TGF-beta 1 to the soluble type II receptor with a similar dissociation constant, similar to 500 pM. In contrast, I-125-TGF-beta 2 cannot bind and be chemically cross-linked to the soluble type II receptor, nor does as much as a 125-fold excess of unlabeled TGF-beta 2 inhibit the binding of I-125-TGF-beta 1 to the soluble receptor. This is the first demonstration of the binding affinities of the type II receptor in the absence of the other cell-surface molecules known to bind TGF-beta. Expressed alone in COS-7 cells the type II receptor also cannot bind TGF-beta 2; co-expression of type III receptor enables the type II receptor to bind TGF-beta 2. Thus, the type III receptor or some other component is required for transmission of TGF-beta 2-induced signals by the type II receptor.	MIT,DEPT BIOL,CAMBRIDGE,MA 02139; TEL AVIV UNIV,DEPT BIOCHEM,IL-69978 TEL AVIV,ISRAEL; BRIGHAM & WOMENS HOSP,DIV GASTROENTEROL,BOSTON,MA 02115	Massachusetts Institute of Technology (MIT); Tel Aviv University; Harvard University; Brigham & Women's Hospital	LIN, HY (corresponding author), WHITEHEAD INST BIOMED RES,9 CAMBRIDGE CTR,CAMBRIDGE,MA 02142, USA.			Henis, Yoav/0000-0002-1408-3877	NATIONAL CANCER INSTITUTE [R01CA063260] Funding Source: NIH RePORTER; NCI NIH HHS [CA-63260] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDRES JL, 1991, J BIOL CHEM, V266, P23282; ARCHER SJ, 1993, BIOCHEMISTRY-US, V32, P1164, DOI 10.1021/bi00055a022; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; BASSING CH, 1994, SCIENCE, V263, P87, DOI 10.1126/science.8272871; BHUSHAN A, 1994, MOL CELL BIOL, V14, P4280, DOI 10.1128/MCB.14.6.4280; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; CHEIFETZ S, 1988, J BIOL CHEM, V263, P10783; CHEIFETZ S, 1990, J BIOL CHEM, V265, P20533; CHEIFETZ S, 1987, CELL, V48, P409, DOI 10.1016/0092-8674(87)90192-9; CHEIFETZ S, 1988, J BIOL CHEM, V263, P16984; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; EBNER R, 1993, SCIENCE, V262, P900, DOI 10.1126/science.8235612; EBNER R, 1993, SCIENCE, V260, P1344, DOI 10.1126/science.8388127; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; GEISER AG, 1992, J BIOL CHEM, V267, P2588; HARLOW E, 1988, ANTIBODIES LABORATOR; HENIS YI, 1994, J CELL BIOL, V126, P139, DOI 10.1083/jcb.126.1.139; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; INAGAKI M, 1993, P NATL ACAD SCI USA, V90, P5359, DOI 10.1073/pnas.90.11.5359; Lin Herbert Y., 1993, Trends in Cell Biology, V3, P14, DOI 10.1016/0962-8924(93)90195-7; LIN HY, 1994, CELL MOL BIOL, V40, P337; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; LIN HY, 1992, CELL, V70, P1069; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; MASSAGUE J, 1992, CELL, V69, P1067, DOI 10.1016/0092-8674(92)90627-O; MASSAGUE J, 1986, P NATL ACAD SCI USA, V83, P8206, DOI 10.1073/pnas.83.21.8206; MASSAGUE J, 1990, ANN REV CELL BIOL, V6, P8597; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; MOUSTAKAS A, 1993, J BIOL CHEM, V268, P22215; OGAWA Y, 1992, J BIOL CHEM, V267, P2325; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P421; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHARF SJ, 1986, SCIENCE, V233, P1076, DOI 10.1126/science.3461561; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; TSUCHIDA K, 1993, P NATL ACAD SCI USA, V90, P11242, DOI 10.1073/pnas.90.23.11242; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; ZUGMAIER G, 1989, J CELL PHYSIOL, V141, P353, DOI 10.1002/jcp.1041410217	42	118	122	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2747	2754		10.1074/jbc.270.6.2747	http://dx.doi.org/10.1074/jbc.270.6.2747			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852346	hybrid			2022-12-27	WOS:A1995QF53500055
J	BAJJALIEH, SM; SCHELLER, RH				BAJJALIEH, SM; SCHELLER, RH			THE BIOCHEMISTRY OF NEUROTRANSMITTER SECRETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							INTEGRAL MEMBRANE-PROTEIN; BINDING YPT1 PROTEIN; SYNAPTIC VESICLES; CHROMAFFIN CELLS; SACCHAROMYCES-CEREVISIAE; VESICULAR TRANSPORT; PITUITARY-CELLS; YEAST GOLGI; SYNAPTOTAGMIN; FUSION				BAJJALIEH, SM (corresponding author), STANFORD UNIV,HOWARD HUGHES MED INST,DEPT CELLULAR & MOLEC PHYSIOL,STANFORD,CA 94305, USA.							AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; AALTO MK, 1992, CELL, V68; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; BARROSO MR, 1994, IN PRESS P NATL ACAD; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; BENNETT M, 1993, IN PRESS CELL, V74; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; CLEVES AE, 1992, ADV MICROB PHYSIOL, V33, P73, DOI 10.1016/S0065-2911(08)60216-7; CLEVES AE, 1989, J CELL BIOL, V109, P2939, DOI 10.1083/jcb.109.6.2939; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; DIANTONIO A, 1994, NEURON, P909; EDELMANN L, 1994, SOC NEUR ABSTR, V20; Edwards R H, 1992, Curr Opin Neurobiol, V2, P586, DOI 10.1016/0959-4388(92)90023-E; ELFERINK LA, 1993, CELL, V72, P153, DOI 10.1016/0092-8674(93)90059-Y; FERRONOVICK S, 1993, ANNU REV CELL BIOL, V9, P575; FERRONOVICK S, 1991, CELL BIOPHYS, V19, P25, DOI 10.1007/BF02989876; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GUNDERSEN CB, 1992, NEURON, V9, P527, DOI 10.1016/0896-6273(92)90190-O; HAY JC, 1993, NATURE, V366, P572, DOI 10.1038/366572a0; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HAY JC, 1994, THESIS U WISCONSIN; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HUNT JM, 1994, NEURON, P1269; Huttner WB, 1989, CURR OPIN CELL BIOL, V1, P648, DOI 10.1016/0955-0674(89)90029-X; INOUE A, 1992, J BIOL CHEM, V267, P10613; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; KOFFER A, 1990, J CELL BIOL, V111, P919, DOI 10.1083/jcb.111.3.919; KOTER M, 1978, BIOCHIM BIOPHYS ACTA, V514, P255, DOI 10.1016/0005-2736(78)90296-1; LISCOVITCH M, 1994, J BIOL CHEM, V269, P24103; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; MALHOTRA V, 1988, CELL, V54, P221, DOI 10.1016/0092-8674(88)90554-5; MARTIN TFJ, 1989, J BIOL CHEM, V264, P10299; MARTIN TFJ, 1994, IN PRESS CURR OPIN N, V4; MCMAHON HT, 1993, NATURE, V364, P246; MCPHERSON PS, 1994, SEMIN NEUROSCI, V6, P137; MONTECUCCO C, 1993, TRENDS BIOCHEM SCI, V18, P324, DOI 10.1016/0968-0004(93)90065-U; MUALLEM S, 1994, IN PRESS J CELL BIOL; NAKAJIMA H, 1991, J CELL BIOL, V113, P245, DOI 10.1083/jcb.113.2.245; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NGSEE JK, 1993, MOL BIOL CELL, V4, P747, DOI 10.1091/mbc.4.7.747; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; PERRIN D, 1987, NATURE, V326, P498, DOI 10.1038/326498a0; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; REIST NE, 1994, SOC NEUR ABSTR, V20; SAPPERSTEIN SK, 1995, IN PRESS P NATL ACAD; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; SEGEV N, 1991, SCIENCE, V252, P1553, DOI 10.1126/science.1904626; SHEKMAN R, 1992, CURR OPIN CELL BIOL, V4, P587; SHINGHAL R, 1993, J NEUROCHEM, V61, P2279, DOI 10.1111/j.1471-4159.1993.tb07470.x; SOGAARD M, 1994, CELL, V78, P937, DOI 10.1016/0092-8674(94)90270-4; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SZTUL E, 1991, CELL, V64, P81, DOI 10.1016/0092-8674(91)90210-P; THOMAS L, 1988, SCIENCE, V242, P1050, DOI 10.1126/science.2461586; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; THOMAS P, 1993, EMBO J, V12, P303, DOI 10.1002/j.1460-2075.1993.tb05657.x; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; VALTORTA PG, 1993, SCIENCE, V259, P780; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; WENDLAND B, 1991, NEURON, V6, P993, DOI 10.1016/0896-6273(91)90239-V; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925; Zerial M, 1993, CURR OPIN CELL BIOL, V5, P613, DOI 10.1016/0955-0674(93)90130-I; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	78	171	175	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					1971	1974		10.1074/jbc.270.5.1971	http://dx.doi.org/10.1074/jbc.270.5.1971			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836421	hybrid			2022-12-27	WOS:A1995QE49300001
J	CHAN, D; COLE, WG; CHOW, CW; MUNDLOS, S; BATEMAN, JF				CHAN, D; COLE, WG; CHOW, CW; MUNDLOS, S; BATEMAN, JF			A COL2A1 MUTATION IN ACHONDROGENESIS TYPE-II RESULTS IN THE REPLACEMENT OF TYPE-II COLLAGES BY TYPE-I AND TYPE-III COLLAGENS IN CARTILAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LANGER-SALDINO ACHONDROGENESIS; SPONDYLOEPIPHYSEAL DYSPLASIA; OSTEOGENESIS IMPERFECTA; SERINE SUBSTITUTION; ALPHA-1(II) CHAIN; GENE COL2A1; IDENTIFICATION; CHONDROCYTES; HYPOCHONDROGENESIS; ABNORMALITIES	An autosomal dominant mutation in the COL2A1 gene was identified in a fetus with achondrogenesis type II, A transition of G(2853) to A in exon 41 produced a substitution of Gly(769) by Ser within the triple helical domain of the alpha 1(II) chain of type II collagen, interrupting the mandatory Gly-X-Y triplet sequence required for the normal formation of stable triple helical type II collagen molecules, resulting in the complete absence of type II collagen in the cartilage, which had a gelatinous composition, Type I and III collagens were the major species found in cartilage tissue and synthesized by cultured chondrocytes along with cartilage type XI collagen, However, cultured chondrocytes produced a trace amount of type II collagen, which was retained within the cells and not secreted, In situ hybridization of cartilage sections showed that the chondrocytes produced both type II and type I collagen mRNA, As a result, it is likely that the chondrocytes produced type II collagen molecules, which were then degraded. The close proximity of the Gly(769) substitution by Ser to the mammalian collagenase cleavage site at Gly(775)-Leu(776) may have produced an unstable domain that was highly susceptible to proteolysis, The type I and III collagens that replaced type II collagen were unable to maintain the normal structure of the hyaline cartilage but did support chondrocyte maturation, evidenced by the expression of type X collagen in the hypertrophic zone of the growth plate cartilage.	UNIV MELBOURNE,ROYAL CHILDRENS HOSP,DEPT PAEDIAT,ORTHOPAED MOLEC BIOL RES UNIT,PARKVILLE,VIC 3052,AUSTRALIA; ROYAL CHILDRENS HOSP,DEPT PATHOL ANAT,PARKVILLE,VIC 3052,AUSTRALIA; HOSP SICK CHILDREN,DIV ORTHOPAED,TORONTO,ON M5G 1X8,CANADA	Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)			Mundlos, Stefan/ABH-9585-2020; Chan, Danny/C-4203-2009	Chan, Danny/0000-0003-3824-5778; Bateman, John/0000-0001-8542-0730				AIGNER T, 1993, VIRCHOWS ARCH B, V63, P205, DOI 10.1007/BF02899263; ALAKOKKO L, 1990, GENOMICS, V8, P454, DOI 10.1016/0888-7543(90)90031-O; APTE SS, 1992, EUR J BIOCHEM, V206, P217, DOI 10.1111/j.1432-1033.1992.tb16919.x; BALDWIN CT, 1989, BIOCHEM J, V262, P521, DOI 10.1042/bj2620521; BATEMAN JF, 1984, BIOCHEM J, V217, P103, DOI 10.1042/bj2170103; BENNETT VD, 1990, J BIOL CHEM, V265, P2223; BOGAERT R, 1992, J BIOL CHEM, V267, P22522; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; CHAN D, 1993, J BIOL CHEM, V268, P15238; CHAN D, 1991, J BIOL CHEM, V266, P12487; CHEAH KSE, 1985, P NATL ACAD SCI USA, V82, P2555, DOI 10.1073/pnas.82.9.2555; CHELLY J, 1989, P NATL ACAD SCI USA, V86, P2617, DOI 10.1073/pnas.86.8.2617; CHU ML, 1984, NATURE, V310, P337, DOI 10.1038/310337a0; COLE WG, 1994, PROG NUCLEIC ACID RE, V47, P29, DOI 10.1016/S0079-6603(08)60249-4; EIKENBERRY EF, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P133; EYRE DR, 1986, AM J HUM GENET, V39, P52; FESHCHENKO SP, 1989, HUM GENET, V82, P49, DOI 10.1007/BF00288271; FREISINGER P, 1994, J BIOL CHEM, V269, P13663; GIBSON GJ, 1982, J CELL BIOL, V93, P767, DOI 10.1083/jcb.93.3.767; GIBSON GJ, 1983, BIOCHEM J, V211, P417, DOI 10.1042/bj2110417; GODFREY M, 1988, AM J HUM GENET, V43, P904; GOUGH NM, 1988, ANAL BIOCHEM, V173, P93, DOI 10.1016/0003-2697(88)90164-9; GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901; HORTON WA, 1987, PEDIATR RES, V22, P324, DOI 10.1203/00006450-198709000-00017; HORTON WA, 1992, P NATL ACAD SCI USA, V89, P4583, DOI 10.1073/pnas.89.10.4583; KIVIRIKKO KI, 1993, ANN MED, V25, P113, DOI 10.3109/07853899309164153; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; LANGER LO, 1969, RADIOLOGY, V92, P285, DOI 10.1148/92.2.285; LEE B, 1989, SCIENCE, V244, P978, DOI 10.1126/science.2543071; MUNDLOS S, 1991, MATRIX, V11, P339, DOI 10.1016/S0934-8832(11)80205-2; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; RITVANIEMI P, 1994, HUM MUTAT, V3, P261, DOI 10.1002/humu.1380030314; SALDINO RM, 1971, AMER J ROENTGENOL RA, V112, P185, DOI 10.2214/ajr.112.1.185; SILLENCE DO, 1979, AM J PATHOL, V96, P811; SPRANGER J, 1988, PATHOL IMMUNOPATH R, V7, P76, DOI 10.1159/000157098; TSCHAN T, 1993, J BIOL CHEM, V268, P5156; VIKKULA M, 1993, GENOMICS, V16, P282, DOI 10.1006/geno.1993.1179; VISSING H, 1989, J BIOL CHEM, V264, P18265; WHITLEY CB, 1983, RADIOLOGY, V148, P693, DOI 10.1148/radiology.148.3.6878687	39	58	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1747	1753		10.1074/jbc.270.4.1747	http://dx.doi.org/10.1074/jbc.270.4.1747			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829510	hybrid			2022-12-27	WOS:A1995QD20400043
J	PROSSNITZ, ER; KIM, CM; BENOVIC, JL; YE, RD				PROSSNITZ, ER; KIM, CM; BENOVIC, JL; YE, RD			PHOSPHORYLATION OF THE N-FORMYL PEPTIDE RECEPTOR CARBOXYL-TERMINUS BY THE G-PROTEIN-COUPLED RECEPTOR KINASE, GRK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-DEPENDENT PHOSPHORYLATION; C5A CHEMOATTRACTANT RECEPTORS; HUMAN INTERLEUKIN-8 RECEPTOR; PLATELET-ACTIVATING-FACTOR; BETA-GAMMA-SUBUNITS; BETA-2-ADRENERGIC RECEPTOR; RHODOPSIN KINASE; EXPRESSION; DESENSITIZATION; SITES	Attenuation of receptor-mediated signal amplification in response to external stimuli, an essential step in the balance of cellular activation, may be mediated by receptor phosphorylation, We have recently shown that the carboxyl-terminal cytoplasmic domain of the N-formyl peptide receptor (FPR) interacts with G proteins and demonstrate here that this same region of the FPR is specifically phosphorylated by a neutrophil cytosolic kinase with properties similar to the G protein-coupled receptor kinase, GRK2. Both kinase activities show a lack of sensitivity toward protein kinase A, protein kinase C, and tyrosine kinase inhibitors but demonstrate almost identical sensitivity toward the kinase inhibitor heparin, Kinetic studies demonstrated that GRK2 has a K-m for the carboxyl-terminal domain of the FPR of approximately 1.5 mu M and that denaturation of the substrate results in an almost complete loss of phosphorylation. Comparative studies reveal that GRK3 has approximately 50% of the activity of GRK2 toward the FPR carboxyl terminus, whereas GRK5 and GRK6 have no detectable activity. Site-directed mutagenesis of numerous regions of the FPR carboxyl terminus demonstrated that, whereas Glu(326)/Asp(327) and Asp(333) are critical for phosphorylation, the carboxyl-terminal 10 amino acids are not required, Simultaneous substitution of Thr(334), Thr(336), Sers(338) and Thr(339) resulted in an similar to 50% reduction in phosphorylation, whereas simultaneous substitution of the upstream Ser(328), Thr(329), Thr(331) and Ser(332) or merely the Ser(328) and Thr(329) residues resulted in an similar to 80% reduction in phosphorylation. The introduction of negatively charged glutamate residues for Ser(328) and Thr(329) or Thr(331) and Ser(332) resulted in marked stimulation of phosphorylation. These results suggest a hierarchical mechanism in which phosphorylation of amino-terminal serine and threonine residues is required for the subsequent phosphorylation of carboxyl-terminal residues. These results provide the first direct evidence that an intracellular domain of a chemoattractant receptor is a high affinity substrate for GRK2 and further suggest a role for GRK2 or a closely related kinase in the attenuation of receptor-mediated activation of inflammatory cells.	THOMAS JEFFERSON UNIV, JEFFERSON CANC INST, DEPT PHARMACOL, PHILADELPHIA, PA 19107 USA	Jefferson University	PROSSNITZ, ER (corresponding author), SCRIPPS RES INST, DEPT IMMUNOL, IMM12, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA.		Ye, Richard/O-5223-2016; Prossnitz, Eric R./B-4543-2008; Ye, Richard/ABF-2413-2020	Ye, Richard/0000-0002-2164-5620; Ye, Richard/0000-0002-2164-5620; Prossnitz, Eric/0000-0001-9190-8302	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI033503, R29AI036357, R01AI033503, R01AI036357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM046572] Funding Source: NIH RePORTER; NIAID NIH HHS [AI36357, AI33503] Funding Source: Medline; NIGMS NIH HHS [GM46572] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALI H, 1993, J BIOL CHEM, V268, P24247; BENOVIC JL, 1989, J BIOL CHEM, V264, P6707; BENOVIC JL, 1987, J BIOL CHEM, V262, P9026; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BENOVIC JL, 1993, J BIOL CHEM, V268, P19521; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; BENOVIC JL, 1990, BR J CLIN PHARM, V1, pS3; BOMMAKANTI RK, 1993, J LEUKOCYTE BIOL, V54, P572, DOI 10.1002/jlb.54.6.572; BOULAY F, 1990, BIOCHEM BIOPH RES CO, V168, P1103, DOI 10.1016/0006-291X(90)91143-G; CHEN CY, 1993, J BIOL CHEM, V268, P7825; CHUANG TT, 1992, J BIOL CHEM, V267, P6886; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; DIDSBURY JR, 1991, P NATL ACAD SCI USA, V88, P11564, DOI 10.1073/pnas.88.24.11564; DOHLMAN HG, 1987, J BIOL CHEM, V262, P14282; GERARD NP, 1990, BIOCHEMISTRY-US, V29, P9274, DOI 10.1021/bi00491a024; HAGA K, 1992, J BIOL CHEM, V267, P2222; HALLET MB, 1989, NEUTROPHIL CELLULAR; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; KIM CM, 1993, RECEPTOR, V3, P39; KUHN H, 1982, FEBS LETT, V20, P1; KUNAPULI P, 1993, P NATL ACAD SCI USA, V90, P5588, DOI 10.1073/pnas.90.12.5588; KUNAPULI P, 1994, J BIOL CHEM, V269, P1099; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; LOUDON RP, 1994, J BIOL CHEM, V269, P22691; MCDOWELL JH, 1993, BIOCHEMISTRY-US, V32, P4968, DOI 10.1021/bi00069a036; MCLEISH KR, 1989, MOL PHARMACOL, V36, P384; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; PROSSNITZ ER, 1991, BIOCHEM BIOPH RES CO, V179, P471, DOI 10.1016/0006-291X(91)91394-R; PROSSNITZ ER, 1993, BIOCHEM J, V294, P581, DOI 10.1042/bj2940581; PULLEN N, 1993, BIOCHEMISTRY-US, V32, P3958, DOI 10.1021/bi00066a016; QUEHENBERGER O, 1992, J BIOL CHEM, V267, P19757; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; SCHREIBER RE, 1993, J LEUKOCYTE BIOL, V53, P470, DOI 10.1002/jlb.53.4.470; SCHREIBER RE, 1994, J BIOL CHEM, V269, P326; TAKANO T, 1994, J BIOL CHEM, V269, P22453; TARDIF M, 1993, J IMMUNOL, V150, P3534; WILDE MW, 1989, J BIOL CHEM, V264, P190; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032; YE RD, 1992, BIOCHEM BIOPH RES CO, V184, P582, DOI 10.1016/0006-291X(92)90629-Y; YE RD, 1991, BIOCHEM BIOPH RES CO, V180, P105, DOI 10.1016/S0006-291X(05)81261-6	46	96	97	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1130	1137		10.1074/jbc.270.3.1130	http://dx.doi.org/10.1074/jbc.270.3.1130			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836371	hybrid			2022-12-27	WOS:A1995QB15600026
J	JUNG, DW; BAYSAL, K; BRIERLEY, GP				JUNG, DW; BAYSAL, K; BRIERLEY, GP			THE SODIUM-CALCIUM ANTIPORT OF HEART-MITOCHONDRIA IS NOT ELECTRONEUTRAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-MITOCHONDRIA; RUTHENIUM RED; FLUORESCENT-PROBE; EFFLUX MECHANISM; MATRIX PH; TRANSPORT; CARRIER; CA-2+; STOICHIOMETRY; PURIFICATION	Heart mitochondria contain a nNa(+)/Ca2+ antiport that participates in the regulation of matrix [Ca2+]. Based largely on a single study (Brand, M. D. (1985) Biochem, J. 229, 161-166), there has been a consensus that this antiport promotes the electroneutral exchange of two Na+ for one Ca2+. However, a recent study in our laboratory (Baysal, K., Jung, D. W., Gunter, K. K., Gunter, T. P., and Brierley, G. P. (1994) Am. J. Physiol. 266, C800-C808) has shown that the Na+-dependent efflux of Ca2+ from heart mitochondria has more energy available to it than can be supplied by a passive 2Na(+)/Ca2+ exchange. We have therefore re-examined Brand's protocols using fluorescent probes to monitor matrix pH and free [Ca2+]. Respiring heart mitochondria, suspended in KCl and treated with ruthenium red to block Ca2+ influx, extrude Ca2+ and establish a large [Ca2+](out):[Ca2+](matrix) gradient. The extrusion of Ca2+ under these conditions is Na+-dependent and diltiazem-sensitive and can be attributed to the nNa(+)/Ca2+ antiport. Addition of nigericin increases the membrane potential (Delta Psi) and decreases Delta pH to 0.1 or less, but has virtually no effect on the magnitude of the [Ca2+] gradient, Under these conditions a gradient maintained by electroneutral 2Na(+)/Ca2+ antiport should be abolished because the mitochondrial Na+/H+ antiport keeps the [Na+] gradient equivalent to the [H+] gradient. The [Ca2+] gradient is abolished, however, when an uncoupler is added to dissipate Delta Psi or when the exogenous electroneutral antiport BrA23187 is added. In addition, [Ca2+] influx via the nNa(+)/Ca2+ antiport in nonrespiring mitochondria is enhanced when Delta Psi is abolished. These results are consistent with Ca2+ extrusion by an electrophoretic antiport that can respond to Delta Psi but not with an electroneutral antiport.			JUNG, DW (corresponding author), OHIO STATE UNIV, DEPT MED BIOCHEM, 333 HAMILTON HALL, COLUMBUS, OH 43210 USA.				NHLBI NIH HHS [HL09364-29] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AFFOLTER H, 1980, BIOCHEM BIOPH RES CO, V95, P193, DOI 10.1016/0006-291X(80)90723-8; ANDEREGG G, 1982, PURE APPL CHEM, V54, P2693, DOI 10.1351/pac198254122693; AZZONE G, 1993, BIOCHIM BIOPHYS ACTA, V1183, P1, DOI 10.1016/0005-2728(93)90002-W; BAYSAL K, 1991, ARCH BIOCHEM BIOPHYS, V291, P383, DOI 10.1016/0003-9861(91)90150-H; BAYSAL K, 1994, AM J PHYSIOL, V266, pC800, DOI 10.1152/ajpcell.1994.266.3.C800; BRAND MD, 1985, BIOCHEM J, V225, P413, DOI 10.1042/bj2250413; BRAND MD, 1985, BIOCHEM J, V229, P161, DOI 10.1042/bj2290161; BRIERLEY GP, 1984, J BIOL CHEM, V259, P4672; BRIERLEY GP, 1989, BIOCHEMISTRY-US, V28, P4347, DOI 10.1021/bi00436a034; BROWN GC, 1986, BIOCHEM J, V234, P75, DOI 10.1042/bj2340075; CROMPTON M, 1977, EUR J BIOCHEM, V79, P549, DOI 10.1111/j.1432-1033.1977.tb11839.x; CROMPTON M, 1985, CURR TOP MEMBR TRANS, V25, P231; CROMPTON M, 1978, EUR J BIOCHEM, V91, P599, DOI 10.1111/j.1432-1033.1978.tb12713.x; CROMPTON M, 1990, INTRACELLULAR CALCIU, P181; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNTER KK, 1991, J BIOL CHEM, V266, P21640; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; HANSFORD RG, 1985, REV PHYSIOL BIOCH P, V102, P1, DOI 10.1007/BFb0034084; HAYAT LH, 1987, BIOCHEM J, V244, P533, DOI 10.1042/bj2440533; JENSEN BD, 1986, ARCH BIOCHEM BIOPHYS, V248, P305, DOI 10.1016/0003-9861(86)90427-3; JUNG DW, 1982, BIOCHEM BIOPH RES CO, V105, P432, DOI 10.1016/0006-291X(82)91452-8; JUNG DW, 1990, BIOCHEMISTRY-US, V29, P4121, DOI 10.1021/bi00469a015; JUNG DW, 1989, ANAL BIOCHEM, V178, P348, DOI 10.1016/0003-2697(89)90651-9; JUNG DW, 1992, AM J PHYSIOL, V262, pC1047, DOI 10.1152/ajpcell.1992.262.4.C1047; JUNG DW, 1988, ARCH BIOCHEM BIOPHYS, V263, P1928; KHANANSHVILI D, 1994, BIOCHEMISTRY-US, V33, P312, DOI 10.1021/bi00167a041; LI W, 1993, THESIS MED COLLEGE O; LI WH, 1992, J BIOL CHEM, V267, P17983; LUFT JH, 1971, ANAT REC, V171, P347, DOI 10.1002/ar.1091710302; MURPHY E, 1980, J BIOL CHEM, V255, P6600; NICHOLLS DG, 1992, BIOENERGETICS, V2, P27; PITTS BJR, 1979, J BIOL CHEM, V254, P6232; STAPPEN R, 1993, BIOCHIM BIOPHYS ACTA, V1149, P40, DOI 10.1016/0005-2736(93)90022-R; WINGROVE DE, 1986, J BIOL CHEM, V261, P5166	35	112	115	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					672	678		10.1074/jbc.270.2.672	http://dx.doi.org/10.1074/jbc.270.2.672			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822294	hybrid			2022-12-27	WOS:A1995QB81600028
J	HASSETT, R; KOSMAN, DJ				HASSETT, R; KOSMAN, DJ			EVIDENCE FOR CU(II) REDUCTION AS A COMPONENT OF COPPER UPTAKE BY SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON UPTAKE; FERRIC REDUCTASE; YEAST; RESISTANCE; TRANSPORT; KINETICS; CELLS	The yeast Saccharomyces cerevisiae contains a plasma membrane reductase activity associated with the gene product of the FRE1 locus. This reductase is required for Fe(III) uptake by this yeast; transcription from FRE1 is repressed by iron (Dancis, A., Klausner, R. D., Hinnebusch, A. G., and Barriocanal, J. G. (1990) Mol. Cell. Biol. 10, 2294-2301). We show here that Cu(II) is equally efficient at repressing FRE1 transcription and is an excellent substrate for the Fre1p reductase. This reductase activity is required for 50-70% of the uptake of Cu-64 by wild type cells. Under conditions of low Fre1-dependent activity, cells retain 30-70% of Cu(II) reductase activity but only 8-25% of Fe(III) reductase activity. While Fre1p-dependent activity is 100% inhibitable by Pt(II), this residual Cu(II) reduction is insensitive to this inhibitor. The data suggest the presence of a Fre1p-independent reductase activity in the yeast plasma membrane which is relatively specific for Cu(II) and which supports copper uptake in the absence of FRE1 expression. The gene product of MAC1, which is required for regulation of FRE1 transcription, is also required for expression of Cu(II) reduction activity. This is due in part to its role in the regulation of FRE1; however, it is required for expression of the putative Cu(II) reductase, as well. Similarly, a gain-of function mutation, MAC1(up1), which causes elevated and unregulated transcription from FRE1 and elevated Fe(III) reduction and Fe-59 uptake exhibits a similar phenotype with respect to Cu(II) reduction and Cu-64 uptake. Ascorbate, which reduces periplasmic Cu(II) to Cu(I), suppresses the dependence of Cu-64 uptake on plasma membrane reductase activity as is the case for ascorbate-supported Fe-59 uptake. The close parallels between Cu(II) and Fe(III) reduction, and Cu-64 and Fe-59 uptake, strongly suggest that Cu(II) uptake by yeast involves a Cu(I) intermediate. This results in the reductive mobilization of the copper from periplasmic chelating agents, making the free ion available for translocation across the plasma membrane.	SUNY BUFFALO,SCH MED & BIOMED SCI,DEPT BIOCHEM,BUFFALO,NY 14214	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046787] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM46787] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BASOLO F, 1967, MECHANISMS INORGANIC; CARTWRIGHT GE, 1956, BLOOD, V11, P143, DOI 10.1182/blood.V11.2.143.143; CHA JS, 1991, P NATL ACAD SCI USA, V88, P8915, DOI 10.1073/pnas.88.20.8915; CLARK RA, 1990, J INFECT DIS, V161, P1140, DOI 10.1093/infdis/161.6.1140; CRANE FL, 1982, J BIOENERG BIOMEMBR, V14, P191, DOI 10.1007/BF00745020; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; DANCIS A, 1990, MOL CELL BIOL, V10, P2294, DOI 10.1128/MCB.10.5.2294; DEROME L, 1987, FEMS MICROBIOL LETT, V43, P283, DOI 10.1016/0378-1097(87)90413-7; EIDE D, 1992, J BIOL CHEM, V267, P20774; EMERY T, 1987, IRON TRANSPORT MICRO, P235; FRIEDEN E, 1979, COPPER ENV, V2, P241; GREEN LM, 1989, P NATL ACAD SCI USA, V86, P4047, DOI 10.1073/pnas.86.11.4047; HOLMQUIST B, 1988, METHOD ENZYMOL, V158, P6, DOI 10.1016/0076-6879(88)58042-4; JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x; KOSMAN DJ, 1993, METAL IONS FUNGI, P1; LEE GR, 1968, J CLIN INVEST, V47, P2058, DOI 10.1172/JCI105891; LESTER RL, 1961, BIOCHIM BIOPHYS ACTA, V47, P475, DOI 10.1016/0006-3002(61)90543-1; LESUISSE E, 1989, J GEN MICROBIOL, V135, P257; LESUISSE E, 1987, J GEN MICROBIOL, V133, P3229; LESUISSE E, 1990, BIOCHIM BIOPHYS ACTA, V1038, P253, DOI 10.1016/0167-4838(90)90213-Y; LIN CM, 1993, J GEN MICROBIOL, V139, P1617, DOI 10.1099/00221287-139-7-1617; LIN CM, 1990, J BIOL CHEM, V265, P9194; NEILANDS JB, 1987, IRON TRANSPORT MICRO, P1; ODERMATT A, 1993, J BIOL CHEM, V268, P12775; OGUR M, 1957, SCIENCE, V125, P928, DOI 10.1126/science.125.3254.928; PERCIVAL SS, 1989, J NUTR, V119, P779, DOI 10.1093/jn/119.5.779; RAGUZZI F, 1988, FEBS LETT, V231, P253, DOI 10.1016/0014-5793(88)80742-7; SCHIENBERG IH, 1957, J CLIN INVEST, V36, P1193; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stewart P R, 1975, Methods Cell Biol, V12, P111; THORSTENSEN K, 1990, BIOCHIM BIOPHYS ACTA, V1052, P29, DOI 10.1016/0167-4889(90)90053-G; WAKATSUKI T, 1988, J FERMENT BIOENG, V66, P257, DOI 10.1016/0385-6380(88)90102-1; WAKATSUKI T, 1991, J FERMENT BIOENG, V72, P158, DOI 10.1016/0922-338X(91)90209-Y; WALDROP GL, 1990, AM J PHYSIOL, V259, pG212, DOI 10.1152/ajpgi.1990.259.2.G212; 1984, DIFCO MANUAL, P1135	38	289	292	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					128	134		10.1074/jbc.270.1.128	http://dx.doi.org/10.1074/jbc.270.1.128			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814363	hybrid			2022-12-27	WOS:A1995QA28700024
J	TAMAI, K; LI, KH; SILOS, S; RUDNICKA, L; HASHIMOTO, T; NISHIKAWA, T; UITTO, J				TAMAI, K; LI, KH; SILOS, S; RUDNICKA, L; HASHIMOTO, T; NISHIKAWA, T; UITTO, J			INTERFERON-GAMMA-MEDIATED INACTIVATION OF TRANSCRIPTION OF THE 230-KDA BULLOUS PEMPHIGOID ANTIGEN GENE (BPAG1) PROVIDES NOVEL INSIGHT INTO KERATINOCYTE DIFFERENTIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED HUMAN KERATINOCYTES; PROTEIN-TYROSINE KINASES; BASEMENT-MEMBRANE ZONE; MESSENGER-RNA; IFN-GAMMA; CDNA CLONING; DNA; EXPRESSION; COLLAGEN; ACTIVATION	Interferon-gamma (IFN-gamma) has been shown to regulate epidermal keratinocyte growth and differentiation. In this study, we examined the effects of recombinant human IFN-gamma on the expression of the gene encoding the 230-kDa bullous pemphigoid antigen (BPAG1), a marker of the mitotic basal cell phenotype in the epidermis. Northern analysis revealed a dose- and time-dependent suppression of BPAG1 expression by IFN-gamma in cultured human keratinocytes from several different donors, and incubation of the cells with IFN-gamma in the presence of cycloheximide demonstrated that this effect required ongoing protein synthesis. The inhibition of BPAG1 gene expression was also demonstrated at the protein level by indirect immunofluorescence using a mono clonal antibody recognizing the human 230-kDa bullous pemphigoid antigen. Transient transfections of cultured keratinocytes with BPAG1 promoter-chloramphenicol acetyltransferase reporter gene plasmids indicated marked suppression of the promoter activity by IFN-gamma, and deletion constructs were able to identify a defined region containing the responsive element (IFN-gamma inhibitory element). Reduced transcription of the BPAG1 gene by IFN-gamma was also demonstrated by in vitro nuclear run-on assays. These data, which indicate inactivation of transcription of a basal keratinocyte-specific gene (BPAG1) by IFN-gamma, provide novel insight into the mechanisms of IFN-gamma-mediated keratinocyte gene regulation and epidermal differentiation in inflammatory diseases.	THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT DERMATOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON INST MOLEC MED,MOLEC DERMATOL SECT,PHILADELPHIA,PA 19107; KEIO UNIV,SCH MED,DEPT DERMATOL,TOKYO 160,JAPAN	Jefferson University; Jefferson University; Jefferson University; Keio University			Rudnicka, Lidia/L-7529-2019	Rudnicka, Lidia/0000-0002-8308-1023	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007561, P01AR038923] Funding Source: NIH RePORTER; NIAMS NIH HHS [P01-AR38923, T32-AR7561] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BASHAM TY, 1984, J INVEST DERMATOL, V83, P88, DOI 10.1111/1523-1747.ep12262597; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COHEN B, 1988, EMBO J, V7, P1411, DOI 10.1002/j.1460-2075.1988.tb02958.x; DAVIS L, 1994, BASIC METHODS MOL BI, P384; DECKER T, 1991, EMBO J, V10, P927, DOI 10.1002/j.1460-2075.1991.tb08026.x; DEMAEYER E, 1992, CURR OPIN IMMUNOL, V4, P321, DOI 10.1016/0952-7915(92)90083-Q; DIAZ LA, 1990, J CLIN INVEST, V86, P1088, DOI 10.1172/JCI114812; DUSTIN ML, 1988, J EXP MED, V167, P132; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GIUDICE GJ, 1991, J CLIN INVEST, V87, P734, DOI 10.1172/JCI115054; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HARPUR AG, 1992, ONCOGENE, V7, P1347; KAHARI VM, 1990, J CLIN INVEST, V86, P1489, DOI 10.1172/JCI114866; LEVER WF, 1965, PEMPHIGUS PEMPHIGOID, P75; LEVY DE, 1988, GENE DEV, V2, P383, DOI 10.1101/gad.2.4.383; LI K, 1991, J BIOL CHEM, V266, P24064; LI KH, 1993, J BIOL CHEM, V268, P8825; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; NICKOLOFF BJ, 1986, ULTRASTRUCT PATHOL, V10, P17, DOI 10.3109/01913128609015559; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; PORTER ACG, 1988, EMBO J, V7, P85, DOI 10.1002/j.1460-2075.1988.tb02786.x; REICH N, 1987, P NATL ACAD SCI USA, V84, P6394, DOI 10.1073/pnas.84.18.6394; Sambrook J, 1989, MOL CLONING LABORATO; SAUNDERS NA, 1994, J BIOL CHEM, V269, P2016; SAWAMURA D, 1990, GENOMICS, V8, P722, DOI 10.1016/0888-7543(90)90261-R; SAWAMURA D, 1992, J INVEST DERMATOL, V98, P942; SAWAMURA D, 1991, J INVEST DERMATOL, V96, P908, DOI 10.1111/1523-1747.ep12475433; SAWAMURA D, 1991, J BIOL CHEM, V266, P17784; SEN GC, 1992, J BIOL CHEM, V267, P5017; SILVENNOINEN O, 1993, NATURE, V366, P583, DOI 10.1038/366583a0; STANLEY JR, 1988, J CLIN INVEST, V82, P1864, DOI 10.1172/JCI113803; STANLEY JR, 1989, J CLIN INVEST, V83, P1443, DOI 10.1172/JCI114036; STANLEY JR, 1981, CELL, V24, P897, DOI 10.1016/0092-8674(81)90115-X; SUGI T, 1989, J CLIN INVEST, V84, P1050, DOI 10.1172/JCI114266; TAMAI K, 1993, J CLIN INVEST, V92, P814, DOI 10.1172/JCI116655; TAMAI K, 1994, J BIOL CHEM, V269, P493; TAMAI K, 1994, J INVEST DERMATOL, V102, P524; TANAKA T, 1991, J BIOL CHEM, V266, P12555; TANNENBAUM CS, 1993, J IMMUNOL, V151, P6833; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; UITTO J, 1992, J CLIN INVEST, V90, P687, DOI 10.1172/JCI115938; WIKNER NE, 1986, J INVEST DERMATOL, V87, P559, DOI 10.1111/1523-1747.ep12455746; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	45	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					392	396		10.1074/jbc.270.1.392	http://dx.doi.org/10.1074/jbc.270.1.392			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814399	hybrid			2022-12-27	WOS:A1995QA28700062
J	BROWN, CM; TATE, WP				BROWN, CM; TATE, WP			DIRECT RECOGNITION OF MESSENGER-RNA STOP SIGNALS BY ESCHERICHIA-COLI POLYPEPTIDE-CHAIN RELEASE FACTOR-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							16S RIBOSOMAL-RNA; MESSENGER-RNA; CROSS-LINKING; TRANSLATIONAL TERMINATION; PROTEIN-SYNTHESIS; DECODING SITE; CODON; ANALOGS; 4-THIOURIDINE; SUPPRESSOR	The interaction between the translational stop signal and the polypeptide chain release factor protein (RF) within complexes of Escherichia coli ribosomes has been investigated by site-directed photochemical crosslinking experiments. Twelve mRNA analogues containing 4-thiouridine residues as part of stop signals were synthesized. Highly efficient cross-linking to RF-2 from 4-thiouridine (sU) residues of sUGAN-containing mRNAs was observed, and cross-linking from those of sUAAN was observed at a lower efficiency. This indicates that RF-2 is in close physical contact with the stop signal on the ribosome, The yield of the RF-2 mRNA cross-link depended on the identity of the fourth base for the sUGAN set of signals, suggesting that the fourth base of the stop signal affects the interaction between RF-2 and the stop codon, A region previously implicated as part of the decoding site of the small ribosomal subunit, 1385-1420 of the 16 S rRNA, was also cross-linked with these mRNAs. No new cross-links were obtained in the presence of the release factor. The data are consistent with models in which the RF has an anticodon-like domain that contacts the stop signal directly at or near the ribosomal site in which sense codons are decoded.	UNIV OTAGO, DEPT BIOCHEM, DUNEDIN, NEW ZEALAND; UNIV OTAGO, CTR GENE RES, DUNEDIN, NEW ZEALAND	University of Otago; University of Otago								BRIMACOMBE R, 1988, METHOD ENZYMOL, V164, P287; BRIMACOMBE R, 1990, RIBOSOMES PROTEIN SY, P131; BROWN CM, 1993, NUCLEIC ACIDS RES, V21, P2109, DOI 10.1093/nar/21.9.2109; BROWN CM, 1990, NUCLEIC ACIDS RES, V18, P2079, DOI 10.1093/nar/18.8.2079; BUCKINGHAM K, 1987, BIOCHIM BIOPHYS ACTA, V909, P92, DOI 10.1016/0167-4781(87)90030-3; DONTSOVA O, 1992, EMBO J, V11, P3105, DOI 10.1002/j.1460-2075.1992.tb05383.x; DUBREUIL YL, 1991, NUCLEIC ACIDS RES, V19, P3653; EGGERTSSON G, 1988, MICROBIOL REV, V52, P354, DOI 10.1128/MMBR.52.3.354-374.1988; FAVRE A, 1991, NEW J CHEM, V15, P593; FLUCK MM, 1977, MOL GEN GENET, V151, P137, DOI 10.1007/BF00338688; GORINGER HU, 1991, P NATL ACAD SCI USA, V88, P6603, DOI 10.1073/pnas.88.15.6603; GROSJEAN H, 1986, STRUCTURE DYNAMICS R, P161; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; LIM V, 1992, NUCLEIC ACIDS RES, V20, P2627, DOI 10.1093/nar/20.11.2627; LIM VI, 1994, J MOL BIOL, V240, P8, DOI 10.1006/jmbi.1994.1413; MAJOR F, 1991, SCIENCE, V253, P1255, DOI 10.1126/science.1716375; MOFFAT JG, 1994, J BIOL CHEM, V269, P18899; MORAS D, 1986, P NATL ACAD SCI USA, V83, P932, DOI 10.1073/pnas.83.4.932; MURGOLA EJ, 1988, P NATL ACAD SCI USA, V85, P4162, DOI 10.1073/pnas.85.12.4162; PEDERSEN WT, 1991, J MOL BIOL, V219, P231, DOI 10.1016/0022-2836(91)90564-M; PRESCOTT CD, 1991, BIOCHIMIE, V73, P1121, DOI 10.1016/0300-9084(91)90155-T; RAUE HA, 1990, STRUCTURE FUNCTION G, P217; RINKEAPPEL J, 1993, NUCLEIC ACIDS RES, V21, P2853, DOI 10.1093/nar/21.12.2853; SCHROEDER R, 1993, SCIENCE, V260, P1443, DOI 10.1126/science.8502988; STADE K, 1989, NUCLEIC ACIDS RES, V17, P9889, DOI 10.1093/nar/17.23.9889; TATE W, 1990, NUCLEIC ACIDS RES, V18, P6537, DOI 10.1093/nar/18.22.6537; TATE WP, 1983, J BIOL CHEM, V258, P360; TATE WP, 1992, BIOCHEMISTRY-US, V31, P2443, DOI 10.1021/bi00124a001; TATE WP, 1990, RIBOSOME, P393; TATE WP, 1993, TRANSLATIONAL APPARATUS, P253; Yarus M, 1992, TRANSFER RNA PROTEIN, P319	31	60	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					33164	33170						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806547				2022-12-27	WOS:A1994QA63800066
J	KARNAUCHOV, I; CAI, DG; SCHMIDT, I; HERRMANN, RG; KLOSGEN, RB				KARNAUCHOV, I; CAI, DG; SCHMIDT, I; HERRMANN, RG; KLOSGEN, RB			THE THYLAKOID TRANSLOCATION OF SUBUNIT-3 OF PHOTOSYSTEM-I, THE PSAF GENE-PRODUCT, DEPENDS ON A BIPARTITE TRANSIT PEPTIDE AND PROCEEDS ALONG AN AZIDE-SENSITIVE PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-EVOLVING COMPLEX; NUCLEOTIDE-SEQUENCE; PRECURSOR PROTEIN; PREPROTEIN TRANSLOCASE; CHLOROPLAST GENOME; CHROMOPHYTIC ALGA; LUMENAL PROTEINS; ESCHERICHIA-COLI; PROTON GRADIENT; PLASTID GENOME	Subunit 3 of photosystem I (PSI-3), the product of the nuclear psaF gene, is the docking protein for plastocyanin during photosynthetic electron transport in thylakoid membranes and is synthesized in the cytosol with a transit peptide that resembles structurally the bipartite targeting signals of hydrophilic, lumenal components such as plastocyanin, In organello import experiments performed with the authentic PSI-3 precursor and chimeric polypeptides consisting of residue-correct fusions of transit peptides and mature proteins derived from different plastid proteins demonstrate that the PSI-3 transit peptide is indeed capable of translocating proteins into the thylakoid lumen and that, conversely, mature PSI-3 depends on a bipartite transit peptide for its thylakoid transfer, Of the three recently described translocation/integration pathways for nucleus encoded proteins carrying bipartite transit peptides that are distinct in their physiological requirements and strictly protein-specific, PSI-3, like plastocyanin and the 33-kDa protein of the oxygen evolving complex, is translocated by a pathway that involves stromal factors but no proton gradient across the membrane, It is not affected by saturating amounts of the precursor for the 23-kDa protein of the oxygen-evolving complex that follows the latter route. Thylakoid translocation of PSI-3 is, however, impaired in the presence of sodium azide, which indicates that a homolog to the bacterial SecA protein might be involved in this process suggesting, thus, a prokaryote-like translocation pathway, The azide sensitive factor appears to interact predominantly with the transit peptide of a precursor protein, since chimeras consisting of a presequence from an azide-resistant precursor and a mature part of an azide-sensitive polypeptide are still translocated in the presence of the inhibitor.	UNIV MUNICH,INST BOT,D-80638 MUNICH,GERMANY	University of Munich								BARTLING D, 1990, BOT MAG TOKYO, V2, P119; BASSHAM DC, 1991, J BIOL CHEM, V266, P23606; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BREYTON C, 1994, J BIOL CHEM, V269, P7597; BRIGGS LM, 1990, PLANT MOL BIOL, V15, P633, DOI 10.1007/BF00017837; BROCK IW, 1993, PLANT MOL BIOL, V23, P717, DOI 10.1007/BF00021527; CAI D, 1993, PLANT J, V3, P383, DOI 10.1046/j.1365-313X.1993.t01-21-00999.x; CHAMBERLAIN JP, 1979, ANAL BIOCHEM, V98, P132, DOI 10.1016/0003-2697(79)90716-4; CHITNIS PR, 1991, J BIOL CHEM, V266, P20146; CLAUSMEYER S, 1993, J BIOL CHEM, V268, P13869; CLINE K, 1992, J BIOL CHEM, V267, P2688; CLINE K, 1993, EMBO J, V12, P4105, DOI 10.1002/j.1460-2075.1993.tb06094.x; COZENS AL, 1987, J MOL BIOL, V194, P359, DOI 10.1016/0022-2836(87)90667-X; DOUGLAS SE, 1992, FEBS LETT, V298, P93, DOI 10.1016/0014-5793(92)80029-G; FLACHMANN R, 1993, J BIOL CHEM, V268, P7514; GOLBECK JH, 1987, BIOCHIM BIOPHYS ACTA, V895, P167, DOI 10.1016/S0304-4173(87)80002-2; HAEHNEL W, 1994, EMBO J, V13, P1028, DOI 10.1002/j.1460-2075.1994.tb06351.x; HAGEMAN J, 1986, NATURE, V324, P567, DOI 10.1038/324567a0; HAVAUX M, 1991, Z NATURFORSCH C, V46, P1038; HENRY R, 1994, J BIOL CHEM, V269, P10189; Herrmann R. G., 1991, Plant molecular biology 2. Proceedings of a NATO Advanced Study Institute, 14-23 May 1990, Elmau, Germany., P411; HERRMANN RG, 1993, FEBS LETT, V326, P192, DOI 10.1016/0014-5793(93)81789-3; HIPPLER M, 1989, FEBS LETT, V250, P280, DOI 10.1016/0014-5793(89)80738-0; HULFORD A, 1994, J BIOL CHEM, V269, P3251; JAMES HE, 1989, J BIOL CHEM, V264, P19573; JANSEN T, 1987, FEBS LETT, V216, P234, DOI 10.1016/0014-5793(87)80696-8; KLOSGEN RB, 1992, PLANT MOL BIOL, V18, P1031, DOI 10.1007/BF00019226; KNOTT TG, 1994, J BIOL CHEM, V269, P7843; KO K, 1989, EMBO J, V8, P3187, DOI 10.1002/j.1460-2075.1989.tb08477.x; KUWABARA T, 1987, P NATL ACAD SCI USA, V84, P8230, DOI 10.1073/pnas.84.23.8230; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPPA GK, 1988, J BIOL CHEM, V263, P14996; MADUENO F, 1993, PLANT CELL, V5, P1865, DOI 10.1105/tpc.5.12.1865; MARGUILES MM, 1989, PLANT SCI, V54, P1; Margulis L., 1993, SYMBIOSIS CELL EVOLU; MICHL D, 1994, EMBO J, V13, P1310, DOI 10.1002/j.1460-2075.1994.tb06383.x; MOULD RM, 1991, J BIOL CHEM, V266, P17286; MOULD RM, 1991, J BIOL CHEM, V266, P12189; NELSON N, 1992, BIOCHIM BIOPHYS ACTA, V1100, P109; NIELSEN VS, 1994, J BIOL CHEM, V269, P3762; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; OTTO J, 1989, FEBS LETT, V259, P625; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; REITH M, 1993, PLANT CELL, V5, P465, DOI 10.1105/tpc.5.4.465; ROBINSON C, 1994, EMBO J, V13, P279, DOI 10.1002/j.1460-2075.1994.tb06260.x; ROTHER C, 1986, CURR GENET, V11, P171, DOI 10.1007/BF00420603; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCARAMUZZI CD, 1992, FEBS LETT, V304, P119, DOI 10.1016/0014-5793(92)80601-C; SCARAMUZZI CD, 1992, CURR GENET, V22, P421, DOI 10.1007/BF00352444; SCHELLER HV, 1990, PHYSIOL PLANTARUM, V78, P484, DOI 10.1034/j.1399-3054.1990.780326.x; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; SEIDLER A, 1990, EMBO J, V9, P1743, DOI 10.1002/j.1460-2075.1990.tb08298.x; SMEEKENS S, 1986, CELL, V46, P365, DOI 10.1016/0092-8674(86)90657-4; STEPPUHN J, 1988, FEBS LETT, V237, P218, DOI 10.1016/0014-5793(88)80205-9; STEPPUHN J, 1987, MOL GEN GENET, V210, P171, DOI 10.1007/BF00337775; THEG SM, 1989, J BIOL CHEM, V264, P6730; TJUS SE, 1991, PHOTOSYNTH RES, V27, P209, DOI 10.1007/BF00035842; TYAGI A, 1987, MOL GEN GENET, V207, P288, DOI 10.1007/BF00331591; VALENTIN K, 1993, MOL GEN GENET, V236, P245, DOI 10.1007/BF00277119; VIITANEN PV, 1988, J BIOL CHEM, V263, P15000; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; WALKER JE, 1985, MOL BIOL PHOTOSYNTHE, P141; WYNN RM, 1988, BIOCHEMISTRY-US, V27, P5863, DOI 10.1021/bi00416a007; ZILBER AL, 1992, PLANT PHYSIOL, V99, P901, DOI 10.1104/pp.99.3.901	65	38	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					32871	32878						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806513				2022-12-27	WOS:A1994QA63800026
J	MOK, SS; MASUDA, K; HAUSELMANN, HJ; AYDELOTTE, MB; THONAR, EJMA				MOK, SS; MASUDA, K; HAUSELMANN, HJ; AYDELOTTE, MB; THONAR, EJMA			AGGRECAN SYNTHESIZED BY MATURE BOVINE CHONDROCYTES SUSPENDED IN ALGINATE - IDENTIFICATION OF 2 DISTINCT METABOLIC MATRIX POOLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWARM RAT CHONDROSARCOMA; ARTICULAR-CARTILAGE; INTERGLOBULAR DOMAIN; SUB-POPULATIONS; PROTEOGLYCANS; TURNOVER; BIOSYNTHESIS; CATABOLISM; CULTURES; EXPLANTS	Proteoglycans synthesized by chondrocytes in alginate beads are found in two compartments: the cell-associated matrix and the further removed matrix (Hauselmann, H. J,, Aydelotte M, B,, Schumacher B, L,, Kuettner K, E,, Gitelis, S, Ii,, and Thonar, E, J,-M, A (1992) Matrix 12, 116-129), To study the metabolism of aggrecan in these two compartments, mature bovine articular chondrocytes in alginate beads were pulsed with [S-35]sulfate for 30 min or 16 h on day 7 of culture and then chased in isotope-free medium for up to 21 days, At different times, the two matrix pools were separately isolated, and the S-35-proteoglycans quantified, purified, and characterized, Radiolabeled aggrecan molecules exhibited a very long average half life in the beads (t(1/2) = 95 days), In contrast, small non-aggregating proteoglycans, which made up approximately 4% of the S-35-proteoglycans synthesized, were rapidly lost from the beads (t(1/2) = <24 h), Approximately half the S-35-aggrecan subunits, representing mostly molecules which showed a delay in ability to form aggregates in the presence of exogenous hyaluronan and link protein, spent only a short time (t(1/2) = 4 h) in the cell-associated matrix before moving into the further removed matrix, They exhibited a much longer average half life in the beads than S-35-aggrecan molecules which became resident of the cell-associated matrix (t(1/2) = >95 days versus 15 days), Radiolabeled aggrecan subunits in the two matrix compartments had a similar average hydrodynamic size and polydispersity; importantly, the size of these molecules did not change during the chase period, Catabolism of S-35-aggrecan in the cell-associated matrix was the only significant contributor to the appearance in the medium of partially degraded S-35-aggrecan which had lost the ability to bind to hyaluronan, These results strongly suggest aggrecan molecules which reside in the pericellular and territorial matrix compartments in close proximity to the chondrocytes have a much faster rate of turnover than their counterpart in the interterritorial areas further removed from the cells,	RUSH PRESBYTERIAN ST LUKES MED CTR,RUSH MED COLL,DEPT BIOCHEM,CHICAGO,IL 60612; RUSH PRESBYTERIAN ST LUKES MED CTR,RUSH MED COLL,DEPT INTERNAL MED,CHICAGO,IL 60612; UNIV ZURICH HOSP,DEPT RHEUMATOL,CH-8091 ZURICH,SWITZERLAND; UNIV BERN,ME MULLER INST BIOMECH,CH-3010 BERN,SWITZERLAND	Rush University; Rush University; University of Zurich; University Zurich Hospital; University of Bern					NIAMS NIH HHS [1-P50-AR39239] Funding Source: Medline; NIA NIH HHS [AG04736] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR039239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG004736] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AYDELOTTE MB, 1988, CONNECT TISSUE RES, V18, P223, DOI 10.3109/03008208809016809; AYDELOTTE MB, 1988, CONNECT TISSUE RES, V18, P205, DOI 10.3109/03008208809016808; Aydelotte MB, 1986, ARTICULAR CARTILAGE, P235; BARONEVARELAS J, 1991, CONNECT TISSUE RES, V26, P101, DOI 10.3109/03008209109152167; BAYLISS MT, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P487; BAYLISS MT, 1987, ORTHOP T, V11, P289; CAMPBELL MA, 1984, ARCH BIOCHEM BIOPHYS, V234, P275, DOI 10.1016/0003-9861(84)90350-3; CHANDRASEKHAR S, 1987, ANAL BIOCHEM, V161, P103, DOI 10.1016/0003-2697(87)90658-0; EYRE DR, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P119; EYRE DR, 1990, METHODS CARTILAGE RE, P28; HARDINGHAM TE, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P5; HARDINGHAM TE, 1972, BIOCHEM J, V126, P791, DOI 10.1042/bj1260791; HASCALL VC, 1994, IN PRESS STRUCTURE F; HAUSELMANN HJ, 1994, J CELL SCI, V107, P17; HAUSELMANN HJ, 1992, MATRIX, V12, P116; HUNZIKER EB, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P183; ILIC MZ, 1992, ARCH BIOCHEM BIOPHYS, V294, P115, DOI 10.1016/0003-9861(92)90144-L; KUETTNER KE, 1990, CARTILAGE CHANGES OS, P3; LEE GM, 1993, J CELL BIOL, V123, P1899, DOI 10.1083/jcb.123.6.1899; LOHMANDER S, 1977, ARCH BIOCHEM BIOPHYS, V180, P93, DOI 10.1016/0003-9861(77)90012-1; MAROUDAS A, 1985, IN PRESS ORTHOP T; MAROUDAS A, 1992, CONNECT TISSUE RES, V27, P1; MOLLENHAUER HH, 1964, STAIN TECHNOL, V39, P111; OEGEMA TR, 1975, J BIOL CHEM, V250, P6151; PETIT B, 1995, IN PRESS ORTHOP T; RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754; Roughley P J, 1986, Agents Actions Suppl, V18, P19; SANDELL LJ, 1991, J CELL BIOL, V114, P1307, DOI 10.1083/jcb.114.6.1307; SANDY JD, 1978, BIOCHIM BIOPHYS ACTA, V543, P536, DOI 10.1016/0304-4165(78)90308-2; SANDY JD, 1992, J CLIN INVEST, V89, P1512, DOI 10.1172/JCI115742; SANDY JD, 1991, J BIOL CHEM, V266, P8683; SANDY JD, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P21; SANDY JD, 1989, ARCH BIOCHEM BIOPHYS, V271, P300, DOI 10.1016/0003-9861(89)90280-4; STEVENS RL, 1981, J BIOL CHEM, V256, P2045; THONAR EJMA, 1983, J BIOL CHEM, V258, P1564; THONAR EJMA, 1986, J BIOL CHEM, V261, P2467; VANKAMPEN GPJ, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P281; WIGHT TN, 1991, CELL BIOL EXTRACELLU, P45, DOI DOI 10.1007/978-1-4615-3770-0_3	38	139	141	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					33021	33027						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806530				2022-12-27	WOS:A1994QA63800046
J	WILLIAMS, FMR; FLINTOFF, WF				WILLIAMS, FMR; FLINTOFF, WF			ISOLATION OF A HUMAN CDNA THAT COMPLEMENTS A MUTANT HAMSTER-CELL DEFECTIVE IN METHOTREXATE UPTAKE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLATE-BINDING-PROTEIN; HUMAN KB CELLS; MEDIATED GENE-TRANSFER; L1210 LEUKEMIA-CELLS; OVARY CELLS; MOLECULAR-CLONING; MEMBRANE CARRIER; TUMOR-CELLS; TRANSPORT; RECEPTOR	A clone has been isolated from a human lymphoblastic cDNA expression library that complements a mutant Chinese hamster cell defective in the uptake of the folate analogue methotrexate. When transfected with this clone the mutant cells regain the ability to transport the drug and, as a consequence, become sensitive to its cytotoxic action. The clone is 2863 base pairs long and has an open reading frame of 1770 base pairs that codes for a putative protein of 64 kDa. The putative protein has 51 and 50% identity at the amino acid level with the mouse and hamster functions, respectively, involved in the transport of reduced folates. Together these three proteins share 47% identity and have similar predicted structural features. The data are consistent with this human clone encoding either the reduced folate transporter or an auxiliary function that interacts with this transporter.	UNIV WESTERN ONTARIO,DEPT MICROBIOL & IMMUNOL,LONDON,ON N6A 5C1,CANADA	Western University (University of Western Ontario)								ANTONY AC, 1985, J BIOL CHEM, V260, P4911; BRIGLE KE, 1991, J BIOL CHEM, V266, P17243; CAMPBELL IG, 1991, CANCER RES, V51, P5329; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; CHUNG KN, 1992, J CLIN INVEST, V91, P1289; CONEY LR, 1991, CANCER RES, V51, P6125; DEUTSCH JC, 1989, ARCH BIOCHEM BIOPHYS, V274, P327, DOI 10.1016/0003-9861(89)90446-3; DIXON KH, 1992, J BIOL CHEM, V267, P24140; DIXON KH, 1994, J BIOL CHEM, V269, P17; ELWOOD PC, 1986, J BIOL CHEM, V261, P5416; ELWOOD PC, 1989, J BIOL CHEM, V264, P14893; FAN JG, 1991, J BIOL CHEM, V266, P14862; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISCHBARG J, 1993, P NATL ACAD SCI USA, V90, P11658, DOI 10.1073/pnas.90.24.11658; FLINTOFF WF, 1976, SOMAT CELL GENET, V2, P245, DOI 10.1007/BF01538963; FLINTOFF WF, 1983, ARCH BIOCHEM BIOPHYS, V223, P433, DOI 10.1016/0003-9861(83)90607-0; HENDERSON GB, 1990, ANNU REV NUTR, V10, P319, DOI [10.1146/annurev.nutr.10.1.319, 10.1146/annurev.nu.10.070190.001535]; HENDERSON GB, 1988, J MEMBRANE BIOL, V101, P247, DOI 10.1007/BF01872839; HENDERSON GB, 1984, J BIOL CHEM, V259, P4558; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; HRESKO RC, 1994, J BIOL CHEM, V269, P20482; JANSEN G, 1989, CANCER RES, V49, P1959; JANSEN G, 1990, J BIOL CHEM, V265, P18272; KAMEN BA, 1991, J CLIN INVEST, V87, P1442, DOI 10.1172/JCI115150; KANE MA, 1989, LAB INVEST, V60, P737; KANE MA, 1986, J BIOL CHEM, V261, P44; KANE MA, 1986, J BIOL CHEM, V261, P5625; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LACEY SW, 1989, J CLIN INVEST, V84, P715, DOI 10.1172/JCI114220; MATHERLY LH, 1994, BIOCHEM PHARMACOL, V47, P1094, DOI 10.1016/0006-2952(94)90423-5; MATHERLY LH, 1992, J BIOL CHEM, V267, P23253; MATHERLY LH, 1991, CANCER RES, V51, P3420; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P7853, DOI 10.1021/bi00420a040; SADASIVAN E, 1989, J BIOL CHEM, V264, P5806; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIROTNAK FM, 1985, CANCER RES, V45, P3992; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; UNDERHILL TM, 1989, MOL CELL BIOL, V9, P1754, DOI 10.1128/MCB.9.4.1754; UNDERHILL TM, 1989, SOMAT CELL MOLEC GEN, V15, P49, DOI 10.1007/BF01534669; UNDERHILL TM, 1992, SOMAT CELL MOLEC GEN, V18, P337, DOI 10.1007/BF01235757; WEITMAN SD, 1992, CANCER RES, V52, P3396; WESTERHOF GR, 1991, CANCER RES, V51, P5507; WILLIAMS FMR, 1994, J BIOL CHEM, V269, P5810; 1991, PROGRAM MANUAL GCG P	45	115	117	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					2987	2992		10.1074/jbc.270.7.2987	http://dx.doi.org/10.1074/jbc.270.7.2987			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852378	hybrid			2022-12-27	WOS:A1995QG47100018
J	MASSON, PJ; COUP, D; MILLET, J; BROWN, NL				MASSON, PJ; COUP, D; MILLET, J; BROWN, NL			THE EFFECT OF THE BETA-D-XYLOSIDE NAROPARCIL ON CIRCULATING PLASMA GLYCOSAMINOGLYCANS - AN EXPLANATION OF ITS KNOWN ANTITHROMBOTIC ACTIVITY IN THE RABBIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN COFACTOR-II; CHONDROITIN SULFATE CHAINS; EMBRYONIC-CHICKEN CARTILAGE; DERMATAN SULFATE; THROMBIN INHIBITION; ENDOTHELIAL-CELLS; MATRIX FORMATION; CULTURED-CELLS; BIOSYNTHESIS; PROTEOGLYCAN	beta-D-Xylosides are known to initiate or prime free glycosaminoglycan (GAG) chain synthesis in cell and tissue culture. As such, the effect of the venous antithrombotic beta-D-xyloside, naroparcil, was investigated on the plasma GAG profile in the rabbit after oral administration, Using dose-response experiments, we showed that antithrombin activity via antithrombin III and heparin cofactor II was increased in parallel with GAG plasma levels compared to control, A more detailed qualitative examination of plasma GAGs by cellulose acetate electrophoresis and ion-exchange chromatography, following oral administration of naroparcil at 400 mg/kg, revealed the presence of higher density charged molecules compared to control, The extracted GAGs were found to activate inhibition of thrombin by heparin cofactor II and contained approximately 25% of a dermatan sulfate-like compound (undetectable in control), which could be responsible for the antithrombotic effect, Using radiolabeled naroparcil, we found radiolabeled GAG fractions and the fact that naroparcil was a substrate for galactosyltransferase I, the second enzyme responsible for GAG chain polymerization, suggested that the compound could initiate in vivo the biosynthesis of antithrombotic free GAG chains, This is, to our knowledge, the first description of the in vivo effect of a beta-D-xyloside on GAG biosynthesis; furthermore, this is correlated with an antithrombotic action.			MASSON, PJ (corresponding author), LABS FOURNIER SCA, CTR RECH & DEV, 50 RUE DIJON, BP 90, F-21121 DAIX, FRANCE.							AMAR J, 1990, BRIT J HAEMATOL, V76, P94, DOI 10.1111/j.1365-2141.1990.tb07842.x; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAY B, 1989, BIOCHEM J, V262, P225, DOI 10.1042/bj2620225; COSTER L, 1991, BIOCHEM J, V276, P533, DOI 10.1042/bj2760533; DUPOUY D, 1988, THROMB HAEMOSTASIS, V60, P236; FERNANDEZ FA, 1987, THROMB HAEMOSTASIS, V57, P286; FISCHER AM, 1982, THROMB HAEMOSTASIS, V47, P104; FRANSSON LA, 1992, GLYCOCONJUGATE J, V9, P45, DOI 10.1007/BF00731177; FRITZ TA, 1994, J BIOL CHEM, V269, P300; GALLIGANI L, 1975, J BIOL CHEM, V250, P5400; GENSINI GF, 1990, HAEMOSTASIS, V20, P129; GORDON PB, 1986, CARBOHYD RES, V151, P121, DOI 10.1016/S0008-6215(00)90334-3; HEMKER HC, 1991, SEMIN THROMB HEMOST, V17, P29; IMANARI T, 1992, J CHROMATOGR-BIOMED, V574, P142, DOI 10.1016/0378-4347(92)80109-4; JANDROTPERRUS M, 1988, EUR J BIOCHEM, V174, P359, DOI 10.1111/j.1432-1033.1988.tb14106.x; KANWAR YS, 1984, J CELL BIOL, V99, P715, DOI 10.1083/jcb.99.2.715; KOLSET SO, 1990, BIOCHEM J, V265, P637, DOI 10.1042/bj2650637; LINHARDT RJ, 1989, ANAL BIOCHEM, V181, P288, DOI 10.1016/0003-2697(89)90245-5; LINHARDT RJ, 1986, APPL BIOCHEM BIOTECH, V12, P135; LUGEMWA FN, 1991, J BIOL CHEM, V266, P6674; MILLET J, 1994, THROMB HAEMOSTASIS, V72, P874; MILLET J, 1992, THROMB HAEMOSTASIS, V67, P176; MILLET J, 1992, THROMB RES, V65, pS158; MURATA K, 1980, METHODS CARBOHYDRATE, V8, P81; MURRAY E, 1983, BIOCHIM BIOPHYS ACTA, V763, P299, DOI 10.1016/0167-4889(83)90138-6; NAGASAKA T, 1989, EXP HEMATOL, V17, P923; OFOSU FA, 1988, THROMB HAEMOSTASIS, V60, P188; OFOSU FA, 1984, BLOOD, V64, P727; OKAYAMA M, 1973, J BIOCHEM-TOKYO, V74, P1069; RAPRAEGER A, 1989, J CELL BIOL, V109, P2509, DOI 10.1083/jcb.109.5.2509; ROBINSON HC, 1975, BIOCHEM J, V148, P25, DOI 10.1042/bj1480025; ROBINSON J, 1984, J BIOL CHEM, V259, P3818; ROBINSON JA, 1981, BIOCHEM J, V194, P839, DOI 10.1042/bj1940839; SCHWARTZ NB, 1979, J BIOL CHEM, V254, P2271; SCHWARTZ NB, 1974, P NATL ACAD SCI USA, V71, P4047, DOI 10.1073/pnas.71.10.4047; SCOTT TA, 1953, ANAL CHEM, V25, P1656, DOI 10.1021/ac60083a023; SCULLY MF, 1988, BIOCHEM J, V254, P547, DOI 10.1042/bj2540547; SENO N, 1970, ANAL BIOCHEM, V37, P197, DOI 10.1016/0003-2697(70)90280-0; SHIMADA K, 1991, JPN CIRC J, V55, P1016, DOI 10.1253/jcj.55.1016; SHIMADA K, 1987, ARTERIOSCLEROSIS, V7, P627, DOI 10.1161/01.ATV.7.6.627; SIE P, 1993, BLOOD, V81, P1771; SOBUE M, 1987, BIOCHEM J, V241, P591, DOI 10.1042/bj2410591; STEVENS RL, 1983, J BIOL CHEM, V258, P5977; STEVENS RL, 1982, J BIOL CHEM, V257, P253; TAGAKI K, 1991, J BIOCHEM-TOKYO, V109, P514; TERHO TT, 1971, ANAL BIOCHEM, V41, P471, DOI 10.1016/0003-2697(71)90167-9; TOLLEFSEN DM, 1986, J BIOL CHEM, V261, P8854; VANRYNMCKENNA J, 1989, ANN NY ACAD SCI, V556, P304	49	75	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2662	2668		10.1074/jbc.270.6.2662	http://dx.doi.org/10.1074/jbc.270.6.2662			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852334	hybrid			2022-12-27	WOS:A1995QF53500042
J	MURAKAMI, M; KARNIK, SS; HUSAIN, A				MURAKAMI, M; KARNIK, SS; HUSAIN, A			HUMAN PROCHYMASE ACTIVATION - A NOVEL ROLE FOR HEPARIN IN ZYMOGEN PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL PEPTIDASE-I; MAST-CELL PROTEASE; MOLECULAR-CLONING; SERINE PROTEASE; SUBSTANCE-P; HUMAN HEART; CHYMASE; IDENTIFICATION; GENE; PURIFICATION	Human prochymase is packaged with heparin in mast cell granules and appears to be activated by dipeptidylpeptidase I. We show that a high affinity interaction between heparin and prochymase allows the 2-residue propeptide to be cleaved by dipeptidylpeptidase I. A conserved Glu in the propeptide is necessary for this heparin effect. Following propeptide cleavage, capture of the newly generated NH2 terminus by an ''activation groove'' on the enzyme activates the enzyme and concurrently prevents a progressive degradation of the NH2 terminus by dipeptidylpeptidase I. Surrogate peptide studies show that the activation groove is unoccupied in prochymase and is specific for the chymase NH2 terminus. These observations indicate that heparin is an important cofactor in the prochymase activation process and explain how dipeptidylpeptidase I, a nonspecific processing enzyme, can effect a specific cleavage of the zymogen propeptide.	CLEVELAND CLIN FDN, RES INST, DEPT MOLEC CARDIOL, CLEVELAND, OH 44195 USA	Cleveland Clinic Foundation			Karnik, Sadashiva/Y-2477-2019; Husain, Ahsan/J-6861-2012	Karnik, Sadashiva/0000-0003-0746-2753; Husain, Ahsan/0000-0003-3426-3469	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR004871] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044201, P50HL033713] Funding Source: NIH RePORTER; NCRR NIH HHS [RR04871] Funding Source: Medline; NHLBI NIH HHS [HL44201, HL33713, R01 HL057470] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BENFEY PN, 1987, J BIOL CHEM, V262, P5377; BRAIN SD, 1988, NATURE, V335, P73, DOI 10.1038/335073a0; CAUGHEY GH, 1990, BIOCHEMISTRY-US, V29, P5166, DOI 10.1021/bi00473a024; CAUGHEY GH, 1988, J PHARMACOL EXP THER, V244, P133; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DEYOUNG MB, 1987, ARCH BIOCHEM BIOPHYS, V254, P222, DOI 10.1016/0003-9861(87)90098-1; DIKOV MM, 1994, J BIOL CHEM, V269, P25897; EVIN G, 1984, P NATL ACAD SCI-BIOL, V81, P48, DOI 10.1073/pnas.81.1.48; FLETCHER TS, 1987, BIOCHEMISTRY-US, V26, P7256, DOI 10.1021/bi00397a010; GOLDSTEIN SM, 1987, J IMMUNOL, V139, P2724; JENNE DE, 1989, BIOCHEMISTRY-US, V28, P7953, DOI 10.1021/bi00445a060; KINOSHITA A, 1991, J BIOL CHEM, V266, P19192; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LAGUNOFF D, 1976, ARCH BIOCHEM BIOPHYS, V173, P554, DOI 10.1016/0003-9861(76)90292-7; LETRONG H, 1987, P NATL ACAD SCI USA, V84, P364; MCGUIRE MJ, 1993, J BIOL CHEM, V268, P2458; MCGUIRE MJ, 1992, ARCH BIOCHEM BIOPHYS, V295, P280, DOI 10.1016/0003-9861(92)90519-3; REMINGTON SJ, 1988, BIOCHEMISTRY-US, V27, P8097, DOI 10.1021/bi00421a019; SALI A, 1993, J BIOL CHEM, V268, P9023; SALVESEN G, 1987, BIOCHEMISTRY-US, V26, P2289, DOI 10.1021/bi00382a032; SALVESEN G, 1990, BIOCHEMISTRY-US, V29, P5304, DOI 10.1021/bi00474a013; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHWARTZ LB, 1981, J BIOL CHEM, V256, P1939; SERAFIN WE, 1990, J BIOL CHEM, V265, P423; SOMMERHOFF CP, 1989, J IMMUNOL, V142, P2450; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; Summers MD, 1987, TEXAS AGR EXPT STATI; TANI T, 1988, J BIOL CHEM, V263, P1231; URATA H, 1991, J BIOL CHEM, V266, P17173; URATA H, 1990, J BIOL CHEM, V265, P22348; URATA H, 1993, J BIOL CHEM, V268, P24318; URATA H, 1993, J CLIN INVEST, V91, P1269, DOI 10.1172/JCI116325; WIGHT TN, 1991, CELL BIOL EXTRACELLU, P45, DOI DOI 10.1007/978-1-4615-3770-0_3; WINTROUB BU, 1984, J INVEST DERMATOL, V83, P336, DOI 10.1111/1523-1747.ep12264144	35	63	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2218	2223		10.1074/jbc.270.5.2218	http://dx.doi.org/10.1074/jbc.270.5.2218			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836453	hybrid			2022-12-27	WOS:A1995QE49300038
J	YEH, JI; GULVE, EA; RAMEH, L; BIRNBAUM, MJ				YEH, JI; GULVE, EA; RAMEH, L; BIRNBAUM, MJ			THE EFFECTS OF WORTMANNIN ON RAT SKELETAL-MUSCLE - DISSOCIATION OF SIGNALING PATHWAYS FOR INSULIN-ACTIVATED AND CONTRACTION-ACTIVATED HEXOSE-TRANSPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY; GLUCOSE-TRANSPORT; EPITROCHLEARIS MUSCLE; RECEPTOR SUBSTRATE-1; STIMULATION; LIVER; PHOSPHORYLATION; TRANSDUCTION; RESISTANT; HYPOXIA	Both the anabolic hormone insulin and contractile activity stimulate the uptake of glucose into mammalian skeletal muscle, In this study, we examined the role of phosphatidylinositol 3-kinase (PI 3-kinase), a putative mediator of insulin actions, in the stimulation of hexose uptake in response to hormone and contraction, Phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 3,4,5-triphosphate accumulate in skeletal muscle exposed to insulin but not hypoxia, which mimics stimulation of the contractile-dependent pathway of hexose transport activation, The fungal metabolite wortmannin, an inhibitor of PI 3-kinase, completely blocks the appearance of 3'-phospholipids in response to insulin, Moreover, wortmannin entirely prevented the increase in hexose uptake in muscle exposed to insulin but was without effect on muscle stimulated by repetitive contraction or hypoxia, These results support the view that PI 3-kinase is involved in the signaling pathways mediating insulin-responsive glucose transport in skeletal muscle but is not required for stimulation by hypoxia or contraction, Furthermore, these data indicate that there exist at least two signaling pathways leading to activation of glucose transport in skeletal muscle with differential sensitivities to wortmannin.	HARVARD UNIV,SCH MED,DEPT CELL BIOL,BOSTON,MA 02115; GD SEARLE & CO,ST LOUIS,MO 63167; BETH ISRAEL HOSP,DEPT MED,DIV SIGNAL TRANSDUCT,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center				Birnbaum, Morris/0000-0001-9972-8680	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039519] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK39519] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARNARD RJ, 1992, FASEB J, V6, P3238, DOI 10.1096/fasebj.6.14.1426762; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CARPENTER CL, 1993, MOL CELL BIOL, V13, P1657, DOI 10.1128/MCB.13.3.1657; CARTEE GD, 1991, J APPL PHYSIOL, V70, P1593, DOI 10.1152/jappl.1991.70.4.1593; CARTEE GD, 1992, AM J PHYSIOL, V263, pR70, DOI 10.1152/ajpregu.1992.263.1.R70; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; CHEN KS, 1993, AM J PHYSIOL, V265, pE736, DOI 10.1152/ajpendo.1993.265.5.E736; CLARKE JF, 1994, BIOCHEM J, V300, P631, DOI 10.1042/bj3000631; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; DOUEN AG, 1990, J BIOL CHEM, V265, P13427; FOLLI F, 1993, J CLIN INVEST, V92, P1787, DOI 10.1172/JCI116768; FOLLI F, 1992, J BIOL CHEM, V267, P22171; Goldberg A L, 1975, Methods Enzymol, V39, P82; HANSEN PA, 1994, J APPL PHYSIOL, V76, P979, DOI 10.1152/jappl.1994.76.2.979; HENRIKSEN EJ, 1989, AM J PHYSIOL, V256, pE662, DOI 10.1152/ajpendo.1989.256.5.E662; HEYDRICK SJ, 1993, J CLIN INVEST, V91, P1358, DOI 10.1172/JCI116337; JOLY M, 1994, SCIENCE, V263, P684, DOI 10.1126/science.8303278; KANAI F, 1993, BIOCHEM BIOPH RES CO, V195, P762, DOI 10.1006/bbrc.1993.2111; KELLY KL, 1992, J BIOL CHEM, V267, P3423; KIPNIS DM, 1959, ANN NY ACAD SCI, V82, P354, DOI 10.1111/j.1749-6632.1959.tb44916.x; NESHER R, 1980, AM J PHYSIOL, V239, pE454, DOI 10.1152/ajpendo.1980.239.6.E454; NESHER R, 1985, AM J PHYSIOL, V249, pC226, DOI 10.1152/ajpcell.1985.249.3.C226; OKADA T, 1994, J BIOL CHEM, V269, P3568; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; SAAD MJA, 1993, J CLIN INVEST, V92, P2065, DOI 10.1172/JCI116803; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; VLAHOS CJ, 1992, FEBS LETT, V309, P242, DOI 10.1016/0014-5793(92)80781-B; WHITE MF, 1994, J BIOL CHEM, V269, P1; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; YOUNG DA, 1986, J BIOL CHEM, V261, P6049	30	312	312	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2107	2111		10.1074/jbc.270.5.2107	http://dx.doi.org/10.1074/jbc.270.5.2107			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836438	hybrid			2022-12-27	WOS:A1995QE49300021
J	BOBOLA, N; HIRSCH, E; ALBINI, A; ALTRUDA, F; NOONAN, D; RAVAZZOLO, R				BOBOLA, N; HIRSCH, E; ALBINI, A; ALTRUDA, F; NOONAN, D; RAVAZZOLO, R			A SINGLE CIS-ACTING ELEMENT IN A SHORT PROMOTER SEGMENT OF THE GENE ENCODING THE INTERPHOTORECEPTOR RETINOID-BINDING PROTEIN CONFERS TISSUE-SPECIFIC EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MICE; IRBP PROMOTER; MESSENGER-RNA; SEQUENCE; REGION; FAMILY; SITE	Interphotoreceptor retinoid-binding protein (IRBP) is the major protein component of the interphotoreceptor matrix, IRBP has a highly restricted tissue-specific expression in retinal photoreceptor cells and in a subgroup of pinealocytes, With the purpose of understanding how transcriptional regulation contributes to the expression of human IRBP, we have studied a short promoter fragment (from -123 to +18, relative to the transcription start site), We demonstrate, by analysis of the expression of the lacZ reporter gene fused to this short promoter fragment in transgenic mice, that it is sufficient to confer tissue-specific expression in retinal photoreceptors and in pinealocytes, DNA/protein binding assays, performed to identify binding sites for tissue-specific trans-acting factors, have shown that an element between -45 and -58 binds a factor present only in nuclear extracts of retinoblastoma derived cell lines, which express IRBP. An element further upstream, between -86 and -106, binds apparently ubiquitous factors, Site-directed mutagenesis was performed to disrupt a GATTAA motif included in the -45 to -58 binding site and a second inverted GATTAA motif present shortly upstream. In transgenic mice bearing the mutated version of the promoter fragment, the expression of the reporter gene was completely abolished, thus suggesting that this element is essential for tissue-specific expression. A GATTAA motif appears in the 5'-flanking regions of several photoreceptor-specific genes, suggesting that this could be the recognition site for a photoreceptor-specific factor.	UNIV GENOA,INST BIOL & GENET,I-16132 GENOA,ITALY; UNIV TURIN,DEPT GENET BIOL & MED CHEM,I-10126 TURIN,ITALY; IST NAZL RIC CANC,I-16132 GENOA,ITALY	University of Genoa; University of Turin; University of Genoa; IRCCS AOU San Martino IST			Hirsch, Emilio/F-4848-2013; Noonan, Douglas M/A-8620-2010	Hirsch, Emilio/0000-0002-9073-6024; Noonan, Douglas M/0000-0001-8058-0719; Albini, Adriana/0000-0002-9624-5103				ADLER AJ, 1985, J BIOL CHEM, V260, P4850; AHMAD I, 1994, J NEUROCHEM, V62, P396; ALBINI A, 1990, NUCLEIC ACIDS RES, V18, P5181, DOI 10.1093/nar/18.17.5181; BAAZAN NG, 1985, J BIOL CHEM, V260, P13677; BORST DE, 1989, J BIOL CHEM, V264, P1115; CHADER GJ, 1989, INVEST OPHTH VIS SCI, V30, P7; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FASSINA G, 1993, INT J ONCOL, V2, P745; FORTINI ME, 1990, GENE DEV, V4, P444, DOI 10.1101/gad.4.3.444; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HIRSCH E, 1993, CELL ADHES COMMUN, V1, P203, DOI 10.3109/15419069309097254; HO MTP, 1989, J BIOL CHEM, V264, P928; HOGAN B, 1986, MANIPULATING MOUSE E, P157; INOUYE LN, 1989, EXP EYE RES, V49, P171, DOI 10.1016/0014-4835(89)90087-0; KAUFMANN J, 1994, GENE DEV, V8, P821, DOI 10.1101/gad.8.7.821; KIKUCHI T, 1993, MOL CELL BIOL, V13, P4400, DOI 10.1128/MCB.13.7.4400; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; KUTTY G, 1994, EXP EYE RES, V58, P65, DOI 10.1006/exer.1994.1195; LAI YL, 1982, NATURE, V298, P848, DOI 10.1038/298848a0; LIOU GI, 1991, BIOCHEM BIOPH RES CO, V181, P159, DOI 10.1016/S0006-291X(05)81395-6; LIOU GI, 1990, J BIOL CHEM, V265, P8373; LIOU GI, 1994, DEV BIOL, V161, P345, DOI 10.1006/dbio.1994.1036; LIOU GI, 1989, J BIOL CHEM, V264, P8200; LIOU GI, 1987, SOMAT CELL MOLEC GEN, V13, P315, DOI 10.1007/BF01534925; Maxam A M, 1980, Methods Enzymol, V65, P499; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; MORABITO MA, 1991, J BIOL CHEM, V266, P9667; NICKERSON JM, 1993, INVEST OPHTH VIS SCI, V34, P830; PFEFFER B, 1983, J CELL PHYSIOL, V117, P333, DOI 10.1002/jcp.1041170308; Sambrook J, 1989, MOL CLONING LABORATO; VANVEEN T, 1986, FEBS LETT, V208, P133, DOI 10.1016/0014-5793(86)81547-2; YOKOYAMA T, 1992, EXP EYE RES, V55, P225, DOI 10.1016/0014-4835(92)90186-V	32	51	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1289	1294		10.1074/jbc.270.3.1289	http://dx.doi.org/10.1074/jbc.270.3.1289			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836393	hybrid			2022-12-27	WOS:A1995QB15600048
J	KOLLAR, R; PETRAKOVA, E; ASHWELL, G; ROBBINS, PW; CABIB, E				KOLLAR, R; PETRAKOVA, E; ASHWELL, G; ROBBINS, PW; CABIB, E			ARCHITECTURE OF THE YEAST-CELL WALL - THE LINKAGE BETWEEN CHITIN AND BETA(1-]3)-GLUCAN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; GLUCAN; PURIFICATION; ENZYME; OLIGOSACCHARIDES	To isolate the putative linkage region between chitin and beta(1-->3)-glucan, Saccharomyces cerevisiae cell walls were digested with beta(1-->3)-endoglucanase and the reducing ends of the enzyme-resistant glucose chain stubs were labeled by reduction with borotritide, The radioactive material was further digested with exochitinase to remove the bulk of the chitin, and the Liberated oligosaccharides were fractionated on a sizing column, A single peak (compound I) was found to consist of N-acetylglucosamine, glucose, and glucitol residues in the ratio 1:2:1, By digestion with beta-N-acetylglucosaminidase and by NMR spectroscopy, N-acetylglucosamine was identified as the nonreducing terminus, linked to laminaritriitol by a beta(1-->4) bond, Five additional oligosaccharides were recovered, two being analogs of compound I, with 1 or 3 glucose units, respectively; the remaining three were shown to be the reduced analogs of laminaribiose, laminaritriose, and laminaritetraose. The presence of N-acetylglucosamine-containing oligosaccharides arises from the activity of chitinase in cleaving 2 sugar units sequentially in those chains containing an odd number of N-acetylglucosamine residues; correspondingly, oligosaccharides containing only glucose and sorbitol derive from even-numbered chitin chains, a result implying that chitinase can hydrolyze the linkage between N-acetylglucosamine and glucose. It is concluded that the terminal reducing residue of a chitin chain is attached to the nonreducing end of a beta(1-->3)-glucan chain by a beta(1-->4) linkage. Experiments with appropriate mutants showed that synthesis of the chitin combined with glucan is catalyzed by chitin synthetase 3. The timing and possible mechanism of formation of the chitin-glucan linkage is discussed.	NIDDKD,BIOCHEM & METAB LAB,BETHESDA,MD 20892; NIDDKD,MED CHEM LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)				Robbins, Phillips/0000-0002-5121-1524	NIDDK NIH HHS [DK0016] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOCK K, 1984, ADV CARBOHYD CHEM BI, V42, P193, DOI 10.1016/S0065-2318(08)60125-0; BULAWA CE, 1990, P NATL ACAD SCI USA, V87, P7424, DOI 10.1073/pnas.87.19.7424; CABIB E, 1989, J CELL BIOL, V108, P1665, DOI 10.1083/jcb.108.5.1665; CABIB E, 1982, ANNU REV BIOCHEM, V51, P763, DOI 10.1146/annurev.bi.51.070182.003555; CABIB E, 1988, MICROBIOL SCI, V5, P370; FLEET GH, 1976, J GEN MICROBIOL, V94, P180, DOI 10.1099/00221287-94-1-180; HARTLAND RP, YEAST, V10, P1591; HORISBERGER M, 1977, ARCH MICROBIOL, V115, P1, DOI 10.1007/BF00427837; KANG MS, 1984, J BIOL CHEM, V259, P4966; KHAN SH, 1994, CARBOHYD RES, V262, P283, DOI 10.1016/0008-6215(94)84185-3; KITAMURA K, 1974, J GEN APPL MICROBIOL, V20, P323, DOI 10.2323/jgam.20.323; MANNERS DJ, 1973, BIOCHEM J, V135, P19, DOI 10.1042/bj1350019; MOL PC, 1987, FEMS MICROBIOL LETT, V41, P95; MOLANO J, 1980, J CELL BIOL, V8, P199; REISSIG JL, 1955, J BIOL CHEM, V217, P959; ROBBINS PW, 1967, SCIENCE, V158, P1536, DOI 10.1126/science.158.3808.1536; ROBERTS RL, 1982, ANAL BIOCHEM, V127, P402, DOI 10.1016/0003-2697(82)90194-4; ROBERTS RL, 1983, MOL CELL BIOL, V3, P92; SHAW JA, 1991, J CELL BIOL, V114, P11; SIETSMA JH, 1979, J GEN MICROBIOL, V114, P99, DOI 10.1099/00221287-114-1-99; SURARIT R, 1988, J GEN MICROBIOL, V134, P1723; TREVELYAN WE, 1952, BIOCHEM J, V50, P298, DOI 10.1042/bj0500298; VANRINSUM J, 1991, YEAST, V7, P717, DOI 10.1002/yea.320070707; YAMASHITA K, 1982, METHOD ENZYMOL, V83, P105; ZLOTNIK H, 1984, J BACTERIOL, V159, P1018, DOI 10.1128/JB.159.3.1018-1026.1984	25	226	231	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1170	1178		10.1074/jbc.270.3.1170	http://dx.doi.org/10.1074/jbc.270.3.1170			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836376	hybrid			2022-12-27	WOS:A1995QB15600031
J	SIMON, A; HELLMAN, U; WERNSTEDT, C; ERIKSSON, U				SIMON, A; HELLMAN, U; WERNSTEDT, C; ERIKSSON, U			THE RETINAL-PIGMENT EPITHELIAL-SPECIFIC 11-CIS RETINOL DEHYDROGENASE BELONGS TO THE FAMILY OF SHORT-CHAIN ALCOHOL DEHYDROGENASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; MEMBRANE-RECEPTOR; BOVINE; IDENTIFICATION; SEQUENCE; CDNA; TRANSPORT; RIBOSOMES; INVITRO	We have isolated and partially characterized a 32-kDa membrane-associated protein (p32), which forms a complex with p63, an abundant membrane protein in bovine retinal pigment epithelium. The sequence of a cDNA clone for p32 revealed an open reading frame encoding 318 amino acid residues. Several hydrophobic regions could be identified, suggesting that p32 is an integral membrane protein. A search of data bases identified p32 as a member of the superfamily of short chain alcohol dehydrogenases. Transcripts for p32 were specifically expressed in retinal pigment epithelium. Overexpression of p32 in Cos cells produced a membrane-bound stereospecific 11-cis retinol dehydrogenase, active in the presence of NAD(+) as cofactor but not in the presence of NADP. We propose that p32 is the stereospecific 11-cis retinol dehydrogenase, which catalyzes the final step in the biosynthesis of 11-cis retinaldehyde, the universal chromophore of visual pigments.	LUDWIG INST CANC RES,CTR BIOMED,UPPSALA BRANCH,S-75122 UPPSALA,SWEDEN	Ludwig Institute for Cancer Research	SIMON, A (corresponding author), LUDWIG INST CANC RES,STOCKHOLM BRANCH,BOX 240,S-17177 STOCKHOLM,SWEDEN.			Simon, Andras/0000-0002-1018-1891				ADLER AJ, 1982, BIOCHEM BIOPH RES CO, V108, P1601, DOI 10.1016/S0006-291X(82)80091-0; BAVIK CO, 1991, J BIOL CHEM, V266, P14978; BAVIK CO, 1992, J BIOL CHEM, V267, P23035; BAVIK CO, 1993, J BIOL CHEM, V268, P20540; BERNSTEIN PS, 1987, P NATL ACAD SCI USA, V84, P1849, DOI 10.1073/pnas.84.7.1849; BLISS AF, 1948, J BIOL CHEM, V172, P165; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; BRIDGES CDB, 1984, RETINOIDS, V2, P125; CHURCHILL P, 1992, BIOCHEMISTRY-US, V31, P3793, DOI 10.1021/bi00130a009; DUESTER G, 1994, EXS, V71, P279; DUESTER G, 1991, ALCOHOL CLIN EXP RES, V15, P568, DOI 10.1111/j.1530-0277.1991.tb00562.x; Goodman DS, 1984, RETINOIDS, P41, DOI DOI 10.1016/B978-0-12-658102-7.50008-7; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; HELLER J, 1973, J BIOL CHEM, V248, P6308; HELLER J, 1975, J BIOL CHEM, V250, P3613; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LAI YL, 1982, NATURE, V298, P848, DOI 10.1038/298848a0; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; LIOU GI, 1982, VISION RES, V22, P1457, DOI 10.1016/0042-6989(82)90210-3; Luu The V, 1989, Mol Endocrinol, V3, P1301; PELTOKETO H, 1988, FEBS LETT, V239, P73, DOI 10.1016/0014-5793(88)80548-9; PERSSON B, 1991, EUR J BIOCHEM, V200, P537, DOI 10.1111/j.1432-1033.1991.tb16215.x; POSCH KC, 1991, BIOCHEMISTRY-US, V30, P6224, DOI 10.1021/bi00239a021; RAWLINGS M, 1992, J BIOL CHEM, V267, P5751; ROSENFELD J, 1992, ANAL BIOCHEM, V15, P173; SAARI JC, 1982, J BIOL CHEM, V257, P13329; SAARI JC, 1993, ANAL BIOCHEM, V213, P128, DOI 10.1006/abio.1993.1395; Sambrook J, 1989, MOL CLONING LABORATO; SUZUKI Y, 1993, BIOCHIM BIOPHYS ACTA, V1163, P201, DOI 10.1016/0167-4838(93)90182-Q; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; ZGOMBICKNIGHT M, 1994, J BIOL CHEM, V269, P6790; ZIMMERMAN WF, 1976, EXP EYE RES, V23, P159, DOI 10.1016/0014-4835(76)90199-8; ZIMMERMAN WF, 1976, EXP EYE RES, V21, P325	35	216	226	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1107	1112		10.1074/jbc.270.3.1107	http://dx.doi.org/10.1074/jbc.270.3.1107			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836368	hybrid			2022-12-27	WOS:A1995QB15600023
J	ACKERMANN, EJ; CONDEFRIEBOES, K; DENNIS, EA				ACKERMANN, EJ; CONDEFRIEBOES, K; DENNIS, EA			INHIBITION OF MACROPHAGE CA2+-INDEPENDENT PHOSPHOLIPASE A(2) BY BROMOENOL LACTONE AND TRIFLUOROMETHYL KETONES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-INDEPENDENT PHOSPHOLIPASE-A2; CYTOSOLIC PHOSPHOLIPASE-A2; SUICIDE INHIBITION; CELL-LINE; PURIFICATION; SOLUBILIZATION; CHYMOTRYPSIN; U937	A novel Ca2+-independent phospholipase A(2) (PLA(2)) has recently been purified from the murine macrophage-like cell line P388D(1) (Ackermann, E. J., Kempner, E. S., and Dennis, E. A. (1994) J. Biol. Chem. 269, 9227-9233). This enzyme is now shown to be inhibited by palmitoyl trifluoromethyl ketone (PACOCF(3)), arachidonyl trifluoromethyl ketone (AACOCF(3)), and a bromoenol lactone (EEL). Both PACOCF(3) and AACOCF(3) were found to inhibit the macrophage PLA(2) in a concentration-dependent manner, PACOCF(3) was found to be similar to 4-fold more potent than AACOCF(3), with IC50 values of 3.8 mu M (0.0075 mol fraction) and 15 mu M (0.028 mol fraction), respectively. Reaction progress curves in the presence of either inhibitor were found to be linear, and the PACOCF(3).PLA(2) complex rapidly dissociated upon dilution. BEL was also found to inhibit the macrophage PLA(2) in a concentration-dependent manner, with half-maximal inhibition observed at 60 nM after a 5-min preincubation at 40 degrees C, Inhibition was not reversed after extensive dilution of the enzyme into assay buffer, Treatment of the PLA(2) with EEL resulted in a linear, time-dependent inactivation of activity, and the rate of this inactivation was diminished in the presence of PACOCF(3). In addition, PLA(2) treated with [H-3]BEL resulted in the covalent labeling of a major band at M(r) 80,000. Inactivation of the PLA(2) by 5,5'-dithiobis(2-nitrobenzoic acid) prior to treatment with [H-3]BEL resulted in the near complete lack of labeling consistent with covalent irreversible suicide inhibition of the enzyme. The labeling of a M(r) 80,000 band rather than a M(r) 40,000 band upon treatment with [H-3]BEL distinguishes the macrophage Ca2+-independent PLA(2) from a previously identified myocardial Ca2+-independent PLA(2) and provides strong evidence that the M(r) 80,000 protein is the catalytic subunit.	UNIV CALIF SAN DIEGO,REVELLE COLL,DEPT CHEM & BIOCHEM,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,SCH MED,LA JOLLA,CA 92093	University of California System; University of California San Diego; University of California System; University of California San Diego			Dennis, Edward A./M-5554-2019	Dennis, Edward A./0000-0003-3738-3140; Conde-Frieboes, Kilian/0000-0001-5303-4448	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026171] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-26171] Funding Source: Medline; NIGMS NIH HHS [GM-20501, GM-51606] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACKERMANN EJ, 1994, J BIOL CHEM, V269, P9227; BAEK DJ, 1991, BIOCHEM BIOPH RES CO, V178, P1335, DOI 10.1016/0006-291X(91)91040-J; BARBOUR SE, 1993, J BIOL CHEM, V268, P21875; BARTOLI F, 1994, J BIOL CHEM, V269, P15625; BOIVIN J, 1992, TETRAHEDRON LETT, V33, P1285, DOI 10.1016/S0040-4039(00)91602-2; CLARK JD, 1990, P NATL ACAD SCI USA, V87, P7708, DOI 10.1073/pnas.87.19.7708; DANIELS SB, 1983, J BIOL CHEM, V258, P5046; DENNIS EA, 1987, BIO-TECHNOL, V5, P1294, DOI 10.1038/nbt1287-1294; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; DENNIS EA, 1983, ENZYMES, P307; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; DOLE VP, 1956, J CLIN INVEST, V35, P150, DOI 10.1172/JCI103259; DURLEY RC, 1992, J LABELLED COMPD RAD, V31, P685, DOI 10.1002/jlcr.2580310907; HAZEN SL, 1990, J BIOL CHEM, V265, P10622; HAZEN SL, 1991, J BIOL CHEM, V266, P14526; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; HAZEN SL, 1993, J BIOL CHEM, V268, P9892; IBRAHIM SA, 1967, BIOCHIM BIOPHYS ACTA, V137, P413, DOI 10.1016/0005-2760(67)90122-1; KRAMER RM, 1991, J BIOL CHEM, V266, P5268; LICHTENBERG D, 1983, BIOCHIM BIOPHYS ACTA, V737, P285, DOI 10.1016/0304-4157(83)90004-7; PLESNIAK LA, 1993, BIOCHEMISTRY-US, V32, P5009, DOI 10.1021/bi00070a006; RIENDEAU D, 1994, J BIOL CHEM, V269, P15619; SILVERMANN RB, 1988, MECHANISM BASED ENZY; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; ULEVITCH RJ, 1988, J BIOL CHEM, V263, P3079; VERHEIJ HM, 1981, REV PHYSIOL BIOCH P, V91, P91; ZUPAN LA, 1993, J MED CHEM, V36, P95, DOI 10.1021/jm00053a012	27	378	387	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					445	450		10.1074/jbc.270.1.445	http://dx.doi.org/10.1074/jbc.270.1.445			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814408	hybrid, Green Submitted			2022-12-27	WOS:A1995QA28700070
J	BAJT, ML; GOODMAN, T; MCGUIRE, SL				BAJT, ML; GOODMAN, T; MCGUIRE, SL			BETA(2) (CD18) MUTATIONS ABOLISH LIGAND RECOGNITION BY I-DOMAIN INTEGRINS LFA-1 (ALPHA(L)BETA(2), CD11A/CD18) AND MAC-1 (ALPHA(M)BETA(2), CD11B/CD18)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; COMPLEMENT RECEPTOR TYPE-3; LEUKOCYTE ADHESION GLYCOPROTEIN; FUNCTION ASSOCIATED MOLECULE-1; ALPHA-SUBUNIT; VONWILLEBRAND-FACTOR; COUNTER-RECEPTOR; EPITHELIAL-CELLS; ICAM-1 CD54; CLONING	The ''I'' domains of the beta(2) (CD18) leukocyte integrins are implicated in ligand binding function. Moreover, rather than recognizing linear peptide sequences, this class of integrins generally recognizes multiple discontinuous sites on immunoglobulin superfamily adhesion receptors. A conserved cluster of oxygenated residues is involved in ligand recognition by beta(1) and beta(3) integrins. In the present study, we evaluated the role of this region in the I domain-containing beta(2) integrins. Recombinant alpha(L) beta(2) (LFA-1, CD11a/CD18) and alpha(M) beta(2) (MAC-1, CD11b/CD18) were expressed on COS cells, and function was assessed by adhesion to ICAM-1 or iC3b, respectively. Alanine substitution at position Asp(134) or Ser(136) in beta(2) produced a complete loss in the capacity of both alpha(L) beta(2) and alpha(M) beta(2) to support cell adhesion. In contrast, substitution at Asp(128) or Ser(138) resulted in loss of beta(2) surface expression when co-transfected with alpha(L) (CD11a) or alpha(M) (CD11b). These data provide the first evidence for involvement of the beta(2) subunit in ligand binding to I domain integrins.			BAJT, ML (corresponding author), UPJOHN CO,UPJOHN LABS,CELL BIOL & INFLAMMAT RES,KALAMAZOO,MI 49001, USA.							ALTIERI DC, 1988, J BIOL CHEM, V263, P7007; ANDERSON DC, 1994, METABOLIC BASIS INHE; ARGRAVES WS, 1987, J CELL BIOL, V105, P1183, DOI 10.1083/jcb.105.3.1183; ARNAOUT MA, 1990, IMMUNOL REV, V114, P145, DOI 10.1111/j.1600-065X.1990.tb00564.x; ARNAOUT MA, 1988, J CELL BIOL, V106, P2153, DOI 10.1083/jcb.106.6.2153; BAJT ML, 1992, J BIOL CHEM, V267, P22211; BAJT ML, 1994, J BIOL CHEM, V269, P20913; BELLER DI, 1982, J EXP MED, V156, P1000, DOI 10.1084/jem.156.4.1000; BILSLAND CAG, 1994, J IMMUNOL, V152, P4582; CORBI AL, 1987, EMBO J, V6, P4023, DOI 10.1002/j.1460-2075.1987.tb02746.x; CORBI AL, 1988, J BIOL CHEM, V263, P12403; DEFOUGEROLLES AR, 1992, J EXP MED, V175, P185, DOI 10.1084/jem.175.1.185; DIAMOND MS, 1993, J CELL BIOL, V120, P1031, DOI 10.1083/jcb.120.4.1031; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; DRANSFIELD I, 1989, EMBO J, V12, P3759; DREYER WJ, 1991, CIRCULATION, V84, P400, DOI 10.1161/01.CIR.84.1.400; DSOUZA SE, 1988, SCIENCE, V242, P91, DOI 10.1126/science.3262922; ERLE DJ, 1991, J BIOL CHEM, V266, P11009; FITZGERALD LA, 1987, J BIOL CHEM, V262, P3936; GINSBERG MH, 1993, THROMB HAEMOSTASIS, V79, P87; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HIBBS ML, 1990, J CLIN INVEST, V85, P674, DOI 10.1172/JCI114491; HOGERVORST F, 1990, EMBO J, V9, P765, DOI 10.1002/j.1460-2075.1990.tb08171.x; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; KAMATA T, 1994, J BIOL CHEM, V269, P9659; KISHIMOTO TK, 1987, CELL, V48, P681, DOI 10.1016/0092-8674(87)90246-7; KLOCZEWIAK M, 1984, BIOCHEMISTRY-US, V23, P1767, DOI 10.1021/bi00303a028; KRETSINGER RH, 1980, CRC CR REV BIOCH MOL, V8, P119, DOI 10.3109/10409238009105467; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LARSON RS, 1989, J CELL BIOL, V108, P703, DOI 10.1083/jcb.108.2.703; LOFTUS JC, 1990, SCIENCE, V249, P915, DOI 10.1126/science.2392682; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; MILLER LJ, 1986, J IMMUNOL, V137, P2891; MOYLE M, 1991, J BIOL CHEM, V266, P19650; NILSSON UR, 1993, SCAND J IMMUNOL, V37, P349, DOI 10.1111/j.1365-3083.1993.tb02564.x; PYTELA R, 1988, EMBO J, V7, P1371, DOI 10.1002/j.1460-2075.1988.tb02953.x; RAMASWAMY H, 1990, EMBO J, V9, P1561, DOI 10.1002/j.1460-2075.1990.tb08275.x; RANDI AM, 1994, J BIOL CHEM, V269, P12395; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; SANCHEZMADRID F, 1983, J EXP MED, V158, P1785, DOI 10.1084/jem.158.6.1785; SHEPPARD D, 1990, J BIOL CHEM, V265, P11502; SHUSTER DE, 1992, P NATL ACAD SCI USA, V89, P9225, DOI 10.1073/pnas.89.19.9225; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STANLEY P, 1994, EMBO J, V13, P1790, DOI 10.1002/j.1460-2075.1994.tb06447.x; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; STAUNTON DE, 1989, NATURE, V339, P61, DOI 10.1038/339061a0; SUZUKI S, 1990, EMBO J, V9, P757, DOI 10.1002/j.1460-2075.1990.tb08170.x; TAKADA Y, 1992, J CELL BIOL, V119, P913, DOI 10.1083/jcb.119.4.913; TANIGUCHISIDLE A, 1992, J BIOL CHEM, V267, P635; WAYNER EA, 1989, J CELL BIOL, V109, P1321, DOI 10.1083/jcb.109.3.1321; WEGNER CD, 1990, SCIENCE, V247, P567; WRIGHT SD, 1988, P NATL ACAD SCI USA, V85, P7734, DOI 10.1073/pnas.85.20.7734; WRIGHT SD, 1983, P NATL ACAD SCI-BIOL, V80, P5699, DOI 10.1073/pnas.80.18.5699; YONG K, 1990, BLOOD REV, V4, P211, DOI 10.1016/0268-960X(90)90001-9	56	83	83	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					94	98		10.1074/jbc.270.1.94	http://dx.doi.org/10.1074/jbc.270.1.94			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814426	hybrid			2022-12-27	WOS:A1995QA28700020
J	RANDRIAMAMPITA, C; TSIEN, RY				RANDRIAMAMPITA, C; TSIEN, RY			DEGRADATION OF A CALCIUM INFLUX FACTOR (CIF) CAN BE BLOCKED BY PHOSPHATASE INHIBITORS OR CHELATION OF CA2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CYCLOSPORINE-A; OKADAIC ACID; CA-2+ ENTRY; STORES; DEPLETION; OSCILLATIONS; MECHANISM; MESSENGER; CELLS	In many cell types, depletion of Ca2+ stores causes activation of Ca2+ influx by a mechanism whose molecular basis remains unclear, We recently described a new messenger that is released by empty Ca2+ stores and that activates Ca2+ influx in heterologous cells (Randriamampita, C. & Tsien, R. Y. (1993) Nature 364, 809-814). This factor, provisionally named CIF (for Ca2+ influx factor), seems to be a small nonprotein factor possessing a phosphate group. Meanwhile Parekh et al, reported that okadaic acid, an inhibitor of protein phosphatases 1 and 2A, potentiates Ca2+ influx in Xenopus oocytes (Parekh, A. B., Terlau, H. and Stuhmer, W. (1993) Nature 364, 814-818). A link between these two observations is presented in this paper, We show that in astrocytoma cells, okadaic acid and cyclosporin A (an inhibitor of calcineurin) both potentiate the Ca2+ elevations due to low doses of CIF, thapsigargin, or carbachol. In lymphocytes, okadaic acid potentiates the Ca2+ elevations due to low doses of phytohemagglutinin and increases the amount of extractable CIF. CIF degradation can be observed in cell-free homogenates of lymphocytes and is prevented by the above phosphatase inhibitors, an effect that can at least partly explain their potentiation of Ca2+ influx. CIF degradation is also prevented by lowering free Ca2+ concentrations, which could be a feedback mechanism to enhance Ca2+ influx when cells are depleted of Ca2+.	UNIV CALIF SAN DIEGO,HOWARD HUGHES MED INST,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,DEPT PHARMACOL,LA JOLLA,CA 92093	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	RANDRIAMAMPITA, C (corresponding author), ECOLE NORMALE SUPER,NEUROBIOL LAB,46 RUE ULM,F-75005 PARIS,FRANCE.			Randriamampita, Clotilde/0000-0001-8594-7831	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027177, R01NS027177] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-27177] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALLOU LM, 1986, ENZYMES, V17, P311; BERLIN RD, 1993, CELL CALCIUM, V144, P379; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; DONNADIEU E, 1994, CURR BIOL, V4, P584, DOI 10.1016/S0960-9822(00)00130-5; FASOLATO C, 1994, TRENDS PHARMACOL SCI, V15, P77, DOI 10.1016/0165-6147(94)90282-8; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; LEWIS RS, 1989, CELL REGUL, V1, P99, DOI 10.1091/mbc.1.1.99; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MISSIAEN L, 1994, J BIOL CHEM, V269, P5817; MONTERO M, 1992, BIOCHEM J, V288, P519, DOI 10.1042/bj2880519; NISHIWAKI S, 1990, CARCINOGENESIS, V11, P1837, DOI 10.1093/carcin/11.10.1837; PAREKH AB, 1993, NATURE, V364, P814, DOI 10.1038/364814a0; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	20	92	92	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					29	32		10.1074/jbc.270.1.29	http://dx.doi.org/10.1074/jbc.270.1.29			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814389	hybrid			2022-12-27	WOS:A1995QA28700008
J	SAKAKIBARA, J; WATANABE, R; KANAI, Y; ONO, T				SAKAKIBARA, J; WATANABE, R; KANAI, Y; ONO, T			MOLECULAR-CLONING AND EXPRESSION OF RAT SQUALENE EPOXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CHOLESTEROL-BIOSYNTHESIS; LIVER MICROSOMES; INHIBITOR; 2,3-OXIDOSQUALENE; SEQUENCES; PROTEINS; ENZYMES; CELLS	Squalene epoxidase (SE) (EC 1.14.99.7) catalyzes the first oxygenation step in sterol biosynthesis and is suggested to be one of the rate-limiting enzymes in this pathway, Rat SE cDNA was isolated by selecting yeast transformants expressing rat cDNA in the presence of terbinafine, an inhibitor specific for fungal SE. The expression of rat SE in the isolated terbinafine resistant clone was confirmed by its survival in the presence of either terbinafine or an inhibitor specific for mammalian SE, NB-598, but not in the presence of both terbinafine and NB-598. Rat SE polypeptide deduced from the nucleotide sequence contains 573 amino acids, and its molecular weight is 63,950 Da. The amino acid sequence reveals one potential transmembrane domain, a hydrophobic segment (Leu(27) to Tyr(43)) in the NH2-terminal region. This region also contains a beta 1-alpha A-beta 2 motif, which is the consensus sequence for an FAD binding domain, suggesting that SE is a flavoenzyme. This deduced rat SE sequence is 30.2% identical to the ERG 1 gene, which encodes SE from an allylamine-resistant Saccharomyces cerevisiae mutant. Expression of a full-length rat SE protein in Escherichia coli confirms this polypeptide as a functional SE. This is the first report of the molecular cloning of mammalian SE.	NIIGATA UNIV,FAC AGR,DEPT AGR CHEM,NIIGATA 95021,JAPAN	Niigata University	SAKAKIBARA, J (corresponding author), NIIGATA UNIV,SCH MED,DEPT BIOCHEM,1-757 ASAHIMACHIDORI,NIIGATA 951,JAPAN.							BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; CHANG TY, 1979, J BIOL CHEM, V254, P1258; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; GIBBS JB, 1991, CELL, V65, P1, DOI 10.1016/0092-8674(91)90352-Y; GLOMSET JA, 1993, TRENDS BIOCH SOC, V4, P230; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; GOLLUB EG, 1977, J BIOL CHEM, V252, P2846; GOLLUB EG, 1974, BIOCHEM BIOPH RES CO, V56, P471, DOI 10.1016/0006-291X(74)90866-3; GONZALEZ R, 1979, ARCH BIOCHEM BIOPHYS, V196, P574, DOI 10.1016/0003-9861(79)90310-2; HIDAKA Y, 1990, J LIPID RES, V31, P2087; HORIE M, 1990, J BIOL CHEM, V265, P18075; JANDROSITZ A, 1991, GENE, V107, P155, DOI 10.1016/0378-1119(91)90310-8; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KYTE J, 1982, J MOL BIOL, V175, P105; NELSON JA, 1981, J BIOL CHEM, V256, P1067; NELSON JA, 1978, J AM CHEM SOC, V100, P4900, DOI 10.1021/ja00483a050; OKAZAKI K, 1991, NUCLEIC ACIDS RES, V18, P6485; ONO T, 1985, METHOD ENZYMOL, V110, P375; ONO T, 1975, J BIOL CHEM, V250, P1571; ONO T, 1982, BIOCHIM BIOPHYS ACTA, V709, P84, DOI 10.1016/0167-4838(82)90424-1; ONO T, 1979, BIOCH ASPECTS NUTRIT, P115; POPJAK G, 1978, P R SOC LOND B BIOL, V232, P273; RICHARD DS, 1989, P NATL ACAD SCI USA, V86, P1421, DOI 10.1073/pnas.86.4.1421; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; Rudney Harry, 1993, Current Opinion in Lipidology, V4, P230, DOI 10.1097/00041433-199306000-00009; RYDER NS, 1985, BIOCHEM J, V230, P765, DOI 10.1042/bj2300765; SATOH T, 1990, J LIPID RES, V31, P2095; SAUCIER SE, 1985, J BIOL CHEM, V260, P4571; SCHULZ GE, 1982, J MOL BIOL, V160, P287, DOI 10.1016/0022-2836(82)90177-2; SPENCER TA, 1994, ACCOUNTS CHEM RES, V27, P83, DOI 10.1021/ar00039a004; Steinberg D., 1988, ATHEROSCLER REV, V18, P1; TAI HH, 1972, J BIOL CHEM, V247, P3767; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; YAMAMOTO S, 1970, J BIOL CHEM, V245, P1670	34	71	79	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					17	20		10.1074/jbc.270.1.17	http://dx.doi.org/10.1074/jbc.270.1.17			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814369	hybrid			2022-12-27	WOS:A1995QA28700005
J	DEB, A; BHATTACHARYYA, D; DAS, J				DEB, A; BHATTACHARYYA, D; DAS, J			A 25-KDA BETA-LACTAM-INDUCED OUTER-MEMBRANE PROTEIN OF VIBRIO-CHOLERAE - PURIFICATION AND CHARACTERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA; POLYACRYLAMIDE GELS; CELLS; ANTIBIOTICS; RESOLUTION; MUTANTS; PORIN	A 25-kDa outer membrane protein, induced following treatment of Vibrio cholerae cells with beta-lactam antibiotics and constituting about 8-10% of the total outer membrane proteins of beta-lactam-resistant mutants, has been purified to homogeneity. It is a basic (pI 8.5) protein rich in beta-sheet structure and is a homodimer, the monomers being held together by hydrophobic interactions. The effective hydrophobicity of the protein is low, and a large part of the protein is exposed on the surface of the outer membrane. The protein does not have beta-lactamase or autolytic activity and is not a penicillin-binding protein. The Stoke's radius of the 25-kDa protein (26 A) is comparable to the pore size of the V. cholerae OmpF-like porin. Proteoliposome swelling assay showed that the 25-kDa protein might block the pores of OmpF through which beta-lactam antibiotics normally enter the cells. Twenty-two amino acid residues from the N-terminal end of the 25-kDa protein have been sequenced, and a 32-mer oligonucleotide probe was synthesized using the amino acid residues 2-12. This probe was used to identify the gene encoding the 25-kDa protein. The beta-lactam-resistant cells are insensitive to changes in the osmolarity of the growth medium in contrast to the wild type cells which exhibit osmoregulation of OmpF and OmpC synthesis. All beta-lactam-resistant mutants examined are resistant to novobiocin.	INDIAN INST CHEM BIOL, DEPT BIOPHYS, Kolkata 700032, W BENGAL, INDIA; INDIAN INST CHEM BIOL, DIV PROT ENGN, Kolkata 700032, W BENGAL, INDIA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)								CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; CHAKRABARTI D, 1984, J GEN MICROBIOL, V130, P2023; CHEN YH, 1971, BIOCHEM BIOPH RES CO, V44, P1285, DOI 10.1016/S0006-291X(71)80225-5; CORBETT RJT, 1984, BIOCHEMISTRY-US, V23, P1888, DOI 10.1021/bi00303a047; HALES BA, 1985, J ANTIMICROB CHEMOTH, V16, P671, DOI 10.1093/jac/16.5.671; KATO A, 1980, BIOCHIM BIOPHYS ACTA, V624, P13, DOI 10.1016/0005-2795(80)90220-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOHIA A, 1984, J GEN MICROBIOL, V130, P2027; LOHIA A, 1985, J BACTERIOL, V163, P1158, DOI 10.1128/JB.163.3.1158-1166.1985; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUGTENBERG B, 1975, FEBS LETT, V58, P254, DOI 10.1016/0014-5793(75)80272-9; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; NIKAIDO H, 1991, J BIOL CHEM, V266, P770; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PAUL S, 1992, J GEN MICROBIOL, V138, P755, DOI 10.1099/00221287-138-4-755; PRESTIDGE LS, 1957, J BACTERIOL, V74, P48, DOI 10.1128/JB.74.1.48-59.1957; ROY NK, 1982, J GEN MICROBIOL, V128, P349; SAMMONS DW, 1981, ELECTROPHORESIS, V2, P135, DOI 10.1002/elps.1150020303; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHIFFERLI DM, 1988, ANTIMICROB AGENTS CH, V32, P1609, DOI 10.1128/AAC.32.11.1609; SCHOENLE EJ, 1984, J BIOL CHEM, V259, P2112; SEN K, 1991, J BACTERIOL, V173, P926, DOI 10.1128/jb.173.2.926-928.1991; SENGUPTA TK, 1990, BIOCHEM BIOPH RES CO, V171, P1175, DOI 10.1016/0006-291X(90)90808-Z; SENGUPTA TK, 1992, ANTIMICROB AGENTS CH, V36, P788, DOI 10.1128/AAC.36.4.788; SIEHNEL R, 1990, MOL MICROBIOL, V4, P831, DOI 10.1111/j.1365-2958.1990.tb00653.x; SUGARMAN B, 1979, J INFECT DIS, V140, P622, DOI 10.1093/infdis/140.4.622; SUKUPOLVI S, 1989, BIOCHIM BIOPHYS ACTA, V988, P377, DOI 10.1016/0304-4157(89)90011-7; TAI PC, 1985, ANAL BIOCHEM, V144, P199, DOI 10.1016/0003-2697(85)90105-8; ZACHARIUS RM, 1969, ANAL BIOCHEM, V30, P148, DOI 10.1016/0003-2697(69)90383-2	30	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					2914	2920		10.1074/jbc.270.7.2914	http://dx.doi.org/10.1074/jbc.270.7.2914			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852369	hybrid			2022-12-27	WOS:A1995QG47100008
J	NIINO, YS; CHAKRABORTY, S; BROWN, BJ; MASSEY, V				NIINO, YS; CHAKRABORTY, S; BROWN, BJ; MASSEY, V			A NEW OLD YELLOW ENZYME OF SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST; SEQUENCE; EXPRESSION; CLONING; OXIDASE; CONSTANTS; PROTEINS; RNA	In 1993, the first gene of Old Yellow Enzyme (OYE) of Saccharomyces cerevisiae was cloned (Stott, K,, Saito, K,, Thiele, D. J,, and Massey, V, (1993) J, Biol, Chem, 268, 6097-6106) and named OYE2 to distinguish it from the first OYE gene cloned from Saccharomyces carlsbergenesis (Saito, K,, Thiele, D, J,, Davio, M,, Lockridge, O., and Massey, V, (1991) J, Biol, Chem, 266, 20720-20724), The analysis of an OYE2 deletion mutant suggested that S, cerevisiae had at least two OYE genes. In the present study, we cloned a new OYE species named OYE3 and analyzed the OYE3 protein expressed in Escherichia coli, OYE3 consists of 400 amino acid residues and its molecular mass calculated by electrospray mass spectrometry is 44,788 daltons, in good agreement with the value of 44,920 daltons predicted from the amino acid sequence derived from the DNA sequence, In the downstream region of the OYE3 gene, the cytochrome oxidase (COX10) gene exists with a 426-base pair intermediate sequence, Some of the physicochemical and kinetic properties of OYE2 and OYE3 have been determined. Although the two enzymes are clearly closely related, they show differences in ligand binding properties and in their catalytic activities with oxygen and cyclohexen-2-one as accepters.	UNIV MICHIGAN,SCH MED,DEPT BIOL CHEM,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan					NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM011106, R01GM011106] Funding Source: NIH RePORTER; NCRR NIH HHS [M01RR00042] Funding Source: Medline; NIGMS NIH HHS [GM 11106] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMOVITZ AS, 1975, J BIOL CHEM, V251, P5321; BEINERT WD, 1985, EUR J BIOCHEM, V152, P573, DOI 10.1111/j.1432-1033.1985.tb09234.x; Bevington P. R., 1969, DATA REDUCTION ERROR, P235; BOYED G, 1992, FEBS LETT, V308, P271; Bright H.B., 1975, ENZYMES, V12B, P421; Brown BJ, 1994, FLAVINS AND FLAVOPROTEINS 1993, P391; CIGAN AM, 1987, GENE, V59, P1; CLELAND WW, 1975, BIOCHEMISTRY-US, V14, P3220, DOI 10.1021/bi00685a029; DONAHUE TF, 1990, METHOD ENZYMOL, V185, P366; FELDMAN D, 1984, P NATL ACAD SCI-BIOL, V81, P4722, DOI 10.1073/pnas.81.15.4722; FISH KM, 1990, J BIOL CHEM, V265, P19665; Fox KM, 1994, FLAVINS AND FLAVOPROTEINS 1993, P381; FRANKLUND CV, 1993, J BACTERIOL, V175, P3002, DOI 10.1128/JB.175.10.3002-3012.1993; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HENIKOFF S, 1983, CELL, V33, P607, DOI 10.1016/0092-8674(83)90441-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU XL, 1993, BIOCHIM BIOPHYS ACTA, V1174, P187, DOI 10.1016/0167-4781(93)90113-R; MADANI ND, 1994, P NATL ACAD SCI USA, V91, P922, DOI 10.1073/pnas.91.3.922; MALLONEE DH, 1990, J BACTERIOL, V172, P7011, DOI 10.1128/jb.172.12.7011-7019.1990; MASSEY V, 1986, J BIOL CHEM, V261, P1215; MASSEY V, 1991, FLAVINS AND FLAVOPROTEINS 1990, P59; Massey V, 1994, FLAVINS AND FLAVOPROTEINS 1993, P371; MIURA R, 1986, J BIOCHEM-TOKYO, V99, P901, DOI 10.1093/oxfordjournals.jbchem.a135551; NAKAMURA T, 1965, J BIOCHEM, V57, P554, DOI 10.1093/oxfordjournals.jbchem.a128114; NOBREGA MP, 1990, J BIOL CHEM, V265, P14220; NOEL D, 1979, BIOCHEMISTRY-US, V18, P4159, DOI 10.1021/bi00586a017; SAIKI RK, 1993, SCIENCE, V239, P487; SAITO K, 1991, J BIOL CHEM, V266, P20720; Sambrook J, 1989, MOL CLONING LABORATO; SCHOPFER LM, 1991, STUDY ENZYMES, V2, P247; SHERMAN F, 1986, LABORATORY COURSE MA; STOTT K, 1993, J BIOL CHEM, V268, P6097; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TANAKA S, 1989, CELL, V57, P675, DOI 10.1016/0092-8674(89)90136-0; Theorell H, 1935, BIOCHEM Z, V275, P344; Warburg O, 1933, BIOCHEM Z, V266, P377; ZARET KS, 1982, CELL, V28, P563, DOI 10.1016/0092-8674(82)90211-2	39	103	113	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					1983	1991		10.1074/jbc.270.5.1983	http://dx.doi.org/10.1074/jbc.270.5.1983			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836424	hybrid			2022-12-27	WOS:A1995QE49300004
J	BINSCHECK, T; BARTELS, F; BERGEL, H; BIGALKE, H; YAMASAKI, S; HAYASHI, T; NIEMANN, H; POHLNER, J				BINSCHECK, T; BARTELS, F; BERGEL, H; BIGALKE, H; YAMASAKI, S; HAYASHI, T; NIEMANN, H; POHLNER, J			IGA PROTEASE FROM NEISSERIA-GONORRHOEAE INHIBITS EXOCYTOSIS IN BOVINE CHROMAFFIN CELLS LIKE TETANUS TOXIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOTULINUM-A NEUROTOXINS; NEUROTRANSMITTER RELEASE; CLEAVAGE; SYNAPTOBREVIN; GANGLIOSIDES; CELLUBREVIN; FUSION	When tetanus toxin from Clostridium tetani or IgA protease from Neisseria gonorrhoeae is translocated artificially into the cytosol of chromaffin cells, both enzymes inhibit calcium-induced exocytosis, which can be measured by changes in membrane capacitance. The block of exocytosis caused by both proteases cannot be reversed by enforced stimulation with increased calcium concentration. This effect differs from the botulinum A neurotoxin-induced block of exocytosis that can be overcome by elevation of the intracellular calcium concentration. Tetanus toxin is about 50-fold more potent than IgA protease in cells stimulated by carbachol. In this case, the release of [H-3]noradrenaline was determined. Trypsin and endoprotease Glu-C are hardly effective and only at concentrations that disturb the integrity of the cells. Like tetanus toxin, IgA protease also splits synaptobrevin II, though at a different site of the molecule. However, unlike tetanus toxin, it does not cleave cellubrevin. It is concluded that the membranes of chromaffin vesicles contain synaptobrevin II, which, as in neurons, appears to play a crucial part in exocytosis.	HANNOVER MED SCH,INST TOXICOL,D-30625 HANNOVER,GERMANY; FED RES CTR VIRUS DIS ANIM,DEPT MICROBIOL,D-72001 TUBINGEN,GERMANY; MAX PLANCK INST BIOL,D-72076 TUBINGEN,GERMANY	Hannover Medical School; Max Planck Society								ASHTON AC, 1991, J NEUROCHEM, V56, P827, DOI 10.1111/j.1471-4159.1991.tb01998.x; BARTELS F, 1994, J BIOL CHEM, V269, P8122; BARTELS F, 1992, INFECT IMMUN, V60, P302, DOI 10.1128/IAI.60.1.302-307.1992; BIGALKE H, 1993, BOTULINUM AND TETANUS NEUROTOXINS, P241; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; GALLI T, 1994, J CELL BIOL, V125, P1015, DOI 10.1083/jcb.125.5.1015; HELL JW, 1988, EMBO J, V7, P3023, DOI 10.1002/j.1460-2075.1988.tb03166.x; KISTNER A, 1992, N-S ARCH PHARMACOL, V343, P323; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDAU M, 1989, PLFUGERS ARCH EUR J, V411, P137; LINK E, 1993, J BIOL CHEM, V268, P18423; LINK E, 1992, BIOCHEM BIOPH RES CO, V189, P1017, DOI 10.1016/0006-291X(92)92305-H; LIVETT BG, 1984, PHYSIOL REV, V64, P1103, DOI 10.1152/physrev.1984.64.4.1103; MARXEN P, 1989, TOXICON, V27, P849, DOI 10.1016/0041-0101(89)90097-4; MARXEN P, 1991, N-S ARCH PHARMACOL, V344, P387; MARXEN P, 1989, NEUROSCI LETT, V107, P261, DOI 10.1016/0304-3940(89)90828-8; MAYER T, 1988, J BIOL CHEM, V263, P14956; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; NEHER E, 1988, NEUROSCIENCE, V26, P727, DOI 10.1016/0306-4522(88)90094-2; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; PENNER R, 1986, NATURE, V324, P76, DOI 10.1038/324076a0; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1992, EMBO J, V11, P3577, DOI 10.1002/j.1460-2075.1992.tb05441.x; SIMPSON DA, 1988, J BACTERIOL, V170, P1866, DOI 10.1128/jb.170.4.1866-1873.1988; WOOD SG, 1991, INFECT IMMUN, V59, P1818, DOI 10.1128/IAI.59.5.1818-1822.1991; YAMASAKI S, 1994, J BIOL CHEM, V269, P12764; YAVIN E, 1994, J TOXICOL-TOXIN REV, V13, P101, DOI 10.3109/15569549409006482	27	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1770	1774		10.1074/jbc.270.4.1770	http://dx.doi.org/10.1074/jbc.270.4.1770			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829513				2022-12-27	WOS:A1995QD20400046
J	GOLDSMITH, ME; GUDAS, JM; SCHNEIDER, E; COWAN, KH				GOLDSMITH, ME; GUDAS, JM; SCHNEIDER, E; COWAN, KH			WILD-TYPE P53 STIMULATES EXPRESSION FROM THE HUMAN MULTIDRUG-RESISTANCE PROMOTER IN A P53-NEGATIVE CELL-LINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; P-GLYCOPROTEIN GENE; RNA POLYMERASE-II; HUMAN MDR1 GENE; DNA-BINDING; LUNG-CANCER; HEAT-SHOCK; MUTANT P53; TRANSCRIPTION; SEQUENCE	The effect of human wild type and mutant p53 proteins on the human multidrug resistance (MDR1) promoter was studied in a p53-negative human cell line. Transient expression of MDR1 promoter-chloramphenicol acetyltransferase reporter gene constructs (MDRCAT) cotransfected with p53 expression vectors was analyzed in H358 lung carcinoma cells. Cotransfection with a wild type p53 expression vector stimulated MDRCAT activity, while cotransfection with mutant p53 expression vectors altered at amino acid positions 181, 252, 258, or 273 failed to stimulate expression, Wild type p53 stimulation of MDRCAT activity was time dependent with maximal expression occurring 24-30 h following transfection and correlating with high p53 protein levels, MDR1 promoter deletion analysis suggested that the sequences involved in wild type p53 stimulation of MDRCAT activity were contained within the region from -39 to +53 relative to the start of transcription at +1. This region contains no TATA or p53 consensus binding sequence but does contain an initiator sequence. Wild type p53 stimulation of MDRCAT expression also occurred in parental and doxorubicin-resistant SW620 colon and parental 2780 ovarian cancer cell lines, indicating that wild type p53-mediated simulation of the MDR1 promoter is not restricted to a single cell line.			GOLDSMITH, ME (corresponding author), NCI,MED BRANCH,BLDG 10,RM 12N226,BETHESDA,MD 20892, USA.							AGOFF SN, 1993, SCIENCE, V259, P84, DOI 10.1126/science.8418500; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BORELLINI F, 1993, J BIOL CHEM, V268, P7928; CHAUDHARY PM, 1993, J NATL CANCER I, V85, P632, DOI 10.1093/jnci/85.8.632; CHEN JY, 1993, ONCOGENE, V8, P2159; CHIN KV, 1990, J BIOL CHEM, V265, P221; CHIN KV, 1992, SCIENCE, V255, P459, DOI 10.1126/science.1346476; CHIN KV, 1990, CELL GROWTH DIFFER, V1, P361; CORNWELL MM, 1990, CELL GROWTH DIFFER, V1, P607; CORNWELL MM, 1993, J BIOL CHEM, V268, P19505; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELROUBY S, 1993, BLOOD, V82, P3452; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; FREBOURG T, 1992, P NATL ACAD SCI USA, V89, P6413, DOI 10.1073/pnas.89.14.6413; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; GOLDSMITH ME, 1993, J BIOL CHEM, V268, P5856; GOLDSTEIN LJ, 1989, J NATL CANCER I, V81, P116, DOI 10.1093/jnci/81.2.116; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; GUDAS JM, 1994, CELL GROWTH DIFFER, V5, P295; JUVEN T, 1993, ONCOGENE, V8, P3411; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; KIOKA N, 1992, FEBS LETT, V301, P37, DOI 10.1016/0014-5793(92)80205-U; KOHNO K, 1990, J BIOL CHEM, V265, P19690; KOHNO K, 1989, BIOCHEM BIOPH RES CO, V165, P1415, DOI 10.1016/0006-291X(89)92761-7; LAI GM, 1991, INT J CANCER, V49, P696, DOI 10.1002/ijc.2910490512; LEVINE AJ, 1994, BRIT J CANCER, V69, P409, DOI 10.1038/bjc.1994.76; LOUIE KG, 1986, BIOCHEM PHARMACOL, V35, P467, DOI 10.1016/0006-2952(86)90221-2; MACK DH, 1993, NATURE, V363, P281, DOI 10.1038/363281a0; MADDEN MJ, 1993, J BIOL CHEM, V268, P8290; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; MARGULIES L, 1993, J BIOL CHEM, V268, P15096; MARTIN DW, 1993, J BIOL CHEM, V268, P13062; MICKLEY LA, 1989, J BIOL CHEM, V264, P18031; MITSUDOMI T, 1992, ONCOGENE, V7, P171; MORRIS GF, 1990, J BIOL CHEM, V265, P16116; OSHEAGREENFIELD A, 1992, J BIOL CHEM, V267, P1391; PIETENPOL JA, 1994, P NATL ACAD SCI USA, V91, P1998, DOI 10.1073/pnas.91.6.1998; PIETENPOL JA, 1993, NATURE, V365, P17, DOI 10.1038/365017a0; PREUDHOMME C, 1993, LEUKEMIA, V7, P1888; RENNINSON J, 1993, BRIT J CANCER, V69, P609; SCHNEIDER E, 1994, CANCER RES, V54, P152; SETO E, 1992, P NATL ACAD SCI USA, V89, P12028, DOI 10.1073/pnas.89.24.12028; SUBLER MA, 1992, J VIROL, V66, P4757, DOI 10.1128/JVI.66.8.4757-4762.1992; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; UCHIUMI T, 1993, CELL GROWTH DIFFER, V4, P147; UEDA K, 1987, J BIOL CHEM, V262, P17432; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; WEIS L, 1992, FASEB J, V6, P3300, DOI 10.1096/fasebj.6.14.1426767; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; YU LJ, 1993, J BIOL CHEM, V268, P7520; ZAMBETTI GP, 1992, GENE DEV, V6, P1143, DOI 10.1101/gad.6.7.1143; ZAMBETTI GP, 1993, FASEB J, V7, P855, DOI 10.1096/fasebj.7.10.8344485; ZASTAWNY RL, 1993, ONCOGENE, V8, P1529; ZHANG W, 1993, ONCOGENE, V8, P2555	59	63	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1894	1898		10.1074/jbc.270.4.1894	http://dx.doi.org/10.1074/jbc.270.4.1894			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829527	hybrid			2022-12-27	WOS:A1995QD20400062
J	HANSEN, PA; GULVE, EA; MARSHALL, BA; GAO, JP; PESSIN, JE; HOLLOSZY, JO; MUECKLER, M				HANSEN, PA; GULVE, EA; MARSHALL, BA; GAO, JP; PESSIN, JE; HOLLOSZY, JO; MUECKLER, M			SKELETAL-MUSCLE GLUCOSE-TRANSPORT AND METABOLISM ARE ENHANCED IN TRANSGENIC MICE OVEREXPRESSING THE GLUT4 GLUCOSE-TRANSPORTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESPONSIVE TISSUES; INDUCED TRANSLOCATION; EXERCISE; PROTEIN; CLONING; IDENTIFICATION; SEQUENCE; RATS; GENE	Skeletal muscle glucose transport and metabolism were studied in a line of transgenic mice overexpressing the human Glut4 facilitative glucose transporter, Skeletal muscle Glut4 protein levels were increased 2-4-fold in transgenic animals relative to their nontransgenic litter mates, Glut4 overexpression increased total transport activity (measured with 1 mM a deoxy-D-glucose) in the isolated extensor digitorum brevis muscle in the presence of insulin; this increase was due to 1) an increase in basal glucose transport (0.8 +/- 0.1 versus 0.5 +/- 0.1 mu mol.ml(-1).20 min(-1) in transgenic and control mice, respectively) and 2) an increase in insulin-stimulated transport (1.5 +/- 0.1 versus 0.8 +/- 0.1 mu mol.ml(-1).20 min(-1) above basal transport in transgenic and control mice, respectively), Glut4 overexpression also increased glucose transport stimulated by muscle contractions. In addition, glycolysis and glucose incorporation into glycogen were enhanced in muscle isolated from transgenic mice compared to controls, These data demonstrate that Glut4 overexpression in skeletal muscle increases insulin and contraction-stimulated glucose transport activity and glucose metabolism, These findings are consistent with the role of Glut4 as the primary mediator of transport stimulated by insulin or contractions.	WASHINGTON UNIV, SCH MED, DEPT CELL BIOL & PHYSIOL, ST LOUIS, MO 63110 USA; UNIV IOWA, DEPT PHYSIOL & BIOPHYS, IOWA CITY, IA 52242 USA	Washington University (WUSTL); University of Iowa	HANSEN, PA (corresponding author), WASHINGTON UNIV, SCH MED,DEPT MED,APPL PHYSIOL SECT,4566 SCOTT AVE, BOX 8113, ST LOUIS, MO 63110 USA.		Mueckler, Mike M/F-6115-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038495, R01DK018986, R01DK042452] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK020541, DK38495, DK18986, DK42452] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; BIRNBAUM MJ, 1986, P NATL ACAD SCI USA, V83, P5784, DOI 10.1073/pnas.83.16.5784; BURANT CF, 1991, RECENT PROG HORM RES, V47, P349; CHARRON MJ, 1989, P NATL ACAD SCI USA, V86, P2535, DOI 10.1073/pnas.86.8.2535; CONSTABLE SH, 1988, J APPL PHYSIOL, V64, P2329, DOI 10.1152/jappl.1988.64.6.2329; DEEMS RO, 1994, BIOCHEM BIOPH RES CO, V199, P662, DOI 10.1006/bbrc.1994.1279; DEFRONZO RA, 1981, J CLIN INVEST, V68, P1468, DOI 10.1172/JCI110399; DOUEN AG, 1990, J BIOL CHEM, V265, P13527; FUKUMOTO H, 1989, J BIOL CHEM, V264, P7776; GAO J, 1993, AM J PHYSIOL, V266, pE186; GOODYEAR LJ, 1991, AM J PHYSIOL, V261, pE795, DOI 10.1152/ajpendo.1991.261.6.E795; GULVE EA, 1993, AM J PHYSIOL, V264, pE319, DOI 10.1152/ajpendo.1993.264.3.E319; GULVE EA, 1994, J BIOL CHEM, V269, P18366; HANSEN PA, 1994, J APPL PHYSIOL, V76, P979, DOI 10.1152/jappl.1994.76.2.979; HIRSHMAN MF, 1990, J BIOL CHEM, V265, P987; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; KAESTNER KH, 1989, P NATL ACAD SCI USA, V86, P3150, DOI 10.1073/pnas.86.9.3150; KRAEGEN EW, 1985, AM J PHYSIOL, V248, pE353; LIU ML, 1993, P NATL ACAD SCI USA, V90, P11346, DOI 10.1073/pnas.90.23.11346; LUND S, 1993, FEBS LETT, V330, P312, DOI 10.1016/0014-5793(93)80895-2; MARETTE A, 1992, AM J PHYSIOL, V263, pC443, DOI 10.1152/ajpcell.1992.263.2.C443; MARSHALL BA, 1993, J BIOL CHEM, V268, P18442; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; NESHER R, 1985, AM J PHYSIOL, V246, pC226; OLSON AL, 1993, J BIOL CHEM, V268, P9839; Passonneau J.V., 1972, FLEXIBLE SYSTEM ENZY; PASSONNEAU JV, 1974, ANAL BIOCHEM, V60, P405, DOI 10.1016/0003-2697(74)90248-6; REN JM, 1993, J BIOL CHEM, V268, P16113; RODNICK KJ, 1992, J BIOL CHEM, V267, P6278; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; STAUFFACHER W, 1969, AM J PHYSIOL, V216, P98, DOI 10.1152/ajplegacy.1969.216.1.98; UYEDA K, 1965, J BIOL CHEM, V240, P4682; WALLBERGHENRIKSSON H, 1988, J APPL PHYSIOL, V65, P909, DOI 10.1152/jappl.1988.65.2.909; WATANABE T, 1984, J BIOL CHEM, V259, P3117; WILSON CM, 1994, BIOCHEM J, V299, P755, DOI 10.1042/bj2990755; YOUNG DA, 1986, J BIOL CHEM, V261, P6049; ZAWALICH WS, 1977, ENDOCRINOLOGY, V100, P1; ZIEL FH, 1988, DIABETES, V37, P885, DOI 10.2337/diabetes.37.7.885	39	154	154	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1679	1684						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829503				2022-12-27	WOS:A1995QD20400033
J	SCHWIEGELSHOHN, B; PRESLEY, JF; GORECKI, M; VOGEL, T; CARPENTIER, YA; MAXFIELD, FR; DECKELBAUM, RJ				SCHWIEGELSHOHN, B; PRESLEY, JF; GORECKI, M; VOGEL, T; CARPENTIER, YA; MAXFIELD, FR; DECKELBAUM, RJ			EFFECTS OF APOPROTEIN-E ON INTRACELLULAR METABOLISM OF MODEL TRIGLYCERIDE-RICH PARTICLES ARE DISTINCT FROM EFFECTS ON CELL PARTICLE UPTAKE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; MOUSE PERITONEAL-MACROPHAGES; APOLIPOPROTEIN-E SYNTHESIS; J774 MACROPHAGES; GRANULOSA-CELLS; RECEPTOR; HYPERCHOLESTEROLEMIA; ACCUMULATION; INHIBITION; EXPRESSION	Apoprotein E (apoE) enhances uptake of triglyceride-rich lipoprotein particles (TGRP). We questioned whether apoE would also modulate intracellular metabolism of TGRP in addition to its effects on particle uptake. We prepared model TGRP with triolein and cholesteryl oleate (1:1, w/w) as the core lipids, emulsified by egg yolk phosphatidylcholine, and containing a non-degradable marker, [H-3]cholesteryl hexadecyl ether. Particles were intermediate density lipoprotein-sized as determined by core lipid/phospholipid ratios (2.0-3.0/1) and gel filtration chromatography on Sepharose CL-2B. Emulsions were incubated with J774 macrophages for 5 min to 6 h at core lipid concentrations of 300-1200 mu g/ml and 0-0.2 mu g recombinant apoE/mg core lipid. Particle uptake was determined by [H-3]cholesteryl ether uptake and fluorescence microscopy in the absence and presence of apoE. Similar uptake of particles with and without apoE was achieved by utilizing a 4 times higher particle concentration in the absence of apoE. At equivalent levels of uptake, particles with apoE lead to one-half of the triglyceride mass accumulation and twice the triglyceride utilization as compared to particles without apoE. Further, apoE doubles cell cholesteryl ester hydrolysis and to a lesser extent (similar to 30%) increases cholesteryl ester resynthesis by acyl-CoA cholesterol acyl-transferase. Particles, both with and without apoE, reach the lysosomal compartment as determined by colocalization with fluorescein-labeled alpha(2)-macroglobulin. These results suggest that, in addition to its role in enhancing TGRP uptake, apoE has additional effects on modulating the cellular metabolism of both triglyceride and cholesteryl ester, after particle internalization.	COLUMBIA UNIV,COLL PHYS & SURG,DEPT PEDIAT,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT PHYSIOL,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,INST HUMAN NUTR,NEW YORK,NY 10032; BIOTECHNOL GEN LTD,REHOVOT,ISRAEL; FREE UNIV BRUSSELS,L DELOYERS LAB EXPTL SURG,BRUSSELS,BELGIUM	Columbia University; Columbia University; Columbia University; Columbia University; Universite Libre de Bruxelles; Vrije Universiteit Brussel			Maxfield, Fred/A-1718-2011; Maxfield, Fred/M-6747-2019	Maxfield, Fred/0000-0003-4396-8866	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040404, P50HL021006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027083, R01DK027083] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-21006, HL-40404] Funding Source: Medline; NIDDK NIH HHS [DK-27083] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALHAIDERI M, 1993, CIRCULATION, V88, P321; AVIRAM M, 1989, ARTERIOSCLEROSIS, V9, P67, DOI 10.1161/01.ATV.9.1.67; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BLUE ML, 1983, P NATL ACAD SCI-BIOL, V80, P283, DOI 10.1073/pnas.80.1.283; BRADLEY WA, 1986, J LIPID RES, V27, P40; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DECKELBAUM RJ, 1987, ATHEROSCLEROSIS BIOL, V28, P251; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; GOLDSTEIN JL, 1975, J BIOL CHEM, V250, P7854; GRANOT E, 1985, BIOCHIM BIOPHYS ACTA, V833, P308, DOI 10.1016/0005-2760(85)90203-6; GRANOT E, 1994, IN PRESS BIOCHEMISTR; HAMILTON RL, 1990, J LIPID RES, V31, P1589; HUSSAIN MM, 1989, J BIOL CHEM, V264, P9571; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAZZONE T, 1992, J BIOL CHEM, V267, P1081; MYERS JN, 1993, J CELL BIOL, V123, P1389, DOI 10.1083/jcb.123.6.1389; NICOSIA M, 1992, MOL ENDOCRINOL, V6, P978, DOI 10.1210/me.6.6.978; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; OSWALD B, 1987, J LIPID RES, V28, P798; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; REYLAND ME, 1991, P NATL ACAD SCI USA, V88, P2375, DOI 10.1073/pnas.88.6.2375; SALZMAN NH, 1989, J CELL BIOL, V109, P2097, DOI 10.1083/jcb.109.5.2097; TABAS I, 1991, J CELL BIOL, V115, P1547, DOI 10.1083/jcb.115.6.1547; TABAS I, 1985, P NATL ACAD SCI USA, V82, P416, DOI 10.1073/pnas.82.2.416; TABAS I, 1986, J BIOL CHEM, V261, P3147; TAJIMA S, 1983, J BIOL CHEM, V258, P73; TYCKO B, 1983, ANN NY ACAD SCI, V421, P424, DOI 10.1111/j.1749-6632.1983.tb18136.x; VOGEL T, 1985, P NATL ACAD SCI USA, V82, P8696, DOI 10.1073/pnas.82.24.8696; WERB Z, 1989, AM J PATHOL, V134, P661; WILLIAMS DL, 1985, J BIOL CHEM, V260, P2444; WOLF DE, 1985, BIOCHEMISTRY-US, V24, P582, DOI 10.1021/bi00324a006; WYNE KL, 1989, J BIOL CHEM, V264, P981; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	34	54	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1761	1769		10.1074/jbc.270.4.1761	http://dx.doi.org/10.1074/jbc.270.4.1761			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829512	hybrid			2022-12-27	WOS:A1995QD20400045
J	DYCK, JRB; SILVA, NLCL; FLIEGEL, L				DYCK, JRB; SILVA, NLCL; FLIEGEL, L			ACTIVATION OF THE NA+/H+ EXCHANGER GENE BY THE TRANSCRIPTION FACTOR AP-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ACETYL-COA CARBOXYLASE; NA/H ANTIPORTER; PROMOTER SEQUENCES; INSULIN INDUCTION; BINDING-PROTEINS; CAMP ACTION; EXPRESSION; CELLS; ACID	We have isolated and characterized regions important for expression of the mouse Na+/H+ exchanger gene. A 1.1-kilobase fragment upstream of the 5'-untranslated region contains specific DNA moths characteristic of promoter and enhancer elements including a TATA box two CAAT boxes, an SP-1 site, a cyclic AMP response element-binding site, and an AP-2-like site. This 1.1-kilobase fragment directs transcription of a luciferase reporter gene in mouse fibroblasts (NIH 3T3) and human Hep G2 cells, Deletion or mutation of an AP-2-like site 100 base pairs from the start site of transcription resulted in loss of most of the reporter plasmid activity. In addition, cotransfection of an AP-2 expression plasmid and the mouse promoter/luciferase plasmid increased the amount of Na+/H+ exchanger-directed transcription in AP-2-deficient Hep G2 cells, Moreover, mobility shift analysis indicated that a putative AP-2-binding site is capable of binding purified AP-2 protein and a specific protein from nuclear extracts of NIH 3T3 cells. The results show that the transcription factor AP-2 may play an important role in regulation of transcription of the mouse Na+/H+ exchanger gene.	UNIV ALBERTA,FAC MED,DEPT PEDIAT,CARDIOVASC DIS RES GRP,EDMONTON,AB T6G 2S2,CANADA; UNIV ALBERTA,FAC MED,DEPT BIOCHEM,CARDIOVASC DIS RES GRP,EDMONTON,AB T6G 2S2,CANADA	University of Alberta; University of Alberta				Dyck, Jason/0000-0002-7045-2884				ARGENTIN S, 1991, J BIOL CHEM, V266, P23315; BORON WF, 1993, J GEN PHYSIOL, V81, P29; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; DYCK JRB, 1992, FEBS LETT, V310, P255, DOI 10.1016/0014-5793(92)81343-K; FENSTERMAKER RA, 1989, MOL ENDOCRINOL, V3, P1070, DOI 10.1210/mend-3-7-1070; FLIEGEL L, 1993, MOL CELL BIOCHEM, V125, P137, DOI 10.1007/BF00936442; FLIEGEL L, 1991, FEBS LETT, V279, P25, DOI 10.1016/0014-5793(91)80241-T; FLIEGEL L, 1993, BIOCHEM J, V296, P273, DOI 10.1042/bj2960273; GRINSTEIN S, 1983, J GEN PHYSIOL, V82, P619, DOI 10.1085/jgp.82.5.619; HORIE S, 1992, P NATL ACAD SCI USA, V89, P5236, DOI 10.1073/pnas.89.12.5236; HORIE S, 1992, J CLIN INVEST, V89, P365, DOI 10.1172/JCI115594; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; JONES KA, 1985, NATURE, V317, P179, DOI 10.1038/317179a0; KOLYADA AY, 1994, BBA-GENE STRUCT EXPR, V1217, P54; MILLER RT, 1991, J BIOL CHEM, V266, P10813; MILLER RT, 1987, J BIOL CHEM, V262, P9115; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; MOE OW, 1991, J CLIN INVEST, V88, P1703, DOI 10.1172/JCI115487; PARK K, 1993, J BIOL CHEM, V268, P17811; PARK KR, 1991, J BIOL CHEM, V266, P12249; POUYSSEGUR J, 1985, TRENDS BIOCHEM SCI, V10, P453, DOI 10.1016/0968-0004(85)90030-1; RAO GN, 1992, J CELL PHYSIOL, V151, P361, DOI 10.1002/jcp.1041510217; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557	25	47	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1375	1381		10.1074/jbc.270.3.1375	http://dx.doi.org/10.1074/jbc.270.3.1375			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836405	hybrid			2022-12-27	WOS:A1995QB15600060
J	PAPINI, E; ROSSETTO, O; CUTLER, DF				PAPINI, E; ROSSETTO, O; CUTLER, DF			VESICLE-ASSOCIATED MEMBRANE-PROTEIN (VAMP) SYNAPTOBREVIN-2 IS ASSOCIATED WITH DENSE CORE SECRETORY GRANULES IN PC12 NEUROENDOCRINE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL-MEDULLARY CELLS; SYNAPTIC VESICLE; TETANUS-TOXIN; CATECHOLAMINE RELEASE; SYNAPTOBREVIN; BIOGENESIS; NEUROTOXICITY; RECEPTORS; CLEAVAGE; SURFACE	The presence and intracellular distribution of vesicle-associated membrane protein-1 (VAMP-1) and VAMP-2 were investigated in the PC12 neuroendocrine cell line using isotype-specific polyclonal antibodies. VAMP-2 was detected in the total membrane fraction, while VAMP-1 was undetectable. Subcellular fractionation demonstrates that a substantial amount of the VAMP-2 (24-36%) is associated with dense core, catecholamine-containing granules (DCGs). This was confirmed by immunofluorescence microscopy. The L chain of tetanus neurotoxin, known to inhibit granule mediated secretion in permeabilized PC12 cells, as well as botulinum neurotoxins F and G, effectively cleaved DCG-associated VAMP-2. These data demonstrate that VAMP-2 is present on the secretory granules of PC12 cells.	UNIV LONDON UNIV COLL,MRC,MOLEC CELL BIOL LAB,LONDON WC1E 6BT,ENGLAND; UNIV LONDON UNIV COLL,DEPT BIOL,LONDON WC1E 6BT,ENGLAND; UNIV PADUA,DIPARTIMENTO SCI BIOMED,I-35100 PADUA,ITALY	University of London; University College London; University of London; University College London; University of Padua			rossetto, ornella/AAC-3866-2022; Papini, Emanuele/AAE-6961-2022	rossetto, ornella/0000-0002-6113-3857; Papini, Emanuele/0000-0001-6033-4473; Cutler, Daniel/0000-0002-4288-7530	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bartlett S F, 1974, Methods Enzymol, V31, P379; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BITTNER MA, 1988, J NEUROCHEM, V51, P451, DOI 10.1111/j.1471-4159.1988.tb01059.x; BRAUN JEA, 1994, J BIOL CHEM, V269, P5328; CAIN CC, 1992, J BIOL CHEM, V267, P11681; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; CAMERON PL, 1991, J CELL BIOL, V115, P151, DOI 10.1083/jcb.115.1.151; CHIN AC, 1993, GENE, V131, P175, DOI 10.1016/0378-1119(93)90291-A; CLIFTOGRADY L, 1990, J CELL BIOL, V110, P1693, DOI 10.1083/jcb.110.5.1693; CRAMER LP, 1992, PROTEIN TARGETING PR; CUTLER DF, 1990, J CELL BIOL, V110, P721, DOI 10.1083/jcb.110.3.721; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; FACCHIANO F, 1992, J BIOL CHEM, V267, P13267; GAISANO HY, 1994, J BIOL CHEM, V269, P17062; HOHNEZELL B, 1993, FEBS LETT, V336, P175, DOI 10.1016/0014-5793(93)81635-D; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; KNIGHT DE, 1982, J MEMBRANE BIOL, V68, P107, DOI 10.1007/BF01872259; KNIGHT DE, 1986, FEBS LETT, V207, P222, DOI 10.1016/0014-5793(86)81492-2; KNIGHT DE, 1985, NATURE, V317, P719, DOI 10.1038/317719a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; RALSTON E, 1994, J BIOL CHEM, V269, P15403; RINDLER M J, 1992, Current Opinion in Cell Biology, V4, P616, DOI 10.1016/0955-0674(92)90080-V; ROSSETTO O, 1992, BIOCHEM J, V285, P9, DOI 10.1042/bj2850009; ROTHMAN JE, 1994, CURR BIOL, V4, P220, DOI 10.1016/S0960-9822(00)00051-8; SCHIAVO G, 1990, INFECT IMMUN, V58, P4136, DOI 10.1128/IAI.58.12.4136-4141.1990; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1993, J BIOL CHEM, V268, P23784; SCHIAVO G, 1993, J BIOL CHEM, V268, P11516; SCHIAVO G, 1994, J BIOL CHEM, V269, P20213; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; TOOZE SA, 1991, J CELL BIOL, V115, P1491, DOI 10.1083/jcb.115.6.1491; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; VAITUKAITIS JL, 1981, METHOD ENZYMOL, V73, P4652	37	42	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1332	1336		10.1074/jbc.270.3.1332	http://dx.doi.org/10.1074/jbc.270.3.1332			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836399	hybrid			2022-12-27	WOS:A1995QB15600054
J	SPECTOR, NL; HARDY, L; RYAN, C; MILLER, WH; HUMES, JL; NADLER, LM; LUEDKE, E				SPECTOR, NL; HARDY, L; RYAN, C; MILLER, WH; HUMES, JL; NADLER, LM; LUEDKE, E			28-KDA MAMMALIAN HEAT-SHOCK PROTEIN, A NOVEL SUBSTRATE OF A GROWTH-REGULATORY PROTEASE INVOLVED IN DIFFERENTIATION OF HUMAN LEUKEMIA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ACUTE PROMYELOCYTIC LEUKEMIA; TRANS-RETINOIC ACID; COLONY-STIMULATING FACTOR; STRESS PROTEINS; TYROSINE PHOSPHORYLATION; T(15-17) TRANSLOCATION; ACTIN POLYMERIZATION; RAR-ALPHA; KINASE; ARREST	Because of their differentiating effects in neoplastic cells in vitro, the use of retinoids in the treatment of various malignant and premalignant conditions is under investigation, To date, signal transduction pathways involved in retinoid-induced differentiation remain poorly understood. Differentiation of HL-60 cells by all trans-retinoic acid (tRA) is directly mediated by down-regulation of the serine protease myeloblastin (mbn). In this report, we investigate the possibility that the 28-kDa heat shock protein (hsp28), previously linked to differentiation of normal and neoplastic cells including HL-60, may be regulated by mbn, Using NB4 promyelocytic leukemic cells as a differentiative model, we show that tRA induces initial suppression and subsequent up regulation of hsp28 protein, mirroring tRA-induced changes in mbn protein. The progressive reduction in hsp28 mRNA levels in response to tRA suggests that changes in hsp28 protein levels might be posttranscriptionally mediated, raising the possibility that hsp28 may be targeted by mbn. To address this, we developed an assay using purified mbn and recombinant hsp28 and now show that hsp28 is hydrolyzed by mbn but not its homologue, human neutrophil elastase, Moreover, mbn does not indiscriminately hydrolyze other proteins, Identifying hsp28 as a substrate of mbn strongly suggests that hsp28 may be a key component of the tRA signaling pathway involved in regulating cell differentiation.	HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DIV TUMOR IMMUNOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA; JEWISH GEN HOSP, LADY DAVIS INST MED RES, MONTREAL, PQ 4365, CANADA; MERCK & CO INC, BIOCHEM & MOLEC PATHOL, RAHWAY, NJ 07065 USA; AMGEN CORP, THOUSAND OAKS, CA 91320 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Lady Davis Institute; McGill University; Merck & Company; Amgen	SPECTOR, NL (corresponding author), UNIV MIAMI, SCH MED,SYLVESTER COMPREHENS CANC CTR, DIV HEMATOL ONCOL,1475 NW 12TH AVE, D8-4, MIAMI, FL 33136 USA.				NCI NIH HHS [CA-40216-06, IF32CA08954-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA040216, F32CA008954] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARRIGO AP, 1990, MOL CELL BIOL, V10, P1276, DOI 10.1128/MCB.10.3.1276; BORIES D, 1989, CELL, V59, P959, DOI 10.1016/0092-8674(89)90752-6; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANCOLINI C, 1992, J CELL BIOL, V117, P1251, DOI 10.1083/jcb.117.6.1251; BREITMAN TR, 1981, BLOOD, V57, P1000; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; BRUGGE JS, 1986, CURR TOP MICROBIOL, V123, P1; CASTAIGNE S, 1990, BLOOD, V76, P1704; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; COURTNEIDGE SA, 1982, P NATL ACAD SCI-BIOL, V79, P7117, DOI 10.1073/pnas.79.23.7117; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GOMEZCAMBRONERO J, 1992, P NATL ACAD SCI USA, V89, P7551, DOI 10.1073/pnas.89.16.7551; HICKEY E, 1986, NUCLEIC ACIDS RES, V14, P4127, DOI 10.1093/nar/14.10.4127; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; JAKOB U, 1993, J BIOL CHEM, V268, P1517; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; KAO RC, 1988, J CLIN INVEST, V82, P1963, DOI 10.1172/JCI113816; KAUR P, 1989, FEBS LETT, V258, P269, DOI 10.1016/0014-5793(89)81671-0; KINDASMUGGE I, 1994, CELL GROWTH DIFFER, V5, P777; LABBAYE C, 1993, BLOOD, V81, P475; LANDRY J, 1992, J BIOL CHEM, V267, P794; LANOTTE M, 1991, BLOOD, V77, P1080; LARSON RA, 1984, AM J MED, V76, P827, DOI 10.1016/0002-9343(84)90994-X; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; MING Z, 1993, J BIOL CHEM, V268, P35; MIRON T, 1988, EUR J BIOCHEM, V178, P543, DOI 10.1111/j.1432-1033.1988.tb14481.x; MIRON T, 1991, J CELL BIOL, V114, P255, DOI 10.1083/jcb.114.2.255; MIYASAKA T, 1990, J BIOL CHEM, V265, P4730; OKUDA K, 1992, BLOOD, V79, P2880; PRENDERGAST GC, 1994, MOL CELL BIOL, V14, P4193, DOI 10.1128/MCB.14.6.4193; RAINES MA, 1992, BLOOD, V79, P3350; REGAZZI R, 1988, BIOCHEM BIOPH RES CO, V152, P62, DOI 10.1016/S0006-291X(88)80680-6; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; SHAKOORI AR, 1992, J CELL BIOCHEM, V48, P277, DOI 10.1002/jcb.240480308; SHIBANUMA M, 1992, BIOCHEM BIOPH RES CO, V187, P1418, DOI 10.1016/0006-291X(92)90460-3; SPECTOR NL, 1994, FEBS LETT, V337, P184, DOI 10.1016/0014-5793(94)80270-X; SPECTOR NL, 1993, J CELL PHYSIOL, V156, P619, DOI 10.1002/jcp.1041560322; SPECTOR NL, 1992, J IMMUNOL, V148, P1668; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; WARRELL RP, 1991, NEW ENGL J MED, V324, P1385, DOI 10.1056/NEJM199105163242002; WELCH WJ, 1985, J BIOL CHEM, V260, P3058; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074; ZANTEMA A, 1989, J VIROL, V63, P3368, DOI 10.1128/JVI.63.8.3368-3375.1989; ZHAO S, 1993, BLOOD, V82, pA1962	50	51	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1003	1006		10.1074/jbc.270.3.1003	http://dx.doi.org/10.1074/jbc.270.3.1003			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836350	hybrid			2022-12-27	WOS:A1995QB15600005
J	CAIRO, G; TACCHINI, L; POGLIAGHI, G; ANZON, E; TOMASI, A; BERNELLIZAZZERA, A				CAIRO, G; TACCHINI, L; POGLIAGHI, G; ANZON, E; TOMASI, A; BERNELLIZAZZERA, A			INDUCTION OF FERRITIN SYNTHESIS BY OXIDATIVE STRESS - TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL REGULATION BY EXPANSION OF THE FREE IRON POOL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT BINDING-PROTEIN; HEME OXYGENASE; RAT-LIVER; TRANSFERRIN RECEPTOR; GENE-EXPRESSION; MESSENGER-RNAS; HEAVY-SUBUNIT; SKIN FIBROBLASTS; LIGHT-SUBUNIT; METABOLISM	Ferritin, by regulating the ''free'' intracellular iron pool, controls iron-catalyzed generation of reactive oxygen species, but its role in oxidative damage is still unclear. We show that ferritin synthesis is significantly stimulated in the liver of rats subjected to oxidative stress by treatment with phorone, a glutathione-depleting drug, RNA-bandshift assays document reduced activity of iron regulatory factor, in particular of IRF(B), the cytoplasmic protein that post-transcriptionally controls ferritin mRNA translation, Furthermore, Northern blot analysis shows increased accumulation of H and L subunit mRNAs, and nuclear run-on experiments provide evidence of transcriptional activation, Direct measurements of intracellular free iron levels by EPR indicate that the increased ferritin synthesis can be mediated by an expansion of the free iron pool, An early drop of ferritin content after phorone treatment indicates that part of the iron that fuels the free pool might derive from ferritin degradation, Present data seem to suggest that, under conditions of oxidative stress, liver ferritin can represent either a pro- or an anti-oxidant in a time-dependent manner, In fact, its early degradation contributes to expand the intracellular free iron pool that, later on, activates multiple molecular mechanisms to reconstitute ferritin content, thus Limiting the prooxidant challenge of iron.	UNIV MODENA,DIPARTIMENTO SCI BIOMED,I-41100 MODENA,ITALY	Universita di Modena e Reggio Emilia	CAIRO, G (corresponding author), UNIV MILAN,IST PATOL GEN,CTR STUDIO PATOL CELLULARE,CNR,VIA MANGIAGALLI 31,I-20133 MILAN,ITALY.		Cairo, Gaetano/M-5104-2016; Tomasi, Aldo/F-8513-2017; Tacchini, Lorenza/L-1418-2016	Cairo, Gaetano/0000-0002-8147-4720; Tomasi, Aldo/0000-0002-1356-3430; Tacchini, Lorenza/0000-0002-4863-178X				ANDREWS SC, 1992, J INORG BIOCHEM, V47, P161, DOI 10.1016/0162-0134(92)84062-R; AROSIO P, 1989, IRON IMMUNITY CANCER, P55; AUST S D, 1985, Journal of Free Radicals in Biology and Medicine, V1, P3, DOI 10.1016/0748-5514(85)90025-X; BALLA G, 1992, J BIOL CHEM, V267, P18148; BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; BERGELSON S, 1994, CANCER RES, V54, P36; BERNELLIZAZZERA A, 1966, BIOCHEM J, V100, P114, DOI 10.1042/bj1000114; CAIRO G, 1985, BIOCHEM BIOPH RES CO, V133, P314, DOI 10.1016/0006-291X(85)91877-7; CAIRO G, 1991, BIOCHEM J, V275, P813, DOI 10.1042/bj2750813; CAIRO G, 1993, EXP CELL RES, V206, P255, DOI 10.1006/excr.1993.1145; CAIRO G, 1994, J BIOL CHEM, V269, P6405; CLAYTON DF, 1985, MOL CELL BIOL, V5, P2623, DOI 10.1128/MCB.5.10.2623; COCCIA EM, 1992, MOL CELL BIOL, V12, P3015, DOI 10.1128/MCB.12.7.3015; Colburn N.H., 1992, BIOL CONSEQUENCES OX, P121; DRYSDALE JW, 1988, PROG NUCLEIC ACID RE, V35, P127, DOI 10.1016/S0079-6603(08)60612-1; GUO B, 1993, FASEB J, V7, pA1084; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HENDERSON BR, 1993, J BIOL CHEM, V268, P27327; IANNONE A, 1990, BIOCHIM BIOPHYS ACTA, V1034, P290, DOI 10.1016/0304-4165(90)90053-Y; KEYSE SM, 1990, MOL CELL BIOL, V10, P4967, DOI 10.1128/MCB.10.9.4967; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; KUHN LC, 1992, J INORG BIOCHEM, V47, P183, DOI 10.1016/0162-0134(92)84064-T; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; LEIBOLD EA, 1992, ANNU REV NUTR, V12, P345, DOI 10.1146/annurev.nu.12.070192.002021; LEIBOLD EA, 1984, J BIOL CHEM, V259, P4327; MINOTTI G, 1989, CHEM-BIOL INTERACT, V71, P1, DOI 10.1016/0009-2797(89)90087-2; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; MUNRO H, 1993, NUTR REV, V51, P65, DOI 10.1111/j.1753-4887.1993.tb03072.x; MUNRO HN, 1978, PHYSIOL REV, V58, P317, DOI 10.1152/physrev.1978.58.2.317; MURRAY MT, 1987, P NATL ACAD SCI USA, V84, P7438, DOI 10.1073/pnas.84.21.7438; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; ORRENIUS S, 1988, OXY RADICALS MOL BIO, P327; PIETRANGELO A, 1992, GASTROENTEROLOGY, V102, P802, DOI 10.1016/0016-5085(92)90161-Q; REIF DW, 1992, FREE RADICAL BIO MED, V12, P417, DOI 10.1016/0891-5849(92)90091-T; SAKAIDA I, 1990, MOL PHARMACOL, V37, P435; SCHIAFFONATI L, 1990, J CELL PHYSIOL, V143, P79, DOI 10.1002/jcp.1041430110; SHIBAHARA S, 1985, P NATL ACAD SCI USA, V82, P7865, DOI 10.1073/pnas.82.23.7865; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; TACCHINI L, 1992, BIOCHIM BIOPHYS ACTA, V1131, P133, DOI 10.1016/0167-4781(92)90067-A; THEIL EC, 1990, J BIOL CHEM, V265, P4771; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; VILE GF, 1994, P NATL ACAD SCI USA, V91, P2607, DOI 10.1073/pnas.91.7.2607; VILE GF, 1993, J BIOL CHEM, V268, P14678; WHITE K, 1988, J BIOL CHEM, V263, P8938; YEGOROV DY, 1993, FREE RADICAL BIO MED, V15, P565, DOI 10.1016/0891-5849(93)90158-Q; YOSHIDA T, 1987, BIOCHEM BIOPH RES CO, V145, P502, DOI 10.1016/0006-291X(87)91349-0	47	290	300	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					700	703		10.1074/jbc.270.2.700	http://dx.doi.org/10.1074/jbc.270.2.700			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822298	hybrid			2022-12-27	WOS:A1995QB81600032
J	DUA, R; WU, SK; CHO, WH				DUA, R; WU, SK; CHO, WH			A STRUCTURE-FUNCTION STUDY OF BOVINE PANCREATIC PHOSPHOLIPASE A(2) USING POLYMERIZED MIXED LIPOSOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITION-STATE ANALOG; ACTIVE-SITE; INTERFACIAL ACTIVATION; VENOM PHOSPHOLIPASE-A2; CRYSTAL-STRUCTURE; MECHANISM; SPECIFICITY; LYSINE-56; PROTEINS; MUTAGENESIS	A new combinatorial approach that includes the genetic variation of protein structure and the chemical modification of phospholipid structure in polymerized mixed liposomes was used to delineate the structure-function relationships in the interfacial catalysis of bovine pancreatic phospholipase A(2) (PLA(2)). Based on previous structural and mutational studies, several bovine PLA(2) mutants were generated in which a positive charge of putatively important lysyl side chains was reversed (K10E, K53E, K56E, and K116E) or neutralized (K56Q and K116Q). Kinetic parameters of bovine wild type and mutant PLA(2)s determined using polymerized mixed liposomes consisting of 1-hexadecanoyl-2-(1-pyrenedecanoyl)-sn-glycero-3-phosphoethanolamine (or -phosphoglycerol) and 1,2-bis[12-(lipoyloxy)dodecanoyl]-sn-glycero-3-phosphoglycerol showed that Lys-53 is involved specifically in the interaction with a substrate bound in the active site. Also, these results showed that Lys-10 and Lys-116 are involved in the interaction of bovine PLA(2) with anionic interfaces but not in the interaction with the active site-bound substrate, In particular, Lys-116 makes more significant contribution than Lys-10 by similar to 1.0 kcal/mol to the binding to anionic interfaces. Most importantly, Lys-56 was shown to participate in the interaction with both the active site-bound substrate and anionic interfaces. These findings establish Lys-56 and Lys-116 as essential residues for the binding of bovine pancreatic PLA(2) to anionic interfaces. Lastly, our structure-function analysis based on the use of polymerized mixed liposomes was further supported by equilibrium binding measurements of these proteins using 1,2-bis[12-(lipoyloxy)dodecanoyl]-sn-glycero-3-phosphoglycerol polymerized liposomes and by kinetic analyses using monomeric substrates, 1,2-dihexanoyl-sn-glycero-3-phosphoethanolamine and -phosphoglycerol.	UNIV ILLINOIS, DEPT CHEM MC111, CHICAGO, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital								BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; CHO WH, 1991, METHOD ENZYMOL, V197, P75; CHO WW, 1988, J BIOL CHEM, V263, P11237; CHO WW, 1988, J AM CHEM SOC, V110, P5166, DOI 10.1021/ja00223a043; DENG TL, 1990, GENE, V93, P229, DOI 10.1016/0378-1119(90)90229-K; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; DIJKSTRA BW, 1978, J MOL BIOL, V124, P53, DOI 10.1016/0022-2836(78)90146-8; DIJKSTRA BW, 1981, NATURE, V289, P604, DOI 10.1038/289604a0; DUA R, 1994, EUR J BIOCHEM, V221, P481, DOI 10.1111/j.1432-1033.1994.tb18761.x; DUPUREUR CM, 1992, BIOCHEMISTRY-US, V31, P10576, DOI 10.1021/bi00158a021; DUPUREUR CM, 1992, BIOCHEMISTRY-US, V31, P6402, DOI 10.1021/bi00143a007; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V1002, P127, DOI 10.1016/0005-2760(89)90281-6; KATES M, 1986, TECHNIQUES LIPIDOLOG, P115; KUIPERS OP, 1989, SCIENCE, V244, P82, DOI 10.1126/science.2704992; KUIPERS OP, 1990, PROTEIN ENG, V3, P599, DOI 10.1093/protein/3.7.599; KUIPERS OP, 1989, PROTEIN ENG, V2, P467, DOI 10.1093/protein/2.6.467; LUGTIGHEID RB, 1993, EUR J BIOCHEM, V213, P517, DOI 10.1111/j.1432-1033.1993.tb17789.x; LUGTIGHEID RB, 1993, EUR J BIOCHEM, V216, P519, DOI 10.1111/j.1432-1033.1993.tb18170.x; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; NOEL JP, 1991, BIOCHEMISTRY-US, V30, P11801, DOI 10.1021/bi00115a010; NOEL JP, 1990, J AM CHEM SOC, V112, P3704, DOI 10.1021/ja00165a090; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOTT DL, 1994, ADV PROTEIN CHEM, V45, P53; SCOTT DL, 1994, BIOPHYS J, V67, P493, DOI 10.1016/S0006-3495(94)80546-6; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; SCOTT DL, 1991, SCIENCE, V254, P1007, DOI 10.1126/science.1948070; SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788; SHEN Z, 1994, BIOCHEMISTRY-US, V33, P11598, DOI 10.1021/bi00204a022; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; THANNHAUSER TW, 1984, ANAL BIOCHEM, V138, P181, DOI 10.1016/0003-2697(84)90786-3; THUNNISSEN MMGM, 1990, NATURE, V347, P689, DOI 10.1038/347689a0; TOMASSELLI AG, 1989, J BIOL CHEM, V264, P10041; VANDENBERGH CJ, 1988, EUR J BIOCHEM, V176, P353; VANDERWIELE FC, 1988, BIOCHEMISTRY-US, V27, P1688, DOI 10.1021/bi00405a046; VANDERWIELE FC, 1988, BIOCHEMISTRY-US, V27, P1683, DOI 10.1021/bi00405a045; WELLS MA, 1974, BIOCHEMISTRY-US, V13, P2248, DOI 10.1021/bi00708a002; WHITE SP, 1990, SCIENCE, V250, P1560, DOI 10.1126/science.2274787; WU SK, 1994, ANAL BIOCHEM, V221, P152, DOI 10.1006/abio.1994.1391; WU SK, 1993, BIOCHEMISTRY-US, V32, P13902, DOI 10.1021/bi00213a020; YUAN W, 1990, BIOCHEMISTRY-US, V29, P6082, DOI 10.1021/bi00477a028	41	51	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					263	268		10.1074/jbc.270.1.263	http://dx.doi.org/10.1074/jbc.270.1.263			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814384	hybrid			2022-12-27	WOS:A1995QA28700042
J	MORINO, N; MIMURA, T; HAMASAKI, K; TOBE, K; UEKI, K; KIKUCHI, K; TAKEHARA, K; KADOWAKI, T; YAZAKI, Y; NOJIMA, Y				MORINO, N; MIMURA, T; HAMASAKI, K; TOBE, K; UEKI, K; KIKUCHI, K; TAKEHARA, K; KADOWAKI, T; YAZAKI, Y; NOJIMA, Y			MATRIX/INTEGRIN INTERACTION ACTIVATES THE MITOGEN-ACTIVATED PROTEIN-KINASE, P44(ERK-1) AND P42(ERK-2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; EXTRACELLULAR-MATRIX; CELL-ADHESION; GENE-EXPRESSION; MAP KINASES; T-CELLS; FIBRONECTIN; THREONINE; INSULIN	Cell adhesion to extracellular matrix proteins is a dynamic process leading to dramatic changes in the cell phenotype. Integrins are one of the major receptor families that mediate cell-matrix contact. Evidence that integrins can act as signal transducing molecules has accumulated over the past few years. We report here that p44(erk-1) and p42(erk-2) mitogen-activated protein (MAP) kinases are rapidly phosphorylated on tyrosine residues upon adhesion of human skin fibroblasts to fibronectin or upon cross-linking of beta 1 integrins with antibody. The tyrosine phosphorylation of both kinases is associated with increased enzymatic activity. Pretreatment of the cells with cytochalasin D, which selectively disrupts the network of the actin filaments, completely inhibits this adhesion-mediated MAP kinase activation. Thus, our findings indicate that ligation of beta 1 integrins induces an increase in both tyrosine phosphorylation and enzymatic activity of p44(erk-1) and p42(erk-2) MAP kinases, and that the integrity of the actin cytoskeleton is essential in this process. Since MAP kinase behaves as a convergence point for diverse receptor-initiated signaling events at the plasma membrane, this serine/threonine kinase plays a key role and helps to account for the diversity of integrin-dependent cell functions.	UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,BUNKYO KU,TOKYO 113,JAPAN; UNIV TOKYO,FAC MED,DEPT DERMATOL,TOKYO 113,JAPAN	University of Tokyo; University of Tokyo								AKIYAMA SK, 1994, J BIOL CHEM, V269, P15961; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BOCKHOLT SM, 1993, J BIOL CHEM, V268, P14565; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; BURRIDGE K, 1987, ANN REV CELL BIOL, V4, P487; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DHAWAN J, 1990, J BIOL CHEM, V265, P9015; GUAN JL, 1991, CELL REGUL, V2, P951, DOI 10.1091/mbc.2.11.951; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; HAIMOVICH B, 1993, J BIOL CHEM, V268, P15868; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; INGBER DE, 1990, J CELL BIOL, V110, P1803, DOI 10.1083/jcb.110.5.1803; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; KANNER SB, 1991, EMBO J, V10, P1689, DOI 10.1002/j.1460-2075.1991.tb07693.x; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392; NAKIELNY S, 1992, EMBO J, V11, P2123, DOI 10.1002/j.1460-2075.1992.tb05271.x; NOJIMA Y, 1992, J EXP MED, V175, P1045, DOI 10.1084/jem.175.4.1045; NOJIMA Y, 1990, J EXP MED, V172, P1185, DOI 10.1084/jem.172.4.1185; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; SCHMIDHAUSER C, 1990, P NATL ACAD SCI USA, V87, P9118, DOI 10.1073/pnas.87.23.9118; SHIMIZU Y, 1990, J IMMUNOL, V145, P59; THOMAS G, 1992, CELL, V68, P3, DOI 10.1016/0092-8674(92)90199-M; TOBE K, 1991, J BIOL CHEM, V266, P24793; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; ZACHARY I, 1992, J BIOL CHEM, V267, P19031	32	263	265	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					269	273		10.1074/jbc.270.1.269	http://dx.doi.org/10.1074/jbc.270.1.269			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814385	hybrid			2022-12-27	WOS:A1995QA28700043
J	OGIERDENIS, E; COUVINEAU, A; MAORET, JJ; HOURI, JJ; BAUVY, C; DESTEFANIS, D; ISIDORO, C; LABURTHE, M; CODOGNO, P				OGIERDENIS, E; COUVINEAU, A; MAORET, JJ; HOURI, JJ; BAUVY, C; DESTEFANIS, D; ISIDORO, C; LABURTHE, M; CODOGNO, P			A HETEROTRIMERIC G(I3)-PROTEIN CONTROLS AUTOPHAGIC SEQUESTRATION IN THE HUMAN COLON-CANCER CELL-LINE HT-29	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							G-PROTEINS; ENTEROCYTIC DIFFERENTIATION; HEPATOCYTIC AUTOPHAGY; ENDOPLASMIC-RETICULUM; ADENYLYL CYCLASE; EPITHELIAL-CELLS; GOLGI MEMBRANES; TRANSPORT; DEGRADATION; INHIBITION	Human colon cancer HT-29 cells exhibit a differentiation dependent autophagic lysosomal pathway that is responsible for the degradation of a pool of newly synthesized N-linked glycoproteins in undifferentiated cells. In the present study, we have investigated the molecular control of this degradative pathway in undifferentiated HT-29 cells. For this purpose, we have modulated the function and expression of the heterotrimeric G-proteins (G(8) and G(i)) in these cells. After pertussis toxin treatment which ADP-ribosylates heterotrimeric G(i)-proteins, we observed an inhibition of autophagic sequestration and the complete restoration of the passage of N-linked glycoproteins through the Golgi complex. In contrast, autophagic sequestration was not reduced by cholera toxin, which acts on heterotrimeric G(s)-proteins. Further insights on the nature of the pertussis toxin-sensitive alpha subunit controlling autophagic sequestration were obtained by cDNA transfections of alpha(i) subunits. Overexpression of the alpha(i3), subunit increased autophagic sequestration and degradation in undifferentiated cells, whereas overexpression of the alpha(i2) subunit, the only other pertussis toxin-sensitive alpha subunit expressed in HT-29 cells, did not alter the rate of autophagy.	FAC XAVIER BICHAT,INSERM,U410,F-75018 PARIS,FRANCE; UNIV TURIN,DIPARTIMENTO MED & ONCOL SPERIMENTALE,GEN PATHOL SEZ,I-10125 TURIN,ITALY	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Turin			couvineau, alain/T-3466-2019; couvineau, alain/G-3641-2013; Ogier-Denis, Eric/E-5030-2016; LABURTHE, Marc/C-1875-2012; Codogno, Patrice/G-1384-2013; Isidoro, Ciro/J-6063-2016	couvineau, alain/0000-0003-2912-5168; couvineau, alain/0000-0003-2912-5168; Codogno, Patrice/0000-0002-5492-3180; Isidoro, Ciro/0000-0002-5494-3034; Ogier-Denis, Eric/0000-0002-0057-7593				AUDIGIER Y, 1988, J BIOL CHEM, V263, P16352; BOMSEL M, 1992, MOL BIOL CELL, V3, P1317, DOI 10.1091/mbc.3.12.1317; CARLSSON SR, 1988, J BIOL CHEM, V263, P18911; CARTER LL, 1993, J CELL BIOL, V120, P37, DOI 10.1083/jcb.120.1.37; COUVINEAU A, 1992, AM J PHYSIOL, V262, pC1478, DOI 10.1152/ajpcell.1992.262.6.C1478; DARMOUL D, 1992, J BIOL CHEM, V267, P4824; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; ERCOLANI L, 1990, P NATL ACAD SCI USA, V87, P4635, DOI 10.1073/pnas.87.12.4635; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GORDON PB, 1993, J BIOL CHEM, V268, P26107; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HERMOUET S, 1992, FEBS LETT, V312, P223, DOI 10.1016/0014-5793(92)80940-I; HIRSIMAKI P, 1983, PATHOBIOLOGY CELL ME, V3, P201; HOFMANN KP, 1993, GTPASES BIOL, V2, P267; HOLEN I, 1993, EUR J BIOCHEM, V215, P113, DOI 10.1111/j.1432-1033.1993.tb18013.x; HOURI JJ, 1993, BIOCHEM BIOPH RES CO, V197, P805, DOI 10.1006/bbrc.1993.2550; JARRY A, 1994, EUR J PHARM-MOLEC PH, V267, P95, DOI 10.1016/0922-4106(94)90229-1; KADOWAKI M, 1994, J BIOL CHEM, V269, P3703; LENCER WI, 1990, AM J PHYSIOL, V258, pG96, DOI 10.1152/ajpgi.1990.258.1.G96; MORTIMORE GE, 1989, DIABETES METAB REV, V5, P49, DOI 10.1002/dmr.5610050105; MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303; OGIERDENIS E, 1988, J BIOL CHEM, V263, P6031; OLKKONEN VM, 1993, J CELL SCI, V106, P1249; OSTERMANN J, 1993, CELL, V75, P1015, DOI 10.1016/0092-8674(93)90545-2; PIMPLIKAR SW, 1993, NATURE, V362, P456, DOI 10.1038/362456a0; SCHWANINGER R, 1991, J BIOL CHEM, V266, P13055; SCHWANINGER R, 1992, J CELL BIOL, V119, P1077, DOI 10.1083/jcb.119.5.1077; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; SEGLEN PO, 1986, EXP CELL RES, V162, P273, DOI 10.1016/0014-4827(86)90446-5; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SIMONDS WF, 1989, P NATL ACAD SCI USA, V86, P7809, DOI 10.1073/pnas.86.20.7809; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; STRYER L, 1986, ANNU REV CELL BIOL, V2, P391, DOI 10.1146/annurev.cb.02.110186.002135; TRUGNAN G, 1991, J BIOL CHEM, V266, P20849; VANDENBERGHE N, 1991, BIOCHEM J, V278, P565, DOI 10.1042/bj2780565; WICE BM, 1985, J BIOL CHEM, V260, P139; WILSON BS, 1994, ENDOCRINOLOGY, V134, P233, DOI 10.1210/en.134.1.233	40	87	88	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					13	16		10.1074/jbc.270.1.13	http://dx.doi.org/10.1074/jbc.270.1.13			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814364	hybrid			2022-12-27	WOS:A1995QA28700004
J	FEHLBAUM, P; BULET, P; MICHAUT, L; LAGUEUX, M; BROEKAERT, WF; HETRU, C; HOFFMANN, JA				FEHLBAUM, P; BULET, P; MICHAUT, L; LAGUEUX, M; BROEKAERT, WF; HETRU, C; HOFFMANN, JA			INSECT IMMUNITY - SEPTIC INJURY OF DROSOPHILA INDUCES THE SYNTHESIS OF A POTENT ANTIFUNGAL PEPTIDE WITH SEQUENCE HOMOLOGY TO PLANT ANTIFUNGAL PEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHITIN-BINDING PROTEINS; ANTIMICROBIAL PEPTIDES; L SEEDS; FAMILY; MODEL	In response to a septic injury (pricking with a bacteria-soaked needle) larvae and adults of Drosophila produce considerable amounts of a 44-residue peptide containing 8 cysteines engaged in intramolecular disulfide bridges, The peptide is synthesized in the fat body, a functional homologue of the mammalian liver, and secreted into the blood of the insect. It exhibits potent antifungal activity but is inactive against bacteria, This novel inducible peptide, which we propose to name drosomycin, shows a significant homology with a family of 5-kDa cysteine-rich plant antifungal peptides recently isolated from seeds of Brassicaceae, This finding underlines that plants and insects can rely on similar molecules in their innate host defense.	INST BIOL MOLEC & CELLULAIRE,CNRS,UPR 9022,F-67084 STRASBOURG,FRANCE; CATHOLIC UNIV LEUVEN,FA JANSSENS LAB GENET,B-3001 HEVERLEE,BELGIUM	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; KU Leuven			BULET, Philippe/C-8557-2014	BULET, Philippe/0000-0001-9016-265X				BOMAN HG, 1991, EUR J BIOCHEM, V201, P23, DOI 10.1111/j.1432-1033.1991.tb16252.x; BOWLES DJ, 1990, ANNU REV BIOCHEM, V59, P873, DOI 10.1146/annurev.bi.59.070190.004301; BROEKAERT WF, 1990, FEMS MICROBIOL LETT, V69, P55, DOI [10.1111/j.1574-6968.1990.tb04174.x, 10.1016/S0378-1097(98)00477-7]; BROEKAERT WF, 1992, BIOCHEMISTRY-US, V31, P4308, DOI 10.1021/bi00132a023; BULET P, 1993, J BIOL CHEM, V268, P14893; CAMMUE BPA, 1992, J BIOL CHEM, V267, P2228; COCIANCICH S, 1994, PARASITOL TODAY, V10, P132, DOI 10.1016/0169-4758(94)90260-7; DIMARCQ JL, 1994, EUR J BIOCHEM, V221, P201, DOI 10.1111/j.1432-1033.1994.tb18730.x; HOFFMANN JA, 1993, FEBS LETT, V325, P63, DOI 10.1016/0014-5793(93)81414-U; HULTMARK D, 1993, TRENDS GENET, V9, P178, DOI 10.1016/0168-9525(93)90165-E; IJIMA R, 1993, J BIOL CHEM, V268, P12055; KREIL G, 1990, TRENDS BIOCHEM SCI, V15, P23, DOI 10.1016/0968-0004(90)90126-V; RAIKHEL NV, 1993, ANNU REV PLANT PHYS, V44, P591, DOI 10.1146/annurev.pp.44.060193.003111; ROBERTS WK, 1986, BIOCHIM BIOPHYS ACTA, V880, P161, DOI 10.1016/0304-4165(86)90076-0; TAUTZ D, 1989, CHROMOSOMA, V98, P80; TERRAS FRG, 1993, FEBS LETT, V316, P233, DOI 10.1016/0014-5793(93)81299-F; TERRAS FRG, 1992, J BIOL CHEM, V267, P15301; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; WICKER C, 1990, J BIOL CHEM, V265, P22493	19	332	361	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					33159	33163						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806546				2022-12-27	WOS:A1994QA63800065
J	ATAR, D; BACKX, PH; APPEL, MM; GAO, WD; MARBAN, E				ATAR, D; BACKX, PH; APPEL, MM; GAO, WD; MARBAN, E			EXCITATION-TRANSCRIPTION COUPLING MEDIATED BY ZINC INFLUX THROUGH VOLTAGE-DEPENDENT CALCIUM CHANNELS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; PITUITARY-CELLS; SPATIAL MEMORY; HEAVY-METALS; MEMBRANE; DEXAMETHASONE; STIMULATION; BINDING; NEURONS; CA-2+	Electrical activity initiates a program of selective gene expression in excitable cells, Although such transcriptional activation is commonly attributed to depolarization-induced changes in intracellular Ca2+, zinc represents a viable alternative given its prominent role as a cofactor in DNA-binding proteins coupled with evidence that Zn2+ can enter excitable cells in a voltage-dependent manner. Here it is shown that Zn2+ entry into heart cells depends upon electrical stimulation and occurs via dihydropyridine-sensitive Ca2+ channels. The addition of extracellular Zn2+ to spontaneously depolarizing GH3 pituitary tumor cells induced the expression of a reporter gene driven by the metallothionein promoter, an effect that was prevented by exposure to dihydropyridine Ca2+ channel blockers. Thus, Zn2+ influx through L-type Ca2+ channels can mediate voltage-dependent gene expression.	JOHNS HOPKINS UNIV,SCH MED,DEPT MED,DIV CARDIOL,BALTIMORE,MD 21205	Johns Hopkins University			Marban, Eduardo/GWC-8514-2022		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044065] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL 44065] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARSLAN P, 1985, J BIOL CHEM, V260, P2719; BACKX PH, 1993, CIRC RES, V72, P890, DOI 10.1161/01.RES.72.4.890; BACKX PH, 1993, AM J PHYSIOL, V264, pH1098, DOI 10.1152/ajpheart.1993.264.4.H1098; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BERG JM, 1990, J BIOL CHEM, V265, P6513; BERS DM, 1991, EXCITATION CONTRACTI, P17; BUSSELBERG D, 1992, BRAIN RES, V593, P77, DOI 10.1016/0006-8993(92)91266-H; COLEMAN TA, 1991, MOL CELL ENDOCRINOL, V75, P91, DOI 10.1016/0303-7207(91)90223-F; DAVIS JRE, 1991, MOL ENDOCRINOL, V5, P8, DOI 10.1210/mend-5-1-8; DURNAM DM, 1981, J BIOL CHEM, V256, P5712; FABIATO A, 1979, J PHYSIOL-PARIS, V72, P463; FREDERICKSON RE, 1990, BEHAV BRAIN RES, V38, P25, DOI 10.1016/0166-4328(90)90021-6; FUCHS F, 1971, BIOCHIM BIOPHYS ACTA, V245, P221, DOI 10.1016/0005-2728(71)90025-9; FUKUDA J, 1977, SCIENCE, V196, P309, DOI 10.1126/science.847472; GAO WD, 1994, CIRC RES, V74, P408, DOI 10.1161/01.RES.74.3.408; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUIDOLIN D, 1992, ANN NY ACAD SCI, V673, P187, DOI 10.1111/j.1749-6632.1992.tb27452.x; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HILLE B, 1992, IONIC CHANNELS EXCIT, P83; KALMAN D, 1988, J GEN PHYSIOL, V92, P531, DOI 10.1085/jgp.92.4.531; KARIN M, 1980, NATURE, V286, P295, DOI 10.1038/286295a0; KARIN M, 1979, SCIENCE, V204, P176, DOI 10.1126/science.432639; KAWA K, 1979, J MEMBRANE BIOL, V49, P325, DOI 10.1007/BF01868990; MOE GW, 1989, J AM COLL CARDIOL, V13, P173, DOI 10.1016/0735-1097(89)90567-6; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; NGUYEN VT, 1988, ANAL BIOCHEM, V171, P404, DOI 10.1016/0003-2697(88)90505-2; OHALLORAN TV, 1993, SCIENCE, V261, P715, DOI 10.1126/science.8342038; SCHERUBL H, 1991, P ROY SOC B-BIOL SCI, V245, P127, DOI 10.1098/rspb.1991.0098; SCHWARTZ O, 1990, GENE, V88, P197, DOI 10.1016/0378-1119(90)90032-M; SHANG M, 1990, NEURON, V4, P477; Smith RM, 1974, CRITICAL STABILITY C, V1-6; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; WILLIAMS DA, 1987, SCIENCE, V235, P1644, DOI 10.1126/science.3103219; WINEGAR BD, 1990, J PHYSIOL-LONDON, V425, P563, DOI 10.1113/jphysiol.1990.sp018118	35	201	208	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2473	2477		10.1074/jbc.270.6.2473	http://dx.doi.org/10.1074/jbc.270.6.2473			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852308	hybrid			2022-12-27	WOS:A1995QF53500014
J	KNOPS, J; SUOMENSAARI, S; LEE, M; MCCONLOGUE, L; SEUBERT, P; SINHA, S				KNOPS, J; SUOMENSAARI, S; LEE, M; MCCONLOGUE, L; SEUBERT, P; SINHA, S			PROTEIN-TYPE SPECIFIC-INHIBITION OF A-BETA RELEASE BY BAFILOMYCIN A1, A SELECTIVE INHIBITOR OF VACUOLAR ATPASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							AMYLOID PRECURSOR PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; H+-ATPASE; CULTURED-CELLS; PEPTIDE; MUTATION; IDENTIFICATION; ACIDIFICATION; INTERMEDIATE; DEGRADATION	Treatment of human 293 cells transfected with amyloid precursor protein (APP)(K595N,M596L) (the ''Swedish'' mutation) with a specific inhibitor of the vacuolar H+-ATPases, bafilomycin A1 (baf A), leads to a patent inhibition of the release of the A beta peptide. This is accompanied by a selective inhibition of beta-secretase activity. Surprisingly, baf A did not inhibit the production of A beta from either wild-type APP (WT APP) or from APP(V717I) (the ''Hardy'' mutation), expressed in the same cell type. In contrast, the robust production of A beta from a human neuroglioma-derived cell line (HS683) transfected with WT APP, or from primary human mixed brain cultures (HMBC) expressing genomic WT APP, were also effectively inhibited by baf A. The inhibition of A beta production from the HMBC was also accompanied by the inhibition of beta-s-APP release. No inhibition of alpha-s-APP release was seen in any of the cell types tested. These results indicate that intracellular acidic processes are rate-limiting for beta-secretase cleavage and A beta production from SW APP, but not WT APP, in the peripheral 293 cell line. Furthermore, such acidic processes also play a rate-limiting role in A beta release from human central nervous system-derived cells, including HMBC. Differential trafficking of the SW APP into an acidic compartment conducive to beta-secretase cleavage and A beta release could be one explanation for the increased production of A beta observed on expression of this mutation.	ATHENA NEUROSCI INC,S SAN FRANCISCO,CA 94080									BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; DOVEY HF, 1993, NEUROREPORT, V4, P1039, DOI 10.1097/00001756-199308000-00011; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; FLOOR E, 1990, J NEUROCHEM, V55, P1663, DOI 10.1111/j.1471-4159.1990.tb04954.x; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1993, J BIOL CHEM, V268, P3021; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HAASS C, 1994, P NATL ACAD SCI USA, V91, P1564, DOI 10.1073/pnas.91.4.1564; KNOPS J, 1992, J BIOL CHEM, V267, P16022; KUENTZEL SL, 1993, BIOCHEM J, V295, P367, DOI 10.1042/bj2950367; LUKACS GL, 1990, J BIOL CHEM, V265, P21099; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; NELSON N, 1991, TRENDS PHARMACOL SCI, V12, P71, DOI 10.1016/0165-6147(91)90501-I; ODA K, 1991, BIOCHEM BIOPH RES CO, V178, P369, DOI 10.1016/0006-291X(91)91823-U; OLTERSDORF T, 1990, J BIOL CHEM, V265, P4492; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; SELKOE DJ, 1995, IN PRESS ANN REV CEL, V10; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	26	103	115	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2419	2422		10.1074/jbc.270.6.2419	http://dx.doi.org/10.1074/jbc.270.6.2419			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852298	hybrid			2022-12-27	WOS:A1995QF53500003
J	ZVARITCH, E; VELLANI, F; GUERINI, D; CARAFOLI, E				ZVARITCH, E; VELLANI, F; GUERINI, D; CARAFOLI, E			A SIGNAL FOR ENDOPLASMIC-RETICULUM RETENTION LOCATED AT THE CARBOXYL-TERMINUS OF THE PLASMA-MEMBRANE CA2+-ATPASE ISOFORM 4CI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-BINDING DOMAIN; ION MOTIVE ATPASES; CA2+ PUMP; GOLGI RETENTION; CALCIUM-PUMP; TRANSMEMBRANE DOMAIN; MOLECULAR CHARACTERIZATION; CYTOPLASMIC DOMAINS; PROTEIN-DEGRADATION; HUMAN-ERYTHROCYTES	The plasma membrane Ca2+-ATPase isoform 4b (PMCA4CI) with truncations in the cytoplasmically exposed COOH-terminal tail was expressed in COS and HeLa cells and in Sf9 cells using the baculovirus system. The truncated protein terminating with the acidic sequence Glu(1067)-Arg(1087) was retained within the endoplasmic reticulum (ER), whereas mutants lacking this sequence or having it at a distance from the COOH terminus were delivered to the plasma membrane. Although the truncated protein retained in the endoplasmic reticulum was still able to form a Ca2+-dependent phosphoenzyme, it underwent partial degradation, Substitution of glutamic and aspartic residue(s) in the acidic region promoted rescue of the protein to the plasma membrane. The results suggest that the sequence Glu(1067)-Arg(1087) encodes a mashed signal for ER retention and for the degradation of the protein. However, its presence at the COOH terminus was not sufficient to induce ER-retention and degradation; when the sequence was attached to the full-length PMCA protein, normal plasma delivery was observed. Evidently, ER retention and degradation required the presence of the sequence in its specific location within the PMCA structure. The degradation of the protein retained in the endoplasmic reticulum occurred through the proteolytic attack at cytoplasmically exposed residues (amino acid sequence 720-750) by a cytoplasmic PEST sequence-related protease different from calpain.	ETH ZURICH, INST BIOCHEM, CH-8092 ZURICH, SWITZERLAND; RUSSIAN ACAD SCI, SHEMYAKIN INST BIOORGAN CHEM, MOSCOW 117871, RUSSIA	ETH Zurich; Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences			Carafoli, Ernesto/K-5192-2016	Carafoli, Ernesto/0000-0002-7826-0094				ADAMO HP, 1992, BIOCHEM J, V285, P791, DOI 10.1042/bj2850791; ADAMO HP, 1992, J BIOL CHEM, V267, P14244; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BONIFACINO J S, 1991, Current Opinion in Cell Biology, V3, P592, DOI 10.1016/0955-0674(91)90028-W; BONIFACINO JS, 1991, EMBO J, V10, P2783, DOI 10.1002/j.1460-2075.1991.tb07827.x; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRODIN P, 1992, EUR J BIOCHEM, V204, P939, DOI 10.1111/j.1432-1033.1992.tb16715.x; CARAFOLI E, 1992, J BIOL CHEM, V267, P2115; CARAFOLI E, 1991, PHYSIOL REV, V71, P129, DOI 10.1152/physrev.1991.71.1.129; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; CARAFOLI E, 1993, TRENDS CARDIOVAS MED, V3, P177, DOI 10.1016/1050-1738(93)90003-O; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CIEHANOVER A, 1989, TRENDS BIOCHEM SCI, V14, P483; DOYLE C, 1986, J CELL BIOL, V103, P1193, DOI 10.1083/jcb.103.4.1193; ENYEDI A, 1993, J BIOL CHEM, V268, P10621; ENYEDI A, 1987, J BIOL CHEM, V262, P6425; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GAROFF H, 1983, J CELL BIOL, V97, P652, DOI 10.1083/jcb.97.3.652; HEIM R, 1992, J BIOL CHEM, V267, P24476; HOFMANN F, 1993, J BIOL CHEM, V268, P10252; HUMPHREY JS, 1993, J CELL BIOL, V120, P1123, DOI 10.1083/jcb.120.5.1123; INESI G, 1992, J BIOENERG BIOMEMBR, V24, P271; JAMES P, 1988, J BIOL CHEM, V263, P2905; JAMES P, 1989, J BIOL CHEM, V264, P8289; JAMES PH, 1989, BIOCHEMISTRY-US, V28, P4253, DOI 10.1021/bi00436a020; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEDERKREMER GZ, 1991, J BIOL CHEM, V266, P1237; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; MURRE C, 1984, NATURE, V307, P432, DOI 10.1038/307432a0; NILSSON T, 1991, EMBO J, V10, P3567, DOI 10.1002/j.1460-2075.1991.tb04923.x; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P186, DOI 10.1016/0968-0004(87)90090-9; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; PUDDINGTON L, 1986, J CELL BIOL, V102, P2147, DOI 10.1083/jcb.102.6.2147; RECHSTEINER M, 1988, ADV ENZYME REGUL, V27, P135; RENAUD KJ, 1991, J BIOL CHEM, V266, P20491; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARKADI B, 1986, J BIOL CHEM, V261, P9552; STAFFORD FJ, 1991, J CELL BIOL, V115, P1225, DOI 10.1083/jcb.115.5.1225; STREHLER EE, 1991, J MEMBRANE BIOL, V120, P1, DOI 10.1007/BF01868586; SUMMERS MD, 1987, TEX AGR EXP STN B, V1555; SWIFT AM, 1991, J CELL BIOL, V115, P19, DOI 10.1083/jcb.115.1.19; TEASDALE RD, 1992, J BIOL CHEM, V267, P4084; TSAO YS, 1992, J CELL BIOL, V116, P57, DOI 10.1083/jcb.116.1.57; WANG KKW, 1991, J BIOL CHEM, V266, P9078; WANG KKW, 1989, BIOCHEM J, V262, P693, DOI 10.1042/bj2620693; WIKSTROM L, 1992, J BIOL CHEM, V267, P5; WONG SH, 1992, J CELL BIOL, V117, P245, DOI 10.1083/jcb.117.2.245; ZIMMERMANN J, 1990, NUCLEIC ACIDS RES, V18, P1067, DOI 10.1093/nar/18.4.1067; ZVARITCH E, 1990, BIOCHEMISTRY-US, V29, P8070, DOI 10.1021/bi00487a012; ZVARITCH E, 1992, 8TH INT S CALC BIND	53	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2679	2688		10.1074/jbc.270.6.2679	http://dx.doi.org/10.1074/jbc.270.6.2679			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852337	hybrid			2022-12-27	WOS:A1995QF53500045
J	ALTMANN, SW; KASTELEIN, RA				ALTMANN, SW; KASTELEIN, RA			RATIONAL DESIGN OF A MOUSE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-RECEPTOR ANTAGONIST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GM-CSF RECEPTOR; 3-DIMENSIONAL STRUCTURE; MONOCLONAL-ANTIBODIES; HUMAN INTERLEUKIN-4; AFFINITY BINDING; ESCHERICHIA-COLI; GROWTH-HORMONE; LIGAND-BINDING; CLONING; PROTEIN	Mouse granulocyte-macrophage colony-stimulating factor (mGM-CSF) proteins with substitutions at residues in the first alpha-helix were examined for biological activity and receptor binding properties. Substitution at the buried residue His(15) affected both bioactivity and receptor binding. Of the four surface-exposed positions examined (Arg(11), Lys(14), Lys(20), and Glu(21)) only substitutions at Glu(21) impaired bioactivity. Proteins with charge reversal substitutions at this position were partial agonists and weak antagonists of native mGM-CSF action. All substitutions at Glu(21) abrogated high affinity binding. Lys(14) and Lys(20) substitution proteins showed various receptor binding defects. Qualitative and quantitative measurement of these binding defects identified Lys(14) as a residue that interacts specifically with the beta subunit of the mGM-CSF receptor, whereas Lys(20) appeared to exist at the GM-R alpha-subunit/GM-R beta-subunit interface as substitutions at this position produce both high and low affinity binding losses. These determinations permitted the design of a more potent mGM-CSF antagonist.	DNAX RES INST MOLEC & CELLULAR BIOL INC, DEPT MOLEC BIOL, PALO ALTO, CA 94304 USA	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.								ABDELMEGUID SS, 1987, P NATL ACAD SCI USA, V84, P6434, DOI 10.1073/pnas.84.18.6434; ABRAMS JS, 1992, IMMUNOL REV, V127, P5, DOI 10.1111/j.1600-065X.1992.tb01406.x; ALTMANN SW, 1991, J BIOL CHEM, V266, P5333; BARRY SC, 1994, J BIOL CHEM, V269, P8488; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BROWN CB, 1990, J IMMUNOL, V144, P2184; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DIEDERICHS K, 1991, SCIENCE, V254, P1779, DOI 10.1126/science.1837174; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; GREENBERG R, 1988, CURR MICROBIOL, V17, P321, DOI 10.1007/BF01570872; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; HERCUS TR, 1994, BLOOD, V83, P3500; HOWARDFLANDERS P, 1964, GENETICS, V49, P237; ITOH N, 1990, SCIENCE, V247, P324, DOI 10.1126/science.2404337; KANAKURA Y, 1991, BLOOD, V77, P1033; KASTELEIN RA, 1993, ONCOGENE, V8, P231; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; KITAMURA T, 1991, P NATL ACAD SCI USA, V88, P5082, DOI 10.1073/pnas.88.12.5082; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEE C, 1991, J MOL BIOL, V217, P373, DOI 10.1016/0022-2836(91)90550-P; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; LOPEZ AF, 1992, EMBO J, V11, P909, DOI 10.1002/j.1460-2075.1992.tb05129.x; LUNDELL D, 1990, J IND MICROBIOL, V5, P215, DOI 10.1007/BF01569679; MCKAY DB, 1992, SCIENCE, V257, P412, DOI 10.1126/science.257.5068.412; MEROPOL NJ, 1992, J BIOL CHEM, V267, P14266; MESSING J, 1983, METHOD ENZYMOL, V101, P20; METCALF D, 1985, SCIENCE, V229, P16, DOI 10.1126/science.2990035; METCALF D, 1986, BLOOD, V67, P257; MILBURN MV, 1993, NATURE, V363, P172, DOI 10.1038/363172a0; MIYAJIMA A, 1986, EMBO J, V5, P1193, DOI 10.1002/j.1460-2075.1986.tb04346.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MUNSON PJ, 1983, METHOD ENZYMOL, V92, P543; PANDIT J, 1992, SCIENCE, V258, P1358, DOI 10.1126/science.1455231; PARK LS, 1992, P NATL ACAD SCI USA, V89, P4295, DOI 10.1073/pnas.89.10.4295; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEELIG GF, 1994, J BIOL CHEM, V269, P5548; SHANAFELT AB, 1991, J BIOL CHEM, V266, P13804; SHANAFELT AB, 1992, J BIOL CHEM, V267, P25466; SHANAFELT AB, 1991, EMBO J, V10, P4105, DOI 10.1002/j.1460-2075.1991.tb04987.x; SHANAFELT AB, 1989, P NATL ACAD SCI USA, V86, P4872, DOI 10.1073/pnas.86.13.4872; SMITH LJ, 1992, J MOL BIOL, V224, P899, DOI 10.1016/0022-2836(92)90457-U	41	17	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2233	2240		10.1074/jbc.270.5.2233	http://dx.doi.org/10.1074/jbc.270.5.2233			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836455	hybrid			2022-12-27	WOS:A1995QE49300040
J	OBRIEN, MC; MCKAY, DB				OBRIEN, MC; MCKAY, DB			HOW POTASSIUM AFFECTS THE ACTIVITY OF THE MOLECULAR CHAPERONE HSC70 .1. POTASSIUM IS REQUIRED FOR OPTIMAL ATPASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHOCK COGNATE PROTEIN; UNCOATING ATPASE; PEPTIDE BINDING; HYDROLYSIS; FRAGMENT; HSP70; GROEL; SITE; K+	Several functions of the 70-kilodalton heat shock cognate protein (Hsc70), such as peptide binding/release and clathrin uncoating, have been shown to require potassium ions. We have examined the effect of monovalent ions on the ATPase activity of Hsc70. The steady-state ATPase activities of Hsc70 and its amino-terminal 44-kDa ATPase fragment are minimal in the absence of K+ and reach a maximum at similar to 0.1 M [K+]. Activation of the ATPase turnover correlates with the ionic radii of monovalent ions; those that are at least 0.3 Angstrom smaller (Na+ and Li+) or larger (Cs+) than K+ show negligible activation, whereas ions with radii differing only similar to 0.1 Angstrom from that of K+ (NH4+ and Rb+) activate to approximately half the turnover rate observed with K+. Single turnover experiments with Hsc70 demonstrate that ATP hydrolysis is 5-fold slower with Na+ than with K+. The equilibrium binding of ADP or ATP to Hsc70 is unperturbed when K+ is replaced with Na+. These results are consistent with a role for monovalent ions as specific cofactors in the enzymatic hydrolysis of ATP.	STANFORD UNIV,SCH MED,DEPT CELL BIOL,BECKMAN LABS STRUCT BIOL,STANFORD,CA 94305	Stanford University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039928, F32GM015141] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-39928, GM-15141] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHAPPELL TG, 1987, J BIOL CHEM, V262, P746; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; DELUCAFLAHERTY C, 1990, CELL, V62, P375; EVANS HJ, 1966, ANN REV PLANT PHYSIO, V17, P47, DOI 10.1146/annurev.pp.17.060166.000403; FERSHT A, 1985, ENZYME STRUCTURE MEC, P131; FLAHERTY KM, 1991, P NATL ACAD SCI USA, V88, P5041, DOI 10.1073/pnas.88.11.5041; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; GAO BC, 1994, BIOCHEMISTRY-US, V33, P2048, DOI 10.1021/bi00174a010; GAO BC, 1993, J BIOL CHEM, V268, P8507; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Hightower LE, 1994, BIOL HEAT SHOCK PROT, P179; HUTCHISON KA, 1992, J BIOL CHEM, V267, P14047; LARSEN TM, 1994, BIOCHEMISTRY-US, V33, P6301, DOI 10.1021/bi00186a033; MCKAY DB, 1993, ADV PROTEIN CHEM, V44, P67, DOI 10.1016/S0065-3233(08)60564-1; MCKAY DB, 1994, BIOL HEAT SHOCK PROT, P153; OBRIEN MC, 1993, J BIOL CHEM, V268, P24323; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; SADIS S, 1992, BIOCHEMISTRY-US, V31, P9406, DOI 10.1021/bi00154a012; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; SUELTER CH, 1970, SCIENCE, V168, P789, DOI 10.1126/science.168.3933.789; TODD MJ, 1993, BIOCHEMISTRY-US, V32, P8560, DOI 10.1021/bi00084a024; TONEY MD, 1993, SCIENCE, V261, P756, DOI 10.1126/science.8342040; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003; WANG TF, 1993, J BIOL CHEM, V268, P26049; WEAST RC, 1982, CRC HDB CHEM PHYSICS, pF156; WILBANKS SM, 1994, J BIOL CHEM, V269, P12893; WILBANKS SM, 1995, J BIOL CHEM, V270, P2251, DOI 10.1074/jbc.270.5.2251	28	99	100	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2247	2250		10.1074/jbc.270.5.2247	http://dx.doi.org/10.1074/jbc.270.5.2247			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836457	hybrid			2022-12-27	WOS:A1995QE49300042
J	WILBANKS, SM; MCKAY, DB				WILBANKS, SM; MCKAY, DB			HOW POTASSIUM AFFECTS THE ACTIVITY OF THE MOLECULAR CHAPERONE HSC70 .2. POTASSIUM BINDS SPECIFICALLY IN THE ATPASE ACTIVE-SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHOCK COGNATE PROTEIN; HYDROLYSIS; COMPLEX; RESOLUTION; FRAGMENT; HSP70	Crystallographic anomalous scattering from potassium at 1.7 Angstrom resolution reveals two monovalent ions that interact with MgADP and P-i in the nucleotide binding cleft of wild-type recombinant bovine Hsc70 ATPase fragment. K+ at site 1 interacts with oxygens of the beta-phosphate of ADP, whereas K+ at site 2 interacts with an oxygen of P-i. Both K+ ions also interact with specific H2O molecules in the first hydration shell of the octahedrally coordinated Mg2+ ion and with specific protein ligands. In crystals that have Na+ present, K+ is replaced by a Na+ ion at site 1 and by a Na(+)similar to H2O pair at site 2. The K+ ions are positioned where they could stabilize binding of a beta,gamma-bidentate MgATP complex with Hsc70, as well as a transition state during ATP hydrolysis, suggesting that monovalent ions act as specific metal cofactors in the ATPase reaction of Hsc70.	STANFORD UNIV, SCH MED, DEPT CELL BIOL, BECKMAN LABS STRUCT BIOL, STANFORD, CA 94305 USA	Stanford University				Wilbanks, Sigurd/0000-0001-7565-8913	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039928] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-39928] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMIAK DA, 1980, ACTA CRYSTALLOGR B, V36, P2585, DOI 10.1107/S056774088000948X; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BUCHBERGER A, 1994, NAT STRUCT BIOL, V1, P95, DOI 10.1038/nsb0294-95; CHAPPELL TG, 1987, J BIOL CHEM, V262, P746; DELUCAFLAHERTY C, 1988, J MOL BIOL, V200, P749, DOI 10.1016/0022-2836(88)90487-1; EVANS HJ, 1966, ANN REV PLANT PHYSIO, V17, P47, DOI 10.1146/annurev.pp.17.060166.000403; FLAHERTY KM, 1991, P NATL ACAD SCI USA, V88, P5041, DOI 10.1073/pnas.88.11.5041; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FLAHERTY KM, 1994, J BIOL CHEM, V269, P12899; FLETTERICK RJ, 1975, P NATL ACAD SCI USA, V72, P38, DOI 10.1073/pnas.72.1.38; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; HUTCHISON KA, 1992, J BIOL CHEM, V267, P14047; Ibers J. A., 1974, INT TABLES XRAY CRYS, VIV, P149; JONES TA, 1986, EMBO J, V5, P819, DOI 10.1002/j.1460-2075.1986.tb04287.x; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KENNARD O, 1971, PROC R SOC LON SER-A, V325, P401, DOI 10.1098/rspa.1971.0177; LARSEN TM, 1994, BIOCHEMISTRY-US, V33, P6301, DOI 10.1021/bi00186a033; LOWENSTEIN JM, 1960, BIOCHEM J, V75, P269, DOI 10.1042/bj0750269; MCKAY DB, 1994, BIOL HEAT SHOCK PROT, P153; MERRITT EA, 1980, ACTA CRYSTALLOGR B, V36, P2576, DOI 10.1107/S0567740880009478; OBRIEN MC, 1993, J BIOL CHEM, V268, P24323; OBRIEN MC, 1995, J BIOL CHEM, V270, P2247, DOI 10.1074/jbc.270.5.2247; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; ROSE IA, 1960, J BIOL CHEM, V235, P1170; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; STEIGEMANN W, 1974, THESIS TU MUNCHEN; SUELTER CH, 1970, SCIENCE, V168, P789, DOI 10.1126/science.168.3933.789; SWAMINATHAN P, 1980, ACTA CRYSTALLOGR B, V36, P2576; TONEY MD, 1993, SCIENCE, V261, P756, DOI 10.1126/science.8342040; WILBANKS SM, 1994, J BIOL CHEM, V269, P12893	33	130	131	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2251	2257		10.1074/jbc.270.5.2251	http://dx.doi.org/10.1074/jbc.270.5.2251			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836458	hybrid			2022-12-27	WOS:A1995QE49300043
J	KAN, JLC; MORAN, RG				KAN, JLC; MORAN, RG			ANALYSIS OF A MOUSE GENE ENCODING 3 STEPS OF PURINE SYNTHESIS REVEALS USE OF AN INTRONIC POLYADENYLATION SIGNAL WITHOUT ALTERNATIVE EXON USAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINAMIDE RIBONUCLEOTIDE SYNTHETASE; PHENOL-CHLOROFORM EXTRACTION; MESSENGER-RNA; SEQUENCE REQUIREMENTS; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; POLY(A) SITE; TRANSCRIPTION; TRANSFORMYLASE; DROSOPHILA	A single mouse genomic locus encodes proteins catalyzing three steps of purine synthesis, glycinamide ribonucleotide synthetase (GARS), aminoimidazole ribonucleotide synthetase (AIRS), and glycinamide ribo nucleotide formyltransferase (GART). This gene has 22 exons and spans 28 kilobases. The existence of a second genetic locus and closely related pseudogenes was ruled out by Southern analysis, Mouse tissues express two related classes of messages encoded by this single locus: a trifunctional GARS-AIRS-GART mRNA and a monofunctional GARS mRNA. These transcripts used the same set of multiple transcriptional start sites, and both used the same first 10 exons, CCAAT and TATA elements were not found for this locus. Exon 11, which represented the last coding sequence of the GARS domain, was differentially utilized for the two messages, The trifunctional mRNA was generated by splicing exon 11 to exon 12, the first coding sequence for the AIRS domain with subsequent use of a polyadenylation signal at the end of exon 22. Genomic sequence corresponding to the 3'-UTR of the monofunctional GARS mRNA was contiguous with exon 11, so that the smaller message arose from the recognition of one of the multiple polyadenylation signals present within the intron between exons 11 and 12. Hence, polyadenylation of the primary transcript at a position corresponding to an intron of the genomic locus was responsible for the generation of the monofunctional GARS class of mRNAs. This utilization of an intronic polyadenylation site without alternative exon usage is comparable to the mechanism whereby both secreted and membrane bound forms of the immunoglobulin mu heavy chain are made from a single genetic locus.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,MASSEY CANC CTR,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHARMACOL & TOXICOL,RICHMOND,VA 23298	Virginia Commonwealth University; Virginia Commonwealth University					NCI NIH HHS [CA 27605] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA027605] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AIMI J, 1990, NUCLEIC ACIDS RES, V18, P6665, DOI 10.1093/nar/18.22.6665; ALT FW, 1980, CELL, V20, P381; BENECH P, 1985, NUCLEIC ACIDS RES, V13, P1267; BENTLEY DL, 1988, CELL, V53, P245, DOI 10.1016/0092-8674(88)90386-8; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DAUBNER SC, 1985, BIOCHEMISTRY-US, V24, P7059, DOI 10.1021/bi00346a006; DAUBNER SC, 1986, BIOCHEMISTRY-US, V25, P2951, DOI 10.1021/bi00358a033; EBBOLE DJ, 1987, J BIOL CHEM, V262, P8274; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; HENIKOFF S, 1986, P NATL ACAD SCI USA, V83, P720, DOI 10.1073/pnas.83.3.720; HENIKOFF S, 1983, CELL, V34, P405, DOI 10.1016/0092-8674(83)90374-4; HENIKOFF S, 1987, GENETICS, V117, P711; KAN JLC, 1993, GENE, V137, P195, DOI 10.1016/0378-1119(93)90006-O; LAUDET V, 1991, NUCLEIC ACIDS RES, V19, P1105, DOI 10.1093/nar/19.5.1105; LEVITT N, 1989, GENE DEV, V3, P1019, DOI 10.1101/gad.3.7.1019; MECHTI N, 1991, MOL CELL BIOL, V11, P2832, DOI 10.1128/MCB.11.5.2832; PETERSON ML, 1989, MOL CELL BIOL, V9, P726, DOI 10.1128/MCB.9.2.726; PUISSANT C, 1990, BIOTECHNIQUES, V8, P148; REDDY CD, 1989, P NATL ACAD SCI USA, V86, P12; Sambrook J, 1989, MOL CLONING LABORATO; SAUNDERS ME, 1985, EMBO J, V4, P1761, DOI 10.1002/j.1460-2075.1985.tb03848.x; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; SHEN Y, 1990, BIOCHEMISTRY-US, V29, P218, DOI 10.1021/bi00453a030; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SMITH JM, 1987, J BIOL CHEM, V262, P10565; SMITH JM, 1986, J BIOL CHEM, V261, P632; TSURUSHITA N, 1988, SCIENCE, V239, P494, DOI 10.1126/science.3124268; TSURUSHITA N, 1987, MOL CELL BIOL, V7, P4603; WHITE JH, 1985, NATURE, V315, P350, DOI 10.1038/315350a0; WINKELMANN JC, 1990, J BIOL CHEM, V265, P20449	34	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1823	1832		10.1074/jbc.270.4.1823	http://dx.doi.org/10.1074/jbc.270.4.1823			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829519				2022-12-27	WOS:A1995QD20400053
J	KEPPLER, OT; STEHLING, P; HERRMANN, M; KAYSER, H; GRUNOW, D; REUTTER, W; PAWLITA, M				KEPPLER, OT; STEHLING, P; HERRMANN, M; KAYSER, H; GRUNOW, D; REUTTER, W; PAWLITA, M			BIOSYNTHETIC MODULATION OF SIALIC ACID-DEPENDENT VIRUS-RECEPTOR INTERACTIONS OF 2 PRIMATE POLYOMA VIRUSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE RECEPTOR; LINKED OLIGOSACCHARIDES; BINDING; LECTIN; GLYCOPROTEINS; ANALOGS; HEMAGGLUTININ; GANGLIOSIDES; ERYTHROCYTES; DETERMINANT	Sialic acids are essential components of the cell surface receptors of many microorganisms including viruses, A synthetic, N-substituted D-mannosamine derivative has been shown to act as precursor for structurally altered sialic acid incorporated into glycoconjugates in vivo (Kayser, H., Zeitler, R., Kannicht, C., Grunow, D., Nuck, R., and Reutter, W. (1992) J. Biol. Chem. 267, 16934-16938). In this study we have analyzed the potential of three different sialic acid precursor analogues to modulate sialic acid-dependent virus receptor function on different cells, We show that treatment with these D-mannosamine derivatives can result in the structural modification of about 50% of total cellular sialic acid content, Treatment interfered drastically and specifically with sialic acid-dependent infection of two distinct primate polyoma viruses, Both inhibition (over 95%) and enhancement (up to 7-fold) of virus binding and infection were observed depending on the N-acyl substitution at the C-5 position of sialic acid, These effects were attributed to the synthesis of metabolically modified, sialylated virus receptors, carrying elongated N-acyl groups, with altered binding affinities for virus particles, Thus, the principle of biosynthetic modification of sialic acid by application of appropriate sialic acid precursors to tissue culture or in vivo offers new means to specifically influence sialic acid-dependent ligand-receptor interactions and could be a potent tool to further clarify the biological functions of sialic acid, in particular its N-acyl side chain.	DEUTSCH KREBSFORSCHUNGSZENTRUM,ANGEW TUMORVIROL,D-69120 HEIDELBERG,GERMANY; FREE UNIV BERLIN,INST MOLEK BIOL & BIOCHEM,D-14195 BERLIN,GERMANY	Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin			Pawlita, Labor/C-9720-2011	Pawlita, Michael/0000-0002-4720-8306				BALL RK, 1984, EMBO J, V3, P1485, DOI 10.1002/j.1460-2075.1984.tb02000.x; BAST BJEG, 1992, J CELL BIOL, V116, P423, DOI 10.1083/jcb.116.2.423; BROSSMER R, 1993, FEBS LETT, V323, P96, DOI 10.1016/0014-5793(93)81456-A; CLAYSON ET, 1989, J VIROL, V63, P1095, DOI 10.1128/JVI.63.3.1095-1100.1989; CORFIELD AP, 1982, SIALIC ACIDS CHEM ME, P5; FRIED H, 1981, VIROLOGY, V10, P188; GARDNER SD, 1971, RECENT ADV CLIN VIRO, P93; GEILEN CC, 1992, ARCH BIOCHEM BIOPHYS, V296, P108, DOI 10.1016/0003-9861(92)90551-7; GENTSCH JR, 1985, J VIROL, V56, P356, DOI 10.1128/JVI.56.2.356-364.1985; Gottschalk A, 1959, VIRUSES, V3, P51; GRUNHOLZ HJ, 1981, CARBOHYD RES, V96, P259, DOI 10.1016/S0008-6215(00)81876-5; HADLEY TJ, 1986, ANNU REV MICROBIOL, V40, P451, DOI 10.1146/annurev.mi.40.100186.002315; HAUN G, 1993, J VIROL, V67, P7482, DOI 10.1128/JVI.67.12.7482-7492.1993; HEERZE LD, 1990, BIOCHEM BIOPH RES CO, V172, P1224, DOI 10.1016/0006-291X(90)91579-H; Howe C, 1972, Adv Virus Res, V17, P1, DOI 10.1016/S0065-3527(08)60746-0; KAYSER H, 1992, J BIOL CHEM, V267, P16934; KAYSER H, 1993, EXPERIENTIA, V49, P885, DOI 10.1007/BF01952603; KELM S, 1992, EUR J BIOCHEM, V205, P147, DOI 10.1111/j.1432-1033.1992.tb16762.x; KEPPLER OT, 1992, EUR J IMMUNOL, V22, P2777, DOI 10.1002/eji.1830221104; KNIBBS RN, 1993, J BIOL CHEM, V268, P18524; KO HL, 1987, INFECTION, V15, P237, DOI 10.1007/BF01644121; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LISANTI MP, 1991, EMBO J, V10, P1969, DOI 10.1002/j.1460-2075.1991.tb07726.x; MARKWELL MAK, 1981, P NATL ACAD SCI-BIOL, V78, P5406, DOI 10.1073/pnas.78.9.5406; MENEZES J, 1975, BIOMEDICINE, V22, P276; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; REUTER G, 1994, METHOD ENZYMOL, V230, P168; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; SCHAUER R, 1987, METHOD ENZYMOL, V138, P132, DOI 10.1016/0076-6879(87)38012-7; SCHAUER R, 1985, TRENDS BIOCHEM SCI, V10, P357, DOI 10.1016/0968-0004(85)90112-4; SEIF I, 1981, DNA TUMOR VIRUSES MO, P911; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; SINIBALDI L, 1990, ARCH VIROL, V113, P291, DOI 10.1007/BF01316682; SWEELEY CC, 1963, J AM CHEM SOC, V85, P2497, DOI 10.1021/ja00899a032; TAVAKKOL A, 1990, BIOCHEMISTRY-US, V29, P10684, DOI 10.1021/bi00499a016; TENEBERG S, 1990, FEBS LETT, V263, P10, DOI 10.1016/0014-5793(90)80693-D; VARKI A, 1984, ANAL BIOCHEM, V137, P236, DOI 10.1016/0003-2697(84)90377-4; VARKI A, 1992, GLYCOBIOLOGY, V2, P25, DOI 10.1093/glycob/2.1.25; VLASAK R, 1988, P NATL ACAD SCI USA, V85, P4526, DOI 10.1073/pnas.85.12.4526; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; WANG WC, 1988, J BIOL CHEM, V263, P4576; ZURHAUSEN H, 1979, MED MICROBIOL IMMUN, V167, P137, DOI 10.1007/BF02121180	42	148	156	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1308	1314		10.1074/jbc.270.3.1308	http://dx.doi.org/10.1074/jbc.270.3.1308			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836396	hybrid			2022-12-27	WOS:A1995QB15600051
J	PEREZPAYA, E; HOUGHTEN, RA; BLONDELLE, SE				PEREZPAYA, E; HOUGHTEN, RA; BLONDELLE, SE			THE ROLE OF AMPHIPATHICITY IN THE FOLDING, SELF-ASSOCIATION AND BIOLOGICAL-ACTIVITY OF MULTIPLE SUBUNIT SMALL PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM; SECONDARY STRUCTURE; ANTIMICROBIAL ACTIVITIES; AQUEOUS MELITTIN; AMINO-ACIDS; PEPTIDE; STABILITY; HELIX; MODEL; AGGREGATION	The effect that altering amphipathicity has on the folding process and self association of melittin, a small model protein, has been investigated using single amino acid substitutions of lysine 7, a residue distant from the contact residues involved in the hydrophobic core of tetrameric melittin. While substitutions of such a residue were not expected to interfere with the packing process, the largest alterations in the potential overall amphipathicity of melittin were found to prevent the folding into an alpha-helical conformation to occur and, in turn, to prevent the self association. Amphiphathic alpha-helices were found to be a key determining feature in the early folding process of the self association of peptides and protein segments. Those substitutions, which prevented the inducible amphipathic folding ability, were also found to result in a loss in hemolytic and antimicrobial activity. These results, combined with studies of the binding to artificial liposomes and to polysialic acids, indicate that the losses in activity were due to an initial inability to be induced into an amphipathic alpha-helix and to self associate. Ultimately, melittins's self association is proposed to be required to penetrate the carbohydrate barrier in biological membranes.	TORREY PINES INST MOLEC STUDIES, SAN DIEGO, CA 92121 USA	Torrey Pines Institute for Molecular Studies, California					NIGMS NIH HHS [GM 45583] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045583] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BATENBURG AM, 1988, BIOSCIENCE REP, V8, P299, DOI 10.1007/BF01115220; BELLO J, 1982, BIOCHEMISTRY-US, V21, P461, DOI 10.1021/bi00532a007; BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P52, DOI 10.1021/bi00453a007; BLABER M, 1993, SCIENCE, V260, P1637, DOI 10.1126/science.8503008; BLONDELLE S E, 1991, Peptide Research, V4, P12; BLONDELLE SE, 1992, BIOCHEMISTRY-US, V31, P12688, DOI 10.1021/bi00165a020; BLONDELLE SE, 1993, BIOCHIM BIOPHYS ACTA, V1202, P331, DOI 10.1016/0167-4838(93)90024-L; BLONDELLE SE, 1991, BIOCHEMISTRY-US, V30, P4671, DOI 10.1021/bi00233a006; BROWN LR, 1980, BIOCHIM BIOPHYS ACTA, V622, P231, DOI 10.1016/0005-2795(80)90034-3; DEFRANCESCO R, 1991, BIOCHEMISTRY-US, V30, P143, DOI 10.1021/bi00215a021; DEGRADO WF, 1982, BIOPHYS J, V37, P329, DOI 10.1016/S0006-3495(82)84681-X; DEKRUIJFF B, 1990, BIOSCIENCE REP, V10, P127; DEMPSEY CE, 1991, FEBS LETT, V281, P240, DOI 10.1016/0014-5793(91)80402-O; DEMPSEY CE, 1990, BIOCHIM BIOPHYS ACTA, V1031, P143, DOI 10.1016/0304-4157(90)90006-X; DUFOURCQ J, 1986, BIOCHIM BIOPHYS ACTA, V859, P33, DOI 10.1016/0005-2736(86)90315-9; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; GOTO Y, 1992, BIOCHEMISTRY-US, V31, P732, DOI 10.1021/bi00118a014; GREENFIELD NJ, 1993, PROTEIN SCI, V2, P1263, DOI 10.1002/pro.5560020809; HABERMANN E, 1967, H-S Z PHYSIOL CHEM, V348, P37, DOI 10.1515/bchm2.1967.348.1.37; HOUGHTEN RA, 1986, INT J PEPT PROT RES, V27, P673; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; JOHN E, 1992, BIOPHYS J, V63, P1536, DOI 10.1016/S0006-3495(92)81737-X; JOHN E, 1991, BIOPHYS J, V60, P319, DOI 10.1016/S0006-3495(91)82056-2; JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145, DOI 10.1146/annurev.bb.17.060188.001045; KNOPPEL E, 1979, BIOCHEMISTRY-US, V18, P4177; LEAR JD, 1987, J BIOL CHEM, V262, P6500; LEHRMAN SR, 1990, BIOCHEMISTRY-US, V29, P5590, DOI 10.1021/bi00475a025; LIN GSB, 1983, BIOCHIM BIOPHYS ACTA, V732, P683, DOI 10.1016/0005-2736(83)90247-X; LYU PC, 1990, SCIENCE, V250, P669, DOI 10.1126/science.2237416; MADUKE M, 1993, SCIENCE, V260, P364, DOI 10.1126/science.8385804; MATOUSCHEK A, 1990, NATURE, V346, P440, DOI 10.1038/346440a0; MERUTKA G, 1990, BIOCHEMISTRY-US, V29, P7511, DOI 10.1021/bi00484a021; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; OOMEN RP, 1992, BIOCHEMISTRY-US, V31, P5698, DOI 10.1021/bi00140a003; PEREZPAYA E, 1994, BIOCHEM J, V299, P587, DOI 10.1042/bj2990587; QUAY SC, 1983, BIOCHEMISTRY-US, V22, P695, DOI 10.1021/bi00272a026; QUAY SC, 1985, BIOCHIM BIOPHYS ACTA, V831, P22, DOI 10.1016/0167-4838(85)90144-X; SMITH CK, 1994, BIOCHEMISTRY-US, V33, P5510, DOI 10.1021/bi00184a020; STEWART JM, 1993, AMPHIPATHIC HELIX, P21; TAKEDA K, 1991, J AM CHEM SOC, V113, P1040, DOI 10.1021/ja00003a046; TAYLOR JW, 1987, METHOD ENZYMOL, V154, P473; TERWILLIGER TC, 1982, J BIOL CHEM, V257, P6010; TERWILLIGER TC, 1982, BIOPHYS J, V37, P353, DOI 10.1016/S0006-3495(82)84683-3; TOSTESON MT, 1990, BIOPHYS J, V58, P1367, DOI 10.1016/S0006-3495(90)82483-8; WILCOX W, 1992, PROTEIN SCI, V1, P641, DOI 10.1002/pro.5560010510; YANG JT, 1986, METHOD ENZYMOL, V130, P208; ZHONG LX, 1992, P NATL ACAD SCI USA, V89, P4462, DOI 10.1073/pnas.89.10.4462; ZHOU NE, 1992, J BIOL CHEM, V267, P2664	48	88	95	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1048	1056		10.1074/jbc.270.3.1048	http://dx.doi.org/10.1074/jbc.270.3.1048			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836358	hybrid			2022-12-27	WOS:A1995QB15600013
J	SPRINGMAN, EB; DIKOV, MM; SERAFIN, WE				SPRINGMAN, EB; DIKOV, MM; SERAFIN, WE			MAST-CELL PROCARBOXYPEPTIDASE-A - MOLECULAR MODELING AND BIOCHEMICAL-CHARACTERIZATION OF ITS PROCESSING WITHIN SECRETORY GRANULES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYPEPTIDASE-A; 3-DIMENSIONAL STRUCTURE; ACTIVATION SEGMENT; SERINE PROTEASES; INTERNAL-PH; MOUSE; IDENTIFICATION; CLONING; PROTEIN; RAT	Previously, we characterized murine mast cell procarboxypeptidase A (MC-proCPA) as an inactive zymogen, To investigate the mechanisms for this lack of enzymatic activity and the processing of the zymogen to the active form, we now have performed molecular modeling of the tertiary structure of murine MC-proCPA based on the x-ray crystallographic structures of porcine pancreatic procarboxypeptidases A and B. Our model predicts that MC-proCPA retains a high degree of structural similarity to its pancreatic homologues, The globular propeptide physically blocks access to the fully formed active site of the catalytic domain and contains a salt bridge to the substrate-binding region that precludes docking of even small substrates, Based on consideration of the predicted tertiary structure and charge field characteristics of the model, the activation site (between Glu(A94) and Ile(1)) appears to be highly exposed even after MC-proCPA binds to secretory granule proteoglycans, Based on the steady-state levels of MC-proCPA versus IMC-CPA, cycloheximide inhibition of protein synthesis, and brefeldin A blockage of protein sorting, we show that MC-proCPA is processed rapidly in murine mast cell line KiSV-MC14 with a half-life of 26 +/- 5 min (mean +/- S.D., n = 3), and the processing occurs within the secretory granules, The enzyme responsible for this processing may be a thiol protease since treatment of the KiSV-MC14 with 200 mu M E-64d, a selective thiol-protease inhibitor, increases MC-proCPA by 2.7 +/- 0.2-fold (mean +/- S.D., n = 3) within 6 h of application.	VANDERBILT UNIV,SCH MED,DEPT PHARMACOL,DIV CLIN PHARMACOL,NASHVILLE,TN 37232; VANDERBILT UNIV,SCH MED,DEPT MED,DIV ALLERGY,NASHVILLE,TN 37232	Vanderbilt University; Vanderbilt University					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM015431, T32GM007569, P50GM015431] Funding Source: NIH RePORTER; NIAID NIH HHS [AI31273] Funding Source: Medline; NIGMS NIH HHS [GM15431, GM-07569] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AVILES FX, 1993, EUR J BIOCHEM, V211, P381, DOI 10.1111/j.1432-1033.1993.tb17561.x; BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; BLUNDELL TL, 1987, NATURE, V326, P347, DOI 10.1038/326347a0; BURGOS FJ, 1991, BIOCHEMISTRY-US, V30, P4082, DOI 10.1021/bi00230a038; COLL M, 1991, EMBO J, V10, P1; DEYOUNG MB, 1987, ARCH BIOCHEM BIOPHYS, V254, P222, DOI 10.1016/0003-9861(87)90098-1; DIKOV MM, 1994, J BIOL CHEM, V269, P25897; EDER J, 1993, BIOCHEMISTRY-US, V32, P18, DOI 10.1021/bi00052a004; EVERITT MT, 1980, FEBS LETT, V110, P292, DOI 10.1016/0014-5793(80)80095-0; GOLDSTEIN SM, 1987, J IMMUNOL, V139, P2724; GREEN GDJ, 1981, J BIOL CHEM, V256, P1923; GREER J, 1980, J MOL BIOL, V153, P1027; GUASCH A, 1992, J MOL BIOL, V224, P141, DOI 10.1016/0022-2836(92)90581-4; HANADA K, 1983, PROTEINASE INHIBITOR, P25; HAYES N, 1993, BIOCHEM BIOPH RES CO, V190, P881, DOI 10.1006/bbrc.1993.1131; JOHNSON RG, 1980, FEBS LETT, V120, P75, DOI 10.1016/0014-5793(80)81050-7; LAGUNOFF D, 1983, EXP CELL RES, V144, P353, DOI 10.1016/0014-4827(83)90414-7; LETRONG H, 1987, P NATL ACAD SCI USA, V84, P2266; MCGUIRE MJ, 1993, J BIOL CHEM, V268, P2458; NAVIA MA, 1989, NATURE, V337, P615, DOI 10.1038/337615a0; RAZIN E, 1984, J IMMUNOL, V132, P1479; REYNOLDS DS, 1989, P NATL ACAD SCI USA, V86, P9480, DOI 10.1073/pnas.86.23.9480; REYNOLDS DS, 1989, J BIOL CHEM, V264, P20094; REYNOLDS DS, 1991, J BIOL CHEM, V266, P3847; REYNOLDS DS, 1988, J BIOL CHEM, V263, P12783; REYNOLDS DS, 1990, P NATL ACAD SCI USA, V87, P3230, DOI 10.1073/pnas.87.8.3230; SCHECHTER NM, 1986, J IMMUNOL, V137, P962; SCHWARTZ LB, 1982, J IMMUNOL, V128, P1128; SCHWARTZ LB, 1981, J BIOL CHEM, V256, P1939; SEKIZAWA K, 1989, J CLIN INVEST, V83, P175, DOI 10.1172/JCI113855; SERAFIN WE, 1991, J BIOL CHEM, V266, P1934; SERAFIN WE, 1990, J BIOL CHEM, V265, P423; SERAFIN WE, 1991, P NATL ACAD SCI USA, V88, P5984, DOI 10.1073/pnas.88.14.5984; SERAFIN WE, 1987, J IMMUNOL, V139, P3771; SERAFIN WE, 1993, J ALLERGY CLIN IMMUN, V91, P255; SERAFIN WE, 1986, J BIOL CHEM, V261, P5017; SILEN JL, 1989, NATURE, V341, P462, DOI 10.1038/341462a0; SOMMERHOFF CP, 1989, J IMMUNOL, V142, P2450; SPRINGMAN EB, 1994, BIOL MAST CELL PROTE, P169; SUGUMARAN G, 1992, BIOCHEM BIOPH RES CO, V183, P357, DOI 10.1016/0006-291X(92)90488-7; TCHEKNEVA E, 1994, J IMMUNOL, V152, P5912; URATA H, 1990, J BIOL CHEM, V265, P22348; UREN JR, 1974, BIOCHEMISTRY-US, V13, P3512, DOI 10.1021/bi00714a016; VARUGHESE KI, 1992, BIOCHEMISTRY-US, V31, P5172, DOI 10.1021/bi00137a012; VENDRELL J, 1992, BIOL CHEM H-S, V373, P387, DOI 10.1515/bchm3.1992.373.2.387; VENDRELL J, 1986, BIOCHEM BIOPH RES CO, V141, P517, DOI 10.1016/S0006-291X(86)80203-0; VENDRELL J, 1990, J BIOL CHEM, V265, P6949; VENSEL WH, 1971, BIOCHIM BIOPHYS ACTA, V250, P395, DOI 10.1016/0005-2744(71)90196-3; WEBER IT, 1989, SCIENCE, V243, P928, DOI 10.1126/science.2537531; WEBER IT, 1990, PROTEINS, V7, P172, DOI 10.1002/prot.340070206; WOODBURY RG, 1981, METHOD ENZYMOL, V80, P588; YAMAMOTO D, 1990, BIOCHEM BIOPH RES CO, V171, P711, DOI 10.1016/0006-291X(90)91204-6; ZHU XL, 1989, NATURE, V339, P483, DOI 10.1038/339483a0	53	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1300	1307		10.1074/jbc.270.3.1300	http://dx.doi.org/10.1074/jbc.270.3.1300			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836395	hybrid			2022-12-27	WOS:A1995QB15600050
J	ZUCKER, SD; GOESSLING, W; GOLLAN, JL				ZUCKER, SD; GOESSLING, W; GOLLAN, JL			KINETICS OF BILIRUBIN TRANSFER BETWEEN SERUM-ALBUMIN AND MEMBRANE-VESICLES - INSIGHT INTO THE MECHANISM OF ORGANIC ANION DELIVERY TO THE HEPATOCYTE PLASMA-MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFUSED-RAT-LIVER; SURFACE-MEDIATED DISSOCIATION; HEPATIC TRANSPORT; FATTY-ACIDS; ROSE-BENGAL; PHOSPHATIDYLCHOLINE VESICLES; UNCONJUGATED BILIRUBIN; PHOSPHOLIPID-BILAYERS; UNILAMELLAR VESICLES; CELL-SURFACE	Unconjugated bilirubin is transported in the plasma bound primarily to serum albumin, from which it is taken up and metabolized by the liver. To better characterize the mechanism of bilirubin delivery to the hepatocyte, stopped-flow techniques were utilized to study the kinetics of bilirubin transfer between serum albumin and both model phospholipid and native hepatocyte plasma membrane vesicles. The transfer process was best described by a single exponential function, with rate constants of 0.93 +/- 0.04, 0.61 +/- 0.03, and 0.10 +/- 0.01 s(-1) (+/- S.D.) at 25 degrees C for human, rat, and bovine serum albumins, respectively. The observed variations in rate with respect to donor and acceptor concentrations provide strong evidence for the diffusional transfer of free bilirubin. Thermodynamic analysis suggests that the binding site on bovine serum albumin demonstrates higher specificity for the bilirubin molecule than that on human or rat serum albumin, which exhibit similar binding characteristics. Kinetic analysis of bilirubin transfer from rat serum albumin to isolated rat basolateral liver plasma membranes indicates that the delivery of albumin-bound bilirubin to the hepatocyte surface occurs via aqueous diffusion, rather than a collisional process, thereby mitigating against the presence of an ''albumin receptor.''	HARVARD UNIV, CTR DIGEST DIS, BOSTON, MA 02115 USA	Harvard University	ZUCKER, SD (corresponding author), HARVARD UNIV, BRIGHAM & WOMENS HOSP, SCH MED, DIV GASTROENTEROL, 75 FRANCIS ST, BOSTON, MA 02115 USA.		Zucker, Stephen/AAJ-3359-2020	Zucker, MD, Stephen/0000-0003-1451-905X; Goessling, Wolfram/0000-0001-9972-1569	NIDDK NIH HHS [DK-02047, DK-36887, DK-43955] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036887, K11DK002047, R01DK043955] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARION WJ, 1989, METHOD ENZYMOL, V174, P58; BARENHOLZ Y, 1977, BIOCHEMISTRY-US, V16, P2806, DOI 10.1021/bi00631a035; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BEAVEN GH, 1973, EUR J BIOCHEM, V33, P500, DOI 10.1111/j.1432-1033.1973.tb02709.x; BLAIR JNR, 1988, BIOCHIM BIOPHYS ACTA, V964, P161, DOI 10.1016/0304-4165(88)90162-6; BLAUER G, 1970, J BIOL CHEM, V245, P372; BLITZER BL, 1985, AM J PHYSIOL, V249, pG34, DOI 10.1152/ajpgi.1985.249.1.G34; BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; BRANCA M, 1983, BIOCHIM BIOPHYS ACTA, V742, P341, DOI 10.1016/0167-4838(83)90320-5; BRODERSEN R, 1979, J BIOL CHEM, V254, P2364; Chen R. F., 1973, FLUORESCENCE TECHNIQ; CHEN RF, 1974, ARCH BIOCHEM BIOPHYS, V160, P106, DOI 10.1016/S0003-9861(74)80014-7; COOKE JR, 1969, CLIN CHIM ACTA, V26, P425, DOI 10.1016/0009-8981(69)90070-9; CU A, 1975, J AM CHEM SOC, V97, P2579, DOI 10.1021/ja00842a066; DANIELS C, 1985, BIOCHEMISTRY-US, V24, P3286, DOI 10.1021/bi00334a032; DEPIERRE JW, 1988, LIVER BIOL PATHOBIOL, P165; FAERCH T, 1975, ARCH BIOCHEM BIOPHYS, V168, P351, DOI 10.1016/0003-9861(75)90263-5; FLEISCHER AB, 1986, J CLIN INVEST, V77, P964, DOI 10.1172/JCI112397; FORKER EL, 1985, HEPATOLOGY, V5, P1236, DOI 10.1002/hep.1840050630; FORKER EL, 1985, AM J PHYSIOL, V248, pG702, DOI 10.1152/ajpgi.1985.248.6.G702; FORKER EL, 1982, J PHARMACOL EXP THER, V223, P342; FORKER EL, 1985, AM J PHYSIOL, V248, pG709, DOI 10.1152/ajpgi.1985.248.6.G709; FORKER EL, 1981, J CLIN INVEST, V67, P1517, DOI 10.1172/JCI110182; FORKER EL, 1983, J CLIN INVEST, V72, P1764, DOI 10.1172/JCI111136; FRICKER G, 1989, J CLIN INVEST, V84, P876, DOI 10.1172/JCI114248; GLUSHKO V, 1982, BIOCHIM BIOPHYS ACTA, V719, P65, DOI 10.1016/0304-4165(82)90308-7; GOLDBARG JA, 1958, CANCER, V11, P283, DOI 10.1002/1097-0142(195803/04)11:2<283::AID-CNCR2820110209>3.0.CO;2-8; GOLLAN J, 1981, J CLIN INVEST, V67, P1003, DOI 10.1172/JCI110111; GRAY RD, 1978, J BIOL CHEM, V253, P4370; HAHM JS, 1992, J LIPID RES, V33, P1123; HAMILTON JA, 1989, P NATL ACAD SCI USA, V86, P2663, DOI 10.1073/pnas.86.8.2663; HRKAL Z, 1984, INT J BIOCHEM, V16, P799, DOI 10.1016/0020-711X(84)90192-7; HUANG C, 1978, P NATL ACAD SCI USA, V75, P308, DOI 10.1073/pnas.75.1.308; INOUE M, 1985, J BIOCHEM-TOKYO, V97, P737, DOI 10.1093/oxfordjournals.jbchem.a135113; KAMP F, 1993, BIOCHEMISTRY-US, V32, P11074, DOI 10.1021/bi00092a017; KAMP F, 1992, P NATL ACAD SCI USA, V89, P11367, DOI 10.1073/pnas.89.23.11367; LEE JJ, 1981, PHOTOCHEM PHOTOBIOL, V33, P757, DOI 10.1111/j.1751-1097.1981.tb05486.x; LEVINE RL, 1977, CLIN CHEM, V23, P2292; LIGHTNER DA, 1977, PHOTOCHEM PHOTOBIOL, V26, P427, DOI 10.1111/j.1751-1097.1977.tb07510.x; LIGHTNER DA, 1982, BILIRUBIN CHEM, V1, P2; MEIER PJ, 1990, METHOD ENZYMOL, V192, P534; MORGAN DJ, 1985, HEPATOLOGY, V5, P1231, DOI 10.1002/hep.1840050629; MOSELEY RH, 1986, AM J PHYSIOL, V250, pG35, DOI 10.1152/ajpgi.1986.250.1.G35; NICHOLS JW, 1982, BIOCHEMISTRY-US, V21, P1720, DOI 10.1021/bi00537a003; NICHOLS JW, 1988, BIOCHEMISTRY-US, V27, P1889, DOI 10.1021/bi00406a014; NOY N, 1992, BIOPHYS CHEM, V42, P177, DOI 10.1016/0301-4622(92)85007-Q; NUNES R, 1988, J HEPATOL, V7, P293, DOI 10.1016/S0168-8278(88)80001-1; ONISHI S, 1985, BIOCHEM J, V230, P561, DOI 10.1042/bj2300561; OSTROW JD, 1963, J CLIN INVEST, V42, P1286, DOI 10.1172/JCI104813; PEDERSEN AO, 1977, EUR J BIOCHEM, V72, P213, DOI 10.1111/j.1432-1033.1977.tb11242.x; REED RG, 1977, J BIOL CHEM, V252, P7483; REED RG, 1989, J BIOL CHEM, V264, P9867; ROSEI MA, 1983, EXPERIENTIA, V39, P165, DOI 10.1007/BF01958878; RUBALTELLI FF, 1979, PHOTOCHEM PHOTOBIOL, V29, P991, DOI 10.1111/j.1751-1097.1979.tb07803.x; SCHARSCHMIDT BF, 1979, J LAB CLIN MED, V93, P790; SCHARSCHMIDT BF, 1975, J CLIN INVEST, V56, P1280, DOI 10.1172/JCI108204; SORRENTINO D, 1989, J CLIN INVEST, V84, P1325, DOI 10.1172/JCI114301; STOLLMAN YR, 1983, J CLIN INVEST, V72, P718, DOI 10.1172/JCI111021; STREMMEL W, 1983, BIOCHIM BIOPHYS ACTA, V756, P20, DOI 10.1016/0304-4165(83)90019-3; TIRIBELLI C, 1993, HEPATOLOGY, V17, P715, DOI 10.1002/hep.1840170428; VANDERSLUIJS P, 1987, HEPATOLOGY, V7, P688; WATSON D, 1962, CLIN SCI, V22, P435; WEISIGER R, 1980, GASTROENTEROLOGY, V79, P1065; WEISIGER R, 1981, SCIENCE, V211, P1048, DOI 10.1126/science.6258226; WEISIGER RA, 1987, J CLIN INVEST, V79, P1070, DOI 10.1172/JCI112920; WEISIGER RA, 1984, HEPATOLOGY, V4, P492, DOI 10.1002/hep.1840040323; WEISIGER RA, 1989, AM J PHYSIOL, V257, pG904, DOI 10.1152/ajpgi.1989.257.6.G904; WEISIGER RA, 1985, P NATL ACAD SCI USA, V82, P1563, DOI 10.1073/pnas.82.5.1563; WEISIGER RA, 1991, AM J PHYSIOL, V261, pG872, DOI 10.1152/ajpgi.1991.261.5.G872; Weisiger Richard A., 1993, P171; WOLKOFF AW, 1987, HEPATOLOGY, V7, P777, DOI 10.1002/hep.1840070427; WOLKOFF AW, 1987, J CLIN INVEST, V79, P1259, DOI 10.1172/JCI112946; WRIGHT TL, 1987, HEPATOLOGY, V7, P294, DOI 10.1002/hep.1840070214; ZUCKER SD, 1994, J BIOL CHEM, V269, P19262; ZUCKER SD, 1992, BIOCHEMISTRY-US, V31, P3184, DOI 10.1021/bi00127a020	75	61	61	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1074	1081		10.1074/jbc.270.3.1074	http://dx.doi.org/10.1074/jbc.270.3.1074			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836362	hybrid			2022-12-27	WOS:A1995QB15600017
J	HAN, XY; GALLOWAY, DR				HAN, XY; GALLOWAY, DR			ACTIVE-SITE MUTATIONS OF PSEUDOMONAS-AERUGINOSA EXOTOXIN-A - ANALYSIS OF THE HIS(440) RESIDUE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION FACTOR-II; DIPHTHERIA-TOXIN; GLUTAMIC ACID-553; ASPARTIC-ACID; NAD; MUTAGENESIS; MECHANISM; HOMOLOGY; TOXICITY; PROTEIN	Pseudomonas aeruginosa exotoxin A (ETA) is a member of the family of bacterial ADP-ribosylating toxins which use NAD(+) as the ADP-ribose donor, By analogy to diphtheria and pertussis toxins, the His(440) residue of ETA has been proposed to be one of the critical residues within the active site of the toxin. In this study the role of the His(440) residue was explored through site-directed mutagenesis which resulted in the production of ETA proteins containing Ala, Asn, and Phe substitutions at the 440 position, The His(440) substituted ETA proteins were purified and analyzed. All substitutions at the 440 site displayed severely reduced ADP-ribosylation activity (>1000-fold). However, NAD glycohydrolase activity remained intact and in the case of ETAH440N actually increased 10-fold. NAD(+) binding is not affected by substitutions at the 440 site as indicated by similar K-m values for the ETA variants tested. Conformational integrity of the mutant toxins appears to be largely unaffected as assessed by analysis with a conformation-sensitive monoclonal antibody as well as sensitivity to proteinase digestion. In view of the location of His(440) residue within or close to the proposed NAD(+)-binding site, these results suggest that His(440) may be a catalytic residue involved in the transfer of the ADP-ribose moiety to the EF-2 substrate.	OHIO STATE UNIV,DEPT MICROBIOL,COLUMBUS,OH 43210	University System of Ohio; Ohio State University					NIAID NIH HHS [AI123429-06] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLURED VS, 1986, P NATL ACAD SCI USA, V83, P1320, DOI 10.1073/pnas.83.5.1320; ANTOINE R, 1994, J BIOL CHEM, V269, P6450; BARBIERI JT, 1989, INFECT IMMUN, V57, P3549, DOI 10.1128/IAI.57.11.3549-3554.1989; BLANKE SR, 1994, BIOCHEMISTRY-US, V33, P5155, DOI 10.1021/bi00183a019; BRANDHUBER BJ, 1988, PROTEINS, V3, P146, DOI 10.1002/prot.340030303; CARROLL SF, 1987, J BIOL CHEM, V262, P8707; CARROLL SF, 1988, MOL MICROBIOL, V2, P293, DOI 10.1111/j.1365-2958.1988.tb00031.x; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; COLLIER RJ, 1975, BACTERIOL REV, V39, P54, DOI 10.1128/MMBR.39.1.54-85.1975; DOMENIGHINI M, 1991, MOL MICROBIOL, V5, P23, DOI 10.1111/j.1365-2958.1991.tb01822.x; DOUGLAS CM, 1987, J BACTERIOL, V169, P4967, DOI 10.1128/jb.169.11.4967-4971.1987; DOUGLAS CM, 1990, BIOCHEMISTRY-US, V29, P5043, DOI 10.1021/bi00473a007; ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X; GALLOWAY DR, 1989, J BIOL CHEM, V264, P14869; GALSKI HL, 1988, P NATL ACAD SCI USA, V85, P1922; GUIDIRONTANI C, 1987, MOL MICROBIOL, V1, P67, DOI 10.1111/j.1365-2958.1987.tb00528.x; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HWANG J, 1987, CELL, V48, P129, DOI 10.1016/0092-8674(87)90363-1; IGLEWSKI BH, 1975, P NATL ACAD SCI USA, V72, P2284, DOI 10.1073/pnas.72.6.2284; JOHNSON VG, 1994, J BIOL CHEM, V269, P4349; KANDEL J, 1974, J BIOL CHEM, V249, P2088; KESSLER SP, 1992, J BIOL CHEM, V267, P19107; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEPPLA SH, 1978, BIOCHEM BIOPH RES CO, V81, P532, DOI 10.1016/0006-291X(78)91567-X; LUKAC M, 1988, J BIOL CHEM, V263, P6146; MCGOWAN JL, 1991, J BIOL CHEM, V266, P4911; OLSEN RH, 1982, J BACTERIOL, V150, P60, DOI 10.1128/JB.150.1.60-69.1982; Sambrook J, 1989, MOL CLONING LABORATO; WICK MJ, 1990, MOL MICROBIOL, V4, P527, DOI 10.1111/j.1365-2958.1990.tb00620.x; WILSON BA, 1990, BIOCHEMISTRY-US, V29, P8643, DOI 10.1021/bi00489a021; WILSON BA, 1992, CURR TOP MICROBIOL, V175, P27; WOZNIAK DJ, 1988, P NATL ACAD SCI USA, V85, P8880, DOI 10.1073/pnas.85.23.8880	33	22	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					679	684		10.1074/jbc.270.2.679	http://dx.doi.org/10.1074/jbc.270.2.679			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822295	hybrid			2022-12-27	WOS:A1995QB81600029
J	COUSTRY, F; MAITY, SN; DECROMBRUGGHE, B				COUSTRY, F; MAITY, SN; DECROMBRUGGHE, B			STUDIES ON TRANSCRIPTION ACTIVATION BY THE MULTIMERIC CCAAT-BINDING FACTOR CBF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; MAMMALIAN-CELLS; MOLECULAR-CLONING; SEQUENCE IDENTITY; COLLAGEN PROMOTER; ESCHERICHIA-COLI; B-SUBUNIT; DROSOPHILA; DOMAINS; YEAST	The CGAAT-binding factor CBF is a heteromeric transcription factor that specifically binds to CCAAT sequences in many eukaryotic genes. CBF consists of three subunits, CBF-A, CBF-B, and CBF-C, all three of which are necessary for DNA binding. In this study we examined the transcription activation function of CBF by two different approaches. We first used a heterologous system in which a series of deletion mutations of CBF-B, fused to the bacterial LexA DNA binding domain, were transfected into HeLa cells together with a reporter gene driven by a minimal promoter containing LexA binding sites. These experiments showed that CBF-B needed both a glutamine-rich domain and an adjacent serine/threonine-rich domain to activate the reporter gene optimally. The glutamine-rich domain by itself activated transcription only modestly. We also set up an in vitro transcription reconstituted system in which trans-activation by CBF occurred through a physiological CCAAT motif. Nuclear extracts from NIH 3T3 cells were first depleted of CBF and then complemented with recombinant CBF-B and a highly purified fraction containing native CBF-A and CBF-C. Recombinant full-length CBF-B together with CBF-A and CBF-C activated transcription of several alpha 2(I) collagen gene promoter constructs. We then tested whether in this system the glutamine- and serine/threonine-rich domains of CBF-B were needed for trans activation by CBF. We generated a truncated form of CBF-B that was still able to bind DNA in the presence of CBF-A and CBF-C, Even in the absence of the glutamine- and serine/threonine-rich domains of CBF-B, reconstituted CBF did activate transcription, suggesting that CBF transcriptional activation can also be mediated by the other subunits of CBF or by another transcription factor present in the nuclear extracts that interacts with CBF. Taken together our results suggest a model in which CBF has the potential to activate transcription either through the glutamine- and serine/threonine-rich domains of CBF-B or through the other subunits of CBF or through another component recruited by CBF.	UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MOLEC GENET,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center				Maity, Sankar/0000-0002-2387-6545	NCI NIH HHS [CA49515] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA049515] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ATTARDI LD, 1993, GENE DEV, V7, P1341, DOI 10.1101/gad.7.7b.1341; BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DRIEVER W, 1989, NATURE, V342, P149, DOI 10.1038/342149a0; GOLDBERG H, 1992, J BIOL CHEM, V267, P19622; GONZALEZ GA, 1991, MOL CELL BIOL, V11, P1306, DOI 10.1128/MCB.11.3.1306; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; HWANG JJ, 1993, EMBO J, V12, P2337, DOI 10.1002/j.1460-2075.1993.tb05888.x; INGRAHAM HA, 1990, CELL, V61, P1021, DOI 10.1016/0092-8674(90)90067-O; LI XY, 1992, J BIOL CHEM, V267, P8984; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; MAITY SN, 1990, P NATL ACAD SCI USA, V87, P5378, DOI 10.1073/pnas.87.14.5378; MAITY SN, 1988, SCIENCE, V241, P582, DOI 10.1126/science.3399893; MAITY SN, 1992, J BIOL CHEM, V267, P8286; MAITY SN, 1992, J BIOL CHEM, V267, P16574; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MUDRYJ M, 1988, NUCLEIC ACIDS RES, V16, P7513, DOI 10.1093/nar/16.15.7513; OLESEN JT, 1990, GENE DEV, V4, P1714, DOI 10.1101/gad.4.10.1714; PIRROTTA V, 1987, EMBO J, V6, P791, DOI 10.1002/j.1460-2075.1987.tb04821.x; SCHNEUWLY S, 1986, EMBO J, V5, P733, DOI 10.1002/j.1460-2075.1986.tb04275.x; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; VANHUIJSDUIJNEN RH, 1990, EMBO J, V9, P3119, DOI 10.1002/j.1460-2075.1990.tb07509.x; VUORIO T, 1990, J BIOL CHEM, V265, P22480; WICKENS MP, 1973, J BIOL CHEM, V253, P2483; WINTER B, 1992, EMBO J, V11, P1843, DOI 10.1002/j.1460-2075.1992.tb05236.x; WOOD WM, 1989, J BIOL CHEM, V264, P14840	29	76	79	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					468	475		10.1074/jbc.270.1.468	http://dx.doi.org/10.1074/jbc.270.1.468			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814413	hybrid			2022-12-27	WOS:A1995QA28700074
J	SOUTHWICK, FS				SOUTHWICK, FS			GAIN-OF-FUNCTION MUTATIONS CONFERRING ACTIN-SEVERING ACTIVITY TO HUMAN MACROPHAGE CAP-G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CAPPING PROTEIN; GELSOLIN; DOMAINS; MUTAGENESIS; COMPLEX	Nonmuscle cell motility requires marked changes in the consistency and shape of the peripheral cytoplasm. These changes are regulated by a gel-sol transformation of the actin filament network, and actin filament-severing proteins are responsible for network solation. Macrophage Cap G, unlike all other proteins in the gelsolin family, caps but does not sever actin filaments. Two amino acid stretches in Cap G diverge markedly from the severing proteins: (84)LNTLLGE and (124)AFHKTS. Discrete mutations in Cap G have been generated to determine if these amino acid sequences are critical for actin filament severing. Conversion of (84)LNTLLGE to the gelsolin actin-binding helix sequence ((84)LDDYLGG) renders Cap G capable of severing actin filaments (half-maximal severing, 1-2 mu M). Adding a second set of mutations, converting (124)AFHKTS to (124)GFKHV, enhances severing by 10-fold (half-maximal severing, 0.1-0.2 mu M). These experiments support a critical role for these two regions in actin filament severing and showcase the power of gain-of-function mutations in clarifying structure-function relationships.	UNIV FLORIDA,COLL MED,DEPT BIOCHEM & MOLEC BIOL,GAINESVILLE,FL 32610	State University System of Florida; University of Florida	SOUTHWICK, FS (corresponding author), UNIV FLORIDA,COLL MED,DEPT MED,DIV INFECT DIS,POB 100277,GAINESVILLE,FL 32610, USA.				NIAID NIH HHS [R01 AI23262, R01 AI023262] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023262] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDRE E, 1988, J BIOL CHEM, V263, P722; DABIRI GA, 1992, J BIOL CHEM, V267, P16545; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; FUXIN Y, 1991, J BIOL CHEM, V266, P19269; HARTWIG JH, 1991, CURR OPIN CELL BIOL, V3, P353; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KWIATKOWSKI DJ, 1989, J CELL BIOL, V108, P1717, DOI 10.1083/jcb.108.5.1717; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; PRENDERGAST GC, 1991, EMBO J, V10, P757, DOI 10.1002/j.1460-2075.1991.tb08007.x; SOUTHWICK FS, 1986, J BIOL CHEM, V261, P14191; SUN HQ, 1994, J BIOL CHEM, V269, P9473; WAY M, 1992, J CELL BIOL, V119, P835, DOI 10.1083/jcb.119.4.835; WAY M, 1989, J CELL BIOL, V109, P593, DOI 10.1083/jcb.109.2.593; YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0; YOUNG CL, 1990, BIOCHEMISTRY-US, V29, P2232, DOI 10.1021/bi00461a005; YU FX, 1990, SCIENCE, V250, P1413, DOI 10.1126/science.2255912	17	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					45	48		10.1074/jbc.270.1.45	http://dx.doi.org/10.1074/jbc.270.1.45			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814409	hybrid			2022-12-27	WOS:A1995QA28700012
J	ZHANG, R; CHEN, LR; VILLERET, V; FROMM, HJ				ZHANG, R; CHEN, LR; VILLERET, V; FROMM, HJ			GLYCINE-122 IS ESSENTIAL FOR COOPERATIVITY AND BINDING OF MG2+ TO PORCINE FRUCTOSE-1,6-BISPHOSPHATASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT LIVER FRUCTOSE-1,6-BISPHOSPHATASE; FRUCTOSE 2,6-BISPHOSPHATE; ESCHERICHIA-COLI; 2.8-A RESOLUTION; PHOSPHOFRUCTOKINASE; BISPHOSPHATASE; STIMULATOR; AMP; 1,6-BISPHOSPHATASE; 6-PHOSPHATE	Site directed mutagenesis of an amino acid residue in the substrate binding site of porcine fructose-1,6-bisphosphatase was carried out based on the crystal structure of the enzyme (Zhang, Y., Liang, J.-Y., Huang, S., Ke, H., and Lipscomb, W. N. (1993) Biochemistry 32, 1844-1857), A mutant enzyme form of fructose-1,6-bisphosphatase, G122A, was purified and characterized by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, circular dichroism spectrometry (CD), and initial rate kinetics, There were no discernible differences between the secondary structures of the wild-type and the mutant enzyme on the basis of CD data, Altering Gly-122 to alanine caused a significant decrease in the enzyme's activity and affinity for Mg2+. The k(cat) for this mutant enzyme was only about 5% of that of wild-type fructose-1,6-bisphosphatase, and the K-a for Mg2+ was about 20-fold higher than that of the wild-type enzyme, The K-i for AMP was increased 77-fold in the case of the mutant enzyme; however, the Hill coefficient was unaltered, Most importantly, it was observed that replacement of Gly-122 with alanine caused the total loss of cooperativity for Mg2+. It is concluded that Gly-122 is essential for Mg2+ cooperativity and important for binding of Mg2+ and AMP as well as for enzyme activity.	IOWA STATE UNIV SCI & TECHNOL, DEPT BIOCHEM & BIOPHYS, AMES, IA 50011 USA; HARVARD UNIV, GIBBS CHEM LAB, CAMBRIDGE, MA 02138 USA	Iowa State University; Harvard University				Villeret, Vincent/0000-0003-4504-056X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM006920, R01GM006920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS010546, R01NS010546] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM06920] Funding Source: Medline; NINDS NIH HHS [NS 10546] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BENKOVIC PA, 1978, P NATL ACAD SCI USA, V75, P2185, DOI 10.1073/pnas.75.5.2185; BENKOVIC SJ, 1982, ADV ENZYMOL RAMB, V53, P45; BURTON VA, 1993, BIOCHEM BIOPH RES CO, V192, P511, DOI 10.1006/bbrc.1993.1445; CHEN LR, 1993, ARCH BIOCHEM BIOPHYS, V307, P350, DOI 10.1006/abbi.1993.1599; CHEN M, 1994, J BIOL CHEM, V269, P5554; ELMAGHRABI MR, 1993, J BIOL CHEM, V268, P9466; GANSON NJ, 1982, BIOCHEM BIOPH RES CO, V108, P233, DOI 10.1016/0006-291X(82)91856-3; Gomori G, 1943, J BIOL CHEM, V148, P139; HERS HG, 1982, BIOCHEM J, V206, P1; HUBERT E, 1970, ARCH BIOCHEM BIOPHYS, V138, P590, DOI 10.1016/0003-9861(70)90385-1; KE H, 1990, J MOL BIOL, V212, P513, DOI 10.1016/0022-2836(90)90329-K; KE HM, 1990, P NATL ACAD SCI USA, V87, P5243, DOI 10.1073/pnas.87.14.5243; KE HM, 1991, BIOCHEMISTRY-US, V30, P4412, DOI 10.1021/bi00232a007; KE HM, 1989, P NATL ACAD SCI USA, V86, P1475, DOI 10.1073/pnas.86.5.1475; KREBS HA, 1963, ADV ENZYME REGUL, V1, P385; LEATHERBARROW RJ, 1987, ENZFITTER, P13; LIANG JY, 1992, OCT P RA WELCH F C C; LIU F, 1988, J BIOL CHEM, V263, P9122; LIU F, 1990, J BIOL CHEM, V265, P7401; MARCUS F, 1982, P NATL ACAD SCI-BIOL, V79, P7161, DOI 10.1073/pnas.79.23.7161; MCGILVERY RW, 1964, FRUCTOSE 1 6 DIPHOSP, P3; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; NIMMO HG, 1975, EUR J BIOCHEM, V58, P575, DOI 10.1111/j.1432-1033.1975.tb02408.x; NIMMO HG, 1975, EUR J BIOCHEM, V58, P567, DOI 10.1111/j.1432-1033.1975.tb02407.x; PILKIS SJ, 1981, J BIOL CHEM, V256, P3619; PONTREMODI S, 1907, METHOD ENZYMOL, V42, P369; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHEFFLER JE, 1986, BIOCHEMISTRY-US, V25, P6659, DOI 10.1021/bi00369a050; TEJWANI GA, 1983, ADV ENZYMOL RAMB, V54, P121; UNDERWOOD AH, 1965, BIOCHEM J, V95, P767, DOI 10.1042/bj0950767; VANSCHAFTINGEN E, 1980, BIOCHEM BIOPH RES CO, V96, P1524; VANSCHAFTINGEN E, 1980, BIOCHEM J, V192, P887, DOI 10.1042/bj1920887; VANSCHAFTINGEN E, 1980, BIOCHEM J, V192, P897, DOI 10.1042/bj1920897; ZHANG YP, 1993, BIOCHEMISTRY-US, V32, P1844, DOI 10.1021/bi00058a019	34	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					54	58		10.1074/jbc.270.1.54	http://dx.doi.org/10.1074/jbc.270.1.54			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814419	hybrid			2022-12-27	WOS:A1995QA28700014
J	BARRY, J; ALBERTS, B				BARRY, J; ALBERTS, B			PURIFICATION AND CHARACTERIZATION OF BACTERIOPHAGE-T4 GENE-59 PROTEIN - A DNA HELICASE ASSEMBLY PROTEIN INVOLVED IN DNA-REPLICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CHROMOSOME; RNA PRIMER SYNTHESIS; PRIMASE-HELICASE; ACCESSORY PROTEINS; 45 PROTEINS; LAMBDA-P; FACTOR-C; INVITRO; POLYMERASE; RECOMBINATION	The T4 bacteriophage gene 59 protein is required for normal T4 DNA replication. We have purified this protein to homogeneity in two steps and show that it binds both to single-stranded DNA and to the T4 gene 32 protein, a DNA single strand binding protein. In in vitro assays, covering DNA with 32 protein makes this DNA inaccessible to the 41 protein, the highly processive DNA helicase, that associates with the T4 DNA primase (gene 61 protein) to form an active primosome. However, the 59 protein brings about the rapid assembly of 41 protein onto single stranded DNA, even if this DNA is covered with 32 protein. The 59 protein is therefore a DNA helicase assembly protein. The observed requirements for the 59 protein in in vivo T4 DNA replication are explained by there being two alternative pathways for loading the 41 protein onto a replication fork at early times of T4 DNA synthesis, with only a 59 protein-mediated pathway remaining operative for the recombination-mediated replication that dominates later in infection (Barry, J., and Alberts, B. M. (1994) J. Biol. Chem. 269, 33063-33068).	UNIV CALIF SAN FRANCISCO, DEPT BIOCHEM & BIOPHYS, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco					NIGMS NIH HHS [GM24020] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024020, R37GM024020] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alberts B.M., 1971, METHODS ENZYMOL, V21, P198; ALBERTS BM, 1984, COLD SPRING HARB SYM, V49, P1; ALBERTS BM, 1970, NATURE, V227, P1313, DOI 10.1038/2271313a0; ALBERTS BM, 1980, MECHANISTIC STUDIES, P449; ALLEN GC, 1993, J BIOL CHEM, V268, P19204; ALLEN GC, 1991, J BIOL CHEM, V266, P22096; ALLEN GC, 1993, CELL, V74, P713, DOI 10.1016/0092-8674(93)90518-U; BAKER TA, 1987, J BIOL CHEM, V262, P6877; BARRY J, 1994, J BIOL CHEM, V269, P33063; BEDINGER P, 1983, CELL, V34, P115, DOI 10.1016/0092-8674(83)90141-1; BITTNER M, 1979, J BIOL CHEM, V254, P9565; BURKE RL, 1985, J BIOL CHEM, V260, P1711; Carpousis A. J., 1994, P176; CARPOUSIS AJ, 1989, MOL GEN GENET, V219, P39, DOI 10.1007/BF00261155; CHA TA, 1986, J BIOL CHEM, V261, P7001; CHA TA, 1989, J BIOL CHEM, V264, P12220; CUNNINGHAM RP, 1977, VIROLOGY, V80, P67, DOI 10.1016/0042-6822(77)90381-6; DANNENBERG R, 1983, J VIROL, V45, P813, DOI 10.1128/JVI.45.2.813-831.1983; DODSON M, 1985, P NATL ACAD SCI USA, V82, P4678, DOI 10.1073/pnas.82.14.4678; EPSTEIN RH, 1963, COLD SPRING HARB SYM, V28, P375, DOI 10.1101/SQB.1963.028.01.053; FIEN K, 1992, MOL CELL BIOL, V12, P155, DOI 10.1128/MCB.12.1.155; FORMOSA T, 1986, CELL, V47, P793, DOI 10.1016/0092-8674(86)90522-2; FORMOSA T, 1983, P NATL ACAD SCI-BIOL, V80, P2442, DOI 10.1073/pnas.80.9.2442; FORMOSA T, 1991, METHOD ENZYMOL, V208, P24; FUNNELL BE, 1987, J BIOL CHEM, V262, P10327; GAUSS P, 1994, J BACTERIOL, V176, P1667, DOI 10.1128/jb.176.6.1667-1672.1994; GOLD L, 1976, J BIOL CHEM, V251, P7251; HACKER K, 1989, J CELL BIOCHEM, V13, P87; HACKER KJ, 1994, J BIOL CHEM, V269, P24209; HAHN S, 1986, NUCLEIC ACIDS RES, V14, P9311, DOI 10.1093/nar/14.23.9311; HINTON DM, 1985, J BIOL CHEM, V260, P2851; HINTON DM, 1987, J BIOL CHEM, V262, P10873; HOLLINGSWORTH HC, 1991, J BIOL CHEM, V266, P1888; KNOPF KW, 1977, EUR J BIOCHEM, V73, P33, DOI 10.1111/j.1432-1033.1977.tb11289.x; KORNBERG A, 1991, COLD SH Q B, V56, P275; KRISCH HM, 1981, J MOL BIOL, V148, P199, DOI 10.1016/0022-2836(81)90535-0; Kutter E., 1983, BACTERIOPHAGE T4, P277; Kutter Elizabeth, 1994, P491; LIN TC, 1987, P NATL ACAD SCI USA, V84, P7000, DOI 10.1073/pnas.84.20.7000; LIU CC, 1981, J BIOL CHEM, V256, P2813; LIU CC, 1979, COLD SPRING HARB SYM, V43, P469, DOI 10.1101/SQB.1979.043.01.053; LIU CC, 1981, J BIOL CHEM, V256, P2821; LIU LF, 1980, CELL, V19, P697, DOI 10.1016/S0092-8674(80)80046-8; LOHMAN TM, 1986, CRIT REV BIOCHEM MOL, V19, P191, DOI 10.3109/10409238609084656; MACE DC, 1984, J MOL BIOL, V177, P279, DOI 10.1016/0022-2836(84)90457-1; MALLORY JB, 1990, J BIOL CHEM, V265, P13297; MARSZALEK J, 1994, J BIOL CHEM, V269, P4883; MORRICAL SW, 1994, J BIOL CHEM, V269, P33069; MORRIS CF, 1979, J BIOL CHEM, V254, P6797; MORRIS CF, 1979, J BIOL CHEM, V254, P6787; MUELLER R, 1991, THESIS RUH U BOCHUM; NEIDHARDT FC, 1984, ANNU REV GENET, V18, P295, DOI 10.1146/annurev.ge.18.120184.001455; Nossal N.G., 1994, MOL BIOL BACTERIOP T, P43; Nossal N.G., 1983, BACTERIOPHAGE T4, P71; NOSSAL NG, 1987, J BIOL CHEM, V262, P10879; NOSSAL NG, 1980, J BIOL CHEM, V255, P2176; NOSSAL NG, 1979, J BIOL CHEM, V254, P6032; ODONNELL M, 1993, NUCLEIC ACIDS RES, V21, P1, DOI 10.1093/nar/21.1.1; PIPERNO JR, 1978, J BIOL CHEM, V253, P5174; RICHARDSON RW, 1989, J BIOL CHEM, V264, P4725; RICHARDSON RW, 1989, J BIOL CHEM, V264, P4732; RUSH J, 1989, PREP BIOCHEM, V19, P329, DOI 10.1080/10826068908544921; RUSSEL M, 1976, J BIOL CHEM, V251, P7263; SELICK HE, 1988, J BIOL CHEM, V263, P11336; SHAH DB, 1976, J VIROL, V17, P175, DOI 10.1128/JVI.17.1.175-182.1976; SILVER LL, 1982, J BIOL CHEM, V257, P1696; SINHA NK, 1980, J BIOL CHEM, V255, P4290; SPACCIAPOLI P, 1994, J BIOL CHEM, V269, P447; SPICER EK, 1988, J BIOL CHEM, V263, P7478; SPICER EK, 1983, BACTERIOPHAGE T4, P291; TSURIMOTO T, 1990, P NATL ACAD SCI USA, V87, P1023, DOI 10.1073/pnas.87.3.1023; VENKATESAN M, 1982, J BIOL CHEM, V257, P2426; WOOD WB, 1976, BACTERIOL REV, V40, P847, DOI 10.1128/MMBR.40.4.847-868.1976; WU JR, 1984, J VIROL, V52, P1028, DOI 10.1128/JVI.52.3.1028-1031.1984; WU R, 1974, VIROLOGY, V59, P108, DOI 10.1016/0042-6822(74)90209-8; WU R, 1975, J VIROL, V16, P5, DOI 10.1128/JVI.16.1.5-16.1975; YONESAKI T, 1994, J BIOL CHEM, V269, P1284; YOUNG MC, 1994, J MOL BIOL, V235, P1447, DOI 10.1006/jmbi.1994.1100	78	71	71	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					33049	33062						14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806533				2022-12-27	WOS:A1994QA63800050
J	GARDNER, K; MOORE, TC; DAVISSMYTH, T; KRUTZSCH, H; LEVENS, D				GARDNER, K; MOORE, TC; DAVISSMYTH, T; KRUTZSCH, H; LEVENS, D			PURIFICATION AND CHARACTERIZATION OF A MULTICOMPONENT AP-1 JUND COMPLEX FROM T-CELLS - DEPENDENCE ON A SEPARATE CELLULAR FACTOR FOR ENHANCED DNA-BINDING ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; TRANSCRIPTION FACTOR AP-1; APE LEUKEMIA-VIRUS; FOS-JUN; GENE-EXPRESSION; LYMPHOCYTES-T; HETERODIMER FORMATION; SIGNAL TRANSDUCTION; INTERLEUKIN-2 GENE; MOLECULAR-CLONING	TAP-1 (T-cell AP-1) is a previously identified DNA-binding activity that is rapidly induced in activated T cells in the absence of protein synthesis, This activity has been purified over 2,000-fold from the T-cell line MLA144. Purified TAP-1 is a multicomponent complex composed of 38-kDa and 43-kDa junD polypeptides in association with a separate factor(s), distinct from fos, that partly dissociate from the complex during affinity purification but is required for full TAP-1 DNA-binding activity. When reconstituted with TAP-1, this partly dissociated component strongly enhances the DNA-binding activity of the TAP-1 complex. W-cross linking analysis identifies the dissociable component of the TAP-1 complex as a separate class of low molecular mass (23-29-kDa) DNA-binding polypeptide(s). 23-29-kDa polypeptides have been partially purified from nuclear extracts derived from MLA144 that enhance TAP-1 DNA-binding activity over 100-fold and increase its contacts with flanking DNA sequence. These results define TAP-1 as a distinct AP-l junD-containing complex in T cells whose DNA-binding activity is regulated by the interaction of distinct and separate cellular factor(s).			GARDNER, K (corresponding author), NCI,PATHOL LAB,BLDG 10,RM 2N212,BETHESDA,MD 20892, USA.		Levens, David/C-9216-2009	Levens, David/0000-0002-7616-922X				ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; ABATE C, 1990, P NATL ACAD SCI USA, V87, P1032, DOI 10.1073/pnas.87.3.1032; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; ARMSTRONG AP, 1993, P NATL ACAD SCI USA, V90, P7303, DOI 10.1073/pnas.90.15.7303; AUWERX J, 1992, ONCOGENE, V7, P2271; BAKER SJ, 1992, MOL CELL BIOL, V12, P4694, DOI 10.1128/MCB.12.10.4694; BENBROOK DM, 1990, ONCOGENE, V5, P295; BENNETT V, 1981, P NATL ACAD SCI-BIOL, V78, P7550, DOI 10.1073/pnas.78.12.7550; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; BURDACH S, 1991, J CLIN INVEST, V87, P2114, DOI 10.1172/JCI115242; BUSCH SJ, 1990, ONCOGENE, V5, P1549; CHAUHAN D, 1993, BLOOD, V81, P1540; CHEN D, 1993, MOL CELL BIOL, V13, P228, DOI 10.1128/MCB.13.1.228; CHIU R, 1987, NATURE, V329, P648, DOI 10.1038/329648a0; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; CURRAN T, 1983, MOL CELL BIOL, V3, P914, DOI 10.1128/MCB.3.5.914; CURRAN T, 1985, MOL CELL BIOL, V5, P167, DOI 10.1128/MCB.5.1.167; DAVIS J, 1983, J BIOL CHEM, V258, P7757; DEGROOT R, 1991, MOL CELL BIOL, V11, P192, DOI 10.1128/MCB.11.1.192; DEGROOT RP, 1991, EMBO J, V10, P2523, DOI 10.1002/j.1460-2075.1991.tb07792.x; DEGROOT RP, 1991, NUCLEIC ACIDS RES, V19, P775, DOI 10.1093/nar/19.4.775; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; FARINA AR, 1993, J BIOL CHEM, V268, P26466; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HENTSCH B, 1992, NUCLEIC ACIDS RES, V20, P2657, DOI 10.1093/nar/20.11.2657; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; JAIN J, 1992, J IMMUNOL, V148, P1240; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN J, 1992, J EXP MED, V175, P853, DOI 10.1084/jem.175.3.853; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KANG SM, 1992, SCIENCE, V257, P1134, DOI 10.1126/science.257.5073.1134; KONIGSBERG WH, 1983, METHOD ENZYMOL, V91, P254; KUWABARA MD, 1987, BIOCHEMISTRY-US, V26, P7234, DOI 10.1021/bi00397a006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MINER JN, 1991, CELL GROWTH DIFFER, V2, P525; MONTECLARO FS, 1993, P NATL ACAD SCI USA, V90, P6726, DOI 10.1073/pnas.90.14.6726; MORGAN IM, 1992, CELL PROLIFERAT, V25, P205, DOI 10.1111/j.1365-2184.1992.tb01395.x; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NAKABEPPU Y, 1989, EMBO J, V8, P3833, DOI 10.1002/j.1460-2075.1989.tb08561.x; NAKAGAWA TY, 1986, P NATL ACAD SCI USA, V83, P2007, DOI 10.1073/pnas.83.7.2007; NIKOLAKAKI E, 1993, ONCOGENE, V8, P833; NISHINA H, 1990, P NATL ACAD SCI USA, V87, P3619, DOI 10.1073/pnas.87.9.3619; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; QUINN JP, 1989, MOL CELL BIOL, V9, P4713, DOI 10.1128/MCB.9.11.4713; QUINN JP, 1989, J VIROL, V63, P1737, DOI 10.1128/JVI.63.4.1737-1742.1989; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; ROSENSTREICH DL, 1979, J IMMUNOL, V123, P1749; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; RYSECK RP, 1991, ONCOGENE, V6, P533; SERFLING E, 1989, EMBO J, V8, P465, DOI 10.1002/j.1460-2075.1989.tb03399.x; SHOEMAKER SG, 1990, P NATL ACAD SCI USA, V87, P9650, DOI 10.1073/pnas.87.24.9650; SHUMAN JD, 1990, SCIENCE, V249, P771, DOI 10.1126/science.2202050; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; SUNG SSJ, 1991, J IMMUNOL, V147, P2047; SWANSON MS, 1987, MOL CELL BIOL, V7, P171; ULLMAN KS, 1993, GENE DEV, V7, P188, DOI 10.1101/gad.7.2.188; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x; WALKER PR, 1993, EXP CELL RES, V207, P142, DOI 10.1006/excr.1993.1173; WOODGETT JR, 1993, ADV SEC MESS PHOSPH, V28, P261; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	74	19	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					32963	32971						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806526				2022-12-27	WOS:A1994QA63800039
J	GOLDWASSER, E; ALIBALI, P; GARDNER, A				GOLDWASSER, E; ALIBALI, P; GARDNER, A			DIFFERENTIAL INHIBITION BY IODONIUM COMPOUNDS OF INDUCED ERYTHROPOIETIN EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT CAROTID-BODY; NADPH OXIDASE; PO2 SENSOR; PROTEIN; CELLS; GENE; NEUTROPHILS	Diphenylene iodonium chloride suppresses the cobaltous chloride-induced expression of erythropoietin by Hep3B cells to about 50% at a concentration of 30 nM. At that concentration, it has no effect on the response to low oxygen. The related compound iodonium diphenyl chloride acts similarly but is a much less effective inhibitor. If, as reported, diphenylene iodonium chloride is a specific inhibitor of cytochrome b, it follows that the response to CoCl2 is dependent on that enzyme but the response to hypoxia is not.	UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,CHICAGO,IL 60637	University of Chicago					NHLBI NIH HHS [HL30121, HL21676] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030121, R37HL021676] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ACKER H, 1989, FEBS LETT, V256, P75, DOI 10.1016/0014-5793(89)81721-1; BERU N, 1986, MOL CELL BIOL, V6, P2571, DOI 10.1128/MCB.6.7.2571; CROSS AR, 1987, BIOCHEM PHARMACOL, V36, P489, DOI 10.1016/0006-2952(87)90356-X; DELPIANO MA, 1989, BRAIN RES, V482, P235, DOI 10.1016/0006-8993(89)91186-4; ELLIS JA, 1988, BIOCHEM J, V251, P887, DOI 10.1042/bj2510887; FISHMAN MC, 1985, P NATL ACAD SCI USA, V82, P1448, DOI 10.1073/pnas.82.5.1448; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; GOLDBERG MA, 1982, P NATL ACAD SCI USA, V84, P7972; GOLDWASSER E, 1957, SCIENCE, V125, P1085, DOI 10.1126/science.125.3257.1085; GORLACH A, 1993, BIOCHEM J, V290, P771; JIANG C, 1994, P NATL ACAD SCI USA, V91, P7198, DOI 10.1073/pnas.91.15.7198; KOUREMBANAS S, 1990, J CLIN INVEST, V86, P670, DOI 10.1172/JCI114759; SHERWOOD JB, 1979, BLOOD, V54, P885; YOUNGSON C, 1993, NATURE, V365, P153, DOI 10.1038/365153a0	16	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2628	2629		10.1074/jbc.270.6.2628	http://dx.doi.org/10.1074/jbc.270.6.2628			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852328	hybrid			2022-12-27	WOS:A1995QF53500036
J	KULAS, DT; ZHANG, WR; GOLDSTEIN, BJ; FURLANETTO, RW; MOONEY, RA				KULAS, DT; ZHANG, WR; GOLDSTEIN, BJ; FURLANETTO, RW; MOONEY, RA			INSULIN-RECEPTOR SIGNALING IS AUGMENTED BY ANTISENSE INHIBITION OF THE PROTEIN-TYROSINE-PHOSPHATASE LAR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							LEUKOCYTE COMMON ANTIGEN; TRANSMEMBRANE PHOSPHOTYROSINE PHOSPHATASE; GROWTH FACTOR-I; PHOSPHATIDYLINOSITOL 3'-KINASE; INTACT-CELLS; DEPHOSPHORYLATION; ACTIVATION; EXPRESSION; KINASE; STIMULATION	Considerable evidence has shown that most physiologic responses to insulin require activation of the intrinsic tyrosine kinase of the insulin receptor, Biochemical studies have also supported the hypothesis that receptor kinase activity can be modulated by cellular protein tyrosine phosphatases (PTPases), which have not yet been identified, To test the hypothesis that the transmembrane PTPase LAR can modulate insulin receptor signaling in vivo, antisense RNA expression was used to specifically suppress LAR protein levels by 63% in the rat hepatoma cell line, McA-RH7777. Hormone-dependent autophosphorylation of the insulin receptor was increased by approximately 150% in the antisense-expressing cells at all insulin concentrations tested. This increase in autophosphorylation was paralleled by a 35% increase in insulin receptor tyrosine kinase activity. Reduced LAR levels did not alter non-hormone-dependent tyrosine phosphorylation nor basal insulin receptor tyrosine phosphorylation and kinase activity. Most significantly, reduced LAR levels resulted in a 350% increase in insulin-dependent phosphatidylinositol 3-kinase activity. These studies provide unique in vivo evidence that LAR is involved In the modulation of insulin receptor signaling in intact cells.	UNIV ROCHESTER,SCH MED & DENT,DEPT LAB MED & PATHOL,ROCHESTER,NY 14642; UNIV ROCHESTER,SCH MED & DENT,DEPT PEDIAT,ROCHESTER,NY 14642; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT MED,DIV ENDOCRINOL & METAB DIS,PHILADELPHIA,PA 19107	University of Rochester; University of Rochester; Jefferson University					NCI NIH HHS [R01-CA38981] Funding Source: Medline; NIDDK NIH HHS [R01-DK43396, R01-DK38138] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA038981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038138, R01DK043396] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; BACKER JM, 1993, J BIOL CHEM, V268, P8204; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; GOLDSTEIN BJ, 1993, RECEPTOR, V3, P1; GOLDSTEIN BJ, 1991, ADV PROTEIN PHOSPHAT, V6, P1; HASHIMOTO N, 1992, BIOCHEM BIOPH RES CO, V188, P1305, DOI 10.1016/0006-291X(92)91373-X; HASHIMOTO N, 1992, BIOCHEM J, V284, P569, DOI 10.1042/bj2840569; HASHIMOTO N, 1992, J BIOL CHEM, V267, P13811; LAMMERS R, 1993, J BIOL CHEM, V268, P22456; LONGO FM, 1993, J BIOL CHEM, V268, P26503; MARGOLIS RN, 1988, P NATL ACAD SCI USA, V85, P7256, DOI 10.1073/pnas.85.19.7256; MOONEY RA, 1992, J BIOL CHEM, V267, P23443; MOONEY RA, 1992, J BIOL CHEM, V267, P14054; OKADA T, 1994, J BIOL CHEM, V269, P3568; STREULI M, 1988, J EXP MED, V168, P1523, DOI 10.1084/jem.168.5.1523; STREULI M, 1992, EMBO J, V11, P897, DOI 10.1002/j.1460-2075.1992.tb05128.x; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; VOGEL W, 1993, SCIENCE, V259, P1611, DOI 10.1126/science.7681217; WAY BA, 1993, J BIOL CHEM, V268, P26409; WHITE MF, 1994, J BIOL CHEM, V269, P1; YAMAUCHI K, 1993, J BIOL CHEM, V268, P14597	21	141	145	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2435	2438		10.1074/jbc.270.6.2435	http://dx.doi.org/10.1074/jbc.270.6.2435			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852302	hybrid			2022-12-27	WOS:A1995QF53500007
J	STROHMEIER, GR; REPPERT, SM; LENCER, WI; MADARA, JL				STROHMEIER, GR; REPPERT, SM; LENCER, WI; MADARA, JL			THE A(2B) ADENOSINE RECEPTOR MEDIATES CAMP RESPONSES TO ADENOSINE RECEPTOR AGONISTS IN HUMAN INTESTINAL EPITHELIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL-DERIVED SECRETAGOGUE; CHLORIDE SECRETION; CELL-LINE; MOLECULAR-CLONING; CL SECRETION; T84 CELLS; ELECTROLYTE SECRETION; MESSENGER SYSTEMS; APICAL MEMBRANE; EXPRESSION	Adenosine is thought to be a major effector in immunological stimulation of Cl- secretion in intestinal epithelia. Previous studies indicate that both apical and basolateral domains of intestinal epithelial cells possess functionally defined adenosine receptors. However, it is unclear whether the same receptor subclass is expressed, what the receptor subclass(es) is, or how the receptors signal the Cl- secretory response. We now characterize the intestinal epithelial adenosine receptor subtype using the model epithelium, T84. Both apical and basolateral adenosine receptor agonist response profiles revealed a hierarchy (ED(50)) of 5'-(N-ethylcarboxamido)adenosine > adenosine > CGS-21680. Similarly, inhibition studies revealed identical ID50 hierarchies for apical and basolateral antagonism by xanthine amine congener > 1,3-diethyl-8-phenylxanthine > aminophylline. Analyses of both agonist and antagonist pharmacological hierarchies in Chinese hamster ovary cells stably expressing the A(2b) receptor revealed these same hierarchies, Northern blots performed on RNA extracted from polarized T84 monolayers demonstrated no detectable message for A(1) or A(2a) adenosine receptor, but strong hybridization was detected for the A(2b) adenosine receptor. Subsequent Northern blots of RNA prepared from human alimentary tract revealed that A(2b) adenosine receptor message was heavily expressed throughout the colon, in the appendix, and more modestly expressed in the small intestine (ileum), Analyses of cAMP generation in T84 cells in response to adenosine indicated that the basolateral A(2b) receptor elicits Cl- secretion through this signaling pathway, Stimulation of Cl- secretion through the apical A(2b) receptor exhibited relatively small but significant increases in cAMP compared with basolateral stimulation, The protein kinase A inhibitor H-89, used at concentrations that did not affect short circuit current responses to the Ca2+-mediated agonist carbachol, effectively inhibited short circuit current elicited by either apical or basolateral adenosine, These data suggest that the major intestinal epithelial adenosine receptor is the A(2b) subclass, which is positively coupled to adenylate cyclase, Such observations have potentially important implications for the treatment of diarrheal diseases.	MASSACHUSETTS GEN HOSP,DEPT PEDIAT,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115; CHILDRENS HOSP,BOSTON,MA 02115	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	STROHMEIER, GR (corresponding author), BRIGHAM & WOMENS HOSP,DEPT PATHOL,DIV GASTROINTESTINAL PATHOL,20 SHATTUCK ST,THORN 1419,BOSTON,MA 02115, USA.			Lencer, Wayne/0000-0001-7346-2730	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047662, R01DK035932, R01DK042125, R37DK035932] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-35932, DK-42125, DK-47662] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARRETT KE, 1993, AM J PHYSIOL, V264, pC446, DOI 10.1152/ajpcell.1993.264.2.C446; BARRETT KE, 1993, AM J PHYSIOL, V265, pC859; BARRETT KE, 1989, AM J PHYSIOL, V256, pC197; BARRETT KE, 1990, AM J PHYSIOL, V258, pC902, DOI 10.1152/ajpcell.1990.258.5.C902; Binder HJ, 1987, PHYSL GASTROINTESTIN, P1389; BRUNER G, 1993, NEUROSCI LETT, V162, P105, DOI 10.1016/0304-3940(93)90571-2; BRUNS RF, 1986, MOL PHARMACOL, V29, P331; Chang Eugene B., 1994, P2027; COLGAN SP, 1992, J LEUKOCYTE BIOL, V52, P183, DOI 10.1002/jlb.52.2.183; COTECCHIA S, 1990, J BIOL CHEM, V265, P63; CRONSTEIN BN, 1992, J IMMUNOL, V148, P2201; CRONSTEIN BN, 1990, J CLIN INVEST, V85, P1150, DOI 10.1172/JCI114547; DHO S, 1992, AM J PHYSIOL, V262, pC67, DOI 10.1152/ajpcell.1992.262.1.C67; DOBBINS JW, 1984, J CLIN INVEST, V74, P929, DOI 10.1172/JCI111511; FENOGLIOPREISER CM, 1989, GASTROINTESTINAL PAT, P427; GRASL M, 1984, J PHYSIOL-LONDON, V346, P93, DOI 10.1113/jphysiol.1984.sp015009; HALM DR, 1988, AM J PHYSIOL, V254, pC505, DOI 10.1152/ajpcell.1988.254.4.C505; HALM DR, 1990, TXB SECRETORY DIARRH, P47; KEMP PJ, 1993, AM J PHYSIOL, V265, pL323, DOI 10.1152/ajplung.1993.265.4.L323; KUMAR NB, 1982, AM J SURG PATHOL, V6, P523, DOI 10.1097/00000478-198209000-00004; LINDEN J, 1993, MOL PHARMACOL, V44, P524; LONDOS C, 1980, P NATL ACAD SCI-BIOL, V77, P2551, DOI 10.1073/pnas.77.5.2551; MADARA JL, 1992, J CLIN INVEST, V89, P1938, DOI 10.1172/JCI115800; MADARA JL, 1993, J CLIN INVEST, V91, P2320, DOI 10.1172/JCI116462; MADARA JL, 1985, J CELL BIOL, V101, P2124, DOI 10.1083/jcb.101.6.2124; MANDEL KG, 1986, J BIOL CHEM, V261, P704; MARQUARDT DL, 1984, P NATL ACAD SCI-BIOL, V81, P6192, DOI 10.1073/pnas.81.19.6192; MOHUCZYDOMINIAK D, 1992, AM J PHYSIOL, V263, pC1289, DOI 10.1152/ajpcell.1992.263.6.C1289; NASH S, 1991, J CLIN INVEST, V87, P1474, DOI 10.1172/JCI115156; NASH S, 1987, J CLIN INVEST, V80, P1104, DOI 10.1172/JCI113167; PARKOS CA, 1992, J CELL BIOL, V117, P757, DOI 10.1083/jcb.117.4.757; PARKOS CA, 1991, J CLIN INVEST, V88, P1605, DOI 10.1172/JCI115473; PIERCE KD, 1992, BIOCHEM BIOPH RES CO, V187, P86, DOI 10.1016/S0006-291X(05)81462-7; PRATT AD, 1986, AM J PHYSIOL, V251, pC167, DOI 10.1152/ajpcell.1986.251.2.C167; REPPERT SM, 1991, MOL ENDOCRINOL, V5, P1037, DOI 10.1210/mend-5-8-1037; RIVKEES SA, 1992, MOL ENDOCRINOL, V6, P1598, DOI 10.1210/me.6.10.1598; SHAPIRO M, 1991, J CLIN INVEST, V87, P1903, DOI 10.1172/JCI115215; SMBROOK J, 1989, MOL CLONING LABORTOR; STEHLE JH, 1992, MOL ENDOCRINOL, V6, P384, DOI 10.1210/me.6.3.384; WANG YZ, 1990, AM J PHYSIOL, V258, pG432, DOI 10.1152/ajpgi.1990.258.3.G432; WEINSTEIN L, 1978, SEMINARS INFECTIOUS, V1, P89; WELSH MJ, 1992, NEURON, V8, P821, DOI 10.1016/0896-6273(92)90196-K; WELSH MJ, 1982, SCIENCE, V218, P1219, DOI 10.1126/science.6293054; WILLIAMS M, 1987, ANNU REV PHARMACOL, V27, P315	44	198	202	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2387	2394		10.1074/jbc.270.5.2387	http://dx.doi.org/10.1074/jbc.270.5.2387			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836474	hybrid, Green Submitted			2022-12-27	WOS:A1995QE49300062
J	BOENSCH, C; KUO, MD; CONNOLLY, DT; HUANG, SS; HUANG, JS				BOENSCH, C; KUO, MD; CONNOLLY, DT; HUANG, SS; HUANG, JS			IDENTIFICATION, PURIFICATION, AND CHARACTERIZATION OF CELL-SURFACE RETENTION SEQUENCE-BINDING PROTEINS FROM HUMAN SK-HEP CELLS AND BOVINE LIVER PLASMA-MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-A-CHAIN; SIMIAN SARCOMA-VIRUS; ALTERNATIVELY SPLICED EXON; ENDOTHELIAL GROWTH-FACTOR; AUTOCRINE TRANSFORMATION; FACTOR RECEPTOR; CULTURED-CELLS; MESSENGER-RNA; V-SIS; GENE	Cell-surface retention is a newly identified mechanism associated with the secretion of certain polypeptide growth factors and cytokines. This novel form of secretion appears to be mediated by cell-surface retention sequences (CRS) in the polypeptide molecules. To test the hypothesis that high-affinity CRS-binding proteins (CRS-BPs) are responsible for the cell-surface re retention, we identified and characterized the high-affinity binding sites on various cell types for I-125-labeled CRS peptide (sis) and CRS peptide (VEGF). each of which contained the putative CRS motifs of platelet-derived growth factor B (c-sis) and vascular endothelial cell growth factor, respectively. Scatchard plot analysis revealed a single class of high-affinity binding sites with K-d = 0.5-0.7 nM and similar to 22,000-55,000 sites/cell. High-affinity binding activity could be demonstrated between pH 4.5 and 8.0, but was much greater below 6.0 (maximum pH 5.0-5.5). The ligand binding activity was inhibited by heparin, polylysine, and protamine, but not by cytochrome c. CRS-BPs responsible for the high affinity binding were identified as 60-72-kDa proteins by ligand affinity labeling. CRS-BPs were purified from human SK-Hep cells and bovine liver plasma membranes by Triton X-100 extraction followed by affinity column chromatography on wheat germ lectin Sepharose 4B and CRS peptide (sis)-Affi-Gel 10. Purified CRS-BPs exhibited ligand binding properties (pH profile and inhibitor sensitivity) similar to those of the high-affinity binding sites for CRS pep tides on cultured cells, The major CRS BPs (p60, p66, and p72) purified from bovine liver plasma membranes were found to have identical N-terminal amino acid sequence and were assumed to represent different forms of the same gene product, which we have designated CRS-BP1.	ST LOUIS UNIV,SCH MED,DEPT BIOCHEM & MOLEC BIOL,ST LOUIS,MO 63104; MONSANTO CO,ST LOUIS,MO 63167	Saint Louis University; Monsanto					NCI NIH HHS [CA-38808] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA038808] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSSON M, 1994, J BIOL CHEM, V269, P926; Ausubel F.M., 1992, SHORT PROTOCOLS MOL; BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; BONTHRON DT, 1988, P NATL ACAD SCI USA, V85, P1492, DOI 10.1073/pnas.85.5.1492; BOULIKAS T, 1994, J CELL BIOCHEM, V55, P32, DOI 10.1002/jcb.240550106; DICKSON C, 1984, CELL, V37, P529, DOI 10.1016/0092-8674(84)90383-0; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; FUNG YKT, 1985, MOL CELL BIOL, V5, P3337, DOI 10.1128/MCB.5.12.3337; HAUSER S, 1993, GROWTH FACTORS, V9, P259, DOI 10.3109/08977199308991586; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; HUANG JS, 1986, J BIOL CHEM, V261, P1600; HUANG SS, 1988, J BIOL CHEM, V263, P12608; HUANG SS, 1984, COLD SPRING HARBOR C, V1, P43; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; KHACHIGIAN LM, 1992, J BIOL CHEM, V267, P1660; KIEFER P, 1991, MOL CELL BIOL, V11, P5929, DOI 10.1128/MCB.11.12.5929; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; KUO MD, 1990, J BIOL CHEM, V265, P16455; LAROCHELLE WJ, 1991, GENE DEV, V5, P1191, DOI 10.1101/gad.5.7.1191; LAU LF, 1991, CELL GROWTH DIFFER, V2, P351; LEE BA, 1987, MOL CELL BIOL, V7, P3527, DOI 10.1128/MCB.7.10.3527; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; LOKESHWAR VB, 1990, J BIOL CHEM, V265, P1665; MAHER DW, 1989, MOL CELL BIOL, V9, P2251, DOI 10.1128/MCB.9.5.2251; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; OBRIEN TP, 1990, MOL CELL BIOL, V10, P3569, DOI 10.1128/MCB.10.7.3569; OGRADY P, 1991, J BIOL CHEM, V266, P8583; OSTMAN A, 1991, CELL REGUL, V2, P503, DOI 10.1091/mbc.2.7.503; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; RAINES EW, 1992, J CELL BIOL, V116, P533, DOI 10.1083/jcb.116.2.533; SEHGAL D, 1994, ANAL BIOCHEM, V218, P87, DOI 10.1006/abio.1994.1144; SMOLICH BD, 1993, MOL BIOL CELL, V4, P1267, DOI 10.1091/mbc.4.12.1267; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0	34	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1807	1816		10.1074/jbc.270.4.1807	http://dx.doi.org/10.1074/jbc.270.4.1807			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829517	hybrid			2022-12-27	WOS:A1995QD20400051
J	ELLIS, TJ; WAGNER, GF				ELLIS, TJ; WAGNER, GF			POSTTRANSCRIPTIONAL REGULATION OF THE STANNIOCALCIN GENE BY CALCIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; ISOLATED EEL GILL; RAINBOW-TROUT; INSULIN-BIOSYNTHESIS; ANGUILLA-ROSTRATA; PANCREATIC-ISLETS; PROTEIN-SYNTHESIS; SALMO-GAIRDNERI; AMERICAN EELS; COHO SALMON	Stanniocalcin (STC) is a Ca2+-regulating hormone produced by the corpuscles of Stannius in bony fish. Calcium has been shown to stimulate STC synthesis at multiple levels including the level of gene expression. The purpose of this study was to determine the effects of Ca2+ on STC mRNA stability, The half-life of STC mRNA was measured in primary cultured trout corpuscles of Stannius cells maintained in either normal (1.2 mm) or high (1.9 mM) levels of extracellular calcium and treated with the transcriptional inhibitor alpha-amanitin. In cells maintained in 1.2 mM Ca2+, STC mRNA levels decreased progressively over time with an estimated half-life of similar to 71 h. However, message levels remained unchanged for up to 4 days in cells maintained in 1.9 mM Ca2+, indicating that the transcript had been stabilized in response to Ca2+ stimulation. Blocking transcription prior to exposing cells to high Ca2+ did not alter the stabilizing effects of the cation, indicating that synthesis and processing of the mRNA transcript were not involved in message stabilization. Inhibiting protein synthesis with cycloheximide also had no influence on the stabilizing effects of high calcium, The experiments involving cycloheximide further suggested that the mechanism of mRNA stabilization involved protein-nucleic acid interactions in the cytoplasm, whereby the polysomal complex protected the mRNA from degradation, These data demonstrate that the stimulatory effect of Ca2+ on STC gene expression is due, in part, to mRNA stabilization.	UNIV WESTERN ONTARIO, FAC MED, DEPT PHYSIOL, LONDON, ON N6A 5C1, CANADA	Western University (University of Western Ontario)								AHMAD N, 1990, ARCH BIOL, V101, P285; BROCK ML, 1983, CELL, V34, P207, DOI 10.1016/0092-8674(83)90151-4; BRUNSTEDT J, 1982, BIOCHEM BIOPH RES CO, V106, P1383, DOI 10.1016/0006-291X(82)91267-0; CARRAZANA EJ, 1988, MOL CELL BIOL, V8, P2267, DOI 10.1128/MCB.8.6.2267; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FENWICK JC, 1991, GEN COMP ENDOCR, V82, P459, DOI 10.1016/0016-6480(91)90321-V; FENWICK JC, 1974, J EXP ZOOL, V188, P125, DOI 10.1002/jez.1401880112; FLEMING WR, 1973, AM ZOOL, V73, P793; FONTAINE M, 1964, CR ACAD SCI D NAT, V529, P875; Garrett FD, 1942, J MORPHOL, V70, P41, DOI 10.1002/jmor.1050700104; GRODSKY GM, 1963, AM J PHYSIOL, V205, P638, DOI 10.1152/ajplegacy.1963.205.4.638; HAWA NS, 1993, J MOL ENDOCRINOL, V10, P43, DOI 10.1677/jme.0.0100043; KRISHNAMURTHY VG, 1976, INT REV CYTOL, V46, P177, DOI 10.1016/S0074-7696(08)60992-4; LU MQ, 1994, AM J PHYSIOL-REG I, V267, pR1356, DOI 10.1152/ajpregu.1994.267.5.R1356; MILLIKEN CE, 1990, GEN COMP ENDOCR, V77, P416, DOI 10.1016/0016-6480(90)90232-B; MOULAND AJ, 1991, ENDOCRINOLOGY, V128, P441, DOI 10.1210/endo-128-1-441; NAVEHMANY T, 1989, ENDOCRINOLOGY, V125, P275, DOI 10.1210/endo-125-1-275; NAVEHMANY T, 1990, J CLIN INVEST, V86, P1313, DOI 10.1172/JCI114840; NEILSEN DA, 1985, J BIOL CHEM, V250, P6134; OBRIG TG, 1971, J BIOL CHEM, V246, P174; OKAMOTO H, 1981, MOL CELL BIOCHEM, V37, P43, DOI 10.1007/BF02355886; PELTZ S W, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P99; PERMUTT MA, 1972, J BIOL CHEM, V247, P1194; SHAPIRO DJ, 1987, BIOESSAYS, V6, P221, DOI 10.1002/bies.950060507; SO YP, 1979, GEN COMP ENDOCR, V37, P143, DOI 10.1016/0016-6480(79)90101-1; SO YP, 1977, J EXP ZOOL, V200, P259, DOI 10.1002/jez.1402000207; Stannius H, 1839, ARCH ANAT PHYSIOL, V6, P97; STIMAC E, 1984, MOL CELL BIOL, V4, P2082, DOI 10.1128/MCB.4.10.2082; THEODORAKIS NG, 1987, MOL CELL BIOL, V7, P4357, DOI 10.1128/MCB.7.12.4357; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; WAGNER GF, 1992, MOL CELL ENDOCRINOL, V90, P7, DOI 10.1016/0303-7207(92)90095-N; WAGNER GF, 1986, GEN COMP ENDOCR, V63, P481, DOI 10.1016/0016-6480(86)90149-8; WAGNER GF, 1994, MOL CELL ENDOCRINOL, V99, P315, DOI 10.1016/0303-7207(94)90023-X; WAGNER GF, 1989, MOL CELL ENDOCRINOL, V62, P31, DOI 10.1016/0303-7207(89)90110-X; WAGNER GF, 1988, GEN COMP ENDOCR, V72, P237, DOI 10.1016/0016-6480(88)90206-7; WAGNER GF, 1985, CAN J ZOOL, V63, P2778, DOI 10.1139/z85-414; WAGNER GF, 1993, MOL CELL ENDOCRINOL, V93, P185, DOI 10.1016/0303-7207(93)90122-Z; Wagner Graham F., 1993, Biochemistry and Molecular Biology of Fishes, V2, P419; WELSH M, 1986, BIOCHEM J, V235, P459, DOI 10.1042/bj2350459; WELSH M, 1985, J BIOL CHEM, V260, P3590	40	24	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1960	1965		10.1074/jbc.270.4.1960	http://dx.doi.org/10.1074/jbc.270.4.1960			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829534				2022-12-27	WOS:A1995QD20400071
J	GRABCZYK, E; FISHMAN, MC				GRABCZYK, E; FISHMAN, MC			A LONG PURINE-PYRIMIDINE HOMOPOLYMER ACTS AS A TRANSCRIPTIONAL DIODE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELIX FORMATION; HOMOPURINE-HOMOPYRIMIDINE SEQUENCES; H-DNA; SUPERCOILED DNA; FORMING OLIGONUCLEOTIDES; MIRROR REPEATS; RNA; BINDING; TEMPLATE; REGION	Polypurine-polypyrimidine (R.Y) sequences have the unusual ability to form DNA triple helices. Such tracts are overrepresented upstream of eukaryotic genes, although a function there has not been clear. We report that transcription in vitro into one such upstream R.Y tract in the direction that makes a predominantly purine RNA is effectively blocked by formation of an intramolecular triple helix. The tripler is triggered by transcription and stabilized by the binding of nascent purine RNA to the template. Transcription in the opposite direction is not restricted. Polypurine-polypyrimidine DNA may provide a dynamic and selective block to transcription without the aid of accessory proteins.	MASSACHUSETTS GEN HOSP E, DEV BIOL LAB, BOSTON, MA 02129 USA; MASSACHUSETTS GEN HOSP E, CARDIOVASC RES CTR, BOSTON, MA 02129 USA; HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02129 USA	Harvard University; Harvard Medical School								ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BEAL PA, 1991, SCIENCE, V251, P1360, DOI 10.1126/science.2003222; BEHE MJ, 1987, BIOCHEMISTRY-US, V26, P7870, DOI 10.1021/bi00398a050; BELOTSERKOVSKII BP, 1992, NUCLEIC ACIDS RES, V20, P1903, DOI 10.1093/nar/20.8.1903; BERNUES J, 1989, EMBO J, V8, P2087, DOI 10.1002/j.1460-2075.1989.tb03617.x; BERNUES J, 1990, NUCLEIC ACIDS RES, V18, P4067, DOI 10.1093/nar/18.14.4067; COLLIER DA, 1990, J BIOL CHEM, V265, P10652; COONEY M, 1988, SCIENCE, V241, P456, DOI 10.1126/science.3293213; DICKSON KR, 1989, GENE, V84, P197, DOI 10.1016/0378-1119(89)90156-X; DURLAND RH, 1991, BIOCHEMISTRY-US, V30, P9246, DOI 10.1021/bi00102a017; DUVALVALENTIN G, 1992, P NATL ACAD SCI USA, V89, P504, DOI 10.1073/pnas.89.2.504; GEE JE, 1992, J BIOL CHEM, V267, P11163; GORDON CN, 1968, BIOCHIM BIOPHYS ACTA, V155, P305, DOI 10.1016/0005-2787(68)90363-8; GRABCZYK E, 1990, EUR J NEUROSCI, V2, P822, DOI 10.1111/j.1460-9568.1990.tb00393.x; GRIGORIEV M, 1993, P NATL ACAD SCI USA, V90, P3501, DOI 10.1073/pnas.90.8.3501; HANVEY JC, 1988, J BIOL CHEM, V263, P7386; HTUN H, 1988, SCIENCE, V241, P1791, DOI 10.1126/science.3175620; HTUN H, 1989, SCIENCE, V243, P1571, DOI 10.1126/science.2648571; JAEGER JA, 1989, P NATL ACAD SCI USA, V86, P7706, DOI 10.1073/pnas.86.20.7706; KANG S, 1992, J BIOL CHEM, V267, P20887; KLYSIK J, 1992, J BIOL CHEM, V267, P17430; KOHWI Y, 1993, GENE DEV, V7, P1766, DOI 10.1101/gad.7.9.1766; KOHWI Y, 1988, P NATL ACAD SCI USA, V85, P3781, DOI 10.1073/pnas.85.11.3781; KOHWI Y, 1992, J MOL BIOL, V223, P817, DOI 10.1016/0022-2836(92)90242-C; KOLLER T, 1974, BIOPOLYMERS, V13, P995, DOI 10.1002/bip.1974.360130514; LARSEN A, 1982, CELL, V29, P609, DOI 10.1016/0092-8674(82)90177-5; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; MANOR H, 1988, J MOL EVOL, V27, P96, DOI 10.1007/BF02138367; MICHEL D, 1992, NUCLEIC ACIDS RES, V20, P439, DOI 10.1093/nar/20.3.439; MIRKIN SM, 1987, NATURE, V330, P495, DOI 10.1038/330495a0; MURCHIE AIH, 1987, NUCLEIC ACIDS RES, V15, P9641, DOI 10.1093/nar/15.23.9641; ORSON FM, 1991, NUCLEIC ACIDS RES, V19, P3435, DOI 10.1093/nar/19.12.3435; PILCH DS, 1991, BIOCHEMISTRY-US, V30, P6083, DOI 10.1021/bi00239a001; PILCH DS, 1990, NUCLEIC ACIDS RES, V18, P5743, DOI 10.1093/nar/18.19.5743; RADHAKRISHNAN I, 1991, J MOL BIOL, V221, P1403, DOI 10.1016/0022-2836(91)90941-X; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; STAVNEZER J, 1991, NATURE, V351, P447, DOI 10.1038/351447b0; TENHEGGELERBORDIER B, 1992, EMBO J, V11, P667, DOI 10.1002/j.1460-2075.1992.tb05098.x; VOLOSHIN ON, 1988, NATURE, V333, P475, DOI 10.1038/333475a0; WELLS RD, 1988, FASEB J, V2, P2939, DOI 10.1096/fasebj.2.14.3053307; WU HY, 1988, CELL, V53, P433, DOI 10.1016/0092-8674(88)90163-8; YOUNG SL, 1991, P NATL ACAD SCI USA, V88, P10023, DOI 10.1073/pnas.88.22.10023; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	43	61	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1791	1797		10.1074/jbc.270.4.1791	http://dx.doi.org/10.1074/jbc.270.4.1791			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829515	hybrid			2022-12-27	WOS:A1995QD20400049
J	LIU, Y; KAHN, ML				LIU, Y; KAHN, ML			ADP-RIBOSYLATION OF RHIZOBIUM-MELILOTI GLUTAMINE-SYNTHETASE-III IN-VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PHOSPHORYLATION; RHODOSPIRILLUM-RUBRUM; LEGUMINOSARUM; BACTERIA; PHOSPHOTYROSINE; GENE	The control of glutamine synthetase (GS), the first enzyme in the main pathway used by Rhizobium meliloti to assimilate ammonia, is central to cellular nitrogen metabolism. R. meliloti is unusual in having three distinct types of GS, including a unique GS, GSIII, that differs considerably from both GSI, which resembles other bacterial GS proteins and GSII, which resembles the GS found in eukaryotes. We show here that GSIII can be post-translationally modified in vivo by ADP-ribosylation at an arginine residue. (PO4)-P-32 attached to GSIII during bacterial growth as part of the modifying group could be removed by treatment with snake venom phosphodiesterase or by turkey erythrocyte ADP-ribosylarginine hydrolase. Treatment of modified GSIII with hydroxylamine at neutral pH releases a chromophore that has the retention time of ADP-ribose when analyzed by reversed-phase high performance liquid chromatography. ADP-ribosylation inhibits GSIII activity.	WASHINGTON STATE UNIV, INST BIOL CHEM, PULLMAN, WA 99164 USA; WASHINGTON STATE UNIV, DEPT BIOCHEM & BIOPHYS, PULLMAN, WA 99164 USA; WASHINGTON STATE UNIV, DEPT MICROBIOL, PULLMAN, WA 99164 USA	Washington State University; Washington State University; Washington State University				Kahn, Michael/0000-0002-5204-561X				BOCHNER BR, 1981, ANAL BIOCHEM, V117, P81, DOI 10.1016/0003-2697(81)90695-3; CARLSON TA, 1986, NATURE, V322, P568, DOI 10.1038/322568a0; CERVANTESLAUREAN D, 1993, BIOCHEMISTRY-US, V32, P1528, DOI 10.1021/bi00057a017; CHIURAZZI M, 1992, GENE, V119, P1, DOI 10.1016/0378-1119(92)90060-3; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; DARROW RA, 1977, BIOCHEM BIOPH RES CO, V78, P554, DOI 10.1016/0006-291X(77)90214-5; DARROW RA, 1980, GLUTAMINE METABOLISM, P139; DEBRUIJN FJ, 1989, J BACTERIOL, V171, P1673, DOI 10.1128/jb.171.3.1673-1682.1989; EDMANDS J, 1987, P NATL ACAD SCI USA, V84, P6126, DOI 10.1073/pnas.84.17.6126; ESPIN G, 1990, MOL GEN GENET, V223, P513, DOI 10.1007/BF00264461; FARMER EE, 1991, J BIOL CHEM, V266, P3140; Fishman P.H., 1990, ADP RIBOSYLATING TOX, P127; FISHMAN PH, 1990, ADP RIBOSYLATING TOX, P127; FOSTER R, 1989, J BACTERIOL, V171, P272, DOI 10.1128/jb.171.1.272-279.1989; FUCHS RL, 1980, J BACTERIOL, V141, P996, DOI 10.1128/JB.141.2.996-998.1980; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANCO G, 1992, J GEN MICROBIOL, V138, P1453, DOI 10.1099/00221287-138-7-1453; Miflin B. J., 1980, The biochemistry of plants. A comprehensive treatise. Volume 5. Amino acids and derivatives., P169; MOSS J, 1990, J BIOL CHEM, V265, P21056; POPE MR, 1985, P NATL ACAD SCI USA, V82, P3173, DOI 10.1073/pnas.82.10.3173; Reitzer L.J., 1987, E COLI SALMONELLA CE, P302; RHEE SG, 1985, METHOD ENZYMOL, V113, P213; Sambrook J, 1989, MOL CLONING LABORATO; SHATTERS RG, 1989, J BACTERIOL, V171, P5087, DOI 10.1128/jb.171.9.5087-5094.1989; SHATTERS RG, 1993, J BIOL CHEM, V268, P469; SHATTERS RG, 1989, J MOL EVOL, V29, P422, DOI 10.1007/BF02602912; SOMERVILLE JE, 1983, J BACTERIOL, V156, P168, DOI 10.1128/JB.156.1.168-176.1983; STADTMAN ER, 1990, METHOD ENZYMOL, V182, P793; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; WOEHLE DL, 1990, J BIOL CHEM, V265, P13741	30	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1624	1628		10.1074/jbc.270.4.1624	http://dx.doi.org/10.1074/jbc.270.4.1624			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829494	hybrid			2022-12-27	WOS:A1995QD20400024
J	YIN, WS; SMILEY, E; GERMILLER, J; SANGUINETI, C; LAWTON, T; PEREIRA, L; RAMIREZ, F; BONADIO, J				YIN, WS; SMILEY, E; GERMILLER, J; SANGUINETI, C; LAWTON, T; PEREIRA, L; RAMIREZ, F; BONADIO, J			PRIMARY STRUCTURE AND DEVELOPMENTAL EXPRESSION OF FBN-1, THE MOUSE FIBRILLIN GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROFIBRIL-ASSOCIATED GLYCOPROTEIN; ELASTIN-ASSOCIATED MICROFIBRILS; FACTOR-LIKE DOMAIN; EGF-LIKE DOMAIN; HUMAN FACTOR-IX; EXTRACELLULAR-MATRIX; CALCIUM-BINDING; CONNECTIVE-TISSUE; MARFAN-SYNDROME; MESSENGER-RNA	Previous studies have reported >10 kilobases of human fibrillin-1 cDNA sequence, but a consensus regarding the 5' end of the transcript remains to be worked out. One approach to developing a clear consensus would be to search for regions of evolutionary conservation in transcripts from a related species such as mouse. As reported here, the mouse fibrillin-1 transcript encodes a highly conserved polypeptide of 2,871 amino acids. The upstream sequence that flanks the ATG is considerably less well conserved, however. Indeed, the ATG codon (which occurs in the context of a Kozak consensus sequence and is located just upstream of a consensus signal peptide) signals the point where human and mouse fibrillin-1 sequences cease to be nearly identical. Together, these results are consistent with previous efforts by Pereira et al. (Pereira, L., D'Alessio, M., Ramirez, F., Lynch, J. R., Sykes, B., Pangilinan, T., and Bonadio, J. (1993) Human Mel. Genet. 2, 961-968) to identify the human fibrillin-1 translational start site. Sequences immediately upstream of the ATG are GC-rich and devoid of TATA and CCAAT boxes, which suggests that the mouse fibrillin-1 gene will be broadly expressed. A survey of expression in mouse embryo tissues is consistent with this hypothesis and suggests two novel functions for fibrillin-associated microfibrils in non elastic connective tissues.	UNIV MICHIGAN,DEPT PATHOL,ANN ARBOR,MI 48109; UNIV MICHIGAN,ORTHOPAED RES LABS,ORTHOPAED SURG SECT,ANN ARBOR,MI 48109; CUNY MT SINAI SCH MED,BROOKDALE CTR MOLEC BIOL,NEW YORK,NY 10029	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai								ARBEILLE BB, 1991, J HISTOCHEM CYTOCHEM, V39, P1367, DOI 10.1177/39.10.1940308; BACCARANI-CONTRI M, 1989, Matrix, V9, P428; BRESSAN GM, 1993, J CELL BIOL, V121, P201, DOI 10.1083/jcb.121.1.201; CASTELLUCCI M, 1991, HISTOCHEMISTRY, V95, P449, DOI 10.1007/BF00315740; CHEN YP, 1993, J BIOL CHEM, V268, P27381; CLEARY EG, 1983, INT REV CONNECT TISS, V10, P97; COLOSETTI P, 1993, FEBS LETT, V320, P140, DOI 10.1016/0014-5793(93)80079-A; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; DAHLBACK K, 1989, J INVEST DERMATOL, V92, P727, DOI 10.1111/1523-1747.ep12721619; DIETZ HC, 1991, NATURE, V353, P337; ENGEL J, 1989, FEBS LETT, V251, P1, DOI 10.1016/0014-5793(89)81417-6; FARRAR JD, 1992, BIOL REPROD, V46, P1095, DOI 10.1095/biolreprod46.6.1095; FEINBERG RF, 1989, LAB INVEST, V61, P20; GALLAGHER BC, 1993, DEV DYNAM, V196, P70, DOI 10.1002/aja.1001960109; GIBSON MA, 1989, J BIOL CHEM, V264, P4590; GIBSON MA, 1991, J BIOL CHEM, V266, P7596; GOLDFISCHER S, 1985, TISSUE CELL, V17, P441, DOI 10.1016/0040-8166(85)90023-0; GRONKE RS, 1989, P NATL ACAD SCI USA, V86, P3609, DOI 10.1073/pnas.86.10.3609; HANDFORD PA, 1990, EMBO J, V9, P475, DOI 10.1002/j.1460-2075.1990.tb08133.x; HORRIGAN SK, 1992, J BIOL CHEM, V267, P10087; INOUE S, 1986, AM J ANAT, V176, P121, DOI 10.1002/aja.1001760203; KAGAN HM, 1986, J CELL BIOL, V103, P1121, DOI 10.1083/jcb.103.3.1121; Kaufman M.H., 1992, ATLAS MOUSE DEV; KOBAYASHI R, 1989, J BIOL CHEM, V264, P17437; KOZAK M, 1991, J BIOL CHEM, V266, P19867; LEE B, 1991, NATURE, V353, P330; LI X, 1993, GENOMICS, V18, P667, DOI 10.1016/S0888-7543(05)80371-4; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Mecham R. P., 1994, EXTRACELLULAR MATRIX, P281; MILEWICZ DM, 1992, J CLIN INVEST, V89, P79, DOI 10.1172/JCI115589; MULHOLLAND J, 1992, BIOL REPROD, V46, P1136, DOI 10.1095/biolreprod46.6.1136; OHLIN AK, 1988, J BIOL CHEM, V263, P7411; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; PERSSON E, 1989, J BIOL CHEM, V264, P16897; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; SELANDERSUNNERH.M, 1992, J BIOL CHEM, V0267; SENIOR PV, 1988, DEVELOPMENT, V104, P431; SERAFINIFRACASS.A, 1981, BIOCHEMISTRY-US, V20, P5425; STEINER DF, 1992, J BIOL CHEM, V267, P23435; STENFLO J, 1987, P NATL ACAD SCI USA, V84, P368, DOI 10.1073/pnas.84.2.368; STREETEN BW, 1988, CURR EYE RES, V7, P139, DOI 10.3109/02713688808995743; SUTHERLAND AE, 1993, DEVELOPMENT, V119, P1175; VRACKO R, 1990, J MOL CELL CARDIOL, V22, P749, DOI 10.1016/0022-2828(90)90087-I; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855; ZHOU Y, 1993, J CLIN INVEST, V91, P950, DOI 10.1172/JCI116316	46	33	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1798	1806		10.1074/jbc.270.4.1798	http://dx.doi.org/10.1074/jbc.270.4.1798			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829516	hybrid			2022-12-27	WOS:A1995QD20400050
J	JARVIS, JA; RYAN, MT; HOOGENRAAD, NJ; CRAIK, DJ; HOJ, PB				JARVIS, JA; RYAN, MT; HOOGENRAAD, NJ; CRAIK, DJ; HOJ, PB			SOLUTION STRUCTURE OF THE ACETYLATED AND NONCLEAVABLE MITOCHONDRIAL TARGETING SIGNAL OF RAT CHAPERONIN-10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; INTERPROTON DISTANCE RESTRAINTS; PROTEIN SECONDARY STRUCTURE; ALDEHYDE DEHYDROGENASE; LIVER MITOCHONDRIA; NMR-SPECTROSCOPY; CHEMICAL-SHIFT; BETA-SUBUNIT; HELIX DIPOLE; AMINO-ACIDS	Chaperonin 10 (Cpn10) is one of only a few mitochondrial matrix proteins synthesized without a cleavable targeting signal. Using a truncated form of Cpn10 and synthetic peptides in mitochondrial import assays, we show that the N-terminal region is both necessary and sufficient for organellar targeting in vitro. To elucidate the structural features of this topogenic signal, peptides representing residues 1-25 of rat Cpn10 were synthesized with and without the naturally occurring N-terminal acetylation, H-1 NMR spectroscopy in 20% CF3CH2OH, H2O showed that both peptides assume a stable helix-turn-helix moth and are highly amphiphilic in nature, Chemical shift and coupling constant data revealed that the N-terminal helix is stabilized by N-acetylation, whereas NOE and exchange studies were used to derive a three dimensional structure for the acetylated peptide. These findings are discussed with respect to a recent model predicting that targeting sequences forming a continuous alpha-helix of more than 11 residues cannot adopt a conformation necessary for proteolysis by the matrix located signal peptidases (Hammen, P. K., Gorenstein, D. G., and Weiner, H, (1994) Biochemistry 33, 8610-8617).	LA TROBE UNIV,SCH BIOCHEM,BUNDOORA,VIC 3083,AUSTRALIA; MONASH UNIV,SCH PHARMACEUT CHEM,PARKVILLE,VIC 3052,AUSTRALIA	La Trobe University; Monash University			Ryan, Michael/X-2152-2019; Ryan, Michael T/C-6673-2011; Hoj, Peter B/E-8526-2011; Craik, David/B-1695-2010; Hoogenraad, Nicholas J/C-7505-2011	Ryan, Michael/0000-0003-2586-8829; Ryan, Michael T/0000-0003-2586-8829; Craik, David/0000-0003-0007-6796; 				AMAYA Y, 1988, J BIOL CHEM, V263, P14463; ARAKAWA H, 1990, J BIOCHEM-TOKYO, V107, P160, DOI 10.1093/oxfordjournals.jbchem.a123001; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROWN JL, 1976, J BIOL CHEM, V251, P1009; BRUCH MD, 1992, BIOCHIM BIOPHYS ACTA, V1159, P81, DOI 10.1016/0167-4838(92)90078-R; BRUNGER AT, 1992, XPLOR VERSION 3 0 MA; CLORE GM, 1986, J MOL BIOL, V191, P523, DOI 10.1016/0022-2836(86)90146-4; DEGRADO WF, 1989, SCIENCE, V243, P622, DOI 10.1126/science.2464850; DETLEFSEN DJ, 1991, BIOCHEMISTRY-US, V30, P9040, DOI 10.1021/bi00101a019; DYSON HJ, 1991, ANNU REV BIOPHYS BIO, V20, P519; DYSON HJ, 1988, J MOL BIOL, V201, P201, DOI 10.1016/0022-2836(88)90447-0; ENDO T, 1989, J BIOCHEM, V106, P396, DOI 10.1093/oxfordjournals.jbchem.a122864; FINOCCHIARO G, 1993, EUR J BIOCHEM, V213, P1003, DOI 10.1111/j.1432-1033.1993.tb17847.x; FLING SP, 1986, ANAL BIOCHEM, V155, P83, DOI 10.1016/0003-2697(86)90228-9; HAMMEN PK, 1994, BIOCHEMISTRY-US, V33, P8610, DOI 10.1021/bi00194a028; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; HOL WGJ, 1985, PROG BIOPHYS MOL BIO, V45, P149, DOI 10.1016/0079-6107(85)90001-X; HOYT DW, 1991, J BIOL CHEM, V266, P21693; KARSLAKE C, 1990, BIOCHEMISTRY-US, V29, P9872, DOI 10.1021/bi00494a017; KLINE AD, 1988, J MOL BIOL, V204, P675, DOI 10.1016/0022-2836(88)90364-6; LEMIRE BD, 1989, J BIOL CHEM, V264, P20206; LINGELBACH KR, 1986, EUR J BIOCHEM, V161, P19, DOI 10.1111/j.1432-1033.1986.tb10119.x; LYU PC, 1990, SCIENCE, V250, P669, DOI 10.1126/science.2237416; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; MATSUSHITA Y, 1993, EUR J BIOCHEM, V214, P577, DOI 10.1111/j.1432-1033.1993.tb17956.x; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MILLER DM, 1991, J BIOL CHEM, V266, P4686; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; PAK YK, 1990, J BIOL CHEM, V265, P14298; PERALTA D, 1993, EUR J BIOCHEM, V211, P881, DOI 10.1111/j.1432-1033.1993.tb17621.x; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; REDFIELD AG, 1975, J MAGN RESON, V19, P250, DOI 10.1016/0022-2364(75)90073-6; RIZO J, 1993, BIOCHEMISTRY-US, V32, P4881, DOI 10.1021/bi00069a025; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; ROSPERT S, 1993, FEBS LETT, V335, P358, DOI 10.1016/0014-5793(93)80419-U; RYAN MT, 1994, FEBS LETT, V337, P152, DOI 10.1016/0014-5793(94)80263-7; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHOEMAKER KR, 1987, NATURE, V326, P563, DOI 10.1038/326563a0; THORNTON K, 1993, J BIOL CHEM, V268, P19906; VENKATACHALAPATHI, 1993, PROTEINS, V15, P349; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; WAGNER G, 1987, J MOL BIOL, V196, P611, DOI 10.1016/0022-2836(87)90037-4; WANG Y, 1993, J BIOL CHEM, V268, P4759; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K., 1986, NMR PROTEINS NUCL AC; ZARDENETA G, 1992, J BIOL CHEM, V267, P24193	49	59	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1323	1331		10.1074/jbc.270.3.1323	http://dx.doi.org/10.1074/jbc.270.3.1323			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836398	hybrid			2022-12-27	WOS:A1995QB15600053
J	CHANG, MS; MCNINCH, J; BASU, R; SHUTTER, J; HSU, RY; PERKINS, C; MAR, V; SUGGS, S; WELCHER, A; LI, L; LU, H; BARTLEY, T; HUNT, P; MARTIN, F; SAMAL, B; BOGENBERGER, J				CHANG, MS; MCNINCH, J; BASU, R; SHUTTER, J; HSU, RY; PERKINS, C; MAR, V; SUGGS, S; WELCHER, A; LI, L; LU, H; BARTLEY, T; HUNT, P; MARTIN, F; SAMAL, B; BOGENBERGER, J			CLONING AND CHARACTERIZATION OF THE HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (MGDF) GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ACUTE NONLYMPHOCYTIC LEUKEMIA; PROMOTER REGION; CHROMOSOME-3; SEQUENCE; ENCODES	The megakaryocyte growth and development factor (MGDF) is a cytokine that regulates megakaryocyte development and is a ligand for the MPL receptor, In this study, we describe the genomic structure of the human MGDF gene. The MGDF gene was found to consist of seven exons and six introns spanning 8 kilobases. The protein is encoded by exons 3 through 7. The human MGDF gene has been mapped to chromosome 3q26.3. In addition to the previously described full-length cDNA, two cDNA variants were isolated from human fetal liver. Comparison of these two cDNA sequences with the genomic sequence indicates that they arise by differential splicing.			CHANG, MS (corresponding author), AMGEN INC, DEPT DEV BIOL, 14-1-B-219, 1840 DEHAVILLAND DR, THOUSAND OAKS, CA 91320 USA.		Samal, Babru/ABE-5931-2020; Samal, Babru B/C-5563-2008					BARTLEY TD, 1994, CELL, V77, P1117, DOI 10.1016/0092-8674(94)90450-2; BERNSTEIN R, 1982, BLOOD, V60, P613; CHANG MS, 1994, BLOOD, V83, P3199; CHAVRIER P, 1990, EMBO J, V9, P1209, DOI 10.1002/j.1460-2075.1990.tb08228.x; DESAUVAGE FJ, 1994, NATURE, V369, P533, DOI 10.1038/369533a0; DYNAN WS, 1986, TRENDS GENET, V2, P196, DOI 10.1016/0168-9525(86)90226-X; HALLETT JM, 1989, BRIT J HAEMATOL, V71, P291, DOI 10.1111/j.1365-2141.1989.tb04269.x; HANNINK M, 1990, ONCOGENE, V5, P1843; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; JORCYK CL, 1991, ONCOGENE, V6, P523; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; LEMAIRE P, 1990, MOL CELL BIOL, V10, P3456, DOI 10.1128/MCB.10.7.3456; LOK S, 1994, NATURE, V369, P565, DOI 10.1038/369565a0; MAZUR E, 1985, EXP HEMATOL, V13, P1165; MCDONALD TP, 1975, BIOCHEM MED METAB B, V13, P101, DOI 10.1016/0006-2944(75)90145-3; METHIA N, 1993, BLOOD, V82, P1395; MIGNOTTE V, 1994, GENOMICS, V20, P5, DOI 10.1006/geno.1994.1120; ODELL TT, 1961, P SOC EXP BIOL MED, V108, P428; OGATA K, 1990, INT J CELL CLONING, V8, P103, DOI 10.1002/stem.5530080710; PINTADO T, 1985, CANCER, V55, P535, DOI 10.1002/1097-0142(19850201)55:3<535::AID-CNCR2820550311>3.0.CO;2-4; ROWLEY JD, 1976, BLOOD, V47, P705	21	84	93	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					511	514		10.1074/jbc.270.2.511	http://dx.doi.org/10.1074/jbc.270.2.511			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822271	hybrid			2022-12-27	WOS:A1995QB81600003
J	DANIELSEN, E; BAUER, R; HEMMINGSEN, L; ANDERSEN, ML; BJERRUM, MJ; BUTZ, T; TROGER, W; CANTERS, GW; HOITINK, CWG; KARLSSON, G; HANSSON, O; MESSERSCHMIDT, A				DANIELSEN, E; BAUER, R; HEMMINGSEN, L; ANDERSEN, ML; BJERRUM, MJ; BUTZ, T; TROGER, W; CANTERS, GW; HOITINK, CWG; KARLSSON, G; HANSSON, O; MESSERSCHMIDT, A			STRUCTURE OF METAL SITE IN AZURIN, MET(121) MUTANTS OF AZURIN, AND STELLACYANIN INVESTIGATED BY CD-111M PERTURBED-ANGULAR-CORRELATION (PAC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-QUADRUPOLE INTERACTION; BLUE COPPER PROTEINS; PSEUDOMONAS-AERUGINOSA; COORDINATION GEOMETRY; CORRELATION SPECTROSCOPY; CRYSTAL-STRUCTURE; CADMIUM; MODEL; REDUCTION; COMPLEXES	The geometries of the metal sites in cadmium-substituted azurins have been investigated by Cd-111m perturbed angular correlation (PAC), The study includes wild type azurin as well as Met(121) mutants of azurin, where methionine has been substituted by Ala, Asn, Asp, Gin, Glu, and Leu. The nuclear quadrupole interaction of wild type azurin analyzed in the angular overlap model is well described as coordination of His(46), His(117), and Cys(112) and cannot be described by coordination of Met(121) and/or Gly(45). For most of the mutants, there exist two coordination geometries of the cadmium ion, With the exception of the Gau and Asp mutants, one of the conformations is similar to the wild type conformation. The other coordination geometries are either best described by a coordinating water molecule close to the original methionine position or by coordination by the substituting amino acid, These experiments show that even though the methionine does not coordinate it plays an important role for the geometry of the metal site. The nuclear quadrupole interaction of stellacyanin was also measured, The value resembles the most prominent nuclear quadrupole interaction of the Met(121) --> Gin mutant of Alcaligenes denitrificans azurin, indicating that the structures of the two metal sites are similar.	ROYAL VET & AGR UNIV,DEPT CHEM,DK-1871 FREDERIKSBERG C,DENMARK; UNIV LEIPZIG,FAC PHYS & GEOSCI,O-7010 LEIPZIG,GERMANY; LEIDEN UNIV,LEIDEN INST CHEM,2300 RA LEIDEN,NETHERLANDS; CHALMERS UNIV TECHNOL,S-41390 GOTHENBURG,SWEDEN; MAX PLANCK INST BIOCHEM,W-8033 MARTINSRIED,GERMANY	University of Copenhagen; Leipzig University; Leiden University; Leiden University - Excl LUMC; Chalmers University of Technology; Max Planck Society	DANIELSEN, E (corresponding author), ROYAL VET & AGR UNIV,DEPT MATH & PHYS,THORVALDSENSVEJ 40,DK-1871 FREDERIKSBERG C,DENMARK.		Hansson, Orjan/D-1282-2009; Hemmingsen, Lars/A-6780-2015; Messerschmidt, Albrecht/A-8337-2008; Hemmingsen, Lars/AAD-1318-2020; Karlsson, Göran/E-8686-2011	Hemmingsen, Lars/0000-0002-1823-3035; Hemmingsen, Lars/0000-0002-1823-3035; 				ADMAN ET, 1978, J MOL BIOL, V123, P35, DOI 10.1016/0022-2836(78)90375-3; ADMAN ET, 1991, ADV PROTEIN CHEM, V42, P145; BAKER EN, 1988, J MOL BIOL, V203, P1071, DOI 10.1016/0022-2836(88)90129-5; BAUER R, 1991, ACTA CHEM SCAND, V45, P593, DOI 10.3891/acta.chem.scand.45-0593; BAUER R, 1979, J CHEM PHYS, V70, P4117, DOI 10.1063/1.438036; BAUER R, 1991, EUR BIOPHYS J, V20, P215, DOI 10.1007/BF00183458; BAUER R, 1988, HYPERFINE INTERACT, V39, P203, DOI 10.1007/BF02394319; BAUER R, 1985, Q REV BIOPHYS, V18, P1, DOI 10.1017/S0033583500004972; BEVINGTON PR, 1969, DATA REDUCTION ERROR, P315; BUTZ T, 1989, NUCL INSTRUM METH A, V284, P417, DOI 10.1016/0168-9002(89)90311-2; Cantor CR, 1980, BIOPHYSICAL CHEM 2, P461; DANIELSEN E, 1992, HYPERFINE INTERACT, V62, P311; FIELDS BA, 1991, J MOL BIOL, V222, P1053, DOI 10.1016/0022-2836(91)90593-U; FRAUENFELDER H, 1965, ALPHA BETA GAMMA RAY, V2, P97; Gray H. B., 1983, COMMENTS INORG CHEM, V2, P203; GRUFF ES, 1990, J AM CHEM SOC, V112, P1245, DOI 10.1021/ja00159a054; HAAS H, 1973, J CHEM PHYS, V58, P3339, DOI 10.1063/1.1679661; KARLSSON BG, 1989, FEBS LETT, V253, P99, DOI 10.1016/0014-5793(89)80938-X; KARLSSON BG, 1991, PROTEIN ENG, V4, P343, DOI 10.1093/protein/4.3.343; KARLSSON G, 1993, THESIS CHALMERS U TE; LOWERY MD, 1992, INORG CHIM ACTA, V200, P233; MURATA M, 1982, P NATL ACAD SCI-BIOL, V79, P6434, DOI 10.1073/pnas.79.21.6434; MURPHY LM, 1993, BIOCHEMISTRY-US, V32, P1965, DOI 10.1021/bi00059a013; NAR H, 1992, EUR J BIOCHEM, V205, P1123, DOI 10.1111/j.1432-1033.1992.tb16881.x; NAR H, 1991, J MOL BIOL, V221, P765, DOI 10.1016/0022-2836(91)80173-R; NAR H, 1992, THESIS TU MUNICH; PASCHER T, 1993, EUR J BIOCHEM, V212, P289, DOI 10.1111/j.1432-1033.1993.tb17661.x; REINHAMM.B, 1970, BIOCHIM BIOPHYS ACTA, V205, P35, DOI 10.1016/0005-2728(70)90059-9; ROMERO A, 1993, J MOL BIOL, V229, P1007, DOI 10.1006/jmbi.1993.1101; SANTOS RA, 1991, J AM CHEM SOC, V113, P469, DOI 10.1021/ja00002a014; SHEPARD WEB, 1990, J AM CHEM SOC, V112, P7817, DOI 10.1021/ja00177a065; VITTAL JJ, 1993, INORG CHEM, V32, P791, DOI 10.1021/ic00058a007; WHITLOW SH, 1975, ACTA CRYSTALLOGR B, V31, P2531, DOI 10.1107/S0567740875008035	33	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					573	580		10.1074/jbc.270.2.573	http://dx.doi.org/10.1074/jbc.270.2.573			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822282	hybrid			2022-12-27	WOS:A1995QB81600014
J	SHAPIRO, MJ; PANOMITROS, D; KOSHLAND, DE				SHAPIRO, MJ; PANOMITROS, D; KOSHLAND, DE			INTERACTIONS BETWEEN THE METHYLATION SITES OF THE ESCHERICHIA-COLI ASPARTATE RECEPTOR-MEDIATED BY THE METHYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIERARCHICAL PROTEIN-PHOSPHORYLATION; ACCEPTING CHEMOTAXIS PROTEINS; BACTERIAL SENSING SYSTEM; SENSORY TRANSDUCTION; GENE-PRODUCT; ADAPTATION; IDENTIFICATION; METHYLESTERASE; ESTERIFICATION	Mutations made at and near the methylation sites of the Escherichia coli aspartate receptor were found to affect the methylation rates of the remaining methylation sites. The results supported a model in which the methyltransferase enzyme contacts a residue seven amino acids to the C terminus of a site being methylated. The presence of a negatively charged residue at that position inhibits methylation, whereas a neutral residue has no effect. Methylation sites in the wild type receptor may also influence the methylation of other sites which are 7 residues away through a physical contact with the methyltransferase.	UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK009765, R01DK009765] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK09765] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CLARKE S, 1979, J BIOL CHEM, V254, P9695; GOY MF, 1977, P NATL ACAD SCI USA, V74, P4964, DOI 10.1073/pnas.74.11.4964; KEHRY MR, 1982, CELL, V29, P761, DOI 10.1016/0092-8674(82)90438-X; KEHRY MR, 1983, P NATL ACAD SCI-BIOL, V80, P3599, DOI 10.1073/pnas.80.12.3599; KEHRY MR, 1982, J BIOL CHEM, V257, P378; KOSHLAND DE, 1988, BIOCHEMISTRY-US, V27, P5829, DOI 10.1021/bi00416a001; MOWBRAY SL, 1987, CELL, V50, P171, DOI 10.1016/0092-8674(87)90213-3; NOWLIN DM, 1988, PROTEINS, V3, P102, DOI 10.1002/prot.340030205; ROACH PJ, 1990, FASEB J, V4, P2961, DOI 10.1096/fasebj.4.12.2168324; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; RUSSO AF, 1983, SCIENCE, V220, P1016, DOI 10.1126/science.6302843; SHAPIRO MJ, 1994, J BIOL CHEM, V269, P11054; SIBLEY DR, 1987, CELL, V48, P913, DOI 10.1016/0092-8674(87)90700-8; SIMMS SA, 1985, J BIOL CHEM, V260, P161; SIMMS SA, 1987, J BIOL CHEM, V262, P8537; SPRINGER MS, 1977, P NATL ACAD SCI USA, V74, P3312, DOI 10.1073/pnas.74.8.3312; SPRINGER WR, 1977, P NATL ACAD SCI USA, V74, P533, DOI 10.1073/pnas.74.2.533; STOCK JB, 1978, P NATL ACAD SCI USA, V75, P3659, DOI 10.1073/pnas.75.8.3659; TERWILLIGER TC, 1986, J BIOL CHEM, V261, P814; TERWILLIGER TC, 1986, P NATL ACAD SCI USA, V83, P6707, DOI 10.1073/pnas.83.18.6707; TERWILLIGER TC, 1983, J BIOL CHEM, V258, P9608; TERWILLIGER TC, 1984, J BIOL CHEM, V259, P7719; WANG EA, 1980, P NATL ACAD SCI-BIOL, V77, P7157, DOI 10.1073/pnas.77.12.7157; WOLFE AJ, 1987, J BACTERIOL, V169, P1878, DOI 10.1128/jb.169.5.1878-1885.1987	24	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					751	755		10.1074/jbc.270.2.751	http://dx.doi.org/10.1074/jbc.270.2.751			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822306	hybrid			2022-12-27	WOS:A1995QB81600040
J	SMERZBERTLING, C; DUSCHL, A				SMERZBERTLING, C; DUSCHL, A			BOTH INTERLEUKIN-4 AND INTERLEUKIN-13 INDUCE TYROSINE PHOSPHORYLATION OF THE 140-KDA SUBUNIT OF THE INTERLEUKIN-4 RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; GAMMA-CHAIN; IL-2 RECEPTOR; CELL-LINE; PROLIFERATIVE ACTIVITY; FUNCTIONAL COMPONENT; HEMATOPOIETIC-CELLS; B-CELLS; PROTEIN; BINDING	We have investigated tyrosine phosphorylation of cellular proteins induced by interleukin (IL) 4 and compared it with the effects of three related cytokines, IL-2, IL-7, and IL-13. We show here that both IL-4 and IL-13 stimulate tyrosine phosphorylation of the 140-kDa IL-4 receptor subunit, which suggests that this receptor protein is used by both cytokines. Receptor phosphorylation induced by IL-13 was both weaker and slower than with IL-4. Stimulation of cells with IL-2 and IL-7 induced identical phosphorylation patterns to each other but not phosphorylation of the 140-kDa IL-4 receptor subunit. The only signal appearing upon stimulation with any of the four cytokines was the weak phosphorylation of an unidentified protein of 160 kDa. SH2 domains of p56(lck) and p59(fyn) precipitated the same proteins as anti-phosphotyrosine antibodies after IL-4 stimulation, which suggests that a src-type kinase may be involved in signal transduction through the IL-4 receptor.	THEODOR BOVERI INST BIOWISSENSCH, D-97074 WURZBURG, GERMANY				Duschl, Albert/E-5872-2011	Duschl, Albert/0000-0002-7034-9860				ASAO H, 1993, P NATL ACAD SCI USA, V90, P4127, DOI 10.1073/pnas.90.9.4127; AVERSA G, 1993, J EXP MED, V178, P2213, DOI 10.1084/jem.178.6.2213; BOULAY JL, 1993, CURR BIOL, V3, P573, DOI 10.1016/0960-9822(93)90002-6; COFFMAN RL, 1986, J IMMUNOL, V136, P4538; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DEFRANCE T, 1994, J EXP MED, V179, P135, DOI 10.1084/jem.179.1.135; Duschl A, 1992, Eur Cytokine Netw, V3, P97; GATELY MK, 1991, J IMMUNOL, V147, P874; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; HORAK ID, 1991, P NATL ACAD SCI USA, V88, P1996, DOI 10.1073/pnas.88.5.1996; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; IZUHARA K, 1993, BIOCHEM BIOPH RES CO, V190, P992, DOI 10.1006/bbrc.1993.1147; IZUHARA K, 1993, J BIOL CHEM, V268, P13097; IZUHARA K, 1994, J BIOL CHEM, V269, P18623; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; KEEGAN AD, 1994, CELL, V76, P811, DOI 10.1016/0092-8674(94)90356-5; KEEGAN AD, 1994, J LEUKOCYTE BIOL, V55, P272, DOI 10.1002/jlb.55.2.272; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; KOBAYASHI N, 1993, P NATL ACAD SCI USA, V90, P4201, DOI 10.1073/pnas.90.9.4201; KOHLER I, 1993, EUR J IMMUNOL, V23, P3066, DOI 10.1002/eji.1830231204; KOHLER I, 1994, FEBS LETT, V345, P187, DOI 10.1016/0014-5793(94)00438-2; KOHLER I, 1994, EUR J IMMUNOL, V345, P187; KONDO M, 1994, SCIENCE, V263, P1453, DOI 10.1126/science.8128231; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; KOTANIDES H, 1993, SCIENCE, V262, P1265, DOI 10.1126/science.7694370; KRUSE N, 1992, EMBO J, V11, P3237, DOI 10.1002/j.1460-2075.1992.tb05401.x; KRUSE N, 1991, FEBS LETT, V286, P58, DOI 10.1016/0014-5793(91)80939-Z; LAVAN BE, 1992, J BIOL CHEM, V267, P11631; MALEFYT RD, 1993, RES IMMUNOL, V144, P629, DOI 10.1016/S0923-2494(05)80016-1; MIRESLUIS AR, 1991, J BIOL CHEM, V266, P18113; MORLA AO, 1988, MOL CELL BIOL, V8, P2214, DOI 10.1128/MCB.8.5.2214; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; PAUL WE, 1991, BLOOD, V77, P1859; PAYNE G, 1993, P NATL ACAD SCI USA, V90, P4902, DOI 10.1073/pnas.90.11.4902; PERLMUTTER RM, 1993, ANNU REV IMMUNOL, V11, P451, DOI 10.1146/annurev.iy.11.040193.002315; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; ROMAGNANI S, 1991, IMMUNOL TODAY, V12, P256, DOI 10.1016/0167-5699(91)90120-I; RUFFJAMISON S, 1993, J IMMUNOL, V150, P3389; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SCHINDLER C, 1994, EMBO J, V13, P1350, DOI 10.1002/j.1460-2075.1994.tb06388.x; SHIBUYA H, 1992, CELL, V70, P57, DOI 10.1016/0092-8674(92)90533-I; STAHL N, 1993, CELL, V74, P587, DOI 10.1016/0092-8674(93)90506-L; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TONY HP, 1994, EUR J BIOCHEM, V225, P659, DOI 10.1111/j.1432-1033.1994.00659.x; TORIGOE T, 1992, P NATL ACAD SCI USA, V89, P2674, DOI 10.1073/pnas.89.7.2674; VENKITARAMAN AR, 1992, P NATL ACAD SCI USA, V89, P12083, DOI 10.1073/pnas.89.24.12083; WANG LM, 1992, EMBO J, V11, P4899, DOI 10.1002/j.1460-2075.1992.tb05596.x; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; WANG LM, 1993, P NATL ACAD SCI USA, V90, P4032, DOI 10.1073/pnas.90.9.4032; WEIGEL U, 1989, EUR J BIOCHEM, V180, P295, DOI 10.1111/j.1432-1033.1989.tb14647.x; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; ZURAWSKI G, 1994, IMMUNOL TODAY, V15, P19, DOI 10.1016/0167-5699(94)90021-3; ZURAWSKI SM, 1993, EMBO J, V12, P2663, DOI 10.1002/j.1460-2075.1993.tb05927.x	56	122	126	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					966	970		10.1074/jbc.270.2.966	http://dx.doi.org/10.1074/jbc.270.2.966			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822337	hybrid			2022-12-27	WOS:A1995QB81600072
J	VOGT, A; QIAN, YM; BLASKOVICH, MA; FOSSUM, RD; HAMILTON, AD; SEBTI, SM				VOGT, A; QIAN, YM; BLASKOVICH, MA; FOSSUM, RD; HAMILTON, AD; SEBTI, SM			A NONPEPTIDE MIMETIC OF RAS-CAAX - SELECTIVE-INHIBITION OF FARNESYLTRANSFERASE AND RAS PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN FARNESYLTRANSFERASE; TETRAPEPTIDE INHIBITORS; MEMBRANE ASSOCIATION; P21RAS; FARNESYL; TRANSFORMATION; CELLS; PEPTIDOMIMETICS; TRANSFERASE; TERMINUS	Cysteine farnesylation of the carboxyl-terminal tetrapeptide CAAX (C = Cys, A = Leu, ne, or Val, X = Met or Ser) of the oncogene product Ras is required for its malignant transformation activity. As a consequence farnesyltransferase (FTase), the enzyme responsible for this lipid modification, has become one of the most sought-after targets for anticancer drug development. We have recently designed peptide mimics of the COOH-terminal Cys-Val-Ile-Met of K-B-Ras where the dipeptide Val-ne was replaced by aminobenzoic acid derivatives. Although these peptidomimetics are potent inhibitors of FTase in vitro, they retain several undesirable peptide features that hamper their use in vivo. We report here the design, synthesis, and biological activity of the first non-peptide mimetics of CAAX where the tripeptide AAX was replaced by biphenyl derivatives, (R)-4-[N-(3-mercapto-2-aminopropyl)]amino-3'-carboxybiphenyl, where the cysteine is linked to the biphenyl derivative through a secondary amine, contains no amino acids, lacks peptidic features, and has no hydrolyzable bonds. This peptidomimetic is a potent inhibitor of FTase in vitro (IC50 = 50-150 nM) and disrupts Ras processing in whole cells. Furthermore, this non-peptide mimetic of CAAX is highly selective for FTase (666-fold) relative to the closely related geranylgeranyl-transferase I. This selectivity is also respected in vivo since the processing of has but not the geranylgeranylated Rap1A was disrupted in whole cells. Structure activity relationship studies revealed that FTase recognition and inhibitory potency of CAAX peptidomimetics require free thiol and carboxylate groups separated by a hydrophobic moiety, and that precise positioning of these functional groups must correspond to that of the parent CAAX. The true CAAX peptidomimetic described in this manuscript has several desirable features for further develop ment as a potential anticancer agent. It is not metabolically inactivated by FTase, does not require a prodrug strategy for inhibition in vivo, and is selective for farnesylation relative to geranylgeranylation.	UNIV PITTSBURGH,FAC ARTS & SCI,DEPT CHEM,PITTSBURGH,PA 15261; UNIV PITTSBURGH,SCH MED,DEPT PHARMACOL,PITTSBURGH,PA 15261	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh								BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BROWN MS, 1992, P NATL ACAD SCI USA, V89, P8313, DOI 10.1073/pnas.89.17.8313; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; CASEY PJ, 1992, J LIPID RES, V33, P1731; COX AD, 1992, MOL CELL BIOL, V12, P2606, DOI 10.1128/MCB.12.6.2606; Cox Adrienne D., 1992, Current Opinion in Cell Biology, V4, P1008, DOI 10.1016/0955-0674(92)90133-W; GARCIA AM, 1993, J BIOL CHEM, V268, P18415; GIBBS JB, 1991, CELL, V65, P1, DOI 10.1016/0092-8674(91)90352-Y; GIBBS JB, 1994, CELL, V77, P175, DOI 10.1016/0092-8674(94)90308-5; GOLDSTEIN JL, 1991, J BIOL CHEM, V266, P15575; GRAHAM SL, 1994, J MED CHEM, V37, P725, DOI 10.1021/jm00032a004; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; JACKSON JH, 1990, P NATL ACAD SCI USA, V87, P3042, DOI 10.1073/pnas.87.8.3042; JAMES GL, 1993, SCIENCE, V260, P1937, DOI 10.1126/science.8316834; KATO K, 1992, P NATL ACAD SCI USA, V89, P6403, DOI 10.1073/pnas.89.14.6403; KOHL NE, 1993, SCIENCE, V260, P1934, DOI 10.1126/science.8316833; LACAL JC, 1984, P NATL ACAD SCI-BIOL, V81, P5305, DOI 10.1073/pnas.81.17.5305; MANNE V, 1990, P NATL ACAD SCI USA, V87, P7541, DOI 10.1073/pnas.87.19.7541; MCCORMICK F, 1993, NATURE, V363, P15, DOI 10.1038/363015a0; MOORES SL, 1991, J BIOL CHEM, V266, P14603; NIGAM M, 1993, J BIOL CHEM, V268, P20695; POMPLIANO DL, 1992, BIOCHEMISTRY-US, V31, P3800, DOI 10.1021/bi00130a010; QIAN YM, 1994, BIOORG MED CHEM LETT, V4, P2579, DOI 10.1016/S0960-894X(01)80287-0; QIAN YM, 1994, J BIOL CHEM, V269, P12410; REISS Y, 1991, P NATL ACAD SCI USA, V88, P732, DOI 10.1073/pnas.88.3.732; REISS Y, 1991, J BIOL CHEM, V266, P10672; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; SEBTI SM, 1991, CANCER COMMUN, V3, P141, DOI 10.3727/095535491820873371; STRADLEY SJ, 1993, BIOCHEMISTRY-US, V32, P12586, DOI 10.1021/bi00210a006; WATANABE T, 1992, SYNLETT, V3, P207; WILLUMSEN BM, 1984, EMBO J, V3, P2581, DOI 10.1002/j.1460-2075.1984.tb02177.x; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0	34	110	133	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					660	664		10.1074/jbc.270.2.660	http://dx.doi.org/10.1074/jbc.270.2.660			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822292	hybrid			2022-12-27	WOS:A1995QB81600026
J	BURKE, JR; GREGOR, KR; TRAMPOSCH, KM				BURKE, JR; GREGOR, KR; TRAMPOSCH, KM			MECHANISM OF INHIBITION OF HUMAN NONPANCREATIC SECRETED PHOSPHOLIPASE A(2) BY THE ANTIINFLAMMATORY AGENT BMS-181162	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTHRITIC SYNOVIAL-FLUID; INTERFACIAL CATALYSIS; COMPETITIVE INHIBITORS; SCOOTING MODE; EXTRACELLULAR PHOSPHOLIPASE-A2; PANCREATIC PHOSPHOLIPASE-A2; ANTIINFLAMMATORY ACTIVITY; SUBSTRATE SPECIFICITIES; KINETIC-ANALYSIS; VESICLES	Many important mediators of inflammation result from the liberation of free arachidonic acid from phospholipid pools which is thought to result from the action of phospholipase A(2) (PLA(2)), It is believed, therefore, that the inhibition of PLA(2) would be an important treatment in many inflammatory disease states, The anti-inflammatory agent BMS-181162 (4-(3'-carboxyphenyl)-3,7-dimethyl-9-(2'',6'',6''-trimethyl-1''-cyclohexenyl)-2Z,4E,6E,8E-nonatetraenoic acid) selectively inhibits PLA(2) and has been shown to block arachidonic acid release in whole cells, The mechanism of inhibition of human nonpancreatic-secreted PLA(2) by BMS-181162 is investigated in this paper, A scooting mode assay in which the enzyme is irreversibly bound to vesicles of 1,2-dimyristoyl-sn-glycero-3-phosphomethanol containing 5 mol % of 1-palmitoyl-2-[1-C-14]arachidonoyl-sn-glycero-3-phosphocholine, was used to characterize the inhibition, With this assay system, BMS-181162 inhibited the enzyme in a dose-dependent manner, Compounds which inhibit in the scooting mode have been shown to be competitive inhibitors in the interface (Gelb, M, H., Berg, O., and Jain, M, K, (1991) Curr. Op, Struct, Biol, 1, 836-843), This was verified by demonstrating that the inhibition was not due to the desorption of the enzyme from the lipid-water interface, Additionally, the compound did not measurably affect the rate of association onto the vesicles, Therefore, the inhibition was not the result of a modulation of the bilayer morphology nor an interaction with the interfacial binding site on the enzyme, The degree of inhibition was dependent on the reaction volume which indicates that the inhibitor is only partially partitioned into the bilayer, After compensating for this partitioning, the dose-dependent inhibition could be defined by kinetic equations describing competitive inhibition at the interface, The equilibrium dissociation constant for the inhibitor bound to the enzyme at the interface (K-I*) was determined to be 0.013 mol fraction, thus demonstrating that BMS-181162 represents a novel structural class of tight-binding competitive inhibitors of human nonpancreatic secreted PLA(2). Using Escherichia coli membranes as substrate, to which the enzyme binds to the interface reversibly, the inhibition showed a nonclassical kinetic pattern which is also consistent with a partial partitioning of the inhibitor into the bilayer, This was verified by a direct measurement of the amount of inhibitor remaining in solution, The implications for in vivo efficacy which result from this mechanism are discussed.			BURKE, JR (corresponding author), BRISTOL MYERS SQUIBB CO, PHARMACEUT RES INST, DERMATOL DISCOVERY RES, 100 FOREST AVE, BUFFALO, NY 14213 USA.							BASSOLINOKLIMAS D, 1993, BIOCHEMISTRY-US, V32, P12624, DOI 10.1021/bi00210a010; BAYBURT T, 1993, BIOCHEMISTRY-US, V32, P573, DOI 10.1021/bi00053a024; BERG OG, 1991, BIOCHEMISTRY-US, V30, P7283, DOI 10.1021/bi00243a034; CROWL R, 1990, ADV EXP MED BIOL, V279, P173; DEEMS RA, 1975, J BIOL CHEM, V250, P9013; DENNIS EA, 1987, DRUG DEVELOP RES, V10, P205, DOI 10.1002/ddr.430100404; DIEZ E, 1992, J BIOL CHEM, V267, P18342; GELB MH, 1992, BIOORG MED CHEM LETT, V2, P1335, DOI 10.1016/S0960-894X(00)80508-9; Gelb MH, 1991, CURR OPIN STRUC BIOL, V1, P836, DOI 10.1016/0959-440X(91)90187-X; HENDRICKSON HS, 1984, J BIOL CHEM, V259, P5734; Jain M K, 1992, Mediators Inflamm, V1, P85, DOI 10.1155/S0962935192000164; JAIN MK, 1992, J MED CHEM, V35, P3584, DOI 10.1021/jm00097a018; JAIN MK, 1991, BIOCHEMISTRY-US, V30, P7306, DOI 10.1021/bi00243a036; JAIN MK, 1991, BIOCHEMISTRY-US, V30, P10256, DOI 10.1021/bi00106a025; JAIN MK, 1986, BIOCHIM BIOPHYS ACTA, V860, P435, DOI 10.1016/0005-2736(86)90541-9; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V1002, P127, DOI 10.1016/0005-2760(89)90281-6; JAIN MK, 1993, BIOCHEMISTRY-US, V32, P11319, DOI 10.1021/bi00093a008; JAIN MK, 1991, METHOD ENZYMOL, V197, P112; JAIN MK, 1985, BIOCHIM BIOPHYS ACTA, V814, P319, DOI 10.1016/0005-2736(85)90451-1; JAIN MK, 1989, BIOCHEMISTRY-US, V28, P4135, DOI 10.1021/bi00436a002; KANDA A, 1989, BIOCHEM BIOPH RES CO, V163, P42, DOI 10.1016/0006-291X(89)92096-2; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; LAI CY, 1988, BIOCHEM BIOPH RES CO, V157, P488, DOI 10.1016/S0006-291X(88)80275-4; LEMAHIEU RA, 1993, J MED CHEM, V36, P3029, DOI 10.1021/jm00072a025; LIN HK, 1993, J AM CHEM SOC, V115, P3932, DOI 10.1021/ja00063a012; RAGHUPATHI R, 1987, FASEB J, V46, P1945; RECKLIES AD, 1991, ARTHRITIS RHEUM, V34, P1106, DOI 10.1002/art.1780340906; SCOTT DL, 1991, SCIENCE, V254, P1007, DOI 10.1126/science.1948070; SCRUTTON MC, 1965, J BIOL CHEM, V240, P3714; Segel I. H., 1975, ENZYME KINETICS, pxxii; SEILHAMER JJ, 1989, J BIOL CHEM, V264, P5335; STEFANSKI E, 1986, J BIOCHEM-TOKYO, V100, P1297, DOI 10.1093/oxfordjournals.jbchem.a121836; TRAMPOSCH KM, 1992, BIOCHEM BIOPH RES CO, V189, P272, DOI 10.1016/0006-291X(92)91554-4; TRAMPOSCH KM, 1994, IN PRESS J PHARM EXP; VADAS P, 1985, LIFE SCI, V36, P579, DOI 10.1016/0024-3205(85)90640-X; VADAS P, 1988, AGENTS ACTIONS, V24, P320, DOI 10.1007/BF02028289; VERHEIJ HM, 1980, BIOCHEMISTRY-US, V19, P743, DOI 10.1021/bi00545a021; VOLWERK JJ, 1974, BIOCHEMISTRY-US, V13, P1446, DOI 10.1021/bi00704a020; WERY JP, 1991, NATURE, V352, P79, DOI 10.1038/352079a0; WONG PYK, 1990, ADV EXP MED BIOL, V275; YU BZ, 1993, BIOCHEMISTRY-US, V32, P6485, DOI 10.1021/bi00076a024	41	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					274	280		10.1074/jbc.270.1.274	http://dx.doi.org/10.1074/jbc.270.1.274			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814386	hybrid			2022-12-27	WOS:A1995QA28700044
J	DUSTIN, ML; BARANSKI, TJ; SAMPATH, D; KORNFELD, S				DUSTIN, ML; BARANSKI, TJ; SAMPATH, D; KORNFELD, S			A NOVEL MUTAGENESIS STRATEGY IDENTIFIES DISTANTLY SPACED AMINO-ACID-SEQUENCES THAT ARE REQUIRED FOR THE PHOSPHORYLATION OF BOTH THE OLIGOSACCHARIDES OF PROCATHEPSIN-D BY N-ACETYLGLUCOSAMINE 1-PHOSPHOTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL-ENZYME N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE; PROTEIN RECOGNITION DETERMINANTS; HUMAN CATHEPSIN-D; CRYSTAL-STRUCTURES; TARGETING SIGNAL; RECEPTOR; BINDING; CELLS; CDNA; GLYCOPROTEINS	A novel combinatorial mutagenesis strategy (shuffle mutagenesis) was developed to identify sequences in the propiece and amino lobe of cathepsin D which direct oligosaccharide phosphorylation by UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine l-phosphotransferase. Propiece restriction fragments and oligonucleotide cassettes corresponding to 13 regions of the cathepsin D and glyco pepsinogen amino lobes were randomly shuffled together to generate a large library of chimeric molecules, The library was inserted into an expression vector encoding the carboxyl lobe of cathepsin D with a carboxyl-terminal myc epitope and a CD8 transmembrane extension. Transfected COS1 cells expressing the membrane-anchored forms of the cathepsin D/glycopepsinogen chimeras at the cell surface were selected with solid phase mannose 6-phosphate receptor or an antibody to the myc epitope, Plasmids were rescued in Escherichia coli and sequenced by hybridization to the original oligonucleotide cassettes. Two regions of the cathepsin D amino lobe (segments 7 and 12) were found to contribute to proper folding, surface expression, and selective phosphorylation of the carboxyl lobe oligosaccharide. Two different cathepsin D regions (the propiece and segment 5) cooperated with a previously identified recognition element in the carboxyl lobe to allow efficient phosphorylation of both the amino and carboxyl lobe oligosaccharides. Three general models for extending the catalytic reach of N-acetylglucosamine l-phosphotransferase to widely spaced oligosaccharides are presented.	WASHINGTON UNIV,SCH MED,DEPT MED,ST LOUIS,MO 63110	Washington University (WUSTL)			Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389	NCI NIH HHS [CA 08759] Funding Source: Medline; NIGMS NIH HHS [GM-07200] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA008759, R37CA008759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALDWIN ET, 1993, P NATL ACAD SCI USA, V90, P6796, DOI 10.1073/pnas.90.14.6796; BARANSKI TJ, 1992, J BIOL CHEM, V267, P23342; BARANSKI TJ, 1990, CELL, V63, P281, DOI 10.1016/0092-8674(90)90161-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANTOR AB, 1992, J BIOL CHEM, V267, P23349; CANTOR AB, 1992, J BIOL CHEM, V267, P23357; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DUSTIN ML, 1989, J EXP MED, V169, P503, DOI 10.1084/jem.169.2.503; EVAN GI, 1985, MOL CELL BIOL, V4, P2843; FAUST PL, 1985, P NATL ACAD SCI USA, V82, P4910, DOI 10.1073/pnas.82.15.4910; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HARTSUCK JA, 1992, PROTEINS, V13, P1, DOI 10.1002/prot.340130102; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; KETCHAM CM, 1992, J BIOL CHEM, V267, P11645; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; MANIATIS T, 1987, MOL CLONING; MARGOLSKEE RF, 1988, MOL CELL BIOL, V8, P2837, DOI 10.1128/MCB.8.7.2837; METCALF P, 1993, EMBO J, V12, P1293, DOI 10.1002/j.1460-2075.1993.tb05774.x; Montreuil J, 1980, Adv Carbohydr Chem Biochem, V37, P157; MUNRO S, 1989, P NATL ACAD SCI USA, V86, P9248, DOI 10.1073/pnas.86.23.9248; PELHAM HRB, 1988, EMBO J, V7, P913, DOI 10.1002/j.1460-2075.1988.tb02896.x; PETERSON A, 1987, NATURE, V329, P842, DOI 10.1038/329842a0; POSNER RG, 1992, BIOCHEMISTRY-US, V31, P5350, DOI 10.1021/bi00138a015; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; REITMAN ML, 1984, METHOD ENZYMOL, V107, P163; SALI A, 1992, PROTEINS, V12, P158, DOI 10.1002/prot.340120209; VARKI A, 1983, J BIOL CHEM, V258, P2808; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167	29	36	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					170	179		10.1074/jbc.270.1.170	http://dx.doi.org/10.1074/jbc.270.1.170			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814370	hybrid			2022-12-27	WOS:A1995QA28700030
J	KARNS, LR; KARIYA, K; SIMPSON, PC				KARNS, LR; KARIYA, K; SIMPSON, PC			M-CAT, CARG, AND SP1 ELEMENTS ARE REQUIRED FOR ALPHA(1)-ADRENERGIC INDUCTION OF THE SKELETAL ALPHA-ACTIN PROMOTER DURING CARDIAC MYOCYTE HYPERTROPHY - TRANSCRIPTIONAL ENHANCER FACTOR-I AND PROTEIN-KINASE-C AS CONSERVED TRANSDUCERS OF THE FETAL PROGRAM IN CARDIAC GROWTH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE ELEMENT; HEAVY-CHAIN GENE; RAT-HEART MYOCYTES; TROPONIN-T-GENE; BINDING-FACTOR; MUSCLE-CELLS; STIMULATED HYPERTROPHY; PRESSURE-OVERLOAD; MYOCARDIAL-CELLS; MESSENGER-RNAS	Induction of the fetal isogenes skeletal alpha-actin (skACT) and beta-myosin heavy chain (beta-MHC) is characteristic of cardiac growth in many models, suggesting a conserved signaling pathway. However, divergent regulation has also been observed. beta-Protein kinase C (PKC) and transcriptional enhancer factor-1 (TEF-1) are involved in induction of beta-MHC in alpha(1)-adrenergic stimulated hypertrophy of cultured cardiac myocytes (Kariya, K., Farrance, I. K. G., and Simpson, P. C. (1993) J. Biol. Chem. 268, 26658-26662; Kariya, K., Karns, L. R., and Simpson, P. C. (1994) J. Biol. Chem. 269, 3775-3782). In the present study, we asked whether the skACT promoter used the same mechanism. A mouse skACT promoter fragment (-113/-46) was induced by both alpha(1)-adrenergic stimulation and co-transfection of activated beta-PKC, and contained three required DNA sequence elements: M-CAT, CArG, and Sp1. The skACT M-CAT element bound TEF-1 in cardiac myocytes. Thus the skACT and beta-MHC promoters both require a TEF-1 binding site for activation by alpha(1)-adrenerse stimulation, but differ in that skACT also requires a CArG box. These results provide a potential molecular basis for divergent regulation of the fetal program, and also imply that PKC and TEF-1 are conserved transducers for this program during cardiac growth.	VET AFFAIRS MED CTR, DIV CARDIOL, SAN FRANCISCO, CA 94121 USA; VET AFFAIRS MED CTR, RES SERV, SAN FRANCISCO, CA 94121 USA; UNIV CALIF SAN FRANCISCO, CARDIOVASC RES INST, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT MED, SAN FRANCISCO, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031113] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL031113] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AOYAGI T, 1993, J BIOL CHEM, V268, P27176; ARDATI A, 1993, EMBO J, V12, P5131, DOI 10.1002/j.1460-2075.1993.tb06208.x; ASANTE EA, 1994, TRANSGENIC RES, V3, P59, DOI 10.1007/BF01976028; BISHOPRIC NH, 1987, J CLIN INVEST, V80, P1194, DOI 10.1172/JCI113179; BISHOPRIC NH, 1991, P NATL ACAD SCI USA, V88, P2132, DOI 10.1073/pnas.88.6.2132; BOHELER KR, 1992, J BIOL CHEM, V267, P12979; BOXER LM, 1989, MOL CELL BIOL, V9, P515, DOI 10.1128/MCB.9.2.515; BURGLIN TR, 1991, CELL, V66, P11, DOI 10.1016/0092-8674(91)90132-I; CARRIER L, 1992, CIRC RES, V70, P999, DOI 10.1161/01.RES.70.5.999; CHEN Z, 1994, GENE DEV, V8, P2293, DOI 10.1101/gad.8.19.2293; CHOW KL, 1990, MOL CELL BIOL, V10, P528, DOI 10.1128/MCB.10.2.528; DELEON JR, 1994, P NATL ACAD SCI USA, V91, P519, DOI 10.1073/pnas.91.2.519; DISATNIK MH, 1994, EXP CELL RES, V210, P287, DOI 10.1006/excr.1994.1041; FARRANCE IKG, 1992, J BIOL CHEM, V267, P17234; FLINK IL, 1992, J BIOL CHEM, V267, P9917; HENRICH CJ, 1988, J MOL CELL CARDIOL, V20, P1081, DOI 10.1016/0022-2828(88)90588-3; HU MCT, 1986, MOL CELL BIOL, V6, P15, DOI 10.1128/MCB.6.1.15; IANNELLO RC, 1991, J BIOL CHEM, V266, P3309; IZUMO S, 1987, J CLIN INVEST, V79, P970, DOI 10.1172/JCI112908; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KARIYA K, 1993, J BIOL CHEM, V268, P26658; KARIYA K, 1991, J BIOL CHEM, V266, P10023; KARIYA K, 1994, J BIOL CHEM, V269, P3775; KARIYA K, 1994, CIRCULATION, V90, P580; KOMURO I, 1993, ANNU REV PHYSIOL, V55, P55, DOI 10.1146/annurev.ph.55.030193.000415; LONG CS, 1989, J CLIN INVEST, V83, P1078, DOI 10.1172/JCI113951; LONG CS, 1991, CELL REGUL, V2, P1081, DOI 10.1091/mbc.2.12.1081; MACLELLAN WR, 1994, J BIOL CHEM, V269, P16754; MAR JH, 1988, P NATL ACAD SCI USA, V85, P6404, DOI 10.1073/pnas.85.17.6404; MAR JH, 1990, MOL CELL BIOL, V10, P4271, DOI 10.1128/MCB.10.8.4271; MAR JH, 1988, J CELL BIOL, V107, P573, DOI 10.1083/jcb.107.2.573; MOCHLYROSEN D, 1990, CELL REGUL, V1, P693, DOI 10.1091/mbc.1.9.693; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P5056, DOI 10.1128/MCB.14.8.5056; NIKOVITS W, 1986, NUCLEIC ACIDS RES, V14, P3377, DOI 10.1093/nar/14.8.3377; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; PARKER TG, 1992, J BIOL CHEM, V267, P3343; PARKER TG, 1991, ANNU REV PHYSIOL, V53, P179; PARMACEK MS, 1992, MOL CELL BIOL, V12, P1967, DOI 10.1128/MCB.12.5.1967; RINDT H, 1993, J BIOL CHEM, V268, P5332; SANTORO IM, 1991, MOL CELL BIOL, V11, P6296, DOI 10.1128/MCB.11.12.6296; SARTORELLI V, 1992, P NATL ACAD SCI USA, V89, P4047, DOI 10.1073/pnas.89.9.4047; SCHIAFFINO S, 1989, CIRC RES, V64, P937, DOI 10.1161/01.RES.64.5.937; SCHWARTZ K, 1993, J AM COLL CARDIOL, V22, pA30, DOI 10.1016/0735-1097(93)90459-E; SCHWARTZ K, 1986, CIRC RES, V59, P551, DOI 10.1161/01.RES.59.5.551; SHIMIZU N, 1993, NUCLEIC ACIDS RES, V21, P4103, DOI 10.1093/nar/21.17.4103; SIMPSON P, 1983, J CLIN INVEST, V72, P732, DOI 10.1172/JCI111023; SIMPSON PC, 1989, J MOL CELL CARDIOL, V21, P79, DOI 10.1016/0022-2828(89)90774-8; SOULEZ M, 1993, BIOCHEM BIOPH RES CO, V195, P400, DOI 10.1006/bbrc.1993.2057; STERNBERG EA, 1988, MOL CELL BIOL, V8, P2896, DOI 10.1128/MCB.8.7.2896; STEWART AFR, 1994, J BIOL CHEM, V269, P3147; TAKAHASHI T, 1992, J CLIN INVEST, V89, P939, DOI 10.1172/JCI115675; THOMPSON WR, 1991, J BIOL CHEM, V266, P22678; TREISMAN R, 1992, TRENDS BIOCHEM SCI, V17, P423, DOI 10.1016/0968-0004(92)90013-Y; VONHARSDORF R, 1993, CIRC RES, V72, P688, DOI 10.1161/01.RES.72.3.688; WASPE LE, 1990, J CLIN INVEST, V85, P1206, DOI 10.1172/JCI114554; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G	58	159	163	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					410	417		10.1074/jbc.270.1.410	http://dx.doi.org/10.1074/jbc.270.1.410			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814403	hybrid			2022-12-27	WOS:A1995QA28700065
J	TOLSTRUP, AB; BEJDER, A; FLECKNER, J; JUSTESEN, J				TOLSTRUP, AB; BEJDER, A; FLECKNER, J; JUSTESEN, J			TRANSCRIPTIONAL REGULATION OF THE INTERFERON-GAMMA-INDUCIBLE TRYPTOPHANYL-TRANSFER-RNA SYNTHETASE INCLUDES ALTERNATIVE SPLICING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; CHAIN-RELEASE FACTOR; SIGNAL-TRANSDUCTION PATHWAY; DNA-BINDING PROTEINS; MUTANT-CELL LINE; TYROSINE PHOSPHORYLATION; MOLECULAR-CLONING; GENE-EXPRESSION; GROWTH-FACTOR; INDOLEAMINE 2,3-DIOXYGENASE	We have investigated the transcriptional control elements of the human interferon (IFN)-gamma-induced tryptophanyl-tRNA synthetase (hWRS) gene and characterized the transcripts. Transcription leads to a series of mRNAs with different combinations of the first exons. The full-length mRNA codes for a 55-kDa protein (hWRS), but a mRNA lacking exon II is present in almost as high amounts as the full-length transcript. This alternatively spliced mRNA is probably translated into a 48-kDa protein starting from Met(48) in exon III. The predicted 48-kDa protein corresponds exactly to an IFN-gamma-inducible protein previously detected by two-dimensional gel electrophoresis. By isolation of genomic clones and construction of plasmids containing hWRS promoter fragments fused to the secreted alkaline phosphatase reporter gene we have mapped a promoter region essential for IFN-mediated gene activation. This region contains IFN stimulated response elements (ISRE) as well as a Y-box and a gamma-activated sequence (GAS) element. IFN-gamma inducibility of hWRS depends on ongoing protein synthesis, suggesting that so far undescribed scribed transcription factors apart from the latent GAS-binding protein p91 contribute to gene activation. This could be interferon-regulatory factor-1, which binds ISRE elements.	AARHUS UNIV,DEPT MOLEC BIOL,DK-8000 AARHUS C,DENMARK	Aarhus University								Baron S, 1992, INTERFERON PRINCIPLE; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; BLANAR MA, 1989, EMBO J, V8, P1139, DOI 10.1002/j.1460-2075.1989.tb03484.x; BUWITT U, 1992, EMBO J, V11, P489, DOI 10.1002/j.1460-2075.1992.tb05079.x; CARLIN JM, 1989, EXPERIENTIA, V45, P535, DOI 10.1007/BF01990503; CELIS JE, 1987, LEUKEMIA, V12, P800; CHEBATH J, 1987, J BIOL CHEM, V262, P3852; CHEBATH J, 1987, NATURE, V330, P587, DOI 10.1038/330587a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DEMAEYER E, 1991, CYTOKINE HDB, P215; FLECKNER J, 1991, P NATL ACAD SCI USA, V88, P11520, DOI 10.1073/pnas.88.24.11520; FLECKNER J, 1995, IN PRESS CYTOKINE, V7; FROLOVA LY, 1991, GENE, V109, P291, DOI 10.1016/0378-1119(91)90624-K; FROLOVA LY, 1993, GENE, V128, P237, DOI 10.1016/0378-1119(93)90568-N; FROLOVA LY, 1993, EMBO J, V12, P4013; FROLOVA LY, 1993, EUR J BIOCHEM, V212, P457, DOI 10.1111/j.1432-1033.1993.tb17682.x; FU XY, 1993, CELL, V74, P1135, DOI 10.1016/0092-8674(93)90734-8; GAUSS GH, 1992, NUCLEIC ACIDS RES, V20, P6739, DOI 10.1093/nar/20.24.6739; GUPTA SL, 1992, INTERFERON PRINCIPLE, P193; HARROCH S, 1994, EMBO J, V13, P1942, DOI 10.1002/j.1460-2075.1994.tb06463.x; HASSANAIN HH, 1993, J BIOL CHEM, V268, P5077; HONORE B, 1993, EUR J BIOCHEM, V218, P421, DOI 10.1111/j.1432-1033.1993.tb18392.x; IGARASHI K, 1993, MOL CELL BIOL, V13, P3984, DOI 10.1128/MCB.13.7.3984; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; JOHNSON DR, 1994, MOL CELL BIOL, V14, P1322, DOI 10.1128/MCB.14.2.1322; KANNO Y, 1993, MOL CELL BIOL, V13, P3951, DOI 10.1128/MCB.13.7.3951; KIMURA T, 1994, SCIENCE, V264, P1921, DOI 10.1126/science.8009222; KISSELEV L, 1993, TRENDS BIOCHEM SCI, V18, P263, DOI 10.1016/0968-0004(93)90178-P; LARNER AC, 1993, SCIENCE, V261, P1730, DOI 10.1126/science.8378773; LEE CC, 1990, P NATL ACAD SCI USA, V87, P3508, DOI 10.1073/pnas.87.9.3508; MEURS EF, 1992, J VIROL, V66, P5805, DOI 10.1128/JVI.66.10.5805-5814.1992; MEURS EF, 1993, P NATL ACAD SCI USA, V90, P232, DOI 10.1073/pnas.90.1.232; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; OZES ON, 1994, J INTERFERON RES, V14, P25, DOI 10.1089/jir.1994.14.25; PEARSE RN, 1993, P NATL ACAD SCI USA, V90, P4314, DOI 10.1073/pnas.90.9.4314; PELLEGRINI S, 1993, TRENDS BIOCHEM SCI, V18, P338, DOI 10.1016/0968-0004(93)90070-4; PEREZ C, 1993, MOL CELL BIOL, V13, P2182, DOI 10.1128/MCB.13.4.2182; PFEFFERKORN ER, 1984, P NATL ACAD SCI-BIOL, V81, P908, DOI 10.1073/pnas.81.3.908; PINE R, 1994, EMBO J, V13, P158, DOI 10.1002/j.1460-2075.1994.tb06245.x; REID LE, 1989, P NATL ACAD SCI USA, V86, P840, DOI 10.1073/pnas.86.3.840; REIS LFL, 1992, EMBO J, V11, P185, DOI 10.1002/j.1460-2075.1992.tb05041.x; RUBIN BY, 1991, J BIOL CHEM, V266, P24245; RUFFJAMISON S, 1993, SCIENCE, V261, P1733, DOI 10.1126/science.8378774; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SEN GC, 1992, J BIOL CHEM, V267, P5017; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; SILVENNOINEN O, 1993, SCIENCE, V261, P1736, DOI 10.1126/science.8378775; STREHLOW I, 1993, J BIOL CHEM, V268, P16590; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0	57	94	100	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					397	403		10.1074/jbc.270.1.397	http://dx.doi.org/10.1074/jbc.270.1.397			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814400	hybrid			2022-12-27	WOS:A1995QA28700063
J	THOMAS, EL; BOZEMAN, PM; JEFFERSON, MM; KING, CC				THOMAS, EL; BOZEMAN, PM; JEFFERSON, MM; KING, CC			OXIDATION OF BROMIDE BY THE HUMAN-LEUKOCYTE ENZYMES MYELOPEROXIDASE AND EOSINOPHIL PEROXIDASE - FORMATION OF BROMAMINES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLET OXYGEN PRODUCTION; ANTI-MICROBIAL SYSTEM; HYDROGEN-PEROXIDE; ISOLATED NEUTROPHILS; ESCHERICHIA-COLI; AMINO-ACIDS; CHLORIDE; THIOCYANATE; OXIDANTS; BROMOPEROXIDASE	Myeloperoxidase and eosinophil peroxidase catalyzed the oxidation of bromide ion by hydrogen peroxide (H2O2) and produced a brominating agent that reacted with amine compounds to form bromamines, which are long-lived oxidants containing covalent nitrogen-bromine bonds. Results were consistent with oxidation of bromide to an equilibrium mixture of hypobromous acid (HOBr) and hypobromite ion (OBr-). Up to 1 mol of bromamine was produced per mole of H2O2, indicating that bromamine formation prevented the reduction of HOBr/OBr- by H2O2 and the loss of oxidizing and brominating activity. Bromamines differed from HOBr/OBr- in that bromamines reacted slowly with H2O2, were not reduced by dimethyl sulfoxide, and had absorption spectra similar to those of chloramines, but shifted 36 nm toward higher wavelengths. Mono- and di-bromo derivatives (RNHBr and RNHBr(2)) of the beta-amino acid taurine were relatively stable with half-lives of 70 and 16 h at pH 7, 37 degrees C. The mono-bromamine was obtained with a 200-fold excess of amine over the amount of HOBr/OBr- and the di-bromamine at a 2:1 ratio of HOBr/OBr- to the amine. In the presence of physiologic levels of both bromide (0.1 mM) and chloride (0.1 M), myeloperoxidase and eosinophil peroxidase produced mixtures of bromamines and chloramines containing 6 +/- 4% and 88 +/- 4% bromamine. In contrast, only the mono-chloramine derivative (RNHCl) was formed when a mixture of hypochlorous acid (HOCl) and hypochlorite ion (OCl-) was added to solutions containing bromide and excess amine. The rapid formation of the chloramine prevented the oxidation of bromide by HOCl/OCl-, and the chloramine did not react with bromide within 1 h at 37 degrees C. The results indicate that when enzyme catalyzed bromide or chloride oxidation took place in the presence of an amine compound at 10 mM or higher, bromamines were not produced in secondary reactions such as the oxidation of bromide by HOCl/OCl- and the exchange of bromide with chlorine atoms of chloramines. Therefore, the amount of bromamine produced by myeloperoxidase or eosinophil peroxidase was equal to the amount of bromide oxidized by the enzyme. Bromide was preferred over chloride as the substrate for both enzymes.	UNIV TENNESSEE, DENT RES CTR, MEMPHIS, TN 38163 USA; UNIV TENNESSEE, DEPT BIOCHEM, MEMPHIS, TN 38163 USA; ST JUDE CHILDRENS RES HOSP, DIV CRIT CARE & PULM MED, MEMPHIS, TN 38105 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital				Jefferson, M. Margaret/0000-0001-8650-3159	NHLBI NIH HHS [HL02373] Funding Source: Medline; NIAID NIH HHS [AI16795] Funding Source: Medline; NIDCR NIH HHS [DE04235] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K11HL002373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE004235] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AGNER K, 1963, ACTA CHEM SCAND, V17, pS332; ANDREWS PC, 1981, J BIOL CHEM, V256, P4211; AUNE TM, 1977, EUR J BIOCHEM, V80, P209, DOI 10.1111/j.1432-1033.1977.tb11873.x; BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V784, P177, DOI 10.1016/0167-4838(84)90125-0; BOZEMAN PM, 1992, BIOCHEM PHARMACOL, V44, P553, DOI 10.1016/0006-2952(92)90449-S; BOZEMAN PM, 1990, J IMMUNOL METHODS, V126, P125, DOI 10.1016/0022-1759(90)90020-V; BUCHBERGER W, 1988, J CHROMATOGR-BIOMED, V432, P57, DOI 10.1016/S0378-4347(00)80633-7; CARLSON MGC, 1985, J IMMUNOL, V134, P1875; CRAMER R, 1981, BLOOD, V58, P1112; FOOTE CS, 1983, NATURE, V301, P715, DOI 10.1038/301715a0; GRISHAM MB, 1984, J BIOL CHEM, V259, P404; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; HARRISON JE, 1976, CANCER ENZYMOLOGY, V2, P305; HOLZBECHER J, 1980, CLIN BIOCHEM, V13, P277, DOI 10.1016/S0009-9120(80)80009-9; HOOGLAND H, 1987, BIOCHIM BIOPHYS ACTA, V916, P76, DOI 10.1016/0167-4838(87)90212-3; HURST JK, 1984, J BIOL CHEM, V259, P4812; HURST JK, 1991, PEROXIDASES CHEM BIO, V1, P37; JONG EC, 1980, J IMMUNOL, V124, P1378; KANOFSKY JR, 1989, ARCH BIOCHEM BIOPHYS, V274, P229, DOI 10.1016/0003-9861(89)90434-7; KANOFSKY JR, 1984, J CLIN INVEST, V74, P1489, DOI 10.1172/JCI111562; KANOFSKY JR, 1983, J BIOL CHEM, V258, P5991; KANOFSKY JR, 1988, J BIOL CHEM, V263, P9692; KANOFSKY JR, 1984, J BIOL CHEM, V259, P5596; KETTLE AJ, 1991, BIOCHEM PHARMACOL, V41, P1485, DOI 10.1016/0006-2952(91)90565-M; KNIGHT LC, 1978, BIOCHIM BIOPHYS ACTA, V534, P185, DOI 10.1016/0005-2795(78)90001-6; LEARN DB, 1990, J LEUKOCYTE BIOL, V48, P174, DOI 10.1002/jlb.48.2.174; MANTHEY JA, 1984, METHOD ENZYMOL, V107, P439; MAYENO AN, 1989, J BIOL CHEM, V264, P5660; MCELVANY KD, 1980, J NUCL MED, V21, P953; OKA S, 1981, ANAL CHEM, V53, P588, DOI 10.1021/ac00227a007; RAMSEY PG, 1982, J IMMUNOL, V128, P415; RITTER CL, 1989, CHEM RES TOXICOL, V2, P325, DOI 10.1021/tx00011a010; SLUNGAARD A, 1991, J BIOL CHEM, V266, P4903; SLUNGAARD A, 1990, J EXP MED, V171, P2025, DOI 10.1084/jem.171.6.2025; TEST ST, 1986, ADV FREE RADICAL BIO, V2, P91, DOI 10.1016/S8755-9668(86)80025-4; Thomas E L, 1986, Methods Enzymol, V132, P569; THOMAS EL, 1979, INFECT IMMUN, V25, P110, DOI 10.1128/IAI.25.1.110-116.1979; THOMAS EL, 1987, MUTAT RES, V188, P35, DOI 10.1016/0165-1218(87)90112-1; THOMAS EL, 1979, INFECT IMMUN, V23, P522, DOI 10.1128/IAI.23.2.522-531.1979; THOMAS EL, 1983, J CLIN INVEST, V72, P441, DOI 10.1172/JCI110992; THOMAS EL, 1986, J BIOL CHEM, V261, P9694; THOMAS EL, 1985, J BIOL CHEM, V260, P3321; THOMAS EL, 1991, PEROXIDASES CHEM BIO, V1, P83; WAJON JE, 1982, INORG CHEM, V21, P4258, DOI 10.1021/ic00142a030; WEISS SJ, 1986, SCIENCE, V234, P200, DOI 10.1126/science.3018933; WOOD JL, 1975, CHEM BIOCH THIOCYANI, P156	46	173	181	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					2906	2913		10.1074/jbc.270.7.2906	http://dx.doi.org/10.1074/jbc.270.7.2906			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852368	hybrid			2022-12-27	WOS:A1995QG47100007
J	LEFRANCOISMARTINEZ, AM; MARTINEZ, A; ANTOINE, B; RAYMONDJEAN, M; KAHN, A				LEFRANCOISMARTINEZ, AM; MARTINEZ, A; ANTOINE, B; RAYMONDJEAN, M; KAHN, A			UPSTREAM STIMULATORY FACTOR PROTEINS ARE MAJOR COMPONENTS OF THE GLUCOSE RESPONSE COMPLEX OF THE L-TYPE PYRUVATE-KINASE GENE PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR BINDS; S14 GENE; ELEMENT; DNA; HEPATOCYTES; EXPRESSION; TISSUE; USF	L-type pyruvate kinase (L-PK) gene transcription is induced by glucose through its glucose response element (GIRE) composed of two degenerated E boxes able to bind in vitro ubiquitous upstream stimulator factor (USF) proteins. Here we demonstrate in vivo, by transient transfections in hepatoma cells, that (i) native USF proteins synthesized from expression vectors can act as transactivators of the L-PK promoter via the GIRE, stimulating transcription without glucose and, therefore, decreasing the glucose responsiveness of the promoter; (ii) expression of the truncated USF proteins, able to bind the GIRE but devoid of the NH2-terminal activation domain, represses the activation of the L-PK promoter by glucose; and (iii) a similar repression of the glucose effect is observed upon expression of mutant USF proteins devoid of the basic DNA binding domain, able to dimerize with endogenous USF but not to bind the GIRE. We conclude that USF proteins are components of the transcriptional glucose response complex assembled on the L-PK gene promoter.	UNIV PARIS 05, INST COCHIN GENET MOLEC, INSERM, U129, F-75014 PARIS, FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite								BERGOT MO, 1992, NUCLEIC ACIDS RES, V20, P1871, DOI 10.1093/nar/20.8.1871; CARTHEW RW, 1985, CELL, V43, P439, DOI 10.1016/0092-8674(85)90174-6; CARTHEW RW, 1987, GENE DEV, V1, P973, DOI 10.1101/gad.1.9.973; CHODOSH LA, 1987, SCIENCE, V238, P684, DOI 10.1126/science.3672119; COGNET M, 1991, J BIOL CHEM, V266, P7368; DOIRON B, 1994, J BIOL CHEM, V269, P10213; FOUFELLE F, 1992, J BIOL CHEM, V267, P20543; GERMAN MS, 1994, MOL CELL BIOL, V14, P4067, DOI 10.1128/MCB.14.6.4067; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; GUERRA MJMD, 1993, MOL CELL BIOL, V13, P7725, DOI 10.1128/MCB.13.12.7725; HENRION A, 1994, IN PRESS GENOMICS; JACOBY DB, 1989, J BIOL CHEM, V264, P17623; LEFRANCOISMARTINEZ AM, 1994, FASEB J, V8, P89, DOI 10.1096/fasebj.8.1.8299894; LEVRAT F, 1993, EXP CELL RES, V209, P307, DOI 10.1006/excr.1993.1315; PANI L, 1992, MOL CELL BIOL, V12, P3723, DOI 10.1128/MCB.12.9.3723; POGNONEC P, 1991, MOL CELL BIOL, V11, P5125, DOI 10.1128/MCB.11.10.5125; SHIH HM, 1994, J BIOL CHEM, V269, P9380; SHIH HM, 1992, J BIOL CHEM, V267, P13222; SIRITO M, 1994, NUCLEIC ACIDS RES, V22, P427, DOI 10.1093/nar/22.3.427; THOMPSON KS, 1991, J BIOL CHEM, V266, P8679; VAULONT S, 1989, J MOL BIOL, V209, P205, DOI 10.1016/0022-2836(89)90273-8	21	112	113	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2640	2643		10.1074/jbc.270.6.2640	http://dx.doi.org/10.1074/jbc.270.6.2640			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852331	hybrid			2022-12-27	WOS:A1995QF53500039
J	MANUEL, RC; LATHAM, KA; DODSON, ML; LLOYD, RS				MANUEL, RC; LATHAM, KA; DODSON, ML; LLOYD, RS			INVOLVEMENT OF GLUTAMIC-ACID-23 IN THE CATALYTIC MECHANISM OF T4 ENDONUCLEASE-V	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; BETA-ELIMINATION REACTION; DIMER-DNA GLYCOSYLASE; ABASIC SITES; T4-ENDONUCLEASE-V; BACTERIOPHAGE-T4; GENE; TERMINUS; REPAIR; SYN	Bacteriophage T4 endonuclease V has both pyrimidine dimer-specific DNA glycosylase and abasic (AP) lyase activities, which are sequential yet biochemically separable functions, Previous studies using chemical modification and site-directed mutagenesis techniques have shown that the catalytic activities are mediated through the alpha-amino group of the enzyme forming a covalent (imino) intermediate, However, in addition to the amino-terminal active site residue, examination of the x-ray crystal structure of endonuclease V reveals the presence of Glu-23 near the active site, and this residue has been strongly implicated in the reaction chemistry, In order to understand the role of Glu-23 in the reaction mechanism, four different mutations (E23Q, E23C, E23H, E23D) were constructed, and the mutant proteins were evaluated for DNA glycosylase and AP lyase activities using defined substrates and specific in vitro and in vivo assays, Replacement of Glu-23 with Gln, Cys, or His completely abolished DNA glycosylase and AP lyase activities, while replacement with Asp retained negligible amounts of glycosylase activity, but retained near wild type levels of AP lyase activity, Gel shift assays revealed that all four mutant proteins can recognize and bind to thymine dimers, The results indicate that Glu-23 is the candidate for stabilizing the charge of the imino intermediate that is likely to require an acidic group in the active site of the enzyme.	UNIV TEXAS,MED BRANCH,SEALY CTR MOLEC SCI,GALVESTON,TX 77555	University of Texas System; University of Texas Medical Branch Galveston				Lloyd, R. Stephen/0000-0001-7273-372X	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004091] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES04091] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		DODSON ML, 1993, BIOCHEMISTRY-US, V32, P8284, DOI 10.1021/bi00083a032; DODSON ML, 1989, MUTAT RES, V218, P49, DOI 10.1016/0921-8777(89)90011-6; DOI T, 1992, P NATL ACAD SCI USA, V89, P9420, DOI 10.1073/pnas.89.20.9420; DOWD DR, 1989, BIOCHEMISTRY-US, V28, P8699, DOI 10.1021/bi00448a005; FERGUSON KA, 1964, METABOLISM, V13, P985, DOI 10.1016/S0026-0495(64)80018-4; GRUSKIN EA, 1986, J BIOL CHEM, V261, P9607; HORI N, 1992, NUCLEIC ACIDS RES, V20, P4761, DOI 10.1093/nar/20.18.4761; HOWARDFL.P, 1969, J BACTERIOL, V97, P1134, DOI 10.1128/JB.97.3.1134-1141.1969; LATHAM AK, 1994, BIOCHEMISTRY-US, V33, P9024; LATHAM AK, 1994, ANN NY ACAD SCI, V726, P181; MAZUMDER A, 1989, J AM CHEM SOC, V111, P8029, DOI 10.1021/ja00202a062; MORIKAWA K, 1992, SCIENCE, V256, P523, DOI 10.1126/science.1575827; NAKABEPPU Y, 1981, P NATL ACAD SCI-BIOL, V78, P2742, DOI 10.1073/pnas.78.5.2742; ORCHARD K, 1993, NUCLEIC ACIDS RES, V21, P3335, DOI 10.1093/nar/21.14.3335; RADANY EH, 1980, NATURE, V286, P182, DOI 10.1038/286182a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHROCK RD, 1991, J BIOL CHEM, V266, P17631; SCHROCK RD, 1993, J BIOL CHEM, V268, P880; SEAWELL PC, 1980, BIOCHEMISTRY-US, V19, P1685, DOI 10.1021/bi00549a026; SEAWELL PC, 1980, J VIROL, V35, P790, DOI 10.1128/JVI.35.3.790-796.1980; SMITH CA, 1993, J BIOL CHEM, V268, P11143; TAKESHITA M, 1987, J BIOL CHEM, V262, P10171	22	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2652	2661		10.1074/jbc.270.6.2652	http://dx.doi.org/10.1074/jbc.270.6.2652			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852333	hybrid			2022-12-27	WOS:A1995QF53500041
J	TOTH, I; ROGERS, JT; MCPHEE, JA; ELLIOTT, SM; ABRAMSON, SL; BRIDGES, KR				TOTH, I; ROGERS, JT; MCPHEE, JA; ELLIOTT, SM; ABRAMSON, SL; BRIDGES, KR			ASCORBIC-ACID ENHANCES IRON-INDUCED FERRITIN TRANSLATION IN HUMAN LEUKEMIA AND HEPATOMA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT BINDING-PROTEIN; RESPONSIVE ELEMENT; MESSENGER-RNA; TRANSFERRIN RECEPTOR; REGULATORY ELEMENT; GENE; BIOSYNTHESIS; EXPRESSION; METABOLISM; INDUCTION	Ascorbate is an important cofactor in many cellular metabolic reactions and is intimately linked to iron homeostasis. Continuously cultured cells are ascorbate deficient due to the lability of the vitamin in solution and to the fact that daily supplementation of media with ascorbate is unusual. We found that ascorbate repletion alone did not alter ferritin synthesis. However, ascorbate-replete human hepatoma cells, Hep3B and HepG2, as well as K562 human leukemia cells achieved a substantially higher cellular ferritin content in response to a challenge with iron than did their ascorbate-deficient counterparts grown under standard culture conditions. Most of the elevation in ferritin content was due to an increase in de novo ferritin synthesis of greater than 50-fold, as shown by in vivo labeling with [S-35]methionine and immunoprecipitation. RNA-blot analysis showed only minor changes in steady state levels of ferritin mRNA, suggesting that ascorbate enhances iron-induced ferritin synthesis primarily by post-transcriptional events. Transient gene expression experiments using chloramphenicol acetyltransferase reporter gene constructs showed that the ascorbate effect on ferritin translation is not mediated through the stem-loop near the translational start site that transduces ferritin synthesis in response to cytokines. The data suggest that ascorbate possibly modifies the action of the iron-responsive element on ferritin translation, although more precise structure-function studies are needed to clarify this issue. These data demonstrate a novel role of ascorbate as a signaling molecule in posttranscriptional gene regulation. The mechanism by which ascorbate modulates cellular iron metabolism is complex and requires additional detailed investigation.			TOTH, I (corresponding author), HARVARD UNIV, BRIGHAM & WOMENS HOSP, SCH MED, DEPT MED, DIV HEMATOL ONCOL, BOSTON, MA 02115 USA.			Rogers, Jack/0000-0003-1262-8578	NHLBI NIH HHS [HL 45794] Funding Source: Medline; NIAID NIH HHS [AI 32717] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI032717] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BETTANY AJE, 1992, J BIOL CHEM, V267, P16531; BRIDGES KR, 1986, J BIOL CHEM, V261, P14273; BRIDGES KR, 1987, J BIOL CHEM, V262, P14773; BRIDGES KR, 1984, J BIOL CHEM, V259, P2970; BURNS JJ, 1957, NATURE, V180, P552, DOI 10.1038/180553a0; CAUGHMAN SW, 1988, J BIOL CHEM, V263, P19048; CONSTABLE A, 1992, P NATL ACAD SCI USA, V89, P4554, DOI 10.1073/pnas.89.10.4554; Constanzo F, 1986, NUCLEIC ACIDS RES, V14, P721; COULSON RMR, 1993, P NATL ACAD SCI USA, V90, P7613, DOI 10.1073/pnas.90.16.7613; DANDEKAR T, 1991, EMBO J, V10, P1903, DOI 10.1002/j.1460-2075.1991.tb07716.x; DENTE L, 1985, NUCLEIC ACIDS RES, V13, P3941, DOI 10.1093/nar/13.11.3941; EMERYGOODMAN A, 1993, NUCLEIC ACIDS RES, V21, P1457, DOI 10.1093/nar/21.6.1457; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; GOESSLING LS, 1992, SCIENCE, V256, P670, DOI 10.1126/science.1316633; GOOSSEN B, 1992, MOL CELL BIOL, V12, P1959, DOI 10.1128/MCB.12.5.1959; HAILE DJ, 1989, MOL CELL BIOL, V9, P5055, DOI 10.1128/MCB.9.11.5055; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P11735, DOI 10.1073/pnas.89.24.11735; HALLIWELL B, 1985, MOL ASPECTS MED, V8, P89, DOI 10.1016/0098-2997(85)90001-9; HARRELL CM, 1991, P NATL ACAD SCI USA, V88, P4166, DOI 10.1073/pnas.88.10.4166; HENTZE MW, 1988, GENE, V72, P201, DOI 10.1016/0378-1119(88)90145-X; HICKSTEIN DD, 1993, BLOOD, V82, P2537; HIRLING H, 1994, EMBO J, V13, P453, DOI 10.1002/j.1460-2075.1994.tb06280.x; HOFFMAN KE, 1991, AM J CLIN NUTR, V54, pS1188, DOI 10.1093/ajcn/54.6.1188s; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; LESCOAT G, 1991, LIVER, V11, P24; LOBREAUX S, 1993, EMBO J, V12, P651, DOI 10.1002/j.1460-2075.1993.tb05698.x; MATTIA E, 1986, J BIOL CHEM, V261, P4587; MEISTER A, 1994, J BIOL CHEM, V269, P9397; MILLER LL, 1991, P NATL ACAD SCI USA, V88, P4946, DOI 10.1073/pnas.88.11.4946; Moser U., 1991, HDB VITAMINS, P195; MULLNER EW, 1988, CELL, V53, P815, DOI 10.1016/0092-8674(88)90098-0; MUNRO HN, 1990, J CELL BIOCHEM, V44, P107, DOI 10.1002/jcb.240440205; NISHIKIMI M, 1991, AM J CLIN NUTR, V54, pS1203, DOI 10.1093/ajcn/54.6.1203s; OWEN D, 1987, EMBO J, V6, P1287, DOI 10.1002/j.1460-2075.1987.tb02366.x; ROGERS J, 1987, P NATL ACAD SCI USA, V84, P2277, DOI 10.1073/pnas.84.8.2277; ROGERS JT, 1990, J BIOL CHEM, V265, P14572; ROGERS JT, 1994, NUCLEIC ACIDS RES, V22, P2678, DOI 10.1093/nar/22.13.2678; ROUAULT TA, 1988, SCIENCE, V241, P1207, DOI 10.1126/science.3413484; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; STADTMAN ER, 1991, AM J CLIN NUTR, V54, pS1125, DOI 10.1093/ajcn/54.6.1125s; Szent-Gyorgyi A, 1928, BIOCHEM J, V22, P1387, DOI 10.1042/bj0221387; TESTA U, 1991, J BIOL CHEM, V266, P13925; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; WEISS G, 1993, EMBO J, V12, P3651, DOI 10.1002/j.1460-2075.1993.tb06039.x	46	47	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2846	2852		10.1074/jbc.270.6.2846	http://dx.doi.org/10.1074/jbc.270.6.2846			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852359	hybrid			2022-12-27	WOS:A1995QF53500069
J	MELLON, SH; BAIR, SR; MONIS, H				MELLON, SH; BAIR, SR; MONIS, H			P450C11B3 MESSENGER-RNA, TRANSCRIBED FROM A 3RD P450C11 GENE, IS EXPRESSED IN A TISSUE-SPECIFIC, DEVELOPMENTALLY, AND HORMONALLY REGULATED FASHION IN THE RODENT ADRENAL AND ENCODES A PROTEIN WITH BOTH 11-HYDROXYLASE AND 18-HYDROXYLASE ACTIVITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDOSTERONE SYNTHASE CYTOCHROME-P-450; AMINO-ACID-SEQUENCE; MOLECULAR-CLONING; MESSENGER-RNAS; RAT; CORTEX; BIOSYNTHESIS; HYPERTENSION; MUTATIONS; CYP11B1	The rat genome contains four P450c11 genes, One of these (CYP11B1) encodes P450c11 beta, which is the steroid 11 beta-hydroxylase found solely in the adrenal zona fas ciculata/reticularis, and is responsible for the conversion of 11-deoxycorticosterone to corticosterone. A second P450c11 gene (CYP11B2) encodes P450c11AS, which is the aldosterone synthase found solely in the adrenal zona glomerulosa, P450c11AS has three activities, 11 beta-hydroxylase, 18-hydroxylase, and 18-oxidase, and is responsible for the conversion of 11-deoxycorticosterone to aldosterone. Recently, two more rat P450c11 genes, P450c11B3 and P450c11B4, were cloned, P450c11B4 appears to be a pseudogene, as two exons are replaced by unrelated DNA, P450c11B3 closely resembles P450c11 beta in mRNA and encoded amino acid sequences, predicting a protein of 498 amino acids. However, the expression of this mRNA and protein have not been demonstrated to date, We now demonstrate that this P450c11B3 mRNA is expressed in the adrenal gland several days after birth and is not expressed during fetal development or in the adult rat adrenal. Like P450c11 beta mRNA, P450c11B3 mRNA is expressed in the zona fasciculata/reticularis and not in the zona glomerulosa, However, the regulation of P450c11B3 mRNA expression is different from that of P450c11 beta mRNA, in that its abundance is decreased by ACTH in a sex dependent fashion, Transfection of eukaryotic cells with a vector expressing P450c11B3 shows that this form of P450c11 can convert 11-deoxycorticosterone (DOG) to corticosterone and thus has the same enzymatic activity as P450c11 beta. In addition, P450c11B3 can convert DOC to 18-OH DOC and corticosterone to 18-OH corticosterone and thus has 18-hydroxylase activity similar to P450c11AS, but it lacks detectable 18-oxidase activity, Thus, P450c11B3 catalyzes 11 beta- and 18-hydroxylation and thus has a spectrum of activities midway between P450c11 beta and P450c11AS.	UNIV CALIF SAN FRANCISCO,METAB RES UNIT,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	MELLON, SH (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT OBSTET GYNECOL & REPROD SCI,SAN FRANCISCO,CA 94143, USA.				NICHD NIH HHS [HD27970, HD11979] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD011979, R01HD027970] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BIGLIERI EG, 1991, CLIN CHEM, V37, P1843; CICILA GT, 1993, NAT GENET, V3, P346, DOI 10.1038/ng0493-346; CURNOW KM, 1993, P NATL ACAD SCI USA, V90, P4552, DOI 10.1073/pnas.90.10.4552; CURNOW KM, 1991, MOL ENDOCRINOL, V5, P1513, DOI 10.1210/mend-5-10-1513; DAHL LK, 1962, J EXP MED, V115, P1173, DOI 10.1084/jem.115.6.1173; DOMALIK LJ, 1991, MOL ENDOCRINOL, V5, P1853, DOI 10.1210/mend-5-12-1853; GALLANT S, 1992, ENDOCR RES, V18, P145, DOI 10.1080/07435809209035404; IMAI M, 1990, FEBS LETT, V263, P299, DOI 10.1016/0014-5793(90)81398-8; ITOH S, 1976, Folia Endocrinologica Japonica, V52, P1220; KIRITA S, 1990, J BIOCHEM, V108, P1030, DOI 10.1093/oxfordjournals.jbchem.a123302; KOMIYA I, 1991, CARDIOLOGY, V78, P99, DOI 10.1159/000174773; LAUBER M, 1989, ARCH BIOCHEM BIOPHYS, V274, P109, DOI 10.1016/0003-9861(89)90421-9; MALEE MP, 1991, P NATL ACAD SCI USA, V88, P4731, DOI 10.1073/pnas.88.11.4731; MATSUKAWA N, 1993, J BIOL CHEM, V268, P9117; MELLON SH, 1991, DNA CELL BIOL, V10, P339, DOI 10.1089/dna.1991.10.339; MILLER WL, 1988, ENDOCR REV, V9, P295, DOI 10.1210/edrv-9-3-295; MORNET E, 1989, J BIOL CHEM, V264, P20961; MOROHASHI K, 1990, J BIOCHEM, V107, P635, DOI 10.1093/oxfordjournals.jbchem.a123099; MUKAI K, 1993, J BIOL CHEM, V268, P9130; MULLER J, 1989, J STEROID BIOCHEM, V34, P271, DOI 10.1016/0022-4731(89)90091-5; MYERS RM, 1985, SCIENCE, V230, P1242, DOI 10.1126/science.4071043; NONAKA Y, 1989, FEBS LETT, V255, P21, DOI 10.1016/0014-5793(89)81053-1; NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759; OGISHIMA T, 1992, ENDOCRINOLOGY, V130, P2971, DOI 10.1210/en.130.5.2971; OGISHIMA T, 1989, J BIOL CHEM, V264, P10935; OONK RB, 1989, J BIOL CHEM, V264, P21934; OZOLS J, 1981, J BIOL CHEM, V256, P1405; PASCOE L, 1992, P NATL ACAD SCI USA, V89, P8327, DOI 10.1073/pnas.89.17.8327; QUINN SJ, 1988, ANNU REV PHYSIOL, V50, P409, DOI 10.1146/annurev.ph.50.030188.002205; SANDER M, 1994, P NATL ACAD SCI USA, V91, P148, DOI 10.1073/pnas.91.1.148; SCHAPIRO S, 1962, ENDOCRINOLOGY, V71, P986, DOI 10.1210/endo-71-6-986; TOWNSEND SF, 1990, J BIOL CHEM, V265, P22117; TREMBLAY A, 1992, ENDOCRINOLOGY, V130, P3152, DOI 10.1210/en.130.6.3152; WALKER CD, 1986, ENDOCRINOLOGY, V118, P1445, DOI 10.1210/endo-118-4-1445; WHITE PC, 1991, J CLIN INVEST, V87, P1664, DOI 10.1172/JCI115182; YANAGIBASHI K, 1986, J BIOL CHEM, V261, P3556	36	57	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1643	1649		10.1074/jbc.270.4.1643	http://dx.doi.org/10.1074/jbc.270.4.1643			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829497	hybrid			2022-12-27	WOS:A1995QD20400027
J	RAMARAO, MK; STRAUB, P; KEMPER, B				RAMARAO, MK; STRAUB, P; KEMPER, B			IDENTIFICATION BY IN-VITRO MUTAGENESIS OF THE INTERACTION OF 2 SEGMENTS OF C2MSTC1, A CHIMERA OF CYTOCHROMES P450-2C2 AND P450-2C1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; HYDROXYLATION; REQUIREMENTS; SEQUENCES; ENZYMES; REGION	A hybrid cytochrome P450, C2MstC1, with 306 N-terminal amino acids derived from cytochrome P450 2C2 sequence and 184 C-terminal amino acids from cytochrome P450 2C1 acquires a novel progesterone 21-hydroxylase activity which is absent in the parent enzymes, Extension of the cytochrome P450 2C2 sequence to residue 382 reduced progesterone hydroxylase activity to 5% of that of C2MstC1, while further extension to residue 411 or 462 increased activity back to about 30 or 40%, respectively, In the chimera with cytochrome P450 2C2 sequence to residue 382, substitution of cytochrome P450 2C1 amino acids at positions 368, 369, and 374 increased progesterone hydroxylase activity to a level equivalent to that of C2MstC1, In the chimera with cytochrome P450 2C2 sequence extending to residue 411, substitutions of P450 2C1 amino acids at positions 386 and 388, in addition those at 368, 369, and 374, were required to obtain activities equivalent to that of C2MstC1, which suggests an interaction between these two regions. The lauric acid hydroxylase activities of all chimeras and mutant cytochromes P450 differed by fl-fold or less, demonstrating that the changes in progesterone hydroxylase activity reflected altered interactions with the substrate, Alignment of cytochrome P450 2C1 sequence with cytochromes P450(cam), P450(BM-3), and P450(terp) predicts that residues 368/369 and 386/388 are in adjacent antiparallel strands of the same beta-sheet, in agreement with the experimental data suggesting an interaction between these two regions.	UNIV ILLINOIS,DEPT PHYSIOL & BIOPHYS,URBANA,IL 61801	University of Illinois System; University of Illinois Urbana-Champaign					NIGMS NIH HHS [GM35897] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035897] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		GEFFEN I, 1993, J BIOL CHEM, V268, P20772; GONZALEZ FJ, 1990, TRENDS GENET, V6, P6; GOTOH O, 1992, J BIOL CHEM, V267, P83; GOTOH O, 1989, FRONTIERS BIOTRANSFO, V1, P196; HASEMANN CA, 1994, J MOL BIOL, V236, P1169, DOI 10.1016/0022-2836(94)90019-1; HE YA, 1994, BIOCHEMISTRY-US, V33, P4419, DOI 10.1021/bi00180a040; HSU MH, 1993, J BIOL CHEM, V268, P6939; IMAI Y, 1988, J BIOCHEM-TOKYO, V103, P143, DOI 10.1093/oxfordjournals.jbchem.a122220; JOHNSON EF, 1992, FASEB J, V6, P700, DOI 10.1096/fasebj.6.2.1537459; KRONBACH T, 1991, BIOCHEMISTRY-US, V30, P6097, DOI 10.1021/bi00239a003; LAETHEM RM, 1992, MOL PHARMACOL, V42, P958; LINDBERG RLP, 1989, NATURE, V339, P632, DOI 10.1038/339632a0; Luo Zongshu, 1994, Archives of Biochemistry and Biophysics, V309, P52; MATSUNAGA E, 1990, J BIOL CHEM, V265, P17197; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; STRAUB P, 1994, BIOCHEMISTRY-US, V33, P8029, DOI 10.1021/bi00192a006; STRAUB P, 1993, J BIOL CHEM, V268, P21997; STRAUB P, 1993, ARCH BIOCHEM BIOPHYS, V306, P521, DOI 10.1006/abbi.1993.1547; UNO T, 1990, BIOCHEM BIOPH RES CO, V167, P498, DOI 10.1016/0006-291X(90)92051-Z; UNO T, 1992, J BIOCHEM-TOKYO, V112, P155, DOI 10.1093/oxfordjournals.jbchem.a123856	22	16	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1873	1880		10.1074/jbc.270.4.1873	http://dx.doi.org/10.1074/jbc.270.4.1873			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829524	hybrid			2022-12-27	WOS:A1995QD20400059
J	SRINIVASAN, M; KALOUSEK, F; CURTHOYS, NP				SRINIVASAN, M; KALOUSEK, F; CURTHOYS, NP			IN-VITRO CHARACTERIZATION OF THE MITOCHONDRIAL PROCESSING AND THE POTENTIAL FUNCTION OF THE 68-KDA SUBUNIT OF RENAL GLUTAMINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATE-DEPENDENT GLUTAMINASE; PURIFIED PRECURSOR PROTEIN; RAT-KIDNEY; INTERMEMBRANE SPACE; PEPTIDASE; IMPORT; LIVER; CELLS; TRANSLOCATION; BIOSYNTHESIS	Rat renal mitochondrial glutaminase (GA) is initially synthesized in primary cultures of proximal tubule cells as a 74-kDa precursor and is processed via a 72-kDa intermediate to generate a heterotetrameric enzyme which contains three 66-kDa subunits and one 68-kDa subunit (Perera, S. Y., Chen, T. C., and Curthoys, N. P. (1990) J. Biol. Chem. 265, 17764-17770). The two mature subunits may be derived by either of two possible mechanisms: 1) alternative proteolytic processing or 2) initial synthesis of the 66-kDa subunit followed by its covalent modification to generate the 68-kDa subunit. An in vitro system was utilized to further characterize this unique processing pathway and to investigate the potential function of the 68-kDa subunit, In vitro transcription and translation of the GA cDNA yields a single 74-kDa precursor, Upon incubation with isolated rat liver mitochondria, the precursor is translocated into the mitochondria and processed via a 72-kDa intermediate to yield a 3:1 ratio of the 66- and 68-kDa subunits, respectively, The kinetics of the in vitro processing reaction also closely approximate the kinetics observed in cultured cells, Mitochondrial processing is blocked by o-phenanthroline, an inhibitor of the matrix processing peptidase (MPP), The 72-amino acid presequence of the 66-kDa subunit contains a large proportion of basic amino acids, Two-dimensional gel electrophoresis of mature GA established that the 68-kDa subunit is slightly more basic than the 66-kDa subunit, In addition, incubation of the 74-kDa precursor with purified MPP yields equimolar amounts of the two mature peptides, A cDNA construct, p Delta GA, was created which lacks the nucleotides that encode the amino acid residues 32 through 72 of GA, When transcribed and translated in vitro, p Delta GA yields a 70-kDa precursor, This precursor is processed by mitochondria to a single mature subunit with a M of 66 kDa. This observation suggests that the 68-kDa subunit is not produced by covalent modification of the 66-kDa subunit and further supports the conclusion that the two mature subunits of GA are produced by alternative processing reactions which can be catalyzed by MPP, However, the yield of products obtained in intact mitochondria may be determined by some unidentified accessory factor, Submitochondrial fractionation of imported GA and Delta GA precursors suggest that the 68-kDa subunit may function to retain the mature GA within the mitochondrial matrix.	COLORADO STATE UNIV,DEPT BIOCHEM & MOLEC BIOL,FT COLLINS,CO 80523; YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06520	Colorado State University; Yale University					NIDDK NIH HHS [DK-09527, DK-37124] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK009527, R01DK037124] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHEN WJ, 1987, J BIOL CHEM, V262, P15605; COHEN NS, 1985, BIOCHEM J, V229, P205, DOI 10.1042/bj2290205; CURTHOYS NP, 1974, J BIOL CHEM, V249, P3261; CURTHOYS NP, 1976, ARCH BIOCHEM BIOPHYS, V172, P162, DOI 10.1016/0003-9861(76)90062-X; CURTHOYS NP, 1988, PH HOMEOSTASIS MECHA, P323; EILERS M, 1988, EMBO J, V7, P1139, DOI 10.1002/j.1460-2075.1988.tb02923.x; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; FAHIEN LA, 1989, J BIOL CHEM, V264, P12303; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; GROSS M, 1994, PROTEIN SCI, V3, P1058, DOI 10.1002/pro.5560030708; Hannavy K, 1993, CURR OPIN CELL BIOL, V5, P694, DOI 10.1016/0955-0674(93)90142-D; HARTL FU, 1987, CELL, V51, P1027, DOI 10.1016/0092-8674(87)90589-7; HARTL FU, 1990, SCIENCE, V247, P930, DOI 10.1126/science.2406905; HASER WG, 1985, BIOCHEM J, V229, P399, DOI 10.1042/bj2290399; ISAYA G, 1991, J CELL BIOL, V113, P65, DOI 10.1083/jcb.113.1.65; JAGUS R, 1987, METHOD ENZYMOL, V152, P267; KALOUSEK F, 1993, TRENDS BIOCHEM SCI, V18, P249, DOI 10.1016/0968-0004(93)90174-L; KALOUSEK F, 1992, EMBO J, V11, P2803, DOI 10.1002/j.1460-2075.1992.tb05347.x; KLEIBER J, 1990, P NATL ACAD SCI USA, V87, P7978, DOI 10.1073/pnas.87.20.7978; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maniatis T, 1989, DECONTAMINATION DILU; NUNNARI J, 1993, SCIENCE, V262, P1997, DOI 10.1126/science.8266095; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PACES V, 1993, P NATL ACAD SCI USA, V90, P5355, DOI 10.1073/pnas.90.11.5355; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; PERERA SY, 1990, J BIOL CHEM, V265, P17764; PERERA SY, 1991, BIOCHEM J, V273, P265, DOI 10.1042/bj2730265; PERERA SY, 1989, THESIS U PITTSBURGH; SCHIFFER M, 1992, PROTEIN ENG, V5, P213, DOI 10.1093/protein/5.3.213; SCHOOLWERTH AC, 1980, J BIOL CHEM, V255, P3403; SHAPIRO RA, 1987, BIOCHEM J, V242, P743, DOI 10.1042/bj2420743; SHAPIRO RA, 1991, J BIOL CHEM, V266, P18792; SRINIVASAN M, 1995, J BIOL CHEM, V270, P1191, DOI 10.1074/jbc.270.3.1191; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VIJAYASARATHY C, 1989, J BIOL CHEM, V264, P7772	36	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1185	1190		10.1074/jbc.270.3.1185	http://dx.doi.org/10.1074/jbc.270.3.1185			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836378	hybrid			2022-12-27	WOS:A1995QB15600033
J	HOLNESS, CL; BATES, PA; LITTLER, AJ; BUCKLEY, CD; MCDOWALL, A; BOSSY, D; HOGG, N; SIMMONS, DL				HOLNESS, CL; BATES, PA; LITTLER, AJ; BUCKLEY, CD; MCDOWALL, A; BOSSY, D; HOGG, N; SIMMONS, DL			ANALYSIS OF THE BINDING-SITE ON INTERCELLULAR-ADHESION MOLECULE-3 FOR THE LEUKOCYTE INTEGRIN LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-LIKE DOMAINS; HUMAN CD4; CRYSTAL-STRUCTURE; COUNTER-RECEPTOR; ICAM-1 CD54; LFA-1; EXPRESSION; CLONING; RESOLUTION; DISTINCT	Intercellular adhesion molecule 3 (ICAM-3, CD50) is a member of the immunoglobulin superfamily and is a constitutively expressed ligand for the leukocyte integrin LFA-1 (CD11a/CD18). ICAM-3 is expressed at high levels by all resting leukocyte populations and antigen presenting cells and is a major ligand for LFA-1 in the resting immune system. ICAM-3 is a signal transducer and may play a hey role in initiating immune responses. Mutant ICAM-3 Fc-chimeric proteins were quantitatively analyzed for their ability to bind COS cells expressing human LFA-1. The LFA-1-binding site on ICAM-3 is located in the N-terminal 2 Ig domains. Domains 3-5 do not significantly contribute to adhesion. The binding site has been further resolved by rational targeting of. 14 point mutations throughout domains 1 and 2, coupled with modeling studies. Within domain 1 a cluster of residues (Glu(37), Leu(66), Ser(68), and Gln(75)), that are predicted to lie on the CC'FG face of the Ig fold, play a dominant role in LFA-1 binding.	JOHN RADCLIFFE HOSP, INST MOLEC MED, IMPERIAL CANC RES FUND, CELL ADHESION LAB, OXFORD OX3 9DU, ENGLAND; IMPERIAL CANC RES FUND, LEUKOCYTE ADHESION LAB, LONDON WC2A 3PX, ENGLAND; IMPERIAL CANC RES FUND, BIOMOLEC MODELLING LAB, LONDON WC2A 3PX, ENGLAND	University of Oxford; Cancer Research UK; Cancer Research UK				McDowall, Alison/0000-0003-2018-1462; Bates, Paul/0000-0003-0621-0925				ACEVEDO A, 1993, AM J PATHOL, V143, P774; ANDREW D, 1993, EUR J IMMUNOL, V23, P2217, DOI 10.1002/eji.1830230925; ARULANANDAM ARN, 1993, P NATL ACAD SCI USA, V90, P11613, DOI 10.1073/pnas.90.24.11613; BERENDT AR, 1992, CELL, V68, P71, DOI 10.1016/0092-8674(92)90207-S; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; BOSSY D, 1994, IN PRESS EUR J IMMUN; BRADY RL, 1993, SCIENCE, V260, P979, DOI 10.1126/science.8493535; CABANAS C, 1993, P NATL ACAD SCI USA, V90, P5838, DOI 10.1073/pnas.90.12.5838; CAMPANERO MR, 1993, J CELL BIOL, V123, P1007, DOI 10.1083/jcb.123.4.1007; CID MC, 1994, EUR J IMMUNOL, V24, P1377, DOI 10.1002/eji.1830240621; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DEFOUGEROLLES AR, 1994, J EXP MED, V179, P619, DOI 10.1084/jem.179.2.619; DEFOUGEROLLES AR, 1993, J EXP MED, V177, P1187, DOI 10.1084/jem.177.4.1187; DEFOUGEROLLES AR, 1991, J EXP MED, V174, P253, DOI 10.1084/jem.174.1.253; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; DOUSSISANAGNOSTOPOULOU I, 1993, AM J PATHOL, V143, P1040; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; DRANSFIELD I, 1989, EMBO J, V8, P3759, DOI 10.1002/j.1460-2075.1989.tb08552.x; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; FAWCETT J, 1992, NATURE, V360, P481, DOI 10.1038/360481a0; GARRETT TPJ, 1993, J MOL BIOL, V234, P763, DOI 10.1006/jmbi.1993.1625; HAMMOND L, 1993, GENBANK RELEASE 80 0; HERNANDEZCASELLES T, 1993, EUR J IMMUNOL, V23, P2799, DOI 10.1002/eji.1830231112; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HONG X, 1992, J IMMUNOL, V149, P2650; HORLEY KJ, 1989, EMBO J, V8, P2889, DOI 10.1002/j.1460-2075.1989.tb08437.x; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; JUAN M, 1994, J EXP MED, V179, P1747, DOI 10.1084/jem.179.6.1747; KITA Y, 1992, BIOCHIM BIOPHYS ACTA, V1131, P108, DOI 10.1016/0167-4781(92)90107-B; Klickstein L. B., 1993, Tissue Antigens, V42, P270; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LANDIS RC, 1994, J CELL BIOL, V126, P529, DOI 10.1083/jcb.126.2.529; LANDIS RC, 1993, J CELL BIOL, V120, P1519, DOI 10.1083/jcb.120.6.1519; LARSON RS, 1990, CELL REGUL, V1, P359, DOI 10.1091/mbc.1.4.359; MOEBIUS U, 1993, P NATL ACAD SCI USA, V90, P8259, DOI 10.1073/pnas.90.17.8259; OSBORN L, 1994, J CELL BIOL, V124, P601, DOI 10.1083/jcb.124.4.601; PARDI R, 1992, J CELL BIOL, V116, P1211, DOI 10.1083/jcb.116.5.1211; RENZ ME, 1994, J CELL BIOL, V125, P1395, DOI 10.1083/jcb.125.6.1395; ROTHLEIN R, 1986, J IMMUNOL, V137, P1270; RUEGG C, 1992, J CELL BIOL, V117, P179, DOI 10.1083/jcb.117.1.179; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; SIMMONS D, 1988, NATURE, V331, P624, DOI 10.1038/331624a0; SIMMONS DL, 1993, CELLULAR INTERACTION, P93; SOMOZA C, 1993, J EXP MED, V178, P549, DOI 10.1084/jem.178.2.549; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; STAUNTON DE, 1989, NATURE, V339, P61, DOI 10.1038/339061a0; VANKOOYK Y, 1989, NATURE, V342, P811, DOI 10.1038/342811a0; VAZEUX R, 1992, NATURE, V360, P485, DOI 10.1038/360485a0; VONDERHEIDE RH, 1994, J CELL BIOL, V125, P215, DOI 10.1083/jcb.125.1.215; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; WITHKA JM, 1993, STRUCTURE, V1, P69, DOI 10.1016/0969-2126(93)90009-6	56	73	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					877	884		10.1074/jbc.270.2.877	http://dx.doi.org/10.1074/jbc.270.2.877			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822326	hybrid, Green Published			2022-12-27	WOS:A1995QB81600060
J	WANG, SK; KUSSIE, P; DENG, LP; TALL, A				WANG, SK; KUSSIE, P; DENG, LP; TALL, A			DEFECTIVE BINDING OF NEUTRAL LIPIDS BY A CARBOXYL-TERMINAL DELETION MUTANT OF CHOLESTERYL ESTER TRANSFER PROTEIN - EVIDENCE FOR A CARBOXYL-TERMINAL CHOLESTERYL ESTER BINDING-SITE ESSENTIAL FOR NEUTRAL LIPID TRANSFER ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEINS; HUMAN-PLASMA; MONOCLONAL-ANTIBODY; PHOSPHOLIPIDS; PURIFICATION; MUTATION; GENE	The plasma cholesteryl ester transfer protein (CETP, 476 amino acids) transfers cholesteryl ester (CE) from high density lipoprotein (HDL) to triglyceride-rich lipoproteins and plays a major role in HDL catabolism. Using deletional and site-directed mutagenesis, we previously showed that the carboxyl terminus of human CETP comprises the epitope of a neutralizing monoclonal antibody and is necessary for neutral lipid transfer activity, To assess the nature of the involvement of the COOH terminus in cholesteryl ester transfer activity, we characterized a deletion mutant of CETP lacking amino acid residues 470-475 in terms of CE transfer kinetics, association with HDL, and capacity to bind CE, triglyceride (TG), and phosphatidylcholine (PC), Kinetic analysis indicated a major catalytic defect of the deletion mutant, as shown by markedly decreased maximum cholesteryl ester transfer activities (apparent V-max) for donor (HDL) and acceptor (low density lipoprotein (LDL)) lipoproteins but there were no significant changes of concentrations of the donor and acceptor at 50% V-max (apparent K-m). The binding of CETP to HDL, as determined by native gel electrophoresis, was similar for wild-type and mutant protein, When egg PC/CE vesicles were incubated with wild type CETP and then separated by gel filtration chromatography, there was maximum binding of about 1 mol of CE/mol of CETP, Under similar conditions the mutant CETP bound 0.09-0.37 mol of CE/mol of protein, Similarly, when egg PC/TG vesicles were incubated with the CETP proteins, there was a maximum binding of 0.5 mol of triglyceride/mol of wild-type CETP, whereas there was only 0.00-0.07 mol of TG/mol of deletion mutant, The binding of phosphatidylcholine was similar for wild type and the deletion mutant. The studies suggest that amino acids 470-475 (forming part of a COOH-terminal amphipathic helix) are involved in CE and TG binding by CETP but are not required either for the binding of PC by CETP or the association of CETP with HDL. The COOH terminus of CETP may comprise a neutral lipid binding site directly involved in the lipid transfer mechanism.	COLUMBIA UNIV, DEPT MED, DIV MOLEC MED, NEW YORK, NY 10032 USA	Columbia University	WANG, SK (corresponding author), SCHERING PLOUGH CORP, RES INST, KENILWORTH, NJ 07033 USA.		Tall, Alan/AAT-8528-2021					AGELLON LB, 1991, J BIOL CHEM, V266, P10796; AUYOUNG J, 1992, P NATL ACAD SCI USA, V89, P4094, DOI 10.1073/pnas.89.9.4094; BARTER PJ, 1980, J LIPID RES, V21, P238; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; Cleland W W, 1979, Methods Enzymol, V63, P103; DRAYNA D, 1987, NATURE, V327, P632, DOI 10.1038/327632a0; GLOMSET JA, 1968, J LIPID RES, V9, P155; HESLER CB, 1988, J BIOL CHEM, V263, P5020; HESLER CB, 1987, J BIOL CHEM, V262, P2275; IHM J, 1982, J LIPID RES, V27, P361; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAROTTI KR, 1993, NATURE, V364, P73, DOI 10.1038/364073a0; MATRUNAGA A, 1993, BIOCHIM BIOPHYS ACTA, V1166, P131; MORTON RE, 1982, J LIPID RES, V23, P1058; MORTON RE, 1983, J BIOL CHEM, V258, P1751; MORTON RE, 1988, J LIPID RES, V29, P1367; OHNISHI T, 1990, J LIPID RES, V31, P397; PATTNAIK NM, 1979, J BIOL CHEM, V254, P2782; SAMMETT D, 1985, J BIOL CHEM, V260, P6687; STEVENSON SC, 1993, BIOCHEMISTRY-US, V32, P5121, DOI 10.1021/bi00070a021; SWENSON TL, 1988, J BIOL CHEM, V263, P5150; SWENSON TL, 1989, J BIOL CHEM, V264, P14318; TAKAHASHI K, 1993, J CLIN INVEST, V92, P2060, DOI 10.1172/JCI116802; TAKAYAMA M, 1977, CLIN CHIM ACTA, V79, P93, DOI 10.1016/0009-8981(77)90465-X; WANG S, 1992, J BIOL CHEM, V267, P17487; WANG S, 1991, BIOCHEMISTRY-US, V30, P3484, DOI 10.1021/bi00228a019; WANG SK, 1993, J BIOL CHEM, V268, P1955; WIRTZ KWA, 1991, ANNU REV BIOCHEM, V60, P73, DOI 10.1146/annurev.biochem.60.1.73	30	40	43	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					612	618		10.1074/jbc.270.2.612	http://dx.doi.org/10.1074/jbc.270.2.612			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822286	hybrid			2022-12-27	WOS:A1995QB81600019
J	RAHMATULLAH, M; GINNAN, R; ROBISHAW, JD				RAHMATULLAH, M; GINNAN, R; ROBISHAW, JD			SPECIFICITY OF G-PROTEIN ALPHA-GAMMA SUBUNIT INTERACTIONS - N-TERMINAL 15 AMINO-ACIDS OF GAMMA-SUBUNIT SPECIFIES INTERACTION WITH ALPHA-SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA; BOVINE BRAIN; RECEPTORS; CELLS	The existence of multiple alpha, beta, and gamma subunits raises questions regarding the assembly of particular G proteins. Based on the results of a previous study (Rahmatullah, M., and Robishaw, J. D. (1994) J. Biol. Chem. 269, 3574-3580), we hypothesized that the assembly of G proteins may be determined by the interactions of the more structurally diverse alpha and gamma subunits. This hypothesis was confirmed in the present study by showing striking differences in the abilities of the gamma(1) and gamma(2) subunits to interact with the the alpha(o) subunit. Chimeras of the gamma(1) and gamma(2) subunits were used to delineate which region is responsible. Support for the importance of the N-terminal region of the gamma subunit comes from our observations that 1) the gamma(2) subunit and the gamma(211) chimera bound strongly to the alpha(o)-agarose matrix, but the gamma(1) subunit and the gamma(112) chimera bound weakly, if at all; 2) an N-terminal peptide made to the gamma(2) subunit blocked the binding of the gamma(211) chimera to the alpha(o) agarose matrix; 3) both the gamma(211) chimera and the N-terminal peptide were able to partially protect the alpha(o) subunit against tryptic cleavage; and 4) the gamma(211) chimera, but not the gamma(112) chimera, supported ADP-ribosylation of the alpha(o) subunit.	GEISINGER MED CLIN, WEIS CTR RES, DANVILLE, PA 17822 USA	Geisinger Medical Center					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM039867, R01GM039867] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM39867] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; CALI JJ, 1992, J BIOL CHEM, V267, P24023; CASEY PJ, 1989, BIOCHEMISTRY-US, V28, P611, DOI 10.1021/bi00428a029; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; INIGUEZLLUHI JA, 1992, J BIOL CHEM, V267, P23409; KLEUSS C, 1992, NATURE, V358, P424, DOI 10.1038/358424a0; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; KLEUSS C, 1993, SCIENCE, V259, P832, DOI 10.1126/science.8094261; LUPAS AN, 1992, FEBS LETT, V314, P105, DOI 10.1016/0014-5793(92)80952-D; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P5873, DOI 10.1073/pnas.87.15.5873; MUMBY SM, 1991, METHOD ENZYMOL, V195, P215; PRONIN AN, 1992, P NATL ACAD SCI USA, V89, P6220, DOI 10.1073/pnas.89.13.6220; RAHMATULLAH M, 1994, J BIOL CHEM, V269, P3574; ROBISHAW JD, 1994, METHOD ENZYMOL, V237, P498; ROBISHAW JD, 1993, ANAL BIOCHEM, V208, P283, DOI 10.1006/abio.1993.1047; ROBISHAW JD, 1986, J BIOL CHEM, V261, P9587; ROBISHAW JD, 1989, J BIOL CHEM, V264, P15758; ROBISHAW JD, 1992, BIOCHEM J, V286, P677, DOI 10.1042/bj2860677; SCHMIDT CJ, 1992, J BIOL CHEM, V267, P13807; SOHMA H, 1992, BIOCHEM BIOPH RES CO, V184, P175, DOI 10.1016/0006-291X(92)91175-P; SPRRING DJ, 1994, J BIOL CHEM, V269, P22882; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; UEDA N, 1994, J BIOL CHEM, V269, P4388	23	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					2946	2951		10.1074/jbc.270.7.2946	http://dx.doi.org/10.1074/jbc.270.7.2946			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852373				2022-12-27	WOS:A1995QG47100012
J	KRAMER, D; METT, H; EVANS, A; REGENASS, U; DIEGELMAN, P; PORTER, CW				KRAMER, D; METT, H; EVANS, A; REGENASS, U; DIEGELMAN, P; PORTER, CW			STABLE AMPLIFICATION OF THE S-ADENOSYLMETHIONINE DECARBOXYLASE GENE IN CHINESE-HAMSTER OVARY CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERMIDINE SPERMINE N1-ACETYLTRANSFERASE; ACTIVATED IRREVERSIBLE INHIBITOR; ADENOSYL-L-METHIONINE; L1210 LEUKEMIA-CELLS; ORNITHINE DECARBOXYLASE; METHYLGLYOXAL BIS(GUANYLHYDRAZONE); POLYAMINE ANALOGS; MAMMALIAN-CELLS; MELANOMA-CELLS; POTENT	A Chinese hamster ovary cell subline (CHO/664) >1000-fold resistant to the S-adenosylmethionine decarboxylase (AdoMetDC) inhibitor, CGP-48664 (4-(aminoiminomethyl)-2,3-dihydro-1H-inden-l-one-diamino-methylenehydrazone), has been developed and characterized, The cells were also cross-resistant to the highly specific nucleoside analog inhibitor of AdoMetDC, MDL-73811. These unique cells stably overexpress AdoMetDC due to a 10-16-fold amplification of the AdoMetDC gene, which resulted in a similar increase in AdoMetDC transcript levels. In the presence of 100 mu M CGP-48664, the CHO/664 cells displayed AdoMetDC activities similar to the parental line. Following removal of the inhibitor, AdoMetDC activity increased steadily over 20 days to 10-12 times that found in parental CHO cells, Decarboxylated (de) AdoMet pools accumulated rapidly from <5 pmol/10(6) cells to similar to 1000-1500 pmol/10(6) cells at 3 days due to diffusion away of intracellular inhibitor and to the depletion of putrescine and spermidine as aminopropyl accepters in dcAdoMet-mediated synthase reactions, Polyamine pools shifted as putrescine, and spermidine pools were processed forward to spermine, During the period from 3 days to 20 days, dcAdoMet pools fell steadily and eventually stabilized at 100-200 pmol/10(6) cells, Providing excess putrescine at this time as an aminopropyl acceptor rapidly lowered dcAdoMet pools and led to a near normalization of polyamine pools, indicating that both dcAdoMet and putrescine are essential in maintaining steady-state polyamine pool profiles, As with cell line variants that overproduce ornithine decarboxylase, polyamine transport was found to be increased in CHO/664 cells due to an apparent inability of the system to down-regulate polyamine transport in response to polyamine excess, Given the unique metabolic disturbances seen in these cells, we anticipate that in addition to providing a useful system for evaluating the specificity of newly developed AdoMetDC inhibitors, they will undoubtedly prove valuable for investigating the various regulatory interrelationships involved in polyamine homeostasis and possibly other aspects of purine metabolism.	ROSWELL PK CANC INST,GRACE CANC DRUG CTR,BUFFALO,NY 14263; CIBA GEIGY LTD,RES DEPT,DIV PHARMACEUT,CH-4002 BASEL,SWITZERLAND	Roswell Park Cancer Institute; Novartis					NATIONAL CANCER INSTITUTE [R01CA022153] Funding Source: NIH RePORTER; NCI NIH HHS [CA-16406, CA-22153] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSEN LR, 1988, FOCUS, V10, P35; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; BERGERON RJ, 1989, CANCER RES, V49, P2959; BERGERON RJ, 1988, J MED CHEM, V31, P1183, DOI 10.1021/jm00401a019; CASARA P, 1989, J AM CHEM SOC, V111, P9111, DOI 10.1021/ja00207a024; FOGELPETROVIC M, 1993, J BIOL CHEM, V268, P19118; HYVONEN T, 1994, BBA-MOL CELL RES, V1221, P279, DOI 10.1016/0167-4889(94)90251-8; IGARASHI K, 1984, CANCER RES, V44, P5326; KABRA PM, 1986, J CHROMATOGR, V380, P19, DOI 10.1016/S0378-4347(00)83621-X; KAMEJI T, 1993, BIOCHEM J, V289, P581, DOI 10.1042/bj2890581; KANAMOTO R, 1993, J BIOL CHEM, V268, P9393; KHAN NA, 1992, J CELL PHYSIOL, V152, P310, DOI 10.1002/jcp.1041520212; KHOMUTOV RM, 1983, BIOORG KHIM+, V9, P130; KRAMER DL, 1993, J CELL PHYSIOL, V155, P399, DOI 10.1002/jcp.1041550222; KRAMER DL, 1989, BIOCHEM J, V259, P325, DOI 10.1042/bj2590325; LIBBY PR, 1991, ARCH BIOCHEM BIOPHYS, V284, P238, DOI 10.1016/0003-9861(91)90291-P; MAMONT PS, 1978, BIOCHEM BIOPH RES CO, V81, P58, DOI 10.1016/0006-291X(78)91630-3; MAMONT PS, 1982, EUR J BIOCHEM, V123, P499; MANDEL JL, 1978, J CELL PHYSIOL, V97, P335, DOI 10.1002/jcp.1040970308; MANIATIS T, 1989, MOL CLONING LABORATO, P458; MARIC SC, 1992, J BIOL CHEM, V267, P18915; MCCONLOGUE L, 1984, P NATL ACAD SCI-BIOL, V81, P540, DOI 10.1073/pnas.81.2.540; MCCONLOGUE L, 1983, J BIOL CHEM, V258, P2083; MIHICH E, 1975, HDB EXPT PHARMACOLOG, V38, P766; MITCHELL JLA, 1992, BIOCHEM BIOPH RES CO, V186, P81, DOI 10.1016/S0006-291X(05)80778-8; MOSHIER JA, 1993, CANCER RES, V53, P2618; PACKHAM G, 1994, MOL CELL BIOL, V14, P5741, DOI 10.1128/MCB.14.9.5741; PAJUNEN A, 1988, J BIOL CHEM, V263, P17040; PEGG AE, 1988, CANCER RES, V48, P759; PEGG AE, 1982, BIOCHEM J, V202, P519, DOI 10.1042/bj2020519; PEGG AE, 1988, BIOCHEMISTRY-US, V27, P1408, DOI 10.1021/bi00405a003; PERSSON L, 1988, CANCER RES, V48, P4807; Porter C. W., 1992, V62, P301; PORTER CW, 1985, CANCER RES, V45, P2050; PORTER CW, 1990, BIOCHEM J, V268, P207, DOI 10.1042/bj2680207; PULKKA A, 1993, GENOMICS, V16, P342, DOI 10.1006/geno.1993.1195; REGENASS U, 1994, CANCER RES, V54, P3210; REGENASS U, 1992, CANCER RES, V52, P4712; ROSS J, 1976, J MOL BIOL, V106, P403, DOI 10.1016/0022-2836(76)90093-0; SHANTZ LM, 1994, CANCER RES, V54, P2313; SHANTZ LM, 1992, BIOCHEM J, V288, P511, DOI 10.1042/bj2880511; SHAPPELL NW, 1993, FEBS LETT, V321, P179, DOI 10.1016/0014-5793(93)80103-2; SIREAR S, 1987, CANCER RES, V47, P1339; SNAPKA RM, 1983, P NATL ACAD SCI-BIOL, V80, P7533, DOI 10.1073/pnas.80.24.7533; STANEK J, 1993, J MED CHEM, V36, P2168, DOI 10.1021/jm00067a014; STANEK J, 1993, J MED CHEM, V36, P46, DOI 10.1021/jm00053a007; STJERNBORG L, 1991, BIOCHIM BIOPHYS ACTA, V1090, P188, DOI 10.1016/0167-4781(91)90100-Z; SUZUKI T, 1993, EUR J BIOCHEM, V215, P247, DOI 10.1111/j.1432-1033.1993.tb18029.x; WILLIAMSASHMAN HG, 1986, BIOCHEM PHARMACOL, V35, P1217, DOI 10.1016/0006-2952(86)90263-7; WISEMAN A, 1983, CANCER RES, V43, P5937; WU YQ, 1992, J MED CHEM, V35, P3196, DOI 10.1021/jm00095a015; YARLETT N, 1988, MOL BIOCHEM PARASIT, V27, P1, DOI 10.1016/0166-6851(88)90019-9	52	54	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2124	2132		10.1074/jbc.270.5.2124	http://dx.doi.org/10.1074/jbc.270.5.2124			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836441	hybrid			2022-12-27	WOS:A1995QE49300024
J	OGATA, M; SAWADA, M; FUJINO, Y; HAMAOKA, T				OGATA, M; SAWADA, M; FUJINO, Y; HAMAOKA, T			CDNA CLONING AND CHARACTERIZATION OF A NOVEL RECEPTOR-TYPE PROTEIN-TYROSINE-PHOSPHATASE EXPRESSED PREDOMINANTLY IN THE BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOCYTE COMMON ANTIGEN; CENTRAL-NERVOUS-SYSTEM; MOLECULAR-CLONING; RAT-BRAIN; DROSOPHILA; SEQUENCE; FAMILY; KINASE; DOMAIN; REGION	Protein tyrosine phosphatase has the potential to control various cellular events by negatively regulating the extent of tyrosine phosphorylation. Here, we report the isolation of a murine receptor protein tyrosine phosphatase, PTPBR7, which is expressed almost exclusively in the brain. Though the cytoplasmic portion of PTPBR7 reveals high similarity to HePTP/LC-PTP and STEP, these are, unlike PTPBR7, non-receptor protein tyrosine phosphatases. Unlike most receptor protein tyrosine phosphatases, PTPBR7 has only one cytoplasmic phosphatase domain, and its extracellular domain reveals no obvious structural similarity to known molecules. Thus, PTPBR7 defines a new subfamily of receptor-type protein tyrosine phosphatases. The putative extracellular domain of PTPBR7 was expressed in COS-7 cells as a chimeric fusion protein with an immunoglobulin Fc portion (PTPBR7-Fc). PTPBR7-Fc was secreted in the culture supernatant, confirming the capability of the extracellular domain of PTPBR7 to translocate across the cytoplasmic membrane. The cytoplasmic portion of PTPBR7 was expressed as a fusion protein in bacteria and was demonstrated to have catalytic activity. The expression of PTPBR7 was detectable in brain and especially in cerebellum but undetectable in liver, lung, heart, kidney, thymus, bone marrow, and spleen. In situ hybridization analysis revealed the most prominent signal in Purkinje cells, The predominant expression of PTPBR7 in the brain suggests that PTPBR7 may have role(s) in neuronal cells.			OGATA, M (corresponding author), OSAKA UNIV, SCH MED, BIOMED RES CTR, 2-2 YAMADAOKA, SUITA, OSAKA 565, JAPAN.							ADACHI M, 1992, BIOCHEM BIOPH RES CO, V186, P1607, DOI 10.1016/S0006-291X(05)81592-X; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BARNEA G, 1994, J BIOL CHEM, V269, P14349; BARNEA G, 1993, MOL CELL BIOL, V13, P1497, DOI 10.1128/MCB.13.3.1497; BLISKA JB, 1992, J EXP MED, V176, P1625, DOI 10.1084/jem.176.6.1625; BRADYKALNAY SM, 1993, J CELL BIOL, V122, P961, DOI 10.1083/jcb.122.4.961; CHARBONNEAU H, 1992, ANNU REV CELL BIOL, V8, P463, DOI 10.1146/annurev.cellbio.8.1.463; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COHENCORY S, 1991, J NEUROSCI, V11, P462; COX KH, 1984, DEV BIOL, V101, P485, DOI 10.1016/0012-1606(84)90162-3; EDWARDS JBDM, 1991, NUCLEIC ACIDS RES, V19, P5227, DOI 10.1093/nar/19.19.5227; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; GEBBINK MFBG, 1993, J BIOL CHEM, V268, P16101; GILMAN M, 1990, CURRENT PROTOCOLS MO; GRANDORI C, 1991, ONCOGENE, V6, P1063; HIRANO AA, 1988, J NEUROCHEM, V50, P1447, DOI 10.1111/j.1471-4159.1988.tb03029.x; JIRIK FR, 1990, FEBS LETT, V273, P239, DOI 10.1016/0014-5793(90)81094-5; KAPLAN R, 1990, P NATL ACAD SCI USA, V87, P7000, DOI 10.1073/pnas.87.18.7000; KORSCHING S, 1993, J NEUROSCI, V13, P2739; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KRUEGER NX, 1990, EMBO J, V9, P3241, DOI 10.1002/j.1460-2075.1990.tb07523.x; KRUEGER NX, 1992, P NATL ACAD SCI USA, V89, P7417, DOI 10.1073/pnas.89.16.7417; KUDO A, 1985, GENE, V33, P181; LEVY JB, 1993, J BIOL CHEM, V268, P10573; LOMBROSO PJ, 1991, P NATL ACAD SCI USA, V88, P7242, DOI 10.1073/pnas.88.16.7242; LONGO FM, 1993, J BIOL CHEM, V268, P26503; MATOZAKI T, 1994, J BIOL CHEM, V269, P2075; MATTHEWS RJ, 1990, P NATL ACAD SCI USA, V87, P4444, DOI 10.1073/pnas.87.12.4444; MATTHEWS RJ, 1991, IMMUNOGENETICS, V33, P33; MAUREL P, 1994, P NATL ACAD SCI USA, V91, P2512, DOI 10.1073/pnas.91.7.2512; MIZUNO K, 1993, MOL CELL BIOL, V13, P5513, DOI 10.1128/MCB.13.9.5513; OGATA M, 1994, J IMMUNOL, V153, P4478; OGATA M, 1989, J LEUKOCYTE BIOL, V45, P69, DOI 10.1002/jlb.45.1.69; PAN MG, 1993, J BIOL CHEM, V268, P19284; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; SAHIN M, 1993, J NEUROSCI, V13, P4968; Sambrook J, 1989, MOL CLONING LABORATO; SAP J, 1990, P NATL ACAD SCI USA, V87, P6112, DOI 10.1073/pnas.87.16.6112; SAP J, 1994, MOL CELL BIOL, V14, P1; STREULI M, 1988, J EXP MED, V168, P1523, DOI 10.1084/jem.168.5.1523; STREULI M, 1990, EMBO J, V9, P2399, DOI 10.1002/j.1460-2075.1990.tb07415.x; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; TIAN SS, 1991, CELL, V67, P675, DOI 10.1016/0092-8674(91)90063-5; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WALTON KM, 1993, ANNU REV BIOCHEM, V62, P101; WALTON KM, 1993, NEURON, V11, P387, DOI 10.1016/0896-6273(93)90193-U; YAN H, 1993, J BIOL CHEM, V268, P24880; YANG XH, 1991, CELL, V67, P661, DOI 10.1016/0092-8674(91)90062-4; ZANKE B, 1992, EUR J IMMUNOL, V22, P235, DOI 10.1002/eji.1830220134; ZHANG ZY, 1992, J BIOL CHEM, V267, P23759	53	57	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2337	2343		10.1074/jbc.270.5.2337	http://dx.doi.org/10.1074/jbc.270.5.2337			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836467				2022-12-27	WOS:A1995QE49300055
J	ORDENTLICH, A; BARAK, D; KRONMAN, C; ARIEL, N; SEGALL, Y; VELAN, B; SHAFFERMAN, A				ORDENTLICH, A; BARAK, D; KRONMAN, C; ARIEL, N; SEGALL, Y; VELAN, B; SHAFFERMAN, A			CONTRIBUTION OF AROMATIC MOIETIES OF TYROSINE-133 AND OF THE ANIONIC SUBSITE TRYPTOPHAN-86 TO CATALYTIC EFFICIENCY AND ALLOSTERIC MODULATION OF ACETYLCHOLINESTERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT HUMAN ACETYLCHOLINESTERASE; ACTIVE-CENTER; MOLECULAR RECOGNITION; TORPEDO-CALIFORNICA; BINDING; RESIDUES; RECEPTOR; SITE; TRIMETHYL; PROTEIN	Substitution of Trp-86, in the active center of human acetylcholinesterase (HuAChE), by aliphatic but not by aromatic residues resulted in a several thousandfold decrease in reactivity toward charged substrate and inhibitors but only a severalfold decrease for noncharged substrate and inhibitors. The W86A and W86E HuAChE enzymes exhibit at least a 100-fold increase in the Michaelis-Menten constant or 100-10,000-fold increase in inhibition constants toward various charged inhibitors, as compared to W86F HuAChE or the wild type enzyme. On the other hand, replacement of Glu-202, the only acidic residue proximal to the catalytic site, by glutamine resulted in a nonselective decrease in reactivity toward charged and noncharged substrates or inhibitors. Thus, the quaternary nitrogen groups of substrates and other active center ligands, are stabilized by cation-aromatic interaction with Trp-86 rather than by ionic interactions, while noncharged ligands appear to bind to distinct site(s) in HuAChE. Analysis of the Y133F and Y133A HuAChE mutated enzymes suggests that the highly conserved Tyr-133 plays a dual role in the active center: (a) its hydroxyl appears to maintain the functional orientation of Glu-202 by hydrogen bonding and (b) its aromatic moiety maintains the functional orientation of the anionic subsite Trp-86. In the absence of aromatic interactions between Tyr-133 and Trp-86, the tryptophan acquires a conformation that obstructs the active site leading, in the Y133A enzyme, to several hundredfold decrease in rates of catalysis, phosphorylation, or in affinity to reversible active site inhibitors. It is proposed that allosteric modulation of acetylcholinesterase activity, induced by binding to the peripheral anionic sites, proceeds through such conformational change of Trp-86 from a functional anionic subsite state to one that restricts access of substrates to the active center.	ISRAEL INST BIOL RES, DEPT BIOCHEM, IL-70450 NESS ZIONA, ISRAEL; ISRAEL INST BIOL RES, DEPT ORGAN CHEM, IL-70450 NESS ZIONA, ISRAEL									AXELSEN PH, 1994, PROTEIN SCI, V3, P188; BARAK D, 1992, MULTIDISCIPLINARY APPROACHES TO CHOLINESTERASE FUNCTIONS, P195; BARAK D, 1994, J BIOL CHEM, V269, P6296; BARNETT P, 1977, J BIOL CHEM, V252, P7200; BERMAN HA, 1992, MULTIDISCIPLINARY APPROACHES TO CHOLINESTERASE FUNCTIONS, P149; BERMAN HA, 1986, BIOCHIM BIOPHYS ACTA, V872, P125, DOI 10.1016/0167-4838(86)90155-X; BERMAN HA, 1990, BIOCHEMISTRY-US, V29, P10640, DOI 10.1021/bi00499a010; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; CHANGEUX JP, 1966, MOL PHARMACOL, V2, P369; COHEN SG, 1987, BIOORG CHEM, V15, P237, DOI 10.1016/0045-2068(87)90022-8; COHEN SG, 1984, J MED CHEM, V27, P1643, DOI 10.1021/jm00378a020; DOUGHERTY DA, 1990, SCIENCE, V250, P1558, DOI 10.1126/science.2274786; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FOURNIER D, 1993, CHEM-BIOL INTERACT, V87, P233, DOI 10.1016/0009-2797(93)90047-3; FRAENKEL Y, 1990, BIOCHEMISTRY-US, V29, P2617, DOI 10.1021/bi00462a027; GALZI JL, 1991, FEBS LETT, V294, P198, DOI 10.1016/0014-5793(91)80668-S; GAO J, 1993, BIOPHYS J, V65, P43, DOI 10.1016/S0006-3495(93)81031-2; GAREL L, 1993, J AM CHEM SOC, V115, P11652, DOI 10.1021/ja00077a096; GENTRY MK, 1991, CHOLINESTERASES STRU, P394; GNATT A, 1994, J NEUROCHEM, V62, P749; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; HASAN FB, 1980, J BIOL CHEM, V255, P3898; HIBERT MF, 1993, TRENDS PHARMACOL SCI, V14, P7, DOI 10.1016/0165-6147(93)90106-T; KEARNEY PC, 1993, J AM CHEM SOC, V115, P9907, DOI 10.1021/ja00075a006; KRONMAN C, 1992, GENE, V121, P295, DOI 10.1016/0378-1119(92)90134-B; MASSOULIE J, 1992, MULTIDISCIPLINARY APPROACHES TO CHOLINESTERASE FUNCTIONS, P285; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MCCURDY A, 1992, J AM CHEM SOC, V114, P10314, DOI 10.1021/ja00052a031; NAIR HK, 1994, BIOCHEMISTRY-US, V33, P8566, DOI 10.1021/bi00194a023; OBRIEN RD, 1971, DRUG DESIGN, V2, P161; ORDENTLICH A, 1993, FEBS LETT, V334, P215, DOI 10.1016/0014-5793(93)81714-B; ORDENTLICH A, 1993, J BIOL CHEM, V268, P17083; QUINN DM, 1987, CHEM REV, V87, P955, DOI 10.1021/cr00081a005; RADIC Z, 1994, J BIOL CHEM, V269, P11233; RADIC Z, 1992, BIOCHEMISTRY-US, V31, P9760, DOI 10.1021/bi00155a032; RADIC Z, 1991, MOL PHARMACOL, V39, P98; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; REMERS WA, 1971, CHEM HETEROCYCLIC CO, V25, P57; RIPOLL DR, 1993, P NATL ACAD SCI USA, V90, P5128, DOI 10.1073/pnas.90.11.5128; ROSENBERRY TL, 1975, ADV ENZYMOL RAMB, V43, P103; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; SAXENA A, 1993, BIOCHEM BIOPH RES CO, V197, P343, DOI 10.1006/bbrc.1993.2481; SCHNEIDER HJ, 1991, ANGEW CHEM INT EDIT, V30, P1417, DOI 10.1002/anie.199114171; SHAFFERMAN A, 1994, EMBO J, V13, P3448, DOI 10.1002/j.1460-2075.1994.tb06650.x; SHAFFERMAN A, 1992, EMBO J, V11, P3561, DOI 10.1002/j.1460-2075.1992.tb05439.x; SHAFFERMAN A, 1992, J BIOL CHEM, V267, P17640; SOREQ H, 1990, P NATL ACAD SCI USA, V87, P9688, DOI 10.1073/pnas.87.24.9688; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; VELAN B, 1991, J BIOL CHEM, V266, P23977; VELLOM DC, 1993, BIOCHEMISTRY-US, V32, P12, DOI 10.1021/bi00052a003; WEISE C, 1990, EMBO J, V9, P3885, DOI 10.1002/j.1460-2075.1990.tb07607.x; WESS J, 1993, LIFE SCI, V53, P1447, DOI 10.1016/0024-3205(93)90618-D; WILSON IB, 1952, J BIOL CHEM, V197, P215	54	102	107	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2082	2091		10.1074/jbc.270.5.2082	http://dx.doi.org/10.1074/jbc.270.5.2082			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836436	hybrid			2022-12-27	WOS:A1995QE49300018
J	CHAZENBALK, GD; RAPOPORT, B				CHAZENBALK, GD; RAPOPORT, B			EXPRESSION OF THE EXTRACELLULAR DOMAIN OF THE THYROTROPIN RECEPTOR IN THE BACULOVIRUS SYSTEM USING A PROMOTER ACTIVE EARLIER THAN THE POLYHEDRIN PROMOTER - IMPLICATIONS FOR THE EXPRESSION OF FUNCTIONAL HIGHLY GLYCOSYLATED PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHORIONIC-GONADOTROPIN RECEPTOR; SITE-DIRECTED MUTAGENESIS; TSH RECEPTOR; INSECT CELLS; RADIORECEPTOR ASSAY; HORMONE RECEPTOR; GRAVES-DISEASE; BINDING; AUTOANTIBODIES; REGION	Conventional baculovirus vectors that utilize the very late polyhedrin promoter have not proved successful for expressing a thyrotropin (TSH) receptor capable of ligand and Graves' disease autoantibody binding comparable to the receptor produced in mammalian cells. Because of the clinical importance of high level expression of this protein, we reassessed the baculovirus system using a new transfer vector (pAcMP3) containing the late basic protein promoter, which functions earlier than the classical polyhedrin promoter. Maximal synthesis of the [S-35]methionine labeled TSH receptor extracellular domain, affinity-purified using a 6-histidine tag, occurred earlier (1 day after insect cell infection) than with a vector (pVL1393) containing the polyhedrin promoter. The pAcMP3-derived TSH receptor extracellular domain was larger (similar to 68 kDa) than the pVL1393-derived protein (similar to 63 kDa). Only the 68-kDa product was secreted, albeit in trace amounts detectable only by pre cursor labeling. Enzymatic deglycosylation reduced both 68- and 63-kDa cellular proteins to similar to 54 kDa, indicating that the pAcMP3 vector generated a protein with greater carbohydrate content. However, despite its greater degree of glycosylation, most of the 68-kDa protein remained within the cell, almost entirely in the particulate fraction. Remarkably, the trace amounts of 68-kDa receptor protein affinity-purified from the soluble cytosolic fraction of infected insect cells completely neutralized TSH receptor autoantibodies in patients' sera and partly inhibited TSH binding. In conclusion, a baculovirus vector with a promoter active earlier than the conventional polyhedrin promoter generates a more glycosylated and functional TSH receptor extracellular domain protein, albeit at low levels. These data carry important implications for the expression by baculovirus vectors of functional, highly glycosylated proteins.	VET ADM MED CTR,THYROID MOLEC BIOL UNIT,SAN FRANCISCO,CA 94121; UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94121	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019289] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK19289] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHAZENBALK GD, 1990, J BIOL CHEM, V265, P20970; CHRISTOPHE S, 1993, BIOCHEM BIOPH RES CO, V196, P402, DOI 10.1006/bbrc.1993.2263; FILETTI S, 1991, J CLIN ENDOCR METAB, V72, P1096, DOI 10.1210/jcem-72-5-1096; GREENFIELD C, 1989, EMBO J, V8, P4115, DOI 10.1002/j.1460-2075.1989.tb08596.x; GRUENWALD S, 1993, BACULOVIRUS EXPRESSI; HARFST E, 1992, MOL CELL ENDOCRINOL, V83, P117, DOI 10.1016/0303-7207(92)90152-V; HARFST E, 1994, MOL CELL ENDOCRINOL, V102, P77, DOI 10.1016/0303-7207(94)90100-7; HARFST E, 1992, J MOL ENDOCRINOL, V9, P227, DOI 10.1677/jme.0.0090227; HARFST E, 1992, LANCET, V339, P193, DOI 10.1016/0140-6736(92)90273-6; HUANG GC, 1992, J MOL ENDOCRINOL, V8, P137, DOI 10.1677/jme.0.0080137; HUANG GC, 1993, J MOL ENDOCRINOL, V10, P127, DOI 10.1677/jme.0.0100127; JARVIS DL, 1993, J BIOL CHEM, V268, P16754; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU XB, 1993, J BIOL CHEM, V268, P1513; LOOSFELT H, 1992, P NATL ACAD SCI USA, V895, P3765; NAGAYAMA Y, 1991, P NATL ACAD SCI USA, V88, P902, DOI 10.1073/pnas.88.3.902; NAGAYAMA Y, 1992, MOL ENDOCRINOL, V6, P145, DOI 10.1210/me.6.2.145; NAGAYAMA Y, 1991, J CLIN INVEST, V88, P336, DOI 10.1172/JCI115297; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; PARKER EM, 1991, J BIOL CHEM, V266, P519; PAUL JI, 1990, J BIOL CHEM, V265, P13074; PETAJAREPO UE, 1993, BIOCHEM J, V292, P839, DOI 10.1042/bj2920839; REILANDER H, 1991, FEBS LETT, V2, P441; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEETHARAMAIAH GS, 1993, AUTOIMMUNITY, V14, P315, DOI 10.3109/08916939309079234; SEETHARAMAIAH GS, 1994, ENDOCRINOLOGY, V134, P549, DOI 10.1210/en.134.2.549; SHEWRING G, 1982, CLIN ENDOCRINOL, V17, P409, DOI 10.1111/j.1365-2265.1982.tb01607.x; SHI YF, 1993, THYROID, V3, P129, DOI 10.1089/thy.1993.3.129; SISSOM J, 1994, BIOCHEM J, V261, P119; SMITH BR, 1988, ENDOCR REV, V9, P106, DOI 10.1210/edrv-9-1-106; Summers MD, 1987, MANUAL METHODS BACUL; TAKAI O, 1991, BIOCHEM BIOPH RES CO, V179, P319, DOI 10.1016/0006-291X(91)91372-J; VASUDEVAN S, 1991, FEBS LETT, V283, P52, DOI 10.1016/0014-5793(91)80551-D; ZHANG R, 1991, BIOCHEM BIOPH RES CO, V181, P804, DOI 10.1016/0006-291X(91)91261-A	35	73	107	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1543	1549		10.1074/jbc.270.4.1543	http://dx.doi.org/10.1074/jbc.270.4.1543			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829482	hybrid			2022-12-27	WOS:A1995QD20400012
J	MUTERO, A; CAMP, S; TAYLOR, P				MUTERO, A; CAMP, S; TAYLOR, P			PROMOTER ELEMENTS OF THE MOUSE ACETYLCHOLINESTERASE GENE - TRANSCRIPTIONAL REGULATION DURING MUSCLE DIFFERENTIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SUBUNIT GENE; CREATINE-KINASE ENHANCER; DNA-BINDING; UNTRANSLATED REGIONS; MYOGENIC FACTORS; CHAIN GENE; EXPRESSION; RECEPTOR; MYOD; PROTEIN	The increase in acetylcholinesterase expression during muscle differentiation from myoblasts to myotubes was shown previously to reflect primarily a greater stability of the messenger RNA (mRNA). Here, we investigate the regulation of the acetylcholinesterase gene during early determination of the muscle phenotype. (i) We employ myogenic transcription factors to transform non-muscle cells into myoblasts in order to assess the role of the myogenic transcription factors in this regulation. (ii) We analyze the Ache promoter region by deletion analysis, point mutagenesis, and gel mobility shift assays, The myogenic transcription factors do not accelerate transcription of the Ache gene in spite of the presence of E-boxes at -335 base pairs from the start of transcription and in the first intron, and they are not able to trigger stabilization of the Ache mRNA when constitutively expressed in 10T1/2 fibroblasts. A GC-rich region (at -105 to -59 base pairs from the start of transcription) containing overlapping binding sites for the transcription factors Sp1 and Egr-1 is essential for promoter activity, Mutation of the Sp1 sites dramatically reduces the promoter activity while mutation of the Egr-1 sites has little effect. Sp1 and Egr-1 compete for binding to overlapping sites and an increase in Egr-1 decreases the expression of the Ache gene.			MUTERO, A (corresponding author), UNIV CALIF SAN DIEGO, DEPT PHARMACOL, LA JOLLA, CA 92093 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018360, R01GM018360] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 18360] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BALDWIN TJ, 1988, J CELL BIOL, V107, P2271, DOI 10.1083/jcb.107.6.2271; BASSELDUBY R, 1994, MOL CELL BIOL, V14, P4596, DOI 10.1128/MCB.14.7.4596; BERGSMA DJ, 1986, MOL CELL BIOL, V6, P2462, DOI 10.1128/MCB.6.7.2462; BESSEREAU JL, 1994, P NATL ACAD SCI USA, V91, P1304, DOI 10.1073/pnas.91.4.1304; BESSEREAU JL, 1993, EMBO J, V12, P443, DOI 10.1002/j.1460-2075.1993.tb05676.x; BLAKE MC, 1990, MOL CELL BIOL, V10, P6632, DOI 10.1128/MCB.10.12.6632; BOUVAGNET PF, 1987, MOL CELL BIOL, V7, P4377, DOI 10.1128/MCB.7.12.4377; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; BRENNAN TJ, 1991, P NATL ACAD SCI USA, V88, P3822, DOI 10.1073/pnas.88.9.3822; BUONANNO A, 1986, J BIOL CHEM, V261, P1452; BUSKIN JN, 1989, MOL CELL BIOL, V9, P2627, DOI 10.1128/MCB.9.6.2627; CSERJESI P, 1992, DEVELOPMENT, V115, P1087; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DUSING MR, 1994, NUCLEIC ACIDS RES, V22, P669, DOI 10.1093/nar/22.4.669; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; EVANS S, 1987, J BIOL CHEM, V262, P4911; FUENTES ME, 1993, NEURON, V10, P679, DOI 10.1016/0896-6273(93)90169-R; GIDONI D, 1984, NATURE, V312, P409, DOI 10.1038/312409a0; GIDONI D, 1985, SCIENCE, V230, P511, DOI 10.1126/science.2996137; GILMOUR BP, 1991, J BIOL CHEM, V266, P19871; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; HOWE JG, 1986, P NATL ACAD SCI USA, V83, P9006, DOI 10.1073/pnas.83.23.9006; ISHII S, 1985, P NATL ACAD SCI USA, V82, P4920, DOI 10.1073/pnas.82.15.4920; ISHII S, 1985, SCIENCE, V230, P1378, DOI 10.1126/science.2999983; KAGEYAMA R, 1989, CELL, V59, P815, DOI 10.1016/0092-8674(89)90605-3; KLARSFELD A, 1991, EMBO J, V10, P625, DOI 10.1002/j.1460-2075.1991.tb07990.x; KOLLMAR R, 1994, J BIOL CHEM, V269, P2252; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LANS MS, 1994, J BIOL CHEM, V269, P14170; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LI Y, 1993, J BIOL CHEM, V268, P3563; MAR JH, 1990, MOL CELL BIOL, V10, P4271, DOI 10.1128/MCB.10.8.4271; MELTON DW, 1984, P NATL ACAD SCI-BIOL, V81, P2147, DOI 10.1073/pnas.81.7.2147; MERLIE JP, 1994, J BIOL CHEM, V269, P2461; MERLIE JP, 1989, NATURE, V317, P86; MINER JH, 1990, P NATL ACAD SCI USA, V87, P1089, DOI 10.1073/pnas.87.3.1089; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; PIETTE J, 1989, EMBO J, V8, P687, DOI 10.1002/j.1460-2075.1989.tb03427.x; PIETTE J, 1990, NATURE, V345, P353, DOI 10.1038/345353a0; POLLOCK R, 1991, GENE DEV, V5, P2327, DOI 10.1101/gad.5.12a.2327; POLLWEIN P, 1993, BIOCHEM BIOPH RES CO, V190, P637, DOI 10.1006/bbrc.1993.1096; PRODY CA, 1991, J BIOL CHEM, V266, P22588; PRODY CA, 1992, NUCLEIC ACIDS RES, V20, P2367, DOI 10.1093/nar/20.9.2367; RASTINEJAD F, 1993, CELL, V72, P903, DOI 10.1016/0092-8674(93)90579-F; RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209; REYNOLDS GA, 1984, CELL, V38, P275, DOI 10.1016/0092-8674(84)90549-X; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; SALMON AM, 1992, NEUROREPORT, V3, P973, DOI 10.1097/00001756-199211000-00006; Sambrook J, 1989, MOL CLONING LABORATO; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; SUNYER T, 1993, J NEUROSCI RES, V36, P224, DOI 10.1002/jnr.490360213; WALSH K, 1988, MOL CELL BIOL, V8, P1800, DOI 10.1128/MCB.8.4.1800; WENTWORTH BM, 1991, P NATL ACAD SCI USA, V88, P1242, DOI 10.1073/pnas.88.4.1242; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783	59	71	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1866	1872		10.1074/jbc.270.4.1866	http://dx.doi.org/10.1074/jbc.270.4.1866			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829523	hybrid			2022-12-27	WOS:A1995QD20400058
J	PERELROIZEN, I; CARLIER, MF; PANTALONI, D				PERELROIZEN, I; CARLIER, MF; PANTALONI, D			BINDING OF BIVALENT CATION AND NUCLEOTIDE TO G-ACTIN IN THE PRESENCE OF PROFILIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIVALENT METAL-ION; LOW-AFFINITY SITES; ACANTHAMOEBA PROFILIN; MONOMERIC ACTIN; F-ACTIN; ATP; FILAMENT; EXCHANGE; THYMOSIN-BETA-4; MECHANISM	The effect of profilin, a G-actin binding protein, on the mechanism of exchange of the tightly bound metal ion and nucleotide on G-actin, has been investigated, 1) In low ionic strength buffer, profilin increases the rates of Ca2+ and Mg2+ dissociation from G-actin 250- and 50-fold, respectively, On the profilin-actin complex as well as on G-actin alone, nucleotide exchange is dependent on the concentration of divalent metal ion and is kinetically limited, at low concentration of metal ion, by the dissociation of the metal ion, 2) Under physiological ionic conditions, nucleotide exchange on G-actin is 1 order of magnitude faster than at low ionic strength. The rate of MgATP dissociation is increased by profilin from 0.05 s(-1) to 2 s(-1), the rate of MgADP dissociation is increased from 0.2 s(-1) to 24 s(-1). The dependences of the exchange rates on profilin concentration are consistent with a high affinity (5 x 10(6) to 10(7) M(-1)) of profilin for ATP G-actin, and a 20-fold lower affinity for ADP-G-actin, Profilin binding to actin lowers the affinity of metal-nucleotide by about 1 order of magnitude, These results restrain the possible roles of profilin in actin assembly in vivo.			PERELROIZEN, I (corresponding author), CNRS,ENZYMOL LAB,F-91198 GIF SUR YVETTE,FRANCE.							ATTRI AK, 1991, J BIOL CHEM, V266, P6815; Carlier Marie-France, 1994, Seminars in Cell Biology, V5, P183, DOI 10.1006/scel.1994.1023; CARLIER MF, 1986, J BIOL CHEM, V261, P785; CARLIER MF, 1984, J BIOL CHEM, V259, P9983; CARLIER MF, 1993, P NATL ACAD SCI USA, V90, P5034, DOI 10.1073/pnas.90.11.5034; CARLIER MF, 1986, J BIOL CHEM, V261, P778; CARLIER MF, 1991, J BIOL CHEM, V266, P1; ESTES JE, 1987, J BIOL CHEM, V262, P4952; ESTES JE, 1992, J MUSCLE RES CELL M, V13, P272, DOI 10.1007/BF01766455; FRIEDEN C, 1982, J BIOL CHEM, V257, P2882; FRIEDEN C, 1988, BIOCHEMISTRY-US, V27, P3812, DOI 10.1021/bi00410a044; GERSHMAN LC, 1991, J BIOL CHEM, V266, P76; GERSHMAN LC, 1986, BIOCHEM BIOPH RES CO, V135, P607, DOI 10.1016/0006-291X(86)90036-7; GOLDSCHMIDTCLER.PJ, 1991, J CELL BIOL, V113, P1081; GOLDSCHMIDTCLER.PJ, 1992, MOL BIOL CELL, V3, P1015; GORDON DJ, 1977, J BIOL CHEM, V252, P8300; HARTWIG JH, 1992, J CELL BIOL, V118, P1421, DOI 10.1083/jcb.118.6.1421; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; KABSCH W, NATURE, V347, P37; KINOSIAN HJ, 1993, J BIOL CHEM, V268, P8683; Machesky Laura M., 1993, Trends in Cell Biology, V3, P381, DOI 10.1016/0962-8924(93)90087-H; Maciver S. K., 1993, Molecular Biology of the Cell, V4, p152A; MALM B, 1984, FEBS LETT, V173, P399, DOI 10.1016/0014-5793(84)80813-3; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; MCLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18; MOCKRIN SC, 1990, BIOCHEMISTRY-US, V19, P5359; NACHMIAS VT, 1990, CURR OPIN CELL BIOL, V5, P56; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P1160, DOI 10.1021/bi00326a015; NOWAK E, 1988, BIOCHEMISTRY-US, V27, P1785, DOI 10.1021/bi00405a060; PANTALONI D, 1984, J BIOL CHEM, V259, P6274; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; PERELROIZEN I, 1994, BIOCHEMISTRY-US, V33, P8472, DOI 10.1021/bi00194a011; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; PRING M, 1992, BIOCHEMISTRY-US, V31, P1827, DOI 10.1021/bi00121a035; SAFER D, 1991, J BIOL CHEM, V266, P4029; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; SELDEN LA, 1989, J BIOL CHEM, V264, P9271; SOHN RH, 1994, BIOESSAYS, V16, P465, DOI 10.1002/bies.950160705; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; THERIOT J, 1993, CELL, V75, P836; Theriot Julie A., 1992, Trends in Cell Biology, V2, P219, DOI 10.1016/0962-8924(92)90298-2; TOBACMAN LS, 1987, BIOCHEMISTRY-US, V26, P492, DOI 10.1021/bi00376a022; TSENG PCH, 1984, J CELL BIOL, V98, P214, DOI 10.1083/jcb.98.1.214; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; VALENTINRANC C, 1991, J BIOL CHEM, V266, P7668; VALENTINRANC C, 1989, J BIOL CHEM, V264, P20871; ZIMMERLE CT, 1988, BIOCHEMISTRY-US, V27, P7759, DOI 10.1021/bi00420a026	47	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1501	1508		10.1074/jbc.270.4.1501	http://dx.doi.org/10.1074/jbc.270.4.1501			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829477	hybrid			2022-12-27	WOS:A1995QD20400006
J	PERLMAN, S; SCHAMBYE, HT; RIVERO, RA; GREENLEE, WJ; HJORTH, SA; SCHWARTZ, TW				PERLMAN, S; SCHAMBYE, HT; RIVERO, RA; GREENLEE, WJ; HJORTH, SA; SCHWARTZ, TW			NONPEPTIDE ANGIOTENSIN AGONIST - FUNCTIONAL AND MOLECULAR INTERACTION WITH THE AT(1) RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							II RECEPTOR; EXPRESSION; NK1; ANTAGONISTS; EPITOPES; CLONING	Non-peptide ligands for peptide receptors of the G-protein-coupled type are generally antagonists, except in the opiate system, Recently, it was observed that a subset of biphenylimidazole derivatives surprisingly possessed angiotensin-like activity in vivo. In COS-7 cells transfected with the rat AT(1) receptor a prototype of these compounds, L-162,313 stimulated phosphoinositide hydrolysis with an EC(50) of 33 +/- 11 nM. The maximal response to the compound was 50% of that of angiotensin II in COS-7 cells but only 3% in stably transfected Chinese hamster ovary cells, The agonistic effect of L 162,313 was blocked by the AT(1)-specific antagonist L-158,809 and was not observed in untransfected cells, In Chinese hamster ovary cells, L-162,313 also acted as an insurmountable antagonist of the angiotensin stimulated phosphoinositide hydrolysis, In contrast to previously tested non-peptide ligands, L-162,313 bound with reasonably high affinity to the Xenopus laevis AT(1) receptor. In the human receptor, the binding of L 162,313 was found to be unaffected by point mutations in transmembrane segments III and VII, which impaired the binding of biphenylimidazole antagonists. Substitutions in the extracellular domains of the human and rat receptor, which impaired the binding of angiotensin II, did not affect the binding of L-162,313, It is concluded that a subset of biphenylimidazole compounds can act as high affinity partial agonists on the AT(1) receptor, These compounds have molecular interactions with the receptor which appear to differ both from that of the structurally similar non-peptide antagonists and from that of their functional counterpart, the peptide agonist.	UNIV COPENHAGEN,RIGSHOSP 6321,DEPT CLIN BIOCHEM,MOLEC ENDOCRINOL LAB,DK-2000 COPENHAGEN,DENMARK; MERCK & CO INC,MERCK SHARP & DOHME RES LABS,DEPT EXPLORATORY CHEM,RAHWAY,NJ 07065	Rigshospitalet; University of Copenhagen; Merck & Company				Schwartz, Thue W./0000-0002-0261-6904; Hjorth, Siv Annegrethe/0000-0002-6470-650X				BERGSMA DJ, 1992, BIOCHEM BIOPH RES CO, V183, P989, DOI 10.1016/S0006-291X(05)80288-8; BERGSMA DJ, 1993, MOL PHARMACOL, V44, P277; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; BURNS HD, 1994, J NUCL MED, V35; Freidinger Roger M., 1993, V40, P33; GETHER U, 1993, NATURE, V362, P345, DOI 10.1038/362345a0; GETHER U, 1993, J BIOL CHEM, V268, P7893; GETHER U, 1993, P NATL ACAD SCI USA, V90, P6194, DOI 10.1073/pnas.90.13.6194; GETHER U, 1994, MOL PHARMACOL, V45, P500; HJORTH SA, 1994, J BIOL CHEM, V269, P30953; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; JI H, 1994, J BIOL CHEM, V269, P16533; JOHANSEN TE, 1990, FEBS LETT, V267, P289, DOI 10.1016/0014-5793(90)80947-H; MANTLO NB, 1991, J MED CHEM, V34, P2919, DOI 10.1021/jm00113a035; MUKOYAMA M, 1993, J BIOL CHEM, V268, P24539; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; RIVERO RA, 1994, 24TH NAT MED CHEM S, P43; SANDBERG K, 1994, TRENDS ENDOCRIN MET, V5, P28, DOI 10.1016/1043-2760(94)90118-X; SCHAMBYE HT, 1994, P NATL ACAD SCI USA, V91, P7046, DOI 10.1073/pnas.91.15.7046; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; SHARPES ES, 1983, ANAL BIOCHEM, V124, P421; WEXLER RR, 1992, AM J HYPERTENS, V5, P209	22	104	104	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1493	1496		10.1074/jbc.270.4.1493	http://dx.doi.org/10.1074/jbc.270.4.1493			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829475	hybrid			2022-12-27	WOS:A1995QD20400004
J	EITZEN, GA; AITCHISON, JD; SZILARD, RK; VEENHUIS, M; NUTTLEY, WM; RACHUBINSKI, RA				EITZEN, GA; AITCHISON, JD; SZILARD, RK; VEENHUIS, M; NUTTLEY, WM; RACHUBINSKI, RA			THE YARROWIA-LIPOLYTICA GENE PAY2 ENCODES A 42-KDA PEROXISOMAL INTEGRAL MEMBRANE-PROTEIN ESSENTIAL FOR MATRIX PROTEIN IMPORT AND PEROXISOME ENLARGEMENT BUT NOT FOR PEROXISOME PROLIFERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER PEROXISOMES; YEAST PICHIA-PASTORIS; SACCHAROMYCES-CEREVISIAE; ZELLWEGER SYNDROME; TARGETING SIGNAL; HANSENULA-POLYMORPHA; CANDIDA-TROPICALIS; 3-KETOACYL-COA THIOLASE; DEFICIENT MUTANTS; CARBOXY TERMINUS	PAY genes are required for peroxisome assembly in the yeast Yarrowia lipolytica. Here we show that a mutant strain, pay2, is disrupted for the import of proteins targeted by either peroxisomal targeting signal-1 or -2. Electron microscopy of pay2 cells revealed the presence of small peroxisomal ''ghosts,'' similar to the vesicular structures found in fibroblasts of patients with the human peroxisome assembly disorder, Zellweger syndrome. Functional complementation of pay2 with a plasmid library of Y. lipolytica genomic DNA identified a gene, PAY2, that restores growth of pay2 on oleic acid, import of catalase and multifunctional enzyme into peroxisomes, and formation of wild type peroxisomes. The PAY2 gene encodes Pay2p, a hydrophobic polypeptide of 404 amino acids. An antibody raised against Pay2p recognizes a polypeptide of similar to 42-kDa whose synthesis is induced by growth of Y. lipolytica on oleic acid, Pay2p is a peroxisomal integral membrane protein, as it localizes to carbonate stripped peroxisomal membranes. Pay2p shows no identity to any known protein. Our results suggest that Pay2p is essential for the activity of the peroxisomal import machinery but does not affect the initial steps of peroxisomal membrane proliferation.	UNIV ALBERTA,DEPT ANAT & CELL BIOL,EDMONTON,AB T6G 2H7,CANADA; UNIV GRONINGEN,ELECTRON MICROSCOPY LAB,9750 AA HAREN,NETHERLANDS	University of Alberta; University of Groningen			Eitzen, Gary/D-3682-2009					AITCHISON JD, 1991, J BIOL CHEM, V266, P23197; Ausubel FM, 1988, MOL REPROD DEV; BAUDHUIN P, 1964, BIOCHEM J, V92, P179, DOI 10.1042/bj0920179; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CIGAN AM, 1987, GENE, V59, P1; COOPERSTEIN SJ, 1951, J BIOL CHEM, V189, P665; CRANE DI, 1994, J BIOL CHEM, V269, P21835; CREGG JM, 1990, YEAST, V6, P87, DOI 10.1002/yea.320060202; DEDUVE C, 1966, PHYSIOL REV, V46, P323, DOI 10.1152/physrev.1966.46.2.323; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; ERDMANN R, 1991, CELL, V64, P499, DOI 10.1016/0092-8674(91)90234-P; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P2432; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; FUJIKI Y, 1984, P NATL ACAD SCI-BIOL, V81, P7127, DOI 10.1073/pnas.81.22.7127; FUJIKI Y, 1986, J BIOL CHEM, V261, P5787; GAILLARDIN CM, 1973, ARCH MIKROBIOL, V92, P69, DOI 10.1007/BF00409513; GARTNER J, 1992, NAT GENET, V1, P16, DOI 10.1038/ng0492-16; GLOVER JR, 1994, J BIOL CHEM, V269, P7558; GODECKE A, 1989, CURR GENET, V16, P13, DOI 10.1007/BF00411078; GOULD SJ, 1988, J CELL BIOL, V107, P897, DOI 10.1083/jcb.107.3.897; GOULD SJ, 1992, YEAST, V8, P613, DOI 10.1002/yea.320080805; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; GOULD SJ, 1990, EMBO J, V9, P85, DOI 10.1002/j.1460-2075.1990.tb08083.x; HAJRA AK, 1982, ANN NY ACAD SCI, V386, P170, DOI 10.1111/j.1749-6632.1982.tb21415.x; HOHFELD J, 1991, J CELL BIOL, V114, P1167, DOI 10.1083/jcb.114.6.1167; KAMIRYO T, 1982, J BACTERIOL, V152, P269; KRISANS SK, 1985, J LIPID RES, V26, P1324; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043; LITHGOW T, 1993, FEBS LETT, V329, P1, DOI 10.1016/0014-5793(93)80179-X; LIU H, 1992, J BACTERIOL, V174, P4943, DOI 10.1128/JB.174.15.4943-4951.1992; MCCAMMON MT, 1994, J CELL BIOL, V124, P915, DOI 10.1083/jcb.124.6.915; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; NEEDLEMAN RB, 1975, ANAL BIOCHEM, V64, P545, DOI 10.1016/0003-2697(75)90466-2; NUTTLEY WM, 1994, J BIOL CHEM, V269, P556; NUTTLEY WM, 1993, YEAST, V9, P507, DOI 10.1002/yea.320090506; OSUMI T, 1979, BIOCHEM BIOPH RES CO, V89, P580, DOI 10.1016/0006-291X(79)90669-7; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; RAO JKM, 1986, BIOCHIM BIOPHYS ACTA, V869, P197, DOI 10.1016/0167-4838(86)90295-5; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTOS MJ, 1988, J BIOL CHEM, V263, P10502; SANTOS MJ, 1988, SCIENCE, V239, P1536, DOI 10.1126/science.3281254; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; SPONG AP, 1993, J CELL BIOL, V123, P535, DOI 10.1083/jcb.123.3.535; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; THOMPSON SL, 1987, J BIOL CHEM, V262, P17420; VANDERKLEI IJ, 1991, YEAST, V7, P195, DOI 10.1002/yea.320070302; VANDERLEIJ I, 1992, J CELL BIOL, V119, P153, DOI 10.1083/jcb.119.1.153; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; VEENHUIS M, 1990, J CELL SCI, V96, P583; WALTON PA, 1992, MOL CELL BIOL, V12, P531, DOI 10.1128/MCB.12.2.531; WATERHAM HR, 1992, YEAST, V8, P961, DOI 10.1002/yea.320081106; WENDLAND M, 1993, J CLIN INVEST, V92, P2462, DOI 10.1172/JCI116854; WIEBEL FF, 1992, NATURE, V359, P73, DOI 10.1038/359073a0; YAJIMA S, 1992, HUM GENET, V88, P491, DOI 10.1007/BF00219334; ZHANG H, 1988, NUCLEIC ACIDS RES, V16, P1220, DOI 10.1093/nar/16.3.1220; ZHANG JW, 1993, J CELL BIOL, V123, P1133, DOI 10.1083/jcb.123.5.1133	63	47	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1429	1436		10.1074/jbc.270.3.1429	http://dx.doi.org/10.1074/jbc.270.3.1429			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836411	Green Submitted, hybrid			2022-12-27	WOS:A1995QB15600068
J	REZZONICO, R; PONZIO, G; LOUBAT, A; LALLEMAND, D; PROUDFOOT, A; ROSSI, B				REZZONICO, R; PONZIO, G; LOUBAT, A; LALLEMAND, D; PROUDFOOT, A; ROSSI, B			2 DISTINCT SIGNALING PATHWAYS ARE INVOLVED IN THE CONTROL OF THE BIPHASIC JUNB TRANSCRIPTION INDUCED BY INTERLEUKIN-6 IN THE B-CELL HYBRIDOMA-7TD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATORY FACTOR-II; DNA-BINDING ACTIVITY; PLASMACYTOMA GROWTH-FACTOR; C-JUN; RESPONSE ELEMENT; TYROSINE KINASE; GENE-TRANSCRIPTION; CYCLE PROGRESSION; NUCLEAR FACTOR; MESSENGER-RNA	We have measured the level of junB mRNA in the B hybridoma cell line 7TD1, under interleukin-6 (IL-6) stimulation. IL-6 increases junB mRNA in a biphasic fashion, The first early-induced peak was transient and likely corresponds to the well documented typical junB mRNA, stimulated in response to numerous growth factors, including IL-6, At variance, the second peak which has never been reported previously, lasted several hours, As a consequence of its effect on junB mRNA, IL-6 stimulated, in a biphasic fashion, the nuclear accumulation of the JunB protein, In this study, we demonstrated that IL-6 regulation occurred exclusively at the transcriptional level and that the bimodal increase of junB mRNA and JunB protein can be accounted for by a biphasic stimulation of junB transcription. Furthermore, our data point to two major differences between the mechanism of control of the early and the late IL-6-induced junB transcription waves. First, cycloheximide strongly potentiated the transcription of the second wave, whereas it failed to affect the early-induced burst, Second, tyrphostin, a tyrosine kinase inhibitor, impaired the expression of the first but not the second junB mRNA peak, Conversely, genistein, another tyrosine kinase inhibitor, totally abolished the expression of the second peak of junB mRNA whereas it did not affect the expression of the first peak. Altogether these data indicate that, in 7TD1 cells, IL-6 controls junB transcription in a biphasic fashion by means of two separate transduction pathways.	FAC MED NICE,INSERM,U364,F-06107 NICE 02,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur			lallemand, dominique/O-7445-2017; Ponzio, Gilles/Q-1256-2016; REZZONICO, Roger/N-9626-2016	lallemand, dominique/0000-0002-0212-7342; Ponzio, Gilles/0000-0003-2741-0248; REZZONICO, Roger/0000-0002-8460-1641				AGBOTOUNOU WK, 1994, BIOCHEM PHARMACOL, V48, P505, DOI 10.1016/0006-2952(94)90280-1; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; ANAFI M, 1992, J BIOL CHEM, V267, P4518; ANDUS T, 1987, FEBS LETT, V221, P18, DOI 10.1016/0014-5793(87)80344-7; BINETRUY B, 1991, NATURE, V351, P122, DOI 10.1038/351122a0; BOISE LH, 1993, MOL CELL BIOL, V13, P1911, DOI 10.1128/MCB.13.3.1911; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; CARTER R, 1991, ONCOGENE, V6, P229; CASTELLAZZI M, 1991, P NATL ACAD SCI USA, V88, P8890, DOI 10.1073/pnas.88.20.8890; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DEGROOT RP, 1991, NUCLEIC ACIDS RES, V19, P775, DOI 10.1093/nar/19.4.775; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOGLIO A, 1986, BIOCHEM J, V238, P123, DOI 10.1042/bj2380123; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; HAMA T, 1989, NEUROSCI LETT, V104, P340, DOI 10.1016/0304-3940(89)90600-9; HARROCH S, 1994, EMBO J, V13, P1942, DOI 10.1002/j.1460-2075.1994.tb06463.x; HATTORI M, 1990, P NATL ACAD SCI USA, V87, P2364, DOI 10.1073/pnas.87.6.2364; HIRANO T, 1985, P NATL ACAD SCI USA, V82, P5490, DOI 10.1073/pnas.82.16.5490; HOCKE GM, 1992, MOL CELL BIOL, V12, P2282, DOI 10.1128/MCB.12.5.2282; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; KITABAYASHI I, 1993, J BIOL CHEM, V266, P14482; KOVARY K, 1991, MOL CELL BIOL, V11, P4466, DOI 10.1128/MCB.11.9.4466; KOVARY K, 1991, MOL CELL BIOL, V11, P2451, DOI 10.1128/MCB.11.5.2451; LEVITZKI A, 1992, FASEB J, V6, P3275, DOI 10.1096/fasebj.6.14.1426765; LINASSIER C, 1990, BIOCHEM PHARMACOL, V39, P187, DOI 10.1016/0006-2952(90)90664-7; LORD KA, 1991, MOL CELL BIOL, V11, P4371, DOI 10.1128/MCB.11.9.4371; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; MELAMED D, 1993, MOL CELL BIOL, V13, P5255, DOI 10.1128/MCB.13.9.5255; MELAMED D, 1993, CELL GROWTH DIFFER, V4, P689; MIYAURA C, 1988, FEBS LETT, V234, P17, DOI 10.1016/0014-5793(88)81293-6; MURAGUCHI A, 1988, J EXP MED, V167, P332, DOI 10.1084/jem.167.2.332; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; NAKAJIMA K, 1991, MOL CELL BIOL, V11, P1409, DOI 10.1128/MCB.11.3.1409; NAKAJIMA K, 1993, MOL CELL BIOL, V13, P3027, DOI 10.1128/MCB.13.5.3027; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; NORDAN RP, 1986, SCIENCE, V233, P566, DOI 10.1126/science.3726549; OFFIR R, 1990, NATURE, V348, P78; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; PROUDFOOT AEI, 1993, J PROTEIN CHEM, V12, P489, DOI 10.1007/BF01025050; PULVERER BJ, 1993, ONCOGENE, V8, P407; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; SATOH T, 1988, MOL CELL BIOL, V8, P3546, DOI 10.1128/MCB.8.8.3546; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; TAKAI Y, 1988, J IMMUNOL, V140, P508; TREJO J, 1992, MOL CELL BIOL, V12, P4742, DOI 10.1128/MCB.12.10.4742; UYTTENHOVE C, 1988, J EXP MED, V167, P1417, DOI 10.1084/jem.167.4.1417; VANDAMME J, 1987, J EXP MED, V165, P914, DOI 10.1084/jem.165.3.914; Vogt P K, 1990, Adv Cancer Res, V55, P1, DOI 10.1016/S0065-230X(08)60466-2; WEGENKA UM, 1994, MOL CELL BIOL, V14, P3186, DOI 10.1128/MCB.14.5.3186; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	56	21	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1261	1268		10.1074/jbc.270.3.1261	http://dx.doi.org/10.1074/jbc.270.3.1261			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836389	hybrid			2022-12-27	WOS:A1995QB15600044
J	MARFATIA, SM; LUE, RA; BRANTON, D; CHISHTI, AH				MARFATIA, SM; LUE, RA; BRANTON, D; CHISHTI, AH			IDENTIFICATION OF THE PROTEIN 4.1 BINDING INTERFACE ON GLYCOPHORIN-C AND GLYCOPHORIN-P55, A HOMOLOG OF THE DROSOPHILA DISKS-LARGE TUMOR-SUPPRESSOR PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN; SEPTATE JUNCTIONS; ERYTHROCYTE; GENE; SKELETON; STABILITY; CONTAINS; LINKAGE; KINASE; DOMAIN	Protein 4.1 is the prototype of a family of proteins that include ezrin, talin, brain tumor suppressor merlin, and tyrosine phosphatases, All members of the protein 4.1 superfamily share a highly conserved N-terminal 30-kDa domain whose biological function is poorly understood. It is believed that the attachment of the cytoskeleton to the membrane may be mediated via this 30-kDa domain, a function that requires formation of multiprotein complexes at the plasma membrane, In this investigation, synthetically tagged peptides and bacterially expressed proteins were used to map the protein 4.1 binding site on human erythroid glycophorin C, a transmembrane glycoprotein, and on human erythroid p55, a palmitoylated peripheral membrane phosphoprotein. The results show that the 30-kDa domain of protein 4.1 binds to a 12-amino acid segment within the cytoplasmic domain of glycophorin C and to a positively charged, 39-amino acid motif in p55, Sequences similar to this charged motif are conserved in other members of the p55 superfamily, including the Drosophila discs-large tumor suppressor protein, Our data provide new insights into how protein 4.1, glycophorin C, p55, and their non-erythroid homologues, interact with the cytoskeleton to exert their physiological effects.	TUFTS UNIV,SCH MED,ST ELIZABETH MED RES,DEPT BIOMED RES,BOSTON,MA 02135; HARVARD UNIV,DEPT MOLEC & CELLULAR BIOL,CAMBRIDGE,MA 02138	St. Elizabeth's Medical Center; Tufts University; Harvard University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL037462, R01HL017411, R01HL051445, R56HL051445] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL17411, HL51445, HL37462] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; ALLOISIO N, 1993, BLOOD, V82, P1323, DOI 10.1182/blood.V82.4.1323.bloodjournal8241323; ANDERSON RA, 1984, NATURE, V307, P655, DOI 10.1038/307655a0; ANDERSON RA, 1985, NATURE, V318, P295, DOI 10.1038/318295a0; ANDERSON RA, 1989, RED BLOOD CELL MEMBR, P187; ARPIN M, 1994, CURR OPIN CELL BIOL, V6, P136, DOI 10.1016/0955-0674(94)90127-9; CHASIS JA, 1992, BLOOD, V80, P1869; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; COLIN Y, 1986, J BIOL CHEM, V261, P229; CORREAS I, 1991, BIOCHEM J, V279, P581, DOI 10.1042/bj2790581; CORREAS I, 1986, J BIOL CHEM, V261, P3310; FEHON RG, 1994, DEVELOPMENT, V120, P545; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HEMMING NJ, 1994, BIOCHEM J, V299, P191, DOI 10.1042/bj2990191; ITOH M, 1993, J CELL BIOL, V121, P491, DOI 10.1083/jcb.121.3.491; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; JONS T, 1992, EMBO J, V11, P2863, DOI 10.1002/j.1460-2075.1992.tb05354.x; KIM CLV, 1989, J BIOL CHEM, V264, P20407; KISTNER U, 1993, J BIOL CHEM, V268, P4580; LETO TL, 1984, J BIOL CHEM, V259, P4603; LETO TL, 1986, MEMBRANE SKELETONS C, P201; LING E, 1988, J BIOL CHEM, V263, P2209; LOWINGER L, 1988, EMBO J, V7, P2301; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; MARFATIA SM, 1994, J BIOL CHEM, V269, P8631; OHANIAN V, 1984, EUR J BIOCHEM, V144, P375, DOI 10.1111/j.1432-1033.1984.tb08474.x; PASTERNACK GR, 1985, J BIOL CHEM, V260, P3676; REID ME, 1987, BLOOD, V69, P1068; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; RUFF P, 1991, P NATL ACAD SCI USA, V88, P6595, DOI 10.1073/pnas.88.15.6595; TAKAKUWA Y, 1986, J CLIN INVEST, V78, P80, DOI 10.1172/JCI112577; TCHERNIA G, 1981, J CLIN INVEST, V68, P454, DOI 10.1172/JCI110275; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7; YONEMURA S, 1993, J CELL BIOL, V120, P437, DOI 10.1083/jcb.120.2.437	38	170	174	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					715	719		10.1074/jbc.270.2.715	http://dx.doi.org/10.1074/jbc.270.2.715			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822301	hybrid			2022-12-27	WOS:A1995QB81600035
J	NORRIS, FA; UNGEWICKELL, E; MAJERUS, PW				NORRIS, FA; UNGEWICKELL, E; MAJERUS, PW			INOSITOL HEXAKISPHOSPHATE BINDS TO CLATHRIN ASSEMBLY PROTEIN 3(AP-3/AP180) AND INHIBITS CLATHRIN CAGE ASSEMBLY IN-VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPHOSPHATE RECEPTOR; MONOCLONAL-ANTIBODIES; PLASMA-MEMBRANE; COATED VESICLES; BRAIN; NP185; AP-2	We have isolated an inositol hexakisphosphate binding protein from rat brain by affinity elution chromatography from Mono S cation exchange resin using 0.1 mM inositol hexakisphosphate (InsP(6)). The amino acid sequences of six tryptic peptides from the protein were identical to the sequences predicted from the cDNA encoding a previously isolated protein designated as AP-3 or AP180. This protein is localized in nerve endings and promotes assembly of clathrin into coated vesicles. The isolated protein-bound InsP(6) with a dissociation constant of 1.2 mu M and a stoichiometry of 0.9 mel of InsP(6) bound/mol of AP-3. Recombinant AP-3 expressed in Escherichia coli also bound InsP(6) with a similar affinity. InsP(6) inhibited clathrin cage assembly mediated by AP-3, in an in vitro assay, but had little effect AP-3 binding to preformed cages. We speculate that InsP(6) and perhaps highly phosphorylated inositol lipids may play a role in coated vesicle formation.	WASHINGTON UNIV, SCH MED, DEPT BIOCHEM & MOLEC BIOPHYS, DIV HEMATOL ONCOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, CTR IMMUNOL, DEPT PATHOL, ST LOUIS, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	NORRIS, FA (corresponding author), WASHINGTON UNIV, SCH MED, DEPT INTERNAL MED, DIV HEMATOL ONCOL, ST LOUIS, MO 63110 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016634, T32HL007088, P50HL014147, R01HL016634] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL14147, HL16634, HL07088] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AHLE S, 1988, EMBO J, V7, P919, DOI 10.1002/j.1460-2075.1988.tb02897.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BECK KA, 1991, J BIOL CHEM, V266, P4442; CHADWICK CC, 1992, J BIOL CHEM, V267, P3473; DAYHOFF MO, 1983, METHOD ENZYMOL, V91, P524; JOLY M, 1994, SCIENCE, V263, P684, DOI 10.1126/science.8303278; KOHTZ DS, 1988, J BIOL CHEM, V263, P7418; LINDNER R, 1991, BIOCHEMISTRY-US, V30, P9097, DOI 10.1021/bi00101a027; LINDNER R, 1992, J BIOL CHEM, V267, P16567; MARTIN JB, 1987, BIOCHIM BIOPHYS ACTA, V931, P16, DOI 10.1016/0167-4889(87)90045-0; Morris SA, 1989, CURR OPIN CELL BIOL, V1, P684, DOI 10.1016/0955-0674(89)90034-3; MORRIS SA, 1993, EMBO J, V12, P667, DOI 10.1002/j.1460-2075.1993.tb05700.x; MURPHY JE, 1991, J BIOL CHEM, V266, P4401; NORRIS FA, 1994, J BIOL CHEM, V269, P8716; PITTET D, 1989, J BIOL CHEM, V264, P18489; RAWAL N, 1992, BIOCHEM J, V287, P929, DOI 10.1042/bj2870929; ROBINSON MS, 1987, J CELL BIOL, V104, P887, DOI 10.1083/jcb.104.4.887; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; THEIBERT AB, 1991, P NATL ACAD SCI USA, V88, P3165, DOI 10.1073/pnas.88.8.3165; TIMERMAN AP, 1992, P NATL ACAD SCI USA, V89, P8976, DOI 10.1073/pnas.89.19.8976; Trowbridge IS, 1991, CURR OPIN CELL BIOL, V3, P1062, DOI 10.1016/0955-0674(91)90130-Q; VOGLMAIER SM, 1992, BIOCHEM BIOPH RES CO, V187, P158, DOI 10.1016/S0006-291X(05)81473-1; ZHOU SB, 1992, J NEUROSCI, V12, P2144; ZHOU SB, 1993, J BIOL CHEM, V268, P12655	24	101	101	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					214	217		10.1074/jbc.270.1.214	http://dx.doi.org/10.1074/jbc.270.1.214			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814377	hybrid			2022-12-27	WOS:A1995QA28700036
J	CLAUS, P; SCHULZE, E; WISNIEWSKI, JR				CLAUS, P; SCHULZE, E; WISNIEWSKI, JR			INSECT PROTEINS HOMOLOGOUS TO MAMMALIAN HIGH-MOBILITY GROUP PROTEINS-I/Y (HMG-I/Y) - CHARACTERIZATION AND BINDING TO LINEAR AND 4-WAY JUNCTION DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; CHROMOSOMAL PROTEIN; DROSOPHILA-MELANOGASTER; PREFERENTIAL BINDING; SATELLITE DNA; BASE-PAIRS; HISTONE H1; CDNAS; CHROMATIN; DOMAINS	A chromosomal high mobility group (HMG) protein from an epithelial cell line of Chironomus tentans (Diptera) was purified to homogeneity and chemically characterized. cDNA clones encoding this protein were isolated and sequenced. The deduced amino acid sequence revealed a high similarity to HMG protein I of mammalia. This insect protein has therefore been designated cHMGI. It has a deduced molecular mass of 10,371 kDa and appears to be a product of a single gene copy. Similarly to mammalian HMGI/Y proteins the insect cHMGI protein has three putative DNA-binding motifs with a sequence K/RXRGRP that are each encoded by one exon of the gene. Using synthetic peptides we have shown that the first and the second moth are necessary for high-affinity binding of the protein to DNA. Protein cHMGI binds preferentially to AT-rich DNA with a half-saturation value of 1.1 nM. Both cHMGI and human HMGI proteins recognize specifically a four-way junction DNA. We have also purified a related protein with similar physico-chemical properties from Drosophila melanogaster It, cells. The identification and characterization of HMGI proteins in insects with polytene chromosomes and with the cytologic and genetic potential of Chironomus and Drosophila opens new possibilities for studying function(s) of this group of chromosomal proteins.	UNIV GOTTINGEN,ZOOL INST ENTWICKLUNGSBIOL,DEPT ZOOL DEV BIOL 3,D-37073 GOTTINGEN,GERMANY	University of Gottingen			Claus, Peter/A-7978-2008	Claus, Peter/0000-0003-3824-9445				ASHLEY CT, 1989, J BIOL CHEM, V264, P8394; BIANCHI ME, 1988, EMBO J, V7, P843, DOI 10.1002/j.1460-2075.1988.tb02883.x; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; BUSTIN M, 1990, BIOCHIM BIOPHYS ACTA, V1049, P231, DOI 10.1016/0167-4781(90)90092-G; CAREY J, 1988, P NATL ACAD SCI USA, V85, P975, DOI 10.1073/pnas.85.4.975; Echalier G., 1976, INVERTEBRATE TISSUE, P131, DOI [10.1016/B978-0-12-429740-1.50014-X, DOI 10.1016/B978-0-12-429740-1.50014-X]; ECKNER R, 1989, NUCLEIC ACIDS RES, V17, P5947, DOI 10.1093/nar/17.15.5947; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRIEDMANN M, 1993, NUCLEIC ACIDS RES, V21, P4259, DOI 10.1093/nar/21.18.4259; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GEIERSTANGER BH, 1994, BIOCHEMISTRY-US, V33, P5347, DOI 10.1021/bi00183a043; GRASSER KD, 1991, NUCLEIC ACIDS RES, V19, P2573, DOI 10.1093/nar/19.10.2573; HAYASHI T, 1989, J BIOCHEM-TOKYO, V105, P577, DOI 10.1093/oxfordjournals.jbchem.a122707; JOHNSON KR, 1989, MOL CELL BIOL, V9, P2114, DOI 10.1128/MCB.9.5.2114; KARLSON JR, 1989, BIOCHEM BIOPH RES CO, V158, P646, DOI 10.1016/0006-291X(89)92770-8; KOLODRUBETZ D, 1990, J BIOL CHEM, V265, P3234; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSMAN D, 1986, J BIOL CHEM, V261, P6082; LAUX T, 1991, NUCLEIC ACIDS RES, V19, P4768, DOI 10.1093/nar/19.17.4768; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; LUND T, 1987, BIOCHEM BIOPH RES CO, V146, P725, DOI 10.1016/0006-291X(87)90589-4; LUND T, 1983, FEBS LETT, V152, P163, DOI 10.1016/0014-5793(83)80370-6; MANFIOLETTI G, 1991, NUCLEIC ACIDS RES, V19, P6793, DOI 10.1093/nar/19.24.6793; MCGINNIS W, 1983, CELL, V34, P75, DOI 10.1016/0092-8674(83)90137-X; NER SS, 1993, NUCLEIC ACIDS RES, V21, P4369, DOI 10.1093/nar/21.18.4369; NICOLAS RH, 1982, HMG CHROMOSOMAL PROT, P41; NIETOSOTELO J, 1994, PLANT CELL, V6, P287, DOI 10.1105/tpc.6.2.287; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; RADIC MZ, 1992, CHROMOSOMA, V101, P602, DOI 10.1007/BF00360537; REECK GR, 1982, NATURE, V300, P76, DOI 10.1038/300076a0; REEVES R, 1990, J BIOL CHEM, V265, P8573; REEVES R, 1991, P NATL ACAD SCI USA, V88, P1671, DOI 10.1073/pnas.88.5.1671; ROTH SY, 1987, NUCLEIC ACIDS RES, V15, P8112, DOI 10.1093/nar/15.19.8112; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMIDT ER, 1981, FEBS LETT, V129, P21, DOI 10.1016/0014-5793(81)80745-4; SOLOMON MJ, 1986, P NATL ACAD SCI USA, V83, P1276, DOI 10.1073/pnas.83.5.1276; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STRAUSS F, 1984, CELL, V37, P889, DOI 10.1016/0092-8674(84)90424-0; TJADEN G, 1994, PLANT CELL, V6, P107, DOI 10.1105/tpc.6.1.107; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; VARGAWEISZ P, 1993, J BIOL CHEM, V268, P20699; VARGAWEISZ P, 1994, P NATL ACAD SCI USA, V91, P3525, DOI 10.1073/pnas.91.9.3525; WAGNER CR, 1992, MOL CELL BIOL, V12, P1915, DOI 10.1128/MCB.12.5.1915; WISNIEWSKI JR, 1992, J BIOL CHEM, V267, P17170; WISNIEWSKI JR, 1994, J BIOL CHEM, V269, P10713; WISNIEWSKI JR, 1994, J BIOL CHEM, V269, P29261; WISNIEWSKI JR, 1994, IN PRESS EUR J BIOCH; WYSS C, 1982, EXP CELL RES, V139, P309, DOI 10.1016/0014-4827(82)90255-5; ZHAO K, 1993, EMBO J, V12, P3237, DOI 10.1002/j.1460-2075.1993.tb05993.x; ZWEIDLER A, 1972, Federation Proceedings, V31, P926	50	53	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					33042	33048						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806532				2022-12-27	WOS:A1994QA63800049
J	MODIANO, JF; DOMENICO, J; SZEPESI, A; LUCAS, JJ; GELFAND, EW				MODIANO, JF; DOMENICO, J; SZEPESI, A; LUCAS, JJ; GELFAND, EW			DIFFERENTIAL REQUIREMENTS FOR INTERLEUKIN-2 DISTINGUISH THE EXPRESSION AND ACTIVITY OF THE CYCLIN-DEPENDENT KINASES CDK4 AND CDK2 IN HUMAN T-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LYMPHOCYTES-T; NF-KAPPA-B; GENE-EXPRESSION; PHORBOL ESTERS; PROTEIN-KINASE; GROWTH-FACTOR; NUCLEAR PROTEINS; CYCLOSPORINE-A; ACTIVATION; RECEPTOR	We examined the expression and activity of Cdk4 and Cdk2 in resting, competent, and proliferating normal human T cells, Expression of Cdk4 but not of Cdk2 was induced in competent T cells independent of an IL-2 signal, This up-regulation of Cdk4 mRNA and protein was resistant to the immunosuppressant drugs cyclosporin A (CsA) and FK506, A further increase in Cdk4 expression was seen upon stimulation of competent T cells by IL 2, as was de novo expression of Cdk2. Cyclin D2, a Cdk4 partner, showed similar patterns of regulation as Cdk4, The increases in Cdk4 and cyclin D2 expression seen in competent T cells were functionally significant since Cdk4 immunoprecipitates from these cells phosphorylated recombinant RE protein in vitro, Despite the lack of an increase in the expression of Cdk2, a small pool of pre-existing Cdk2 protein detected in resting T cells could be activated upon induction of competence, These data demonstrate that 1) the signals that lead to induction of competence in T cells stimulate an IL-Q-independent and CsA resistant phase of Cdk4 and cyclin D2 expression, Cdk4 kinase activity, and Cdk2 kinase activity, and 2) IL-2 stimulates a second phase of Cdk4 and cyclin D2 expression and de novo expression of Cdk2 in these cells, The data show that the expression and activity of these major cell cycle regulatory proteins are controlled differentially by growth factors and indicate a role for Cdk4 and cyclin D2 in T cell cycle entry and/or early G(1) progression and for Cdk2 in later G(1) progression and G(1)/S transition.	NATL JEWISH CTR IMMUNOL & RESP MED, DEPT PEDIAT, DIV BASIC SCI, DENVER, CO 80206 USA	National Jewish Health			MODIANO, JAIME/K-3583-2019	MODIANO, JAIME/0000-0001-6398-7648	NHLBI NIH HHS [HL-09154, P0I-HL-36577] Funding Source: Medline; NIAID NIH HHS [AI-26490] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026490] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AJCHENBAUM F, 1993, J BIOL CHEM, V268, P4113; CHIU R, 1987, NATURE, V329, P648, DOI 10.1038/329648a0; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; ELLEDGE SJ, 1992, P NATL ACAD SCI USA, V89, P2907, DOI 10.1073/pnas.89.7.2907; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; EWEN ME, 1993, CELL, V74, P1009, DOI 10.1016/0092-8674(93)90723-4; GELFAND EW, 1989, ADV REGULATION CELL, V1, P119; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; HANKS SK, 1987, P NATL ACAD SCI USA, V84, P388, DOI 10.1073/pnas.84.2.388; HOLBROOK NJ, 1984, P NATL ACAD SCI-BIOL, V81, P1634, DOI 10.1073/pnas.81.6.1634; HORI T, 1987, BLOOD, V70, P1069; HUNTER T, 1993, CELL, V75, P839, DOI 10.1016/0092-8674(93)90528-X; KERN JA, 1986, J IMMUNOL, V137, P764; KUMAGAI N, 1988, J IMMUNOL, V141, P3747; KUMAGAI N, 1987, J IMMUNOL, V139, P1393; KUMAGAI N, 1988, J IMMUNOL, V140, P37; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; LOWENTHAL JW, 1988, P NATL ACAD SCI USA, V85, P4468, DOI 10.1073/pnas.85.12.4468; LUCAS JJ, 1992, J IMMUNOL, V148, P1804; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; MERIDA I, 1991, J IMMUNOL, V147, P2202; MEYERSON M, 1991, COLD SPRING HARB SYM, V56, P177; MILLS GB, 1988, CELL, V55, P91, DOI 10.1016/0092-8674(88)90012-8; MODIANO JF, 1991, J BIOL CHEM, V266, P10552; MODIANO JF, 1988, J CELL PHYSIOL, V135, P451, DOI 10.1002/jcp.1041350312; MURRAY AW, 1989, SCIENCE, V246, P614, DOI 10.1126/science.2683077; OR R, 1992, CLIN IMMUNOL IMMUNOP, V64, P210, DOI 10.1016/0090-1229(92)90202-Y; REED JC, 1985, J IMMUNOL, V135, P2478; REED JC, 1986, P NATL ACAD SCI USA, V83, P3982, DOI 10.1073/pnas.83.11.3982; REED SI, 1991, COLD SH Q B, V56, P61; SAWAMI H, 1992, J CELL PHYSIOL, V151, P367, DOI 10.1002/jcp.1041510218; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; SHIBUYA H, 1992, CELL, V70, P57, DOI 10.1016/0092-8674(92)90533-I; SMITH KA, 1985, P NATL ACAD SCI USA, V82, P864, DOI 10.1073/pnas.82.3.864; SUGGS SV, 1981, P NATL ACAD SCI-BIOL, V78, P6613, DOI 10.1073/pnas.78.11.6613; TAKASE K, 1992, CELL GROWTH DIFFER, V3, P515; TERADA N, 1992, J BIOL CHEM, V267, P21207; TERADA N, 1994, GROWTH FACTOR SIGNAL; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; Weiss A, 1991, Semin Immunol, V3, P313; WILKINSON M, 1988, NUCLEIC ACIDS RES, V16, P10933, DOI 10.1093/nar/16.22.10933; WINSTON JT, 1991, J CELL BIOCHEM, V47, P79, DOI 10.1002/jcb.240470110; WINSTON JT, 1993, MOL BIOL CELL, V4, P1133, DOI 10.1091/mbc.4.11.1133	46	63	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					32972	32978						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806527				2022-12-27	WOS:A1994QA63800040
J	BAECKSTROM, D; KARLSSON, N; HANSSON, GC				BAECKSTROM, D; KARLSSON, N; HANSSON, GC			PURIFICATION AND CHARACTERIZATION OF SIALYL-LE(A)-CARRYING MUCINS OF HUMAN BILE - EVIDENCE FOR THE PRESENCE OF MUC1 AND MUC3 APOPROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMORPHIC EPITHELIAL MUCIN; MONOCLONAL-ANTIBODIES; MOLECULAR-CLONING; INTESTINAL MUCIN; DIFUCOGANGLIOSIDE VI3NEUACV3III3FUC2NLC6; CA50-CARRYING ANTIGEN; PANCREATIC-CANCER; GALLBLADDER MUCIN; SEQUENCE-ANALYSIS; CORE PROTEIN	Purification of sialyl-Le(a)-carrying mucins from primary human bile by trichloroacetic acid precipitation, delipidation, and gel filtration in guanidinium chloride gave three separable fractions, one of which was further purified by affinity chromatography. These fractions, named SBG1 (for soluble bile glycoprotein), SBG2, and SBG3 had molecular masses of >1100, 800-950, and 100-250 kDa, respectively, as estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Their mucin characteristics were indicated by a high carbohydrate content, ranging from 74 to 95%. The carbohydrate compositions indicated the presence of very long fucosylated polylactosamine chains. Amino acid analyses showed high abundance of serine and threonine in all three fractions (19-36%), confirming their mucin-like nature. Immunochemical analyses of deglycosylated samples detected the MUC1 mucin apoprotein in SBG2 and the MUC3 protein in SBG1. To our knowledge, this is the first report of a MUC3 mucin being purified. This mucin showed no significant reduction in size upon trypsin treatment or disulfide bond reduction and alkylation. Gel filtration of three samples of secondary bile showed that the size distribution of sialyl-Le(a)-carrying glycoproteins was similar to that found in primary bile, and immunochemical analysis showed that the MUC1 protein was present in all three samples. In one sample an additional fraction was isolated, which was insoluble in 6 M guanidinium chloride, but was solubilized upon reduction and alkylation. mRNAs hom gallbladder epithelia were analyzed in Northern blot hybridizations showing that the MUC1 and MUC3 but not the MUC2 mucin apoprotein genes were expressed.			BAECKSTROM, D (corresponding author), GOTHENBURG UNIV,DEPT MED BIOCHEM,MED AREGATAN 9,S-41390 GOTHENBURG,SWEDEN.		Karlsson, Niclas/G-5235-2013; Hansson, Gunnar C/A-1236-2009; Hansson, Gunnar C./AAF-7324-2019	Karlsson, Niclas/0000-0002-3045-2628; Hansson, Gunnar C/0000-0002-1900-1869; Hansson, Gunnar C./0000-0002-1900-1869				ALBERT MB, 1988, DIGEST DIS SCI, V33, P1223, DOI 10.1007/BF01536670; BAECKSTROM D, 1991, J BIOL CHEM, V266, P21537; BAECKSTROM D, 1993, CANCER RES, V53, P755; BOBEK LA, 1993, J BIOL CHEM, V268, P20563; BROCKHAUS M, 1985, VOX SANG, V48, P34, DOI 10.1111/j.1423-0410.1985.tb00142.x; BURCHELL J, 1987, CANCER RES, V47, P5476; CARLSTEDT I, 1985, ESSAYS BIOCHEM, V20, P40; CARLSTEDT I, 1993, J BIOL CHEM, V268, P18771; FUKUSHI Y, 1985, CANCER RES, V45, P3711; FUKUSHI Y, 1984, J BIOL CHEM, V259, P511; GENDLER S, 1988, J BIOL CHEM, V263, P12820; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; GENDLER SJ, 1987, P NATL ACAD SCI USA, V84, P6060, DOI 10.1073/pnas.84.17.6060; GUM JR, 1990, BIOCHEM BIOPH RES CO, V171, P407, DOI 10.1016/0006-291X(90)91408-K; GUM JR, 1989, J BIOL CHEM, V264, P6480; GUM JR, 1987, J BIOL CHEM, V262, P1092; GUM JR, 1992, J BIOL CHEM, V267, P21375; HAGLUND C, 1987, INT J CANCER, V39, P477, DOI 10.1002/ijc.2910390412; HANSSON GC, 1994, BIOCHEM BIOPH RES CO, V198, P181, DOI 10.1006/bbrc.1994.1026; HEMMILA I, 1984, ANAL BIOCHEM, V137, P335, DOI 10.1016/0003-2697(84)90095-2; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; HILKENS J, 1992, TRENDS BIOCHEM SCI, V17, P359, DOI 10.1016/0968-0004(92)90315-Z; HILKENS J, 1984, INT J CANCER, V34, P197, DOI 10.1002/ijc.2910340210; HO SB, 1993, CANCER RES, V53, P641; JOHANSSON C, 1991, TUMOR BIOL, V12, P159, DOI 10.1159/000217701; JOHANSSON C, 1991, INT J CANCER, V48, P757, DOI 10.1002/ijc.2910480521; KJELDSEN T, 1988, CANCER RES, V48, P2214; LAN MS, 1987, J BIOL CHEM, V262, P12863; LINDHOLM L, 1983, INT ARCH ALLER A IMM, V71, P178, DOI 10.1159/000233384; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; MARTENSSON S, 1988, SCAND J CLIN LAB INV, V48, P633, DOI 10.3109/00365518809085783; MASUZAWA Y, 1992, J BIOCHEM-TOKYO, V112, P609, DOI 10.1093/oxfordjournals.jbchem.a123948; Neutra M.R., 1987, PHYSL GASTROINTESTIN, V2, P975; OHSHIO G, 1990, AM J GASTROENTEROL, V85, P1370; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; SMITH BF, 1984, J BIOL CHEM, V259, P2170; SMITH BF, 1990, HEPATOLOGY, V12, pS183; SOJAR HT, 1987, METHOD ENZYMOL, V138, P341; STROUS GJ, 1992, CRIT REV BIOCHEM MOL, V27, P57, DOI 10.3109/10409239209082559; THORNTON DJ, 1989, ANAL BIOCHEM, V182, P160, DOI 10.1016/0003-2697(89)90735-5; YAMASAKI T, DIGEST DIS SCI, V909, P93; YANG HJ, 1971, J BIOL CHEM, V246, P1192	42	57	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 20	1994	269	20					14430	14437						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NM065	7848403				2022-12-27	WOS:A1994NM06500022
J	POTTER, JD; SHENG, ZL; PAN, BS; ZHAO, JJ				POTTER, JD; SHENG, ZL; PAN, BS; ZHAO, JJ			A DIRECT REGULATORY ROLE FOR TROPONIN-T AND A DUAL ROLE FOR TROPONIN-C IN THE CA2+ REGULATION OF MUSCLE-CONTRACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; BIOLOGICAL-ACTIVITY; INHIBITORY REGION; CROSS-LINKING; TROPOMYOSIN; BINDING; FRAGMENTS; SUBUNITS; ACTIN; CA-2+	Troponin (Tn), containing three subunits: Ca2+ binding (TnC), inhibitory (TnI), and tropomyosin binding (TnT), plays a crucial role in the Ca2+ regulation of vertebrate striated muscle contraction. These three subunits function by interacting with each other and with the other thin filament proteins. Previous studies suggested that the primary role of TnT is to anchor the TnI.TnC complex to the thin filament, primarily through its interactions with TnI and tropomyosin. We propose here a new role for TnT. Our results indicate that, when TnT is combined with the TnI.TnC complex, there is an activation of actomyosin ATPase that is Ca2+-dependent. To determine whether the latter results from a direct effect of TnC on TnT or indirectly from an effect of TnC on TnI which is transmitted to TnT, we prepared a deletion mutant (deletion of residues 1-57) of TnI, TnI(d57) (Sheng et al. (1992) J. Biol. Chem. 267, 25407-25413), which interacts with TnC but not TnT. Both wild type (TnI.TnC.TnT) and mutant (TnI(d57).Tnc.TnT) Tn complexes demonstrated equivalent activity in the Ca2+ regulation of actomyosin-S1 ATPase activity. Similarly, both TnT and TnI(d57) could equally reconstitute TnI-depleted skinned muscle fibers. Therefore, since TnI(d57) does not interact with TnT, these results suggest that TnT reconstitutes native Ca2+ sensitivity via direct interaction with TnC. Thus Ca2+ binding to TnC would have a dual role: 1) release of the ATPase inhibition by TnI and 2) activation of the ATPase through interaction with TnT.			POTTER, JD (corresponding author), UNIV MIAMI,SCH MED,DEPT MOLEC & CELLULAR PHARMACOL,MIAMI,FL 33101, USA.				NIAMS NIH HHS [AR37701, AR40727] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040727, R01AR037701] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		CARTER SG, 1982, J BIOCHEM BIOPH METH, V7, P7, DOI 10.1016/0165-022X(82)90031-8; CHONG PCS, 1982, J BIOL CHEM, V257, P1667; FARAH CS, 1994, J BIOL CHEM, V269, P5230; GRABAREK Z, 1981, J BIOL CHEM, V256, P3121; GRABAREK Z, 1992, J MUSCLE RES CELL M, V13, P383, DOI 10.1007/BF01738034; Greaser M. L., 1972, COLD SPRING HARB SYM, V37, P235; GREASER ML, 1973, J BIOL CHEM, V248, P2125; HEELEY DH, 1987, J BIOL CHEM, V262, P9971; HITCHCOCK SE, 1975, EUR J BIOCHEM, V52, P255, DOI 10.1111/j.1432-1033.1975.tb03993.x; HITCHCOCKDEGREG.SE, 1982, J BIOL CHEM, V257, P7372; HORWITZ J, 1979, J BIOL CHEM, V254, P350; LEAVIS PC, 1984, CRC CR REV BIOCH MOL, V16, P235, DOI 10.3109/10409238409108717; LESZYK J, 1988, BIOCHEMISTRY-US, V27, P6983, DOI 10.1021/bi00418a047; LESZYK J, 1990, BIOCHEMISTRY-US, V29, P299, DOI 10.1021/bi00453a041; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; PAN BS, 1992, J BIOL CHEM, V267, P23052; PARDER JD, 1982, METHOD ENZYMOL, V85, P234; PEARLSTONE JR, 1978, CAN J BIOCHEM CELL B, V56, P521, DOI 10.1139/o78-080; PEARLSTONE JR, 1982, J BIOL CHEM, V257, P587; PEARLSTONE JR, 1983, J BIOL CHEM, V258, P2534; PERRY SV, 1972, COLD SPRING HARB SYM, V37, P251; POTTER JD, 1982, METHOD ENZYMOL, V85, P241; POTTER JD, 1975, J BIOL CHEM, V250, P4628; POTTER JD, 1974, BIOCHEMISTRY-US, V13, P2697, DOI 10.1021/bi00710a007; POTTER JD, 1993, BIOPHYS J, V64, pA137; REISER PJ, 1992, J PHYSIOL-LONDON, V449, P573, DOI 10.1113/jphysiol.1992.sp019102; ROBERTSON S, 1984, METHOD PHARMACOL, V5, P63, DOI DOI 10.1007/978-1-4684-4778-1_6; SCHACHAT FH, 1987, J MOL BIOL, V198, P551, DOI 10.1016/0022-2836(87)90300-7; SHENG Z, 1991, J BIOL CHEM, V266, P5711; SHENG Z, 1993, BIOPHYS J, V64, pA136; SHENG Z, 1992, J BIOL CHEM, V268, P25407; SHENG ZL, 1990, J BIOL CHEM, V265, P21554; SHENG ZL, 1992, J BIOL CHEM, V267, P25407; SHENG ZL, 1993, J BIOL CHEM, V268, P3016; STRAUSS JD, 1992, FEBS LETT, V310, P229, DOI 10.1016/0014-5793(92)81338-M; TOBACMAN LS, 1987, J BIOL CHEM, V262, P4059; WEEKS RA, 1978, BIOCHEM J, V173, P449, DOI 10.1042/bj1730449; ZOT AS, 1987, ANNU REV BIOPHYS BIO, V16, P535	38	144	147	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2557	2562		10.1074/jbc.270.6.2557	http://dx.doi.org/10.1074/jbc.270.6.2557			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852318	hybrid			2022-12-27	WOS:A1995QF53500026
J	SCHONFELD, HJ; SCHMIDT, D; SCHRODER, H; BUKAU, B				SCHONFELD, HJ; SCHMIDT, D; SCHRODER, H; BUKAU, B			THE DNAK CHAPERONE SYSTEM OF ESCHERICHIA-COLI - QUATERNARY STRUCTURES AND INTERACTIONS OF THE DNAK AND GRPE COMPONENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATPASE ACTIVITY; PROTEIN; PURIFICATION	The DnaK (Hsp70), DnaJ, and GrpE heat shock proteins of Escherichia coli constitute a cellular chaperone system for protein folding, Substrate interactions are controlled by the ATPase activity of DnaK which itself is regulated by the nucleotide exchange factor GrpE, To understand the structure-function relationship of this chaperone system, the quaternary structures of DnaK, GrpE, and DnaK-GrpE complexes were analyzed by gel filtration chromatography, dynamic light scattering, analytical ultracentrifugation, and native gel electrophoresis. GrpE formed dimers in solution, DnaK formed monomers, dimers, and higher mole mass oligomers, the equilibrium between these forms being dependent on the DnaK concentration, The behavior of DnaK and GrpE in gel filtration and dynamic light scattering suggested elongated shapes of both molecules, In the absence of added nucleotides, DnaK and GrpE formed stable complexes containing one molecule of DnaK and two molecules of GrpE. A 44-kDa N-terminal ATPase fragment of DnaK also formed complexes with GrpE with the same 1:2 stoichiometry. DnaK-GrpE complex formation was unaffected by elimination of DnaK-bound nucleotides or addition of saturating concentrations of a DnaK peptide substrate. These findings allow the correlation of DnaK-GrpE interactions with a role for GrpE in the functional cycle of the DnaK chaperone system.	UNIV HEIDELBERG,ZENTRUM MOLEK BIOL,D-69120 HEIDELBERG,GERMANY	Ruprecht Karls University Heidelberg	SCHONFELD, HJ (corresponding author), F HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES NEW TECHNOL,CH-4002 BASEL,SWITZERLAND.			Bukau, Bernd/0000-0003-0521-7199				ANG D, 1988, THESIS U UTAH SALT L; BLONDELGUINDI S, 1993, J BIOL CHEM, V268, P12730; BUCHBERGER A, 1994, NAT STRUCT BIOL, V1, P95, DOI 10.1038/nsb0294-95; BUCHBERGER A, 1994, EMBO J, V13, P1687, DOI 10.1002/j.1460-2075.1994.tb06433.x; CASPERS P, 1994, CELL MOL BIOL, V40, P635; CHAPPELL TG, 1987, J BIOL CHEM, V262, P746; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; GEORGOPOULOS C, 1992, TRENDS BIOCHEM SCI, V17, P295, DOI 10.1016/0968-0004(92)90439-G; GEORGOPOULOS C, 1990, STRESS PROTEINS BIOL, P191; JOHNSON C, 1989, J BACTERIOL, V171, P1590, DOI 10.1128/jb.171.3.1590-1596.1989; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; MORIMOTO RI, 1994, BIOL HEAT SHOCK PROT, P1; PALLEROS DR, 1994, J BIOL CHEM, V269, P13107; PALLEROS DR, 1993, FEBS LETT, V336, P124, DOI 10.1016/0014-5793(93)81624-9; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6; SCHOENFELD HJ, 1991, J BIOL CHEM, V266, P3863; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; SCHUCK P, 1994, PROG COLL POL SCI S, V94, P1; WELCH WJ, 1985, MOL CELL BIOL, V5, P1229, DOI 10.1128/MCB.5.6.1229; ZYLICZ M, 1984, J BIOL CHEM, V259, P8820; ZYLICZ M, 1987, J BIOL CHEM, V262, P17437; [No title captured]	25	147	149	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2183	2189		10.1074/jbc.270.5.2183	http://dx.doi.org/10.1074/jbc.270.5.2183			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836448	hybrid			2022-12-27	WOS:A1995QE49300033
J	RANDO, RF; OJWANG, J; ELBAGGARI, A; REYES, GR; TINDER, R; MCGRATH, MS; HOGAN, ME				RANDO, RF; OJWANG, J; ELBAGGARI, A; REYES, GR; TINDER, R; MCGRATH, MS; HOGAN, ME			SUPPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITY IN-VITRO BY OLIGONUCLEOTIDES WHICH FORM INTRAMOLECULAR TETRADS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYTRICHA TELOMERIC DNA; PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES; MESSENGER-RNAS; INFECTED-CELLS; INHIBITION; REPLICATION; OLIGODEOXYCYTIDINE; GROWTH	An oligonucleotide (I100-15) composed of only deoxyguanosine and thymidine was able to inhibit human immunodeficiency virus type-1 (HIV-1) in culture assay systems. I100-15 did not block virus entry into cells but did reduce viral-specific transcripts. As assessed by NMR and polyacrylamide gel methods, I100-15 appears to form a structure in which two stacked guanosine tetrads are connected by three two-base long loops. Structure/activity experiments indicated that formation of intramolecular guanosine tetrads was necessary to achieve maximum antiviral activity. The single deoxyguanosine nucleotide present in each loop was found to be extremely important for the overall antiviral activity. The toxicity of I100-15 was determined to be well above the 50% effective dose (ED(50)) in culture which yielded a high therapeutic index (>100). The addition of a cholesterol moiety to the 3' terminus of I100-15 (1100-23) reduced the ED(50) value to less than 50 nM (from 0.12 mu M for I100-15) and increased the duration of viral suppression to greater than 21 days (versus 7-10 days for I100-16) after removal of the drug from infected cell cultures. The favorable therapeutic index of such molecules coupled with the prolonged suppression of HIV-1, suggest that such compounds further warrant investigation as potential therapeutic agents.	UNIV CALIF SAN FRANCISCO, SAN FRANCISCO GEN HOSP, DEPT LAB MED, SAN FRANCISCO, CA 94110 USA; BAYLOR COLL MED, CTR BIOTECHNOL, THE WOODLANDS, TX 77381 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Baylor College of Medicine	RANDO, RF (corresponding author), TRIPLEX PHARMACEUT CORP, 9391 GROGANS MILL RD, THE WOODLANDS, TX 77380 USA.							BIRG F, 1990, NUCLEIC ACIDS RES, V18, P2901, DOI 10.1093/nar/18.10.2901; CHEUNG SC, 1992, J VIROL, V66, P6714, DOI 10.1128/JVI.66.11.6714-6720.1992; DASH P, 1987, P NATL ACAD SCI USA, V84, P7896, DOI 10.1073/pnas.84.22.7896; DITTRICH K, 1994, BIOCHEMISTRY-US, V33, P4111, DOI 10.1021/bi00180a003; DURLAND RH, 1991, BIOCHEMISTRY-US, V30, P9246, DOI 10.1021/bi00102a017; GAO W, 1989, J BIOL CHEM, V264, P11521; GAO WY, 1990, J BIOL CHEM, V265, P20172; GAO WY, 1992, MOL PHARMACOL, V41, P223; GAO WY, 1990, ANTIMICROB AGENTS CH, V34, P808, DOI 10.1128/AAC.34.5.808; HAWKINS JW, 1993, ANTISENSE RES DEV, V3, P233; IYER RP, 1990, J ORG CHEM, V55, P4693, DOI 10.1021/jo00302a039; KANG C, 1992, NATURE, V356, P126, DOI 10.1038/356126a0; LETSINGER RL, 1989, P NATL ACAD SCI USA, V86, P6553, DOI 10.1073/pnas.86.17.6553; LISZIEWICZ J, 1993, P NATL ACAD SCI USA, V90, P3860, DOI 10.1073/pnas.90.9.3860; MANIATIS T, 1983, MOL CLONING; MARSHALL WS, 1993, SCIENCE, V259, P1564, DOI 10.1126/science.7681216; MARSHALL WS, 1992, P NATL ACAD SCI USA, V89, P6265, DOI 10.1073/pnas.89.14.6265; MATSUKURA M, 1987, P NATL ACAD SCI USA, V84, P7706, DOI 10.1073/pnas.84.21.7706; MCGRATH MS, 1989, P NATL ACAD SCI USA, V86, P2844, DOI 10.1073/pnas.86.8.2844; NELSON PS, 1989, NUCLEIC ACIDS RES, V17, P7187, DOI 10.1093/nar/17.18.7187; OJWANG J, 1994, ANTIVIR RES, V25, P27, DOI 10.1016/0166-3542(94)90091-4; OJWANG J, 1994, J ACQ IMMUN DEF SYND, V7, P560; ORSON FM, 1991, NUCLEIC ACIDS RES, V19, P3435, DOI 10.1093/nar/19.12.3435; PONTE P, 1984, NUCLEIC ACIDS RES, V12, P1687, DOI 10.1093/nar/12.3.1687; RAO TS, 1992, TETRAHEDRON LETT, V33, P7651, DOI 10.1016/0040-4039(93)88007-6; SCHULTZE P, 1994, J MOL BIOL, V235, P1532, DOI 10.1006/jmbi.1994.1105; SMITH FW, 1992, NATURE, V356, P164, DOI 10.1038/356164a0; VU H, 1994, BIOCONJUGATE CHEM, V5, P666, DOI 10.1021/bc00030a024; WYATT JR, 1994, P NATL ACAD SCI USA, V91, P1356, DOI 10.1073/pnas.91.4.1356; ZACK JA, 1992, J VIROL, V66, P1717, DOI 10.1128/JVI.66.3.1717-1725.1992	30	121	133	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1754	1760		10.1074/jbc.270.4.1754	http://dx.doi.org/10.1074/jbc.270.4.1754			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829511	hybrid			2022-12-27	WOS:A1995QD20400044
J	TEDESCHI, G; CHEN, S; MASSEY, V				TEDESCHI, G; CHEN, S; MASSEY, V			DT-DIAPHORASE - REDOX POTENTIAL, STEADY-STATE, AND RAPID REACTION STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUINONE ACCEPTOR OXIDOREDUCTASE; RAT-LIVER; ONE-ELECTRON; MECHANISM; REDUCTION; SYSTEMS; NAD(P)H; GLUTATHIONE; DIAZIQUONE; CELLS	NAD(P)H:quinone oxidoreductase (DT-diaphorase) appears to be a 2-electron transfer flavoprotein, which catalyzes the conversion of quinones into hydroquinones. Upon photoreduction in the presence of dimethylformamide, the enzyme forms a red semiquinone. In the absence of dimethylformamide, only 10% of the radical form is thermodynamically stabilized. This indicates a redox potential of the enzyme-bound semiquinone/reduced flavin couple that is higher than the midpoint potential for the oxidized flavin/semiquinone couple, The 2-electron redox potential was determined to be -159 +/- 3 mV at 25 degrees C, pH 7.0, In the presence of benzoquinone or 3-aminopyridine adenine dinucleotide phosphate, as NADPH analogue, there is no change in the redox properties of the enzyme flavin. A significant decrease is observed in the presence of the competitive inhibitor dicumarol (E(m) = -234 +/- 2 mV at pH 7.0). The reaction mechanism of the flavoprotein has been investigated by steady-state and stopped-flow kinetic methods using NADPH, NADH, deamino-NADPH, and 3-acetylpyridine adenine dinucleotide reduced form (APADH) as electron donors and K3Fe(CN)(6), 4,5-dihydro-4,5-dioxo-1H-pyrrolo-[2,3-f]quinoline-2,7,9-tricarboxylic acid (PQQ), and 2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone (AZQ) as electron accepters in 50 mM phosphate buffer, pH 7.0, 25 degrees C. No evidence could be obtained to indicate that semiquinoid intermediates play a part in the catalytic mechanism of DT-diaphorase with quinones as accepters. The rates of the reduction by NADPH, NADH, deamino-NADPH, and APADH (1.3 x 10(9), 8.8 x 10(8), 8.3 x 10(8) and 9.8 x 10(6) M(-1) min(-1), respectively) as well as the rates of the reoxidation by PQQ and AZQ (9 x 10(4) and 2.8 x 10(6) M(-1) min(-1), respectively) are directly proportional to substrate concentration, and there is no evidence of the formation of enzyme-substrate complexes. If such complexes do indeed exist, the affinity of the enzyme for substrate must be extremely low. Using K3Fe(CN)(6) as electron acceptor, the rate of oxidation of fully reduced enzyme is 4.6 x 10(7) M(-1) min(-1) and it is accurately proportional to ferricyanide concentration. This rate represents that of flavin semiquinone formation, with the subsequent oxidation of the semiquinone being much faster, since no spectral evidence for semiquinone formation could be obtained. Studies were also conducted attempting to use apo-DT-diaphorase reconstituted with PQQ as coenzyme. The lack of activity toward AZQ, K3Fe(CN)(6), and menadione suggests that DT-diaphorase can use PQQ only as electron acceptor and not as redox cofactor.	UNIV MICHIGAN,SCH MED,DEPT BIOL CHEM,ANN ARBOR,MI 48109; CITY HOPE NATL MED CTR,BECKMAN RES INT,DIV IMMUNOL,DUARTE,CA 91010	University of Michigan System; University of Michigan; City of Hope; Beckman Research Institute of City of Hope			Tedeschi, Gabriella/I-6247-2017	Tedeschi, Gabriella/0000-0003-2082-6443	NIGMS NIH HHS [GM-11106] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM011106, R37GM011106] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEATY NB, 1981, J BIOL CHEM, V256, P4611; Bevington P. R., 1969, DATA REDUCTION ERROR, P235; BLANKENHORN G, 1976, EUR J BIOCHEM, V67, P67, DOI 10.1111/j.1432-1033.1976.tb10634.x; BRISSETTE P, 1989, ANAL BIOCHEM, V181, P234, DOI 10.1016/0003-2697(89)90235-2; BRUNMARK A, 1988, FREE RADICAL BIO MED, V5, P133, DOI 10.1016/0891-5849(88)90076-7; BUFINTON GD, 1988, BIOCHEM J, V257, P561; BUTLER J, 1987, BIOCHIM BIOPHYS ACTA, V925, P144, DOI 10.1016/0304-4165(87)90103-6; CHEN HH, 1992, BIOCHEM J, V284, P855, DOI 10.1042/bj2840855; CHEN S, 1994, PROTEIN SCI, V3, P51; CHEN SU, 1992, MOL PHARMACOL, V42, P545; Clark W.M., 1960, OXIDATION REDUCTION, P184; DALZIEL K, 1957, ACTA CHEM SCAND, V11, P1706, DOI 10.3891/acta.chem.scand.11-1706; DEFLORA S, 1985, CANCER RES, V45, P3188; DODD NJF, 1984, BIOCHEM PHARMACOL, V33, P379, DOI 10.1016/0006-2952(84)90229-6; DUINE JA, 1990, TRENDS BIOCHEM SCI, V15, P96, DOI 10.1016/0968-0004(90)90189-I; ERNSTER L, 1987, CHEM SCRIPTA, V27A, P1; ERNSTER L, 1967, METHOD ENZYMOL, V10, P309, DOI DOI 10.1016/0076-6879(67)10059-1; FULTZ ML, 1982, ANAL CHIM ACTA, V140, P1, DOI 10.1016/S0003-2670(01)95447-9; HOSODA S, 1974, J BIOL CHEM, V249, P6416; HUANG MT, 1979, J BIOL CHEM, V254, P3930; HUANG MT, 1978, BIOCHEM BIOPH RES CO, V83, P1253, DOI 10.1016/0006-291X(78)91356-6; IYANAGI T, 1970, BIOCHIM BIOPHYS ACTA, V216, P282, DOI 10.1016/0005-2728(70)90220-3; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P9, DOI 10.1021/bi00594a002; MASSEY V, 1969, J BIOL CHEM, V244, P3999; Massey V, 1990, FLAVINS FLAVOPROTEIN, P59; MCWHIRTER RB, 1990, BIOCHEMISTRY-US, V269, P6919; MINNAERT K, 1965, BIOCHIM BIOPHYS ACTA, V110, P42, DOI 10.1016/S0926-6593(65)80093-5; Muller OH, 1942, J BIOL CHEM, V145, P425; NISHIGORI H, 1989, LIFE SCI, V45, P593, DOI 10.1016/0024-3205(89)90044-1; ORDONEZ ID, 1992, BIOCHEM J, V286, P481, DOI 10.1042/bj2860481; PROCHASKA HJ, 1991, OXIDATIVE STRESS OXI, P195; RILEY RJ, 1992, BIOCHEM PHARMACOL, V43, P1657, DOI 10.1016/0006-2952(92)90694-E; RILEY RJ, 1992, BIOCHEM PHARMACOL, V43, P167, DOI 10.1016/0006-2952(92)90274-M; SIEGEL D, 1990, CANCER RES, V50, P7293; SUGIMURA T, 1966, CANCER RES, V26, P1717; SUGIOKA K, 1988, BIOCHIM BIOPHYS ACTA, V964, P175, DOI 10.1016/0304-4165(88)90164-X	36	96	98	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1198	1204		10.1074/jbc.270.3.1198	http://dx.doi.org/10.1074/jbc.270.3.1198			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836380	hybrid			2022-12-27	WOS:A1995QB15600035
J	BOGDANOV, M; DOWHAN, W				BOGDANOV, M; DOWHAN, W			PHOSPHATIDYLETHANOLAMINE IS REQUIRED FOR IN-VIVO FUNCTION OF THE MEMBRANE-ASSOCIATED LACTOSE PERMEASE OF ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROCHEMICAL PROTON GRADIENT; PHOSPHOLIPID-COMPOSITION; ACIDIC PHOSPHOLIPIDS; ACTIVE-TRANSPORT; INNER MEMBRANES; VESICLES; CARRIER; TRANSLOCATION; PROTEIN; PHOSPHATIDYLGLYCEROL	Experiments with mutant Escherichia coli cells lacking phosphatidylethanolamine (PE) as a membrane component (DeChavigny, A., Heacock, P. N., and Dowhan, W. (1991) J. Biol. Chem. 266, 5323-5332) were carried out to establish whether or not PE is necessary for full function of the lac permease in vivo. The V-max for active transport of both lactose (in cells lacking beta-galactosidase, lacZ) and the unhydrolyzable lactose analog, methyl-beta-D-galactopyranoside (TMG), by mutant cells lacking PE was reduced 5-10-fold relative to cells containing PE, while the K-m for the uptake of both substrates was the same in both types of cells, The low rate of TMG and lactose uptake by PE-deficient cells was unaffected by the presence of a protonophore (uncoupler) and for TMG uptake was on the order of the greatly reduced rate of uptake in uncoupler-treated cells containing PE, The rate of entry of lactose into lacZ(+) derivatives of both types of cells, as a measure of facilitated diffusion, was nearly the same. The K-m for lactose (lacZ cells) and TMG transport in PE-deficient cells was unaffected by the presence of an uncoupler which had a small effect on V-max. In PE-containing cells these kinetic parameters for TMG transport were reduced by an uncoupler to the level found with PE-deficient cells while an uncoupler reduced lactose uptake by PE-containing (lacZ) cells to below measureable levels. Inverted membrane vesicles made from both types of cells could be loaded with TMG, but energizing TMG-loaded vesicles by ATP only induced rapid, uphill, permease-dependent efflux of TMG from PE-containing vesicles, The decrease in apparent active transport activity of cells with no PE was not due to a change in membrane permeability, to a reduced Delta(mu H+) (proton electrochemical gradient) across the cell membrane, or to a reduced level of membrane-associated lac permease protein, These results suggest that in the absence of PE the Iac permease cannot couple substrate uptake to Delta(mu H+) in order to effect accumulation of substrate and as a result only carries out facilitated diffusion.	UNIV TEXAS,SCH MED,DEPT BIOCHEM & MOLEC BIOL,HOUSTON,TX 77225	University of Texas System			Bogdanov, Mikhail/J-3695-2017		NIGMS NIH HHS [GM 20478] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020478, R01GM020478] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BIBI E, 1990, P NATL ACAD SCI USA, V87, P4325, DOI 10.1073/pnas.87.11.4325; BOGDANOV M, 1994, FASEB J, V8, pA1449; BOGDANOV M, 1993, FASEB J, V7, pA1141; BOGDANOV M, 1986, DOKLADY BIOCH, V288, P200; BRABETZ W, 1993, J BACTERIOL, V175, P7488, DOI 10.1128/JB.175.22.7488-7491.1993; CHEN CC, 1984, J BIOL CHEM, V259, P150; CONSLER TG, 1991, BIOCHEMISTRY-US, V30, P1291, DOI 10.1021/bi00219a019; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; DEVRIJE T, 1988, NATURE, V334, P173, DOI 10.1038/334173a0; DOWHAN W, 1992, METHOD ENZYMOL, V209, P7; DRIESSEN AJM, 1987, J BIOL CHEM, V262, P12438; FISCHER W, 1978, BIOCHIM BIOPHYS ACTA, V528, P288, DOI 10.1016/0005-2760(78)90018-8; GHAZI A, 1981, BIOCHIM BIOPHYS ACTA, V645, P305; HAWROT E, 1978, J BIOL CHEM, V253, P8213; INTVELD G, 1992, BIOCHIM BIOPHYS ACTA, V1104, P250, DOI 10.1016/0005-2736(92)90037-M; ITO K, 1991, MOL MICROBIOL, V5, P2243, DOI 10.1111/j.1365-2958.1991.tb02154.x; KABACK HR, 1992, INT REV CYTOL, V137A, P97; KABACK HR, 1993, J BIOENERG BIOMEMBR, V25, P627; KACZOROWSKI GJ, 1979, BIOCHEMISTRY-US, V18, P3697, DOI 10.1021/bi00584a010; KILLIAN JA, 1994, BBA-BIOMEMBRANES, V1189, P225; KUSTERS R, 1991, J BIOL CHEM, V266, P8659; LANCASTER JR, 1977, J BIOL CHEM, V252, P7657; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; MALONEY PC, 1975, METHODS MEMBRANE BIO, V5, P1; Maniatis T., 1982, MOL CLONING; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; MILEYKOVSKAYA EI, 1993, J BIOL CHEM, V268, P24824; Miller J.H., 1972, EXPT MOL GENETICS; MINNIKIN DE, 1971, BIOCHEM J, V124, P447, DOI 10.1042/bj1240447; NEWMAN MJ, 1981, J BIOL CHEM, V256, P1804; PADAN E, 1976, EUR J BIOCHEM, V63, P533, DOI 10.1111/j.1432-1033.1976.tb10257.x; PAGE MGP, 1988, J BIOL CHEM, V263, P15897; POOLMAN B, 1993, BIOCHIM BIOPHYS ACTA, V1183, P5, DOI 10.1016/0005-2728(93)90003-X; RAMOS S, 1977, BIOCHEMISTRY-US, V16, P854, DOI 10.1021/bi00624a007; REENSTRA WW, 1980, BIOCHEMISTRY-US, V19, P1, DOI 10.1021/bi00542a001; RIETVELD AG, 1993, J BIOL CHEM, V268, P12427; Rilfors L, 1984, MEMBRANE FLUIDITY, P205; ROBERTSON DE, 1980, BIOCHEMISTRY-US, V19, P5692, DOI 10.1021/bi00566a005; SAHINTOTH M, 1993, PROTEIN SCI, V2, P1024, DOI 10.1002/pro.5560020615; Seto-Young D, 1985, J MEMBRANE BIOL, V84, P256; SMITH TF, 1971, J MOL BIOL, V59, P273, DOI 10.1016/0022-2836(71)90051-9; URATANI Y, 1986, J BIOL CHEM, V261, P5450; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; WILSON DM, 1985, MEMBRANE BIOCHEM, V5, P269, DOI 10.3109/09687688509150282	44	121	122	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					732	739		10.1074/jbc.270.2.732	http://dx.doi.org/10.1074/jbc.270.2.732			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822303	hybrid			2022-12-27	WOS:A1995QB81600037
J	NALDINI, L; VIGNA, E; BARDELLI, A; FOLLENZI, A; GALIMI, F; COMOGLIO, PM				NALDINI, L; VIGNA, E; BARDELLI, A; FOLLENZI, A; GALIMI, F; COMOGLIO, PM			BIOLOGICAL ACTIVATION OF PRO-HGF (HEPATOCYTE GROWTH-FACTOR) BY UROKINASE IS CONTROLLED BY A STOICHIOMETRIC REACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BOUND UROKINASE; FACTOR SCATTER FACTOR; HUMAN-MELANOMA CELLS; C-MET PROTOONCOGENE; SINGLE CHAIN FORM; PLASMINOGEN-ACTIVATOR; MOLECULAR-CLONING; EPITHELIAL-CELLS; TYROSINE KINASE; HEPATOPOIETIN-A	Hepatocyte growth factor (HGF) is a paracrine inducer of morphogenesis and invasive growth in epithelial and endothelial cells. HGF is secreted by mesenchymal cells as an inactive precursor (pro-HGF). The crucial step for HGF activation is the extracellular hydrolysis of the Arg(494)-Val(495) bond, which converts pro-HGF into alpha beta-HGF, the high-affinity ligand for the Met receptor. We previously reported that the urokinase-type plasminogen activator (uPA) activates pro-HGF in vitro. We now show that this is a stoichiometric reaction, and provide evidence for its occurrence in tissue culture. Activation involves the formation of a stable complex between pro-HGF and uPA. This complex was isolated from the in vitro reaction of pure uPA with recombinant pro-HGF, as well as from the membrane of target cells, after sequential addition of uPA and pro-HGF. On the cell membrane, the uPA HGF complex was bound to the Met receptor. Monocytic cell lines, and primary monocytes after adhesion, activated efficiently pro-HGF both on their surface and in the culture medium. This activation was inhibited by anti-catalytic anti-uPA antibodies, and occurred by a stoichiometric reaction. The stoichiometry of the activation reaction suggests that the biological effects of HGF can be titrated in vivo by the level of uPA activity. Adequate amounts of uPA can be locally provided by the macrophages, which would condition the tissue microenvironment by rendering HGF bioavailable to its target cells.			NALDINI, L (corresponding author), UNIV TURIN, SCH MED, DEPT BIOMED SCI & ONCOL, CORSO MASSIMO AZEGLIO 52, I-10126 TURIN, ITALY.		Galimi, Francesco/J-4238-2012; Naldini, Luigi/E-9083-2012; BARDELLI, Alberto/J-9721-2018	Comoglio, Paolo/0000-0002-7056-5328; BARDELLI, Alberto/0000-0003-1647-5070; NALDINI, Luigi/0000-0002-7835-527X; Vigna, Elisa/0000-0001-9787-5732; Follenzi, Antonia/0000-0001-9780-300X				APPELLA E, 1987, J BIOL CHEM, V262, P4437; AXELROD JH, 1989, MOL CELL BIOL, V9, P2133, DOI 10.1128/MCB.9.5.2133; BLASI F, 1987, J CELL BIOL, V104, P801, DOI 10.1083/jcb.104.4.801; BOCCACCIO C, 1994, J BIOL CHEM, V269, P12846; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; COOPER CS, 1986, EMBO J, V5, P2623, DOI 10.1002/j.1460-2075.1986.tb04543.x; DIRENZO MF, 1991, ONCOGENE, V6, P1997; DIRENZO MF, 1992, ONCOGENE, V7, P2549; ELLIS V, 1991, J BIOL CHEM, V266, P12752; FRANCO P, 1992, J BIOL CHEM, V267, P19369; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; GALIMI F, 1993, STEM CELLS, V11, P22; GENTON C, 1987, J CELL BIOL, V104, P705, DOI 10.1083/jcb.104.3.705; GHERARDI E, 1989, P NATL ACAD SCI USA, V86, P5844, DOI 10.1073/pnas.86.15.5844; GIORDANO S, 1993, P NATL ACAD SCI USA, V90, P649, DOI 10.1073/pnas.90.2.649; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; GOHDA E, 1988, J CLIN INVEST, V81, P414, DOI 10.1172/JCI113334; GRANT DS, 1993, P NATL ACAD SCI USA, V90, P1937, DOI 10.1073/pnas.90.5.1937; HALABAN R, 1992, ONCOGENE, V7, P2195; HARTMANN G, 1992, P NATL ACAD SCI USA, V89, P11574, DOI 10.1073/pnas.89.23.11574; HEARING VJ, 1988, CANCER RES, V48, P1270; HECHT P M, 1992, Trends in Cell Biology, V2, P197, DOI 10.1016/0962-8924(92)90246-J; HIGUCHI O, 1991, BIOCHEM BIOPH RES CO, V176, P599, DOI 10.1016/S0006-291X(05)80226-8; IGAWA T, 1991, BIOCHEM BIOPH RES CO, V174, P831, DOI 10.1016/0006-291X(91)91493-V; IYER A, 1990, CELL GROWTH DIFFER, V1, P87; KAN M, 1991, BIOCHEM BIOPH RES CO, V174, P331, DOI 10.1016/0006-291X(91)90524-B; KASAI S, 1985, J BIOL CHEM, V260, P2382; KIRCHHEIMER JC, 1987, FASEB J, V1, P125, DOI 10.1096/fasebj.1.2.3038646; KIRCHHEIMER JC, 1989, BLOOD, V74, P1396; KIRCHHEIMER JC, 1989, P NATL ACAD SCI USA, V86, P5424, DOI 10.1073/pnas.86.14.5424; LIU C, 1992, ONCOGENE, V7, P181; LOKKER NA, 1992, EMBO J, V11, P2503, DOI 10.1002/j.1460-2075.1992.tb05315.x; MANCHANDA N, 1990, J IMMUNOL, V145, P4174; MARS WM, 1993, AM J PATHOL, V143, P949; MASUMOTO A, 1991, BIOCHEM BIOPH RES CO, V174, P90, DOI 10.1016/0006-291X(91)90489-T; MATSUMOTO K, 1991, EXP CELL RES, V196, P114, DOI 10.1016/0014-4827(91)90462-4; MCGROGAN M, 1988, BIO-TECHNOL, V6, P172, DOI 10.1038/nbt0288-172; MEISSAUER A, 1991, EXP CELL RES, V192, P453, DOI 10.1016/0014-4827(91)90064-2; MICHALOPOULOS G, 1984, CANCER RES, V44, P4414; MIYAZAWA K, 1993, J BIOL CHEM, V268, P10024; MIYAZAWA K, 1989, BIOCHEM BIOPH RES CO, V163, P967, DOI 10.1016/0006-291X(89)92316-4; MIZUNO K, 1992, BIOCHEM BIOPH RES CO, V189, P1631, DOI 10.1016/0006-291X(92)90264-L; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; MORIMOTO A, 1991, BIOCHEM BIOPH RES CO, V179, P1042, DOI 10.1016/0006-291X(91)91924-2; NAGAIKE M, 1991, J BIOL CHEM, V266, P22781; NAKA D, 1992, J BIOL CHEM, V267, P20114; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NAKAMURA T, 1987, FEBS LETT, V224, P311, DOI 10.1016/0014-5793(87)80475-1; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; NALDINI L, 1992, EMBO J, V11, P4825, DOI 10.1002/j.1460-2075.1992.tb05588.x; NALDINI L, 1991, ONCOGENE, V6, P501; NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x; OSSOWSKI L, 1988, CELL, V52, P321, DOI 10.1016/S0092-8674(88)80025-4; OSSOWSKI L, 1988, J CELL BIOL, V107, P2437, DOI 10.1083/jcb.107.6.2437; OSSOWSKI L, 1983, CELL, V35, P611, DOI 10.1016/0092-8674(83)90093-4; PATTHY L, 1984, FEBS LETT, V171, P131, DOI 10.1016/0014-5793(84)80473-1; PEPPER MS, 1992, J BIOL CHEM, V267, P20493; PETERSEN LC, 1988, J BIOL CHEM, V263, P11189; PONZETTO C, 1991, ONCOGENE, V6, P553; PYKE C, 1991, AM J PATHOL, V138, P1059; REDDY KNN, 1972, J BIOL CHEM, V247, P1683; RONG S, 1992, MOL CELL BIOL, V12, P5152, DOI 10.1128/MCB.12.11.5152; RUBIN JS, 1991, P NATL ACAD SCI USA, V88, P415, DOI 10.1073/pnas.88.2.415; RUSSELL WE, 1984, J CELL PHYSIOL, V119, P183, DOI 10.1002/jcp.1041190207; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; SATO Y, 1990, J CELL BIOL, V111, P757, DOI 10.1083/jcb.111.2.757; SHIMOMURA T, 1992, CYTOTECHNOLOGY, V8, P219, DOI 10.1007/BF02522039; SHIMOMURA T, 1993, J BIOL CHEM, V268, P22927; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; SOTTRUPJENSEN L, 1978, PROGR CHEM FIBRINOLY, V3, P191; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; STOPPELLI MP, 1986, CELL, V45, P675, DOI 10.1016/0092-8674(86)90782-8; TSUBOUCHI H, 1991, HEPATOLOGY, V13, P1; VASSALLI JD, 1984, J EXP MED, V159, P1653, DOI 10.1084/jem.159.6.1653; VASSALLI JD, 1985, J CELL BIOL, V100, P86, DOI 10.1083/jcb.100.1.86; WEIDNER KM, 1990, J CELL BIOL, V111, P2097, DOI 10.1083/jcb.111.5.2097; WEIDNER KM, 1991, P NATL ACAD SCI USA, V88, P7001, DOI 10.1073/pnas.88.16.7001; WOLF HK, 1991, HEPATOLOGY, V14, P488, DOI 10.1016/0270-9139(91)90188-2; ZARNEGAR R, 1990, P NATL ACAD SCI USA, V87, P1252, DOI 10.1073/pnas.87.3.1252; ZARNEGAR R, 1989, CANCER RES, V49, P3314	81	227	234	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					603	611		10.1074/jbc.270.2.603	http://dx.doi.org/10.1074/jbc.270.2.603			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822285	hybrid			2022-12-27	WOS:A1995QB81600018
J	WEDEGAERTNER, PB; WILSON, PT; BOURNE, HR				WEDEGAERTNER, PB; WILSON, PT; BOURNE, HR			LIPID MODIFICATIONS OF TRIMERIC G-PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ALPHA-SUBUNIT; BETA-GAMMA; PHOSPHOLIPID-VESICLES; MEMBRANE ATTACHMENT; MYRISTOYLATION; CELLS; PALMITOYLATION; BINDING; ASSOCIATION; PRENYLATION		UNIV CALIF SAN FRANCISCO,DEPT PHARMACOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,CTR NEUROBIOL & PSYCHIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco					NATIONAL CANCER INSTITUTE [R01CA054427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027800, R01GM027800] Funding Source: NIH RePORTER; NCI NIH HHS [CA-54427] Funding Source: Medline; NIGMS NIH HHS [GM-27800] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CAMP LA, 1993, J BIOL CHEM, V268, P22566; CAMP LA, 1994, J BIOL CHEM, V269, P23212; CASEY PJ, 1994, RECENT PROG HORM RES, V49, P215; CHANG WJ, 1994, J CELL BIOL, V126, P127, DOI 10.1083/jcb.126.1.127; DEGTYAREV MY, 1994, J BIOL CHEM, V269, P30898; DEGTYAREV MY, 1993, J BIOL CHEM, V268, P23769; DIETRICH A, 1994, EUR J BIOCHEM, V219, P171, DOI 10.1111/j.1432-1033.1994.tb19927.x; DOHLMAN HG, 1993, P NATL ACAD SCI USA, V90, P9688, DOI 10.1073/pnas.90.20.9688; Fishman P.H., 1990, ADP RIBOSYLATING TOX, P127; FUKADA Y, 1994, J BIOL CHEM, V269, P5163; GALBIATI F, 1994, BIOCHEM J, V303, P697, DOI 10.1042/bj3030697; GALLEGO C, 1992, P NATL ACAD SCI USA, V89, P9695, DOI 10.1073/pnas.89.20.9695; GORDON JI, 1991, J BIOL CHEM, V266, P8647; GRASSIE MA, 1994, BIOCHEM J, V302, P913, DOI 10.1042/bj3020913; HALLAK H, 1994, J BIOL CHEM, V269, P4713; HALLAK H, 1993, J BIOL CHEM, V269, P4571; HIGGINS JB, 1994, J BIOL CHEM, V269, P9067; HOUSLAY MD, 1991, CELL SIGNAL, V3, P1, DOI 10.1016/0898-6568(91)90002-C; INIGUEZLLUHI JA, 1992, J BIOL CHEM, V267, P23409; JOHNSON RS, 1994, J BIOL CHEM, V269, P21067; JONES TLZ, 1990, P NATL ACAD SCI USA, V87, P568, DOI 10.1073/pnas.87.2.568; JONES TLZ, 1994, G PROTEINS, P49; KISSELEV OG, 1994, J BIOL CHEM, V269, P21399; KOKAME K, 1992, NATURE, V359, P749, DOI 10.1038/359749a0; LEVIS MJ, 1992, J CELL BIOL, V119, P1297, DOI 10.1083/jcb.119.5.1297; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; LINDER ME, 1991, J BIOL CHEM, V266, P4654; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; MANENTI S, 1994, J BIOL CHEM, V269, P8309; MARSHALL CJ, 1993, SCIENCE, V259, P1865, DOI 10.1126/science.8456312; MCCALLUM JF, 1994, IN PRESS BIOCH SOC T; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P728, DOI 10.1073/pnas.87.2.728; MUMBY SM, 1994, P NATL ACAD SCI USA, V91, P2800, DOI 10.1073/pnas.91.7.2800; NEUBERT TA, 1992, J BIOL CHEM, V267, P18274; OHGURO H, 1991, EMBO J, V10, P3669, DOI 10.1002/j.1460-2075.1991.tb04934.x; PARENTI M, 1993, BIOCHEM J, V291, P349, DOI 10.1042/bj2910349; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; RANSNAS LA, 1989, P NATL ACAD SCI USA, V86, P7900, DOI 10.1073/pnas.86.20.7900; RODGERS W, 1994, MOL CELL BIOL, V14, P5384, DOI 10.1128/MCB.14.8.5384; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; SILVIUS JR, 1994, BIOCHEMISTRY-US, V33, P3014, DOI 10.1021/bi00176a034; SIMONDS WF, 1994, G PROTEINS, P95; STERNWEIS PC, 1986, J BIOL CHEM, V261, P631; TAUSSIG R, 1993, SCIENCE, V261, P218, DOI 10.1126/science.8327893; THISSEN JA, 1993, J BIOL CHEM, V268, P13780; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6	48	380	383	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					503	506		10.1074/jbc.270.2.503	http://dx.doi.org/10.1074/jbc.270.2.503			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822269	hybrid			2022-12-27	WOS:A1995QB81600001
J	STULL, TL; HYUN, L; SHARETZSKY, C; WOOTEN, J; MCCAULEY, JP; SMITH, AB				STULL, TL; HYUN, L; SHARETZSKY, C; WOOTEN, J; MCCAULEY, JP; SMITH, AB			PRODUCTION AND OXIDATION OF INDOLE BY HAEMOPHILUS-INFLUENZAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; HEMOPHILUS-INFLUENZAE; NITRATE ASSIMILATION; GENES; REDUCTASE	During growth in high concentrations of iron nitrate, H. influenzae produces compounds reactive in biochemical assays for hydroxamates. Mixing experiments established that nitrate was responsible for inducing these compounds, Analysis by H-1 and C-13 NMR and high resolution mass spectrometry identified the active species as 2,2-bis(3'-indolyl)indoxyl. Bacterial production of the latter compound has been previously observed only in Pseudomonas aureofaciens. A mutant defective in the production of 2,2-bis(3'-indolyl)indoxyl was constructed by marker insertion, The formation of indole and 2,2-bis(3'-indolyl)indoxyl was quantitated by reverse-phase high pressure liquid chromatography during growth in high concentrations of nitrate. The mutant produced high concentrations of indole, but only minimal amounts of 2,2-bis(3'-indolyl)indoxyl, and also proved to be defective in nitrate reduction, These data suggest that indole may function as an electron donor for nitrate reductase in H. influenzae.	MED COLL PENN, DEPT PEDIAT, PHILADELPHIA, PA 19129 USA; MED COLL PENN, DEPT MICROBIOL IMMUNOL, PHILADELPHIA, PA 19129 USA; UNIV PENN, DEPT CHEM, PHILADELPHIA, PA 19104 USA	Drexel University; Drexel University; University of Pennsylvania					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029611, R56AI029611] Funding Source: NIH RePORTER; NIAID NIH HHS [AI29611] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALEXANDER HE, 1953, J EXP MED, V97, P17, DOI 10.1084/jem.97.1.17; [Anonymous], 1984, COMPREHENSIVE HETERO; ATKIN CL, 1968, BIOCHEMISTRY-US, V7, P3734, DOI 10.1021/bi00850a054; CALI BM, 1989, J BACTERIOL, V171, P2666, DOI 10.1128/jb.171.5.2666-2672.1989; CAMPBELL WH, 1990, TRENDS BIOCHEM SCI, V15, P315, DOI 10.1016/0968-0004(90)90021-3; CAPDEVIELLE P, 1993, TETRAHEDRON LETT, V34, P2953, DOI 10.1016/S0040-4039(00)60490-2; Conn HJ, 1936, J BACTERIOL, V31, P225, DOI 10.1128/JB.31.3.225-233.1936; CRAWFORD IP, 1975, BACTERIOL REV, V39, P87, DOI 10.1128/MMBR.39.2.87-120.1975; CSAKY TZ, 1948, ACTA CHEM SCAND, V2, P450, DOI 10.3891/acta.chem.scand.02-0450; ENOCH HG, 1974, BIOCHEM BIOPH RES CO, V61, P1234, DOI 10.1016/S0006-291X(74)80416-X; GIBSON F, 1969, BIOCHIM BIOPHYS ACTA, V192, P175, DOI 10.1016/0304-4165(69)90353-5; GODFREY C, 1987, BIOCHEM J, V243, P241, DOI 10.1042/bj2430241; Hamill R, 1967, Antimicrob Agents Chemother (Bethesda), V7, P388; JETER RM, 1984, J BACTERIOL, V157, P673, DOI 10.1128/JB.157.2.673-677.1984; KRONE WJA, 1985, A VAN LEEUW J MICROB, V51, P203, DOI 10.1007/BF02310013; LAWLOR KM, 1984, J BACTERIOL, V160, P266, DOI 10.1128/JB.160.1.266-272.1984; MOAT AG, 1988, MICROBIAL PHYSL, P251; Neilands J B, 1990, Adv Inorg Biochem, V8, P63; NOHNO T, 1989, NUCLEIC ACIDS RES, V17, P2947, DOI 10.1093/nar/17.8.2947; OWEN RJ, 1987, NUCLEIC ACIDS RES, V15, P3631, DOI 10.1093/nar/15.8.3631; PIDCOCK KA, 1988, INFECT IMMUN, V56, P721, DOI 10.1128/IAI.56.4.721-725.1988; SHARETZSKY C, 1991, J BACTERIOL, V173, P1561, DOI 10.1128/jb.173.4.1561-1564.1991; SIAS SR, 1980, J GEN MICROBIOL, V118, P229; STEINHART WL, 1968, J BACTERIOL, V96, P1718, DOI 10.1128/JB.96.5.1718-1724.1968; STULL TL, 1984, INFECT IMMUN, V46, P787, DOI 10.1128/IAI.46.3.787-796.1984; WILLIAMS PH, 1979, INFECT IMMUN, V26, P925, DOI 10.1128/IAI.26.3.925-932.1979; WITKOP B, 1947, LIEBIGS ANN CHEM, V558, P98; WITKOP B, 1951, J AM CHEM SOC, V73, P713, DOI 10.1021/ja01146a066	28	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					5	8		10.1074/jbc.270.1.5	http://dx.doi.org/10.1074/jbc.270.1.5			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814418	hybrid			2022-12-27	WOS:A1995QA28700002
J	WHITELEGGE, JP; KOO, D; DINER, BA; DOMIAN, I; ERICKSON, JM				WHITELEGGE, JP; KOO, D; DINER, BA; DOMIAN, I; ERICKSON, JM			ASSEMBLY OF THE PHOTOSYSTEM-II OXYGEN-EVOLVING COMPLEX IS INHIBITED IN PSBA SITE-DIRECTED MUTANTS OF CHLAMYDOMONAS-REINHARDTII - ASPARTATE-170 OF THE D1 POLYPEPTIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC ELECTRON-TRANSPORT; MANGANESE-STABILIZING PROTEIN; RIBOSOMAL-RNA GENES; CHLOROPLAST TRANSFORMATION; NUCLEAR TRANSFORMATION; O2 EVOLUTION; D2 PROTEIN; MEMBRANES; BINDING; YIELD	Photosystem II catalyzes the photooxidation of water to molecular oxygen, providing electrons to the photosynthetic electron transfer chain. The D1 and D2 chloroplast encoded reaction center polypeptides bind cofactors essential for Photosystem II function. Transformation of the chloroplast genome of the eukaryotic green alga Chlamydomonas reinhardtii has allowed us to engineer site-directed mutants in which aspartate residue 170 of D1 is replaced by histidine (D170H), asparagine (D170N), threonine (D170T), or proline (D170P). Mutants D170T and D170P are completely deficient in oxygen evolution, but retain normal (D170T) or 50% (D170P) levels of Photosystem II reaction centers. D170H and D170N accumulate wild-type levels of PSII centers, yet evolve oxygen at rates approximately 45% and 15% those of control cells, respectively. Kinetic analysis of chlorophyll fluorescence in the mutants reveals a specific defect in electron donation to the reaction center. Measurements of oxygen flash yields in D170H show, however, that those reaction centers capable of evolving oxygen function normally. We conclude that aspartate residue 170 of the D1 polypeptide plays a critical role in the initial binding of manganese as the functional chloroplast oxygen-evolving complex is assembled.	UNIV CALIF LOS ANGELES,DEPT BIOL,LOS ANGELES,CA 90024; DUPONT CO INC,DEPT CENT RES & DEV,WILMINGTON,DE 19880; UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; DuPont; University of California System; University of California Los Angeles					NCRR NIH HHS [S07-RR07009-26RR] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR007009] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANDERSSON B, 1987, LIGHT REACTIONS, P379; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; BENNOUN P, 1986, PLANT MOL BIOL, V6, P151, DOI 10.1007/BF00021484; Bennoun P, 1982, METHODS CHLOROPLAST, P25; BLOWERS AD, 1989, PLANT CELL, V1, P123, DOI 10.1105/tpc.1.1.123; BLUBAUGH DJ, 1991, BIOCHEMISTRY-US, V30, P7586, DOI 10.1021/bi00244a030; BLUBAUGH DJ, 1990, BIOCHEMISTRY-US, V29, P5109, DOI 10.1021/bi00473a016; BOCKHOLT R, 1991, FEBS LETT, V294, P59, DOI 10.1016/0014-5793(91)81343-7; BOERNER RJ, 1992, BIOCHEMISTRY-US, V31, P6660, DOI 10.1021/bi00144a005; BOSCHETTI A, 1985, BIOCHIM BIOPHYS ACTA, V810, P12, DOI 10.1016/0005-2728(85)90201-4; BOYNTON JE, 1993, METHOD ENZYMOL, V217, P510; BOYNTON JE, 1988, SCIENCE, V240, P1534, DOI 10.1126/science.2897716; BURNAP RL, 1992, BIOCHEMISTRY-US, V31, P7404, DOI 10.1021/bi00147a027; BUTLER WL, 1973, BIOCHIM BIOPHYS ACTA, V292, P140, DOI 10.1016/0005-2728(73)90258-2; CHUA NH, 1977, J CELL BIOL, V74, P441, DOI 10.1083/jcb.74.2.441; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CRITCHLEY C, 1985, BIOCHIM BIOPHYS ACTA, V811, P33, DOI 10.1016/0304-4173(85)90004-7; DEBUCHY R, 1989, EMBO J, V8, P2803, DOI 10.1002/j.1460-2075.1989.tb08426.x; DEBUS RJ, 1988, BIOCHEMISTRY-US, V27, P9071, DOI 10.1021/bi00426a001; DEBUS RJ, 1992, BIOCHIM BIOPHYS ACTA, V1102, P269, DOI 10.1016/0005-2728(92)90133-M; DEROSE VJ, 1991, BIOCHEMISTRY-US, V30, P1335, DOI 10.1021/bi00219a025; DINER BA, 1992, BIOCHIM BIOPHYS ACTA, V1101, P134, DOI 10.1016/0005-2728(92)90196-9; DINER BA, 1988, J BIOL CHEM, V263, P8972; Diner BA, 1991, CURR OPIN STRUC BIOL, V1, P546, DOI 10.1016/S0959-440X(05)80076-4; ERICKSON JM, 1986, EMBO J, V5, P1745, DOI 10.1002/j.1460-2075.1986.tb04422.x; ERICKSON JM, 1984, EMBO J, V3, P2753, DOI 10.1002/j.1460-2075.1984.tb02206.x; ERICKSON JM, 1992, PHOTOSYSTEMS STRUCTU, P101; ERICKSON JM, 1992, CURRENT RES PHOTOSYN, V3, P421; FERNANDEZ E, 1989, P NATL ACAD SCI USA, V86, P6449, DOI 10.1073/pnas.86.17.6449; FICHOT O, 1990, NUCLEIC ACIDS RES, V18, P6162, DOI 10.1093/nar/18.20.6162; FORBUSH B, 1971, PHOTOCHEM PHOTOBIOL, V14, P307, DOI 10.1111/j.1751-1097.1971.tb06175.x; GHANOTAKIS DF, 1990, ANNU REV PLANT PHYS, V41, P255, DOI 10.1146/annurev.pp.41.060190.001351; GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961; GUENTHER JE, 1990, PHOTOSYNTH RES, V23, P105, DOI 10.1007/BF00030070; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; HARRIS EH, 1989, GENETICS, V123, P281; HEISS S, 1992, PHOTOSYNTH RES, V34, P311, DOI 10.1007/BF00033448; HORTON P, 1992, METHODS PLANT BIOCH, V4, P259; IKEUCHI M, 1992, BOT MAG TOKYO, V105, P327, DOI 10.1007/BF02489425; JOHANNINGMEIER U, 1987, FEBS LETT, V211, P221, DOI 10.1016/0014-5793(87)81440-0; Joliot P., 1975, BIOENERG PHOTOSYNTH, P387; KINDLE KL, 1991, P NATL ACAD SCI USA, V88, P1721, DOI 10.1073/pnas.88.5.1721; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LERS A, 1992, J BIOL CHEM, V267, P17494; MARDER JB, 1987, PLANT MOL BIOL, V9, P325, DOI 10.1007/BF00014907; MATTOO AK, 1984, P NATL ACAD SCI-BIOL, V81, P1380, DOI 10.1073/pnas.81.5.1380; MATTOO AK, 1989, CELL, V56, P241, DOI 10.1016/0092-8674(89)90897-0; MAYES SR, 1991, BIOCHIM BIOPHYS ACTA, V1060, P1, DOI 10.1016/S0005-2728(05)80112-4; MAYFIELD SP, 1990, P NATL ACAD SCI USA, V87, P2087, DOI 10.1073/pnas.87.6.2087; MAYFIELD SP, 1987, EMBO J, V6, P313, DOI 10.1002/j.1460-2075.1987.tb04756.x; MAYFIELD SP, 1987, P NATL ACAD SCI USA, V84, P749, DOI 10.1073/pnas.84.3.749; MESSING J, 1983, METHOD ENZYMOL, V101, P20; METZ JG, 1989, BIOCHEMISTRY-US, V28, P6960, DOI 10.1021/bi00443a028; METZ JG, 1980, FEBS LETT, V114, P61, DOI 10.1016/0014-5793(80)80861-1; METZ JG, 1986, FEBS LETT, V205, P269, DOI 10.1016/0014-5793(86)80911-5; MIYAOTOKUTOMI M, 1992, BIOCHEMISTRY-US, V31, P526, DOI 10.1021/bi00117a032; MONOD C, 1994, EMBO J, V13, P2747, DOI 10.1002/j.1460-2075.1994.tb06568.x; NANBA O, 1987, P NATL ACAD SCI USA, V84, P109, DOI 10.1073/pnas.84.1.109; NEWMAN SM, 1990, GENETICS, V126, P875; NIXON PJ, 1992, BIOCHEMISTRY-US, V31, P10859, DOI 10.1021/bi00159a029; NIXON PJ, 1992, BIOCHEMISTRY-US, V31, P942, DOI 10.1021/bi00118a041; NIXON PJ, 1992, PLANT PROTEIN ENG, P93; OETTMEIER W, 1992, PHOTOSYSTEMS STRUCTU, P349; OHAD I, 1984, J CELL BIOL, V99, P481, DOI 10.1083/jcb.99.2.481; PALMER JD, 1983, NATURE, V301, P92, DOI 10.1038/301092a0; PHILBRICK JB, 1991, J BIOL CHEM, V266, P13370; PRASIL O, 1992, PHOTOSYSTEMS STRUCTU, P220; PRZIBILLA E, 1991, PLANT CELL, V2, P169; Rochaix J. D., 1988, PLANT MOL BIOL PRACT, P253; ROCHAIX JD, 1978, J MOL BIOL, V126, P597, DOI 10.1016/0022-2836(78)90011-6; ROCHAIX JD, 1988, TRENDS BIOCHEM SCI, V13, P56, DOI 10.1016/0968-0004(88)90029-1; Rochaix JD, 1992, CURR OPIN GENET DEV, V2, P785, DOI 10.1016/S0959-437X(05)80140-6; ROFFEY RA, 1994, BBA-BIOENERGETICS, V1185, P257, DOI 10.1016/0005-2728(94)90240-2; ROFFEY RA, 1991, P NATL ACAD SCI USA, V88, P9122, DOI 10.1073/pnas.88.20.9122; RUFFLE SV, 1991, PHOTOSYNTH RES, V34, P287; Rutherford A.W., 1992, PHOTOSYSTEMS STRUCTU, P179; Sambrook J, 1989, MOL CLONING LABORATO; SANFORD JC, 1993, METHOD ENZYMOL, V217, P483; SCHRADER S, 1992, PLANT MOL BIOL, V10, P251; SCHREIBER U, 1986, PHOTOSYNTH RES, V9, P261, DOI 10.1007/BF00029749; SHEN JR, 1992, FEBS LETT, V301, P145, DOI 10.1016/0014-5793(92)81235-E; STEWART AC, 1985, BIOCHIM BIOPHYS ACTA, V808, P353, DOI 10.1016/0005-2728(85)90145-8; SVENSSON B, 1991, Z NATURFORSCH C, V46, P765; SVENSSON B, 1990, EMBO J, V9, P2051, DOI 10.1002/j.1460-2075.1990.tb07372.x; TAKAHASHI Y, 1994, PLANT MOL BIOL, V5, P779; TAMURA N, 1987, BIOCHIM BIOPHYS ACTA, V890, P179, DOI 10.1016/0005-2728(87)90019-3; TANG XS, 1990, FEBS LETT, V273, P257, DOI 10.1016/0014-5793(90)81098-9; TANG XS, 1994, P NATL ACAD SCI USA, V91, P704, DOI 10.1073/pnas.91.2.704; TISCHER W, 1977, BIOCHIM BIOPHYS ACTA, V460, P113, DOI 10.1016/0005-2728(77)90157-8; TREBST A, 1991, HERBICIDE RESISTANCE IN WEEDS AND CROPS, P145; TREBST A, 1987, Z NATURFORSCH C, V42, P742; VERMAAS W, 1990, BIOCHEMISTRY-US, V29, P5325, DOI 10.1021/bi00474a017; VERMAAS WFJ, 1992, PHOTOSYSTEMS STRUCTU, P231; WEBBER AN, 1989, FEBS LETT, V242, P259, DOI 10.1016/0014-5793(89)80481-8; WURTZ EA, 1979, MOL GEN GENET, V170, P235, DOI 10.1007/BF00267056	98	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					225	235		10.1074/jbc.270.1.225	http://dx.doi.org/10.1074/jbc.270.1.225			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814379	hybrid			2022-12-27	WOS:A1995QA28700038
J	KUDEROVA, A; TANHA, J; LEE, JS				KUDEROVA, A; TANHA, J; LEE, JS			CHARACTERIZATION OF 4 NUCLEIC ACID-BINDING SINGLE-CHAIN FV-FRAGMENTS BY DIRECT AND COMPETITIVE SOLID-PHASE RADIOIMMUNOASSAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MONOCLONAL-ANTIBODIES; INCLUSION-BODIES; RNA-POLYMERASE; STRANDED-DNA; EXPRESSION; PROTEINS; FAB; RENATURATION; PURIFICATION	The heavy- and light-chain variable region genes of four different nucleic acid-binding antibodies (Jel 274 and Jel 72 (specific for duplex DNA), Jel 103 (specific for poly(rI)), and Jel 318 (specific for DNA triplexes)) were cloned. Single-chain Fv fragments (scFv) in which the heavy and light chains were joined by a linker were constructed by polymerase chain reaction. The linker of 21 amino acids also served as a tag since it consisted of a repeating heptapeptide that was recognized by a specific antipeptide antibody. scFv were expressed in the cytoplasm of Escherichia coli as inclusion bodies. After purification and renaturation, a cross-linking assay was used to demonstrate that >90% of scFv were in the form of monomers. The specificity of scFv was analyzed by both direct and competitive solid-phase radioimmunoassays. scFv.103 retained its specificity for poly(rI), whereas the other three scFv still bound the original antigen, but subtle changes in the overall specificity were noted. Thus, in some cases, the conformation of the binding site may be different in the context of an scFv compared with the original IgG.	UNIV SASKATCHEWAN,DEPT BIOCHEM,SASKATOON,SK S7N 0W0,CANADA	University of Saskatchewan			Kuderova, Alena/E-3627-2012					AGAZIE YM, 1994, J BIOL CHEM, V269, P7019; ANAND NN, 1991, J BIOL CHEM, V266, P21874; BARRY MM, 1994, J BIOL CHEM, V269, P3623; BARRY MM, 1993, MOL IMMUNOL, V30, P833, DOI 10.1016/0161-5890(93)90006-W; BATRA JK, 1990, J BIOL CHEM, V265, P15198; BETTER M, 1988, SCIENCE, V240, P1040; BOWDEN GA, 1991, BIO-TECHNOL, V9, P725, DOI 10.1038/nbt0891-725; BRAUN RP, 1986, MOL IMMUNOL, V23, P685, DOI 10.1016/0161-5890(86)90107-0; BRAUN RP, 1986, NUCLEIC ACIDS RES, V14, P5049, DOI 10.1093/nar/14.12.5049; BRIGIDO MM, 1993, J IMMUNOL, V150, P469; BUCHNER J, 1992, ANAL BIOCHEM, V205, P263, DOI 10.1016/0003-2697(92)90433-8; BUCHNER J, 1991, BIO-TECHNOL, V9, P157, DOI 10.1038/nbt0291-157; CHOTHIA C, 1992, J MOL BIOL, V227, P799, DOI 10.1016/0022-2836(92)90224-8; COLMAN PM, 1987, NATURE, V326, P358, DOI 10.1038/326358a0; ESIG NA, 1993, J MOL BIOL, V231, P897; FREUND C, 1993, FEBS LETT, V320, P97, DOI 10.1016/0014-5793(93)80070-B; GIVOL D, 1991, MOL IMMUNOL, V28, P1379, DOI 10.1016/0161-5890(91)90040-Q; GLOCKSHUBER R, 1990, BIOCHEMISTRY-US, V29, P1362, DOI 10.1021/bi00458a002; HERRON JN, 1991, PROTEINS, V11, P159, DOI 10.1002/prot.340110302; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE JS, 1982, BIOCHEMISTRY-US, V21, P4940, DOI 10.1021/bi00263a017; LEE JS, 1987, NUCLEIC ACIDS RES, V15, P1047, DOI 10.1093/nar/15.3.1047; LEE JS, 1984, BIOCHEMISTRY-US, V23, P3277, DOI 10.1021/bi00309a024; MARSTON FAO, 1986, BIOCHEM J, V240, P1, DOI 10.1042/bj2400001; MOL CD, 1994, J BIOL CHEM, V269, P3615; MOL CD, 1994, J BIOL CHEM, V269, P3605; MONTESANO L, 1982, BIOCHEM BIOPH RES CO, V109, P7, DOI 10.1016/0006-291X(82)91558-3; MOYLE M, 1989, MOL CELL BIOL, V9, P5750, DOI 10.1128/MCB.9.12.5750; PANTOLIANO MW, 1991, BIOCHEMISTRY-US, V30, P10117, DOI 10.1021/bi00106a007; PLUCKTHUN A, 1991, BIO-TECHNOL, V9, P545, DOI 10.1038/nbt0691-545; POKKULURI PR, 1994, IN PRESS J MOL BIOL; POLYMENIS M, 1994, J IMMUNOL, V152, P5318; POWER BE, 1992, GENE, V113, P95, DOI 10.1016/0378-1119(92)90674-E; RICH A, 1984, ANNU REV BIOCHEM, V53, P791, DOI 10.1146/annurev.bi.53.070184.004043; RUMBLEY CA, 1993, J BIOL CHEM, V268, P13667; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; STOLLAR BD, 1991, MOL IMMUNOL, V28, P1399, DOI 10.1016/0161-5890(91)90042-I; STOLLAR BD, 1994, FASEB J, V8, P337, DOI 10.1096/fasebj.8.3.7511550; STOLLAR BD, 1981, CLIN IMMUNOL ALLERGY, V1, P243; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TABUR S, 1985, P NATL ACAD SCI USA, V82, P1074; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0	42	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					32957	32962						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806525				2022-12-27	WOS:A1994QA63800038
J	LIU, GH; PESSAH, IN				LIU, GH; PESSAH, IN			MOLECULAR INTERACTION BETWEEN RYANODINE RECEPTOR AND GLYCOPROTEIN TRIADIN INVOLVES REDOX CYCLING OF FUNCTIONALLY IMPORTANT HYPERREACTIVE SULFHYDRYLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE CHANNEL; MUSCLE SARCOPLASMIC-RETICULUM; RABBIT SKELETAL-MUSCLE; CA-2+ RELEASE; CA2+ RELEASE; FOOT PROTEIN; LOCALIZATION; OXIDATION; COMPLEX; CDNA	The fluorogenic maleimide 7-diethylamino-3-(4'-maleimidylphenyl)-4-methylcoumarin (CPM) has been shown to selectively form Michael adducts with hyperreactive sulfhydryls on the skeletal sarcoplasmic reticulum (SR) ryanodine receptor (RyR1) and triadin which are essential for normal Ca2+ channel function (Liu, G., Abramson, J, J,, Zable, A. C,, and Pessah, I. N, (1994) Mel. Pharmacol, 45, 189-200), The present report demonstrates a functionally important interaction between RyR1 and triadin which involves, in part, redox cycling of hyperreactive sulfhydryls in response to channel activation and inactivation, Nanomolar CPM is shown to selectively label RyR1 and triadin only in the presence of Ca2+ channel inhibitors (Mg2+, neomycin, ruthenium red, or anti-triadin antibody), Treatment of SR with channel activators (micromolar Ca2+, nanomolar ryanodine, or millimolar caffeine), 1) slows CPM labeling kinetics >10-fold, 2) negates CPM labeling of channel-associated sulfhydryls, and 3) stabilizes a high molecular weight complex (HMWC) which appears on nonreducing SDS-polyacrylamide gel electrophoresis gels, The HMWC is positively identified as RyR1 and triadin by Western blot and immunoprecipitation analyses, High-affinity [H-3]ryanodine-binding sites are immunoprecipitated by either anti-RyR1 or anti-triadin antibody dose dependently, 1,4-Naphthoquinone (less than or equal to 40 pmol/mu g protein) selectively oxidizes hyperreactive sulfhydryls on RyR1 and triadin, induces Ca2+ efflux from SR, and stabilizes the HMWC. The HMWC is reduced by beta-mercaptoethanol or dithiothreitol into its component RyR1 and triadin protomers, The results provide direct evidence for the existence of a functionally important complex between RyR1 and triadin whose stability is determined by the redox state of hyperreactive sulfhydryl moieties which are allosterically regulated by physiological and pharmacological channel ligands, The present results suggest a possible molecular mechanism by which localized transient changes in the redox state within the RyR1 triadin complex can signal information across the SE membrane.	UNIV CALIF DAVIS, SCH VET MED, DEPT MOLEC BIOSCI, DIV PHARMACOL & TOXICOL, DAVIS, CA 95616 USA	University of California System; University of California Davis			Pessah, Isaac N/K-7985-2017	Pessah, Isaac N/0000-0002-8149-588X	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R29ES005002, R01ES005002] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES05002, ES05707] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ABRAMSON JJ, 1988, MOL CELL BIOCHEM, V82, P81; ABRAMSON JJ, 1989, J BIOENERG BIOMEMBR, V21, P283, DOI 10.1007/BF00812073; AIREY JA, 1990, J BIOL CHEM, V265, P14187; BRANDT NR, 1993, J MEMBRANE BIOL, V131, P219, DOI 10.1007/BF02260110; BRANDT NR, 1992, FEBS LETT, V299, P57, DOI 10.1016/0014-5793(92)80100-U; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; CAMPBELL KP, 1987, J BIOL CHEM, V262, P6460; CASWELL AH, 1991, BIOCHEMISTRY-US, V30, P7507, DOI 10.1021/bi00244a020; CHEN SRW, 1993, BIOCHEMISTRY-US, V32, P3743, DOI 10.1021/bi00065a029; CHIESI M, 1988, BIOCHEM BIOPH RES CO, V154, P1, DOI 10.1016/0006-291X(88)90641-9; COLLINS JH, 1991, BIOCHEM BIOPH RES CO, V178, P1288, DOI 10.1016/0006-291X(91)91033-9; FLUCHER BE, 1993, J CELL BIOL, V123, P1161, DOI 10.1083/jcb.123.5.1161; GILCHRIST JSC, 1992, J BIOL CHEM, V267, P20850; IKEMOTO N, 1991, BIOCHEMISTRY-US, V30, P5230, DOI 10.1021/bi00235a017; IMAGAWA T, 1987, J BIOL CHEM, V262, P16636; JAYARAMAN T, 1992, J BIOL CHEM, V49, P467; KANG JJ, 1992, BIOCHEMISTRY-US, V31, P3288, DOI 10.1021/bi00127a034; KNUDSON CM, 1993, J BIOL CHEM, V268, P12637; KNUDSON CM, 1993, J BIOL CHEM, V268, P12646; KOSHITA M, 1993, EXPERIENTIA, V49, P282, DOI 10.1007/BF01923402; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; LIU GH, 1994, MOL PHARMACOL, V45, P189; LIU GH, 1990, JPN J PHYSL; LIU QY, 1989, BIOPHYS J, V55, P415, DOI 10.1016/S0006-3495(89)82835-8; LU XY, 1994, J BIOL CHEM, V269, P6511; MA JJ, 1993, J GEN PHYSIOL, V102, P1031, DOI 10.1085/jgp.102.6.1031; MACK MM, 1992, J PHARMACOL EXP THER, V262, P1028; MACK MM, 1994, J BIOL CHEM, V269, P23236; MARKS AR, 1989, P NATL ACAD SCI USA, V86, P8683, DOI 10.1073/pnas.86.22.8683; MARTY I, 1994, P NATL ACAD SCI USA, V91, P2270, DOI 10.1073/pnas.91.6.2270; MAYRLEITNER M, 1994, CELL CALCIUM, V15, P99, DOI 10.1016/0143-4160(94)90048-5; MIYAMOTO H, 1982, J MEMBRANE BIOL, V66, P193, DOI 10.1007/BF01868494; OHKUSA T, 1991, J BIOCHEM-TOKYO, V109, P609, DOI 10.1093/oxfordjournals.jbchem.a123428; PESSAH IN, 1987, MOL PHARMACOL, V31, P232; PESSAH IN, 1990, MOL PHARMACOL, V37, P503; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; SIPPEL TO, 1981, J HISTOCHEM CYTOCHEM, V29, P314, DOI 10.1177/29.2.7019305; SMITH JS, 1988, J GEN PHYSIOL, V92, P1, DOI 10.1085/jgp.92.1.1; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TIMERMAN AP, 1993, J BIOL CHEM, V268, P22992; WYSKOVSKY W, 1990, EUR J BIOCHEM, V194, P549, DOI 10.1111/j.1432-1033.1990.tb15651.x; ZAIDI NF, 1989, J BIOL CHEM, V264, P21725; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	44	91	92	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					33028	33034						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806531				2022-12-27	WOS:A1994QA63800047
J	HERRMANN, C; MARTIN, GA; WITTINGHOFER, A				HERRMANN, C; MARTIN, GA; WITTINGHOFER, A			QUANTITATIVE-ANALYSIS OF THE COMPLEX BETWEEN P21(RAS) AND THE RAS-BINDING DOMAIN OF THE HUMAN RAF-1 PROTEIN-KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; HA-RAS; ACTIVATING PROTEIN; GRB2; P21; IDENTIFICATION; ASSOCIATION; P21(H-RAS); INTERACTS; MECHANISM	The Ras-binding domain (RBD) of human Raf-1 was purified from Escherichia coli, and its interaction with Ras was investigated. Its dissociation constant with p21(ras)guanyl-5'-yl imidodiphosphate was found to be 18 nM, with a slight preference for H-ras over K- and N-ras. Oncogenic forms bind with slightly lower affinity. The affinity of RED for effector region mutants or the GDP-bound form of p21(ras) is in the micromolar range, which means that 100-fold lower affinity is not sufficient for signal transduction. The rate of the GTPase of p21(ras) is not modified by RED. Since P-i release is found not to be rate limiting, the Ras-Raf signal of the cell may be terminated by the intrinsic GTPase of p2l(ras).	MAX PLANCK INST MOLEK PHYSIOL,D-44139 DORTMUND,GERMANY; ONYX PHARMACEUT,RICHMOND,CA 94806	Max Planck Society								ADARI H, 1988, SCIENCE, V240, P518, DOI 10.1126/science.2833817; BONNER TI, 1986, NUCLEIC ACIDS RES, V14, P1009, DOI 10.1093/nar/14.2.1009; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; CALES C, 1988, NATURE, V32, P548; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; CHUANG E, 1994, MOL CELL BIOL, V14, P5318, DOI 10.1128/MCB.14.8.5318; ECCLESTON JF, 1993, J BIOL CHEM, V268, P27012; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; EMERSON SD, 1994, BIOCHEMISTRY-US, V33, P7745, DOI 10.1021/bi00191a001; FABIAN JR, 1994, P NATL ACAD SCI USA, V91, P5982, DOI 10.1073/pnas.91.13.5982; FEUERSTEIN J, 1987, J BIOL CHEM, V262, P8455; FRANKEN SM, 1993, BIOCHEMISTRY-US, V32, P8411, DOI 10.1021/bi00084a005; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; GIBBS JB, 1988, P NATL ACAD SCI USA, V85, P5026, DOI 10.1073/pnas.85.14.5026; GRUSSENMEYER T, 1985, P NATL ACAD SCI USA, V82, P7952, DOI 10.1073/pnas.82.23.7952; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; JOHN J, 1993, J BIOL CHEM, V268, P923; JOHN J, 1988, J BIOL CHEM, V263, P11792; JOHN J, 1992, THESIS U HEIDELBERG; KOIDE H, 1993, P NATL ACAD SCI USA, V90, P8683, DOI 10.1073/pnas.90.18.8683; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; SCHEFFLER JE, 1994, J BIOL CHEM, V269, P22340; SCHWEINS T, 1994, STRUCT BIOL, V1, P476; SHHIROUZU M, 1994, ONCOGENE, V9, P2153; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P4725, DOI 10.1073/pnas.83.13.4725; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213, DOI 10.1073/pnas.90.13.6213; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; WIESMULLER L, 1994, CELL SIGNAL, V6, P247, DOI 10.1016/0898-6568(94)90030-2; YAMASAKI K, 1994, BIOCHEMISTRY-US, V33, P65, DOI 10.1021/bi00167a009; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	37	294	299	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					2901	2905		10.1074/jbc.270.7.2901	http://dx.doi.org/10.1074/jbc.270.7.2901			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852367				2022-12-27	WOS:A1995QG47100006
J	BLAKESLEY, VA; KATO, H; ROBERTS, CT; LEROITH, D				BLAKESLEY, VA; KATO, H; ROBERTS, CT; LEROITH, D			MUTATION OF A CONSERVED AMINO-ACID RESIDUE (TRYPTOPHAN-1173) IN THE TYROSINE KINASE DOMAIN OF THE IGF-I RECEPTOR ABOLISHES AUTOPHOSPHORYLATION BUT DOES NOT ELIMINATE BIOLOGIC FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INSULIN-RECEPTOR; SIGNAL TRANSDUCTION; GROWTH; REPLACEMENT; FAMILY; HORMONE; MUTANT; SITES	The amino acid sequence of the tyrosine kinase domain of the insulin-like growth factor-I (IGF-I) receptor is 84% identical to the sequence of the analogous region of the insulin receptor, A naturally occurring mutation of the tryptophan residue at position 1200 of the insulin receptor to serine results in impaired beta subunit autophosphorylation of wheat germ agglutinin-purified receptors, severely impaired thymidine incorporation and moderately reduced glycogen synthesis; however, glucose uptake was unaffected. To study the importance of this residue in IGF-I receptor function, we mutated the analogous tryptophan residue at position 1173 of the IGF-I receptor to serine and overexpressed the mutant receptor in NIH-3T3 cells, In cell Lines overexpressing this mutant IGF-I receptor, beta subunit autophosphorylation was severely reduced. Additionally, the overexpressed mutant receptors exhibited a dominant-negative effect on IGF-I-stimulated autophosphorylation of endogenous mouse IGF-I receptors, Phosphorylation of insulin receptor substrate (IRS)-1 in intact cells by the mutant IGF-I receptors was similar to the level of IRS-1 phosphorylation seen in the parental NIH-3T3 cells, but there was no obvious dominant-negative effect on IRS-1 phosphorylation. Wheat germ agglutinin-purified mutant receptors were as active in phosphorylating poly(Glu,Tyr) 4:1 as wild-type IGF-I receptors, suggesting that, in intact cells, additional factors are necessary in order for the IGF-I receptor to phosphorylate IRS-1, Thymidine incorporation was severely reduced in one clone overexpressing the mutant IGF-I receptor and abolished in a second clone, Glucose uptake in both clones was reduced to about half of that seen in a cell line overexpressing mild-type IGF-I receptors. Thus, we propose that the tryptophan residue at position 1173 of the IGF-I receptor is important in the regulation of autophosphorylation in vivo. This study again confirms that high levels of autophosphorylation are not required for mediation of all of the biologic activities of the IGF-I receptor.	NIDDK,DIABET BRANCH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)			Roberts, Charles/K-6953-2017	Roberts, Charles/0000-0003-1756-5772				ADAMO M, 1991, BIOFACTORS, V3, P151; [Anonymous], 1991, INSULIN LIKE GROWTH; DEBANT A, 1988, P NATL ACAD SCI USA, V85, P8032, DOI 10.1073/pnas.85.21.8032; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; EBINA Y, 1987, P NATL ACAD SCI USA, V84, P704, DOI 10.1073/pnas.84.3.704; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; FARIA TN, 1994, J BIOL CHEM, V269, P13922; FILIPEK A, 1993, MOL CELL BIOCHEM, V120, P103, DOI 10.1007/BF00926082; FORMISANO P, 1993, J BIOL CHEM, V268, P5241; GRONBORG M, 1993, J BIOL CHEM, V268, P23435; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; IWANISHI M, 1993, DIABETOLOGIA, V36, P414, DOI 10.1007/BF00402277; KATO H, 1994, MOL ENDOCRINOL, V8, P40, DOI 10.1210/me.8.1.40; KATO H, 1993, J BIOL CHEM, V268, P2655; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MOLLER DE, 1991, J BIOL CHEM, V266, P10995; MOLLER DE, 1990, MOL ENDOCRINOL, V4, P1183, DOI 10.1210/mend-4-8-1183; MURAKAMI MS, 1991, J BIOL CHEM, V266, P22653; RAFAELOFF R, 1991, BIOCHEM BIOPH RES CO, V179, P912, DOI 10.1016/0006-291X(91)91905-R; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SHEMER J, 1987, J BIOL CHEM, V262, P7693; SHIER P, 1989, J BIOL CHEM, V264, P14605; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; WILDEN PA, 1990, P NATL ACAD SCI USA, V87, P3358, DOI 10.1073/pnas.87.9.3358; WILDEN PA, 1992, J BIOL CHEM, V267, P16660; WILDEN PA, 1992, J BIOL CHEM, V267, P13719; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; YONEZAWA K, 1991, MOL ENDOCRINOL, V5, P194, DOI 10.1210/mend-5-2-194; ZHANG B, 1991, J BIOL CHEM, V266, P990	30	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2764	2769		10.1074/jbc.270.6.2764	http://dx.doi.org/10.1074/jbc.270.6.2764			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852347	hybrid			2022-12-27	WOS:A1995QF53500057
J	CORBETT, JD; MICKOLS, WE; MAESTRE, MF				CORBETT, JD; MICKOLS, WE; MAESTRE, MF			EFFECT OF HEMOGLOBIN CONCENTRATION ON NUCLEATION AND POLYMER FORMATION IN SICKLE RED-BLOOD-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S POLYMERIZATION; DELAY TIME; DEOXYGENATION; ERYTHROCYTES; SCATTERING; MECHANISM; KINETICS; GELATION; LIGHT; SHEAR	We have used differential polarization imaging microscopy to measure the amount and orientation of aligned sickle hemoglobin polymer in quickly deoxygenated sickle red blood cells. Images of the angular orientation of the aligned polymer at each point in the cell allowed for determination of the inclination of individual domains, providing detailed information regarding the polymerization and elongation of sickle hemoglobin polymers ex vivo. We found that the number of aligned polymer domains increased with increasing mean cell hemoglobin concentration. Sickle and holly leaf-shaped cells contained single or few domains of aligned polymer, while more compact cells such as irreversibly sickled cells contained many domains. A new class of cells was discovered by examination of images of the angular orientation of aligned polymer, which contained a single central nucleation site, with growth of polymer occurring outward in all directions in a spherulite-like domain.	UNIV CALIF BERKELEY, LAWRENCE BERKELEY LAB, DEPT CHEM, BERKELEY, CA 94720 USA; UNIV CALIF BERKELEY, LAWRENCE BERKELEY LAB, CHEM BIODYNAM LAB, BERKELEY, CA 94720 USA; UNIV CALIF BERKELEY, LAWRENCE BERKELEY LAB, DIV BIOL & MED, BERKELEY, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley					NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI008427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM010840, R01GM010840] Funding Source: NIH RePORTER; NCRR NIH HHS [RR 01613] Funding Source: Medline; NIAID NIH HHS [AI 08427] Funding Source: Medline; NIGMS NIH HHS [GM 10840] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASAKURA T, 1984, J LAB CLIN MED, V104, P987; BASAK S, 1988, BIOPHYS J, V54, P829, DOI 10.1016/S0006-3495(88)83020-0; BEACH DA, 1987, BIOPHYS J, V52, P947, DOI 10.1016/S0006-3495(87)83287-3; BERTLES JF, 1969, BLOOD-J HEMATOL, V33, P884, DOI 10.1182/blood.V33.6.884.884; BRIEHL RW, 1982, BLOOD CELLS, V8, P201; BRIEHL RW, 1989, ANN NY ACAD SCI, V565, P295, DOI 10.1111/j.1749-6632.1989.tb24177.x; CHRISTOPH GW, 1983, BIOPHYS J, V41, pA415; DOU Q, 1993, BIOPHYS J, V65, P2068, DOI 10.1016/S0006-3495(93)81237-2; DYKES G, 1978, NATURE, V272, P506, DOI 10.1038/272506a0; Eaton W A, 1990, Adv Protein Chem, V40, P63, DOI 10.1016/S0065-3233(08)60287-9; FERRONE FA, 1985, J MOL BIOL, V183, P611, DOI 10.1016/0022-2836(85)90175-5; FERRONE FA, 1980, BIOPHYS J, V32, P361, DOI 10.1016/S0006-3495(80)84962-9; FERRONE FA, 1985, J MOL BIOL, V183, P591, DOI 10.1016/0022-2836(85)90174-3; GILL SJ, 1980, J MOL BIOL, V140, P299, DOI 10.1016/0022-2836(80)90107-2; HARRIS JW, 1950, P SOC EXP BIOL MED, V75, P197, DOI 10.3181/00379727-75-18144; HOFRICHTER J, 1973, P NATL ACAD SCI USA, V70, P3604, DOI 10.1073/pnas.70.12.3604; HOFRICHTER J, 1978, BIOPHYS J, V21, P20; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; KAUL DK, 1991, BLOOD, V77, P1353; KAUL DK, 1989, P NATL ACAD SCI USA, V86, P3356, DOI 10.1073/pnas.86.9.3356; KIM M, 1991, BIOPHYS J, V59, P1171, DOI 10.1016/S0006-3495(91)82333-5; KIM M, 1987, BIOPHYS J, V52, P929, DOI 10.1016/S0006-3495(87)83286-1; KIM M, 1987, BIOPHYS J, V52, P911, DOI 10.1016/S0006-3495(87)83285-X; MADGOFFFAIRCHIL.B, 1986, BIOPHYS J, V49, P67; MADONIA F, 1983, NATURE, V302, P412, DOI 10.1038/302412a0; MAKHIJANI VB, 1990, BIOPHYS J, V58, P1025, DOI 10.1016/S0006-3495(90)82446-2; MICKOLS W, 1985, REV SCI INSTRUM, V56, P2228, DOI 10.1063/1.1138354; MICKOLS W, 1985, P NATL ACAD SCI USA, V82, P6527, DOI 10.1073/pnas.82.19.6527; MICKOLS WE, 1988, J BIOL CHEM, V263, P4338; MICKOLS WE, 1987, POLARIZED SPECTROSCO, P297; MITZUKAMI H, 1986, AM J HEMATOL, V21, P233; MOHANDAS N, 1986, BLOOD, V68, P506; MOZZARELLI A, 1987, SCIENCE, V237, P500, DOI 10.1126/science.3603036; NOGUCHI CT, 1983, J CLIN INVEST, V72, P846, DOI 10.1172/JCI111055; PERUTZ MF, 1950, NATURE, V166, P677, DOI 10.1038/166677a0; POYART C, 1984, DYNAMIC ANAL DEOXYGE, P137; PUMPHREY JG, 1976, BIOCHEM BIOPH RES CO, V69, P99, DOI 10.1016/S0006-291X(76)80278-1; RUSSU IM, 1980, P NATL ACAD SCI-BIOL, V77, P6577, DOI 10.1073/pnas.77.11.6577; SHIBATA K, 1977, J BIOL CHEM, V252, P7468; SINGER K, 1953, BLOOD, V8, P1008, DOI 10.1182/blood.V8.11.1008.1008; SORETTE MP, 1987, BLOOD, V69, P316; SUNSHINE HR, 1979, J MOL BIOL, V133, P435, DOI 10.1016/0022-2836(79)90402-9; SUNSHINE HR, 1982, J MOL BIOL, V158, P251, DOI 10.1016/0022-2836(82)90432-6; WATERMAN MR, 1976, BIOCHEM BIOPH RES CO, V73, P639, DOI 10.1016/0006-291X(76)90858-5; WATERMAN MR, 1979, J MOL BIOL, V129, P337, DOI 10.1016/0022-2836(79)90287-0; WHITE JG, 1968, BLOOD, V31, P561, DOI 10.1182/blood.V31.5.561.561; WINSLOW RM, 1978, HEMOGLOBIN INTERACTI, P369	47	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2708	2715		10.1074/jbc.270.6.2708	http://dx.doi.org/10.1074/jbc.270.6.2708			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852341	hybrid			2022-12-27	WOS:A1995QF53500049
J	LAWLER, J; MCHENRY, K; DUQUETTE, M; DERICK, L				LAWLER, J; MCHENRY, K; DUQUETTE, M; DERICK, L			CHARACTERIZATION OF HUMAN THROMBOSPONDIN-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PLATELET THROMBOSPONDIN; OLIGOMERIC MATRIX PROTEIN; ELECTRON-MICROSCOPY; GENE FAMILY; CARTILAGE; EXPRESSION; CLEAVAGE; CALCIUM; SITES; ACID	The thrombospondins are a family of extracellular calcium binding proteins that are involved in cell proliferation, adhesion, and migration. We have sequenced full-length human thrombospondin-4 and characterized the recombinant protein. In contrast to Xenopus laevis thrombospondin-4, the human protein contains an RGD cell binding sequence in the third type 3 repeat. Transfection of mouse NIH3T3 fibroblasts or C2C12 myoblasts with a full-length human thrombospondin-4 cDNA results in the expression of a polypeptide with a reduced molecular weight of 140,000. In the absence of reducing agent, the expressed protein has an apparent molecular weight of 550,000. Recombinant thrombospondin-4 has been purified from the culture supernatant by heparin-Sepharose and anti-thrombospondin-4 antibody-Affi-gel affinity chromatography. Electron microscopy indicates that thrombospondin-4 is composed of five subunits with globular domains at each end. The observation of a calcium-dependent change in the electron microscopic appearance of thrombospondin-4 is consistent with limited tryptic digestion data that indicate that thrombospondin-4 is resistant to digestion in the presence of calcium. These data indicate that thrombospondin-4 is a pentameric protein that binds to heparin and calcium.	HARVARD UNIV,SCH MED,BOSTON,MA 02115; TUFTS UNIV,ST ELIZABETHS HOSP,DEPT BIOMED RES,BOSTON,MA 02135	Harvard University; Harvard Medical School; Tufts University	LAWLER, J (corresponding author), BRIGHAM & WOMENS HOSP,DEPT PATHOL,DIV VASC RES,BOSTON,MA 02115, USA.		Lawler, Jack/AAJ-1379-2020		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028749, R01HL049081] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL28749, HL49081] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS J, 1993, CURR BIOL, V3, P188, DOI 10.1016/0960-9822(93)90270-X; ADAMS JC, 1993, J CELL SCI, V104, P1061; BORNSTEIN P, 1993, GENOMICS, V15, P607, DOI 10.1006/geno.1993.1114; BORNSTEIN P, 1992, FASEB J, V6, P3290, DOI 10.1096/fasebj.6.14.1426766; EFIMOV VP, 1994, FEBS LETT, V34, P54; GALVIN NJ, 1985, J CELL BIOL, V101, P1434, DOI 10.1083/jcb.101.4.1434; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWLER J, 1993, J CELL BIOL, V120, P1059, DOI 10.1083/jcb.120.4.1059; LAWLER J, 1993, J MOL EVOL, V36, P509, DOI 10.1007/BF00556355; LAWLER J, 1985, J BIOL CHEM, V260, P3762; LAWLER J, 1982, J BIOL CHEM, V257, P2257; LAWLER J, 1992, BIOCHEMISTRY-US, V31, P1173, DOI 10.1021/bi00119a029; LAWLER J, 1986, J CELL BIOL, V103, P1635, DOI 10.1083/jcb.103.5.1635; MORGELIN M, 1992, J BIOL CHEM, V267, P6137; NEWTON G, 1994, IN PRESS GENOMICS; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; OROURKE KM, 1992, J BIOL CHEM, V767, P24921; QABAR AN, 1994, J BIOL CHEM, V269, P1262; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STENFLO J, 1988, J BIOL CHEM, V263, P21; TYLER JM, 1980, J ULTRA MOL STRUCT R, V71, P95, DOI 10.1016/S0022-5320(80)90098-2; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683	24	72	78	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2809	2814		10.1074/jbc.270.6.2809	http://dx.doi.org/10.1074/jbc.270.6.2809			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852353	hybrid, Green Submitted			2022-12-27	WOS:A1995QF53500063
J	MORRIS, JC; LEI, PS; SHEN, TY; MENSAWILMOT, K				MORRIS, JC; LEI, PS; SHEN, TY; MENSAWILMOT, K			GLYCAN REQUIREMENTS OF GLYCOSYLPHOSPHATIDYLINOSITOL PHOSPHOLIPASE-C FROM TRYPANOSOMA-BRUCEI - GLUCOSAMINYLINOSITOL DERIVATIVES INHIBIT PHOSPHATIDYLINOSITOL PHOSPHOLIPASE-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VARIANT SURFACE GLYCOPROTEIN; BACILLUS-CEREUS; MEMBRANE ANCHOR; MIXED MICELLES; BIOSYNTHESIS; THURINGIENSIS; PURIFICATION; DETERGENT; MUTANTS; THY-1	Glycosylphosphatidylinositol phospholipase C (GPI-PLC) from Trypanosoma brucei and phosphatidylinositol phospholipase C (PI-PLC) from Bacillus sp. both cleave glycosylphosphatidylinositols (GPIs), However, phosphatidylinositol, which is efficiently cleaved by PI-PLC, is a very poor substrate for GPI-PLC, We examined GPI-PLC substrate requirements using glycoinositol analogs of GPI components as potential inhibitors. Glucosaminyl(alpha 1-->6)-D-myo-inositol (GlcN(alpha 1-->6)Ins), GlcN(alpha 1-->6)Ins 1,2-cyclic phosphate, GlcN(alpha 1-->6)-2-deoxy-Ins, and GlcN(alpha 1-->6)Ins 1-dodecyl phosphonate inhibited GPI-PLC. GlcN(alpha 1-->6)Ins was as effective as Man(alpha 1-->4)GlcN((alpha 1-->6)Ins; we surmise that GlcN(alpha 1-->6)Ins is the crucial glycan motif for GPI-PLC recognition. Inhibition by GlcN(alpha 1-->6)Ins 1,2-cyclic phosphate suggests product inhibition since GPIs cleaved by GPI-PLC possess a GlcN(alpha 1-->6)Ins 1,2-cyclic phosphate at the terminus of the residual glycan. The effectiveness of GlcN(alpha 1-->6)-2-deoxy-Ins indicates that the D-myo-inositol (Ins) 2-hydroxyl is not required for substrate recognition, although it is probably essential for catalysis. GlcN(alpha 1-->6)-2-deoxy-L-myo-inositol, unlike GlcN(alpha 1-->6)2-deoxy-Ins, had no effect on GPI-PLC; hence, GPI-PLC can distinguish between the two enantiomers of Ins, Surprisingly, GlcN(alpha 1-->6)Ins 1,2-cyclic phosphate was not a potent inhibitor of Bacillus cereus PI-PLC, and GlcN(alpha 1-->6)Ins had no effect on the enzyme. However, both GlcN(alpha 1-->6)Ins 1-phosphate and GlcN(alpha 1-->6)Ins 1-dodecyl phosphonate were competitive inhibitors of PI-PLC. These observations suggest an important role for a phosphoryl group at the Ins 1-position in PI-PLC recognition of GPIs. Other studies indicate that abstraction of a proton from the Ins 2-hydroxyl is not an early event in PI-PLC cleavage of GPIs. Furthermore, both GlcN(alpha 1-->6)-2-deoxy-Ins 1-phosphate and GlcN(alpha 1-->6)-2-deoxy-L-myo-inositol inhibited PI-PLC without affecting GPI-PLC. Last, the aminoglycoside G418 stimulated PI-PLC, but had no effect on GPI-PLC. Thus, these enzymes represent mechanistic subclasses of GPI phospholipases C, distinguishable by their sensitivity to GlcN(alpha 1-->6)Ins derivatives and aminoglycosides, Possible allosteric regulation of PI-PLC by GlcN(alpha 1-->6)Ins analogs is discussed.	UNIV VIRGINIA, DEPT CHEM, CHARLOTTESVILLE, VA 22901 USA	University of Virginia	MORRIS, JC (corresponding author), UNIV GEORGIA, DEPT CELLULAR BIOL, 724 BIOL SCI BLDG, ATHENS, GA 30602 USA.			Morris, James/0000-0003-2515-5714	NIAID NIH HHS [1-T32-AIO-7322, AI 33383] Funding Source: Medline; NIGMS NIH HHS [GM 47109] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007322, R29AI033383, R01AI033383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047109] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; BERG OG, 1991, BIOCHEMISTRY-US, V30, P7283, DOI 10.1021/bi00243a034; BERLIN WK, 1991, TETRAHEDRON, V47, P1, DOI 10.1016/0040-4020(91)80003-K; BRUZIK KS, 1992, BIOCHEMISTRY-US, V31, P5183, DOI 10.1021/bi00137a014; BULOW R, 1986, J BIOL CHEM, V261, P1918; CARRINGTON M, 1991, CELL BIOL INT REP, V15, P1101, DOI 10.1016/0309-1651(91)90058-Q; DOERING TL, 1989, J BIOL CHEM, V264, P11168; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4547; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; FOX JA, 1986, J BIOL CHEM, V261, P5767; GRIFFITH OH, 1991, METHOD ENZYMOL, V197, P493; GUPTA D, 1988, SCIENCE, V242, P1446, DOI 10.1126/science.2904699; HENNER DJ, 1988, NUCLEIC ACIDS RES, V16, P10383, DOI 10.1093/nar/16.21.10383; HERELD D, 1986, J BIOL CHEM, V261, P3813; JAIN MK, 1993, BIOCHEMISTRY-US, V32, P8360, DOI 10.1021/bi00083a040; JAIN MK, 1989, BIOCHEMISTRY-US, V28, P4135, DOI 10.1021/bi00436a002; KRAKOW JL, 1989, MOL BIOCHEM PARASIT, V36, P263, DOI 10.1016/0166-6851(89)90174-6; KUPPE A, 1989, J BACTERIOL, V171, P6077, DOI 10.1128/jb.171.11.6077-6083.1989; Low M.G., 1992, LIPID MODIFICATION P, P117; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; Mensa-Wilmot K., 1991, P43; MENSAWILMOT K, 1994, J CELL BIOL, V124, P935, DOI 10.1083/jcb.124.6.935; MENSAWILMOT K, 1992, MOL BIOCHEM PARASIT, V56, P311, DOI 10.1016/0166-6851(92)90180-R; MENSAWILMOT K, 1995, IN PRESS METHODS ENZ; NEWTON AC, 1993, ANNU REV BIOPH BIOM, V22, P1, DOI 10.1146/annurev.bb.22.060193.000245; PLOURDE R, 1992, J ORG CHEM, V57, P2606, DOI 10.1021/jo00035a015; ROBSON RJ, 1978, BIOCHIM BIOPHYS ACTA, V508, P513, DOI 10.1016/0005-2736(78)90096-2; SHASHIDHAR MS, 1990, BIOCHIM BIOPHYS ACTA, V1042, P410, DOI 10.1016/0005-2760(90)90172-T; STEVENS VL, 1991, J BIOL CHEM, V266, P10039; TURCO SJ, 1992, ANNU REV MICROBIOL, V46, P65, DOI 10.1146/annurev.mi.46.100192.000433; VACCA JP, 1989, TETRAHEDRON, V45, P5679, DOI 10.1016/S0040-4020(01)89510-7; VIDUGIRIENE J, 1994, J CELL BIOL, V127, P333, DOI 10.1083/jcb.127.2.333; VOLWERK JJ, 1994, BIOCHEMISTRY-US, V33, P3464, DOI 10.1021/bi00178a002; VOLWERK JJ, 1990, BIOCHEMISTRY-US, V29, P8056, DOI 10.1021/bi00487a010	36	29	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2517	2524		10.1074/jbc.270.6.2517	http://dx.doi.org/10.1074/jbc.270.6.2517			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852313	hybrid			2022-12-27	WOS:A1995QF53500021
J	WANG, JX; KULISZEWSKI, M; YEE, W; SEDLACKOVA, L; XU, J; TSEU, I; POST, M				WANG, JX; KULISZEWSKI, M; YEE, W; SEDLACKOVA, L; XU, J; TSEU, I; POST, M			CLONING AND EXPRESSION OF GLUCOCORTICOID-INDUCED GENES IN PETAL RAT LUNG FIBROBLASTS - TRANSFORMING GROWTH FACTOR-BETA(3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BETA; TGF-BETA; PRETRANSLATIONAL LEVEL; PNEUMONOCYTE FACTOR; EPITHELIAL-CELLS; RNA EXPRESSION; MESSENGER-RNA; FETAL LUNG; TGF-BETA-1; DIFFERENTIATION	Glucocorticoids have been shown to accelerate fetal lung type II cell maturation, and this effect appears, in part, to be mediated via fibroblasts. To identify glucocorticoid induced genes in fetal lung fibroblasts, we screened a cDNA Library from cortisol-treated fetal lung fibroblasts with a subtracted cDNA probe which was enriched for sequences specific for cortisol-treated fetal lung fibroblasts. Fifty-seven clones were isolated from the cDNA library. One cDNA represented approximate to 30% of the 57 clones. Analysis of DNA sequence homology suggested that this cDNA encodes the rat transforming growth factor-beta(3) (TGF beta(3)). We found that TGF beta(3) mRNA was expressed in fetal lung fibroblasts but not epithelial cells. Expression of message in fetal lung fibroblasts was developmentally regulated. TGF beta(3) mRNA levels were low during the pseudoglandular stage (day 18), peaked during the early canalicular stage of lung development (day 19), then fell again at days 20 and 21 (term = 22 days). Exposure of fetal lung fibroblasts to cortisol increased TGF beta(3) mRNA expression in a time- and dose-dependent manner. Maternal administration of dexamethasone also enhanced mRNA expression of TGF beta(3) in fetal lung fibroblasts. These data suggest that glucocorticoids may mediate their stimulatory effect on lung maturation by inducing TGF beta(3) expression in fetal lung fibroblasts.	UNIV TORONTO,HOSP SICK CHILDREN,RES INST,DIV NEONATOL,MED RES COUNCIL,LUNG DEV GRP,TORONTO,ON M5G 1X8,CANADA; UNIV TORONTO,HOSP SICK CHILDREN,RES INST,DEPT PAEDIAT,DIV NEONATAL RES,TORONTO,ON M5G 1X8,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)								BASCOM CC, 1989, MOL CELL BIOL, V9, P5508, DOI 10.1128/MCB.9.12.5508; CANIGGIA I, 1991, AM J PHYSIOL, V261, pL424, DOI 10.1152/ajplung.1991.261.6.L424; DANIELPOUR D, 1989, J CELL PHYSIOL, V138, P79, DOI 10.1002/jcp.1041380112; FLOROS J, 1987, J BIOL CHEM, V262, P13592; FLOROS J, 1985, J BIOL CHEM, V260, P2265; FLOROS J, 1986, PROGR DEV BIOL, P333; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; JETTEN AM, 1986, EXP CELL RES, V167, P539, DOI 10.1016/0014-4827(86)90193-X; KELLEY J, 1993, AM J RESP CELL MOL, V8, P417, DOI 10.1165/ajrcmb/8.4.417; KELLEY J, 1991, AM J PHYSIOL, V260, pL123, DOI 10.1152/ajplung.1991.260.2.L123; LAWRENCE D, 1985, BIOCHEM BIOPH RES CO, V133, P1026, DOI 10.1016/0006-291X(85)91239-2; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; MASUI T, 1986, P NATL ACAD SCI USA, V83, P2438, DOI 10.1073/pnas.83.8.2438; MILLER DA, 1989, MOL ENDOCRINOL, V3, P1926, DOI 10.1210/mend-3-12-1926; MIYAZONO K, 1989, NATURE, V338, P158, DOI 10.1038/338158a0; NIELSEN HC, 1992, BIOCHIM BIOPHYS ACTA, V1175, P95, DOI 10.1016/0167-4889(92)90014-3; PELTON RW, 1990, DEVELOPMENT, V110, P609; PIRCHER R, 1984, CANCER RES, V44, P5538; Post M, 1992, PULMONARY SURFACTANT, P379; ROBERTS AB, 1991, PEPTIDE GROWTH FACTO, V1, P419; Sambrook J, 1989, MOL CLONING LABORATO; SCHMID P, 1991, DEVELOPMENT, V111, P117; SIEBERT PD, 1993, BIOTECHNIQUES, V14, P244; SMITH BT, 1993, CYTOKINES LUNG LUNG, P403; SMITH BT, 1989, AM J PHYSIOL, V1, pL174; SMITH BT, 1991, LUNG, V1, P671; THEODORESCU D, 1993, IN VITRO CELL DEV-AN, V29, P105; TORDAY JS, 1990, DEV BIOL, V139, P35, DOI 10.1016/0012-1606(90)90276-O; WHITSETT JA, 1987, J BIOL CHEM, V262, P7908	29	62	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2722	2728		10.1074/jbc.270.6.2722	http://dx.doi.org/10.1074/jbc.270.6.2722			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852342	hybrid			2022-12-27	WOS:A1995QF53500051
J	JAYADEV, S; LIU, B; BIELAWSKA, AE; LEE, JY; NAZAIRE, F; PUSHKAREVA, MY; OBEID, LM; HANNUN, YA				JAYADEV, S; LIU, B; BIELAWSKA, AE; LEE, JY; NAZAIRE, F; PUSHKAREVA, MY; OBEID, LM; HANNUN, YA			ROLE FOR CERAMIDE IN CELL-CYCLE ARREST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NECROSIS-FACTOR-ALPHA; SPHINGOMYELIN TURNOVER; MEDIATED BIOLOGY; FREE SYSTEM; DIFFERENTIATION; ACTIVATION; SPHINGOSINE; EXPRESSION; APOPTOSIS	The dependence of some cell types on serum factors for growth may represent a powerful, but poorly studied, model for antimitogenic pathways, In this study, we examine ceramide as a candidate intracellular mediator of serum factor dependence. In Molt-4 leukemia cells, serum withdrawal caused a significant arrest in cell cycle progression (80% of cells in G(0)/G(1)), accompanied by a modest apoptotic cell death (12%), Serum deprivation of these cells resulted in significant sphingomyelin hydrolysis (72%; corresponding to hydrolysis of 47 pmol/nmol phosphate), which was accompanied by a profound and progressive elevation (up to 10-15-fold) in endogenous levels of ceramide, Withdrawal of serum caused the activation of a distinct, particulate, and magnesium-dependent sphingomyelinase. The addition of exogenous C-6-ceramide induced a dramatic arrest in the G(0)/G(1) phase of the cell cycle comparable to the effects observed with serum withdrawal, albeit occurring much sooner, Unlike serum withdrawal, however, the addition of C-6-ceramide resulted in more pronounced apoptosis, Because of the previously noted ability of exogenously added phorbol esters to inhibit ceramide-mediated apoptosis, we investigated the hypothesis that endogenous activation of the diacylglycerol/protein kinase C pathway may modulate the response to serum withdrawal. Indeed, serum withdrawal resulted in 3-4-fold elevation in endogenous diacylglycerol levels, The addition of exogenous diacylglycerols resulted in selective attenuation of ceramide's effects on apoptosis but not on cell cycle arrest, Thus, the combination of ceramide and diacylglycerol recapitulated the complex effects of serum withdrawal on cell cycle arrest and apoptosis, These studies identify a novel role for ceramide in cell cycle regulation, and they may provide the first evidence for an intracellular signal transduction pathway in mammalian cells mediating cell cycle arrest, These studies also underscore the importance of lipid second messengers and the significance of the, interplay between glycerolipid-derived and sphingolipid-derived lipid mediators.	DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT CELL BIOL,DURHAM,NC 27710	Duke University; Duke University				obeid, lina/0000-0002-0734-0847	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043825, R37GM043825] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM43825] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMES BN, 1960, J BIOL CHEM, V235, P769; BALLOU LR, 1992, J BIOL CHEM, V267, P20044; BELL RM, 1986, CELL, V45, P631, DOI 10.1016/0092-8674(86)90774-9; BIELAWSKA A, 1993, J BIOL CHEM, V268, P26226; BIELAWSKA A, 1992, FEBS LETT, V307, P211, DOI 10.1016/0014-5793(92)80769-D; BIELAWSKA A, 1992, J BIOL CHEM, V267, P18493; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; DEAN M, 1986, J BIOL CHEM, V261, P9161; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; DRESSLER KA, 1992, SCIENCE, V255, P1715, DOI 10.1126/science.1313189; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HANNUN YA, 1993, BIOCHIM BIOPHYS ACTA, V1154, P223, DOI 10.1016/0304-4157(93)90001-5; HEROLD P, 1988, HELV CHIM ACTA, V71, P354, DOI 10.1002/hlca.19880710208; HOWARD MK, 1993, J NEUROCHEM, V60, P1783, DOI 10.1111/j.1471-4159.1993.tb13404.x; ISHIZUKA T, 1989, FEBS LETT, V249, P234, DOI 10.1016/0014-5793(89)80630-1; JARVIS WD, 1994, P NATL ACAD SCI USA, V91, P73, DOI 10.1073/pnas.91.1.73; JAYADEV S, 1994, J BIOL CHEM, V269, P5757; KIM MY, 1991, J BIOL CHEM, V266, P484; LISCOVITCH M, 1992, TRENDS BIOCHEM SCI, V17, P393, DOI 10.1016/0968-0004(92)90007-V; MATHIAS S, 1993, SCIENCE, V259, P519, DOI 10.1126/science.8424175; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; OKAZAKI T, 1994, J BIOL CHEM, V269, P4070; OKAZAKI T, 1990, J BIOL CHEM, V265, P15823; PREISS J, 1986, J BIOL CHEM, V261, P8597; RHEE SG, 1992, J BIOL CHEM, V267, P12393; SHICHIRI M, 1993, CELL GROWTH DIFFER, V4, P93; VANVELDHOVEN PP, 1989, ANAL BIOCHEM, V183, P177, DOI 10.1016/0003-2697(89)90186-3; WALKER PR, 1993, EXP CELL RES, V207, P142, DOI 10.1006/excr.1993.1173	31	450	461	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2047	2052		10.1074/jbc.270.5.2047	http://dx.doi.org/10.1074/jbc.270.5.2047			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836432	hybrid			2022-12-27	WOS:A1995QE49300013
J	RENKEMA, GH; BOOT, RG; MUIJSERS, AO; DONKERKOOPMAN, WE; AERTS, JMFG				RENKEMA, GH; BOOT, RG; MUIJSERS, AO; DONKERKOOPMAN, WE; AERTS, JMFG			PURIFICATION AND CHARACTERIZATION OF HUMAN CHITOTRIOSIDASE, A NOVEL MEMBER OF THE CHITINASE FAMILY OF PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOTENSIN-CONVERTING ENZYME; GAUCHERS-DISEASE; LYSOZYME; SERUM; CELLS	Recently we noted (Hollak, C. E. M., van Weely, S., van Oers, M. H. J., and Aerts, J. M. F. G. (1994) J. Clin. Invest. 93, 1288-1292) that the clinical manifestation of Gaucher disease is associated with a several hundred-fold increase in chitotriosidase activity in plasma, We report on the purification and characterization of the protein. Two major isoforms of chitotriosidase with isoelectric points of 7.2 and 8.0 and molecular masses of 50 and 39 kDa, respectively, were purified from the spleen of a Gaucher patient, The N-terminal amino acid sequence of the two forms proved to be identical, An antiserum raised against the purified 39-kDa chitotriosidase precipitated all isozymes, Chitotriosidase activity was earlier found to be completely absent in some individuals, These findings in combination suggest that a single gene may encode the different isoforms of chitotriosidase. Both the N-terminal sequence and an internal sequence chitotriosidase proved to be homologous to sequences in proteins that are members of the chitinase family (Hakala, B. E., White, C., and Recklies, A. D. (1993) J. Biol. Chem. 268, 25803-25810), The human chitotriosidase described here showed chitinolytic activity toward artificial substrates as well as chitin and may therefore be considered to be a chitinase.	UNIV AMSTERDAM,ACAD MED CTR,EC SLATER INST BIOCHEM RES,DEPT BIOCHEM,1100 DE AMSTERDAM,NETHERLANDS	University of Amsterdam; Academic Medical Center Amsterdam			Aerts, Johannes/A-1028-2009; Renkema, Herma/L-1489-2015	Aerts, Johannes/0000-0001-8168-2565; Renkema, Herma/0000-0002-8174-6538; Boot, Rolf/0000-0002-7031-3390				Barranger J. A., 1989, METABOLIC BASIS INHE, P1677; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; BLAISEAU PL, 1992, GENE, V120, P243, DOI 10.1016/0378-1119(92)90099-B; DENTANDT WR, 1993, INT J BIOCHEM, V25, P113, DOI 10.1016/0020-711X(93)90497-3; DENTANDT WR, 1988, INT J BIOCHEM, V20, P713, DOI 10.1016/0020-711X(88)90167-X; DONNELLY KM, 1991, MOL ENDOCRINOL, V5, P356, DOI 10.1210/mend-5-3-356; FUHRMAN JA, 1992, P NATL ACAD SCI USA, V89, P1548, DOI 10.1073/pnas.89.5.1548; HACKMAN RH, 1964, ANAL BIOCHEM, V8, P397, DOI 10.1016/0003-2697(64)90075-2; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; HULTBERG B, 1980, CLIN CHIM ACTA, V100, P33, DOI 10.1016/0009-8981(80)90182-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIEBERMAN J, 1976, NEW ENGL J MED, V294, P1442, DOI 10.1056/NEJM197606242942609; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MORSKY P, 1983, ANAL BIOCHEM, V128, P77, DOI 10.1016/0003-2697(83)90347-0; NYIRKOS P, 1990, BIOCHEM J, V268, P265; OCKERMAN PA, 1967, CLIN CHEM, V15, P61; RAGHAVAN N, 1994, INFECT IMMUN, V62, P1901, DOI 10.1128/IAI.62.5.1901-1908.1994; REJMAN JJ, 1988, BIOCHEM BIOPH RES CO, V150, P329, DOI 10.1016/0006-291X(88)90524-4; ROBINSON DB, 1980, CLIN CHEM, V26, P371; SAHAI AS, 1993, FEMS MICROBIOL REV, V11, P317, DOI 10.1111/j.1574-6976.1993.tb00004.x; SENDAI Y, 1994, BIOL REPROD, V50, P927, DOI 10.1095/biolreprod50.4.927; SILVERSTEIN E, 1977, CLIN CHIM ACTA, V74, P21, DOI 10.1016/0009-8981(77)90382-5; WATANABE T, 1993, J BIOL CHEM, V268, P18567; WEINREB NJ, 1976, CLIN RES, V24, pA295; YANG Y, 1980, J BIOCHEM-TOKYO, V88, P829, DOI 10.1093/oxfordjournals.jbchem.a133037	26	258	282	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2198	2202		10.1074/jbc.270.5.2198	http://dx.doi.org/10.1074/jbc.270.5.2198			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836450	Green Published, hybrid			2022-12-27	WOS:A1995QE49300035
J	ASTATKE, M; GRINDLEY, NDF; JOYCE, CM				ASTATKE, M; GRINDLEY, NDF; JOYCE, CM			DEOXYNUCLEOSIDE TRIPHOSPHATE AND PYROPHOSPHATE BINDING-SITES IN THE CATALYTICALLY COMPETENT TERNARY COMPLEX FOR THE POLYMERASE REACTION CATALYZED BY DNA-POLYMERASE-I (KLENOW FRAGMENT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; KINETIC MECHANISM; ACTIVE-SITE; AMINO-ACID; EXONUCLEASE ACTIVITY; 3'-5' EXONUCLEASE; CRYSTAL-STRUCTURE; IDENTIFICATION; SEQUENCE; GENE	We have employed site directed mutagenesis to identify those amino acid residues that interact with the deoxynucleoside triphosphate (dNTP) and pyrophosphate in the Klenow fragment-DNA-dNTP ternary complex, Earlier structural, mutagenesis, and labeling studies have suggested that the incoming dNTP molecule contacts a region on one side of the polymerase cleft, primarily involving residues within the so-called ''fingers'' subdomain. We have made mutations in residues seen to be close to the dNTP in the crystal structure of the Klenow fragment-dNTP binary complex and have examined their kinetic parameters, particularly K-m(dNTP). The results are consistent with the notion that there are significant differences between the dNTP interactions in the binary and ternary complexes, although some contacts may be present in both, When dTTP is the incoming nucleotide, the side chains of Arg(754) and phe(762) make the largest contributions to binding; measurement of K-m(PPi) suggests that Arg(754) contacts the beta- or gamma-phosphate of the dNTP. With dGTP, the contribution of Arg(754) remains the same, but the additional interactions are provided by both Lys(758) and phe(762), suggesting that the binding of the incoming dNTP is not identical under all circumstances. Mutations in Arg(754) and Lys(758) also cause a substantial decrease in the rate of polymerase-catalyzed incorporation, and sulfur elemental effect measurements indicate that loss of Arg(754) (and perhaps also Lys(758)) slows the rate of the chemical step of the reaction, Mutations of Arg(682), His(734) and Tyr(766) affect the binding of DNA, suggesting that these mutations, whose effect on dNTP binding is small, may influence dNTP binding indirectly via the positioning of the DNA template-primer.	YALE UNIV,BASS CTR MOLEC & STRUCT BIOL,DEPT MOLEC BIOPHYS & BIOCHEM,NEW HAVEN,CT 06520	Yale University					NIGMS NIH HHS [GM-28550] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028550] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTAO VP, 1992, NUCLEIC ACIDS RES, V20, P819, DOI 10.1093/nar/20.4.819; ASAKURA K, 1993, J FERMENT BIOENG, V76, P265, DOI 10.1016/0922-338X(93)90191-A; BASU A, 1987, BIOCHEMISTRY-US, V26, P1704, DOI 10.1021/bi00380a032; BECK PJ, 1989, J MOL BIOL, V210, P687, DOI 10.1016/0022-2836(89)90102-2; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BEESE LS, 1993, BIOCHEMISTRY-US, V32, P14095, DOI 10.1021/bi00214a004; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; BLASCO MA, 1992, J BIOL CHEM, V267, P19427; BLASCO MA, 1993, J BIOL CHEM, V268, P16763; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; BRYANT FR, 1983, BIOCHEMISTRY-US, V22, P3537, DOI 10.1021/bi00284a001; BURGERS PMJ, 1979, J BIOL CHEM, V254, P6889; CARROLL SS, 1991, BIOCHEMISTRY-US, V30, P804, DOI 10.1021/bi00217a034; CHENG CH, 1993, BIOCHEMISTRY-US, V32, P8568, DOI 10.1021/bi00084a025; DAHLBERG ME, 1991, BIOCHEMISTRY-US, V30, P4835, DOI 10.1021/bi00234a002; DAVIES JF, 1994, CELL, V76, P1123, DOI 10.1016/0092-8674(94)90388-3; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; DERBYSHIRE V, 1991, EMBO J, V10, P17, DOI 10.1002/j.1460-2075.1991.tb07916.x; DERBYSHIRE V, 1988, SCIENCE, V240, P199, DOI 10.1126/science.2832946; DONG Q, 1993, J BIOL CHEM, V268, P24163; EGER BT, 1992, BIOCHEMISTRY-US, V31, P9227, DOI 10.1021/bi00153a016; EGER BT, 1991, BIOCHEMISTRY-US, V30, P1441, DOI 10.1021/bi00219a039; FREEMONT P S, 1986, Proteins Structure Function and Genetics, V1, P66, DOI 10.1002/prot.340010111; FREEMONT PS, 1988, P NATL ACAD SCI USA, V85, P8924, DOI 10.1073/pnas.85.23.8924; GUTMAN PD, 1993, J BACTERIOL, V175, P3581, DOI 10.1128/jb.175.11.3581-3590.1993; HATFULL GF, 1993, MOL MICROBIOL, V7, P395, DOI 10.1111/j.1365-2958.1993.tb01131.x; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; JOYCE CM, 1995, IN PRESS METHODS ENZ; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Kornberg A., 1992, DNA REPLICATION, VSecond, P113; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; MCCLURE WR, 1975, J BIOL CHEM, V250, P4073; MUSHAK P, 1972, BIOCHEMISTRY-US, V11, P201, DOI 10.1021/bi00752a009; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; PANDEY VN, 1990, J BIOL CHEM, V265, P3679; PANDEY VN, 1993, EUR J BIOCHEM, V214, P59, DOI 10.1111/j.1432-1033.1993.tb17896.x; PANDEY VN, 1994, J BIOL CHEM, V269, P13259; PANDEY VN, 1987, BIOCHEMISTRY-US, V26, P7744, DOI 10.1021/bi00398a031; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; POLESKY AH, 1992, J BIOL CHEM, V267, P8417; POLESKY AH, 1990, J BIOL CHEM, V265, P14579; RUSH J, 1990, J BIOL CHEM, V265, P4821; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; STEITZ TA, 1993, CURR OPIN STRUC BIOL, V3, P31, DOI 10.1016/0959-440X(93)90198-T; STEITZ TA, 1994, IN PRESS SCIENCE; TROWBRIDGE CG, 1963, BIOCHEMISTRY-US, V2, P843, DOI 10.1021/bi00904a037; UEMORI T, 1993, J BIOCHEM-TOKYO, V113, P401, DOI 10.1093/oxfordjournals.jbchem.a124058	49	108	118	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1945	1954		10.1074/jbc.270.4.1945	http://dx.doi.org/10.1074/jbc.270.4.1945			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829532	hybrid			2022-12-27	WOS:A1995QD20400069
J	BHATTACHARYYA, T; KARNEZIS, AN; MURPHY, SP; HOANG, T; FREEMAN, BC; PHILLIPS, B; MORIMOTO, RI				BHATTACHARYYA, T; KARNEZIS, AN; MURPHY, SP; HOANG, T; FREEMAN, BC; PHILLIPS, B; MORIMOTO, RI			CLONING AND SUBCELLULAR-LOCALIZATION OF HUMAN MITOCHONDRIAL HSP70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK; STRESS PROTEINS; BINDING; MEMBER; FAMILY; IDENTIFICATION; MOUSE; MORTALIN; GRP-75; HSP-58	We report the cloning, nucleotide sequence, and localization of mitochondrial hsp70, a member of the human hsp70 multi-gene family, The human mthsp75 gene was cloned by screening an expression library with monoclonal antibody 3A3 that recognizes three members of the human hsp70 family (hsp70, hsc70, and a 75-kDa protein with characteristics identical to that previously established for mitochondrial hsp70), The identity of the 75-kDa protein was confirmed by subcellular fractionation of HeLa cells and the demonstration that the 3A3-reactive 75-kDa protein co-fractionates with mitochondrial localized proteins, The nucleotide sequence of the respective cDNA clone revealed an open reading frame of 679 amino acids with extensive sequence identity with members of the human hsp70 family, The derived amino-terminal pre-sequence shares features common to other mitochondrial targeting sequences, The identity of the cDNA was unequivocally established by introduction of an epitope-tag at the carboxyl terminus of the cloned gene, transfection and analysis by immunofluorescence, The tagged 75-kDa protein localizes to mito chondria, thus providing conclusive evidence that it corresponds to the human mitochondrial hsp70, referred to here as mthsp75.	NORTHWESTERN UNIV, DEPT BIOCHEM MOLEC & CELL BIOL, EVANSTON, IL 60208 USA	Northwestern University					NIGMS NIH HHS [GM47150, GM38109] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038109, R01GM047150, R01GM038109] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; Brodsky JL, 1994, BIOL HEAT SHOCK PROT; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; DOMANICO SZ, 1993, MOL CELL BIOL, V13, P3598, DOI 10.1128/MCB.13.6.3598; ENGMAN DM, 1989, MOL CELL BIOL, V9, P5163, DOI 10.1128/MCB.9.11.5163; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; JOHNSON LV, 1980, P NATL ACAD SCI-BIOL, V77, P990, DOI 10.1073/pnas.77.2.990; KAUL SC, 1993, BIOCHEM BIOPH RES CO, V193, P348, DOI 10.1006/bbrc.1993.1630; MARSH M, 1987, J CELL BIOL, V104, P875, DOI 10.1083/jcb.104.4.875; MICHIKAWA Y, 1993, BIOCHEM BIOPH RES CO, V196, P223, DOI 10.1006/bbrc.1993.2238; MILARSKI KL, 1989, J CELL BIOL, V109, P1947, DOI 10.1083/jcb.109.5.1947; MIZZEN LA, 1989, J BIOL CHEM, V264, P20664; MIZZEN LA, 1991, CELL REGUL, V2, P165, DOI 10.1091/mbc.2.2.165; MORIMOTO RI, 1994, BIOL HEAT SHOCK PROT; PINOLROMA S, 1988, GENE DEV, V2, P215, DOI 10.1101/gad.2.2.215; Sambrook J, 1989, MOL CLONING LABORATO; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; TSAI MY, 1994, J BIOL CHEM, V269, P5958; WADHWA R, 1993, J BIOL CHEM, V268, P6615; WADHWA R, 1993, BIOCHEM BIOPH RES CO, V197, P202, DOI 10.1006/bbrc.1993.2461; WANG TF, 1993, J BIOL CHEM, V268, P26049; WATOWICH SS, 1988, MOL CELL BIOL, V8, P393, DOI 10.1128/MCB.8.1.393	25	171	179	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1705	1710		10.1074/jbc.270.4.1705	http://dx.doi.org/10.1074/jbc.270.4.1705			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829505				2022-12-27	WOS:A1995QD20400036
J	DONZE, D; TOWNES, TM; BIEKER, JJ				DONZE, D; TOWNES, TM; BIEKER, JJ			ROLE OF ERYTHROID KRUPPEL-LIKE FACTOR IN HUMAN GAMMA-GLOBIN TO BETA-GLOBIN GENE SWITCHING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAGE SELECTOR ELEMENT; MEGAPRIMER METHOD; CONTROL REGION; TRANSCRIPTION; PROMOTER; MUTAGENESIS; EXPRESSION; LOCUS; SITE; CLUSTER	Erythroid Kruppel-like factor (EKLF) is an erythroid-specific transcription factor that contains zinc finger domains similar to the Kruppel protein of Drosophila melanogaster. Previous studies demonstrated that EKLF binds to the CACCC box in the human beta-globin gene promoter and activates transcription. CACCC box mutations that cause severe beta-thalassemias in humans inhibit EKLF binding. Results described in this paper suggest that EKLF functions predominately in adult erythroid tissue. The EKLF gene is expressed at a 3-fold higher level in adult erythroid tissue than in fetal erythroid tissue, and the EKLF protein binds to the human beta-globin promoter 8-fold more efficiently than to the human gamma-globin promoter. Co-transfection experiments in the human fetal-like erythroleukemia cell line K562 demonstrate that over expression of EKLF activates a beta-globin reporter construct 1000-fold; a linked gamma-globin reporter is activated only S-fold. Mutation of the beta-globin CACCC box severely inhibits activation. These results demonstrate that EKLF is a developmental stage-enriched protein that preferentially activates human beta-globin gene expression. The data strongly suggest that EKLF is an important factor involved in human gamma- to beta-globin gene switching.	UNIV ALABAMA,SCH MED,DEPT BIOCHEM & MOLEC GENET,BIRMINGHAM,AL 35294; UNIV ALABAMA,SCH DENT,DEPT BIOCHEM & MOLEC GENET,BIRMINGHAM,AL 35294; CUNY MT SINAI SCH MED,BROOKDALE CTR MOLEC BIOL,NEW YORK,NY 10029; CUNY MT SINAI SCH MED,DEPT BIOCHEM,NEW YORK,NY 10029	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai					NHLBI NIH HHS [HL35559, HL43508] Funding Source: Medline; NIDDK NIH HHS [DK46865] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046865] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AIYAR A, 1993, BIOTECHNIQUES, V14, P366; ANTONIOU M, 1990, GENE DEV, V4, P1007, DOI 10.1101/gad.4.6.1007; BARIK S, 1991, BIOTECHNIQUES, V10, P489; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P1006, DOI 10.1093/nar/22.6.1006; CATERINA JJ, 1994, NUCLEIC ACIDS RES, V22, P2383, DOI 10.1093/nar/22.12.2383; CHARNAY P, 1985, MOL CELL BIOL, V5, P1498, DOI 10.1128/MCB.5.6.1498; DIERKS P, 1983, CELL, V32, P695, DOI 10.1016/0092-8674(83)90055-7; DILLON N, 1993, TRENDS GENET, V9, P134, DOI 10.1016/0168-9525(93)90208-Y; ENGEL JD, 1993, TRENDS GENET, V9, P304, DOI 10.1016/0168-9525(93)90248-G; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; FENG WC, 1994, J BIOL CHEM, V269, P1493; HARDISON R, 1993, NUCLEIC ACIDS RES, V21, P1265, DOI 10.1093/nar/21.5.1265; IKUTA T, 1991, P NATL ACAD SCI USA, V88, P10188, DOI 10.1073/pnas.88.22.10188; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; JANE SM, 1992, EMBO J, V11, P2961, DOI 10.1002/j.1460-2075.1992.tb05366.x; JANE SM, 1993, MOL CELL BIOL, V13, P3272, DOI 10.1128/MCB.13.6.3272; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; MYERS RM, 1986, SCIENCE, V232, P613, DOI 10.1126/science.3457470; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; REDDY PMS, 1994, J BIOL CHEM, V269, P8287; RYAN TM, 1989, GENE DEV, V3, P314, DOI 10.1101/gad.3.3.314; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; STAMATOYANNOPOU.G, 1994, MOL BASIS BLOOD DISE, P108; TOWNES TM, 1990, TRENDS GENET, V6, P219, DOI 10.1016/0168-9525(90)90182-6; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0	28	174	179	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1955	1959		10.1074/jbc.270.4.1955	http://dx.doi.org/10.1074/jbc.270.4.1955			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829533	Green Published, hybrid			2022-12-27	WOS:A1995QD20400070
J	MATTEN, SR; SCHEMIDT, RA; BRUSILOW, WSA				MATTEN, SR; SCHEMIDT, RA; BRUSILOW, WSA			CONSTRUCTION AND FUNCTION OF CHIMERIC BETA-SUBUNITS CONTAINING REGIONS FROM THE BETA-SUBUNITS OF THE F1F0 ATPASES OF ESCHERICHIA-COLI AND BACILLUS-MEGATERIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROTON-TRANSLOCATING ATPASE; STIMULATED ADENOSINE-TRIPHOSPHATASE; F1-ATPASE; SITES; COMPLEMENTATION; IDENTIFICATION; SEQUENCES; SYNTHASE; DELETION; RESIDUE	The highly conserved beta subunit of the Escherichia coli F1F0 ATPase was divided into three sections, each of which was exchanged with the homologous section of the beta subunit of the obligate aerobe Bacillus megaterium. Plasmids coding for the resultant six chimeric beta subunits varied in their abilities to complement two E. colt beta mutants as measured by testing transformed cells for aerobic growth on a nonfermentable carbon source or anaerobic growth on rich medium containing glucose. Two chimeras were able to restore both growth on succinate and anaerobic growth on rich medium. The genetic results corresponded to increased levels of membrane-bound ATPase and ATP synthase activities. These chimeric subunits were therefore capable of being assembled into functional E. coli ATPase complexes. The results indicate that chimeric beta subunits can be used to analyze assembly of the beta subunit and that the final 181 amino acids of the beta subunit might contain a region involved in functional energy coupling.	WAYNE STATE UNIV,SCH MED,DEPT BIOCHEM,DETROIT,MI 48201	Wayne State University								ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ALLISON WS, 1992, J BIOENERG BIOMEMBR, V24, P469, DOI 10.1007/BF00762364; ANDREWS WW, 1984, J BIOL CHEM, V259, P4378; BLOSTEIN R, 1993, J BIOL CHEM, V268, P10654; BOHREN KM, 1992, J BIOL CHEM, V267, P20965; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; COX GB, 1978, BIOCHEM J, V170, P593, DOI 10.1042/bj1700593; DUNCAN TM, 1992, J BIOENERG BIOMEMBR, V24, P453, DOI 10.1007/BF00762362; FAYLE DRH, 1978, BIOCHEM J, V172, P523, DOI 10.1042/bj1720523; GUNSALUS RP, 1982, P NATL ACAD SCI-BIOL, V79, P320, DOI 10.1073/pnas.79.2.320; HAWTHORNE CA, 1986, J BIOL CHEM, V261, P5245; LEE RSF, 1991, BIOCHEMISTRY-US, V30, P6842, DOI 10.1021/bi00242a006; OGAWA T, 1992, J MOL BIOL, V226, P651, DOI 10.1016/0022-2836(92)90622-Q; POST K, 1993, BIOCHEMISTRY-US, V32, P5508, DOI 10.1021/bi00072a004; SCARPETTA MA, 1991, J BIOL CHEM, V266, P18567; SENIOR AE, 1993, J BIOL CHEM, V268, P6989; SENIOR AE, 1992, J BIOENERG BIOMEMBR, V24, P479, DOI 10.1007/BF00762365; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; TAGAYA M, 1988, FEBS LETT, V233, P347, DOI 10.1016/0014-5793(88)80457-5; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WALKER JE, 1985, J MOL BIOL, V184, P677, DOI 10.1016/0022-2836(85)90313-4; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	22	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1489	1492		10.1074/jbc.270.4.1489	http://dx.doi.org/10.1074/jbc.270.4.1489			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829474	hybrid			2022-12-27	WOS:A1995QD20400003
J	SINGAL, DP; YE, M; QUADRI, SA				SINGAL, DP; YE, M; QUADRI, SA			MAJOR HISTOCOMPATIBILITY-ENCODED HUMAN PROTEASOME LMP2 - GENOMIC ORGANIZATION AND A NEW FORM OF MESSENGER-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-II REGION; ANTIGEN PRESENTATION; HUMAN MHC; RMA-S; SUBUNITS; COMPLEX; GENE; TRANSPORTER; EXPRESSION; MOLECULES	LMP2 is one of the two proteasome subunits encoded by genes in the major histocompatibility complex class II region. Here we report the genomic organization of human LMP2 gene. Sequence analysis of polymerase chain reaction amplified cDNA from a number of lymphoblastoid cell lines demonstrated two forms of LMPB mRNA, one (LMP2.1) complete and homologous to the published LMP2 genomic sequence from cosmid clones, and the other (LMP2.s) a smaller transcript resulting from splicing of a 30-base pair fragment from the first exon. Antibodies to recombinant LMP2.s protein (22.3 kDa) were raised in rabbits. This anti-LMP2.s serum recognized both recombinant proteins (LMP2.1 = 23.3 kDa and LMP2.s = 22.3 kDa) and a single protein of 21.5 kDa molecular mass in lysates from human lymphoblastoid cell lines. Pulse-chase experiments demonstrated that LMPB polypeptide also undergoes processing from 22.3- to 21.5-kDa protein when incorporated into proteasomes. These data suggest that the processing of human LMP2 subunit takes place both at the transcription and post-translational levels. Northern blot analysis showed that the LMP2 mRNA is expressed in lymphoblastoid cell lines and in fibroblasts following gamma-interferon induction, but not in brain, smooth muscle, fibroblasts (uninduced), and colon epithelial cells.			SINGAL, DP (corresponding author), MCMASTER UNIV,DEPT PATHOL,1200 MAIN ST W,HAMILTON,ON L8N 3Z5,CANADA.							ARNOLD D, 1992, NATURE, V360, P171, DOI 10.1038/360171a0; ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; BROWN MG, 1993, J IMMUNOL, V151, P1193; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEVERSON EV, 1990, NATURE, V348, P738, DOI 10.1038/348738a0; DRISCOLL J, 1993, NATURE, V365, P262, DOI 10.1038/365262a0; FRENTZEL S, 1993, EUR J BIOCHEM, V216, P119, DOI 10.1111/j.1432-1033.1993.tb18123.x; FRUH K, 1992, J BIOL CHEM, V267, P22131; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; GLYNNE R, 1991, NATURE, V353, P357, DOI 10.1038/353357a0; GUAN C, 1988, GENE, V67, P21; KELLY A, 1991, NATURE, V353, P667, DOI 10.1038/353667a0; MARTINEZ CK, 1991, NATURE, V353, P664, DOI 10.1038/353664a0; MOMBURG F, 1992, NATURE, V360, P174, DOI 10.1038/360174a0; MONACO JJ, 1990, SCIENCE, V250, P1723, DOI 10.1126/science.2270487; MONACO JJ, 1992, IMMUNOL TODAY, V13, P173, DOI 10.1016/0167-5699(92)90122-N; MONACO JJ, 1986, HUM IMMUNOL, V15, P416, DOI 10.1016/0198-8859(86)90019-4; PATEL SD, 1994, P NATL ACAD SCI USA, V91, P296, DOI 10.1073/pnas.91.1.296; POWIS SJ, 1991, NATURE, V354, P528, DOI 10.1038/354528a0; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; SINGAL DP, 1992, ANN RHEUM DIS, V51, P23, DOI 10.1136/ard.51.1.23; SINGAL DP, 1993, IMMUNOGENETICS, V37, P143; SPIES T, 1991, NATURE, V351, P323, DOI 10.1038/351323a0; SPIES T, 1990, NATURE, V348, P744, DOI 10.1038/348744a0; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; TROWSDALE J, 1990, NATURE, V348, P741, DOI 10.1038/348741a0	28	13	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1966	1970		10.1074/jbc.270.4.1966	http://dx.doi.org/10.1074/jbc.270.4.1966			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829535	hybrid			2022-12-27	WOS:A1995QD20400072
J	NAIDU, A; QUON, D; CORDELL, B				NAIDU, A; QUON, D; CORDELL, B			BETA-AMYLOID PEPTIDE PRODUCED IN-VITRO IS DEGRADED BY PROTEINASES RELEASED BY CULTURED-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE-INHIBITOR DOMAIN; PRECURSOR MESSENGER-RNA; ALZHEIMERS-DISEASE; HUMAN-BRAIN; INVITRO; NEUROTOXICITY; EXPRESSION	The primary histopathological feature of Alzheimer's disease is the accumulation of beta-amyloid in the brains of afflicted individuals. This peptide has been shown to be produced and liberated both in vitro and in vivo by normal physiological processes. The mechanism by which beta-amyloid is formed, as well as that by which it may be cleared, are events likely to impact on the development and progression of this disease. Thus, the fate of beta-amyloid peptides secreted by cultured mammalian cells was investigated It was found that levels of the soluble peptide are reduced over time due to the activity of multiple types of proteinases including those from the metallo, aspartyl, and thiol classes, Inhibitors to each class of proteinase can only partially block beta-amyloid degradation, but, if used in combination, they can fully prevent its catabolism. The Kunitz serine proteinase inhibitor domain, present on two beta-amyloid precursor protein isoforms, was found to be an effective inhibitor of beta-amyloid peptide degradation. These data indicate that modulations in expression of secreted proteinases and/or beta-amyloid precursor isoforms may influence levels of beta-amyloid.	SCIOS NOVA INC,MT VIEW,CA 94043	Scios								BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; CORDELL B, 1994, ANNU REV PHARMACOL, V34, P69; COTMAN CW, 1992, NEUROBIOL AGING, V13, P587, DOI 10.1016/0197-4580(92)90060-B; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1993, J BIOL CHEM, V268, P3021; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JOHNSON SA, 1990, SCIENCE, V248, P854, DOI 10.1126/science.2111579; JOHNSON SA, 1988, EXP NEUROL, V102, P264, DOI 10.1016/0014-4886(88)90104-5; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KIDO H, 1990, BIOCHEM BIOPH RES CO, V167, P716, DOI 10.1016/0006-291X(90)92084-D; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; KNAUER MF, 1992, P NATL ACAD SCI USA, V89, P7437, DOI 10.1073/pnas.89.16.7437; LANDSBURY PT, 1992, BIOCHEMISTRY-US, V31, P6865; MIYAZAKI K, 1993, NATURE, V362, P839, DOI 10.1038/362839a0; NEVE RL, 1988, NEURON, V1, P669, DOI 10.1016/0896-6273(88)90166-3; PALMERT MR, 1989, P NATL ACAD SCI USA, V86, P6338, DOI 10.1073/pnas.86.16.6338; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; PIKE CJ, 1993, J NEUROSCI, V13, P1676; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; SCHILLING J, 1991, GENE, V98, P225, DOI 10.1016/0378-1119(91)90177-D; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHOJI M, 1993, SCIENCE, V258, P126; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; TANAKA S, 1988, BIOCHEM BIOPH RES CO, V157, P472, DOI 10.1016/S0006-291X(88)80273-0; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; ZHONG ZY, 1994, J BIOL CHEM, V269, P12179	29	41	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1369	1374		10.1074/jbc.270.3.1369	http://dx.doi.org/10.1074/jbc.270.3.1369			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836404	hybrid			2022-12-27	WOS:A1995QB15600059
J	MORISHIMAKAWASHIMA, M; HASEGAWA, M; TAKIO, K; SUZUKI, M; YOSHIDA, H; TITANI, K; IHARA, Y				MORISHIMAKAWASHIMA, M; HASEGAWA, M; TAKIO, K; SUZUKI, M; YOSHIDA, H; TITANI, K; IHARA, Y			PROLINE-DIRECTED AND NON-PROLINE-DIRECTED PHOSPHORYLATION OF PHF-TAU	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; MICROTUBULE-ASSOCIATED PROTEIN; ALZHEIMER-LIKE STATE; GLYCOGEN-SYNTHASE KINASE-3; FETAL-TYPE PHOSPHORYLATION; SENILE PLAQUE NEURITES; NEUROFIBRILLARY TANGLES; DISEASE BRAIN; ABNORMAL PHOSPHORYLATION; NEUROPIL THREADS	To gain insight into the abnormal phosphorylation of PHF-tau, we have determined the phosphorylation sites by identifying phosphopeptides by means of ion spray mass spectrometry followed by sequencing of ethane-thiol-modified peptides. Nineteen sites have been identified; all but Ser-262 are localized to the amino- and carboxyl-terminal flanking regions of the microtubule binding domain, Eleven sites correspond to fetal type sites. Unexpectedly, 10 are non-proline-directed, whereas the others are proline-directed. Thus, the abnormal phosphorylation of PHF-tau can be considered to consist of fetal type phosphorylation and additional pro line-directed and non-proline directed phosphorylation. This non-fetal type phosphorylation may provide PHF-tau with the unusual characteristics.	UNIV TOKYO, FAC MED,INST BRAIN RES,DEPT NEUROPATHOL,BUNKYO KU, TOKYO 113, JAPAN; RIKEN, INST PHYS & CHEM RES, DIV BIOMOLEC CHARACTERIZAT, WAKO, SAITAMA 35101, JAPAN; RIKEN, INST PHYS & CHEM RES, BIODESIGN RES GRP, WAKO, SAITAMA 35101, JAPAN; FUJITA HLTH UNIV, SCH MED, INST COMPREHENS MED SCI, DIV BIOMED POLYMER SCI, TOYOAKE, AICHI 47011, JAPAN	University of Tokyo; RIKEN; RIKEN; Fujita Health University								ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; ARIOKA M, 1993, J NEUROCHEM, V60, P461, DOI 10.1111/j.1471-4159.1993.tb03173.x; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; BAUM L, 1992, BRAIN RES, V573, P126, DOI 10.1016/0006-8993(92)90121-O; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BRION JP, 1991, BIOCHEM J, V273, P127, DOI 10.1042/bj2730127; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; CORREAS I, 1992, J BIOL CHEM, V267, P15721; CROWTHER RA, 1994, FEBS LETT, V337, P135, DOI 10.1016/0014-5793(94)80260-2; DREWES G, 1993, FEBS LETT, V336, P425, DOI 10.1016/0014-5793(93)80850-T; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; FIORE RS, 1993, NEUROSCIENCE, V55, P463, DOI 10.1016/0306-4522(93)90516-I; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOEDERT M, 1992, FEBS LETT, V312, P95, DOI 10.1016/0014-5793(92)81418-L; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; GREENWOOD JA, 1994, J BIOL CHEM, V269, P4373; GUSTKE N, 1992, FEBS LETT, V307, P199, DOI 10.1016/0014-5793(92)80767-B; HASEGAWA M, 1993, J NEUROCHEM, V60, P2068, DOI 10.1111/j.1471-4159.1993.tb03491.x; HASEGAWA M, 1992, J BIOL CHEM, V267, P17047; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; IQBAL K, 1989, P NATL ACAD SCI USA, V86, P5646, DOI 10.1073/pnas.86.14.5646; ISHIGURO K, 1991, NEUROSCI LETT, V128, P195, DOI 10.1016/0304-3940(91)90259-V; ISHIGURO K, 1988, J BIOCHEM-TOKYO, V104, P319, DOI 10.1093/oxfordjournals.jbchem.a122465; ISHIGURO K, 1992, NEUROSCI LETT, V148, P202, DOI 10.1016/0304-3940(92)90839-Y; ISHIGURO K, 1993, FEBS LETT, V325, P167, DOI 10.1016/0014-5793(93)81066-9; IWATSUBO T, 1992, AM J PATHOL, V140, P277; KANEMARU K, 1992, J NEUROCHEM, V58, P1667, DOI 10.1111/j.1471-4159.1992.tb10039.x; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KOBAYASHI S, 1993, FEBS LETT, V335, P171, DOI 10.1016/0014-5793(93)80723-8; KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; KSIEZAKREDING H, 1991, NEURON, V6, P717, DOI 10.1016/0896-6273(91)90169-Z; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LEW J, 1992, J BIOL CHEM, V267, P25922; LICHTENBERGKRAAG B, 1992, P NATL ACAD SCI USA, V89, P5384, DOI 10.1073/pnas.89.12.5384; LIU WK, 1993, J NEUROSCI RES, V34, P371, DOI 10.1002/jnr.490340315; LU Q, 1993, J NEUROSCI, V13, P508; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; MANN DMA, 1989, NEUROBIOL AGING, V10, P397, DOI 10.1016/0197-4580(89)90073-0; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; MEYER HE, 1991, METHOD ENZYMOL, V201, P169; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; MORI H, 1987, SCIENCE, V235, P1641, DOI 10.1126/science.3029875; MORISHIMAKAWASHIMA M, 1993, NEURON, V10, P1151, DOI 10.1016/0896-6273(93)90063-W; MULLAN M, 1993, TRENDS NEUROSCI, V16, P398, DOI 10.1016/0166-2236(93)90007-9; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; PEARSON RCA, 1985, P NATL ACAD SCI USA, V82, P4531, DOI 10.1073/pnas.82.13.4531; PERRY G, 1987, P NATL ACAD SCI USA, V84, P3033, DOI 10.1073/pnas.84.9.3033; PERRY G, 1991, J NEUROSCI, V11, P1748; SCOTT CW, 1993, J BIOL CHEM, V268, P1166; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; STEINER B, 1990, EMBO J, V9, P3539, DOI 10.1002/j.1460-2075.1990.tb07563.x; SZENDREI GI, 1993, J NEUROSCI RES, V34, P243, DOI 10.1002/jnr.490340212; TAKASHIMA A, 1993, P NATL ACAD SCI USA, V90, P7789, DOI 10.1073/pnas.90.16.7789; TERRY RD, 1981, ANN NEUROL, V10, P184, DOI 10.1002/ana.410100209; TROJANOWSKI JQ, 1993, BRAIN RES, V618, P333, DOI 10.1016/0006-8993(93)91286-2; VINCENT IJ, 1992, P NATL ACAD SCI USA, V89, P2878, DOI 10.1073/pnas.89.7.2878; VULLIET R, 1992, J BIOL CHEM, V267, P22570; WATANABE A, 1993, J BIOL CHEM, V268, P25712; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; YANG SD, 1993, J NEUROCHEM, V61, P1742, DOI 10.1111/j.1471-4159.1993.tb09811.x; YANG SD, 1993, BIOCHEM BIOPH RES CO, V197, P400, DOI 10.1006/bbrc.1993.2493; YOSHIDA H, 1993, J NEUROCHEM, V61, P1183, DOI 10.1111/j.1471-4159.1993.tb03642.x	72	519	540	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					823	829		10.1074/jbc.270.2.823	http://dx.doi.org/10.1074/jbc.270.2.823			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822317	hybrid			2022-12-27	WOS:A1995QB81600051
J	MUTA, T; SEKI, N; TAKAKI, Y; HASHIMOTO, R; ODA, T; IWANAGA, A; TOKUNAGA, F; IWANAGA, S				MUTA, T; SEKI, N; TAKAKI, Y; HASHIMOTO, R; ODA, T; IWANAGA, A; TOKUNAGA, F; IWANAGA, S			PURIFIED HORSESHOE-CRAB FACTOR-G - RECONSTITUTION AND CHARACTERIZATON OF THE (1-]3)-BETA-D-GLUCAN-SENSITIVE SERINE-PROTEASE CASCADE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TACHYPLEUS-TRIDENTATUS HEMOCYTES; FACTOR-C; PROCLOTTING ENZYME; LIMULUS-POLYPHEMUS; CDNA CLONING; BOMBYX-MORI; FACTOR-B; PURIFICATION; COAGULATION; ACTIVATION	Horseshoe crab hemocyte lysate responds to (1-->3)-beta-D-glucans, initiating an enzymatic cascade, which culminates in clot formation,We have purified to homogeneity the serine protease zymogen factor G, which is directly activated by (1-->3)-beta-D-glucans and which initiates the hemolymph clotting cascade, Factor G is a heterodimeric protein composed of two noncovalently associated subunits alpha (72 kDa) and beta (37 kDa), In the presence of (1-->3)-beta-D-glucans such as curdlan and paramylon, factor G is autocatalytically activated to an active serine protease named factor ($) over bar G. This activation is accompanied by limited proteolysis of both subunits: the 72-kDa subunit a is cleaved to 55-kDa and 17-kDa fragments, and the 37-kDa subunit beta is shortened to 34 kDa. Longer incubations with (1-->3)-beta-D-glucans result in cleavage of the 55-kDa fragment to 46 kDa and the 34-kDa fragment to 32 kDa, with concomitant loss of amidase activity. Reconstitution experiments using purified proteins participating in the hemolymph clotting cascade demonstrate that factor ($) over bar is capable of activating proclotting enzyme directly, resulting in the conversion of coagulogen to coagulin gel. Thus, purified factor G is shown to be the primary initiator of the (1-->3)-beta-D-glucan-sensitive coagulation pathway in the horseshoe crab hemocyte lysate.	KYUSHU UNIV 33,FAC SCI,DEPT BIOL,FUKUOKA 812,JAPAN; KYUSHU UNIV 33,GRAD SCH MED SCI,DEPT BIOL MOLEC,FUKUOKA 812,JAPAN	Kyushu University; Kyushu University				Tokunaga, Fuminori/0000-0003-3626-9119				AKETAGAWA J, 1986, J BIOL CHEM, V261, P7357; ASHIDA M, 1981, INSECT BIOCHEM, V11, P57, DOI 10.1016/0020-1790(81)90041-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; DUVIC B, 1990, J BIOL CHEM, V265, P9327; EISENTHAL R, 1974, BIOCHEM J, V139, P715, DOI 10.1042/bj1390715; IWANAGA S, 1993, CURR OPIN IMMUNOL, V5, P74, DOI 10.1016/0952-7915(93)90084-6; IWANAGA S, 1992, THROMB RES, V68, P1, DOI 10.1016/0049-3848(92)90124-S; KAKINUMA A, 1981, BIOCHEM BIOPH RES CO, V101, P433; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MIURA Y, 1994, J BIOL CHEM, V269, P542; MIURA Y, 1993, SEIKAGAKU, V65, P924; MIYATA T, 1984, J BIOL CHEM, V259, P8924; MORITA T, 1981, FEBS LETT, V129, P318, DOI 10.1016/0014-5793(81)80192-5; MUTA T, 1991, J BIOL CHEM, V266, P6554; MUTA T, 1993, J BIOL CHEM, V268, P21384; MUTA T, 1990, J BIOL CHEM, V265, P22426; NAKAMURA S, 1982, J BIOCHEM, V92, P781, DOI 10.1093/oxfordjournals.jbchem.a133990; NAKAMURA S, 1976, J BIOCHEM, V80, P1011, DOI 10.1093/oxfordjournals.jbchem.a131357; NAKAMURA T, 1988, J BIOL CHEM, V263, P16709; NAKAMURA T, 1986, EUR J BIOCHEM, V154, P511, DOI 10.1111/j.1432-1033.1986.tb09427.x; NAKAMURA T, 1988, EUR J BIOCHEM, V176, P89, DOI 10.1111/j.1432-1033.1988.tb14254.x; NAKAMURA T, 1986, J BIOCHEM, V99, P847, DOI 10.1093/oxfordjournals.jbchem.a135545; NAKAMURA T, 1985, J BIOCHEM, V97, P1561, DOI 10.1093/oxfordjournals.jbchem.a135213; OCHIAI M, 1988, J BIOL CHEM, V263, P12056; PEARSON FC, 1984, ARTIF ORGANS, V8, P291, DOI 10.1111/j.1525-1594.1984.tb04293.x; SEKI N, 1994, J BIOL CHEM, V269, P1670; SELJELID R, 1981, EXP CELL RES, V131, P121, DOI 10.1016/0014-4827(81)90413-4; SHIGENAGA T, 1990, J BIOL CHEM, V265, P21350; SODERHALL K, 1983, COMP BIOCHEM PHYS B, V74, P221, DOI 10.1016/0305-0491(83)90003-2; SODERHALL K, 1988, INSECT BIOCHEM, V18, P323, DOI 10.1016/0020-1790(88)90045-5; SODERHALL K, 1985, BIOL BULL-US, V169, P661, DOI 10.2307/1541308; STONE BA, 1992, CHEM BIOL 1 RIGHT AR; SUGO T, 1985, EUR J BIOCHEM, V146, P43, DOI 10.1111/j.1432-1033.1985.tb08617.x; TANAKA H, 1970, J GEN APPL MICROBIOL, V16, P39, DOI 10.2323/jgam.16.1_39; TANAKA S, 1991, CARBOHYD RES, V218, P167, DOI 10.1016/0008-6215(91)84095-V; Whistler R L, 1976, Adv Carbohydr Chem Biochem, V32, P235	38	62	69	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					892	897		10.1074/jbc.270.2.892	http://dx.doi.org/10.1074/jbc.270.2.892			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822328	hybrid			2022-12-27	WOS:A1995QB81600062
J	WANGE, RL; ISAKOV, N; BURKE, TR; OTAKA, A; ROLLER, PP; WATTS, JD; AEBERSOLD, R; SAMELSON, LE				WANGE, RL; ISAKOV, N; BURKE, TR; OTAKA, A; ROLLER, PP; WATTS, JD; AEBERSOLD, R; SAMELSON, LE			F-2(PMP)(2)-TAM-ZETA(3), A NOVEL COMPETITIVE INHIBITOR OF THE BINDING OF ZAP-70 TO THE T-CELL ANTIGEN RECEPTOR, BLOCKS EARLY T-CELL SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZETA-CHAIN; TYROSINE PHOSPHORYLATION; PHOSPHOLIPASE C-GAMMA-1; SH2 DOMAINS; ACTIVATION; PROTEIN; KINASE; CD3-EPSILON; STIMULATION; RESIDUES	Signaling by the T cell antigen receptor (TCR) is mediated by 17-residue tyrosine-based activation motifs (TAM) present in the cytoplasmic tails of the TCR zeta and CD3 chains. TAMs become tyrosine-phosphorylated upon TCR stimulation, creating a high affinity binding site for the tandem SH2 domains of ZAP-70. In permeabilized T cells, the association of TCR and ZAP-70 was inhibited by a protein tyrosine phosphatase (PTPase)resistant TAM peptide analog, in which difluorophosphonomethyl phenylalanyl (F(2)Pmp) residues replaced phosphotyrosine. Inhibition of this association prevented TCR-stimulated tyrosine phosphorylation of ZAP-70 and reduced ZAP-70 kinase activity to basal levels. The reduction in ZAP-70 activity coincided with reduced tyrosine phosphorylation of a number of substrates. Such PTPase-resistant peptides, capable of disrupting SH2 domain-mediated protein-protein interactions, should prove useful in further dissection of multiple signaling pathways and may serve as models for rationally designed chemotherapeutic agents for the treatment of autoimmune and neoplastic disorders.	NICHHD, CELL BIOL & METAB BRANCH, BETHESDA, MD 20892 USA; NCI, DCT, DTP, MED CHEM LAB, BETHESDA, MD 20892 USA; UNIV BRITISH COLUMBIA, BIOMED RES CTR, VANCOUVER, BC V6T 1Z3, CANADA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of British Columbia			Burke, Terrence R/N-2601-2014; Wange, Ronald/AAI-2505-2021	Wange, Ronald/0000-0001-9593-3572; Isakov, Noah/0000-0002-1412-0957; Burke, Terrence/0000-0001-9925-8586				BANIYASH M, 1988, J BIOL CHEM, V263, P18225; BEYERS AD, 1992, P NATL ACAD SCI USA, V89, P2945, DOI 10.1073/pnas.89.7.2945; BRUGGE JS, 1993, SCIENCE, V260, P918, DOI 10.1126/science.8388123; BURKE TR, 1993, TETRAHEDRON LETT, V34, P4125, DOI 10.1016/S0040-4039(00)60508-7; BURKE TR, 1994, BIOCHEMISTRY-US, V33, P6490, DOI 10.1021/bi00187a015; BURKHARDT AL, 1994, J BIOL CHEM, V269, P23642; BUSTELO XR, 1992, NATURE, V356, P68, DOI 10.1038/356068a0; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHAN AC, 1994, J IMMUNOL, V152, P4758; CONTI A, 1993, J BIOL CHEM, V268, P783; COUTURE C, 1994, P NATL ACAD SCI USA, V91, P5301, DOI 10.1073/pnas.91.12.5301; DUPLAY P, 1994, J EXP MED, V179, P1163, DOI 10.1084/jem.179.4.1163; EGERTON M, 1992, EMBO J, V11, P3533, DOI 10.1002/j.1460-2075.1992.tb05436.x; GARCIAMORALES P, 1990, P NATL ACAD SCI USA, V87, P9255, DOI 10.1073/pnas.87.23.9255; HARRISON ML, 1994, J BIOL CHEM, V269, P955; IRVING BA, 1993, J EXP MED, V177, P1093, DOI 10.1084/jem.177.4.1093; ISAKOV N, 1994, J LEUKOCYTE BIOL, V55, P265, DOI 10.1002/jlb.55.2.265; ISAKOV N, 1995, IN PRESS J EXP MED, P95; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; JUNE CH, 1990, J IMMUNOL, V144, P1591; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; O'SHEA JJ, 1992, P NATL ACAD SCI USA, V89, P10306, DOI 10.1073/pnas.89.21.10306; OTAKA A, 1993, TETRAHEDRON LETT, V34, P7039, DOI 10.1016/S0040-4039(00)61591-5; PARK DJ, 1991, P NATL ACAD SCI USA, V88, P5453, DOI 10.1073/pnas.88.12.5453; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; QIAN DP, 1993, J BIOL CHEM, V268, P4488; RAVICHANDRAN KS, 1993, SCIENCE, V262, P902, DOI 10.1126/science.8235613; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; ROMEO C, 1992, CELL, V68, P889, DOI 10.1016/0092-8674(92)90032-8; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; SAMELSON LE, 1992, J BIOL CHEM, V267, P24913; SANCHO J, 1993, EUR J IMMUNOL, V23, P1636, DOI 10.1002/eji.1830230736; SAROSI GA, 1992, INT IMMUNOL, V4, P1211, DOI 10.1093/intimm/4.11.1211; SECRIST JP, 1993, J BIOL CHEM, V268, P5886; SMYTH MS, 1994, TETRAHEDRON LETT, V35, P551, DOI 10.1016/S0040-4039(00)75835-7; WANG CC, 1992, PROTEIN SCI, V1, P1206, DOI 10.1002/pro.5560010913; WANGE RL, 1992, J BIOL CHEM, V267, P11685; WANGE RL, 1993, J BIOL CHEM, V268, P19797; WATTS JD, 1992, J BIOL CHEM, V267, P901; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISS A, 1991, P NATL ACAD SCI USA, V88, P5484, DOI 10.1073/pnas.88.13.5484; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	43	86	95	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					944	948		10.1074/jbc.270.2.944	http://dx.doi.org/10.1074/jbc.270.2.944			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822334	hybrid			2022-12-27	WOS:A1995QB81600069
J	ZACHARIAS, U; XU, YC; HAGEGE, J; SRAER, JD; BRASS, LF; RONDEAU, E				ZACHARIAS, U; XU, YC; HAGEGE, J; SRAER, JD; BRASS, LF; RONDEAU, E			THROMBIN, PHORBOL ESTER, AND CAMP REGULATE THROMBIN RECEPTOR PROTEIN AND MESSENGER-RNA EXPRESSION BY DIFFERENT PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MESANGIAL CELLS; HUMAN BETA-2-ADRENERGIC RECEPTOR; BETA-ADRENERGIC-RECEPTOR; SMOOTH-MUSCLE CELLS; GROWTH-FACTOR; MOLECULAR-CLONING; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; CROSS-REGULATION; DOWN-REGULATION	Human mesangial cells have been used to study the regulation of thrombin receptor protein and mRNA expression during cross-talk between different signal transduction pathways. Persistent activation of thrombin receptor by thrombin led to homologous down-regulation of thrombin receptor protein, However, thrombin receptor mRNA expression was not affected, suggesting that increased receptor degradation is responsible for homologous down-regulation. Chronic activation of protein kinase C by phorbol 12-myristate 13-acetate (PMA) and of adenylylcyclase by prostaglandin E1 (PGE1) resulted in heterologous down-regulation of thrombin receptor protein. In contrast to thrombin, PMA and PGE1 reduced in parallel thrombin receptor mRNA levels to 51% and 24% of control, respectively, indicating that heterologous downregulation of thrombin receptor protein is, at least in part, due to inhibition of receptor mRNA expression. The mechanisms of heterologous down-regulation of thrombin receptor protein have been studied in detail and compared to homologous down-regulation. PMA induced down-regulation was completely blocked by GF 109 203 X, an inhibitor of protein kinase C. However, the loss of thrombin receptor induced by thrombin was not prevented by GF 109 203 X, indicating that homologous regulation is not dependent on protein kinase C activation. The heterologous effect of PGE1 was mimicked by 8-bromo-cAMP, isobutylmethylxanthine, and forskolin, suggesting that an increase in intracellular cAMP level is involved in heterologous regulation, Interestingly, heterologous down regulation induced by PGE1 seems not to require previous internalization of thrombin receptor. These data indicate that thrombin receptor protein and mRNA expression can be regulated in homologous and heterologous ways by different mechanisms.	HOP TENON, INSERM, U64, F-75020 PARIS, FRANCE; HOP TENON, ASSOC CLAUDE BERNARD, F-75020 PARIS, FRANCE; UNIV PENN, HEMATOL ONCOL SECT, PHILADELPHIA, PA 19104 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Pennsylvania			Zacharias, Ute/AAS-4998-2020					BARAK LS, 1994, J BIOL CHEM, V269, P2790; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRASS LF, 1992, J BIOL CHEM, V267, P6044; BRASS LF, 1992, J BIOL CHEM, V267, P13795; CAMPBELL PT, 1991, MOL PHARMACOL, V39, P192; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; COLUCCI WS, 1986, CIRC RES, V58, P393, DOI 10.1161/01.RES.58.3.393; DANIEL TO, 1986, J BIOL CHEM, V261, P9579; FENTON JW, 1988, SEMIN THROMB HEMOST, V14, P234, DOI 10.1055/s-2007-1002783; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; HADCOCK JR, 1991, J BIOL CHEM, V266, P11915; HAUSDORFF WP, 1991, P NATL ACAD SCI USA, V88, P2979, DOI 10.1073/pnas.88.8.2979; HE CJ, 1992, J CELL PHYSIOL, V150, P475, DOI 10.1002/jcp.1041500307; HILL SJ, 1989, CELL SIGNAL, V1, P135, DOI 10.1016/0898-6568(89)90002-8; HOXIE JA, 1993, J BIOL CHEM, V268, P13756; HUNG DT, 1992, J BIOL CHEM, V267, P20831; ISHII K, 1994, J BIOL CHEM, V269, P1125; IZZO NJ, 1994, J BIOL CHEM, V269, P1705; KANFER A, 1991, INT YB NEPHROLOGY, P3; KANTHOU C, 1992, FEBS LETT, V314, P143, DOI 10.1016/0014-5793(92)80961-F; LACAVE R, 1989, KIDNEY INT, V35, P806, DOI 10.1038/ki.1989.56; LAMORTE VJ, 1993, J CELL BIOL, V121, P91, DOI 10.1083/jcb.121.1.91; LEE NH, 1993, J BIOL CHEM, V268, P7949; LEE NH, 1994, J BIOL CHEM, V269, P4291; LOHSE MJ, 1993, BIOCHIM BIOPHYS ACTA, V1179, P171, DOI 10.1016/0167-4889(93)90139-G; MARI B, 1994, J BIOL CHEM, V269, P8517; MEULDERS Q, 1992, KIDNEY INT, V42, P327, DOI 10.1038/ki.1992.293; MORRIS GM, 1991, J BIOL CHEM, V266, P2233; NELKEN NA, 1992, J CLIN INVEST, V90, P1614, DOI 10.1172/JCI116031; NEVEU I, 1993, J NEUROCHEM, V60, P858, DOI 10.1111/j.1471-4159.1993.tb03230.x; PORT JD, 1992, J BIOL CHEM, V267, P24103; RASMUSSEN UB, 1991, FEBS LETT, V288, P123, DOI 10.1016/0014-5793(91)81017-3; RENNICK RE, 1993, EUR J PHARMACOL, V230, P367, DOI 10.1016/0014-2999(93)90575-3; RONNE E, 1991, FEBS LETT, V288, P233, DOI 10.1016/0014-5793(91)81042-7; SCARBOROUGH RM, 1992, J BIOL CHEM, V267, P13146; SHUMAN MA, 1986, ANN NY ACAD SCI, V485, P228, DOI 10.1111/j.1749-6632.1986.tb34585.x; SIBLEY DR, 1987, CELL, V48, P913, DOI 10.1016/0092-8674(87)90700-8; STUBBS MT, 1993, THROMB RES, V69, P1, DOI 10.1016/0049-3848(93)90002-6; TIRUPPATHI C, 1992, AM J PHYSIOL, V263, pL595, DOI 10.1152/ajplung.1992.263.5.L595; TOKUNAGA K, 1987, CANCER RES, V47, P5616; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; VALIQUETTE M, 1990, P NATL ACAD SCI USA, V87, P5089, DOI 10.1073/pnas.87.13.5089; VILLAMEDIANA LM, 1990, KIDNEY INT, V38, P956, DOI 10.1038/ki.1990.297; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WEKSLER BB, 1978, J CLIN INVEST, V62, P923, DOI 10.1172/JCI109220; ZACHARIAS U, 1993, FEBS LETT, V334, P225, DOI 10.1016/0014-5793(93)81716-D; ZACHARIAS U, 1994, IN PRESS EXP CELL RE; ZHONG CZ, 1992, J BIOL CHEM, V267, P16975	48	27	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					545	550		10.1074/jbc.270.2.545	http://dx.doi.org/10.1074/jbc.270.2.545			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822278	hybrid			2022-12-27	WOS:A1995QB81600010
J	SAKURABA, H; NOGUCHI, T				SAKURABA, H; NOGUCHI, T			ALCOHOL-NAD(+) OXIDOREDUCTASE IS PRESENT IN RAT-LIVER PEROXISOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SJOGREN-LARSSON SYNDROME; FATTY ALCOHOL; CULTURED FIBROBLASTS; OXIDATION; DEHYDROGENASE; ACIDS; METABOLISM	Alcohol:NAD(+) oxidoreductase was found in the peroxisomes of animal liver for the first time as follows. The distribution of alcohol:NAD(+) oxidoreductase activity with nonanol as substrate in the light mitochondrial fraction (peroxisome-enriched fraction) of rat liver was examined by centrifugation in a sucrose density gradient. Most of the enzyme activity was localized in the mitochondria, with some activity in the peroxisomes. The administration of clofibrate, a peroxisome proliferator, to rats resulted in a marked increase of the enzyme activity in the peroxisomes, but not in the mitochondria. The enzyme was found to be located in the matrix of the peroxisomes. The evidence was obtained that the enzyme differed from alcohol dehydrogenases and alcohol oxidizing systems found previously. The enzyme activity was not affected by pyrazole, an inhibitor of alcohol dehydrogenase and sodium azide, an inhibitor of catalase. The enzyme was NAD(+)-dependent and oxidized straight chain aliphatic alcohols with a variety of carbon chains (C-2-C-18), showing the maximum on nonanol. K-m values toward these aliphatic alcohols decreased with increasing chain length. The major reaction product was identified as the carboxylic acid by using high performance liquid chromatography.	KYUSHU DENT COLL, DEPT BIOCHEM, KITAKYUSHU 803, FUKUOKA, JAPAN	Kyushu Dental University								Aebi H., 1974, METHODS ENZYMATIC AN, Vsecond, P673, DOI [DOI 10.1016/B978-0-12-091302-2.50032-3, 10.1016/B978-0-12-091302-2.50032-3]; BOLEDA MD, 1993, ARCH BIOCHEM BIOPHYS, V307, P85, DOI 10.1006/abbi.1993.1564; BOLEDA MD, 1989, ARCH BIOCHEM BIOPHYS, V274, P74, DOI 10.1016/0003-9861(89)90416-5; BONNICHSEN RK, 1955, METHOD ENZYMOL, V1, P495, DOI 10.1016/0076-6879(55)01083-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branden C.-I., 1975, ENZYMES, V11, P103; CHANCE B, 1971, BIOCHEM J, V122, P225, DOI 10.1042/bj1220225; CHANCE B, 1977, ALCOHOL ALDEHYDE MET, P261; DONALDSO.RP, 1972, ARCH BIOCHEM BIOPHYS, V152, P199, DOI 10.1016/0003-9861(72)90208-1; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; HAJRA AK, 1982, ANN NY ACAD SCI, V386, P170, DOI 10.1111/j.1749-6632.1982.tb21415.x; HSIEH B, 1976, J BIOL CHEM, V251, P4408; Lazarow P B, 1981, Methods Enzymol, V72, P315; LAZAROW PB, 1978, J BIOL CHEM, V253, P1522; LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043; LAZO O, 1991, MOL CELL BIOCHEM, V100, P159; LEE T, 1979, J BIOL CHEM, V254, P2892; LEIGHTON F, 1969, J CELL BIOL, V41, P521, DOI 10.1083/jcb.41.2.521; NICHOLLS P, 1964, BIOCHEM J, V90, P331, DOI 10.1042/bj0900331; PIETRUSZKO R, 1979, BIOCH PHARMACOLOGY E, V1, P87; RIZZO WB, 1988, J CLIN INVEST, V81, P738, DOI 10.1172/JCI113379; RIZZO WB, 1991, J CLIN INVEST, V88, P1643, DOI 10.1172/JCI115478; RIZZO WB, 1987, J BIOL CHEM, V262, P17412; SCHMIDT E, 1974, METHOD ENZYMAT AN, V2, P650; SHAIKH B, 1978, ANAL BIOCHEM, V85, P47, DOI 10.1016/0003-2697(78)90272-5; THEORELL H, 1969, ACTA CHEM SCAND, V23, P255, DOI 10.3891/acta.chem.scand.23-0255; THURMAN RG, 1972, EUR J BIOCHEM, V25, P420, DOI 10.1111/j.1432-1033.1972.tb01711.x	27	19	19	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					37	40		10.1074/jbc.270.1.37	http://dx.doi.org/10.1074/jbc.270.1.37			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814397	hybrid			2022-12-27	WOS:A1995QA28700010
J	MOHAN, S; KELLY, TM; EVELAND, SS; RAETZ, CRH; ANDERSON, MS				MOHAN, S; KELLY, TM; EVELAND, SS; RAETZ, CRH; ANDERSON, MS			AN ESCHERICHIA-COLI GENE (FABZ) ENCODING (3R)-HYDROXYMYRISTOYL ACYL CARRIER PROTEIN DEHYDRASE - RELATION TO FABA AND SUPPRESSION OF MUTATIONS IN LIPID A BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID BIOSYNTHESIS; BETA-HYDROXYDECANOYLTHIOESTER DEHYDRASE; UDP-N-ACETYLGLUCOSAMINE; ENDOTOXIN BIOSYNTHESIS; PHOSPHOLIPID-SYNTHESIS; THIOESTER DEHYDRASE; SEQUENCE-ANALYSIS; 1ST STEP; ACYLTRANSFERASE; STRAINS	Escherichia coli strain SM101 harbors a temperature-sensitive allele (lpxA2) of the gene encoding UDP-GlcNAc acyltransferase (the first enzyme of the lipid A pathway), SM101 is temperature-sensitive for lipid A biosynthesis and growth, To determine whether or not E. coli mutants lacking lipid A can be isolated, we examined temperature-resistant revertants of SM101, All regained the ability to synthesize lipid A. However, some were not true revertants but had acquired mutations in a neighboring gene (orf17), while retaining the original lpxA2 lesion, Cell extracts of such revertants displayed 2-5 fold reductions in the specific activity of (3R)-hydroxymyristoyl-ACP dehydrase, Wild-type cells that overproduced the protein encoded by orf17 overproduced (3R)-hydroxymyristoyl-ACP dehydrase activity as much as 170-fold, suggesting that orf17 is the structural gene for the dehydrase. The proposed function of orf17 is further supported by its sequence similarity to fabA, the structural gene for (3R)-hydroxydecanoyl dehydrase of E. coli. We suggest that bypass of the lpxA2 phenotype by mutations in orf17 may be due to an increased (3R)-hydroxymyristoyl-ACP pool. The orf17 gene (which we now designate fabZ) is not regulated by fadR, However, orf17 may be related to sefA, a suppressor of certain lesions in the cell division/lipid A biosynthesis gene, envA.	MERCK & CO INC,MERCK SHARP & DOHME RES LABS,DEPT BIOCHEM,RAHWAY,NJ 07065	Merck & Company								ANDERSON MS, 1993, J BIOL CHEM, V268, P19858; ANDERSON MS, 1987, J BIOL CHEM, V262, P5159; BACHMANN B, 1990, NUCLEIC ACIDS RES, V18, P1309, DOI 10.1093/nar/18.5.1309; BEALL B, 1987, J BACTERIOL, V169, P5408, DOI 10.1128/jb.169.12.5408-5415.1987; BIRGE CH, 1967, BIOCHEM BIOPH RES CO, V29, P808, DOI 10.1016/0006-291X(67)90291-4; BIRGE CH, 1972, J BIOL CHEM, V247, P4930; BLOCH K, 1970, ENZYMES, V5, P441; BURKS C, 1992, NUCLEIC ACIDS RES, V20, P2065, DOI 10.1093/nar/20.suppl.2065; COLEMAN J, 1986, J BACTERIOL, V170, P1268; CRONAN JE, 1972, J BACTERIOL, V112, P206, DOI 10.1128/JB.112.1.206-211.1972; CRONAN JE, 1988, J BIOL CHEM, V263, P4641; DIRUSSO CC, 1985, J BACTERIOL, V161, P583, DOI 10.1128/JB.161.2.583-588.1985; FOSTER SJ, 1993, FEMS MICROBIOL LETT, V110, P295, DOI 10.1016/0378-1097(93)90118-L; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; GANONG BR, 1982, J BIOL CHEM, V257, P389; GHUYSEN JM, 1968, COMPREHENSIVE BIOC A, V26, P53; GRUNDSTROM T, 1980, J BACTERIOL, V144, P884; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HENRY MF, 1991, J MOL BIOL, V222, P843, DOI 10.1016/0022-2836(91)90574-P; HIRVAS L, 1990, BIOCHEM BIOPH RES CO, V173, P53, DOI 10.1016/S0006-291X(05)81020-4; JACKOWSKI S, 1994, J BIOL CHEM, V269, P2921; KASSLR, 1967, P NATL ACAD SCI USA, V58, P1138; KELLY TM, 1993, J BIOL CHEM, V268, P19866; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Maniatis T., 1982, MOL CLONING; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Miller JH, 1972, EXPT MOL GENETICS, P201; NORMARK S, 1976, J BACTERIOL, V128, P401, DOI 10.1128/JB.128.1.401-412.1976; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; POSTBEITTENMILL.D, 1991, J BIOL CHEM, V266, P1858; RAETZ CRH, 1993, J BACTERIOL, V175, P5745, DOI 10.1128/JB.175.18.5745-5753.1993; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; RAETZ CRH, 1986, ANNU REV GENET, V20, P253, DOI 10.1146/annurev.ge.20.120186.001345; RALEIGH EA, 1988, NUCLEIC ACIDS RES, V16, P1563, DOI 10.1093/nar/16.4.1563; ROCK CO, 1982, J BIOL CHEM, V257, P10759; SCHWAB JM, 1986, J CHEM SOC CHEM COMM, P357, DOI 10.1039/c39860000357; SCHWAB JM, 1986, J AM CHEM SOC, V108, P5309, DOI 10.1021/ja00277a041; SCHWAB JM, 1984, J AM CHEM SOC, V106, P7217, DOI 10.1021/ja00335a060; SHAW EI, 1994, GENE, V140, P109, DOI 10.1016/0378-1119(94)90739-0; SILBERT DF, 1975, ANNU REV BIOCHEM, V44, P315, DOI 10.1146/annurev.bi.44.070175.001531; SIMONS RW, 1980, J BACTERIOL, V142, P621, DOI 10.1128/JB.142.2.621-632.1980; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TOMASIEWICZ HG, 1987, J BACTERIOL, V169, P5735, DOI 10.1128/jb.169.12.5735-5744.1987; YOUNG K, 1991, J BACTERIOL, V173, P3609, DOI 10.1128/JB.173.12.3609-3614.1991; YOUNG K, 1993, FED PROC, V7, P1252	47	117	128	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					32896	32903						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806516				2022-12-27	WOS:A1994QA63800029
J	CHABRY, J; BOTTO, JM; NOUEL, D; BEAUDET, A; VINCENT, JP; MAZELLA, J				CHABRY, J; BOTTO, JM; NOUEL, D; BEAUDET, A; VINCENT, JP; MAZELLA, J			THR-422 AND TYR-424 RESIDUES IN THE CARBOXYL-TERMINUS ARE CRITICAL FOR THE INTERNALIZATION OF THE RAT NEUROTENSIN RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							NEURONS; BINDING; DOMAINS	In order to identify the amino acid sequences responsible for the internalization of the cloned rat brain neurotensin receptor, we carried out site-directed mutagenesis of the cDNA encoding the receptor followed by expression of the receptor into mammalian COS 7 cells, In cells transfected with the full-length neurotensin receptor, 56% of iodinated neurotensin specifically bound to the cells after 60 min of incubation at 37 degrees C was internalized. Deletions made in the third intracellular loop did not affect receptor internalization. By contrast, internalization was reduced to 5% of total in cells in which almost all the carboxyl-terminal tail of the receptor had been deleted (R392stop), In order to determine which part of the tail was responsible for this effect, several Ser and Thr residues were deleted in the carboxyl cytoplasmic sequence of the receptor, Almost all of these receptors were internalized as efficiently as the wild type, Only the form of the neurotensin receptor truncated at Glu-421 (deletion of the last three residues, TLY) produced a significant decrease in the amount of ligand internalized, Finally, point mutations of Thr-422 and Tyr-424 residues to Gly led to an almost complete loss of ligand internalization demonstrating the involvement of these 2 residues in the internalization process, Replacement of the last three amino acids by the cytoplasmic endocytosis signal of the vesicular stomatitis virus did not restore the efficiency of neurotensin receptor internalization. These biochemical results were confirmed by confocal microscopic analysis, Cells transfected with the wild type receptor showed a temperature-dependent intracellular accumulation of a fluorescent analog of neurotensin, whereas cells transfected with a receptor truncated at the carboxyl terminus showed a clustering of the fluorescent peptide at the cell surface.	CNRS,INST PHARMACOL MOLEC & CELLULAIRE,UPR 411,F-06560 VALBONNE,FRANCE; MCGILL UNIV,MONTREAL NEUROL INST,NEUROBIOL GRP,MONTREAL,PQ H3A 2B4,CANADA	Centre National de la Recherche Scientifique (CNRS); McGill University			Mazella, Jean/A-6767-2012; Chabry, Joelle/O-2101-2016					BARAK LS, 1994, J BIOL CHEM, V269, P2790; BENYA RV, 1993, J BIOL CHEM, V268, P20285; CAMPBELL PT, 1991, MOL PHARMACOL, V39, P192; CHABRY J, 1993, J BIOL CHEM, V268, P17138; CHABRY J, 1994, J NEUROCHEM, V63, P19; FAURE MP, 1994, J HISTOCHEM CYTOCHEM, V42, P755, DOI 10.1177/42.6.8189037; GAUDRIAULT G, 1992, PEPTIDES, V13, P1187, DOI 10.1016/0196-9781(92)90027-Z; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAMEH J, 1992, J BIOL CHEM, V267, P13406; LUTZ W, 1990, P NATL ACAD SCI USA, V87, P6507, DOI 10.1073/pnas.87.17.6507; MAZELLA J, 1991, BRAIN RES, V564, P249, DOI 10.1016/0006-8993(91)91460-I; NUSSENZVEIG DR, 1993, J BIOL CHEM, V268, P2389; PERLMAN JH, 1992, J BIOL CHEM, V267, P24413; ROTH MG, 1986, J CELL BIOL, V102, P1271, DOI 10.1083/jcb.102.4.1271; Sambrook J, 1989, MOL CLONING LABORATO; SLICE LW, 1994, J BIOL CHEM, V269, P21755; TANAKA K, 1990, NEURON, V4, P847, DOI 10.1016/0896-6273(90)90137-5; VANISBERG MA, 1991, BIOCHEM PHARMACOL, V42, P2265, DOI 10.1016/0006-2952(91)90229-X	18	61	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2439	2442		10.1074/jbc.270.6.2439	http://dx.doi.org/10.1074/jbc.270.6.2439			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852303	hybrid			2022-12-27	WOS:A1995QF53500008
J	CHEN, PCH; DUBOIS, GC; CHEN, MJ				CHEN, PCH; DUBOIS, GC; CHEN, MJ			MAPPING THE DOMAIN(S) CRITICAL FOR THE BINDING OF HUMAN TUMOR-NECROSIS-FACTOR-ALPHA TO ITS 2 RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR TNF RECEPTOR; MOLECULAR-CLONING; FACTOR-BETA; EXPRESSION; 55-KDA; IDENTIFICATION; RESOLUTION; RESPONSES; MUTANTS; SITE	The extracellular domains of the two human tumor necrosis factor (TNF) receptors critical for binding TNF-alpha were examined by deletion mapping, The Ligand binding capability of full-length and truncated recombinant soluble TNF receptors (TNFRs) was assessed by ligand blot analysis and their binding affinity determined by Scatchard analysis, The results showed that deletion of the fourth cysteine-rich domain of the p55 receptor (TNFR-1) did not alter Ligand binding affinity significantly, Deletion of domains 3 and 4 of TNFR-1 resulted in no ligand binding, suggesting that domain 3, but not 4, of TNFR-1 binds directly to Ligand, Deletion of domain 4 of TNFR-2 resulted in drastically reduced protein yield and 3-fold reduction in Ligand binding affinity, while deletion of both domains 4 and 3 yielded no protein, Thus, the domain 4 of TNFR-2, but not that of TNFR-1, appears to be involved directly in binding TNF, although it is also possible that the domain 4 of TNFR-2 is involved in the correct folding of other domains. These results suggest that the modes of interaction between TNF-alpha and its dual receptors are different, providing opportunity to modulate each receptor specifically for research and therapeutic purposes.	THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT MICROBIOL & IMMUNOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT PHARMACOL,PHILADELPHIA,PA 19107; JEFFERSON CANC INST,PHILADELPHIA,PA 19107	Jefferson University; Jefferson University; Jefferson University					NATIONAL CANCER INSTITUTE [R01CA059832] Funding Source: NIH RePORTER; NCI NIH HHS [CA-59832] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALON R, 1994, J IMMUNOL, V152, P1304; ARAKAWA T, 1987, J BIOL CHEM, V262, P7484; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; BERAN M, 1987, BLOOD, V69, P721; BEUTLER B, 1988, ANNU REV BIOCHEM, V57, P505, DOI 10.1146/annurev.bi.57.070188.002445; BEUTLER B, 1994, SCIENCE, V264, P667, DOI 10.1126/science.8171316; BEUTLER BE, 1992, TUMOR NECROSIS FACTO; CAMUSSI G, 1991, EUR J BIOCHEM, V202, P3, DOI 10.1111/j.1432-1033.1991.tb16337.x; CHEN MJ, 1988, MONOKINES OTHER NONL, P243; ECK MJ, 1992, J BIOL CHEM, V267, P2119; ECK MJ, 1989, J BIOL CHEM, V264, P17595; FIERS W, 1993, TUMOR NECROSIS FACTO; GOODWIN RG, 1991, MOL CELL BIOL, V11, P3020, DOI 10.1128/MCB.11.6.3020; GRAY PW, 1990, P NATL ACAD SCI USA, V87, P7380, DOI 10.1073/pnas.87.19.7380; HOHMANN HP, 1989, J BIOL CHEM, V264, P14927; HWANG C, 1991, P ROY SOC B-BIOL SCI, V245, P115, DOI 10.1098/rspb.1991.0096; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; Kircheis R, 1992, Eur Cytokine Netw, V3, P381; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; KUNITANI MG, 1988, J CHROMATOGR, V443, P205, DOI 10.1016/S0021-9673(00)94794-0; LIE BL, 1992, BIOCHEM BIOPH RES CO, V188, P503, DOI 10.1016/0006-291X(92)91084-4; LOCKSLEY RM, 1987, J IMMUNOL, V139, P1891; LOETSCHER H, 1991, J BIOL CHEM, V266, P18324; LOETSCHER H, 1993, J BIOL CHEM, V268, P26350; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; LUCAS R, 1994, SCIENCE, V263, P814, DOI 10.1126/science.8303299; OSTER W, 1987, BLOOD, V70, P1700; RATHJEN DA, 1991, MOL IMMUNOL, V28, P79, DOI 10.1016/0161-5890(91)90089-3; ROSENTHAL HE, 1967, ANAL BIOCHEM, V20, P525, DOI 10.1016/0003-2697(67)90297-7; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; SMITH RA, 1987, J BIOL CHEM, V262, P6951; Tao Deling, 1994, European Cytokine Network, V5, P90; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; THOMA B, 1990, J EXP MED, V172, P1019, DOI 10.1084/jem.172.4.1019; VANOSTADE X, 1994, PROTEIN ENG, V7, P5, DOI 10.1093/protein/7.1.5; VANOSTADE X, 1993, NATURE, V361, P266; VILCEK J, 1991, J BIOL CHEM, V266, P7313; ZHANG XM, 1992, J BIOL CHEM, V267, P24069	40	21	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2874	2878		10.1074/jbc.270.6.2874	http://dx.doi.org/10.1074/jbc.270.6.2874			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852363	hybrid			2022-12-27	WOS:A1995QF53500073
J	GOODSON, ML; SARGE, KD				GOODSON, ML; SARGE, KD			HEAT-INDUCIBLE DNA FINDING OF PURIFIED HEAT-SHOCK TRANSCRIPTION FACTOR-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							AMINO-ACID-ANALOGS; BINDING ACTIVITY; GENE-EXPRESSION; ACTIVATION; PROTEINS; STRESS; HSP70; OLIGOMERIZATION; POLYPEPTIDES; CHAPERONES	The heat-induced expression of heat shock proteins, called the cellular stress response, is mediated by heat shock transcription factor 1 (HSF1). HSF1 exists in unstressed cells in an inactive form, which is converted to the DNA binding form upon exposure of cells to elevated temperature. We have developed a protocol for isolation of the non-DNA binding form of recombinant mouse HSF1, involving expression and affinity purification of HSF1 as a fusion with the glutathione S-transferase protein in Escherichia coli, followed by specific protease cleavage to release pure HSF1 protein, We report here that the purified inactive HSF1 can be converted to the DNA binding form by heat treatment in vitro, Chemical cross-linking analysis demonstrates that this conversion is accompanied by oligomerization of HSF1 from a monomeric to a trimeric native structure, similar to that observed for HSF1 in heat-shocked cells, These results indicate that elements residing in the HSF1 polypeptide are sufficient both for maintenance of this factor in the non-DNA binding form and for its heat-induced conversion to the DNA binding form and support a role for HSF1 as the ''molecular thermostat'' in eukaryotic cells, which senses adverse environmental conditions and activates the cellular stress response.	UNIV KENTUCKY, ALBERT B CHANDLER MED CTR, DEPT BIOCHEM, LEXINGTON, KY 40536 USA	University of Kentucky			Goodson, Michael L/G-4175-2010	Goodson, Michael/0000-0002-3464-490X				ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; ANANTHAN J, 1986, SCIENCE, V232, P522, DOI 10.1126/science.3083508; BALER R, 1992, J CELL BIOL, V117, P1151, DOI 10.1083/jcb.117.6.1151; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; CLOS J, 1993, NATURE, V364, P252, DOI 10.1038/364252a0; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; CRAIG EA, 1991, TRENDS BIOCHEM SCI, V16, P135, DOI 10.1016/0968-0004(91)90055-Z; DIDOMENICO BJ, 1982, CELL, V31, P593, DOI 10.1016/0092-8674(82)90315-4; EDINGTON BV, 1989, J CELL PHYSIOL, V139, P219, DOI 10.1002/jcp.1041390202; GAMER J, 1992, CELL, V69, P833, DOI 10.1016/0092-8674(92)90294-M; GEKKO K, 1983, J BIOCHEM-TOKYO, V94, P199, DOI 10.1093/oxfordjournals.jbchem.a134330; GOMEZPUYOU MTD, 1978, ARCH BIOCHEM BIOPHYS, V187, P72, DOI 10.1016/0003-9861(78)90007-3; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HIGHTOWER LE, 1980, J CELL PHYSIOL, V102, P407, DOI 10.1002/jcp.1041020315; HIGHTOWER LE, 1991, CELL, V66, P191, DOI 10.1016/0092-8674(91)90611-2; KELLEY PM, 1978, CELL, V15, P1277, DOI 10.1016/0092-8674(78)90053-3; KINGSTON RE, 1991, HORMONAL CONTROL GEN, P377; LARSON JS, 1988, NATURE, V335, P372, DOI 10.1038/335372a0; LIBEREK K, 1992, P NATL ACAD SCI USA, V89, P3516, DOI 10.1073/pnas.89.8.3516; LIS J, 1992, TRANSCRIPTIONAL REGU, P907; MORIMOTO RI, 1992, J BIOL CHEM, V267, P21987; Morimoto RI, 1990, STRESS PROTEINS BIOL; MOSSER DD, 1990, P NATL ACAD SCI USA, V87, P3748, DOI 10.1073/pnas.87.10.3748; MOSSER DD, 1993, MOL CELL BIOL, V13, P5427, DOI 10.1128/MCB.13.9.5427; MOSSER DD, 1988, MOL CELL BIOL, V8, P4736, DOI 10.1128/MCB.8.11.4736; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; RABINDRAN SK, 1994, MOL CELL BIOL, V14, P6552, DOI 10.1128/MCB.14.10.6552; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SARGE KD, 1991, GENE DEV, V5, P1902, DOI 10.1101/gad.5.10.1902; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; STRAUS D, 1990, GENE DEV, V4, P2202, DOI 10.1101/gad.4.12a.2202; STRAUS D, 1989, GENE DEV, V2, P1851; WESTWOOD JT, 1993, MOL CELL BIOL, V13, P3481, DOI 10.1128/MCB.13.6.3481; WESTWOOD JT, 1991, NATURE, V353, P822, DOI 10.1038/353822a0; ZUO JR, 1994, MOL CELL BIOL, V14, P7557, DOI 10.1128/MCB.14.11.7557	37	54	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2447	2450		10.1074/jbc.270.6.2447	http://dx.doi.org/10.1074/jbc.270.6.2447			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852305	hybrid			2022-12-27	WOS:A1995QF53500010
J	KIELISZEWSKI, MJ; ONEILL, M; LEYKAM, J; ORLANDO, R				KIELISZEWSKI, MJ; ONEILL, M; LEYKAM, J; ORLANDO, R			TANDEM MASS-SPECTROMETRY AND STRUCTURAL ELUCIDATION OF GLYCOPEPTIDES FROM A HYDROXYPROLINE-RICH PLANT-CELL WALL GLYCOPROTEIN INDICATE THAT CONTIGUOUS HYDROXYPROLINE RESIDUES ARE THE MAJOR SITES OF HYDROXYPROLINE O-ARABINOSYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZEA-MAYS; GLYCOSYLATION SITES; CONTAINING PROTEINS; EXTENSIN; SEQUENCE; PEPTIDES; CHROMATOGRAPHY; ARABINOSIDES; ACCUMULATION; CONFORMATION	Hydroxyproline-rich glycoproteins (HRGPs) occur in the extracellular matrix of land plants and green algae. HRGPs contain from 2 to 95% of their dry weight as carbohydrate, predominantly as oligoarabinosides and/or as heteropolysaccharides which are O-linked to the hydroxyproline residues. A glycosylation code that determines the presence or absence and extent of arabinosylation at each hydroxyproline residue is likely, as each HRCP has a unique arabinosylation profile. Previously we noted a positive correlation between the contiguity of hydroxyproline residues and the extent of HRGP O-arabinosylation (Kieliszewski, M., deZacks, R., Leykam, J. F., and Lamport, D. T. A. (1992) Plant Physiol. 98, 919-926); most arabinosylated hydroxyproline residues and the longer arabinofuranoside chains occur in HRGPs where Hyp residues occur as blocks of tetrahydroxyproline, while those with little or no contiguous Hyp exhibit very little Hyp arabinosylation. In order to test this Hyp contiguity hypothesis, we have for the first time determined the arabinosylation site specifics of an HRGP, namely the proline and hydroxyproline-rich glycoprotein (PHRGP) isolated from Douglas fir (Pseudotsuga menziesii). Pronase digests of PHRGP yielded a major peptide and three glycopeptides whose structures were determined directly from the unfractionated, underivatized Pronase digest by tandem mass spectrometry using collisionally induced dissociation. We corroborated the peptide and glycopeptide structures by Edman degradation, neutral sugar analyses, hydroxyproline arabinoside profiles, and further mass spectrometric analyses after purification of the major peptide and glycopeptides by a combination of hydrophilic interaction and reverse phase column chromatography. Consistent with the Hyp contiguity hypothesis, the structural analyses indicate that while the sequence ne-Pro-Pro-Hyp is never arabinosylated and Lys-Pro-Ile-Val-Hyp is only occasionally monoarabinosylated at Hyp-5, the peptide containing contiguous Hyp, Lys-Pro-Hyp-Hyp-Val, is always arabinosylated at Hyp-3, mainly by a triarabinoside. We also obtained precise molecular masses for both intact and anhydrous hydrogen fluoride-deglycosylated PHRGPs (73.113 and 53.834 kDa) via matrix-assisted laser desorption/ionization time of flight mass spectrometry, representing the first HRGP to be analyzed by this method.	UNIV GEORGIA,DEPT BIOCHEM,ATHENS,GA 30602; MICHIGAN STATE UNIV,DEPT BIOCHEM,E LANSING,MI 48824	University System of Georgia; University of Georgia; Michigan State University	KIELISZEWSKI, MJ (corresponding author), UNIV GEORGIA,COMPLEX CARBOHYDRATE RES CTR,220 RIVERBEND RD,ATHENS,GA 30602, USA.				NCRR NIH HHS [P41-RR05351] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AKIYAMA Y, 1980, AGR BIOL CHEM TOKYO, V44, P2487, DOI 10.1080/00021369.1980.10864347; ALBERSHEIM PETER, 1967, CARBOHYD RES, V5, P340, DOI 10.1016/S0008-6215(00)80510-8; ASHFORD D, 1982, BIOCHEM J, V201, P199, DOI 10.1042/bj2010199; Beavis R C, 1989, Rapid Commun Mass Spectrom, V3, P432, DOI 10.1002/rcm.1290031207; BIEMANN K, 1992, ANNU REV BIOCHEM, V61, P977, DOI 10.1146/annurev.bi.61.070192.004553; BIEMANN K, 1989, ANN REV BIOCH, V61, P977; BROWNLEADER MD, 1993, PLANTA, V191, P457, DOI 10.1007/BF00195747; CHAIT BT, 1992, SCIENCE, V257, P1885, DOI 10.1126/science.1411504; CHEN J, 1985, EMBO J, V4, P2145, DOI 10.1002/j.1460-2075.1985.tb03908.x; CONBOY JJ, 1992, J AM SOC MASS SPECTR, V3, P804, DOI 10.1016/1044-0305(92)80003-4; COSTELLO CE, 1990, METHOD ENZYMOL, V193, P738, DOI 10.1016/0076-6879(90)93448-T; DATTA K, 1989, PLANT CELL, V1, P945, DOI 10.1105/tpc.1.9.945; EPSTEIN L, 1984, PHYTOCHEMISTRY, V23, P1241, DOI 10.1016/S0031-9422(00)80433-1; ERTL H, 1992, EMBO J, V11, P2055, DOI 10.1002/j.1460-2075.1992.tb05263.x; ESQUERRETUGAYE MT, 1979, PLANT PHYSIOL, V64, P314, DOI 10.1104/pp.64.2.314; FINCHER GB, 1983, ANNU REV PLANT PHYS, V34, P47, DOI 10.1146/annurev.pp.34.060183.000403; HECKMAN JW, 1988, PLANT PHYSIOL, V86, P848, DOI 10.1104/pp.86.3.848; HILL JA, 1992, INT J MASS SPECTROM, V111, P1; JANES SM, 1990, SCIENCE, V248, P981, DOI 10.1126/science.2111581; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; KELLER B, 1989, GENE DEV, V3, P1639, DOI 10.1101/gad.3.10.1639; KIELISZEWSKI M, 1987, PLANT PHYSIOL, V85, P823, DOI 10.1104/pp.85.3.823; KIELISZEWSKI M, 1992, PLANT PHYSIOL, V98, P919, DOI 10.1104/pp.98.3.919; KIELISZEWSKI M, 1994, PLANT J, V5, P1; KIELISZEWSKI M, 1994, PLANT J, V5; KIELISZEWSKI MJ, 1990, PLANT PHYSIOL, V92, P316, DOI 10.1104/pp.92.2.316; KIELISZEWSKI MJ, 1992, PLANT PHYSIOL, V99, P538, DOI 10.1104/pp.99.2.538; Lamport D. T. A., 1977, RECENT ADV PHYTOCHEM, V11, P79; LAMPORT DTA, 1967, NATURE, V216, P1322, DOI 10.1038/2161322a0; LAMPORT DTA, 1973, BIOCHEM J, V133, P125, DOI 10.1042/bj1330125; LAMPORT DTA, 1971, PLANT PHYSIOL, V48, P454, DOI 10.1104/pp.48.4.454; LAMPORT DTA, 1970, ANN REV PLANT PHYSIO, V21, P235, DOI 10.1146/annurev.pp.21.060170.001315; LOO JA, 1993, ANAL CHEM, V65, P425, DOI 10.1021/ac00052a020; MAZAU D, 1986, PHYSIOL MOL PLANT P, V29, P147, DOI 10.1016/S0048-4059(86)80017-0; MCNEIL M, 1984, ANNU REV BIOCHEM, V53, P625, DOI 10.1146/annurev.bi.53.070184.003205; MEDZIHRADSZKY KF, 1990, BIOMED ENVIRON MASS, V19, P777, DOI 10.1002/bms.1200191205; MILLER DH, 1972, SCIENCE, V176, P918, DOI 10.1126/science.176.4037.918; MORT AJ, 1977, ANAL BIOCHEM, V82, P289, DOI 10.1016/0003-2697(77)90165-8; NAYLOR S, 1986, J AM CHEM SOC, V108, P6359, DOI 10.1021/ja00280a037; PISANO A, 1993, GLYCOBIOLOGY, V3, P429, DOI 10.1093/glycob/3.5.429; POPE DG, 1977, PLANT PHYSIOL, V59, P894, DOI 10.1104/pp.59.5.894; QI W, 1991, PLANT PHYSIOL, V96, P848, DOI 10.1104/pp.96.3.848; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; SANGER MP, 1983, ANAL BIOCHEM, V128, P66, DOI 10.1016/0003-2697(83)90345-7; SETTINERI CA, 1990, BIOMED ENVIRON MASS, V19, P665, DOI 10.1002/bms.1200191106; SHOWALTER AM, 1985, P NATL ACAD SCI USA, V82, P6551, DOI 10.1073/pnas.82.19.6551; SMITH JJ, 1984, PHYTOCHEMISTRY, V23, P1233, DOI 10.1016/S0031-9422(00)80432-X; STAFSTROM JP, 1986, PLANT PHYSIOL, V81, P234, DOI 10.1104/pp.81.1.234; STIEFEL V, 1988, PLANT MOL BIOL, V11, P483, DOI 10.1007/BF00039029; TANAKA K, 1965, J BIOL CHEM, V240, P1487; TOMITA M, 1975, P NATL ACAD SCI USA, V72, P2964, DOI 10.1073/pnas.72.8.2964; TUOMANEN E, 1989, J BIOL CHEM, V264, P11093; VANDEVELDE MC, 1985, CARBOHYD POLYM, V5, P251, DOI 10.1016/0144-8617(85)90034-7; VANHOLST GJ, 1984, PLANT PHYSIOL, V74, P247, DOI 10.1104/pp.74.2.247; VANHOLST GJ, 1986, BIOCHEM J, V233, P731, DOI 10.1042/bj2330731	55	85	96	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2541	2549		10.1074/jbc.270.6.2541	http://dx.doi.org/10.1074/jbc.270.6.2541			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852316	hybrid			2022-12-27	WOS:A1995QF53500024
J	KURODA, S; SHIMIZU, K; YAMAMORI, B; MATSUDA, S; IMAZUMI, K; KAIBUCHI, K; TAKAI, Y				KURODA, S; SHIMIZU, K; YAMAMORI, B; MATSUDA, S; IMAZUMI, K; KAIBUCHI, K; TAKAI, Y			PURIFICATION AND CHARACTERIZATION OF REKS FROM XENOPUS EGGS - IDENTIFICATION OF REKS AS A RAS-DEPENDENT MITOGEN-ACTIVATED PROTEIN-KINASE KINASE KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP EXCHANGE PROTEIN; MAP KINASE; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; ADENYLATE-CYCLASE; OOCYTES; RAF-1; CELLS; RAS-P21	We have previously identified a protein factor, named REKS (Ras-dependent Extracellular signal-regulated kinase/Mitogen-activated protein kinase kinase (MEK) Stimulator), which is necessary for Ras-dependent MEK activation. In this study, we attempted to highly purify and characterize REKS. We have highly purified REKS by successive column chromatographies using a cell-free assay system in which REKS activates recombinant extracellular signal-regulated kinase 2 through recombinant MER in a guanosine 5'-O-(thiotriphosphate) (GTP gamma S)-Ki-Ras-dependent manner. REKS formed a stable complex with GTP gamma S-Ras; REKS was coimmunoprecipitated with GTP gamma S-Ki-Ras or GTP gamma S-Ha-Ras, but not with GDP-Ki-Ras or GDP-Ha-Ras by an anti-Ras antibody. REKS was adsorbed to a GTP gamma S-glutathione S-transferase (GST)-Ha-Ras-coupled glutathione-agarose column but not to a GDP-GST-Ha-Ras-coupled glutathione-agarose column and was coeluted with GTP gamma S-GST-Ha-Ras by reduced glutathione. The minimum molecular mass of REKS was estimated to be about 98 kDa on SDS-polyacrylamide gel electrophoresis. REKS phosphorylated this 98-kDa protein as well as recombinant MEK. REKS was not recognized by any of the anti-c-Raf-1, anti-Mos, and anti-mSte11 antibodies. These results indicate that REKS is a Ras-dependent MEK kinase.	OSAKA UNIV,SCH MED,DEPT MOLEC BIOL & BIOCHEM,SUITA,OSAKA 565,JAPAN; KOBE UNIV,SCH MED,DEPT BIOCHEM,KOBE 650,JAPAN; NATL INST PHYSIOL SCI,DEPT CELL PHYSIOL,OKAZAKI,AICHI 444,JAPAN	Osaka University; Kobe University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)			KURODA, SHINYA/G-4961-2014					AELST LV, 1993, P NATL ACAD SCI USA, V90, P6213; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOWTELL D, 1992, P NATL ACAD SCI USA, V89, P6511, DOI 10.1073/pnas.89.14.6511; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DICKSON B, 1992, NATURE, V360, P600, DOI 10.1038/360600a0; FERRELL JE, 1991, MOL CELL BIOL, V11, P1965, DOI 10.1128/MCB.11.4.1965; GERHART J, 1984, J CELL BIOL, V98, P1247, DOI 10.1083/jcb.98.4.1247; HAN M, 1993, NATURE, V363, P133, DOI 10.1038/363133a0; HATTORI S, 1992, J BIOL CHEM, V267, P20346; HORIUCHI H, 1992, MOL CELL BIOL, V12, P4515, DOI 10.1128/MCB.12.10.4515; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; ITOH T, 1993, P NATL ACAD SCI USA, V90, P975, DOI 10.1073/pnas.90.3.975; ITOH T, 1993, J BIOL CHEM, V268, P3025; KIKUCHI A, 1994, J BIOL CHEM, V269, P20054; KISHI K, 1993, J CELL BIOL, V120, P1187, DOI 10.1083/jcb.120.5.1187; KODAKI T, 1994, CURR BIOL, V4, P798, DOI 10.1016/S0960-9822(00)00177-9; KOIDE H, 1993, P NATL ACAD SCI USA, V90, P8683, DOI 10.1073/pnas.90.18.8683; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; KURODA Y, 1993, SCIENCE, V259, P683, DOI 10.1126/science.8430318; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGECARTER CA, 1994, SCIENCE, V265, P1458, DOI 10.1126/science.8073291; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; MARTEGANI E, 1992, EMBO J, V11, P2151, DOI 10.1002/j.1460-2075.1992.tb05274.x; MATSUDA S, 1993, J BIOL CHEM, V268, P3277; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; NEBREDA AR, 1993, EMBO J, V12, P1979, DOI 10.1002/j.1460-2075.1993.tb05847.x; POSADA J, 1993, MOL CELL BIOL, V13, P2546, DOI 10.1128/MCB.13.4.2546; RODRIGUEZVICIAN.P, 1994, NATURE, V370, P527; SAGATA N, 1989, SCIENCE, V245, P643, DOI 10.1126/science.2474853; SAMBROOK J, 1989, MOL CLONING LABORATO, P1574; SHIBUYA EK, 1992, EMBO J, V11, P3963, DOI 10.1002/j.1460-2075.1992.tb05490.x; SHIBUYA EK, 1992, P NATL ACAD SCI USA, V89, P9831, DOI 10.1073/pnas.89.20.9831; SHIMIZU K, 1994, J BIOL CHEM, V269, P22917; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; TRAHEY M, 1988, SCIENCE, V242, P1697, DOI 10.1126/science.3201259; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	52	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2460	2465		10.1074/jbc.270.6.2460	http://dx.doi.org/10.1074/jbc.270.6.2460			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852306	hybrid			2022-12-27	WOS:A1995QF53500012
J	WAHLE, E				WAHLE, E			POLY(A) TAIL LENGTH CONTROL IS CAUSED BY TERMINATION OF PROCESSIVE SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA PRECURSORS; SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION; SPECIFICITY FACTOR; END FORMATION; POLYMERASE; POLYADENYLATION; CLEAVAGE; DEADENYLATION; PROTEIN	Poly(A) polymerase synthesizes poly(A) tails rapidly and processively only when the substrate RNA is bound simultaneously by two stimulatory proteins, the cleavage and polyadenylation specificity factor (CPSF) and poly(A)-binding protein II (PAB II). A burst of synthesis terminates after the addition of about 250 nucleotides, a length corresponding to that of newly synthesized poly(A) tails in vivo. Further elongation is slow. Length control can be reproduced with premade poly(A) tails of different lengths and is insensitive to large changes in the elongation rate. Thus, the control mechanism truly measures the length of the poly(A) tail. The stimulatory action of PAB II is similar on long and short tails. Coating of poly(A) with one PAB IT molecule for approximately 30 nucleotides is required, such that the number of PAB II molecules in the polyadenylation complex is a direct measure of poly(A) tail length. CPSF also stimulates poly(A) polymerase on long and short tails. Long tails differ from short ones only in that they do not permit the simultaneous stimulation of poly(A) polymerase by CPSF and PAB II. Consequently, elongation of long tails is distributive. Thus, length control is brought about by an interruption of the interactions responsible for rapid and processive elongation of short tails. The 3'-end of the poly(A) tail is not sequestered in the protein-RNA complex when the correct length has been reached. Neither ATP hydrolysis nor turnover of the polymerized AMP is involved in length control.			WAHLE, E (corresponding author), UNIV BASEL, BIOZENTRUM, DEPT CELL BIOL, KLINGELBERGSTR 70, CH-4056 BASEL, SWITZERLAND.			Wahle, Elmar/0000-0003-2504-0677				ABRAHAM AK, 1978, P NATL ACAD SCI USA, V75, P2085, DOI 10.1073/pnas.75.5.2085; BACHVAROVA RF, 1992, CELL, V69, P895, DOI 10.1016/0092-8674(92)90606-D; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; BIENROTH S, 1991, J BIOL CHEM, V266, P19768; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAWERMAN G, 1981, CRC CR REV BIOCH MOL, V10, P1, DOI 10.3109/10409238109114634; BRUTLAG D, 1972, J BIOL CHEM, V247, P241; CHRISTOFORI G, 1988, CELL, V54, P875, DOI 10.1016/S0092-8674(88)91263-9; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; ECKNER R, 1991, EMBO J, V10, P3513, DOI 10.1002/j.1460-2075.1991.tb04915.x; GALILI G, 1988, J BIOL CHEM, V263, P5764; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; HOCHULI E, 1987, J CHROMATOGR, V411, P177, DOI 10.1016/S0021-9673(00)93969-4; JACKSON RJ, 1990, CELL, V62, P15, DOI 10.1016/0092-8674(90)90235-7; KASSAVETIS GA, 1993, SCIENCE, V259, P944, DOI 10.1126/science.7679800; KELLER W, 1991, EMBO J, V10, P4241, DOI 10.1002/j.1460-2075.1991.tb05002.x; KORNBERG A, 1992, DNA REPLICATION, P130; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINGNER J, 1991, NATURE, V354, P496, DOI 10.1038/354496a0; LINGNER J, 1991, J BIOL CHEM, V266, P8741; LOWELL JE, 1992, GENE DEV, V6, P2088, DOI 10.1101/gad.6.11.2088; MUHLRAD D, 1992, GENE DEV, V6, P2100, DOI 10.1101/gad.6.11.2100; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; MUNROE D, 1990, MOL CELL BIOL, V10, P3441, DOI 10.1128/MCB.10.7.3441; MURTHY KGK, 1992, J BIOL CHEM, V267, P14804; PARIS J, 1990, MOL CELL BIOL, V10, P5634, DOI 10.1128/MCB.10.11.5634; RAABE T, 1991, NATURE, V353, P229, DOI 10.1038/353229a0; ROBINSON BG, 1988, SCIENCE, V241, P342, DOI 10.1126/science.3388044; SACHS A, 1993, J BIOL CHEM, V268, P22955; Sachs A, 1990, CURR OPIN CELL BIOL, V2, P1092, DOI 10.1016/0955-0674(90)90161-7; SACHS AB, 1990, SCIENCE, V247, P1077, DOI 10.1126/science.2408148; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; SACHS AB, 1989, CELL, V58, P857, DOI 10.1016/0092-8674(89)90938-0; Sambrook J, 1989, MOL CLONING LABORATO; SAWICKI SG, 1977, J MOL BIOL, V113, P219, DOI 10.1016/0022-2836(77)90051-1; SCHIAVI SC, 1994, J BIOL CHEM, V269, P3441; SCOPES RK, 1987, PROTEIN PURIFICATION, P305; SHEETS MD, 1989, GENE DEV, V3, P1401, DOI 10.1101/gad.3.9.1401; SHEETS MD, 1994, GENE DEV, V8, P926, DOI 10.1101/gad.8.8.926; SHYU AB, 1991, GENE DEV, V5, P221, DOI 10.1101/gad.5.2.221; STAYTON MM, 1983, J BIOL CHEM, V258, P3205; SURRATT CK, 1991, P NATL ACAD SCI USA, V88, P7983, DOI 10.1073/pnas.88.18.7983; TARUI Y, 1989, EUR J BIOCHEM, V186, P591, DOI 10.1111/j.1432-1033.1989.tb15249.x; VASSALLI JD, 1989, GENE DEV, V3, P2163, DOI 10.1101/gad.3.12b.2163; WAHLE E, 1991, J BIOL CHEM, V266, P3131; WAHLE E, 1991, EMBO J, V10, P4251, DOI 10.1002/j.1460-2075.1991.tb05003.x; WAHLE E, 1993, J BIOL CHEM, V268, P2937; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; WAHLE E, 1992, ANNU REV BIOCHEM, V61, P419; WICKENS M, 1984, SCIENCE, V226, P1045, DOI 10.1126/science.6208611; WICKENS M, 1992, SEM DEV BIOL, V3, P399; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0	52	159	179	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2800	2808		10.1074/jbc.270.6.2800	http://dx.doi.org/10.1074/jbc.270.6.2800			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852352				2022-12-27	WOS:A1995QF53500062
J	EGGLESTON, AK; ONEILL, TE; BRADBURY, EM; KOWALCZYKOWSKI, SC				EGGLESTON, AK; ONEILL, TE; BRADBURY, EM; KOWALCZYKOWSKI, SC			UNWINDING OF NUCLEOSOMAL DNA BY A DNA HELICASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI RECBCD ENZYME; HOMOLOGOUS PAIRING INVITRO; T7 RNA-POLYMERASE; ESCHERICHIA-COLI; DUPLEX DNA; RECOMBINATION HOTSPOT; SACCHAROMYCES-CEREVISIAE; SUBSTRATE-SPECIFICITY; RECB(2109)CD ENZYME; NUCLEASE ACTIVITY	We have asked whether a DNA helicase can unwind DNA contained within both isolated native chromatin and reconstituted chromatin containing regularly spaced arrays of nucleosome cores on a linear tandem repeat sequence, We find that Escherichia coli recBCD enzyme is capable of unwinding these DNA substrates and displacing the nucleosomes, although both the rate and the processivity of enzymatic unwinding are inhibited (a maximum of 3- and >25-fold, respectively) as the nucleosome density on the template is increased. The observed rate of unwinding is not affected if the histone octamer is chemically cross-linked; thus, dissociation, or splitting, of the histone octamer is not required for unwinding to occur, The unwinding of native chromatin isolated from HeLa cell nuclei occurs both in the absence and in the presence of linker histone H1, These results suggest that as helicases unwind DNA, they facilitate nuclear processes by acting to clear DNA of histones or DNA-binding proteins in general.	UNIV CALIF DAVIS,MICROBIOL SECT,DAVIS,CA 95616; UNIV CALIF DAVIS,MOLEC & CELLULAR BIOL SECT,DAVIS,CA 95616; UNIV CALIF DAVIS,DEPT BIOL CHEM,DAVIS,CA 95616; LOS ALAMOS NATL LAB,DIV LIFE SCI,LOS ALAMOS,NM 87545	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Energy (DOE); Los Alamos National Laboratory				Eggleston, Angela/0000-0001-8682-397X	NIGMS NIH HHS [GM-26901, GM-41347] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026901, R01GM041347] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN MJ, 1993, BIOCHEMISTRY-US, V32, P8390, DOI 10.1021/bi00084a002; ALMOUZNI G, 1990, NUCLEIC ACIDS RES, V18, P5767, DOI 10.1093/nar/18.19.5767; BONNEANDREA C, 1990, NATURE, V343, P719, DOI 10.1038/343719a0; BUTTIN G, 1968, COLD SPRING HARB SYM, V33, P259, DOI 10.1101/SQB.1968.033.01.030; CHENG KC, 1989, GENETICS, V123, P5; CLARK DJ, 1992, CELL, V71, P11, DOI 10.1016/0092-8674(92)90262-B; DIXON DA, 1991, CELL, V66, P361, DOI 10.1016/0092-8674(91)90625-9; DIXON DA, 1993, CELL, V73, P87, DOI 10.1016/0092-8674(93)90162-J; DIXON DA, 1994, P NATL ACAD SCI USA, V91, P2980, DOI 10.1073/pnas.91.8.2980; DONG F, 1990, P NATL ACAD SCI USA, V87, P5724, DOI 10.1073/pnas.87.15.5724; EGGLESTON AK, 1993, J MOL BIOL, V231, P621, DOI 10.1006/jmbi.1993.1314; EGGLESTON AK, 1993, J MOL BIOL, V231, P605, DOI 10.1006/jmbi.1993.1313; EICHLER DC, 1977, J BIOL CHEM, V252, P499; ENNIS DG, 1987, GENETICS, V115, P11; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; GANESAN S, 1993, J MOL BIOL, V229, P67, DOI 10.1006/jmbi.1993.1008; GOLDMARK PJ, 1972, J BIOL CHEM, V247, P1849; HABER JE, 1992, TRENDS GENET, V8, P446, DOI 10.1016/0168-9525(92)90329-3; HANSEN JC, 1993, J BIOL CHEM, V268, P5840; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P2129; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; JACKSON V, 1990, BIOCHEMISTRY-US, V29, P719, DOI 10.1021/bi00455a019; KARU AE, 1973, J BIOL CHEM, V248, P4874; KIROV N, 1992, EMBO J, V11, P1941, DOI 10.1002/j.1460-2075.1992.tb05247.x; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; KRUDE T, 1991, MOL CELL BIOL, V11, P6257, DOI 10.1128/MCB.11.12.6257; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; LEBOWITZ JH, 1985, THESIS J HOPKINS U; LORENTZ A, 1992, MOL GEN GENET, V233, P436, DOI 10.1007/BF00265441; MEERSSEMAN G, 1991, J MOL BIOL, V220, P89, DOI 10.1016/0022-2836(91)90383-H; ONEILL TE, 1992, J MOL BIOL, V223, P67, DOI 10.1016/0022-2836(92)90716-W; ONEILL TE, 1993, P NATL ACAD SCI USA, V90, P6203, DOI 10.1073/pnas.90.13.6203; PONTICELLI AS, 1992, P NATL ACAD SCI USA, V89, P227, DOI 10.1073/pnas.89.1.227; RAMDAS J, 1989, J BIOL CHEM, V264, P17395; RAMDAS J, 1991, P NATL ACAD SCI USA, V88, P1344, DOI 10.1073/pnas.88.4.1344; RANDALL SK, 1992, J BIOL CHEM, V267, P14259; ROMAN LJ, 1992, J BIOL CHEM, V267, P4207; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2873, DOI 10.1021/bi00433a019; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2868; RUYECHAN WT, 1976, BIOCHEMISTRY-US, V15, P5047; Sambrook J, 1989, MOL CLONING LABORATO; SHIMAMURA A, 1989, MOL CELL BIOL, V9, P5573, DOI 10.1128/MCB.9.12.5573; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; SMITH GR, 1990, NUCLEIC ACIDS MOL BI, V4, P78; TAKADA S, 1989, BIOCHEM BIOPH RES CO, V160, P711, DOI 10.1016/0006-291X(89)92491-1; TAYLOR A, 1980, CELL, V22, P447, DOI 10.1016/0092-8674(80)90355-4; TAYLOR AF, 1985, J MOL BIOL, V185, P431, DOI 10.1016/0022-2836(85)90414-0; TAYLOR AF, 1988, GENETIC RECOMBINATIO, P231; TELANDERMUSKAVI.KM, 1982, J BIOL CHEM, V257, P2641; VANHOLDE KE, 1992, J BIOL CHEM, V267, P2837; WHITE MA, 1993, P NATL ACAD SCI USA, V90, P6621, DOI 10.1073/pnas.90.14.6621; WOLFFE A, 1992, CHROMATIN STRUCTURE; WRIGHT M, 1971, J BIOL CHEM, V246, P6543	53	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2024	2031		10.1074/jbc.270.5.2024	http://dx.doi.org/10.1074/jbc.270.5.2024			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836428				2022-12-27	WOS:A1995QE49300009
J	GUY, HI; EVANS, DR				GUY, HI; EVANS, DR			SUBSTRUCTURE OF THE AMIDOTRANSFERASE DOMAIN OF MAMMALIAN CARBAMYL-PHOSPHATE SYNTHETASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIFUNCTIONAL PROTEIN CAD; INITIATES PYRIMIDINE BIOSYNTHESIS; GLUTAMINE BINDING-SITE; ESCHERICHIA-COLI; ASPARTATE-TRANSCARBAMYLASE; NUCLEOTIDE-SEQUENCE; DIHYDROOROTASE DOMAIN; HAMSTER CELLS; YEAST GENE; SUBUNIT	The amidotransferase or glutaminase (GLNase) domain of mammalian carbamyl phosphate synthetase (CPSase), part of the 243-kDa CAD polypeptide, consists of a carboxyl half that is homologous to all trpG-type amidotransferases and an amino half unique to the carbamyl phosphate synthetases, The two halves of the mammalian GLNase domain have been cloned separately, expressed in Escherichia coli, and purified, The 21-kDa carboxyl half, the catalytic subdomain, As extraordinarily active, The k(cat) is 347-fold higher and the K-m(Gln) is 40-fold lower than the complete GLNase domain, Unlike the GLNase domain, the catalytic subdomain does not form a stable hybrid complex with the E. coli CPSase synthetase subunit, Nevertheless, titration of the synthetase subunit with the catalytic subdomain partially restores glutamine-dependent CPSase activity, The 19-kDa amino half, the interaction subdomain, binds tightly to the E. coli CPSase large subunit, Thus, the GLNase domain consists of two subdomains which can autonomously fold and function, The catalytic subdomain weakly interacts with the synthetase domain and has all of the residues necessary for catalysis, The interaction subdomain is required for complex formation and also attenuates the intrinsically high activity of the catalytic subdomain and, thus, may be a key element of the interdomain functional linkage.			GUY, HI (corresponding author), WAYNE STATE UNIV, SCH MED, DEPT BIOCHEM, DETROIT, MI 48201 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047399] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM47399] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON PM, 1973, BIOCHEM BIOPH RES CO, V55, P246, DOI 10.1016/S0006-291X(73)80086-5; ANDERSON PM, 1975, BIOCHEMISTRY-US, V14, P3688, DOI 10.1021/bi00687a027; ANDERSON PM, 1966, BIOCHEMISTRY-US, V5, P3157, DOI 10.1021/bi00874a012; BEIN K, 1991, J BIOL CHEM, V266, P3791; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAPARIAN MG, 1991, J BIOL CHEM, V266, P3387; COLEMAN PF, 1977, J BIOL CHEM, V252, P6379; DAVIDSON JN, 1981, J BIOL CHEM, V256, P5220; FAURE M, 1989, EUR J BIOCHEM, V179, P345, DOI 10.1111/j.1432-1033.1989.tb14560.x; FREUND JN, 1987, J MOL BIOL, V193, P1, DOI 10.1016/0022-2836(87)90621-8; GRAYSON DR, 1985, J BIOL CHEM, V260, P5840; GRAYSON DR, 1983, J BIOL CHEM, V258, P4123; GUILLOU F, 1989, P NATL ACAD SCI USA, V86, P8304, DOI 10.1073/pnas.86.21.8304; GUY HI, 1994, J BIOL CHEM, V269, P23808; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; HAWKES R, 1982, ANAL BIOCHEM, V119, P142, DOI 10.1016/0003-2697(82)90677-7; KELLY RE, 1986, J BIOL CHEM, V261, P6073; KELLY RE, 1986, THESIS WAYNE STATE U; KHEDOURI E, 1966, BIOCHEMISTRY-US, V5, P3552, DOI 10.1021/bi00875a024; KILSTRUP M, 1988, EUR J BIOCHEM, V176, P421, DOI 10.1111/j.1432-1033.1988.tb14299.x; KIM HS, 1992, J BIOL CHEM, V267, P7177; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUSTY CJ, 1983, J BIOL CHEM, V258, P4466; MALLY MI, 1980, J BIOL CHEM, V255, P1372; MALLY MI, 1981, P NATL ACAD SCI-BIOL, V78, P6647, DOI 10.1073/pnas.78.11.6647; Maniatis T., 1982, MOL CLONING; MEI B, 1989, J BIOL CHEM, V264, P16613; MEISTER A, 1989, ADV ENZYMOL RAMB, V62, P315; MIRAN SG, 1991, BIOCHEMISTRY-US, V30, P7901, DOI 10.1021/bi00246a005; MORI M, 1975, BIOCHEMISTRY-US, V14, P2622, DOI 10.1021/bi00683a010; NOWLAN SF, 1985, J BIOL CHEM, V260, P4712; PIETTE J, 1988, P NATL ACAD SCI USA, V85, P3401, DOI 10.1073/pnas.85.10.3401; PINKUS LM, 1972, J BIOL CHEM, V247, P6119; RAUSHEL FM, 1978, BIOCHEMISTRY-US, V17, P5587, DOI 10.1021/bi00619a001; RUBINO SD, 1987, J BIOL CHEM, V262, P4382; SCHAUDER B, 1987, GENE, V52, P279, DOI 10.1016/0378-1119(87)90054-0; SHIGESADA K, 1985, MOL CELL BIOL, V5, P1735, DOI 10.1128/MCB.5.7.1735; SHOAF WT, 1973, BIOCHEMISTRY-US, V12, P4039, DOI 10.1021/bi00745a004; SIMMER JP, 1990, J BIOL CHEM, V265, P10395; SIMMER JP, 1990, P NATL ACAD SCI USA, V87, P174, DOI 10.1073/pnas.87.1.174; SIMMER JP, 1989, P NATL ACAD SCI USA, V86, P4382, DOI 10.1073/pnas.86.12.4382; SOUCIET JL, 1987, MOL GEN GENET, V79, P59; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TROTTA PP, 1971, P NATL ACAD SCI USA, V68, P2599, DOI 10.1073/pnas.68.10.2599; WELLNER VP, 1975, J BIOL CHEM, V250, P3261; WENG M, 1987, J BACTERIOL, V169, P3023, DOI 10.1128/jb.169.7.3023-3028.1987; WERNER M, 1985, EUR J BIOCHEM, V146, P371, DOI 10.1111/j.1432-1033.1985.tb08663.x; ZALKIN H, 1980, MULTIFUNCTIONAL PROT, P123	48	14	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2190	2197		10.1074/jbc.270.5.2190	http://dx.doi.org/10.1074/jbc.270.5.2190			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836449	hybrid			2022-12-27	WOS:A1995QE49300034
J	HOROWITZ, PM; HUA, S; GIBBONS, DL				HOROWITZ, PM; HUA, S; GIBBONS, DL			HYDROPHOBIC SURFACES THAT ARE HIDDEN IN CHAPERONIN CPN60 CAN BE EXPOSED BY FORMATION OF ASSEMBLY-COMPETENT MONOMERS OR BY IONIC PERTURBATION OF THE OLIGOMER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; ESCHERICHIA-COLI; CENTRAL CAVITY; GROEL; RHODANESE; POLYPEPTIDE; INTERMEDIATE; PURIFICATION; CARBOXYLASE; BINDS	The oligomeric form (14-mer) of the chaperonin protein, Cpn60 (GroEL) from Eschericia coli, displays restricted hydrophobic surfaces and binds tightly one to two molecules of the fluorescent hydrophobic reporter, 1,1'-bi(4-anilino)naphthalene- 5,5'-disulfonic acid (bisANS). The 14-mer is resistant to proteolysis by chymotrypsin, and none of the three sulfhydryl groups/monomer react with 6-iodoacetamidofluorescein. When monomers of Cpn60 that are folded and competent to participate in protein folding are formed by low concentrations of urea (< 2.5 M), the hydrophobic exposure increases to accommodate approximately 14 molecules of bisANS/14-mer, the binding affinity for bisANS decreases, and 1 sulfhydryl group/monomer reacts with 6-iodoacetamidofluorescein. These monomers display limited proteolysis by chymotrypsin at several points within a hydrophobic sequence centered around residue 250 to produce a relatively stable N-terminal fragment (congruent to 26 kDa) and a partially overlapping C-terminal fragment (congruent to 44 kDa). The exposure of hydrophobic surfaces is facilitated by ATPMg. Ions increase hydrophobic exposure more effectively than urea without dissociation of Cpn(60). For example, subdenaturing concentrations of guanidinium chloride (less than or equal to 0.75 M) or the stabilizing salt, guanidinium sulfate, as well as NaCl or KCl are effective. The trivalent cation, spermidine, induces maximum exposure at 5 mM. The results suggest that hydrophobic surfaces can be involved in stabilizing the oligomer and/or in binding proteins to be folded, and they are consistent with suggestions that amphiphilic structures, presenting hydrophobic surfaces within a charged context, would be particularly effective in binding to Cpn60.			HOROWITZ, PM (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT BIOCHEM,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284, USA.				NIEHS NIH HHS [ES05729] Funding Source: Medline; NIGMS NIH HHS [GM25177] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025177] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BRAIG K, 1993, P NATL ACAD SCI USA, V90, P3978, DOI 10.1073/pnas.90.9.3978; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; CHANDRASEKHAR GN, 1986, J BIOL CHEM, V261, P2414; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; FISHER MT, 1992, BIOCHEMISTRY-US, V31, P3955, DOI 10.1021/bi00131a010; Georgopoulos C, 1990, Semin Cell Biol, V1, P19; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; HAYERHARTL MK, 1990, FEBS LETT, V320, P83; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HENDRIX RW, 1979, J MOL BIOL, V129, P375, DOI 10.1016/0022-2836(79)90502-3; HOROVITZ A, 1993, J MOL BIOL, V231, P58, DOI 10.1006/jmbi.1993.1256; HOROWITZ PM, 1993, J BIOL CHEM, V268, P2500; HUTCHINSON EG, 1989, EMBO J, V8, P1485, DOI 10.1002/j.1460-2075.1989.tb03532.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANDRY SJ, 1991, BIOCHEMISTRY-US, V30, P7359, DOI 10.1021/bi00244a001; LANDRY SJ, 1992, NATURE, V355, P455, DOI 10.1038/355455a0; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MARTIN J, 1993, NATURE, V366, P228, DOI 10.1038/366228a0; MENDOZA JA, 1992, J PROTEIN CHEM, V11, P589, DOI 10.1007/BF01024958; MENDOZA JA, 1991, J BIOL CHEM, V266, P13044; MENDOZA JA, 1994, J BIOL CHEM, V269, P25963; MENDOZA JA, 1994, J BIOL CHEM, V269, P2447; MERRILL GA, 1993, J BIOL CHEM, V268, P15611; OKAZAKI A, 1994, STRUCT BIOL, V1, P439; PRICE NC, 1993, BIOCHIM BIOPHYS ACTA, V1161, P52, DOI 10.1016/0167-4838(93)90195-W; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; ROSEN CG, 1969, BIOCHEMISTRY-US, V8, P3915, DOI 10.1021/bi00838a006; ROSENBERG HF, 1993, J BIOL CHEM, V268, P4499; TURNER DC, 1968, BIOCHEMISTRY-US, V7, P3381, DOI 10.1021/bi00850a011; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003; VIITANEN PV, 1992, PROTEIN SCI, V1, P363; VONHIPPE.PH, 1965, J BIOL CHEM, V240, P3909; ZAHN R, 1994, J MOL BIOL, V242, P150, DOI 10.1006/jmbi.1994.1566; ZAHN R, 1993, J MOL BIOL, V229, P579, DOI 10.1006/jmbi.1993.1062; ZWICKL P, 1990, J STRUCT BIOL, V103, P197, DOI 10.1016/1047-8477(90)90037-D	41	65	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1535	1542		10.1074/jbc.270.4.1535	http://dx.doi.org/10.1074/jbc.270.4.1535			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829481	hybrid			2022-12-27	WOS:A1995QD20400011
J	KRISTINA, S; ROTH, RA				KRISTINA, S; ROTH, RA			CHARACTERIZATION OF THE ENDOGENOUS INSULIN RECEPTOR-RELATED RECEPTOR IN NEUROBLASTOMAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; FACTOR-I RECEPTOR; MONOCLONAL-ANTIBODIES; LIGAND-BINDING; PROTEIN-KINASE; EXPRESSION; CELLS; SPECIFICITY; ACTIVATION; FAMILY	A gene encoding a putative third member of the insulin receptor family (called the insulin receptor-related receptor or IRR) was isolated in 1989. However, the naturally occurring protein product encoded by this gene has yet to be described, In the present studies, we have generated four monoclonal antibodies to a recombinantly expressed chimera, which contains the extracellular domain of human IRR. These antibodies were found to specifically recognize the chimeric IRR (and not the insulin or insulin-like growth factor I receptors), and two of the antibodies were capable of acting as partial agonists in the cells expressing the chimeric IRR. These antibodies have therefore been utilized to study the expression and properties of the native receptor, In contrast to the two other members of this receptor family, the endogenous IRR protein had only a very limited expression, being detected only in neuroblastomas. In primary neuroblastomas, the levels of the receptor were highest in samples from stage A tumors (those which are generally more highly differentiated and have higher levels of the nerve growth factor receptor), The endogenous IRR could also be detected in a neuroblastoma cell line (called IMR-5 cells), In these cells, IRR could be shown to be partly present as a hybrid with the insulin and insulin-like growth factor-I receptors but not with the receptor for nerve growth factor, The intrinsic tyrosine kinase activity of this endogenous IRR was activated by the agonist monoclonal antibody to IRR but not by nerve growth factor, insulin-like growth factor I, or insulin, Finally, this monoclonal antibody was found to stimulate mitogen-activated protein kinase activity in these cells, In summary, these studies demonstrate for the first time that the IRR protein is normally expressed, that its levels are highest in neuronal tissues, and that it can form hybrid receptors with the two other members of this receptor family but not with the more distantly related nerve growth factor receptor.	STANFORD UNIV,SCH MED,DEPT MOLEC PHARMACOL,STANFORD,CA 94305	Stanford University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045652] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 45652] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHEN RH, 1990, MOL CELL BIOL, V10, P3204, DOI 10.1128/MCB.10.6.3204; DESTGROTH SF, 1980, J IMMUNOL METHODS, V35, P1, DOI 10.1016/0022-1759(80)90146-5; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; HAGINO H, 1994, DIABETES, V43, P274, DOI 10.2337/diabetes.43.2.274; ITOH N, 1993, J BIOL CHEM, V268, P17983; JUI HY, 1994, J BIOL CHEM, V269, P22446; KURACHI H, 1992, BIOCHEM BIOPH RES CO, V187, P934, DOI 10.1016/0006-291X(92)91287-Z; MIYASAKA T, 1990, J BIOL CHEM, V265, P4730; MORGAN DO, 1987, BIOCHEMISTRY-US, V26, P2959, DOI 10.1021/bi00385a001; MORGAN DO, 1985, ENDOCRINOLOGY, V116, P1224, DOI 10.1210/endo-116-3-1224; MORGAN DO, 1986, P NATL ACAD SCI USA, V83, P328, DOI 10.1073/pnas.83.2.328; MOXHAM CP, 1992, J CELL BIOCHEM, V48, P136, DOI 10.1002/jcb.240480205; NAKAGAWARA A, 1993, NEW ENGL J MED, V328, P847, DOI 10.1056/NEJM199303253281205; REINHARDT RR, 1994, J NEUROSCI, V14, P4674; REINHARDT RR, 1993, ENDOCRINOLOGY, V133, P3, DOI 10.1210/en.133.1.3; ROTH RA, 1985, HDB RECEPTOR RES INS, P46; SETA KA, 1993, ADV EXP MED BIOL, V343, P113; SHIER P, 1992, MOL ENDOCRINOL, V6, P723, DOI 10.1210/me.6.5.723; SHIER P, 1989, J BIOL CHEM, V264, P14605; SHOELSON SE, 1992, P NATL ACAD SCI USA, V89, P2027, DOI 10.1073/pnas.89.6.2027; SIDDLE K, 1994, HORM RES, V41, P56, DOI 10.1159/000183962; SOOS MA, 1992, J BIOL CHEM, V267, P12955; STEELEPERKINS G, 1988, J BIOL CHEM, V263, P11486; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; ZHANG B, 1991, P NATL ACAD SCI USA, V88, P9858, DOI 10.1073/pnas.88.21.9858; ZHANG B, 1991, BIOCHEMISTRY-US, V30, P5113, DOI 10.1021/bi00235a001; ZHANG B, 1992, J BIOL CHEM, V267, P18320	27	20	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1881	1887		10.1074/jbc.270.4.1881	http://dx.doi.org/10.1074/jbc.270.4.1881			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829525	hybrid			2022-12-27	WOS:A1995QD20400060
J	PILLAY, TS; SASAOKA, T; OLEFSKY, JM				PILLAY, TS; SASAOKA, T; OLEFSKY, JM			INSULIN STIMULATES THE TYROSINE DEPHOSPHORYLATION OF PP125 FOCAL ADHESION KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SWISS 3T3 CELLS; COOH-TERMINAL TRUNCATION; PHOSPHORYLATION; RECEPTOR; BOMBESIN; AUTOPHOSPHORYLATION; IDENTIFICATION; VASOPRESSIN; ACTIVATION	The phosphorylation state of pp125 focal adhesion kinase in response to insulin was examined in parental and transfected Rat-1 fibroblasts expressing both wildtype (HIRc cells) and mutant human insulin receptor cDNAs lacking the C-terminal twin tyrosine phosphorylation sites (YFB cells) or a deletion mutant lacking the distal 43 amino acids of the beta-subunit (Delta CT cells). In HIRc cells insulin stimulated the tyrosine dephosphorylation of pp125(fak), whereas IGF-I did not, In contrast, the tyrosine phosphorylation state of pp125(fak) was unchanged in the parental Rat-1 fibroblasts and the YF2 or Delta CT mutant cell lines in response to insulin. Analysis of the supernatants revealed that pp125(fak) was only one component of the major M(r) 120-130-kDa phosphotyrosine band seen in HIRc cells. We conclude that: 1) in contrast to other growth factors, insulin stimulates the dephosphorylation of pp125(fak); 2) the presence of the insulin receptor C-terminal tyrosines 1328 and 1334 is required for the insulin-stimulated tyrosine dephosphorylation of pp125(fak), suggesting a possible SH2 domain-dependent interaction; 3) insulin may modulate integrin-mediated signaling through pp125(fak) by altering the phosphorylation state of pp125(fak).	UNIV CALIF SAN DIEGO,DEPT MED,DIV ENDOCRINOL & METAB,LA JOLLA,CA 92093; VET ADM MED CTR,RES SERV,SAN DIEGO,CA 92161	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)				pillay, tahir/0000-0002-9982-9710	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033651, R37DK033651] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK33651] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; COGHLAN MP, 1994, BIOCHEM J, V303, P893, DOI 10.1042/bj3030893; DEVOR BB, 1993, BIOCHEM BIOPH RES CO, V190, P1084, DOI 10.1006/bbrc.1993.1160; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; FENG GS, 1994, TRENDS GENET, V10, P54, DOI 10.1016/0168-9525(94)90149-X; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; HAMAWY MM, 1993, J BIOL CHEM, V268, P6851; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993; HORDIJK PL, 1994, J BIOL CHEM, V269, P645; KANNER SB, 1990, P NATL ACAD SCI USA, V87, P3328, DOI 10.1073/pnas.87.9.3328; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; KUMAGAI N, 1993, FEBS LETT, V329, P273, DOI 10.1016/0014-5793(93)80236-N; LEWIS RE, 1994, J BIOL CHEM, V269, P26259; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; MAEGAWA H, 1988, J BIOL CHEM, V263, P8912; MCCLAIN DA, 1988, J BIOL CHEM, V263, P8904; MILARSKI KL, 1994, J BIOL CHEM, V269, P21239; MOLLER NPH, 1994, P NATL ACAD SCI USA, V91, P7477, DOI 10.1073/pnas.91.16.7477; MYERS MG, 1994, TRENDS BIOCHEM SCI, V19, P289, DOI 10.1016/0968-0004(94)90007-8; PILLAY TS, 1992, FEBS LETT, V308, P38, DOI 10.1016/0014-5793(92)81045-N; POLANOWSKAGRABO.R, 1993, BIOCHEM J, V296, P543; RANKIN S, 1994, J BIOL CHEM, V269, P704; SABVILLE MK, 1994, BIOCHEM J, V301, P407; SASAOKA T, 1994, J BIOL CHEM, V269, P13689; SCHALLER MD, 1993, MOL CELL BIOL, V13, P785, DOI 10.1128/MCB.13.2.785; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; SEUFFERLEIN T, 1994, J BIOL CHEM, V269, P9345; SINNETTSMITH J, 1993, J BIOL CHEM, V268, P14261; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; STAUBS PA, 1994, J BIOL CHEM, V269, P27186; TAKATA Y, 1992, J BIOL CHEM, V267, P9065; UGI S, 1994, FEBS LETT, V340, P216, DOI 10.1016/0014-5793(94)80141-X; WHITE MF, 1994, CURR OPIN GENET DEV, V4, P47, DOI 10.1016/0959-437X(94)90090-6; XIAO S, 1994, J BIOL CHEM, V269, P21244; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; ZACHARY I, 1992, CELL, V71, P891, DOI 10.1016/0092-8674(92)90385-P; ZACHARY I, 1993, J BIOL CHEM, V268, P22060; ZACHARY I, 1992, J BIOL CHEM, V267, P19031	40	64	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					991	994		10.1074/jbc.270.3.991	http://dx.doi.org/10.1074/jbc.270.3.991			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836419	hybrid			2022-12-27	WOS:A1995QB15600002
J	POWERS, T; NOLLER, HF				POWERS, T; NOLLER, HF			A TEMPERATURE-DEPENDENT CONFORMATIONAL REARRANGEMENT IN THE RIBOSOMAL-PROTEIN S4-CENTER-DOT-16-S RIBOSOMAL-RNA COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PRIMER EXTENSION; BINDING-SITES; RNA; SUBUNITS; DNA; ACID	Ribosomal protein S4 protects a characteristic set of bases in 16 S rRNA from attack by chemical probes. Use of hydroxyl radical as a probe of the RNA backbone shows that ribose residues in these same regions are also protected by S4, confirming the localization of its interactions with 16 S rRNA to the junction of five helical elements in the proximal region of the 5' domain. At 0 degrees C, the nucleotides protected by S4 from base-specific probes are confined almost exclusively to the two compound helices formed by residues 404-499. After subsequent heating of the complex briefly at 30 or 42 degrees C, nucleotides in the three adjacent helices are additionally protected, resulting in a pattern of protection that is identical to that which is observed when 54 is incubated with 16 S rRNA under in vitro reconstitution conditions. Preincubation of the protein or the RNA (or both) separately at elevated temperature does not substitute for heating the S4.RNA complex. The regions in the RNA affected by the heat step are known to interact with proteins S12 and S16, both of which depend upon 54 for their binding to the RNA. Thus, the finding that 54 recruits additional sites of interaction in the RNA following its initial binding suggests a possible mechanism to insure the sequential addition of proteins during ribosomal assembly.	UNIV CALIF SANTA CRUZ, SINSHEIMER LABS, SANTA CRUZ, CA 95064 USA	University of California System; University of California Santa Cruz					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM017129, R01GM017129] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM17129] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BURKHOFF AM, 1987, CELL, V48, P935, DOI 10.1016/0092-8674(87)90702-1; CELANDER DW, 1990, BIOCHEMISTRY-US, V29, P1355, DOI 10.1021/bi00458a001; EHRESMANN C, 1977, FEBS LETT, V81, P188, DOI 10.1016/0014-5793(77)80956-3; GARRETT RA, 1977, CELL BIOL INT REP, V1, P487, DOI 10.1016/0309-1651(77)90086-8; GARRETT RA, 1984, GENE EXPRESSION, P331; GREUER B, 1987, NUCLEIC ACIDS RES, V15, P3241, DOI 10.1093/nar/15.8.3241; HELD WA, 1974, J BIOL CHEM, V249, P3103; LATHAM JA, 1989, SCIENCE, V245, P276, DOI 10.1126/science.2501870; MOAZED D, 1986, J MOL BIOL, V187, P399, DOI 10.1016/0022-2836(86)90441-9; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; SAPAG A, 1990, BIOCHIM BIOPHYS ACTA, V1050, P34, DOI 10.1016/0167-4781(90)90137-Q; SCHAUP HW, 1971, MOL GEN GENET, V112, P1, DOI 10.1007/BF00266926; SCHULTE C, 1974, BIOCHEMISTRY-US, V13, P1032, DOI 10.1021/bi00702a031; STERN S, 1988, METHOD ENZYMOL, V164, P481; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; STERN S, 1986, J MOL BIOL, V192, P101, DOI 10.1016/0022-2836(86)90467-5; STERN S, 1988, J MOL BIOL, V200, P291, DOI 10.1016/0022-2836(88)90241-0; TULLIUS TD, 1986, P NATL ACAD SCI USA, V83, P5469, DOI 10.1073/pnas.83.15.5469; UNGEWICKELL E, 1975, EUR J BIOCHEM, V51, P165, DOI 10.1111/j.1432-1033.1975.tb03917.x; VARTIKAR JV, 1989, J MOL BIOL, V209, P221, DOI 10.1016/0022-2836(89)90274-X; WEITZMANN CJ, 1993, FASEB J, V7, P177, DOI 10.1096/fasebj.7.1.7916699; Zimmermann R. A., 1980, RIBOSOMES STRUCTURE, P135; ZIMMERMANN RA, 1972, P NATL ACAD SCI USA, V69, P1282, DOI 10.1073/pnas.69.5.1282	23	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1238	1242		10.1074/jbc.270.3.1238	http://dx.doi.org/10.1074/jbc.270.3.1238			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836385	hybrid			2022-12-27	WOS:A1995QB15600040
J	YOUNG, TN; PIZZO, SV; STACK, MS				YOUNG, TN; PIZZO, SV; STACK, MS			A PLASMA MEMBRANE-ASSOCIATED COMPONENT OF OVARIAN ADENOCARCINOMA CELLS ENHANCES THE CATALYTIC EFFICIENCY OF MATRIX METALLOPROTEINASE-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							HUMAN CANCER-CELLS; IV COLLAGENASE; PLASMINOGEN ACTIVATORS; PRO-UROKINASE; BINDING-SITE; IDENTIFICATION; GELATINASE; COMPLEX	Several recent investigations have demonstrated that matrix metalloproteinase-2 (MMP-2) binds to the cell surface and undergoes zymogen activation via a plasma membrane associated activity, The purpose of this study was to determine if association of MMP-2 with the plasma membrane also modulates the catalytic efficiency of the active enzyme. Using density gradient centrifugation, we isolated the plasma membrane fractions of two ovarian adenocarcinoma cell lines, DOV 13 and OVCA 432, previously described either to express MMP-2 or to express no gelatinolytic: metalloproteinases, respectively, While DOV 13 cells contained plasma membrane-associated MMP-2 and OVCA 432 did not, both cell types were able to bind exogenous MMP-2. Furthermore, plasma membrane fractions from these cells significantly enhanced the rate of cleavage of [C-14]gelatin I substrate by both MMP-2 tissue inhibitor of metalloproteinases-2 (TIMP-2) complex (2.5-8-fold) and TIMP-2-free MMP-2 (5.9-fold), This stimulatory activity was dose-dependent, soluble in Triton X-100, and abolished by trypsin treatment of the membranes, but was stable to heat treatment, Plasma membrane stimulation of MMP-2 resulted in a 3.8-4.6-fold increase in the catalytic efficiency of gelatinolysis. These data suggest that, in addition to promoting zymogen activation, cell surface binding of MMP-2 may regulate enzyme activity by increasing the rate of substrate cleavage. Via this mechanism, tumor cell types that do not express MMPs (such as OVCA 432) nevertheless may be able to utilize exogenous MMP-2 to mediate proteolysis associated with invasion and metastasis.	NORTHWESTERN UNIV,SCH MED,DEPT OBSTET & GYNECOL,CHICAGO,IL 60611; DUKE UNIV,MED CTR,DEPT PATHOL,DURHAM,NC 27710	Northwestern University; Duke University					NATIONAL CANCER INSTITUTE [R55CA058900, R01CA058900] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043339, R01HL031932] Funding Source: NIH RePORTER; NCI NIH HHS [CA-58900] Funding Source: Medline; NHLBI NIH HHS [HL-43339, HL-31932] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aronson N N Jr, 1974, Methods Enzymol, V31, P90; BROWN PD, 1993, KIDNEY INT, V43, P163, DOI 10.1038/ki.1993.27; CAWSTON TE, 1979, ANAL BIOCHEM, V99, P340, DOI 10.1016/S0003-2697(79)80017-2; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; EMONARD HP, 1992, CANCER RES, V52, P5845; HARRIS ED, 1972, BIOCHIM BIOPHYS ACTA, V258, P566, DOI 10.1016/0005-2744(72)90249-5; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; Liotta L A, 1990, Semin Cancer Biol, V1, P99; LIOTTA LA, 1986, ANNU REV BIOCHEM, V55, P1037, DOI 10.1146/annurev.biochem.55.1.1037; MILES LA, 1987, THROMB HAEMOSTASIS, V58, P936; MOLL UM, 1990, CANCER RES, V50, P6995; MOSER TL, 1994, INT J CANCER, V56, P552, DOI 10.1002/ijc.2910560415; MURPHY G, 1992, BIOCHEM J, V283, P637, DOI 10.1042/bj2830637; NIELSEN LS, 1988, J BIOL CHEM, V263, P2358; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; STEPHENS RW, 1989, J CELL BIOL, V108, P1987, DOI 10.1083/jcb.108.5.1987; STETLERSTEVENSO.WG, 1989, J BIOL CHEM, V264, P1353; STOPPELLI MP, 1986, CELL, V45, P675, DOI 10.1016/0092-8674(86)90782-8; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; TRYGGVASON K, 1993, BREAST CANCER RES TR, V24, P209, DOI 10.1007/BF01833261; VASSALLI JD, 1985, J CELL BIOL, V100, P86, DOI 10.1083/jcb.100.1.86; WARD RV, 1991, BIOCHIM BIOPHYS ACTA, V1079, P242, DOI 10.1016/0167-4838(91)90132-J; YOUNG TN, 1994, AM J OBSTET GYNECOL, V170, P1285; ZUCKER S, 1990, INT J CANCER, V45, P1137, DOI 10.1002/ijc.2910450625; ZUCKER S, 1987, CANCER RES, V47, P1608	25	40	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					999	1002		10.1074/jbc.270.3.999	http://dx.doi.org/10.1074/jbc.270.3.999			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836420	hybrid			2022-12-27	WOS:A1995QB15600004
J	SHIPTON, CA; PARMRYD, I; SWIEZEWSKA, E; ANDERSSON, B; DALLNER, G				SHIPTON, CA; PARMRYD, I; SWIEZEWSKA, E; ANDERSSON, B; DALLNER, G			ISOPRENYLATION OF PLANT-PROTEINS IN-VIVO - ISOPRENYLATED PROTEINS ARE ABUNDANT IN THE MITOCHONDRIA AND NUCLEI OF SPINACH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; GUANINE-NUCLEOTIDE-BINDING; GAMMA SUBUNITS CONTAIN; RAT-LIVER; PRENYLATED PROTEINS; ISOPRENOID BIOSYNTHESIS; CIS-PRENYLTRANSFERASE; MEMBRANE ASSOCIATION; CARBOXYL METHYLATION; DOLICHYL PHOSPHATE	Protein isoprenylation in vivo is demonstrated using spinach seedlings labeled with [H-3]mevalonate, This report provides evidence for the occurrence of a large number of isoprenylated proteins in plants. Seedlings, without roots, were labeled quantitatively through the cut stem. Mevinolin treatment of the seedlings resulted in increased incorporation of radiolabel into proteins. Approximately 30 labeled bands could be detected after autoradiography of SDS-polyacrylamide gel electrophoresis-separated polypeptides, ranging in molecular mass from 6 to 200 kDa, Methyl iodide hydrolysis resulted in the release of covalently bound farnesol, geranylgeraniol, phytol, and some unidentified isoprenoid compounds from mevalonate-labeled proteins, It was found that all cellular fractions contained some isoprenylated proteins, although most were located in the mitochondria and nuclei. Subfractionation of the nucleus revealed that the majority of isoprenylated proteins in this compartment were components of the nuclear matrix. The results demonstrate that in vivo labeling of a complex organism can be performed using a plant system in order to study protein isoprenylation and distribution of modified proteins in different cellular compartments.	UNIV STOCKHOLM, ARRHENIUS LABS NAT SCI, DEPT BIOCHEM, S-10691 STOCKHOLM, SWEDEN; POLISH ACAD SCI, INST BIOCHEM & BIOPHYS, PL-02532 WARSAW, POLAND; KAROLINSKA INST, NOVUM, CLIN RES CTR, S-14186 HUDDINGE, SWEDEN	Stockholm University; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Karolinska Institutet			Andersson, Bertil/C-9328-2009	Parmryd, Ingela/0000-0003-4834-3611; Swiezewska, Ewa/0000-0002-3439-8948				ALBERTS AW, 1980, P NATL ACAD SCI-BIOL, V77, P3957, DOI 10.1073/pnas.77.7.3957; ANANT JS, 1992, J BIOL CHEM, V267, P687; BECK LA, 1990, J CELL BIOL, V110, P1489, DOI 10.1083/jcb.110.5.1489; BLUMBERG H, 1991, NATURE, V349, P627, DOI 10.1038/349627a0; BRUENGER E, 1986, BIOCHEM BIOPH RES CO, V139, P209, DOI 10.1016/S0006-291X(86)80100-0; BUSS JE, 1991, MOL CELL BIOL, V11, P1523, DOI 10.1128/MCB.11.3.1523; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; CHIN DJ, 1982, P NATL ACAD SCI-BIOL, V79, P1185, DOI 10.1073/pnas.79.4.1185; DROBAK BK, 1988, BIOCHEM BIOPH RES CO, V150, P899, DOI 10.1016/0006-291X(88)90713-9; EPSTEIN WW, 1991, P NATL ACAD SCI USA, V88, P9668, DOI 10.1073/pnas.88.21.9668; EPSTEIN WW, 1990, P NATL ACAD SCI USA, V87, P7352, DOI 10.1073/pnas.87.19.7352; ERICSSON J, 1992, J BIOL CHEM, V267, P18708; ERICSSON J, 1992, J BIOL CHEM, V267, P19730; ERICSSON J, 1993, J BIOL CHEM, V268, P832; FARNSWORTH CC, 1990, SCIENCE, V247, P320, DOI 10.1126/science.2296721; FAUST JR, 1991, J BIOL CHEM, V266, P9961; GIANNAKOUROS T, 1992, FEBS LETT, V297, P103, DOI 10.1016/0014-5793(92)80337-G; GLASER E, 1995, IN PRESS METHODS CEL, V64; GRAY JC, 1987, ADV BOT RES, V14, P25; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; JACOBS M, 1988, BIOCHEM BIOPH RES CO, V155, P1478, DOI 10.1016/S0006-291X(88)81308-1; KAWATA M, 1990, P NATL ACAD SCI USA, V87, P8960, DOI 10.1073/pnas.87.22.8960; KELLER RK, 1986, J BIOL CHEM, V261, P2053; KINSELLA BT, 1991, J BIOL CHEM, V266, P9786; KITTEN GT, 1991, J CELL BIOL, V113, P13, DOI 10.1083/jcb.113.1.13; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI RK, 1990, P NATL ACAD SCI USA, V87, P7673, DOI 10.1073/pnas.87.19.7673; LI AC, 1988, J LIPID RES, V29, P781; LONG BH, 1979, CELL, V18, P1079, DOI 10.1016/0092-8674(79)90221-6; MALTESE WA, 1987, J CELL PHYSIOL, V133, P471, DOI 10.1002/jcp.1041330307; MARDER JB, 1986, METHOD ENZYMOL, V118, P384; MATSUI M, 1989, GENE, V76, P313, DOI 10.1016/0378-1119(89)90171-6; MOORES SL, 1991, J BIOL CHEM, V266, P14603; MORRE DJ, 1991, PROTOPLASMA, V160, P49, DOI 10.1007/BF01539956; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P5873, DOI 10.1073/pnas.87.15.5873; OVCHINNIKOV YA, 1985, FEBS LETT, V179, P107, DOI 10.1016/0014-5793(85)80201-5; PALME K, 1992, P NATL ACAD SCI USA, V89, P787, DOI 10.1073/pnas.89.2.787; RANDALL SK, 1993, PLANT CELL, V5, P433, DOI 10.1105/tpc.5.4.433; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; REPKO EM, 1989, J BIOL CHEM, V264, P9945; RILLING HC, 1990, SCIENCE, V247, P318, DOI 10.1126/science.2296720; RUNQUIST M, 1994, J BIOL CHEM, V269, P5804; SCHAFER WR, 1992, ANNU REV GENET, V26, P209, DOI 10.1146/annurev.ge.26.120192.001233; SCHAFER WR, 1989, SCIENCE, V245, P379, DOI 10.1126/science.2569235; SEABRA MC, 1992, CELL, V70, P1049, DOI 10.1016/0092-8674(92)90253-9; SEPPLORENZINO L, 1989, FEBS LETT, V245, P110, DOI 10.1016/0014-5793(89)80202-9; SWIEZEWSKA E, 1993, BIOCHEM BIOPH RES CO, V192, P161, DOI 10.1006/bbrc.1993.1395; TERRYN N, 1992, FEBS LETT, V299, P287, DOI 10.1016/0014-5793(92)80133-2; THELIN A, 1991, EUR J BIOCHEM, V195, P755, DOI 10.1111/j.1432-1033.1991.tb15763.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WOLDA SL, 1988, J BIOL CHEM, V263, P5997; YAMANE HK, 1990, P NATL ACAD SCI USA, V87, P5868, DOI 10.1073/pnas.87.15.5868; YAMANE HK, 1991, P NATL ACAD SCI USA, V88, P286, DOI 10.1073/pnas.88.1.286; YANG ZB, 1993, PLANT PHYSIOL, V101, P667, DOI 10.1104/pp.101.2.667; YANG ZB, 1993, P NATL ACAD SCI USA, V90, P8732, DOI 10.1073/pnas.90.18.8732; ZHU JK, 1993, P NATL ACAD SCI USA, V90, P8557, DOI 10.1073/pnas.90.18.8557	57	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					566	572		10.1074/jbc.270.2.566	http://dx.doi.org/10.1074/jbc.270.2.566			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822281	hybrid			2022-12-27	WOS:A1995QB81600013
J	SCHRODER, WP; ARELLANO, JB; BITTNER, T; BARON, M; ECKERT, HJ; RENGER, G				SCHRODER, WP; ARELLANO, JB; BITTNER, T; BARON, M; ECKERT, HJ; RENGER, G			FLASH-INDUCED ABSORPTION-SPECTROSCOPY STUDIES OF COPPER INTERACTION WITH PHOTOSYSTEM-II IN HIGHER-PLANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC ELECTRON-TRANSPORT; CU(II)-INHIBITORY BINDING-SITE; ABSORBANCE DIFFERENCE SPECTRA; MEMBRANE-FRAGMENTS; SPINACH-CHLOROPLASTS; REDUCTION KINETICS; THYLAKOID MEMBRANES; OXYGEN EVOLUTION; NANOSECOND RANGE; REACTION CENTERS	Measurements of flash-induced absorption changes at 325, 436, and 830 nm and of oxygen evolution were performed in order to analyze in detail the inhibition of photosystem II (PS II) by Cu(II) in PS II membrane fragments from spinach. (a) The kinetics of P680(+) reduction become markedly slower in the presence of 100 mu M CuSO4. (b) The CuSO4-induced kinetics of P680(+) reduction are dominated by a 140-160-mu s decay, (c) The extent of these 140-160-mu s kinetics, normalized to the overall decay, remains virtually unaffected by addition of the exogenous PS II donor, NH2OH. (d) In thoroughly dark-adapted samples the CuSO4-induced 140-160-mu s kinetics are already observed after the first flash and remain unchanged by a train of excitation flashes. (e) The extent of P680(+) and Q(A)(-) formation under repetitive flash excitation is not diminished by addition of 100 mu M CuSO4. (f) The induction of mu s kinetics of P680(+) reduction at the expense of ns kinetics and the inhibition of the saturation rate of oxygen evolution exhibit the same dependence on CuSO4 concentration, (g) CuSO4 also transforms the 10-20-mu s reduction of P680(+) by Tyr(Z) in Tris-washed PS II membrane fragments into 140-160-mu s kinetics without any effect on the extent of flash-induced P680(+) formation. These results unambiguously show that Cu(II) does not affect the charge separation (P680(+)Q(A)(-)), but instead specifically modifies Tyr(Z) and/or its micro environment so that the electron transfer to P680(+) becomes blocked.	CSIC, DEPT PLANT BIOCHEM, ESTAC EXPTL ZAIDIN, E-18008 GRANADA, SPAIN; TECH UNIV BERLIN, MAX VOLMER INST, D-10623 BERLIN, GERMANY	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Technical University of Berlin	SCHRODER, WP (corresponding author), UNIV STOCKHOLM, ARRHENIUS LABS NAT SCI, DEPT BIOCHEM, S-10691 STOCKHOLM, SWEDEN.		Arellano, Juan B./D-7174-2013; Schröder, Wolfgang/A-8799-2008; Barón, Matilde/G-6940-2015	Arellano, Juan B./0000-0001-8677-8697; Barón, Matilde/0000-0002-8184-6045; Schroder, Wolfgang/0000-0001-9831-1533				ARELLANO JB, 1994, PHYSIOL PLANTARUM, V91, P369, DOI 10.1111/j.1399-3054.1994.tb02962.x; AYALA MB, 1992, PHYSIOL PLANTARUM, V84, P1, DOI 10.1034/j.1399-3054.1992.840101.x; BASZYNSKI T, 1988, J PLANT PHYSIOL, V132, P708, DOI 10.1016/S0176-1617(88)80233-5; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; BOHNER H, 1980, BIOCHIM BIOPHYS ACTA, V592, P103, DOI 10.1016/0005-2728(80)90117-6; BRETTEL K, 1983, PHOTOBIOCH PHOTOBIOP, V6, P253; CEDENOMALDONADO A, 1972, PLANT PHYSIOL, V50, P698, DOI 10.1104/pp.50.6.698; CHENIAE GM, 1971, PLANT PHYSIOL, V47, P568, DOI 10.1104/pp.47.4.568; CONJEAUD H, 1980, BIOCHIM BIOPHYS ACTA, V590, P353, DOI 10.1016/0005-2728(80)90206-6; DEKKER JP, 1984, BIOCHIM BIOPHYS ACTA, V767, P1, DOI 10.1016/0005-2728(84)90073-2; DORING G, 1969, Z NATURFORSCH PT B, VB 24, P1139, DOI 10.1515/znb-1969-0911; DROPPA M, 1984, P NATL ACAD SCI-BIOL, V81, P2369, DOI 10.1073/pnas.81.8.2369; DROPPA M, 1990, CRIT REV PLANT SCI, V9, P111, DOI 10.1080/07352689009382284; ECKERT HJ, 1991, PHOTOSYNTH RES, V27, P97, DOI 10.1007/BF00033249; ECKERT HJ, 1984, FEBS LETT, V167, P316, DOI 10.1016/0014-5793(84)80149-0; ECKERT HJ, 1988, FEBS LETT, V236, P425, DOI 10.1016/0014-5793(88)80070-X; ECKERT HJ, 1992, PHOTOSYNTHETICA, V27, P355; FORD RC, 1985, BIOCHIM BIOPHYS ACTA, V807, P1, DOI 10.1016/0005-2728(85)90047-7; GERKEN S, 1989, BIOCHIM BIOPHYS ACTA, V977, P52, DOI 10.1016/S0005-2728(89)80008-8; GLASER M, 1976, Z NATURFORSCH C, V31, P712, DOI 10.1515/znc-1976-11-1216; Greenfield SS, 1942, AM J BOT, V29, P121, DOI 10.2307/2437439; HAAG E, 1990, EUR J BIOCHEM, V189, P47, DOI 10.1111/j.1432-1033.1990.tb15458.x; HAVEMAN J, 1976, BIOCHIM BIOPHYS ACTA, V440, P346, DOI 10.1016/0005-2728(76)90069-4; HOGANSON CW, 1991, BIOCHIM BIOPHYS ACTA, V1057, P399, DOI 10.1016/S0005-2728(05)80154-9; HSU BD, 1988, PLANT PHYSIOL, V87, P116, DOI 10.1104/pp.87.1.116; LAVERGNE J, 1991, BIOCHIM BIOPHYS ACTA, V1060, P175, DOI 10.1016/S0005-2728(09)91005-2; LIU B, 1993, BIOCHIM BIOPHYS ACTA, V1142, P129, DOI 10.1016/0005-2728(93)90094-V; LJUNGBERG U, 1984, FEBS LETT, V175, P255, DOI 10.1016/0014-5793(84)80746-2; MACDOWALL FDH, 1949, PLANT PHYSIOL, V24, P462, DOI 10.1104/pp.24.3.462; MATHIS P, 1981, ISRAEL J CHEM, V21, P316; MOHANTY N, 1989, PLANT PHYSIOL, V90, P175, DOI 10.1104/pp.90.1.175; RENGANATHAN M, 1989, BIOCHIM BIOPHYS ACTA, V974, P247, DOI 10.1016/S0005-2728(89)80240-3; RENGANATHAN M, 1990, PHOTOSYNTH RES, V23, P95, DOI 10.1007/BF00030068; RENGER G, 1976, BIOCHIM BIOPHYS ACTA, V423, P610, DOI 10.1016/0005-2728(76)90214-0; Renger G., 1991, Impact of global climatic changes on photosynthesis and plant productivity. Proceedings of the Indo-US workshop held on 8-12 January 1991 at New Delhi, India., P39; RENGER G, 1992, FEBS LETT, V299, P28, DOI 10.1016/0014-5793(92)80092-U; RENGER G, 1982, FEBS LETT, V137, P217, DOI 10.1016/0014-5793(82)80353-0; RENGER G, 1982, FEBS LETT, V149, P203, DOI 10.1016/0014-5793(82)81101-0; RENGER G, 1993, Z NATURFORSCH C, V48, P234; RENGER G, 1983, OXYGEN EVOLVING SYST, P73; SAMUELSSON G, 1980, PLANT CELL PHYSIOL, V21, P445; Sandmann G., 1983, Inorganic plant nutrition, P563; SCHANSKER G, 1993, PHOTOSYNTH RES, V37, P165, DOI 10.1007/BF02187475; SCHATZ GH, 1985, BIOCHIM BIOPHYS ACTA, V810, P283, DOI 10.1016/0005-2728(85)90212-9; SHIOI Y, 1978, PHYSIOL PLANTARUM, V44, P434, DOI 10.1111/j.1399-3054.1978.tb01651.x; SHIOI Y, 1978, PLANT CELL PHYSIOL, V19, P203; SINGH DP, 1987, PLANT PHYSIOL, V83, P12, DOI 10.1104/pp.83.1.12; STEEMANNNIELSEN E, 1969, PHYSIOL PLANTARUM, V22, P1121; VANBEST JA, 1978, BIOCHIM BIOPHYS ACTA, V503, P178, DOI 10.1016/0005-2728(78)90170-6; VANLEEUWEN PJ, 1993, PHOTOSYNTH RES, V38, P323, DOI 10.1007/BF00046757; VELTHUYS BR, 1988, BIOCHIM BIOPHYS ACTA, V933, P249, DOI 10.1016/0005-2728(88)90032-1; VIERKE G, 1977, Z NATURFORSCH C, V32, P605; VOLKER M, 1987, BIOCHIM BIOPHYS ACTA, V890, P66, DOI 10.1016/0005-2728(87)90069-7; WEISS W, 1986, BIOCHIM BIOPHYS ACTA, V850, P173, DOI 10.1016/0005-2728(86)90172-6; YRUELA I, 1992, PHOTOSYNTH RES, V33, P227, DOI 10.1007/BF00030033; YRUELA I, 1991, J BIOL CHEM, V266, P22847; YRUELA I, 1993, J BIOL CHEM, V268, P1684	57	49	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					32865	32870						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806512				2022-12-27	WOS:A1994QA63800025
J	GUBITOSIKLUG, RA; YU, SP; CHOI, DW; GROSS, RW				GUBITOSIKLUG, RA; YU, SP; CHOI, DW; GROSS, RW			CONCOMITANT ACCELERATION OF THE ACTIVATION AND INACTIVATION KINETICS OF THE HUMAN DELAYED RECTIFIER K+ CHANNEL (KV1.1) BY CA2+-INDEPENDENT PHOSPHOLIPASE A(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CALCIUM-INDEPENDENT PHOSPHOLIPASE-A2; ARACHIDONIC-ACID METABOLITES; ION CHANNELS; POTASSIUM CHANNELS; FATTY-ACIDS; CELLS; IDENTIFICATION; PLASMALOGEN; GLYCEROPHOSPHOLIPIDS; CHROMATOGRAPHY	The electrophysiologic sequelae of arachidonic acid re lease mediated by the major phospholipase A(2)(PLA(2)) in electrically active tissues (i.e. the 40-kDa Ca2+-independent PLA(2)) were assessed in Sf9 cells expressing the human recombinant delayed rectifier K+ channel Kv1.1. Intracellular administration of Ca2+-independent PLA(2) increased the rate of activation of the macroscopic current (from tau(act) = 6.25 +/- 0.76 ms to tau(act,PLA2) = 2.78 +/- 0.78 ms at 40 mV) and resulted in channel inactivation (from no observed inactivation to tau(inact) = 103 +/- 6 ms at 40 mV), which were: 1) dependent on the enrichment of Sf9 cell phospholipids in esterified arachidonic acid; 2) ablated by pretreatment of the PLA(2) by the mechanism-based inhibitor (E)-6-(bromomethylene)-3-(1-naphthalenyl)-2H-tetrahydropyran-2-one; and 3) manifest prior to development of alterations in cellular permeability. The bidirectional effects of Ca2+-independent PLA(2) were indistinguishable from the effects of exogenously applied arachidonic acid (AA), which specifically and reversibly increased the rates of channel activation (from tau(act) = 5.73 +/- 0.88 ms to tau(act,AA) = 1.91 +/- 0.39 ms at 40 mV) and inactivation (from no observed inactivation to tau(inact) = 76.6 +/- 1.4 ms at 40 mV). These electrophysiologic alterations resulted from the effects of arachidonic acid per se since Sf9 cells did not produce oxygenated eicosanoid metabolites, and neither exogenous administration nor in situ generation of other fatty acids resulted in these effects. Collectively, these results unambiguously demonstrate the role of arachidonic acid per se on Kv1.1 electrophysiologic function and suggest the importance of Ca2+-independent PLA(2) as an enzymic modulator of ion channel function in electrically active tissues.	WASHINGTON UNIV,SCH MED,DEPT MED,DIV BIOORGAN CHEM & MOLEC PHARMACOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT CHEM,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOL & PHARMACOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT NEUROL,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)					PHS HHS [41250] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BELARDETTI F, 1989, NEURON, V3, P497, DOI 10.1016/0896-6273(89)90208-0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; DAMRON DS, 1993, J BIOL CHEM, V268, P27335; FRASER D, 1993, NEURON, V11, P638; GROSS RW, 1985, BIOCHEMISTRY-US, V24, P1662, DOI 10.1021/bi00328a014; GROSS RW, 1984, BIOCHEMISTRY-US, V23, P158, DOI 10.1021/bi00296a026; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAN XL, 1994, P NATL ACAD SCI USA, V91, P10635, DOI 10.1073/pnas.91.22.10635; HAZEN SL, 1990, J BIOL CHEM, V265, P10622; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; HILLE B, 1992, IONIC CHANNELS EXCIT, P1; HIRASHIMA Y, 1992, J NEUROCHEM, V59, P708, DOI 10.1111/j.1471-4159.1992.tb09426.x; HONORE E, 1994, P NATL ACAD SCI USA, V91, P1937, DOI 10.1073/pnas.91.5.1937; JAN LY, 1989, CELL, V56, P13, DOI 10.1016/0092-8674(89)90979-3; KAMB A, 1992, METHOD ENZYMOL, V207, P423; KIM D, 1989, SCIENCE, V244, P1174, DOI 10.1126/science.2727703; MANCINI JA, 1993, EUR J BIOCHEM, V218, P477, DOI 10.1111/j.1432-1033.1993.tb18399.x; ORDWAY RW, 1989, SCIENCE, V244, P1176, DOI 10.1126/science.2471269; ORDWAY RW, 1991, TRENDS NEUROSCI, V14, P96, DOI 10.1016/0166-2236(91)90069-7; PEPPELENBOSCH MP, 1992, CELL, V69, P295, DOI 10.1016/0092-8674(92)90410-E; RAMASWAMI M, 1990, Molecular and Cellular Neuroscience, V1, P214, DOI 10.1016/1044-7431(90)90004-N; SALMON JA, 1982, METHOD ENZYMOL, V86, P477; SCHWEITZER P, 1990, NATURE, V346, P464, DOI 10.1038/346464a0; VILLARROEL A, 1993, FEBS LETT, V335, P184, DOI 10.1016/0014-5793(93)80726-B; WANG H, 1994, J NEUROSCI, V14, P4588; WOLF RA, 1985, J BIOL CHEM, V260, P7295; YABUUCHI H, 1968, J LIPID RES, V9, P65; ZONA C, 1993, NEUROREPORT, V4, P359, DOI 10.1097/00001756-199304000-00004	28	50	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					2885	2888		10.1074/jbc.270.7.2885	http://dx.doi.org/10.1074/jbc.270.7.2885			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852365	hybrid			2022-12-27	WOS:A1995QG47100002
J	GORVEL, JP; ESCOLA, JM; STANG, E; BAKKE, O				GORVEL, JP; ESCOLA, JM; STANG, E; BAKKE, O			INVARIANT CHAIN INDUCES A DELAYED TRANSPORT FROM EARLY TO LATE ENDOSOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; HLA-DR; ENDOCYTIC PATHWAY; HISTOCOMPATIBILITY ANTIGENS; INTRACELLULAR-TRANSPORT; SURFACE EXPRESSION; MEMBRANE-PROTEINS; CARRIER VESICLES; FUSION INVITRO; MOLECULES	Invariant chain associated with class II molecules is proteolytically processed in several distinct intermediates during its transport through the endocytic pathway. Using subcellular fractionation, early and late endosomal compartments were separated in human fibroblasts transfected with HLA-DR (4N5 cells) and supertransfected with invariant chain (4N5Li cells) or invariant chain lacking most of the cytoplasmic tail (4N5 Delta 20Ii cells). Early and late endosome membrane fractions were characterized by morphology and by analyzing the presence of the Rab5 and Rab7 GTPases as markers of early and late endosomes, respectively. The transfer of endocytosed horseradish peroxidase from early to late endosomes proceeded relatively rapid both in 4N5 and 4N5 Delta 20Ii cells (t(1/2) = 25 min), whereas this transfer was significantly delayed (t(1/2) = 2 h) in 4N5Ii cells. Pulse-chase experiments showed that invariant chain and its degradation products were first observed in early endosomes and thereafter in late endosomes. Our results strongly suggest that invariant chain induces a retention mechanism in the endocytic pathway.	UNIV OSLO,DEPT BIOL,DIV MOLEC CELL BIOL,N-0316 OSLO,NORWAY; CNRS,INSERM,CTR IMMUNOL,F-13288 MARSEILLE 9,FRANCE	University of Oslo; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)			Gorvel, Jean-Pierre/O-1332-2018	Gorvel, Jean-Pierre/0000-0002-2829-9804; Bakke, Oddmund/0000-0003-4843-7626				BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; BREMNES B, 1994, J CELL SCI, V107, P2021; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CLAESSON L, 1983, P NATL ACAD SCI-BIOL, V80, P7395, DOI 10.1073/pnas.80.24.7395; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GRIFFITHS G, 1989, J CELL BIOL, V109, P2703, DOI 10.1083/jcb.109.6.2703; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; KVIST S, 1982, CELL, V29, P61, DOI 10.1016/0092-8674(82)90090-3; LAMB CA, 1992, J IMMUNOL, V148, P3478; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; LOSS GE, 1993, J IMMUNOL, V150, P3187; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MARKS MS, 1990, J CELL BIOL, V111, P839, DOI 10.1083/jcb.111.3.839; MELLINS E, 1994, J EXP MED, V179, P541, DOI 10.1084/jem.179.2.541; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; NGUYEN QV, 1989, J BIOL CHEM, V264, P1631; PAPINI E, 1993, J BIOL CHEM, V268, P1567; PARTON RG, 1989, J CELL BIOL, V109, P3259, DOI 10.1083/jcb.109.6.3259; PELHAM HRB, 1993, CELL, V75, P603, DOI 10.1016/0092-8674(93)90479-A; PIETERS J, 1991, J CELL BIOL, V115, P1213, DOI 10.1083/jcb.115.5.1213; PIETERS J, 1993, J CELL SCI, V106, P831; QUARANTA V, 1984, J IMMUNOL, V132, P1900; ROCHE PA, 1993, P NATL ACAD SCI USA, V90, P8581, DOI 10.1073/pnas.90.18.8581; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; ROCHE PA, 1992, EMBO J, V11, P2841, DOI 10.1002/j.1460-2075.1992.tb05351.x; ROMAGNOLI P, 1993, J EXP MED, V177, P583, DOI 10.1084/jem.177.3.583; SCHMITT HD, 1986, CELL, V47, P401, DOI 10.1016/0092-8674(86)90597-0; SIMONSEN A, 1993, INT IMMUNOL, V5, P903, DOI 10.1093/intimm/5.8.903; STRUBIN M, 1984, EMBO J, V3, P869, DOI 10.1002/j.1460-2075.1984.tb01898.x; SUNG E, 1981, MOL IMMUNOL, V18, P899, DOI 10.1016/0161-5890(81)90013-4; TOOZE J, 1991, J CELL BIOL, V115, P635, DOI 10.1083/jcb.115.3.635; ZACHGO S, 1992, J CELL SCI, V103, P811	36	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2741	2746		10.1074/jbc.270.6.2741	http://dx.doi.org/10.1074/jbc.270.6.2741			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852345	hybrid			2022-12-27	WOS:A1995QF53500054
J	LUSSIER, M; GENTZSCH, M; SDICU, AM; BUSSEY, H; TANNER, W				LUSSIER, M; GENTZSCH, M; SDICU, AM; BUSSEY, H; TANNER, W			PROTEIN O-GLYCOSYLATION IN YEAST - THE PMT2 GENE SPECIFIES A 2ND PROTEIN O-MANNOSYLTRANSFERASE THAT FUNCTIONS IN ADDITION TO THE PMT1-ENCODED ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; GLYCOPROTEIN-BIOSYNTHESIS; TRANSFORMATION; CELLS; ENCODES	The PMT2 gene from Saccharomyces cerevisiae was identified as FUN25, a transcribed open reading frame on the left arm of chromosome I (Ouellette, B. F. F., Clark, M. W. C., Keng, T., Storms, R. G., Zhong, W., Zeng, B., Fortin, N., Delaney, S., Barton, A., Kaback, D. B., and Bussey, H. (1993) Genome 36, 32-42). The product encoded by the PMT2 gene shows significant similarity with the dolichyl phosphate-D-mannose:protein O-D-mannosyltransferase, Pmt1p (EC 2.4.1.109), which is required for initiating the assembly of O-linked oligosaccharides in S. cerevisiae (Strahl-Bolsinger, S., Immervoll, T., Deutzmann, R., and Tanner, TY. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 8164-8168). The PMT2 gene encodes a new protein O-D-mannosyltransferase. Yeast cells carrying a PMT2 disruption show a diminished in vitro and in vivo O-mannosylation activity and resemble mutants with a nonfunctional PMT1 gene. Strains bearing a pmt1 pmt2 double disruption show a severe growth defect but retain residual O-mannosylation activity indicating the presence of at least one more protein-O-mannosyltransferase.	MCGILL UNIV, DEPT BIOL, MONTREAL, PQ H3A 1B1, CANADA; UNIV REGENSBURG, LEHRSTUHL ZELLBIOL & PFLANZENPHYSIOL, D-93040 REGENSBURG, GERMANY	McGill University; University of Regensburg			Gentzsch, Martina/AAY-1815-2021					Altschul SF, 1990, J MOL BIOL, V215, P403; BALLOU CE, 1990, METHOD ENZYMOL, V185, P441; BARTON AB, 1994, J BACTERIOL, V176, P1872, DOI 10.1128/jb.176.7.1872-1880.1994; BOONE C, 1990, J CELL BIOL, V110, P1833, DOI 10.1083/jcb.110.5.1833; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN JL, 1993, MOL CELL BIOL, V13, P6346, DOI 10.1128/MCB.13.10.6346; BROWN JL, 1994, MOL GENETICS YEAST P, P217; BUSSEY H, 1991, MOL MICROBIOL, V5, P2339, DOI 10.1111/j.1365-2958.1991.tb02079.x; ELHAMMER A, 1984, J CELL BIOL, V98, P327; GENTZSCH M, 1995, IN PRESS GLYCOBIOLOG; HASELBECK A, 1983, FEBS LETT, V158, P335, DOI 10.1016/0014-5793(83)80608-5; HAUSLER A, 1992, GLYCOBIOLOGY, V2, P77, DOI 10.1093/glycob/2.1.77; HAUSLER A, 1992, P NATL ACAD SCI USA, V89, P6846, DOI 10.1073/pnas.89.15.6846; HERSCOVICS A, 1993, FASEB J, V7, P540, DOI 10.1096/fasebj.7.6.8472892; HILL K, 1992, GENETICS, V130, P273; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; KURANDA MJ, 1991, J BIOL CHEM, V266, P19758; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LOCKER JK, 1992, J BIOL CHEM, V267, P14094; LUSSIER M, 1993, YEAST, V9, P1057, DOI 10.1002/yea.320091004; MORT AJ, 1977, ANAL BIOCHEM, V82, P289, DOI 10.1016/0003-2697(77)90165-8; OUELLETTE BFF, 1993, GENOME, V96, P32; RILES L, 1993, GENETICS, V134, P81; ROTH J, 1984, J CELL BIOL, V98, P399, DOI 10.1083/jcb.98.2.399; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; ROUSSEL P, 1988, BIOCHIMIE, V70, P1471, DOI 10.1016/0300-9084(88)90284-2; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SHARMA CB, 1974, EUR J BIOCHEM, V46, P35, DOI 10.1111/j.1432-1033.1974.tb03594.x; STRAHLBOLSINGER S, 1993, P NATL ACAD SCI USA, V90, P8164, DOI 10.1073/pnas.90.17.8164; STRAHLBOLSINGER S, 1991, EUR J BIOCHEM, V196, P185, DOI 10.1111/j.1432-1033.1991.tb15802.x; TANNER W, 1987, BIOCHIM BIOPHYS ACTA, V906, P81, DOI 10.1016/0304-4157(87)90006-2; YIP CL, 1994, P NATL ACAD SCI USA, V91, P2723, DOI 10.1073/pnas.91.7.2723	33	78	83	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2770	2775		10.1074/jbc.270.6.2770	http://dx.doi.org/10.1074/jbc.270.6.2770			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852348	hybrid			2022-12-27	WOS:A1995QF53500058
J	AMRI, EZ; BONINO, F; AILHAUD, G; ABUMRAD, NA; GRIMALDI, PA				AMRI, EZ; BONINO, F; AILHAUD, G; ABUMRAD, NA; GRIMALDI, PA			CLONING OF A PROTEIN THAT MEDIATES TRANSCRIPTIONAL EFFECTS OF FATTY-ACIDS IN PREADIPOCYTES - HOMOLOGY TO PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE CELL-DIFFERENTIATION; AP2 GENE-EXPRESSION; COA OXIDASE GENE; RESPONSE ELEMENT; HETERODIMER; MEMBER; IDENTIFICATION; SUPERFAMILY; MECHANISMS; INDUCTION	Exposure of preadipocytes to long chain fatty acids induces expression of several gene markers of adipocyte differentiation. This report describes the cloning, from a preadipocyte library, of a cDNA encoding a fatty acid-activated receptor, FAAR. The cDNA had the characteristics and ligand-binding domains of nuclear hormone receptors and encoded a 440 amino acid protein related to peroxisome proliferator-activated receptors, PPAR. The deduced protein sequence was 88% homologous to that of hNUC I, isolated from human osteosarcoma cells, FAAR mRNA was abundant in adipose tissue, intestine, brain, heart, and skeletal muscles and less abundant in kidney, liver, testis, and spleen, The mRNA was undetectable in growing Ob1771 and 3T3-F442A preadipocytes, was strongly induced early during differentiation, and was increased by fatty acid, Transcription assays using hybrid receptor showed strong stimulation by fatty acid and weaker induction by fibrates, Transfection of 3T3-C2 fibroblasts, with a FAAR expression vector, conferred fatty acid inducibility of the adipocyte lipid-binding protein and the fatty acid transporter, Transcriptional induction of these genes exhibited inducer specificity identical to that described in preadipocytes, In summary, the data indicate that FAAR is likely a mediator of fatty acid transcriptional effects in preadipocytes.	FAC SCI NICE,CTR BIOCHIM,CNRS,UMR 134,F-06108 NICE,FRANCE; SUNY STONY BROOK,HLTH SCI CTR,DEPT PHYSIOL & BIOPHYS,STONY BROOK,NY 11794	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook				Ailhaud, Gerard/0000-0003-0596-2906; amri, Ez-Zoubir/0000-0001-8426-5396				ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; AMRI EZ, 1991, J LIPID RES, V32, P1457; AMRI EZ, 1991, J LIPID RES, V32, P1449; AMRI EZ, 1986, BIOCHEM J, V238, P115, DOI 10.1042/bj2380115; ARMESILLA AL, 1994, J BIOL CHEM, V269, P18985; BARDOT O, 1993, BIOCHEM BIOPH RES CO, V192, P37, DOI 10.1006/bbrc.1993.1378; CHAWLA A, 1994, P NATL ACAD SCI USA, V91, P1786, DOI 10.1073/pnas.91.5.1786; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; CHEN F, 1993, BIOCHEM BIOPH RES CO, V196, P671, DOI 10.1006/bbrc.1993.2302; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COOK KS, 1985, J CELL BIOL, V100, P514, DOI 10.1083/jcb.100.2.514; DISTEL RJ, 1992, J BIOL CHEM, V267, P5937; DOGLIO A, 1986, BIOCHEM J, V238, P123, DOI 10.1042/bj2380123; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; GRAVES RA, 1992, MOL CELL BIOL, V12, P1202, DOI 10.1128/MCB.12.3.1202; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; GREEN S, 1992, BIOCHEM PHARMACOL, V43, P393, DOI 10.1016/0006-2952(92)90554-V; GRIMALDI PA, 1992, P NATL ACAD SCI USA, V89, P10930, DOI 10.1073/pnas.89.22.10930; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; ISSEMANN I, 1993, J MOL ENDOCRINOL, V11, P37, DOI 10.1677/jme.0.0110037; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; LEVAYYOUNG BK, 1989, ENDOCRINOLOGY, V125, P1513; MARI E, 1994, J LIPID RES, V35, P930; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V175, P866, DOI 10.1016/0006-291X(91)91645-S; SCHMIDT A, 1992, MOL ENDOCRINOL, V6, P1634, DOI 10.1210/me.6.10.1634; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; ZHU YJ, 1993, J BIOL CHEM, V268, P26817	30	339	348	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2367	2371		10.1074/jbc.270.5.2367	http://dx.doi.org/10.1074/jbc.270.5.2367			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836471	hybrid			2022-12-27	WOS:A1995QE49300059
J	COTNER, T; PIOUS, D				COTNER, T; PIOUS, D			HLA-DR-BETA CHAINS ENTER INTO AN AGGREGATED COMPLEX CONTAINING GRP-78/BIP PRIOR TO THEIR DEGRADATION BY THE PRE-GOLGI DEGRADATIVE PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN HEAVY-CHAIN; VESICULAR STOMATITIS-VIRUS; NEWLY SYNTHESIZED PROTEINS; PLASMA-MEMBRANE PROTEINS; CELL-SURFACE-ANTIGENS; ENDOPLASMIC-RETICULUM; BINDING-PROTEIN; INFLUENZA HEMAGGLUTININ; INTRACELLULAR-TRANSPORT; TRANSIENT ASSOCIATION	HLA class II molecules are membrane proteins which are assembled in the endoplasmic reticulum shortly after synthesis of the alpha and beta and invariant chain (Ii) monomers. DR beta chains, in the absence of DR alpha, are rapidly and completely degraded by the pre-Golgi degradative pathway, Here we have examined those factors which target DR beta chains for degradation in a DR alpha deficient cell line, 9.22.3. The DR beta monomers in 9.22.3 were initially incorporated into a proteinaceous complex containing BiP. With time, the DR beta complexes were further aggregated, In wild type cells, which can assemble DR alpha-beta dimers, the secondary phase of aggregation of DR beta was not seen, Additional evidence that aggregation of DR beta in 9.22.3 cells was progressive was that a more mature form of DR beta was found exclusively in the largest DR beta complexes, Furthermore, the most highly aggregated DR beta chains were degraded more rapidly than bulk DR beta chains, These data suggest that DR beta aggregates are intermediates in the pre-Golgi pathway of DR beta degradation, They further suggest that formation of large DR beta aggregates is a proximal event to DR beta degradation, We conclude that DR beta chains are targeted for degradation as a consequence of a change of state, coincident with their aggregation into slow forming, high molecular weight complexes.	UNIV WASHINGTON,DEPT IMMUNOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	COTNER, T (corresponding author), UNIV WASHINGTON,DEPT PEDIAT,SEATTLE,WA 98195, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI016689, R01AI016689] Funding Source: NIH RePORTER; NIAID NIH HHS [AI16689] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON KS, 1994, EMBO J, V13, P675, DOI 10.1002/j.1460-2075.1994.tb06306.x; ANTUSCH D, 1990, J IMMUNOL, V145, P885; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; BERGMAN LW, 1979, J BIOL CHEM, V254, P5690; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BONIFACINO J S, 1991, Current Opinion in Cell Biology, V3, P592, DOI 10.1016/0955-0674(91)90028-W; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; CLARK EA, 1984, LEUCOCYTE TYPING, P195; COTNER T, 1981, P NATL ACAD SCI-BIOL, V78, P3858, DOI 10.1073/pnas.78.6.3858; COTNER T, 1989, J BIOL CHEM, V264, P11107; COTNER T, 1992, J IMMUNOL, V148, P2163; DEGEN E, 1991, J CELL BIOL, V112, P1099, DOI 10.1083/jcb.112.6.1099; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; FORSAYETH JR, 1992, J CELL BIOL, V117, P841, DOI 10.1083/jcb.117.4.841; FREIDEN PJ, 1992, EMBO J, V11, P63, DOI 10.1002/j.1460-2075.1992.tb05028.x; GETHING MJ, 1986, CELL, V46, P939, DOI 10.1016/0092-8674(86)90076-0; GLADSTONE P, 1982, P NATL ACAD SCI-BIOL, V79, P1235, DOI 10.1073/pnas.79.4.1235; GRAHAM KS, 1990, J BIOL CHEM, V265, P20463; GRIMES M, 1992, J CELL BIOL, V117, P539, DOI 10.1083/jcb.117.3.539; HENDERSHOT LM, 1990, J CELL BIOL, V111, P829, DOI 10.1083/jcb.111.3.829; HUBBARD AL, 1975, J CELL BIOL, V64, P461, DOI 10.1083/jcb.64.2.461; HURTLEY SM, 1989, J CELL BIOL, V108, P2117, DOI 10.1083/jcb.108.6.2117; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; KELLY R B, 1991, Current Opinion in Cell Biology, V3, P654, DOI 10.1016/0955-0674(91)90037-Y; KIM PS, 1992, J CELL BIOL, V118, P541, DOI 10.1083/jcb.118.3.541; KNITTLER MR, 1992, EMBO J, V11, P1573, DOI 10.1002/j.1460-2075.1992.tb05202.x; LE AQ, 1992, J BIOL CHEM, V267, P1072; LEAVITT R, 1977, J BIOL CHEM, V252, P9018; LIPPINCOTTSCHWA.J, 1988, CELL, V54, P209; MACHAMER CE, 1990, J BIOL CHEM, V265, P6879; MARQUARDT T, 1992, J CELL BIOL, V117, P505, DOI 10.1083/jcb.117.3.505; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; NAVARRO D, 1991, VIROLOGY, V184, P253, DOI 10.1016/0042-6822(91)90842-Y; NG DTW, 1989, J CELL BIOL, V109, P3273, DOI 10.1083/jcb.109.6.3273; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; PIOUS D, 1985, J EXP MED, V162, P1193, DOI 10.1084/jem.162.4.1193; ROUX L, 1990, VIROLOGY, V175, P161, DOI 10.1016/0042-6822(90)90196-X; SINGH I, 1990, EMBO J, V9, P631, DOI 10.1002/j.1460-2075.1990.tb08155.x; STAFFORD FJ, 1991, J CELL BIOL, V115, P1225, DOI 10.1083/jcb.115.5.1225; SUZUKI CK, 1991, J CELL BIOL, V114, P189, DOI 10.1083/jcb.114.2.189; TWETO J, 1976, J BIOL CHEM, V251, P872; VALETTI C, 1991, J CELL BIOL, V115, P983, DOI 10.1083/jcb.115.4.983; WIKSTROM L, 1991, J CELL BIOL, V113, P997, DOI 10.1083/jcb.113.5.997; WILEMAN T, 1990, CELL REGUL, V1, P907, DOI 10.1091/mbc.1.12.907	46	22	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2379	2386		10.1074/jbc.270.5.2379	http://dx.doi.org/10.1074/jbc.270.5.2379			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836473	hybrid			2022-12-27	WOS:A1995QE49300061
J	SA, G; MURUGESAN, G; JAYE, M; IVASHCHENKO, Y; FOX, PL				SA, G; MURUGESAN, G; JAYE, M; IVASHCHENKO, Y; FOX, PL			ACTIVATION OF CYTOSOLIC PHOSPHOLIPASE A(2) BY BASIC FIBROBLAST GROWTH-FACTOR VIA A P42 MITOGEN-ACTIVATED PROTEIN KINASE-DEPENDENT PHOSPHORYLATION PATHWAY IN ENDOTHELIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL TRANSDUCTION; ARACHIDONIC-ACID; PERTUSSIS TOXIN; 3T3 CELLS; POINT MUTATION; INHIBITION; PURIFICATION; MACROPHAGES; INVOLVEMENT; EXPRESSION	Basic fibroblast growth factor (FGF) stimulates the proliferation, differentiation, and motility of multiple cell types, Signal transduction by FGF is mediated by high affinity FGF receptors that have autophosphorylating tyrosine kinase activity and also elicit the release of low molecular weight signaling molecules, including inositol 1,4,5-trisphosphate, diacylglycerol, and arachidonate. We have shown previously that basic FGF-stimulated, phospholipase A(2) (PLA(2))-mediated arachidonate release regulates endothelial cell (EC) motility (Sa, G., and Fox, P. L. (1994) J. Biol. Chem, 269, 3219-3225). Here we identify the phospholipase responsible for basic FGF-mediated arachidonate release as cytosolic PLA(2) (cPLA(2)) by demonstrating in EC lysates a requirement for micromolar Ca2+, dithiothreitol insensitivity, and inactivation by anti-cPLA(2), antiserum, The role of cPLA(2) is also indicated by the observed mechanisms of activation which show a requirement for p42 mitogen-activated protein kinase activity, cPLA(2) phosphorylation, and cPLA(2) translocation from cytosol to membranes, Phosphorylation of cPLA(2), arachidonate release from prelabeled intact cells, and cell motility all have similar concentration dependencies on basic FGF, Since arachidonate release is required for basic FGF-stimulated motility of EC, our results show that p42 mitogen-activated protein kinase activation of cPLA, may be a regulatory event in stimulation of cellular release of this important eicosanoid precursor during cellular responses to basic FGF.	CLEVELAND CLIN FDN,RES INST,DEPT CELL BIOL,CLEVELAND,OH 44195; RHONE POULENC RORER CENT RES,DIV MOLEC BIOL,COLLEGEVILLE,PA 19426	Cleveland Clinic Foundation					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041178, P01HL029582, R29HL040352] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL29582, HL40352, HL41178] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOUTHERINFALSON O, 1990, BIOCHEM BIOPH RES CO, V172, P306, DOI 10.1016/S0006-291X(05)80210-4; CAI H, 1990, MOL CELL BIOL, V10, P5314, DOI 10.1128/MCB.10.10.5314; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; CLARK JD, 1990, P NATL ACAD SCI USA, V87, P7708, DOI 10.1073/pnas.87.19.7708; CLYMAN RI, 1994, CELL ADHES COMMUN, V1, P333, DOI 10.3109/15419069409097264; COCKCROFT S, 1991, BIOCHEM SOC T, V19, P333, DOI 10.1042/bst0190333; DAVIET I, 1990, FEBS LETT, V259, P315, DOI 10.1016/0014-5793(90)80035-H; DELL RB, 1973, CIRC RES, V32, P71, DOI 10.1161/01.RES.32.1.71; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; DOMIN J, 1993, J BIOL CHEM, V268, P8927; DURSTIN M, 1994, P NATL ACAD SCI USA, V91, P3142, DOI 10.1073/pnas.91.8.3142; FAFEUR V, 1991, J CELL PHYSIOL, V149, P277, DOI 10.1002/jcp.1041490214; FOX PL, 1987, J BIOL CHEM, V262, P6046; GOLIGORSKY MS, 1989, J BIOL CHEM, V264, P16771; HAJJAR DP, 1992, FASEB J, V6, P2933, DOI 10.1096/fasebj.6.11.1644257; HOECK WG, 1993, P NATL ACAD SCI USA, V90, P4475, DOI 10.1073/pnas.90.10.4475; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; KAST R, 1993, J BIOL CHEM, V268, P16795; KELVIN DJ, 1989, J CELL BIOL, V108, P169, DOI 10.1083/jcb.108.1.169; KITAGAWA K, 1987, BIOCHIM BIOPHYS ACTA, V931, P110, DOI 10.1016/0167-4889(87)90056-5; KREMER NE, 1991, J CELL BIOL, V115, P809, DOI 10.1083/jcb.115.3.809; LALLEMAIN G, 1991, CELL REGUL, V2, P675, DOI 10.1091/mbc.2.8.675; LESLIE CC, 1988, BIOCHIM BIOPHYS ACTA, V963, P476, DOI 10.1016/0005-2760(88)90316-5; LIN LL, 1992, P NATL ACAD SCI USA, V89, P6147, DOI 10.1073/pnas.89.13.6147; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; LOGAN A, 1991, CELL SIGNAL, V3, P215, DOI 10.1016/0898-6568(91)90047-X; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; MOHAMMADI M, 1992, NATURE, V358, P681, DOI 10.1038/358681a0; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; MURAKAMI M, 1993, J BIOL CHEM, V268, P839; MURUGESAN G, 1993, J CELL BIOL, V120, P1011, DOI 10.1083/jcb.120.4.1011; NAKAMURA T, 1992, EMBO J, V11, P4917, DOI 10.1002/j.1460-2075.1992.tb05598.x; NEMENOFF RA, 1993, J BIOL CHEM, V268, P1960; PATTE C, 1992, CELL MOL BIOL, V38, P429; Patte C, 1992, GROWTH FACTORS, V7, P107, DOI 10.3109/08977199209046400; PETERS KG, 1992, NATURE, V358, P678, DOI 10.1038/358678a0; PRPIC V, 1984, J BIOL CHEM, V259, P1382; QIU ZH, 1993, J BIOL CHEM, V268, P24506; SA G, 1994, J BIOL CHEM, V269, P3219; SHARP JD, 1991, J BIOL CHEM, V266, P14850; SPIVAKKROIZMAN T, 1994, J BIOL CHEM, V269, P14419; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; TUCKER RW, 1989, J CELL BIOCHEM, V39, P139, DOI 10.1002/jcb.240390206; VIRDEE K, 1994, BBA-MOL CELL RES, V1220, P171, DOI 10.1016/0167-4889(94)90132-5; WHATLEY RE, 1988, ARTERIOSCLEROSIS, V8, P321, DOI 10.1161/01.ATV.8.3.321; WIJKANDER J, 1992, FEBS LETT, V311, P299, DOI 10.1016/0014-5793(92)81124-5; WINITZ S, 1994, J BIOL CHEM, V269, P1889; WU T, 1994, J CLIN INVEST, V93, P571, DOI 10.1172/JCI117009; XING MZ, 1994, J BIOL CHEM, V269, P3117; ZHAN X, 1993, J BIOL CHEM, V268, P24427	51	149	150	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2360	2366		10.1074/jbc.270.5.2360	http://dx.doi.org/10.1074/jbc.270.5.2360			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836470	hybrid			2022-12-27	WOS:A1995QE49300058
J	DSCHIDA, WJA; BOWMAN, BJ				DSCHIDA, WJA; BOWMAN, BJ			THE VACUOLAR ATPASE - SULFITE STABILIZATION AND THE MECHANISM OF NITRATE INACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-BOUND ATPASE; VESICLE PROTON PUMP; H+-ATPASE; NEUROSPORA-CRASSA; PLASMA-MEMBRANE; SACCHAROMYCES-CEREVISIAE; V-ATPASES; SULFOLOBUS-ACIDOCALDARIUS; ADENOSINE-TRIPHOSPHATASE; TRANSLOCATING ATPASE	Using vacuolar membranes from Neurospora crassa, we observed that sulfite prevented the loss of vacuolar ATPase activity that otherwise occurred during 36 h at room temperature. Sulfite neither activated nor changed the kinetic behavior of the enzyme. Further, in the presence of sulfite, the vacuolar ATPase was not inhibited by nitrate. We tested the hypothesis that sulfite acts as a reducing agent to stabilize the enzyme, while nitrate acts as an oxidizing agent, inhibiting the enzyme by promoting the formation of disulfide bonds. All reducing agents tested, dithionite, selenite, thiophosphate, dithiothreitol and glutathione, prevented the loss of ATPase activity. On the other hand, all oxidizing agents tested, bromate, iodate, arsenite, perchlorate, and hydrogen peroxide, were potent inhibitors of ATPase activity. The inhibitory effect of the oxidizing agents was specific for the vacuolar ATPase. The mitochondrial ATPase, assayed under identical conditions, was not inhibited by any of the oxidizing agents. Analysis of proteins with two-dimensional gel electrophoresis indicated that nitrate can promote the formation of disufide bonds between proteins in the vacuolar membrane. These data suggest a mechanism to explain why nitrate specifically inhibits vacuolar ATPases, and they support the proposal by Feng and Forgac (Feng, Y., and Forgac, M. (1994) J. Biol. Chem. 269, 13244-13230) that oxidation and reduction of critical cysteine residues may regulate the activity of vacuolar ATPases in vivo.	UNIV CALIF SANTA CRUZ, DEPT BIOL, SINSHEIMER LABS, SANTA CRUZ, CA 95064 USA	University of California System; University of California Santa Cruz					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008132, R01GM028703] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM08132, GM28703] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLISON JP, 1982, J IMMUNOL, V129, P2293; ANRAKU Y, 1992, J EXP BIOL, V172, P67; ARAI H, 1989, BIOCHEMISTRY-US, V28, P3075, DOI 10.1021/bi00433a051; BAUERLE C, 1993, J BIOL CHEM, V268, P12749; BELTRAN C, 1992, J BIOL CHEM, V267, P774; BENNETT AB, 1988, METHOD ENZYMOL, V157, P579; BERNASCONI P, 1990, J BIOL CHEM, V265, P17428; BOWMAN BJ, 1981, J BIOL CHEM, V256, P2343; BOWMAN BJ, 1992, J EXP BIOL, V172, P57; BOWMAN BJ, 1989, J BIOL CHEM, V264, P15606; BOWMAN BJ, 1992, J BIOENERG BIOMEMBR, V24, P361, DOI 10.1007/BF00762529; BOWMAN EJ, 1983, J BIOL CHEM, V258, P5238; BOWMAN EJ, 1988, J BIOL CHEM, V263, P13994; BOWMAN EJ, 1982, J BACTERIOL, V151, P1326, DOI 10.1128/JB.151.3.1326-1337.1982; BOWMAN EJ, 1988, METHOD ENZYMOL, V157, P562; CHATTERJEE D, 1993, BIOCHEMISTRY-US, V32, P2808, DOI 10.1021/bi00062a011; DU ZY, 1990, BIOCHEMISTRY-US, V29, P402, DOI 10.1021/bi00454a014; FENG Y, 1992, J BIOL CHEM, V267, P5817; FENG Y, 1992, J BIOL CHEM, V267, P19769; FENG Y, 1994, J BIOL CHEM, V269, P13224; FORGAC M, 1989, PHYSIOL REV, V69, P765, DOI 10.1152/physrev.1989.69.3.765; FORGAC M, 1992, J BIOENERG BIOMEMBR, V24, P339, DOI 10.1007/BF00762526; FOURY F, 1990, J BIOL CHEM, V265, P18554; GALLOWAY CJ, 1988, METHOD ENZYMOL, V157, P601; GARDLIK S, 1991, J BIOL CHEM, V266, P16627; GLUCK S, 1992, J EXP BIOL, V172, P29; GRAF R, 1994, BBA-BIOMEMBRANES, V1190, P193, DOI 10.1016/0005-2736(94)90053-1; GUERRIERI F, 1982, EUR J BIOCHEM, V128, P9; HASEBE M, 1992, BIOCHEM BIOPH RES CO, V183, P856, DOI 10.1016/0006-291X(92)90562-Y; Hatefi Y, 1974, Methods Enzymol, V31, P770; HIRSCH S, 1988, P NATL ACAD SCI USA, V85, P3004, DOI 10.1073/pnas.85.9.3004; HO MN, 1993, J BIOL CHEM, V268, P18286; INATOMI K, 1986, J BACTERIOL, V167, P837, DOI 10.1128/jb.167.3.837-841.1986; KAKINUMA Y, 1981, J BIOL CHEM, V256, P859; KANE PM, 1989, J BIOL CHEM, V264, P19236; KANE PM, 1992, J BIOENERG BIOMEMBR, V24, P383, DOI 10.1007/BF00762531; KIBAK H, 1993, J BIOL CHEM, V268, P23325; KONISHI J, 1987, J BIOCHEM, V102, P1379, DOI 10.1093/oxfordjournals.jbchem.a122184; LAI SP, 1988, J BIOL CHEM, V263, P16731; LUBBEN M, 1987, EUR J BIOCHEM, V164, P533, DOI 10.1111/j.1432-1033.1987.tb11159.x; MANDALA S, 1986, J BIOL CHEM, V261, P2850; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; MEANS GE, 1970, CHEM MODIFICATION PR, P149; MELLMAN I, 1992, J EXP BIOL, V172, P39; MORIYAMA Y, 1989, J BIOL CHEM, V264, P3577; MORIYAMA Y, 1989, BIOCHIM BIOPHYS ACTA, V980, P241, DOI 10.1016/0005-2736(89)90405-7; NANBA T, 1987, J BIOCHEM-TOKYO, V102, P591, DOI 10.1093/oxfordjournals.jbchem.a122092; NELSON H, 1990, J BIOL CHEM, V265, P20390; NELSON N, 1992, J BIOENERG BIOMEMBR, V24, P407, DOI 10.1007/BF00762533; NELSON N, 1992, J EXP BIOL, V172, P149; PENG SB, 1994, J BIOL CHEM, V269, P17262; PUOPOLO K, 1990, J BIOL CHEM, V265, P14836; PUOPOLO K, 1992, J BIOL CHEM, V267, P3696; RANDALL SK, 1986, J BIOL CHEM, V261, P1364; REA PA, 1987, BIOCHIM BIOPHYS ACTA, V904, P1, DOI 10.1016/0005-2736(87)90080-0; SCHOBERT B, 1989, J BIOL CHEM, V264, P12805; STONE DK, 1989, J BIOENERG BIOMEMBR, V21, P605, DOI 10.1007/BF00808116; TAIZ L, 1994, BBA-BIOMEMBRANES, V1194, P329, DOI 10.1016/0005-2736(94)90315-8; TAUT RR, 1988, PROTEIN FUNCTION PRA, P101; VANHILLE B, 1993, J BIOL CHEM, V268, P7075; VASILYEVA EA, 1982, BIOCHEM J, V202, P15, DOI 10.1042/bj2020015; WANG SY, 1988, J BIOL CHEM, V263, P17638; WANG ZQ, 1990, J BIOL CHEM, V265, P21957; WARD JM, 1992, PLANT PHYSIOL, V99, P161, DOI 10.1104/pp.99.1.161; WIECZOREK H, 1992, J EXP BIOL, V172, P335	65	63	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1557	1563		10.1074/jbc.270.4.1557	http://dx.doi.org/10.1074/jbc.270.4.1557			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829484	hybrid			2022-12-27	WOS:A1995QD20400014
J	FRANZEN, S; BOHN, B; POYART, C; DEPILLIS, G; BOXER, SG; MARTIN, JL				FRANZEN, S; BOHN, B; POYART, C; DEPILLIS, G; BOXER, SG; MARTIN, JL			FUNCTIONAL-ASPECTS OF ULTRA-RAPID HEME DOMING IN HEMOGLOBIN, MYOGLOBIN, AND THE MYOGLOBIN MUTANT H93G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN-SPECTRA; MOLECULAR-DYNAMICS; CARBON-MONOXIDE; REACTIVITY; SIMULATION; ABSORPTION; PHOTOLYSIS; PROTOHEME; PROTEINS	Heme iron out-of-plane displacement following ligand dissociation in hemoglobin, myoglobin, and the proximal cavity mutant H93G is shown to be as rapid as the heme iron out-of plane vibrational period by sub-picosecond time-resolved resonance Raman spectroscopy. The results demonstrate that the effect of steric repulsion initiated by the spin change of the iron gives rise to heme doming independent of covalent attachment of the proximal ligand to the protein, It is concluded that the protein plays a passive role in the initial ultrafast heme iron motion toward the out-of-plane position observed in the deoxy structure of hemoglobin and myoglobin, The results suggest that the spin change of the heme iron is the primary cause of rapid heme doming and that steric repulsion of the proximal ligand with the heme plays a secondary role in forcing the iron out of the heme plane.	ECOLE POLYTECH,ECOLE NATL SUPER & TECH AVANCEES,F-91120 PALAISEAU,FRANCE; HOP BICETRE,INSERM,U299,F-94275 LE KREMLIN BICETR,FRANCE; STANFORD UNIV,DEPT CHEM,STANFORD,CA 94305	Institut Polytechnique de Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Stanford University				Boxer, Steven/0000-0001-9167-4286				BALDWIN J, 1979, J MOL BIOL, V129, P175, DOI 10.1016/0022-2836(79)90277-8; BANGCHAROENPAUR.O, 1984, J AM CHEM SOC, V106, P5688; BARRICK D, 1994, BIOCHEMISTRY-US, V33, P6546, DOI 10.1021/bi00187a023; CHOI SH, 1983, J AM CHEM SOC, V105, P3683, DOI 10.1021/ja00349a056; DEIPILLIS G, 1994, J AM CHEM SOC, V116, P6981; FINDSEN EW, 1985, SCIENCE, V229, P661, DOI 10.1126/science.4023704; FRANKE G, 1894, ARCH LARYNGOL RHINOL, V1, P230; FRANZEN S, 1994, IN PRESS BIOCHEMISTR; GIBSON QH, 1992, J BIOL CHEM, V267, P22022; HENRY ER, 1985, P NATL ACAD SCI USA, V82, P2034, DOI 10.1073/pnas.82.7.2034; HOFRICHTER J, 1983, P NATL ACAD SCI-BIOL, V80, P2235, DOI 10.1073/pnas.80.8.2235; KITAGAWA T, 1979, FEBS LETT, V104, P376, DOI 10.1016/0014-5793(79)80856-X; KUCZERA K, 1990, J MOL BIOL, V213, P351, DOI 10.1016/S0022-2836(05)80196-2; MARTIN JL, 1983, P NATL ACAD SCI-BIOL, V80, P173, DOI 10.1073/pnas.80.1.173; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; OLAFSON BD, 1977, P NATL ACAD SCI USA, V74, P1315, DOI 10.1073/pnas.74.4.1315; PERUTZ MF, 1979, ANNU REV BIOCHEM, V48, P327, DOI 10.1146/annurev.bi.48.070179.001551; PETRICH JW, 1988, BIOCHEMISTRY-US, V27, P4049, DOI 10.1021/bi00411a022; SAWICKI CA, 1976, J BIOL CHEM, V251, P1533; TSUBAKI M, 1982, BIOCHEMISTRY-US, V21, P1132, DOI 10.1021/bi00535a004; ZHU L, 1994, PHYS REV LETT, V72, P301, DOI 10.1103/PhysRevLett.72.301	21	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1718	1720		10.1074/jbc.270.4.1718	http://dx.doi.org/10.1074/jbc.270.4.1718			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829506	hybrid			2022-12-27	WOS:A1995QD20400038
J	SPEELMAN, BA; ALLEN, K; GROUNDS, TL; NEUTRA, MR; KIRCHHAUSEN, T; WILSON, JM				SPEELMAN, BA; ALLEN, K; GROUNDS, TL; NEUTRA, MR; KIRCHHAUSEN, T; WILSON, JM			MOLECULAR CHARACTERIZATION OF AN APICAL EARLY ENDOSOMAL GLYCOPROTEIN FROM DEVELOPING RAT INTESTINAL EPITHELIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; FACTOR-II RECEPTOR; GROWTH-FACTOR; LDL-RECEPTOR; ALPHA-2-MACROGLOBULIN RECEPTOR; ABSORPTIVE CELLS; CYTOPLASMIC TAIL; PLASMA-MEMBRANE; BIOGENESIS; SEQUENCE	The apical endosomal compartment is thought to be involved in the sorting and selective transport of receptors and ligands across polarized epithelia. To learn about the protein components of this compartment, we have isolated and sequenced a cDNA that encodes a glycoprotein that is located in the apical endosomal tubules of developing rat intestinal epithelial cells, The deduced amino acid sequence predicts a protein of 1216 amino acids with a molecular mass of 133,769 Da. The deduced amino acid sequence together with aminoterminal amino acid sequencing indicate that there is a cleaved 21-amino acid signal sequence at the NH2-terminal portion of the molecule, There is a single hydrophobic region near the carboxyl terminus that has the characteristics of a membrane-spanning domain and a 36-amino acid cytoplasmic tail, We have found that the major form of this protein in intestinal epithelial cells has a molecular mass of 55-60 kDa, which is significantly smaller than the size predicted from the cDNA sequence, suggesting that the protein is synthesized as a large precursor and processed to the smaller form, The smaller form remains associated with the membrane, however, possibly through noncovalent association with the transmembrane portion of the molecule or with another membrane protein, The extracytoplasmic do main is cysteine-rich, with three cysteine rich repeats that are similar to cysteine repeats present in several receptor proteins, However, there is no other significant similarity to other proteins in the GenBank. The cytoplasmic tail contains a possible internalization motif and several consensus motifs for serine/threonine kinases, Northern blot analysis suggests a single abundant message, and Southern blot analysis is consistent with a single gene and the absence of pseudogenes for this unique endosomal protein.	UNIV ARIZONA, STEELE MEM CHILDRENS RES CTR, DEPT CELL BIOL & ANAT, TUCSON, AZ 85724 USA; UNIV ARIZONA, STEELE MEM CHILDRENS RES CTR, DEPT PEDIAT, TUCSON, AZ 85724 USA; CHILDRENS HOSP, GASTROINTESTINAL CELL BIOL RES LAB, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT CELL BIOL, BOSTON, MA 02135 USA; CTR BLOOD RES, BOSTON, MA 02135 USA	University of Arizona; University of Arizona; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)					NIDDK NIH HHS [DK-43329] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK043329, R56DK043329, R01DK043329] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAHAMSON DR, 1981, J CELL BIOL, V91, P270, DOI 10.1083/jcb.91.1.270; APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; BARTLES JR, 1985, J BIOL CHEM, V260, P2792; BREWER CB, 1991, J CELL BIOL, V114, P413, DOI 10.1083/jcb.114.3.413; CASANOVA JE, 1990, SCIENCE, V248, P742, DOI 10.1126/science.2110383; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; CORNELL R, 1969, AM J ANAT, V125, P291, DOI 10.1002/aja.1001250304; DISCIPIO RG, 1984, P NATL ACAD SCI-BIOL, V81, P7298, DOI 10.1073/pnas.81.23.7298; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GEUZE HJ, 1987, J CELL BIOL, V104, P1715, DOI 10.1083/jcb.104.6.1715; GEUZE HJ, 1984, CELL, V37, P195, DOI 10.1016/0092-8674(84)90315-5; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; GONNELLA PA, 1987, J CLIN INVEST, V80, P22, DOI 10.1172/JCI113051; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; HAURI HP, 1979, P NATL ACAD SCI USA, V76, P5183, DOI 10.1073/pnas.76.10.5183; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; JADOT M, 1992, J BIOL CHEM, V267, P11069; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEGENDRE N, 1989, PRACTICAL GUIDE TO PROTEIN AND PEPTIDE PURIFICATION FOR MICROSEQUENCING, P49; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; PIETERS J, 1993, J CELL SCI, V106, P831; RODEWALD R, 1980, J CELL BIOL, V85, P18, DOI 10.1083/jcb.85.1.18; Sambrook J, 1989, MOL CLONING LABORATO; SEMENZA G, 1986, ANNU REV CELL BIOL, V2, P255, DOI 10.1146/annurev.cellbio.2.1.255; SIMINOSKI K, 1986, J CELL BIOL, V103, P1979, DOI 10.1083/jcb.103.5.1979; STONE KL, 1989, PRACTICAL GUIDE TO PROTEIN AND PEPTIDE PURIFICATION FOR MICROSEQUENCING, P31; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; VERHEY KJ, 1994, J BIOL CHEM, V269, P2353; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WILSON JM, 1987, J CELL BIOL, V105, P691, DOI 10.1083/jcb.105.2.691; WILSON JM, 1991, J CELL SCI, V100, P133	39	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1583	1588		10.1074/jbc.270.4.1583	http://dx.doi.org/10.1074/jbc.270.4.1583			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829488	hybrid			2022-12-27	WOS:A1995QD20400018
J	TSUCHIDA, K; AOYAGI, Y; ODANI, S; MITA, T; ISEMURA, M				TSUCHIDA, K; AOYAGI, Y; ODANI, S; MITA, T; ISEMURA, M			ISOLATION OF A NOVEL COLLAGEN-BINDING PROTEIN FROM THE MUSHROOM, HYPSIZIGUS-MARMOREUS, WHICH INHIBITS THE LEWIS LUNG-CARCINOMA CELL-ADHESION TO TYPE-IV COLLAGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							EXPERIMENTAL METASTASIS; MELANOMA-CELLS; FIBRONECTIN; LAMININ; SEQUENCE; ATTACHMENT; PEPTIDE; LINES	A type IV collagen-binding protein of 23 kDa was isolated from the mushroom, Hypsizigus marmoreus. This protein, HM 23, bound to type TV and type I collagens and gelatin, and to much lesser extent to fibronectin, but not to laminin or bovine serum albumin. The adhesion of Lewis lung carcinoma cells was inhibited when the type TV collagen substratum was pretreated with HM 23. A computer search of the determined partial amino acid sequence indicated no homologous proteins reported. These results indicate that HM 23 is a hitherto undescribed fungus protein that can interact with animal extracellular matrix proteins.	UNIV SHIZUOKA,DEPT FOOD SCI & NUTR,YADA,SHIZUOKA 422,JAPAN; NIIGATA UNIV,SCH MED,DEPT INTERNAL MED 3,NIIGATA 951,JAPAN; NIIGATA UNIV,COLL SCI,DEPT BIOL,NIIGATA 950,JAPAN	University of Shizuoka; Niigata University; Niigata University								ANTONSSON P, 1993, BIOCHIM BIOPHYS ACTA, V1174, P204, DOI 10.1016/0167-4781(93)90117-V; BENMANSOUR A, 1992, VIROLOGY, V187, P33, DOI 10.1016/0042-6822(92)90292-W; BUXTON TB, 1990, MICROB PATHOGENESIS, V8, P441, DOI 10.1016/0882-4010(90)90031-K; Chang S., 1991, MUSHROOM J, V504, P15; DUMONT JA, 1992, CANCER RES, V52, P1195; FUJITA S, 1992, JPN J CANCER RES, V83, P1317, DOI 10.1111/j.1349-7006.1992.tb02764.x; Hook M, 1989, FIBRONECTIN, P295; HUMPHRIES MJ, 1986, SCIENCE, V233, P467, DOI 10.1126/science.3726541; HYNES RO, 1981, CELL BIOL EXTRACELLU, P295; ISEMURA M, 1993, CELL BIOL INT, V17, P559, DOI 10.1006/cbir.1993.1099; ISEMURA M, 1987, J BIOL CHEM, V262, P8926; ISEMURA M, 1991, CELL BIOL INT REP, V15, P965, DOI 10.1016/0309-1651(91)90146-A; IWAMOTO Y, 1987, SCIENCE, V238, P1132, DOI 10.1126/science.2961059; KANDA T, 1991, EUR J BIOCHEM, V197, P759, DOI 10.1111/j.1432-1033.1991.tb15968.x; KATO Y, 1992, J BIOL CHEM, V267, P11424; KOSTRZYNSKA M, 1992, ZBL BAKT-INT J MED M, V277, P80; KUMAGAI H, 1991, BIOCHEM BIOPH RES CO, V177, P74, DOI 10.1016/0006-291X(91)91950-H; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIOTTA LA, 1986, ANNU REV BIOCHEM, V55, P1037, DOI 10.1146/annurev.biochem.55.1.1037; Piez K.A., 1976, BIOCH COLLAGENS, P1; SAIKI I, 1990, JPN J CANCER RES, V81, P1003, DOI 10.1111/j.1349-7006.1990.tb03338.x; SPIRO RG, 1967, J BIOL CHEM, V242, P4813; SWITALSKI LM, 1989, J BIOL CHEM, V264, P21080; TANIGUCHI S, 1992, CANCER LETT, V65, P51, DOI 10.1016/0304-3835(92)90212-E; TIDBALL JG, 1992, J BIOL CHEM, V267, P21211; TIMPL R, 1984, BASEMENT MEMBRANES C, P25; TURPEENNIEMIHUJ.T, 1986, J BIOL CHEM, V261, P1883; VERCELLOTTI GM, 1985, AM J PATHOL, V120, P13; YAMADA KM, 1983, ANNU REV BIOCHEM, V52, P761, DOI 10.1146/annurev.bi.52.070183.003553; 1981, WEBSTERS 3RD NEW INT, P506	30	33	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1481	1484		10.1074/jbc.270.4.1481	http://dx.doi.org/10.1074/jbc.270.4.1481			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829472	hybrid			2022-12-27	WOS:A1995QD20400001
J	KELLEY, CA; OBERMAN, F; YISRAELI, JK; ADELSTEIN, RS				KELLEY, CA; OBERMAN, F; YISRAELI, JK; ADELSTEIN, RS			A XENOPUS NONMUSCLE MYOSIN HEAVY-CHAIN ISOFORM IS PHOSPHORYLATED BY CYCLIN-P34(CDC2) KINASE DURING MEIOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; CONTROL GENE CDC2+; PROTEIN-KINASE; LIGHT CHAIN; CELL-CYCLE; M-PHASE; MESSENGER-RNAS; TYROSINE PHOSPHORYLATION; MAP KINASE; MITOSIS	There are two vertebrate nonmuscle myosin heavy chain (MHC) genes that encode two separate isoforms of the heavy chain, MHC-A and MHC-B. Recent work has identified additional, alternatively spliced isoforms of MRC-R cDNA with inserted sequences of 30 nucleotides (chicken and human) or 48 nucleotides (Xenopus) at a site corresponding to the ATP binding region in the MHC protein (Takahashi, M., Kawamoto, S. and Adelstein, R. S. (1992) J. Biol. Chem. 267, 17864-17871) and Bhatia-Dey, N., Adelstein, R. S., and Dawid, I. B. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 2856-2859). The deduced amino acid sequence of these inserts contains a consensus sequence for phosphorylation by cyclin-p34(cdc2) (cdc2) kinase. In cultured Xenopus XTC cells, we have identified two inserted MHC-B isoforms and a noninserted MHC-A isoform by immunoblotting of cell extracts. When myosin was immunoprecipitated from XTC cells and phosphorylated in vitro with cdc2 kinase, the kinase catalyzed the phosphorylation of both inserted MRC-B isoforms but not MHC-A. Isoelectric focusing of tryptic peptides generated from MHC-B phosphorylated with cdc2 kinase revealed one major phosphopeptide that was purified by reverse phase high performance liquid chromatography and sequenced. The phosphorylated residue was Ser-214, the cdc2 kinase consensus site within the insert near the ATP binding region. The same site was phosphorylated in intact XTC cells during log phase of growth and in cell-free lysates of Xenopus eggs stabilized in second meiotic metaphase but not interphase. Moreover, Ser-214 phosphorylation was detected during maturation of Xenopus oocytes when the cdc2 kinase-containing maturation-promoting factor was activated, but not in G(2) interphase-arrested oocytes. These results demonstrate that MBC-B phosphorylation is tightly regulated by cdc2 kinase during meiotic cell cycles. Furthermore, MHC-A and MHC-B isoforms are differentially phosphorylated at these stages, suggesting that they may serve different functions in these cells.	HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT ANAT & EMBRYOL,IL-91010 JERUSALEM,ISRAEL	Hebrew University of Jerusalem	KELLEY, CA (corresponding author), NHLBI,MOLEC CARDIOL LAB,BLDG 10,RM 8N-202,10 CTR DR MSC 1762,BETHESDA,MD 20892, USA.		Yisraeli, Joel/S-2031-2019	Yisraeli, Joel/0000-0001-6538-6686; Adelstein, Robert/0000-0002-8683-2144				BABIJ P, 1989, J MOL BIOL, V210, P673, DOI 10.1016/0022-2836(89)90142-3; BABIJ P, 1993, NUCLEIC ACIDS RES, V21, P1467, DOI 10.1093/nar/21.6.1467; BENGUR AR, 1987, J BIOL CHEM, V262, P7613; BHATIADEY N, 1993, P NATL ACAD SCI USA, V900, P2856; Capco D.G., 1991, Progress in Molecular and Subcellular Biology, V12, P59; CHENEY RE, 1993, CELL MOTIL CYTOSKEL, V24, P215, DOI 10.1002/cm.970240402; CHOU YH, 1990, CELL, V62, P1063, DOI 10.1016/0092-8674(90)90384-Q; DRAETTA G, 1989, CELL, V56, P829, DOI 10.1016/0092-8674(89)90687-9; DUNPHY WG, 1988, CELL, V54, P423, DOI 10.1016/0092-8674(88)90205-X; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; FERRELL JE, 1991, MOL CELL BIOL, V11, P1965, DOI 10.1128/MCB.11.4.1965; FUKUI Y, 1990, J CELL BIOL, V110, P367, DOI 10.1083/jcb.110.2.367; GAUTIER J, 1988, CELL, V54, P433, DOI 10.1016/0092-8674(88)90206-1; GOODSON HV, 1993, P NATL ACAD SCI USA, V90, P659, DOI 10.1073/pnas.90.2.659; GOTOH Y, 1991, NATURE, V349, P251, DOI 10.1038/349251a0; GOTOH Y, 1991, EMBO J, V10, P2661, DOI 10.1002/j.1460-2075.1991.tb07809.x; GRAF JD, 1991, METHOD CELL BIOL, V36, P19; HAMADA Y, 1990, BIOCHEM BIOPH RES CO, V170, P53, DOI 10.1016/0006-291X(90)91239-O; HARTSHORNE DJ, 1987, PHYSL GASTROINTESTIN, P423; IKEBE M, 1990, BIOCHEMISTRY-US, V29, P2713, DOI 10.1021/bi00463a014; KATSURAGAWA Y, 1989, EUR J BIOCHEM, V184, P611, DOI 10.1111/j.1432-1033.1989.tb15057.x; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; KAWAMOTO S, 1988, J BIOL CHEM, V263, P1099; KAWAMOTO S, 1989, J BIOL CHEM, V234, P2258; KELLEY CA, 1992, J BIOL CHEM, V267, P2127; KELLEY CA, 1993, J BIOL CHEM, V268, P12848; LABBE JC, 1989, EMBO J, V8, P3053, DOI 10.1002/j.1460-2075.1989.tb08456.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUDOWYKE RI, 1989, J BIOL CHEM, V264, P12492; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; MAUPIN P, 1994, J CELL SCI, V107, P3077; MINSHULL J, 1989, CELL, V56, P947, DOI 10.1016/0092-8674(89)90628-4; MURAKAMI N, 1990, J BIOL CHEM, V265, P1041; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; NAGAI R, 1989, J BIOL CHEM, V264, P9734; NAKABAYASHI H, 1991, FEBS LETT, V294, P144, DOI 10.1016/0014-5793(91)81362-C; NEWPORT J, 1987, CELL, V48, P219, DOI 10.1016/0092-8674(87)90425-9; NIGG EA, 1990, SEMIN CELL BIOL, V2, P261; NISHIKAWA M, 1984, J BIOL CHEM, V259, P8808; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; PASTERNAK C, 1989, NATURE, V341, P549, DOI 10.1038/341549a0; PENG HB, 1991, METHOD CELL BIOL, V36, P657; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; POSADA J, 1991, MOL CELL BIOL, V11, P2517, DOI 10.1128/MCB.11.5.2517; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; SANGER JW, 1976, CELL MOTILITY, P1295; SATTERWHITE LL, 1992, J CELL BIOL, V118, P595, DOI 10.1083/jcb.118.3.595; SCHROEDER TE, 1976, CELL MOTILITY, P265; SIMANIS V, 1986, CELL, V45, P261, DOI 10.1016/0092-8674(86)90390-9; SMITH JC, 1991, METHOD CELL BIOL, V36, P635; SMITH LD, 1971, DEV BIOL, V25, P232, DOI 10.1016/0012-1606(71)90029-7; TAKAHASHI M, 1992, J BIOL CHEM, V267, P17864; WARRICK HM, 1987, ANNU REV CELL BIOL, V3, P379, DOI 10.1146/annurev.cb.03.110187.002115; WHITE S, 1993, AM J PHYSIOL, V264, pC1252, DOI 10.1152/ajpcell.1993.264.5.C1252; WILSON KL, 1988, J CELL BIOL, V107, P57, DOI 10.1083/jcb.107.1.57; YAMAKITA Y, 1994, J CELL BIOL, V124, P129, DOI 10.1083/jcb.124.1.129; YAMASHIRO S, 1990, NATURE, V344, P675, DOI 10.1038/344675a0; YAMASHIRO S, 1991, NATURE, V349, P169, DOI 10.1038/349169a0	58	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1395	1401		10.1074/jbc.270.3.1395	http://dx.doi.org/10.1074/jbc.270.3.1395			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836406	hybrid			2022-12-27	WOS:A1995QB15600063
J	TAKEBAYASHI, K; AKAZAWA, C; NAKANISHI, S; KAGEYAMA, R				TAKEBAYASHI, K; AKAZAWA, C; NAKANISHI, S; KAGEYAMA, R			STRUCTURE AND PROMOTER ANALYSIS OF THE GENE ENCODING THE MOUSE HELIX-LOOP-HELIX FACTOR HES-5 - IDENTIFICATION OF THE NEURAL PRECURSOR CELL-SPECIFIC PROMOTER ELEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHARACTERIZATION; DROSOPHILA-HAIRY; NEGATIVE REGULATOR; DNA-BINDING; PROTEIN; TRANSCRIPTION; POLYMERASE; EXPRESSION; ENHANCER; CLONING	HES-5 is a mammalian basic helix-loop-helix factor that has a distant sequence homology to the product of the Drosophila pair-rule gene hairy. HES-5 mRNA is present exclusively in the developing nervous system, but its level decreases as neural differentiation proceeds. In this study, to characterize the molecular mechanism of the neural-specific expression of HES-5 we isolated the mouse HES-5 gene. This gene consists of three exons, and Southern blot analysis shows that it is a single copy gene. The transcription initiation site, determined by primer extension and reverse transcriptase-mediated polymerase chain reaction, is located 26 nucleotides downstream of a TATA box. Transient transfection analysis shows that the upstream region of the HES-5 gene can direct efficient expression in neural precursor cells and moderate expression in undifferentiated NCB20 neuroblastoma-brain hybrid cells but not in glioma or fibroblast cells. The moderate level of expression in NCB20 cells decreases when differentiation into neuron-like cells is induced. Further promoter analysis shows that this undifferentiated neural-specific expression is mediated by the multiple GC stretches present in the HES-5 promoter. Gel mobility shift analysis suggests the presence of a neural precursor cell-specific protein that binds to the GC stretches. These results raise the possibility that HES-5 expression in the developing nervous system is regulated by the GC stretch-binding protein.	KYOTO UNIV,FAC MED,INST IMMUNOL,SAKYO KU,KYOTO 606,JAPAN	Kyoto University								AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; CHRISTY BA, 1991, P NATL ACAD SCI USA, V88, P1815, DOI 10.1073/pnas.88.5.1815; DUNCAN M, 1992, DEV BIOL, V154, P1, DOI 10.1016/0012-1606(92)90042-F; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; ISHIBASHI M, 1993, EUR J BIOCHEM, V215, P645, DOI 10.1111/j.1432-1033.1993.tb18075.x; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Jacobson M., 1991, DEV NEUROBIOLOGY; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KAGEYAMA R, 1991, J BIOL CHEM, V266, P15525; KITANI H, 1991, IN VITRO CELL DEV B, V27, P615; LEE CC, 1988, SCIENCE, V239, P1288, DOI 10.1126/science.3344434; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; MACDERMOT J, 1979, P NATL ACAD SCI USA, V76, P1135, DOI 10.1073/pnas.76.3.1135; NEUMAN T, 1993, DEV BIOL, V160, P186, DOI 10.1006/dbio.1993.1297; NIRENBERG M, 1983, SCIENCE, V222, P794, DOI 10.1126/science.6314503; OW DW, 1986, SCIENCE, V234, P856, DOI 10.1126/science.234.4778.856; RUSHLOW CA, 1989, EMBO J, V8, P3095, DOI 10.1002/j.1460-2075.1989.tb08461.x; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; TOMOOKA Y, 1993, P NATL ACAD SCI USA, V90, P9683, DOI 10.1073/pnas.90.20.9683; Wilkinson D.G., 1993, ESSENTIAL DEV BIOL P, P257	26	78	82	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1342	1349		10.1074/jbc.270.3.1342	http://dx.doi.org/10.1074/jbc.270.3.1342			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836401	hybrid			2022-12-27	WOS:A1995QB15600056
J	SORKIN, A; MCKINSEY, T; SHIH, W; KIRCHHAUSEN, T; CARPENTER, G				SORKIN, A; MCKINSEY, T; SHIH, W; KIRCHHAUSEN, T; CARPENTER, G			STOICHIOMETRIC INTERACTION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR WITH THE CLATHRIN-ASSOCIATED PROTEIN COMPLEX AP-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-INDUCED INTERNALIZATION; COATED VESICLE PROTEINS; AMINO-ACID SEQUENCE; PLASMA-MEMBRANE; MEDIATED ENDOCYTOSIS; ADAPTER PROTEIN; INVITRO BINDING; KINASE-ACTIVITY; PITS; CLONING	Plasma membrane clathrin-associated protein complexes (AP-2) have been shown to co-immunoprecipitate with the epidermal growth factor (EGF) receptor (Sorkin A., and Carpenter, G. (1993) Science 261, 612-615). Hence, we analyzed the stoichiometry of the EGF receptor interaction with AP-2 using a new antibody that efficiently immunoprecipitates native AP-2. EGF receptor AP-2 complexes were isolated from S-35-labeled cells treated with EGF by EGF receptor affinity chroma tography followed by precipitation with the antibody to AP-2. Quantitation of the relative molar concentrations of the proteins found in the complex revealed that 1 mol of AP-2 was associated with approximately 1.1 mol of EGF receptor. No other proteins were present in significant molar concentrations relative to AP-2. indicating that other proteins are not stoichiometrically involved in the interaction of EGF receptors and AP-2 in vitro. Co-immunoprecipitation experiments in cells expressing a mutant EGF receptor demonstrated that the cyto plasmic carboxyl-terminal 214 residues of the EGF receptor are essential for interaction with AP-2.	VANDERBILT UNIV, SCH MED, DEPT BIOCHEM, NASHVILLE, TN 37232 USA; HARVARD UNIV, SCH MED, DEPT CELL BIOL, BOSTON, MA 02115 USA; CTR BLOOD RES, BOSTON, MA 02115 USA	Vanderbilt University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)				Sorkin, Alexander/0000-0002-4446-1920	NCI NIH HHS [CA24071] Funding Source: Medline; NIDDK NIH HHS [DK46817] Funding Source: Medline; NIGMS NIH HHS [GM36548] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA024071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK046817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036548] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHLE S, 1989, J BIOL CHEM, V264, P20089; AHLE S, 1988, EMBO J, V7, P919, DOI 10.1002/j.1460-2075.1988.tb02897.x; BECK KA, 1991, J BIOL CHEM, V266, P4437; BELTZER JP, 1991, EMBO J, V10, P3735, DOI 10.1002/j.1460-2075.1991.tb04942.x; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; CHANG CP, 1993, J BIOL CHEM, V268, P19312; CHANG MP, 1993, EMBO J, V12, P2169, DOI 10.1002/j.1460-2075.1993.tb05865.x; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; COHEN S, 1980, J BIOL CHEM, V255, P4834; DUNN WA, 1984, J CELL BIOL, V98, P2148, DOI 10.1083/jcb.98.6.2148; GALLUSSER A, 1993, EMBO J, V12, P5237, DOI 10.1002/j.1460-2075.1993.tb06219.x; GLICKMAN JN, 1989, EMBO J, V8, P1041, DOI 10.1002/j.1460-2075.1989.tb03471.x; HAIGLER HT, 1979, J CELL BIOL, V81, P382, DOI 10.1083/jcb.81.2.382; HANOVER JA, 1984, CELL, V39, P283, DOI 10.1016/0092-8674(84)90006-0; HEUSER J, 1985, J ULTRASTRUCT RES, V92, P2457; KEEN JH, 1990, ANNU REV BIOCHEM, V59, P415, DOI 10.1146/annurev.biochem.59.1.415; KIRCHHAUSEN T, 1991, J BIOL CHEM, V266, P11153; KIRCHHAUSEN T, 1989, P NATL ACAD SCI USA, V86, P2612, DOI 10.1073/pnas.86.8.2612; KIRCHHAUSEN T, 1993, CURR OPIN STRUC BIOL, V3, P182, DOI 10.1016/S0959-440X(05)80150-2; LAMAZE C, 1993, MOL BIOL CELL, V4, P715, DOI 10.1091/mbc.4.7.715; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; LUND KA, 1990, J BIOL CHEM, V265, P15713; MATSUI W, 1990, BIOCHEMISTRY-US, V29, P10791, DOI 10.1021/bi00500a011; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; PEARSE BMF, 1988, EMBO J, V7, P3331, DOI 10.1002/j.1460-2075.1988.tb03204.x; PONNAMBALAM S, 1990, J BIOL CHEM, V265, P4814; ROBINSON M S, 1992, Trends in Cell Biology, V2, P293, DOI 10.1016/0962-8924(92)90118-7; ROBINSON MS, 1989, J CELL BIOL, V108, P833, DOI 10.1083/jcb.108.3.833; ROBINSON MS, 1987, J CELL BIOL, V104, P887, DOI 10.1083/jcb.104.4.887; ROBINSON MS, 1990, J CELL BIOL, V111, P2319, DOI 10.1083/jcb.111.6.2319; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAVAGE CR, 1972, J BIOL CHEM, V247, P7609; SCHMID SL, 1992, BIOESSAYS, V14, P589, DOI 10.1002/bies.950140903; SORKIN A, 1992, J BIOL CHEM, V267, P8672; SORKIN A, 1991, J BIOL CHEM, V266, P23453; SORKIN A, 1993, SCIENCE, V261, P612, DOI 10.1126/science.8342026; SORKIN A, 1993, BIOESSAYS, V15, P375, DOI 10.1002/bies.950150603; SOSA MA, 1993, J BIOL CHEM, V268, P12537; STARBUCK C, 1992, BIOTECHNOL PROGR, V8, P132, DOI 10.1021/bp00014a007; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; THURIEAU C, 1988, DNA-J MOLEC CELL BIO, V7, P663, DOI 10.1089/dna.1988.7.663; Trowbridge IS, 1991, CURR OPIN CELL BIOL, V3, P1062, DOI 10.1016/0955-0674(91)90130-Q; TUCKER KL, 1990, NUCLEIC ACIDS RES, V18, P5306, DOI 10.1093/nar/18.17.5306; VIGERS GPA, 1986, EMBO J, V5, P2079, DOI 10.1002/j.1460-2075.1986.tb04469.x; WILEY HS, 1988, J CELL BIOL, V107, P801, DOI 10.1083/jcb.107.2.801; WILEY HS, 1991, J BIOL CHEM, V266, P11083; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035	50	101	103	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					619	625		10.1074/jbc.270.2.619	http://dx.doi.org/10.1074/jbc.270.2.619			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822287	hybrid			2022-12-27	WOS:A1995QB81600020
J	YAMASHITA, H; OKADOME, T; FRANZEN, P; TENDIJKE, P; HELDIN, CH; MIYAZONO, K				YAMASHITA, H; OKADOME, T; FRANZEN, P; TENDIJKE, P; HELDIN, CH; MIYAZONO, K			A RAT PITUITARY-TUMOR CELL-LINE (GH(3)) EXPRESSES TYPE-I AND TYPE-II RECEPTORS AND OTHER CELL-SURFACE BINDING PROTEIN(S) FOR TRANSFORMING GROWTH-FACTOR-BETA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE THREONINE KINASE; ACTIVIN RECEPTOR; CARCINOMA-CELLS; CLONING; INHIBITION; BETAGLYCAN; COMPONENT; COMPLEXES; SIGNALS; LIGAND	A rat pituitary tumor cell line (GH(3)) has been reported to express transforming grow-th factor-beta (TGF-beta) binding components of 70-74 kDa (ligand included), denoted TGF-beta type IV receptor. We investigated whether the type IV receptor corresponds to any of the recently cloned type I receptors for proteins in the TGF-beta superfamily. TGF-beta type I receptor (T beta R-I) complexes of 69-72 kDa formed a heteromeric complex with T beta R-II in GH(3) cells, as detected by immunoprecipitation. In addition, TGF-beta formed complexes of 72-74 kDa, which were different from T beta R-I and the other known type I receptors, and were not dependent on T beta R-II for binding, The GH(3) cells were resistant to the growth inhibitory activity of TGF-beta, but a transcriptional response was activated by TGF-beta in this cell line, presumably through the T beta R-II and T beta R-I complex. These results indicate that GH(3) cells have T beta R-I and T beta R-II and, in addition, other binding protein(s) which form 72-74-kDa complexes with TGF-beta; the function of the latter component(s) remains to be elucidated.	LUDWIG INST CANC RES,CTR BIOMED,S-75124 UPPSALA,SWEDEN	Ludwig Institute for Cancer Research			Dijke, Peter ten/AAG-4660-2021	Dijke, Peter ten/0000-0002-7234-342X				ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; BASSING CH, 1994, SCIENCE, V263, P87, DOI 10.1126/science.8272871; BASSING CH, 1994, J BIOL CHEM, V269, P14861; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; CHEIFETZ S, 1991, J BIOL CHEM, V266, P20767; CHEIFETZ S, 1988, J BIOL CHEM, V263, P17225; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; ESTEVEZ M, 1993, NATURE, V365, P644, DOI 10.1038/365644a0; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; FRANZEN P, 1993, EXP CELL RES, V207, P1, DOI 10.1006/excr.1993.1156; FROLIK CA, 1984, J BIOL CHEM, V259, P995; GEISER AG, 1992, J BIOL CHEM, V267, P2588; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; ICHIJO H, 1990, EXP CELL RES, V187, P263, DOI 10.1016/0014-4827(90)90090-W; INAGAKI M, 1993, P NATL ACAD SCI USA, V90, P5359, DOI 10.1073/pnas.90.11.5359; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; LAIHO M, 1990, J BIOL CHEM, V265, P18518; Lin Herbert Y., 1993, Trends in Cell Biology, V3, P14, DOI 10.1016/0962-8924(93)90195-7; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; MASSAGUE J, 1992, CELL, V69, P1067, DOI 10.1016/0092-8674(92)90627-O; MASSAGUE J, 1990, ANN NY ACAD SCI, V593, P59; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; MATHEWS LS, 1992, SCIENCE, V255, P1702, DOI 10.1126/science.1313188; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; MIYAZONO K, 1994, ADV IMMUNOL, V55, P181; MOUSTAKAS A, 1993, J BIOL CHEM, V268, P22215; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P419; Ten Dijke Peter, 1994, Progress in Growth Factor Research, V5, P55, DOI 10.1016/0955-2235(94)90017-5; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; TENDIJKE P, 1993, ONCOGENE, V8, P2879; TSUCHIDA K, 1993, BIOCHEM BIOPH RES CO, V191, P790, DOI 10.1006/bbrc.1993.1286; VALE W, 1990, PEPTIDE GROWTH FACTO, P211; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; YAMASHITA H, 1994, J BIOL CHEM, V269, P1995; YAMASHITA H, 1994, J BIOL CHEM, V269, P20172	41	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					770	774		10.1074/jbc.270.2.770	http://dx.doi.org/10.1074/jbc.270.2.770			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822309	hybrid			2022-12-27	WOS:A1995QB81600043
J	ZHENG, Y; BENDER, A; CERIONE, RA				ZHENG, Y; BENDER, A; CERIONE, RA			INTERACTIONS AMONG PROTEINS INVOLVED IN BUD-SITE SELECTION AND BUD-SITE ASSEMBLY IN SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; CELL POLARITY; GENETIC-CONTROL; BUDDING YEAST; RAS; MORPHOGENESIS; CDC42; RSR1; PATHWAY; PRODUCT	Bud formation in yeast involves the actions of the Ras-type GTPase Rsr1, which is required for the proper selection of the bud site, and the Rho-type GTPase Cdc42, which is necessary for the assembly of cytoskeletal structures at that site. The Cdc24 protein is required both for proper bud-site selection and bud-site assembly and has been recently shown to display guanine-nucleotide-exchange factor (GEF) activity toward Cdc42. Here, we demonstrate, using recombinant proteins, that Cdc24 can also bind directly to Rsr1. This binding has no effect on the ability of Rsr1 to undergo intrinsic or GEF-stimulated GDP-GTP exchange, However, Cdc24 can inhibit both the intrinsic and GTPase-activating protein-stimulated GTPase activity of Rsr1 and thereby acts as a GTPase-inhibitor protein for Rsr1. Cdc24 thus appears to bind preferentially to the activated form of Rsr1. The SH3 domain-containing bud-site assembly protein Bem1 also binds directly to Cdc24, and we show here that this interaction is inhibited by Ca2+. Neither Bem1 nor Cdc42 affects the GTPase-inhibitor protein activity of Cdc24 toward Rsr1, and neither Bem1 nor Rsr1 affects the GEF activity of Cdc24 toward Cdc42. Taken together, these results suggest that Cdc24 enables the direct convergence of a Ras-like protein (Rsr1) and a Rho-like protein (Cdc42) with the SH3-domain-containing protein (Bem1) and that independent domains of Cdc24 are responsible for these different interactions. These results also suggest that rather than directly controlling the GEF activity of Cdc24, the primary roles of Rsr1 and Bem1 might be to control the positioning of Cdc24 within the cell.	INDIANA UNIV,DEPT BIOL,BLOOMINGTON,IN 47405	Indiana University System; Indiana University Bloomington	ZHENG, Y (corresponding author), CORNELL UNIV,DEPT PHARMACOL,SCHURMANN HALL,ITHACA,NY 14850, USA.		Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074	NIGMS NIH HHS [GM46271, GM47458] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458, R01GM046271, R29GM046271] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; BENDER A, 1993, P NATL ACAD SCI USA, V90, P9926, DOI 10.1073/pnas.90.21.9926; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; BENTON BK, 1993, EMBO J, V12, P5267, DOI 10.1002/j.1460-2075.1993.tb06222.x; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOLLAG G, 1991, ANNU REV CELL BIOL, V7, P601, DOI 10.1146/annurev.cellbio.7.1.601; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; CHANT J, 1991, CELL, V65, P1213, DOI 10.1016/0092-8674(91)90016-R; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; CHENEVERT J, 1992, NATURE, V356, P77, DOI 10.1038/356077a0; CVRCKOVA F, 1993, EMBO J, V12, P5277, DOI 10.1002/j.1460-2075.1993.tb06223.x; DRUBIN DG, 1991, CELL, V65, P1093, DOI 10.1016/0092-8674(91)90001-F; HART MJ, 1994, J BIOL CHEM, V269, P62; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; HOLDEN JL, 1991, J BIOL CHEM, V266, P16992; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; OHYA Y, 1986, J BACTERIOL, V165, P28, DOI 10.1128/jb.165.1.28-33.1986; PARK HO, 1993, NATURE, V365, P269, DOI 10.1038/365269a0; PETERSON J, 1994, IN PRESS J CELL BIOL; POWERS S, 1991, CELL, V65, P1225, DOI 10.1016/0092-8674(91)90017-S; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; RUGGIERI R, 1992, MOL CELL BIOL, V12, P758, DOI 10.1128/MCB.12.2.758; SETTLEMAN J, 1992, NATURE, V359, P153, DOI 10.1038/359153a0; SLOAT BF, 1981, J CELL BIOL, V89, P395, DOI 10.1083/jcb.89.3.395; ZHENG Y, 1994, J BIOL CHEM, V269, P18727; ZHENG Y, 1994, J BIOL CHEM, V269, P2369; ZIMAN M, 1994, YEAST, V10, P463, DOI 10.1002/yea.320100405	31	150	152	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					626	630		10.1074/jbc.270.2.626	http://dx.doi.org/10.1074/jbc.270.2.626			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822288	hybrid			2022-12-27	WOS:A1995QB81600021
J	OUWENS, DM; VANDERZON, GCM; PRONK, GJ; BOS, JL; MOLLER, W; CHEATHAM, B; KAHN, CR; MAASSEN, JA				OUWENS, DM; VANDERZON, GCM; PRONK, GJ; BOS, JL; MOLLER, W; CHEATHAM, B; KAHN, CR; MAASSEN, JA			A MUTANT INSULIN-RECEPTOR INDUCES FORMATION OF A SHC-GROWTH FACTOR-RECEPTOR BOUND PROTEIN-2 (GRB2) COMPLEX AND P21(RAS)-GTP WITHOUT DETECTABLE INTERACTION OF INSULIN-RECEPTOR SUBSTRATE-1 (IRS1) WITH GRB2 - EVIDENCE FOR IRS1-INDEPENDENT P21(RAS)-GTP FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE DOMAIN AUTOPHOSPHORYLATION; GUANINE-NUCLEOTIDE EXCHANGE; SIGNAL-TRANSDUCTION; TYROSINE KINASES; PHOSPHATIDYLINOSITOL 3'-KINASE; GENE-EXPRESSION; RAS; ACTIVATION; P21RAS; PHOSPHORYLATION	The activation of p21(ras) by receptor tyrosine kinases involves the translocation of the growth factor receptor bound protein 2-mammalian son of sevenless protein (Grb2.SOS) complex to the plasma membrane where p21(ras) is localized, Insulin receptors induce p21(ras)-GTP formation by two possible mechanisms: tyrosine phosphorylation of insulin receptor substrate 1 (IRS1) and its subsequent association with Grb2, or Shc phosphorylation and its subsequent association with Grb2. We investigated the contribution of the major tyrosine autophosphorylation sites Tyr(1158), Tyr(1162), and Tyr(1163) of the insulin receptor to IRS1.Grb2 and Shc.Grb2 association and the formation of p21(ras)-GTP. Chinese hamster ovary-derived cell lines were used overexpressing mutant insulin receptors in which the major tyrosine autophosphorylation sites were stepwise replaced by phenylalanines. In cell lines expressing wild type or mutant Y1158F,Y1162,Y1163 (FYY) receptors, insulin stimulated tyrosine phosphorylation of IRS1 and She and the formation of IRS1.Grb2 and Shc.Grb2 protein complexes, together with an increase in p21(ras)-GTP. Cell lines expressing mutant Y1158,Y1162F,Y1163F (YFF) receptors showed insulin-induced tyrosine phosphorylation of Shc, Shc.Grb2 complex formation, and p21(ras)-GTP formation, whereas tyrosine phosphorylation of IRS1 was strongly decreased and formation of IRS1.Grb2 complexes was undetectable. The activity of FYY and YFF receptors to mediate p21(ras)-GTP formation correlated with their activity to induce She phosphorylation and Shc.Grb2 association. The mutant insulin receptors Y1158F,Y1162F,Y1163 and Y1158F,Y1162F,Y1163F were inactive in inducing any of these responses, We conclude that phosphorylation of Tyr(1158) and Tyr(1162) of the insulin receptor is linked to distinct post-receptor processes and that YFF receptors generate p21(ras)-GTP via the Shc.Grb2 pathway rather than one involving IRS1.Grb2 interaction.	LEIDEN STATE UNIV,DEPT BIOCHEM MED,SYLVIUS LAB,PROT SYNTH & HORMONE REGULAT SECT,2333 AL LEIDEN,NETHERLANDS; UNIV UTRECHT,PHYSIOL CHEM LAB,3584 CG UTRECHT,NETHERLANDS; JOSLIN DIABET CTR,BOSTON,MA 02215	Leiden University; Leiden University - Excl LUMC; Utrecht University; Harvard University; Joslin Diabetes Center, Inc.			Ouwens, Margriet/H-2442-2013; Kahn, Ronald/AAY-2435-2021	Ouwens, Margriet/0000-0001-6709-2702; Kahn, Ronald/0000-0002-7583-9228				BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; BALTENSPERGER K, 1993, SCIENCE, V260, P1950, DOI 10.1126/science.8391166; BOWTELL D, 1992, P NATL ACAD SCI USA, V89, P6511, DOI 10.1073/pnas.89.14.6511; BUDAY L, 1993, MOL CELL BIOL, V13, P1903, DOI 10.1128/MCB.13.3.1903; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; BURGERING BMT, 1991, EMBO J, V10, P1103, DOI 10.1002/j.1460-2075.1991.tb08050.x; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; DEVRIESSMITS AMM, 1992, NATURE, V357, P602, DOI 10.1038/357602a0; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; GIORGETTI S, 1993, J BIOL CHEM, V268, P7358; KASUGA M, 1981, SCIENCE, V215, P185; KOVACINA KS, 1993, BIOCHEM BIOPH RES CO, V192, P1303, DOI 10.1006/bbrc.1993.1558; KUHNE MR, 1993, J BIOL CHEM, V268, P11479; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MATSUGUCHI T, 1994, J BIOL CHEM, V269, P5016; MATUOKA K, 1992, P NATL ACAD SCI USA, V89, P9015, DOI 10.1073/pnas.89.19.9015; MCGLADE J, 1992, P NATL ACAD SCI USA, V89, P8869, DOI 10.1073/pnas.89.19.8869; MEDEMA RH, 1991, MOL CELL BIOL, V11, P5963, DOI 10.1128/MCB.11.12.5963; MEDEMA RH, 1993, MOL CELL BIOL, V13, P155, DOI 10.1128/MCB.13.1.155; MYERS MG, 1993, DIABETES, V42, P643, DOI 10.2337/diabetes.42.5.643; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; OHMICHI M, 1994, J BIOL CHEM, V269, P1143; OSTEROP APRM, 1992, J BIOL CHEM, V267, P14647; PANG DT, 1985, ARCH BIOCHEM BIOPHYS, V242, P176, DOI 10.1016/0003-9861(85)90491-6; PELICCI G, 1992, CELL, V70, P98; PRONK GJ, 1994, MOL CELL BIOL, V14, P1575, DOI 10.1128/MCB.14.3.1575; PRONK GJ, 1993, ONCOGENE, V8, P2773; PRONK GJ, 1993, J BIOL CHEM, V268, P5748; RIEDEL H, 1986, NATURE, V324, P68, DOI 10.1038/324068a0; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; RUFFJAMISON S, 1993, J BIOL CHEM, V268, P7610; SASAOKA T, 1994, J BIOL CHEM, V269, P10734; SATO N, 1993, EMBO J, V12, P4181, DOI 10.1002/j.1460-2075.1993.tb06102.x; SEGATTO O, 1993, ONCOGENE, V8, P2105; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; TAUCHI T, 1994, J EXP MED, V179, P167, DOI 10.1084/jem.179.1.167; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TOBE K, 1993, J BIOL CHEM, V268, P11167; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VANDENBERGHE N, 1994, MOL CELL BIOL, V14, P2372, DOI 10.1128/MCB.14.4.2372; WHITE MF, 1987, J BIOL CHEM, V262, P9769; WILDEN PA, 1992, J BIOL CHEM, V267, P16660; WILDEN PA, 1994, MOL ENDOCRINOL, V8, P558, DOI 10.1210/me.8.5.558; WILDEN PA, 1992, J BIOL CHEM, V267, P13719; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; ZHANG B, 1991, J BIOL CHEM, V266, P990; ZHU XY, 1994, J BIOL CHEM, V269, P5518	57	72	72	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					33116	33122						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806540				2022-12-27	WOS:A1994QA63800058
J	PALHA, JA; EPISKOPOU, V; MAEDA, S; SHIMADA, K; GOTTESMAN, ME; SARAIVA, MJM				PALHA, JA; EPISKOPOU, V; MAEDA, S; SHIMADA, K; GOTTESMAN, ME; SARAIVA, MJM			THYROID-HORMONE METABOLISM IN A TRANSTHYRETIN-NULL MOUSE STRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROXINE-BINDING GLOBULIN; MESSENGER-RIBONUCLEIC-ACID; RAT-LIVER; CHOROID-PLEXUS; RING DEIODINATION; PREALBUMIN; TRANSPORT; PROTEINS; SERUM; 5'-DEIODINASE	Transthyretin (TTR) is the principal carrier of thyroid hormones in rodent plasma and the major protein synthesized by the choroid plexus. Mice lacking TTR generated by targeted disruption (Episkopou, V., Maeda, S., Nishiguchi, S., Shimada, K., Gaitanaris, G. A., Gottesman, M. E., and Robertson, E. J. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 2375-2379) had a 50% decrease in total thyroxine (T-4) plasma levels but had normal free hormone levels as compared to wild-type mice. In the mutant serum there was increased T-4 binding to thyroxine-binding globulin. Thyroxine-binding globulin mRNA levels were the same in mutant and wild-type animals. Wild-type serum depleted of TTR also presented increased T-4 binding to thyroxine-binding globulin, suggesting that TTR competes with thyroxine-binding globulin for T-4 binding. Total and free triiodothyronine and thyrotropin-stimulating hormone levels were not affected by the absence of TTR. Liver deiodinase-I activity, mRNA levels, and brain deiodinase II activity were normal in the mutant mice, suggesting that the absence of TTR does not affect tissue thyroid hormone content. The low T-4 levels found in the mutant mice sera cannot be accounted for by increased glucuronidation because the liver activity of UDP-glucuronosyltransferase was not affected in the TTR-deficient mice. We concluded that transthyretin-deficient mice are euthyroid in the absence of the major plasma T-4 carrier. We ascribed this to the normal free hormone levels in the serum of the mutant mice. Our data, therefore, strongly supported the free hormone hypothesis for thyroxine uptake (Mendel, C. M. (1989) Endocr. Rev. 10, 232-274).	COLUMBIA UNIV, INST CANC RES, NEW YORK, NY 10032 USA; INST CIENCIAS BIOMED ABEL SALAZAR, P-4000 OPORTO, PORTUGAL; CTR ESTUDOS PARAMILOIDOSE, P-4000 OPORTO, PORTUGAL; ST MARYS HOSP, DEPT BIOCHEM & MOLEC GENET, LONDON W2 1PG, ENGLAND; YAMANASHI MED UNIV, DEPT BIOCHEM, YAMANASHI 40938, JAPAN; RES INST MICROBIAL DIS, DEPT MED GENET, DIV MOLEC BIOMED, OSAKA 565, JAPAN	Columbia University; Universidade do Porto; Imperial College London; University of Yamanashi			Palha, Joana Almeida/C-2745-2009; Episkopou, Vasso/E-2952-2010; Saraiva, Maria João/K-3907-2013	Palha, Joana Almeida/0000-0002-8866-368X; Saraiva, Maria João/0000-0002-3360-6899	MRC [MC_U120074332] Funding Source: UKRI; Medical Research Council [MC_U120074332] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BARTALENA L, 1990, ENDOCR REV, V11, P47, DOI 10.1210/edrv-11-1-47; BERRY MJ, 1990, MOL ENDOCRINOL, V4, P743, DOI 10.1210/mend-4-5-743; BERRY MJ, 1991, NATURE, V349, P438, DOI 10.1038/349438a0; BERRY MJ, 1993, J CLIN INVEST, V92, P1517, DOI 10.1172/JCI116730; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; BURGER A, 1986, THYROID HORMONE META, P255; DAVIS PJ, 1970, ENDOCRINOLOGY, V87, P978, DOI 10.1210/endo-87-5-978; DESANDRO V, 1992, BIOCHEM PHARMACOL, V43, P1563, DOI 10.1016/0006-2952(92)90215-5; DICKSON PW, 1986, J BIOL CHEM, V261, P3475; DISTEFANO JJ, 1988, AM ZOOL, V28, P373; DIVINO CM, 1990, J BIOL CHEM, V265, P1425; EPISKOPOU V, 1993, P NATL ACAD SCI USA, V90, P2375, DOI 10.1073/pnas.90.6.2375; FARWELL AP, 1993, J BIOL CHEM, V268, P5055; GERSHENGORN MC, 1978, ENDOCRINOLOGY, V102, P1122, DOI 10.1210/endo-102-4-1122; GOODMAN DS, 1984, RETINOIDS, V2, P1; GRIMALDI S, 1982, BIOCHEMISTRY-US, V21, P145, DOI 10.1021/bi00530a025; HARMS PJ, 1991, COMP BIOCHEM PHYS B, V99, P239, DOI 10.1016/0305-0491(91)90035-C; HIGUERET P, 1979, J ENDOCRINOL, V80, P223, DOI 10.1677/joe.0.0800223; IMAMURA S, 1991, BIOCHEMISTRY-US, V30, P5406, DOI 10.1021/bi00236a012; KAMBE F, 1988, MOL ENDOCRINOL, V2, P181, DOI 10.1210/mend-2-2-181; KAPLAN MM, 1985, ENDOCRINOLOGY, V117, P1858, DOI 10.1210/endo-117-5-1858; KAPLAN MM, 1983, ENDOCRINOLOGY, V112, P35, DOI 10.1210/endo-112-1-35; KOHRLE J, 1989, ENDOCRINOLOGY, V125, P532, DOI 10.1210/endo-125-1-532; KOHRLE J, 1991, THYROID, P144; MENDEL CM, 1987, ENDOCRINOLOGY, V120, P1742, DOI 10.1210/endo-120-5-1742; MENDEL CM, 1989, J CLIN INVEST, V83, P143, DOI 10.1172/JCI113851; MENDEL CM, 1989, ENDOCR REV, V10, P232, DOI 10.1210/edrv-10-3-232; MENDEL CM, 1992, ENDOCRINOLOGY, V130, P1525, DOI 10.1210/en.130.3.1525; MENJO M, 1993, ENDOCRINOLOGY, V133, P2984, DOI 10.1210/en.133.6.2984; MOL JA, 1985, ENDOCRINOLOGY, V117, P8, DOI 10.1210/endo-117-1-8; NAVAB M, 1977, J BIOL CHEM, V252, P5107; OTTEN MH, 1984, ENDOCRINOLOGY, V115, P887, DOI 10.1210/endo-115-3-887; PARDRIDGE WM, 1987, AM J PHYSIOL, V252, pE157, DOI 10.1152/ajpendo.1987.252.2.E157; PORTERFIELD SP, 1993, ENDOCR REV, V14, P94, DOI 10.1210/er.14.1.94; REFETOFF S, 1989, ENDOCR REV, V10, P275, DOI 10.1210/edrv-10-3-275; ROBBINS J, 1984, THYROID HORMONE META, P3; ROUAZEROMET M, 1992, ACTA ENDOCRINOL-COP, V127, P441, DOI 10.1530/acta.0.1270441; Sambrook J, 1989, MOL CLONING LABORATO; SARAIVA MJM, 1988, ADV NEUROL, V48, P201; SARNE DH, 1988, J CLIN ENDOCR METAB, V67, P1166, DOI 10.1210/jcem-67-6-1166; SAVU L, 1991, BIOCHIM BIOPHYS ACTA, V1097, P19, DOI 10.1016/0925-4439(91)90017-4; SAVU L, 1989, BIOCHEM BIOPH RES CO, V159, P919, DOI 10.1016/0006-291X(89)92196-7; SCHREIBER G, 1990, AM J PHYSIOL, V258, pR338; SILVA JE, 1985, ENDOCRINOLOGY, V116, P1627, DOI 10.1210/endo-116-4-1627; SPANKA M, 1988, BIOL MED, V2, P341; STEIN SA, 1989, NEUROENDOCRINOLOGY, V49, P509, DOI 10.1159/000125160; STEIN SA, 1991, ADV EXP MED BIOL, V299, P47; VISSER TJ, 1993, ENDOCRINOLOGY, V133, P2177, DOI 10.1210/en.133.5.2177; VRANCKX R, 1990, BIOCHEM BIOPH RES CO, V167, P317, DOI 10.1016/0006-291X(90)91767-M; YOUNG RA, 1985, ENDOCRINOLOGY, V116, P1248, DOI 10.1210/endo-116-4-1248	50	75	76	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					33135	33139						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806543				2022-12-27	WOS:A1994QA63800061
J	REEMS, JA; MCHENRY, CS				REEMS, JA; MCHENRY, CS			ESCHERICHIA-COLI DNA-POLYMERASE-III HOLOENZYME FOOTPRINTS 3 HELICAL TURNS OF ITS PRIMER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; INITIATION COMPLEX; BETA-SUBUNIT; ACCESSORY PROTEINS; BINDING-PROTEIN; ATP ACTIVATION; SIZE CLASSES; PURIFICATION; TEMPLATE; IDENTIFICATION	Escherichia coli DNA polymerase III holoenzyme in the presence of ATP and E. coli single-stranded DNA-binding protein forms an initiation complex on a primed template capable of rapid and highly processive DNA replication. DNase I digestion of initiation complexes demonstrated that holoenzyme protected 27-30 nucleotides of primer. Like the formation of initiation complexes, this protection required both ATP and E. coli single-stranded DNA-binding protein. Initiation complexes assembled with core DNA polymerase III (alpha, epsilon, and theta subunits), gamma-complex (gamma, delta, delta', chi, and psi) and the beta subunit produced a footprint identical to that formed with intact holoenzyme, indicating that initiation complexes formed with reconstituted enzyme and those formed with holoenzyme were equivalent. The presence of the tau subunit in reconstitituted initiation complexes did not alter the DNase I footprint. Preinitiation complexes (gamma-complex plus beta subunit) assembled onto primer-template in an ATP-dependent reaction protected a larger region of the primer than did holoenzyme. The addition of core DNA polymerase III to preinitiation complexes restored the 30-nucleotide footprint observed with intact holoenzyme. These results suggest that holoenzyme subunits rearrange during initiation complex formation.	UNIV COLORADO,HLTH SCI CTR,PROGRAM MOLEC BIOL,DENVER,CO 80262	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	REEMS, JA (corresponding author), UNIV COLORADO,HLTH SCI CTR,DEPT BIOCHEM BIOPHYS & GENET,DENVER,CO 80262, USA.				NIGMS NIH HHS [R01 GM 35695] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035695] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERKOWITZ SA, 1971, BIOCHEMISTRY-US, V13, P4825; BURGERS PMJ, 1982, J BIOL CHEM, V257, P1474; BURGERS PMJ, 1982, J BIOL CHEM, V257, P1468; CHRYSOGELOS S, 1982, P NATL ACAD SCI-BIOL, V79, P5803, DOI 10.1073/pnas.79.19.5803; FAY PJ, 1981, J BIOL CHEM, V256, P976; FAY PJ, 1982, J BIOL CHEM, V257, P5692; GRIEP MA, 1990, BIOCHEMISTRY-US, V29, P9006, DOI 10.1021/bi00490a018; GRIEP MA, 1989, J BIOL CHEM, V264, P11294; HAGERMAN PJ, 1985, BIOCHEMISTRY-US, V24, P7033, DOI 10.1021/bi00346a001; JOHANSON KO, 1980, J BIOL CHEM, V255, P984; JOHANSON KO, 1982, J BIOL CHEM, V257, P2310; JOHANSON KO, 1984, J BIOL CHEM, V259, P4589; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; LADUCA RJ, 1983, BIOCHEMISTRY-US, V22, P5177, DOI 10.1021/bi00291a018; MAKI S, 1988, J BIOL CHEM, V263, P6555; MANIATIS T, 1982, MOL CLONING LABORATO, P142; MCHENRY C, 1977, J BIOL CHEM, V252, P6478; MCHENRY CS, 1982, J BIOL CHEM, V257, P2657; MCHENRY CS, 1988, ANNU REV BIOCHEM, V57, P519; MCHENRY CS, 1979, J BIOL CHEM, V254, P1748; MCHENRY CS, 1980, J SUPRAMOL STRUCT S, V4, P369; MCHENRY CS, 1986, MECHANISMS DNA REPLI, P47; MEYER RR, 1980, J BIOL CHEM, V255, P2897; MEYER RR, 1990, MICROBIOL REV, V4, P342; MOLINEUX IJ, 1975, NUCLEIC ACIDS RES, V2, P1821, DOI 10.1093/nar/2.10.1821; MUNN M, 1986, THESIS U CALIFORNIA; OBERFELDER R, 1987, J BIOL CHEM, V262, P4190; ODONNELL M, 1990, J BIOL CHEM, V265, P1179; ODONNELL ME, 1987, J BIOL CHEM, V262, P16558; REEMS JA, 1991, J BIOL CHEM, V266, P4878; STUDWELLVAUGHAN PS, 1991, J BIOL CHEM, V266, P19833; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; TU SD, 1980, GENE, V10, P177; WICKNER S, 1976, P NATL ACAD SCI USA, V73, P3511, DOI 10.1073/pnas.73.10.3511; WICKNER W, 1973, P NATL ACAD SCI USA, V70, P3679, DOI 10.1073/pnas.70.12.3679; WU CA, 1992, J BIOL CHEM, V267, P4030; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YOUSAF SI, 1984, GENE, V27, P309, DOI 10.1016/0378-1119(84)90075-1	40	15	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					33091	33096						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806536				2022-12-27	WOS:A1994QA63800054
J	AKAMA, H; JOHNSON, CAC; COLTEN, HR				AKAMA, H; JOHNSON, CAC; COLTEN, HR			HUMAN-COMPLEMENT PROTEIN C2 - ALTERNATIVE SPLICING GENERATES TEMPLATES FOR SECRETED AND INTRACELLULAR C2 PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-B; GENE-EXPRESSION; MESSENGER-RNA; GAMMA-INTERFERON; BLOOD MONOCYTES; COMPONENT C2; PLASMID DNA; BIOSYNTHESIS; CELLS; FIBROBLASTS	Alternative splicing of the primary transcript for human complement protein C2 generates templates for translation of a secreted (C2 long) protein and an intracellular (C2 short) form in liver, bronchoalveolar macrophages, and fibroblasts. The approximate ratio of C2 long to C2 short mRNA is 2:1. The C2 short mRNA does not contain the 396-base pair encompassed by exons 2 and 3 of the full-length C2 long and thus lacks codons for the 5 carboxyl-terminal residues of the signal peptide, Synthesis of C2 in cells transfected with full-length INA corresponding to each of the transcripts show that C2 long is secreted within a half-time of approximately 1 h and that C2 short is not secreted. Cell-free biosynthesis in the presence of microsomes demonstrate that this intracellular C2 protein (70 kDa) is apparently capable of traversing the membrane of the endoplasmic reticulum. Though the function of the intracellular C2 protein is unknown, it is abundant in all cell types that express the C2 gene.	WASHINGTON UNIV,SCH MED,EDWARD MALLINCKRODT DEPT PEDIAT,ST LOUIS,MO 63110	Washington University (WUSTL)					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD017461] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024836] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL37591] Funding Source: Medline; NIAID NIH HHS [AI24836] Funding Source: Medline; NICHD NIH HHS [HD17461] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BARNUM SR, 1992, BIOCHEM J, V287, P595, DOI 10.1042/bj2870595; BENTLEY DR, 1986, BIOCHEM J, V239, P339, DOI 10.1042/bj2390339; BIRNBOIM HC, 1983, METHOD ENZYMOL, V100, P243; CARROLL MC, 1984, NATURE, V307, P237, DOI 10.1038/307237a0; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHENG JH, 1994, J IMMUNOL, V152, P1774; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLE FS, 1982, IMMUNOLOGY, V46, P429; COOPER NR, 1975, BIOCHEMISTRY-US, V14, P4245, DOI 10.1021/bi00690a015; GARNIER G, 1992, J EXP MED, V175, P471, DOI 10.1084/jem.175.2.471; Garnier Gerard, 1993, Molecular Immunology, V30, P11; GILOH H, 1982, SCIENCE, V217, P1252, DOI 10.1126/science.7112126; HORIUCHI T, 1990, J BIOL CHEM, V265, P6521; ISHIKAWA N, 1990, J BIOL CHEM, V265, P19040; JOHNSON CA, 1992, J BIOL CHEM, V267, P9347; JOHNSON CA, 1992, NEW ENGL J MED, V326, P871, DOI 10.1056/NEJM199203263261306; KATZ Y, 1988, J EXP MED, V167, P1, DOI 10.1084/jem.167.1.1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPPIN DF, 1992, BIOCHEM J, V281, P437, DOI 10.1042/bj2810437; MANIATIS T, 1989, MOL CLONING LABORATO, P197; MORRIS KM, 1982, J CLIN INVEST, V70, P906, DOI 10.1172/JCI110687; NONAKA M, 1989, J IMMUNOL, V142, P1377; OGLESBY TJ, 1988, J IMMUNOL, V141, P926; PASSWELL J, 1988, J CLIN INVEST, V82, P1676, DOI 10.1172/JCI113780; PERLMUTTER DH, 1984, J BIOL CHEM, V259, P380; PERLMUTTER DH, 1985, J CLIN INVEST, V76, P1449, DOI 10.1172/JCI112123; POLLEY MJ, 1968, J EXP MED, V128, P533, DOI 10.1084/jem.128.3.533; SMITH CWJ, 1989, ANNU REV GENET, V23, P527, DOI 10.1146/annurev.genet.23.1.527; STRUNK RC, 1988, J CLIN INVEST, V81, P1419, DOI 10.1172/JCI113472; STRUNK RC, 1985, J BIOL CHEM, V260, P5280; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; WHALEY K, 1980, J EXP MED, V151, P501, DOI 10.1084/jem.151.3.501; WOODS DE, 1984, J CLIN INVEST, V74, P634, DOI 10.1172/JCI111461	34	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2674	2678		10.1074/jbc.270.6.2674	http://dx.doi.org/10.1074/jbc.270.6.2674			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852336	hybrid			2022-12-27	WOS:A1995QF53500044
J	BERGET, SM				BERGET, SM			EXON RECOGNITION IN VERTEBRATE SPLICING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PRE-MESSENGER-RNA; NUCLEAR RIBONUCLEOPROTEIN PARTICLE; SITE SELECTION; U1 SNRNP; PREMESSENGER RNA; SR-PROTEINS; INTRON; INVITRO; POLYADENYLATION; SEQUENCES				BERGET, SM (corresponding author), BAYLOR COLL MED, VERNA & MARRS MCLEAN DEPT BIOCHEM, HOUSTON, TX 77030 USA.							ABOVICH N, 1994, GENE DEV, V8, P843, DOI 10.1101/gad.8.7.843; BLACK DL, 1992, CELL, V69, P795, DOI 10.1016/0092-8674(92)90291-J; BLACK DL, 1991, GENE DEV, V5, P389, DOI 10.1101/gad.5.3.389; BOELENS WC, 1993, CELL, V72, P881, DOI 10.1016/0092-8674(93)90577-D; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; CAROTHERS AM, 1993, MOL CELL BIOL, V13, P5085, DOI 10.1128/MCB.13.8.5085; CHEN IT, 1994, MOL CELL BIOL, V14, P2140, DOI 10.1128/MCB.14.3.2140; COOPER TA, 1989, NUCLEIC ACIDS RES, V17, P7905, DOI 10.1093/nar/17.19.7905; DIRKSEN WP, 1994, J BIOL CHEM, V269, P6431; DOMINSKI Z, 1992, MOL CELL BIOL, V12, P2108, DOI 10.1128/MCB.12.5.2108; DOMINSKI Z, 1991, MOL CELL BIOL, V11, P6075, DOI 10.1128/MCB.11.12.6075; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; EPERON IC, 1993, EMBO J, V12, P3607, DOI 10.1002/j.1460-2075.1993.tb06034.x; FU XD, 1992, P NATL ACAD SCI USA, V89, P11224, DOI 10.1073/pnas.89.23.11224; GRABOWSKI PJ, 1991, MOL CELL BIOL, V11, P5919, DOI 10.1128/MCB.11.12.5919; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; GUTHRIE C, 1991, SCIENCE, V253, P157, DOI 10.1126/science.1853200; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; HEDLEY ML, 1991, CELL, V65, P579, DOI 10.1016/0092-8674(91)90090-L; HOFFMAN BE, 1992, GENE DEV, V6, P2554, DOI 10.1101/gad.6.12b.2554; INOUE K, 1992, P NATL ACAD SCI USA, V88, P683; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; JAMISON SF, 1992, MOL CELL BIOL, V12, P4279, DOI 10.1128/MCB.12.10.4279; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; KUO HC, 1991, SCIENCE, V251, P1045, DOI 10.1126/science.1825520; LAMOND AI, 1987, GENE DEV, V1, P532, DOI 10.1101/gad.1.6.532; LAVIGUEUR A, 1993, GENE DEV, V7, P2405, DOI 10.1101/gad.7.12a.2405; LIAO XLC, 1993, GENE DEV, V7, P419, DOI 10.1101/gad.7.3.419; LUTZ CS, 1994, GENE DEV, V8, P576, DOI 10.1101/gad.8.5.576; MANLEY JL, 1994, GENE DEV, V8, P259, DOI 10.1101/gad.8.3.259; MARDON HJ, 1987, NUCLEIC ACIDS RES, V15, P7725, DOI 10.1093/nar/15.19.7725; MICHAUD S, 1993, GENE DEV, V7, P1008, DOI 10.1101/gad.7.6.1008; MING G, 1993, MOL CELL BIOL, V13, P1104, DOI 10.1128/MCB.13.2.1104; Moore M., 1993, RNA WORLD, P303; MOUNT SM, 1992, NUCLEIC ACIDS RES, V20, P4255, DOI 10.1093/nar/20.16.4255; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; NIWA M, 1990, GENE DEV, V4, P1552, DOI 10.1101/gad.4.9.1552; NIWA M, 1991, GENE DEV, V5, P2086, DOI 10.1101/gad.5.11.2086; OACERES JF, 1994, SCIENCE, V265, P1706; OHNO M, 1987, P NATL ACAD SCI USA, V84, P5187, DOI 10.1073/pnas.84.15.5187; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; ROSBASH M, 1991, TRENDS BIOCHEM SCI, V16, P187, DOI 10.1016/0968-0004(91)90073-5; RUBY SW, 1991, TRENDS GENET, V7, P79; RYNER LC, 1991, GENE DEV, V5, P2071, DOI 10.1101/gad.5.11.2071; STAKNIS D, 1994, MOL CELL BIOL, V14, P7670, DOI 10.1128/MCB.14.11.7670; STAMM S, 1994, NUCLEIC ACIDS RES, V22, P1515, DOI 10.1093/nar/22.9.1515; STERNER DA, 1993, MOL CELL BIOL, V13, P2677, DOI 10.1128/MCB.13.5.2677; STREULI M, 1989, EMBO J, V8, P787, DOI 10.1002/j.1460-2075.1989.tb03439.x; TALERICO M, 1994, MOL CELL BIOL, V14, P3434, DOI 10.1128/MCB.14.5.3434; TALERICO M, 1990, MOL CELL BIOL, V10, P6299, DOI 10.1128/MCB.10.12.6299; TIAN M, 1994, GENE DEV, V8, P1703, DOI 10.1101/gad.8.14.1703; TSUKAHARA T, 1994, NUCLEIC ACIDS RES, V22, P2318, DOI 10.1093/nar/22.12.2318; WASSARMAN KM, 1993, GENE DEV, V7, P647, DOI 10.1101/gad.7.4.647; WATAKABE A, 1993, GENE DEV, V7, P407, DOI 10.1101/gad.7.3.407; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; XU RS, 1993, MOL CELL BIOL, V13, P3660, DOI 10.1128/MCB.13.6.3660; YANG XM, 1994, P NATL ACAD SCI USA, V91, P6924, DOI 10.1073/pnas.91.15.6924; YEAKLEY JM, 1993, MOL CELL BIOL, V13, P5999, DOI 10.1128/MCB.13.10.5999; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; ZHANG MQ, 1994, NUCLEIC ACIDS RES, V22, P1750, DOI 10.1093/nar/22.9.1750; ZUO P, 1994, P NATL ACAD SCI USA, V91, P3363, DOI 10.1073/pnas.91.8.3363	61	855	869	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2411	2414		10.1074/jbc.270.6.2411	http://dx.doi.org/10.1074/jbc.270.6.2411			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852296	hybrid			2022-12-27	WOS:A1995QF53500001
J	GAZIT, E; SHAI, Y				GAZIT, E; SHAI, Y			THE ASSEMBLY AND ORGANIZATION OF THE ALPHA-5 AND ALPHA-7 HELICES FROM THE PORE-FORMING DOMAIN OF BACILLUS-THURINGIENSIS DELTA-ENDOTOXIN - RELEVANCE TO A FUNCTIONAL-MODEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE ENERGY-TRANSFER; PLANAR LIPID BILAYERS; PHOSPHOLIPID-MEMBRANES; PEPTIDE ALAMETHICIN; CIRCULAR-DICHROISM; SELECTIVE CHANNELS; VAR ISRAELENSIS; SODIUM-CHANNEL; PROTEIN; SPECIFICITY	The pore-forming domain of Bacillus thuringiensis insecticidal CryIIIA delta-endotoxin contains two helices, alpha 5 and alpha 7, that are highly conserved within all different Cry S-endotoxins, To gain information on the mode of action of delta-endotoxins, we have used a spectrofluorimetric approach and characterized the structure, the organization state, and the ability to self-assemble and to co-assemble within lipid membranes of alpha 5 and alpha 7. Circular dichroism (CD) spectroscopy revealed that alpha 7 adopts a predominantly alpha-helical structure in methanol, similar to what has been found for alpha 5, and consistent with its structure in the intact molecule, The hydrophobic moment of alpha 7 is higher than that calculated for alpha 5; however, alpha 7 has a lesser ability to permeate phospholipids as compared to alpha 5. Binding experiments with 7-nitrobenz-2-oxa-1,3-diazole-4-yl (NBD)-labeled peptide demonstrated that alpha 7 binds to phospholipid vesicles with a partition coefficient in the order of 10(4) M(-1) similar to alpha 5, but with reduced kinetics and in a noncooperative manner, as opposed to the fast kinetics and cooperativity found with (alpha 5. Resonance energy transfer measurements between fluorescently labeled pairs of donor (NBD)/acceptor (rhodamine) peptides revealed that, in their membrane bound state, alpha 5 self-associates but alpha 7 does not, and that (alpha 5 coassembles with alpha 7 but not with an unrelated membrane bound alpha-helical peptide, Furthermore, resonance energy transfer experiments, using alpha 5 segments, specifically labeled in either the Nor C-terminal sides, suggest a parallel organization of alpha 5 monomers within the membranes, Taken together the results are consistent with an umbrella model suggested for the pore forming activity of delta-endotoxin (Li, J., Caroll, J., and Ellar, D. J. (1991) Nature 353, 815-821), where alpha 5 has transmembrane localization and may be part of the pore lining segment(s) while alpha 7 may serve as a binding sensor that initiates the binding of the pore domain to the membrane.	WEIZMANN INST SCI, DEPT MEMBRANE RES & BIOPHYS, IL-76100 REHOVOT, ISRAEL	Weizmann Institute of Science			Gazit, Ehud/C-3715-2011; Gazit, Ehud/AHE-9332-2022; Gazit, Ehud/M-8026-2019	Gazit, Ehud/0000-0001-5764-1720; Gazit, Ehud/0000-0001-5764-1720				AHMAD W, 1990, FEMS MICROBIOL LETT, V68, P97, DOI 10.1111/j.1574-6968.1990.tb04130.x; ANGSUTHANASOMBAT C, 1993, FEMS MICROBIOL LETT, V111, P255; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P52, DOI 10.1021/bi00453a007; BIBI E, 1990, P NATL ACAD SCI USA, V87, P4325, DOI 10.1073/pnas.87.11.4325; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; CUMMINGS CE, 1994, MOL MEMBR BIOL, V11, P87, DOI 10.3109/09687689409162225; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; ENGLISH L, 1992, INSECT BIOCHEM MOLEC, V22, P1, DOI 10.1016/0965-1748(92)90093-T; Forster T., 1959, DISCUSS FARADAY SOC, V27, P7, DOI DOI 10.1039/DF9592700007; FREY S, 1990, BIOCHEM J, V272, P713, DOI 10.1042/bj2720713; FUNG BKK, 1978, BIOCHEMISTRY-US, V17, P5241, DOI 10.1021/bi00617a025; GAZIT E, 1993, BIOCHEMISTRY-US, V32, P12363, DOI 10.1021/bi00097a013; GAZIT E, 1993, BIOCHEMISTRY-US, V32, P3429, DOI 10.1021/bi00064a029; GAZIT E, 1994, BIOCHEMISTRY-US, V33, P10681, DOI 10.1021/bi00201a016; GE AZ, 1989, P NATL ACAD SCI USA, V86, P4037, DOI 10.1073/pnas.86.11.4037; GILL SS, 1992, ANNU REV ENTOMOL, V37, P615, DOI 10.1146/annurev.en.37.010192.003151; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; HAIDER MZ, 1989, BIOCHIM BIOPHYS ACTA, V978, P216, DOI 10.1016/0005-2736(89)90118-1; Hodgman T C, 1990, DNA Seq, V1, P97, DOI 10.3109/10425179009016037; HOFMANN C, 1988, P NATL ACAD SCI USA, V85, P7844, DOI 10.1073/pnas.85.21.7844; HOFTE H, 1989, MICROBIOL REV, V53, P242; INOUYE M, 1974, P NATL ACAD SCI USA, V71, P2396, DOI 10.1073/pnas.71.6.2396; KAHN TW, 1992, BIOCHEMISTRY-US, V31, P6144, DOI 10.1021/bi00141a027; KENNER RA, 1971, BIOCHEMISTRY-US, V10, P4433, DOI 10.1021/bi00800a013; KNOWLES BH, 1993, BIOESSAYS, V15, P469, DOI 10.1002/bies.950150706; KNOWLES BH, 1994, ADV INSECT PHYSIOL, V24, P275, DOI 10.1016/S0065-2806(08)60085-5; KNOWLES BH, 1987, BIOCHIM BIOPHYS ACTA, V924, P509, DOI 10.1016/0304-4165(87)90167-X; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; LAKEY JH, 1991, J MOL BIOL, V218, P639, DOI 10.1016/0022-2836(91)90707-D; LEAR JD, 1988, SCIENCE, V240, P1177, DOI 10.1126/science.2453923; LEE MK, 1992, J BIOL CHEM, V267, P3115; LEMON MA, 1992, CURR OPIN STRUC BIOL, V2, P511; LI J, 1992, CURR OPIN STRUC BIOL, V2, P545; LI JD, 1991, NATURE, V353, P815, DOI 10.1038/353815a0; LIAO MJ, 1984, J BIOL CHEM, V259, P4200; LOEW LM, 1983, BIOCHEMISTRY-US, V22, P837, DOI 10.1021/bi00273a020; MADDRELL SHP, 1989, J CELL SCI, V94, P601; MAO D, 1984, BIOCHEMISTRY-US, V23, P2667, DOI 10.1021/bi00307a020; MATSUZAKI K, 1989, BIOCHIM BIOPHYS ACTA, V981, P130, DOI 10.1016/0005-2736(89)90090-4; MERRIFIELD RB, 1982, BIOCHEMISTRY-US, V21, P5020, DOI 10.1021/bi00263a028; PAPAHADJ.D, 1967, BIOCHIM BIOPHYS ACTA, V135, P624, DOI 10.1016/0005-2736(67)90094-6; PARKER MW, 1993, TRENDS BIOCHEM SCI, V18, P391, DOI 10.1016/0968-0004(93)90096-6; POPOT JL, 1987, J MOL BIOL, V198, P655, DOI 10.1016/0022-2836(87)90208-7; POUNY Y, 1992, BIOCHEMISTRY-US, V31, P12416, DOI 10.1021/bi00164a017; RAJARATHNAM K, 1989, BIOCHEMISTRY-US, V28, P3168, DOI 10.1021/bi00434a009; RAPAPORT D, 1991, J BIOL CHEM, V266, P23769; RAPAPORT D, 1992, J BIOL CHEM, V267, P6502; RIZZO V, 1987, BIOCHEMISTRY-US, V26, P2751, DOI 10.1021/bi00384a015; SACCHI VF, 1986, FEBS LETT, V204, P213, DOI 10.1016/0014-5793(86)80814-6; SAHINTOTH M, 1993, BIOCHEMISTRY-US, V32, P10027, DOI 10.1021/bi00089a019; SCHWARTZ JL, 1993, J MEMBRANE BIOL, V132, P53, DOI 10.1007/BF00233051; SCHWARTZ JL, 1991, BIOCHIM BIOPHYS ACTA, V1065, P250, DOI 10.1016/0005-2736(91)90237-3; SCHWARZ G, 1986, BIOCHIM BIOPHYS ACTA, V861, P141, DOI 10.1016/0005-2736(86)90412-8; SCHWARZ G, 1987, BIOPHYS J, V52, P685, DOI 10.1016/S0006-3495(87)83263-0; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; SHAI Y, 1990, J BIOL CHEM, V265, P20202; SHAI Y, 1991, J BIOL CHEM, V266, P22346; SIMS PJ, 1974, BIOCHEMISTRY-US, V13, P3315, DOI 10.1021/bi00713a022; SLATIN SL, 1990, BIOCHEM BIOPH RES CO, V169, P765, DOI 10.1016/0006-291X(90)90397-6; STANKOWSKI S, 1990, BIOCHIM BIOPHYS ACTA, V1025, P164, DOI 10.1016/0005-2736(90)90094-5; THIAUDIERE E, 1991, EUR J BIOCHEM, V195, P203, DOI 10.1111/j.1432-1033.1991.tb15696.x; TOSTESON MT, 1981, BIOPHYS J, V36, P109, DOI 10.1016/S0006-3495(81)84719-4; VANRIE J, 1990, SCIENCE, V247, P72, DOI 10.1126/science.2294593; WALTERS FS, 1993, BIOCHEM BIOPH RES CO, V196, P921, DOI 10.1006/bbrc.1993.2337; WU CSC, 1981, BIOCHEMISTRY-US, V20, P566, DOI 10.1021/bi00506a019; WU D, 1992, J BIOL CHEM, V267, P2311; YUNOVITZ H, 1988, FEBS LETT, V230, P105, DOI 10.1016/0014-5793(88)80651-3	71	78	87	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2571	2578		10.1074/jbc.270.6.2571	http://dx.doi.org/10.1074/jbc.270.6.2571			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852320	hybrid			2022-12-27	WOS:A1995QF53500028
J	GOODE, NT; HAJIBAGHERI, MAN; PARKER, PJ				GOODE, NT; HAJIBAGHERI, MAN; PARKER, PJ			PROTEIN-KINASE-C (PKC)-INDUCED PKC DOWN-REGULATION - ASSOCIATION WITH UP-REGULATION OF VESICLE TRAFFIC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR GENETIC-ANALYSIS; SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; GH4C1 CELLS; ACTIVATION; ZETA; ISOZYMES; GAMMA; ALPHA; PURIFICATION	Phorbol esters cause long term activation of protein kinase C (PKC) and frequently the down-regulation of PKC protein levels in mammalian cells. Mammalian PKC-gamma, -delta, and -eta down-regulate in response to phorbol esters when expressed in Schizosaccharomyces pombe. However, PKC-epsilon does not down-regulate in S. pombe, in contrast to the behavior of this isotype in mammalian cells. Go-expression of PKC-gamma or -delta with PKC-epsilon in S. pombe renders PKC-epsilon susceptible to down-regulation. A protein kinase defective form of PKC-delta does not downregulate efficiently in S. pombe but, like PKC-epsilon, is susceptible when co-expressed with PKC-gamma or full-length PKC-delta. Thus, down-regulation is a consequence of the catalytic function of certain PKC isotypes with other isotypes being affected in trans, PKC down-regulation parallels a striking accumulation of Vesicles in S. pombe, suggesting a direct relationship between these events.	IMPERIAL CANC RES FUND, ELECTRON MICROSCOPY UNIT, LONDON WC2A 3PX, ENGLAND; IMPERIAL CANC RES FUND, PROT PHOSPHORYLAT LAB, LONDON WC2A 3PX, ENGLAND	Cancer Research UK; Cancer Research UK	GOODE, NT (corresponding author), UNIV LONDON ROYAL COLL VET SURG, DEPT VET BASIC SCI, ROYAL COLL ST, LONDON NW1 0TU, ENGLAND.		Parker, Peter j/D-5192-2013	parker, peter/0000-0002-6218-2933				ASHENDEL CL, 1985, BIOCHIM BIOPHYS ACTA, V822, P219, DOI 10.1016/0304-4157(85)90009-7; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; BELL RM, 1991, J BIOL CHEM, V266, P4661; CAZAUBON S, 1989, EUR J BIOCHEM, V182, P401, DOI 10.1111/j.1432-1033.1989.tb14845.x; FREISEWINKEL I, 1991, FEBS LETT, V280, P262, DOI 10.1016/0014-5793(91)80307-O; GOODE NT, 1994, MOL BIOL CELL, V5, P907, DOI 10.1091/mbc.5.8.907; GOODE NT, 1994, FEBS LETT, V340, P145, DOI 10.1016/0014-5793(94)80190-8; GRUENBERG J, 1992, Current Opinion in Cell Biology, V4, P593, DOI 10.1016/0955-0674(92)90077-P; GSCHWENDT M, 1992, FEBS LETT, V307, P151, DOI 10.1016/0014-5793(92)80756-7; HUANG KP, 1989, TRENDS NEUROSCI, V12, P425, DOI 10.1016/0166-2236(89)90091-X; JUNCO M, 1994, EUR J BIOCHEM, V223, P259, DOI 10.1111/j.1432-1033.1994.tb18990.x; KAIBUCHI K, 1989, J BIOL CHEM, V264, P13489; KILEY SC, 1991, J BIOL CHEM, V266, P23761; KILEY SC, 1992, MOL ENDOCRINOL, V6, P120, DOI 10.1210/me.6.1.120; KISHIMOTO A, 1989, J BIOL CHEM, V264, P4088; KOCHS G, 1993, EUR J BIOCHEM, V216, P597, DOI 10.1111/j.1432-1033.1993.tb18179.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MURRAY AW, 1987, TRENDS BIOCHEM SCI, V12, P53, DOI 10.1016/0968-0004(87)90026-0; NAKANISHI H, 1992, J BIOL CHEM, V267, P16347; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; OHNO S, 1990, J BIOL CHEM, V265, P6296; OLIVIER AR, 1992, J CELL PHYSIOL, V152, P240, DOI 10.1002/jcp.1041520204; OLIVIER AR, 1994, J BIOL CHEM, V269, P2758; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; PATEL G, 1989, CELL SIGNAL, V1, P227, DOI 10.1016/0898-6568(89)90040-5; PEARS C, 1991, FEBS LETT, V284, P120, DOI 10.1016/0014-5793(91)80776-Y; PRYER NK, 1992, ANNU REV BIOCHEM, V61, P471; RHEE SG, 1992, J BIOL CHEM, V267, P12393; RODRIGUEZPENA A, 1984, BIOCHEM BIOPH RES CO, V120, P1053, DOI 10.1016/S0006-291X(84)80213-2; STABEL S, 1991, PHARMACOL THERAPEUT, V51, P71, DOI 10.1016/0163-7258(91)90042-K; WAYS DK, 1992, J BIOL CHEM, V267, P4799; YOUNG S, 1987, BIOCHEM J, V244, P775, DOI 10.1042/bj2440775; ZIDOVETZKI R, 1992, BIOCHIM BIOPHYS ACTA, V1134, P261, DOI 10.1016/0167-4889(92)90185-E; [No title captured]	37	49	49	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2669	2673		10.1074/jbc.270.6.2669	http://dx.doi.org/10.1074/jbc.270.6.2669			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852335	hybrid			2022-12-27	WOS:A1995QF53500043
J	SUN, XY; ELIASSON, R; PONTIS, E; ANDERSSON, J; BUIST, G; SJOBERG, BM; REICHARD, P				SUN, XY; ELIASSON, R; PONTIS, E; ANDERSSON, J; BUIST, G; SJOBERG, BM; REICHARD, P			GENERATION OF THE GLYCYL RADICAL OF THE ANAEROBIC ESCHERICHIA-COLI RIBONUCLEOTIDE REDUCTASE REQUIRES A SPECIFIC ACTIVATING ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROTEIN; SEQUENCE; GENE; IRON	The anaerobic ribonucleotide reductase from Escherichia coli contains a glycyl radical as part of its polypeptide structure. The radical is generated by an enzyme system present in E. coli. The reductase is coded for by the nrdD gene located at 96 min. Immediately downstream, we now find an open reading frame with the potential to code for a 17.5-kDa protein with sequence homology to a protein required for the generation of the glycyl radical of pyruvate formate lyase, The protein corresponding to this open reading frame is required for the generation of the glycyl radical of the anaerobic reductase and binds tightly to the reductase, The ''activase'' contains iron, required for activity, The general requirements for generation of a glycyl radical are identical for the reductase and pyruvate formate lyase. For the reductase, the requirement of an iron-containing activase suggests the possibility that the iron-sulfur cluster of the enzyme is not involved in radical generation but may participate directly in the reduction of the ribonucleotide.	KAROLINSKA INST,MBB,MED NOBEL INST,DEPT BIOCHEM 1,S-17177 STOCKHOLM,SWEDEN; UNIV GRONINGEN,DEPT GENET,9741 NN HAREN,NETHERLANDS	Karolinska Institutet; University of Groningen				Sjoberg, Britt-Marie/0000-0001-5953-3360				ATKIN CL, 1973, J BIOL CHEM, V248, P7464; BIANCHI V, 1993, J BACTERIOL, V175, P1590, DOI 10.1128/JB.175.6.1590-1595.1993; BIANCHI V, 1993, BIOCHEM BIOPH RES CO, V197, P792, DOI 10.1006/bbrc.1993.2548; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; ELIASSON R, 1992, J BIOL CHEM, V267, P25541; FREY M, 1994, J BIOL CHEM, V269, P12432; HARDER J, 1992, J BIOL CHEM, V267, P25548; Higuchi R., 1989, PCR TECHNOLOGY, P61; HOLM RH, 1976, BIOL ASPECTS INORGAN, P71; MULLIEZ E, 1993, J BIOL CHEM, V268, P2296; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; REICHARD P, 1993, J BIOL CHEM, V268, P8383; REICHARD P, 1993, SCIENCE, V260, P1773, DOI 10.1126/science.8511586; STUBBE JA, 1989, ANNU REV BIOCHEM, V58, P257; SUN XY, 1993, P NATL ACAD SCI USA, V90, P577, DOI 10.1073/pnas.90.2.577; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; WAGNER AFV, 1992, P NATL ACAD SCI USA, V89, P996, DOI 10.1073/pnas.89.3.996; WONG KK, 1993, BIOCHEMISTRY-US, V32, P14102, DOI 10.1021/bi00214a005; YOUNG P, 1994, J BIOL CHEM, V269, P27815	20	77	81	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2443	2446		10.1074/jbc.270.6.2443	http://dx.doi.org/10.1074/jbc.270.6.2443			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852304	hybrid			2022-12-27	WOS:A1995QF53500009
J	GOROVITS, B; RAMAN, CS; HOROWITZ, PM				GOROVITS, B; RAMAN, CS; HOROWITZ, PM			HIGH HYDROSTATIC-PRESSURE INDUCES THE DISSOCIATION OF CPN60 TETRADECAMERS AND REVEALS A PLASTICITY OF THE MONOMERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSIBLE DISSOCIATION; GROEL; CARBOXYLASE; NUCLEOTIDES; HYDROLYSIS; DEPENDENCE; RHODANESE; PROTEINS; MUTATION; CYCLE	Hydrostatic pressures up to 2 kbar have been used to form monomers from the 14-subunit oligomer of the chaperonin, Cpn60. The fluorescence of 1,1'-bi(4-anilino)naphthalene-5,5'-disulfonic acid (bisANS), followed at high pressure, demonstrated an increase in hydrophobic exposure on dissociation, Cpn60 dissociated with first order kinetics, The transition occurred between 1.3 and 2 kbar (P-50 = 1.75 kbar), and it was facilitated by MgATP (P-50 = 1.1 kbar), With MgATP, the fluorescence showed a rapid first order phase (t1/2 = 3.7 min) in addition to a phase that was similar to the single phase for Cpn60 alone (t1/2 = 11.4 min), The bisANS fluorescence decreased slowly after depressurization, and the relaxation was faster at 25 degrees C (t1/2 = 58 h) than at 4 degrees C (t1/2 = 86 h) and faster still if the sample at 4 degrees C contained MgATP when it was pressurized (t1/2 = 18 h). There was no significant effect if the MgATP was added after depressurization, Analytical ultracentrifugation, after depressurization, confirmed that metastable monomers were produced that slowly reassociated to form the oligomers (t1/2 = 150 h at 25 degrees C), Immediately after depressurization, the monomers (a) had all three sulfhydryl groups exposed for labeling with 6-iodoacetamidofluorescein, (5) showed a proteolytic susceptibility that was intermediate between native Cpn60 and Cpn60 in 2.5 M urea, and (c) were not able to capture a folding intermediate of the enzyme rhodanese, After incubation at atmospheric pressure, monomeric Cpn60 regained the ability to interact with rhodanese intermediates, and the sulfhydryl reactivity fell before significantly reassociating to 14-mers, The different rates of recovery of the native properties indicate that a complex series of conformational events occur following depressurization. Finally, the monomers resulting from pressure were different from those produced from Cpn60 by the action of 2.5 M urea, These results demonstrate that there is a fast, pressure-induced dissociation of the Cpn60 14-mer followed by a conformational drift of the dissociated monomers that can be influenced by the presence of MgATP.	UNIV TEXAS, HLTH SCI CTR, DEPT BIOCHEM, SAN ANTONIO, TX 78284 USA	University of Texas System; University of Texas Health San Antonio				Raman, C. S./0000-0002-1036-3193	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025177] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES05729] Funding Source: Medline; NIGMS NIH HHS [GM25177] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANEYX F, 1992, J BIOL CHEM, V267, P11637; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; ERIJMAN L, 1993, BIOCHEMISTRY-US, V32, P5187, DOI 10.1021/bi00070a030; ERIJMAN L, 1991, BIOCHEMISTRY-US, V30, P1595, DOI 10.1021/bi00220a022; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HOROVITZ A, 1993, J MOL BIOL, V231, P58, DOI 10.1006/jmbi.1993.1256; HOROWITZ PM, 1978, ANAL BIOCHEM, V86, P751, DOI 10.1016/0003-2697(78)90803-5; JACKSON GS, 1993, BIOCHEMISTRY-US, V32, P2554, DOI 10.1021/bi00061a013; JAMESON DM, 1987, BIOCHEMISTRY-US, V26, P3894, DOI 10.1021/bi00387a023; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; LISSIN NM, 1993, FEBS LETT, V324, P41, DOI 10.1016/0014-5793(93)81528-8; MARTIN J, 1993, NATURE, V366, P228, DOI 10.1038/366228a0; MENDOZA JA, 1991, J BIOL CHEM, V266, P13044; MENDOZA JA, 1994, J BIOL CHEM, V269, P2447; NEUMAN RC, 1973, J PHYS CHEM-US, V77, P2687, DOI 10.1021/j100640a025; PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; SILVA JL, 1989, J BIOL CHEM, V264, P15863; SILVA JL, 1986, BIOCHEMISTRY-US, V25, P5780, DOI 10.1021/bi00367a065; SORBO BH, 1953, ACTA CHEM SCAND, V7, P1129, DOI 10.3891/acta.chem.scand.07-1129; TAGUCHI H, 1994, J BIOL CHEM, V269, P8529; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003; WEBER G, 1983, Q REV BIOPHYS, V16, P89, DOI 10.1017/S0033583500004935; WEBER G, 1992, PROTEIN INTERACTIONS, P211	28	37	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2061	2066		10.1074/jbc.270.5.2061	http://dx.doi.org/10.1074/jbc.270.5.2061			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836434	hybrid			2022-12-27	WOS:A1995QE49300015
J	ISHIDA, A; FUJISAWA, H				ISHIDA, A; FUJISAWA, H			STABILIZATION OF CALMODULIN-DEPENDENT PROTEIN-KINASE-II THROUGH THE AUTOINHIBITORY DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; MOLECULAR-CLONING; CA-2+-INDEPENDENT ACTIVITY; AUTOPHOSPHORYLATION SITES; SMOOTH-MUSCLE; MUTANT MICE; BRAIN; ACTIVATION; INHIBITION; MYOSIN	The active 30-kDa chymotryptic fragment of calmodulin dependent protein kinase II (CaM kinase II), devoid of the autoinhibitory domain, and the enzyme, autothiophosphorylated at Thr(286)/Thr(287), were much more labile than was the original native enzyme. They were markedly stabilized by synthetic peptides, designed after the sequence around the autophosphorylation site in the autoinhibitory domain, such as autocamtide-2 and CaMK-(281-309), but such marked stabilizations were not observed with the ordinary exogenous substrates, such as syntide-2. These results suggest that the autoinhibitory domain of CaM kinase II plays a crucial role in stabilizing the enzyme, A nonphosphorylatable analog of autocamtide-2, AIP, strongly inhibited the activity of the 30-kDa fragment, Kinetic analysis revealed that the inhibition by AIP was competitive with respect to autocamtide-2 and CaMK-(281-289) and noncompetitive with respect to syntide-2 and ATP/Mg2+, suggesting that CaM kinase II possesses at least two distinct substrate-binding sites; one for ordinary exogenous substrates such as syntide-2 and the other for an endogenous substrate, the autophosphorylation site (Thr(286)/Thr(287)) in the autoinhibitory domain, Fluorescence analysis of the binding of 7-nitrobenz-2-oxa-1,3-diazole-4-yl labeled AIP to the 30-kDa fragment also supported this contention, Thus, the autoinhibitory domain appears to play a crucial role in keeping the enzyme stable by binding to the substrate-binding site for the autophosphorylation site.			ISHIDA, A (corresponding author), ASAHIKAWA MED COLL,DEPT BIOCHEM,ASAHIKAWA 078,HOKKAIDO,JAPAN.							ALLEGRINI PR, 1983, EUR J BIOCHEM, V132, P603, DOI 10.1111/j.1432-1033.1983.tb07406.x; BENFENATI F, 1992, NATURE, V359, P419; BENNETT MK, 1987, P NATL ACAD SCI USA, V84, P1794, DOI 10.1073/pnas.84.7.1794; BULLEIT RF, 1988, NEURON, V1, P63, DOI 10.1016/0896-6273(88)90210-3; CHAMBERLAIN JP, 1979, ANAL BIOCHEM, V98, P132, DOI 10.1016/0003-2697(79)90716-4; Colbran R J, 1990, Curr Top Cell Regul, V31, P181; COLBRAN RJ, 1988, J BIOL CHEM, V263, P18145; COLBRAN RJ, 1989, J BIOL CHEM, V264, P4800; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; EBASHI S, 1976, J BIOCHEM-TOKYO, V79, P229, DOI 10.1093/oxfordjournals.jbchem.a131052; FAUX MC, 1993, J BIOL CHEM, V268, P12484; FUJISAWA H, 1990, BIOESSAYS, V12, P27, DOI 10.1002/bies.950120106; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; HASHIMOTO Y, 1987, ARCH BIOCHEM BIOPHYS, V252, P418, DOI 10.1016/0003-9861(87)90048-8; HVALBY O, 1994, P NATL ACAD SCI USA, V91, P4761, DOI 10.1073/pnas.91.11.4761; IKEDA A, 1991, J BIOL CHEM, V266, P11582; ISHIDA A, 1994, J BIOCHEM-TOKYO, V115, P1075, DOI 10.1093/oxfordjournals.jbchem.a124460; KATOH T, 1991, BIOCHIM BIOPHYS ACTA, V1091, P205, DOI 10.1016/0167-4889(91)90063-4; KATOH T, 1991, J BIOL CHEM, V266, P3039; KNIGHTON DR, 1992, SCIENCE, V258, P130, DOI 10.1126/science.1439761; KURET J, 1985, J BIOL CHEM, V260, P6427; KWIATKOWSKI AP, 1988, J BIOL CHEM, V263, P6484; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI Y, 1986, P NATL ACAD SCI USA, V83, P4253, DOI 10.1073/pnas.83.12.4253; LIN CR, 1987, P NATL ACAD SCI USA, V84, P5962, DOI 10.1073/pnas.84.16.5962; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; LOU LL, 1989, J NEUROSCI, V9, P2020; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; MILLER SG, 1988, NEURON, V1, P593, DOI 10.1016/0896-6273(88)90109-2; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; PEARS CJ, 1990, EUR J BIOCHEM, V194, P89, DOI 10.1111/j.1432-1033.1990.tb19431.x; PERRIE WT, 1970, BIOCHEM J, V119, P31, DOI 10.1042/bj1190031; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PIOMELLI D, 1989, P NATL ACAD SCI USA, V86, P8550, DOI 10.1073/pnas.86.21.8550; RAPAPORT D, 1991, J BIOL CHEM, V266, P23769; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; SCHWORER CM, 1988, J BIOL CHEM, V263, P13486; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SODERLING TR, 1990, J BIOL CHEM, V265, P1823; THIEL G, 1988, P NATL ACAD SCI USA, V85, P6337, DOI 10.1073/pnas.85.17.6337; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; TOBIMATSU T, 1988, J BIOL CHEM, V263, P16082; YAMAGATA Y, 1991, J BIOL CHEM, V266, P15391; YAMAUCHI T, 1980, FEBS LETT, V116, P141, DOI 10.1016/0014-5793(80)80628-4; YAMAUCHI T, 1983, EUR J BIOCHEM, V132, P15, DOI 10.1111/j.1432-1033.1983.tb07319.x; YAMAUCHI T, 1981, BIOCHEM BIOPH RES CO, V100, P807, DOI 10.1016/S0006-291X(81)80246-X; YAMAUCHI T, 1985, BIOCHEM BIOPH RES CO, V129, P213, DOI 10.1016/0006-291X(85)91424-X	53	70	79	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2163	2170		10.1074/jbc.270.5.2163	http://dx.doi.org/10.1074/jbc.270.5.2163			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836445	hybrid			2022-12-27	WOS:A1995QE49300030
J	OUSPENSKI, II; MUELLER, UW; MATYNIA, A; SAZER, S; ELLEDGE, SJ; BRINKLEY, BR				OUSPENSKI, II; MUELLER, UW; MATYNIA, A; SAZER, S; ELLEDGE, SJ; BRINKLEY, BR			RAN-BINDING PROTEIN-1 IS AN ESSENTIAL COMPONENT OF THE RAN RCC1 MOLECULAR SWITCH SYSTEM IN BUDDING YEAST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MITOTIC CHROMOSOME TRANSMISSION; SACCHAROMYCES-CEREVISIAE; S-CEREVISIAE; RCC1; FIDELITY; MUTANTS; MAINTENANCE; RAN/TC4; GENES; PRP20	We have performed a screen for genes that affect chromosome stability when overexpressed in the budding yeast Saccharomyces cerevisiae, Two of the genes recovered in the screen, CST17 and CST20, share a number of phenotypic properties, suggesting their involvement in the same cellular process, DNA sequence analysis of these genes revealed that they encode components of the Ran/RCC1 molecular switch system: CST17 is Ran itself (Ras-like nuclear protein) and CST20 is a novel yeast protein with a high degree of similarity to mammalian RanBP1, which is known to interact with Ran-GTP in vitro, We demonstrate that the CST20 protein can interact with Ran-GTP in vitro under similar conditions, indicating that it is the functional yeast homolog of mammalian RanBP1, The results of immunoprecipitation experiments show that the two yeast proteins form a complex in vivo. Deletion of the gene encoding RanBP1 revealed that it is essential for viability, as are Ran and RCC1, Similar phenotypic consequences of overproduction of either Ran or RanBP1 indicate that the latter protein is a functional component of the Ran/RCC1 molecular switch system, which is implicated in the control of a number of nuclear functions, Our finding that overproduction of two components of this system results in mitotic chromosome nondisjunction and sensitivity to an anti-microtubule drug benomyl suggest their involvement in mitosis as well, Thus RanBP1 is a functional component of a highly conserved molecular system that affects diverse cellular processes. The availability of this gene in S, cerevisiae provides a genetic system for the analysis of RanBP1 function in vivo.	BAYLOR COLL MED, DEPT BIOCHEM, HOUSTON, TX 77030 USA; BAYLOR COLL MED, INST MOLEC GENET, HOUSTON, TX 77030 USA; BAYLOR COLL MED, HOWARD HUGHES MED INST, HOUSTON, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	OUSPENSKI, II (corresponding author), BAYLOR COLL MED, DEPT CELL BIOL, 126A, 1 BAYLOR PLAZA, HOUSTON, TX 77030 USA.				NCI NIH HHS [CA41424] Funding Source: Medline; NIGMS NIH HHS [GM44664, GM49119] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA041424, R37CA041424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044664, R37GM044664, R01GM049119] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AEBI M, 1990, MOL GEN GENET, V224, P72, DOI 10.1007/BF00259453; AMBERG DC, 1993, EMBO J, V12, P233, DOI 10.1002/j.1460-2075.1993.tb05649.x; BELHUMEUR P, 1993, MOL CELL BIOL, V13, P2152, DOI 10.1128/MCB.13.4.2152; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1991, P NATL ACAD SCI USA, V88, P10830, DOI 10.1073/pnas.88.23.10830; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; BROWN MT, 1993, J CELL BIOL, V123, P387, DOI 10.1083/jcb.123.2.387; BURKE D, 1989, MOL CELL BIOL, V9, P1049, DOI 10.1128/MCB.9.3.1049; CLARK KL, 1989, MOL CELL BIOL, V9, P2682, DOI 10.1128/MCB.9.6.2682; COUTAVAS E, 1993, NATURE, V366, P585, DOI 10.1038/366585a0; DASSO M, 1992, MOL CELL BIOL, V12, P3337, DOI 10.1128/MCB.12.8.3337; DRIVAS GT, 1990, MOL CELL BIOL, V10, P1793, DOI 10.1128/MCB.10.4.1793; FORRESTER W, 1992, GENE DEV, V6, P1914, DOI 10.1101/gad.6.10.1914; HARLOW E, 1988, ANTIBODIES LABORATOR; HARTWELL LH, 1985, GENETICS, V110, P381; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; KADOWAKI T, 1992, P NATL ACAD SCI USA, V89, P2312, DOI 10.1073/pnas.89.6.2312; KIRKPATRICK D, 1994, GENETICS, V137, P381; LIU HP, 1992, GENETICS, V132, P665; LOUNSBURY KM, 1994, J BIOL CHEM, V269, P11285; MATSUMOTO T, 1991, CELL, V66, P347, DOI 10.1016/0092-8674(91)90624-8; MEEKSWAGNER D, 1986, CELL, V44, P53, DOI 10.1016/0092-8674(86)90484-8; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; SAZER S, 1994, EMBO J, V13, P606, DOI 10.1002/j.1460-2075.1994.tb06298.x; SPENCER F, 1990, GENETICS, V124, P237	27	61	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					1975	1978		10.1074/jbc.270.5.1975	http://dx.doi.org/10.1074/jbc.270.5.1975			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836422	hybrid			2022-12-27	WOS:A1995QE49300002
J	SERIZAWA, A; DANDO, PM; BARRETT, AJ				SERIZAWA, A; DANDO, PM; BARRETT, AJ			CHARACTERIZATION OF A MITOCHONDRIAL METALLOPEPTIDASE REVEALS NEUROLYSIN AS A HOMOLOG OF THIMET OLIGOPEPTIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PZ-PEPTIDASE; MICROSOMAL ENDOPEPTIDASE; INTERMEDIATE PEPTIDASE; PROCESSING PROPROTEINS; SUBSTRATE-SPECIFICITY; POTENT INHIBITORS; MOLECULAR-CLONING; BINDING PROTEIN; RAT; LIVER	We have isolated a metallopeptidase from rat liver, The peptidase is primarily located in the mitochondrial intermembrane space, where it interacts non-covalently with the inner membrane, The enzyme hydrolyzes oligopeptides, the largest substrate molecule found being dynorphin A(1-17); it has no action on proteins, and does not interact with alpha(2)-macroglobulin, and can therefore be classified as an oligopeptidase, We term the enzyme oligopeptidase M, Oligopeptidase M acts similarly to thimet oligopeptidase (EC 3.4.24.15) on bradykinin and several other peptides, but hydrolyzes neurotensin exclusively at the -Pro+Tyr- bond (the symbol + is used to indicate a scissile peptide bond) rather than the -Arg+Arg- bond. The enzyme is inhibited by chelating agents and some thiol-blocking compounds, but differs from thimet oligopeptidase in not being activated by thiol compounds, The peptidase is inhibited by Pro-Ile, unlike thimet oligopeptidase, and the two enzymes are separable in chromatography on hydroxyapatite, The N-terminal amino acid sequence of rat mitochondrial oligopeptidase M contains 19 out of 20 residues identical with a segment of rabbit microsomal endopeptidase and 17 matching the corresponding segment of pig-soluble angiotensin II-binding protein, Moreover, the rat protein is recognized by a monoclonal antibody against rabbit soluble angiotensin II-binding protein, all of which is consistent with these proteins being species variants of a single protein that is a homologue of thimet oligopeptidase, The biochemical properties of the mitochondrial oligopeptidase leave us in no doubt that it is neurolysin (EC 3.4.24.16), for which no sequence has previously been reported, and which has not been thought to be mitochondrial.	SNOW BRAND MILK PROD CO LTD, SAPPORO RES LAB, SAPPORO, HOKKAIDO 065, JAPAN; STRANGEWAYS RES LAB, DEPT BIOCHEM, CAMBRIDGE CB1 4RN, ENGLAND	Snow Brand Milk Products Co., Ltd.			Barrett, Alan J/G-8970-2013	Barrett, Alan J/0000-0002-6082-4437				Alberts B., 1994, MOL BIOL CELL; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BARELLI H, 1993, EUR J BIOCHEM, V211, P79, DOI 10.1111/j.1432-1033.1993.tb19872.x; BARELLI H, 1994, BRIT J PHARMACOL, V112, P127, DOI 10.1111/j.1476-5381.1994.tb13041.x; BARELLI H, 1992, BIOCHEM J, V287, P621, DOI 10.1042/bj2870621; BARRETT AJ, 1990, BIOCHEM J, V271, P701, DOI 10.1042/bj2710701; BARRETT AJ, 1989, BIOCHEM J, V260, P259, DOI 10.1042/bj2600259; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; Barrett AJ, 1977, LYSOSOMES LABORATORY, P19; BARRETT AJ, 1995, IN PRESS METHODS ENZ; BROWN JP, 1976, BIOCHEM J, V155, P419, DOI 10.1042/bj1550419; BUCHLER M, 1994, EUR J BIOCHEM, V219, P627, DOI 10.1111/j.1432-1033.1994.tb19978.x; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; CONLIN CA, 1995, IN PRESS METHODS ENZ; DAHMS P, 1992, EUR J BIOCHEM, V208, P145, DOI 10.1111/j.1432-1033.1992.tb17168.x; DANDO PM, 1993, BIOCHEM J, V294, P451, DOI 10.1042/bj2940451; DAUCH P, 1992, J NEUROCHEM, V59, P1862, DOI 10.1111/j.1471-4159.1992.tb11021.x; DAUCH P, 1991, EUR J BIOCHEM, V202, P269, DOI 10.1111/j.1432-1033.1991.tb16372.x; DAUCH P, 1991, BIOCHEM J, V280, P421, DOI 10.1042/bj2800421; DEVINE PL, 1990, BIOTECHNIQUES, V8, P492; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; HEIDRICH HG, 1969, H-S Z PHYSIOL CHEM, V350, P1430, DOI 10.1515/bchm2.1969.350.2.1430; HEIDRICH HG, 1973, H-S Z PHYSIOL CHEM, V354, P1399, DOI 10.1515/bchm2.1973.354.2.1399; HURT EC, 1986, TRENDS BIOCHEM SCI, V11, P204, DOI 10.1016/0968-0004(86)90007-1; ISAYA G, 1994, MOL CELL BIOL, V14, P5603, DOI 10.1128/MCB.14.8.5603; ISAYA G, 1992, P NATL ACAD SCI USA, V89, P8317, DOI 10.1073/pnas.89.17.8317; KALOUSEK F, 1992, EMBO J, V11, P2803, DOI 10.1002/j.1460-2075.1992.tb05347.x; KATO A, 1994, EUR J BIOCHEM, V221, P159, DOI 10.1111/j.1432-1033.1994.tb18725.x; KAWABATA S, 1992, J BIOL CHEM, V267, P10331; KAWABATA S, 1993, J BIOL CHEM, V268, P12498; KNIGHT CG, 1991, FEBS LETT, V294, P183, DOI 10.1016/0014-5793(91)80664-O; KNIGHT CG, 1991, BIOCHEM J, V274, P45, DOI 10.1042/bj2740045; KNIGHT CG, 1995, IN PRESS BIOCH J; LOEWENSTEIN J, 1970, Biochimica et Biophysica Acta, V223, P432, DOI 10.1016/0005-2728(70)90201-X; MCKIE N, 1993, BIOCHEM J, V295, P57, DOI 10.1042/bj2950057; MCKIE N, 1995, IN PRESS BIOCH J; MENTLEIN R, 1994, J NEUROCHEM, V62, P27; MILLICAN PE, 1991, BIOCHEM J, V276, P583, DOI 10.1042/bj2760583; MONNET V, 1995, IN PRESS METHODS ENZ; ORLOWSKI M, 1988, BIOCHEMISTRY-US, V27, P597, DOI 10.1021/bi00402a015; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PIEROTTI A, 1990, BIOCHEMISTRY-US, V29, P10323, DOI 10.1021/bi00497a006; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; RAWLINGS ND, 1990, COMPUT APPL BIOSCI, V6, P118; RAWLINGS ND, 1995, IN PRESS METHODS ENZ; SCHNAITMAN C, 1968, J CELL BIOL, V38, P158, DOI 10.1083/jcb.38.1.158; SOFFER RL, 1991, METHODS NEUROSCI, V8, P192; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; SUGIURA N, 1992, J BIOL CHEM, V267, P18067; SWANSON MA, 1955, METHOD ENZYMOL, V2, P541, DOI 10.1016/S0076-6879(55)02247-7; TISLJAR U, 1990, FEBS LETT, V264, P84, DOI 10.1016/0014-5793(90)80771-A; TISLJAR U, 1990, ANAL BIOCHEM, V186, P112, DOI 10.1016/0003-2697(90)90582-T; TSURU D, 1988, J BIOCHEM, V104, P580, DOI 10.1093/oxfordjournals.jbchem.a122514; VINCENT B, 1994, EUR J BIOCHEM, V221, P297, DOI 10.1111/j.1432-1033.1994.tb18741.x; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; WUNSCH E, 1963, H-S Z PHYSIOL CHEM, V333, P149, DOI 10.1515/bchm2.1963.333.1.149; 1994, EUR J BIOCHEM, V223, P1; 1992, ENZYME NOMENCLATURE	58	61	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2092	2098		10.1074/jbc.270.5.2092	http://dx.doi.org/10.1074/jbc.270.5.2092			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836437	hybrid			2022-12-27	WOS:A1995QE49300019
J	WALL, D; ZYLICZ, M; GEORGOPOULOS, C				WALL, D; ZYLICZ, M; GEORGOPOULOS, C			THE CONSERVED G/F MOTIF OF THE DNAJ CHAPERONE IS NECESSARY FOR THE ACTIVATION OF THE SUBSTRATE-BINDING PROPERTIES OF THE DNAK CHAPERONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; ENDOPLASMIC-RETICULUM MEMBRANE; LAMBDA-P-PROTEIN; ESCHERICHIA-COLI; PEPTIDE-BINDING; GRPE; REPLICATION; HSP70; SPECIFICITY; INITIATION	The universally conserved DnaK and DnaJ molecular chaperone proteins bind in a coordinate manner to protein substrates to prevent aggregation, to disaggregate proteins, or to regulate proper protein function. To further examine their synergistic mechanism of action, we constructed and characterized two DnaJ deletion proteins. One has an Il amino acid internal deletion that spans amino acid residues 77-87 (DnaJ Delta 77-87) and the other amino acids 77-107 (DnaJ Delta 77-107). The DnaJ Delta 77-87 mutant protein, was normal in all respects analyzed. The DnaJ Delta 77-107 mutant protein has its entire GIF (Gly/Phe) motif deleted. This motif is found in most, but not all DnaJ family members. In vivo DnaJ Delta 77-107 supported bacteriophage lambda growth, albeit at reduced levels, demonstrating that at least some protein function was retained. However, DnaJP Delta 77-107 did not exhibit other wild type properties, such as proper down-regulation of the heat-shock response, and had an overall poisoning effect of cell growth. The purified DnaJ Delta 77-107 protein was shown to physically interact and stimulate DnaK's ATPase activity at wild type levels, unlike the previously characterized DnaJ259 point mutant (DnaJH33Q). Moreover, both DnaJ Delta 77-107 and DnaJ259 bound to substrate proteins, such as sigma(32), at similar affinities as DnaJ(+). However, DnaJ Delta 77-107 was found to be largely defective in activating the ATP-dependent substrate binding mode of DnaK, In vivo, the ability of the mutant DnaJ proteins to down-regulate the heat-shock response was correlated only with their in vitro ability to activate DnaK to bind sigma(32), in an ATP-dependent manner, and not with their ability to bind sigma(32). We conclude, that although the G/F motif of DnaJ does not directly participate in the stimulation of DnaK's ATPase activity, nevertheless, it is involved in an important manner in modulating DnaK's substrate binding activity.	UNIV UTAH, MED CTR, DEPT CELLULAR VIRAL & MOLEC BIOL, SALT LAKE CITY, UT 84132 USA; CTR MED UNIV GENEVA, DEPT BIOCHIM MED, CH-1211 GENEVA 4, SWITZERLAND; UNIV GDANSK, DEPT MOLEC BIOL, DIV BIOPHYS, PL-80822 GDANSK, POLAND	Utah System of Higher Education; University of Utah; University of Geneva; Fahrenheit Universities; University of Gdansk				Wall, Daniel/0000-0002-0273-1371	NIGMS NIH HHS [GM23917] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023917, R01GM023917] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALFANO C, 1989, J BIOL CHEM, V264, P10709; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; BORK P, 1992, TRENDS BIOCHEM SCI, V17, P129, DOI 10.1016/0968-0004(92)90319-5; BRODSKY JL, 1993, J CELL BIOL, V120, pD95; BUCHBERGER A, 1994, EMBO J, V13, P1687, DOI 10.1002/j.1460-2075.1994.tb06433.x; BUKAU B, 1993, MOL MICROBIOL, V9, P671, DOI 10.1111/j.1365-2958.1993.tb01727.x; CRAIG EA, 1991, TRENDS BIOCHEM SCI, V16, P135, DOI 10.1016/0968-0004(91)90055-Z; FELDHEIM D, 1992, MOL CELL BIOL, V12, P3288, DOI 10.1128/MCB.12.7.3288; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; GAMER J, 1992, CELL, V69, P833, DOI 10.1016/0092-8674(92)90294-M; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HOFFMANN HJ, 1992, P NATL ACAD SCI USA, V89, P12108, DOI 10.1073/pnas.89.24.12108; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; KAWULA TH, 1994, J BACTERIOL, V176, P610, DOI 10.1128/jb.176.3.610-619.1994; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LIBEREK K, 1993, P NATL ACAD SCI USA, V90, P11019, DOI 10.1073/pnas.90.23.11019; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; LIBEREK K, 1992, P NATL ACAD SCI USA, V89, P3516, DOI 10.1073/pnas.89.8.3516; MARSZALEK J, 1994, J BIOL CHEM, V269, P4883; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MISSIAKAS D, 1993, J BACTERIOL, V175, P2613, DOI 10.1128/JB.175.9.2613-2624.1993; OSIPIUK J, 1993, J BIOL CHEM, V268, P4821; PALLEROS DR, 1992, J BIOL CHEM, V267, P5279; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Sambrook J, 1989, MOL CLONING LABORATO; SANDERS SL, 1992, J BIOL CHEM, V267, P13791; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; SEATON BL, 1994, P NATL ACAD SCI USA, V91, P2066, DOI 10.1073/pnas.91.6.2066; SELL SM, 1990, J BACTERIOL, V172, P4827, DOI 10.1128/jb.172.9.4827-4835.1990; SHERMAN MY, 1993, P NATL ACAD SCI USA, V90, P8648, DOI 10.1073/pnas.90.18.8648; SILVER PA, 1993, CELL, V74, P5, DOI 10.1016/0092-8674(93)90287-Z; STRAUS D, 1990, GENE DEV, V4, P2202, DOI 10.1101/gad.4.12a.2202; STRAUS DB, 1987, NATURE, V329, P348, DOI 10.1038/329348a0; TILLY K, 1983, CELL, V34, P641, DOI 10.1016/0092-8674(83)90396-3; UEGUCHI C, 1994, NATL ACAD SCI US, V91, P1054; WALL D, 1994, J BIOL CHEM, V269, P5446; WALL D, 1994, THESIS U UTAH SALT L; WICKNER S, 1991, NATURE, V350, P165, DOI 10.1038/350165a0; YURA T, 1993, ANNU REV MICROBIOL, V47, P321, DOI 10.1146/annurev.mi.47.100193.001541; YURA T, 1992, NUCLEIC ACIDS RES, V20, P3305, DOI 10.1093/nar/20.13.3305; ZYLICZ M, 1989, EMBO J, V8, P1601, DOI 10.1002/j.1460-2075.1989.tb03544.x; ZYLICZ M, 1993, PHILOS T ROY SOC B, V339, P271, DOI 10.1098/rstb.1993.0025; ZYLICZ M, 1987, J BIOL CHEM, V262, P17437; ZYLICZ M, 1985, J BIOL CHEM, V260, P7591	48	111	113	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2139	2144		10.1074/jbc.270.5.2139	http://dx.doi.org/10.1074/jbc.270.5.2139			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836443	hybrid			2022-12-27	WOS:A1995QE49300026
J	WEN, W; TAYLOR, SS; MEINKOTH, JL				WEN, W; TAYLOR, SS; MEINKOTH, JL			THE EXPRESSION AND INTRACELLULAR-DISTRIBUTION OF THE HEAT-STABLE PROTEIN-KINASE INHIBITOR IS CELL-CYCLE-REGULATED	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OOCYTE MEIOTIC MATURATION; CATALYTIC SUBUNIT; GOLGI-COMPLEX; LIVING CELLS; CHICK KIDNEY; RAT TESTIS; CAMP; AMP; LOCALIZATION; MOUSE	The heat stable protein kinase inhibitor (PKI) is a potent and specific inhibitor of the catalytic (C) subunit of the cAMP-dependent protein kinase, We report the isolation of a polyclonal antibody raised to purified recombinant PKI alpha. Using this antibody, the intracellular distribution of endogenous PKI alpha was assessed by immunostaining. The PKI alpha expression and intracellular distribution varied as a function of cell cycle progression. PKI alpha expression appeared low in serum starved cells and in cells in G(1) and increased as cells progressed through S phase, Its distribution became increasingly nuclear as cells entered G(2)/M. Nuclear levels of PKI alpha remained high through cell division and decreased again as cells reentered G(1). The cell cycle regulated expression and nuclear distribution suggests a specific role for PKI alpha in the nucleus during the G(2)/M phases of the cell cycle, Consistent with this, microinjection of PKI alpha antibody into serum-starved cells prevented their subsequent cell cycle progression, Similarly, overexpression of C subunit in cells arrested at the G(1)/S boundary prevented their subsequent division, Together these results support the idea that PKI alpha plays an important role in the inhibition of nuclear C subunit activity required for cell cycle progression, although a determination of the relative amounts of endogenous nuclear PKI and C-subunit will be required to substantiate this hypothesis.	UNIV CALIF SAN DIEGO,DEPT BIOCHEM,LA JOLLA,CA 92093; UNIV PENN,SCH MED,DEPT PHARMACOL,PHILADELPHIA,PA 19104	University of California System; University of California San Diego; University of Pennsylvania	WEN, W (corresponding author), UNIV CALIF SAN DIEGO,DEPT CHEM,LA JOLLA,CA 92093, USA.		Meinkoth, Judy L/G-2900-2010					ADAMS SR, 1991, NATURE, V349, P694, DOI 10.1038/349694a0; ALABDALY FA, 1989, ENDOCRINOLOGY, V124, P2901, DOI 10.1210/endo-124-6-2901; BRAUTIGAN DL, 1990, NATURE, V344, P74, DOI 10.1038/344074a0; COSTA M, 1977, BIOCHEM BIOPH RES CO, V78, P1311, DOI 10.1016/0006-291X(77)91435-8; DOREE M, 1981, EXP CELL RES, V135, P237, DOI 10.1016/0014-4827(81)90159-2; FANTOZZI DA, 1992, J BIOL CHEM, V267, P16824; FANTOZZI DA, 1994, J BIOL CHEM, V269, P2676; HOHMANN P, 1993, CELL PROLIFERAT, V26, P195, DOI 10.1111/j.1365-2184.1993.tb00019.x; IKEGAMI S, 1978, NATURE, V275, P458, DOI 10.1038/275458a0; LAMB NJC, 1991, EMBO J, V10, P1523, DOI 10.1002/j.1460-2075.1991.tb07672.x; LAMORTE VJ, 1992, J BIOL CHEM, V267, P691; LANGECARTER CA, 1990, J BIOL CHEM, V265, P7814; MALLER JL, 1977, J BIOL CHEM, V252, P1712; MEDNIEKS MI, 1987, EUR J CELL BIOL, V44, P308; MEDNIEKS MI, 1989, J HISTOCHEM CYTOCHEM, V37, P339, DOI 10.1177/37.3.2537353; MEIJER L, 1989, DEV BIOL, V133, P58, DOI 10.1016/0012-1606(89)90296-0; MEINKOTH J, 1992, J BIOL CHEM, V267, P1323; MEINKOTH JL, 1990, P NATL ACAD SCI USA, V87, P9595, DOI 10.1073/pnas.87.24.9595; MOLLOY S, 1992, EXP CELL RES, V201, P494, DOI 10.1016/0014-4827(92)90299-N; MONTMINY MR, 1990, TRENDS NEUROSCI, V13, P185; NIGG EA, 1985, CELL, V41, P1039, DOI 10.1016/S0092-8674(85)80084-2; NIGG EA, 1985, EMBO J, V4, P2801, DOI 10.1002/j.1460-2075.1985.tb04006.x; OLSEN SR, 1991, J BIOL CHEM, V266, P11158; POSNER JB, 1964, BIOCHEMISTRY-US, V3, P1040, DOI 10.1021/bi00896a005; RUDACKGARCIA D, 1981, J BIOL CHEM, V256, P781; SCARPETTA MA, 1993, J BIOL CHEM, V268, P10927; SCHULTZ RM, 1983, DEV BIOL, V97, P264, DOI 10.1016/0012-1606(83)90085-4; TASH JS, 1980, CELL, V21, P57, DOI 10.1016/0092-8674(80)90114-2; TASH JS, 1979, J BIOL CHEM, V254, P1241; THOMAS J, 1991, J BIOL CHEM, V266, P10906; URNER F, 1983, ENDOCRINOLOGY, V113, P1170, DOI 10.1210/endo-113-3-1170; VANPATTEN SM, 1987, J BIOL CHEM, V262, P3398; VANPATTEN SM, 1992, MOL ENDOCRINOL, V6, P2114, DOI 10.1210/me.6.12.2114; VANPATTEN SM, 1991, P NATL ACAD SCI USA, V88, P5383, DOI 10.1073/pnas.88.12.5383; Walsh D.A., 2018, PEPT PROT PHOSPH, P43; WALSH DA, 1971, J BIOL CHEM, V246, P1977	36	31	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2041	2046		10.1074/jbc.270.5.2041	http://dx.doi.org/10.1074/jbc.270.5.2041			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836431	hybrid			2022-12-27	WOS:A1995QE49300012
J	WOLF, DE; MCKINNON, CA; DAOU, MC; STEPHENS, RM; KAPLAN, DR; ROSS, AH				WOLF, DE; MCKINNON, CA; DAOU, MC; STEPHENS, RM; KAPLAN, DR; ROSS, AH			INTERACTION WITH TRKA IMMOBILIZES GP75 IN THE HIGH-AFFINITY NERVE GROWTH-FACTOR RECEPTOR COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATERAL DIFFUSION; NGF RECEPTOR; TRANSLATIONAL DIFFUSION; NEUROTROPHIC FACTOR; LIGAND-BINDING; CHICK-EMBRYO; CELLS; MOBILITY; DIFFERENTIATION; INTERNALIZATION	It has been proposed that the high affinity nerve growth factor (NGF) receptor required for NGF response is a complex of two receptor proteins, gp75 and the tyrosine kinase TrkA, but direct biochemical or biophysical evidence has been lacking, We have previously shown using fluorescence recovery after photobleaching that gp75 is highly mobile on NGF-nonresponsive cells, but relatively immobile on NGF-responsive cells. In this report, we show that a physical interaction with TrkA causes gp75 immobilization We found that gp75 is relatively mobile on TrkA negative nnr5 cells, a PC12 variant which is nonresponsive to NGF. In contrast, on T14 nnr5 cells (which bear a TrkA expression vector) gp75 is relatively immobile, Similarly, using baculoviruses to express gp75 and TrkA on Sf9 insect cells, we found that TrkA immobilizes gp75 molecules, The related receptor, TrkB, caused a more modest immobilization of gp75. Immobilization was found to require intact TrkA kinase and gp75 cytoplasmic domains, paralleling the requirements of high affinity binding of NGF, Analysis of gp75 diffusion coefficients indicates that mutated gp75 and TrkA molecules may form a complex, even in the absence of the ability to bind NGF with high affinity.	NCI, FREDERICK CANC RES & DEV CTR, ABL BASIC RES PROGRAM, FREDERICK, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	WOLF, DE (corresponding author), WORCESTER FDN EXPTL BIOL INC, 222 MAPLE AVE, SHREWSBURY, MA 01545 USA.				NINDS NIH HHS [NS21716, NS28760] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021716, R01NS028760] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; BENEDETTI M, 1993, P NATL ACAD SCI USA, V90, P7859, DOI 10.1073/pnas.90.16.7859; Bevington P. R, 1969, DATA REDUCTION ERROR; CHANDLER CE, 1984, J BIOL CHEM, V259, P6882; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; EDIDIN M, 1984, J CELL BIOL, V99, P2333, DOI 10.1083/jcb.99.6.2333; GONCALVES E, 1993, P NATL ACAD SCI USA, V90, P5762, DOI 10.1073/pnas.90.12.5762; GORDONCARDO C, 1991, CELL, V66, P173; GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830; HANTZOPOULOS PA, 1994, NEURON, V13, P187, DOI 10.1016/0896-6273(94)90469-3; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEMPSTEAD BL, 1990, J BIOL CHEM, V265, P9595; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; LEBIVIC A, 1991, J CELL BIOL, V115, P607, DOI 10.1083/jcb.115.3.607; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; LIVNEH E, 1986, J CELL BIOL, V103, P327, DOI 10.1083/jcb.103.2.327; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; MAO SY, 1991, J IMMUNOL, V146, P958; MARANO N, 1987, J NEUROCHEM, V48, P225, DOI 10.1111/j.1471-4159.1987.tb13151.x; PACCAUD JP, 1993, J BIOL CHEM, V268, P23191; RODRIGEUZTEBAR A, 1988, J NEUROSCI, V8, P3337; RODRIGUEZTEBAR A, 1990, NEURON, V4, P487, DOI 10.1016/0896-6273(90)90107-Q; ROSS AH, 1985, ARCH BIOCHEM BIOPHYS, V242, P540, DOI 10.1016/0003-9861(85)90241-3; ROSS AH, 1984, P NATL ACAD SCI-BIOL, V81, P6681, DOI 10.1073/pnas.81.21.6681; SCULLION BF, 1987, J CELL BIOL, V105, P69, DOI 10.1083/jcb.105.1.69; SHEETZ MP, 1980, NATURE, V285, P510, DOI 10.1038/285510a0; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; SUMMERS MD, 1987, TEX AGR EXP STN B, V1555; SUTTER A, 1979, J BIOL CHEM, V254, P5972; VENKATAKRISHNAN G, 1991, BIOCHEMISTRY-US, V30, P2748, DOI 10.1021/bi00225a002; VENKATAKRISHNAN G, 1990, CELL REGUL, V1, P605, DOI 10.1091/mbc.1.8.605; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; VOLONTE C, 1993, MOL BIOL CELL, V4, P71, DOI 10.1091/mbc.4.1.71; WADE WF, 1989, J CELL BIOL, V109, P3325, DOI 10.1083/jcb.109.6.3325; WIER M, 1988, SCIENCE, V242, P412, DOI 10.1126/science.3175663; WOLF DE, 1989, METHOD CELL BIOL, V30, P271; WOLF DE, 1980, BIOCHEMISTRY-US, V19, P3893, DOI 10.1021/bi00558a002; WOLF DE, 1981, TECHNIQUES CEL 105 P, V1, P1; ZHANG F, 1993, BIOESSAYS, V15, P579, DOI 10.1002/bies.950150903	45	77	77	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2133	2138		10.1074/jbc.270.5.2133	http://dx.doi.org/10.1074/jbc.270.5.2133			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836442				2022-12-27	WOS:A1995QE49300025
J	KARAPLIS, AC; LIM, SK; BABA, H; ARNOLD, A; KRONENBERG, HM				KARAPLIS, AC; LIM, SK; BABA, H; ARNOLD, A; KRONENBERG, HM			INEFFICIENT MEMBRANE TARGETING, TRANSLOCATION, AND PROTEOLYTIC PROCESSING BY SIGNAL PEPTIDASE OF A MUTANT PREPROPARATHYROID HORMONE PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ISOLATED HYPOPARATHYROIDISM; RECOGNITION PARTICLE RECEPTOR; POST-TRANSLATIONAL CLEAVAGE; MALTOSE-BINDING-PROTEIN; ENDOPLASMIC-RETICULUM; MICROSOMAL-MEMBRANES; ESCHERICHIA-COLI; GTP-BINDING; PARATHYROID-HORMONE; SECRETORY PROTEIN	A preproparathyroid hormone allele from a patient with familial isolated hypoparathyroidism was shown to have a single point mutation in the hydrophobic core of the signal sequence, This mutation, changing a cysteine to an arginine codon at the -8 position of the signal peptide, was associated with deleterious effects on the processing of preproparathyroid hormone to proparathyroid hormone in vitro, To examine the biochemical consequence(s) of this mutation, proteins produced by cell-free translation of wild type and mutant cRNAs were used in assays that reconstitute the early steps of the secretory pathway, We find that the mutation impairs interaction of the nascent protein with signal recognition particle and the translocation machinery, Moreover, cleavage of the mutant signal sequence by solubilized signal peptidase is ineffective, The consequence of this mutation on processing and secretion of parathyroid hormone is confirmed in intact cells by pulse-chase experiments following transient expression of the mutant protein in COS-7 cells. The inability of the mutant signal sequence, however, to interfere with the targeting and processing of other secreted proteins does not support obstruction of the translocation apparatus as the mechanism underlying the dominant mode of inheritance of hypoparathyroidism in this family.	MASSACHUSETTS GEN HOSP,ENDOCRINE UNIT,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02114	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School					NIDDK NIH HHS [DK11794] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK011794] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHN TG, 1986, MEDICINE, V65, P73, DOI 10.1097/00005792-198603000-00001; ARNOLD A, 1990, J CLIN INVEST, V86, P1084, DOI 10.1172/JCI114811; BABA H, 1992, J BONE MINER RES, V7, P199; BASSFORD PJ, 1979, J BACTERIOL, V139, P19, DOI 10.1128/JB.139.1.19-31.1979; BEDOUELLE H, 1980, NATURE, V285, P78, DOI 10.1038/285078a0; CIOFFI JA, 1989, J BIOL CHEM, V264, P15052; CONNOLLY T, 1989, CELL, V57, P599, DOI 10.1016/0092-8674(89)90129-3; CONNOLLY T, 1986, J CELL BIOL, V103, P2253, DOI 10.1083/jcb.103.6.2253; GILMORE R, 1993, CELL, V75, P589, DOI 10.1016/0092-8674(93)90476-7; ITO M, 1993, J CLIN INVEST, V91, P2565, DOI 10.1172/JCI116494; JACKSON RC, 1977, P NATL ACAD SCI USA, V74, P5598, DOI 10.1073/pnas.74.12.5598; LIM SK, 1992, ENDOCRINOLOGY, V131, P2325, DOI 10.1210/en.131.5.2325; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; MEYER DI, 1982, NATURE, V297, P647, DOI 10.1038/297647a0; MILLER JD, 1993, NATURE, V366, P351, DOI 10.1038/366351a0; PARKINSON DB, 1992, NAT GENET, V1, P149, DOI 10.1038/ng0592-149; PERARA E, 1985, J CELL BIOL, V101, P2292, DOI 10.1083/jcb.101.6.2292; PERLMAN D, 1983, J MOL BIOL, V167, P391, DOI 10.1016/S0022-2836(83)80341-6; RACCHI M, 1993, J BIOL CHEM, V268, P5735; RAPIEJKO PJ, 1992, J CELL BIOL, V117, P493, DOI 10.1083/jcb.117.3.493; SIMON SM, 1992, CELL, V69, P677, DOI 10.1016/0092-8674(92)90231-Z; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WALTER P, 1983, METHOD ENZYMOL, V96, P84; WALTER P, 1984, CELL, V38, P5, DOI 10.1016/0092-8674(84)90520-8; WALTER P, 1981, J CELL BIOL, V91, P557, DOI 10.1083/jcb.91.2.557; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; WIREN KM, 1988, J BIOL CHEM, V263, P19771; ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468	29	77	78	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1629	1635		10.1074/jbc.270.4.1629	http://dx.doi.org/10.1074/jbc.270.4.1629			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829495	hybrid, Green Submitted			2022-12-27	WOS:A1995QD20400025
J	KOZASA, T; GILMAN, AG				KOZASA, T; GILMAN, AG			PURIFICATION OF RECOMBINANT G-PROTEINS FROM SF9 CELLS BY HEXAHISTIDINE TAGGING OF ASSOCIATED SUBUNITS - CHARACTERIZATION OF ALPHA(12), AND INHIBITION OF ADENYLYL-CYCLASE BY ALPHA(Z)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE HYDROLYSIS; PHOSPHOLIPASE-C ISOZYMES; REGULATORY PROTEINS; GAMMA-SUBUNITS; BINDING; GTP; G-ALPHA-12; ACTIVATION; PRENYLATION; EXPRESSION	A method is described for purification of G protein alpha and beta gamma subunits from Sf9 cells infected with recombinant baculoviruses. The subunit to be purified is coexpressed with an associated subunit bearing a hexahistidine tag. After adsorption of the oligomer to a Ni2+-containing column, the subunit to be purified is eluted specifically by promoting subunit dissociation with AlF4-. The a subunits of G(12), G(q), G(z), and G(i1) and the beta(1) gamma(2) subunit complex were easily and efficiently purified by this method, Results were superior to established procedures in all cases. Purified alpha(12) was characterized for the first time. The protein has a slow rate of guanine nucleotide exchange (k(on,GTP gamma S) = 0.01 min(-1)) and a very slow k(cat) for hydrolysis of GTP (0.1-0.2 min(-1)). GTP gamma S (guanosine 5'-3-O-(thio)triphosphate).alpha(12), does not influence the activity of several adenylyl cyclases or phospholipases. Activated alpha(z) inhibits the activity of type I and type V adenylyl cyclases. It is a somewhat more potent inhibitor of type V adenylyl cyclase than is activated alpha(i1).			KOZASA, T (corresponding author), UNIV TEXAS, SW MED CTR, DEPT PHARMACOL, DALLAS, TX 75235 USA.							ANGLESON JK, 1993, NEURON, V11, P939, DOI 10.1016/0896-6273(93)90123-9; ARSHAVSKY VY, 1992, NATURE, V357, P416, DOI 10.1038/357416a0; BERSTEIN G, 1992, J BIOL CHEM, V267, P8081; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; CASEY PJ, 1990, J BIOL CHEM, V265, P2383; CHAN AML, 1993, MOL CELL BIOL, V13, P762, DOI 10.1128/MCB.13.2.762; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; DHANASEKARAN N, 1994, J BIOL CHEM, V269, P11802; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRABER G, 1994, METHOD ENZYMOL, V237, P212; GRAZIANO MP, 1989, J BIOL CHEM, V264, P409; GUTOWSKI S, 1991, J BIOL CHEM, V266, P20519; HEPLER JR, 1993, J BIOL CHEM, V268, P14367; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P3597; HOCHST H, 1988, J VAC SCI TECHNOL B, V6, P1320, DOI 10.1116/1.584257; HOCHULI E, 1987, J CHROMATOGR, V411, P177, DOI 10.1016/S0021-9673(00)93969-4; INIGUEZLLUHI JA, 1992, J BIOL CHEM, V267, P23409; JIANG HP, 1993, FEBS LETT, V330, P319, DOI 10.1016/0014-5793(93)80896-3; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; KOZASA T, 1993, P NATL ACAD SCI USA, V90, P9176, DOI 10.1073/pnas.90.19.9176; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE E, 1994, METHOD ENZYMOL, V237, P146; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; LINDER ME, 1990, J BIOL CHEM, V265, P8243; MUNTZ KH, 1992, MOL BIOL CELL, V3, P49, DOI 10.1091/mbc.3.1.49; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; NORTHUP JK, 1982, J BIOL CHEM, V257, P1416; PARKS S, 1991, CELL, V64, P447, DOI 10.1016/0092-8674(91)90652-F; ROBISHAW JD, 1989, J BIOL CHEM, V264, P15758; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SINGER WD, 1994, J BIOL CHEM, V269, P19796; SMIGEL MD, 1986, J BIOL CHEM, V261, P1976; SPICHER K, 1994, BIOCHEM BIOPH RES CO, V198, P906, DOI 10.1006/bbrc.1994.1129; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; STRATHMANN MP, 1991, P NATL ACAD SCI USA, V88, P5582, DOI 10.1073/pnas.88.13.5582; SUMMERS MD, 1987, TEXAS AGR EXP STN B, V1555; TAUSSIG R, 1994, J BIOL CHEM, V269, P6093; UEDA N, 1994, J BIOL CHEM, V269, P4388; WONG YH, 1992, SCIENCE, V255, P339, DOI 10.1126/science.1347957; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; XU NZ, 1993, P NATL ACAD SCI USA, V90, P6741, DOI 10.1073/pnas.90.14.6741	48	277	281	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1734	1741		10.1074/jbc.270.4.1734	http://dx.doi.org/10.1074/jbc.270.4.1734			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829508	hybrid			2022-12-27	WOS:A1995QD20400041
J	LI, Y; RUBIN, CS				LI, Y; RUBIN, CS			MUTAGENESIS OF THE REGULATORY SUBUNIT (RII-BETA) OF CAMP-DEPENDENT PROTEIN-KINASE II-BETA REVEALS HYDROPHOBIC AMINO-ACIDS THAT ARE ESSENTIAL FOR RII-BETA DIMERIZATION AND/OR ANCHORING RII-BETA TO THE CYTOSKELETON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY BINDING-PROTEIN; CAENORHABDITIS-ELEGANS; MOLECULAR CHARACTERIZATION; DEVELOPMENTAL REGULATION; SKELETAL-MUSCLE; LEUCINE ZIPPER; BOVINE BRAIN; HUMAN TESTIS; EXPRESSION; CLONING	In neurons cAMP-dependent protein kinase II beta (PKAII beta) is sequestered in the dendritic cytoskeleton because the regulatory subunit (RII beta) of the enzyme is tightly bound by A Kinase Anchor Proteins (AKAPs). The prototypic neuronal anchor protein AKAP75 has a COOH terminal 22-residue RII beta binding (tethering) site. A key feature of the tethering site is that several amino acids with large aliphatic side chains mediate the high-affinity binding of RII beta. Mutagenesis, recombinant protein expression, and physicochemical characterization were used to investigate the structural basis for the homodimerization and AKAP75 binding activities of RII beta. Several crucial residues are located in an NH2-terminal region that encompasses amino acids 13-36., Substitution of Ala for Leu(13) or Phe(36) generates monomeric RII beta subunits that cannot bind AKAP75. The results are not due to general misfolding since mutant RII beta monomers bind cAMP and inhibit the catalytic subunit of PKAII beta with the same affinity and efficacy as wild type RII beta dimers. Moreover, substitution of Ala for Leu(12), Val(20), Leu(21), Phe(31), Leu(33), or Leu(39) and replacement of Leu(13) with Ile or Val did not impair the dimerization reaction. Evidently, large hydrophobic side chains of Leu(13) and Phe(36) play pivotal roles in stabilizing RII beta-RII beta interactions. A secondary consequence of destabilizing RII beta dimers is the loss of intracellular targeting/anchoring capacity because monomers fail to bind AKAP75. Other NH2-terminal residues directly modulate the affinity of RII beta dimers for the AKAP75 tethering site. Replacement of Val(20)-Leu(21) with Ala-Ala produced a dimeric RII beta protein that binds AKAP75 similar to 4% as avidly as wild-type RII beta. It is possible that the aliphatic side chains of Val(20) and Leu(21) interact with the essential Leu and ne residues in the AKAP75 tethering region.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,ALTRAN LABS,DEPT MOLEC PHARMACOL,BRONX,NY 10461	Yeshiva University; Albert Einstein College of Medicine					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022792] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM22792] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BREGMAN DB, 1991, J BIOL CHEM, V266, P7207; BREGMAN DB, 1989, J BIOL CHEM, V264, P4648; CARR DW, 1992, J BIOL CHEM, V267, P16816; CARR DW, 1991, J BIOL CHEM, V266, P14188; CARR DW, 1993, J BIOL CHEM, V268, P20729; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; DOSKELAND SO, 1988, METHOD ENZYMOL, V159, P147; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; ERLICHMA.J, 1973, J BIOL CHEM, V248, P7607; ERLICHMAN J, 1980, J BIOL CHEM, V255, P8179; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; GLANTZ SB, 1993, J BIOL CHEM, V268, P12796; GLANTZ SB, 1992, MOL BIOL CELL, V3, P1215, DOI 10.1091/mbc.3.11.1215; GOLDENBERG DP, 1988, PROTEIN STRUCTURE PR, P225; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; GROSS RE, 1990, J BIOL CHEM, V265, P8152; HAUSKEN ZE, 1994, J BIOL CHEM, V269, P24245; HIRSCH AH, 1992, J BIOL CHEM, V267, P2131; HU E, 1991, J BIOL CHEM, V266, P19796; HU E, 1990, J BIOL CHEM, V265, P20609; HU ED, 1990, J BIOL CHEM, V265, P5072; LAND M, 1994, J BIOL CHEM, V269, P14820; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEISER M, 1986, J BIOL CHEM, V261, P1904; LEVY FO, 1988, MOL ENDOCRINOL, V2, P1364, DOI 10.1210/mend-2-12-1364; LUO ZJ, 1990, J BIOL CHEM, V265, P21804; NDUBUKA C, 1993, J BIOL CHEM, V268, P7621; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; OYEN O, 1989, FEBS LETT, V246, P57, DOI 10.1016/0014-5793(89)80253-4; REIMANN EM, 1986, BIOCHEMISTRY-US, V25, P119, DOI 10.1021/bi00349a018; ROSE GD, 1993, ANNU REV BIOPH BIOM, V22, P381, DOI 10.1146/annurev.bb.22.060193.002121; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; Rubin C S, 1974, Methods Enzymol, V38, P308; RUBIN CS, 1979, J BIOL CHEM, V254, P3797; SARKAR D, 1984, J BIOL CHEM, V259, P9840; SCOTT JD, 1991, PHARMACOL THERAPEUT, V50, P123, DOI 10.1016/0163-7258(91)90075-W; SCOTT JD, 1990, J BIOL CHEM, V265, P21561; SCOTT JD, 1987, P NATL ACAD SCI USA, V84, P5192, DOI 10.1073/pnas.84.15.5192; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; STEIN JC, 1987, J BIOL CHEM, V262, P3002; TAKIO K, 1984, BIOCHEMISTRY-US, V23, P4200, DOI 10.1021/bi00313a029; THEURKAUF WE, 1982, J BIOL CHEM, V257, P3284; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; ZOLLER MJ, 1979, J BIOL CHEM, V254, P2408	46	58	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1935	1944		10.1074/jbc.270.4.1935	http://dx.doi.org/10.1074/jbc.270.4.1935			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829531	hybrid			2022-12-27	WOS:A1995QD20400068
J	ELDARFINKELMAN, H; SEGER, R; VANDENHEEDE, JR; KREBS, EG				ELDARFINKELMAN, H; SEGER, R; VANDENHEEDE, JR; KREBS, EG			INACTIVATION OF GLYCOGEN-SYNTHASE KINASE-3 BY EPIDERMAL GROWTH-FACTOR IS MEDIATED BY MITOGEN-ACTIVATED PROTEIN KINASE/P90 RIBOSOMAL-PROTEIN S6 KINASE SIGNALING PATHWAY IN NIH/3T3 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RABBIT SKELETAL-MUSCLE; ATP-CITRATE LYASE; INSULIN ACTION; PHOSPHORYLATION; PHOSPHATASE; PURIFICATION; SEQUENCE; SUBUNIT; FAMILY; SITES	The role of the p90 ribosomal protein S6 kinase/mitogen-activated protein kinase (RSK/MAPK) signaling pathway in regulating glycogen synthase kinase-3 (GSK-3) activity was investigated. In vitro studies showed that GSK-3 was inactivated by 50% upon incubation with RSK purified from epidermal growth factor (EGF)-stimulated NIH/3T3 cells. Subsequently, the effect of EGF on GSK-3 activity was measured in NIH/3T3 cells that stably overexpressed mutated forms of MAPK kinase (MAPKK). The activation of RSK by EGF was markedly decreased in cell lines expressing the dominant negative MAPKK mutants S222A and K97A and was increased in cells expressing the S222E mutant as compared with control cell lines. EGF induced a rapid decrease in GSK-3 beta activity (50%) in control and S222E cells; however, only 25 and 10% inhibition in GSK-3 beta activity was observed in cell lines expressing the dominant negative mutants K97A and S222A, respectively, suggesting that inhibition of GSK-3 was partially blocked in these cells. Taken together, these results suggest that the action of EGF on GSK-3 inactivation is mediated by the RSK/MAPK signaling pathway in NIH/3T3 cells and provide evidence for a mechanism regulating GSK-3 activity in intact cells.	UNIV WASHINGTON,DEPT PHARMACOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195; UNIV WASHINGTON,HOWARD HUGHES MED INST,SEATTLE,WA 98195; WEIZMANN INST SCI,DEPT MEMBRANE RES & BIOPHYS,IL-76100 REHOVOT,ISRAEL; KATHOLIEKE UNIV LEUVEN,FAC GENEESKUNDE,AFDELING BIOCHEM,B-300 LOUVAIN,BELGIUM	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Weizmann Institute of Science; KU Leuven			Eldar-Finkelman, Hagit/AAF-8329-2019	Eldar-Finkelman, Hagit/0000-0002-8460-9686	NIDDK NIH HHS [DK 42528] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042528] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; BOYLE WJ, 1990, CELL, V29, P7617; CHAN CP, 1985, P NATL ACAD SCI USA, V82, P4563, DOI 10.1073/pnas.82.14.4563; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; FIOL CJ, 1990, J BIOL CHEM, V265, P6061; GOODE N, 1992, J BIOL CHEM, V267, P16878; HEMMINGS BA, 1981, EUR J BIOCHEM, V119, P443, DOI 10.1111/j.1432-1033.1981.tb05628.x; HEMMINGS BA, 1982, EUR J BIOCHEM, V127, P473; HUASDORFF SF, 1994, J BIOL CHEM, V269, P21391; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; HUGHES K, 1992, BIOCHEM J, V288, P309, DOI 10.1042/bj2880309; KOZMA L, 1993, P NATL ACAD SCI USA, V90, P4460, DOI 10.1073/pnas.90.10.4460; LITCHFIELD DW, 1990, J BIOL CHEM, V265, P7638; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; NIKOLAKAKI E, 1993, ONCOGENE, V8, P833; PLYTE SE, 1992, BIOCHIM BIOPHYS ACTA, V1114, P147, DOI 10.1016/0304-419X(92)90012-N; PUZISS JW, 1994, MOL CELL BIOL, V14, P831, DOI 10.1128/MCB.14.1.831; RAMAKRISHNA S, 1990, BIOCHEMISTRY-US, V29, P7617, DOI 10.1021/bi00485a011; RAMAKRISHNA S, 1988, J BIOL CHEM, V263, P12677; ROBINSON LJ, 1993, J BIOL CHEM, V268, P26422; RYLATT DB, 1980, EUR J BIOCHEM, V107, P529; SAITO Y, 1994, BIOCHEM J, V303, P27, DOI 10.1042/bj3030027; SEGER R, 1994, J BIOL CHEM, V269, P25699; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; SUTHERLAND C, 1994, FEBS LETT, V338, P37, DOI 10.1016/0014-5793(94)80112-6; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; VANDENHEEDE JR, 1980, J BIOL CHEM, V255, P1768; VANLINT J, 1993, ANAL BIOCHEM, V208, P132, DOI 10.1006/abio.1993.1018; WANG QM, 1994, J BIOL CHEM, V269, P14566; WELSH GI, 1993, BIOCHEM J, V294, P625, DOI 10.1042/bj2940625; WELSH GI, 1994, BIOCHEM J, V303, P15, DOI 10.1042/bj3030015; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; WOODGETT JR, 1991, TRENDS BIOCHEM SCI, V16, P177, DOI 10.1016/0968-0004(91)90071-3; YU JS, 1994, J BIOL CHEM, V269, P14341; ZHENG CF, 1994, EMBO J, V13, P1123, DOI 10.1002/j.1460-2075.1994.tb06361.x	35	190	196	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					987	990		10.1074/jbc.270.3.987	http://dx.doi.org/10.1074/jbc.270.3.987			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836418	hybrid			2022-12-27	WOS:A1995QB15600001
J	LI, YM; MARNERAKIS, M; STIMSON, ER; MAGGIO, JE				LI, YM; MARNERAKIS, M; STIMSON, ER; MAGGIO, JE			MAPPING PEPTIDE-BINDING DOMAINS OF THE SUBSTANCE-P (NK-1) RECEPTOR FROM P388D(1) CELLS WITH PHOTOLABILE AGONISTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROKININ-1 RECEPTOR; BIOCHEMICAL-CHARACTERIZATION; TACHYKININ RECEPTORS; AMINO-ACID; PROTEINS; NK1; SPECIFICITY; ANTAGONIST; EPITOPES; GLAND	The tachykinin substance P (SP) is a peptide trans mitter of primary afferents, Its actions on both central and peripheral targets are mediated by a G-protein-coupled receptor of known primary structure. To identify contact sites between the undecapeptide SP and its receptor, we prepared radiolabeled photoreactive analogs of SP (H-RPKPQQFFGLM-NH2) by replacing amino acids in the peptide with p-benzoyl-L-phenylalanine (BPA). SP, EPA(3)-SP, and BPA(8)-SP bind with high affinity (K-d < 3 nM) to SP receptors on the murine cell line P388D(1), triggering intracellular calcium responses. Both binding and calcium responses are blocked by the specific SP receptor antagonist CP-96345. On photolysis, radioiodinated BPA(3)-SP and BPA(8)-SP covalently label a heterogeneously glycosylated protein of about 75 kDa; labeling is abolished by excess unlabeled SP or CP-96345. The labeled receptors were digested with V8 protease and/or trypsin, and the resulting fragments were analyzed by electrophore sis, high pressure liquid chromatography, and chemical or enzymatic modification. BPA(3)-SP and BPA(8)-SP photoincorporate into different regions of the murine SP receptor. The results establish that the third and the eighth positions of SP, respectively, interact with the NH2-terminal extracellular tail (residues 1-21) and second extracellular loop (residues 173-183) of the SP receptor. A model for the agonist peptide binding sites of the SP receptor is proposed based on photoaffinity labeling and mutagenesis studies.	HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115	Harvard University; Harvard Medical School					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015904] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-15904] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALDWIN JM, 1994, CURR OPIN CELL BIOL, V6, P180, DOI 10.1016/0955-0674(94)90134-1; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; Bockaert J, 1991, Curr Opin Neurobiol, V1, P32, DOI 10.1016/0959-4388(91)90008-U; BOYD ND, 1991, ANN NY ACAD SCI, V632, P79, DOI 10.1111/j.1749-6632.1991.tb33096.x; BOYD ND, 1991, BIOCHEMISTRY-US, V30, P336, DOI 10.1021/bi00216a005; BOYD ND, 1993, J NEUROCHEM, V61, pS63; BOYD ND, 1994, TACHYKININ RECEPTORS, P219; CASCIERI MA, 1994, J BIOL CHEM, V269, P6587; DAM TV, 1987, BIOCHEM BIOPH RES CO, V149, P297, DOI 10.1016/0006-291X(87)91638-X; DAWE CJ, 1957, AM J PATHOL, V33, P603; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; FONG TM, 1994, J BIOL CHEM, V269, P2728; FONG TM, 1992, J BIOL CHEM, V267, P25664; FONG TM, 1992, BIOCHEMISTRY-US, V31, P11806, DOI 10.1021/bi00162a019; FONG TM, 1994, J BIOL CHEM, V269, P14957; FONG TM, 1993, NATURE, V362, P350; FOURNIER A, 1982, J MED CHEM, V25, P64, DOI 10.1021/jm00343a012; GERARD NP, 1993, REGUL PEPTIDES, V43, P21, DOI 10.1016/0167-0115(93)90404-V; GERSZTEN RE, 1994, NATURE, V368, P648, DOI 10.1038/368648a0; GETHER U, 1993, NATURE, V362, P345, DOI 10.1038/362345a0; GETHER U, 1993, J BIOL CHEM, V268, P7893; GETHER U, 1993, P NATL ACAD SCI USA, V90, P6194, DOI 10.1073/pnas.90.13.6194; GETHER U, 1994, MOL PHARMACOL, V45, P500; HUANG RRC, 1994, MOL PHARMACOL, V45, P690; HUANG RRC, 1994, BIOCHEMISTRY-US, V33, P3007, DOI 10.1021/bi00176a033; JENSEN CJ, 1994, MOL PHARMACOL, V45, P294; KAGE R, 1993, J NEUROCHEM, V60, P347, DOI 10.1111/j.1471-4159.1993.tb05857.x; KAUER JC, 1986, J BIOL CHEM, V261, P695; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CM, 1983, MOL PHARMACOL, V23, P563; LI YM, 1995, IN PRESS ANESTHESIOL; MAGGIO JE, 1992, P NATL ACAD SCI USA, V89, P5462, DOI 10.1073/pnas.89.12.5462; MAGGIO JE, 1988, ANNU REV NEUROSCI, V11, P13, DOI 10.1146/annurev.neuro.11.1.13; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; OTSUKA M, 1993, PHYSIOL REV, V73, P229, DOI 10.1152/physrev.1993.73.2.229; PERLMAN JH, 1994, J BIOL CHEM, V269, P1610; PERNOW B, 1983, PHARMACOL REV, V35, P85; PERSICO FJ, 1988, J IMMUNOL, V141, P3564; SACHAIS BS, 1993, J BIOL CHEM, V268, P2319; SHOELSON SE, 1993, J BIOL CHEM, V268, P4085; SUNDELIN JB, 1992, EUR J BIOCHEM, V203, P625, DOI 10.1111/j.1432-1033.1992.tb16592.x; TOO HP, 1991, METHODS NEUROSCI, V6, P232; TRUMPPKALLMEYER S, 1994, TACHYKININ RECEPTORS, P237; VIGER A, 1983, J NEUROCHEM, V40, P1030, DOI 10.1111/j.1471-4159.1983.tb08089.x; YOKOTA Y, 1992, EMBO J, V11, P3585, DOI 10.1002/j.1460-2075.1992.tb05442.x; ZOFFMANN S, 1993, FEBS LETT, V336, P506, DOI 10.1016/0014-5793(93)80865-R	48	84	84	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1213	1220		10.1074/jbc.270.3.1213	http://dx.doi.org/10.1074/jbc.270.3.1213			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836382	hybrid			2022-12-27	WOS:A1995QB15600037
J	NEGRESCU, EV; DEQUINTANA, KL; SIESS, W				NEGRESCU, EV; DEQUINTANA, KL; SIESS, W			PLATELET SHAPE CHANGE INDUCED BY THROMBIN RECEPTOR ACTIVATION - RAPID STIMULATION OF TYROSINE PHOSPHORYLATION OF NOVEL PROTEIN SUBSTRATES THROUGH AN INTEGRIN-INDEPENDENT AND CA2+-INDEPENDENT MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS 3T3 CELLS; MEMBRANE SKELETON; CYCLIC-AMP; KINASE; ASSOCIATION; IDENTIFICATION; MYOSIN; PP60(C-SRC); VASOPRESSIN; AGGREGATION	Activation of human platelets by the peptide YFLLRNP has been shown to induce shape change but not secretion, Ca2+ mobilization, or pleckstrin phosphorylation (Rasmussen, U. B., Gachet, C., Schlesinger, Y., Hanau, D., Ohlmann, P., Van Obberghen-Schilling, E., Pouyssegur, J., Cazenave, J.-P., and Pavirani, A. (1993) J. Biol. Chem. 268, 14322-14328). YFLLRNP was added to washed human platelets that had been pretreated with EGTA at 37 degrees C or preincubated with the fibrinogen receptor antagonist RGDS to preclude the activation of the integrin alpha(IIb)beta(3) (fibrinogen receptor). YFLLRNP induced shape change and stimulated the tyrosine phosphorylation of proteins of 62, 68, and 130 kDa within 7 s. Tyrosine phosphorylation of these proteins reached maximum levels (2-3-fold) 15-30 s after addition of YFLLRNP and decreased subsequently. The chelation of intracellular Ca2+ by BAPTA-AM decreased basal tyrosine protein phosphorylation of P62, P68, and P130 or the shape change induced by YFLLRNP. Preincubation of platelets with the tyrosine kinase inhibitors genistein or tyrphostin A23 completely inhibited platelet shape change and protein tyrosine phosphorylation induced by YFLLRNP. The inactive structural analogs daidzein P130, which exhibited increased tyrosine phosphorylation upon the stimulation with YFLLRNP, were found in the cytoskeleton. P130 was not identical to vinculin or the focal adhesion kinase pp125(FAK). The results indicate that stimulation of G-protein-coupled thrombin receptors rapidly induces protein tyrosine kinase activation through a Ca2+- and integrin-independent mechanism. Protein tyrosine kinase activation and tyrosine phosphorylation of novel protein substrates seem to play an essential role in the induction of platelet shape change.	INST PROPHYLAXE & EPIDEMIOL KREISLAUFKRANKHEITEN,D-80336 MUNICH,GERMANY				Siess, Wolfgang/A-6430-2009	Siess, Wolfgang/0000-0003-0698-6416				CICHOWSKI K, 1992, J BIOL CHEM, V267, P5025; CLARK EA, 1993, MOL CELL BIOL, V13, P1863, DOI 10.1128/MCB.13.3.1863; DANIEL JL, 1984, J BIOL CHEM, V259, P9826; FOX JEB, 1982, J BIOL CHEM, V257, P4120; FOX JEB, 1985, J CLIN INVEST, V76, P1673, DOI 10.1172/JCI112153; FOX JEB, 1993, J BIOL CHEM, V268, P25973; GOLDEN A, 1986, P NATL ACAD SCI USA, V83, P852, DOI 10.1073/pnas.83.4.852; HALLAM TJ, 1985, BIOCHEM J, V232, P373, DOI 10.1042/bj2320373; HORVATH AR, 1992, EMBO J, V11, P855, DOI 10.1002/j.1460-2075.1992.tb05123.x; JALINK K, 1992, J CELL BIOL, V118, P411, DOI 10.1083/jcb.118.2.411; LIEBENHOFF U, 1993, BIOCHEM J, V295, P41, DOI 10.1042/bj2950041; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; LUBER K, 1994, CELL SIGNAL, V6, P279, DOI 10.1016/0898-6568(94)90032-9; ODA A, 1992, J BIOL CHEM, V267, P20075; PHILLIPS DR, 1980, J CELL BIOL, V86, P77, DOI 10.1083/jcb.86.1.77; POLANOWSKAGRABO.R, 1993, BIOCHEM J, V296, P543; RASMUSSEN UB, 1993, J BIOL CHEM, V268, P14322; RINK TJ, 1982, FEBS LETT, V148, P21, DOI 10.1016/0014-5793(82)81234-9; SHATTIL SJ, 1994, J BIOL CHEM, V269, P14738; SIESS W, 1990, BIOCHEM J, V271, P815, DOI 10.1042/bj2710815; SIESS W, 1993, CELL SIGNAL, V5, P209, DOI 10.1016/0898-6568(93)90071-S; SIESS W, 1984, J BIOL CHEM, V259, P8286; SIESS W, 1989, PHYSIOL REV, V69, P58, DOI 10.1152/physrev.1989.69.1.58; SIMPSON AWM, 1986, FEBS LETT, V201, P301, DOI 10.1016/0014-5793(86)80628-7; TANIGUCHI T, 1993, J BIOL CHEM, V268, P2277; VOSTAL JG, 1993, BIOCHEM J, V294, P675, DOI 10.1042/bj2940675; ZACHARY I, 1993, J BIOL CHEM, V268, P22060; ZACHARY I, 1992, J BIOL CHEM, V267, P19031	28	67	67	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1057	1061		10.1074/jbc.270.3.1057	http://dx.doi.org/10.1074/jbc.270.3.1057			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836359	hybrid			2022-12-27	WOS:A1995QB15600014
J	PISONI, RL; PARK, GY; VELILLA, VQ; THOENE, JG				PISONI, RL; PARK, GY; VELILLA, VQ; THOENE, JG			DETECTION AND CHARACTERIZATION OF A TRANSPORT-SYSTEM MEDIATING CYSTEAMINE ENTRY INTO HUMAN FIBROBLAST LYSOSOMES - SPECIFICITY FOR AMINOETHYLTHIOL AND AMINOETHYLSULFIDE DERIVATIVES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER LYSOSOMES; LEUKOCYTE GRANULAR FRACTIONS; AMINO-ACID TRANSPORT; ACETYL COENZYME-A; SIALIC-ACID; NEPHROPATHIC CYSTINOSIS; MEMBRANE-VESICLES; THYROID CELLS; CARRIER; MONOIODOTYROSINE	The uptake of [H-3]cysteamine by Percoll-purified hu man fibroblast lysosomes was investigated to determine whether lysosomes contain a transport system recognizing cysteamine, Lysosomal cysteamine uptake is a Na+-independent process which rapidly attains a steady state within 1 min at pH 7.0 and 37 degrees C. A biphasic Arrhenius plot is observed for cysteamine uptake, giving a Q(10) of 2.2 from 17 to 26 degrees C and a Q(10) of 1.2 from 27 to 35 degrees C. The rate of lysosomal cysteamine uptake is maximal at pH 8.2, half-maximal at pH 6.8, and declines similar to 50-fold from the maximum to show very little transport at pH 5.0. Cysteamine uptake into fibroblast lysosomes displays complete saturability with a K-m of 0.88 mM and V-max of 1410 pmol of beta-N-acetylhexosaminidase/min at pH 7.0 and 37 degrees C. Analog inhibition studies demonstrated that all analogs recognized thus far by the cysteamine carrier are either aminothiols or aminosulfides and contain an amino group and sulfur atom separated by a carbon chain, 2 carbon atoms in length. The K-i constants for these analogs as competitive inhibitors of lysosomal cysteamine uptake are 2-(ethylthio)ethylamine (0.64 mM), 1-amino-2-methyl-2-propanethiol (0.74 mM), 2-dimethylaminoethanethiol (0.87 mM), thiocholine (1.6 mM), and bis(2-aminoethyl)sulfide (4.9 mM), L-Cysteine, D-penicillamine, and analogs lacking either a sulfur atom or amino group are not recognized by the cysteamine carrier including ethanolamine, choline, taurine, beta-mercaptoethanol, ethylenediamine, cadaverine, spermine, spermidine, histamine, dopamine, and 3-hydroxytyramine. In a cystine depletion assay, a 2-h exposure of cystinotic fibroblasts to 1 mM 1-amino-2-methyl-2-propanethiol lowers cell cystine levels to the same low level obtained with cysteamine, Thus, all four aminothiols, known to deplete cystinotic fibroblasts of their accumulated cystine, are recognized as substrates by the lysosomal cysteamine carrier, suggesting the importance of this transporter in the delivery of aminothiols to the lysosomal compartment.			PISONI, RL (corresponding author), UNIV MICHIGAN, SCH MED, DEPT PEDIAT & COMMUNICABLE DIS, ANN ARBOR, MI 48109 USA.		Thoene, Jess/AAF-5305-2020		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025548] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK25548] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSSON HC, 1990, J BIOL CHEM, V265, P10950; BAME KJ, 1985, J BIOL CHEM, V260, P1293; BARRUECO JR, 1991, J BIOL CHEM, V266, P11732; BERNAR J, 1986, J BIOL CHEM, V261, P7107; BIRD SJ, 1990, BIOCHIM BIOPHYS ACTA, V1024, P267, DOI 10.1016/0005-2736(90)90353-P; BLOM HJ, 1990, BIOCHEM J, V268, P621, DOI 10.1042/bj2680621; BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; Cleland W W, 1979, Methods Enzymol, V63, P103; COLLARINI EJ, 1989, BIOCHIM BIOPHYS ACTA, V987, P139, DOI 10.1016/0005-2736(89)90536-1; DANEHY JP, 1960, J AM CHEM SOC, V82, P2511, DOI 10.1021/ja01495a028; ELDJARN L, 1954, ARCH INT PHYS BIOCH, V62, P476; GAHL WA, 1983, BIOCHEM J, V216, P393, DOI 10.1042/bj2160393; GAHL WA, 1985, BIOCHEM J, V228, P545, DOI 10.1042/bj2280545; GAHL WA, 1987, NEW ENGL J MED, V316, P971, DOI 10.1056/NEJM198704163161602; GAHL WA, 1982, SCIENCE, V217, P1263, DOI 10.1126/science.7112129; GREENE AA, 1987, BIOCHEM J, V246, P547, DOI 10.1042/bj2460547; IDRISS JM, 1991, J BIOL CHEM, V266, P9438; JOCELYN P, 1972, BIOCH SH GROUP, P122; Jocelyn P.C., 1972, BIOCH SH GROUP, P52; JONAS AJ, 1990, J BIOL CHEM, V265, P17545; JONAS AJ, 1982, P NATL ACAD SCI-BIOL, V79, P4442, DOI 10.1073/pnas.79.14.4442; JONAS AJ, 1990, BIOCHEM J, V272, P323, DOI 10.1042/bj2720323; JONAS AJ, 1989, J BIOL CHEM, V264, P4953; LEMONS RM, 1991, J BIOL CHEM, V266, P14378; MANCINI GMS, 1989, J BIOL CHEM, V264, P15247; MANCINI GMS, 1990, J BIOL CHEM, V265, P12380; MANCINI GMS, 1991, J CLIN INVEST, V87, P1329, DOI 10.1172/JCI115136; ORLOFF S, 1981, PEDIATR RES, V15, P1063, DOI 10.1203/00006450-198107000-00018; OSHIMA RG, 1974, J BIOL CHEM, V249, P6033; PIHL A, 1958, 4TH INT C BIOCH, V14, P43; PISONI RL, 1989, J BIOL CHEM, V264, P4850; PISONI RL, 1991, J BIOL CHEM, V266, P979; PISONI RL, 1991, BIOCHIM BIOPHYS ACTA, V1071, P351, DOI 10.1016/0304-4157(91)90002-E; PISONI RL, 1990, J CELL BIOL, V110, P327, DOI 10.1083/jcb.110.2.327; PISONI RL, 1987, J BIOL CHEM, V262, P15011; PISONI RL, 1987, J BIOL CHEM, V262, P6010; PISONI RL, 1985, J BIOL CHEM, V260, P4791; RENLUND M, 1986, SCIENCE, V232, P759, DOI 10.1126/science.3961501; ROBISHAW JD, 1985, AM J PHYSIOL, V248, pE1, DOI 10.1152/ajpendo.1985.248.1.E1; ROME LH, 1983, J BIOL CHEM, V258, P3006; ROSENBLATT DS, 1985, SCIENCE, V228, P1319, DOI 10.1126/science.4001945; Segel I. H., 1975, ENZYME KINETICS, p[107, 132]; SMITH ML, 1987, J BIOL CHEM, V262, P1244; SMOLIN LA, 1988, PEDIATR RES, V23, P616, DOI 10.1203/00006450-198806000-00018; STEWART BH, 1989, BIOCHIM BIOPHYS ACTA, V987, P145, DOI 10.1016/0005-2736(89)90537-3; THOENE JG, 1976, J CLIN INVEST, V58, P180, DOI 10.1172/JCI108448; TIETZE F, 1989, J BIOL CHEM, V264, P4762	47	35	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1179	1184		10.1074/jbc.270.3.1179	http://dx.doi.org/10.1074/jbc.270.3.1179			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836377	hybrid			2022-12-27	WOS:A1995QB15600032
J	SCHEIFFELE, P; PANSEGRAU, W; LANKA, E				SCHEIFFELE, P; PANSEGRAU, W; LANKA, E			INITIATION OF AGROBACTERIUM-TUMEFACIENS T-DNA PROCESSING - PURIFIED PROTEINS VIRD1 AND VIRD2 CATALYZE SITE-SPECIFIC AND STRAND-SPECIFIC CLEAVAGE OF SUPERHELICAL T-BORDER DNA IN-VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNALS; PLASMID RP4; ESCHERICHIA-COLI; ILLEGITIMATE RECOMBINATION; MOLECULAR CHARACTERIZATION; BACTERIAL CONJUGATION; NUCLEOTIDE-SEQUENCE; VIRE2 PROTEIN; GENE-PRODUCT; NICK REGIONS	T-DNA processing during agroinfection of plants is initiated by site- and strand-specific incision at the T-DNA border sequences of the Ti plasmid, Two proteins are required for this reaction: VirD2 (49.6 kDa), catalyzing a site specific cleaving-joining reaction on single-stranded DNA in vitro (Pansegrau, W., Schoumacher, F., Hohn, B., and Lanka, E. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 11538-11542), and VirD1 (16.1 kDa), an accessory protein required for VirD2-mediated specific cleavage of double-stranded DNA, Following efficient overproduction, VirD1 was isolated in active form from inclusion bodies and purified to near homogeneity. The protein was applied together with purified VirD2 protein for specific cleavage of double-stranded T-DNA border sequences in vitro. The reaction proceeds on negative superhelical DNA and requires Mg2+ ions. Relaxed DNA is not cleaved. The 5' terminus of the broken DNA strand is covalently associated with protein, most probably VirD2, and the cleavage site is located at the same position that is found in vivo, indicating that the in vitro reaction mimics the one that takes place in induced agrobacteria. Relaxation of plasmid DNA occurs only upon addition of protein denaturants, suggesting that the DNA in the VirD1/VirD2 complex is topologically constrained by strong protein-DNA interactions. The characteristics of the VirD1/VirD2-mediated cleavage reaction strongly resemble those observed with relaxosomes of IncP plasmids involved in initiation of transfer DNA replication during bacterial conjugation.	MAX PLANCK INST MOLEC GENET,SCHUSTER ABT,D-14195 BERLIN,GERMANY	Max Planck Society								ALDOORI Z, 1982, GENET RES, V39, P99, DOI 10.1017/S0016672300020772; ALTMOERBE J, 1986, EMBO J, V5, P1129, DOI 10.1002/j.1460-2075.1986.tb04337.x; BALZER D, 1992, NUCLEIC ACIDS RES, V20, P1851, DOI 10.1093/nar/20.8.1851; CHRISTIE PJ, 1988, J BACTERIOL, V170, P2659, DOI 10.1128/jb.170.6.2659-2667.1988; CITOVSKY V, 1989, P NATL ACAD SCI USA, V86, P1193, DOI 10.1073/pnas.86.4.1193; CITOVSKY V, 1994, P NATL ACAD SCI USA, V91, P3210, DOI 10.1073/pnas.91.8.3210; CITOVSKY V, 1992, SCIENCE, V256, P1802, DOI 10.1126/science.1615325; COVARRUBIAS L, 1982, GENE, V17, P79, DOI 10.1016/0378-1119(82)90103-2; De Vos G, 1989, Mol Plant Microbe Interact, V2, P43, DOI 10.1094/MPMI-2-043; DURRENBERGER F, 1989, P NATL ACAD SCI USA, V86, P9154, DOI 10.1073/pnas.86.23.9154; FILICHKIN SA, 1993, MOL MICROBIOL, V8, P915, DOI 10.1111/j.1365-2958.1993.tb01637.x; GHAI J, 1989, P NATL ACAD SCI USA, V86, P3109, DOI 10.1073/pnas.86.9.3109; GHEYSEN G, 1991, GENE DEV, V5, P287, DOI 10.1101/gad.5.2.287; GIETL C, 1987, P NATL ACAD SCI USA, V84, P9006, DOI 10.1073/pnas.84.24.9006; GRINTER NJ, 1981, PLASMID, V5, P267, DOI 10.1016/0147-619X(81)90004-4; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HIRAYAMA T, 1988, MOL GEN GENET, V213, P229, DOI 10.1007/BF00339586; HOWARD EA, 1989, P NATL ACAD SCI USA, V86, P4017, DOI 10.1073/pnas.86.11.4017; ILYINA TV, 1992, NUCLEIC ACIDS RES, V20, P3279, DOI 10.1093/nar/20.13.3279; JASPER F, 1994, P NATL ACAD SCI USA, V91, P694, DOI 10.1073/pnas.91.2.694; JAYASWAL RK, 1987, J BACTERIOL, V169, P5035, DOI 10.1128/jb.169.11.5035-5045.1987; JIN SG, 1990, J BACTERIOL, V172, P4945, DOI 10.1128/jb.172.9.4945-4950.1990; KADO CI, 1994, MOL MICROBIOL, V12, P17, DOI 10.1111/j.1365-2958.1994.tb00990.x; KADO CI, 1993, MOL MICROBIOL, V9, P803; KOONIN EV, 1993, BIOSYSTEMS, V30, P241, DOI 10.1016/0303-2647(93)90074-M; KULDAU GA, 1990, MOL GEN GENET, V221, P256, DOI 10.1007/BF00261729; LESSL M, 1992, J BIOL CHEM, V267, P20471; LESSL M, 1994, CELL, V77, P321, DOI 10.1016/0092-8674(94)90146-5; LLOSA M, 1994, J MOL BIOL, V235, P448, DOI 10.1006/jmbi.1994.1005; MAYERHOFER R, 1991, EMBO J, V10, P697, DOI 10.1002/j.1460-2075.1991.tb07999.x; MCDONNELL MW, 1994, J MEMBRANE BIOL, V110, P119; Miller J. H., 1972, EXPT MOL GENETICS, P433; PANSEGRAU W, 1994, J BIOL CHEM, V269, P2782; PANSEGRAU W, 1990, J BIOL CHEM, V265, P10637; PANSEGRAU W, 1993, P NATL ACAD SCI USA, V90, P11538, DOI 10.1073/pnas.90.24.11538; PANSEGRAU W, 1994, J MOL BIOL, V239, P623, DOI 10.1006/jmbi.1994.1404; PANSEGRAU W, 1993, P NATL ACAD SCI USA, V90, P2925, DOI 10.1073/pnas.90.7.2925; PANSEGRAU W, 1991, NUCLEIC ACIDS RES, V19, P3455, DOI 10.1093/nar/19.12.3455; PANSEGRAU W, 1990, P NATL ACAD SCI USA, V87, P6565; POHLMAN RF, 1993, NUCLEIC ACIDS RES, V21, P4867, DOI 10.1093/nar/21.21.4867; PORTER SG, 1987, NUCLEIC ACIDS RES, V15, P7503, DOI 10.1093/nar/15.18.7503; REES CED, 1990, MOL MICROBIOL, V4, P1199, DOI 10.1111/j.1365-2958.1990.tb00695.x; ROSENBERG AH, 1993, J BACTERIOL, V175, P716, DOI 10.1128/JB.175.3.716-722.1993; ROSSI L, 1993, MOL GEN GENET, V239, P345, DOI 10.1007/BF00276932; Sambrook J, 1989, MOL CLONING LABORATO; SANO T, 1990, P NATL ACAD SCI USA, V87, P142, DOI 10.1073/pnas.87.1.142; SAYERS JR, 1988, NUCLEIC ACIDS RES, V16, P791, DOI 10.1093/nar/16.3.791; SHIRASU K, 1990, MOL MICROBIOL, V4, P1153, DOI 10.1111/j.1365-2958.1990.tb00690.x; STACHEL SE, 1987, EMBO J, V6, P857, DOI 10.1002/j.1460-2075.1987.tb04831.x; STACHEL SE, 1986, CELL, V46, P325, DOI 10.1016/0092-8674(86)90653-7; THOMPSON DV, 1988, NUCLEIC ACIDS RES, V16, P4621, DOI 10.1093/nar/16.10.4621; TINLAND B, 1992, P NATL ACAD SCI USA, V89, P7442, DOI 10.1073/pnas.89.16.7442; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VOGEL AM, 1992, J BACTERIOL, V174, P303, DOI 10.1128/jb.174.1.303-308.1992; VOGEL AM, 1992, J BACTERIOL, V174, P5161, DOI 10.1128/JB.174.15.5161-5164.1992; WARD JE, 1988, J BIOL CHEM, V263, P5804; WATERS VL, 1993, MOL MICROBIOL, V9, P1123, DOI 10.1111/j.1365-2958.1993.tb01242.x; WATERS VL, 1991, P NATL ACAD SCI USA, V88, P1456, DOI 10.1073/pnas.88.4.1456; WEISS AA, 1993, P NATL ACAD SCI USA, V90, P2970, DOI 10.1073/pnas.90.7.2970; WINANS SC, 1992, MICROBIOL REV, V56, P12, DOI 10.1128/MMBR.56.1.12-31.1992; YANOFSKY MF, 1986, CELL, V47, P471, DOI 10.1016/0092-8674(86)90604-5; YOUNG C, 1988, J BACTERIOL, V170, P3367, DOI 10.1128/jb.170.8.3367-3374.1988; ZAMBRYSKI P, 1989, CELL, V56, P193, DOI 10.1016/0092-8674(89)90892-1; ZAMBRYSKI PC, 1992, ANNU REV PLANT PHYS, V43, P465, DOI 10.1146/annurev.pp.43.060192.002341; ZIEGELIN G, 1989, J BIOL CHEM, V264, P11989; Ziegelin G, 1991, DNA Seq, V1, P303, DOI 10.3109/10425179109020786; ZIEGELIN G, 1989, THESIS FREIE U BERLI	67	62	72	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1269	1276		10.1074/jbc.270.3.1269	http://dx.doi.org/10.1074/jbc.270.3.1269			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836390	hybrid			2022-12-27	WOS:A1995QB15600045
J	ETCHISON, JR; SRIKRISHNA, G; FREEZE, HH				ETCHISON, JR; SRIKRISHNA, G; FREEZE, HH			A NOVEL METHOD TO CO-LOCALIZE GLYCOSAMINOGLYCAN-CORE OLIGOSACCHARIDE GLYCOSYLTRANSFERASES IN RAT-LIVER GOLGI - COLOCALIZATION OF GALACTOSYLTRANSFERASE-I WITH A SIALYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROUGH ENDOPLASMIC-RETICULUM; ASPARAGINE-LINKED OLIGOSACCHARIDES; PROTEIN LINKAGE REGION; BETA-D-XYLOSIDE; SULFATE PROTEOGLYCANS; MOLECULAR DISSECTION; N-ACETYLGLUCOSAMINE; VESICLE MEMBRANES; MUTANT DEFICIENT; BREFELDIN-A	4-Methylumbelliferyl-beta-xyloside (Xyl beta MU) primes glycosaminoglycan synthesis by first serving as an acceptor for the addition of 2 galactoses and 1 glucuronic acid residue to make the typical core structure, GlcUA beta 1, 3Gal beta 1,3Gal beta 1,4Xyl beta MU. To investigate the relative localization of these biosynthetic enzymes, intact and properly oriented rat liver Golgi preparations were incubated with Xyl beta MU and 1 mu M UDP-[H-3]Gal and then chased with 5 mu M of unlabeled UDP-Gal, UDP-GlcUA, UDP-GlcNAc, UDP-GalNAc, and CMP-Neu5Ac. Under these conditions, no intervesicular transport occurs and acceptor labeling depends entirely upon transporter-mediated delivery of the labeled sugar nucleotides into the lumen of a vesicle and co-localization of the appropriate glycosyltransferases. The labeled products were isolated from the incubation medium and from within the Golgi and their structures analyzed by C18, anion-exchange, and amine adsorption high performance liquid chromatography in combination with glycosidase digestions, Surprisingly, the major products within the Golgi mere two sialylated xylosides (Sia alpha 2,3Gal beta 1,4Xyl beta MU and Sia alpha 2,8Sia alpha 2,3Gal beta 1,4Xyl beta MU) rather than the expected group of partially completed GAG core structures, Less than 10% of the products within the Golgi are the expected core structures containing a second Gal residue or, in addition, GlcUA. The amount of the sialylated products is only partially decreased if the chase is omitted or if the chase is done in the absence of added CMP-Sia, suggesting a pool of previously transported CMP-Sia drives synthesis of the major products, Conversely, when detergent permeabilized vesicles are provided with high concentration of the same sugar nucleotides, the ratio of sialylated products is reduced and replaced by an increase in GAG-like products. These results argue that GAG core-specific Gal transferase I and II are not extensively co-localized within the same Golgi compartment. By contrast, glycosaminoglycan core Gal transferase I is substantially co-localized with an alpha-2,3-sialyltransferase and an alpha-2,8-sialyltransferase. Incubating intact Golgi vesicles with exogenous diffusible accepters offers a novel method to assess the functional co-localization of glycosyltransferases of multiple pathways within the Golgi compartments.	LA JOLLA CANC RES FDN,GLYCOBIOL CARBOHYDRATE CHEM PROGRAM,SAN DIEGO,CA 92037					Freeze, Hudson/0000-0001-6316-0501	NCI NIH HHS [R01-CA38701] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA038701] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BALCH WE, 1984, CELL, V39, P525, DOI 10.1016/0092-8674(84)90459-8; BARINAGA M, 1993, SCIENCE, V260, P487, DOI 10.1126/science.8475382; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; DEUTSCHER SL, 1986, J BIOL CHEM, V261, P96; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; DUNPHY WG, 1985, CELL, V40, P463, DOI 10.1016/0092-8674(85)90161-8; FREEZE HH, 1993, J BIOL CHEM, V268, P1618; GEUZE HJ, 1991, J ELECTRON MICR TECH, V17, P24, DOI 10.1002/jemt.1060170105; GOLDBERG DE, 1983, J BIOL CHEM, V258, P3159; GREEN ED, 1985, J BIOL CHEM, V260, P5623; GRESSNER AM, 1991, CELL MOL BIOL, V37, P549; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; HAYES BK, 1993, J BIOL CHEM, V268, P16139; HAYES BK, 1993, J BIOL CHEM, V268, P16155; HAYES BK, 1993, J BIOL CHEM, V268, P16170; HAYES BK, 1982, ANAL BIOCHEM, V201, P140; HIRSCHBERG CB, 1987, ANNU REV BIOCHEM, V56, P63, DOI 10.1146/annurev.bi.56.070187.000431; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; KRULL NB, 1992, FEBS LETT, V312, P47, DOI 10.1016/0014-5793(92)81407-D; LEELAVATHI DE, 1970, BIOCHIM BIOPHYS ACTA, V211, P124, DOI 10.1016/0005-2736(70)90087-8; LUGEMWA FN, 1991, J BIOL CHEM, V266, P6674; LYON M, 1994, J BIOL CHEM, V269, P11208; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; NILSSON T, 1993, FEBS LETT, V330, P1, DOI 10.1016/0014-5793(93)80906-B; NILSSON T, 1993, J CELL BIOL, V120, P5, DOI 10.1083/jcb.120.1.5; OSTERMANN J, 1993, CELL, V75, P409; PALCIC MM, 1988, GLYCOCONJUGATE J, V5, P49, DOI 10.1007/BF01048331; PEREZ M, 1987, METHOD ENZYMOL, V138, P709; PEREZ M, 1985, J BIOL CHEM, V260, P4671; ROTH J, 1991, J ELECTRON MICR TECH, V17, P121, DOI 10.1002/jemt.1060170202; ROTHMAN JE, 1990, FASEB J, V4, P1460, DOI 10.1096/fasebj.4.5.2407590; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; SAMPATH D, 1992, J BIOL CHEM, V267, P4440; SHIBATA S, 1992, J BIOL CHEM, V267, P6548; SILVA LCF, 1992, BIOCHIM BIOPHYS ACTA, V1138, P133, DOI 10.1016/0925-4439(92)90053-P; SOROKA CJ, 1992, J CELL BIOL, V113, P1231; SUGAHARA K, 1991, EUR J BIOCHEM, V202, P805, DOI 10.1111/j.1432-1033.1991.tb16436.x; SUGAHARA K, 1988, J BIOL CHEM, V263, P10168; SUGUMARAN G, 1992, J BIOL CHEM, V267, P8802; TABAS I, 1979, J BIOL CHEM, V254, P1655; TAKIZAWA PA, 1993, CELL, V73, P1079, DOI 10.1016/0092-8674(93)90638-7; VARKI A, 1991, FASEB J, V5, P226, DOI 10.1096/fasebj.5.2.2004668; VELASCO A, 1993, J CELL BIOL, V122, P39, DOI 10.1083/jcb.122.1.39; VERTEL BM, 1993, J BIOL CHEM, V268, P11105	44	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					756	764		10.1074/jbc.270.2.756	http://dx.doi.org/10.1074/jbc.270.2.756			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822307	hybrid			2022-12-27	WOS:A1995QB81600041
J	WILLIAMS, AJ; KAGUNI, LS				WILLIAMS, AJ; KAGUNI, LS			STIMULATION OF DROSOPHILA MITOCHONDRIAL-DNA POLYMERASE BY SINGLE-STRANDED DNA-BINDING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYRIBONUCLEIC-ACID SYNTHESIS; RAT-LIVER MITOCHONDRIA; ESCHERICHIA-COLI SSB; UNWINDING PROTEIN; III HOLOENZYME; XENOPUS-LAEVIS; SYNTHESIS INVITRO; REPLICATION; PROCESSIVITY; PURIFICATION	Mitochondrial DNA polymerase from Drosophila embryos has been characterized with regard to its mechanism of DNA synthesis in the presence of single-stranded DNA-binding protein from Escherichia coli. The rate of DNA synthesis by DNA polymerase gamma was increased nearly 40-fold upon addition of single-stranded DNA-binding protein. Processivity of mitochondrial DNA polymerase was increased similar to 2-fold, while its intrinsic rate of nucleotide polymerization was unaffected. Primer extension analysis showed that the rate of initiation of DNA strand synthesis by DNA polymerase gamma was increased 25-fold in the presence of single-stranded DNA-binding protein. Our results indicate that the stimulation of Drosophila DNA polymerase gamma by single-stranded DNA-binding protein results primarily from an increased rate of primer recognition and binding. Concurrent achievement of maximal activity and processivity by mitochondrial DNA polymerase in the presence of binding protein suggests that DNA polymerase gamma, like other replicative DNA polymerases, associates with accessory factors in vivo to catalyze efficient and processive DNA synthesis.	MICHIGAN STATE UNIV, DEPT BIOCHEM, E LANSING, MI 48824 USA	Michigan State University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45295] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKER TA, 1986, CELL, V45, P53, DOI 10.1016/0092-8674(86)90537-4; BENEDICT RC, 1988, J BIOL CHEM, V263, P15513; CASASFINET JR, 1987, FEBS LETT, V220, P347, DOI 10.1016/0014-5793(87)80844-X; CHASE JW, 1986, ANNU REV BIOCHEM, V55, P103, DOI 10.1146/annurev.biochem.55.1.103; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; FAY PJ, 1982, J BIOL CHEM, V257, P5692; GHRIR R, 1991, ARCH BIOCHEM BIOPHYS, V291, P395, DOI 10.1016/0003-9861(91)90152-9; GODDARD JM, 1980, NUCLEIC ACIDS RES, V8, P741; HOKE GD, 1990, ARCH BIOCHEM BIOPHYS, V282, P116, DOI 10.1016/0003-9861(90)90094-F; ITO J, 1991, NUCLEIC ACIDS RES, V19, P4045, DOI 10.1093/nar/19.15.4045; KAGUNI LS, 1988, CANCER CELL, V6, P425; KENNY MK, 1989, P NATL ACAD SCI USA, V86, P9757, DOI 10.1073/pnas.86.24.9757; KHAMIS MI, 1987, J BIOL CHEM, V262, P10938; KRAUSS G, 1981, BIOCHEMISTRY-US, V20, P5346, DOI 10.1021/bi00521a040; KUNKEL TA, 1979, P NATL ACAD SCI USA, V76, P6331, DOI 10.1073/pnas.76.12.6331; KUNKEL TA, 1983, BIOCHEMISTRY-US, V22, P2378, DOI 10.1021/bi00279a012; LADUCA RJ, 1983, BIOCHEMISTRY-US, V22, P5177, DOI 10.1021/bi00291a018; LEDWITH BJ, 1986, J BIOL CHEM, V261, P6571; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; MCHENRY CS, 1988, ANNU REV BIOCHEM, V57, P519; MERRILL BM, 1984, J BIOL CHEM, V259, P850; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; MIGNOTTE B, 1985, NUCLEIC ACIDS RES, V13, P1703, DOI 10.1093/nar/13.5.1703; MIGNOTTE B, 1988, EUR J BIOCHEM, V174, P479, DOI 10.1111/j.1432-1033.1988.tb14123.x; MITSIS PG, 1993, BIOCHEMISTRY-US, V32, P5257, DOI 10.1021/bi00070a038; MOLINEUX IJ, 1974, J BIOL CHEM, V249, P6090; MYERS TW, 1988, J BIOL CHEM, V263, P17006; ODONNELL ME, 1987, J BIOL CHEM, V262, P4252; PAVCO PA, 1985, J CELL BIOL, V100, P258, DOI 10.1083/jcb.100.1.258; RUYECHAN WT, 1976, BIOCHEMISTRY-US, V15, P5057, DOI 10.1021/bi00668a017; SHERMAN LA, 1976, J MOL BIOL, V103, P61, DOI 10.1016/0022-2836(76)90052-8; SIGAL N, 1972, P NATL ACAD SCI USA, V69, P3537, DOI 10.1073/pnas.69.12.3537; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; TABOR S, 1987, J BIOL CHEM, V262, P16212; TIRANTI V, 1991, NUCLEIC ACIDS RES, V19, P4291, DOI 10.1093/nar/19.15.4291; TIRANTI V, 1993, GENE, V126, P219, DOI 10.1016/0378-1119(93)90370-I; VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x; VANTUYLE GC, 1981, J BIOL CHEM, V256, P2772; VANTUYLE GC, 1985, J CELL BIOL, V100, P251, DOI 10.1083/jcb.100.1.251; WERNETTE CM, 1988, BIOCHEMISTRY-US, V27, P6046, DOI 10.1021/bi00416a033; WERNETTE CM, 1986, J BIOL CHEM, V261, P4764; WILLIAMS AJ, 1993, J BIOL CHEM, V268, P24855; WONG TW, 1985, CELL, V42, P951, DOI 10.1016/0092-8674(85)90291-0	43	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					860	865		10.1074/jbc.270.2.860	http://dx.doi.org/10.1074/jbc.270.2.860			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822323	hybrid			2022-12-27	WOS:A1995QB81600057
J	LEE, HC; TOUNG, YPS; TU, YSL; TU, CPD				LEE, HC; TOUNG, YPS; TU, YSL; TU, CPD			A MOLECULAR-GENETIC APPROACH FOR THE IDENTIFICATION OF ESSENTIAL RESIDUES IN HUMAN GLUTATHIONE-S-TRANSFERASE FUNCTION IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; 3-DIMENSIONAL STRUCTURE; ACTIVE-SITE; CATALYTIC ACTIVITY; INTRONLESS GENE; SUBUNIT CDNA; PLASMID DNA; HUMAN-LIVER; RAT; PI	The common substrate for glutathione S-transferases (GSTs), 1-chloro-2,4-dinitrobenzene (CDNB), is an inhibitor of Escherichia coli growth. This growth inhibition by CDNB is enhanced when E. coli expresses a functional GST. Cells under growth inhibition have reduced intracellular GSH levels and form filaments when they resume growth. Based on this differential growth inhibition by CDNB we have developed a simple procedure to select for null-mutants of a human GST in E. coli. Null mutations in the human GST gene from hydroxylamine mutagenesis or oligonucleotide directed mutagenesis can be selected for on agar plates containing CDNB after transformation. The molecular nature of each mutation can be identified by DNA sequence analysis of the mutant GST gene. We have identified three essential amino acid residues in an alpha class human GST at Glu(31), Glu(96), and Gly(97). Single substitution at each of these residues, E31K, E96K, G97D, resulted in mutant GST proteins with loss of CDNB conjugation activity and failure in binding to the S-hexyl GSH affinity matrix. In contrast, a mutant GST (Y8F) resulting from substitution of the conserved tyrosine near the N terminus has much reduced CDNB conjugation activity but was still capable of binding to the S-hexyl GSH-agarose. Additional mutant GSTs with substitutions at position 96 (E96F, E96Y) and 97 (G97P, G97T, G97S) resulted in changes in both K-m and k(cat) to different extents. The in vitro CDNB conjugation activity of the purified mutant enzymes correlate negatively with the plating efficiencies of strains encoding them in the presence of CDNB. Based on the x-ray structure model of human GST 1-1, two of these residues are involved in salt bridges (Arg(19)-Glu(31), Arg(68)-Glu(96))) and the third Gly(97) is in the middle of the helix alpha 4. Our results provide evidence in vivo that Tyr(8), Gly(97), and the two salt bridges are important for GST structure-function. This molecular genetic approach for the identification of essential amino acids in GSTs should be applicable to any GSTs with CDNB conjugation activity. It should also complement the x-ray crystallographic approach in understanding the structure and function of GSTs.	PENN STATE UNIV, DEPT BIOCHEM & MOLEC BIOL, UNIVERSITY PK, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park					NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005661] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES 05661] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		APONTOWEIL P, 1975, BIOCHIM BIOPHYS ACTA, V399, P10, DOI 10.1016/0304-4165(75)90206-8; ARMSTRONG RN, 1991, CHEM RES TOXICOL, V4, P131, DOI 10.1021/tx00020a001; AWASTHI YC, 1987, BIOCHEM BIOPH RES CO, V143, P965, DOI 10.1016/0006-291X(87)90345-7; AWASTHI YC, 1981, BLOOD, V58, P733; BATIST G, 1986, J BIOL CHEM, V261, P5544; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BOCHNER BR, 1984, CELL, V37, P225, DOI 10.1016/0092-8674(84)90318-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANG LH, 1990, BIOCHEMISTRY-US, V29, P744, DOI 10.1021/bi00455a022; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHOW NWI, 1988, J BIOL CHEM, V263, P12797; DEJONG JL, 1988, J BIOL CHEM, V263, P8430; ELMORE MJ, 1990, MOL MICROBIOL, V4, P405, DOI 10.1111/j.1365-2958.1990.tb00607.x; FU HH, 1994, ACTA CRYSTALLOGR D, V2, P219; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HASHIMOTO T, 1976, J BACTERIOL, V127, P1561, DOI 10.1128/JB.127.3.1561-1563.1976; HAYES JD, 1990, GLUTATHIONE S TRANSF; HIRATSUKA A, 1990, J BIOL CHEM, V265, P11973; HOESCH RM, 1989, J BIOL CHEM, V264, P17712; Jakoby W B, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P383; JI XH, 1992, BIOCHEMISTRY-US, V31, P10169, DOI 10.1021/bi00157a004; JOHNSON WW, 1993, J BIOL CHEM, V268, P11508; KATUSZ RM, 1991, BIOCHEMISTRY-US, V30, P11230, DOI 10.1021/bi00111a006; KONG KH, 1992, BIOCHEM BIOPH RES CO, V182, P1122, DOI 10.1016/0006-291X(92)91848-K; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; LAI HCJ, 1986, J BIOL CHEM, V261, P3793; LEE PC, 1983, P NATL ACAD SCI-BIOL, V80, P7496, DOI 10.1073/pnas.80.24.7496; Leung DW, 1989, TECHNIQUE, V1, P11; LIU SX, 1992, J BIOL CHEM, V267, P4296; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; MANOHARAN TH, 1992, J BIOL CHEM, V267, P18940; MANOHARAN TH, 1992, J MOL BIOL, V226, P319, DOI 10.1016/0022-2836(92)90949-K; MCLAGGAN D, 1994, J BIOL CHEM, V269, P1911; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MEYER DJ, 1991, BIOCHEM J, V274, P409, DOI 10.1042/bj2740409; NOVOGRODSKY A, 1979, P NATL ACAD SCI USA, V76, P4932, DOI 10.1073/pnas.76.10.4932; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; PENNINGTON CJ, 1992, BIOCHEMISTRY-US, V31, P2912; PICKETT CB, 1989, ANNU REV BIOCHEM, V58, P743, DOI 10.1146/annurev.bi.58.070189.003523; RAGHUNATHAN S, 1994, J MOL BIOL, V238, P815, DOI 10.1006/jmbi.1994.1336; REINEMER P, 1992, J MOL BIOL, V227, P214, DOI 10.1016/0022-2836(92)90692-D; REINEMER P, 1991, EMBO J, V10, P1997, DOI 10.1002/j.1460-2075.1991.tb07729.x; RHOADS DM, 1987, BIOCHEM BIOPH RES CO, V145, P474, DOI 10.1016/0006-291X(87)91345-3; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAMM VL, 1984, J BIOL CHEM, V259, P714; SIMULA TP, 1993, CARCINOGENESIS, V14, P1371, DOI 10.1093/carcin/14.7.1371; SIMULA TP, 1993, CARCINOGENESIS, V14, P2303, DOI 10.1093/carcin/14.11.2303; SINNING I, 1993, J MOL BIOL, V232, P192, DOI 10.1006/jmbi.1993.1376; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STENBERG G, 1991, FEBS LETT, V293, P153, DOI 10.1016/0014-5793(91)81174-7; STENBERG G, 1991, BIOCHEM J, V274, P549, DOI 10.1042/bj2740549; TESSMAN I, 1968, VIROLOGY, V35, P330, DOI 10.1016/0042-6822(68)90275-4; Tew Kenneth D., 1993, STRUCTURE FUNCTION G, V1st; THIER R, 1993, P NATL ACAD SCI USA, V90, P8576, DOI 10.1073/pnas.90.18.8576; TOUNG YPS, 1991, BIOCHEM BIOPH RES CO, V178, P1205, DOI 10.1016/0006-291X(91)91021-4; TOUNG YPS, 1993, J BIOL CHEM, V268, P9737; TOUNG YPS, 1990, P NATL ACAD SCI USA, V87, P31, DOI 10.1073/pnas.87.1.31; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSUCHIDA S, 1992, CRIT REV BIOCHEM MOL, V27, P337, DOI 10.3109/10409239209082566; TU CPD, 1986, BIOCHEM BIOPH RES CO, V141, P229, DOI 10.1016/S0006-291X(86)80358-8; WANG AL, 1985, CANCER TREAT REP, V69, P677; WANG RW, 1992, J BIOL CHEM, V267, P19866; WANG RW, 1991, ARCH BIOCHEM BIOPHYS, V286, P574, DOI 10.1016/0003-9861(91)90082-T	65	19	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					99	109		10.1074/jbc.270.1.99	http://dx.doi.org/10.1074/jbc.270.1.99			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814427	hybrid			2022-12-27	WOS:A1995QA28700021
J	THOMAS, WG; THEKKUMKARA, TJ; MOTEL, TJ; BAKER, KM				THOMAS, WG; THEKKUMKARA, TJ; MOTEL, TJ; BAKER, KM			STABLE EXPRESSION OF A TRUNCATED AT(1A) RECEPTOR IN CHO-KI CELLS - THE CARBOXYL-TERMINAL REGION DIRECTS AGONIST-INDUCED INTERNALIZATION BUT NOT RECEPTOR SIGNALING OR DESENSITIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOTENSIN-II RECEPTOR; SMOOTH-MUSCLE CELLS; CLONING; IDENTIFICATION; ENDOCYTOSIS; SEQUESTRATION; ACTIVATION; PATHWAYS; DOMAINS; LIGAND	Phosphorylation of serine and threonine residues in the carboxyl-terminal region of many G-protein-coupled receptors directs the rapid uncoupling from signal transduction pathways, In Chinese hamster ovary cells, we have stably expressed a truncated mutant of the angiotensin II (AT(1A)) receptor devoid of the carboxyl-terminal 45 amino acids, encompassing 13 serine/threonine residues. One clone, designated TL(314) to indicate truncation after leucine 314, expressed a single class of angiotensin II receptors with a dissociation constant of 1.08 nM and a receptor density of 560 fmol/mg of protein (similar to 75,000 receptors/cell). A nonhydrolyzable analog of GTP accelerated the angiotensin II-induced dissociation of [I-125] angiotensin II from TL(314) plasma membranes 3.6-fold, indicating G-protein coupling. In TL(314) cells, angiotensin II stimulated the release of intracellular calcium and the induction of mitogen-activated protein kinase activity, the levels of which were comparable with the full-length AT(1A) receptor. The AII-stimulated calcium response was rapidly desensitized in both full-length and truncated AT(1A) receptors. Interestingly, angiotensin II-induced endocytosis of the truncated receptor was almost completely inhibited, suggesting that a recognition motif within the carboxyl-terminal 45 amino acids of the AT(1A) receptor promotes sequestration. Thus, truncation of the AT(1A) receptor after leucine 314 inhibits agonist-induced internalization without affecting the capacity of the expressed protein to adopt the correct conformation necessary for high affinity binding of angiotensin II, coupling to G-proteins, and activation of signal transduction pathways, The rapid desensitization and refractoriness of the angiotensin II-induced calcium transient in the TL(314) cell line, in which putative carboxyl-terminal phosphorylation sites are absent, suggests that the mechanism of AT(1A) receptor desensitization differs from that of other prototypical G-protein coupled receptors.	WEIS CTR RES, GEISINGER CLIN, DANVILLE, PA 17822 USA				Thomas, Walter/I-2208-2015	Thomas, Walter/0000-0003-0685-2952; Thekkumkara, Thomas/0000-0001-8865-1446	NHLBI NIH HHS [HL44883, HL44379] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044379, R01HL044883] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABDELLATIF MM, 1991, CIRC RES, V69, P800, DOI 10.1161/01.RES.69.3.800; ANDERSON KM, 1993, AM J PHYSIOL, V264, pC179, DOI 10.1152/ajpcell.1993.264.1.C179; BARAK LS, 1994, J BIOL CHEM, V269, P2790; BIHOREAU C, 1993, P NATL ACAD SCI USA, V90, P5133, DOI 10.1073/pnas.90.11.5133; BOEKHOFF I, 1994, J BIOL CHEM, V269, P37; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CATT KJ, 1993, RENIN ANGIOTENSIN SY, V1; CHEUNG AH, 1990, MOL PHARMACOL, V37, P775; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CYR CR, 1993, J BIOL CHEM, V268, P26071; DAVIDSON JS, 1994, BIOCHEM J, V300, P299, DOI 10.1042/bj3000299; ELTON TS, 1992, BIOCHEM BIOPH RES CO, V184, P1067, DOI 10.1016/0006-291X(92)90700-U; FRAIL DE, 1993, MOL PHARMACOL, V44, P1113; GRIENDLING KK, 1993, SEMIN NEPHROL, V13, P558; GRIENDLING KK, 1987, J BIOL CHEM, V262, P14555; IWAI N, 1992, FEBS LETT, V298, P257, DOI 10.1016/0014-5793(92)80071-N; KAMBAYASHI Y, 1993, J BIOL CHEM, V268, P24543; LEFKOWITZ RJ, 1990, TRENDS PHARMACOL SCI, V11, P190, DOI 10.1016/0165-6147(90)90113-M; LEFKOWITZ RJ, 1992, COLD SPRING HARB SYM, V57, P127, DOI 10.1101/SQB.1992.057.01.016; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; MORI S, 1991, J BIOL CHEM, V266, P21158; MUKOYAMA M, 1993, J BIOL CHEM, V268, P24539; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; NUSSENZVEIG DR, 1993, J BIOL CHEM, V268, P2389; OHNISHI J, 1992, BIOCHEM BIOPH RES CO, V186, P1094, DOI 10.1016/0006-291X(92)90859-J; OHYAMA K, 1992, BIOCHEM BIOPH RES CO, V189, P677, DOI 10.1016/0006-291X(92)92254-U; PAXTON WG, 1994, BIOCHEM BIOPH RES CO, V200, P260, DOI 10.1006/bbrc.1994.1443; PEPPERELL JR, 1993, ENDOCRINOLOGY, V133, P1678, DOI 10.1210/en.133.4.1678; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; ROBERTSON JI, 1993, RENIN ANGIOTENSIN SY, V1; ROHRER J, 1993, MOL BIOL CELL, V4, P511, DOI 10.1091/mbc.4.5.511; SANDBERG K, 1994, TRENDS ENDOCRIN MET, V5, P28, DOI 10.1016/1043-2760(94)90118-X; SASAKI K, 1991, NATURE, V351, P230, DOI 10.1038/351230a0; SASAMURA H, 1992, BIOCHEM BIOPH RES CO, V185, P253, DOI 10.1016/S0006-291X(05)80983-0; SCHELLING JR, 1992, J CLIN INVEST, V90, P2472, DOI 10.1172/JCI116139; SCHELLING JR, 1994, AM J PHYSIOL, V266, pC669, DOI 10.1152/ajpcell.1994.266.3.C669; SCHORB W, 1993, CIRC RES, V72, P1245, DOI 10.1161/01.RES.72.6.1245; SCHORB W, 1994, J BIOL CHEM, V269, P19626; SWILLENS S, 1992, TRENDS PHARMACOL SCI, V13, P430, DOI 10.1016/0165-6147(92)90139-W; THEKKUMKARA TJ, 1992, NUCLEIC ACIDS RES, V20, P683, DOI 10.1093/nar/20.4.683; THEKKUMKARA TJ, 1993, FASEB J, V7, pA491; Trowbridge IS, 1991, CURR OPIN CELL BIOL, V3, P1062, DOI 10.1016/0955-0674(91)90130-Q; ULLIAN ME, 1989, J CLIN INVEST, V84, P840, DOI 10.1172/JCI114244	43	130	130	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					207	213		10.1074/jbc.270.1.207	http://dx.doi.org/10.1074/jbc.270.1.207			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814375	hybrid			2022-12-27	WOS:A1995QA28700035
J	HARNICK, DJ; JAYARAMAN, T; MA, YS; MULIERI, P; GO, LO; MARKS, AR				HARNICK, DJ; JAYARAMAN, T; MA, YS; MULIERI, P; GO, LO; MARKS, AR			THE HUMAN TYPE-1 INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR FROM T-LYMPHOCYTES - STRUCTURE, LOCALIZATION, AND TYROSINE PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTIONAL CHANNEL COMPLEX; MUSCLE SARCOPLASMIC-RETICULUM; SWISS 3T3 CELLS; RYANODINE RECEPTOR; PLASMA-MEMBRANE; SMOOTH-MUSCLE; TRISPHOSPHATE RECEPTOR; ENDOPLASMIC-RETICULUM; MOLECULAR-CLONING; PROTEIN-KINASE	Inositol 1,4,5-trisphosphate receptors (IP3R) are intracellular calcium release channels involved in diverse signaling pathways. An IP3R is thought to play a role in mobilizing calcium required for activation of T lymphocytes. The IP3R is a tetrameric structure comprised of four similar to 300-kDa subunits encoded by a similar to 10-kilobase mRNA. In the present study we determined the structure of the human type 1 IP3R expressed in T lymphocytes (Jurkats). The IP3R in human T cells had a predicted molecular mass of 308 kDa and was most similar to the non-neuronal form of the rodent type 1 IP3R. Two putative tyrosine phosphorylation sites were identified, one near the amino terminus and one near the putative channel pore at the carboxyl terminus. During T cell activation the IP3R was tyrosine phosphorylated. A site-specific anti-IP3R antibody was used to localize the carboxyl terminus of the IP3R to the cytoplasm in T cells.	CUNY MT SINAI SCH MED,INST CARDIOVASC,DEPT MED,PROGRAM MOLEC MED,NEW YORK,NY 10029; CUNY MT SINAI SCH MED,BROOKDALE CTR MOLEC BIOL,NEW YORK,NY 10029	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029814] Funding Source: NIH RePORTER; NINDS NIH HHS [NS29814] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALLA T, 1994, MOL BIOL CELL, V5, P17, DOI 10.1091/mbc.5.1.17; BEZPROZVANNY I, 1994, J GEN PHYSIOL, V104, P821, DOI 10.1085/jgp.104.5.821; BEZPROZVANNY I, 1994, MOL BIOL CELL, V5, P97, DOI 10.1091/mbc.5.1.97; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; BOURGUIGNON LYW, 1993, J BIOL CHEM, V268, P7290; CHADWICK CC, 1990, P NATL ACAD SCI USA, V87, P2132, DOI 10.1073/pnas.87.6.2132; CIAPA B, 1994, NATURE, V368, P875, DOI 10.1038/368875a0; DANOFF SK, 1991, P NATL ACAD SCI USA, V88, P2951, DOI 10.1073/pnas.88.7.2951; DIVECHA N, 1991, EMBO J, V10, P3207, DOI 10.1002/j.1460-2075.1991.tb04883.x; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FUJIMOTO T, 1992, J CELL BIOL, V119, P1507, DOI 10.1083/jcb.119.6.1507; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GARDNER P, 1989, CELL, V59, P15, DOI 10.1016/0092-8674(89)90865-9; HUGANIR RL, 1984, P NATL ACAD SCI-BIOL, V81, P6968, DOI 10.1073/pnas.81.22.6968; JUNE CH, 1990, J IMMUNOL, V144, P1591; KHAN AA, 1992, SCIENCE, V257, P815, DOI 10.1126/science.1323146; KIJIMA Y, 1993, J BIOL CHEM, V268, P3499; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KUME S, 1993, CELL, V73, P555, DOI 10.1016/0092-8674(93)90142-D; KUNO M, 1987, NATURE, V326, P301, DOI 10.1038/326301a0; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MARANTO AR, 1994, J BIOL CHEM, V269, P1222; MARKS AR, 1990, J BIOL CHEM, V265, P13143; MARKS AR, 1990, J BIOL CHEM, V265, P20719; MARKS AR, 1991, J CELL BIOL, V114, P303, DOI 10.1083/jcb.114.2.303; MARKS AR, 1989, P NATL ACAD SCI USA, V86, P8683, DOI 10.1073/pnas.86.22.8683; MARTELLI AM, 1992, NATURE, V358, P242, DOI 10.1038/358242a0; MAYRLEITNER M, 1991, CELL CALCIUM, V12, P505, DOI 10.1016/0143-4160(91)90032-A; MICHIKAWA T, 1994, J BIOL CHEM, V269, P9184; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; MIGNERY GA, 1989, NATURE, V342, P192, DOI 10.1038/342192a0; MIYAWAKI A, 1991, P NATL ACAD SCI USA, V88, P4911, DOI 10.1073/pnas.88.11.4911; MIYAWAKI A, 1990, NEURON, V5, P11, DOI 10.1016/0896-6273(90)90029-F; MIYAZAKI S, 1992, SCIENCE, V257, P251, DOI 10.1126/science.1321497; MOSCHELLA MC, 1993, J CELL BIOL, V120, P1137, DOI 10.1083/jcb.120.5.1137; MOUREY RJ, 1990, BIOCHEM J, V272, P383, DOI 10.1042/bj2720383; NAKAGAWA T, 1991, P NATL ACAD SCI USA, V88, P6244, DOI 10.1073/pnas.88.14.6244; PETERSON RHF, 1978, J SUPRAMOL STR CELL, V9, P289, DOI 10.1002/jss.400090302; ROSS CA, 1989, NATURE, V339, P468, DOI 10.1038/339468a0; Sambrook J, 1989, MOL CLONING LABORATO; SOMLYO AV, 1977, J CELL BIOL, V74, P828, DOI 10.1083/jcb.74.3.828; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; SUDHOF T, 1991, EMBO J, V11, P3199; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; WIERENGA RK, 1983, NATURE, V302, P842, DOI 10.1038/302842a0; YAMAMOTOHINO M, 1994, RECEPTOR CHANNEL, V2, P9; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	50	68	76	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2833	2840		10.1074/jbc.270.6.2833	http://dx.doi.org/10.1074/jbc.270.6.2833			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852357	hybrid			2022-12-27	WOS:A1995QF53500067
J	KRUSE, M; BRUNKE, M; ESCHER, A; SZALAY, AA; TROPSCHUG, M; ZIMMERMANN, R				KRUSE, M; BRUNKE, M; ESCHER, A; SZALAY, AA; TROPSCHUG, M; ZIMMERMANN, R			ENZYME ASSEMBLY AFTER DE-NOVO SYNTHESIS IN RABBIT RETICULOCYTE LYSATE INVOLVES MOLECULAR CHAPERONES AND IMMUNOPHILINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-TRANS-ISOMERASE; HEAT-SHOCK PROTEINS; M13 PROCOAT PROTEIN; BACTERIAL LUCIFERASE; NEUROSPORA-CRASSA; BINDING PROTEIN; CYCLOSPORINE-A; TRIPLE-HELIX; CYCLOPHILIN; MICROSOMES	The folding kinetics of two luciferases were studied after synthesis in reticulocyte lysates to investigate whether molecular chaperones and/or folding catalysts are involved in the folding reactions. Two bacterial luciferases were used as model proteins: heterodimeric Vibrio harveyi luciferase (LuxAB), and a monomeric luciferase fusion protein (Fab2). Data indicate that folding of these enzymes to the native state occurs in the translation system, and that the extent of folding can be quantified It was found that (i) folding of LuxAB and Faba can clearly be separated in time from synthesis, (ii) folding of Faba and LuxAB is slow because it involves either transient (Faba) or permanent (LuxAB) interaction of polypeptides, (iii) preservation of the assembly competent state of LuxA and/or LuxB and folding of Faba depend on ATP-hydrolysis, (iv) folding of Fab2 and LuxAB is partially sensitive to cyclosporin A (CsA) and FK506, i.e. inhibitors of two distinct peptidylprolyl cis/trans-isomerases. Thus, bacterial luciferases provide a unique system for direct measurement of the effects of ATP-dependent molecular chaperones on protein folding and enzyme assembly in reticulocyte lysates. Furthermore, these two luciferases provide the first direct evidence documenting the involvement of peptidylprolyl cis/trans-isomerases in protein biogenesis in a eukaryotic cytosol.	UNIV GOTTINGEN,INST BIOCHEM & MOLEK ZELLBIOL,D-37073 GOTTINGEN,GERMANY; UNIV ALBERTA,DEPT PLANT SCI,PLANT MOLEC GENET LABS,EDMONTON,AB T6G 2P5,CANADA; UNIV FREIBURG,INST BIOCHEM,D-79104 FREIBURG,GERMANY	University of Gottingen; University of Alberta; University of Freiburg								BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; DAVIS JM, 1989, J BIOL CHEM, V264, P8956; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; ESCHER A, 1993, MOL GEN GENET, V238, P65, DOI 10.1007/BF00279532; ESCHER A, 1989, P NATL ACAD SCI USA, V86, P6528, DOI 10.1073/pnas.86.17.6528; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FLYNN GC, 1993, P NATL ACAD SCI USA, V90, P10826, DOI 10.1073/pnas.90.22.10826; FOXWELL BMJ, 1988, BIOCHIM BIOPHYS ACTA, V938, P447, DOI 10.1016/0005-2736(88)90142-3; FRESKGARD PO, 1992, SCIENCE, V258, P486; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; HARTL FU, 1994, TRENDS BIOCHEM SCI, V19, P20, DOI 10.1016/0968-0004(94)90169-4; JAENICKE R, 1987, PROG BIOPHYS MOL BIO, V49, P117, DOI 10.1016/0079-6107(87)90011-3; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; NIMMESGERN E, 1993, FEBS LETT, V331, P25, DOI 10.1016/0014-5793(93)80290-B; OLSSON O, 1988, MOL GEN GENET, V215, P1, DOI 10.1007/BF00331295; ROMMELAERE H, 1993, P NATL ACAD SCI USA, V90, P11975, DOI 10.1073/pnas.90.24.11975; SCHLENSTEDT G, 1990, J BIOL CHEM, V265, P13960; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; SCHUMACHER RJ, 1994, J BIOL CHEM, V269, P9493; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; SYKES K, 1993, P NATL ACAD SCI USA, V90, P5853, DOI 10.1073/pnas.90.12.5853; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; TROPSCHUG M, 1989, NATURE, V342, P953, DOI 10.1038/342953a0; TROPSCHUG M, 1990, NATURE, V346, P674, DOI 10.1038/346674a0; WADDLE JJ, 1987, BIOCHEMISTRY-US, V26, P4917, DOI 10.1021/bi00390a004; WIECH H, 1987, EMBO J, V6, P1011, DOI 10.1002/j.1460-2075.1987.tb04853.x; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; ZIEGLER MM, 1993, J BIOL CHEM, V268, P10760; ZIMMERMANN R, 1988, EMBO J, V7, P2875, DOI 10.1002/j.1460-2075.1988.tb03144.x	35	46	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2588	2594		10.1074/jbc.270.6.2588	http://dx.doi.org/10.1074/jbc.270.6.2588			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852322	hybrid			2022-12-27	WOS:A1995QF53500030
J	NISHIZAWA, K; SHIMODA, E; KASAHARA, M				NISHIZAWA, K; SHIMODA, E; KASAHARA, M			SUBSTRATE RECOGNITION DOMAIN OF THE GAL2 GALACTOSE TRANSPORTER IN YEAST SACCHAROMYCES-CEREVISIAE AS REVEALED BY CHIMERIC GALACTOSE-GLUCOSE TRANSPORTERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							AMINO-ACID; GLUT1; PERMEASE; TRYPTOPHAN-412; SUBSTITUTION; SEQUENCES; MEMBRANE; PROTEINS; NUMBER; GENE	The Gal2 galactose transporter takes up galactose in yeast. A homologous glucose transporter from the same organism, Hxt2, was selected, and various chimeras between these two transporters were constructed by making use of homologous recombination in Escherichia coli. Comparison of the galactose transport activities of three series of chimeras enabled us to positively identify a crucial substrate recognition region of 101 amino acids that lies close to the carboxyl terminus of the Gal2 transporter.	TEIKYO UNIV, SCH MED, BIOPHYS LAB, HACHIOJI, TOKYO 19203, JAPAN	Teikyo University								ASANO T, 1991, J BIOL CHEM, V266, P24632; BALDWIN SA, 1993, BIOCHIM BIOPHYS ACTA, V1154, P17, DOI 10.1016/0304-4157(93)90015-G; BISSON LF, 1993, CRIT REV BIOCHEM MOL, V28, P259, DOI 10.3109/10409239309078437; BURANT CF, 1992, BIOCHEMISTRY-US, V31, P10414, DOI 10.1021/bi00157a032; CARON MG, 1993, NATURE, V366, P409, DOI 10.1038/366409a0; CASPARI T, 1994, J BIOL CHEM, V269, P3498; GARCIA JC, 1992, J BIOL CHEM, V267, P7770; GIROS B, 1994, J BIOL CHEM, V269, P15985; HASHIRAMOTO M, 1992, J BIOL CHEM, V267, P17502; HEIN J, 1989, MOL BIOL EVOL, V6, P649; HEIN J, 1989, MOL BIOL EVOL, V6, P669; Henderson PJF, 1993, CURR OPIN CELL BIOL, V5, P708, DOI 10.1016/0955-0674(93)90144-F; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; INA Y, 1994, COMPUT APPL BIOSCI, V10, P11; ISHIHARA H, 1991, BIOCHEM BIOPH RES CO, V176, P922, DOI 10.1016/S0006-291X(05)80274-8; KABACK HR, 1992, INT REV CYTOL, V137A, P97; KATAGIRI H, 1991, J BIOL CHEM, V266, P7769; KATAGIRI H, 1992, J BIOL CHEM, V267, P22550; KRUCKEBERG AL, 1990, MOL CELL BIOL, V10, P5903, DOI 10.1128/MCB.10.11.5903; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; MARSHALLCARLSON L, 1990, MOL CELL BIOL, V10, P1105, DOI 10.1128/MCB.10.3.1105; MORI H, 1994, J BIOL CHEM, V269, P11578; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MUECKLER M, 1994, J BIOL CHEM, V269, P17765; MUECKLER M, 1994, J BIOL CHEM, V269, P20533; NEHLIN JO, 1989, GENE, V85, P313, DOI 10.1016/0378-1119(89)90423-X; OGAWA T, 1992, J MOL BIOL, V226, P651, DOI 10.1016/0022-2836(92)90622-Q; OKA Y, 1990, NATURE, V345, P550, DOI 10.1038/345550a0; RAMOS J, 1989, J BACTERIOL, V171, P3539, DOI 10.1128/jb.171.6.3539-3544.1989; SEOL W, 1992, BIOCHEMISTRY-US, V31, P3550, DOI 10.1021/bi00128a032; SHERMAN F, 1986, LABORATORY COURSE MA; SZKUTNICKA K, 1989, J BACTERIOL, V171, P4486, DOI 10.1128/JB.171.8.4486-4493.1989; TAJIMA M, 1986, MOL CELL BIOL, V6, P246, DOI 10.1128/MCB.6.1.246; TAKATA K, 1991, J HISTOCHEM CYTOCHEM, V39, P287, DOI 10.1177/39.3.1993828; TAMORI Y, 1994, J BIOL CHEM, V269, P2982; TSCHOPP JF, 1986, J BACTERIOL, V166, P313, DOI 10.1128/jb.166.1.313-318.1986; WANDEL S, 1994, FEBS LETT, V348, P114, DOI 10.1016/0014-5793(94)00558-3; [No title captured]	38	52	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2423	2426		10.1074/jbc.270.6.2423	http://dx.doi.org/10.1074/jbc.270.6.2423			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852299	hybrid			2022-12-27	WOS:A1995QF53500004
J	KORDELI, E; LAMBERT, S; BENNETT, V				KORDELI, E; LAMBERT, S; BENNETT, V			ANKYRIN(G) - A NEW ANKYRIN GENE WITH NEURAL-SPECIFIC ISOFORMS LOCALIZED AT THE AXONAL INITIAL SEGMENT AND NODE OF RANVIER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT SODIUM-CHANNELS; ERYTHROCYTE ANKYRIN; RAT-BRAIN; CELL; PROTEINS; DOMAINS; BINDING; FAMILY	We have characterized a new ankyrin gene, expressed in brain and other tissues, that is subject to extensive tissue-specific alternative mRNA processing, The full-length polypeptide has a molecular mass of 480 kDa and includes a predicted globular head domain, with membrane- and spectrin-binding activities, as well as an extended ''tail'' domain, We term this gene ankyrin(G) based on its giant size and general expression, Two brain-specific isoforms of 480 kDa and 270 kDa were identified that contain a unique stretch of sequence highly enriched in serine and threonine residues immediately following the globular head domain, Antibodies against the serine-rich domain and spectrin-binding domain revealed labeling of nodes of Ranvier and axonal initial segments, Ankyrin-binding proteins also known to be localized in these specialized membrane domains include the voltage-dependent sodium channel, the sodium/potassium ATPase, sodium/calcium exchanger, and members of the neurofascin/L1 family of cell adhesion molecules, The neural-specific ankyrin(G) polypeptides are candidates to participate in maintenance/targeting of ion channels and cell adhesion molecules to nodes of Ranvier and axonal initial segments.	DUKE UNIV,MED CTR,HOWARD HUGHES MED INST,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT CELL BIOL,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT BIOCHEM,DURHAM,NC 27710	Duke University; Howard Hughes Medical Institute; Duke University; Duke University				Kordeli, Ekaterini/0000-0002-5115-2202	NIDDK NIH HHS [537DK29808] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK029808, R01DK029808] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BENNETT V, 1992, J BIOL CHEM, V267, P8703; CHAN W, 1993, J CELL BIOL, V123, P1463, DOI 10.1083/jcb.123.6.1463; DAVIS JQ, 1993, J CELL BIOL, V121, P121, DOI 10.1083/jcb.121.1.121; FLUCHER BE, 1989, NEURON, V3, P163, DOI 10.1016/0896-6273(89)90029-9; HALL TG, 1987, J BIOL CHEM, V262, P10537; ICHIMURA T, 1991, J NEUROCYTOL, V20, P667, DOI 10.1007/BF01187068; JOE EH, 1992, NATURE, V356, P333, DOI 10.1038/356333a0; KORDELI E, 1990, J CELL BIOL, V110, P1341, DOI 10.1083/jcb.110.4.1341; KORDELI E, 1991, J CELL BIOL, V114, P1243, DOI 10.1083/jcb.114.6.1243; KUNIMOTO M, 1991, J CELL BIOL, V115, P1319, DOI 10.1083/jcb.115.5.1319; LAMBERT S, 1993, J NEUROSCI, V13, P3725; LAMBERT S, 1993, EUR J BIOCHEM, V211, P1, DOI 10.1111/j.1432-1033.1993.tb19863.x; LI ZP, 1993, J BIOL CHEM, V268, P11489; NELSON WJ, 1992, SCIENCE, V258, P948, DOI 10.1126/science.1439806; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; OTTO E, 1991, J CELL BIOL, V114, P241, DOI 10.1083/jcb.114.2.241; PETERS A, 1966, Q J EXP PHYSIOL CMS, V51, P229, DOI 10.1113/expphysiol.1966.sp001852; PETERS A, 1976, FINE STRUCTURE NERVO, V92; Peters L. L., 1993, Molecular Biology of the Cell, V4, p56A; Sambrook J, 1989, MOL CLONING LABORATO; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; WAXMAN SG, 1993, ANN NEUROL, V33, P121, DOI 10.1002/ana.410330202; WILEYLIVINGSTON CA, 1980, DEV BIOL, V79, P334, DOI 10.1016/0012-1606(80)90120-7	23	411	418	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2352	2359		10.1074/jbc.270.5.2352	http://dx.doi.org/10.1074/jbc.270.5.2352			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836469	hybrid			2022-12-27	WOS:A1995QE49300057
J	OZOLS, J				OZOLS, J			LUMENAL ORIENTATION AND POSTTRANSLATIONAL MODIFICATIONS OF THE LIVER MICROSOMAL 11-BETA-HYDROXYSTEROID DEHYDROGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; MINERALOCORTICOID RECEPTOR; ENDOPLASMIC-RETICULUM; MONOOXYGENASE; LOCALIZATION; PROTEINS; MEMBRANE; CLONING; FLAVIN; STATE	The topology and post-translational modifications of microsomal 11 beta-hydroxysteroid dehydrogenase (11 beta-DH) was investigated using the approaches of protein structure analysis, Sequence analysis of peptides generated by chemical and enzymatic cleavages revealed that carbohydrate is attached at Asn-122, -161, and -206. Enzymatic deglycosylation reactions of the protein identified the attached glycans as high mannose carbohydrates, implying that the bulk of the protein molecule is oriented on the lumenal side of the endoplasmic membrane. The carbohydrate moiety of native dehydrogenase was cleaved by endo-N-acetylglucosaminidase H without significantly affecting the 11 beta-DH activity, Chemical modification of cysteinyl residues, followed by amino acid sequence analysis, identified one disulfide bond linking Cys-77 and Cys-212. This disulfide bond was inaccessible to thiol reagents, unless the protein was denatured, Contrary to the partially purified 11 beta-DH preparations, the purified enzymatically active protein failed to bind to a 2,5'-ADP affinity column, suggesting that a conformational change has occurred in the enzyme during purification. The proposed model of the 11 beta-DH has a single trans-membrane segment at the N terminus, with the bulk of the polypeptide chain projecting into the lumen of endoplasmic reticulum. Limited proteolysis studies of 11 beta-DH concluded an absence of a flexible intradomain segment between the membranous and the lumenal domains. The lumenal localization of the 11 beta-DH requires a mechanism by which cortisol is transported to the endoplasmic reticulum of the lumen.			OZOLS, J (corresponding author), UNIV CONNECTICUT, CTR HLTH, DEPT BIOCHEM, FARMINGTON, CT 06030 USA.				NIGMS NIH HHS [R01 GM-26351] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026351] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGARWAL AK, 1989, J BIOL CHEM, V264, P18939; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; EDWARDS CRW, 1988, LANCET, V2, P986, DOI 10.1016/S0140-6736(88)90742-8; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; GHOSH D, 1991, P NATL ACAD SCI USA, V88, P10064, DOI 10.1073/pnas.88.22.10064; HOOG SS, 1994, P NATL ACAD SCI USA, V91, P2517, DOI 10.1073/pnas.91.7.2517; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; KUMAR V, 1994, J BIOL CHEM, V269, P13451; LAKSHMI V, 1988, ENDOCRINOLOGY, V123, P2390, DOI 10.1210/endo-123-5-2390; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; MONDER C, 1991, FASEB J, V5, P3047, DOI 10.1096/fasebj.5.15.1743437; OZOLS J, 1993, P NATL ACAD SCI USA, V90, P5302, DOI 10.1073/pnas.90.11.5302; OZOLS J, 1990, J BIOL CHEM, V265, P10289; OZOLS J, 1989, J BIOL CHEM, V264, P12533; OZOLS J, 1985, J BIOL CHEM, V260, P1953; OZOLS J, 1989, BIOCHEM BIOPH RES CO, V163, P49, DOI 10.1016/0006-291X(89)92097-4; OZOLS J, 1980, METHODS PEPTIDE PROT, P417; OZOLS J, 1990, METHOD ENZYMOL, V182, P225; OZOLS J, 1990, METHOD ENZYMOL, V182, P587; PAULOWSKI JE, 1994, J BIOL CHEM, V269, P13502; PERSSON B, 1991, EUR J BIOCHEM, V200, P537, DOI 10.1111/j.1432-1033.1991.tb16215.x; PRATT WB, 1987, J CELL BIOCHEM, V35, P51, DOI 10.1002/jcb.240350105; RODIN A, 1994, NEW ENGL J MED, V330, P460, DOI 10.1056/NEJM199402173300703; TANNIN GM, 1991, J BIOL CHEM, V266, P16653; VARUGHESE KI, 1994, P NATL ACAD SCI USA, V91, P5582, DOI 10.1073/pnas.91.12.5582; WHITE PC, 1994, NEW ENGL J MED, V331, P250; WIERENGA RK, 1985, BIOCHEMISTRY-US, V24, P1346, DOI 10.1021/bi00327a012; YAMAMOTO KR, 1988, COLD SPRING HARB SYM, V53, P803, DOI 10.1101/SQB.1988.053.01.091; YOKOTA H, 1992, J BIOCHEM, V112, P192, DOI 10.1093/oxfordjournals.jbchem.a123876	29	97	100	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2305	2312		10.1074/jbc.270.5.2305	http://dx.doi.org/10.1074/jbc.270.5.2305			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836463	hybrid			2022-12-27	WOS:A1995QE49300051
J	PEDERSEN, PL; HULLIHEN, J; BIANCHET, M; AMZEL, LM; LEBOWITZ, MS				PEDERSEN, PL; HULLIHEN, J; BIANCHET, M; AMZEL, LM; LEBOWITZ, MS			RAT-LIVER ATP SYNTHASE - RELATIONSHIP OF THE UNIQUE SUBSTRUCTURE OF THE F1 MOIETY TO ITS NUCLEOTIDE-BINDING PROPERTIES, ENZYMATIC STATES, AND CRYSTALLINE FORM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ADENOSINE-TRIPHOSPHATASE; ISOLATED BETA-SUBUNIT; ESCHERICHIA-COLI F1-ATPASE; BOVINE HEART-MITOCHONDRIA; CATALYTIC SITES; F1 MOIETY; OXIDATIVE-PHOSPHORYLATION; QUATERNARY STRUCTURE; PROTEIN INHIBITOR; MECHANISM	The F-1 moiety of rat liver ATP synthase has a molecular mass of 370,000, exhibits the unique substructure alpha(3) beta(3) gamma delta epsilon, and fully restores ATP synthesis to F-1-depleted membranes, Here we provide new information about rat liver F-1 as it relates to the relationship of its unique substructure to its nucleotide binding properties, enzymatic states, and crystalline form. Seven types of experiments were performed in a comprehensive study. First, the capacity of F-1 to bind [H-3]ADP, the substrate for ATP synthesis and [P-32]AMP-PNP (5'-adenylyl-beta,gamma-imidodiphosphate), a nonhydrolyzable ATP analog, was quantified, Second, double label experiments were performed to establish whether ADP and AMP-PNP bind to the same or different sites. Third, total nucleotide binding was assessed by the luciferin-luciferase assay. Fourth, F-1 was subfractionated into an alpha gamma and a beta delta epsilon fraction, both of which were subjected to nucleotide binding assays, Fifth, the nucleotide binding capacity of F-1 was quantified after undergoing ATP hydrolysis. Sixth, the intensity of the fluorescence probe pyrene maleimide bound at cu subunits was monitored before and after F-1 experienced ATP hydrolysis, Finally, the catalytic activity and nucleotide content of F-1, obtained from crystals being used in x-ray crystallographic studies was determined. The picture of rat liver F-1 that emerges is one of an enzyme molecule that 1) loads nucleotide readily at five sites; 2) requires for catalysis both the alpha gamma and the beta delta epsilon fractions; 3) directs the reversible binding of ATP and ADP to different regions of the enzyme's substructure; 4) induces inhibition of ATP hydrolysis only after ADP fills at least five sites; and 5) exists in several distinct forms, one an active, symmetrical form, obtained in the presence of ATP and high P-i and on which an x-ray map at 3.6 Angstrom has been reported (Bianchet, M., Ysern, X., Hullihen, J., Pedersen, P. L., and Amzel, L. M., (1991) J. Biol. Chem. 266, 21197-21201). These results are discussed within the context of a multistate model for rat liver F-1 and also discussed relative to those reported for bovine heart F-1, which has been crystallized with inhibitors in an asymmetrical form and has a propensity for binding nucleotides more tightly.	JOHNS HOPKINS UNIV, SCH MED, MOLEC & CELLULAR BIOENERGET LAB, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT BIOPHYS & PHYS CHEM, BALTIMORE, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	PEDERSEN, PL (corresponding author), JOHNS HOPKINS UNIV, SCH MED, DEPT BIOL CHEM, 725 N WOLFE ST, BALTIMORE, MD 21205 USA.		Bianchet, Mario a/K-2131-2015	Bianchet, Mario a/0000-0001-9032-7549; Amzel, L. Mario/0000-0002-0129-9572	NATIONAL CANCER INSTITUTE [R01CA010951, R37CA010951] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025432] Funding Source: NIH RePORTER; NCI NIH HHS [CA 10951] Funding Source: Medline; NIGMS NIH HHS [GM 25432] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMS JP, 1993, EMBO J, V12, P1775, DOI 10.1002/j.1460-2075.1993.tb05825.x; ACKERS GK, 1992, SCIENCE, V255, P54, DOI 10.1126/science.1553532; AGGELER R, 1992, J BIOL CHEM, V267, P21355; ALLISON WS, 1992, J BIOENERG BIOMEMBR, V24, P469, DOI 10.1007/BF00762364; ALSHAWI MK, 1990, J BIOL CHEM, V265, P5595; AMZEL LM, 1992, J BIOENERG BIOMEMBR, V24, P429, DOI 10.1007/BF00762358; AMZEL LM, 1978, J BIOL CHEM, V253, P2067; BIANCHET M, 1991, J BIOL CHEM, V266, P21197; BOULAY F, 1985, BIOCHEMISTRY-US, V24, P7372, DOI 10.1021/bi00346a052; CAPALDI RA, 1994, TRENDS BIOCHEM SCI, V12, P186; CATTERALL WA, 1972, J BIOL CHEM, V247, P7969; CATTERALL WA, 1971, J BIOL CHEM, V246, P4987; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; CINTRON NM, 1979, J BIOL CHEM, V254, P3439; COX GB, 1978, J BACTERIOL, V133, P287, DOI 10.1128/JB.133.1.287-292.1978; CROSS RL, 1982, J BIOL CHEM, V257, P2101; CROSS RL, 1981, ANNU REV BIOCHEM, V50, P681, DOI 10.1146/annurev.bi.50.070181.003341; CROSS RL, 1982, J BIOL CHEM, V257, P2874; FILLINGAME RH, 1990, BACTERIA TREATISE ST, V12, P345; GOGOL EP, 1990, P NATL ACAD SCI USA, V87, P9585, DOI 10.1073/pnas.87.24.9585; GRESSER MJ, 1982, J BIOL CHEM, V257, P2030; GROMETELHANAN Z, 1984, BIOCHEMISTRY-US, V23, P1022, DOI 10.1021/bi00300a034; GROMETELHANAN Z, 1992, J BIOENERG BIOMEMBR, V24, P447, DOI 10.1007/BF00762361; ISSARTEL JP, 1984, BIOCHEMISTRY-US, V23, P6591, DOI 10.1021/bi00321a048; JAULT JM, 1993, J BIOL CHEM, V268, P1558; KIRONDE FAS, 1987, J BIOL CHEM, V262, P3488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUTTER R, 1993, J MOL BIOL, V229, P787, DOI 10.1006/jmbi.1993.1081; MATSUNOYAGI A, 1990, J BIOL CHEM, V265, P20308; MILGROM YM, 1991, EUR J BIOCHEM, V200, P789, DOI 10.1111/j.1432-1033.1991.tb16246.x; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; NALIN CM, 1985, BIOCHEMISTRY-US, V24, P2318, DOI 10.1021/bi00330a029; PEDERSEN PL, 1978, J BIOL CHEM, V253, P2176; PEDERSEN PL, 1993, J BIOL CHEM, V268, P9937; PEDERSEN PL, 1981, J BIOL CHEM, V256, P1362; PEDERSEN PL, 1987, BIOCHEMISTRY-US, V26, P8631, DOI 10.1021/bi00400a021; PEDERSEN PL, 1976, J BIOL CHEM, V251, P934; PEDERSEN PL, 1975, J SUPRAMOL STR CELL, V3, P222, DOI 10.1002/jss.400030304; PEDERSEN PL, 1974, MEMBRANE PROTEINS TR, P43; PENEFSKY HS, 1991, ADV ENZYMOL RAMB, V64, P173; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; PENIN F, 1988, BIOCHEMISTRY-US, V27, P8969, DOI 10.1021/bi00425a014; RAO R, 1988, J BIOL CHEM, V263, P5569; SENIOR AE, 1984, ARCH BIOCHEM BIOPHYS, V228, P49, DOI 10.1016/0003-9861(84)90045-6; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; SENIOR AE, 1981, J BIOL CHEM, V256, P4763; TURINA P, 1994, J BIOL CHEM, V269, P13465; VOGEL PD, 1991, J BIOL CHEM, V266, P6101; WEBER J, 1993, J BIOL CHEM, V268, P20126; WEBER K, 1969, J BIOL CHEM, V244, P4406; WILLIAMS DE, 1964, ANN NY ACAD SCI, V121, P373, DOI 10.1111/j.1749-6632.1964.tb14210.x; WILLIAMS N, 1987, BIOCHEMISTRY-US, V26, P162, DOI 10.1021/bi00375a023; WILLIAMS N, 1984, BIOCHEMISTRY-US, V23, P780, DOI 10.1021/bi00299a030; WILLIAMS N, 1982, J BIOL CHEM, V257, P2834; WISE JG, 1981, J BIOL CHEM, V256, P383	56	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1775	1784		10.1074/jbc.270.4.1775	http://dx.doi.org/10.1074/jbc.270.4.1775			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829514	hybrid			2022-12-27	WOS:A1995QD20400047
J	LIN, ZL; SCHWARZ, FP; EISENSTEIN, E				LIN, ZL; SCHWARZ, FP; EISENSTEIN, E			THE HYDROPHOBIC NATURE OF GROEL-SUBSTRATE BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROCESSES INVOLVING PROTEINS; CARBONIC-ANHYDRASE-B; SUBTILISIN BPN'; ESCHERICHIA-COLI; INTERMEDIATE; COOPERATIVITY; POLYPEPTIDE; STABILITY	The molecular chaperone GroEL from Escherichia coli is a member of the highly conserved Hsp60 family of proteins that facilitates protein folding. A central question regarding the mechanism of GroEL-assisted refolding of proteins concerns its broad substrate specificity. The nature of GroEL-polypeptide chain interaction was investigated by isothermal titration calorimetry using proteins that maintain a non native conformation in neutral buffer solutions. A single molecule of an unfolded variant of subtilisin BPN' binds non-cooperatively to GroEL with micromolar affinity and a positive enthalpy change. Additional calorimetric titrations of this chain with GroEL show that the positive enthalpy change decreases with increasing temperature between 6 and 25 degrees C, yielding a Delta C-p of -0.85 kcal mol(-1) degree(-1). alpha-Casein similarly binds to GroEL with micromolar affinity and a positive enthalpy change in the range of 15-23 degrees C, yielding a Delta C-p of -0.44 kcal mol(-1) degree(-1). The negative heat capacity change provides strong evidence for the role of hydrophobic interactions as the driving force for the association of these substrates with the GroEL chaperonin.	CTR ADV RES BIOTECHNOL, ROCKVILLE, MD 20850 USA; UNIV MARYLAND, INST BIOTECHNOL, ROCKVILLE, MD 20850 USA; NATL INST STAND & TECHNOL, ROCKVILLE, MD 20850 USA; UNIV MARYLAND, DEPT CHEM & BIOCHEM, BALTIMORE, MD 21228 USA	University System of Maryland; University of Maryland Baltimore; National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland Baltimore			Lin, Zhanglin/A-7232-2011		NIGMS NIH HHS [GM49316] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049316] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; BOCHKAREVA ES, 1992, J BIOL CHEM, V267, P6796; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BRYAN P, 1992, BIOCHEMISTRY-US, V31, P4937, DOI 10.1021/bi00136a003; CHANDRASEKHAR GN, 1986, J BIOL CHEM, V261, P2414; CREAMER LK, 1981, ARCH BIOCHEM BIOPHYS, V211, P689, DOI 10.1016/0003-9861(81)90505-1; DILL KA, 1993, P NATL ACAD SCI USA, V90, P1942, DOI 10.1073/pnas.90.5.1942; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; EDER J, 1993, BIOCHEMISTRY-US, V32, P18, DOI 10.1021/bi00052a004; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; HANSEN JE, 1993, J BIOL CHEM, V268, P21632; HAYERHARTL MK, 1994, EMBO J, V13, P3192, DOI 10.1002/j.1460-2075.1994.tb06618.x; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HORWICH AL, 1993, CELL, V74, P909, DOI 10.1016/0092-8674(93)90470-B; JAENICKE R, 1993, CURR OPIN STRUC BIOL, V3, P104, DOI 10.1016/0959-440X(93)90209-4; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; KLOTZ IM, 1973, ANN NY ACAD SCI, V226, P18, DOI 10.1111/j.1749-6632.1973.tb20465.x; LANDRY SJ, 1991, BIOCHEMISTRY-US, V30, P7359, DOI 10.1021/bi00244a001; LANDRY SJ, 1992, NATURE, V355, P455, DOI 10.1038/355455a0; LORIMER GH, 1992, CURR OPIN STRUC BIOL, V2, P26; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MARTIN J, 1993, NATURE, V366, P279, DOI 10.1038/366279a0; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191; RICHARME G, 1994, J BIOL CHEM, V269, P7095; SCHMIDT M, 1994, J BIOL CHEM, V269, P10304; SCHMIDT M, 1992, J BIOL CHEM, V267, P16829; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; SEMISOTNOV GV, 1987, FEBS LETT, V224, P9, DOI 10.1016/0014-5793(87)80412-X; SPOLAR RS, 1989, P NATL ACAD SCI USA, V86, P8382, DOI 10.1073/pnas.86.21.8382; STRAUSBERG S, 1993, BIOCHEMISTRY-US, V32, P8112, DOI 10.1021/bi00083a009; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; SWAISGOO.HE, 1968, ARCH BIOCHEM BIOPHYS, V125, P344, DOI 10.1016/0003-9861(68)90670-X; VANDYK TK, 1989, NATURE, V342, P451, DOI 10.1038/342451a0; VIITANEN PV, 1992, PROTEIN SCI, V1, P363; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WONG KP, 1973, J BIOL CHEM, V248, P8518; ZAHN R, 1994, NATURE, V368, P261, DOI 10.1038/368261a0; ZAHN R, 1994, J MOL BIOL, V242, P165, DOI 10.1006/jmbi.1994.1567; ZAHN R, 1994, J MOL BIOL, V242, P150, DOI 10.1006/jmbi.1994.1566	40	133	135	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1011	1014		10.1074/jbc.270.3.1011	http://dx.doi.org/10.1074/jbc.270.3.1011			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836352	hybrid			2022-12-27	WOS:A1995QB15600007
J	RAMAN, N; DIRUSSO, CC				RAMAN, N; DIRUSSO, CC			ANALYSIS OF ACYL-COENZYME A BINDING TO THE TRANSCRIPTION FACTOR FADR AND IDENTIFICATION OF AMINO-ACID-RESIDUES IN THE CARBOXYL-TERMINUS REQUIRED FOR LIGAND BINGING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; LAC REPRESSOR; GENE FADR; CLONING; METABOLISM; PROTEIN; DEGRADATION; REGULATOR; STRAINS	The Escherichia coli FadR protein regulates the transcription of many unlinked genes and operons encoding proteins required for fatty acid synthesis and degradation. Previously, we demonstrated that the ability of purified FadR to bind DNA in vitro is inhibited by long chain acyl coenzyme A esters (DiRusso, D. D., Heimert, T. L., and Metzger, A, K. (1992) J. Biol. Chem. 267, 8685-8691). In the present work, we show that FadR binds acyl-CoA directly. Ligand binding resulted in a shift in the apparent pI of FadR from 6.9 to 6.2 and in a marked decrease in intrinsic fluorescence. The K-m for FadR binding of oleoyl coenzyme A was determined to be 12.1 nM using the fluorescence quenching assay, The binding site for acyl-CoA was identified by selection of noninducible mutations in the FadR gene. One altered protein carrying the change Ser(219) to Asn (S219N) was purified and shown to have a reduced affinity for oleoyl coenzyme A as evidenced by a K-m of 257 nM. S219N retained the ability to bind DNA and to repress or activate transcription. Alanine substitution of amino acid residues 215 through 230 identified Gly(216) and Trp(223) as also required specifically for induction. This region of FadR shares amino acid identities and similarities with the coenzyme A-binding site of Clostridium thermoaceticum CO dehydrogenase/acetyl-coenzyme A synthase. Due to the alteration in binding affinity of the purified S219N protein, the non-inducible phenotype of several proteins carrying alanine substitutions and similarities to CO dehydrogenase/acetyl-coenzyme A synthase we propose this region of FadR forms part of the acyl-CoA-binding domain.	UNIV TENNESSEE, DEPT BIOCHEM, MEMPHIS, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center			DiRusso, Concetta C/M-1884-2014	DiRusso, Concetta/0000-0001-7388-9152	NIGMS NIH HHS [GM38104] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM038104] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLACK PN, 1994, BBA-LIPID LIPID MET, V1210, P123, DOI 10.1016/0005-2760(94)90113-9; BLACK PN, 1992, J BIOL CHEM, V267, P25513; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CHANG WI, 1993, J BIOL CHEM, V268, P17613; Cleland W W, 1979, Methods Enzymol, V63, P103; DIRUSSO CC, 1988, NUCLEIC ACIDS RES, V16, P7995, DOI 10.1093/nar/16.16.7995; DIRUSSO CC, 1993, MOL MICROBIOL, V7, P311, DOI 10.1111/j.1365-2958.1993.tb01122.x; DIRUSSO CC, 1992, J BIOL CHEM, V267, P8685; DIRUSSO CC, 1985, J BACTERIOL, V161, P583, DOI 10.1128/JB.161.2.583-588.1985; GORDON AJE, 1988, J MOL BIOL, V200, P239, DOI 10.1016/0022-2836(88)90237-9; HENRY MF, 1992, CELL, V70, P671, DOI 10.1016/0092-8674(92)90435-F; HUGHES KT, 1988, J BACTERIOL, V170, P1666, DOI 10.1128/jb.170.4.1666-1671.1988; KLEINA LG, 1990, J MOL BIOL, V212, P295, DOI 10.1016/0022-2836(90)90126-7; Miller J.H., 1972, EXPT MOL GENETICS; MILLER JH, 1979, J MOL BIOL, V131, P249, DOI 10.1016/0022-2836(79)90075-5; MORTON TA, 1991, J BIOL CHEM, V266, P23824; RUDNICK DA, 1990, J BIOL CHEM, V265, P13370; SHANMUGASUNDARA.T, 1988, BIOCHEMISTRY-US, V28, P7112; SIMONS RW, 1980, J BACTERIOL, V143, P726, DOI 10.1128/JB.143.2.726-730.1980; SUDIER FW, 1990, METHOD ENZYMOL, V185, P60; WARD LD, 1985, METHOD ENZYMOL, V117, P400; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	22	61	63	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1092	1097		10.1074/jbc.270.3.1092	http://dx.doi.org/10.1074/jbc.270.3.1092			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836365	hybrid			2022-12-27	WOS:A1995QB15600020
J	SIRES, UI; DUBLET, B; AUBERTFOUCHER, E; VANDERREST, M; WELGUS, HG				SIRES, UI; DUBLET, B; AUBERTFOUCHER, E; VANDERREST, M; WELGUS, HG			DEGRADATION OF THE COL1 DOMAIN OF TYPE-XIV COLLAGEN BY 92-KDA GELATINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKIN FIBROBLAST COLLAGENASE; FIBRIL-ASSOCIATED COLLAGENS; BASEMENT-MEMBRANE COLLAGEN; AMINO-ACID SEQUENCE; FETAL BOVINE SKIN; IV COLLAGENASE; IX COLLAGEN; MATRIX METALLOPROTEINASES; SUBSTRATE-SPECIFICITY; II COLLAGEN	Type XIV collagen is a newly described member of the fibril-associated collagens with interrupted triple helices (FACITs). Expression of this collagen has been localized to various embryonic tissues, suggesting that it has a functional role in development. All FACITs thus far described (types IX, XII, XIV, and XVI) contain a highly homologous carboxyl-terminal triple helical domain designated COL1. We have studied the capacity of various matrix metalloproteinases (interstitial collagenase, stromelysin, matrilysin, and 92-kDa gelatinase) to degrade the COL1 domain of collagen XIV. We found that only 92-kDa gelatinase cleaves COL1. Furthermore, digestion of whole native collagen XIV by the 92-kDa gelatinase indicates that this enzyme specifically region of the molecule. COL1 is cleaved by 92-kDa gelatinase at 30 degrees C, a full 5-6 degrees C below the melting temperature (T-m) of this domain; native collagen XIV is also degraded at 30 degrees C. In comparison to interstitial collagenase degradation of its physiologic native type I collagen substrate, the 92-kDa enzyme cleaved COL1 (XIV) with comparable catalytic efficacy. Interestingly, following thermal denaturation of the COL1 fragment, its susceptibility to 92-kDa gelatinase increases, but only to a degree that leaves it several orders of magnitude less sensitive to degradation than denatured collagens I and III. These data indicate that native COL1 and collagen XIV are readily and specifically cleaved by 92-kDa gelatinase. They also suggest a role for 92-kDa gelatinase activity in the structural tissue remodeling of the developing embryo.	ST LOUIS CHILDRENS HOSP, DEPT PEDIAT, ST LOUIS, MO 63110 USA; INST BIOL & CHEM PROT, CNRS, UPR 412, LYON, FRANCE	St. Louis Children's Hospital; Washington University (WUSTL); Centre National de la Recherche Scientifique (CNRS)	SIRES, UI (corresponding author), WASHINGTON UNIV, JEWISH HOSP ST LOUIS,SCH MED,DEPT MED,DIV DERMATOL, 216 S KINGSHIGHWAY BLVD, ST LOUIS, MO 63110 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007284, R01AR035805] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL47328] Funding Source: Medline; NIAMS NIH HHS [T32-AR07284, AR35805] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AUBERTFOUCHER E, 1992, J BIOL CHEM, V267, P15759; BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0; BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053; BRAZEL D, 1988, EUR J BIOCHEM, V172, P35, DOI 10.1111/j.1432-1033.1988.tb13852.x; BROWN JC, 1993, J CELL BIOL, V120, P557, DOI 10.1083/jcb.120.2.557; BRUCKNER P, 1984, EUR J BIOCHEM, V140, P397, DOI 10.1111/j.1432-1033.1984.tb08115.x; CASTAGNOLA P, 1992, EUR J CELL BIOL, V59, P340; CHU ML, 1988, J BIOL CHEM, V263, P18601; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; DEAN DD, 1989, J CLIN INVEST, V84, P678, DOI 10.1172/JCI114215; DUBLET B, 1990, ANN NY ACAD SCI, V580, P436, DOI 10.1111/j.1749-6632.1990.tb17953.x; DUBLET B, 1991, J BIOL CHEM, V266, P6853; EYRE DR, 1987, FEBS LETT, V220, P337, DOI 10.1016/0014-5793(87)80842-6; FLENNIKEN AM, 1990, GENE DEV, V4, P1094, DOI 10.1101/gad.4.7.1094; FONT B, 1993, J BIOL CHEM, V268, P25015; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; Gordon MK, 1990, CURR OPIN CELL BIOL, V2, P833, DOI 10.1016/0955-0674(90)90080-X; GORDON MK, 1989, J BIOL CHEM, V264, P19772; GORDON MK, 1991, EUR J BIOCHEM, V201, P333, DOI 10.1111/j.1432-1033.1991.tb16290.x; HASTY KA, 1990, J BIOL CHEM, V265, P11421; KING J, 1971, J MOL BIOL, V62, P465, DOI 10.1016/0022-2836(71)90148-3; LETHIAS C, 1993, J INVEST DERMATOL, V101, P92, DOI 10.1111/1523-1747.ep12360433; LUNSTRUM GP, 1991, J CELL BIOL, V113, P963, DOI 10.1083/jcb.113.4.963; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; MURPHY G, 1991, BIOCHEM J, V277, P277, DOI 10.1042/bj2770277; NAGASE H, 1980, ANAL BIOCHEM, V107, P385, DOI 10.1016/0003-2697(80)90400-5; OGATA Y, 1992, J BIOL CHEM, V267, P3581; OLSEN BR, 1989, CONNECT TISSUE RES, V23, P115, DOI 10.3109/03008208909002411; PAN TC, 1992, P NATL ACAD SCI USA, V89, P6565, DOI 10.1073/pnas.89.14.6565; PIHLAJANIEMI T, 1990, J BIOL CHEM, V265, P16922; QUANTIN B, 1989, BIOCHEMISTRY-US, V28, P5327, DOI 10.1021/bi00439a004; REPONEN P, 1992, J BIOL CHEM, V267, P7856; ROSWIT WT, 1988, ARCH BIOCHEM BIOPHYS, V262, P67, DOI 10.1016/0003-9861(88)90169-5; SAARIALHOKERE UK, 1992, J CLIN INVEST, V90, P1952, DOI 10.1172/JCI116073; SELTZER JL, 1985, J CHROMATOGR, V326, P147, DOI 10.1016/S0021-9673(01)87440-9; SENGEL P, 1983, BIOCH PHYSL SKIN, P102; SENIOR RM, 1991, J BIOL CHEM, V266, P7870; SHAW LM, 1991, TRENDS BIOCHEM SCI, V16, P191, DOI 10.1016/0968-0004(91)90074-6; SIRES UI, 1993, J BIOL CHEM, V268, P2069; STETLERSTEVENSON WG, 1990, CANCER METAST REV, V9, P289, DOI 10.1007/BF00049520; STRICKLIN GP, 1977, BIOCHEMISTRY-US, V16, P1607, DOI 10.1021/bi00627a013; STRICKLIN GP, 1983, J BIOL CHEM, V258, P2252; SUGRUE SP, 1989, J CELL BIOL, V109, P939, DOI 10.1083/jcb.109.2.939; TRELSTAD RL, 1976, ANAL BIOCHEM, V71, P114, DOI 10.1016/0003-2697(76)90016-6; TRUEB J, 1992, EUR J BIOCHEM, V207, P549, DOI 10.1111/j.1432-1033.1992.tb17081.x; VANDERREST M, 1988, J BIOL CHEM, V263, P1615; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; VANDERREST M, 1990, BIOCHIMIE, V72, P473, DOI 10.1016/0300-9084(90)90071-N; VANDERREST M, 1991, BIOCHEM SOC T, V19, P820, DOI 10.1042/bst0190820; VANDERREST M, 1990, STRUCTURE FUNCTION C, P195; WATT SL, 1992, J BIOL CHEM, V267, P20093; WELGUS HG, 1990, J BIOL CHEM, V265, P13521; WELGUS HG, 1981, J BIOL CHEM, V256, P9511; WELGUS HG, 1990, J CLIN INVEST, V86, P1496, DOI 10.1172/JCI114867; WILHELM SM, 1987, P NATL ACAD SCI USA, V84, P6725, DOI 10.1073/pnas.84.19.6725; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; WOESSNER JF, 1988, J BIOL CHEM, V263, P16918; YAMAGATA M, 1991, J CELL BIOL, V115, P209, DOI 10.1083/jcb.115.1.209	58	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1062	1067		10.1074/jbc.270.3.1062	http://dx.doi.org/10.1074/jbc.270.3.1062			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836360	hybrid			2022-12-27	WOS:A1995QB15600015
J	CZUPRYN, MJ; MCCOY, JM; SCOBLE, HA				CZUPRYN, MJ; MCCOY, JM; SCOBLE, HA			STRUCTURE-FUNCTION-RELATIONSHIPS IN HUMAN INTERLEUKIN-11 - IDENTIFICATION OF REGIONS INVOLVED IN ACTIVITY BY CHEMICAL MODIFICATION AND SITE-DIRECTED MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; RECEPTOR-BINDING SITE; HUMAN GROWTH-HORMONE; IL-6 SIGNAL TRANSDUCER; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; MOLECULAR-CLONING; EXTRACELLULAR DOMAIN; SECONDARY STRUCTURE; AMINO-ACIDS	Chemical modification approaches combined with site-directed and deletion mutagenesis have been used to identify functionally critical regions/residues of recombinant human IL-11 (rhIL-11), Incubation of rhIL-11 with iodoacetic acid results in specific alkylation of a single methionine residue, Met(58), and a 25-fold reduction of in vitro biological activity on mouse plasmacytoma cells. A similar decrease in activity is observed when Met(58) is substituted with Ala, Leu, Gin, Glu, or Lys by site-directed mutagenesis. Treatment of rhIL-11 with succinic anhydride leads to modification of the aminoterminal amino group and partial labeling of 2 lysines, Lys(4l) and Lys(98), and to a 3-fold decrease in activity. The activity losses can be attributed to modification of the lysine residues, since the succinyl derivative of the amino terminus is fully active. In addition, carboxyl-terminal deletion mutagenesis studies have demonstrated that removal of the last 4 residues reduces rhIL-11 activity 25-fold, whereas removal of 8 or more amino acids results in an inactive molecule. Based on secondary structure predictions and the location of exon/intron boundaries in the IL-11 genomic structure, we propose a four-helix bundle topology as a structural model for rhIL-11. This model has been tested by limited proteolysis using three side chain-specific endoproteinases. A limited number of protease-sensitive cleavage sites are present in rhIL-11, and all but two are located in the postulated helix interconnecting loops or at helix termini, alpha-Helices, which in the proposed structure form a compact core of the molecule, are inaccessible to digestion under limiting conditions. According to the model, Met(58), Lys(41) and Lys(98) are located on the surface of the molecule, in agreement with their preferential accessibility to chemical modification. By analogy with human growth hormone, we postulate that Met(58) and the carboxyl terminus of rhIL-11 are involved in the primary receptor binding site (site I), whereas Lys(41) and Lys(98) may be a part of binding site II.			CZUPRYN, MJ (corresponding author), GENET INST INC, 1 BURTT RD, ANDOVER, MA 01810 USA.							ABDELMEGUID SS, 1987, P NATL ACAD SCI USA, V84, P6434, DOI 10.1073/pnas.84.18.6434; BAUMANN H, 1991, J BIOL CHEM, V266, P20424; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; BAZAN JF, 1992, SCIENCE, V257, P410, DOI 10.1126/science.1631562; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; BOULAY JL, 1993, CURR BIOL, V3, P573, DOI 10.1016/0960-9822(93)90002-6; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; DENOTO FM, 1981, NUCLEIC ACIDS RES, V9, P3719, DOI 10.1093/nar/9.15.3719; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DIEDERICHS K, 1991, SCIENCE, V254, P1779, DOI 10.1126/science.1837174; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HILL CP, 1993, P NATL ACAD SCI USA, V90, P5167, DOI 10.1073/pnas.90.11.5167; JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145, DOI 10.1146/annurev.bb.17.060188.001045; KAUSHANSKY K, 1993, BLOOD, V82, P3229; KAWASHIMA I, 1991, FEBS LETT, V283, P199, DOI 10.1016/0014-5793(91)80587-S; KRUTTGEN A, 1990, FEBS LETT, V273, P95, DOI 10.1016/0014-5793(90)81059-W; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; LE HV, 1991, BIOCHEMISTRY-US, V30, P9576, DOI 10.1021/bi00104a003; LEEBEEK FWG, 1992, J BIOL CHEM, V267, P14832; MAIER R, 1993, J BIOL CHEM, V268, P21527; MCKAY DB, 1992, SCIENCE, V257, P412, DOI 10.1126/science.257.5068.412; MCKINLEY D, 1992, GENOMICS, V13, P814, DOI 10.1016/0888-7543(92)90158-O; MILBURN MV, 1993, NATURE, V363, P172, DOI 10.1038/363172a0; MUSASHI M, 1991, P NATL ACAD SCI USA, V88, P765, DOI 10.1073/pnas.88.3.765; NAGATA S, 1986, EMBO J, V5, P575, DOI 10.1002/j.1460-2075.1986.tb04249.x; PANDIT J, 1992, SCIENCE, V258, P1358, DOI 10.1126/science.1455231; PAUL SR, 1990, P NATL ACAD SCI USA, V87, P7512, DOI 10.1073/pnas.87.19.7512; PAUL SR, 1992, INT J CELL CLONING, V10, P135, DOI 10.1002/stem.5530100303; POWERS R, 1993, BIOCHEMISTRY-US, V32, P6744, DOI 10.1021/bi00077a030; RAMANATHAN L, 1993, BIOCHEMISTRY-US, V32, P3549, DOI 10.1021/bi00065a005; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; SAVINO R, 1993, P NATL ACAD SCI USA, V90, P4067, DOI 10.1073/pnas.90.9.4067; SMITH LJ, 1992, J MOL BIOL, V224, P899, DOI 10.1016/0022-2836(92)90457-U; WALTER MR, 1992, J BIOL CHEM, V267, P20371; WALTER MR, 1992, J MOL BIOL, V224, P1075, DOI 10.1016/0022-2836(92)90470-5; WARD LD, 1993, PROTEIN SCI, V2, P1472, DOI 10.1002/pro.5560020911; WLODAVER A, 1992, FEBS LETT, V309, P59, DOI 10.1016/0014-5793(92)80739-4; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; YANG YC, 1992, BIOFACTORS, V4, P15; YASUKAWA K, 1987, EMBO J, V6, P2939, DOI 10.1002/j.1460-2075.1987.tb02598.x; YIN TG, 1992, J BIOL CHEM, V267, P8347; YIN TG, 1993, J IMMUNOL, V151, P2555	45	46	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					978	985		10.1074/jbc.270.2.978	http://dx.doi.org/10.1074/jbc.270.2.978			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822338	hybrid			2022-12-27	WOS:A1995QB81600074
J	KUBLAOUI, B; LEE, J; PILCH, PF				KUBLAOUI, B; LEE, J; PILCH, PF			DYNAMICS OF SIGNALING DURING INSULIN-STIMULATED ENDOCYTOSIS OF ITS RECEPTOR IN ADIPOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; ISOLATED RAT ADIPOCYTES; KINASE-ACTIVITY; PHOSPHATIDYLINOSITOL 3-KINASE; GLUCOSE-TRANSPORT; ADIPOSE CELL; INTERNALIZATION; PHOSPHORYLATION; ACTIVATION; IRS-1	Insulin causes rapid insulin receptor autophosphorylation, receptor endocytosis, and phosphorylation of its principle substrate (IRS-I). Using rat adipocytes, we studied the dynamics of receptor autophosphorylation, the kinase activity, and the IRS-1 phosphorylation state relative to the subcellular localization of these proteins. After 2 min of insulin exposure, the specific phosphotyrosine content of the insulin receptor in the internal membranes (IM) peaks at a level 5-6-fold higher than the plasma membrane (PM) receptor and then declines after 5-8 min to a level similar to the PM receptor. The exogenous kinase activity of these receptors exactly mirrored their phosphotyrosine content. The distribution of IRS-1 is 80% cytosolic, 20% IM-associated, and essentially undetectable in the PM, The phosphorylation state of IRS-1 in the IM parallels that of the insulin receptor, but cytosolic IRS-1 phosphorylation remains constant. Insulin-dependent GLUT4 translocation to the PM occurs after the peak of IRS-1 phosphorylation. The data are consistent with the hypothesis that insulin action may be mediated by receptor internalization and interaction with its substrate(s) associated with internal membranes. A small fraction of phosphorylated insulin receptors is sufficient for signal transduction, The dephosphorylation of the insulin receptor and IRS-1 in the IM appears to be a concerted process, possibly mediated by the same enzyme.	BOSTON UNIV,SCH MED,DEPT BIOCHEM,BOSTON,MA 02118	Boston University			Lee, Jongsoon/AAG-1674-2020	Lee, Jongsoon/0000-0002-0891-5059; Pilch, Paul/0000-0003-1997-0499	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030425, R01DK036424] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-30425, DK-36424] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BACKER JM, 1989, J BIOL CHEM, V264, P1694; BACKER JM, 1991, J CELL BIOL, V115, P1535, DOI 10.1083/jcb.115.6.1535; BALTENSPERGER K, 1993, SCIENCE, V260, P1950, DOI 10.1126/science.8391166; BIRNBAUM MJ, 1992, INT REV CYTOL, V137A, P239; BRAUTIGAN DL, 1992, BIOCHIM BIOPHYS ACTA, V1114, P63, DOI 10.1016/0304-419X(92)90007-L; BURGESS JW, 1992, J BIOL CHEM, V267, P10077; DELVECCHIO RL, 1989, BIOCHIM BIOPHYS ACTA, V986, P41, DOI 10.1016/0005-2736(89)90270-8; DELVECCHIO RL, 1991, J BIOL CHEM, V266, P13278; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; ENDEMANN G, 1990, J BIOL CHEM, V265, P396; FEHLMANN M, 1982, P NATL ACAD SCI-BIOL, V79, P5921, DOI 10.1073/pnas.79.19.5921; HASHIMOTO N, 1992, J BIOL CHEM, V267, P13811; HUECKSTEADT T, 1986, J BIOL CHEM, V261, P8655; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; KELLER SR, 1993, BIOCHIM BIOPHYS ACTA, V1172, P323, DOI 10.1016/0167-4781(93)90222-Y; KELLY KL, 1992, J BIOL CHEM, V267, P3423; KELLY KL, 1993, J BIOL CHEM, V268, P4391; KHAN MN, 1989, J BIOL CHEM, V264, P12931; KLEIN HH, 1987, J BIOL CHEM, V262, P10557; KLEIN HH, 1986, J BIOL CHEM, V261, P4691; KUHNE MR, 1993, J BIOL CHEM, V268, P11479; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE JS, 1994, AM J PHYSIOL, V266, pC319, DOI 10.1152/ajpcell.1994.266.2.C319; MARSHALL S, 1981, J BIOL CHEM, V256, P1464; MARSHALL S, 1985, J BIOL CHEM, V260, P4136; MARSHALL S, 1979, J BIOL CHEM, V254, P153; MCCLAIN DA, 1987, J BIOL CHEM, V262, P14663; MOONEY RA, 1989, J BIOL CHEM, V264, P6850; MORGAN DO, 1987, P NATL ACAD SCI USA, V84, P41, DOI 10.1073/pnas.84.1.41; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; OHARE T, 1989, J BIOL CHEM, V264, P602; OKADA T, 1994, J BIOL CHEM, V269, P3568; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; SIMPSON IA, 1986, ANNU REV BIOCHEM, V55, P1059, DOI 10.1146/annurev.biochem.55.1.1059; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; SONNE O, 1984, BIOCHIM BIOPHYS ACTA, V804, P404, DOI 10.1016/0167-4889(84)90067-3; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; TAVARE JM, 1993, BIOCHIM BIOPHYS ACTA, V1178, P21, DOI 10.1016/0167-4889(93)90106-Y; TAYLOR SI, 1992, ENDOCR REV, V13, P566, DOI 10.1210/er.13.3.566; TONKS NK, 1992, COLD SPRING HARB SYM, V57, P87, DOI 10.1101/SQB.1992.057.01.012; WALTON KM, 1993, ANNU REV BIOCHEM, V62, P101; WANG CC, 1983, J BIOL CHEM, V258, P5129; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; WHITE MF, 1994, J BIOL CHEM, V269, P1; WILEY HS, 1989, J BIOL CHEM, V264, P18912	48	106	107	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					59	65		10.1074/jbc.270.1.59	http://dx.doi.org/10.1074/jbc.270.1.59			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814420	hybrid			2022-12-27	WOS:A1995QA28700015
J	PERRINO, BA; NG, LY; SODERLING, TR				PERRINO, BA; NG, LY; SODERLING, TR			CALCIUM REGULATION OF CALCINEURIN PHOSPHATASE-ACTIVITY BY ITS B-SUBUNIT AND CALMODULIN - ROLE OF THE AUTOINHIBITORY DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; BINDING PROTEIN; ALPHA-SUBUNIT; DEPHOSPHORYLATION; IDENTIFICATION; PURIFICATION; DETERMINANTS; MUTAGENESIS; PROMOTER; SEQUENCE	Calcineurin (CaN) contains an autoinhibitory element (residues 457-482) 43 residues COOH-terminal of the calmodulin binding domain (Hashimoto, Y., Perrino, B. A., and Soderling, T. R. (1990) J. Biol. Chem. 265, 1924-1927) that regulates the Ca2+-dependent activation of its phosphatase activity, Substitution of Arg(476) and Arg(477) or Asp(467) to Ala in the autoinhibitory peptide 457-482 significantly decreased its inhibitory potency. CaN A subunits with these residues mutated to Ala were coexpressed with the Ca2+-binding B subunit using the baculovirus/Sf9 cell system. Kinetic analysis showed that although the purified mutants had no activity in the absence of calcium, they were less dependent than the wild-type enzyme on calcium and calmodulin for activity. To determine if additional autoinhibitory motifs were present in the COOH terminus of calcineurin, the A subunit was truncated at residues 457 or 420 and co expressed with B subunit. The V-max values of both truncation mutants with or without Ca2+ were increased relative to wild-type calcineurin. The increased Ca2+-independent activity of CaN420 relative to CaN457 indicates the presence of additional autoinhibitory element(s) within residues 420-457. CaN420 had similar high V-max values with or without Ca2+, but the K-m value for peptide substrate was increased 5-fold to 125 mu M in the absence of Ca2+. The K-m values of all the expressed calcineurin species were increased in the absence of Ca2+. The CaN A or CaN A(420) subunits alone have low V-max and high K-m (115 mu M) values even in the presence of Ca2+. These results indicate that 1) there are several autoinhibitory motifs between the CaM-binding domain and the COOH terminus that are relieved by Ca2+ binding to CaM and the B subunit, 2) Ca2+ binding to the B subunit also regulates enzyme activity by lowering the K-m of the catalytic subunit for substrate, 3) binding of the B sub-unit is required for high V-max values even after removal of the autoinhibitory domain. These results are consistent with synergistic activation of calcineurin by Ca2+ acting through both CaM and the B subunit.	OREGON HLTH SCI UNIV,VOLLUM INST,PORTLAND,OR 97201	Oregon Health & Science University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK017808, T32DK007680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041292] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK17808, DK07680] Funding Source: Medline; NIGMS NIH HHS [GM41292] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLUMENTHAL DK, 1986, J BIOL CHEM, V261, P8140; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRICKEY DA, 1994, J BIOL CHEM, V269, P29047; ENSLEN H, 1994, J BIOL CHEM, V269, P20872; FONG YL, 1990, J BIOL CHEM, V265, P11091; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; GUERINI D, 1989, DNA-J MOLEC CELL BIO, V8, P675, DOI 10.1089/dna.1.1989.8.675; HASHIMOTO Y, 1990, J BIOL CHEM, V265, P1924; HASHIMOTO Y, 1987, ARCH BIOCHEM BIOPHYS, V257, P418; HIGUCHI S, 1991, J BIOL CHEM, V256, P18104; HOGER JH, 1991, NEURON, V6, P227, DOI 10.1016/0896-6273(91)90358-7; HUBBARD MJ, 1989, BIOCHEMISTRY-US, V28, P1868, DOI 10.1021/bi00430a066; KINCAID RL, 1988, METHOD ENZYMOL, V159, P627; KINCAID RL, 1988, P NATL ACAD SCI USA, V85, P8923; KING MM, 1987, J BIOL CHEM, V262, P10658; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; MAHAJAN PB, 1993, J BIOL CHEM, V268, P16693; MCCAFFREY PG, 1993, J BIOL CHEM, V268, P3747; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; MURPHY BJ, 1993, J BIOL CHEM, V268, P27355; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; OLSEN DB, 1990, P NATL ACAD SCI USA, V87, P1451, DOI 10.1073/pnas.87.4.1451; PERRINO BA, 1992, J BIOL CHEM, V267, P15965; PERRINO BA, 1990, FASEB J, V4, pA2237; SAITOH Y, 1991, BIOMED RES-TOKYO, V12, P215, DOI 10.2220/biomedres.12.215; SCHWANINGER M, 1993, J BIOL CHEM, V268, P111; SMITH MK, 1992, J BIOL CHEM, V267, P1761; Stemmer P, 1991, Curr Opin Neurobiol, V1, P53, DOI 10.1016/0959-4388(91)90010-5; STEWART AA, 1983, EUR J BIOCHEM, V132, P289, DOI 10.1111/j.1432-1033.1983.tb07361.x; UEKI K, 1993, J BIOL CHEM, V268, P6554; WOLFF DJ, 1985, J BIOL CHEM, V260, P4195	33	142	147	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					340	346		10.1074/jbc.270.1.340	http://dx.doi.org/10.1074/jbc.270.1.340			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814394	hybrid			2022-12-27	WOS:A1995QA28700054
J	CARDINAUX, JR; CHAPEL, S; WAHLI, W				CARDINAUX, JR; CHAPEL, S; WAHLI, W			COMPLEX ORGANIZATION OF CTF/NF-I, C/EBP, AND HNF3 BINDING SITES WITHIN THE PROMOTER OF THE LIVER-SPECIFIC VITELLOGENIN GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROID-DEPENDENT INTERACTION; ESTROGEN-RESPONSIVE ELEMENT; TUMOR VIRUS PROMOTER; XENOPUS-LAEVIS; TRANSCRIPTION FACTORS; INVITRO TRANSCRIPTION; NUCLEAR FACTOR; YOLK PROTEINS; DNA-BINDING; RAT-LIVER	Vitellogenin genes are expressed specifically in the liver of female oviparous vertebrates under the strict control of estrogen. To explain this tissue-specific expression, we performed a detailed analysis of the Xenopus laevis vitellogenin gene B1 promoter by DNase I footprinting and gel mobility-shift assays. We characterized five binding sites for the ubiquitous factor CTF/NF-I. Two of these sites are close to the TATA-box, whereas the others are located on both sides of the estrogen responsive unit formed by two imperfect estrogen response elements. Moreover two liver-enriched factors, C/EBP and HNF3, were found to interact with multiple closely spaced proximal promoter elements in the first 100 base pairs upstream of the TATA-box. To confirm the physiological significance of this in vitro analysis, in vivo DNase I footprinting experiments were carried out using the ligation-mediated polymerase chain reaction technique. The various cis-elements characterized in vitro as binding sites for known transcription factors and more particularly for liver enriched transcription factors are efficiently recognized in vivo as well, suggesting that they play an important role in the control of the liver-specific vitellogenin gene B1 expression.	UNIV LAUSANNE, INST BIOL ANIM, CH-1015 LAUSANNE, SWITZERLAND	University of Lausanne			Wahli, Walter/I-3194-2019; Cardinaux, Jean-René/G-5391-2012; Wahli, Walter/B-1398-2009	Cardinaux, Jean-René/0000-0001-6423-0014; Wahli, Walter/0000-0002-5966-9089				ARCHER TK, 1991, MOL CELL BIOL, V11, P688, DOI 10.1128/MCB.11.2.688; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; BAKKER O, 1988, MOL CELL BIOL, V8, P4557, DOI 10.1128/MCB.8.10.4557; BECKER PB, 1986, NATURE, V324, P686, DOI 10.1038/324686a0; BECKER PB, 1987, CELL, V51, P435, DOI 10.1016/0092-8674(87)90639-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BYRNE BM, 1989, PROG BIOPHYS MOL BIO, V53, P33, DOI 10.1016/0079-6107(89)90005-9; CHANG TC, 1990, J BIOL CHEM, V265, P8176; CORDINGLEY MG, 1987, CELL, V48, P261, DOI 10.1016/0092-8674(87)90429-6; CORTHESY B, 1989, MOL CELL BIOL, V9, P5548, DOI 10.1128/MCB.9.12.5548; CORTHESY B, 1990, P NATL ACAD SCI USA, V87, P7878, DOI 10.1073/pnas.87.20.7878; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; De Simone V, 1991, CURR OPIN CELL BIOL, V3, P960, DOI 10.1016/0955-0674(91)90114-E; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DOBBELING U, 1988, EMBO J, V7, P2495, DOI 10.1002/j.1460-2075.1988.tb03096.x; DODSON RE, 1994, MOL CELL BIOL, V14, P3130, DOI 10.1128/MCB.14.5.3130; DREWES T, 1991, NUCLEIC ACIDS RES, V19, P6383, DOI 10.1093/nar/19.23.6383; GERBERHUBER S, 1987, NUCLEIC ACIDS RES, V15, P4737, DOI 10.1093/nar/15.12.4737; GERMOND JE, 1983, NUCLEIC ACIDS RES, V11, P2979, DOI 10.1093/nar/11.10.2979; GIL G, 1988, P NATL ACAD SCI USA, V85, P8963, DOI 10.1073/pnas.85.23.8963; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; GRANGE T, 1991, NUCLEIC ACIDS RES, V19, P131, DOI 10.1093/nar/19.1.131; GREELEY MS, 1986, COMP BIOCHEM PHYS B, V84, P1, DOI 10.1016/0305-0491(86)90262-2; GREGORI C, 1993, NUCLEIC ACIDS RES, V21, P897, DOI 10.1093/nar/21.4.897; HSU W, 1994, MOL CELL BIOL, V14, P268, DOI 10.1128/MCB.14.1.268; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; KALING M, 1991, MOL CELL BIOL, V11, P93, DOI 10.1128/MCB.11.1.93; KLEINHITPASS L, 1986, CELL, V46, P1053, DOI 10.1016/0092-8674(86)90705-1; KUGLER W, 1990, NUCLEIC ACIDS RES, V18, P6943, DOI 10.1093/nar/18.23.6943; LAI E, 1991, TRENDS BIOCHEM SCI, V16, P427, DOI 10.1016/0968-0004(91)90169-V; LAMB P, 1991, TRENDS BIOCHEM SCI, V16, P417, DOI 10.1016/0968-0004(91)90167-T; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; MARILLEY D, 1994, MOL CELL ENDOCRINOL, V101, P227, DOI 10.1016/0303-7207(94)90239-9; MARTINEZ E, 1987, EMBO J, V6, P3719, DOI 10.1002/j.1460-2075.1987.tb02706.x; MARTINEZ E, 1989, EMBO J, V8, P3781, DOI 10.1002/j.1460-2075.1989.tb08555.x; Maxam A M, 1980, Methods Enzymol, V65, P499; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; PAONESSA G, 1988, EMBO J, V7, P3115, DOI 10.1002/j.1460-2075.1988.tb03178.x; PHILIPSEN JNJ, 1988, NUCLEIC ACIDS RES, V16, P9663, DOI 10.1093/nar/16.20.9663; PINA B, 1990, CELL, V60, P719, DOI 10.1016/0092-8674(90)90087-U; RIGAUD G, 1991, CELL, V67, P977, DOI 10.1016/0092-8674(91)90370-E; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; SALUZ HP, 1988, P NATL ACAD SCI USA, V85, P6697, DOI 10.1073/pnas.85.18.6697; SALUZ HP, 1987, LABORATORY GUIDE GEN; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SCHILD C, 1993, EMBO J, V12, P423, DOI 10.1002/j.1460-2075.1993.tb05674.x; SCHORPP M, 1988, J MOL BIOL, V202, P307, DOI 10.1016/0022-2836(88)90460-3; SEAL SN, 1991, MOL CELL BIOL, V11, P2704, DOI 10.1128/MCB.11.5.2704; SEILERTUYNS A, 1986, NUCLEIC ACIDS RES, V14, P8755, DOI 10.1093/nar/14.22.8755; SHEN XY, 1993, CELL TISSUE RES, V272, P459, DOI 10.1007/BF00318552; Sladek FM, 1992, CURR OPIN GENET DEV, V2, P256, DOI 10.1016/S0959-437X(05)80282-5; TRONCHE F, 1992, BIOESSAYS, V14, P579, DOI 10.1002/bies.950140902; VANHUIJSDUIJNEN RH, 1990, EMBO J, V9, P3119, DOI 10.1002/j.1460-2075.1990.tb07509.x; WAHLI W, 1979, CELL, V16, P535, DOI 10.1016/0092-8674(79)90028-X; WAHLI W, 1981, SCIENCE, V212, P298, DOI 10.1126/science.7209528; WAHLI W, 1988, TRENDS GENET, V4, P227, DOI 10.1016/0168-9525(88)90155-2; WAHLI W, 1989, J STEROID BIOCHEM, V34, P17, DOI 10.1016/0022-4731(89)90062-9; WAHLI W, 1982, P NATL ACAD SCI-BIOL, V79, P6832, DOI 10.1073/pnas.79.22.6832; WAHLI W, 1980, CELL, V20, P107, DOI 10.1016/0092-8674(80)90239-1; WALKER P, 1983, EMBO J, V2, P2271, DOI 10.1002/j.1460-2075.1983.tb01734.x; WALKER P, 1984, NUCLEIC ACIDS RES, V12, P8611, DOI 10.1093/nar/12.22.8611; Wallace R A, 1985, Dev Biol (N Y 1985), V1, P127; WIJNHOLDS J, 1991, NUCLEIC ACIDS RES, V19, P33, DOI 10.1093/nar/19.1.33; WIJNHOLDS J, 1988, EMBO J, V7, P2757, DOI 10.1002/j.1460-2075.1988.tb03130.x; XANTHOPOULOS KG, 1993, EUR J BIOCHEM, V216, P353, DOI 10.1111/j.1432-1033.1993.tb18152.x; XU QL, 1992, MECH DEVELOP, V38, P69, DOI 10.1016/0925-4773(92)90039-M; YOUNG D, 1983, MOL CELL BIOL, V3, P720, DOI 10.1128/MCB.3.4.720	67	52	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					32947	32956						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806524				2022-12-27	WOS:A1994QA63800037
J	DOURSZIMMERMANN, MT; ZIMMERMANN, DR				DOURSZIMMERMANN, MT; ZIMMERMANN, DR			A NOVEL GLYCOSAMINOGLYCAN ATTACHMENT DOMAIN IDENTIFIED IN 2 ALTERNATIVE SPLICE VARIANTS OF HUMAN VERSICAN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR-BETA-1; LARGE AGGREGATING PROTEOGLYCAN; CORE PROTEIN; PG-M; GENE-EXPRESSION; CARTILAGE; AGGRECAN; CLONING; MATRIX	We have cloned an alternatively spliced glycosaminoglycan attachment domain (GAG-alpha) of human versican from cDNA libraries derived from U251MG glioma cells, Inserted carboxyl-terminal of the hyaluronan-binding region, this domain adds another 987 amino acids to the original versican (V1) core protein giving rise to the large V0 isoform with 3396 amino acids and 17-23 putative glycosaminoglycan attachment sites, The GAG-alpha domain is encoded by exon 7 of the human versican gene (Naso ct al., J, Biol, Chem,, 32999-33008), Sequence comparisons revealed a slight similarity to the alternative splice domain of PG-M, further supporting the notion that PG-M is the chicken homologue of versican, On immunoblots of a proteoglycan preparation from U251MG culture medium, anti-GAG-alpha antibodies reacted exclusively with the larger of two versican core proteins recognized by antibodies against the original GAG-beta domain, Using reverse transcription-polymerase chain reaction, we detected both the V0 and V1 isoforms in the cerebral cortex, aorta, intervertebral disc, liver, myometrium, and prostate, whereas keratinocytes exclusively expressed versican V1, In brain tissue, we identified a short versican variant (V2) including only the GAG-alpha domain, By expressing particular splice forms of versican, cells may control the hydration properties of their pericellular hyaluronan coat and thus could modulate interactions with the extracellular matrix or neighboring cells.	UNIV ZURICH,INST CLIN PATHOL,DEPT PATHOL,CH-8091 ZURICH,SWITZERLAND	University of Zurich								BALDWIN CT, 1989, J BIOL CHEM, V264, P15747; BOYD CD, 1993, MATRIX, V13, P457, DOI 10.1016/S0934-8832(11)80112-5; CHANDRASEKARAN L, 1992, BIOCHEM J, V288, P903, DOI 10.1042/bj2880903; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DOEGE K, 1987, J BIOL CHEM, V262, P17757; DOEGE KJ, 1991, J BIOL CHEM, V266, P894; FULOP C, 1993, J BIOL CHEM, V268, P17377; GROVER J, 1993, BIOCHEM J, V291, P361, DOI 10.1042/bj2910361; Heinegard Dick, 1993, P189; HERRIN DL, 1988, BIOTECHNIQUES, V6, P196; IOZZO RV, 1992, GENOMICS, V14, P845, DOI 10.1016/S0888-7543(05)80103-X; KAHARI VM, 1991, J BIOL CHEM, V266, P10608; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; KRUSIUS T, 1987, J BIOL CHEM, V262, P13120; Lander A D, 1993, Curr Opin Neurobiol, V3, P716, DOI 10.1016/0959-4388(93)90143-M; MARGOLIS RK, 1993, EXPERIENTIA, V49, P429, DOI 10.1007/BF01923587; NASO MF, 1994, J BIOL CHEM, V269, P32999; PERIDES G, 1992, J BIOL CHEM, V267, P23883; RAUCH U, 1992, J BIOL CHEM, V267, P19536; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; SCHMIDTCHEN A, 1990, BIOCHEM J, V265, P389; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; SHINOMURA T, 1990, ANAT EMBRYOL, V181, P227; SHINOMURA T, 1993, J BIOL CHEM, V268, P14461; Toole B. P., 1991, CELL BIOL EXTRACELLU, P305; YAMADA H, 1994, J BIOL CHEM, V269, P10119; YAMAGATA M, 1993, J CELL SCI, V106, P55; YAMAGATA M, 1989, J BIOL CHEM, V264, P8012; YAMAGATA M, 1986, J BIOL CHEM, V261, P3526; YAO LY, 1994, MATRIX BIOL, V14, P213, DOI 10.1016/0945-053X(94)90185-6; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x; ZIMMERMANN DR, 1994, J CELL BIOL, V124, P817, DOI 10.1083/jcb.124.5.817	32	192	202	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					32992	32998						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806529				2022-12-27	WOS:A1994QA63800043
J	BORONENKOV, IV; ANDERSON, RA				BORONENKOV, IV; ANDERSON, RA			THE SEQUENCE OF PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE DEFINES A NOVEL FAMILY OF LIPID KINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PHOSPHOLIPASE-C GENE; SACCHAROMYCES-CEREVISIAE; PHOSPHOINOSITIDE KINASES; 4,5-BISPHOSPHATE; DIACYLGLYCEROL; LOCALIZATION; MEMBRANES; PLC1	Phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2) occupies an essential position in the phosphoinositide signal transduction cascades as the precursor to second messengers and is thought to regulate many cellular proteins directly. The final step in the synthesis of PtdIns(4,5)P-2 is the phosphorylation of PtdIns(4)P by PtdIns(4)P 5-kinase (PIP5K). Using peptide sequences from a purified PIP5H, a cDNA for a human placental PIP5K was isolated and sequenced. Expression of this cDNA in Escherichia coli produced an active PIP5K. Surprisingly, the sequence of this PIP5K has no homology to known PtdIns kinases or protein kinases, However, the PIP5K is homologous to the Saccharomyces cerevisiae proteins Fab1p and Mss4p.	UNIV WISCONSIN,SCH MED,DEPT PHARMACOL,MADISON,WI 53706; UNIV WISCONSIN,SCH MED,DEPT BIOMOLEC CHEM,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison				Anderson, Richard/0000-0001-6265-8359	NIGMS NIH HHS [GM38906, GM51966] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051966, R37GM051966, R29GM038906, R01GM038906] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS MD, 1993, NAT GENET, V4, P256, DOI 10.1038/ng0793-256; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDERSON RA, 1985, NATURE, V318, P295, DOI 10.1038/318295a0; BAZENET CE, 1990, J BIOL CHEM, V265, P18012; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BOSSEMEYER D, 1994, TRENDS BIOCHEM SCI, V19, P201, DOI 10.1016/0968-0004(94)90022-1; BROCKMAN JL, 1992, P NATL ACAD SCI USA, V89, P9454, DOI 10.1073/pnas.89.20.9454; BROCKMAN JL, 1991, J BIOL CHEM, V266, P2508; BROOKSBANK CEL, 1993, BIOCHEM J, V291, P77, DOI 10.1042/bj2910077; CARPENTER CL, 1990, BIOCHEMISTRY-US, V29, P11147, DOI 10.1021/bi00503a001; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; FLANAGAN CA, 1993, SCIENCE, V262, P1444, DOI 10.1126/science.8248783; FLICK JS, 1993, MOL CELL BIOL, V13, P5861, DOI 10.1128/MCB.13.9.5861; FUKAMI K, 1994, J BIOL CHEM, V269, P1518; GARCIABUSTOS JF, 1994, EMBO J, V13, P2352, DOI 10.1002/j.1460-2075.1994.tb06519.x; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; HAY JC, 1994, NATURE, V366, P572; Herman Paul K., 1992, Trends in Cell Biology, V2, P363, DOI 10.1016/0962-8924(92)90048-R; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; JENKINS GH, 1993, J BIOL CHEM, V269, P11547; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; LEE MH, 1991, BIOCHEMISTRY-US, V30, P1041, DOI 10.1021/bi00218a023; LISCOVITCH M, 1994, J BIOL CHEM, V269, P21403; MAGDOLEN V, 1988, MOL CELL BIOL, V8, P5108, DOI 10.1128/MCB.8.12.5108; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; PAYNE WE, 1993, MOL CELL BIOL, V13, P4351, DOI 10.1128/MCB.13.7.4351; PAYRASTRE B, 1992, J BIOL CHEM, V267, P5078; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; RHEE SG, 1992, J BIOL CHEM, V267, P12393; Sambrook J, 1989, MOL CLONING LABORATO; Staeheli Peter, 1993, Trends in Cell Biology, V3, P268, DOI 10.1016/0962-8924(93)90055-6; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; YOKOO T, 1993, P NATL ACAD SCI USA, V90, P1804, DOI 10.1073/pnas.90.5.1804; YOSHIDA S, 1994, MOL GEN GENET, V242, P631, DOI 10.1007/BF00283416; YOSHIDA S, 1994, J BIOL CHEM, V269, P1166; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	38	128	135	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					2881	2884		10.1074/jbc.270.7.2881	http://dx.doi.org/10.1074/jbc.270.7.2881			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852364	hybrid			2022-12-27	WOS:A1995QG47100001
J	BLASCO, MA; MENDEZ, J; LAZARO, JM; BLANCO, L; SALAS, M				BLASCO, MA; MENDEZ, J; LAZARO, JM; BLANCO, L; SALAS, M			PRIMER TERMINUS STABILIZATION AT THE PHI-29 DNA-POLYMERASE ACTIVE-SITE - MUTATIONAL ANALYSIS OF CONSERVED MOTIF KXY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-T7 RNA-POLYMERASE; EXONUCLEASE ACTIVITY; PROTEIN; PHAGE-PHI-29; INITIATION; REPLICATION; POLYMERIZATION; MUTAGENESIS; EXPRESSION; MUTANTS	phi 29 DNA polymerase shares with other DNA-dependent DNA polymerases several regions of amino acid homology along the primary structure. A conserved amino acid motif, located in the C-terminal portion of the polypeptide and characterized by the amino acid sequence KK(K/R)Y, is conserved in the group of eukaryotic-type DNA polymerases. In the subgroup of DNA polymerases that have a protein-priming mechanism, this motif is restricted to the sequence KXY, X never being a positively charged amino acid. Residues Lys(498) and Tyr(500) form this conserved motif in phi 29 DNA polymerase. Mutant K498T, in which the positive charge of the motif has been eliminated, was strongly affected both in initiation (terminal protein-dAMP formation, using terminal protein as primer) and DNA polymerization reactions. Mutants K498R and Y500S were able to carry out the initiation reaction to a higher or similar extent, respectively, than wild-type phi 29 DNA polymerase but were affected in DNA polymerization reactions. Ah of the mutations severely affected the stable binding of the polymerase to a primer-template DNA. In addition, all of the mutant polymerases analyzed in this work showed an unusually strong 3'-5' exonuclease activity both under polymerization or non-polymerization conditions. The results obtained suggest a role of the conserved residues of the KXY motif in stabilizing the primer terminus at the polymerization active site, the positive charge of residue Lys(498) being critical for the synthetic activities of phi 29 DNA polymerase.	UNIV AUTONOMA MADRID,CSIC,CTR BIOL MOLEC SEVERO OCHOA,E-28049 MADRID,SPAIN	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)			Mendez, Juan/K-8001-2014; Blanco, Luis/I-1848-2015; Salas, Margarita/J-9873-2014; Blasco, Maria A./M-1694-2014	Mendez, Juan/0000-0002-3235-2559; Salas, Margarita/0000-0001-5939-3441; Blasco, Maria A./0000-0002-4211-233X	NIGMS NIH HHS [5R01 GM27242-15] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027242] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERNAD A, 1987, EMBO J, V6, P4219, DOI 10.1002/j.1460-2075.1987.tb02770.x; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; BERNAD A, 1990, P NATL ACAD SCI USA, V87, P4610, DOI 10.1073/pnas.87.12.4610; BLANCO L, 1985, NUCLEIC ACIDS RES, V13, P1239, DOI 10.1093/nar/13.4.1239; BLANCO L, 1985, P NATL ACAD SCI USA, V82, P6404, DOI 10.1073/pnas.82.19.6404; BLANCO L, 1991, GENE, V100, P27, DOI 10.1016/0378-1119(91)90346-D; BLANCO L, 1986, VIROLOGY, V153, P179, DOI 10.1016/0042-6822(86)90021-8; BLANCO L, 1984, P NATL ACAD SCI-BIOL, V81, P5325, DOI 10.1073/pnas.81.17.5325; BLANCO L, 1992, J BIOL CHEM, V267, P1225; BLASCO MA, 1992, J BIOL CHEM, V267, P19427; BLASCO MA, 1993, J BIOL CHEM, V268, P16763; BLASCO MA, 1993, J BIOL CHEM, V268, P24106; BLASCO MA, 1991, J BIOL CHEM, V266, P7904; BLASCO MA, 1990, NUCLEIC ACIDS RES, V18, P4763; BLASCO MA, 1992, CHROMOSOMA, V102, P32; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; CULLMANN G, 1993, GENE, V134, P191, DOI 10.1016/0378-1119(93)90093-I; ESTEBAN JA, 1993, J BIOL CHEM, V268, P2719; GARMENDIA C, 1992, J BIOL CHEM, V267, P2594; GIBBS JS, 1988, P NATL ACAD SCI USA, V85, P6672, DOI 10.1073/pnas.85.18.6672; HERMOSO JM, 1985, NUCLEIC ACIDS RES, V13, P7715, DOI 10.1093/nar/13.21.7715; HWANG CBC, 1992, J VIROL, V66, P1774, DOI 10.1128/JVI.66.3.1774-1776.1992; INCIARTE MR, 1976, VIROLOGY, V74, P314, DOI 10.1016/0042-6822(76)90338-X; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; LARDER BA, 1987, EMBO J, V6, P169, DOI 10.1002/j.1460-2075.1987.tb04735.x; LAZARO JM, 1994, IN PRESS METHODS ENZ; MENDEZ J, 1994, J BIOL CHEM, V269, P30030; MORRISON A, 1989, J BACTERIOL, V171, P5659, DOI 10.1128/jb.171.10.5659-5667.1989; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; PENALVA MA, 1982, P NATL ACAD SCI-BIOL, V79, P5522, DOI 10.1073/pnas.79.18.5522; RODRIGUEZ JM, 1993, GENE, V136, P103, DOI 10.1016/0378-1119(93)90453-A; ROHE M, 1991, CURR GENET, V20, P527, DOI 10.1007/BF00334782; SALAS M, 1991, ANNU REV BIOCHEM, V60, P39, DOI 10.1146/annurev.bi.60.070191.000351; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; WATABE K, 1984, BIOCHEM BIOPH RES CO, V123, P1019, DOI 10.1016/S0006-291X(84)80235-1; ZABALLOS A, 1989, GENE, V83, P187, DOI 10.1016/0378-1119(89)90104-2	37	36	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2735	2740		10.1074/jbc.270.6.2735	http://dx.doi.org/10.1074/jbc.270.6.2735			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852344	hybrid			2022-12-27	WOS:A1995QF53500053
J	FISONE, G; SNYDER, GL; FRYCKSTEDT, J; CAPLAN, MJ; APERIA, A; GREENGARD, P				FISONE, G; SNYDER, GL; FRYCKSTEDT, J; CAPLAN, MJ; APERIA, A; GREENGARD, P			NA+,K+-ATPASE IN THE CHOROID-PLEXUS - REGULATION BY SEROTONIN PROTEIN-KINASE-C PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CEREBROSPINAL-FLUID PRODUCTION; EPITHELIAL-CELLS; BRAIN-BARRIER; RAPHE ORIGIN; PHOSPHORYLATION; NA,K-ATPASE; ATPASE; RAT; LOCALIZATION; RECEPTOR	In the choroid plexus, the ion pump Na+,K+-ATPase regulates the production of cerebrospinal fluid. We now report that incubation of choroid plexus with an activator of protein kinase C, phorbol 12,13-dibutyrate, strongly stimulates the phosphorylation of Na+,K+-ATPase and inhibits its activity. Similar effects were obtained with serotonin, which in the choroid plexus stimulates phosphoinositide turnover, thereby activating protein kinase C. Serotonin (10 mu M) increased by about 10-fold the amount of phosphorylated Na+,K+-ATPase and significantly reduced its activity. Two-dimensional peptide mapping showed comigration of Na+,K+-ATPase phosphorylated by either phorbol 12,13-dibutyrate or serotonin in intact cells and by protein kinase C in vitro. These results demonstrate that first messengers can regulate the activity of Na+,K+-ATPase through a mechanism involving protein phosphorylation. Moreover, they provide a plausible mechanism for the demonstrated ability of serotonin to decrease cerebrospinal fluid production.	KAROLINSKA INST,ST GORANS CHILDRENS HOSP,DEPT PEDIAT,S-11281 STOCKHOLM,SWEDEN; YALE UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,NEW HAVEN,CT 06510	Karolinska Institutet; Yale University	FISONE, G (corresponding author), ROCKEFELLER UNIV,MOLEC & CELLULAR NEUROSCI LAB,1230 YORK AVE,NEW YORK,NY 10021, USA.			Fisone, Gilberto/0000-0002-0719-8000; Caplan, Michael/0000-0001-5768-4405; Fryckstedt, Jessica/0000-0003-4944-8909	NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH040899] Funding Source: NIH RePORTER; NIMH NIH HHS [MH-40899] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AGHAJANIAN GK, 1975, BRAIN RES, V88, P221, DOI 10.1016/0006-8993(75)90386-8; BERTORELLO AM, 1991, P NATL ACAD SCI USA, V88, P11359, DOI 10.1073/pnas.88.24.11359; CHIBALIN AV, 1992, J BIOL CHEM, V267, P22378; CONN PJ, 1986, P NATL ACAD SCI USA, V83, P4086, DOI 10.1073/pnas.83.11.4086; CONN PJ, 1986, J NEUROCHEM, V47, P1754, DOI 10.1111/j.1471-4159.1986.tb13085.x; CONN PJ, 1987, BRAIN RES, V400, P396, DOI 10.1016/0006-8993(87)90641-X; DOUCET A, 1979, AM J PHYSIOL, V237, pF105, DOI 10.1152/ajprenal.1979.237.2.F105; ERNST SA, 1986, J HISTOCHEM CYTOCHEM, V34, P189, DOI 10.1177/34.2.3003182; FISONE G, 1994, J BIOL CHEM, V269, P9368; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P36, DOI 10.1016/0005-2736(74)90292-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDVALL M, 1979, EXP NEUROL, V64, P132, DOI 10.1016/0014-4886(79)90010-4; LINDVALL M, 1978, SCIENCE, V201, P176, DOI 10.1126/science.663649; LINDVALLAXELSSO.M, 1988, EXP NEUROL, V99, P362; LOWNDES JM, 1990, BIOCHIM BIOPHYS ACTA, V1052, P143, DOI 10.1016/0167-4889(90)90069-P; MAEDA K, 1983, Nihon University Journal of Medicine, V25, P155; MIDDLETON JP, 1993, J BIOL CHEM, V268, P15958; MOSKOWITZ MA, 1979, BRAIN RES, V169, P590, DOI 10.1016/0006-8993(79)90410-4; PAZOS A, 1985, EUR J PHARMACOL, V106, P539; PIETRINI G, 1992, P NATL ACAD SCI USA, V89, P8414, DOI 10.1073/pnas.89.18.8414; POLLAY M, 1985, NEUROSURGERY, V17, P768, DOI 10.1227/00006123-198511000-00007; QUINTON PM, 1973, J CELL BIOL, V58, P724, DOI 10.1083/jcb.58.3.724; STEARDO L, 1987, SCIENCE, V235, P470, DOI 10.1126/science.2879355; WRIGHT EM, 1978, REV PHYSIOL BIOCH P, V83, P1; YAGALOFF KA, 1985, J NEUROSCI, V5, P3178; ZLOKOVIC BV, 1993, J BIOL CHEM, V268, P8019	26	84	86	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2427	2430		10.1074/jbc.270.6.2427	http://dx.doi.org/10.1074/jbc.270.6.2427			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852300	hybrid			2022-12-27	WOS:A1995QF53500005
J	KIM, EJ; ZHEN, RG; REA, PA				KIM, EJ; ZHEN, RG; REA, PA			SITE-DIRECTED MUTAGENESIS OF VACUOLAR H+-PYROPHOSPHATASE - NECESSITY OF CYS(634) FOR INHIBITION BY MALEIMIDES BUT NOT CATALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATING INORGANIC PYROPHOSPHATASE; SUBSTRATE-BINDING SUBUNIT; PHENOTYPIC SELECTION; MOLECULAR-CLONING; MEMBRANE; PLANTS; CELLS; METABOLISM; KINETICS; ATPASES	A characteristic feature of the vacuolar H+-translocating inorganic pyrophosphatase (V-PPase) of plant cells is its high sensitivity to irreversible inhibition by N-ethylmaleimide (NEM) and other sulfhydryl reagents, Previous investigations in this laboratory have demonstrated that the primary site for substrate-protectable covalent modification of the V-PPase by C-14-labeled NEM maps to a single M(r) 14,000 V8 protease fragment (V8(14K)) (Zhen, R.-G., Kim, E. J., and Rea, P. A. (1994) J. Biol. Chem. 269, 23342-23350). Here, we describe site-directed mutagenesis of the cDNA encoding the V-PPase hom Arabidopsis thaliana, its heterologous expression in Saccharomyces cerevisiae and single substitution of all 9 conserved Cys residues to either Ser or Ala. In all cases, except one, Cys mutagenesis exerts little or no effect on either the catalytic activity or susceptibility of the enzyme to inhibition by NEM. By contrast, and in complete agreement with the results of peptide mapping experiments, substitution of Cys(634), the sole conserved cysteine residue encompassed by V8(14K), with Ser or Ala generates enzyme that is insensitive to NEM but active in both PPi hydrolysis and PPi-dependent H+ translocation. The specific requirement for Cys(634) for inhibition by NEM and the dispensability of all of the conserved Cys residues, including Cys(634), for V-PPase function indicate that the inhibitory action of maleimides reflects steric constraints imposed by the addition of a substituted alkyl group to the side chain of Cys(634) rather than direct participation of this amino acid residue in catalysis.	UNIV PENN, INST PLANT SCI, DEPT BIOL, PHILADELPHIA, PA 19104 USA	University of Pennsylvania								Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; BAYKOV AA, 1993, FEBS LETT, V327, P199, DOI 10.1016/0014-5793(93)80169-U; BAYKOV AA, 1993, EUR J BIOCHEM, V217, P755, DOI 10.1111/j.1432-1033.1993.tb18303.x; BLACK CC, 1987, PHYSIOL PLANTARUM, V69, P387, DOI 10.1111/j.1399-3054.1987.tb04305.x; BRITTEN CJ, 1989, FEBS LETT, V256, P200, DOI 10.1016/0014-5793(89)81748-X; COOPERMAN BS, 1992, TRENDS BIOCHEM SCI, V17, P262, DOI 10.1016/0968-0004(92)90406-Y; DENNIS DT, 1987, PHYSIOL PLANTARUM, V69, P395, DOI 10.1111/j.1399-3054.1987.tb04306.x; HUBER SC, 1986, PLANT PHYSIOL, V81, P1008, DOI 10.1104/pp.81.4.1008; JONES EW, 1991, METHOD ENZYMOL, V194, P428; KABACK HR, 1992, INT REV CYTOL, V137A, P97; KIM EJ, 1994, P NATL ACAD SCI USA, V91, P6128, DOI 10.1073/pnas.91.13.6128; KIM YC, 1994, PLANT PHYSIOL, V106, P375, DOI 10.1104/pp.106.1.375; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEIGH RA, 1992, PLANT PHYSIOL, V100, P1698, DOI 10.1104/pp.100.4.1698; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; QUICK P, 1989, BIOCHIM BIOPHYS ACTA, V973, P263, DOI 10.1016/S0005-2728(89)80431-1; Rea P.A., 1990, METHODS PLANT BIOCH, V3, P385, DOI DOI 10.1016/B978-0-12-461013-2.50035-6; REA PA, 1992, PLANT PHYSIOL, V100, P723, DOI 10.1104/pp.100.2.723; REA PA, 1987, PHYSIOL PLANTARUM, V71, P131, DOI 10.1111/j.1399-3054.1987.tb04630.x; REA PA, 1992, TRENDS BIOCHEM SCI, V17, P348, DOI 10.1016/0968-0004(92)90313-X; REA PA, 1993, ANNU REV PLANT PHYS, V44, P157, DOI 10.1146/annurev.pp.44.060193.001105; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARAFIAN V, 1992, P NATL ACAD SCI USA, V89, P1775, DOI 10.1073/pnas.89.5.1775; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SZE H, 1992, J BIOENERG BIOMEMBR, V24, P371, DOI 10.1007/BF00762530; TAIZ L, 1994, BBA-BIOMEMBRANES, V1194, P329, DOI 10.1016/0005-2736(94)90315-8; TANAKA Y, 1993, BIOCHEM BIOPH RES CO, V190, P1110, DOI 10.1006/bbrc.1993.1164; VANIWAARDEN PR, 1991, BIOCHEMISTRY-US, V30, P9595, DOI 10.1021/bi00104a005; ZHEN RG, 1994, J BIOL CHEM, V269, P23342	31	71	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2630	2635		10.1074/jbc.270.6.2630	http://dx.doi.org/10.1074/jbc.270.6.2630			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852329	hybrid			2022-12-27	WOS:A1995QF53500037
J	WEIL, R; CLOUTIER, JF; FOURNEL, M; VEILLETTE, A				WEIL, R; CLOUTIER, JF; FOURNEL, M; VEILLETTE, A			REGULATION OF ZAP-70 BY SRC FAMILY TYROSINE PROTEIN-KINASES IN AN ANTIGEN-SPECIFIC T-CELL LINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZETA-CHAIN; RECEPTOR STIMULATION; CD4 RECEPTOR; ACTIVATION; P56LCK; PHOSPHORYLATION; RESPONSIVENESS; IDENTIFICATION; COMPONENTS; BINDS	To further understand the interactions between Zap-70, Src family kinases, and other T-cell proteins, we have examined the regulation of Zap-70 in the antigen-specific T-cell line BI-141. By analyzing derivatives containing an activated version of either p56(lck) or p59(fynT), it was observed that the two Src-related enzymes augmented T-cell receptor (TCR)-mediated tyrosine phosphorylation of Zap-70, as well as its association with components of the antigen receptor complex. Importantly, the accumulation of TCR Zap-70 complexes quantitatively and temporally correlated with the induction of tyrosine phosphorylation of the CD3 and zeta chains of TCR, Using a CD4-positive variant of BI-141, we also found that the ability of Zap-70 to undergo tyrosine phosphorylation and associate with TCR was enhanced by aggregation of TCR with the CD4 co-receptor. Further studies allowed the identification of two distinct pools of tyrosine-phosphorylated Zap-70 in activated T-cells. While one population was associated with TCR, the other was co-immunoprecipitated with a 120-kDa tyrosine-phosphorylated protein of unknown identity, In addition to supporting the notion that Src-related enzymes regulate the recruitment of Zap-70 in TCR signaling, these data added further complexity to previous models of regulation of Zap-70. Furthermore, they suggested that p120 may be an effector and/or a regulator of Zap-70 in activated T-lymphocytes.	MCGILL UNIV, MCGILL CANC CTR, MONTREAL, PQ H3G 1Y6, CANADA; MCGILL UNIV, DEPT MED, MONTREAL, PQ H3G 1Y6, CANADA; MCGILL UNIV, DEPT BIOCHEM & ONCOL, MONTREAL, PQ H3G 1Y6, CANADA; MONTREAL GEN HOSP, DEPT MED, MONTREAL, PQ H3G 1A4, CANADA; MONTREAL GEN HOSP, DEPT ONCOL, MONTREAL, PQ H3G 1A4, CANADA	McGill University; McGill University; McGill University; McGill University; McGill University			Cloutier, Jean-François/K-2003-2012	Weil, Robert/0000-0001-5235-0932				ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; BALLHAUSEN WG, 1988, J EXP MED, V167, P1493, DOI 10.1084/jem.167.4.1493; BANIYASH M, 1988, J BIOL CHEM, V263, P9874; CARON L, 1992, MOL CELL BIOL, V12, P2720, DOI 10.1128/MCB.12.6.2720; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; COUTURE C, 1994, P NATL ACAD SCI USA, V91, P5301, DOI 10.1073/pnas.91.12.5301; DASILVA AJ, 1993, J EXP MED, V178, P2107, DOI 10.1084/jem.178.6.2107; DAVIDSON D, 1992, J EXP MED, V175, P1483, DOI 10.1084/jem.175.6.1483; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; KOYASU S, 1992, J BIOL CHEM, V267, P3375; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LUO KX, 1990, MOL CELL BIOL, V10, P5305, DOI 10.1128/MCB.10.10.5305; PERLMUTTER RM, 1993, ANNU REV IMMUNOL, V11, P451, DOI 10.1146/annurev.iy.11.040193.002315; QIAN DP, 1993, J BIOL CHEM, V268, P4488; REEDQUIST KA, 1994, P NATL ACAD SCI USA, V91, P4135, DOI 10.1073/pnas.91.10.4135; RESKEKUNZ AB, 1985, EUR J IMMUNOL, V15, P1048, DOI 10.1002/eji.1830151017; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SAMELSON LE, 1992, J BIOL CHEM, V267, P24913; STAERZ UD, 1985, J IMMUNOL, V134, P3994; STRAUS DB, 1993, J EXP MED, V178, P1523, DOI 10.1084/jem.178.5.1523; TIMSONGAUEN LK, 1994, MOL CELL BIOL, V14, P3729; TSYGANKOV AY, 1994, J BIOL CHEM, V269, P7792; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VEILLETTE A, 1988, ONCOGENE RES, V2, P385; VEILLETTE A, 1992, TRENDS GENET, V8, P61, DOI 10.1016/0168-9525(92)90045-6; WANGE RL, 1992, J BIOL CHEM, V267, P11685; WANGE RL, 1993, J BIOL CHEM, V268, P19797; WEIL R, 1994, J BIOL CHEM, V269, P22830; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WILDE DB, 1983, J IMMUNOL, V131, P2178	37	43	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2791	2799		10.1074/jbc.270.6.2791	http://dx.doi.org/10.1074/jbc.270.6.2791			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852351	hybrid			2022-12-27	WOS:A1995QF53500061
J	BLOMMAART, EFC; LUIKEN, JJFP; BLOMMAART, PJE; VANWOERKOM, GM; MEIJER, AJ				BLOMMAART, EFC; LUIKEN, JJFP; BLOMMAART, PJE; VANWOERKOM, GM; MEIJER, AJ			PHOSPHORYLATION OF RIBOSOMAL-PROTEIN S6 IS INHIBITORY FOR AUTOPHAGY IN ISOLATED RAT HEPATOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACIDS; HEPATIC PROTEOLYSIS; PLASMA-MEMBRANE; OKADAIC ACID; DEGRADATION; GLUCAGON; INSULIN; KINASE; LIVER; SITES	In rat hepatocytes, autophagy is known to be inhibited by amino acids, Insulin and cell swelling promote inhibition by amino acids, Each of the conditions leading to inhibition of autophagic proteolysis was found to be associated with phosphorylation of a 31-kDa protein that we identified as ribosomal protein S6. A combination of leucine, tyrosine, and phenylalanine, which efficiently inhibits autophagic proteolysis, was particularly effective in stimulating S6 phosphorylation, The relationship between the percentage inhibition of proteolysis and the degree of Se phosphorylation was linear, Thus, inhibition of autophagy and phosphorylation of S6 are under the control of the same signal transduction pathway, Stimulation of S6 phosphorylation by the presence of amino acids was due to activation of S6 kinase and not to inhibition of S6 phosphatase. The inhibition by amino acids of both autophagic proteolysis and autophagic sequestration of electro-injected cytosolic [C-14]sucrose was partially prevented by rapamycin, a compound known to inhibit activation of p70 S6 kinase, In addition, rapamycin partially inhibited the rate of protein synthesis. We conclude that the fluxes through the autophagic and protein synthetic pathways are regulated in an opposite manner by the degree to which S6 is phosphorylated. Possible mechanisms by which S6 phosphorylation can cause inhibition of autophagy are discussed.	UNIV AMSTERDAM, EC SLATER INST, ACAD MED CTR, DEPT BIOCHEM, 1100 DE AMSTERDAM, NETHERLANDS; UNIV AMSTERDAM, DEPT ANAT & EMBRYOL, AMSTERDAM, NETHERLANDS	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam								BANDI HR, 1993, J BIOL CHEM, V268, P4530; BLOMMAART PJE, 1993, J BIOL CHEM, V268, P1610; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; DAHL SV, 1991, BIOCHEM J, V278, P771, DOI 10.1042/bj2780771; DUNN WA, 1990, J CELL BIOL, V110, P1935, DOI 10.1083/jcb.110.6.1935; FURUNO K, 1990, EXP CELL RES, V189, P261, DOI 10.1016/0014-4827(90)90245-6; GARRISON JC, 1978, J BIOL CHEM, V253, P7091; GROEN AK, 1982, EUR J BIOCHEM, V122, P87, DOI 10.1111/j.1432-1033.1982.tb05851.x; HENSGENS HESJ, 1979, BIOCHIM BIOPHYS ACTA, V582, P525, DOI 10.1016/0304-4165(79)90143-0; HOLEN I, 1993, EUR J BIOCHEM, V215, P113, DOI 10.1111/j.1432-1033.1993.tb18013.x; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; JONSSON LMV, 1987, EUR J BIOCHEM, V164, P171, DOI 10.1111/j.1432-1033.1987.tb11008.x; Kacser H, 1979, BIOCHEM SOC T, V7, P1149, DOI 10.1042/bst0071149; KADOWAKI M, 1992, J BIOL CHEM, V267, P22060; KOZMA SC, 1989, CELL SIGNAL, V1, P219, DOI 10.1016/0898-6568(89)90039-9; KRIEG J, 1988, J BIOL CHEM, V263, P11473; LANE HA, 1993, NATURE, V363, P170, DOI 10.1038/363170a0; LEVERVE XM, 1987, FEBS LETT, V219, P455, DOI 10.1016/0014-5793(87)80271-5; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; MEIJER AJ, 1993, EUR J BIOCHEM, V215, P449, DOI 10.1111/j.1432-1033.1993.tb18053.x; MEIJER AJ, 1985, EUR J BIOCHEM, V148, P189, DOI 10.1111/j.1432-1033.1985.tb08824.x; MIOTTO G, 1992, J BIOL CHEM, V267, P22066; MORLEY SJ, 1993, BIOCHIMIE, V75, P985, DOI 10.1016/0300-9084(93)90149-M; MORLEY SJ, 1990, J BIOL CHEM, V265, P10611; MORTIMORE GE, 1989, DIABETES METAB REV, V5, P49, DOI 10.1002/dmr.5610050105; MORTIMORE GE, 1987, J BIOL CHEM, V262, P16322; MORTIMORE GE, 1994, BIOCHEM BIOPH RES CO, V203, P200, DOI 10.1006/bbrc.1994.2168; PALEN E, 1987, J BIOL CHEM, V262, P3518; POLI A, 1981, J CELL SCI, V48, P1; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; SCHWORER CM, 1979, P NATL ACAD SCI USA, V76, P3169, DOI 10.1073/pnas.76.7.3169; SEGLEN PO, 1984, J CELL BIOL, V99, P435, DOI 10.1083/jcb.99.2.435; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; TEWS JK, 1974, BIOCHEM PHARMACOL, V23, P1777, DOI 10.1016/0006-2952(74)90404-3; THOMAS G, 1993, BIOCHEM SOC T, V21, P901, DOI 10.1042/bst0210901; WETTENHALL REH, 1982, FEBS LETT, V148, P207, DOI 10.1016/0014-5793(82)80809-0; WOOL IG, 1979, ANNU REV BIOCHEM, V48, P719, DOI 10.1146/annurev.bi.48.070179.003443	39	542	554	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2320	2326		10.1074/jbc.270.5.2320	http://dx.doi.org/10.1074/jbc.270.5.2320			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836465	hybrid			2022-12-27	WOS:A1995QE49300053
J	GARCIA, CK; BROWN, MS; PATHAK, RK; GOLDSTEIN, JL				GARCIA, CK; BROWN, MS; PATHAK, RK; GOLDSTEIN, JL			CDNA CLONING OF MCT2, A 2ND MONOCARBOXYLATE TRANSPORTER EXPRESSED IN DIFFERENT CELLS THAN MCT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTATE; PROTEIN; MEVALONATE; NEPHRON	Low stringency screening of a cDNA library from hamster liver yielded a cDNA encoding MCT2, a monocarboxylate transporter that is 60% identical to hamster MCT1, the first monocarboxylate transporter to be isolated, The functional properties of the two MCTs were compared by expression in Sf9 insect cells using recombinant baculovirus vectors, Like MCT1, MCT2 transported pyruvate and lactate, The two transporters were sensitive to inhibition by phloretin and by alpha-cyano-4-hydroxycinnamate, MCT1, but not MCT2, was sensitive to organomercurial thiol reagents such as p-chloromercuribenzoic acid, Immunoblotting and immunofluorescence studies revealed a strikingly different tissue distribution of the two MCTs, MCT1 was present in erythrocytes and on the basolateral surfaces of intestinal epithelial cells, MCT2 was not detectable in these tissues, but it was abundant on the surface of hepatocytes, In the stomach, MCT1 was present on the basolateral surfaces of epithelial cells; in contrast, MCT2 was expressed on parietal cells of the oxyntic gland, In the kidney, MCT1 was present on the basolateral surfaces of epithelial cells in proximal tubules, whereas MCT2 was restricted to the collecting ducts. MCT1 was expressed on sperm heads in the testis and proximal epididymis, In the distal epididymis, it disappeared from sperm and appeared on the microvillar surface of the lining epithelium. In contrast, MCT2 was present on sperm tails throughout the epididymis and not on the epithelium. Both transporters were expressed in mitochondria-rich (oxidative) skeletal muscle fibers and cardiac myocytes, These findings suggest that MCT1 and MCT2 are adapted to play different roles in monocarboxylate transport in different cells of the body.	UNIV TEXAS,SW MED CTR,DEPT CELL BIOL,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	GARCIA, CK (corresponding author), UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007062] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 08014, GM 07062] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAGNASCO S, 1985, AM J PHYSIOL, V248, pF522, DOI 10.1152/ajprenal.1985.248.4.F522; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; EDLUND GL, 1988, BIOCHEM J, V249, P117, DOI 10.1042/bj2490117; FAUST J, 1987, J BIOL CHEM, V262, P1996; GARCIA CK, 1994, CELL, V76, P865, DOI 10.1016/0092-8674(94)90361-1; GROEBE DR, 1990, NUCLEIC ACIDS RES, V18, P4033, DOI 10.1093/nar/18.13.4033; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HINTZ M, 1977, DEV BIOL, V57, P375, DOI 10.1016/0012-1606(77)90222-6; KIM CM, 1992, J BIOL CHEM, V267, P23113; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; PATHAK RK, 1990, J CELL BIOL, V111, P347, DOI 10.1083/jcb.111.2.347; POOLE RC, 1993, AM J PHYSIOL, V264, pC761, DOI 10.1152/ajpcell.1993.264.4.C761; Sambrook J, 1989, MOL CLONING LABORATO; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; UCHIDA S, 1988, AM J PHYSIOL, V255, pF977, DOI 10.1152/ajprenal.1988.255.5.F977	17	275	285	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1843	1849		10.1074/jbc.270.4.1843	http://dx.doi.org/10.1074/jbc.270.4.1843			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829520	hybrid			2022-12-27	WOS:A1995QD20400055
J	KIM, J; KLOOSTER, S; SHAPIRO, DJ				KIM, J; KLOOSTER, S; SHAPIRO, DJ			INTRINSICALLY BENT DNA IN A EUKARYOTIC TRANSCRIPTION FACTOR RECOGNITION SEQUENCE POTENTIATES TRANSCRIPTION ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC RECOMBINATION; RNA-POLYMERASE; ESCHERICHIA-COLI; RESPONSE ELEMENT; KINETOPLAST DNA; PROTEIN; PROMOTER; INVITRO; BINDING; GENE	Many eukaryotic transcription factors induce DNA bending on binding to their recognition sequences. DNA bending could play a structural role by altering contacts between the protein and DNA. Alternatively, DNA bending could play a more direct role in transcription activation. To distinguish between these possibilities, we inserted two to eight copies of the intrinsic bending sequence, AAAAAACGTG, into a minimal promoter containing only a TATA box. The intrinsic DNA bending sequence was a potent activator of transcription in both in vivo transfection experiments and in a cell-free transcription system. A protein binds to the intrinsic bending sequence with high specificity in gel mobility shift assays and was required for its transcription in cell-free extracts, The intercalator, distamycin, which eliminates the ability of the sequence to bend, specifically reduced its transcription by about 60%. Mutations in the sequence which abolished DNA bending reduced transcription by approximately 70% in vivo. Competition gel mobility shift assays showed that the transcription factor bound equally well to mutants in which DNA bending was abolished and to the intrinsic bending sequence. These data indicate that DNA bending can play a direct role in the activation of eukaryotic transcription.	UNIV ILLINOIS,DEPT BIOCHEM,URBANA,IL 61801	University of Illinois System; University of Illinois Urbana-Champaign					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016720] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-16720] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADAMS CC, 1993, CELL, V72, P305, DOI 10.1016/0092-8674(93)90109-4; BAZETTJONES DP, 1994, SCIENCE, V264, P1134, DOI 10.1126/science.8178172; BRACCO L, 1989, EMBO J, V8, P4289, DOI 10.1002/j.1460-2075.1989.tb08615.x; BURKHOFF AM, 1987, CELL, V48, P935, DOI 10.1016/0092-8674(87)90702-1; CHANG TC, 1990, J BIOL CHEM, V265, P8176; CHANG TC, 1992, MOL ENDOCRINOL, V6, P346, DOI 10.1210/me.6.3.346; CHURCHILL MEA, 1989, EMBO J, V8, P4189, DOI 10.1002/j.1460-2075.1989.tb08604.x; CROTHERS DM, 1990, J BIOL CHEM, V265, P7093; DOBBELING U, 1988, EMBO J, V7, P2495, DOI 10.1002/j.1460-2075.1988.tb03096.x; DU W, 1993, CELL, V74, P887, DOI 10.1016/0092-8674(93)90468-6; FISHER DE, 1992, P NATL ACAD SCI USA, V89, P11779, DOI 10.1073/pnas.89.24.11779; GARTENBERG MR, 1991, J MOL BIOL, V219, P217, DOI 10.1016/0022-2836(91)90563-L; GARTENBERG MR, 1988, NATURE, V333, P824, DOI 10.1038/333824a0; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GOODMAN SD, 1989, NATURE, V341, P251, DOI 10.1038/341251a0; GOODMAN SD, 1992, P NATL ACAD SCI USA, V89, P11910, DOI 10.1073/pnas.89.24.11910; GRIFFITH J, 1986, CELL, V46, P717, DOI 10.1016/0092-8674(86)90347-8; HAHN S, 1993, CELL, V72, P481, DOI 10.1016/0092-8674(93)90064-W; HORIKOSHI M, 1992, P NATL ACAD SCI USA, V89, P1060, DOI 10.1073/pnas.89.3.1060; HOROWITZ DS, 1984, J MOL BIOL, V173, P75, DOI 10.1016/0022-2836(84)90404-2; KERPPOLA TK, 1991, CELL, V66, P317, DOI 10.1016/0092-8674(91)90621-5; KING IN, 1993, J BIOL CHEM, V268, P495; KING IN, J BIOL CHEM, V268, P495; KOO HS, 1986, NATURE, V320, P501, DOI 10.1038/320501a0; KOO HS, 1990, BIOCHEMISTRY-US, V29, P4227, DOI 10.1021/bi00469a027; LEIDIG F, 1992, J BIOL CHEM, V267, P913; LIN YS, 1991, CELL, V64, P971, DOI 10.1016/0092-8674(91)90321-O; LU XP, 1993, MOL CELL BIOL, V13, P6509, DOI 10.1128/MCB.13.10.6509; LUE NF, 1989, P NATL ACAD SCI USA, V86, P486, DOI 10.1073/pnas.86.2.486; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979; MARINI JC, 1982, P NATL ACAD SCI-BIOL, V79, P7664, DOI 10.1073/pnas.79.24.7664; MCALLISTER CF, 1989, J BIOL CHEM, V264, P10451; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; NARDULLI AM, 1993, MOL ENDOCRINOL, V7, P331, DOI 10.1210/me.7.3.331; NARDULLI AM, 1992, MOL CELL BIOL, V12, P2037, DOI 10.1128/MCB.12.5.2037; NATESAN S, 1993, GENE DEV, V7, P2497, DOI 10.1101/gad.7.12b.2497; NIELSEN DA, 1989, ANAL BIOCHEM, V179, P19, DOI 10.1016/0003-2697(89)90193-0; ONATE SA, 1994, MOL CELL BIOL, V14, P3376, DOI 10.1128/MCB.14.5.3376; PAOLELLA DN, 1994, SCIENCE, V264, P1130, DOI 10.1126/science.8178171; PEREZMARTIN J, 1993, SCIENCE, V260, P805, DOI 10.1126/science.8387228; PRENTKI P, 1987, NUCLEIC ACIDS RES, V15, P10060, DOI 10.1093/nar/15.23.10060; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; ROBERTSON CA, 1988, J BIOL CHEM, V263, P3554; ROJO F, 1991, EMBO J, V10, P3429, DOI 10.1002/j.1460-2075.1991.tb04907.x; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; SABBAH M, 1992, BIOCHEM BIOPH RES CO, V185, P944, DOI 10.1016/0006-291X(92)91718-6; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; SCHROTH GP, 1992, J BIOL CHEM, V267, P9958; SHAPIRO DJ, 1988, DNA CELL BIOL, V7, P44; SHATZKYSCHWARTZ M, 1992, BIOCHEMISTRY-US, V31, P2339, DOI 10.1021/bi00123a019; STRUHL K, 1994, SCIENCE, V263, P1103, DOI 10.1126/science.8108728; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; VANDERVLIET PC, 1993, BIOESSAYS, V15, P25, DOI 10.1002/bies.950150105; WESCHLER DS, 1992, P NATL ACAD SCI USA, V89, P7635; WOLFFE AP, 1994, SCIENCE, V264, P1100, DOI 10.1126/science.8178167; WONG YC, 1985, CHROMOSOMA, V92, P124, DOI 10.1007/BF00328464; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; ZAHN K, 1987, SCIENCE, V236, P416, DOI 10.1126/science.2951850; ZINKEL SS, 1987, NATURE, V328, P178, DOI 10.1038/328178a0; ZINKEL SS, 1991, J MOL BIOL, V219, P201, DOI 10.1016/0022-2836(91)90562-K	60	52	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1282	1288		10.1074/jbc.270.3.1282	http://dx.doi.org/10.1074/jbc.270.3.1282			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836392	hybrid			2022-12-27	WOS:A1995QB15600047
J	MATTINGLY, JR; IRIARTE, A; MARTINEZCARRION, M				MATTINGLY, JR; IRIARTE, A; MARTINEZCARRION, M			HOMOLOGOUS PROTEINS WITH DIFFERENT AFFINITIES FOR GROEL - THE REFOLDING OF THE ASPARTATE-AMINOTRANSFERASE ISOZYMES AT VARYING TEMPERATURES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; MITOCHONDRIAL MALATE-DEHYDROGENASE; ESCHERICHIA-COLI; MOLECULAR CHAPERONE; DIHYDROFOLATE-REDUCTASE; POLYPEPTIDE; COMPLEX; PRECURSOR; INVITRO; CELL	The homologous cytosolic and mitochondrial isozymes of aspartate aminotransferase (c- and mAspAT, respectively) seem to follow very different folding pathways after synthesis in rabbit reticulocyte lysate, suggesting that the nascent proteins interact differently with molecular chaperones (Mattingly, J. R., Jr., Iriarte, A., and Martinez-Carrion, M. (1993) J. Biol. Chem. 268, 26320-26327). In an attempt to discern the structural basis for this phenomenon, we have begun to study the effect of temperature on the refolding of the guanidine hydrochloride-denatured, purified proteins and their interaction with the groEL/groES molecular chaperone system for Escherichia coli. In the absence of chaperones, temperature has a critical effect on the refolding of the two isozymes, with mAspAT being more susceptible than cAspAT to diminishing refolding yields at increasing temperatures. No refolding is observed for mAspAT at physiological temperatures. The molecular chaperons groEL and groES can extend the temperature range over which the AspAT isozymes successfully refold; however, cAspAT can still refold at higher temperatures than mAspAT. In the absence of groES and MgATP, the two isozymes interact differently with groEL. groEL arrests the refolding of mAspAT throughout the temperature range of 0-45 degrees C. Adding only MgATP releases very little mAspAT from groEL; both groES and MgATP are required for significant refolding of mAspAT in the presence of groEL. On the other hand, the extent to which groEL inhibits the refolding of cAspAT depends upon the temperature of the refolding reaction, only slowing the reaction at 0 degrees C but arresting it completely at 30 degrees C. MgATP alone is sufficient to effect the release of cAspAT from groEL at any temperature examined; inclusion of groES along with MgATP has no effect on the refolding yield bu does increase the refolding rate at temperatures greater than 15 degrees C. These results demonstrate that groEL can have significantly different affinities for proteins highly homologous final tertiary and quarternary structures and suggest that dissimilarities in the primary sequence of the protein substrates may control the structure of the folding intermediates captured by groEL and/or the composition of the surfaces through which the folding proteins interact with groEL.	UNIV MISSOURI, SCH BIOL SCI, DIV MOLEC BIOL & BIOCHEM, KANSAS CITY, MO 64110 USA	University of Missouri System; University of Missouri Kansas City					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038341] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-38412] Funding Source: Medline; NIGMS NIH HHS [GM-38341] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDROV N, 1993, PROTEIN SCI, V2, P1989, DOI 10.1002/pro.5560021121; BADCOE IG, 1991, BIOCHEMISTRY-US, V30, P9195, DOI 10.1021/bi00102a010; BECKER J, 1994, EUR J BIOCHEM, V219, P11, DOI 10.1111/j.1432-1033.1994.tb19910.x; BRAIG K, 1993, P NATL ACAD SCI USA, V90, P3978, DOI 10.1073/pnas.90.9.3978; BRUNSCHIER R, 1993, J BIOL CHEM, V268, P2767; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; BUCHWALDER A, 1992, BIOCHEMISTRY-US, V31, P1621, DOI 10.1021/bi00121a006; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; FISHER MT, 1994, J BIOL CHEM, V269, P13629; FISHER MT, 1992, BIOCHEMISTRY-US, V31, P3955, DOI 10.1021/bi00131a010; FRYDMAN J, 1992, EMBO J, V11, P4767, DOI 10.1002/j.1460-2075.1992.tb05582.x; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; GRAY TE, 1993, J MOL BIOL, V232, P1197, DOI 10.1006/jmbi.1993.1471; GUPTA RS, 1990, BIOCHEM INT, V20, P833; HANSEN JE, 1994, J BIOL CHEM, V269, P6286; HANSEN JE, 1993, J BIOL CHEM, V268, P21632; HARTMAN DJ, 1993, P NATL ACAD SCI USA, V90, P2276, DOI 10.1073/pnas.90.6.2276; HARTMANN C, 1991, NATURE, V352, P762, DOI 10.1038/352762b0; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HORWICH AL, 1993, PHILOS T R SOC B, V339, P313, DOI 10.1098/rstb.1993.0030; HUYNH QK, 1980, J BIOCHEM, V88, P231; IRIARTE A, 1984, CHEM BIOL ASPECTS B, P107; JACKSON GS, 1993, BIOCHEMISTRY-US, V32, P2554, DOI 10.1021/bi00061a013; Jansonius J.N., 1987, BIOL MACROMOLECULES, P187; KUBO T, 1993, J BIOL CHEM, V268, P19346; LAIN B, 1994, J BIOL CHEM, V269, P15588; LAMINET AA, 1990, EMBO J, V9, P2315, DOI 10.1002/j.1460-2075.1990.tb07403.x; LANDRY SJ, 1991, BIOCHEMISTRY-US, V30, P7359, DOI 10.1021/bi00244a001; LANDRY SJ, 1992, NATURE, V355, P455, DOI 10.1038/355455a0; LEWIS VA, 1992, NATURE, V358, P249, DOI 10.1038/358249a0; LORIMER GH, 1993, PHILOS T R SOC B, V339, P297, DOI 10.1098/rstb.1993.0028; LUBBEN TH, 1990, P NATL ACAD SCI USA, V87, P7683, DOI 10.1073/pnas.87.19.7683; LUGER K, 1989, SCIENCE, V243, P206, DOI 10.1126/science.2643160; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MARTIN J, 1993, NATURE, V366, P228, DOI 10.1038/366228a0; MATTINGLY JR, 1993, J BIOL CHEM, V268, P3925; MATTINGLY JR, 1993, J BIOL CHEM, V268, P26320; MENDOZA JA, 1992, J PROTEIN CHEM, V11, P589, DOI 10.1007/BF01024958; MENDOZA JA, 1991, J BIOL CHEM, V266, P13044; MILLER AD, 1993, BIOCHEM J, V291, P139, DOI 10.1042/bj2910139; MIZOBATA T, 1992, J BIOL CHEM, V267, P17773; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; PARSELL DA, 1994, J BIOL CHEM, V269, P4480; PERALTA D, 1994, FEBS LETT, V339, P45, DOI 10.1016/0014-5793(94)80381-1; REYES AM, 1993, J BIOL CHEM, V268, P22281; RICHARME G, 1994, J BIOL CHEM, V269, P7095; ROSPERT S, 1993, P NATL ACAD SCI USA, V90, P10967, DOI 10.1073/pnas.90.23.10967; SCHMIDT M, 1994, J BIOL CHEM, V269, P10304; SCHMIDT M, 1992, J BIOL CHEM, V267, P16829; SHEFFIELD WP, 1990, J BIOL CHEM, V265, P11069; STUART RA, 1994, TRENDS BIOCHEM SCI, V19, P87, DOI 10.1016/0968-0004(94)90041-8; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; VIITANEN PV, 1991, BIOCHEMISTRY-US, V30, P9716, DOI 10.1021/bi00104a021; WANG Z, 1992, PROTEIN SCI, V1, P522; YANG YR, 1993, P NATL ACAD SCI USA, V90, P11980, DOI 10.1073/pnas.90.24.11980; ZHANG T, 1993, BIOCHEMISTRY-US, V32, P12311, DOI 10.1021/bi00097a006; ZHENG XX, 1993, J BIOL CHEM, V268, P7489	59	36	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1138	1148		10.1074/jbc.270.3.1138	http://dx.doi.org/10.1074/jbc.270.3.1138			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836372	hybrid			2022-12-27	WOS:A1995QB15600027
J	PAP, EHW; VANDENBERG, PAW; BORST, JW; VISSER, AJWG				PAP, EHW; VANDENBERG, PAW; BORST, JW; VISSER, AJWG			THE INTERACTION BETWEEN PROTEIN-KINASE-C AND LIPID COFACTORS STUDIED BY SIMULTANEOUS OBSERVATION OF LIPID AND PROTEIN FLUORESCENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER BINDING; MIXED MICELLES; RAT-BRAIN; PHOSPHOLIPID-VESICLES; SIGNAL TRANSDUCTION; HYDROPHOBIC REGION; LATERAL DIFFUSION; ENERGY-TRANSFER; ACTIVATION; DIACYLGLYCEROL	The interaction of protein kinase C (PKC) with lipids was probed by a dual approach. Pyrene-labeled lipid analogues of diacylglycerol, phosphatidylserine (PS), phosphatidylinositol (PI), phosphatidylinositol 4-phosphate (PIP), and phosphatidylcholine (PC) were used both as accepters of tryptophan excitation energy of PKC and as membrane probes for intra- and intermolecular lipid chain collisions by measuring the ratio of excimer-to-monomer fluorescence intensity (EM). Both in micelles of polyoxyethylene 9-lauryl ether and in dioleoyl-PC vesicles, interaction of PKC with monopyrenyl PS (pyr-PS) in the absence of calcium resulted in a relatively slow decrease of the EM value. This effect on the lipid dynamics was accompanied by quenching of the tryptophan fluorescence of PKC. Addition of calcium resulted in a rapid further decrease of the EM ratio of pyr-PS and in additional quenching of the tryptophan fluorescence. When 4 mol % of pyr-PS was replaced by 0.5 mol % of dipyrenyl-labeled diacylglycerol a decrease of the intramolecular excimer formation rate and tryptophan fluorescence could only be detected in the presence of calcium and PS. Strong binding was also observed with dipyrenyl-labeled PIP (dipyr-PIP), but not with the other dipyrenyl-labeled lipids: PI, PS, or PC. In addition, the EM ratios of dipyr-PIP were not affected by phorbol 12-myristate 13-acetate, indicating that phorbol 12-myristate 13-acetate and dipyr-PIP can bind simultaneously to PKC.	AGR UNIV WAGENINGEN, DEPT BIOCHEM, 6703 HA WAGENINGEN, NETHERLANDS	Wageningen University & Research			Borst, Jan Willem/B-1259-2011					BANNO Y, 1992, J BIOL CHEM, V267, P6488; BASTIAENS PIH, 1993, BIOPHYS CHEM, V48, P183, DOI 10.1016/0301-4622(93)85009-7; BAZZI MD, 1991, BIOCHEMISTRY-US, V30, P7961, DOI 10.1021/bi00246a013; BAZZI MD, 1987, BIOCHEMISTRY-US, V26, P115, DOI 10.1021/bi00375a017; BAZZI MD, 1990, BIOCHEMISTRY-US, V29, P7624, DOI 10.1021/bi00485a012; BAZZI MD, 1989, BIOCHEMISTRY-US, V28, P3577, DOI 10.1021/bi00434a064; BAZZI MD, 1988, BIOCHEMISTRY-US, V27, P7589, DOI 10.1021/bi00420a003; BAZZI MD, 1991, BIOCHEMISTRY-US, V30, P971, DOI 10.1021/bi00218a013; BELL RM, 1986, CELL, V45, P631, DOI 10.1016/0092-8674(86)90774-9; BONI LT, 1985, J BIOL CHEM, V260, P819; BROCKERHOFF H, 1986, FEBS LETT, V201, P1, DOI 10.1016/0014-5793(86)80559-2; BRUMFELD V, 1990, ARCH BIOCHEM BIOPHYS, V277, P318, DOI 10.1016/0003-9861(90)90586-N; BURNS DJ, 1991, J BIOL CHEM, V266, P18330; BURNS DJ, 1990, J BIOL CHEM, V265, P12044; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; CHAUHAN A, 1989, BIOCHEMISTRY-US, V28, P4952, DOI 10.1021/bi00438a007; COMFURIUS P, 1990, J LIPID RES, V31, P1719; EPAND RM, 1992, EUR J BIOCHEM, V208, P327, DOI 10.1111/j.1432-1033.1992.tb17190.x; FORSTER T, 1955, Z ELEKTROCHEM, V59, P976; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; GALLA HJ, 1974, BIOCHIM BIOPHYS ACTA, V339, P103, DOI 10.1016/0005-2736(74)90336-8; GANONG BR, 1986, P NATL ACAD SCI USA, V83, P1184, DOI 10.1073/pnas.83.5.1184; GSCHWENDT M, 1991, TRENDS BIOCHEM SCI, V16, P167, DOI 10.1016/0968-0004(91)90064-3; HANNUN YA, 1985, J BIOL CHEM, V260, P39; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HUANG KP, 1986, J BIOL CHEM, V261, P4781; HUANG KP, 1988, J BIOL CHEM, V263, P14839; KAIBUCHI K, 1981, J BIOL CHEM, V256, P7146; KREMER JMH, 1977, BIOCHEMISTRY-US, V16, P3932, DOI 10.1021/bi00636a033; LEE MH, 1989, J BIOL CHEM, V264, P14797; LESTER DS, 1990, BIOCHIM BIOPHYS ACTA, V1039, P33, DOI 10.1016/0167-4838(90)90223-3; MAKOWSKE M, 1989, J BIOL CHEM, V264, P16155; MOSIOR M, 1991, BIOPHYS J, V60, P149, DOI 10.1016/S0006-3495(91)82038-0; MYHER JJ, 1984, CAN J BIOCHEM CELL B, V62, P352, DOI 10.1139/o84-049; NEWTON AC, 1993, ANNU REV BIOPH BIOM, V22, P1, DOI 10.1146/annurev.bb.22.060193.000245; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; NISHIZUKA Y, 1989, JAMA-J AM MED ASSOC, V262, P1826, DOI 10.1001/jama.262.13.1826; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; ORR JW, 1992, J BIOL CHEM, V267, P15263; ORR JW, 1992, BIOCHEMISTRY-US, V31, P4667, DOI 10.1021/bi00134a019; ORR JW, 1992, BIOCHEMISTRY-US, V31, P4661, DOI 10.1021/bi00134a018; PAP EHW, 1993, BIOCHEMISTRY-US, V32, P13310, DOI 10.1021/bi00211a044; PATEL KM, 1979, J LIPID RES, V20, P674; RANDO RR, 1984, BIOCHEM BIOPH RES CO, V122, P818, DOI 10.1016/S0006-291X(84)80107-2; SASSAROLI M, 1990, BIOPHYS J, V57, P281, DOI 10.1016/S0006-3495(90)82530-3; SEELIG J, 1990, CELL BIOL INT REP, V14, P353, DOI 10.1016/0309-1651(90)91204-H; SEKIGUCHI K, 1988, J BIOCHEM-TOKYO, V103, P759, DOI 10.1093/oxfordjournals.jbchem.a122343; SHAH J, 1992, BIOCHIM BIOPHYS ACTA, V1119, P19, DOI 10.1016/0167-4838(92)90228-6; SNOEK GT, 1988, BIOCHEM J, V255, P629; SOUVIGNET C, 1991, J BIOL CHEM, V266, P40; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; TAKAI Y, 1979, BIOCHEM BIOPH RES CO, V91, P1218, DOI 10.1016/0006-291X(79)91197-5; TRUDELL JR, 1989, BIOCHEM BIOPH RES CO, V162, P45, DOI 10.1016/0006-291X(89)91959-1; VANDERKOOI JM, 1974, BIOCHEMISTRY-US, V13, P4000, DOI 10.1021/bi00716a028; WALLACH DFH, 1974, EVOLVING STRATEGIES, P74; ZIDOVETZKI R, 1992, BIOCHIM BIOPHYS ACTA, V1134, P261, DOI 10.1016/0167-4889(92)90185-E	56	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1254	1260		10.1074/jbc.270.3.1254	http://dx.doi.org/10.1074/jbc.270.3.1254			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836388	hybrid			2022-12-27	WOS:A1995QB15600043
J	RICCI, G; LOBELLO, M; CACCURI, AM; PASTORE, A; NUCCETELLI, M; PARKER, MW; FEDERICI, G				RICCI, G; LOBELLO, M; CACCURI, AM; PASTORE, A; NUCCETELLI, M; PARKER, MW; FEDERICI, G			SITE-DIRECTED MUTAGENESIS OF HUMAN GLUTATHIONE TRANSFERASE P1-1 - MUTATION OF CYS-47 INDUCES A POSITIVE COOPERATIVITY IN GLUTATHIONE TRANSFERASE P1-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BI-BI MECHANISM; S-TRANSFERASE; 3-DIMENSIONAL STRUCTURE; HUMAN-PLACENTA; ASPARTATE-TRANSCARBAMYLASE; BINDING-PROPERTIES; ACTIVE-SITE; PI; RESOLUTION; RESIDUES	Glutathione transferase P1-1 (EC 2.5.1.18) is a dimeric enzyme composed of identical subunits each containing one binding site for GSH and a second for the co-substrate e.g. 1-chloro-2,4-dinitrobenzene. Steady-state kinetics are strictly hyperbolic toward both these substrates, Replacement of Cys-47 with alanine or serine decreases the affinity for GSH and triggers a positive kinetic cooperativity with respect to this substrate. Hill coefficients were 1.31 and 1.43 for the C47A and C47S mutants, C47A/C101A and C47S/C101S double mutants display lower affinity for GSH and higher sill coefficients (1.57 and 1.56, respectively) when compared with C47A and C47S single mutants, Conversely, replacement of Cys-101 with alanine or serine does not yield any cooperativity and any marked change of kinetic parameters, Fluorometric experiments gave sigmoidal isothermic GSH binding curves for all the Cys-47 mutants, with Hill coefficients similar to that obtained by the kinetic approach, These data, together with the activation experiments performed in the presence of S-hexylglutathione, suggest that the substitution of Cys-47 yields a dimeric low-affinity enzyme which can be converted to a higher affinity state upon binding of GSH on one sub unit. These findings indicate a structural communication between subunits which may be revealed by the lack of a peculiar electrostatic bond between the thiolate form of Cys-47 and the protonated amino group of Lys-54.	ST VINCENTS INST MED RES,FITZROY,VIC 3065,AUSTRALIA	St. Vincent's Institute of Medical Research	RICCI, G (corresponding author), UNIV ROMA TOR VERGATA,DEPT BIOL,VIALE RIC SCI,I-00133 ROME,ITALY.		CACCURI, ANNA MARIA/AFU-2643-2022; Pastore, Anna/J-8409-2014; Parker, Michael W/F-9069-2013	Pastore, Anna/0000-0002-0990-9419; Parker, Michael W/0000-0002-3101-1138; Ricci, Giorgio/0000-0002-7108-2846; CACCURI, ANNA MARIA/0000-0002-3756-4163				ARMSTRONG RN, 1991, CHEM RES TOXICOL, V4, P131, DOI 10.1021/tx00020a001; CACCURI AM, 1991, ITAL J BIOCHEM, V40, P304; COLLINS KD, 1971, J BIOL CHEM, V246, P6599; DANIELSON UH, 1985, BIOCHEM J, V231, P263, DOI 10.1042/bj2310263; DELBOCCIO G, 1991, J BIOL CHEM, V266, P13777; FIRST EA, 1993, BIOCHEMISTRY-US, V32, P13651, DOI 10.1021/bi00212a033; HABIG WH, 1981, METHOD ENZYMOL, V77, P898; IVANETICH KM, 1990, BIOCHEM PHARMACOL, V39, P1999, DOI 10.1016/0006-2952(90)90621-Q; IVANETICH KM, 1989, BIOCHIM BIOPHYS ACTA, V998, P7, DOI 10.1016/0167-4838(89)90111-8; JAKOBSON I, 1979, J BIOL CHEM, V254, P7085; Jakoby W B, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P383; JAKOBY WB, 1984, BIOCHEM PHARMACOL, V33, P2539, DOI 10.1016/0006-2952(84)90621-X; JI XH, 1992, BIOCHEMISTRY-US, V31, P10169, DOI 10.1021/bi00157a004; KONG KH, 1991, BIOCHEM BIOPH RES CO, V181, P748, DOI 10.1016/0006-291X(91)91254-A; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; KUO LC, 1989, SCIENCE, V245, P522, DOI 10.1126/science.2667139; LOBELLO M, 1993, BIOCHEM BIOPH RES CO, V194, P804, DOI 10.1006/bbrc.1993.1893; LOBELLO M, 1993, J BIOL CHEM, V268, P19033; LOBELLO M, 1995, J BIOL CHEM, V270, P1249; MANNERVIK B, 1985, P NATL ACAD SCI USA, V82, P7202, DOI 10.1073/pnas.82.21.7202; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Mannervik B, 1985, Adv Enzymol Relat Areas Mol Biol, V57, P357; MEYER DJ, 1991, BIOCHEM J, V274, P409, DOI 10.1042/bj2740409; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; PICKETT CB, 1989, ANNU REV BIOCHEM, V58, P743, DOI 10.1146/annurev.bi.58.070189.003523; REINEMER P, 1992, J MOL BIOL, V227, P214, DOI 10.1016/0022-2836(92)90692-D; REINEMER P, 1991, EMBO J, V10, P1997, DOI 10.1002/j.1460-2075.1991.tb07729.x; RICCI G, 1991, J BIOL CHEM, V266, P21409; RICCI G, 1989, J BIOL CHEM, V264, P5462; SCHRAMM VL, 1984, J BIOL CHEM, V259, P714; SCRUTTON NS, 1992, SCIENCE, V258, P1140, DOI 10.1126/science.1439821; Segel IH, 1975, ENZYME KINETICS, P460; SINNING I, 1993, J MOL BIOL, V232, P192, DOI 10.1006/jmbi.1993.1376; STEBBINS JW, 1989, BIOCHEMISTRY-US, V28, P2592, DOI 10.1021/bi00432a037; STEBBINS JW, 1992, BIOCHEMISTRY-US, V31, P2328, DOI 10.1021/bi00123a017; TAMAI K, 1991, BIOCHEM BIOPH RES CO, V179, P790, DOI 10.1016/0006-291X(91)91886-H; VANDERJAGT DL, 1981, FEBS LETT, V136, P319, DOI 10.1016/0014-5793(81)80644-8	37	89	90	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1243	1248		10.1074/jbc.270.3.1243	http://dx.doi.org/10.1074/jbc.270.3.1243			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836386	hybrid			2022-12-27	WOS:A1995QB15600041
J	ALTIERI, DC; DUPERRAY, A; PLESCIA, J; THORNTON, GB; LANGUINO, LR				ALTIERI, DC; DUPERRAY, A; PLESCIA, J; THORNTON, GB; LANGUINO, LR			STRUCTURAL RECOGNITION OF A NOVEL FIBRINOGEN GAMMA-CHAIN SEQUENCE(117-133) BY INTERCELLULAR-ADHESION MOLECULE-1 MEDIATES LEUKOCYTE-ENDOTHELIUM INTERACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; ALPHA-CHAIN; ACTIVATION; LIGAND; DOMAIN	In addition to its role in hemostasis, fibrinogen is obligatorily required to mount competent inflammatory responses in vivo. A molecular prerequisite of fibrinogen-dependent inflammation may reside in its ability to associate with intercellular adhesion molecule-1 (ICAM-1), and enhance monocyte adhesion to endothelium by bridging the two cell types. Structure-function characterization of the novel ICAM-1 recognition of fibrinogen was carried out by synthetic peptidyl mimicry of the fibrinogen gamma chain, A novel peptide sequence, N(117)NQKIVNLKEKVAQLEA(133), designated gamma 3, dose-dependently inhibited (IC50 similar to 20-40 mu g/ml) binding of I-125 fibrinogen to endothelial cells or ICAM-1-expressing B lymphoblastoid Daudi cells. In contrast, none of the previously identified vascular cell fibrinogen interacting sequences was effective. Increasing concentrations of gamma 3 completely inhibited fibrinogen-mediated adhesion of peripheral blood mononuclear cells or vitamin D-3-differentiated monocytic HL-60 cells to endothelium, but did not affect leukocyte-endothelium interaction in the absence of fibrinogen, I-125-Labeled gamma 3 bound specifically and saturably to genetically engineered ICAM-1 transfectants, but not to control non-transfected cells, and associated with ICAM-1 on cytokine-activated endothelium with a K-d of 34 mu M. Consistent with functional recognition of ICAM-1, immobilized gamma 3 supported adhesion of JY lymphoblasts in a dose-dependent reaction inhibited by monoclonal antibodies to ICAM-1. We conclude that a novel fibrinogen gamma 3 sequence N(117)NQKIVNLKEKVAQLEA(133) binds to ICAM-1 and modulates ICAM-1-dependent adhesion. These findings define the structural basis of fibrinogen:ICAM-1 recognition and provide a potential selective target for inhibiting fibrinogen-dependent inflammatory responses.	RW JOHNSON PHARMACEUT RES INST,SAN DIEGO,CA 92121	Johnson & Johnson; Johnson & Johnson USA	ALTIERI, DC (corresponding author), YALE UNIV,SCH MED,BOYER CTR MOLEC MED,DEPT PATHOL,295 CONGRESS AVE,NEW HAVEN,CT 06536, USA.		Duperray, Alain/E-8428-2012	Duperray, Alain/0000-0002-2719-252X; Languino, Lucia/0000-0001-9011-7031; Thornton, George/0000-0002-8744-4987	NHLBI NIH HHS [HL-54131, R01 HL-43773] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054131, R01HL043773, R37HL054131] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTIERI DC, 1993, J BIOL CHEM, V268, P1847; ALTIERI DC, 1993, BLOOD, V81, P569; CARLOS TM, 1990, IMMUNOL REV, V114, P5, DOI 10.1111/j.1600-065X.1990.tb00559.x; CHATTOPADHYAY A, 1989, J BIOL CHEM, V264, P11035; COLLINS SJ, 1987, BLOOD, V70, P1233; COLVIN RB, 1973, J EXP MED, V138, P686, DOI 10.1084/jem.138.3.686; DOOLITTLE RF, 1984, ANNU REV BIOCHEM, V53, P195, DOI 10.1146/annurev.bi.53.070184.001211; FARRELL DH, 1992, P NATL ACAD SCI USA, V89, P10729, DOI 10.1073/pnas.89.22.10729; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; LANGUINO LR, 1993, CELL, V73, P1423, DOI 10.1016/0092-8674(93)90367-Y; LI R, 1993, J BIOL CHEM, V268, P17513; LOIKE JD, 1991, P NATL ACAD SCI USA, V88, P1044, DOI 10.1073/pnas.88.3.1044; MCRITCHIE DI, 1991, J LAB CLIN MED, V118, P48; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NOJIMA Y, 1990, J EXP MED, V172, P1185, DOI 10.1084/jem.172.4.1185; OSBORN L, 1990, CELL, V62, P3, DOI 10.1016/0092-8674(90)90230-C; ROTHLEIN R, 1986, J EXP MED, V163, P1132, DOI 10.1084/jem.163.5.1132; SIMMONS D, 1988, NATURE, V331, P624, DOI 10.1038/331624a0; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147; WU XB, 1994, J CLIN INVEST, V94, P928, DOI 10.1172/JCI117459	21	93	96	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					696	699		10.1074/jbc.270.2.696	http://dx.doi.org/10.1074/jbc.270.2.696			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822297	hybrid			2022-12-27	WOS:A1995QB81600031
J	GUREVICH, VV; DION, SB; ONORATO, JJ; PTASIENSKI, J; KIM, CM; STERNEMARR, R; HOSEY, MM; BENOVIC, JL				GUREVICH, VV; DION, SB; ONORATO, JJ; PTASIENSKI, J; KIM, CM; STERNEMARR, R; HOSEY, MM; BENOVIC, JL			ARRESTIN INTERACTIONS WITH G-PROTEIN-COUPLED RECEPTORS - DIRECT BINDING-STUDIES OF WILD-TYPE AND MUTANT ARRESTINS WITH RHODOPSIN, BETA(2)-ADRENERGIC, AND M2-MUSCARINIC CHOLINERGIC RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; LIGHT-DEPENDENT PHOSPHORYLATION; ROD OUTER SEGMENTS; 48-KDA PROTEIN; PHOTORECEPTOR-MEMBRANES; PHOTOEXCITED RHODOPSIN; BETA-2-ADRENERGIC RECEPTOR; SYNTHETIC PEPTIDES; KINASE ACTIVATION; VISUAL ARRESTIN	Arrestins play an important role in quenching signal transduction initiated by G protein-coupled receptors. To explore the specificity of arrestin-receptor interaction, we have characterized the ability of various wildtype arrestins to bind to rhodopsin, the beta(2)-adrenergic receptor (beta(2)AR), and the m2 muscarinic cholinergic receptor (m2 mAChR), Visual arrestin was found to be the most selective arrestin since it discriminated best between the three different receptors tested (highest binding to rhodopsin) as web as between the phosphorylation and activation state of the receptor (>10-fold higher binding to the phosphorylated Light-activated form of rhodopsin compared to any other form of rhodopsin). While beta-arrestin and arrestin 3 were also found to preferentially bind to the phosphorylated activated form of a given receptor, they only modestly discriminated among the three receptors tested. To explore the structural characteristics important in arrestin function, we constructed a series of truncated and chimeric arrestins. Analysis of the binding characteristics of the various mutant arrestins suggests a common molecular mechanism involved in determining receptor binding selectivity. Structural elements that contribute to arrestin binding include: 1) a C-terminal acidic region that serves a regulatory role in controlling arrestin binding selectivity toward the phosphorylated and activated form of a receptor, without directly participating in receptor interaction; 2) a basic N-terminal domain that directly participates in receptor interaction and appears to serve a regulatory role via intramolecular interaction with the C-terminal acidic region; and 3) two centrally localized domains that are directly involved in determining receptor binding specificity and selectivity. A comparative structure-function model of all arrestins and a kinetic model of beta-arrestin and arrestin 3 interaction with receptors are proposed.	THOMAS JEFFERSON UNIV,JEFFERSON CANC INST,DEPT PHARMACOL,PHILADELPHIA,PA 19107; NORTHWESTERN UNIV,SCH MED,DEPT PHARMACOL,CHICAGO,IL 60611; UNIV WISCONSIN,DEPT MED,MADISON,WI 53792	Jefferson University; Northwestern University; University of Wisconsin System; University of Wisconsin Madison			Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351	NIGMS NIH HHS [GM47417, GM44944, GM47120] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047417, R29GM047120, R01GM047417, R01GM044944] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; BENNETT N, 1988, BIOCHEMISTRY-US, V27, P1710, DOI 10.1021/bi00405a049; BENOVIC JL, 1990, BRIT J CLIN PHARMACO, V30, pS3, DOI 10.1111/j.1365-2125.1990.tb05462.x; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; BOWNDS D, 1972, NATURE-NEW BIOL, V237, P125, DOI 10.1038/newbio237125a0; CHEN CY, 1993, J BIOL CHEM, V268, P7825; CRAFT CM, 1994, J BIOL CHEM, V269, P4613; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; FOWLES C, 1988, FEBS LETT, V238, P56, DOI 10.1016/0014-5793(88)80224-2; FRANKE RR, 1988, J BIOL CHEM, V263, P2119; FRANKE RR, 1990, SCIENCE, V250, P123, DOI 10.1126/science.2218504; FRANKE RR, 1992, J BIOL CHEM, V267, P14767; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; GUREVICH VV, 1993, J BIOL CHEM, V268, P16879; GUREVICH VV, 1994, J BIOL CHEM, V269, P8721; HAGA K, 1994, J BIOL CHEM, V269, P12594; KELLEHER DJ, 1990, J BIOL CHEM, V265, P2632; KIM CM, 1993, RECEPTOR, V3, P39; KRUPNICK JG, 1994, J BIOL CHEM, V269, P3226; KUHN H, 1972, FEBS LETT, V20, P1, DOI 10.1016/0014-5793(72)80002-4; KUHN H, 1984, FEBS LETT, V176, P473, DOI 10.1016/0014-5793(84)81221-1; KUHN H, 1978, BIOCHEMISTRY-US, V17, P4389; KWATRA MM, 1987, J BIOL CHEM, V262, P16314; KWATRA MM, 1989, BIOCHEMISTRY-US, V28, P4543, DOI 10.1021/bi00437a005; LEFKOWITZ RJ, 1982, FED PROC, V41, P2664; LIMBIRD LE, 1978, P NATL ACAD SCI USA, V75, P228, DOI 10.1073/pnas.75.1.228; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; MUNCH G, 1991, EUR J BIOCHEM, V198, P357, DOI 10.1111/j.1432-1033.1991.tb16023.x; MURAKAMI A, 1993, FEBS LETT, V334, P203, DOI 10.1016/0014-5793(93)81712-9; NAKATA H, 1994, EUR J BIOCHEM, V220, P29, DOI 10.1111/j.1432-1033.1994.tb18595.x; ODOWD BF, 1988, J BIOL CHEM, V263, P15985; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; PAPAC DI, 1993, BIOCHEMISTRY-US, V32, P5930, DOI 10.1021/bi00074a002; PARRUTI G, 1993, J BIOL CHEM, V268, P9753; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; RAPOPORT B, 1992, MOL CELL ENDOCRINOL, V84, pR39, DOI 10.1016/0303-7207(92)90038-8; RICHARDSON RM, 1993, J BIOL CHEM, V268, P13650; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; SHICHI H, 1978, J BIOL CHEM, V253, P7040; SHINOHARA T, 1987, P NATL ACAD SCI USA, V84, P6975, DOI 10.1073/pnas.84.20.6975; SMITH WC, 1994, J BIOL CHEM, V269, P15407; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; STRADER CD, 1987, J BIOL CHEM, V262, P16439; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; WONG SKF, 1990, J BIOL CHEM, V265, P6219; YAMAKI K, 1990, J BIOL CHEM, V265, P20757	49	316	326	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					720	731		10.1074/jbc.270.2.720	http://dx.doi.org/10.1074/jbc.270.2.720			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822302	hybrid			2022-12-27	WOS:A1995QB81600036
J	KOVOOR, A; HENRY, DJ; CHAVKIN, C				KOVOOR, A; HENRY, DJ; CHAVKIN, C			AGONIST-INDUCED DESENSITIZATION OF THE MU-OPIOID RECEPTOR-COUPLED POTASSIUM CHANNEL (GIRK1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC K+ CHANNELS; LOCUS-CERULEUS NEURONS; GTP-BINDING PROTEINS; EGG CELL-MEMBRANE; ACETYLCHOLINE-RECEPTOR; FUNCTIONAL EXPRESSION; RAT-BRAIN; ACTIVATION; CLONING; SUBUNITS	In Xenopus oocytes expressing the rat mu receptor and the G protein-gated, inwardly rectifying K+ channel (known as KGA or GIRK1), application of [D-Ala(2),MePhe(4),Glyol(5)]enkephalin) , a mu opioid agonist, evoked a dose-dependent increase in KC conductance, With sustained agonist exposure, the amplitude of the response decayed with a t(1/2) of 8 +/- 2 min. In oocytes coexpressing the mu and 5HT1A receptors with GIRK1, stimulation of either receptor resulted in heterologous desensitization of the subsequent response to the other, Injection of guanosine 5'-O-(thiotriphosphate) (1 mM) increased the basal GIRK1 activity and the total response to the application of agonist, but did not affect the rate of desensitization. Basal channel activity in the absence of agonist also desensitized at the same rate when the oocytes were exposed to high K+ (96 mM) solution, The above results indicate that the desensitization of the response occurred at a site downstream of the receptor, possibly at the channel, The rate of desensitization was not significantly altered by any of the following treatments: removal of external Ca2+, preloading the oocytes with 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-tetra-(acetoxymethyl)-ester (0.5-1 mM), elevation of cAMP levels, treatment with phorbol esters (1 mu M), staurosporine (0.5 mu M), okadaic acid (1 mu M), Or cytochalasin B (0.5 mu M). These results suggest that desensitization may not involve a calcium or phosphorylation-dependent mechanism.	UNIV WASHINGTON, DEPT PHARMACOL, SEATTLE, WA 98195 USA; CALTECH, COMPUTAT NEUROSCI PROGRAM, PASADENA, CA 91125 USA	University of Washington; University of Washington Seattle; California Institute of Technology			Chavkin, Charles/G-2797-2010		NIDA NIH HHS [DA 05160, DA 04123] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004123] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BAENZIGER JE, 1993, BIOCHEMISTRY-US, V32, P5448, DOI 10.1021/bi00071a022; BRANN MR, 1993, PROG BRAIN RES, V98, P121; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; CARMELIET E, 1986, J PHYSIOL-LONDON, V371, P239, DOI 10.1113/jphysiol.1986.sp015971; CHEN Y, 1994, J BIOL CHEM, V269, P7839; CHEN Y, 1993, MOL PHARMACOL, V44, P8; CODINA J, 1987, SCIENCE, V236, P442, DOI 10.1126/science.2436299; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P6596, DOI 10.1073/pnas.90.14.6596; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; DASCAL N, 1992, METHODS MOL BIOL, V13; HAGIWARA S, 1977, J GEN PHYSIOL, V70, P269, DOI 10.1085/jgp.70.3.269; HARRIS GC, 1991, J NEUROSCI, V11, P2574; HILLE B, 1988, IONIC CHANNELS EXCIT; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; JOHNSON SM, 1989, PHARMACOL REV, V41, P435; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; KURACHI Y, 1989, PFLUG ARCH EUR J PHY, V413, P325, DOI 10.1007/BF00583550; KURACHI Y, 1987, PFLUG ARCH EUR J PHY, V410, P227, DOI 10.1007/BF00580270; KURACHI Y, 1992, PROG NEUROBIOL, V39, P229, DOI 10.1016/0301-0082(92)90017-9; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; MISSIAEN L, 1991, PHARMACOL THERAPEUT, V50, P191, DOI 10.1016/0163-7258(91)90014-D; MIYAKE M, 1989, P NATL ACAD SCI USA, V86, P3419, DOI 10.1073/pnas.86.9.3419; NESTLER EJ, 1993, NEURON, V11, P995, DOI 10.1016/0896-6273(93)90213-B; NORTH RA, 1989, BRIT J PHARMACOL, V98, P13, DOI 10.1111/j.1476-5381.1989.tb16855.x; NORTH RA, 1987, P NATL ACAD SCI USA, V84, P5487, DOI 10.1073/pnas.84.15.5487; OHMORI H, 1980, J MEMBRANE BIOL, V53, P143, DOI 10.1007/BF01870582; PASTERNAK GW, 1988, OPIATE RECEPTORS; REISINE T, 1993, TRENDS NEUROSCI, V16, P506, DOI 10.1016/0166-2236(93)90194-Q; SAKMANN B, 1983, NATURE, V303, P250, DOI 10.1038/303250a0; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; WIMPEY TL, 1991, NEURON, V6, P281, DOI 10.1016/0896-6273(91)90363-5; YAMADA M, 1994, BIOCHEM BIOPH RES CO, V200, P1484, DOI 10.1006/bbrc.1994.1618; YATANI A, 1988, NATURE, V336, P680, DOI 10.1038/336680a0; YATANI A, 1987, SCIENCE, V235, P207, DOI 10.1126/science.2432660	34	110	110	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					589	595		10.1074/jbc.270.2.589	http://dx.doi.org/10.1074/jbc.270.2.589			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822283	hybrid			2022-12-27	WOS:A1995QB81600016
J	ABRAHAM, DG; PATEL, PP; COOPER, AJL				ABRAHAM, DG; PATEL, PP; COOPER, AJL			ISOLATION FROM RAT-KIDNEY OF A CYTOSOLIC HIGH-MOLECULAR-WEIGHT CYSTEINE-S-CONJUGATE BETA-LYASE WITH ACTIVITY TOWARD LEUKOTRIENE E(4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMINE TRANSAMINASE-K; SERINE O-SULFATE; ASPARTATE-AMINOTRANSFERASE; POLYACRYLAMIDE GELS; PURIFICATION; METABOLISM; ACID; PROTEINS; LIVER; NEPHROTOXICITY	A cytosolic high M(r) cysteine-S-conjugate beta-lyase (apparent M(r) of similar to 330,000) has been partially purified from rat kidneys. The high M(r) lyase is also present in the mitochondria, The purified enzyme contains at least two proteins with apparent M(r) values of similar to 50,000 and similar to 70,000. Activity is stimulated by dithiothreitol, alpha-keto acids, and pyridoxal 5'-phosphate; aminooxyacetate is an inhibitor. The enzyme catalyzes a competing (half) transamination reaction between pyridoxal 5'-phosphate cofactor and cysteine-S-conjugate substrate; added alpha-keto acids promote conversion of active site pyridoxamine 5'-phosphate to pyridoxal 5'-phosphate. The enzyme also catalyzes a full (but weak) transamination between L-phenylalanine and alpha-keto-gamma-methiolbutyrate. The purified enzyme is not recognized by polyclonal rabbit antibodies to cytosolic rat kidney glutamine transaminase K (another cysteine-S-conjugate beta-lyase of rat kidney) and has no obvious similarities to other pyridoxal 5'-phosphate-containing enzymes. In addition to catalyzing elimination reactions with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,1,2,2-tetrafluoroethyl)-L-cysteine, the enzyme reacts with leukotriene E(4) and 5'-S-cysteinyldopamine. Finally, the cytosolic and mitochondrial enzymes are activated by alpha-ketoglutarate. Thus, the possibility must be considered that, in kidneys of animals exposed to various cysteine conjugates, the high M(r) lyase contributes to the generation of pyruvate, ammonia, and reactive fragments in vivo. Many cysteine conjugates are nephrotoxic, and the high M(r) lyase(s) may be involved.	CORNELL UNIV, MED CTR, DEPT BIOCHEM, NEW YORK, NY 10021 USA; CORNELL UNIV, MED CTR, DEPT NEUROL & NEUROSCI, NEW YORK, NY 10021 USA	Cornell University; Cornell University			Cooper, Arthur J.L./H-5171-2016		NIDDK NIH HHS [DK 16739] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK016739] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAHAM DG, 1991, ANAL BIOCHEM, V197, P421, DOI 10.1016/0003-2697(91)90414-O; ALLEN DE, 1990, AM J PHYSIOL, V258, pR1034; BADR KF, 1987, AM J PHYSIOL, V253, pF239, DOI 10.1152/ajprenal.1987.253.2.F239; BERNSTROM K, 1989, ARCH BIOCHEM BIOPHYS, V275, P531, DOI 10.1016/0003-9861(89)90399-8; BLAKESLEY RW, 1977, ANAL BIOCHEM, V82, P580, DOI 10.1016/0003-2697(77)90197-X; Blanchard M, 1944, J BIOL CHEM, V155, P421; BRAUNSTEIN AE, 1984, ADV ENZYMOL RAMB, V56, P1; BUXTON PH, 1967, J NEUROL NEUROSUR PS, V30, P511, DOI 10.1136/jnnp.30.6.511; CAVALLIN.D, 1973, EUR J BIOCHEM, V39, P301, DOI 10.1111/j.1432-1033.1973.tb03127.x; CHAYKIN S, 1969, ANAL BIOCHEM, V31, P375, DOI 10.1016/0003-2697(69)90278-4; CHEN Q, 1990, J BIOL CHEM, V265, P21603; Cooper A J, 1994, Adv Pharmacol, V27, P71, DOI 10.1016/S1054-3589(08)61030-3; COOPER AJL, 1989, ANAL BIOCHEM, V183, P210, DOI 10.1016/0003-2697(89)90469-7; COOPER AJL, 1990, ANN NY ACAD SCI, V585, P118, DOI 10.1111/j.1749-6632.1990.tb28048.x; COOPER AJL, 1981, COMP BIOCHEM PHYS B, V69, P137, DOI 10.1016/0305-0491(81)90223-6; COOPER AJL, 1978, ANAL BIOCHEM, V89, P451, DOI 10.1016/0003-2697(78)90374-3; COOPER AJL, 1993, J NEUROCHEM, V61, P1731, DOI 10.1111/j.1471-4159.1993.tb09810.x; COOPER AJL, 1974, J BIOL CHEM, V249, P2554; DEKANT W, 1988, CHEM RES TOXICOL, V1, P175, DOI 10.1021/tx00003a008; DULEY JA, 1976, EUR J BIOCHEM, V63, P163, DOI 10.1111/j.1432-1033.1976.tb10219.x; Elfarra Adnan A., 1993, P387; FAULER J, 1991, PROSTAGLANDINS, V42, P239, DOI 10.1016/0090-6980(91)90113-T; FILCDERICCO S, 1990, CANCER RES, V50, P4839; GULBINS E, 1991, EUR J CLIN INVEST, V21, P184, DOI 10.1111/j.1365-2362.1991.tb01808.x; HAYDEN PJ, 1990, MOL PHARMACOL, V37, P468; JONES TW, 1988, MOL PHARMACOL, V34, P621; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIKOS JJ, 1982, BIOCHEMISTRY-US, V21, P4377, DOI 10.1021/bi00261a029; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACFARLANE M, 1989, TOXICOL APPL PHARM, V98, P185, DOI 10.1016/0041-008X(89)90224-X; MACFARLANE M, 1993, TOXICOLOGY, V77, P133, DOI 10.1016/0300-483X(93)90144-H; MARTINI F, 1987, J BIOL CHEM, V262, P5499; MEISTER A, 1952, J BIOL CHEM, V197, P309; MILES EW, 1986, VITAMIN B6 PYRIDOXAL, P253; MOORE KP, 1992, KIDNEY INT, V41, P1543, DOI 10.1038/ki.1992.224; MORINO Y, 1974, J BIOL CHEM, V249, P6684; REICHERT D, 1976, ARCH TOXICOL, V37, P23, DOI 10.1007/BF00353352; RELYEA NM, 1974, J BIOL CHEM, V249, P1519; ROSENGREN E, 1985, J NEURAL TRANSM, V63, P247, DOI 10.1007/BF01252029; ROSENTHAL A, 1983, CAN J PHYSIOL PHARM, V61, P325, DOI 10.1139/y83-049; SALA A, 1990, J BIOL CHEM, V265, P21771; SIMON D, 1973, BIOCHIM BIOPHYS ACTA, V321, P361, DOI 10.1016/0005-2744(73)90091-0; SIMONSON MS, 1986, KIDNEY INT, V30, P524, DOI 10.1038/ki.1986.217; SKOVBY F, 1984, J BIOL CHEM, V259, P583; SLIVKA A, 1985, J BIOL CHEM, V260, P5466; SMITH P, 1967, J CHROMATOGR, V30, P273, DOI 10.1016/S0021-9673(00)84158-8; STEVENS JL, 1986, J BIOL CHEM, V261, P5529; STEVENS JL, 1985, J BIOL CHEM, V260, P7945; STEVENS JL, 1990, DRUG METAB REV, V22, P617, DOI 10.3109/03602539008991457; Stevens JL, 1989, GLUTATHIONE CHEM B B, P45; STEWART HB, 1953, BIOCHEM J, V55, pR26; TONG J, 1993, CLIN BIOCHEM, V26, P199, DOI 10.1016/0009-9120(93)90026-3; UENO H, 1982, BIOCHEMISTRY-US, V21, P4387, DOI 10.1021/bi00261a030; WARD L D, 1991, Peptide Research, V4, P187; Williamson D. H., 1974, METHODS ENZYMATIC AN, P2266, DOI [10.1016/B978-0-12-091304-6.50093-8, DOI 10.1016/B978-0-12-091304-6.50093-8]; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; YAMAUCHI A, 1993, PROTEIN EXPRES PURIF, V4, P552, DOI 10.1006/prep.1993.1073	57	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					180	188		10.1074/jbc.270.1.180	http://dx.doi.org/10.1074/jbc.270.1.180			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814371	hybrid			2022-12-27	WOS:A1995QA28700031
J	MACAULAY, C; MEIER, E; FORBES, DJ				MACAULAY, C; MEIER, E; FORBES, DJ			DIFFERENTIAL MITOTIC PHOSPHORYLATION OF PROTEINS OF THE NUCLEAR-PORE COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATURATION-PROMOTING FACTOR; LINKED N-ACETYLGLUCOSAMINE; DNA TOPOISOMERASE-II; RNA POLYMERASE-II; CASEIN KINASE-II; LAMIN-B RECEPTOR; CELL-FREE SYSTEM; ASSEMBLY INVITRO; XENOPUS OOCYTES; EGG EXTRACTS	During each cell cycle, the nucleus of higher eukaryotes undergoes a dramatic assembly and disassembly, These events can be faithfully reproduced in vitro using cell-free extracts derived from Xenopus eggs, Such extracts contain three major N-acetylglucosaminylated proteins, p200, p97, and p60, Ah three become assembled into reconstituted nuclear pores, Here we show that p200, p97, and p60 exist in eggs in soluble high molecular mass complexes of 1000, 450, and 600 kDA, respectively, The bulk of p60 is stably associated with proteins of 58 and 54 kDa, while p200 is associated with a fraction of p60 in a separate complex lacking p58 and p54. Upon examining the behavior of these proteins in the cell cycle, we find that p200 and p97 are highly phosphorylated at mitosis, both in vivo and in vitro, Moreover, in extracts that cycle between interphase and mitosis, p200 and p97 are specifically phosphorylated at mitosis. Corresponding with their mitotic phosphorylation, both p200 and p97 are specific substrates for purified mitotic Cdc2 kinase, whereas nucleoporin p60 is not, Analysis indicates that the size of the complexes containing the pore N-acetylglucosamine glycoproteins does not change during mitosis, suggesting that such complexes represent stable multicomponent modules into which the nucleus disassembles at mitosis.			MACAULAY, C (corresponding author), UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093, USA.			Macaulay, Colin/0000-0003-0118-7674	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033279] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM33279, R01 GM033279] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI Y, 1991, CELL, V64, P137, DOI 10.1016/0092-8674(91)90215-K; AIZAWA H, 1991, BIOCHEM BIOPH RES CO, V179, P1620, DOI 10.1016/0006-291X(91)91760-A; APPELBAUM J, 1990, J BIOL CHEM, V265, P4181; BEMENT WM, 1990, J ELECTRON MICR TECH, V16, P202, DOI 10.1002/jemt.1060160303; BLOEMENDAL H, 1989, BIOCHIM BIOPHYS ACTA, V1007, P245, DOI 10.1016/0167-4781(89)90144-9; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; CAPONY JP, 1986, DEV BIOL, V117, P1, DOI 10.1016/0012-1606(86)90342-8; CARDENAS ME, 1993, J CELL SCI, V104, P533; CORBETT AH, 1993, BIOCHEMISTRY-US, V32, P2090, DOI 10.1021/bi00059a029; CORDES V, 1991, EUR J CELL BIOL, V55, P31; CORDES VC, 1993, J CELL BIOL, V123, P1333, DOI 10.1083/jcb.123.6.1333; COURVALIN JC, 1992, J BIOL CHEM, V267, P19035; DA J, 1991, J CELL BIOL, V115, P1203; DABAUVALLE MC, 1990, CHROMOSOMA, V100, P56, DOI 10.1007/BF00337603; DABAUVALLE MC, 1988, CHROMOSOMA, V97, P193, DOI 10.1007/BF00292960; DASSO M, 1990, CELL, V61, P811, DOI 10.1016/0092-8674(90)90191-G; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; DUNPHY WG, 1988, CELL, V55, P925, DOI 10.1016/0092-8674(88)90234-6; FANG F, 1991, CELL, V66, P731, DOI 10.1016/0092-8674(91)90117-H; FELDHERR CM, 1991, J CELL BIOL, V115, P933, DOI 10.1083/jcb.115.4.933; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; FINLAY DR, 1990, CELL, V60, P17, DOI 10.1016/0092-8674(90)90712-N; FINLAY DR, 1987, J CELL BIOL, V104, P189, DOI 10.1083/jcb.104.2.189; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; GAUTIER J, 1990, CELL, V60, P487, DOI 10.1016/0092-8674(90)90599-A; GAUTIER J, 1991, EMBO J, V10, P177, DOI 10.1002/j.1460-2075.1991.tb07934.x; GERACE L, 1980, CELL, V19, P277, DOI 10.1016/0092-8674(80)90409-2; Gerace Larry, 1994, Trends in Cell Biology, V4, P127, DOI 10.1016/0962-8924(94)90067-1; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GOLDMAN AE, 1992, J CELL BIOL, V119, P725, DOI 10.1083/jcb.119.4.725; HANOVER JA, 1987, J BIOL CHEM, V262, P9887; HAREL A, 1989, J CELL SCI, V94, P463; Hart Gerald W., 1992, Current Opinion in Cell Biology, V4, P1017, DOI 10.1016/0955-0674(92)90134-X; HART GW, 1989, ANNU REV BIOCHEM, V58, P841; HENNEKES H, 1993, J CELL BIOL, V120, P1293, DOI 10.1083/jcb.120.6.1293; HIRANO T, 1993, J CELL BIOL, V120, P601, DOI 10.1083/jcb.120.3.601; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; HOCEVAR BA, 1993, J BIOL CHEM, V268, P7545; HOLT GD, 1987, J CELL BIOL, V104, P1157, DOI 10.1083/jcb.104.5.1157; HOLT GD, 1986, J BIOL CHEM, V261, P8049; IZUMI T, 1991, MOL CELL BIOL, V11, P3860, DOI 10.1128/MCB.11.8.3860; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; JACKSON SP, 1989, P NATL ACAD SCI USA, V86, P1781, DOI 10.1073/pnas.86.6.1781; KARIN M, 1994, CURR OPIN CELL BIOL, V6, P415, DOI 10.1016/0955-0674(94)90035-3; KARSENTI E, 1984, J CELL BIOL, V98, P1730, DOI 10.1083/jcb.98.5.1730; KELLY WG, 1993, J BIOL CHEM, V268, P10416; KITA K, 1993, J BIOCHEM-TOKYO, V113, P377, DOI 10.1093/oxfordjournals.jbchem.a124054; Lee G, 1993, CURR OPIN CELL BIOL, V5, P88, DOI 10.1016/S0955-0674(05)80013-4; LITCHFIELD DW, 1992, J BIOL CHEM, V267, P13943; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; LOHKA MJ, 1984, J CELL BIOL, V98, P1222, DOI 10.1083/jcb.98.4.1222; LOHKA MJ, 1985, J CELL BIOL, V101, P518, DOI 10.1083/jcb.101.2.518; LOHKA MJ, 1988, P NATL ACAD SCI USA, V85, P3009, DOI 10.1073/pnas.85.9.3009; MALLER JL, 1985, DEV BIOL, V109, P150, DOI 10.1016/0012-1606(85)90355-0; MAUL GG, 1977, J CELL BIOL, V74, P492, DOI 10.1083/jcb.74.2.492; MEIER J, 1994, EMBO J, V13, P1888, DOI 10.1002/j.1460-2075.1994.tb06458.x; MEIKRANTZ W, 1991, J CELL SCI, V98, P303; MIAKELYE R, 1985, CELL, V41, P165, DOI 10.1016/0092-8674(85)90071-6; MILLER MW, 1994, J BIOL CHEM, V269, P9289; Moir RD, 1993, CURR OPIN CELL BIOL, V5, P408, DOI 10.1016/0955-0674(93)90004-A; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; NEWMEYER DD, 1991, METHOD CELL BIOL, V36, P607; NEWMEYER DD, 1986, J CELL BIOL, V103, P2091, DOI 10.1083/jcb.103.6.2091; NEWMEYER DD, 1986, EMBO J, V5, P501, DOI 10.1002/j.1460-2075.1986.tb04239.x; NEWPORT J, 1987, CELL, V48, P205, DOI 10.1016/0092-8674(87)90424-7; NEWPORT J, 1987, CELL, V48, P219, DOI 10.1016/0092-8674(87)90425-9; Nigg EA, 1993, CURR OPIN CELL BIOL, V5, P187, DOI 10.1016/0955-0674(93)90101-U; OTTAVIANO Y, 1985, J BIOL CHEM, V260, P624; PANTE N, 1994, J CELL BIOL, V126, P603, DOI 10.1083/jcb.126.3.603; PARK MK, 1987, P NATL ACAD SCI USA, V84, P6462, DOI 10.1073/pnas.84.18.6462; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; PETER M, 1990, CELL, V60, P791, DOI 10.1016/0092-8674(90)90093-T; PETER M, 1991, EMBO J, V10, P1535, DOI 10.1002/j.1460-2075.1991.tb07673.x; PFALLER R, 1991, CELL, V65, P209, DOI 10.1016/0092-8674(91)90155-R; RIH HP, 1991, EMBO J, V10, P633; ROBBINS E, 1964, J CELL BIOL, V21, P429, DOI 10.1083/jcb.21.3.429; Robson RM, 1989, CURR OPIN CELL BIOL, V1, P36, DOI 10.1016/S0955-0674(89)80034-1; SHEEHAN MA, 1988, J CELL BIOL, V106, P1, DOI 10.1083/jcb.106.1.1; SHIINA N, 1992, EMBO J, V11, P3977, DOI 10.1002/j.1460-2075.1992.tb05491.x; SIMOS G, 1992, EMBO J, V11, P4027, DOI 10.1002/j.1460-2075.1992.tb05496.x; SMYTHE C, 1991, METHOD CELL BIOL, V35, P449; Solomon MJ, 1993, CURR OPIN CELL BIOL, V5, P180, DOI 10.1016/0955-0674(93)90100-5; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; STEINERT G, 1974, J ULTRA MOL STRUCT R, V49, P188, DOI 10.1016/S0022-5320(74)80031-6; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6; VIGERS GPA, 1992, J CELL SCI, V102, P273; Wiese C, 1993, CURR OPIN CELL BIOL, V5, P387, DOI 10.1016/0955-0674(93)90002-8; YEO JP, 1994, NATURE, V367, P288, DOI 10.1038/367288a0	90	164	167	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					254	262		10.1074/jbc.270.1.254	http://dx.doi.org/10.1074/jbc.270.1.254			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814383	hybrid			2022-12-27	WOS:A1995QA28700041
J	TAUSSIG, R; GILMAN, AG				TAUSSIG, R; GILMAN, AG			MAMMALIAN MEMBRANE-BOUND ADENYLYL CYCLASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BETA-GAMMA-SUBUNITS; CYCLIC-AMP ACCUMULATION; PHORBOL ESTER TREATMENT; G-PROTEIN; MOLECULAR-CLONING; NCB-20 CELLS; RAT-BRAIN; EXPRESSION; INHIBITION; STIMULATION		UNIV TEXAS,SW MED CTR,DEPT PHARMACOL,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas								ABRAMS TW, 1988, TRENDS NEUROSCI, V11, P128, DOI 10.1016/0166-2236(88)90137-3; ANDRADE R, 1993, NEURON, V10, P83, DOI 10.1016/0896-6273(93)90244-L; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; BOYAJIAN CL, 1991, J BIOL CHEM, V266, P4995; CALI JJ, 1994, J BIOL CHEM, V269, P12190; CARLSON KE, 1989, J BIOL CHEM, V264, P13298; CHEN JQ, 1993, J BIOL CHEM, V268, P12253; CHETKOVICH DM, 1991, P NATL ACAD SCI USA, V88, P6467, DOI 10.1073/pnas.88.15.6467; CHINKERS M, 1992, J BIOL CHEM, V267, P18589; CHOI EJ, 1993, BIOCHEMISTRY-US, V32, P1891, DOI 10.1021/bi00059a001; DANIELISSAKANI S, 1989, J BIOL CHEM, V264, P20240; DEBERNARDI MA, 1993, BIOCHEM J, V293, P325, DOI 10.1042/bj2930325; DEBERNARDI MA, 1991, P NATL ACAD SCI USA, V88, P9257, DOI 10.1073/pnas.88.20.9257; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; FEINSTEIN PG, 1991, P NATL ACAD SCI USA, V88, P10173, DOI 10.1073/pnas.88.22.10173; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GAO BN, 1991, P NATL ACAD SCI USA, V88, P10178, DOI 10.1073/pnas.88.22.10178; ISHIKAWA Y, 1992, J BIOL CHEM, V267, P13553; IWATA T, 1991, J BIOCHEM-TOKYO, V110, P35, DOI 10.1093/oxfordjournals.jbchem.a123539; JACOBOWITZ O, 1993, J BIOL CHEM, V268, P3829; KATADA T, 1987, J BIOL CHEM, V262, P11897; KATSUSHIKA S, 1992, P NATL ACAD SCI USA, V89, P8774, DOI 10.1073/pnas.89.18.8774; KAWABE J, 1994, J BIOL CHEM, V269, P16554; KRUPINSKI J, 1992, J BIOL CHEM, V267, P24858; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; LOWE DG, 1992, BIOCHEMISTRY-US, V43, P10421; LUSTIG KD, 1993, J BIOL CHEM, V268, P13900; MOLLNER S, 1988, EUR J BIOCHEM, V171, P265, DOI 10.1111/j.1432-1033.1988.tb13785.x; MONS N, 1993, SYNAPSE, V14, P51, DOI 10.1002/syn.890140108; NAKANE M, 1990, J BIOL CHEM, V265, P16841; NARAYANAN N, 1989, ENDOCRINOLOGY, V124, P484, DOI 10.1210/endo-124-1-484; PFEUFFER E, 1985, EMBO J, V4, P3675, DOI 10.1002/j.1460-2075.1985.tb04134.x; PFEUFFER T, 1982, FEBS LETT, V146, P369, DOI 10.1016/0014-5793(82)80955-1; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; PREMONT RT, 1992, ENDOCRINOLOGY, V131, P2774, DOI 10.1210/en.131.6.2774; PREMONT RT, 1992, P NATL ACAD SCI USA, V89, P9809, DOI 10.1073/pnas.89.20.9809; ROSENBERG GB, 1987, J BIOL CHEM, V262, P7623; SCHULTZ JE, 1992, SCIENCE, V255, P600, DOI 10.1126/science.1371017; SMIGEL MD, 1986, J BIOL CHEM, V261, P1976; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TANG WJ, 1991, J BIOL CHEM, V266, P8595; TAUSSIG R, 1993, J BIOL CHEM, V268, P9; TAUSSIG R, 1993, SCIENCE, V261, P218, DOI 10.1126/science.8327893; TAUSSIG R, 1994, J BIOL CHEM, V269, P6093; VORHERR T, 1993, BIOCHEMISTRY-US, V32, P6081, DOI 10.1021/bi00074a020; WALLACH J, 1994, FEBS LETT, V338, P264; WONG YH, 1991, NATURE, V351, P63, DOI 10.1038/351063a0; WU Z, 1993, J BIOL CHEM, V168, P23766; YEAGER RE, 1985, BIOCHEMISTRY-US, V24, P3776, DOI 10.1021/bi00335a054; YOSHIMURA M, 1992, P NATL ACAD SCI USA, V89, P6716, DOI 10.1073/pnas.89.15.6716; YOSHIMURA M, 1993, J BIOL CHEM, V268, P4604	54	414	423	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					1	4		10.1074/jbc.270.1.1	http://dx.doi.org/10.1074/jbc.270.1.1			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814360	hybrid			2022-12-27	WOS:A1995QA28700001
J	GREENE, LE; ZINNER, R; NAFICY, S; EISENBERG, E				GREENE, LE; ZINNER, R; NAFICY, S; EISENBERG, E			EFFECT OF NUCLEOTIDE ON THE BINDING OF PEPTIDES TO 70-KDA HEAT-SHOCK PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE BIP; UNCOATING ATPASE; MUSCLE-CONTRACTION; UNFOLDED PROTEINS; COATED VESICLES; HSP70; CLATHRIN; DISSOCIATION; COMPLEX; HSC70	In previous work we found that bovine brain hsp70 has a single binding site for nucleotide, and that, with ATP at this site, the rates of association and dissociation of clathrin from hsp70 are fast, whereas with ADP at this site, these rates are unmeasurably slow. In the present study we show, first, that peptide C, cytochrome c peptide, and RNase S peptide bind competitively with clathrin, suggesting that they bind to the same site on hsp70, although RNase S peptide binds an order of magnitude more weakly than peptide C and cytochrome c peptide. Second, we show that, with ADP bound to hsp70, as occurs with clathrin, the rate constant for dissociation of peptide markedly decreases compared to the rate constant observed in ATP. In contrast, ADP only slightly decreases the rate of association of peptide. Based on these data we propose a model in which substrates of hsp70 bind to and dissociate from the ATP form of the enzyme, while, following ATP hydrolysis, they are locked onto the ADP form of the enzyme, unable to dissociate until ADP is released and ATP rebinds.	GEORGETOWN UNIV,SCH MED,WASHINGTON,DC 20007	Georgetown University	GREENE, LE (corresponding author), NHLBI,CELL BIOL LAB,BLDG 3,RM B1-17,3 CTR DR MSC 0301,BETHESDA,MD 20892, USA.							Barouch W., 1993, Molecular Biology of the Cell, V4, p95A; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; BLONDELGUINDI S, 1993, J BIOL CHEM, V268, P12730; BOLE DG, 1986, J CELL BIOL, V10, P1558; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; CHOCK SP, 1979, J BIOL CHEM, V254, P3229; CRAIG EA, 1993, SCIENCE, V260, P1902, DOI 10.1126/science.8100364; EISENBERG E, 1985, SCIENCE, V227, P999, DOI 10.1126/science.3156404; ELLIS J, 1991, ANN REV BIOCH, V60, P331; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; GAO B, 1993, J BIOL CHEM, V26, P8507; GAO BC, 1991, J BIOL CHEM, V266, P19565; GAUT J, 1993, J BIOL CHEM, V26, P7248; GETHING MJ, 1986, CELL, V46, P939, DOI 10.1016/0092-8674(86)90076-0; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GREENE LE, 1990, J BIOL CHEM, V265, P6682; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HUANG SP, 1993, J BIOL CHEM, V268, P2063; JENTOFT N, 1983, METHOD ENZYMOL, V91, P570; LANDRY SJ, 1992, NATURE, V355, P455, DOI 10.1038/355455a0; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; NADLER SG, 1992, SCIENCE, V258, P484, DOI 10.1126/science.1411548; NOVER L, 1991, HEAT SHOCK RESPONSE, P41; PALLEROS DR, 1991, P NATL ACAD SCI USA, V88, P5719, DOI 10.1073/pnas.88.13.5719; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; PRASAD K, 1993, J BIOL CHEM, V268, P23758; PRASAD K, 1994, J BIOL CHEM, V269, P6931; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; SADIS S, 1992, BIOCHEMISTRY-US, V31, P9406, DOI 10.1021/bi00154a012; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; SCHMID SL, 1985, J BIOL CHEM, V260, P10050; SCHMID SL, 1985, J BIOL CHEM, V260, P57; TERLECKY SR, 1992, J BIOL CHEM, V267, P9202; VANBUSKIRK A, 1989, J EXP MED, V170, P1799, DOI 10.1084/jem.170.6.1799; WANG TF, 1993, J BIOL CHEM, V268, P26049; WERNERWASHBURNE M, 1987, MOL CELL BIOL, V7, P2568, DOI 10.1128/MCB.7.7.2568	40	97	103	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					2967	2973		10.1074/jbc.270.7.2967	http://dx.doi.org/10.1074/jbc.270.7.2967			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852376	hybrid			2022-12-27	WOS:A1995QG47100015
J	VIEIRA, AV; SANDERS, EJ; SCHNEIDER, WJ				VIEIRA, AV; SANDERS, EJ; SCHNEIDER, WJ			TRANSPORT OF SERUM TRANSTHYRETIN INTO CHICKEN OOCYTES - A RECEPTOR-MEDIATED MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; RETINOIC ACID RECEPTOR; THYROID-HORMONE; VITAMIN-D; VITELLOGENIN; PROTEIN; YOLK; ESTROGEN; BINDING; LIVER	Transthyretin (TTR) is involved in the transport of thyroid hormones and, due to its interaction with serum retinol-binding protein, also of vitamin A. The importance of both ligands in vertebrate embryonic development has prompted us to investigate the molecular details of TTR transport function in a powerful germ cell system, the rapidly growing chicken oocytes. Yolk TTR is derived from the circulatory system, since biotinylated TTR was recovered by immunoaffinity chromatography of yolk obtained from a hen previously infused with in vitro biotinylated chicken serum proteins. In concordance with the intraoocytic localization in an endosomal compartment, ligand blotting and chemical cross-linking experiments revealed the presence of a similar to 115-kDa TTR-binding oocyte membrane protein. This putative TTR receptor was not detected in chicken ovarian granulosa cells or embryonic fibrobfasts and was different from the previously described oocyte-specific receptor for two estrogen induced chicken serum lipoproteins, vitellogenin and very low density lipoprotein (Barber, D. L., Sanders, E. J., Aebersold, R., and Schneider, W. J. (1991) J. Biol. Chem. 266, 18761-18770). Furthermore, in contrast to the serum levels of the yolk precursor lipoproteins, those of TTR were not significantly changed by estrogen; thus, TTR represents a newly defined, estrogen-independent class of yolk precursor proteins. These data strongly suggest that oocytic TTR is derived from the circulation, where it is a constitutive component, and deposited into yolk as a result of endocytosis mediated by a specific receptor.	UNIV & BIOCTR VIENNA,DEPT MOLEC GENET,VIENNA,AUSTRIA; UNIV ALBERTA,DEPT PHYSIOL,EDMONTON,AB T6G 2S2,CANADA	University of Vienna; University of Alberta								BARBER DL, 1991, J BIOL CHEM, V266, P18761; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; BLONDEAU JP, 1988, J BIOL CHEM, V263, P2685; CHAN L, 1980, ENDOCRINOLOGY, V106, P275, DOI 10.1210/endo-106-1-275; DEELEY RG, 1977, J BIOL CHEM, V252, P8310; DIVINO CM, 1990, J BIOL CHEM, V265, P1425; DUAN W, 1991, EUR J BIOCHEM, V200, P679, DOI 10.1111/j.1432-1033.1991.tb16232.x; ESPISKOPOU V, 1993, P NATL ACAD SCI USA, V90, P2375; FERGUSON RN, 1975, BIOCHEMISTRY-US, V14, P282, DOI 10.1021/bi00673a014; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; HAYASHI K, 1989, J LIPID RES, V30, P1421; JOST JP, 1978, EUR J BIOCHEM, V84, P355, DOI 10.1111/j.1432-1033.1978.tb12175.x; KANAI M, 1968, J CLIN INVEST, V47, P2025, DOI 10.1172/JCI105889; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; LOHNES D, 1993, CELL, V73, P643, DOI 10.1016/0092-8674(93)90246-M; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MADEN M, 1992, BIOESSAYS, V14, P431, DOI 10.1002/bies.950140702; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; MCNABB A, 1987, J EXP ZOOL S1, V51, P281; MURRELL JR, 1992, J BIOL CHEM, V267, P16595; MURTHY US, 1978, BIOCHIM BIOPHYS ACTA, V538, P364, DOI 10.1016/0304-4165(78)90364-1; PERRY MM, 1985, J ULTRA MOL STRUCT R, V90, P313, DOI 10.1016/S0022-5320(85)80009-5; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; ROBBINS J, 1960, PHYSIOL REV, V40, P415, DOI 10.1152/physrev.1960.40.3.415; ROSEN ED, 1993, J BIOL CHEM, V268, P11534; SCHJEIDE OA, 1963, AM ZOOL, V3, P167; SCHUH TJ, 1993, DEVELOPMENT, V119, P785; SECHMAN A, 1988, GEN COMP ENDOCR, V69, P99, DOI 10.1016/0016-6480(88)90057-3; SHEN XY, 1993, CELL TISSUE RES, V272, P459, DOI 10.1007/BF00318552; STIFANI S, 1988, BIOCHEM J, V250, P467, DOI 10.1042/bj2500467; STIFANI S, 1991, J BIOL CHEM, V266, P19079; STIFANI S, 1990, P NATL ACAD SCI USA, V87, P1955, DOI 10.1073/pnas.87.5.1955; TERRY CJ, 1993, EMBO J, V12, P735, DOI 10.1002/j.1460-2075.1993.tb05707.x; THALLER C, 1987, NATURE, V327, P625, DOI 10.1038/327625a0; VANJAARSVELD PP, 1973, J BIOL CHEM, V248, P498; VIEIRA AV, 1993, BIOCHIM BIOPHYS ACTA, V1169, P250, DOI 10.1016/0005-2760(93)90248-8; WILLIAMS DL, 1978, P NATL ACAD SCI USA, V75, P5974, DOI 10.1073/pnas.75.12.5974; WISKOCIL R, 1980, P NATL ACAD SCI-BIOL, V77, P4474, DOI 10.1073/pnas.77.8.4474; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0; ZHOU Y, 1990, J BIOL CHEM, V265, P1700	41	51	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					2952	2956		10.1074/jbc.270.7.2952	http://dx.doi.org/10.1074/jbc.270.7.2952			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852374	hybrid			2022-12-27	WOS:A1995QG47100013
J	DIEHL, JA; TONG, W; SUN, G; HANNINK, M				DIEHL, JA; TONG, W; SUN, G; HANNINK, M			TUMOR NECROSIS FACTOR-ALPHA-DEPENDENT ACTIVATION OF A RELA HOMODIMER IN ASTROCYTES - INCREASED PHOSPHORYLATION OF RELA AND MAD-3 PRECEDE ACTIVATION OF RELA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; PROTEIN; KINASE; INHIBITOR; INVITRO; BETA	Rel proteins are important intracellular mediators of cytokine-induced signal transduction. To understand how cytokines affect different cell populations in the brain, we have characterized Rel activation in astrocytes. A RelA homodimer is uniquely activated in cytokine-stimulated astrocytes. Cytokine-dependent phosphorylation of the RelA inhibitor MAD-3 occurred on discrete peptides prior to its dissociation from RelA. A transient hyperphosphorylation of RelA was also induced. Antioxidant treatment inhibited both RelA activation and phosphorylation of the RelA(.)MAD-3 complex, These results demonstrate that cytokine-dependent activation of the RelA homodimer involves phosphorylation of both RelA and its associated inhibitor. The sole activation of a RelA homodimer suggests that cytokines will activate a unique set of Rel-regulated genes in astrocytes.	UNIV MISSOURI,DEPT BIOCHEM,COLUMBIA,MO 65212	University of Missouri System; University of Missouri Columbia					NATIONAL CANCER INSTITUTE [R29CA055027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030178] Funding Source: NIH RePORTER; NCI NIH HHS [CA55027] Funding Source: Medline; NINDS NIH HHS [NS30178] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALLARD DW, 1990, CELL, V63, P803, DOI 10.1016/0092-8674(90)90146-6; BAUERLE PA, 1988, CELL, V53, P211; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; DIEHL JA, 1994, MOL CELL BIOL, V14, P6635, DOI 10.1128/MCB.14.10.6635; DIEHL JA, 1993, MOL CELL BIOL, V13, P1769, DOI 10.1128/MCB.13.3.1769; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GILLESPIE SKH, 1994, MOL CELL BIOL, V14, P3559, DOI 10.1128/MCB.14.6.3559; HAYASHI T, 1993, J BIOL CHEM, V268, P26790; HERTZ L, 1990, IMMUNOL TODAY, V8, P265; INTEBI AD, 1990, NEUROSCIENCE, V34, P545, DOI 10.1016/0306-4522(90)90163-X; KALTSCHMIDT C, 1994, MOL CELL BIOL, V11, P3981; KERR LD, 1991, GENE DEV, V5, P1464, DOI 10.1101/gad.5.8.1464; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; LINK E, 1992, J BIOL CHEM, V267, P239; Maniatis T., 1982, MOL CLONING; MOSIALOS G, 1991, MOL CELL BIOL, V11, P5867, DOI 10.1128/MCB.11.12.5867; Nolan GP, 1992, CURR OPIN GENET DEV, V2, P211, DOI 10.1016/S0959-437X(05)80276-X; OSTROWSKI J, 1991, J BIOL CHEM, V266, P12722; RADANY EH, 1992, P NATL ACAD SCI USA, V89, P6467, DOI 10.1073/pnas.89.14.6467; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943	24	46	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2703	2707		10.1074/jbc.270.6.2703	http://dx.doi.org/10.1074/jbc.270.6.2703			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852340	hybrid			2022-12-27	WOS:A1995QF53500048
J	MCMILLAN, NAJ; CARPICK, BW; HOLLIS, B; TOONE, WM; ZAMANIANDARYOUSH, M; WILLIAMS, BRG				MCMILLAN, NAJ; CARPICK, BW; HOLLIS, B; TOONE, WM; ZAMANIANDARYOUSH, M; WILLIAMS, BRG			MUTATIONAL ANALYSIS OF THE DOUBLE-STRANDED-RNA (DSRNA) BINDING DOMAIN OF THE DSRNA-ACTIVATED PROTEIN-KINASE, PKR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P68 KINASE; INTERFERON ACTION; ESCHERICHIA-COLI; GENE; IDENTIFICATION; EXPRESSION; PHOSPHORYLATION; MECHANISM; MUTAGENESIS; GROWTH	The interferon-induced, double-stranded RNA (dsRNA)-dependent protein kinase, PKR, is an inhibitor of translation and has antiviral, antiproliferative, and antitumor properties, Previously, the dsRNA binding domain had been located within the N-terminal region of PKR and subsequently shown to include two nearly identical domains comprising residues 55-75 and 145-166. We have undertaken both random and site-directed, alanine-scanning mutagenesis in order to investigate the contribution of individual amino acids within these domains to dsRNA binding, Here we identify 2 residues that were absolutely required for dsRNA binding, glycine 57 and lysine 60, Mutation of 2 other residues within the domain (lysine 64 and leucine 75) resulted in less than 10% binding (compared to wild type), We have also identified a number of other residues that influence dsRNA binding to varying degrees, Mutants that were unable to bind dsRNA were not active in vitro and possessed no antiproliferative activity in vivo, However, dsRNA binding mutants were partially transdominant over wild type PKR in mammalian cells, suggesting that binding of dsRNA activator is not the mechanism responsible for the phenotype of PKR mutants.	CLEVELAND CLIN FDN,RES INST,DEPT CANC BIOL,CLEVELAND,OH 44195	Cleveland Clinic Foundation			McMillan, Nigel/AAQ-5416-2021; Williams, Bryan R. G./A-5021-2009	Williams, Bryan R. G./0000-0002-4969-1151; McMillan, Nigel/0000-0002-9471-1406	PHS HHS [R01 A1 34039-02] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AHN BY, 1990, MOL CELL BIOL, V10, P5433, DOI 10.1128/MCB.10.10.5433; BARBER GN, 1993, P NATL ACAD SCI USA, V90, P4621, DOI 10.1073/pnas.90.10.4621; BUSBY S, 1982, J MOL BIOL, V154, P197, DOI 10.1016/0022-2836(82)90060-2; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; CHONG KL, 1992, EMBO J, V11, P1553, DOI 10.1002/j.1460-2075.1992.tb05200.x; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DEVER TE, 1993, P NATL ACAD SCI USA, V90, P4616, DOI 10.1073/pnas.90.10.4616; FARRELL PJ, 1977, CELL, V11, P187, DOI 10.1016/0092-8674(77)90330-0; FENG GS, 1992, P NATL ACAD SCI USA, V89, P5447, DOI 10.1073/pnas.89.12.5447; GALABRU J, 1987, J BIOL CHEM, V262, P15538; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; GREEN SR, 1992, GENE DEV, V6, P2478, DOI 10.1101/gad.6.12b.2478; HERSHEY JWB, 1989, J BIOL CHEM, V264, P20823; HOVANESSIAN AG, 1989, J INTERFERON RES, V9, P641, DOI 10.1089/jir.1989.9.641; KATZE MG, 1991, MOL CELL BIOL, V11, P5497, DOI 10.1128/MCB.11.11.5497; KATZE MG, 1992, J INTERFERON RES, V12, P241, DOI 10.1089/jir.1992.12.241; KIMURA A, 1986, CELL, V44, P261, DOI 10.1016/0092-8674(86)90760-9; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; LENGYEL P, 1982, ANNU REV BIOCHEM, V51, P251, DOI 10.1146/annurev.bi.51.070182.001343; LUNDBLAD V, 1994, CURRENT PROTOCOLS MO; MAITRA RK, 1994, VIROLOGY, V204, P823, DOI 10.1006/viro.1994.1601; MARAN A, 1994, SCIENCE, V265, P789, DOI 10.1126/science.7914032; MARCH PE, 1985, NUCLEIC ACIDS RES, V13, P4677, DOI 10.1093/nar/13.13.4677; MCCORMACK SJ, 1994, VIROLOGY, V198, P92, DOI 10.1006/viro.1994.1011; MCCORMACK SJ, 1992, VIROLOGY, V188, P47, DOI 10.1016/0042-6822(92)90733-6; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; MEURS EF, 1992, J VIROL, V66, P5805, DOI 10.1128/JVI.66.10.5805-5814.1992; MEURS EF, 1993, P NATL ACAD SCI USA, V90, P232, DOI 10.1073/pnas.90.1.232; PATEL RC, 1992, J BIOL CHEM, V267, P7671; PATEL RC, 1994, J BIOL CHEM, V269, P18593; SAFER B, 1983, CELL, V33, P7, DOI 10.1016/0092-8674(83)90326-4; SAMUEL CE, 1991, VIROLOGY, V183, P1, DOI 10.1016/0042-6822(91)90112-O; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; THOMIS DC, 1992, P NATL ACAD SCI USA, V89, P10837, DOI 10.1073/pnas.89.22.10837	38	80	81	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2601	2606		10.1074/jbc.270.6.2601	http://dx.doi.org/10.1074/jbc.270.6.2601			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852324	hybrid			2022-12-27	WOS:A1995QF53500032
J	MUKHOPADHYAY, B; PURWANTINI, E; PIHL, TD; REEVE, JN; DANIELS, L				MUKHOPADHYAY, B; PURWANTINI, E; PIHL, TD; REEVE, JN; DANIELS, L			CLONING, SEQUENCING, AND TRANSCRIPTIONAL ANALYSIS OF THE COENZYME F-420-DEPENDENT METHYLENE-5,6,7,8-TETRAHYDROMETHANOPTERIN DEHYDROGENASE GENE FROM METHANOBACTERIUM-THERMOAUTOTROPHICUM STRAIN MARBURG AND FUNCTIONAL EXPRESSION IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SEQUENCE; DELTA-H; N-10-METHYLENETETRAHYDROMETHANOPTERIN DEHYDROGENASE; METHYLENETETRAHYDROMETHANOPTERIN DEHYDROGENASE; METHANOGENIC BACTERIA; M REDUCTASE; HYDROGENASE; RNA; SUBUNITS; RELATEDNESS	Two methylenetetrahydromethanopterin dehydrogenases have been purified from Methanobacterium thermoautotrophicum strain Marburg: one (MTD) is coenzyme F-420-dependent and oxygen-stable (Mukhopadhyay, B., and Daniels, L. (1989) Can. J. Microbiol. 35, 499-507), and the other (MTH) is coenzyme F-420-independent (or hydrogenase-type) and oxygen-sensitive (Zirngibl, C., Hedderich, R., and Thauer, R. K. (1990) FEES Lett. 261, 112-116). Based on the NH2-terminal sequence of MTD, a 36-mer oligonucleotide was designed and used to identify and clone a 6.1-kilobase pair EcoRI fragment of M. thermoautotrophicum DNA. Sequencing of this fragment revealed an 825-base pair (bp) MTD encoding gene (mtd), which was expressed in Escherichia coli yielding an enzyme that, like the native enzyme, was oxygen-stable, strictly dependent on coenzyme F-420 thermostable, thermophilic, and exhibited maximum activitythermostable, thermophilic, and exhibited maximum activity at an acidic pH. The amino acid sequence predicts that MTD is a hydrophobic and acidic protein with no identifiable homology to MTH (von Bunau, R., Zirngibl, C., Thauer, R. K., and Klein, A. (1991) Eur. J. Biochem. 202, 1205-1208), but comparisons with coenzyme F-420 utilizing enzymes revealed a conserved region at the NH2 terminus of MTD that could correspond to the ability to interact with coenzyme F-420. The mtd transcript was similar to 900 nucleotides long and initiated 8 bp upstream of the translation initiation codon and 22 bp downstream from an archaeal promoter sequence. The mtd coding sequence was followed by several poly(dT) sequences and an inverted repeat that could be transcription termination signals.	UNIV IOWA, DEPT MICROBIOL, IOWA CITY, IA 52242 USA; OHIO STATE UNIV, DEPT MICROBIOL, COLUMBUS, OH 43210 USA	University of Iowa; University System of Ohio; Ohio State University				Mukhopadhyay, Biswarup/0000-0003-0736-0298				ALEX LA, 1990, BIOCHEMISTRY-US, V29, P7237, DOI 10.1021/bi00483a011; BERGHOFER B, 1988, NUCLEIC ACIDS RES, V16, P8113, DOI 10.1093/nar/16.16.8113; BOKRANZ M, 1988, J BACTERIOL, V170, P568, DOI 10.1128/jb.170.2.568-577.1988; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDIS A, 1981, ZBL BAKT MIK HYG I C, V2, P311, DOI 10.1016/S0721-9571(81)80023-3; CLEMENTS AP, 1992, J BACTERIOL, V174, P5244, DOI 10.1128/JB.174.16.5244-5250.1992; CRAM DS, 1987, P NATL ACAD SCI USA, V84, P3992, DOI 10.1073/pnas.84.12.3992; DANIELS L, 1984, BIOTECHNOL BIOENG, V14, P199; DASSARMA S, 1984, P NATL ACAD SCI-BIOL, V81, P125, DOI 10.1073/pnas.81.1.125; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; DIMARCO AA, 1990, J BIOL CHEM, V265, P472; DUNBAR BS, 1990, METHOD ENZYMOL, V182, P663; EKER APM, 1990, J BIOL CHEM, V265, P8009; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; ENSSLE M, 1991, ARCH MICROBIOL, V155, P483, DOI 10.1007/BF00244966; HARTZELL PL, 1985, THESIS U ILLINOIS UR; HENNIGAN AN, 1994, MOL MICROBIOL, V11, P655, DOI 10.1111/j.1365-2958.1994.tb00344.x; JENAL U, 1991, J BIOL CHEM, V266, P10570; KALMOKOFF ML, 1991, J BACTERIOL, V173, P7113, DOI 10.1128/jb.173.22.7113-7125.1991; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MEAKIN SA, 1991, J MICROBIOL METH, V14, P119, DOI 10.1016/0167-7012(91)90041-N; MONTZKA KA, 1988, P NATL ACAD SCI USA, V85, P8885, DOI 10.1073/pnas.85.23.8885; MUKHOPADHYAY B, 1989, CAN J MICROBIOL, V35, P499, DOI 10.1139/m89-077; MUKHOPADHYAY B, 1993, THESIS U IOWA IOWA C; OLSEN GJ, 1994, J BACTERIOL, V176, P1, DOI 10.1128/JB.176.1.1-6.1994; OSTERGAARD L, 1987, SYST APPL MICROBIOL, V9, P199; PIHL TD, 1994, J BACTERIOL, V176, P6384, DOI 10.1128/jb.176.20.6384-6391.1994; PURWANTINI E, 1992, ANAL BIOCHEM, V205, P342, DOI 10.1016/0003-2697(92)90446-E; REEVE JN, 1989, P NATL ACAD SCI USA, V86, P3031, DOI 10.1073/pnas.86.9.3031; REEVE JN, 1992, ANNU REV MICROBIOL, V46, P165; Sambrook J, 1989, MOL CLONING LABORATO; SCHWORER B, 1991, ARCH MICROBIOL, V155, P459, DOI 10.1007/BF00244962; SHUBER AP, 1986, J BIOL CHEM, V261, P2942; TAKAO M, 1991, J BIOL CHEM, V266, P14151; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VONBUNAU R, 1991, EUR J BIOCHEM, V202, P1205; YASUI A, 1988, NUCLEIC ACIDS RES, V16, P447; ZIRNGIBL C, 1990, FEBS LETT, V261, P112, DOI 10.1016/0014-5793(90)80649-4; ZIRNGIBL C, 1992, EUR J BIOCHEM, V208, P511, DOI 10.1111/j.1432-1033.1992.tb17215.x	39	30	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2827	2832		10.1074/jbc.270.6.2827	http://dx.doi.org/10.1074/jbc.270.6.2827			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852356	hybrid			2022-12-27	WOS:A1995QF53500066
J	VOGEL, LB; FUJITA, DJ				VOGEL, LB; FUJITA, DJ			P70 PHOSPHORYLATION AND BINDING TO P56(LCK) IS AN EARLY EVENT IN INTERLEUKIN-2-INDUCED ONSET OF CELL-CYCLE PROGRESSION IN T-LYMPHOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SH3 DOMAINS; SIGNAL TRANSDUCTION; MOLECULAR-CLONING; SRC-FAMILY; RECEPTOR; PROTEIN; ACTIVATION; CD4; EXPRESSION; KINASES	The cytoplasmic protein tyrosine kinase p56(lck) has been implicated as an effector of interleukin-2-induced cell division in T-lymphocytes, but Little is known about physiological substrates for p56(lck) during these events. We have used p56(lck) fusion proteins to identify potential cytoplasmic signal transduction proteins that bind to p56(lck) in mitotically activated human peripheral blood lymphocytes and in constitutively dividing leukemic T-cell lines. In peripheral blood lymphocytes, we have observed an interleukin-2-dependent tyrosine phosphorylation of a 70-kDa protein and binding of tyrosine phosphorylated p70 to the SH2 domain of p56(lck). A 70-kDa phosphoprotein was also observed to constitutively bind p56(lck) in leukemic T-cells. Affinity purification of p56(lck)-associated p70 and sequencing of proteolytic fragments revealed identity to a 62-kDa protein that has been identified as a ras-GTPase activating protein. These results demonstrate a stimulation-dependent tyrosine phosphorylation of p70 and its interaction with p56(lck) and may provide a link between p56(lck) and GTPase-mediated signal transduction pathways in activated T-lymphocytes.	UNIV CALGARY, MED CTR, CALGARY, AB T2N 4N1, CANADA	University of Calgary	VOGEL, LB (corresponding author), CNRS, BIOL STN, F-29680 ROSCOFF, FRANCE.							BIERER BE, 1989, IMMUNOL REV, V111, P267, DOI 10.1111/j.1600-065X.1989.tb00549.x; BOLEN JB, 1991, ADV CANCER RES, V57, P103; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; FIRPO EJ, 1994, MOL CELL BIOL, V14, P4889, DOI 10.1128/MCB.14.7.4889; FUMAGALLI S, 1994, NATURE, V368, P871, DOI 10.1038/368871a0; FURUKAWA Y, 1990, SCIENCE, V250, P805, DOI 10.1126/science.2237430; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; GUTIERREZ C, 1979, J IMMUNOL METHODS, V29, P57, DOI 10.1016/0022-1759(79)90125-X; HALL A, 1992, CELL, V69, P389, DOI 10.1016/0092-8674(92)90441-E; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; HORAK ID, 1991, P NATL ACAD SCI USA, V88, P1996, DOI 10.1073/pnas.88.5.1996; JANEWAY CA, 1989, IMMUNOL TODAY, V10, P234, DOI 10.1016/0167-5699(89)90260-0; KLAUSNER RD, 1991, CELL, V64, P875, DOI 10.1016/0092-8674(91)90310-U; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; MILLS GB, 1990, J BIOL CHEM, V265, P3561; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMITH KA, 1989, CANCER CELL, V3, P205; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; TELFER JC, 1991, SCIENCE, V254, P439, DOI 10.1126/science.1925604; TRAHEY M, 1988, SCIENCE, V242, P1697, DOI 10.1126/science.3201259; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; VOGEL LB, 1993, MOL CELL BIOL, V13, P7408, DOI 10.1128/MCB.13.12.7408; WONG G, 1992, CELL, V69, P551, DOI 10.1016/0092-8674(92)90455-L	32	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2506	2511		10.1074/jbc.270.6.2506	http://dx.doi.org/10.1074/jbc.270.6.2506			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852312	hybrid			2022-12-27	WOS:A1995QF53500019
J	DAWSON, SP; ARNOLD, JE; MAYER, NJ; REYNOLDS, SE; BILLETT, MA; GORDON, C; COLLEAUX, L; KLOETZEL, PM; TANAKA, K; MAYER, RJ				DAWSON, SP; ARNOLD, JE; MAYER, NJ; REYNOLDS, SE; BILLETT, MA; GORDON, C; COLLEAUX, L; KLOETZEL, PM; TANAKA, K; MAYER, RJ			DEVELOPMENTAL-CHANGES OF THE 26-S-PROTEASOME IN ABDOMINAL INTERSEGMENTAL MUSCLES OF MANDUCA-SEXTA DURING PROGRAMMED CELL-DEATH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							UBIQUITIN-CONJUGATING ENZYME; DEPENDENT PROTEOLYTIC SYSTEM; MULTICATALYTIC PROTEINASE COMPLEX; TAT-MEDIATED TRANSACTIVATION; HUMAN PAPILLOMAVIRUS TYPE-16; MOLECULAR-WEIGHT PROTEASES; SKELETAL-MUSCLE; SACCHAROMYCES-CEREVISIAE; IMMUNOGOLD LOCALIZATION; NUCLEAR ONCOPROTEINS	cDNA clone MS73 codes for an ATPase that is a regulatory subunit of the 26 S proteasome, Reverse transcriptase polymerase chain reaction analysis demonstrates that the expression of the gene dramatically increases in the pre-eclosion period, Western analyses show increases in other related ATPases including MS73, MSS1, and mts2 but not TBP1. A similar increase in the 30-kDa subunit of the 20 S proteasome occurs. There are accompanying large changes in the peptidase activities of the 26 S proteasome. Relative to the 30-kDa subunit, there is no change in MSS1 and MS73, a 3-fold increase in mts2, and a B-fold decline in TBP1. A large increase in the concentration of 26 S proteasomes together with extensive regulatory reprogramming may facilitate rapid muscular proteolysis.	UNIV NOTTINGHAM,QUEENS MED CTR,SCH MED,DEPT BIOCHEM,NOTTINGHAM NG7 2UH,ENGLAND; UNIV BATH,DEPT BIOCHEM & BIOL SCI,BATH BA2 7AY,AVON,ENGLAND; HUMBOLDT UNIV BERLIN,FAC MED CHARITE,INST BIOCHEM,D-10115 BERLIN,GERMANY; UNIV TOKUSHIMA,INST ENZYME RES,TOKUSHIMA 770,JAPAN; WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND	University of Nottingham; University of Bath; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Tokushima University; University of Edinburgh			Reynolds, Stuart/AAI-6616-2021; COLLEAUX, Laurence/H-6455-2017; COLLEAUX, LAURENCE/AAA-8144-2022	Reynolds, Stuart/0000-0001-5043-0242; COLLEAUX, LAURENCE/0000-0002-0987-7648	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; AKIYAMA K, 1994, FEBS LETT, V343, P85, DOI 10.1016/0014-5793(94)80612-8; Alber T, 1992, CURR OPIN GENET DEV, V2, P205, DOI 10.1016/S0959-437X(05)80275-8; ARMON T, 1990, J BIOL CHEM, V265, P20723; BEAULATION J, 1977, J MORPHOL, V154, P39, DOI 10.1002/jmor.1051540104; BELL RA, 1976, ANN ENTOMOL SOC AM, V69, P365, DOI 10.1093/aesa/69.2.365; BENNETT MR, 1994, CIRC RES, V74, P525, DOI 10.1161/01.RES.74.3.525; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; BOES B, 1994, J EXP MED, V179, P901, DOI 10.1084/jem.179.3.901; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CENCIARELLI C, 1992, SCIENCE, V257, P795, DOI 10.1126/science.1323144; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHU-PING M, 1992, Journal of Biological Chemistry, V267, P10515; CIECHANOVER A, 1991, P NATL ACAD SCI USA, V88, P139, DOI 10.1073/pnas.88.1.139; CLARKMAGUIRE S, 1994, GENETICS, V136, P533; CONFALONIERI F, 1994, J MOL BIOL, V235, P396, DOI 10.1016/S0022-2836(05)80047-6; COUX O, 1992, FEBS LETT, V300, P49, DOI 10.1016/0014-5793(92)80162-A; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DJABALLAH H, 1992, BIOCHEMISTRY-US, V31, P4133, DOI 10.1021/bi00131a033; DOHERTY FJ, 1989, BIOCHEM J, V263, P47, DOI 10.1042/bj2630047; DRISCOLL J, 1990, J BIOL CHEM, V265, P4789; DUBIEL W, 1994, BIOL CHEM H-S, V375, P237, DOI 10.1515/bchm3.1994.375.4.237; DUBIEL W, 1993, FEBS LETT, V323, P276, DOI 10.1016/0014-5793(93)81356-5; DUBIEL W, 1992, J BIOL CHEM, V267, P22699; EAKLE KA, 1988, MOL CELL BIOL, V8, P4098, DOI 10.1128/MCB.8.10.4098; EDWARDS SN, 1994, J CELL BIOL, V124, P537, DOI 10.1083/jcb.124.4.537; Ephrussi B, 1936, AM NAT, V70, P218, DOI 10.1086/280658; ERDMANN R, 1991, CELL, V64, P499, DOI 10.1016/0092-8674(91)90234-P; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; EYTAN E, 1993, J BIOL CHEM, V268, P4668; FAGAN JM, 1987, BIOCHEM J, V243, P335, DOI 10.1042/bj2430335; FAHRBACH SE, 1994, J COMP NEUROL, V343, P464, DOI 10.1002/cne.903430309; FALKENBURG PE, 1988, NATURE, V331, P190, DOI 10.1038/331190a0; FROLICH KU, 1991, J CELL BIOL, V114, P443; FRUH K, 1994, EMBO J, V13, P3236, DOI 10.1002/j.1460-2075.1994.tb06625.x; GARCIAMARTINEZ C, 1993, FEBS LETT, V323, P211, DOI 10.1016/0014-5793(93)81341-V; GARCIAMARTINEZ C, 1994, BIOCHEM BIOPH RES CO, V201, P682, DOI 10.1006/bbrc.1994.1754; GERARD GF, 1988, FOCUS BETHESDA, V10, P12; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; GORDON C, 1993, NATURE, V366, P355, DOI 10.1038/366355a0; GROPPER R, 1991, J BIOL CHEM, V266, P3602; HAASS C, 1989, EXP CELL RES, V180, P243, DOI 10.1016/0014-4827(89)90228-0; HARLEY CB, 1987, GENE ANAL TECH, V4, P17, DOI 10.1016/0735-0651(87)90013-6; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HERMIDA L, 1993, FASEB J, V7, pA1187; HERSHKO A, 1991, J BIOL CHEM, V266, P16376; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; HINGAMP PM, 1992, EMBO J, V11, P361, DOI 10.1002/j.1460-2075.1992.tb05058.x; HOUGH R, 1987, J BIOL CHEM, V262, P8303; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; HUNT LT, 1977, BIOCHEM BIOPH RES CO, V74, P650, DOI 10.1016/0006-291X(77)90352-7; ISHIDA N, 1993, FEBS LETT, V324, P345, DOI 10.1016/0014-5793(93)80148-N; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; JENTSCH S, 1992, ANNU REV GENET, V26, P179, DOI 10.1146/annurev.ge.26.120192.001143; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KOLLER KJ, 1987, NATURE, V325, P542, DOI 10.1038/325542a0; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LASZLO L, 1991, FEBS LETT, V279, P175, DOI 10.1016/0014-5793(91)80142-P; LASZLO L, 1990, FEBS LETT, V261, P365, DOI 10.1016/0014-5793(90)80593-8; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; LOW P, 1993, FEBS LETT, V316, P152, DOI 10.1016/0014-5793(93)81205-E; MEDINA R, 1991, BIOMED BIOCHIM ACTA, V50, P347; MIAN IS, 1993, TRENDS BIOCHEM SCI, V18, P125; MURAKAMI K, 1986, P NATL ACAD SCI USA, V83, P7588, DOI 10.1073/pnas.83.20.7588; MURALIDHAR MG, 1993, NEURON, V11, P253, DOI 10.1016/0896-6273(93)90182-Q; NAKAI M, 1993, J BIOL CHEM, V268, P24262; NELBOCK P, 1990, SCIENCE, V248, P1650, DOI 10.1126/science.2194290; NOTHWANG HG, 1992, NUCLEIC ACIDS RES, V20, P1959, DOI 10.1093/nar/20.8.1959; OHANA B, 1993, P NATL ACAD SCI USA, V90, P135; ORINO E, 1991, FEBS LETT, V284, P206, DOI 10.1016/0014-5793(91)80686-W; PETERS JM, 1994, J BIOL CHEM, V269, P7709; PETERS JM, 1990, EMBO J, V9, P1757, DOI 10.1002/j.1460-2075.1990.tb08300.x; PLEASURE IT, 1993, NATURE, V365, P459, DOI 10.1038/365459a0; PRINCE SR, 1994, CLIN RES, V42, pA220; RAFF MC, 1994, SCIENCE, V264, P668, DOI 10.1126/science.8171317; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; SAMUELS RI, 1993, ARCH INSECT BIOCHEM, V24, P33, DOI 10.1002/arch.940240104; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASSONECORSI P, 1988, NATURE, V336, P692, DOI 10.1038/336692a0; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEID MP, 1975, SCIENCE, V190, P1211, DOI 10.1126/science.1081736; SCHMID HP, 1984, EMBO J, V3, P29, DOI 10.1002/j.1460-2075.1984.tb01757.x; SCHMID SR, 1992, MOL MICROBIOL, V6, P283, DOI 10.1111/j.1365-2958.1992.tb01470.x; SCHNALL R, 1994, YEAST, V10, P1141, DOI 10.1002/yea.320100903; SCHWARTZ LM, 1990, P NATL ACAD SCI USA, V87, P6594, DOI 10.1073/pnas.87.17.6594; SCHWARTZ LM, 1983, DEV BIOL, V99, P103, DOI 10.1016/0012-1606(83)90257-9; SCHWARTZ LM, 1990, NEURON, V5, P411, DOI 10.1016/0896-6273(90)90080-Y; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; SHIBUYA H, 1992, NATURE, V357, P700, DOI 10.1038/357700a0; SIEGELMAN M, 1986, SCIENCE, V231, P823, DOI 10.1126/science.3003913; STOCKER RF, 1978, CELL TISSUE RES, V191, P317; SWAFFIELD JC, 1992, NATURE, V357, P698, DOI 10.1038/357698a0; TAYLOR HM, 1974, J COMP PHYSIOL, V90, P367, DOI 10.1007/BF00694177; TOBIAS JW, 1991, J BIOL CHEM, V266, P12021; TSUBUKI S, 1994, FEBS LETT, V344, P229, DOI 10.1016/0014-5793(94)00388-2; UDVARDY A, 1993, J BIOL CHEM, V268, P9055; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WANG AM, 1989, P NATL ACAD SCI USA, V86, P9717, DOI 10.1073/pnas.86.24.9717; WAXMAN L, 1987, J BIOL CHEM, V262, P2451; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; WILSON DW, 1989, NATURE, V339, P355, DOI 10.1038/339355a0; WING SS, 1993, AM J PHYSIOL, V264, pE668, DOI 10.1152/ajpendo.1993.264.4.E668; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; ZWICKL P, 1992, BIOCHEMISTRY-US, V31, P964, DOI 10.1021/bi00119a004	111	132	134	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1850	1858		10.1074/jbc.270.4.1850	http://dx.doi.org/10.1074/jbc.270.4.1850			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829521	hybrid			2022-12-27	WOS:A1995QD20400056
J	BRADY, JP; KANTOROW, M; SAX, CM; DONOVAN, DM; PIATIGORSKY, J				BRADY, JP; KANTOROW, M; SAX, CM; DONOVAN, DM; PIATIGORSKY, J			MURINE TRANSCRIPTION FACTOR ALPHA-A-CRYSTALLIN BINDING-PROTEIN-I - COMPLETE SEQUENCE, GENE STRUCTURE, EXPRESSION, AND FUNCTIONAL INHIBITION VIA ANTISENSE RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; NF-KAPPA-B; ZINC-FINGER PROTEIN; MESSENGER-RNA; EUKARYOTIC CELLS; RAT TESTIS; MOUSE; ENHANCER; PROMOTER; DNA	alpha A-crystallin binding protein I (alpha A-CRYBP1) is a ubiquitously expressed DNA binding protein that was previously identified by its ability to interact with a functionally important sequence in the mouse alpha A-crystallin gene promoter, Here, we have cloned a single copy gene with 10 exons spanning greater than 70 kb of genomic DNA that encodes alpha A-CRYBP1. The mouse alpha A-CRYBP1 gene specifies a 2,688-amino acid protein with 72% amino acid identity to its human homologue, PRDII-BF1. Both the human and the mouse proteins contain two sets of consensus C2H2 zinc fingers at each end as well a central nonconsensus zinc finger. The alpha A-CRYBP1 gene produces a 9.5-kb transcript in II different tissues as well as a testis-specific, 7.7 kb transcript, alpha A-CRYBP1 cDNA clones were isolated from adult mouse brain and testis as well as from cell lines derived from mouse lens (alpha TN4-1) and muscle (C2C12). A single clone isolated from the muscle C2C12 library contains an additional exon near the 5'-end that would prevent production of a functional protein if the normal translation start site were utilized; however, there is another potential initiation codon located downstream that is in frame with the rest of the coding region, In addition, we identified multiple cDNAs from the testis in which the final intron is still present. Finally, we used an antisense expression construct derived from an alpha A-CRYBP1 cDNA clone to provide the first functional evidence that alpha A-CRYBP1 regulates gene expression, When introduced into the alpha TN4-1 mouse lens cell line, the antisense construct significantly inhibited expression from a heterologous promoter that utilized the alpha A-CRYBP1 binding site as an enhancer.	NEI,MOLEC & DEV BIOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)								BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; BALDWIN AS, 1990, MOL CELL BIOL, V10, P1406, DOI 10.1128/MCB.10.4.1406; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CHEN LT, 1994, MOL CELL BIOL, V14, P2140; COHEN JB, 1989, CELL, V58, P461, DOI 10.1016/0092-8674(89)90427-3; COLBEREGARAPIN F, 1981, J MOL BIOL, V150, P1, DOI 10.1016/0022-2836(81)90321-1; DARNELL JE, 1978, SCIENCE, V202, P1257, DOI 10.1126/science.364651; DONOVAN DM, 1992, J MOL EVOL, V35, P337, DOI 10.1007/BF00161171; FAN CM, 1990, GENE DEV, V4, P29, DOI 10.1101/gad.4.1.29; FISCHMAN K, 1990, MOL CELL BIOL, V10, P146, DOI 10.1128/MCB.10.1.146; FOO NC, 1991, ENDOCRINOLOGY, V128, P2118, DOI 10.1210/endo-128-4-2118; GARRETT JE, 1989, MOL CELL BIOL, V9, P4381, DOI 10.1128/MCB.9.10.4381; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAKE LE, 1993, J BIOL CHEM, V268, P4788; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; JEANNOTTE L, 1987, MOL ENDOCRINOL, V1, P749, DOI 10.1210/mend-1-10-749; KANTOROW M, 1993, GENE, V131, P159, DOI 10.1016/0378-1119(93)90289-F; KING CR, 1983, CELL, V32, P707, DOI 10.1016/0092-8674(83)90056-9; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; MAEKAWA T, 1989, J BIOL CHEM, V264, P14591; MANIATIS T, 1992, TRANSCRIPTIONAL REGU, P1193; MEIJER D, 1987, EMBO J, V6, P4041, DOI 10.1002/j.1460-2075.1987.tb02749.x; MITCHELMORE C, 1991, NUCLEIC ACIDS RES, V19, P141, DOI 10.1093/nar/19.1.141; MUCHARDT C, 1992, J VIROL, V66, P244, DOI 10.1128/JVI.66.1.244-250.1992; NAKAMURA T, 1990, MOL CELL BIOL, V10, P3700, DOI 10.1128/MCB.10.7.3700; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; NIELSEN DA, 1983, P NATL ACAD SCI USA, V82, P7815; PIATIGORSKY J, 1989, FASEB J, V3, P1933, DOI 10.1096/fasebj.3.8.2656357; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; RON D, 1991, MOL CELL BIOL, V11, P2887, DOI 10.1128/MCB.11.5.2887; RUSTGI AK, 1990, P NATL ACAD SCI USA, V87, P8707, DOI 10.1073/pnas.87.22.8707; Sambrook J, 1989, MOL CLONING LABORATO; SAMUELS ME, 1991, MOL CELL BIOL, V11, P3584, DOI 10.1128/MCB.11.7.3584; SAX CM, 1990, MOL CELL BIOL, V10, P6813, DOI 10.1128/MCB.10.12.6813; SHAPER NL, 1990, P NATL ACAD SCI USA, V87, P791, DOI 10.1073/pnas.87.2.791; TAKAYAMA KM, 1990, CRIT REV BIOCHEM MOL, V25, P155, DOI 10.3109/10409239009090608; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; TREZISE AEO, 1993, HUM MOL GENET, V2, P801, DOI 10.1093/hmg/2.6.801; VANTVEER LJ, 1992, P NATL ACAD SCI USA, V89, P8971, DOI 10.1073/pnas.89.19.8971; WAEBER G, 1992, ENDOCRINOLOGY, V131, P2010, DOI 10.1210/en.131.4.2010; WALDMAN AS, 1992, CRIT REV ONCOL HEMAT, V12, P49, DOI 10.1016/1040-8428(92)90064-W; WU LC, 1993, NUCLEIC ACIDS RES, V21, P5067, DOI 10.1093/nar/21.22.5067; ZAKERI ZF, 1987, MOL CELL BIOL, V7, P1791, DOI 10.1128/MCB.7.5.1791	45	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1221	1229		10.1074/jbc.270.3.1221	http://dx.doi.org/10.1074/jbc.270.3.1221			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836383	hybrid			2022-12-27	WOS:A1995QB15600038
J	MATUSLEIBOVITCH, N; NUSSENZVEIG, DR; GERSHENGORN, MC; ORON, Y				MATUSLEIBOVITCH, N; NUSSENZVEIG, DR; GERSHENGORN, MC; ORON, Y			TRUNCATION OF THE THYROTROPIN-RELEASING-HORMONE RECEPTOR CARBOXYL TAIL CAUSES CONSTITUTIVE ACTIVITY AND LEADS TO IMPAIRED RESPONSIVENESS IN XENOPUS OOCYTES AND ATT20 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT PITUITARY-CELLS; BETA-2-ADRENERGIC RECEPTOR; INOSITOL TRISPHOSPHATE; MUSCARINIC RESPONSES; MUTATION; CALCIUM; INTERNALIZATION; DESENSITIZATION; SEQUESTRATION; ACTIVATION	We studied the activity of a truncated thyrotropin-releasing hormone receptor (TRH-R), which lacks the last 59 amino acids of the carboxyl tail, where Cys-335 was mutated to a stop codon (C335Stop) (Nussenzveig, D. R., Heinflink, M., and Gershengorn, M. C. (1993) J. Biol. Chem. 268, 2389-2392). In Xenopus laevis oocytes expressing C335Stop TRH-Rs, TRH binding was higher, whereas chloride current, Ca-45(2+) efflux, and [Ca2+](i) responses evoked by TRH were 23, 39, and 21%, respectively, of those in oocytes expressing wild type mouse pituitary TRH-Rs (WT TRH-Rs). In oocytes expressing C335Stop TRH-Rs, basal Ca-45(2+) efflux and [Ca2+](i) were twice those in oocytes expressing WT TRH-Rs; chelation of Ca2+ caused a rapid increase in holding current, which is consistent with basal activation; and coexpression with other receptors caused inhibition of the responses to the other cognate agonists. In AtT20 pituitary cells stably expressing C335Stop TRH-Rs, thyrotropin-releasing hormone (TRH)-independent inositol phosphate formation was 1.32 +/- 0.11-fold higher, basal [Ca2+](i) was 1.8 +/- 0.2-fold higher, and the [Ca2+](i) response to TRH was much lower than in cells expressing WT TRH-Rs. We conclude that a TRH-R mutant truncated at Cys-335 exhibits constitutive activity that results in desensitization of the response to TRH.	TEL AVIV UNIV, SACKLER FAC MED, DEPT PHYSIOL & PHARMACOL, IL-69978 RAMAT AVIV, ISRAEL; CUNY, NEW YORK HOSP, COLL MED, DEPT MED, DIV MOLEC MED, NEW YORK, NY 10021 USA	Tel Aviv University; Sackler Faculty of Medicine; NewYork-Presbyterian Hospital					NIDDK NIH HHS [DK43036] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043036] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AIZAWA T, 1985, ENDOCRINOLOGY, V116, P909, DOI 10.1210/endo-116-3-909; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; BUCK F, 1991, BIOCHEM BIOPH RES CO, V178, P1421, DOI 10.1016/0006-291X(91)91052-E; CHEUNG AH, 1989, MOL PHARMACOL, V35, P132; DASCAL N, 1984, J PHYSIOL-LONDON, V352, P551, DOI 10.1113/jphysiol.1984.sp015310; GERSHENGORN MC, 1994, J BIOL CHEM, V269, P6779; GOLDBERG G, 1992, PFLUG ARCH EUR J PHY, V420, P313, DOI 10.1007/BF00374464; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HERTEL C, 1990, J BIOL CHEM, V265, P17988; IMAI A, 1986, P NATL ACAD SCI USA, V83, P8540, DOI 10.1073/pnas.83.22.8540; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; LIPINSKY D, 1993, PFLUG ARCH EUR J PHY, V425, P140, DOI 10.1007/BF00374514; LUPUMEIRI M, 1990, PFLUG ARCH EUR J PHY, V417, P391, DOI 10.1007/BF00370658; LUPUMEIRI M, 1990, FEBS LETT, V262, P165, DOI 10.1016/0014-5793(90)80180-Q; LUPUMEIRI M, 1993, CELL CALCIUM, V14, P101, DOI 10.1016/0143-4160(93)90080-P; MATUSLEIBOVITCH N, 1992, BIOCHEM J, V285, P753, DOI 10.1042/bj2850753; MATUSLEIBOVITCH N, 1994, BIOCHEM J, V303, P129, DOI 10.1042/bj3030129; NUSSENZVEIG DR, 1993, J BIOL CHEM, V268, P2389; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; ORON Y, 1987, MOL ENDOCRINOL, V1, P918, DOI 10.1210/mend-1-12-918; OVCHINNIKOV YA, 1988, FEBS LETT, V230, P1, DOI 10.1016/0014-5793(88)80628-8; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; REN Q, 1993, J BIOL CHEM, V268, P16483; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; RODRIGUEZ MC, 1992, MOL ENDOCRINOL, V6, P327, DOI 10.1210/me.6.3.327; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SHAPIRA H, 1990, BIOPHYS J, V57, P1281, DOI 10.1016/S0006-3495(90)82646-1; SHENKER A, 1993, NATURE, V365, P652, DOI 10.1038/365652a0; SINGER D, 1990, PFLUG ARCH EUR J PHY, V416, P7, DOI 10.1007/BF00370215; STRADER CD, 1987, CELL, V49, P855, DOI 10.1016/0092-8674(87)90623-4; STRAUB RE, 1989, MOL ENDOCRINOL, V3, P907, DOI 10.1210/mend-3-6-907; STRAUB RE, 1990, P NATL ACAD SCI USA, V87, P9514, DOI 10.1073/pnas.87.24.9514; VALIQUETTE M, 1993, BIOCHEMISTRY-US, V32, P4979, DOI 10.1021/bi00070a002	33	42	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1041	1047		10.1074/jbc.270.3.1041	http://dx.doi.org/10.1074/jbc.270.3.1041			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836357	hybrid			2022-12-27	WOS:A1995QB15600012
J	PETERSON, SR; JESCH, SA; CHAMBERLIN, TN; DVIR, A; RABINDRAN, SK; WU, C; DYNAN, WS				PETERSON, SR; JESCH, SA; CHAMBERLIN, TN; DVIR, A; RABINDRAN, SK; WU, C; DYNAN, WS			STIMULATION OF THE DNA-DEPENDENT PROTEIN-KINASE BY RNA-POLYMERASE-II TRANSCRIPTIONAL ACTIVATOR PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL TRANSACTIVATION DOMAIN; HEAT-SHOCK PROTEIN; GAL4 DERIVATIVES; GENE-TRANSCRIPTION; BINDING ACTIVITY; KU-AUTOANTIGEN; CELL EXTRACTS; PHOSPHORYLATION; TEMPLATE; INVITRO	The DNA dependent protein kinase (DNA-PK) phosphorylates RNA polymerase II and a number of transcription factors. We now show that the activity of DNA-PK is directly stimulated by certain transcriptional activator proteins, including the human heat shock transcription factor 1 (HSF1) and a transcriptionally active N-terminal 147 amino acid GAL4 derivative. Stimulation of DNA-PK activity required specific sequences in the activator proteins outside the minimal DNA binding domains. The stimulation of DNA-PK activity also required DNA and was greater with DNA containing relevant activator binding sites. Comparison of different HSF binding fragments showed that optimal stimulation occurred when two HSF binding sites were present. Stimulation with HSF and GALE was synergistic with Ku protein, another regulator of DNA-PK activity. DNA-PK is tightly associated with the transcriptional template, and an increase in its activity could potentially influence transcription through the phosphorylation of proteins associated with the transcription complex.	UNIV COLORADO,DEPT CHEM & BIOCHEM,BOULDER,CO 80309; NCI,BIOCHEM LAB,BETHESDA,MD 20892	University of Colorado System; University of Colorado Boulder; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)				Dynan, William/0000-0002-4045-5662	NIGMS NIH HHS [GM 35866] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035866] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMSTERCHODER O, 1992, SCIENCE, V257, P1395, DOI 10.1126/science.1382312; ARIAS JA, 1991, J BIOL CHEM, V266, P8055; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BANNISTER AJ, 1993, NUCLEIC ACIDS RES, V21, P1289, DOI 10.1093/nar/21.5.1289; BECKER PB, 1991, P NATL ACAD SCI USA, V88, P4109, DOI 10.1073/pnas.88.10.4109; CAREY M, 1990, NATURE, V345, P361, DOI 10.1038/345361a0; CARTER T, 1990, MOL CELL BIOL, V10, P6460, DOI 10.1128/MCB.10.12.6460; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; DAHMUS ME, 1992, TRANSCRIPTIONAL REGU, P109; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DUBOIS MF, 1993, FEBS LETT, V324, P191, DOI 10.1016/0014-5793(93)81391-C; DVIR A, 1992, P NATL ACAD SCI USA, V89, P11920, DOI 10.1073/pnas.89.24.11920; DVIR A, 1993, J BIOL CHEM, V268, P10440; DYNAN WS, 1987, GENETIC ENG PRINCIPL, V9, P75; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; IIJIMA S, 1992, EUR J BIOCHEM, V206, P595, DOI 10.1111/j.1432-1033.1992.tb16964.x; Jackson S P, 1992, Trends Cell Biol, V2, P104, DOI 10.1016/0962-8924(92)90014-E; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LARSON JS, 1988, NATURE, V335, P372, DOI 10.1038/335372a0; LAYBOURN PJ, 1990, J BIOL CHEM, V265, P13165; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; LEESMILLER SP, 1991, CANCER CELL-MON REV, V3, P341; LEESMILLER SP, 1989, J BIOL CHEM, V264, P17275; LEESMILLER SP, 1990, MOL CELL BIOL, V10, P6472, DOI 10.1128/MCB.10.12.6472; LEGAGNEUX V, 1990, EUR J BIOCHEM, V193, P121, DOI 10.1111/j.1432-1033.1990.tb19312.x; LIN YS, 1988, CELL, V54, P659, DOI 10.1016/S0092-8674(88)80010-2; LIN YS, 1991, NATURE, V353, P569, DOI 10.1038/353569a0; LIS J, 1993, CELL, V74, P1, DOI 10.1016/0092-8674(93)90286-Y; LIU SH, 1993, J BIOL CHEM, V268, P21147; LUSCHER B, 1990, NATURE, V344, P517, DOI 10.1038/344517a0; OBRIEN T, 1994, NATURE, V370, P75, DOI 10.1038/370075a0; PETERSON SR, 1992, GENE DEV, V6, P426, DOI 10.1101/gad.6.3.426; PETERSON SR, 1993, THESIS U COLORADO; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; STRINGER KF, 1990, NATURE, V345, P783, DOI 10.1038/345783a0; WALKER AI, 1985, EMBO J, V4, P139, DOI 10.1002/j.1460-2075.1985.tb02328.x; WEEKS JR, 1993, GENE DEV, V7, P2329, DOI 10.1101/gad.7.12a.2329; WELCH PJ, 1993, CELL, V75, P779, DOI 10.1016/0092-8674(93)90497-E; WORKMAN JL, 1991, CELL, V64, P533, DOI 10.1016/0092-8674(91)90237-S	43	63	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1449	1454		10.1074/jbc.270.3.1449	http://dx.doi.org/10.1074/jbc.270.3.1449			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836414	hybrid			2022-12-27	WOS:A1995QB15600071
J	URADE, Y; TANAKA, T; EGUCHI, N; KIKUCHI, M; KIMURA, H; TOH, H; HAYAISHI, O				URADE, Y; TANAKA, T; EGUCHI, N; KIKUCHI, M; KIMURA, H; TOH, H; HAYAISHI, O			STRUCTURAL-SIGNIFICANCE AND FUNCTIONAL-SIGNIFICANCE OF CYSTEINE RESIDUES OF GLUTATHIONE-INDEPENDENT PROSTAGLANDIN-D SYNTHASE - IDENTIFICATION OF CYS(65) AS AN ESSENTIAL THIOL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOL-BINDING-PROTEIN; VESICULAR GLAND MICROSOMES; BOVINE BETA-LACTOGLOBULIN; RAT-BRAIN; D SYNTHETASE; CEREBROSPINAL-FLUID; CHOROID-PLEXUS; PURIFICATION; SLEEP; CDNA	Glutathione-independent prostaglandin D synthase in rat brain is composed of 189 amino acid residues and catalyzes the isomerization of prostaglandin H-2,to prostaglandin D-2, an endogenous sleep-promoting substance. This enzyme is the only enzyme among members of the lipocalin superfamily composed of various secretory lipophilic ligand-carrier proteins and is recently identified to be a beta-trace protein, a major constituent of human cerebrospinal fluid. We expressed the active enzyme in Escherichia coli and then systematically substituted all cysteine residues of the Delta 1-29 enzyme at positions of 65, 89, and 186 with alanine or serine. The parent and mutant enzymes were purified to apparent homogeneity with a recovery of similar to 30% by chromatography with Sephadex G-50 and S-Sepharose, by which all the enzymes showed identical elution profiles. The purified enzymes, irrespective of the mutation, showed almost the same circular dichroism spectral characteristics as displayed by a highly ordered beta-structure. The recombinant enzymes containing Cys(65) showed the activity comparable with that of the enzyme purified hom rat brain (similar to 3 mu mol/min/mg of protein) in the presence, but not in the absence, of sulfhydryl compounds. However, all of the single, double, and triple mutants without Cys(65) lost the enzyme activity. The purified Delta 1-29 Ala(89,186) enzyme was inactivated reversibly by conjugation with glutathione at Cys(65) and irreversibly by the stoichiometric chemical modification with N-ethylmaleimide. These results indicate that Cys(65) is an essential thiol of the enzyme and that both the intrinsic and extrinsic sulfhydryl groups are necessary for nonoxidative rearrangement of 9,11-endoperoxide of prostaglandin H-2 to produce prostaglandin D-2 catalyzed by the enzyme.	OSAKA BIOSCI INST,DEPT MOLEC BEHAV BIOL,SUITA,OSAKA 565,JAPAN; PROT ENGN RES INST,SUITA,OSAKA 565,JAPAN; KYUSHU INST TECHNOL,IIZUKA,FUKUOKA 820,JAPAN	Kyushu Institute of Technology								ACHEN MG, 1992, J BIOL CHEM, V267, P23170; ALEXANDER LJ, 1989, NUCLEIC ACIDS RES, V17, P6739, DOI 10.1093/nar/17.16.6739; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BERGER MP, 1991, COMPUT APPL BIOSCI, V7, P479; COLANTUONI V, 1983, NUCLEIC ACIDS RES, V11, P7769, DOI 10.1093/nar/11.22.7769; COWAN SW, 1990, PROTEINS, V8, P44, DOI 10.1002/prot.340080108; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FENG DF, 1987, J MOL BIOL, V195, P351; HAYAISHI O, 1991, FASEB J, V5, P2575, DOI 10.1096/fasebj.5.11.1907936; HAYAISHI O, 1993, J LIPID MEDIATOR, V6, P429; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HOFFMANN A, 1993, J NEUROCHEM, V61, P451; IGARASHI M, 1992, P NATL ACAD SCI USA, V89, P5376, DOI 10.1073/pnas.89.12.5376; ISLAM F, 1991, ARCH BIOCHEM BIOPHYS, V289, P161, DOI 10.1016/0003-9861(91)90456-S; ITO S, 1989, PROSTAG LEUKOTR ESS, V37, P219, DOI 10.1016/0952-3278(89)90033-1; JOHNSON CW, 1990, PROTEIN-STRUCT FUNCT, V7, P205; LANDS W, 1971, ANN NY ACAD SCI, V180, P107, DOI 10.1111/j.1749-6632.1971.tb53190.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATSUMURA H, 1991, P NATL ACAD SCI USA, V88, P9046, DOI 10.1073/pnas.88.20.9046; MATSUMURA H, 1994, IN PRESS P NATL ACAD, V91; MCLACHLAN AD, 1971, J MOL BIOL, V61, P409, DOI 10.1016/0022-2836(71)90390-1; MONACO HL, 1987, J MOL BIOL, V197, P695, DOI 10.1016/0022-2836(87)90476-1; MOONEN P, 1982, METHOD ENZYMOL, V86, P84; NAGATA A, 1991, P NATL ACAD SCI USA, V88, P4020, DOI 10.1073/pnas.88.9.4020; OGINO N, 1977, J BIOL CHEM, V252, P890; PEITSCH MC, 1991, TRENDS BIOCHEM SCI, V16, P363, DOI 10.1016/0968-0004(91)90149-P; PENTREATH VW, 1990, T ROY SOC TROP MED H, V84, P795, DOI 10.1016/0035-9203(90)90085-S; PERVAIZ S, 1987, FASEB J, V1, P209, DOI 10.1096/fasebj.1.3.3622999; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TANAKA Y, 1987, J BIOL CHEM, V262, P1374; Toh H, 1992, Mediators Inflamm, V1, P223, DOI 10.1155/S0962935192000346; TOWNEND R, 1967, J BIOL CHEM, V242, P4538; ULLRICH V, 1994, ANGEW CHEM INT EDIT, V33, P1911, DOI 10.1002/anie.199419111; URADE Y, 1989, J BIOL CHEM, V264, P1041; URADE Y, 1987, J BIOL CHEM, V262, P15132; URADE Y, 1993, P NATL ACAD SCI USA, V90, P9070, DOI 10.1073/pnas.90.19.9070; URADE Y, 1985, J BIOL CHEM, V260, P2410; URADE Y, 1994, IN PRESS J LIPID MED; WATANABE K, 1994, BIOCHEM BIOPH RES CO, V203, P1110, DOI 10.1006/bbrc.1994.2297; WHITE DM, 1992, J BIOL CHEM, V267, P23202	41	72	74	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1422	1428		10.1074/jbc.270.3.1422	http://dx.doi.org/10.1074/jbc.270.3.1422			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836410	hybrid			2022-12-27	WOS:A1995QB15600067
J	VANLINT, J; SINNETTSMITH, J; ROZENGURT, E				VANLINT, J; SINNETTSMITH, J; ROZENGURT, E			EXPRESSION AND CHARACTERIZATION OF PKD, A PHORBOL ESTER AND DIACYLGLYCEROL-STIMULATED SERINE PROTEIN-KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C FAMILY; MITOGENIC RESPONSE; MOLECULAR-CLONING; REGULATORY DOMAIN; RAT-BRAIN; BINDING; IDENTIFICATION; ZETA; PURIFICATION; SPECIFICITY	A novel protein kinase (named PKD) with an NH2-terminal region containing two cysteine-rich motifs has been expressed in COS-7 cells and identified as a receptor for phorbol esters. COS-7 cells transfected with a PKD cDNA construct (pcDNA3-PKD) exhibit a marked (4.8-fold) increase in [H-3]phorbol 12,13-dibutyrate binding. An antiserum raised against the COOH-terminal 15 amino acids of PKD specifically recognized a single 110-kDa band in PKD-transfected cells, PKD prepared by elution from immunoprecipitates with the immunizing peptide efficiently phosphorylated the synthetic peptide syntide-2. The enzyme only poorly phosphorylated a variant syntide-2 where arginine 4 has been replaced by an alanine. The addition of [H-3]phorbol 12,13-dibutyrate, 1-oleoyl-2-acetylglycerol, or 1,2-dioctanoyl-sn-glycerol in the presence of dioleoylphosphatidylserine stimulated the syntide-2 kinase activity of PKD in a synergistic fashion (4-6-fold), Furthermore, the autophosphorylation of PKD was strikingly stimulated by the same lipid activators (14-24-fold). Similar properties were found with PKD isolated from mouse lung. The substrate specificity of PKD is different from that of previously identified members of the protein kinase C family since it does not efficiently phosphorylate histone III-S, protamine sulfate, or a synthetic peptide based upon the conserved pseudosubstrate region of the protein kinase C family. Taken together, these data unambiguously establish PKD as a phorbol ester receptor and as a novel phospholipid/diacylglycerol-stimulated protein kinase.	IMPERIAL CANC RES FUND, GROWTH REGULAT LAB, LONDON WC2A 3PX, ENGLAND	Cancer Research UK			Van Lint, Johan/P-9073-2019	Van Lint, Johan/0000-0002-0275-571X				ARECES LB, 1994, J BIOL CHEM, V269, P19553; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BURNS DJ, 1991, J BIOL CHEM, V266, P18330; COLLINS MKL, 1982, J CELL PHYSIOL, V112, P42, DOI 10.1002/jcp.1041120108; DEKKER LV, 1993, J BIOL CHEM, V268, P19498; ERUSALIMSKY JD, 1991, J BIOL CHEM, V266, P7073; EXTON JH, 1990, J BIOL CHEM, V265, P1; GIBSON TJ, 1994, TRENDS BIOCHEM SCI, V19, P349, DOI 10.1016/0968-0004(94)90108-2; GUAN C, 1988, GENE, V67, P21; GULBINS E, 1994, MOL CELL BIOL, V14, P4749, DOI 10.1128/MCB.14.7.4749; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HUBBARD SR, 1991, SCIENCE, V254, P1776; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; KAZANIETZ MG, 1993, MOL PHARMACOL, V44, P298; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; MARAIS RM, 1989, EUR J BIOCHEM, V182, P129, DOI 10.1111/j.1432-1033.1989.tb14809.x; MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729; NAKANISHI H, 1992, J BIOL CHEM, V267, P16347; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1989, CANCER, V63, P1892, DOI 10.1002/1097-0142(19890515)63:10<1892::AID-CNCR2820631005>3.0.CO;2-Z; OHNO S, 1988, CELL, V53, P731, DOI 10.1016/0092-8674(88)90091-8; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; OSADA S, 1992, MOL CELL BIOL, V12, P3930, DOI 10.1128/MCB.12.9.3930; PEARS C, 1991, BIOCHEM J, V276, P257, DOI 10.1042/bj2760257; QUEST AFG, 1994, J BIOL CHEM, V269, P2953; RHEE SG, 1992, J BIOL CHEM, V267, P12393; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; SCHAAP D, 1990, EUR J BIOCHEM, V191, P431, DOI 10.1111/j.1432-1033.1990.tb19139.x; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P25, DOI 10.1016/0959-437X(94)90087-6; SELBIE LA, 1993, J BIOL CHEM, V268, P24296; SODERLING TR, 1990, J BIOL CHEM, V265, P1823; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; WAYS DK, 1992, J BIOL CHEM, V267, P4799; WEINSTEIN IB, 1988, CANCER RES, V48, P4135	36	151	152	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1455	1461		10.1074/jbc.270.3.1455	http://dx.doi.org/10.1074/jbc.270.3.1455			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836415	hybrid			2022-12-27	WOS:A1995QB15600072
J	KERN, G; KERN, D; SCHMID, FX; FISCHER, G				KERN, G; KERN, D; SCHMID, FX; FISCHER, G			A KINETIC-ANALYSIS OF THE FOLDING OF HUMAN CARBONIC-ANHYDRASE-II AND ITS CATALYSIS BY CYCLOPHILIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-TRANS-ISOMERIZATION; PROLYL ISOMERASE; PROLINE ISOMERIZATION; ENZYMATIC CATALYSIS; HOMOLOG NINAA; PROTEIN; ACID; RIBONUCLEASE-T1; MUTAGENESIS; COLLAGEN	The kinetics of unfolding and refolding of human carbonic anhydrase II (HCAII) and its catalysis by the peptidyl-prolyl-cis/trans-isomerase cyclophilin were investigated, HCAII contains 15 trans- and 2 cis-prolyl peptide bonds, and, when long-term denatured, virtually all unfolded molecules contain non-native prolyl isomers, In unfolding these molecules (U-s) are produced slowly in a biphasic process reflecting the isomerization of several trans-prolines and of one cis-proline. In refolding, the rapid formation of an intermediate of the molten globule type is followed by several slow prolyl isomerizations, which determine the rate of reactivation, By a short 10-s incubation in 5.0 M guanidinium chloride at 2 degrees C, unfolded HCAII species with all prolines still in the native conformation (U-f) could be produced, Surprisingly, only a fraction of U-f refolds rapidly, but the other molecules refold slowly. Evidently, some prolyl peptide bonds isomerize early in refolding, at the stage of the molten globule and as a consequence, molecules with incorrect prolyl isomers are formed in competition with the productive folding of U-f. This fraction of slow-folding molecules is strongly increased when cyclophilin is present, because it accelerates the formation of non-native prolyl isomers as long as the molecules remain in the molten globule state, Later cyclophilin catalyzes the isomerization of these prolyl peptide bonds toward the native state, which are stabilized in their conformation by further folding to the native state. This catalysis is very efficient, because only prolines that are accessible in the molten globule are involved in this sequence of isomerization and reisomerization.	UNIV BAYREUTH,BIOCHEM LAB,D-95440 BAYREUTH,GERMANY	University of Bayreuth	KERN, G (corresponding author), MAX PLANCK ARBEITSGRP ENZYMOL PEPTIDBINDUNG,WEINBERGWEG 16A,D-06120 HALLE,GERMANY.							BACHINGER HP, 1987, J BIOL CHEM, V262, P17144; CASSIM JY, 1969, BIOCHEMISTRY-US, V8, P1947, DOI 10.1021/bi00833a026; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; FRANSSON C, 1992, FEBS LETT, V296, P90, DOI 10.1016/0014-5793(92)80410-I; FRESKGARD PO, 1992, SCIENCE, V258, P466, DOI 10.1126/science.1357751; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRATHWOHL C, 1981, BIOPOLYMERS, V20, P2623, DOI 10.1002/bip.1981.360201209; IKAI A, 1979, ARCH BIOCHEM BIOPHYS, V190, P39; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010; KELLEY RF, 1984, BIOCHEMISTRY-US, V23, P5095, DOI 10.1021/bi00317a003; KERN G, 1994, FEBS LETT, V348, P145, DOI 10.1016/0014-5793(94)00591-5; KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P3061, DOI 10.1021/bi00464a024; KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P3053, DOI 10.1021/bi00464a023; LANG K, 1988, NATURE, V331, P453, DOI 10.1038/331453a0; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; LIN LN, 1988, BIOCHIM BIOPHYS ACTA, V956, P256, DOI 10.1016/0167-4838(88)90142-2; LODISH HF, 1991, J BIOL CHEM, V266, P14835; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; MARTENSSON LG, 1993, BIOCHEMISTRY-US, V32, P224, DOI 10.1021/bi00052a029; MATOUSCHEK A, 1990, NATURE, V346, P440, DOI 10.1038/346440a0; MCCOY LF, 1980, BIOCHEMISTRY-US, V19, P4738, DOI 10.1021/bi00562a003; MCCOY LF, 1981, BIOCHEMISTRY-US, V20, P3062, DOI 10.1021/bi00514a012; MUCKE M, 1992, BIOCHEMISTRY-US, V31, P7848; ONDEK B, 1992, J BIOL CHEM, V267, P16460; RAHFELD JU, 1994, FEBS LETT, V343, P65, DOI 10.1016/0014-5793(94)80608-X; SCHMID FX, 1993, ANNU REV BIOPH BIOM, V22, P123, DOI 10.1146/annurev.bb.22.060193.001011; SCHMID FX, 1978, P NATL ACAD SCI USA, V75, P4764, DOI 10.1073/pnas.75.10.4764; SCHMID FX, 1993, ADV PROTEIN CHEM, V44, P25, DOI 10.1016/S0065-3233(08)60563-X; SCHONBRUNNER ER, 1991, J BIOL CHEM, V266, P3630; SEMISOTNOV GV, 1987, FEBS LETT, V224, P9, DOI 10.1016/0014-5793(87)80412-X; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; VEERARAGHAVAN S, 1994, BIOCHEMISTRY-US, V33, P687, DOI 10.1021/bi00169a009	33	62	64	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					740	745		10.1074/jbc.270.2.740	http://dx.doi.org/10.1074/jbc.270.2.740			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822304	hybrid			2022-12-27	WOS:A1995QB81600038
J	MURPHY, C; BECKERS, J; RUTHER, U				MURPHY, C; BECKERS, J; RUTHER, U			REGULATION OF THE HUMAN C-REACTIVE PROTEIN GENE IN TRANSGENIC MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; INTERLEUKIN-6; INFLAMMATION; INDUCTION; PROMOTER; RNA	Human C-reactive protein (hCRP) is a major acute-phase reactant in man. The regulation of the hCRP gene in transgenic mice is similar to that in humans. To map DNA regions required for the correct regulation of the hCRP gene, several constructs have been generated, and their expression in transgenic mice has been analyzed. Constructs lacking DNA regions surrounding the poly(A) site of the gene are not expressed either before or after induction in transgenic mice. Minimal regions 540 base pairs upstream and 1.2 kilobases downstream of the hCRP gene are sufficient for liver-specific expression. Extended 5'- and 3'-flanking regions are required to silence the expression prior to induction. Our findings demonstrate that regulatory sequences shown to confer inducible expression of the hCRP gene in hepatoma cell lines are insufficient in transgenic mice.	EUROPEAN MOLEC BIOL LAB,D-69012 HEIDELBERG,GERMANY; HANNOVER MED SCH,INST MOLEK BIOL,D-30623 HANNOVER,GERMANY	European Molecular Biology Laboratory (EMBL); Hannover Medical School			Murphy, Carol/ABE-4282-2021; Beckers, Johannes/K-7237-2012	Murphy, Carol/0000-0003-1353-8558; Beckers, Johannes/0000-0001-7874-3822				ARCONE R, 1988, NUCLEIC ACIDS RES, V16, P3195, DOI 10.1093/nar/16.8.3195; BAUMANN H, 1989, IN VITRO CELL DEV, V25, P113; BENSI G, 1985, EMBO J, V4, P119, DOI 10.1002/j.1460-2075.1985.tb02325.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CILIBERTO G, 1987, EMBO J, V6, P4017, DOI 10.1002/j.1460-2075.1987.tb02745.x; CILIBERTO G, 1987, NUCLEIC ACIDS RES, V15, P5893; CLARK AR, 1993, BIOCHEM J, V296, P521, DOI 10.1042/bj2960521; DESIMONE V, 1987, EMBO J, V6, P2759, DOI 10.1002/j.1460-2075.1987.tb02570.x; GANTER U, 1989, EMBO J, V8, P3773, DOI 10.1002/j.1460-2075.1989.tb08554.x; GREAVES DR, 1990, CELL, V56, P979; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; HOGAN B, 1986, MANIPULATING MOUSE E; LI SP, 1990, J BIOL CHEM, V265, P4136; MAJELLO B, 1990, EMBO J, V9, P457, DOI 10.1002/j.1460-2075.1990.tb08131.x; MCKNIGHT RA, 1992, P NATL ACAD SCI USA, V89, P6943, DOI 10.1073/pnas.89.15.6943; NEZNANOV N, 1993, MOL CELL BIOL, V13, P2214, DOI 10.1128/MCB.13.4.2214; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; RUTHER U, 1993, ONCOGENE, V8, P87; TONIATTI C, 1990, EMBO J, V9, P4467, DOI 10.1002/j.1460-2075.1990.tb07897.x; TONIATTI C, 1990, MOL BIOL MED, V7, P199; WHITEHEAD AS, 1990, BIOCHEM J, V266, P283, DOI 10.1042/bj2660283; WILLIAMS M, 1991, GENE DEV, V5, P2352	22	35	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					704	708		10.1074/jbc.270.2.704	http://dx.doi.org/10.1074/jbc.270.2.704			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822299	hybrid			2022-12-27	WOS:A1995QB81600033
J	PLASCHKESCHLUTTER, A; BEHRENS, J; GHERARDI, E; BIRCHMEIER, W				PLASCHKESCHLUTTER, A; BEHRENS, J; GHERARDI, E; BIRCHMEIER, W			CHARACTERIZATION OF THE SCATTER FACTOR HEPATOCYTE GROWTH-FACTOR GENE PROMOTER - POSITIVE AND NEGATIVE REGULATORY ELEMENTS DIRECT GENE-EXPRESSION TO MESENCHYMAL CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; HUMAN FIBROBLASTS; MESSENGER-RNA; HEPATOCYTE; RECEPTOR; IDENTIFICATION; REGION; LIVER; DIFFERENTIATION; SECRETION	Scatter factor/hepatocyte growth factor (SF/HGF) and its receptor c-Met represent a paracrine signaling system involved in mesenchymal-epithelial interactions during development and during tumor progression. We have examined the promoters of the mouse and human SF/HGF genes by deletion mapping followed by CAT assays as well as by gel retardation and footprinting analysis. The promoter sequences are highly conserved (89.5% identity) up to position -453 from the major transcription start site but diverged considerably further upstream. Both promoters are active in mesenchymal but not epithelial cells thus reflecting the expression pattern of the SF/HGF gene in cells in vitro and in vivo. We have here identified two regulatory sequences in the SF/HGF promoter: a negative element at positions -239 to -258 and a positive element near the major transcription start site; specific deletions destroyed the activities of these elements. We were not able to localize elements on the SF/HGF promoter region that mediate the previously described effects of transforming growth factor beta, 12-O-tetradecanoylphorbol-13-acetate, and coculture of epithelial cells on SF/HGF gene expression. This study represents a first step toward understanding the intricately regulated and cell type-specific expression of the paracrine acting SF/HGF.	UNIV CAMBRIDGE, SCH MED, IMPERIAL CANC RES FUND, CELL INTERACT LAB, CAMBRIDGE CB2 2QH, ENGLAND	University of Cambridge	PLASCHKESCHLUTTER, A (corresponding author), MAX DELBRUCK CTR MOLEC MED, ROBERT ROSSLE STR 10, D-13125 BERLIN, GERMANY.		Gherardi, Ermanno/AAB-9608-2022	GHERARDI, ERMANNO/0000-0002-0016-2945				ARAVAMUDAN B, 1993, BIOCHEM BIOPH RES CO, V195, P346, DOI 10.1006/bbrc.1993.2050; BEHRENS J, 1991, P NATL ACAD SCI USA, V88, P11495, DOI 10.1073/pnas.88.24.11495; BIRCHMEIER C, 1993, ANNU REV CELL BIOL, V9, P511, DOI 10.1146/annurev.cb.09.110193.002455; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; CHEN YY, 1994, ONCOGENE, V9, P2269; ERLICH AH, 1989, PCR TECHNOLOGY PRINC, P61; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; GOHDA E, 1992, FEBS LETT, V301, P107, DOI 10.1016/0014-5793(92)80220-B; GOHDA E, 1992, CELL BIOL INT REP, V16, P917, DOI 10.1016/S0309-1651(06)80171-2; GOYAL N, 1990, MOL CELL BIOL, V10, P1041, DOI 10.1128/MCB.10.3.1041; HIGASHIO K, 1990, BIOCHEM BIOPH RES CO, V170, P397, DOI 10.1016/0006-291X(90)91287-3; HU Z, 1991, AM J PATHOL, V142, P1823; KAMALATI T, 1992, J CELL SCI, V101, P323; KINOSHITA T, 1989, BIOCHEM BIOPH RES CO, V165, P1229, DOI 10.1016/0006-291X(89)92733-2; LIU YH, 1994, J BIOL CHEM, V269, P4152; LOKKER NA, 1992, EMBO J, V11, P2503, DOI 10.1002/j.1460-2075.1992.tb05315.x; MATSUMOTO K, 1992, P NATL ACAD SCI USA, V89, P3800, DOI 10.1073/pnas.89.9.3800; MEYER D, 1994, P NATL ACAD SCI USA, V91, P1064, DOI 10.1073/pnas.91.3.1064; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; MIYAZAWA K, 1991, BIOCHEMISTRY-US, V30, P9170, DOI 10.1021/bi00102a007; MIYAZAWA K, 1989, BIOCHEM BIOPH RES CO, V163, P967, DOI 10.1016/0006-291X(89)92316-4; MONTESANO R, 1991, CELL, V67, P9011; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NISHINO T, 1991, BIOCHEM BIOPH RES CO, V181, P323, DOI 10.1016/S0006-291X(05)81421-4; OKAJIMA A, 1993, EUR J BIOCHEM, V213, P113, DOI 10.1111/j.1432-1033.1993.tb17740.x; PELES E, 1993, EMBO J, V12, P961, DOI 10.1002/j.1460-2075.1993.tb05737.x; RAMADORI G, 1992, BIOCHEM BIOPH RES CO, V183, P739, DOI 10.1016/0006-291X(92)90545-V; ROSEN EM, 1990, BIOCHEM BIOPH RES CO, V168, P1082, DOI 10.1016/0006-291X(90)91140-N; RUBIN JS, 1991, P NATL ACAD SCI USA, V88, P415, DOI 10.1073/pnas.88.2.415; SAKAKURA T, 1991, INT REV CYTOL, V125, P165, DOI 10.1016/S0074-7696(08)61219-X; Sambrook J, 1989, MOL CLONING LABORATO; Saxen L., 1987, ORGANOGENESIS KIDNEY; SESLAR SP, 1993, CANCER RES, V53, P1233; SHIOTA G, 1992, P NATL ACAD SCI USA, V89, P373, DOI 10.1073/pnas.89.1.373; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; STERN CD, 1990, DEVELOPMENT, V110, P1271; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; TAMURA M, 1993, J BIOL CHEM, V268, P8140; TSUBOUCHI H, 1991, HEPATOLOGY, V13, P1; WEIDNER KM, 1990, J CELL BIOL, V111, P2097, DOI 10.1083/jcb.111.5.2097; WEIDNER KM, 1991, P NATL ACAD SCI USA, V88, P7001, DOI 10.1073/pnas.88.16.7001; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; ZARNEGAR R, 1991, BIOCHEM BIOPH RES CO, V177, P559, DOI 10.1016/0006-291X(91)92020-K; ZARNEGAR R, 1989, CANCER RES, V49, P3314	45	33	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					830	836		10.1074/jbc.270.2.830	http://dx.doi.org/10.1074/jbc.270.2.830			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822318	hybrid			2022-12-27	WOS:A1995QB81600052
J	VIADIU, H; OSUNA, J; FINK, AL; SOBERON, X				VIADIU, H; OSUNA, J; FINK, AL; SOBERON, X			A NEW TEM BETA-LACTAMASE DOUBLE MUTANT WITH BROADENED SPECIFICITY REVEALS SUBSTRATE-DEPENDENT FUNCTIONAL INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-LICHENIFORMIS 749/C; STAPHYLOCOCCUS-AUREUS PC1; CLASS-A; CRYSTAL-STRUCTURE; DIRECTED MUTAGENESIS; RESOLUTION; HYDROLYSIS; CEPHALOSPORINS; SITE; INTERMEDIATE	Using a random combinatorial mutagenesis of TEM beta-lactamase, directed against residues potentially involved in substrate discrimination, followed by selection on third generation cephalosporins, we obtained the double mutant E104M/G238S. Additionally, by using cloning strategies and site-directed mutagenesis we constructed the individual single mutants and also the single modification E104K and the double mutant E104K/G238S, which broaden the specificity of clinically isolated TEM beta-lactamase variants. The kinetic characterization of the purified double mutant E104M/G238S and its single counterparts E104M and G238S was carried out. The single mutant E104M exhibited increased k(cat) values against all substrates tested. K-m values remained similar to the values shown by the wild-type enzyme. The mutation at E104M was responsible for the increased hydrolysis rate against cefuroxime shown by the double mutant E104M/G238S. The effect of mutation G238S varied more pronouncedly, depending on the substrate. In general, a lower K-m was observed, but also a decreased k(cat). The double mutant E104M/G238S exhibited a higher hydrolytic rate against cefotaxime compared with the corresponding single mutations. We observed nearly a 1000-fold greater k(cat)/K-m for the double mutant than for the wild type. This improvement in catalysis was the consequence of increased k(cat) and decreased K-m values. Computed contact interactions from modeling substrate complexes show reliable results only for benzylpenicillin. The modeling results with this substrate confirmed the observed enzyme activities for the different single and double mutants. Analysis of the apparent coupling energies, as calculated from the kinetic parameters of the single and double mutants, showed that the quantitative effect of a second mutation on a single mutant was either absent, additive, partially additive, or synergistic with respect to the first mutation, depending on the substrate analyzed.	UNIV NACL AUTONOMA MEXICO, INST BIOTECNOL, CUERNAVACA 62271, MORELOS, MEXICO; UNIV CALIF SANTA CRUZ, DEPT CHEM & BIOCHEM, SANTA CRUZ, CA 95064 USA	Universidad Nacional Autonoma de Mexico; University of California System; University of California Santa Cruz			Soberon, Xavier/A-8826-2008; Viadiu, Hector/E-7785-2013	Osuna, Joel/0000-0002-8904-0724				AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; CHEN CCH, 1992, J MOL BIOL, V224, P1103, DOI 10.1016/0022-2836(92)90472-V; CHEN CCH, 1993, J MOL BIOL, V234, P165, DOI 10.1006/jmbi.1993.1571; COUTURE F, 1992, MOL MICROBIOL, V6, P1693, DOI 10.1111/j.1365-2958.1992.tb00894.x; HERZBERG O, 1987, SCIENCE, V236, P694, DOI 10.1126/science.3107125; HERZBERG O, 1991, J MOL BIOL, V217, P701, DOI 10.1016/0022-2836(91)90527-D; HERZBERG O, 1991, BIOCHEMISTRY-US, V30, P9503, DOI 10.1021/bi00103a017; HULETSKY A, 1993, J BIOL CHEM, V268, P3690; JACOBY GA, 1991, ANTIMICROB AGENTS CH, V35, P1697, DOI 10.1128/AAC.35.9.1697; JELSCH C, 1993, PROTEINS, V16, P364, DOI 10.1002/prot.340160406; JUTEAU JM, 1992, PROTEIN ENG, V5, P693, DOI 10.1093/protein/5.7.693; KNOX JR, 1991, J MOL BIOL, V220, P435, DOI 10.1016/0022-2836(91)90023-Y; KNOX JR, 1993, PROTEIN ENG, V6, P11, DOI 10.1093/protein/6.1.11; LEE KY, 1991, PROTEINS, V11, P45, DOI 10.1002/prot.340110106; MERINO E, 1992, BIOTECHNIQUES, V12, P508; MOEWS PC, 1990, PROTEINS, V7, P156, DOI 10.1002/prot.340070205; SOUGAKOFF W, 1988, FEMS MICROBIOL LETT, V56, P343, DOI 10.1111/j.1574-6968.1988.tb03204.x; SOWEK JA, 1991, BIOCHEMISTRY-US, V30, P3179, DOI 10.1021/bi00227a004; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; VANHUIJSDUIJNEN RAMH, 1992, NUCLEIC ACIDS RES, V20, P919, DOI 10.1093/nar/20.4.919; WALEY SG, 1974, BIOCHEM J, V139, P789, DOI 10.1042/bj1390789	22	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					781	787		10.1074/jbc.270.2.781	http://dx.doi.org/10.1074/jbc.270.2.781			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822311	hybrid			2022-12-27	WOS:A1995QB81600045
J	CHAMBLISS, KL; CAUDLE, DL; HINSON, DD; MOOMAW, CR; SLAUGHTER, CA; JAKOBS, C; GIBSON, KM				CHAMBLISS, KL; CAUDLE, DL; HINSON, DD; MOOMAW, CR; SLAUGHTER, CA; JAKOBS, C; GIBSON, KM			MOLECULAR-CLONING OF THE MATURE NAD(+)-DEPENDENT SUCCINIC SEMIALDEHYDE DEHYDROGENASE FROM RAT AND HUMAN - CDNA ISOLATION, EVOLUTIONARY HOMOLOGY, AND TISSUE EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDEHYDE DEHYDROGENASE; NUCLEOTIDE-SEQUENCE; BRAIN; LIVER; IDENTIFICATION; ENZYME; GENE	Three rat brain cDNA clones similar to 3500, 1465, and 1135 base pairs in length encoding succinic semialdehyde dehydrogenase (SSADH; EC 1.2.1.24) were isolated from two cDNA libraries using a polymerase chain reaction derived probe. Restriction mapping and DNA sequencing revealed that the 3.5-kilobase clone contained an 84-base pair (28 amino acid) insert in the coding region. Composite clones encoding mature SSADH predicted proteins with 488 amino acids (M(r) = 52,188) when including the insert and 460 amino acids (M(r) = 48,854) without the insert. The cDNA clones were confirmed by expression of enzyme activity in bacteria and protein sequence data obtained from sequencing purified rat brain SSADH. Two human liver SSADH cDNA clones of 1091 and 899 base pairs were also isolated. Human and rat SSADH share 83 and 91% identity in nucleotide and protein sequence, respectively Northern blot analysis revealed two differentially expressed SSADH transcripts of approximately 2.0 and 6.0 kilobases in both rat and human tissues. Human genomic Southern blots indicate that the two SSADH transcripts are encoded by a greater than 20-kilobase single copy gene. Mammalian SSADH contains significant homology to bacterial NADP(+)-succinic semialdehyde dehydrogenase (EC 1.2.1.16) and conserved regions of general aldehyde dehydrogenases (EC 1.2.1.3), suggesting it is a member of the aldehyde dehydrogenase superfamily of proteins.	BAYLOR UNIV,MED CTR,CTR METAB DIS,DALLAS,TX 75226; BAYLOR UNIV,MED CTR,DALLAS,TX 75226; UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235; FREE UNIV AMSTERDAM,DEPT PEDIAT,1081 HV AMSTERDAM,NETHERLANDS	Baylor University; Baylor University Medical Center; Baylor University; Baylor University Medical Center; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Vrije Universiteit Amsterdam								ABRIOLA DP, 1987, BIOCHEMISTRY-US, V26, P5679, DOI 10.1021/bi00392a015; ANDRE B, 1990, NUCLEIC ACIDS RES, V18, P3049, DOI 10.1093/nar/18.10.3049; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; CHAMBLISS KL, 1992, INT J BIOCHEM, V24, P1493, DOI 10.1016/0020-711X(92)90077-E; CHAMBLISS KL, 1993, J INHERIT METAB DIS, V16, P523, DOI 10.1007/BF00711671; CHAMBLISS KL, 1994, PEDIATR RES, V35, pA151; Erdo S.L., 1992, GABA OUTSIDE CNS, P97; FARRES J, 1989, EUR J BIOCHEM, V180, P67, DOI 10.1111/j.1432-1033.1989.tb14616.x; HAU LC, 1985, P NATL ACAD SCI USA, V82, P3771; HEMPEL JD, 1981, J BIOL CHEM, V256, P889; HUANG WM, 1990, P NATL ACAD SCI USA, V87, P8491, DOI 10.1073/pnas.87.21.8491; KURYS G, 1993, EUR J BIOCHEM, V218, P311, DOI 10.1111/j.1432-1033.1993.tb18379.x; KWON OS, 1992, J BIOL CHEM, V267, P7215; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANTHEY CL, 1990, CANCER RES, V50, P4991; MEDINAKAUWE LK, 1994, J NEUROCHEM, V62, P1267; NIEGEMANN E, 1993, ARCH MICROBIOL, V160, P454, DOI 10.1007/BF00245306; Pearl PL, 2006, FUTUR NEUROL, V1, P631, DOI 10.2217/14796708.1.5.631; RYZLAK MT, 1988, ARCH BIOCHEM BIOPHYS, V266, P386, DOI 10.1016/0003-9861(88)90270-6; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SNEAD OC, 1978, NEUROLOGY, V28, P636, DOI 10.1212/WNL.28.7.636; STEFFEN D, 1979, P NATL ACAD SCI USA, V76, P4554, DOI 10.1073/pnas.76.9.4554; [No title captured]	23	68	72	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					461	467		10.1074/jbc.270.1.461	http://dx.doi.org/10.1074/jbc.270.1.461			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814412	hybrid			2022-12-27	WOS:A1995QA28700073
J	HUANG, ZM; CHEN, Y; NISSENSON, RA				HUANG, ZM; CHEN, Y; NISSENSON, RA			THE CYTOPLASMIC TAIL OF THE G-PROTEIN-COUPLED RECEPTOR FOR PARATHYROID-HORMONE AND PARATHYROID HORMONE-RELATED PROTEIN CONTAINS POSITIVE AND NEGATIVE SIGNALS FOR ENDOCYTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; ADENYLATE CYCLASE SYSTEM; OPOSSUM KIDNEY-CELLS; MEDIATED ENDOCYTOSIS; CARBOXYL-TERMINUS; PLASMA-MEMBRANE; DOWN-REGULATION; KINASE-ACTIVITY; BONE-CELLS; INTERNALIZATION	The present studies were done to evaluate the role of the cytoplasmic tail of the G-protein-coupled receptor for parathyroid hormone (PTH) and PTH related protein (PTHrP) in the endocytosis of agonist-occupied receptors. PTH/PTHrP receptor mutants progressively truncated from the C terminus were expressed in COS-7 cells, and their ability to internalize I-125-PTHrP(1-34) amide was determined. Most of the C terminal tail (91 of 127 residues) could be deleted without affecting internalization. However, further truncation removing residues 475-494 resulted in a 50-60% decrease in ligand internalization. A mutant with an internal deletion of these 20 amino acids showed a similar reduction in internalization, confirming the presence of a positive endocytic signal. No additional positive signals were found in the membrane-proximal region of the tail. How ever, alanine mutagenesis of the membrane-proximal residues 459-461 (EVQ --> AAA) resulted in a mutant PTH/PTHrP receptor displaying a 40% increase in ligand endocytosis, indicating that EVQ functions as a negative signal. Treatment of COS-7 cells with hypertonic sucrose (to disrupt clathrin lattices) markedly suppressed (by > 80%) PTH/PTHrP receptor internalization. These results demonstrate the presence of both positive and negative endocytic signals in the membrane-proximal cytoplasmic tail of the PTH/PTHrP receptor and suggest that these signals regulate the ability of the receptor to accumulate in clathrin-coated pits.	VET ADM MED CTR,ENDOCRINE RES UNIT,SAN FRANCISCO,CA 94121; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94121; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94121	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco					NIDDK NIH HHS [DK35323] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035323] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARAK LS, 1994, J BIOL CHEM, V269, P2790; BENYA RV, 1993, J BIOL CHEM, V268, P20285; BROWN RC, 1991, AM J PHYSIOL, V260, pE544, DOI 10.1152/ajpendo.1991.260.4.E544; CARPENTIER JL, 1992, P NATL ACAD SCI USA, V89, P162, DOI 10.1073/pnas.89.1.162; CHANG CP, 1993, J BIOL CHEM, V268, P19312; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; GHINEA N, 1992, J CELL BIOL, V118, P1347, DOI 10.1083/jcb.118.6.1347; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JING SQ, 1990, J CELL BIOL, V110, P283, DOI 10.1083/jcb.110.2.283; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; LAMEH J, 1993, J BIOL CHEM, V267, P13406; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; MAHONEY CA, 1983, J CLIN INVEST, V72, P411, DOI 10.1172/JCI110989; MIETTINEN HM, 1992, J CELL BIOL, V116, P875, DOI 10.1083/jcb.116.4.875; MORO O, 1994, J BIOL CHEM, V269, P6651; NISSENSON RA, 1988, J BIOL CHEM, V263, P12866; NISSENSON RA, 1985, CANCER RES, V45, P5358; NUSSENZVEIG DR, 1993, J BIOL CHEM, V268, P2389; PASTAN IH, 1981, ANNU REV PHYSIOL, V43, P239, DOI 10.1146/annurev.ph.43.030181.001323; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; PERNALETE N, 1990, ENDOCRINOLOGY, V126, P407, DOI 10.1210/endo-126-1-407; RAPOSO G, 1987, BIOL CELL, V60, P117, DOI 10.1111/j.1768-322X.1987.tb00551.x; RAPOSO G, 1989, EUR J CELL BIOL, V50, P340; RODRIGUEZ MC, 1992, MOL ENDOCRINOL, V6, P327, DOI 10.1210/me.6.3.327; ROHER J, 1993, MOL BIOL CELL, V4, P511; SEGRE GV, 1993, TRENDS ENDOCRIN MET, V4, P309, DOI 10.1016/1043-2760(93)90071-L; SILVE CM, 1982, J CELL BIOL, V94, P379, DOI 10.1083/jcb.94.2.379; SMYTHE E, 1991, EUR J BIOCHEM, V202, P689, DOI 10.1111/j.1432-1033.1991.tb16424.x; SORKIN A, 1992, J BIOL CHEM, V267, P8672; SORKIN A, 1991, J BIOL CHEM, V266, P8355; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; TEITELBAUM AP, 1984, ENDOCRINOLOGY, V114, P980, DOI 10.1210/endo-114-3-980; TEITELBAUM AP, 1986, ENDOCRINOLOGY, V118, P595, DOI 10.1210/endo-118-2-595; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; VAUX D, 1992, Trends in Cell Biology, V2, P189, DOI 10.1016/0962-8924(92)90232-C; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; ZANOLARI B, 1992, CELL, V71, P755, DOI 10.1016/0092-8674(92)90552-N	39	120	120	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					151	156		10.1074/jbc.270.1.151	http://dx.doi.org/10.1074/jbc.270.1.151			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814366	hybrid			2022-12-27	WOS:A1995QA28700027
J	SUCHANEK, B; SEEBURG, PH; SPRENGEL, R				SUCHANEK, B; SEEBURG, PH; SPRENGEL, R			GENE STRUCTURE OF THE MURINE N-METHYL-D-ASPARTATE RECEPTOR SUBUNIT NR2C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CENTRAL-NERVOUS-SYSTEM; EXCITATORY AMINO-ACIDS; NMDA RECEPTOR; BINDING-PROTEIN; CHANNEL; FAMILY; EXPRESSION; GENOME; MEMBER	The murine N-methyl D-aspartate receptor subunit NR2C (epsilon-3) is encoded by a unique gene composed of 12 translated and three 5'-untranslated exons that spread over similar to 20 kilobases of genomic sequence. The GC-rich promoter that lacks TATA- and CAAT-positioning elements has two transcriptional start sites separated by 18 base pairs. One of these sites is located in a conserved initiator motif and, together with the first four exons, specifies the 5'-untranslated sequence of 772 nucleo tides. In this sequence, two alternative splice variants were detected that show identical expression patterns in adult mouse brain. Comparison of intron positions in genes encoding different members of the glutamate receptor family confirms a close evolutionary relationship of the NR2C and NMDAR1 subunit genes.	UNIV HEIDELBERG,CTR BIOL MOLEC,NEUROENDOCRINOL MOLEC LAB,D-69120 HEIDELBERG,GERMANY	Ruprecht Karls University Heidelberg								BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; COTMAN CW, 1988, ANNU REV NEUROSCI, V11, P61, DOI 10.1146/annurev.neuro.11.1.61; DYNAN WS, 1985, P NATL ACAD SCI USA, V82, P4915, DOI 10.1073/pnas.82.15.4915; GREGOR P, 1992, MOL BRAIN RES, V16, P179, DOI 10.1016/0169-328X(92)90223-X; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; IKEDA K, 1992, FEBS LETT, V313, P34, DOI 10.1016/0014-5793(92)81178-O; ISHII T, 1993, J BIOL CHEM, V268, P2836; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KOHLER M, 1994, J BIOL CHEM, V269, P17367; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Sambrook J, 1989, MOL CLONING LABORATO; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SPRENGEL R, 1993, FEBS LETT, V325, P90, DOI 10.1016/0014-5793(93)81420-5; SUGIHARA H, 1992, BIOCHEM BIOPH RES CO, V185, P826, DOI 10.1016/0006-291X(92)91701-Q; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; TAKANO H, 1993, BIOCHEM BIOPH RES CO, V197, P922, DOI 10.1006/bbrc.1993.2567; TSUKIYAMA T, 1992, MOL CELL BIOL, V12, P1286, DOI 10.1128/MCB.12.3.1286; WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P25, DOI 10.1016/0165-6147(90)90038-A; WEIHER H, 1983, SCIENCE, V219, P626, DOI 10.1126/science.6297005	28	38	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					41	44		10.1074/jbc.270.1.41	http://dx.doi.org/10.1074/jbc.270.1.41			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814402	hybrid			2022-12-27	WOS:A1995QA28700011
J	TSUCHIYA, Y; TAKAHASHI, T; SAKURAI, Y; IWAMATSU, A; TAKAHASHI, K				TSUCHIYA, Y; TAKAHASHI, T; SAKURAI, Y; IWAMATSU, A; TAKAHASHI, K			PURIFICATION AND CHARACTERIZATION OF A NOVEL MEMBRANE-BOUND ARGININE-SPECIFIC SERINE PROTEINASE FROM PORCINE INTESTINAL-MUCOSA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPIOMELANOCORTIN-CONVERTING ENZYME; SUBSTRATE-SPECIFICITY; YEAST KEX2; RAT-LIVER; PROCESSING ENDOPROTEASES; MICROSOMAL ENDOPEPTIDASE; FUNCTIONAL EXPRESSION; STRUCTURAL HOMOLOGY; PEPTIDE PRECURSORS; CONSENSUS SEQUENCE	A novel membrane-bound serine proteinase has been purified from the microsomal membranes of porcine intestinal mucosa. It was solubilized from the microsomal membrane fraction with 1% sodium deoxycholate, then purified by a series of column chromatographic steps on DE52, butyl-Toyopearl, Bio-Gel P-150, Mono Q, and benzamidine-Sepharose in the presence of 0.02% Lubrol PX. Its molecular mass was estimated to be 50 kDa both by SDS-polyacrylamide gel electrophoresis under nonreducing conditions and by gel filtration, and to be 32 kDa by SDS-polyacrylamide gel electrophoresis under reducing conditions, suggesting that the enzyme may exist as a homodimer in which two subunits are linked by disulfide bond(s). It had a pH optimum at around 9 and did not require Ca2+ for activity. It cleaved several peptide 4-methylcoumaryl-7-amide substrates almost exclusively after arginine residues, the best substrate among those tested being t-butyloxycarbonyl-Gln-Ala-Arg-4-methylcoumaryl-7-amide. Various neuropeptides were also cleaved by this enzyme after arginine, mainly between paired basic amino acid residues, Arg-Arg or Arg-Lys. Activity toward protein substrates was scarcely detected. Further, its partial amino acid sequences were highly homologous, but not identical, with those of trypsin-type serine proteinases. These results indicate that the present enzyme is a novel arginine-specific trypsinlike endopeptidase, possibly involved as a processing proteinase in the production of certain gastrointestinal neuropeptides or peptide hormones from their precursors, or their specific degradation.	UNIV TOKYO,FAC SCI,DEPT BIOPHYS & BIOCHEM,BUNKYO KU,TOKYO 113,JAPAN; KIRIN BREWERY CO LTD,CENT LABS KEY TECHNOL,YOKOHAMA,KANAGAWA 236,JAPAN	University of Tokyo; Kirin Brewery Company Limited								AZARYAN AV, 1993, J BIOL CHEM, V268, P11968; BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; BEINFELD MC, 1989, J BIOL CHEM, V264, P4460; BENOIT R, 1987, SCIENCE, V238, P1126, DOI 10.1126/science.2891188; BOURDAIS J, 1991, J BIOL CHEM, V266, P23386; CHUNG DW, 1986, BIOCHEMISTRY-US, V25, P2410, DOI 10.1021/bi00357a017; CROMLISH JA, 1986, J BIOL CHEM, V261, P850; DEGAN SJF, 1983, BIOCHEMISTRY-US, V22, P2087; DEVI L, 1991, FEBS LETT, V280, P189, DOI 10.1016/0014-5793(91)80290-J; FUKUSHIMA D, 1985, BIOCHEMISTRY-US, V24, P8037, DOI 10.1021/bi00348a030; FULLER RS, 1989, P NATL ACAD SCI USA, V86, P1434, DOI 10.1073/pnas.86.5.1434; FURIE B, 1982, J BIOL CHEM, V257, P3875; GERSHENFELD HK, 1988, P NATL ACAD SCI USA, V85, P1184, DOI 10.1073/pnas.85.4.1184; HARTLEY BS, 1964, NATURE, V201, P1284, DOI 10.1038/2011284a0; HATSUZAWA K, 1990, J BIOL CHEM, V265, P22075; IWAMATSU A, 1992, ELECTROPHORESIS, V13, P142, DOI 10.1002/elps.1150130129; KAWABATA S, 1992, J BIOL CHEM, V267, P10331; KAWABATA S, 1993, J BIOL CHEM, V268, P12498; KESSLER M, 1978, BIOCHIM BIOPHYS ACTA, V506, P136, DOI 10.1016/0005-2736(78)90440-6; KIDO H, 1993, J BIOL CHEM, V268, P13406; KIEFER MC, 1991, DNA CELL BIOL, V10, P757, DOI 10.1089/dna.1991.10.757; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEYTUS SP, 1988, BIOCHEMISTRY-US, V27, P1067, DOI 10.1021/bi00403a032; LOH YP, 1985, J BIOL CHEM, V260, P7194; LUSSON J, 1993, P NATL ACAD SCI USA, V90, P6691, DOI 10.1073/pnas.90.14.6691; MARX J, 1991, SCIENCE, V252, P779, DOI 10.1126/science.1674172; MASSON D, 1986, EMBO J, V5, P1595, DOI 10.1002/j.1460-2075.1986.tb04401.x; MATSUSHIMA M, 1994, J BIOL CHEM, V269, P19976; MIZUNO K, 1988, BIOCHEM BIOPH RES CO, V156, P246, DOI 10.1016/S0006-291X(88)80832-5; NAKAGAWA T, 1993, J BIOCHEM-TOKYO, V113, P132, DOI 10.1093/oxfordjournals.jbchem.a124015; NAKAYAMA K, 1992, J BIOL CHEM, V267, P16335; NAKAYAMA K, 1991, J BIOCHEM, V109, P803, DOI 10.1093/oxfordjournals.jbchem.a123461; NAKAYAMA K, 1992, J BIOL CHEM, V267, P5897; PLEVRAKIS I, 1989, BIOCHEMISTRY-US, V28, P2705, DOI 10.1021/bi00432a051; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHECHTER I, 1968, BIOCHEM BIOPH RES CO, V32, P898, DOI 10.1016/0006-291X(68)90326-4; SCHWARTZ TW, 1986, FEBS LETT, V200, P1, DOI 10.1016/0014-5793(86)80500-2; SILBERRING J, 1992, J BIOL CHEM, V267, P21324; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; SMEEKENS SP, 1990, J BIOL CHEM, V265, P2997; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOGAWA K, 1981, J BIOCHEM-TOKYO, V90, P1243, DOI 10.1093/oxfordjournals.jbchem.a133588; STEINER DF, 1992, J BIOL CHEM, V267, P23435; TAKAHASHI K, 1991, BIOCHEM BIOPH RES CO, V175, P1152, DOI 10.1016/0006-291X(91)91686-7; TAMANOUE Y, 1993, J BIOCHEM-TOKYO, V113, P229, DOI 10.1093/oxfordjournals.jbchem.a124031; VANDENOUWELAND AMW, 1990, NUCLEIC ACIDS RES, V18, P664, DOI 10.1093/nar/18.3.664; VANDERSLICE P, 1990, P NATL ACAD SCI USA, V87, P3811, DOI 10.1073/pnas.87.10.3811; WALSH KA, 1964, P NATL ACAD SCI USA, V52, P834; WISE RJ, 1990, P NATL ACAD SCI USA, V87, P9378, DOI 10.1073/pnas.87.23.9378; YANAGIDA M, 1991, BIOMED RES-TOKYO, V12, P113, DOI 10.2220/biomedres.12.113	50	21	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					32985	32991						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806528				2022-12-27	WOS:A1994QA63800042
J	PAHL, A; FLUGEL, RM				PAHL, A; FLUGEL, RM			CHARACTERIZATION OF THE HUMAN SPUMA RETROVIRUS INTEGRASE BY SITE-DIRECTED MUTAGENESIS, BY COMPLEMENTATION ANALYSIS, AND BY SWAPPING THE ZINC-FINGER DOMAIN OF HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN SPUMARETROVIRUS; ESCHERICHIA-COLI; PROTEIN; DNA; BINDING; IDENTIFICATION; DISINTEGRATION; REGION; GENES	The human spuma retrovirus or foamy virus integrase (HFV IN) is an enzymatically active protein consisting of domains similar to other retroviral integrases: an amino-terminal HH-CC finger, a centrally located region with the conserved D, D-35-E protein motif required for catalytic activity and oligomerization, and at least one DNA binding domain implicated in the 3' DNA processing activity and integrase. Recombinant, purified HFV IN protein carrying 10 histidine residues displays a site-specific endonuclease, an integrase, and a disintegrase activity with oligonucleotide substrates that mimic the viral long terminal repeat (LTR) ends. Site directed mutagenesis of conserved HFV IN residues of the catalytic domain had increased endonuclease and disintegrase activities. Deletion mutants at both ends of the HFV IN protein were generated, purified, and characterized. Unexpectedly, it was found that the HFV integrase and disintegrase activities require an intact NE(2)-terminal sequence and that COOH-terminal deletions led to an increase in disintegrase activity. The HH-CC finger of HFV IN was exchanged with that of the human immunodeficiency virus-1 (HIV-1) IN protein. The resulting chimeric IN had a 3' processing activity that utilized the HFV LTR instead of the HIV LTR, indicating that the central domain is crucial for substrate recognition. Functional complementation of the amino-terminal deletion mutant of HFV IN was achieved by a carboxyl-terminal deletion mutant of the chimeric IN, resulting in high levels of integrase activity.	DEUTSCH KREBSFORSCHUNGSZENTRUM, FORSCHUNGSSCHWERPUNKT ANGEW TUMORVIROL, RETROVIRALE GENEXPRESS ABT, D-69009 HEIDELBERG, GERMANY	Helmholtz Association; German Cancer Research Center (DKFZ)								BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN PO, 1990, CURR TOP MICROBIOL, V157, P19; BURKE CJ, 1992, J BIOL CHEM, V267, P9639; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; BUSHMAN FD, 1994, J VIROL, V68, P2215, DOI 10.1128/JVI.68.4.2215-2223.1994; BUTZ K, 1993, J VIROL, V67, P6476, DOI 10.1128/JVI.67.11.6476-6486.1993; CHOW SA, 1992, SCIENCE, V255, P723, DOI 10.1126/science.1738845; CRAIGIE R, 1992, TRENDS GENET, V8, P187, DOI 10.1016/0168-9525(92)90223-Q; DONZELLA GA, 1993, J VIROL, V67, P7077, DOI 10.1128/JVI.67.12.7077-7087.1993; DRELICH M, 1992, VIROLOGY, V188, P459, DOI 10.1016/0042-6822(92)90499-F; ENGELMAN A, 1993, EMBO J, V12, P3269, DOI 10.1002/j.1460-2075.1993.tb05996.x; ENGELMAN A, 1992, J VIROL, V66, P6361, DOI 10.1128/JVI.66.11.6361-6369.1992; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; FAHL A, 1993, J VIROL, V67, P5426; FLUGEL RM, 1987, EMBO J, V6, P2077, DOI 10.1002/j.1460-2075.1987.tb02473.x; GOFF SP, 1992, ANNU REV GENET, V26, P527, DOI 10.1146/annurev.ge.26.120192.002523; GRANDGENETT DP, 1978, VIROLOGY, V89, P119, DOI 10.1016/0042-6822(78)90046-6; HAZUDA DJ, 1994, J BIOL CHEM, V269, P3999; HOFFMANN A, 1991, NUCLEIC ACIDS RES, V19, P6337, DOI 10.1093/nar/19.22.6337; JONES KS, 1992, J BIOL CHEM, V267, P16037; JONSSON CB, 1993, J BIOL CHEM, V268, P1462; JONSSON CB, 1993, J VIROL, V67, P5562, DOI 10.1128/JVI.67.9.5562-5571.1993; KALPANA GV, 1993, P NATL ACAD SCI USA, V90, P10593, DOI 10.1073/pnas.90.22.10593; LEAVITT AD, 1993, J BIOL CHEM, V268, P2113; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; MAURER B, 1988, J VIROL, V62, P1590, DOI 10.1128/JVI.62.5.1590-1597.1988; MIZUUCHI K, 1992, J BIOL CHEM, V267, P21273; VANGENT DC, 1993, EMBO J, V12, P3261, DOI 10.1002/j.1460-2075.1993.tb05995.x; VINCENT KA, 1993, J VIROL, V67, P425, DOI 10.1128/JVI.67.1.425-437.1993; VINK C, 1993, NUCLEIC ACIDS RES, V21, P1419, DOI 10.1093/nar/21.6.1419; VINK C, 1993, TRENDS GENET, V9, P433, DOI 10.1016/0168-9525(93)90107-S; WHITCOMB JM, 1992, ANNU REV CELL BIOL, V8, P275, DOI 10.1146/annurev.cb.08.110192.001423; WOERNER AM, 1993, NUCLEIC ACIDS RES, V21, P3507, DOI 10.1093/nar/21.15.3507	33	41	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					2957	2966		10.1074/jbc.270.7.2957	http://dx.doi.org/10.1074/jbc.270.7.2957			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852375				2022-12-27	WOS:A1995QG47100014
J	LARK, MW; GORDY, JT; WEIDNER, JR; AYALA, J; KIMURA, JH; WILLIAMS, HR; MUMFORD, RA; FLANNERY, CR; CARLSON, SS; IWATA, M; SANDY, JD				LARK, MW; GORDY, JT; WEIDNER, JR; AYALA, J; KIMURA, JH; WILLIAMS, HR; MUMFORD, RA; FLANNERY, CR; CARLSON, SS; IWATA, M; SANDY, JD			CELL-MEDIATED CATABOLISM OF AGGRECAN EVIDENCE THAT CLEAVAGE AT THE AGGRECANASE SITE (GLU(373)-ALA(37) PROTEOLYSIS OF THE INTERGLOBULAR DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SYNOVIAL-FLUID; PROTEOGLYCAN FRAGMENTS; CARTILAGE CULTURES; LINK PROTEIN; CATHEPSIN-B; OSTEOARTHRITIS; CHONDROCYTES; DEGRADATION; SEQUENCE; RELEASE	A rat chondrosarcoma cell line and primary bovine chondrocytes have been used to study cell-mediated aggrecan catabolism. Addition of 1 mu M retinoic acid to chondrosarcoma cultures resulted in aggrecan proteolysis with the release of greater than 90% of the cell layer aggrecan into the medium within 4 days. NH2-terminal sequencing of chondroitin sulfate-substituted catabolic products gave a single major NH2-terminal sequence of ARGNVILTXK, initiating at Ala(374). This showed that the proteinase, commonly referred to as ''aggrecanase,'' which cleaves the Glu(373)-Ala(374) bond of the interglobular domain of aggrecan (Sandy, J. D., Neame, P. J., Boynton, R. E., and Flannery, C. R. (1990) J. Biol. Chem. 266, 8683-8685), is active in this cell system. Aggrecan G1 domain, generated by cleavage of the interglobular domain, was also liberated during catabolism and this was characterized with three antipeptide antisera. Anti-CDAGWL was used as a general probe for G1 domain. Anti-FVDIPEN was used to specifically detect G1 domain with COOH terminus of Asn(341), the form which is readily generated by cleavage of aggrecan by a wide range of matrix metalloproteinases. Anti-NITEGE antiserum was used to specifically detect G1 domain with COOH terminus of Glu(373), the form which is the expected product of ''aggrecanase''-mediated cleavage of aggrecan. Western blot analysis indicated that a single form of G1 domain of about 60 kDa was formed. G1 domain of this size reacted with both anti-CDAGWL and anti-NITEGE but not with anti-FVDIPEN. Similar experiments with primary bovine chondrocyte cultures, treated with either retinoic acid or interleukin 1, showed that two forms of catabolic G1 domain, of about 62 and 66 kDa, were formed. Both of these forms reacted on Western blots with anti-CDAGWL and also with anti-NITEGE. It is suggested that cell-mediated catabolism of the aggrecan interglobular domain in these culture systems, whether promoted by retinoic acid or interleukin 1, primarily involves cleavage of the Glu(373)-Ala(374) bond by aggrecanase. The accumulation of G1 domain with a COOH-terminal of Glu(373) shows that such aggrecanase-mediated cleavage can occur independent of the cleavage of the Asn(341)-phe(342) bond by matrix metalloproteinases.	SHRINERS HOSP CRIPPLED CHILDREN,TAMPA,FL 33612; MERCK & CO INC,MERCK SHARP & DOHME RES LABS,DEPT IMMUNOL & INFLAMMAT RES,RAHWAY,NJ 07065; UNIV WASHINGTON,DEPT PHYSIOL & BIOPHYS,SEATTLE,WA 98195; HENRY FORD HOSP,CTR BONE & JOINT,DETROIT,MI 48202; UNIV S FLORIDA,COLL MED,TAMPA,FL 33612	Merck & Company; University of Washington; University of Washington Seattle; Henry Ford Health System; Henry Ford Hospital; State University System of Florida; University of South Florida				Gordy, John/0000-0003-2097-872X				BUTTLE DJ, 1993, ARTHRITIS RHEUM, V36, P1709, DOI 10.1002/art.1780361210; DOEGE K, 1987, J BIOL CHEM, V262, P17757; DOEGE KJ, 1991, J BIOL CHEM, V266, P894; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; FLANNERY CR, 1992, J BIOL CHEM, V267, P1008; FLANNERY CR, 1993, ORTHOP T, V17, P677; FOSANG AJ, 1994, BIOCHEM J, V304, P347, DOI 10.1042/bj3040347; FOSANG AJ, 1992, J BIOL CHEM, V267, P19470; FOSANG AJ, 1993, BIOCHEM J, V295, P273, DOI 10.1042/bj2950273; HUA Q, 1993, J CELL SCI, V106, P365; ILIE MZ, 1992, ARCH BIOCHEM BIOPHYS, V294, P115; IWATA M, 1993, J NEUROSCI, V13, P195; KITAGAWA T, 1976, J BIOCHEM-TOKYO, V79, P233, DOI 10.1093/oxfordjournals.jbchem.a131053; KUCHARSKA AM, 1990, J ORTHOPAED RES, V8, P781, DOI 10.1002/jor.1100080602; LARK MW, 1994, IN PRESS BIOCH J; LOHMANDER LS, 1993, ARTHRITIS RHEUM, V36, P1214; LOULAKIS P, 1992, BIOCHEM J, V284, P589, DOI 10.1042/bj2840589; MORALES TI, 1988, J BIOL CHEM, V263, P3632; PLAAS AHK, 1992, MATRIX, V13, P135; RATCLIFFE A, 1986, BIOCHEM J, V238, P571, DOI 10.1042/bj2380571; RHODES C, 1988, J BIOL CHEM, V263, P6063; SANDY JD, 1992, J CLIN INVEST, V89, P1512, DOI 10.1172/JCI115742; SANDY JD, 1991, J BIOL CHEM, V266, P8683; SANDY JD, 1991, ARTICULAR CARTILAGE, P21	24	170	172	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2550	2556		10.1074/jbc.270.6.2550	http://dx.doi.org/10.1074/jbc.270.6.2550			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852317				2022-12-27	WOS:A1995QF53500025
J	RYU, S; RAMSEIER, TM; MICHOTEY, V; SAIER, MH; GARGES, S				RYU, S; RAMSEIER, TM; MICHOTEY, V; SAIER, MH; GARGES, S			EFFECT OF THE FRUR REGULATOR ON TRANSCRIPTION OF THE PTS OPERON IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL PHOSPHOTRANSFERASE SYSTEM; CAMP RECEPTOR PROTEIN; SALMONELLA-TYPHIMURIUM; NUCLEOTIDE-SEQUENCE; POSITIVE REGULATION; MOLECULAR-CLONING; 2 PROMOTERS; CRR GENES; FRUCTOSE; PHOSPHOENOLPYRUVATE	The promoters of the pts operon of Escherichia coli are controlled by the cyclic AMP receptor protein (CRP) complexed with cAMP (CRP.cAMP). In addition, glucose stimulates pts operon expression in vivo. The pts promoter region has a fructose repressor (FruR)-binding site (the FruR box) that partially overlaps with one of the CRP.cAMP-binding sites. The effects of the pleiotropic transcriptional regulator FruR on pfs operon expression were studied to determine whether the in vivo glucose effect on pts operon expression is mediated by FruR. In vitro, FruR can repress P1b transcription, which is activated by CRP.cAMP, and restore P1a transcription, which is repressed by CRP.cAMP. FruR can displace CRP cAMP from its binding site in the presence of RNA polymerase even though FruR and CRP.cAMP can bind simultaneously to their partially overlapping binding sites in the absence of RNA polymerase. FruR had very little effect on the transcription of the P0 promoter, which is most important for regulation by glucose. Consistent with the in vitro results, pts P0 transcription did not increase as much In cells grown in the presence of fructose or in fruR(-) mutant cells as in cells grown in the presence of glucose. These results suggest that FruR alone does not mediate the in vivo glucose effect on pts operon expression.	NCI, MOLEC BIOL LAB, BETHESDA, MD 20892 USA; UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Diego			Michotey, Valerie/AAA-4397-2021	Michotey, Valerie/0000-0001-6639-2877				Adhya S, 1987, ESCHERICHIA COLI SAL, P1503; BALKE VL, 1987, J BACTERIOL, V169, P4499, DOI 10.1128/jb.169.10.4499-4506.1987; BURGESS RR, 1991, METHOD ENZYMOL, V208, P3; BYRNE CR, 1988, J BACTERIOL, V170, P3150, DOI 10.1128/jb.170.7.3150-3157.1988; CHIN AM, 1989, J BACTERIOL, V171, P2424, DOI 10.1128/jb.171.5.2424-2434.1989; CHIN AM, 1987, J BACTERIOL, V169, P897, DOI 10.1128/jb.169.2.897-899.1987; CORDARO JC, 1972, J BACTERIOL, V112, P17, DOI 10.1128/JB.112.1.17-29.1972; CRASNIER M, 1994, MOL GEN GENET, V243, P409, DOI 10.1007/BF00280471; DEREUSE H, 1988, J BACTERIOL, V170, P3827, DOI 10.1128/jb.170.9.3827-3837.1988; DEREUSE H, 1992, J MOL BIOL, V226, P623, DOI 10.1016/0022-2836(92)90620-Y; DEREUSE H, 1991, J BACTERIOL, V173, P727, DOI 10.1128/jb.173.2.727-733.1991; DEREUSE H, 1985, GENE, V35, P199; DEUSCHLE U, 1986, P NATL ACAD SCI USA, V83, P4134, DOI 10.1073/pnas.83.12.4134; FOX DK, 1992, P NATL ACAD SCI USA, V89, P7056, DOI 10.1073/pnas.89.15.7056; FRAENKEL DG, 1968, J BIOL CHEM, V243, P6451; GEERSE RH, 1986, MOL GEN GENET, V203, P435, DOI 10.1007/BF00422068; HANAMURA A, 1992, MOL MICROBIOL, V6, P2489; IRANI M, 1989, J BACTERIOL, V171, P1623, DOI 10.1128/jb.171.3.1623-1630.1989; JAHREIS K, 1991, MOL GEN GENET, V226, P332, DOI 10.1007/BF00273623; KORNBERG HL, 1987, J GEN MICROBIOL, V133, P341; LECLERC G, 1990, J BACTERIOL, V172, P4696, DOI 10.1128/jb.172.8.4696-4700.1990; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; Miller J.H., 1992, SHORT COURSE BACTERI, P150; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; RAMSEIER TM, 1993, J MOL BIOL, V234, P28, DOI 10.1006/jmbi.1993.1561; REINER AM, 1977, J BACTERIOL, V132, P166, DOI 10.1128/JB.132.1.166-173.1977; REPHAELI AW, 1980, J BACTERIOL, V141, P658, DOI 10.1128/JB.141.2.658-663.1980; RYU S, 1994, P NATL ACAD SCI USA, V91, P8582, DOI 10.1073/pnas.91.18.8582; RYU S, 1994, J BIOL CHEM, V269, P4767; RYU S, 1993, P NATL ACAD SCI USA, V90, P75, DOI 10.1073/pnas.90.1.75; SAFFEN DW, 1987, J BIOL CHEM, V262, P16241; SAIER MH, 1989, MICROBIOL REV, V53, P109, DOI 10.1128/MMBR.53.1.109-120.1989; SAIER MH, 1993, J CELL BIOCHEM, V51, P62, DOI 10.1002/jcb.240510112; Sambrook J, 1989, MOL CLONING LABORATO; SOGAARDANDERSEN L, 1990, J BACTERIOL, V172, P5706, DOI 10.1128/jb.172.10.5706-5713.1990; VARTAK NB, 1991, RES MICROBIOL, V142, P951, DOI 10.1016/0923-2508(91)90005-U; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869	37	36	38	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2489	2496		10.1074/jbc.270.6.2489	http://dx.doi.org/10.1074/jbc.270.6.2489			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852310	hybrid			2022-12-27	WOS:A1995QF53500017
J	YAMAMOTOHONDA, R; TOBE, K; KABURAGI, Y; UEKI, K; ASAI, S; YACHI, M; SHIROUZU, M; YODOI, J; AKANUMA, Y; YOKOYAMA, S; YAZAKI, Y; KADOWAKI, T				YAMAMOTOHONDA, R; TOBE, K; KABURAGI, Y; UEKI, K; ASAI, S; YACHI, M; SHIROUZU, M; YODOI, J; AKANUMA, Y; YOKOYAMA, S; YAZAKI, Y; KADOWAKI, T			UPSTREAM MECHANISMS OF GLYCOGEN-SYNTHASE ACTIVATION BY INSULIN AND INSULIN-LIKE GROWTH-FACTOR-I - GLYCOGEN-SYNTHASE ACTIVATION IS ANTAGONIZED BY WORTMANNIN OR LY294002 BUT NOT BY RAPAMYCIN OR BY INHIBITING P21(RAS)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; S6 PROTEIN-KINASE; PHEOCHROMOCYTOMA CELLS; SIGNAL TRANSDUCTION; MAP KINASES; PHOSPHORYLATION; RECEPTOR; RAS; IDENTIFICATION; PURIFICATION	This study was undertaken to define intracellular signaling pathways upstream to glycogen synthase activation, First, we examined the role of the two pathways of insulin signaling, Ras-dependent and wortmannin/LY294002-sensitive, in glycogen synthase activation, Although negative dominant Ras (Ras17N) induction in PC12 cells markedly decreased activities of mitogen-activated protein kinase (MAP) and pp90 S6 kinase in response to insulin or insulin-like growth factor I (IGF-I), activation of glycogen synthase by these agents was unaffected by negative dominant Ras induction. In contrast, wortmannin and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002), inhibitors of phosphatidylinositol 3-kinase, antagonized glycogen synthase activation in response to insulin or IGF-I. Next, we examined the contribution of pp70 S6 kinase, one of the wortmannin/LY294002-sensitive signaling molecules on glycogen synthase activation, Immunosuppressant rapamycin completely blocked activation of pp70 S6 kinase by insulin or IGF-I, but rapamycin alone or in combination with induction of negative dominant Ras failed to antagonize glycogen synthase activation by these hormones, These data suggest that 1) activation of Ras-MAP kinase is not necessary for stimulation of glycogen synthase and 2) activation of wortmannin/LY294002-sensitive pathway, independent of pp70 S6 kinase, plays a key role in glycogen synthase regulation in PC12 cells.	UNIV TOKYO, FAC MED, DEPT INTERNAL MED 3, BUNKYO KU, TOKYO 113, JAPAN; UNIV TOKYO, FAC SCI, DEPT BIOPHYS & BIOCHEM, BUNKYO KU, TOKYO 113, JAPAN; KYOTO UNIV, DEPT BIOL RESPONSES, INFECT LAB, KYOTO 606, JAPAN; KYOTO UNIV, PREVENT INST VIRUS RES, KYOTO 606, JAPAN; ASAHI LIFE FDN, INST DIABET CARE & RES, CHIYODA KU, TOKYO 100, JAPAN	University of Tokyo; University of Tokyo; Kyoto University; Kyoto University; Asahi Life Foundation			Shirouzu, Mikako/A-6521-2016; Yokoyama, Shigeyuki/N-6911-2015	Yokoyama, Shigeyuki/0000-0003-3133-7338				ALCORTA DA, 1989, MOL CELL BIOL, V9, P3850, DOI 10.1128/MCB.9.9.3850; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; BLENIS J, 1986, EMBO J, V5, P3411; BOGARDUS C, 1984, J CLIN INVEST, V73, P1185, DOI 10.1172/JCI111304; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; BURGERING BM, 1990, EMBO J, V10, P1103; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CHAN CP, 1987, J BIOL CHEM, V262, P276; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; CHEN RH, 1990, MOL CELL BIOL, V10, P3204, DOI 10.1128/MCB.10.6.3204; CHOU CK, 1987, J BIOL CHEM, V262, P1842; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; DAHMER MK, 1989, J NEUROCHEM, V53, P1036, DOI 10.1111/j.1471-4159.1989.tb07392.x; DENT P, 1990, NATURE, V348, P302, DOI 10.1038/348302a0; DEVRIESSMITS AMM, 1992, NATURE, V357, P602, DOI 10.1038/357602a0; DOWNWARD J, 1994, NATURE, V371, P378, DOI 10.1038/371378a0; FUKUI Y, 1989, MOL CELL BIOL, V9, P1651, DOI 10.1128/MCB.9.4.1651; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; INGEBRITSEN TS, 1983, SCIENCE, V221, P331, DOI 10.1126/science.6306765; JENO P, 1988, P NATL ACAD SCI USA, V85, P406, DOI 10.1073/pnas.85.2.406; KABURAGI Y, 1993, J BIOL CHEM, V268, P16610; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; KIDA Y, 1990, J CLIN INVEST, V85, P476, DOI 10.1172/JCI114462; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; LAVOINNE A, 1991, EUR J BIOCHEM, V199, P723, DOI 10.1111/j.1432-1033.1991.tb16176.x; Lin Tai-An, 1994, Journal of Biological Chemistry, V269, P21255; MING XF, 1994, NATURE, V371, P426, DOI 10.1038/371426a0; NAKAFUKU M, 1992, J BIOL CHEM, V267, P19448; OHMICHI M, 1993, ENDOCRINOLOGY, V133, P46, DOI 10.1210/en.133.1.46; OKADA T, 1994, J BIOL CHEM, V269, P3568; PARKER PJ, 1983, EUR J BIOCHEM, V130, P227; PRICE DJ, 1989, J BIOL CHEM, V264, P13825; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; ROBINSON LJ, 1993, J BIOL CHEM, V268, P26422; RYLATT DB, 1980, EUR J BIOCHEM, V107, P529; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SATOH T, 1992, J BIOL CHEM, V267, P24149; SHIROUZU M, 1992, ONCOGENE, V7, P475; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; STURGILL TW, 1988, NATURE, V344, P7150; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; SUTHERLAND C, 1993, EUR J BIOCHEM, V212, P518; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TOBE K, 1992, J BIOL CHEM, V267, P21089; TOBE K, 1991, J BIOL CHEM, V266, P4220; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; YAMAMOTOHONDA R, 1990, J BIOL CHEM, V265, P14777	50	83	83	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2729	2734		10.1074/jbc.270.6.2729	http://dx.doi.org/10.1074/jbc.270.6.2729			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852343	hybrid			2022-12-27	WOS:A1995QF53500052
J	CREIGHTON, AM; HULFORD, A; MANT, A; ROBINSON, D; ROBINSON, C				CREIGHTON, AM; HULFORD, A; MANT, A; ROBINSON, D; ROBINSON, C			A MONOMERIC, TIGHTLY FOLDED STROMAL INTERMEDIATE ON THE DELTA-PH-DEPENDENT THYLAKOIDAL PROTEIN-TRANSPORT PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-EVOLVING COMPLEX; TRANSIT PEPTIDE; PRECURSOR PROTEIN; ENERGY-REQUIREMENTS; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; PROTON GRADIENT; PHOTOSYSTEM-II; 23-KDA PROTEIN; IMPORT	Two distinct mechanisms have been previously identified for the transport of proteins across the chloroplast thylakoid membrane, one of which is unusual in that neither soluble factors nor ATP are required; the system requires only the transthylakoidal Delta pH. We have examined this mechanism by studying the properties of one of its substrates: the extrinsic 23-kDa protein (23K) of photosystem II, Previous work has shown that this protein can be transported into isolated thylakoids as the full-length precursor protein; we show that the stromal import intermediate form of this protein is similarly translocation-competent. Gel filtration tests indicate that the stromal intermediate is probably monomeric, Protease sensitivity tests on both the initial in vitro translation product and the stromal import intermediate show that the presequence is highly susceptible to digestion whereas the mature protein is resistant to high concentrations of trypsin, The mature protein be comes very sensitive to digestion if unfolded in urea, or after heating, and we therefore propose that the natural substrate for this translocation system consists of a relatively unfolded presequence together with a tightly folded passenger protein, The ability of thylakoids to import pre 23K is destroyed by prior treatment of the thylakoids with low concentrations of trypsin, demonstrating the involvement of surface-exposed proteins in the import process, However, we can find no evidence for the binding of pre-23K or i23K to the thylakoid surface, and we therefore propose that the initial interaction of these substrates with the thylakoidal translocase is weak, reversible, and probably Delta pH-independent. In the second phase of the translocation mechanism, the Delta pH drives either the translocation and unfolding of proteins, or the translocation of a fully folded protein.	UNIV WARWICK,DEPT BIOL SCI,COVENTRY CV4 7AL,W MIDLANDS,ENGLAND	University of Warwick				Mant, Alexandra/0000-0001-7169-209X				AMERICA T, 1994, PLANT MOL BIOL, V24, P283, DOI 10.1007/BF00020168; BASSHAM DC, 1991, J BIOL CHEM, V266, P23606; BRIGGS LM, 1990, PLANT MOL BIOL, V15, P633, DOI 10.1007/BF00017837; BROCK IW, 1995, J BIOL CHEM, V270, P1657, DOI 10.1074/jbc.270.4.1657; BROCK IW, 1993, PLANT MOL BIOL, V23, P717, DOI 10.1007/BF00021527; CAI D, 1993, PLANT J, V3, P383, DOI 10.1046/j.1365-313X.1993.t01-21-00999.x; CLINE K, 1992, J BIOL CHEM, V267, P2688; CLINE K, 1993, EMBO J, V12, P4105, DOI 10.1002/j.1460-2075.1993.tb06094.x; DELLACIOPPA G, 1986, P NATL ACAD SCI USA, V83, P6873, DOI 10.1073/pnas.83.18.6873; DESHAIES RJ, 1988, TRENDS BIOCHEM SCI, V13, P384, DOI 10.1016/0968-0004(88)90180-6; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; HAGEMAN J, 1986, NATURE, V324, P567, DOI 10.1038/324567a0; HALPIN C, 1989, EMBO J, V8, P3917, DOI 10.1002/j.1460-2075.1989.tb08572.x; HENRY R, 1994, J BIOL CHEM, V269, P10189; HULFORD A, 1994, J BIOL CHEM, V269, P3251; JAMES HE, 1991, PLANT MOL BIOL, V17, P179, DOI 10.1007/BF00036827; JAMES HE, 1989, J BIOL CHEM, V264, P19573; KLOSGEN RB, 1992, PLANT MOL BIOL, V18, P1031, DOI 10.1007/BF00019226; KNOTT TG, 1994, J BIOL CHEM, V269, P7843; KO K, 1989, EMBO J, V8, P3187, DOI 10.1002/j.1460-2075.1989.tb08477.x; KONISHI T, 1993, PLANT CELL PHYSIOL, V34, P315; KUWABARA T, 1987, P NATL ACAD SCI USA, V84, P8230, DOI 10.1073/pnas.84.23.8230; LAMPPA GK, 1988, J BIOL CHEM, V263, P14996; LUIRINK J, 1994, MOL MICROBIOL, V11, P9, DOI 10.1111/j.1365-2958.1994.tb00284.x; MEYER DI, 1988, TRENDS BIOCHEM SCI, V13, P471, DOI 10.1016/0968-0004(88)90233-2; Mills J. D., 1986, Photosynthesis: energy transduction: a practical approach, P143; MOULD RM, 1991, J BIOL CHEM, V266, P17286; MOULD RM, 1991, J BIOL CHEM, V266, P12189; NIELSEN VS, 1994, J BIOL CHEM, V269, P3762; PILON M, 1992, J BIOL CHEM, V267, P19907; ROBINSON C, 1994, EMBO J, V13, P279, DOI 10.1002/j.1460-2075.1994.tb06260.x; SCHNELL DJ, 1990, J CELL BIOL, V111, P1825, DOI 10.1083/jcb.111.5.1825; SEIDLER A, 1990, EMBO J, V9, P1743, DOI 10.1002/j.1460-2075.1990.tb08298.x; SMEEKENS S, 1986, CELL, V46, P365, DOI 10.1016/0092-8674(86)90657-4; THEG SM, 1992, BIOCHEMISTRY-US, V31, P5053, DOI 10.1021/bi00136a018; THEG SM, 1989, J BIOL CHEM, V264, P6730; VIITANEN PV, 1988, J BIOL CHEM, V263, P15000; VONHEIJNE G, 1991, FEBS LETT, V278, P1, DOI 10.1016/0014-5793(91)80069-F; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; WICKNER W, 1991, ANNU REV BIOCHEM, V60, P1165	40	63	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1663	1669		10.1074/jbc.270.4.1663	http://dx.doi.org/10.1074/jbc.270.4.1663			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829500	hybrid			2022-12-27	WOS:A1995QD20400030
J	SHIRO, Y; FUJII, M; IIZUKA, T; ADACHI, S; TSUKAMOTO, K; NAKAHARA, K; SHOUN, H				SHIRO, Y; FUJII, M; IIZUKA, T; ADACHI, S; TSUKAMOTO, K; NAKAHARA, K; SHOUN, H			SPECTROSCOPIC AND KINETIC-STUDIES ON REACTION OF CYTOCHROME P450NOR WITH NITRIC-OXIDE - IMPLICATION FOR ITS NITRIC-OXIDE REDUCTION-MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUSARIUM-OXYSPORUM; INDUCIBLE CYTOCHROME-P-450; PARACOCCUS-DENITRIFICANS; CRYSTAL-STRUCTURE; FUNGUS; PURIFICATION; HEMOPROTEIN; SITE	Cytochrome P450 purified from Fusarium oxysporum (P450nor) is a unique heme enzyme that catalyzes the reduction of nitric oxide to nitrous oxide with electrons directly transferred from NADH (2NO + NADH + H+ --> N2O + H2O + NAD(+)). We studied the reaction of P450nor with NO and NADH using stopped-flow rapid scan and low temperature spectroscopic methods. The NO ligand can bind to the ferric enzyme to form the stable NO bound complex, P450nor(Fe3+NO). Reduction of P450nor(Fe3+NO) with NADH yielded an intermediate, which transiently formed (tau = similar to 100 ms) and spontaneously decomposed to the Fe3+ state. The optical absorption spectrum of the intermediate was different from that of P450nor(Fe2+NO), which was formed by either a one-electron reduction of P450nor(Fe3+NO) with Na2S2O4 or NO binding to P450nor(Fe2+), On the basis of these observations, we suggested that the intermediate is presumably a two electron reduced product of P450nor(Fe3+NO) by NADH, formally the (Fe3+NO)(2-) complex. We determined the rate constants of these re actions at 10 degrees C for the NO binding to P450nor(Fe3+) (2.6 x 10(7) M(-1) s(-1)), the NADH reduction of P450nor(Fe8+NO) (0.9 x 10(6) M(-1) s(-1)), and the spontaneous decomposition of the intermediate (0.027 s(-1)). In these kinetic measurements, it was found that the former two processes are fast enough, while the latter is extremely slow, compared with the fast turnover of the catalytic reaction (1200 s(-1) at 10 degrees C), which we measured by monitoring the NADH consumption, Therefore, we suggested that in the catalytic cycle, decomposition of the intermediate is fairly accelerated by free NO, resulting in such a fast turnover, On the basis of several lines of the spectroscopic and the kinetic evidence, we proposed a possible mechanism of the NO reduction by P450nor.	NIHON UNIV,COLL SCI & TECHNOL,CHIYODA KU,TOKYO 101,JAPAN; UNIV TSUKUBA,INST APPL BIOCHEM,TSUKUBA,IBARAKI 305,JAPAN	Nihon University; University of Tsukuba	SHIRO, Y (corresponding author), INST PHYS & CHEM RES,WAKO,SAITAMA 35101,JAPAN.			Adachi, Shin-ichi/0000-0002-3676-1165; Nakahara, Kazuhiko/0000-0002-7313-6879				CARR GJ, 1990, BIOCHEM J, V269, P423, DOI 10.1042/bj2690423; DERMASTIA M, 1991, J BIOL CHEM, V266, P10899; EBEL RE, 1975, FEBS LETT, V55, P198, DOI 10.1016/0014-5793(75)80991-4; HEISS B, 1989, J BACTERIOL, V171, P3288, DOI 10.1128/jb.171.6.3288-3297.1989; IMAI M, 1989, P NATL ACAD SCI USA, V86, P7823, DOI 10.1073/pnas.86.20.7823; KIZAWA H, 1991, J BIOL CHEM, V266, P10632; NAKAHARA K, 1993, J BIOL CHEM, V268, P8350; OKEEFFE DH, 1978, J BIOL CHEM, V253, P3509; RAAG R, 1991, BIOCHEMISTRY-US, V30, P11420, DOI 10.1021/bi00112a008; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; SHIRO Y, 1994, BIOCHEMISTRY-US, V33, P8673, DOI 10.1021/bi00195a007; SHOUN H, 1983, J BIOCHEM, V94, P1219, DOI 10.1093/oxfordjournals.jbchem.a134467; SHOUN H, 1989, FEBS LETT, V244, P11, DOI 10.1016/0014-5793(89)81151-2; SHOUN H, 1991, J BIOL CHEM, V266, P11078; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; WEEGAERSSENS E, 1988, J AM CHEM SOC, V110, P6851, DOI 10.1021/ja00228a039; WHITE KA, 1992, BIOCHEMISTRY-US, V31, P6627, DOI 10.1021/bi00144a001; YE RW, 1991, J BIOL CHEM, V266, P12848	18	178	180	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1617	1623		10.1074/jbc.270.4.1617	http://dx.doi.org/10.1074/jbc.270.4.1617			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829493				2022-12-27	WOS:A1995QD20400023
J	COFFEY, RL; PURICH, DL				COFFEY, RL; PURICH, DL			NONCOOPERATIVE BINDING OF THE MAP-2 MICROTUBULE-BINDING REGION TO MICROTUBULES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; 2ND REPEATED SEQUENCE; TAU-PROTEIN; CYTOPLASMIC MICROTUBULES; INVITRO; SITE; PHOSPHORYLATION; NEUROFILAMENTS; DYNAMICS; TUBULIN	Microtubule-associated protein (MAP)-2 is a multi-domain cytoskeletal protein that copurifies with brain microtubules (MTs) through repeated cycles of warm polymerization and cold disassembly. Recent equilibrium binding studies of high molecular weight MAP-2ab to taxol-stabilized MTs suggest that the interactions are highly cooperative, as indicated by sigmoidal binding curves, non-linear Scatchard plots, and an apparent all-or-none response in MAP binding in titration experiments (Wallis, K. T., Azhar, S., Rho, M. B., Lewis, S. A., Cowan, N. J., and Murphy, D. B. (1993) J. Biol. Chem. 268, 15158-15167). To learn more about the mechanism of MAP-2 binding to MTs, we investigated the binding properties of bacterially expressed MT-binding region (MTBR) of bovine brain MAP-2. Scatchard plots of the binding data showed no evidence of cooperativity, as reflected by the linear plots of ($) over bar upsilon/[MTBR](free) versus ($) over bar upsilon. The stoichiometry was 1-1.1 mol of MTBR/mol of tubulin dimer, and the dissociation constant for the MTBR was 1.1 mu M. Bovine brain tau protein competitively inhibited MAP-2 binding, as evidenced by an increased K-d value for MTBR binding to MTs. Although the second repeat peptide m(2) (VTSKCGSLKNIRHRPGGG) is thought to play a dominant role in MAP-2 binding to MTs, a MTBR mutant (with m(2) replaced by the third octadecapeptide repeat m(3)) displays an K-d of 2.8 +/- 0.1 mu M and a stoichiometry of 0.9 +/- 0.05 mol of MTBR/mol of tubulin dimer. Another mutant with additional copies of the second repeat, designated by us as MTBR[m(12)m(2)m(32)], displayed noncooperative binding with a K-d of 0.53 +/- 0.05 mu M and a stoichiometry of 2.2 +/- 0.2 mol of mutant MTBR/tubulin dimer. Equilibrium sedimentation experiments demonstrated that the wild-type MTBR is monomeric, whereas MTBR[m(12)m(2)m(32)] self-associates to a stable dimer over the concentration range used in our MT binding studies. This finding indicates that only one of the two MT-binding sites on the dimer is probably linked to a microtubule at any given time.	UNIV FLORIDA,HLTH SCI CTR,COLL MED,DEPT BIOCHEM & MOLEC BIOL,GAINESVILLE,FL 32610	State University System of Florida; University of Florida					NIGMS NIH HHS [GM-44823] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044823] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AAMODT EJ, 1984, BIOCHEMISTRY-US, V23, P6023, DOI 10.1021/bi00320a019; AINSZTEIN AM, 1994, J BIOL CHEM, V269, P28465; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; COFFEY RL, 1994, BIOCHEMISTRY-US, V33, P13199, DOI 10.1021/bi00249a006; ELLISMAN MH, 1980, J CELL BIOL, V87, P464, DOI 10.1083/jcb.87.2.464; ENNULAT DJ, 1989, J BIOL CHEM, V264, P5327; FLYNN G, 1987, BIOCHEM BIOPH RES CO, V148, P1453, DOI 10.1016/S0006-291X(87)80295-4; FLYNN G, 1987, J BIOL CHEM, V262, P15443; FLYNN GC, 1988, THESIS U CALIF, P102; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; GUSTKE N, 1992, FEBS LETT, V307, P199, DOI 10.1016/0014-5793(92)80767-B; HAIMO LT, 1979, P NATL ACAD SCI USA, V76, P5759, DOI 10.1073/pnas.76.11.5759; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; JOB D, 1985, J CELL BIOL, V101, P1680, DOI 10.1083/jcb.101.5.1680; JOLY JC, 1990, BIOCHEMISTRY-US, V29, P8916, DOI 10.1021/bi00490a006; JOLY JC, 1989, J CELL BIOL, V109, P2289, DOI 10.1083/jcb.109.5.2289; KOWALSKI RJ, 1993, J BIOL CHEM, V268, P9847; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; LEWIS SA, 1989, NATURE, V342, P498, DOI 10.1038/342498a0; MACPHERSON MJ, 1991, DIRECTED MUTAGENESIS; MATUS A, 1990, J PHYSIOL-PARIS, V84, P131; MELKI R, 1991, BIOCHEMISTRY-US, V30, P11536, DOI 10.1021/bi00113a008; OBAR RA, 1989, NEURON, V3, P639, DOI 10.1016/0896-6273(89)90274-2; OKABE S, 1988, J CELL BIOL, V107, P651, DOI 10.1083/jcb.107.2.651; OLMSTED JB, 1986, ANNU REV CELL BIOL, V2, P421, DOI 10.1146/annurev.cb.02.110186.002225; RUBINO HM, 1989, NEURON, V3, P631, DOI 10.1016/0896-6273(89)90273-0; SCATCHARD G, 1946, J AM CHEM SOC, V68, P2315, DOI 10.1021/ja01215a054; SCHERSON T, 1984, J CELL BIOL, V99, P425, DOI 10.1083/jcb.99.2.425; TUCKER RP, 1990, BRAIN RES REV, V15, P101, DOI 10.1016/0165-0173(90)90013-E; VALLEE RB, 1977, J BIOL CHEM, V252, P377; WALLIS KT, 1993, J BIOL CHEM, V268, P15158; WICHE G, 1989, BIOCHEM J, V259, P1; WUERKER R B, 1969, Tissue and Cell, V1, P387, DOI 10.1016/S0040-8166(69)80012-1; YAMAUCHI PS, 1993, J NEUROCHEM, V60, P817, DOI 10.1111/j.1471-4159.1993.tb03225.x	36	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1035	1040		10.1074/jbc.270.3.1035	http://dx.doi.org/10.1074/jbc.270.3.1035			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836356	hybrid			2022-12-27	WOS:A1995QB15600011
J	ROLLAND, V; DUGAIL, I; LELIEPVRE, X; LAVAU, M				ROLLAND, V; DUGAIL, I; LELIEPVRE, X; LAVAU, M			EVIDENCE OF INCREASED GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE AND FATTY-ACID SYNTHETASE PROMOTER ACTIVITIES IN TRANSIENTLY TRANSFECTED ADIPOCYTES FROM GENETICALLY-OBESE RATS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; GENE; EXPRESSION; INSULIN; PROTEIN; IDENTIFICATION; SYNTHASE; ENHANCER; CELLS; DNA	Previous studies have shown that the adipose tissue of young genetically obese Zucker rats was characterized by a coordinate overtranscription of lipogenic genes, suggesting that the fa mutation triggers transcription factor(s) acting in common on the promoters of these genes. To test this hypothesis, we developed a system of transient transfection of rat adipocytes with constructs containing glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and fatty acid synthetase (FAS) promoters fused to gene reporter CAT. Those transfected cells expressed high levels of promoter-driven chloramphenicol acetyltransferase (CAT) activity through correctly initiated transcription as shown by primer extension analysis. Using this system we found a direct effect of insulin on GAPDH and FAS gene expression in rat adipocytes, In transfected adipocytes from obese compared to lean rats, activity of GAPDH and FAS promoters fused to CAT, was 2.6- and 8-fold increased, respectively In contrast when reporter gene activity was driven by either phosphoenolpyruvate carboxykinase or beta-actin promoter, no difference could be observed between lean and obese, pointing out the promoter specificity of genotype effect, 5' deletion analysis of GAPDH promoter allowed us to narrow down the fa responsive region to nucleotide -488-329. As assessed by gel retardation and DNase I footprinting analysis, adipocyte nuclear protein interactions to this 159-bp fragment were found to be identical and to footprint the same 20-bp sequence. This study pointed out that overexpression of GAPDH and FAS genes in adipose tissue of genetically obese rats relies on promoter activation, through a 159-bp cis-acting region within the GAPDH promoter. The effects of the fa mutation on trans-acting factors binding to this region remain to be identified.			ROLLAND, V (corresponding author), INST BIOMED CORDELIERS,INSERM,U177,UNITE RECH PHYSIOPATHOL NUTR,15 RUE ECOLE MED,F-75006 PARIS,FRANCE.		Dugail, Isabelle/L-1567-2017	Dugail, Isabelle/0000-0003-3631-2252				ALEXANDER MC, 1988, P NATL ACAD SCI USA, V85, P5092, DOI 10.1073/pnas.85.14.5092; AMY CM, 1990, BIOCHEM J, V271, P675, DOI 10.1042/bj2710675; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DUGAIL I, 1988, BIOCHEM J, V254, P483, DOI 10.1042/bj2540483; DUGAIL I, 1992, BIOCHEM J, V281, P607, DOI 10.1042/bj2810607; GRAVES RA, 1991, GENE DEV, V5, P428, DOI 10.1101/gad.5.3.428; GUICHARD C, 1992, J LIPID RES, V33, P679; HAINAULT I, 1991, J CLIN INVEST, V87, P1127, DOI 10.1172/JCI115077; KAESTNER KH, 1990, P NATL ACAD SCI USA, V87, P251, DOI 10.1073/pnas.87.1.251; KAMEDA K, 1991, J BIOL CHEM, V266, P419; KRIEF S, 1991, P EXP BIOL MED SOC, P528; MAXAM A, 1980, METHOD ENZYMOL, V152, P721; MOUSTAID N, 1994, J BIOL CHEM, V269, P5629; MURATA Y, 1994, J BIOL CHEM, V269, P20674; NASRIN N, 1990, P NATL ACAD SCI USA, V87, P5273, DOI 10.1073/pnas.87.14.5273; QUON MJ, 1993, BIOCHEM BIOPH RES CO, V194, P338, DOI 10.1006/bbrc.1993.1825; RODBELL M, 1964, J BIOL CHEM, V239, P375; Sambrook J, 1989, MOL CLONING LABORATO; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; TRUETT GE, 1991, P NATL ACAD SCI USA, V88, P7806, DOI 10.1073/pnas.88.17.7806; ZUCKER LM, 1961, J HERED, V62, P275	22	53	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1102	1106		10.1074/jbc.270.3.1102	http://dx.doi.org/10.1074/jbc.270.3.1102			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836367	hybrid			2022-12-27	WOS:A1995QB15600022
J	SUN, ZJ; YERGEAU, DA; TUYPENS, T; TAVERNIER, J; PAUL, CC; BAUMANN, MA; TENEN, DG; ACKERMAN, SJ				SUN, ZJ; YERGEAU, DA; TUYPENS, T; TAVERNIER, J; PAUL, CC; BAUMANN, MA; TENEN, DG; ACKERMAN, SJ			IDENTIFICATION AND CHARACTERIZATION OF A FUNCTIONAL PROMOTER REGION IN THE HUMAN EOSINOPHIL IL-5 RECEPTOR-ALPHA SUBUNIT GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; HUMAN INTERLEUKIN-5 RECEPTOR; LUCIFERASE REPORTER GENE; RNA POLYMERASE-II; B-CELL GROWTH; DIFFERENTIATION FACTOR; TRANSCRIPTION INITIATION; HEMATOPOIETIC-CELLS; MOLECULAR-BASIS; CD11B PROMOTER	The molecular basis for the commitment of multipotential myeloid progenitors to the eosinophil lineage, and the transcriptional mechanisms by which eosinophil-specific genes are subsequently expressed and regulated during eosinophil development are currently unknown. Interleukin-5 (IL-5) is a T cell and mast cell-derived cytokine with actions restricted to the eosinophil and closely related basophil lineages in humans. The high affinity receptor for IL-5 (IL-5R) is composed of an alpha subunit (IL-5R alpha) expressed by the eosinophil lineage, that associates with a beta(c) subunit shared with the receptors for IL-3 and granulocyte macrophage colony stimulating factor (GM-CSF). As a prerequisite to studies of the transcriptional regulation of the IL-5R alpha subunit gene, we used three different methods, including primer extension, RNase protection, and 5'-RACE to precisely map the transcriptional start site to a position 15 base pairs (bp) upstream of the 5' end of the published sequence of IL-5R alpha exon 1. To initially identify the IL-5R alpha promoter, 3.5 kilobases (kb) and 561 bp of the 5' sequence flanking the transcriptional start site were subcloned into the promoterless pXP2-luciferase vector, Transient transfection of these constructs into an eosinophil-committed HL-60 subline, clone HL-60-C15, induced the expression of similar to 240-fold greater luciferase activity than the promoterless vector, identifying a strong functionally active promoter region within the 561 bp of sequence proximal to the transcriptional start site and with activity equivalent to pXP2 constructs containing the entire 3.5 kb of upstream sequence. To more precisely localize the cis-acting regulatory elements in this region important for promoter activity, a series of 5' deletion mutants of the 561-bp region were generated in the pXP2-luciferase vector. Deletion of the region between bp -432 and -398 reduced promoter activity by more than 80% in the HL-60-C15 cell line. Further analyses of the activity of the IL-5R alpha promoter constructs in various other eosinophil, myeloid, and non-myeloid cell lines indicated that the promoter was relatively myeloid and eosinophil lineage-specific in its expression. Consensus sequences for known transcription factor binding sites were not present in the 34-bp region of the promoter required for maximal activity, suggesting unique myeloid- and possibly eosinophil-specific regulatory elements, Using electrophoretic mobility shift assays, we have identified a nuclear factor(s) that binds to the 34-bp functional region of the the promoter and that is expressed in the myeloid and eosinophilic cell Lines in which the promoter is active, but not in non-myeloid or non-hematopoietic lines. This functional promoter segment likely serves as the binding site for a myeloid- and possibly eosinophil-specific transcription factor(s). Further study of the IL-5R alpha promoter should elucidate unique transcriptional features of this gene whose expression is essential to the commitment and differentiation of multipotential myeloid progenitors to the eosinophil lineage and to the functional activation of the mature cell.	BETH ISRAEL HOSP,DEPT MED,DIV INFECT DIS,BOSTON,MA 02215; BETH ISRAEL HOSP,DEPT MED,DIV HEMATOL ONCOL,BOSTON,MA 02215; HARVARD UNIV,SCH MED,BOSTON,MA 02215; HOFFMAN LA ROCHE,ROCHE RES GENT,GHENT,BELGIUM; DAYTON VET ADM MED CTR,RES SERV,DAYTON,OH 45435; WRIGHT STATE UNIV,SCH MED,DIV HEMATOL ONCOL,DAYTON,OH 45435	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University System of Ohio; Wright State University Dayton				Tenen, Daniel/0000-0002-6423-3888	NCI NIH HHS [CA41456] Funding Source: Medline; NIAID NIH HHS [AI33043] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA041456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033043] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ausubel F.M., 1994, CURRENT PROTOCOLS MO, V1; BAUMANN MA, 1993, BLOOD, V82, pA241; BUCHER P, 1986, NUCLEIC ACIDS RES, V14, P10009, DOI 10.1093/nar/14.24.10009; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; BURN TC, 1992, BLOOD, V80, P3051; CLUTTERBUCK E, 1987, EUR J IMMUNOL, V17, P1743, DOI 10.1002/eji.1830171210; CLUTTERBUCK EJ, 1989, BLOOD, V73, P1504; DENT LA, 1990, J EXP MED, V172, P1425, DOI 10.1084/jem.172.5.1425; DEVOS R, 1991, EMBO J, V10, P2133, DOI 10.1002/j.1460-2075.1991.tb07747.x; DEVOS R, 1993, J BIOL CHEM, V268, P6581; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DING DXH, 1994, P NATL ACAD SCI USA, V91, P2537, DOI 10.1073/pnas.91.7.2537; FISCHKOFF SA, 1988, LEUKEMIA RES, V12, P679, DOI 10.1016/0145-2126(88)90103-8; GALLI SJ, 1994, EOSINOPHILS ALLERGY, V2, P255; GHOSH D, 1992, NUCLEIC ACIDS RES, V11, P2091; GOMOLIN HI, 1993, BLOOD, V82, P1868; GOODALL GJ, 1993, GROWTH FACTORS, V8, P87, DOI 10.3109/08977199309046929; HOHAUS S, 1994, BLOOD, V84, pA510; IMAMURA F, 1994, DNA CELL BIOL, V13, P283, DOI 10.1089/dna.1994.13.283; KLEIN G, 1974, P NATL ACAD SCI USA, V71, P3283, DOI 10.1073/pnas.71.8.3283; Lopez A F, 1992, Immunol Ser, V57, P549; LOPEZ AF, 1991, J BIOL CHEM, V266, P24741; MITA S, 1993, J IMMUNOL, V151, P6924; MITA S, 1989, P NATL ACAD SCI USA, V86, P2311, DOI 10.1073/pnas.86.7.2311; MIYAJIMA A, 1993, BLOOD, V82, P1960; MURATA Y, 1992, J EXP MED, V175, P341, DOI 10.1084/jem.175.2.341; NAKAGAWA Y, 1994, J BIOL CHEM, V269, P10905; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; ORKIN SH, 1992, BLOOD, V80, P575; OWEN WF, 1989, J EXP MED, V170, P343, DOI 10.1084/jem.170.1.343; OWEN WF, 1990, P NATL ACAD SCI USA, V87, P8647, DOI 10.1073/pnas.87.21.8647; PAHL HL, 1992, BLOOD, V79, P865; PAHL HL, 1991, EXP HEMATOL, V19, P1038; PAHL HL, 1993, J BIOL CHEM, V268, P5014; PALACIOS R, 1987, EMBO J, V6, P3687, DOI 10.1002/j.1460-2075.1987.tb02702.x; PAUL CC, 1994, J LEUKOCYTE BIOL, V56, P74, DOI 10.1002/jlb.56.1.74; PAUL CC, 1993, BLOOD, V81, P1193; PLAETINCK G, 1990, J EXP MED, V172, P683, DOI 10.1084/jem.172.3.683; PLAUT M, 1989, NATURE, V339, P64, DOI 10.1038/339064a0; PUGH BF, 1992, J BIOL CHEM, V267, P679; RISSE G, 1989, EMBO J, V8, P3825, DOI 10.1002/j.1460-2075.1989.tb08560.x; ROBERTS WM, 1992, BLOOD, V79, P586; SAITO H, 1988, P NATL ACAD SCI USA, V85, P2288, DOI 10.1073/pnas.85.7.2288; Sanderson C J, 1990, Immunol Ser, V49, P231; SANDERSON CJ, 1991, INT ARCH ALLER A IMM, V94, P122, DOI 10.1159/000235342; SANDERSON CJ, 1988, IMMUNOL REV, V102, P29, DOI 10.1111/j.1600-065X.1988.tb00740.x; SANDERSON CJ, 1992, BLOOD, V79, P3101, DOI 10.1182/blood.V79.12.3101.3101; SETO Y, 1992, J IMMUNOL, V148, P259; SHOWE MK, 1992, NUCLEIC ACIDS RES, V20, P3153, DOI 10.1093/nar/20.12.3153; SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0; SMITH LA, 1993, BLOOD, V82, pA184; SMITH LT, 1994, BLOOD, V84, pA372; TAKAKI S, 1994, MOL CELL BIOL, V14, P7404, DOI 10.1128/MCB.14.11.7404; TAKAKI S, 1993, J EXP MED, V177, P1523, DOI 10.1084/jem.177.6.1523; TAKATSU K, 1988, IMMUNOL REV, V102, P107, DOI 10.1111/j.1600-065X.1988.tb00743.x; TAKATSU K, 1989, COLD SPRING HARB SYM, V2, P745; TAVERNIER J, 1992, P NATL ACAD SCI USA, V89, P7041, DOI 10.1073/pnas.89.15.7041; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; TOMINAGA A, 1991, J EXP MED, V173, P429, DOI 10.1084/jem.173.2.429; Tuypens T, 1992, Eur Cytokine Netw, V3, P451; WALL L, 1988, GENE DEV, V2, P1089, DOI 10.1101/gad.2.9.1089; YAMAGUCHI Y, 1994, J BIOL CHEM, V269, P19410; YAMAGUCHI Y, 1988, J EXP MED, V167, P43, DOI 10.1084/jem.167.1.43; ZHANG DE, 1994, J BIOL CHEM, V269, P11425; ZHANG DE, 1994, MOL CELL BIOL, V14, P373, DOI 10.1128/MCB.14.1.373; ZHANG DE, 1994, MOL CELL BIOL, V14, P8085, DOI 10.1128/MCB.14.12.8085; ZON LI, 1993, BLOOD, V81, P3234	67	40	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1462	1471		10.1074/jbc.270.3.1462	http://dx.doi.org/10.1074/jbc.270.3.1462			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836416	hybrid			2022-12-27	WOS:A1995QB15600073
J	LOPEZ, MJ; UPCHURCH, BH; RINDI, G; LEITER, AB				LOPEZ, MJ; UPCHURCH, BH; RINDI, G; LEITER, AB			STUDIES IN TRANSGENIC MICE REVEAL POTENTIAL RELATIONSHIPS BETWEEN SECRETIN-PRODUCING CELLS AND OTHER ENDOCRINE CELL-TYPES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC-POLYPEPTIDE; GASTROINTESTINAL-TRACT; INTESTINAL EPITHELIUM; T-ANTIGEN; GENE; EXPRESSION; DIFFERENTIATION; ENTEROENDOCRINE; GLUCAGON; SOMATOSTATIN	We have produced transgenic mice expressing fusion genes consisting of 1.6 kilobase pairs of the secretin gene 5' flanking region to direct the expression of human growth hormone (hGH) or simian virus 40 large T antigen to secretin-producing cells, Analysis of different mouse tissues for hGH transcripts revealed expression in each of the major secretin-producing tissues, namely the intestine and endocrine pancreas. Multiple label immunohistochemistry demonstrated that the transgene was correctly directed to secretin cells in the intestinal tract, including a previously unrecognized population of secretin cells in the colon of adult and developing mice, In the small intestine, subpopulations of hGH-containing cells frequently coexpressed substance P, serotonin, and cholecystokinin whereas in the colon cells expressing hGH frequently coexpressed glucagon, peptide YY, or neurotensin, Transgenic mice expressing large T antigen in secretin cells developed poorly differentiated neuroendocrine tumors of the small intestine, well differentiated colonic tumors containing glucagon-expressing cells, and insulin-producing tumors in pancreas, These studies indicate that the major cis-regulatory sequences necessary for secretin expression in enteroendocrine cells and fetal islets are localized with 1.6 kilobase pairs of the transcriptional start site, Coexpression of reporter transgenes with several gastrointestinal hormones suggests a potential relationships between secretin cells and other enteroendocrine cell types, as well as pancreatic beta cells.	TUFTS UNIV,NEW ENGLAND MED CTR,SCH MED,DIV GASTROENTEROL,BOSTON,MA 02111	Tufts Medical Center; Tufts University				RINDI, Guido/0000-0003-2996-4404	NIDDK NIH HHS [DK34928, DK43673, DK07471] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043673, P30DK034928, T32DK007471] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGUILA MC, 1991, P NATL ACAD SCI USA, V88, P11485, DOI 10.1073/pnas.88.24.11485; BISHOP AE, 1988, PATHOL RES PRACT, V183, P119, DOI 10.1016/S0344-0338(88)80040-2; BRADL M, 1991, P NATL ACAD SCI USA, V88, P6447, DOI 10.1073/pnas.88.15.6447; CETIN Y, 1990, HISTOCHEMISTRY, V93, P601, DOI 10.1007/BF00272202; CHANG TM, 1985, PEPTIDES, V6, P193, DOI 10.1016/0196-9781(85)90039-7; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; EFRAT S, 1988, NEURON, V1, P605, DOI 10.1016/0896-6273(88)90110-9; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FULLER PJ, 1989, J IMMUNOL, V143, P1015; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; HAUFT SM, 1992, J CELL BIOL, V117, P825, DOI 10.1083/jcb.117.4.825; HERRERA PL, 1991, DEVELOPMENT, V113, P1257; HOGAN B, 1986, MANIPULATING MOUSE E; INOKUCHI H, 1985, GASTROENTEROLOGY, V89, P1014, DOI 10.1016/0016-5085(85)90202-1; KOPIN AS, 1990, P NATL ACAD SCI USA, V87, P2299, DOI 10.1073/pnas.87.6.2299; KOPIN AS, 1991, P NATL ACAD SCI USA, V88, P5335, DOI 10.1073/pnas.88.12.5335; LARSSON LI, 1977, CELL TISSUE RES, V181, P361, DOI 10.1007/BF00223111; LEE YC, 1992, J BIOL CHEM, V267, P10705; LEITER AB, 1993, GUT PEPTIDES, P147; MAHON KA, 1987, SCIENCE, V235, P1622, DOI 10.1126/science.3029873; MUTT V, 1979, LIFE SCI, V25, P1703, DOI 10.1016/0024-3205(79)90472-7; RINDI G, 1990, AM J PATHOL, V136, P1349; ROTH KA, 1990, P NATL ACAD SCI USA, V87, P6408, DOI 10.1073/pnas.87.16.6408; ROTH KA, 1992, AM J PHYSIOL, V263, pG174, DOI 10.1152/ajpgi.1992.263.2.G174; ROTH KA, 1990, J CELL BIOL, V110, P1791, DOI 10.1083/jcb.110.5.1791; STRAUS E, 1978, GASTROENTEROLOGY, V75, P401; TEITELMAN G, 1993, DEVELOPMENT, V118, P1031; TSUBOUCHI S, 1979, AM J ANAT, V156, P431, DOI 10.1002/aja.1001560403; UPCHURCH BH, 1994, DEVELOPMENT, V120, P245; WHEELER MB, 1992, MOL CELL BIOL, V12, P3531, DOI 10.1128/MCB.12.8.3531	30	46	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					885	891		10.1074/jbc.270.2.885	http://dx.doi.org/10.1074/jbc.270.2.885			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822327	hybrid			2022-12-27	WOS:A1995QB81600061
J	MITCHELL, J; GUTIERREZ, J; NORTHUP, JK				MITCHELL, J; GUTIERREZ, J; NORTHUP, JK			PURIFICATION, CHARACTERIZATION, AND PARTIAL AMINO-ACID-SEQUENCE OF A G-PROTEIN-ACTIVATED PHOSPHOLIPASE-C FROM SQUID PHOTORECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIMULUS VENTRAL PHOTORECEPTORS; GUANINE-NUCLEOTIDE BINDING; VISUAL EXCITATION; ALPHA-SUBUNITS; IMMUNOLOGICAL IDENTIFICATION; INVERTEBRATE PHOTORECEPTORS; BOVINE BRAIN; DROSOPHILA; LIGHT; MEMBRANES	Invertebrate visual transduction is thought to be initiated by photoactivation of rhodopsin and its subsequent interaction with a guanyl nucleotide-binding protein (G protein), The identities of the G protein and its target effector have remained elusive, although evidence suggests the involvement of a phospholipase C (PLC). We have identified a phosphatidylinositol-specific PLC from the cytosol of squid retina, The enzyme was purified to near-homogeneity by a combination of carboxymethyl-Sepharose and heparin-Sepharose chromatography. The purified PLC, identified as an approximately 140-kDa protein by sodium dodecyl sulfate-polyacrylamide gels, hydrolyzed phosphatidylinositol 4,5-bisphosphate (PIP2) at a rate of 10-15 mu mol/min/mg of protein with 1 mu M Ca2+. The partial amino acid sequence of the protein showed homology with a PLC cloned from a Drosophila head library (PLC21) and lesser homology with Drosophila norpA protein and mammalian PLC beta isozymes. Reconstitution of purified squid PLC with an AIF(-)-activated 44-kDa G protein a subunit extracted from squid photoreceptor membranes resulted in a significant increase in PIP2 hydrolysis over a range of Ca2+ concentrations while reconstitution with mammalian G(t) alpha or G(i)1 alpha was without effect, These results suggest that cephalopod phototransduction is mediated by G alpha-44 activation of a 140-kDa cytosolic PLC.	NIMH, CELL BIOL LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	MITCHELL, J (corresponding author), UNIV TORONTO, DEPT PHARMACOL, MED SCI BLDG, TORONTO, ON M5S 1A8, CANADA.							BACIGALUPO J, 1983, NATURE, V304, P268, DOI 10.1038/304268a0; BENTROP J, 1986, EUR J BIOCHEM, V161, P61, DOI 10.1111/j.1432-1033.1986.tb10124.x; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BOLSOVER SR, 1982, J PHYSIOL-LONDON, V332, P325, DOI 10.1113/jphysiol.1982.sp014416; BROWN JE, 1984, NATURE, V311, P160, DOI 10.1038/311160a0; CHABRE M, 1989, EUR J BIOCHEM, V179, P255, DOI 10.1111/j.1432-1033.1989.tb14549.x; Charbonneau H, 1989, PRACTICAL GUIDE PROT; FAWZI AB, 1990, BIOCHEMISTRY-US, V29, P3804, DOI 10.1021/bi00467a030; FEIN A, 1984, NATURE, V311, P157, DOI 10.1038/311157a0; FEIN A, 1981, SCIENCE, V212, P555, DOI 10.1126/science.6782676; FEIN A, 1979, SCIENCE, V204, P77, DOI 10.1126/science.34877; FEIN A, 1986, SCIENCE, V232, P1543, DOI 10.1126/science.3487116; FUNG BKK, 1983, J BIOL CHEM, V258, P495; INOUE H, 1988, J BIOCHEM-TOKYO, V103, P91, DOI 10.1093/oxfordjournals.jbchem.a122246; INOUE H, 1985, BIOCHEM BIOPH RES CO, V132, P513, DOI 10.1016/0006-291X(85)91163-5; JOHNSON EC, 1986, NATURE, V324, P468, DOI 10.1038/324468a0; KIRKWOOD A, 1989, P NATL ACAD SCI USA, V86, P3872, DOI 10.1073/pnas.86.10.3872; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE YJ, 1990, NEURON, V5, P889, DOI 10.1016/0896-6273(90)90349-K; LIEBMAN PA, 1987, ANNU REV PHYSIOL, V49, P765, DOI 10.1146/annurev.ph.49.030187.004001; MORRIS AJ, 1990, J BIOL CHEM, V265, P13501; NORTHUP JK, 1982, J BIOL CHEM, V257, P1416; PARK DG, 1993, J BIOL CHEM, V268, P3710; Paulsen R., 1986, Progress in Zoology, V33, P299; POTTINGER JDD, 1991, BIOCHEM J, V279, P323, DOI 10.1042/bj2790323; RAAFLAUB J, 1956, Methods Biochem Anal, V3, P301; ROBINSON PR, 1990, BIOCHEM J, V272, P79, DOI 10.1042/bj2720079; RYU SH, 1987, P NATL ACAD SCI USA, V84, P6649, DOI 10.1073/pnas.84.19.6649; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P9113, DOI 10.1073/pnas.87.23.9113; STRYER L, 1991, J BIOL CHEM, V266, P10711; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; TAYLOR SJ, 1990, J BIOL CHEM, V265, P17150; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TOYOSHIMA S, 1990, J BIOL CHEM, V265, P14842; TSUDA M, 1986, FEBS LETT, V198, P5, DOI 10.1016/0014-5793(86)81173-5; TSUDA M, 1987, RETINAL PROTEINS, P393; VANDENBERG CA, 1984, BIOCHEMISTRY-US, V23, P2339, DOI 10.1021/bi00306a003; WANGE RL, 1991, J BIOL CHEM, V266, P11409; WONG F, 1978, NATURE, V276, P76, DOI 10.1038/276076a0; YOSHIOKA T, 1985, J BIOCHEM-TOKYO, V97, P1251, DOI 10.1093/oxfordjournals.jbchem.a135171	43	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					854	859		10.1074/jbc.270.2.854	http://dx.doi.org/10.1074/jbc.270.2.854			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822322	hybrid			2022-12-27	WOS:A1995QB81600056
J	SARUTA, F; KURAMOCHI, T; NAKAMURA, K; TAKAMIYA, S; YU, Y; AOKI, T; SEKIMIZU, K; KOJIMA, S; KITA, K				SARUTA, F; KURAMOCHI, T; NAKAMURA, K; TAKAMIYA, S; YU, Y; AOKI, T; SEKIMIZU, K; KOJIMA, S; KITA, K			STAGE-SPECIFIC ISOFORMS OF COMPLEX-II (SUCCINATE-UBIQUINONE OXIDOREDUCTASE) IN MITOCHONDRIA FROM THE PARASITIC NEMATODE, ASCARIS-SUUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER COMPLEXES; FUMARATE REDUCTASE-ACTIVITY; SULFUR PROTEIN SUBUNIT; CYTOCHROME-C OXIDASE; ESCHERICHIA-COLI; MUSCLE MITOCHONDRIA; NUCLEOTIDE-SEQUENCE; RESPIRATORY-CHAIN; PURIFICATION; FLAVOPROTEIN	Complex II from mitochondria of the adult parasitic nematode, Ascaris suum, exhibits high fumarate reductase activity and plays a key role in the anaerobic electron transport observed in these organelles. In contrast, mitochondria isolated from free living second stage larvae (L2) of A. suum show much lower fumarate reductase activity than those from adults, whereas succinate dehydrogenase activities of mitochondria in both stages are comparable. In the present study, biochemical. and antigenic properties of the partially purified enzymes from both larval and adult mitochondria were compared. Larval complex II eluted hom the DEAE-Cellulofine column chromatography at a lower salt concentration than adult enzyme, whereas the apparent molecular size of both enzyme complexes estimated by gel permeation column chromatography was the same, The fumarate reductase activity of larval complex II was less than 3% of that of adult enzyme, and the K-m values for substrates were significantly different between the two complexes. The flavoprotein subunit of larval complex II could be distinguished from that of adult complex II by two-dimensional gel electrophoresis and peptide mapping. The antibody against the smallest subunit (small subunit of cytochrome b(558)) of the adult enzyme did not cross-react with that of the larval enzyme. These results suggest that larval complex II differs hom adult enzyme and is more similar to aerobic mammalian enzymes with low fumarate reductase activity, This is the first direct indication of the two different stage-specific forms of mitochondrial complex II.	UNIV TOKYO,INST MED SCI,DEPT PARASITOL,MINATO KU,TOKYO 108,JAPAN; JUNTENDO UNIV,SCH MED,DEPT PARASITOL,TOKYO 113,JAPAN; KYUSHU UNIV,FAC PHARMACEUT SCI,FUKUOKA 812,JAPAN	University of Tokyo; Juntendo University; Kyushu University				Kita, Kiyoshi/0000-0002-0426-4308				Ackrell B. A.C, 1992, CHEM BIOCH FLAVOPROT, V3, P229; BISSON R, 1986, J BIOL CHEM, V261, P4373; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; COLE ST, 1982, EUR J BIOCHEM, V122, P479; COLE ST, 1982, EUR J BIOCHEM, V126, P211, DOI 10.1111/j.1432-1033.1982.tb06768.x; DARLISON MG, 1984, BIOCHEM J, V223, P507, DOI 10.1042/bj2230507; ERABI T, 1975, J BIOCHEM-TOKYO, V78, P795, DOI 10.1093/oxfordjournals.jbchem.a130968; HEDERSTEDT L, 1992, MOL MECHANISMS BIOEN, P163; HIRAWAKE H, 1994, J BIOCHEM-TOKYO, V116, P221, DOI 10.1093/oxfordjournals.jbchem.a124497; KADENBACH B, 1982, FEBS LETT, V138, P236, DOI 10.1016/0014-5793(82)80450-X; KITA K, 1988, BIOCHIM BIOPHYS ACTA, V935, P130, DOI 10.1016/0005-2728(88)90210-1; KITA K, 1992, PARASITOL TODAY, V8, P155, DOI 10.1016/0169-4758(92)90009-Q; KITA K, 1988, COMP BIOCHEM PHYS B, V89, P31, DOI 10.1016/0305-0491(88)90256-8; KITA K, 1989, J BIOL CHEM, V264, P2672; KITA K, 1985, BIOCHEM INT, V10, P319; KOHLER P, 1991, PHYSL STRATEGIES GAS, P15; KOMUNIECKI R, 1988, COMP BIOCH PARASITIC, P1; KURAMOCHI T, 1994, IN PRESS MOL BIOCH P; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MA YC, 1993, J BIOL CHEM, V268, P20360; MORRIS AAM, 1994, BBA-BIOENERGETICS, V1185, P125, DOI 10.1016/0005-2728(94)90203-8; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PENNOYER JD, 1988, BIOCHIM BIOPHYS ACTA, V935, P195, DOI 10.1016/0005-2728(88)90216-2; ROBINSON JJ, 1982, CAN J BIOCHEM CELL B, V60, P811, DOI 10.1139/o82-101; TAKAMIYA S, 1990, BIOCHEM INT, V21, P1073; TAKAMIYA S, 1986, BIOCHIM BIOPHYS ACTA, V848, P99, DOI 10.1016/0005-2728(86)90165-9; TAKAMIYA S, 1993, BIOCHIM BIOPHYS ACTA, V1141, P65, DOI 10.1016/0005-2728(93)90190-Q; WOOD D, 1984, BIOCHEM J, V222, P519, DOI 10.1042/bj2220519; YU L, 1987, J BIOL CHEM, V262, P1137	29	69	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					928	932		10.1074/jbc.270.2.928	http://dx.doi.org/10.1074/jbc.270.2.928			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822332	hybrid			2022-12-27	WOS:A1995QB81600067
J	XU, YZ; HUANG, P; PLUNKETT, W				XU, YZ; HUANG, P; PLUNKETT, W			FUNCTIONAL COMPARTMENTATION OF DCTP POOLS - PREFERENTIAL UTILIZATION OF SALVAGED DEOXYCYTIDINE FOR DNA-REPAIR IN HUMAN LYMPHOBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN RIBONUCLEOTIDE REDUCTASE; DEOXYNUCLEOSIDE TRIPHOSPHATE POOLS; HUMAN-LEUKEMIA-CELLS; S-PHASE; THYMIDYLATE SYNTHASE; REPLICATION OCCURS; HUMAN-LYMPHOCYTES; THYMIDINE KINASE; L1210 CELLS; CYCLE	The utilization of dCTP derived from de nora synthesis through ribonucleotide reductase in exponentially growing CCRF-CEM cells was compared with the metabolic fate of dCTP produced by the salvage pathway, Exogenous dCyd was not effectively incorporated into replicating DNA; instead, dCTP derived from 1 ribonucleotide reductase (labeled by [5-H-3]Cyd) was the main precursor for that purpose, apparently because of functional compartmentation of the dCTP pool in these cells, Studies of the metabolic route of incorporation of exogenous [5-H-3]dCyd into DNA of growing CCRF-CEM cells demonstrated that it was mainly incorporated through the DNA repair pathway. Incorporation of [5-H-3]dCyd into DNA of synchronized cell populations was maximal in G(1) cells, whereas [H-3]dThd incorporation occurred predominantly in S phase cells, When cellular DNA was density labeled by incubation with BrdUrd, repaired DNA, which was less dense than replicated DNA, was preferentially labeled by [5-H-3]dCyd. In contrast, replicated DNA was labeled by both [H-3]dThd and [5-H-3]Cyd, The DNA-damaging agents methylmethanesulfonate, ultraviolet irradiation, and gamma-irradiation inhibited [H-3]dThd incorporation, whereas they stimulated the accumulation of [5-H-3]dCyd in DNA. Based on these results, we propose that the dCTP pool is functionally compartmentalized in growing CCRF-CEM cells, dCTP derived from the salvage pathway is utilized predominantly for DNA repair, whereas the de nova pathway supplies dCTP far DNA replication.	UNIV TEXAS, MD ANDERSON CANCER CTR, DEPT CLIN INVEST, HOUSTON, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center					NATIONAL CANCER INSTITUTE [R01CA028596] Funding Source: NIH RePORTER; NCI NIH HHS [CA28596] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARNER ESJ, 1988, EXP CELL RES, V178, P335, DOI 10.1016/0014-4827(88)90403-X; ASHMAN CR, 1981, SOMAT CELL GENET, V7, P751, DOI 10.1007/BF01538762; BALL CR, 1972, CHEM-BIOL INTERACT, V4, P297, DOI 10.1016/0009-2797(72)90024-5; BALZARINI J, 1984, BIOCHEM J, V217, P245, DOI 10.1042/bj2170245; COHEN A, 1983, J BIOL CHEM, V258, P2334; COVERLEY D, 1994, ANNU REV BIOCHEM, V63, P745, DOI 10.1146/annurev.bi.63.070194.003525; COX LS, 1991, CELL, V66, P271, DOI 10.1016/0092-8674(91)90617-8; ELLIOTT GC, 1986, MUTAT RES, V166, P295, DOI 10.1016/0167-8817(86)90029-5; ENGSTROM Y, 1988, EMBO J, V7, P1615, DOI 10.1002/j.1460-2075.1988.tb02987.x; ERIKSSON S, 1984, J BIOL CHEM, V259, P1695; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; FRIEDBERG EC, 1985, DNA REPAIR, P459; GREER WL, 1986, EXP CELL RES, V166, P399, DOI 10.1016/0014-4827(86)90486-6; GREGOIRE V, 1994, CANCER RES, V54, P468; HAMMOND RA, 1989, EXP CELL RES, V183, P284, DOI 10.1016/0014-4827(89)90389-3; HARVEY G, 1988, J CELL PHYSIOL, V134, P25, DOI 10.1002/jcp.1041340104; HEINEMANN V, 1989, BIOCHEM PHARMACOL, V38, P4115, DOI 10.1016/0006-2952(89)90693-X; HEINEMANN V, 1992, CANCER RES, V52, P533; HOLMBERG M, 1988, MUTAT RES, V202, P111, DOI 10.1016/0027-5107(88)90171-6; HOPKINS RL, 1980, P NATL ACAD SCI-BIOL, V77, P1801, DOI 10.1073/pnas.77.4.1801; HORZAK P, 1993, CELL, V73, P361; HUANG P, 1992, ANAL BIOCHEM, V207, P163, DOI 10.1016/0003-2697(92)90518-C; HUANG P, 1991, CANCER RES, V51, P6110; HUANG P, 1990, J BIOL CHEM, V265, P16617; JACKSON DA, 1994, J CELL SCI, V107, P1753; JACKSON RC, 1978, J BIOL CHEM, V253, P7440; JACKSON RC, 1992, THEORETICAL F CANCER, P299; KARLE JM, 1983, CANCER LETT, V19, P147, DOI 10.1016/0304-3835(83)90148-9; KAUFMANN WK, 1993, FASEB J, V7, P1188, DOI 10.1096/fasebj.7.12.8375618; LEEDS JM, 1985, MOL CELL BIOL, V5, P3443, DOI 10.1128/MCB.5.12.3443; LEEDS JM, 1987, MOL CELL BIOL, V7, P532, DOI 10.1128/MCB.7.1.532; LILIEMARK JO, 1986, CANCER RES, V46, P1079; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; MAJOR PP, 1981, P NATL ACAD SCI-BIOL, V78, P3235, DOI 10.1073/pnas.78.5.3235; MATHERLY LH, 1989, ANAL BIOCHEM, V182, P338, DOI 10.1016/0003-2697(89)90605-2; MATHEWS CK, 1992, BIOESSAYS, V14, P295, DOI 10.1002/bies.950140502; MCKENNA PG, 1986, SOMAT CELL MOLEC GEN, V12, P325, DOI 10.1007/BF01570726; MEUTH M, 1974, CELL, V2, P109, DOI 10.1016/0092-8674(74)90099-3; MILLS AD, 1989, J CELL SCI, V94, P471; MOMPARLER RL, 1985, PHARMACOL THERAPEUT, V30, P287, DOI 10.1016/0163-7258(85)90053-1; MOYER JD, 1985, CRC CR REV BIOCH MOL, V19, P45, DOI 10.3109/10409238509086787; NAKAMURA H, 1986, EXP CELL RES, V165, P291, DOI 10.1016/0014-4827(86)90583-5; NGUYEN BT, 1986, BIOCHEM J, V234, P263, DOI 10.1042/bj2340263; NICANDER B, 1983, P NATL ACAD SCI-BIOL, V80, P1347, DOI 10.1073/pnas.80.5.1347; NOGUCHI H, 1983, CELL, V32, P443, DOI 10.1016/0092-8674(83)90464-6; PLAGEMANN PGW, 1978, CANCER RES, V38, P978; PLUNKETT W, 1993, SEMIN ONCOL, V20, P50; Reddy G P, 1993, Crit Rev Eukaryot Gene Expr, V3, P255; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; RUSSEV G, 1992, EUR J BIOCHEM, V204, P267, DOI 10.1111/j.1432-1033.1992.tb16633.x; SASVARISZEKELY M, 1989, BIOCHEM BIOPH RES CO, V163, P1158, DOI 10.1016/0006-291X(89)92342-5; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; SHEWACH DS, 1992, BIOCHEM PHARMACOL, V43, P1579, DOI 10.1016/0006-2952(92)90217-7; SHEWACH DS, 1994, CANCER RES, V54, P3218; SIKORSKA M, 1990, BIOCHEM CELL BIOL, V68, P880, DOI 10.1139/o90-130; SMITH CA, 1981, DNA REPAIR LABORAT B, V1, P289; SNYDER RD, 1984, MUTAT RES, V131, P163, DOI 10.1016/0167-8817(84)90057-9; SPASOKUKOTSKAJA T, 1992, FEBS LETT, V297, P151, DOI 10.1016/0014-5793(92)80348-K; SPYROU G, 1987, J BIOL CHEM, V262, P16425; SPYROU G, 1989, J BIOL CHEM, V264, P960; STARNES MC, 1987, J BIOL CHEM, V262, P988; SWENSON PA, 1966, J MOL BIOL, V15, P201, DOI 10.1016/S0022-2836(66)80221-8; TALJANIDISZ J, 1986, BIOCHIM BIOPHYS ACTA, V885, P266, DOI 10.1016/0167-4889(86)90241-7; WEI X, 1993, P NATL ACAD SCI USA, V90, P2117, DOI 10.1073/pnas.90.6.2117; WU Y, 1994, J CELL BIOCHEM, V54, P32, DOI 10.1002/jcb.240540105; XU YZ, 1993, J BIOL CHEM, V268, P22363; XU YZ, 1992, BIOCHEM PHARMACOL, V44, P1819; YOUNG P, 1994, BIOCHEM BIOPH RES CO, V203, P46, DOI 10.1006/bbrc.1994.2146	68	37	39	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					631	637		10.1074/jbc.270.2.631	http://dx.doi.org/10.1074/jbc.270.2.631			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822289	hybrid			2022-12-27	WOS:A1995QB81600022
J	DIBELLA, EE; MAURER, MC; SCHERAGA, HA				DIBELLA, EE; MAURER, MC; SCHERAGA, HA			EXPRESSION AND FOLDING OF RECOMBINANT BOVINE PRETHROMBIN-2 AND ITS ACTIVATION TO THROMBIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-ALPHA-CHAIN; FIBRINOGEN-LIKE PEPTIDES; PRO-ARG CHLOROMETHYLKETONE; PANCREATIC RIBONUCLEASE-A; BLOOD-COAGULATION; CATALYZED ACTIVATION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; TRP INSERTION; RESIDUES 7-16	Bovine prethrombin-2 has been produced in Escherichia coli using a T7 expression system. The expressed prethrombin-2 formed intracellular inclusion bodies which were solubilized by reversible sulfonation of the cysteines in the presence of 7 M guanidine hydrochloride. Sulfonated prethrombin-2 was refolded in the presence of 4 M guanidine hydrochloride, using oxidized and reduced glutathione as the redox couple. The folded protein was purified by heparin affinity chromatography and activated to thrombin with Echis carinatus snake venom. The resulting thrombin was also purified by heparin affinity chromatography. Kinetic constants were determined for the hydrolysis of H-D-phenylalanyl-L-pipecolyl-L-arginine-p-nitroaniline by recombinant thrombin (k(cat) = 123 +/- 10 s(-1) and K-m = 2.91 +/- 0.3 mu M). These values are in good agreement with those determined for wild-type thrombin (k(cat) = 97 +/- 8 s(-1) and K-m = 2.71 +/- 0.25 mu M). From the thrombin-mediated release of fibrinopeptide A from fibrinogen, k(cat)/K-m was found to be the same for recombinant (17.3 +/- 1.2 mu M(-1) s(-1)) and wild-type (16.7 +/- 2.0 mu M(-1) s(-1)) thrombin. These results, taken together with circular dichroism spectra and the elution position of prethrombin-2 from a heparin affinity resin, indicate that prethrombin-2 was folded into a conformation similar to that of the wild-type protein. In addition, since E. coli produces deglycosylated enzymes, these findings suggest that the carbohydrate on the B chain of wild-type thrombin does not affect the amidolytic and fibrinolytic activities of thrombin. Finally, this expression system can be used to prepare mutants of prethrombin-2 for future structure function studies involving thrombin and its substrates; some preliminary results of this type are presented here.	CORNELL UNIV, BAKER LAB CHEM, ITHACA, NY 14853 USA	Cornell University					NHLBI NIH HHS [HL-30616] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030616] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADLER M, 1988, BIOCHEMISTRY-US, V27, P2471, DOI 10.1021/bi00407a033; ARCONE R, 1994, J CELL BIOCHEM, P150; BAUER RS, 1980, J BIOL CHEM, V255, P5900; Bevington PR, 1969, DATA REDUCTION ERROR, P92; BLOMBACK B, 1969, SCAND J CLIN LAB INV, VS 24, P59; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; BODE W, 1992, PROTEIN SCI, V1, P426; CHOI E H, 1989, Korean Biochemical Journal, V22, P154; COTE HCF, 1994, J BIOL CHEM, V269, P11374; DAVIE EW, 1986, J PROTEIN CHEM, V5, P247, DOI 10.1007/BF01025423; DENTON JB, 1982, BIOCHEMISTRY-US, V21, P5155, DOI 10.1021/bi00264a008; DUDA CT, 1982, J BIOL CHEM, V257, P9866; ESMON CT, 1974, J BIOL CHEM, V249, P8045; ESMON NL, 1982, J BIOL CHEM, V257, P859; GAILANI D, 1991, SCIENCE, V253, P909, DOI 10.1126/science.1652157; GAN ZR, 1994, J BIOL CHEM, V269, P1301; GAN ZR, 1991, BIOCHEMISTRY-US, V30, P11694, DOI 10.1021/bi00114a013; GOEDDEL DV, 1990, METHOD ENZYMOL, V185, P3; HAGEMAN TC, 1975, ARCH BIOCHEM BIOPHYS, V171, P327, DOI 10.1016/0003-9861(75)90039-9; Hartley BS, 1971, ENZYMES, V3, P323; HOYER LW, 1981, J LAB CLIN MED, V97, P50; JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001; JORGENSEN MJ, 1987, J BIOL CHEM, V262, P6729; LAITY JH, 1993, P NATL ACAD SCI USA, V90, P615, DOI 10.1073/pnas.90.2.615; LAURA R, 1980, BIOCHEMISTRY-US, V19, P4859, DOI 10.1021/bi00562a024; LEBONNIEC BF, 1992, J BIOL CHEM, V267, P19341; LEBONNIEC BF, 1991, J BIOL CHEM, V266, P13796; LEWIS SD, 1984, THROMB RES, V35, P111, DOI 10.1016/0049-3848(84)90206-8; LIGHT A, 1979, J BIOL CHEM, V254, P9162; LORAND L, 1964, ARCH BIOCHEM BIOPHYS, V105, P58, DOI 10.1016/0003-9861(64)90235-8; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P558, DOI 10.1016/0167-4838(83)90273-X; MACGILLIVRAY RTA, 1984, BIOCHEMISTRY-US, V23, P1626, DOI 10.1021/bi00303a007; Mann K G, 1976, Methods Enzymol, V45, P123; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MARSH HC, 1982, BIOCHEMISTRY-US, V21, P6167, DOI 10.1021/bi00267a022; MARTIN PD, 1992, J BIOL CHEM, V267, P7911; MARTINELLI RA, 1979, ANAL BIOCHEM, V96, P246, DOI 10.1016/0003-2697(79)90579-7; NESHEIM ME, 1979, J BIOL CHEM, V254, P1326; NI F, 1989, BIOCHEMISTRY-US, V28, P3094, DOI 10.1021/bi00433a053; NI F, 1989, BIOCHEMISTRY-US, V28, P3082, DOI 10.1021/bi00433a052; NI F, 1989, BIOCHEMISTRY-US, V28, P3106, DOI 10.1021/bi00433a054; NI F, 1992, THROMBIN STRUCTURE F, P63; ODORZYNSKI TW, 1979, J BIOL CHEM, V254, P4291; PEI G, 1991, J BIOL CHEM, V266, P9598; SCHERAGA HA, 1986, ANN NY ACAD SCI, V485, P124, DOI 10.1111/j.1749-6632.1986.tb34574.x; SCHERAGA HA, 1957, ADV PROTEIN CHEM, V12, P1, DOI 10.1016/S0065-3233(08)60115-1; SINHA NK, 1975, J BIOL CHEM, V250, P8624; So I. S., 1992, KOREAN BIOCH J, V25, P60; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TAKAGI T, 1974, BIOCHEMISTRY-US, V13, P750, DOI 10.1021/bi00701a018; THANNHAUSER TW, 1984, ANAL BIOCHEM, V138, P181, DOI 10.1016/0003-2697(84)90786-3; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WALZ DA, 1986, ANN NY ACAD SCI, V485, P323, DOI 10.1111/j.1749-6632.1986.tb34594.x; WINZOR DJ, 1964, ARCH BIOCHEM BIOPHYS, V104, P202, DOI 10.1016/S0003-9861(64)80004-7; WU QY, 1991, P NATL ACAD SCI USA, V88, P6775, DOI 10.1073/pnas.88.15.6775; WU QY, 1994, J BIOL CHEM, V269, P3725	56	35	43	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					163	169		10.1074/jbc.270.1.163	http://dx.doi.org/10.1074/jbc.270.1.163			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814368	hybrid			2022-12-27	WOS:A1995QA28700029
J	SMULSON, ME; KANG, VH; NTAMBI, JM; ROSENTHAL, DS; DING, RC; SIMBULAN, CMG				SMULSON, ME; KANG, VH; NTAMBI, JM; ROSENTHAL, DS; DING, RC; SIMBULAN, CMG			REQUIREMENT FOR THE EXPRESSION OF POLY(ADP-RIBOSE) POLYMERASE DURING THE EARLY STAGES OF DIFFERENTIATION OF 3T3-L1 PREADIPOCYTES, AS STUDIED BY ANTISENSE RNA INDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; DNA STRAND BREAKS; GENE-EXPRESSION; CELL-CYCLE; CHICK LIMB; ADIPOCYTE DIFFERENTIATION; TOPOISOMERASE-I; CHROMATIN; PROTEIN; COMPLEX	Poly(ADP-ribose) polymerase (PADPRP) is biologically significant in the rejoining of DNA strand breaks. Post confluent cultures of 3T3-L1 preadipocytes showed marked increases in PADPRP protein and activity when the cells were induced to differentiate into adipocytes. When this increase in PADPRP expression was prevented in stably transfected 3T3-L1 cells by induction of PADPRP antisense RNA synthesis, the cells did not differentiate nor undergo the two or three rounds of DNA replication that are required for initiation of the differentiation process. 3T3-L1 cells expressing PADPRP antisense RNA under differentiation conditions were easily detached from plates and in some cases eventually died. When newly expressed PADPRP protein and DNA synthesis was assessed in cells at zero time or at 24 h after induction of differentiation by incorporation of bromodeoxyuridine or [H-3]thymidine into DNA, significant incorporation was shown to occur in control cells after 24 h, but not in antisense cells. Furthermore, during the first 24 h, the co-immunoprecipitation of PADPRP and DNA polymerase cu was observed in control cells, whereas no such complex formation was noted in the induced antisense cells, nor in uninduced control cells.			SMULSON, ME (corresponding author), GEORGETOWN UNIV, SCH MED,DEPT BIOCHEM & MOLEC BIOL,BASIC SCI BLDG, RM 351, 3900 RESERVOIR RD, WASHINGTON, DC 20007 USA.		Rosenthal, Dean S/J-2360-2014; Simbulan-Rosenthal, Cynthia M./W-8429-2019	Rosenthal, Dean/0000-0002-7624-0209; Simbulan-Rosenthal, Ph.D, Cynthia M./0000-0002-5070-0342	NCI NIH HHS [CA25344] Funding Source: Medline; NIDDK NIH HHS [DK-42825] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA025344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042825] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTHAUS FR, 1985, ADP RIBOSYLATION PRO; BAKSI K, 1987, EXP CELL RES, V172, P110, DOI 10.1016/0014-4827(87)90098-X; BENJAMIN RC, 1980, J BIOL CHEM, V255, P502; BERGER NA, 1987, J CLIN INVEST, V79, P1558, DOI 10.1172/JCI112989; BERGER NA, 1980, BIOCHEMISTRY-US, V19, P289, DOI 10.1021/bi00543a006; BHATIA K, 1990, CARCINOGENESIS, V11, P123, DOI 10.1093/carcin/11.1.123; BHATIA K, 1990, J CELL PHYSIOL, V144, P345, DOI 10.1002/jcp.1041440221; BLAHO JA, 1992, J VIROL, V66, P6398, DOI 10.1128/JVI.66.11.6398-6407.1992; BRAC T, 1985, P446; BUTT TR, 1978, NUCLEIC ACIDS RES, V5, P2775, DOI 10.1093/nar/5.8.2775; BUTT TR, 1980, BIOCHEMISTRY-US, V19, P5243, DOI 10.1021/bi00564a014; BUTT TR, 1979, P NATL ACAD SCI USA, V76, P1628, DOI 10.1073/pnas.76.4.1628; CAPLAN AI, 1979, DEV BIOL, V72, P102, DOI 10.1016/0012-1606(79)90101-5; CAPLAN AI, 1975, P NATL ACAD SCI USA, V72, P1852, DOI 10.1073/pnas.72.5.1852; CHATTERJEE S, 1989, EXP CELL RES, V184, P1, DOI 10.1016/0014-4827(89)90358-3; CHERNEY BW, 1985, DEV BIOL, V112, P115, DOI 10.1016/0012-1606(85)90125-3; CHERNEY BW, 1987, P NATL ACAD SCI USA, V84, P8370, DOI 10.1073/pnas.84.23.8370; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEMURCIA G, 1986, J BIOL CHEM, V261, P7011; DEMURCIA G, 1983, EMBO J, V2, P543, DOI 10.1002/j.1460-2075.1983.tb01460.x; DING RC, 1992, J BIOL CHEM, V267, P12804; FANGTSYR L, 1992, GENE DEV, V6, P533; FARZANEH F, 1982, NATURE, V300, P362, DOI 10.1038/300362a0; FARZANEH F, 1987, NUCLEIC ACIDS RES, V15, P3493, DOI 10.1093/nar/15.8.3493; FERRO AM, 1984, J BIOL CHEM, V259, P547; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; HOTLUND J, 1983, EUR J BIOCHEM, V130, P309; HUPPI K, 1989, NUCLEIC ACIDS RES, V17, P3387, DOI 10.1093/nar/17.9.3387; IZANT JG, 1984, CELL, V36, P1007, DOI 10.1016/0092-8674(84)90050-3; JACOBSON MK, 1989, ADP RIBOSE TRANSFER; JANSSEN OE, 1989, EUR J BIOCHEM, V180, P595, DOI 10.1111/j.1432-1033.1989.tb14686.x; JUAREZSALINAS H, 1979, NATURE, V282, P740, DOI 10.1038/282740a0; JUMP DB, 1980, BIOCHEMISTRY-US, V19, P1031, DOI 10.1021/bi00546a031; KASID UN, 1989, J BIOL CHEM, V264, P18687; KAUFMANN S, 1994, CANCER RES, V54, P3976; KIDWELL WR, 1976, BIOCHEMISTRY-US, V15, P1213, DOI 10.1021/bi00651a006; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; LEWIS JE, 1982, FEBS LETT, V146, P37, DOI 10.1016/0014-5793(82)80700-X; LI CJ, 1993, J CELL BIOCHEM, V53, P405, DOI 10.1002/jcb.240530418; LONN U, 1988, EUR J BIOCHEM, V178, P47, DOI 10.1111/j.1432-1033.1988.tb14427.x; LUDWIG A, 1988, J BIOL CHEM, V263, P6993; MACKALL JC, 1976, J BIOL CHEM, V251, P6462; MATHIS G, 1986, J BIOL CHEM, V261, P5758; MILAM KM, 1984, SCIENCE, V223, P589, DOI 10.1126/science.6420886; MORIOKA K, 1979, GANN, V70, P37; NOSSERI C, 1994, EXP CELL RES, V212, P367, DOI 10.1006/excr.1994.1156; NTAMBI JM, 1988, J BIOL CHEM, V263, P17291; PEKALA PH, 1981, J BIOL CHEM, V256, P4871; PEKALA PH, 1983, MOL CELL BIOCHEM, V53-4, P221; RASTL E, 1978, J BIOL CHEM, V253, P4333; Reddy G P, 1993, Crit Rev Eukaryot Gene Expr, V3, P255; REDDY GPV, 1980, P NATL ACAD SCI-BIOL, V77, P3312; REED BC, 1980, P NATL ACAD SCI-BIOL, V77, P285, DOI 10.1073/pnas.77.1.285; RICE WG, 1992, P NATL ACAD SCI USA, V89, P7703, DOI 10.1073/pnas.89.16.7703; ROBERTS JH, 1974, P NATL ACAD SCI USA, V71, P3212, DOI 10.1073/pnas.71.8.3212; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; SIMBULAN CMG, 1993, J BIOL CHEM, V268, P93; SMERDON MJ, 1989, NATO ADV SCI I A-LIF, V182, P271; SMULSON M, 1994, BIOCHEMISTRY-US, V33, P6186, DOI 10.1021/bi00186a018; SMULSON ME, 1977, CANCER RES, V37, P3006; SUROWY CS, 1985, BIOCHIM BIOPHYS ACTA, V832, P33, DOI 10.1016/0167-4838(85)90171-2; SUZUKI H, 1989, ADP RIBOSE TRANFER R, P511; UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.biochem.54.1.73; VILLARREAL LP, 1991, MICROBIOL REV, V55, P512, DOI 10.1128/MMBR.55.3.512-542.1991; WENZ HM, 1992, P NATL ACAD SCI USA, V89, P1065, DOI 10.1073/pnas.89.3.1065; WONG M, 1983, P NATL ACAD SCI-BIOL, V80, P205, DOI 10.1073/pnas.80.1.205; YAMAGOE S, 1991, MOL CELL BIOL, V11, P3522, DOI 10.1128/MCB.11.7.3522	68	60	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					119	127		10.1074/jbc.270.1.119	http://dx.doi.org/10.1074/jbc.270.1.119			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814362	hybrid			2022-12-27	WOS:A1995QA28700023
J	YOSHIOKA, H; GREENWEL, P; INOGUCHI, K; TRUTER, S; INAGAKI, Y; NINOMIYA, Y; RAMIREZ, F				YOSHIOKA, H; GREENWEL, P; INOGUCHI, K; TRUTER, S; INAGAKI, Y; NINOMIYA, Y; RAMIREZ, F			STRUCTURAL AND FUNCTIONAL-ANALYSIS OF THE PROMOTER OF THE HUMAN ALPHA-1(XI) COLLAGEN GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHABDOMYOSARCOMA CELL-LINE; ARGININE-RICH PROTEIN; V COLLAGEN; NH2-TERMINAL DOMAIN; PRO-ALPHA-1(XI) COLLAGEN; I COLLAGEN; CHAIN; XI; EXPRESSION; CARTILAGE	In order to eventually elucidate the mechanisms regulating alpha 1(XI) collagen expression in cartilaginous and non-cartilaginous tissues, we performed an initial analysis of the structural-functional features of the promoter of the human gene (COL11A1). After cloning and sequencing the 5' portion of COL11A1, primer extension and nuclease protection assays identified several minor transcriptional start sites clustered around a major one located 318 base pairs from the ATG codon. Consistent with this finding, analysis of the upstream sequence revealed the absence of a TATA motif and the presence of several GC boxes. Transient transfection experiments delineated the smallest promoter sequence directing relatively high expression of a reporter gene in a cell type-specific manner. Nine nuclear protein-bound areas were located within this promoter sequence of the COL11A1 gene. Sequence homologies suggested that the majority of the footprints correspond to potential binding sites for ubiquitous nuclear proteins, such as AP2 and Sp1. Additional experimental evidence indicated that one of the protected areas may bind a transcriptional complex that is identical or closely related to the one that regulates tissue specificity in the coordinately expressed alpha 2(V) collagen gene.	MT SINAI MED CTR, BROOKDALE CTR MOLEC BIOL, NEW YORK, NY 10029 USA; OKAYAMA UNIV, SCH MED, DEPT BIOCHEM & MOLEC BIOL, OKAYAMA 700, JAPAN	Icahn School of Medicine at Mount Sinai; Okayama University					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038648, R37AR038648] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-38648] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADACHI E, 1989, MATRIX, V9, P232, DOI 10.1016/S0934-8832(89)80055-1; ADACHI E, 1986, CONNECT TISSUE RES, V14, P257, DOI 10.3109/03008208609017469; ALITALO K, 1980, EUR J BIOCHEM, V109, P247, DOI 10.1111/j.1432-1033.1980.tb04790.x; ALITALO K, 1982, J BIOL CHEM, V257, P9016; BERNARD M, 1988, J BIOL CHEM, V263, P17159; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; BIRK DE, 1990, J CELL SCI, V95, P649; BOAST S, 1990, J BIOL CHEM, V265, P13351; BROWN KE, 1991, J BIOL CHEM, V266, P23268; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DYNAN WS, 1986, TRENDS GENET, V2, P196, DOI 10.1016/0168-9525(86)90226-X; EXPOSITO JY, 1993, J BIOL CHEM, V268, P5249; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P1; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREENSPAN DS, 1991, J BIOL CHEM, V266, P24727; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; INAGAKI Y, 1994, J BIOL CHEM, V269, P14828; KLEMAN JP, 1992, EUR J BIOCHEM, V210, P329, DOI 10.1111/j.1432-1033.1992.tb17425.x; LACKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490; LAWRENCE R, 1994, J BIOL CHEM, V269, P9603; LINSENMAYER TF, 1993, J CELL BIOL, V121, P1181, DOI 10.1083/jcb.121.5.1181; MARTIN JD, 1985, J VIROL, V53, P306, DOI 10.1128/JVI.53.1.306-311.1985; MAYNE R, 1993, J BIOL CHEM, V268, P9381; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; MORRIS GF, 1986, P NATL ACAD SCI USA, V83, P1; NAH HD, 1992, J BIOL CHEM, V267, P22581; NEAME PJ, 1990, J BIOL CHEM, V265, P20401; NIYIBIZI C, 1989, FEBS LETT, V242, P314, DOI 10.1016/0014-5793(89)80492-2; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; TAKAHARA K, 1991, J BIOL CHEM, V266, P13124; TRUTER S, 1993, CONNECT TISSUE RES, V29, P51, DOI 10.3109/03008209309061966; TRUTER S, 1992, J BIOL CHEM, V267, P25389; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201; YOSHIOKA H, 1990, J BIOL CHEM, V265, P6423; ZHIDKOVA NI, 1993, FEBS LETT, V326, P25, DOI 10.1016/0014-5793(93)81753-M	37	26	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					418	424		10.1074/jbc.270.1.418	http://dx.doi.org/10.1074/jbc.270.1.418			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814404	hybrid			2022-12-27	WOS:A1995QA28700066
J	ECKMANN, L; HUANG, GTJ; SMITH, JR; MORZYCKAWROBLEWSKA, E; KAGNOFF, MF				ECKMANN, L; HUANG, GTJ; SMITH, JR; MORZYCKAWROBLEWSKA, E; KAGNOFF, MF			INCREASED TRANSCRIPTION AND COORDINATE STABILIZATION OF MESSENGER-RNAS FOR SECRETED IMMUNOGLOBULIN ALPHA-HEAVY-CHAIN AND KAPPA-LIGHT-CHAIN FOLLOWING STIMULATION OF IMMUNOGLOBULIN-A EXPRESSING B-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; MURINE LYMPHOCYTES-B; HALF-LIFE; ESCHERICHIA-COLI; GENE-EXPRESSION; IGA PRODUCTION; DIFFERENTIATION; GROWTH; LIPOPOLYSACCHARIDE; INTERLEUKIN-5	Immunoglobulin A (IgA) plays a key role in host protection at mucosal surfaces, yet little is known regarding the molecular mechanisms that govern the expression of this isotype, The studies herein investigated mechanisms that control IgA secretion in response to stimulation with interleukin-4 and interleukin-5, cytokines which are known to regulate IgA responses, and to bacterial lipopolysaccharide, Two mechanisms were shown to govern agonist induced IgA expression in a murine IgA expressing B cell line, In the initial period after stimulation, increased mRNA levels for the secreted form of alpha heavy chain (alpha(S)), and kappa light chain were paralleled by a transient increase in transcription rates of the corresponding genes, However, with prolonged agonist stimulation, gene transcription rates decreased to near control levels, and increased mRNA levels were associated with a coordinate increase in alpha(S) and kappa mRNA stability. In striking contrast, these agonists did not affect levels or stability of mRNA for the membrane form of alpha heavy chain (alpha(M)). alpha(S) mRNAs contained multiple poly(A) addition sites located 13-32 nucleotides downstream of a single AAUAAA sequence, Nonetheless, the differential usage of these sites as a mechanism for controlling alpha(S) mRNA stability could be excluded, since the relative abundance of these different alpha(S) mRNAs did not differ significantly after agonist stimulation, These data, taken together, suggest that sequences within 107 nucleotides of the 3' end of alpha(S) mRNA, which are absent in alpha(M) mRNA, are required for the regulation of alpha(S) mRNA stability, possibly by acting as targets for regulated trans-acting cellular factors.			ECKMANN, L (corresponding author), UNIV CALIF SAN DIEGO,DEPT MED 0623D,MUCOSAL IMMUNOL LAB,9500 GILMAN DR,LA JOLLA,CA 92093, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK035108, T32DK007202] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK07202, DK35108] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARNOLD LW, 1988, J IMMUNOL, V140, P4355; BABITZKE P, 1991, P NATL ACAD SCI USA, V88, P1, DOI 10.1073/pnas.88.1.1; BEAGLEY KW, 1989, J EXP MED, V169, P2133, DOI 10.1084/jem.169.6.2133; BERBERICH I, 1990, EUR J IMMUNOL, V20, P445, DOI 10.1002/eji.1830200233; CHEN SS, 1990, CELL IMMUNOL, V128, P353, DOI 10.1016/0008-8749(90)90032-M; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; COX A, 1989, NUCLEIC ACIDS RES, V17, P10439, DOI 10.1093/nar/17.24.10439; DODSON RE, 1994, MOL CELL BIOL, V14, P3130, DOI 10.1128/MCB.14.5.3130; DUNNICK W, 1989, MOL CELL BIOL, V95, P1850; ECKMANN L, 1992, IMMUNOLOGY, V76, P235; FLASPOHLER JA, 1990, J IMMUNOL, V144, P2802; GALLI G, 1987, GENE DEV, V1, P471, DOI 10.1101/gad.1.5.471; GAY DA, 1987, CELL, V50, P671, DOI 10.1016/0092-8674(87)90325-4; GENOVESE C, 1990, MOL IMMUNOL, V27, P733, DOI 10.1016/0161-5890(90)90082-B; GREENBERG JR, 1972, NATURE, V240, P102, DOI 10.1038/240102a0; GRUMMT I, 1980, MOL GEN GENET, V177, P223, DOI 10.1007/BF00267433; HARRIMAN GR, 1988, J IMMUNOL, V140, P3033; HARROLD S, 1991, ANAL BIOCHEM, V198, P19, DOI 10.1016/0003-2697(91)90500-S; HEATH CV, 1990, J BIOL CHEM, V265, P9098; HERMANSON GG, 1988, P NATL ACAD SCI USA, V85, P6890, DOI 10.1073/pnas.85.18.6890; JACK HM, 1988, EMBO J, V7, P1041, DOI 10.1002/j.1460-2075.1988.tb02911.x; KIM PH, 1990, J IMMUNOL, V145, P3773; KING LB, 1990, MOL CELL BIOL, V10, P4211, DOI 10.1128/MCB.10.8.4211; LEBMAN DA, 1992, J IMMUNOL, V148, P3282; LEBMAN DA, 1993, INT IMMUNOL, V6, P113; LEDUC I, 1992, CLIN EXP IMMUNOL, V90, P141; LEE F, 1981, NATURE, V294, P228, DOI 10.1038/294228a0; Marzluff W. F., 1984, TRANSCRIPTION TRANSL, P89; Mason PJ, 1985, NUCLEIC ACID HYBRIDI, P113; MCDOWALL KJ, 1994, J BIOL CHEM, V269, P10790; MUDD EA, 1990, MOL MICROBIOL, V4, P2127, DOI 10.1111/j.1365-2958.1990.tb00574.x; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; MULLNER EW, 1988, CELL, V53, P815, DOI 10.1016/0092-8674(88)90098-0; MURRAY PD, 1987, J IMMUNOL, V139, P2669; PEPPEL K, 1990, BIOTECHNIQUES, V9, P711; POGOLOTTI AL, 1982, ANAL BIOCHEM, V126, P335, DOI 10.1016/0003-2697(82)90524-3; PONTECORVI A, 1988, EMBO J, V7, P1489, DOI 10.1002/j.1460-2075.1988.tb02967.x; RAMSAY AJ, 1994, SCIENCE, V264, P561, DOI 10.1126/science.8160012; SAKAGUCHI N, 1988, EMBO J, V7, P3457, DOI 10.1002/j.1460-2075.1988.tb03220.x; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; SHOCKETT P, 1991, J IMMUNOL, V147, P4374; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; SONODA E, 1989, J EXP MED, V170, P1415, DOI 10.1084/jem.170.4.1415; STANTON LW, 1983, NATURE, V303, P401, DOI 10.1038/303401a0; TOMINAGA A, 1991, J EXP MED, V173, P429, DOI 10.1084/jem.173.2.429; TUCKER PW, 1981, P NATL ACAD SCI-BIOL, V78, P7684, DOI 10.1073/pnas.78.12.7684; VANVLASSELAER P, 1992, J IMMUNOL, V148, P2062; VENKITARAMAN AR, 1991, NATURE, V352, P777, DOI 10.1038/352777a0; WAHLE E, 1992, ANNU REV BIOCHEM, V61, P419; WEBB CF, 1991, MOL CELL BIOL, V11, P5197, DOI 10.1128/MCB.11.10.5197; WORD CJ, 1983, EMBO J, V2, P887, DOI 10.1002/j.1460-2075.1983.tb01518.x; YUAN D, 1989, MOL IMMUNOL, V26, P1059, DOI 10.1016/0161-5890(89)90070-9; YUAN D, 1984, J EXP MED, V160, P564, DOI 10.1084/jem.160.2.564; YUAN D, 1992, J IMMUNOL, V148, P3652; YUAN D, 1982, J EXP MED, V156, P962, DOI 10.1084/jem.156.4.962; ZAK R, 1979, PHYSIOL REV, V59, P407, DOI 10.1152/physrev.1979.59.2.407	58	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					33102	33108						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806538				2022-12-27	WOS:A1994QA63800056
J	PEREZSTABLE, C				PEREZSTABLE, C			DISTINCT NEGATIVE REGULATORY MECHANISMS INVOLVED IN THE REPRESSION OF HUMAN EMBRYONIC EPSILON-GLOBIN AND FETAL G-GAMMA-GLOBIN GENES IN TRANSGENIC MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAGE SELECTOR ELEMENT; LOCUS ACTIVATION REGION; ERYTHROID-SPECIFIC EXPRESSION; BETA-GLOBIN; DEVELOPMENTAL REGULATION; HYPERSENSITIVE SITE; CHROMATIN STRUCTURE; PROMOTER; MOUSE; TRANSCRIPTION	A current model for human beta-globin gene switching proposes that the stage-specific activation of embryonic and fetal globin genes requires the interaction of the beta-globin locus control region with proximal promoter elements. Subsequent repression in fetal and adult stages likely involves negative regulatory promoter elements and factors. To begin addressing these negative regulatory mechanisms, the regulation of human fetal G gamma-globin promoter fused to the SV40 T antigen gene was analyzed in transgenic mice. The results showed correct developmental expression in erythroid tissue, but lower levels of expression were also detected in non erythroid tissue. Thus, the 5'-flanking G gamma-globin promoter sequence contains stage-specific erythroid elements but is lacking nonerythroid-specific negative elements. In contrast, the human embryonic epsilon-globin gene was only expressed in nonerythroid tissue of transgenic embryos, suggesting the presence of an erythroid specific negative element(s). With the locus control region, complete repression of epsilon-globin RNA in fetal liver was observed in epsilon-globin genes without the previously characterized silencer, suggesting the presence of additional negative elements. Overall, this transgenic study suggests that distinct negative regulatory mechanisms function in the repression of embryonic and fetal globin genes.	COLUMBIA UNIV,COLL PHYS & SURG,DEPT GENET & DEV,NEW YORK,NY 10032	Columbia University								AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BARALLE FE, 1980, CELL, V21, P621, DOI 10.1016/0092-8674(80)90425-0; BARKER JE, 1969, DEV BIOL, V18, P14; BEHRINGER RR, 1990, GENE DEV, V4, P380, DOI 10.1101/gad.4.3.380; CAO SX, 1989, P NATL ACAD SCI USA, V86, P5306, DOI 10.1073/pnas.86.14.5306; CHADA K, 1986, NATURE, V319, P685, DOI 10.1038/319685a0; CHADA K, 1985, NATURE, V314, P377, DOI 10.1038/314377a0; CHOI ORB, 1988, CELL, V55, P17, DOI 10.1016/0092-8674(88)90005-0; CLARK AR, 1993, BIOCHEM J, V296, P521, DOI 10.1042/bj2960521; CURTIN PT, 1989, P NATL ACAD SCI USA, V86, P7082, DOI 10.1073/pnas.86.18.7082; DILLON N, 1991, NATURE, V350, P252, DOI 10.1038/350252a0; DILLON N, 1993, TRENDS GENET, V9, P134, DOI 10.1016/0168-9525(93)90208-Y; ENGEL JD, 1993, TRENDS GENET, V9, P304, DOI 10.1016/0168-9525(93)90248-G; ENVER T, 1990, NATURE, V344, P309, DOI 10.1038/344309a0; ENVER T, 1989, P NATL ACAD SCI USA, V86, P7033, DOI 10.1073/pnas.86.18.7033; FARACE MG, 1984, J BIOL CHEM, V259, P7123; FOLEY KP, 1992, GENE DEV, V6, P730, DOI 10.1101/gad.6.5.730; FORRESTER WC, 1989, P NATL ACAD SCI USA, V86, P5439, DOI 10.1073/pnas.86.14.5439; FORRESTER WC, 1987, NUCLEIC ACIDS RES, V15, P10159, DOI 10.1093/nar/15.24.10159; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; GALLARDA JL, 1989, GENE DEV, V3, P1845, DOI 10.1101/gad.3.12a.1845; GONG QH, 1991, MOL CELL BIOL, V11, P2558, DOI 10.1128/MCB.11.5.2558; GONG QH, 1993, MOL CELL BIOL, V13, P911, DOI 10.1128/MCB.13.2.911; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; GROUDINE M, 1983, P NATL ACAD SCI-BIOL, V80, P7551, DOI 10.1073/pnas.80.24.7551; GUMUCIO DL, 1993, P NATL ACAD SCI USA, V90, P6018, DOI 10.1073/pnas.90.13.6018; HANSEN JN, 1982, J BIOL CHEM, V257, P1048; HILL A, 1984, J BIOL CHEM, V259, P3739; HOGAN B, 1986, MANIPULATING MOUSE E; JANE SM, 1992, EMBO J, V11, P2961, DOI 10.1002/j.1460-2075.1992.tb05366.x; JANE SM, 1993, MOL CELL BIOL, V13, P3272, DOI 10.1128/MCB.13.6.3272; KOLLIAS G, 1986, CELL, V46, P89, DOI 10.1016/0092-8674(86)90862-7; LLOYD JA, 1992, MOL CELL BIOL, V12, P1561, DOI 10.1128/MCB.12.4.1561; MAGRAM J, 1989, MOL CELL BIOL, V9, P4581, DOI 10.1128/MCB.9.10.4581; MAGRAM J, 1985, NATURE, V315, P338, DOI 10.1038/315338a0; MOTAMED K, 1993, GENE AMST, V123, P253; PEREZSTABLE C, 1990, MOL CELL BIOL, V10, P1116, DOI 10.1128/MCB.10.3.1116; RAICH N, 1990, SCIENCE, V250, P1147, DOI 10.1126/science.2251502; RAICH N, 1992, BLOOD, V79, P861; RYAN TM, 1989, GENE DEV, V3, P314, DOI 10.1101/gad.3.3.314; SHIH DM, 1993, J BIOL CHEM, V268, P3066; SHIH DM, 1990, NUCLEIC ACIDS RES, V18, P5465, DOI 10.1093/nar/18.18.5465; STAMATOYANNOPOU.G, 1987, HEMOGLOBIN SWITCHING, P66; STAMATOYANNOPOU.G, 1993, MOL CELL BIOL, V13, P7636; TOWNES TM, 1985, EMBO J, V4, P1715, DOI 10.1002/j.1460-2075.1985.tb03841.x; TREPICCHIO WL, 1993, MOL CELL BIOL, V13, P7457, DOI 10.1128/MCB.13.12.7457; TRUDEL M, 1987, REGULATION GLOBIN GE, P305; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; VYAS P, 1992, BLOOD, V80, P1832; WEATHERALL DJ, 1989, METABOLIC BASIS INHE, P2281; WHITELAW E, 1990, MOL CELL BIOL, V10, P6596, DOI 10.1128/MCB.10.12.6596; YU CY, 1991, J BIOL CHEM, V266, P8907	52	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					33109	33115						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806539				2022-12-27	WOS:A1994QA63800057
J	ELDERING, E; VERPY, E; ROEM, D; MEO, T; TOSI, M				ELDERING, E; VERPY, E; ROEM, D; MEO, T; TOSI, M			COOH-TERMINAL SUBSTITUTIONS IN THE SERPIN C1 INHIBITOR THAT CAUSE LOOP OVERINSERTION AND SUBSEQUENT MULTIMERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY ANGIONEUROTIC-EDEMA; REACTIVE-BOND LOOP; ALPHA-1-PROTEINASE INHIBITOR; ALPHA-1-ANTITRYPSIN DEFICIENCY; CONFORMATIONAL STABILITY; PROTEINASE-INHIBITORS; MONOCLONAL-ANTIBODY; PLASMA KALLIKREIN; C1-BAR INHIBITOR; STRUCTURAL BASIS	The region COOH-terminal to the reactive center loop is highly conserved in the serine protease inhibitor (serpin) family, We have studied the structural consequences of three substitutions (Val(451) --> Met, Phe(455) --> Ser, and Pro(476) --> Ser) found in this region of C1 inhibitor in patients suffering from hereditary angioedema, Equivalent substitutions have been described in alpha 1-antitrypsin and antithrombin m. The mutant C1 inhibitor proteins were only partially secreted upon transient transfection into COS-7 cells and were found to be dysfunctional, Immunoprecipitation of conditioned media demonstrated that in the intact, uncleaved form they all bind to a monoclonal antibody which recognizes specifically the protease-complexed or reactive center-cleaved normal C1 inhibitor, A second indication for an intrinsic conformational change was the increased thermostability compared to the normal protein. Furthermore, gel filtration studies showed that the Val(451) --> Met and Pro(476) --> Ser mutant proteins, and to a lesser extent Phe(455) --> Ser, were prone to spontaneous multimerization. Finally, a reduced susceptibility to reactive center cleavage by trypsin was observed for all three mutants, and the cleaved Val(451) --> Met and Pro(476) --> Ser mutants failed to adopt the conformation recognized by a cleavage-specific monoclonal antibody, Investigation of plasmas of patients with the Val(451) --> Met or Pro(476) --> Ser substitutions showed that these dysfunctional proteins circulate at low levels and are recognized by the complex-specific antibody. These results strongly indicate a conformational change as a result of these carboxyl-terminal substitutions, such that anchoring of the reactive center loop at the COOH-terminal side is not achieved properly. We propose that this results in over-insertion of the loop into beta-sheet A, which subsequently leads to multimerization.	INST PASTEUR,INSERM,U276,UNITE IMMUNOGENET,F-75724 PARIS 15,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	ELDERING, E (corresponding author), NETHERLANDS RED CROSS,BLOOD TRANSFUS SERV,CENT LAB,DEPT AUTOIMMUNE DIS,PLESMANLAAN 125,1066 CX AMSTERDAM,NETHERLANDS.							AULAK KS, 1993, J BIOL CHEM, V268, P18088; AULAK KS, 1990, BIOCHEM J, V271, P565, DOI 10.1042/bj2710565; AUSTIN RC, 1991, BLOOD, V77, P2185; BJORK I, 1992, J BIOL CHEM, V267, P1976; BJORK I, 1993, BIOCHEMISTRY-US, V32, P6501; BOCK SC, 1988, BIOCHEMISTRY-US, V27, P6171, DOI 10.1021/bi00416a052; BRODBECK RM, 1992, J BIOL CHEM, V267, P294; BRUCH M, 1988, J BIOL CHEM, V263, P16626; CARRELL RW, 1985, NATURE, V317, P730, DOI 10.1038/317730a0; CARRELL RW, 1991, NATURE, V353, P576, DOI 10.1038/353576a0; CARRELL RW, 1994, STRUCTURE, V2, P257, DOI 10.1016/S0969-2126(00)00028-9; CASO R, 1991, BRIT J HAEMATOL, V77, P87, DOI 10.1111/j.1365-2141.1991.tb07953.x; CRYSTAL RG, 1990, J CLIN INVEST, V85, P1343, DOI 10.1172/JCI114578; CUGNO M, 1990, J CLIN INVEST, V85, P1215, DOI 10.1172/JCI114555; DAVIS AE, 1988, ANNU REV IMMUNOL, V6, P595, DOI 10.1146/annurev.iy.06.040188.003115; DAVIS AE, 1993, NAT GENET, V1, P354; DAWES J, 1994, BIOCHEMISTRY-US, V33, P4375, DOI 10.1021/bi00180a035; DEAGOSTINI A, 1985, P NATL ACAD SCI USA, V82, P5190; DESMET BJGL, 1993, BLOOD, V81, P56, DOI 10.1182/blood.V81.1.56.bloodjournal81156; ELDERING E, 1992, J BIOL CHEM, V267, P7013; ELDERING E, 1988, J BIOL CHEM, V263, P11776; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; HARPEL PC, 1975, J CLIN INVEST, V55, P593, DOI 10.1172/JCI107967; HOFKER MH, 1989, HUM GENET, V81, P264, DOI 10.1007/BF00279001; HOOD DB, 1994, BIOCHEMISTRY-US, V33, P8538, DOI 10.1021/bi00194a020; HOPKINS PCR, 1993, BIOCHEMISTRY-US, V32, P7650, DOI 10.1021/bi00081a008; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; LANE DA, 1992, J CLIN INVEST, V90, P2422, DOI 10.1172/JCI116133; LEWIN MF, 1983, J BIOL CHEM, V258, P6415; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; LOMAS DA, 1993, BIOCHEMISTRY-US, V32, P500, DOI 10.1021/bi00053a014; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; LOMAS DA, 1993, J BIOL CHEM, V268, P15333; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V5, P1295; MAST AE, 1992, BIOCHEMISTRY-US, V31, P2720, DOI 10.1021/bi00125a012; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; NUIJENS JH, 1989, J CLIN INVEST, V84, P443, DOI 10.1172/JCI114185; NUIJENS JH, 1988, BLOOD, V72, P1841; NUIJENS JH, 1987, IMMUNOLOGY, V61, P387; ODERMATT E, 1981, FEBS LETT, V131, P283, DOI 10.1016/0014-5793(81)80385-7; OLDS RJ, 1992, BLOOD, V79, P1206, DOI 10.1182/blood.V79.5.1206.bloodjournal7951206; PATSTON PA, 1991, BIOCHEMISTRY-US, V30, P8876, DOI 10.1021/bi00100a022; PEMBERTON PA, 1989, BIOCHEM J, V258, P193, DOI 10.1042/bj2580193; PERKINS SJ, 1990, J MOL BIOL, V214, P751, DOI 10.1016/0022-2836(90)90290-3; PERRY DJ, 1991, FEBS LETT, V285, P248, DOI 10.1016/0014-5793(91)80809-H; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; ROSEN FS, 1965, SCIENCE, V148, P957, DOI 10.1126/science.148.3672.957; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; SCHULZE AJ, 1994, FEBS LETT, V344, P117, DOI 10.1016/0014-5793(94)00369-6; SCHULZE AJ, 1990, EUR J BIOCHEM, V194, P51, DOI 10.1111/j.1432-1033.1990.tb19425.x; SKRIVER K, 1991, J BIOL CHEM, V266, P9216; STEIN P, 1991, J MOL BIOL, V221, P615, DOI 10.1016/0022-2836(91)80076-7; STEIN PE, 1989, BIOCHEM J, V262, P103, DOI 10.1042/bj2620103; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; VERPY E, 1995, IN PRESS J CLIN INVE	56	91	91	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2579	2587		10.1074/jbc.270.6.2579	http://dx.doi.org/10.1074/jbc.270.6.2579			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852321	hybrid			2022-12-27	WOS:A1995QF53500029
J	KULIAWAT, R; LISANTI, MP; ARVAN, P				KULIAWAT, R; LISANTI, MP; ARVAN, P			POLARIZED DISTRIBUTION AND DELIVERY OF PLASMA-MEMBRANE PROTEINS IN THYROID FOLLICULAR EPITHELIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOPEPTIDASE-N; SURFACE DISTRIBUTION; MDCK CELLS; ANCHORED PROTEINS; IODIDE TRANSPORT; PEROXIDASE; THYROGLOBULIN; LOCALIZATION; LINE; IODINATION	Thyroid follicular cells coordinate several oppositely located surface enzyme activities. Recent studies have raised questions about the basic mechanisms used to achieve thyroid surface polarity. We investigated these mechanisms in primary thyroid epithelial monolayers cultured on porous filters. In the steady state, most Na+/K+-ATPase and aminopeptidase N were available for surface biotinylation, and these proteins exhibited physiological distributions (basolateral and apical, respectively). Glycosylphosphatidylinositol-anchored proteins were also apically distributed. By pulse-chase, newly synthesized transmembrane proteins exhibited polarized surface delivery that was oriented similarly to that observed at steady state. Little time elapsed between acquisition of Golgi-specific processing and cell surface arrival. Interestingly when either newly synthesized or steady state-labeled thyroid peroxidase was similarly analyzed, only similar to 30% of the enzyme was ever detected at the cell surface. Of this, the majority was localized apically. The data suggest that most thyroid peroxidase remains intracellular in these monolayers, consistent with the possibility of intracellular iodination activity in addition to apical extracellular iodination. Nevertheless, in filter-polarized thyrocytes, most newly synthesized plasma membrane proteins appear to be sorted in the Golgi complex for direct delivery to apical and basolateral domains.	HARVARD UNIV, BETH ISRAEL HOSP, SCH MED, DIV ENDOCRINOL, BOSTON, MA 02215 USA; HARVARD UNIV, SCH MED, PROGRAM BIOL & BIOMED SCI, BOSTON, MA 02215 USA; WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA 02142 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute			Lisanti, Michael P/C-6866-2013; Lisanti, Michael/B-6131-2018	Lisanti, Michael/0000-0003-2034-1382; Kuliawat, Regina/0000-0001-8386-2279	NIDDK NIH HHS [DK07516, DK 40344] Funding Source: Medline; NIGMS NIH HHS [GM 50443] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007516, R01DK107516, R29DK040344, R01DK040344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM050443] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALQUIER C, 1989, AUTOIMMUNITY, V3, P113, DOI 10.3109/08916938909019960; ARVAN P, 1991, J CELL BIOL, V112, P365, DOI 10.1083/jcb.112.3.365; BALCAROVASTANDER J, 1984, EMBO J, V3, P2687, DOI 10.1002/j.1460-2075.1984.tb02194.x; BARRIERE H, 1986, CELL TISSUE RES, V245, P159; BARTLES JR, 1987, J CELL BIOL, V105, P1241, DOI 10.1083/jcb.105.3.1241; BJORKMAN U, 1988, ENDOCRINOLOGY, V122, P488; BORDIER C, 1981, J BIOL CHEM, V256, P1604; CHAMBARD M, 1983, J CELL BIOL, V96, P1172, DOI 10.1083/jcb.96.4.1172; CHOW SY, 1986, AM J PHYSIOL, V250, pE464, DOI 10.1152/ajpendo.1986.250.4.E464; CONTRERAS RG, 1989, AM J PHYSIOL, V257, pC896, DOI 10.1152/ajpcell.1989.257.5.C896; CZARNOCKA B, 1986, J ENDOCRINOL INVEST, V9, P135, DOI 10.1007/BF03348084; FERACCI H, 1981, CELL TISSUE RES, V221, P137, DOI 10.1007/BF00216576; FULLER SD, 1985, EMBO J, V4, P297, DOI 10.1002/j.1460-2075.1985.tb03629.x; GERARD C, 1985, EUR J CELL BIOL, V38, P134; GOLSTEIN P, 1992, AM J PHYSIOL, V263, pC590, DOI 10.1152/ajpcell.1992.263.3.C590; GOTTARDI CJ, 1993, SCIENCE, V260, P552, DOI 10.1126/science.8386395; GRUFFAT D, 1991, J ENDOCRINOL, V128, P51, DOI 10.1677/joe.0.1280051; HALLER C, 1993, AM J PHYSIOL, V265, pC1069, DOI 10.1152/ajpcell.1993.265.4.C1069; HAMMERTON RW, 1991, SCIENCE, V254, P847, DOI 10.1126/science.1658934; HANNAN LA, 1993, J CELL BIOL, V120, P353, DOI 10.1083/jcb.120.2.353; HANSEN GH, 1987, EUR J CELL BIOL, V43, P253; HERZLINGER DA, 1984, J CELL BIOL, V98, P1777, DOI 10.1083/jcb.98.5.1777; HERZOG V, 1992, J CELL BIOL, V118, P1071, DOI 10.1083/jcb.118.5.1071; KIM PS, 1992, J CELL BIOL, V118, P541, DOI 10.1083/jcb.118.3.541; KOTANI T, 1986, J CLIN ENDOCR METAB, V62, P928, DOI 10.1210/jcem-62-5-928; KULIAWAT R, 1994, J BIOL CHEM, V269, P4922; LISANTI MP, 1993, J CELL BIOL, V123, P595, DOI 10.1083/jcb.123.3.595; LISANTI MP, 1988, P NATL ACAD SCI USA, V85, P9557, DOI 10.1073/pnas.85.24.9557; LONG Y, 1991, EUR J BIOCHEM, V202, P501, DOI 10.1111/j.1432-1033.1991.tb16401.x; MAGNUSSON RP, 1987, J BIOL CHEM, V262, P13885; MATSUKAWA S, 1979, J BIOCHEM-TOKYO, V86, P199; MATTER K, 1990, CELL, V60, P429, DOI 10.1016/0092-8674(90)90594-5; MAUCHAMP J, 1987, ACTA ENDOCRINOL-COP, V115, P220; MOSTOV K, 1992, J CELL BIOL, V116, P577, DOI 10.1083/jcb.116.3.577; NAKAMURA Y, 1990, J ENDOCRINOL, V126, P275, DOI 10.1677/joe.0.1260275; NELSON WJ, 1992, SCIENCE, V258, P948, DOI 10.1126/science.1439806; NILSSON M, 1987, CELL TISSUE RES, V250, P295, DOI 10.1007/BF00219074; NILSSON M, 1992, ACTA ENDOCRINOL-COP, V126, P67, DOI 10.1530/acta.0.1260067; NITSCH L, 1985, EUR J CELL BIOL, V38, P57; OFVERHOLM T, 1984, ENDOCRINOLOGY, V114, P827; PATHAK RK, 1990, J CELL BIOL, V111, P347, DOI 10.1083/jcb.111.2.347; PRABAKARAN D, 1993, J BIOL CHEM, V268, P9041; RAWITCH AB, 1992, ARCH BIOCHEM BIOPHYS, V297, P321, DOI 10.1016/0003-9861(92)90679-Q; RINDLER MJ, 1985, J CELL BIOL, V100, P136, DOI 10.1083/jcb.100.1.136; RODRIGUEZBOULAN E, 1992, ANNU REV CELL BIOL, V8, P395, DOI 10.1146/annurev.cb.08.110192.002143; ROLLAND M, 1976, BIOCHIM BIOPHYS ACTA, V427, P696, DOI 10.1016/0005-2795(76)90213-0; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; VILIJN F, 1989, J BIOL CHEM, V264, P11901; WATANABE K, 1991, ENDOCRINOL JAPON, V38, P89; WESSELS HP, 1990, J CELL BIOL, V111, P2923, DOI 10.1083/jcb.111.6.2923; WOLLMAN SH, 1989, EUR J CELL BIOL, V50, P247; WOLLNER DA, 1992, J CELL BIOL, V116, P889, DOI 10.1083/jcb.116.4.889; ZURZOLO C, 1993, SCIENCE, V260, P550, DOI 10.1126/science.8386394; ZURZOLO C, 1993, J CELL BIOL, V121, P1031, DOI 10.1083/jcb.121.5.1031; ZURZOLO C, 1992, J CELL BIOL, V117, P551, DOI 10.1083/jcb.117.3.551; ZURZOLO C, 1994, EMBO J, V13, P42, DOI 10.1002/j.1460-2075.1994.tb06233.x; ZURZOLO C, 1992, EMBO J, V11, P2337, DOI 10.1002/j.1460-2075.1992.tb05293.x	57	39	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2478	2482		10.1074/jbc.270.6.2478	http://dx.doi.org/10.1074/jbc.270.6.2478			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852309	hybrid			2022-12-27	WOS:A1995QF53500015
J	LEE, HC; AARHUS, R				LEE, HC; AARHUS, R			A DERIVATIVE OF NADP MOBILIZES CALCIUM STORES INSENSITIVE TO INOSITOL TRISPHOSPHATE AND CYCLIC ADP-RIBOSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEA-URCHIN EGGS; CA2+ RELEASE; METABOLITE; ENZYME; FERTILIZATION	We have previously shown that alkaline treatment of NADP generates a derivative which can mobilize Ca2+ from sea urchin egg homogenates (Clapper, D. L., Walseth, T. F., Dargie, P. J., and Lee, H. C. (1987) J. Biol. Chem. 262, 9561-9568), In this study, the active derivative was purified and shown by high pressure liquid chromatography to be distinct from NADP and NADPH. However, its proton NMR spectrum was virtually identical to that of NADP. The mass of its molecular ion was measured by high resolution mass spectrometry to be 743.0510, one mass unit larger than the corresponding ion of NADP, These results are consistent with the active derivative being nicotinic acid adenine dinucleotide phosphate (NAADP). Ca2+ release induced by NAADP was saturable with a half-maximal concentration of about 30 nM. The release was specific since NADP and nicotinic acid adenine dinucleotide were ineffective even at 10-40-fold higher concentrations, The NAADP-dependent Ca2+ release showed desensitization and was insensitive to heparin and a specific antagonist of cyclic ADP-ribose (cADPR), 8-amino-cADPR. The release mechanism did not require calmodulin, This is similar to the inositol trisphosphate-sensitive release but distinct from that of cADPR. That the NAADP-sensitive Ca2+ stores were different from those sensitive to inositol trisphosphate- or cADPR was further indicated by their differences in distribution on Percoll density gradients. Microinjection of NAADP into live sea urchin eggs induced transient elevation of intracellular Ca2+ and triggered the cortical reaction, indicating the NAADP dependent mechanism is operative in intact cells.			LEE, HC (corresponding author), UNIV MINNESOTA,DEPT PHYSIOL,LYON LAB 6-182,MINNEAPOLIS,MN 55455, USA.		Lee, Hon Cheung/C-4329-2009		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017484, R01HD032040] Funding Source: NIH RePORTER; NICHD NIH HHS [HD17484, HD32040] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; DARGIE PJ, 1990, CELL REGUL, V1, P279, DOI 10.1091/mbc.1.3.279; EPEL D, 1981, CELL, V23, P543, DOI 10.1016/0092-8674(81)90150-1; GALIONE A, 1993, NATURE, V365, P456, DOI 10.1038/365456a0; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; HUA SY, 1994, NEURON, V12, P1073, DOI 10.1016/0896-6273(94)90315-8; LEE HC, 1994, NEWS PHYSIOL SCI, V9, P134; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; LEE HC, 1994, NAT STRUCT BIOL, V1, P143, DOI 10.1038/nsb0394-143; LEE HC, 1989, J BIOL CHEM, V264, P1608; LEE HC, 1993, BIOCHIM BIOPHYS ACTA, V1164, P68, DOI 10.1016/0167-4838(93)90113-6; LEE HC, 1993, SCIENCE, V261, P352, DOI 10.1126/science.8392749; LEE HC, 1994, NATURE, V370, P307, DOI 10.1038/370307a0; LEE HC, 1993, J BIOL CHEM, V268, P293; Lee Hon Cheung, 1994, V48, P199; RUSINKO N, 1989, J BIOL CHEM, V264, P11725; WALSETH TF, 1993, BIOCHIM BIOPHYS ACTA, V1178, P235, DOI 10.1016/0167-4889(93)90199-Y; YAN C, 1987, J BIOL CHEM, V262, P9082	19	392	399	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2152	2157		10.1074/jbc.270.5.2152	http://dx.doi.org/10.1074/jbc.270.5.2152			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836444	hybrid			2022-12-27	WOS:A1995QE49300028
J	BUISSON, B; LAFLAMME, L; BOTTARI, SP; DEGASPARO, M; GALLOPAYET, N; PAYET, MD				BUISSON, B; LAFLAMME, L; BOTTARI, SP; DEGASPARO, M; GALLOPAYET, N; PAYET, MD			A G-PROTEIN IS INVOLVED IN THE ANGIOTENSIN AT(2) RECEPTOR INHIBITION OF THE T-TYPE CALCIUM CURRENT IN NON-DIFFERENTIATED NG108-15 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN; PHOSPHATASE-ACTIVITY; MOLECULAR-CLONING; BINDING-SITES; II RECEPTORS; TUMOR-CELLS; SUBTYPES; MECHANISMS; PATHWAYS; CHANNELS	In non-differentiated NG108-15 cells, both angiotensin II (Ang II) (100 nM) and CGP 42112 (100 nM) decreased the T-type calcium current amplitude by 24 +/- 2% and 21 +/- 3%, respectively. cGMP is not a mediator of the Ang II effect, since loading of cells with 50 mu M cGMP did not prevent the inhibitory effects of Ang II. The effects of Ang II involves a non-identified GTPase activity since incubation with GDP beta S (3 mM) completely reversed the inhibitory effect of Ang II while GTP gamma S mimicked its effect. However, Ang II binding was not affected by GTP gamma S, and the effect of Ang II was not modified in pertussis toxin-treated cells, The inhibitory effect of Ang II on the T-type Ca2+ current involves a phosphotyrosine phosphatase activity since sodium orthovanadate prevented the effects of Ang II, although microcystin-LR, a selective Ser/Thr phosphatase 1 and 2A inhibitor, did not modify the effect of Ang II. These results provide the first evidence of a modulation of membrane conductance by Ang II through the AT(2) receptor and demonstrate the involvement of a phosphotyrosine phosphatase and a G protein in the AT(2) transduction mechanism in NG108-15 cells. Moreover, our data suggest that phosphotyrosine phosphatase activation is proximal to receptor occupation, since sodium orthovanadate inhibits both GTPase activity and T-type current blockage induced by Ang II or CGP 42112, while GTP gamma S inhibition of the T-type calcium current is not impaired.	UNIV SHERBROOKE,FAC MED,DEPT PHYSIOL & BIOPHYS,SHERBROOKE,PQ J1H 5N4,CANADA; UNIV SHERBROOKE,FAC MED,SERV ENDOCRINOL,SHERBROOKE,PQ J1H 5N4,CANADA; CIBA GEIGY AG,DEPT CARDIOVASC RES,DIV PHARMACEUT,CH-4002 BASEL,SWITZERLAND	University of Sherbrooke; University of Sherbrooke; Novartis			Bottari, Serge/ABF-3990-2021	Bottari, Serge P./0000-0002-4172-2400				BARNES JM, 1993, EUR J PHARMACOL, V230, P251, DOI 10.1016/0014-2999(93)90558-Y; BOTTARI SP, 1991, EUR J PHARM-MOLEC PH, V207, P157, DOI 10.1016/0922-4106(91)90091-U; BOTTARI SP, 1992, BIOCHEM BIOPH RES CO, V183, P206, DOI 10.1016/0006-291X(92)91629-5; BOTTARI SP, 1993, FRONT NEUROENDOCRIN, V14, P123, DOI 10.1006/frne.1993.1005; BRECHLER V, 1994, RECEPTOR CHANNEL, V2, P89; BRECHLER V, 1992, REGUL PEPTIDES, V44, P207; BUISSON B, 1992, FEBS LETT, V309, P161, DOI 10.1016/0014-5793(92)81086-2; CARRITHER MD, 1992, SOC NEUR ABSTR, V18; CASSEL D, 1976, BIOCHIM BIOPHYS ACTA, V452, P538, DOI 10.1016/0005-2744(76)90206-0; DUNPHY WG, 1991, CELL, V67, P189, DOI 10.1016/0092-8674(91)90582-J; FLORIO T, 1992, J BIOL CHEM, V267, P24169; GEHLERT DR, 1991, NEUROSCIENCE, V44, P501, DOI 10.1016/0306-4522(91)90073-W; GOLLASCH M, 1991, P NATL ACAD SCI USA, V88, P10262, DOI 10.1073/pnas.88.22.10262; GORDON JA, 1991, METHOD ENZYMOL, V201, pB477; GUILLON G, 1988, BIOCHEM J, V253, P765, DOI 10.1042/bj2530765; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P316; HEEMSKERK FMJ, 1993, NEUROREPORT, V4, P103, DOI 10.1097/00001756-199301000-00027; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HONKANEN RE, 1990, J BIOL CHEM, V265, P19401; JOHNSON MC, 1991, ENDOCRINOLOGY, V129, P1266, DOI 10.1210/endo-129-3-1266; KAMBAYASHI Y, 1993, J BIOL CHEM, V268, P24543; KATER SB, 1991, J NEUROSCI, V11, P891; LEUNG KH, 1992, EUR J PHARM-MOLEC PH, V227, P63, DOI 10.1016/0922-4106(92)90143-J; MILLAN MA, 1991, P NATL ACAD SCI USA, V88, P11440, DOI 10.1073/pnas.88.24.11440; MUKOYAMA M, 1993, J BIOL CHEM, V268, P24539; OBERMULLER N, 1991, NEUROSCI LETT, V132, P11, DOI 10.1016/0304-3940(91)90420-X; ODA H, 1991, P SOC EXP BIOL MED, V196, P175; PAN MG, 1992, SCIENCE, V256, P1215, DOI 10.1126/science.256.5060.1215; PUCELL AG, 1991, ENDOCRINOLOGY, V128, P1947, DOI 10.1210/endo-128-4-1947; RENSDOMIANO S, 1992, MOL PHARMACOL, V42, P28; SHAPIRO MS, 1994, NEURON, V12, P1319, DOI 10.1016/0896-6273(94)90447-2; SHAPIRO MS, 1993, NEURON, V10, P11, DOI 10.1016/0896-6273(93)90237-L; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; SPETH R C, 1989, Peptide Research, V2, P232; SPETH RC, 1993, REGUL PEPTIDES, V44, P189, DOI 10.1016/0167-0115(93)90242-Z; SPITZER NC, 1991, J NEUROBIOL, V22, P659, DOI 10.1002/neu.480220702; SUMNERS C, 1991, P NATL ACAD SCI USA, V88, P7567, DOI 10.1073/pnas.88.17.7567; SUMNERS C, 1991, AM J PHYSIOL, V260, pC79, DOI 10.1152/ajpcell.1991.260.1.C79; TAKAHASI K, 1994, BIOCHEM BIOPH RES CO, V198, P60, DOI 10.1006/bbrc.1994.1009; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; TSUTSUMI K, 1992, MOL PHARMACOL, V41, P290; TSUTSUMI K, 1991, ENDOCRINOLOGY, V129, P1075, DOI 10.1210/endo-129-2-1075; WEBB ML, 1992, PEPTIDES, V13, P499, DOI 10.1016/0196-9781(92)90081-D; WU YY, 1993, J CELL BIOL, V121, P409, DOI 10.1083/jcb.121.2.409	44	108	109	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1670	1674		10.1074/jbc.270.4.1670	http://dx.doi.org/10.1074/jbc.270.4.1670			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829501	hybrid			2022-12-27	WOS:A1995QD20400031
J	MA, L; SPREMULLI, LL				MA, L; SPREMULLI, LL			CLONING AND SEQUENCE-ANALYSIS OF THE HUMAN MITOCHONDRIAL TRANSLATIONAL INITIATION-FACTOR-2 CDNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SYNTHESIS; MESSENGER-RNA; FACTOR-II; ESCHERICHIA-COLI; ELONGATION-FACTORS; GENE; PURIFICATION; DNA; IDENTIFICATION; FEATURES	Complete cDNAs encoding human mitochondrial translational initiation factor 2 (IF-2(mt)) have been obtained from liver, heart, and fetal brain cDNA libraries. These cDNAs have a long open reading frame 2181 residues in length encoding a protein of 727 amino acids. Overall, human IF-2(mt) has 30-40% identity to the corresponding prokaryotic factors. Surprisingly, it is no more homologous to yeast IF-2(mt) than to the IF-2s from bacterial sources. The greatest region of conservation lies in the G-domain of this factor with less conservation in the COOH-terminal half of the protein and very little homology near the amino terminus. The 5'-untranslated leaders of the liver and heart cDNAs contain a number of short open reading frames. These sequences may play a role in the translational activity of the IF-2(mt) mRNA. Northern analysis indicates that the IF-2(mt) gene is expressed in all tissues but that the level of expression varies over a wide range.	UNIV N CAROLINA,LINEBERGER COMPREHENS CANC RES CTR,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill	MA, L (corresponding author), UNIV N CAROLINA,DEPT CHEM,CB 3290,CHAPEL HILL,NC 27599, USA.		Ma, Lan/B-9295-2009	Ma, Lan/0000-0001-9034-5472	NIGMS NIH HHS [GM32734] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032734] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS MD, 1993, NAT GENET, V4, P373, DOI 10.1038/ng0893-373; ARRICK BA, 1991, MOL CELL BIOL, V11, P4306, DOI 10.1128/MCB.11.9.4306; BROMBACH M, 1986, MOL GEN GENET, V205, P97, DOI 10.1007/BF02428037; CAMMARANO P, 1972, BIOCHIM BIOPHYS ACTA, V281, P597, DOI 10.1016/0005-2787(72)90159-1; CENATIEMPO Y, 1987, BIOCHEMISTRY-US, V26, P5070, DOI 10.1021/bi00390a028; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; ERNST H, 1987, J BIOL CHEM, V262, P1206; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRIEDRICH K, 1988, MOL GEN GENET, V214, P595, DOI 10.1007/BF00330501; GASPAR NJ, 1994, J BIOL CHEM, V269, P3415; GOLD L, 1988, ANNU REV BIOCHEM, V57, P199, DOI 10.1146/annurev.bi.57.070188.001215; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; Hershey JW., 1987, ESCHERICHIA COLI SAL, P613; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; HINNEBUSCH AG, 1990, TRENDS BIOCHEM SCI, V15, P148, DOI 10.1016/0968-0004(90)90215-W; KOZAK M, 1991, J BIOL CHEM, V266, P19867; LIAO HX, 1991, J BIOL CHEM, V266, P20714; LIAO HX, 1990, J BIOL CHEM, V265, P13618; MARTH JD, 1988, NATURE, V332, P171, DOI 10.1038/332171a0; MATTHEWS DE, 1982, J BIOL CHEM, V257, P8788; OBRIEN TW, 1976, HDB GENETICS, V5, P535; PAIN VM, 1986, BIOCHEM J, V235, P625, DOI 10.1042/bj2350625; PATHAK VK, 1988, CELL, V54, P633, DOI 10.1016/S0092-8674(88)80007-2; ROTH MJ, 1985, J BIOL CHEM, V260, P9326; SACERDOT C, 1984, P NATL ACAD SCI-BIOL, V81, P7787, DOI 10.1073/pnas.81.24.7787; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAZAND K, 1990, J BACTERIOL, V172, P2675, DOI 10.1128/jb.172.5.2675-2687.1990; VAMBUTAS A, 1991, EUR J BIOCHEM, V201, P643, DOI 10.1111/j.1432-1033.1991.tb16325.x; VANHOLDE KE, 1974, RIBOSOMES, P53; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615; WICKENS M, 1984, SCIENCE, V226, P1045, DOI 10.1126/science.6208611	33	44	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1859	1865		10.1074/jbc.270.4.1859	http://dx.doi.org/10.1074/jbc.270.4.1859			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829522	hybrid, Green Published			2022-12-27	WOS:A1995QD20400057
J	RICHTER, A; DRUMMOND, DR; MACGARVIE, J; PUDDICOMBE, SM; CHAMBERLIN, SG; DAVIES, DE				RICHTER, A; DRUMMOND, DR; MACGARVIE, J; PUDDICOMBE, SM; CHAMBERLIN, SG; DAVIES, DE			CONTRIBUTION OF THE TRANSFORMING GROWTH-FACTOR-ALPHA B-LOOP BETA-SHEET TO BINDING AND ACTIVATION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; SITE-DIRECTED MUTAGENESIS; EGF RECEPTOR; EXPRESSION; SEQUENCES; H-1-NMR; CLONING; STRAINS; CELLS; GENE	We have exploited the differences in binding affinities of the chicken epidermal growth factor (EGF) receptor for EGF and transforming growth factor alpha (TGF alpha) to study the role of the B-loop beta-sheet of these ligands in receptor recognition and activation. Although EGF and TGF alpha share similar secondary and tertiary structures imposed by three highly conserved intramolecular disulfide bonds, they have only 30-40% overall sequence identity. The B-loop beta-sheet is the major structural element in EGF and TGF alpha, but sequence similarity in this region is low. To investigate its role in receptor binding, we constructed two chimeric growth factors (mEGF/hTGF alpha(21-40) and mEGF/hTGF alpha(21-32)) composed of the murine EGF (mEGF) amino acid sequence with residues 21-30 of the B-loop beta-sheet replaced by the equivalent residues of human TGF alpha (hTGF alpha); in chimera mEGF/hTGF alpha(21-32), asparagine 32, which lies at the boundary of the amino and carboxyl domains of mEGF, was also replaced by its hTGF alpha counterpart (valine). In initial studies using unpurified medium, it was found that the recombinant growth factors exhibited differing mitogenic potencies (mEGF/hTGF alpha(21-32) > mEGF/hTGF alpha(21-30) > mEGF) when assayed on chicken fibroblasts, even though they were equivalent in mitogenesis assays us ing cells expressing the human EGF receptor, After purification, mEGF/hTGF alpha(21-32) was found to be 50 times more potent than mEGF in the chick fibroblast mitogenesis assay and exhibited a 10-fold increase in relative affinity for the chicken EGF receptor; both growth factors still exhibited equivalent mitogenic and receptor binding activity when tested on cells expressing human EGF receptors. We conclude that the B-loop beta-sheet of hTGF alpha is an important determinant of EGF receptor binding affinity and biological activity.	SOUTHAMPTON GEN HOSP,CANC RES CAMPAIGN,MED ONCOL UNIT,SOUTHAMPTON SO16 6YD,HANTS,ENGLAND	University of Southampton			Davies, Donna E/H-2993-2012	Drummond, Douglas/0000-0003-4155-3747				AVIVI A, 1991, ONCOGENE, V6, P673; Campbell I D, 1989, Prog Growth Factor Res, V1, P13, DOI 10.1016/0955-2235(89)90038-0; CAMPION SR, 1990, BIOCHEMISTRY-US, V29, P9988, DOI 10.1021/bi00494a032; CAMPION SR, 1993, PROTEIN ENG, V6, P651, DOI 10.1093/protein/6.6.651; CLARE JJ, 1991, GENE, V105, P205, DOI 10.1016/0378-1119(91)90152-2; COOKE RM, 1987, NATURE, V327, P339, DOI 10.1038/327339a0; DAVIES DE, 1994, BRIT J CANCER, V70, P263, DOI 10.1038/bjc.1994.290; DUDGEON TJ, 1990, FEBS LETT, V261, P392, DOI 10.1016/0014-5793(90)80600-N; ENGLER DA, 1990, FEBS LETT, V271, P47, DOI 10.1016/0014-5793(90)80368-S; GREGORY H, 1988, REGUL PEPTIDES, V22, P217, DOI 10.1016/0167-0115(88)90034-1; HOEPRICH PD, 1989, J BIOL CHEM, V264, P19086; KATSUURA M, 1989, J BIOCHEM-TOKYO, V106, P87, DOI 10.1093/oxfordjournals.jbchem.a122826; KLINE TP, 1990, BIOCHEMISTRY-US, V29, P7805, DOI 10.1021/bi00486a005; KOHDA D, 1988, J BIOCHEM-TOKYO, V103, P741, DOI 10.1093/oxfordjournals.jbchem.a122338; KOMORIYA A, 1984, P NATL ACAD SCI-BIOL, V81, P1351, DOI 10.1073/pnas.81.5.1351; KRAMER RH, 1994, J BIOL CHEM, V269, P8708; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAROCHELLE WJ, 1992, J BIOL CHEM, V267, P17074; LAX I, 1988, MOL CELL BIOL, V8, P1970, DOI 10.1128/MCB.8.5.1970; MATSUI Y, 1990, CELL, V61, P1147, DOI 10.1016/0092-8674(90)90077-R; MATSUNAMI RK, 1991, J CELL BIOCHEM, V46, P242, DOI 10.1002/jcb.240460307; MCKENZIE ANJ, 1991, EMBO J, V10, P1193, DOI 10.1002/j.1460-2075.1991.tb08060.x; MONTELIONE GT, 1987, P NATL ACAD SCI USA, V84, P5226, DOI 10.1073/pnas.84.15.5226; PRIGENT S A, 1992, Progress in Growth Factor Research, V4, P1, DOI 10.1016/0955-2235(92)90002-Y; RICHTER A, 1992, BIOCHEMISTRY-US, V31, P9546, DOI 10.1021/bi00155a006; ROBINSON RC, 1994, CELL, V77, P1101, DOI 10.1016/0092-8674(94)90449-9; SAVAGE CR, 1972, J BIOL CHEM, V247, P7609; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	30	30	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1612	1616		10.1074/jbc.270.4.1612	http://dx.doi.org/10.1074/jbc.270.4.1612			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829492				2022-12-27	WOS:A1995QD20400022
J	SAIJO, T; TANAKA, K				SAIJO, T; TANAKA, K			ISOALLOXAZINE RING OF FAD IS REQUIRED FOR THE FORMATION OF THE CORE IN THE HSP60-ASSISTED FOLDING OF MEDIUM-CHAIN ACYL-COA DEHYDROGENASE SUBUNIT INTO THE ASSEMBLY COMPETENT CONFORMATION IN MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A DEHYDROGENASE; RAT-LIVER MITOCHONDRIA; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; ASPARTATE-AMINOTRANSFERASE; 6-HYDROXY-D-NICOTINE OXIDASE; GUANIDINE-HYDROCHLORIDE; RIBOFLAVIN DEFICIENCY; HOLOENZYME FORMATION; STRESS PROTEINS	We studied the role of FAD in the intramitochondrial folding and assembly of medium chain acyl-CoA dehydro genase (MCAD), a homotetrameric mitochondrial enzyme containing a molecule of non-covalently bound FAD/monomer. In the MCAD molecule, FAD is buried in a crevice containing the active center. We have previously shown that upon import into mitochondria, newly processed MCAD is first incorporated into a high molecular weight (hMr) complex and that the hMr complex mainly consisted of MCAD heat shock protein 60 (hsp60) complex (Saijo, T., Welch, W. J., and Tanaka, K (1994) J. Biol. Chem. 269, 4401-4408). In the present study, we incubated in vitro synthesized precursor MCAD with mitochondria isolated fi om normal and riboflavin-deficient rat liver for 10-60 min and fractionated the solubilized mitochondria using gel filtration. The amount of MCAD in the hMr complex was larger and that of tetramer was smaller in riboflavin-deficient mitochondria than in control at any time point, In addition, riboflavin-deficient mitochondria were solubilized after 10-min import in a buffer containing ATP and were chased in the presence of FAD, FMN, or NAD(+) or without any addition. The mitochondrial proteins were analyzed using gel filtration or immunoprecipitated with anti-hsp60 antibody, After 60-min chase in the presence of FAD, the majority of MCAD in the complex with hsp60 was transferred to tetramer, whereas no such transfer occurred after the chase in the absence of FAD. When chase was done in the presence of FMN, a significant amount of MCAD was transferred from the complex with hsp60 to tetramer, but the transfer was not as efficient as in the presence of FAD, The chase in the presence of NAD(+) resulted in no transfer, These data suggest that isoalloxazine ring of FAD plays a critical role, exerting nucleating effect, in the hsp60-assisted folding of MCAD subunit into an assembly competent conformation, probably assisting the formation of the core.	YALE UNIV, SCH MED, DEPT GENET, NEW HAVEN, CT 06510 USA	Yale University					NIDDK NIH HHS [DK38154] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038154] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; BHATTACHARYYA D, 1993, BIOCHEMISTRY-US, V32, P9726, DOI 10.1021/bi00088a027; BLOND S, 1985, J MOL BIOL, V182, P597, DOI 10.1016/0022-2836(85)90245-1; BRANDSCH R, 1992, J BIOL CHEM, V267, P20844; BRANDSCH R, 1993, J BIOL CHEM, V268, P12724; DEAL WC, 1969, BIOCHEMISTRY-US, V8, P2795, DOI 10.1021/bi00835a016; DELUCA C, 1958, BIOCHIM BIOPHYS ACTA, V30, P6, DOI 10.1016/0006-3002(58)90233-6; GERSCHITZ J, 1978, EUR J BIOCHEM, V87, P591, DOI 10.1111/j.1432-1033.1978.tb12411.x; GHISLA S, 1984, BIOCHEMISTRY-US, V23, P3154, DOI 10.1021/bi00309a008; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HEROLD M, 1992, FEBS LETT, V308, P26, DOI 10.1016/0014-5793(92)81042-K; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; HOPPEL CL, 1990, PROG CLIN BIOL RES, V321, P233; IKEDA Y, 1985, BIOCHEMISTRY-US, V24, P7192, DOI 10.1021/bi00346a027; IKEDA Y, 1983, J BIOL CHEM, V258, P1066; IKEDA Y, 1987, ARCH BIOCHEM BIOPHYS, V252, P662, DOI 10.1016/0003-9861(87)90072-5; IKEDA Y, 1985, J BIOL CHEM, V260, P1311; INDO Y, 1991, GENOMICS, V11, P609, DOI 10.1016/0888-7543(91)90068-P; JAENICKE R, 1980, P NATL ACAD SCI-BIOL, V77, P1966, DOI 10.1073/pnas.77.4.1966; KELLY DP, 1987, P NATL ACAD SCI USA, V84, P4068, DOI 10.1073/pnas.84.12.4068; KIM JJP, 1992, PROG CLIN BIOL RES, V375, P111; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; LENZ M, 1993, EUR J BIOCHEM, V217, P429, DOI 10.1111/j.1432-1033.1993.tb18262.x; LOEWENSTEIN J, 1970, Biochimica et Biophysica Acta, V223, P432, DOI 10.1016/0005-2728(70)90201-X; MANNINGKRIEG UC, 1991, EMBO J, V10, P3273, DOI 10.1002/j.1460-2075.1991.tb04891.x; MASUI H, 1994, J BACTERIOL, V176, P1624, DOI 10.1128/jb.176.6.1624-1629.1994; MATSUBARA Y, 1989, J BIOL CHEM, V264, P16321; MATSUBARA Y, 1987, J BIOL CHEM, V262, P10104; MATSUBARA Y, 1986, P NATL ACAD SCI USA, V83, P6543, DOI 10.1073/pnas.83.17.6543; MAYER EJ, 1981, ANAL BIOCHEM, V116, P227, DOI 10.1016/0003-2697(81)90348-1; MIZZEN LA, 1989, J BIOL CHEM, V264, P20664; MIZZEN LA, 1991, CELL REGUL, V2, P165, DOI 10.1091/mbc.2.2.165; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; NAGAO M, 1992, J BIOL CHEM, V267, P17925; OKA M, 1987, J BIOL CHEM, V262, P7418; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; POWELL PJ, 1988, BIOCHEMISTRY-US, V27, P8022, DOI 10.1021/bi00421a008; REYES AM, 1993, J BIOL CHEM, V268, P22281; ROSS NS, 1987, BIOCHEM J, V244, P387, DOI 10.1042/bj2440387; SAIJO T, 1994, J BIOL CHEM, V269, P4401; SAKURAI T, 1982, LIPIDS, V17, P598, DOI 10.1007/BF02535365; SANCHO J, 1991, J MOL BIOL, V221, P1007, DOI 10.1016/0022-2836(91)80188-Z; SATO K, 1992, J BIOCHEM-TOKYO, V112, P804, DOI 10.1093/oxfordjournals.jbchem.a123980; VANBERKEL WJH, 1991, EUR J BIOCHEM, V197, P769; VEITCH K, 1989, BIOCHIM BIOPHYS ACTA, V1006, P335, DOI 10.1016/0005-2760(89)90021-0; VIITANEN PV, 1992, J BIOL CHEM, V267, P695; WEST SM, 1990, BIOCHEM J, V265, P45, DOI 10.1042/bj2650045; YOKOTA I, 1992, J BIOL CHEM, V267, P26004	49	59	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1899	1907		10.1074/jbc.270.4.1899	http://dx.doi.org/10.1074/jbc.270.4.1899			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829528	hybrid			2022-12-27	WOS:A1995QD20400063
J	BELL, AC; KOUDELKA, GB				BELL, AC; KOUDELKA, GB			HOW 434-REPRESSOR DISCRIMINATES BETWEEN O(R)1 AND O(R)3 - THE INFLUENCE OF CONTACTED AND NONCONTACTED BASE-PAIRS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-434 REPRESSOR; LAC REPRESSOR; DNA; OPERATOR; BINDING; RECOGNITION; RESOLUTION; SPECIFICITY; PHAGE-434; AFFINITY	The sequence of the bacteriophage 434 O(R)1 (ACAAAACTTTCTTGT) differs from its O(R)3 (ACAGTTTTTCTTGT) at positions 4-6. X-ray analysis shows that the side chain of Gln(33) of the 434 repressor makes van der Waals' and H-bond contacts with the T at position 4' in complex with O(R)1, but no specific contact is observed at this position in 434 repressor-O(R)3 complexes, No contacts are made by repressor to the bases at positions 5 or 6 in either binding site, The significance of the sequence differences between O(R)1 and O(R)3 in determining the operator affinity for repressor were examined by con structing synthetic variants of these operators, Measurements of the affinity of these operators for repressor as a function of ionic strength revealed that although base pairs 5 and 6 are not contacted by 434 repressor, they can nonetheless influence operator affinity for repressor by modulating the degree to which ionic interactions contribute to the overall binding energy. Both the magnitude and direction of their effect depends on the status of repressor's contacts to the bases at position 4. The role of contact made by Gln(33) to position 4 was examined by mutating this amino acid to Ala and by examining the affinity of wild type repressor for an operator bearing a 5-methylcytosine at position 4' in an O(R)1-4G mutant. These experiments showed that repressor's preferences at operator positions 5 and 6 are linked to its position 4 preference via a van der Waals' contact between amino acid 33 and a methyl group on the base at operator position 4'. Together, the results of the experiments shown here reveal that bases that do not contact the protein alter its preferences for bases at the contacted operator position 4.	SUNY BUFFALO,DEPT SCI BIOL,BUFFALO,NY 14260	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo			Koudelka, Gerald B./AAI-3738-2020	Koudelka, Gerald B./0000-0001-6280-0837	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042138, R29GM042138] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM42138] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; ANDERSON J, 1984, P NATL ACAD SCI-BIOL, V81, P1307, DOI 10.1073/pnas.81.5.1307; BARKLEY MD, 1979, J CHEM PHYS, V70, P2991, DOI 10.1063/1.437838; BELL AC, 1993, J MOL BIOL, V234, P542, DOI 10.1006/jmbi.1993.1610; BUSHMAN FD, 1993, J MOL BIOL, V230, P28, DOI 10.1006/jmbi.1993.1123; BUSHMAN FD, 1986, P NATL ACAD SCI USA, V83, P9353, DOI 10.1073/pnas.83.24.9353; BUSHMAN FD, 1985, NATURE, V316, P651, DOI 10.1038/316651a0; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; CLARKE ND, 1991, SCIENCE, V254, P267, DOI 10.1126/science.1833818; DEHASETH PL, 1977, BIOCHEMISTRY-US, V16, P4783, DOI 10.1021/bi00641a004; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; JOHNSON AD, 1979, P NATL ACAD SCI USA, V76, P5061, DOI 10.1073/pnas.76.10.5061; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; KOO HS, 1986, NATURE, V320, P501, DOI 10.1038/320501a0; KOUDELKA GB, 1987, NATURE, V326, P886, DOI 10.1038/326886a0; KOUDELKA GB, 1993, J BIOL CHEM, V268, P23812; KOUDELKA GB, 1992, NATURE, V355, P89, DOI 10.1038/355089a0; LIN S, 1972, J MOL BIOL, V72, P671, DOI 10.1016/0022-2836(72)90184-2; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Ptashne M., 1986, A GENETIC SWITCH; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; RODGERS DW, 1993, STRUCTURE, V1, P227, DOI 10.1016/0969-2126(93)90012-6; Sambrook J, 1989, MOL CLONING LABORATO; SHIMON LJW, 1993, J MOL BIOL, V232, P826, DOI 10.1006/jmbi.1993.1434; SPASSKY A, 1985, BIOCHEMISTRY-US, V24, P8050, DOI 10.1021/bi00348a032; WHARTON RP, 1987, NATURE, V326, P888, DOI 10.1038/326888a0; WHARTON RP, 1985, NATURE, V316, P601, DOI 10.1038/316601a0; WHARTON RP, 1986, THESIS HARVARD U; WHARTON RP, 1985, CELL, V38, P361	29	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1205	1212		10.1074/jbc.270.3.1205	http://dx.doi.org/10.1074/jbc.270.3.1205			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836381	hybrid			2022-12-27	WOS:A1995QB15600036
J	JIANG, Y; GRALLA, JD				JIANG, Y; GRALLA, JD			NUCLEOTIDE REQUIREMENTS FOR ACTIVATED RNA-POLYMERASE-II OPEN COMPLEX-FORMATION IN-VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL-DOMAIN KINASE; TRANSCRIPTION INITIATION; ATP REQUIREMENT; PROMOTER DNA; LAC PROMOTER; FACTOR-DELTA; RAT-LIVER; MECHANISM; INVITRO; METHYLATION	The role of nucleotides in activated RNA polymerase II transcription was studied, Permanganate footprinting confirmed that there is a strict nucleotide requirement for forming open promoter complexes that cannot be overcome by the addition of a dinucleotide primer corresponding to the start site sequence. However, higher concentrations of other nucleoside triphosphates can substitute for ATP in catalyzing open complex formation. Opening catalyzed by these nucleotides is inhibited by the ATP analogue adenosine 5'-O-(thiotriphosphate), suggesting that they may function through cross-binding to the ATP site. The K-M for ATP for opening and the involvement of other nucleotides in opening differs from the characteristics reported for TFIIH helicase and C-terminal domain kinase activities. This raises the possibility that opening does not involve these activities. The results alleviate very significantly the considerable current uncertainty concerning the role of ATP in the mammalian mRNA transcription initiation pathway.	UNIV CALIF LOS ANGELES,DEPT CHEM & BIOCHEM,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles					NIGMS NIH HHS [GM49048] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049048] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BUNICK D, 1982, CELL, V29, P877, DOI 10.1016/0092-8674(82)90449-4; CAREY M, 1990, SCIENCE, V247, P710, DOI 10.1126/science.2405489; CAREY M, 1990, NATURE, V345, P361, DOI 10.1038/345361a0; CARPOUSIS AJ, 1985, J MOL BIOL, V183, P165, DOI 10.1016/0022-2836(85)90210-4; CONAWAY RC, 1988, J BIOL CHEM, V263, P2962; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; CORDEN JL, 1990, TRENDS BIOCHEM SCI, V15, P383, DOI 10.1016/0968-0004(90)90236-5; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FEAVER WJ, 1991, CELL, V67, P1223, DOI 10.1016/0092-8674(91)90298-D; GAMPER HB, 1982, CELL, V29, P81, DOI 10.1016/0092-8674(82)90092-7; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; GUZDER SN, 1994, NATURE, V369, P578, DOI 10.1038/369578a0; JIANG Y, 1993, MOL CELL BIOL, V13, P4572, DOI 10.1128/MCB.13.8.4572; JIANG Y, 1994, J BIOL CHEM, V269, P5505; JIANG Y, 1993, J BIOL CHEM, V268, P6535; JIANG Y, 1994, IN PRESS NUCLEIC ACI; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KIRKEGAARD K, 1983, P NATL ACAD SCI-BIOL, V80, P2544, DOI 10.1073/pnas.80.9.2544; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; MEIKLEJOHN AL, 1989, J MOL BIOL, V207, P661, DOI 10.1016/0022-2836(89)90236-2; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; PRUSS GJ, 1989, CELL, V56, P521, DOI 10.1016/0092-8674(89)90574-6; SASSEDWIGHT S, 1989, J BIOL CHEM, V264, P8074; SAWADOGO M, 1984, J BIOL CHEM, V250, P5321; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SERIZAWA H, 1993, J BIOL CHEM, V268, P17300; SERIZAWA H, 1992, P NATL ACAD SCI USA, V89, P7476, DOI 10.1073/pnas.89.16.7476; SIEBENLIST U, 1980, CELL, V20, P269, DOI 10.1016/0092-8674(80)90613-3; TIMMERS HTM, 1994, EMBO J, V13, P391, DOI 10.1002/j.1460-2075.1994.tb06273.x; WANG WD, 1992, SCIENCE, V255, P450, DOI 10.1126/science.1310361; WANG WD, 1992, GENE DEV, V6, P1716, DOI 10.1101/gad.6.9.1716; YOUNG RA, 1991, ANNU REV BIOCHEM, V60, P689, DOI 10.1146/annurev.biochem.60.1.689; ZAWEL L, 1993, PROG NUCLEIC ACID RE, V44, P67, DOI 10.1016/S0079-6603(08)60217-2	34	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1277	1281		10.1074/jbc.270.3.1277	http://dx.doi.org/10.1074/jbc.270.3.1277			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836391	hybrid			2022-12-27	WOS:A1995QB15600046
J	SHASTRI, N; NGUYEN, V; GONZALEZ, F				SHASTRI, N; NGUYEN, V; GONZALEZ, F			MAJOR HISTOCOMPATIBILITY CLASS-I MOLECULES CAN PRESENT CRYPTIC TRANSLATION PRODUCTS TO T-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGENIC PEPTIDES; MESSENGER-RNAS; EXPRESSION; GENE; PROTEIN; CLONING; LYMPHOCYTES; DEGRADATION; GENERATION; INITIATION	Self or foreign cellular proteins provide peptides for presentation by major histocompatibility complex (MHC) class I molecules on the surface of antigen presenting cells (APC). Surprisingly, several studies have shown that T-cells can recognize APC transfected with antigen genes that were not present in the appropriate translational context. To understand the basis of this phenomenon, APC were transfected with DNA constructs encoding the OVA257-264 (SL8) peptide, but with varying translation initiation codons. We report that, in addition to ATG, 6 other codons (ATT, ACG, CTG, GCG, TGG, GAT) also allowed presentation to SL8.K-b-specific T-cells, Significantly, this set includes 3 of 4 known non-ATG translation initiation codons strongly suggesting that cryptic translation accounts for this phenomenon, Although expression of the SL8.K-b complex was readily detected by T-cell activation, the amount of processed peptides was below detection limit (<30 copies/cell) in cell extracts. Thus, the fortuitous presence of these cryptic translation initiation sites in transcribed genes can explain how peptide.MHC complexes were obtained in sufficient amounts for T-cell activation, The translation initiation codons identified here could also be useful for identifying potential open reading frames that possess biological and/or immunological activities.			SHASTRI, N (corresponding author), UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,DIV IMMUNOL,LSA 421,BERKELEY,CA 94720, USA.							BOON T, 1989, IMMUNOGENETICS, V29, P75, DOI 10.1007/BF00395854; BOON T, 1989, COLD SH Q B, V54, P587; BRODSKY FM, 1991, ANNU REV IMMUNOL, V9, P707; DELVAL M, 1991, CELL, V66, P1145, DOI 10.1016/0092-8674(91)90037-Y; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FETTEN JV, 1991, J IMMUNOL, V147, P2697; FLORKIEWICZ RZ, 1989, P NATL ACAD SCI USA, V86, P3978, DOI 10.1073/pnas.86.11.3978; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; JARDETZKY TS, 1991, NATURE, V353, P326, DOI 10.1038/353326a0; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LIPFORD GB, 1993, J IMMUNOL, V150, P1212; LURQUIN C, 1989, CELL, V58, P293, DOI 10.1016/0092-8674(89)90844-1; MEHDI H, 1990, GENE, V91, P173, DOI 10.1016/0378-1119(90)90085-6; MICHALEK MT, 1993, NATURE, V363, P552, DOI 10.1038/363552a0; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; ROTZSCHKE O, 1991, J EXP MED, V174, P1059, DOI 10.1084/jem.174.5.1059; SHASTRI N, 1993, J IMMUNOL, V150, P2724; TAIRA M, 1990, J BIOL CHEM, V265, P16491; TAKAHASHI H, 1990, NATURE, V344, P873, DOI 10.1038/344873a0; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; VANBLEEK GM, 1990, NATURE, V348, P213; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; YEWDELL JW, 1992, ADV IMMUNOL, V52, P1, DOI 10.1016/S0065-2776(08)60875-5	29	41	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1088	1091		10.1074/jbc.270.3.1088	http://dx.doi.org/10.1074/jbc.270.3.1088			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836364	hybrid			2022-12-27	WOS:A1995QB15600019
J	SHENNAN, KIJ; TAYLOR, NA; JERMANY, JL; MATTHEWS, G; DOCHERTY, K				SHENNAN, KIJ; TAYLOR, NA; JERMANY, JL; MATTHEWS, G; DOCHERTY, K			DIFFERENCES IN PH OPTIMA AND CALCIUM REQUIREMENTS FOR MATURATION OF THE PROHORMONE CONVERTASES PC2 AND PC3 INDICATES DIFFERENT INTRACELLULAR LOCATIONS FOR THESE EVENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROINJECTED XENOPUS OOCYTES; SITE-DIRECTED MUTAGENESIS; KEX2; CDNA; IDENTIFICATION; PROINSULIN; CLEAVAGE; CELLS; ENDOPEPTIDASE; GLYCOSYLATION	PC2 and PC3, which is also known as PC1, are subtilisin-like proteases that are involved in the intracellular processing of prohormones and proneuropeptides. Both enzymes are synthesized as propolypeptides that undergo proteolytic maturation within the secretory pathway. An in vitro translation/translocation system from Xenopus egg extracts was used to investigate mechanisms in the maturation of pro-PC3 and pro-PC2. Pro-PC3 underwent rapid (t(1/2) < 10 min) processing of the 88-kDa propolypeptide at the sequence RSKR(83) to generate the 80-kDa active form of the enzyme. This processing was blocked when the active site aspartate was changed to asparagine, suggesting that an autocatalytic mechanism was involved. In this system, processing of pro-PCS was optimal between pH 7.0 and 8.0 and was not dependent on additional calcium. These results are consistent with pro-PCS maturation occurring at an early stage in the secretory pathway, possibly within the endoplasmic reticulum, where the pH would be close to neutral and the calcium concentration less than that observed in later compartments. Processing of pro-PC2 in the Xenopus egg extract was much slower than that of pro-PC3 (t(1/2) = 8 h). It exhibited a pH optimum of 5.5-6.0 and was dependent on calcium (K-0.5 = 2-4 mM), The enzymatic properties of pro-PCB processing were similar to that of the mature enzyme. Further studies using mutant pro PCB constructs suggested that cleavage of pro-PC2 was catalyzed by the mature 68-kDa PC2 molecule. The results were consistent with pro-PC2 maturation occurring within a late compartment of the secretory pathway that contains a high calcium concentration and low pH.	UNIV BIRMINGHAM, QUEEN ELIZABETH HOSP, DEPT MED, BIRMINGHAM B15 2TH, W MIDLANDS, ENGLAND; UNIV BIRMINGHAM, SCH BIOCHEM, BIRMINGHAM B15 2TT, W MIDLANDS, ENGLAND	University of Birmingham; University of Birmingham				Docherty, Kevin/0000-0001-6765-2060				ANDERSON RGW, 1988, J CELL BIOL, V106, P539, DOI 10.1083/jcb.106.3.539; BAILYES EM, 1992, BIOCHEM J, V285, P391, DOI 10.1042/bj2850391; BENJANNET S, 1993, BIOCHEM J, V294, P735, DOI 10.1042/bj2940735; BENJANNET S, 1992, J BIOL CHEM, V267, P11417; BLOOMQUIST BT, 1991, MOL ENDOCRINOL, V5, P2014, DOI 10.1210/mend-5-12-2014; BRENNER C, 1993, CURR BIOL, V3, P498, DOI 10.1016/0960-9822(93)90040-U; CREEMERS JWM, 1993, J BIOL CHEM, V268, P21826; GERMAIN D, 1992, FEBS LETT, V299, P283, DOI 10.1016/0014-5793(92)80132-Z; GLUSCHANKOF P, 1994, EMBO J, V13, P2280, DOI 10.1002/j.1460-2075.1994.tb06510.x; GUEST PC, 1992, J BIOL CHEM, V267, P22401; JEAN F, 1993, BIOCHEM J, V292, P891, DOI 10.1042/bj2920891; LAU JTY, 1983, J BIOL CHEM, V258, P5255; LEDUC R, 1992, J BIOL CHEM, V267, P14304; LINDBERG I, 1994, MOL CELL NEUROSCI, V5, P263, DOI 10.1006/mcne.1994.1030; MACH L, 1994, J BIOL CHEM, V269, P13030; MATTHEWS G, 1991, NUCLEIC ACIDS RES, V19, P6405, DOI 10.1093/nar/19.23.6405; MATTHEWS G, 1994, J BIOL CHEM, V269, P588; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; RHODES CJ, 1992, J BIOL CHEM, V267, P22719; RHODES CJ, 1993, J BIOL CHEM, V268, P4267; RUFAUT NW, 1993, J BIOL CHEM, V268, P20291; SEIDAH NG, 1990, DNA CELL BIOL, V9, P415, DOI 10.1089/dna.1990.9.415; SHENNAN KIJ, 1994, J BIOL CHEM, V269, P18646; SHENNAN KIJ, 1991, J BIOL CHEM, V266, P24011; SHENNAN KIJ, 1991, FEBS LETT, V284, P277, DOI 10.1016/0014-5793(91)80703-6; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; SMEEKENS SP, 1990, J BIOL CHEM, V265, P2997; STEINER D F, 1991, Current Biology, V1, P375, DOI 10.1016/0960-9822(91)90198-6; VINDROLA O, 1993, NEUROPEPTIDES, V25, P151, DOI 10.1016/0143-4179(93)90096-S; YI Z, 1993, J BIOL CHEM, V268, P5615; ZHOU Y, 1994, J BIOL CHEM, V269, P18408	31	87	88	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1402	1407		10.1074/jbc.270.3.1402	http://dx.doi.org/10.1074/jbc.270.3.1402			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836407	hybrid			2022-12-27	WOS:A1995QB15600064
J	ANDERSEN, JP				ANDERSEN, JP			FUNCTIONAL CONSEQUENCES OF ALTERATIONS TO AMINO-ACIDS AT THE M5S5 BOUNDARY OF THE CA2+-ATPASE OF SARCOPLASMIC-RETICULUM - MUTATION TYR763-]GLY UNCOUPLES ATP HYDROLYSIS FROM CA2+ TRANSPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC MUTAGENESIS; FROG SKELETAL-MUSCLE; RECONSTITUTED PROTEOLIPOSOMES; CA-2+-ATPASE; OCCLUSION; DOMAIN; STATE; CELLS; CRATP; PUMP	The roles of the hydrophobic side chains of residues Phe(760), Ile(761), Tyr(763), Leu(764), and Ile(765) located at the M5S5 boundary of the Ca2+-ATPase of sarcoplasmic reticulum were analyzed by site-directed mutagenesis. Substitution of Tyr(763) with glycine resulted in a new phenotypic variant of the Ca2+-ATPase that catalyzed a high rate of Ca2+-activated ATP hydrolysis without net accumulation of Ca2+ in the microsomal vesicles. The ATPase activity of the Tyr(763), Gly mutant displayed characteristics similar to the ATPase activity of the mild-type enzyme measured in the presence of calcium ionophore, and the mutant was able to form the ADP-insensitive phosphoenzyme intermediate. Mutants Phe(760) --> Gly, Ile(761) --> Gly, Leu(764) --> Gly, and Ile(765) --> Gly were able to accumulate Ca2+. In mutants Leu(764) --> Gly and Ile(765) --> Gly, the turnover rate was low due to inhibition of dephosphorylation of the ADP-insensitive phosphoenzyme intermediate. On the other hand, mutant Leu(764) --> Lys dephosphorylated rapidly. Mutants Phe(760) --> Gly and Leu(764) --> Lys displayed apparent Ca2+ affinities that were reduced two and three orders of magnitude, respectively, relative to that of the wild-type.			ANDERSEN, JP (corresponding author), AARHUS UNIV,INST PHYSIOL,DANISH BIOMEMBRANE RES CTR,OLE WORMS ALLE 160,UNIV PK,DK-8000 AARHUS C,DENMARK.			Andersen, Jens Peter/0000-0003-0654-4300				ANDERSEN JP, 1994, J BIOL CHEM, V269, P15931; ANDERSEN JP, 1992, J BIOL CHEM, V267, P19383; ANDERSEN JP, 1989, BIOCHIM BIOPHYS ACTA, V988, P47, DOI 10.1016/0304-4157(89)90003-8; ANDERSEN JP, 1992, ACTA PHYSIOL SCAND, V146, P151; ANDERSEN JP, 1989, J BIOL CHEM, V264, P21018; ANDERSEN JP, 1985, J BIOL CHEM, V260, P371; BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; CLARKE DM, 1993, J BIOL CHEM, V268, P18359; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DEMEIS L, 1992, FEBS LETT, V299, P33, DOI 10.1016/0014-5793(92)80093-V; DEMEIS L, 1991, J BIOL CHEM, V266, P5736; DEMEIS L, 1981, TRANSPORT LIFE SCI, V2; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GLYNN IM, 1990, ANNU REV BIOCHEM, V59, P171, DOI 10.1146/annurev.bi.59.070190.001131; GREEN NM, 1989, BIOCHEM SOC T, V17, P972, DOI 10.1042/bst0170972; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEVY D, 1990, J BIOL CHEM, V265, P19524; MACLENNAN DH, 1992, ACTA PHYSIOL SCAND, V146, P141; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; MCINTOSH DB, 1991, P NATL ACAD SCI USA, V88, P6437, DOI 10.1073/pnas.88.15.6437; MILLER C, 1993, SCIENCE, V261, P1692, DOI 10.1126/science.8397443; NORREGAARD A, 1993, FEBS LETT, V336, P248, DOI 10.1016/0014-5793(93)80813-A; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sillen L, 1964, STABILITY CONSTANTS; SUMBILLA C, 1993, J BIOL CHEM, V268, P21185; TAYLOR KA, 1986, J MOL BIOL, V187, P417, DOI 10.1016/0022-2836(86)90442-0; TOYOSHIMA C, 1993, NATURE, V362, P469, DOI 10.1038/362469a0; VILSEN B, 1992, FEBS LETT, V306, P213, DOI 10.1016/0014-5793(92)81003-5; VILSEN B, 1991, J BIOL CHEM, V266, P16157; VILSEN B, 1992, J BIOL CHEM, V267, P3539; VILSEN B, 1992, J BIOL CHEM, V267, P25739; VILSEN B, 1992, FEBS LETT, V306, P247, DOI 10.1016/0014-5793(92)81010-J; VILSEN B, 1987, BIOCHIM BIOPHYS ACTA, V898, P313, DOI 10.1016/0005-2736(87)90072-1; VILSEN B, 1989, J BIOL CHEM, V264, P21024; WOLOSKER H, 1992, J BIOL CHEM, V267, P5785; YU X, 1993, BIOPHYS J, V64, P1232, DOI 10.1016/S0006-3495(93)81489-9	41	58	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					908	914		10.1074/jbc.270.2.908	http://dx.doi.org/10.1074/jbc.270.2.908			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822330	hybrid			2022-12-27	WOS:A1995QB81600064
J	KRUPENKO, SA; WAGNER, C; COOK, RJ				KRUPENKO, SA; WAGNER, C; COOK, RJ			CYSTEINE-707 IS INVOLVED IN THE DEHYDROGENASE ACTIVE-SITE OF RAT 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							FOLATE-BINDING-PROTEIN; ALDEHYDE DEHYDROGENASE; DIRECTED MUTAGENESIS; CYTOSOL-I; LIVER; NITROCELLULOSE; PURIFICATION; FLUORESCENCE; EXPRESSION; STABILITY	The enzyme, 10-formyltetrahydrofolate dehydrogenase (10-FTHFDH) (EC 1.5.1.6) catalyzes both the NADP(+)-dependent oxidation of 10-formyltetrahydrofolate to tetrahydrofolate and CO2 and the NADP(+) independent hydrolysis of 10-formyltetrahydrofolate to tetrahydrofolate and formate, The COOH-terminal domain of the 10-FTHFDH (residues 417-902) shows a 46% identity with a series of NAD(+)-dependent aldehyde dehydrogenases (EC 1.2.1.3), All known members of the aldehyde dehydrogenase family and 10-FTHFDH have a strictly conserved cysteine (Cys-707 for 10-FTHFDH), which has been predicted to be at the active site of these enzymes, Rat liver 10-FTHFDH was expressed in a baculovirus system, and site directed mutagenesis has been used to study the role of cysteine 707 in the activity of 10-FTHFDH. 10-FTHFDH with alanine substituted for cysteine at position 707 had no dehydrogenase activity, while hydrolase activity and binding of NADP(+) were unchanged. Light scattering analysis revealed that wild type and mutant 10-FTHFDH exist as tetramers, We conclude that cysteine 707 is directly involved in the active site of 10-FTHFDH responsible for dehydrogenase activity, and there is a separate site for the hydrolase activity.	DEPT VET AFFAIRS MED CTR,RES SERV,NASHVILLE,TN 37212	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	KRUPENKO, SA (corresponding author), VANDERBILT UNIV,SCH MED,DEPT BIOCHEM,612 LH,NASHVILLE,TN 37232, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046788, R01DK015289, R37DK015289] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK15289, DK46788] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACKERS GK, 1985, ANNU REV BIOCHEM, V54, P597, DOI 10.1146/annurev.bi.54.070185.003121; ALBER T, 1989, ANNU REV BIOCHEM, V58, P765, DOI 10.1146/annurev.biochem.58.1.765; BIRDSALL B, 1983, ANAL BIOCHEM, V132, P353, DOI 10.1016/0003-2697(83)90020-9; BLATTER EE, 1992, BIOCHEM J, V282, P353, DOI 10.1042/bj2820353; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CASE GL, 1988, J BIOL CHEM, V263, P1024; CHOW SF, 1985, J BIOL CHEM, V260, P5516; CLELAND JL, 1990, BIOCHEMISTRY-US, V29, P11072, DOI 10.1021/bi00502a009; COOK RJ, 1991, J BIOL CHEM, V266, P4965; COOK RJ, 1986, METHOD ENZYMOL, V122, P251; COOK RJ, 1982, BIOCHEMISTRY-US, V21, P4427, DOI 10.1021/bi00261a036; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; GARVEY EP, 1990, PROTEIN ENG, P37; Goldenberg David P., 1992, P353; HANIOKA N, 1992, J STEROID BIOCHEM, V43, P1037, DOI 10.1016/0960-0760(92)90331-C; HEMPEL J, 1993, PROTEIN SCI, V2, P1890, DOI 10.1002/pro.5560021111; KUTZBACH C, 1971, METHODS ENZYMOL B, V18, P793; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEARY JJ, 1983, P NATL ACAD SCI-BIOL, V80, P4045, DOI 10.1073/pnas.80.13.4045; LINDAHL R, 1984, BIOCHEM PHARMACOL, V33, P3383, DOI 10.1016/0006-2952(84)90109-6; LUCKOW VA, 1988, BIO-TECHNOL, V6, P47, DOI 10.1038/nbt0188-47; MATTHEWS BW, 1987, BIOCHEMISTRY-US, V26, P6885, DOI 10.1021/bi00396a001; PAKULA AA, 1990, NATURE, V344, P363, DOI 10.1038/344363a0; PONTING CP, 1992, BIOCHIM BIOPHYS ACTA, V1159, P155, DOI 10.1016/0167-4838(92)90020-E; RABINOWITZ JC, 1963, METHOD ENZYMOL, V6, P814, DOI 10.1016/0076-6879(63)06256-X; RIOSORLANDI EM, 1986, BIOCHIM BIOPHYS ACTA, V871, P24, DOI 10.1016/0167-4838(86)90129-9; ROUT UK, 1994, BIOCHEMISTRY-US, V33, P8955, DOI 10.1021/bi00196a013; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIRCH D, 1994, J BIOL CHEM, V269, P24728; SCRUTTON MC, 1979, BIOCHEM J, V177, P833, DOI 10.1042/bj1770833; SMITH GK, 1981, BIOCHEMISTRY-US, V20, P1241, DOI 10.1021/bi00508a029; WEINER H, 1991, ENZYMOLOGY MOL BIOL, V3, P13; WITKOWSKI A, 1994, J BIOL CHEM, V269, P379; YARMUSH DM, 1988, MOL IMMUNOL, V25, P17, DOI 10.1016/0161-5890(88)90086-7	35	22	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					519	522		10.1074/jbc.270.2.519	http://dx.doi.org/10.1074/jbc.270.2.519			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822273	hybrid			2022-12-27	WOS:A1995QB81600005
J	OBRYAN, JP; FRIDELL, YW; KOSKI, R; VARNUM, B; LIU, ET				OBRYAN, JP; FRIDELL, YW; KOSKI, R; VARNUM, B; LIU, ET			THE TRANSFORMING RECEPTOR TYROSINE KINASE, AXL, IS POSTTRANSLATIONALLY REGULATED BY PROTEOLYTIC CLEAVAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CARCINOMA-CELLS; EGF RECEPTOR; C-ERBB; EXPRESSION; PROTEIN; GENE; ACTIVATION; ONCOGENE; LIGAND	Several receptor tyrosine kinases generate soluble ligand binding domains either by differential splicing resulting in a truncated RNA transcript, or by proteolytic cleavage, Although the exact role in vivo of these soluble extracellular domains is unclear, proteolysis may function to down-regulate the receptor, and soluble extracellular domains (ECD) may compete with the intact receptor binding to ligand, Ax1 is a member of a new class of receptor tyrosine kinases characterized by an ECD resembling cell adhesion molecules and unique sequences in the kinase domain, In addition, Ax1 is transforming in both fibroblast and hematopoietic cells, and appears to be involved in mesenchymal development, We now find that Ax1 is post-translationally processed by cleavage in a 14 amino acid region immediately NH2-terminal to the transmembrane domain resulting in a soluble ECD and a membrane bound kinase domain, The sequence of this putative cleavage site shares no homology with recognition sites of known proteases, Characterization of this proteolytic processing shows that it does not require protein synthesis or transport but is augmented by phorbol ester treatment, Since the cleavage of Ax1 enhances turnover of the kinase on the cell surface, we suggest that proteolytic processing down-regulates Ax1 kinase activity.	UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,CURRICULUM GENET,CHAPEL HILL,NC 27599; UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,DEPT MED,CHAPEL HILL,NC 27599; AMGEN CORP,THOUSAND OAKS,CA 91320	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Amgen			Liu, Edison/C-4141-2008	O'Bryan, John/0000-0001-5386-1080	NATIONAL CANCER INSTITUTE [R01CA049240] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA49240] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARGMANN CI, 1988, EMBO J, V7, P2043, DOI 10.1002/j.1460-2075.1988.tb03044.x; BASLER K, 1991, CELL, V64, P1069, DOI 10.1016/0092-8674(91)90262-W; BASU A, 1989, MOL CELL BIOL, V9, P671, DOI 10.1128/MCB.9.2.671; BURNETTE WN, 1988, BIO-TECHNOL, V6, P699, DOI 10.1038/nbt0688-699; DAI W, 1994, ONCOGENE, V9, P975; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DOWNING JR, 1989, MOL CELL BIOL, V9, P2890, DOI 10.1128/MCB.9.7.2890; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; FAUST M, 1992, ONCOGENE, V7, P1287; FLETCHER BS, 1991, J BIOL CHEM, V266, P14511; FLICKINGER TW, 1992, MOL CELL BIOL, V12, P883, DOI 10.1128/MCB.12.2.883; FUJIMOTO J, 1994, ONCOGENE, V9, P693; HALEY JD, 1989, ONCOGENE, V4, P273; JANSSEN JWG, 1991, ONCOGENE, V6, P2113; JIA R, 1992, J VIROL, V66, P5975, DOI 10.1128/JVI.66.10.5975-5987.1992; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; LAX I, 1985, EMBO J, V4, P3179, DOI 10.1002/j.1460-2075.1985.tb04062.x; LIN YZJ, 1991, ONCOGENE, V6, P639; MARK MR, 1994, J BIOL CHEM, V269, P10720; MCCLOSKEY RP, 1994, IN PRESS CELL GROWTH; MERLINO GT, 1985, MOL CELL BIOL, V5, P1722, DOI 10.1128/MCB.5.7.1722; NECKAMEYER WS, 1986, MOL CELL BIOL, V6, P1478, DOI 10.1128/MCB.6.5.1478; NEUBAUER A, 1994, IN PRESS BLOOD; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; OBRYAN JP, 1992, THESIS U N CAROLINA; OHASHI K, 1994, ONCOGENE, V9, P699; PETCH LA, 1990, MOL CELL BIOL, V10, P2973, DOI 10.1128/MCB.10.6.2973; PRAT M, 1991, MOL CELL BIOL, V11, P5954, DOI 10.1128/MCB.11.12.5954; PUPA SM, 1993, ONCOGENE, V8, P2917; RUBIN GM, 1991, TRENDS GENET, V7, P372, DOI 10.1016/0168-9525(91)90258-R; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; TETTEROO PAT, 1984, LEUKEMIA RES, V8, P197, DOI 10.1016/0145-2126(84)90143-7; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; WANG LH, 1987, P NATL ACAD SCI USA, V84, P5725, DOI 10.1073/pnas.84.16.5725; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303	36	131	143	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					551	557		10.1074/jbc.270.2.551	http://dx.doi.org/10.1074/jbc.270.2.551			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822279	hybrid			2022-12-27	WOS:A1995QB81600011
J	NOGALES, D; LIGHTNER, DA				NOGALES, D; LIGHTNER, DA			ON THE STRUCTURE OF BILIRUBIN IN SOLUTION - C-13(H-1) HETERONUCLEAR OVERHAUSER EFFECT NMR ANALYSES IN AQUEOUS BUFFER AND ORGANIC-SOLVENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; INDUCED CIRCULAR-DICHROISM; CONFORMATION; DERIVATIVES; RESOLUTION; SULFOXIDES; C-13	Select hydrogen-carbon distances have been determined from C-13(H-1) heteronuclear Overhauser effects observed in a 99% carbon-13 enriched (CO2H)-C-13 bilirubin analog, [8(3),12(3)-C-13(2)]-mesobilirubin XIII alpha. Analysis of the data confirms that the propionic acid carbonyl lies within hydrogen bonding distance to the dipyrrinone lactam and pyrrole N-H groups in chloroform and indicates, surprisingly, that those distances are only slightly longer in dimethyl sulfoxide solvent or when the carboxyl group is ionized in pH 7.4 aqueous buffered solutions of the pigment. The data supports the presence and persistence of folded, intramolecularly hydrogen-bonded bilirubin conformations in solution.	UNIV NEVADA,DEPT CHEM,RENO,NV 89557; UNIV NEVADA,DEPT BIOCHEM,RENO,NV 89557; UNIV NEVADA,CELL & MOLEC BIOL PROGRAM,RENO,NV 89557	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017779] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-17779] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BOIADJIEV SE, 1992, J AM CHEM SOC, V114, P10123, DOI 10.1021/ja00052a006; BONNETT R, 1978, PROC R SOC SER B-BIO, V202, P249, DOI 10.1098/rspb.1978.0066; BRODERSEN R, 1986, BILE PIGMENTS JAUNDI, P158; CATIVIELA C, 1985, MAGN RESON CHEM, V23, P1072, DOI 10.1002/mrc.1260231209; CISTOLA DP, 1982, J LIPID RES, V23, P795; Falk H., 1989, CHEM LINEAR OLIGOPYR; Fischer H, 1941, H-S Z PHYSIOL CHEM, V268, P197, DOI 10.1515/bchm2.1941.268.5-6.197; GAWRONSKI JK, 1990, TETRAHEDRON, V46, P8053, DOI 10.1016/S0040-4020(01)81462-9; GOLLAN JL, 1988, SEMIN LIVER DIS, V8, P8; HORE PJ, 1983, J MAGN RESON, V54, P539, DOI 10.1016/0022-2364(83)90335-9; HSIEH YZ, 1988, J AM CHEM SOC, V110, P62, DOI 10.1021/ja00209a009; JAMES TL, 1991, ANNU REV PHYS CHEM, V42, P501, DOI 10.1146/annurev.physchem.42.1.501; KAPLAN D, 1981, J CHEM SOC PERK T 2, P1374, DOI 10.1039/p29810001374; KAPLAN D, 1983, ISRAEL J CHEM, V23, P177; KAPLAN D, 1982, BIOCHEM J, V201, P605, DOI 10.1042/bj2010605; KHALED M A, 1983, Journal of the American Chemical Society, V105, P3363, DOI 10.1021/ja00348a083; LEBAS G, 1980, ACTA CRYSTALLOGR B, V36, P3007, DOI 10.1107/S0567740880010692; LIU H, 1993, J AM CHEM SOC, V115, P1590, DOI 10.1021/ja00057a062; MAISELS MJ, 1990, CLIN PERINATOLOGY NE, V17; McDonagh A. F., 1979, PORPHYRINS, VVI; MCDONAGH AF, 1985, PEDIATRICS, V75, P443; MCDONAGH AF, 1991, FALK SYMP, V57, P47; MUKUNDAN S, 1991, J AM CHEM SOC, V113, P3021, DOI 10.1021/ja00008a034; NEUHAUS D, 1988, NUCLEAR OVERHAUSER E; NOGALES DF, 1994, J LABELLED COMPD RAD, V34, P453, DOI 10.1002/jlcr.2580340508; Ostrow JD., 1986, BILE PIGMENTS JAUNDI; PESON RV, 1994, J AM CHEM SOC, V116, P42; PU YM, 1991, TETRAHEDRON, V47, P6163, DOI 10.1016/S0040-4020(01)86549-2; PUZICHA G, 1991, J AM CHEM SOC, V113, P3583, DOI 10.1021/ja00009a055; SEBA HB, 1990, J CHEM SOC CHEM COMM, P996, DOI 10.1039/c39900000996; SHOUT DP, 1993, SPECTROSC LETT, V26, P461; TIRIBELLI C, 1993, HEPATOLOGY, V17, P715, DOI 10.1002/hep.1840170428; TRULL FR, 1987, J HETEROCYCLIC CHEM, V24, P1573, DOI 10.1002/jhet.5570240614; TRULL FR, 1983, ISRAEL J CHEM, V23, P211; TRULL FR, 1992, TETRAHEDRON, V48, P8189, DOI 10.1016/S0040-4020(01)80488-9; YU C, 1984, J AM CHEM SOC, V106, P6533, DOI 10.1021/ja00334a013	36	79	80	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					73	77		10.1074/jbc.270.1.73	http://dx.doi.org/10.1074/jbc.270.1.73			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814422	hybrid			2022-12-27	WOS:A1995QA28700017
J	FUKUDA, M; GOTOH, Y; KOSAKO, H; HATTORI, S; NISHIDA, E				FUKUDA, M; GOTOH, Y; KOSAKO, H; HATTORI, S; NISHIDA, E			ANALYSIS OF THE RAS P21-MITOGEN ACTIVATED PROTEIN-KINASE SIGNALING IN-VITRO AND IN XENOPUS-OOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE; TYROSINE PHOSPHORYLATION; MONOCLONAL-ANTIBODY; ONCOGENIC P21(RAS); ACTS DOWNSTREAM; RAF-1; CELLS; GROWTH; TRANSDUCTION; MATURATION	Ras p21 in the GTP-bound form was shown to act as an upstream activator for mitogen activated protein (MAP) kinase kinase (MAPKK) and MAP kinase, and Raf-1 was reported to act as a MAPKK kinase. Further, physical association between Ras and Raf-1 was demonstrated. Here we have shown that incubation of Xenopus immature oocyte extracts with Ras enhances the ability of endogenous Raf-1 to activate MAPKK. Moreover, a dominant negative form of Raf-1 blocked the Ras-induced activation of MAPKK and MAP kinase in the extracts, but not the cyclin A dependent activation of MAP kinase. When the extracts were depleted of 45-kDa MAPKK with polyclonal anti-MAPKK antibody, no activation of MAP kinase occurred even after incubation with Ras. These results suggest that Ras can activate the MAPKK kinase activity of Raf-1 in the extracts and that MAPKK is indispensable for the Ras-induced MAP kinase activation. It is well known that Ras can induce oocyte maturation when injected into immature Xenopus oocytes. Go-injection of Ras with an anti-MAPKK antibody that inhibits the MAPKK activity prevented the Ras-induced germinal vesicle breakdown, suggesting that MAPKK mediates, at least, one of cellular functions of Ras.	KYOTO UNIV,INST VIRUS RES,DEPT MOLEC BIOL & GENET,SAKYO KU,KYOTO 60601,JAPAN; UNIV TOKYO,FAC SCI,DEPT BIOPHYS & BIOCHEM,TOKYO 113,JAPAN; NATL CTR NEUROL & PSYCHIAT,NATL INST NEUROSCI,DIV BIOCHEM & CELLULAR BIOL,KODAIRA,TOKYO 187,JAPAN	Kyoto University; University of Tokyo; National Center for Neurology & Psychiatry - Japan			Fukuda, Makoto/S-9748-2019; Fukuda, Makoto/I-7915-2014; Fukuda, Makoto/C-9745-2009	Fukuda, Makoto/0000-0003-0112-9925; Fukuda, Makoto/0000-0003-0112-9925; Fukuda, Makoto/0000-0003-0112-9925				BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BIRCHMEIER C, 1985, CELL, V43, P615, DOI 10.1016/0092-8674(85)90233-8; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DESHPANDE AK, 1987, MOL CELL BIOL, V7, P1285, DOI 10.1128/MCB.7.3.1285; DEVRIESSMITS AMM, 1992, NATURE, V357, P602, DOI 10.1038/357602a0; DICKSON B, 1992, NATURE, V360, P600, DOI 10.1038/360600a0; FABIAN JR, 1993, J CELL BIOL, V122, P645, DOI 10.1083/jcb.122.3.645; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; FERRELL JE, 1991, MOL CELL BIOL, V11, P1965, DOI 10.1128/MCB.11.4.1965; FINNEY RE, 1993, CURR BIOL, V3, P805, DOI 10.1016/0960-9822(93)90214-9; GOTOH Y, 1990, EUR J BIOCHEM, V193, P671, DOI 10.1111/j.1432-1033.1990.tb19385.x; GOTOH Y, 1991, NATURE, V349, P251, DOI 10.1038/349251a0; GOTOH Y, 1991, EMBO J, V10, P2661, DOI 10.1002/j.1460-2075.1991.tb07809.x; HAN M, 1993, NATURE, V363, P133, DOI 10.1038/363133a0; HATTORI S, 1985, MOL CELL BIOL, V5, P1449, DOI 10.1128/MCB.5.6.1449; HATTORI S, 1992, J BIOL CHEM, V267, P20346; HEIDECKER G, 1992, ADV CANCER RES, V58, P53, DOI 10.1016/S0065-230X(08)60290-0; HOSHINO M, 1987, J BIOCHEM-TOKYO, V102, P503, DOI 10.1093/oxfordjournals.jbchem.a122082; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; HOWE LR, 1993, J BIOL CHEM, V268, P20717; ITOH T, 1993, P NATL ACAD SCI USA, V90, P975, DOI 10.1073/pnas.90.3.975; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; KOIDE H, 1993, P NATL ACAD SCI USA, V90, P8683, DOI 10.1073/pnas.90.18.8683; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; KORN LJ, 1987, SCIENCE, V236, P1502; KOSAKO H, 1994, EMBO J, V13, P2131, DOI 10.1002/j.1460-2075.1994.tb06489.x; KOSAKO H, 1992, EMBO J, V11, P2903, DOI 10.1002/j.1460-2075.1992.tb05359.x; KYRIAKIS JM, 1993, J BIOL CHEM, V268, P16009; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LACKNER MR, 1994, GENE DEV, V8, P160, DOI 10.1101/gad.8.2.160; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; MATSUDA S, 1993, J BIOL CHEM, V268, P3277; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; MUSLIN AJ, 1993, MOL CELL BIOL, V13, P4197, DOI 10.1128/MCB.13.7.4197; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; POSADA J, 1991, MOL CELL BIOL, V11, P2517, DOI 10.1128/MCB.11.5.2517; RAPP UR, 1991, ONCOGENE, V6, P495; SATOH T, 1988, BIOCHIM BIOPHYS ACTA, V949, P97, DOI 10.1016/0167-4781(88)90059-0; SCHAAP D, 1993, J BIOL CHEM, V268, P20232; SHIBUYA EK, 1992, P NATL ACAD SCI USA, V89, P9831, DOI 10.1073/pnas.89.20.9831; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TRAVERSE S, 1993, ONCOGENE, V8, P3175; TSUDA L, 1993, CELL, V72, P407, DOI 10.1016/0092-8674(93)90117-9; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213, DOI 10.1073/pnas.90.13.6213; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; WARTMANN M, 1994, J BIOL CHEM, V269, P6695; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; WU Y, 1994, GENE DEV, V8, P147, DOI 10.1101/gad.8.2.147; YASHAR BM, 1993, MOL CELL BIOL, V13, P5738, DOI 10.1128/MCB.13.9.5738; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	56	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					33097	33101						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806537				2022-12-27	WOS:A1994QA63800055
J	ALONSO, JC; WEISE, F; ROJO, F				ALONSO, JC; WEISE, F; ROJO, F			THE BACILLUS-SUBTILIS HISTONE-LIKE PROTEIN HBSU IS REQUIRED FOR DNA RESOLUTION AND DNA INVERSION MEDIATED BY THE BETA-RECOMBINASE OF PLASMID PSM19035	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CHROMOSOME; BINDING PROTEIN; TN3 RESOLVASE; CURVED DNA; HU; GENE; REPLICATION; EXPRESSION; DEFICIENT; INDUCTION	The beta recombinase, encoded by the Gram-positive bacterial plasmid pSM19035, is unable to mediate DNA recombination in vitro unless a host factor is provided. The factor has now been identified as the Bacillus subtilis Hbsu protein. Hbsu is a nonspecific DNA-binding and DNA-bending protein. The beta recombinase, in the presence of highly purified Hbsu protein, is able to catalyze in vitro intramolecular recombination between two specific recombination sites on a supercolied DNA molecule. DNA resolution was obtained when the two crossing over sites (six sites) were directly oriented, whereas DNA inversion was the product when the six sites were in inverse orientation. The ability of the Escherichia coli chromatin associated proteins HU, IHF, Fis, and H-NS to substitute for Hbsu was investigated. HU efficiently stimulated beta-mediated recombination, while the effect of IHF was partial and that of Fis and H-NS was undetectable. In addition, the beta protein was able to mediate DNA recombination in both wildtype and IHF-deficient E. coli cells, but failed to do so in an HU-deficient strain. The data presented provide direct evidence that a chromatin-associated protein is strictly required for beta-mediated recombination.	MAX PLANCK INST MOLEC GENET, D-14195 BERLIN, GERMANY	Max Planck Society	ALONSO, JC (corresponding author), UNIV AUTONOMA MADRID, CSIC, CTR NACL BIOTECNOL, CANTO BLANCO, E-28049 MADRID, SPAIN.		Alonso, Juan Carlos/D-2595-2009; Rojo, Fernando/A-7038-2008	Alonso, Juan Carlos/0000-0002-5178-7179; Rojo, Fernando/0000-0003-1848-7745				BAKER TA, 1992, GENE DEV, V6, P2221, DOI 10.1101/gad.6.11.2221; BEDNARZ AL, 1990, GENE DEV, V4, P2366, DOI 10.1101/gad.4.12b.2366; BEHNKE D, 1980, PLASMID, V4, P139, DOI 10.1016/0147-619X(80)90003-7; BENJAMIN HW, 1988, EMBO J, V7, P1897, DOI 10.1002/j.1460-2075.1988.tb03023.x; BOITSOV AS, 1979, FEMS MICROBIOL LETT, V6, P11; BRACCO L, 1989, EMBO J, V8, P4289, DOI 10.1002/j.1460-2075.1989.tb08615.x; BREWER BJ, 1988, CELL, V53, P679, DOI 10.1016/0092-8674(88)90086-4; CEGLOWSKI P, 1994, GENE, V145, P33, DOI 10.1016/0378-1119(94)90319-0; CEGLOWSKI P, 1993, FEMS MICROBIOL LETT, V109, P145, DOI 10.1016/0378-1097(93)90011-P; CEGLOWSKI P, 1993, GENE, V136, P1, DOI 10.1016/0378-1119(93)90441-5; Cox M. M., 1989, MOBILE DNA, P661; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; FINKEL SE, 1992, MOL MICROBIOL, V6, P3257, DOI 10.1111/j.1365-2958.1992.tb02193.x; FLASHNER Y, 1988, CELL, V54, P713, DOI 10.1016/S0092-8674(88)80016-3; FULLER RS, 1981, P NATL ACAD SCI-BIOL, V78, P7370, DOI 10.1073/pnas.78.12.7370; GASSEL M, 1989, MOL MICROBIOL, V3, P1269, DOI 10.1111/j.1365-2958.1989.tb00277.x; GLASGOW AC, 1989, MOBILE DNA, P637; GROCH N, 1992, EUR J BIOCHEM, V207, P677, DOI 10.1111/j.1432-1033.1992.tb17095.x; HAIMA P, 1987, MOL GEN GENET, V209, P335, DOI 10.1007/BF00329663; HAYKINSON MJ, 1993, EMBO J, V12, P2503, DOI 10.1002/j.1460-2075.1993.tb05905.x; HODGESGARCIA Y, 1989, J BIOL CHEM, V264, P14621; HUGHES RE, 1990, CELL, V63, P1331, DOI 10.1016/0092-8674(90)90428-H; HWANG DS, 1992, J BIOL CHEM, V267, P23083; IMBER R, 1987, EUR J BIOCHEM, V165, P547, DOI 10.1111/j.1432-1033.1987.tb11474.x; Johnson RC, 1991, CURR OPIN GENET DEV, V1, P404, DOI 10.1016/S0959-437X(05)80307-7; KAWAMURA F, 1984, J BACTERIOL, V160, P442, DOI 10.1128/JB.160.1.442-444.1984; LAMMI M, 1984, ADV EXP MED BIOL, V179, P467; LAUNDON CH, 1987, BIOCHEMISTRY-US, V26, P3759, DOI 10.1021/bi00387a003; LAVOIE BD, 1993, GENE DEV, V7, P2510, DOI 10.1101/gad.7.12b.2510; LAVOIE BD, 1991, EMBO J, V10, P3051, DOI 10.1002/j.1460-2075.1991.tb07856.x; LAVOIE BD, 1994, J BIOL CHEM, V269, P15571; LILLEY DMJ, 1992, NATURE, V357, P282, DOI 10.1038/357282a0; MICKA B, 1992, BIOCHIMIE, V74, P641, DOI 10.1016/0300-9084(92)90136-3; MICKA B, 1991, J BACTERIOL, V173, P3191, DOI 10.1128/JB.173.10.3191-3198.1991; MIZUUCHI M, 1992, CELL, V70, P303, DOI 10.1016/0092-8674(92)90104-K; OWENHUGHES TA, 1992, CELL, V71, P255, DOI 10.1016/0092-8674(92)90354-F; PETTIJOHN DE, 1988, J BIOL CHEM, V263, P12793; PONTIGGIA A, 1993, MOL MICROBIOL, V7, P343, DOI 10.1111/j.1365-2958.1993.tb01126.x; READ CM, 1993, NUCLEIC ACIDS RES, V21, P3427, DOI 10.1093/nar/21.15.3427; ROJO F, 1993, FEBS LETT, V328, P169, DOI 10.1016/0014-5793(93)80987-6; ROJO F, 1994, J MOL BIOL, V238, P159, DOI 10.1006/jmbi.1994.1278; SAMBROOK J, 1986, MOL CLONING LABORATO; SCHMID MB, 1990, CELL, V63, P451, DOI 10.1016/0092-8674(90)90438-K; SHERRATT D, 1989, MOBILE DNA, P163; SPASSKY A, 1984, NUCLEIC ACIDS RES, V12, P5321, DOI 10.1093/nar/12.13.5321; STARK WM, 1992, TRENDS GENET, V8, P432, DOI 10.1016/0168-9525(92)90176-5; TANAKA I, 1984, NATURE, V310, P376, DOI 10.1038/310376a0; THOMPSON JF, 1989, MOBILE DNA, P1; VANPUTTE P, 1992, TRENDS GENET, V8, P457; WEIR HM, 1993, EMBO J, V12, P1311, DOI 10.1002/j.1460-2075.1993.tb05776.x; WELFLE H, 1992, EUR J BIOCHEM, V204, P1049, DOI 10.1111/j.1432-1033.1992.tb16727.x; WHITE SW, 1989, PROTEINS, V5, P281, DOI 10.1002/prot.340050405; WILSON KS, 1990, PROTEIN ENG, V4, P11, DOI 10.1093/protein/4.1.11; YANG CC, 1989, CELL, V57, P869, DOI 10.1016/0092-8674(89)90801-5	54	55	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					2938	2945		10.1074/jbc.270.7.2938	http://dx.doi.org/10.1074/jbc.270.7.2938			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852372	hybrid			2022-12-27	WOS:A1995QG47100011
J	YOUNG, NM; WATSON, DC; YAGUCHI, M; ADAR, R; ARANGO, R; RODRIGUEZARANGO, E; SHARON, N; BLAY, PKS; THIBAULT, P				YOUNG, NM; WATSON, DC; YAGUCHI, M; ADAR, R; ARANGO, R; RODRIGUEZARANGO, E; SHARON, N; BLAY, PKS; THIBAULT, P			C-TERMINAL POSTTRANSLATIONAL PROTEOLYSIS OF PLANT-LECTINS AND THEIR RECOMBINANT FORMS EXPRESSED IN ESCHERICHIA-COLI - CHARACTERIZATION OF RAGGED ENDS BY MASS-SPECTROMETRY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHRINA-CORALLODENDRON LECTIN; AMINO-ACID-SEQUENCE; CONCANAVALIN-A; SEED LECTIN; PEANUT AGGLUTININ; PHYTOHEMAGGLUTININ; PROTEINS; PRECURSOR; SUBUNITS; VACUOLES	Electrospray mass spectrometry was used to accurately measure the molecular masses of single chain lectins from legume seeds and also of three recombinant lectins, expressed in Escherichia coli, The five single chain lectins, Erythrina corallodendron lectin, soybean and peanut agglutinins, Dolichos biflorus lectin, and Phaseolus vulgaris hemagglutinin E, all showed evidence of C-terminal proteolytic processing, in some cases to ''ragged'' ends, when their masses were compared to those expected from their cDNA sequences and their known carbohydrate chains. Recombinant forms of the lectins from E, corallodendron, soybean, and peanut also showed C-terminal trimming, but not to the same points as the natural forms, Discrepancies between the protein and cDNA sequences of the E. corallodendron lectin were resolved by combined liquid chromatography-mass spectrometry peptide mapping and protein sequencing experiments, and the presence of a second glycosylation site was demonstrated, Our data show that all of these lectins undergo C-terminal proteolytic processing of a readily attacked peptide segment, This trimming is frequently imprecise, and the resulting heterogeneity may be a major contributor to the appearance of isolectin forms of these proteins.	WEIZMANN INST SCI,DEPT MEMBRANE RES & BIOPHYS,IL-76100 REHOVOT,ISRAEL; NATL RES COUNCIL CANADA,INST MARINE BIOSCI,HALIFAX,NS B3H 3Z1,CANADA	Weizmann Institute of Science; International Business Machines (IBM); National Research Council Canada	YOUNG, NM (corresponding author), NATL RES COUNCIL CANADA,INST BIOL SCI,100 SUSSEX DR,OTTAWA,ON K1A 0R6,CANADA.			Arango, Rafael/0000-0002-7276-6035; Thibault, Pierre/0000-0001-5993-0331				ABE Y, 1993, J BIOL CHEM, V268, P3525; ADAR R, 1989, FEBS LETT, V257, P81, DOI 10.1016/0014-5793(89)81791-0; ARANGO R, 1990, FEBS LETT, V264, P109, DOI 10.1016/0014-5793(90)80777-G; ARANGO R, 1992, EUR J BIOCHEM, V205, P575, DOI 10.1111/j.1432-1033.1992.tb16815.x; ASHFORD DA, 1991, CARBOHYD RES, V213, P215, DOI 10.1016/S0008-6215(00)90610-4; BORREBAECK CAK, 1981, J BIOL CHEM, V256, P4723; BOWLES DJ, 1986, J CELL BIOL, V102, P1284, DOI 10.1083/jcb.102.4.1284; CARRINGTON DM, 1985, NATURE, V313, P64, DOI 10.1038/313064a0; CHRISPEELS MJ, 1992, CELL, V68, P613, DOI 10.1016/0092-8674(92)90134-X; Covey T R, 1988, Rapid Commun Mass Spectrom, V2, P249, DOI 10.1002/rcm.1290021111; DORLAND L, 1981, J BIOL CHEM, V256, P7708; ETZLER ME, 1981, J BIOL CHEM, V256, P2367; FAYE L, 1986, EUR J BIOCHEM, V158, P655, DOI 10.1111/j.1432-1033.1986.tb09803.x; HARADA JJ, 1990, J BIOL CHEM, V265, P4997; HIGGINS TJV, 1983, J BIOL CHEM, V258, P9544; HIGGINS TJV, 1984, ANNU REV PLANT PHYS, V35, P191, DOI 10.1146/annurev.pp.35.060184.001203; HOEDEMAEKER FJ, 1994, PLANT MOL BIOL, V24, P75, DOI 10.1007/BF00040575; HOFFMAN LM, 1987, BIO-TECHNOL, V5, P157, DOI 10.1038/nbt0287-157; HOFFMAN LM, 1985, EMBO J, V4, P883, DOI 10.1002/j.1460-2075.1985.tb03714.x; LIS H, 1985, PHYTOCHEMISTRY, V24, P2803, DOI 10.1016/0031-9422(85)80004-2; MANDAL DK, 1994, EUR J BIOCHEM, V221, P547, DOI 10.1111/j.1432-1033.1994.tb18767.x; MANN M, 1989, ANAL CHEM, V61, P1702, DOI 10.1021/ac00190a023; MIN W, 1992, EMBO J, V11, P1303, DOI 10.1002/j.1460-2075.1992.tb05174.x; MURAMATSU M, 1993, EUR J BIOCHEM, V215, P123, DOI 10.1111/j.1432-1033.1993.tb18014.x; PUEPPKE SG, 1991, ARCH BIOCHEM BIOPHYS, V212, P254; ROBERTS DM, 1982, ARCH BIOCHEM BIOPHYS, V218, P213, DOI 10.1016/0003-9861(82)90338-1; RODRIGUEZARANGO E, 1992, FEBS LETT, V307, P185, DOI 10.1016/0014-5793(92)80764-8; SCHROEDER MR, 1993, J EXP BOT, V44, P315; SHELDON PS, 1992, EMBO J, V11, P1297, DOI 10.1002/j.1460-2075.1992.tb05173.x; SILBER KR, 1992, P NATL ACAD SCI USA, V89, P295, DOI 10.1073/pnas.89.1.295; STUBBS ME, 1986, J BIOL CHEM, V261, P6141; STURM A, 1992, EUR J BIOCHEM, V204, P313, DOI 10.1111/j.1432-1033.1992.tb16639.x; THIBAULT P, 1993, TECHNIQUES PROTEIN C, V4, P91; VODKIN LO, 1983, CELL, V34, P1023, DOI 10.1016/0092-8674(83)90560-3; VONSCHAEWEN A, 1993, J EXP BOT, V44, P339; YOUNG NM, 1991, EUR J BIOCHEM, V196, P631, DOI 10.1111/j.1432-1033.1991.tb15859.x; YOUNG NM, 1985, CAN J BIOCHEM CELL B, V63, P268, DOI 10.1139/o85-039	37	52	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2563	2570		10.1074/jbc.270.6.2563	http://dx.doi.org/10.1074/jbc.270.6.2563			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852319	hybrid			2022-12-27	WOS:A1995QF53500027
J	MASUDA, T; KARIYA, K; SHINKAI, M; OKADA, T; KATAOKA, T				MASUDA, T; KARIYA, K; SHINKAI, M; OKADA, T; KATAOKA, T			PROTEIN-KINASE BYR2 IS A TARGET OF RAS1 IN THE FISSION YEAST SCHIZOSACCHAROMYCES-POMBE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SACCHAROMYCES-CEREVISIAE; ADENYLYL CYCLASE; GENE; ENCODES; DOMAIN; RAF-1; MEK	Conservation of the structure and function of Ras proteins has been observed in a variety of eukaryotic organisms, However, the nature of their downstream effecters appears to be quite divergent; adenylyl cyclase and a protein kinase Raf-l, which do not share any structural homology with each other, are effecters of has in the budding yeast and in higher organisms, respectively, We show here that a protein kinase Byr2, which has been known to act downstream of Ras1 in a mating pheromone signal transduction system of Schizosaccharomyces pombe, binds directly to Ras proteins in a GTP-dependent manner, The region of Byr2 responsible for the Has binding was mapped by a gene deletion analysis to its N-terminal segment of 206 amino acid residues, which does not possess any significant homology with the other effecters of Ras, The affinity of the Byr2 N terminus for Saccharomyces cerevisiae Ras2 was determined by measuring its activity to competitively inhibit has-dependent adenylyl cyclase activity and found to be comparable with those of yeast adenylyl cyclase and human Raf-l, with a dissociation constant (K-d) of about 1 nM. Furthermore, Byr2 inhibited a has GTPase-activating activity of IraS, a S, cerevisiae homologue of neurofibromin. These results indicate that Byr2 is an immediate downstream target of Ras1 in S. pombe.	KOBE UNIV, SCH MED, DEPT PHYSIOL 2, CHUO KU, KOBE 650, JAPAN	Kobe University								BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Broach J R, 1990, Adv Cancer Res, V54, P79, DOI 10.1016/S0065-230X(08)60809-X; CHANG EC, 1994, CELL, V79, P131, DOI 10.1016/0092-8674(94)90406-5; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; CREWS CM, 1993, CELL, V74, P215, DOI 10.1016/0092-8674(93)90411-I; FUKUI Y, 1986, CELL, V44, P329, DOI 10.1016/0092-8674(86)90767-1; GIBBS JB, 1989, MICROBIOL REV, V53, P171, DOI 10.1128/MMBR.53.2.171-185.1989; GOTOH Y, 1993, MOL CELL BIOL, V13, P6427, DOI 10.1128/MCB.13.10.6427; KURODA Y, 1993, SCIENCE, V259, P683, DOI 10.1126/science.8430318; LANGECARTER CA, 1994, SCIENCE, V265, P1458, DOI 10.1126/science.8073291; MINATO T, 1994, J BIOL CHEM, V269, P20845; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; NADINDAVIS SA, 1988, EMBO J, V7, P985, DOI 10.1002/j.1460-2075.1988.tb02905.x; RODRIGUEZVICIAN.P, 1994, SCIENCE, V370, P527; TANAKA K, 1990, MOL CELL BIOL, V10, P4303, DOI 10.1128/MCB.10.8.4303; TODA T, 1991, GENE DEV, V5, P60, DOI 10.1101/gad.5.1.60; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213, DOI 10.1073/pnas.90.13.6213; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WANG J, 1992, MOL CELL BIOL, V12, P4937, DOI 10.1128/MCB.12.11.4937; WANG Y, 1991, MOL CELL BIOL, V11, P3554, DOI 10.1128/MCB.11.7.3554; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	23	62	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					1979	1982		10.1074/jbc.270.5.1979	http://dx.doi.org/10.1074/jbc.270.5.1979			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836423	hybrid			2022-12-27	WOS:A1995QE49300003
J	MCMAHON, HT; SUDHOF, TC				MCMAHON, HT; SUDHOF, TC			SYNAPTIC CORE COMPLEX OF SYNAPTOBREVIN, SYNTAXIN, AND SNAP25 FORMS HIGH-AFFINITY ALPHA-SNAP FINDING SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER RELEASE; FUSION PROTEIN; MEMBRANE-FUSION; CLEAVAGE; TETANUS; TRANSPORT; YEAST	SNAPs (soluble NSF attachment proteins) are cytoplasmic proteins that bind to specific membrane receptors and mediate the membrane binding of NSF (N-ethylmaleimide-sensitive factor), a protein that is required for membrane fusion reactions. Three synaptic proteins in brain (SNAP25 (synaptosomal-associated protein of 25 kDa; no relation to the SNAPs for NSF), synaptobrevin/VAMP, and syntaxin) were identified as SNAP receptors by affinity chromatography on immobilized alpha-SNAP complexed to NSF (Sollner, T., Whiteheart, S. W., Brunner, M., Erdjument-Bromage, H., Geromanos, S., Tempst, P. and Rothman, J. E. (1993) Nature 362, 318-324). However, the nature of the alpha-SNAP binding site is unclear. We now show that alpha-SNAP binds tightly to the complex of syntaxin with synaptobrevin. SNAP25 is not required for tight binding of alpha-SNAP to this complex but stabilizes the syntaxin synaptobrevin complex by forming a trimeric core complex with it. alpha-SNAP does not bind to synaptobrevin individually and binds only weakly to syntaxin and SNAP25 in the absence of synaptobrevin. These data suggest that the complex of the vesicular protein synaptobrevin with the plasma membrane protein syntaxin is required for physiological alpha-SNAP binding. Thus, alpha-SNAP probably functions in a late step of the membrane fusion reaction after the formation of the synaptobrevin-syntaxin-SNAP25 core complex.	UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas								ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; BECKERS CJM, 1989, NATURE, V339, P397, DOI 10.1038/339397a0; BENNETT MK, 1994, ANNU REV BIOCHEM, V63, P63, DOI 10.1146/annurev.bi.63.070194.000431; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; DIAZ R, 1989, NATURE, V339, P389; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; GEPPERT M, 1994, CELL, V79, P1; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINK E, 1992, BIOCHEM BIOPH RES CO, V189, P1017, DOI 10.1016/0006-291X(92)92305-H; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; PRYER NK, 1992, ANNU REV BIOCHEM, V61, P471; Sambrook J, 1989, MOL CLONING LABORATO; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1993, CELL, V75, P1; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; WILSON DW, 1989, NATURE, V339, P355, DOI 10.1038/339355a0	25	161	162	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2213	2217		10.1074/jbc.270.5.2213	http://dx.doi.org/10.1074/jbc.270.5.2213			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836452	hybrid			2022-12-27	WOS:A1995QE49300037
J	TANG, XR; LI, HO; SAKATSUME, O; OHTA, T; TSUTSUI, H; SMIT, AFA; HORIKOSHI, M; KOURILSKY, P; ISRAEL, A; GACHELIN, G; YOKOYAMA, K				TANG, XR; LI, HO; SAKATSUME, O; OHTA, T; TSUTSUI, H; SMIT, AFA; HORIKOSHI, M; KOURILSKY, P; ISRAEL, A; GACHELIN, G; YOKOYAMA, K			COOPERATIVITY BETWEEN AN UPSTREAM TATA-LIKE SEQUENCE AND A CAA REPEATED ELEMENT MEDIATES E1A-DEPENDENT NEGATIVE REPRESSION OF THE H-2K(B) CLASS-I GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; NF-KAPPA-B; TRANSFORMED RAT-CELLS; DNA-BINDING PROTEIN; HEAT-SHOCK GENE; RETINOIC ACID; TRANSCRIPTIONAL ACTIVATION; ADENOVIRUS-TYPE-12 E1A; EXPRESSION; MHC	In primary rodent cells transformed by the E1A region of the highly oncogenic adenovirus type 12, repression of transcription mediated by the far upstream TATA-like element was observed only in conjunction with either possible juxtaposition of a CAA repeated element in the presence of E1A and was dependent upon the relative arrangement of both the TATA-like and CAA repeated motifs in both homologous and heterologous promoter constructs, A gel shift competition study demonstrated that the TATA-binding protein (TBP) or a TBP-like protein can bind to both the upstream TATA-like sequence and the regular TATA box on the H-2K(b) basal promoter, Moreover, employing immunoselection and cyclic amplification and selection of targets (CASTing) methods with nuclear extracts derived from Ad12-E1A transformants, we have identified a high affinity binding site in the H-2K(b) class I promoter for E1A-associated DNA-binding proteins. The sequences of the binding sites were identified and were found to contain both the upstream TATA like motif and the CAA repeated motifs. Our results suggest that the TATA like sequence in the far upstream region of the H-2K(b) gene is one of the elements that is required for Ad12-E1A-mediated negative repression.	INST PHYS & CHEM RES, TSUKUBA LIFE SCI CTR, TSUKUBA, IBARAKI 305, JAPAN; CITY HOPE NATL MED CTR, BECKMAN RES INT, DEPT BIOL, DUARTE, CA 91010 USA; UNIV TOKYO, INST MOLEC & CELLULAR BIOSCI, BUNKYO KU, TOKYO 113, JAPAN; INST PASTEUR, DEPT MOLEC BIOL, UNITE BIOL MOLEC EXPRESS GEN, F-75724 PARIS 15, FRANCE; INST PASTEUR, DEPT IMMUNOL, UNITE BIOL MOLEC GENE, F-75724 PARIS 15, FRANCE	RIKEN; City of Hope; Beckman Research Institute of City of Hope; University of Tokyo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris				Sakatsume, Osamu/0000-0003-1340-3661				ACKRILL AM, 1988, ONCOGENE, V3, P483; BALDWIN AS, 1990, MOL CELL BIOL, V10, P1406, DOI 10.1128/MCB.10.4.1406; BALDWIN AS, 1987, MOL CELL BIOL, V7, P305, DOI 10.1128/MCB.7.1.305; BERNARDS R, 1983, NATURE, V305, P776, DOI 10.1038/305776a0; BOYER TG, 1993, GENE DEV, V7, P1810, DOI 10.1101/gad.7.9.1810; BROU C, 1993, EMBO J, V12, P489, DOI 10.1002/j.1460-2075.1993.tb05681.x; BURKE PA, 1989, J EXP MED, V169, P1309, DOI 10.1084/jem.169.4.1309; DAVID-WATINE B, 1990, IMMUNOL TODAY, V11, P286, DOI 10.1016/0167-5699(90)90114-O; DEY A, 1992, MOL CELL BIOL, V12, P3590, DOI 10.1128/MCB.12.8.3590; EAGER KB, 1985, P NATL ACAD SCI USA, V82, P5525, DOI 10.1073/pnas.82.16.5525; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; FAN CM, 1990, GENE DEV, V4, P29, DOI 10.1101/gad.4.1.29; FLINT SJ, 1980, MOL BIOL TUMOR VIRUS, V2, P383; FRIEDMAN DJ, 1988, VIROLOGY, V165, P303, DOI 10.1016/0042-6822(88)90689-7; GE RW, 1992, J VIROL, V66, P6969, DOI 10.1128/JVI.66.12.6969-6978.1992; GEISBERG JV, 1994, P NATL ACAD SCI USA, V91, P2488, DOI 10.1073/pnas.91.7.2488; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HALLENBECK PL, 1992, P NATL ACAD SCI USA, V89, P5572, DOI 10.1073/pnas.89.12.5572; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; HORIKOSHI N, 1991, P NATL ACAD SCI USA, V88, P5124, DOI 10.1073/pnas.88.12.5124; ISRAEL A, 1989, EMBO J, V8, P3793, DOI 10.1002/j.1460-2075.1989.tb08556.x; ISRAEL A, 1987, P NATL ACAD SCI USA, V84, P2653, DOI 10.1073/pnas.84.9.2653; KAO HT, 1983, MOL CELL BIOL, V3, P2058, DOI 10.1128/MCB.3.11.2058; KATOH S, 1990, EMBO J, V9, P127, DOI 10.1002/j.1460-2075.1990.tb08088.x; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; KIMURA A, 1986, CELL, V44, P261, DOI 10.1016/0092-8674(86)90760-9; KIMURA G, 1975, INT J CANCER, V15, P694, DOI 10.1002/ijc.2910150419; KINZLER KW, 1989, NUCLEIC ACIDS RES, V17, P3645, DOI 10.1093/nar/17.10.3645; KRALLI A, 1992, J VIROL, V66, P6979, DOI 10.1128/JVI.66.12.6979-6988.1992; LEE WS, 1991, CELL, V67, P365, DOI 10.1016/0092-8674(91)90188-5; LEUNG K, 1988, NATURE, V333, P776, DOI 10.1038/333776a0; LILY W, 1987, NATURE, V326, P512, DOI 10.1038/326512a0; LIU F, 1994, NATURE, V368, P520, DOI 10.1038/368520a0; LIU XH, 1994, ONCOGENE, V9, P2183; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MARKS MS, 1992, EMBO J, V11, P1419, DOI 10.1002/j.1460-2075.1992.tb05187.x; MEIJER I, 1991, ONCOGENE, V6, P911; MEIJER I, 1989, J VIROL, V63, P4039, DOI 10.1128/JVI.63.9.4039-4042.1989; NAGATA T, 1992, P NATL ACAD SCI USA, V89, P937, DOI 10.1073/pnas.89.3.937; NEVINS JR, 1981, CELL, V26, P213, DOI 10.1016/0092-8674(81)90304-4; NIELSCH U, 1991, EMBO J, V10, P4169, DOI 10.1002/j.1460-2075.1991.tb04995.x; OZAWA K, 1990, NUCLEIC ACIDS RES, V18, P4185, DOI 10.1093/nar/18.14.4185; OZAWA K, 1993, J BIOL CHEM, V268, P27258; PERKINS AS, 1991, MOL CELL BIOL, V11, P2665, DOI 10.1128/MCB.11.5.2665; SAMBROOK DL, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASSONECORSI P, 1987, P NATL ACAD SCI USA, V84, P6430, DOI 10.1073/pnas.84.18.6430; SCHRIER PI, 1983, NATURE, V305, P771, DOI 10.1038/305771a0; SHIROKI K, 1983, J VIROL, V45, P1074, DOI 10.1128/JVI.45.3.1074-1082.1983; SHIROKI K, 1992, J VIROL, V66, P1449, DOI 10.1128/JVI.66.3.1449-1457.1992; SIMON MC, 1988, CELL, V52, P723, DOI 10.1016/0092-8674(88)90410-2; SIMON MC, 1987, MOL CELL BIOL, V7, P2884, DOI 10.1128/MCB.7.8.2884; STEIN R, 1984, MOL CELL BIOL, V4, P2792, DOI 10.1128/MCB.4.12.2792; TANAKA K, 1988, ANNU REV IMMUNOL, V6, P359; TANAKA K, 1985, SCIENCE, V228, P26, DOI 10.1126/science.3975631; VAESSEN RTMJ, 1986, EMBO J, V5, P335, DOI 10.1002/j.1460-2075.1986.tb04217.x; VANTVEER LJ, 1992, P NATL ACAD SCI USA, V89, P8971, DOI 10.1073/pnas.89.19.8971; YANO O, 1987, EMBO J, V6, P3317, DOI 10.1002/j.1460-2075.1987.tb02652.x	59	10	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2327	2336		10.1074/jbc.270.5.2327	http://dx.doi.org/10.1074/jbc.270.5.2327			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836466	hybrid			2022-12-27	WOS:A1995QE49300054
J	CHAKRAVARTHY, BR; ISAACS, RJ; MORLEY, P; DURKIN, JP; WHITFIELD, JF				CHAKRAVARTHY, BR; ISAACS, RJ; MORLEY, P; DURKIN, JP; WHITFIELD, JF			STIMULATION OF PROTEIN-KINASE-C DURING CA2+-INDUCED KERATINOCYTE DIFFERENTIATION - SELECTIVE BLOCKADE OF MARCKS PHOSPHORYLATION BY CALMODULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL TRANSDUCTION; BINDING; ACTIVATION; SUBSTRATE; INVITRO; FAMILY; GROWTH; DOMAIN; BRAIN; CELLS	Raising the external Ca2+ concentration from 0.05 to 1.8 mM stimulated membrane-associated protein kinase Cs (PKCs) activity as strongly as the specific PKCs activator, 12-O-tetradecanoyl phorbol-13-acetate (TPA) in BALB/MK mouse keratinocytes. This was indicated by the increased phosphorylation of a PKC-selective peptide substrate, Ac-FKKSFKL-NH2, by membranes isolated from the Ca2+- or TPA-stimulated keratinocytes. Raising the external Ca2+ concentration to 1.8 mM also triggered a 4-fold rise in the intracellular free Ca2+ concentration. As reported elsewhere (Moscat, J. Fleming, T. P., Molloy, C. J. Lopez-Barahona, M., and Aaronson, S. A. (1989) J. Biol. Chem. 264, 11228-11235), TPA stimulated the phosphorylation of the PKCs substrate, the 85-kDa myristoylated alanine-rich kinase C substrate (MARCKS) protein, in intact keratinocytes, but Ca2+ did not. Furthermore, Ca2+-pretreatment reduced the TPA-induced phosphorylation of the 85-kDa protein in intact cells. There was no significant increase in MARCKS phosphorylation when keratinocytes were treated with a Ca2+.CaM-dependent phosphatase inhibitor, cyclosporin A, before stimulation with 1.8 mM Ca2+.Ca2+.calmodulin suppressed the ability of isolated membranes to phosphorylate the 85-kDa MARCKS holoprotein in vitro in the presence of phosphatase inhibitors such as fluoride, pyrophosphate, and vanadate, and this inhibition was overcome by a calmodulin antagonist, the calmodulin-binding domain peptide. Thus, the ability of 1.8 mM Ca2+ to strongly stimulate the membrane PKCs activity without stimulating the phosphorylation of the MARCKS protein in keratinocytes is consistent with the possibility of Ca2+.calmodulin complexes, formed by the internal Ca2+ surge, binding to, and blocking the phosphorylation of, this PKC protein substrate.			CHAKRAVARTHY, BR (corresponding author), NATL RES COUNCIL CANADA, INST BIOL SCI, 100 SUSSEX DR, OTTAWA, ON K1A 0R6, CANADA.							ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; ALBERT KA, 1984, P NATL ACAD SCI-BIOL, V81, P3622, DOI 10.1073/pnas.81.12.3622; ALEXANDER KA, 1987, J BIOL CHEM, V262, P6108; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN EM, 1991, PHYSIOL REV, V71, P371, DOI 10.1152/physrev.1991.71.2.371; BUSSE R, 1988, N-S ARCH PHARMACOL, V337, P79; CHAKRAVARTHY BR, 1989, BIOCHEM BIOPH RES CO, V160, P340, DOI 10.1016/0006-291X(89)91661-6; CHAKRAVARTHY BR, 1991, ANAL BIOCHEM, V196, P144, DOI 10.1016/0003-2697(91)90130-L; CHAKRAVARTHY BR, 1994, IN PRESS BIOCH J; CHAN SY, 1986, J NEUROSCI, V6, P3618; CHIDA K, 1986, J BIOL CHEM, V261, P3013; CLARKE PR, 1993, FEBS LETT, V336, P37, DOI 10.1016/0014-5793(93)81604-X; DLUGOSZ AA, 1992, MOL CARCINOGEN, V5, P286, DOI 10.1002/mc.2940050409; FALCO JP, 1988, ONCOGENE, V2, P573; GROBLEWSKI GE, 1994, J BIOL CHEM, V269, P15111; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HEEMSKERK FMJ, 1993, BIOCHEM BIOPH RES CO, V190, P236, DOI 10.1006/bbrc.1993.1036; HEGEMANN L, 1991, PHARM SKIN, P357; HINRICHSEN RD, 1993, P NATL ACAD SCI USA, V90, P1585, DOI 10.1073/pnas.90.4.1585; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MORLEY P, 1993, J CELL PHYSIOL, V156, P219, DOI 10.1002/jcp.1041560202; MOSCAT J, 1989, J BIOL CHEM, V264, P11228; NAIRN AC, 1992, CIBA F SYMP, V164, P145; ORR JW, 1992, J BIOL CHEM, V267, P15263; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; ROBINSON PJ, 1993, ANAL BIOCHEM, V210, P172, DOI 10.1006/abio.1993.1169; Sharma R K, 1979, Adv Cyclic Nucleotide Res, V10, P187; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; WEISSMAN B, 1985, MOL CELL BIOL, V5, P3386, DOI 10.1128/MCB.5.12.3386; WEISSMAN BE, 1983, CELL, V32, P599, DOI 10.1016/0092-8674(83)90479-8; WHITFIELD JF, 1992, J CELL PHYSIOL, V150, P299, DOI 10.1002/jcp.1041500212; WILLIAMS RE, 1992, PEPTIDES CHEM BIOL, P923; YUSPA SH, 1988, ANN NY ACAD SCI, V548, P191, DOI 10.1111/j.1749-6632.1988.tb18806.x; YUSPA SH, 1991, ENVIRON HEALTH PERSP, V93, P3, DOI 10.2307/3431160; Yuspa Stuart H., 1993, Proceedings of the American Association for Cancer Research Annual Meeting, V34, P560	39	46	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1362	1368		10.1074/jbc.270.3.1362	http://dx.doi.org/10.1074/jbc.270.3.1362			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836403	hybrid			2022-12-27	WOS:A1995QB15600058
J	FAINZILBER, M; LODDER, JC; KITS, KS; KOFMAN, O; VINNITSKY, I; VANRIETSCHOTEN, J; ZLOTKIN, E; GORDON, D				FAINZILBER, M; LODDER, JC; KITS, KS; KOFMAN, O; VINNITSKY, I; VANRIETSCHOTEN, J; ZLOTKIN, E; GORDON, D			A NEW CONOTOXIN AFFECTING SODIUM CURRENT INACTIVATION INTERACTS WITH THE DELTA-CONOTOXIN RECEPTOR-SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OMEGA-CONOTOXIN; SCORPION TOXIN; CHANNELS; ACID; LOCALIZATION; VENOM; SNAIL; BRAIN	We describe a new peptide conotoxin affecting sodium current inactivation, that competes on binding with S-conotoxin TxVIA (delta TxVIA). The amino acid sequence of the new toxin, designated conotoxin NgVIA (NgVIA), is SKCFSOGTFCGIKOGLCCSVRCFSLFCISFE (where O is trans-4-hydroxyproline). The primary structure of NgVIA has an identical cysteine framework and similar hydrophobicity as delta TxVIA but differs in its net charge. NgVIA competes with delta TxVIA on binding to rat brain synaptosomes and molluscan central nervous system and strongly inhibits sodium current inactivation in snail neurons, as does delta TxVIA. In contrast to delta TxVIA, NgVIA is a potent paralytic toxin in vertebrate systems, its binding appears to be voltage-dependent, and it synergically increases veratridine-induced sodium influx to rat brain synaptosomes. delta TxVIA acts as a partial antagonist to NgVIA in rat brain in vivo. NgVIA appears to act via a receptor site distinct from that of delta TxVIA but similar to that of Conus striatus toxin. This new toxin provides a lead for structure function relationship studies in the delta-conotoxins and will enable analysis of the functional significance of this complex of receptor sites in gating mechanisms of sodium channels.	HEBREW UNIV JERUSALEM,SILBERMAN INST LIFE SCI,DEPT CELL & ANIM BIOL,IL-91904 JERUSALEM,ISRAEL; BEN GURION UNIV NEGEV,BEER SHEVA MENTAL HLTH CTR,IL-84105 BEER SHEVA,ISRAEL; BEN GURION UNIV NEGEV,DEPT BEHAV SCI,IL-84105 BEER SHEVA,ISRAEL; UNIV AIX MARSEILLE 2,FAC MED,DEPT BIOCHEM,F-13916 MARSEILLE 20,FRANCE	Hebrew University of Jerusalem; Ben Gurion University; Ben Gurion University; UDICE-French Research Universities; Aix-Marseille Universite	FAINZILBER, M (corresponding author), VRIJE UNIV AMSTERDAM,FAC BIOL,GRAD SCH NEUROSCI AMSTERDAM,NEUROSCI RES INST,DE BOELELAAN 1087,1081 HV AMSTERDAM,NETHERLANDS.			Fainzilber, Mike/0000-0001-8173-8557				ADAMS ME, 1994, TRENDS NEUROSCI, V17, P151, DOI 10.1016/0166-2236(94)90092-2; BETNER I, 1986, CHROMATOGRAPHIA, V22, P381, DOI 10.1007/BF02268795; BRUSSAARD AB, 1991, J PHYSIOL-LONDON, V441, P385, DOI 10.1113/jphysiol.1991.sp018757; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; CATTERALL WA, 1978, J BIOL CHEM, V253, P7393; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; DREIJER AMC, 1995, IN PRESS NEUROSCIENC; FAINZILBER M, 1992, TOXICON, V30, P465, DOI 10.1016/0041-0101(92)90543-E; FAINZILBER M, 1991, EUR J BIOCHEM, V202, P589, DOI 10.1111/j.1432-1033.1991.tb16412.x; FAINZILBER M, 1994, J BIOL CHEM, V269, P2574; FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269; GONOI T, 1986, MOL PHARMACOL, V29, P347; GONOI T, 1987, MOL PHARMACOL, V32, P691; GORDON D, 1992, BIOCHEMISTRY-US, V31, P7622, DOI 10.1021/bi00148a025; HASSON A, 1993, EUR J NEUROSCI, V5, P56, DOI 10.1111/j.1460-9568.1993.tb00205.x; HILLYARD DR, 1989, BIOCHEMISTRY-US, V28, P358, DOI 10.1021/bi00427a049; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P1207, DOI 10.1021/bi00600a011; KOFMAN O, 1993, PSYCHOPHARMACOLOGY, V110, P229, DOI 10.1007/BF02246978; LORET EP, 1994, J BIOL CHEM, V269, P16785; MOCZYDLOWSKI E, 1986, P NATL ACAD SCI USA, V83, P5321, DOI 10.1073/pnas.83.14.5321; MOSKOWITZ H, 1994, INSECT BIOCHEM MOLEC, V24, P13, DOI 10.1016/0965-1748(94)90118-X; OLIVERA BM, 1991, J BIOL CHEM, V266, P22067; PALLAGHY PK, 1993, J MOL BIOL, V234, P405, DOI 10.1006/jmbi.1993.1595; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; RAY R, 1978, J BIOL CHEM, V25, P7307; SABATIER JM, 1993, BIOCHEMISTRY-US, V32, P2763, DOI 10.1021/bi00062a005; SHON KJ, 1994, BIOCHEMISTRY-US, V33, P11420, DOI 10.1021/bi00204a003; SKALICKY JJ, 1993, PROTEIN SCI, V2, P1591, DOI 10.1002/pro.5560021005; STEPHAN MM, 1994, J MEMBRANE BIOL, V137, P1; TAMKUN MM, 1981, MOL PHARMACOL, V19, P78; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; THOMSEN WJ, 1989, P NATL ACAD SCI USA, V86, P10161, DOI 10.1073/pnas.86.24.10161	32	56	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1123	1129		10.1074/jbc.270.3.1123	http://dx.doi.org/10.1074/jbc.270.3.1123			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836370	hybrid			2022-12-27	WOS:A1995QB15600025
J	CAO, J; SATO, H; TAKINO, T; SEIKI, M				CAO, J; SATO, H; TAKINO, T; SEIKI, M			THE C-TERMINAL REGION OF MEMBRANE TYPE MATRIX METALLOPROTEINASE IS A FUNCTIONAL TRANSMEMBRANE DOMAIN REQUIRED FOR PRO-GELATINASE-C ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE INHIBITOR; IV COLLAGENASE; CELL-SURFACE; INTERSTITIAL COLLAGENASE; SACCHAROMYCES-CEREVISIAE; PLASMINOGEN-ACTIVATOR; HUMAN INTERLEUKIN-2; EXPRESSION; PRECURSOR; INVASION	We identified a new matrix metalloproteinase (membrane type matrix metalloproteinase (MT-MMP)) that has a potential transmembrane (TM) domain at the C terminus and reported its expression on the surface of invasive tumor cells. The expression of MT-MMP induced specific activation of 72-kDa pro-gelatinase A (Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. (1994) Nature 370, 61-65). Thus, MT-MMP on the cell surface is thought to play an important role in various physiological and pathological processes accompanying tissue remodeling. In this study, we demonstrated that the potential TM domain deduced from the amino acid sequence functions as a membrane linker when it is fused to a secretory protein, tissue inhibitor of matrix metalloproteinases-1. The progelatinase A activation function of MT-MMP was abolished by truncation of the TM domain and recovered by fusing the MT-MMP mutant with the TRI domain of interleukin 2 receptor alpha-chain. The truncated MT-MMP was released from the cells into the medium and detected as processed or modified forms. In spite of the deletion of the TM domain some portions of the mutant MT-MMP were still retained on the surface of cells. Thus, MT-MMP has an additional device to keep it on the cell surface. The TM domain however, plays an essential role in the pro-gelatinase A activation function of MT-MMP, probably regulating its fine orientation or the localization that is necessary to interact with substrate.	KANAZAWA UNIV,CANC RES INST,DEPT MOLEC ONCOL & VIROL,KANAZAWA,ISHIKAWA 920,JAPAN; KANAZAWA UNIV,SCH MED,DEPT ORAL SURG,KANAZAWA,ISHIKAWA 920,JAPAN	Kanazawa University; Kanazawa University			SATO, Hiroshi/D-8454-2015; Seiki, Motoharu/K-9443-2015; TAKINO, Takahisa/D-8460-2015					AZZAM HS, 1992, CANCER RES, V52, P4540; AZZAM HS, 1993, J NATL CANCER I, V85, P1758, DOI 10.1093/jnci/85.21.1758; BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0; BROWN PD, 1990, CANCER RES, V50, P6184; BROWN PD, 1993, KIDNEY INT, V43, P163, DOI 10.1038/ki.1993.27; CLEMENTS JM, 1991, GENE, V106, P267, DOI 10.1016/0378-1119(91)90209-T; DOCHERTY AJP, 1985, NATURE, V318, P66, DOI 10.1038/318066a0; EMONARD HP, 1992, CANCER RES, V52, P5845; GABUZDA DH, 1992, J VIROL, V66, P3306, DOI 10.1128/JVI.66.6.3306-3315.1992; GERMAIN D, 1993, FEBS LETT, V323, P129, DOI 10.1016/0014-5793(93)81463-A; HATAKEYAMA M, 1985, NATURE, V318, P467, DOI 10.1038/318467a0; HE CS, 1989, P NATL ACAD SCI USA, V86, P2632, DOI 10.1073/pnas.86.8.2632; HIBBS MS, 1985, J BIOL CHEM, V260, P2493; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; Kleiner DE, 1993, CURR OPIN CELL BIOL, V5, P891, DOI 10.1016/0955-0674(93)90040-W; KLEINER DE, 1993, BIOCHEMISTRY-US, V32, P1583, DOI 10.1021/bi00057a024; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; MARRIOTT D, 1992, MOL ENDOCRINOL, V6, P1441, DOI 10.1210/me.6.9.1441; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; MONSKY WL, 1993, CANCER RES, V53, P3159; NAGASE H, 1990, BIOCHEMISTRY-US, V29, P5783, DOI 10.1021/bi00476a020; NAKAJIMA M, 1989, CANCER RES, V49, P1698; OKADA Y, 1990, EUR J BIOCHEM, V194, P721, DOI 10.1111/j.1432-1033.1990.tb19462.x; OVERALL CM, 1990, J BIOL CHEM, V265, P21141; ROLDAN AL, 1990, EMBO J, V9, P467, DOI 10.1002/j.1460-2075.1990.tb08132.x; SATO H, 1993, J BIOL CHEM, V268, P23460; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; STETLERSTEVENSO.WG, 1993, ANNU REV CELL BIOL, V9, P541; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; SUZUKI K, 1990, BIOCHEMISTRY-US, V29, P10261, DOI 10.1021/bi00496a016; TAKINO T, 1994, IN PRESS GENE AMST; TSUCHIYA Y, 1993, CANCER RES, V53, P1397; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; WARD RV, 1991, BIOCHIM BIOPHYS ACTA, V1079, P242, DOI 10.1016/0167-4838(91)90132-J; WATERHOUSE P, 1990, J BIOL CHEM, V265, P5585; WICKNER RB, 1992, ANNU REV MICROBIOL, V46, P347, DOI 10.1146/annurev.micro.46.1.347; WILLEY RL, 1988, P NATL ACAD SCI USA, V85, P9580, DOI 10.1073/pnas.85.24.9580; ZUCKER S, 1987, BIOCHIM BIOPHYS ACTA, V924, P225, DOI 10.1016/0304-4165(87)90091-2	40	251	255	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					801	805		10.1074/jbc.270.2.801	http://dx.doi.org/10.1074/jbc.270.2.801			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822314	hybrid			2022-12-27	WOS:A1995QB81600048
J	MEDH, JD; FRY, GL; BOWEN, SL; PLADET, MW; STRICKLAND, DK; CHAPPELL, DA				MEDH, JD; FRY, GL; BOWEN, SL; PLADET, MW; STRICKLAND, DK; CHAPPELL, DA			THE 39-KDA RECEPTOR-ASSOCIATED PROTEIN MODULATES LIPOPROTEIN CATABOLISM BY BINDING TO LDL RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEPHRITIS ANTIGENIC COMPLEX; ACTIVATOR INHIBITOR TYPE-1; LOW-DENSITY LIPOPROTEINS; ALPHA-2-MACROGLOBULIN RECEPTOR; PLASMINOGEN-ACTIVATOR; HEYMANN NEPHRITIS; IN-VITRO; CELL-SURFACE; MONOCLONAL-ANTIBODIES; APOLIPOPROTEIN-E	The 39-kDa receptor-associated protein (RAP) is cosynthesized and co-purifies with the low density lipoprotein receptor-related protein (LRP)/alpha(2)-macroglobulin receptor and is thought to modulate Ligand binding to LRP, In addition to binding LRP, RAP binds two other members of the low density lipoprotein (LDL) receptor family, gp330 and very low density lipoprotein (VLDL) receptors, Here, we show that RAP binds to LDL receptors as well, In normal human foreskin fibroblasts, RAP inhibited LDL receptor-mediated binding and catabolism of LDL and VLDL with S-f 20-60 or 100-400, RAP inhibited I-125 labeled LDL and S-f 100-400 lipoprotein binding at 4 degrees C with K-1 values of 60 and 45 nM, respectively, The effective concentrations for 50% inhibition (EC(50)) of cellular degradation of 2.0 nM I-125-labeled LDL, 4.7 nM I-125-labeled S-f 20-60, and 3.6 nM I-125-labeled S-f 100-400 particles were 40, 70, and 51 nM, respectively, Treatment of cells with lovastatin to induce LDL receptors increased cellular binding, internalization, and degradation of RAP by 2.3-, 1.7-, and 2.6-fold, respectively, In solid-phase assays, RAP bound to partially purified LDL receptors in a dose-dependent manner, The dissociation constant (K-D) of RAP binding to LDL receptors in the solid-phase assay was 250 nM, which is higher than that for LRP, gp330, or VLDL receptors in similar assays by a factor of 14 to 350. Also, RAP inhibited I-125-labeled LDL and S-f 100-400 VLDL binding to LDL receptors in solid-phase assays with K-I values of 140 and 130 nM, respectively, Because LDL bind via apolipoprotein (ape) B100 whereas VLDL bind via apoE, our results show that RAP inhibits LDL receptor interactions with both apoB100 and apoE, These studies establish that RAP is capable of binding to LDL receptors and modulating cellular catabolism of LDL and VLDL by this pathway.	UNIV IOWA,COLL MED,DEPT INTERNAL MED,IOWA CITY,IA 52242; AMER RED CROSS,BIOCHEM LAB,ROCKVILLE,MD 20855	University of Iowa; American Red Cross					NHLBI NIH HHS [HL49264, HL50787] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL049264] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; BATTEY FD, 1994, J BIOL CHEM, V269, P23268; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; CHAPPELL DA, 1991, J BIOL CHEM, V266, P19296; CHAPPELL DA, 1992, J BIOL CHEM, V267, P25764; CHAPPELL DA, 1993, J BIOL CHEM, V268, P14168; CHAPPELL DA, 1993, J BIOL CHEM, V268, P25487; CHAPPELL DA, 1992, J BIOL CHEM, V267, P270; CHAPPELL DA, 1994, J BIOL CHEM, V269, P18001; CHAPPELL DA, 1988, J CLIN INVEST, V82, P628, DOI 10.1172/JCI113642; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; ESSER V, 1988, J BIOL CHEM, V263, P13282; HERZ J, 1993, CELL, V73, P428, DOI 10.1016/0092-8674(93)90130-I; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; HERZ J, 1991, J BIOL CHEM, V266, P21232; KNOTT TJ, 1986, NATURE, V323, P734, DOI 10.1038/323734a0; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P21162; KOUNNAS MZ, 1993, J BIOL CHEM, V268, P14176; KOUNNAS MZ, 1993, J BIOL CHEM, V268, P21862; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; KUTT H, 1989, BIOCHIM BIOPHYS ACTA, V1009, P229, DOI 10.1016/0167-4781(89)90107-3; LINDGREN FT, 1972, BLOOD LIPIDS LIPOPRO, P181; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAHLEY RW, 1983, BIOCHIM BIOPHYS ACTA, V737, P197, DOI 10.1016/0304-4157(83)90001-1; MOESTRUP SK, 1991, J BIOL CHEM, V266, P14011; MOESTRUP SK, 1993, J BIOL CHEM, V268, P13691; MOKUNO H, 1994, J BIOL CHEM, V269, P13238; MUNSON PJ, 1983, METHOD ENZYMOL, V92, P543; NYKJAER A, 1993, J BIOL CHEM, V268, P15048; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; ORLANDO RA, 1992, P NATL ACAD SCI USA, V89, P6698, DOI 10.1073/pnas.89.15.6698; ORLANDO RA, 1993, P NATL ACAD SCI USA, V90, P4082, DOI 10.1073/pnas.90.9.4082; ORTH K, 1992, P NATL ACAD SCI USA, V89, P7422, DOI 10.1073/pnas.89.16.7422; RALL SC, 1982, P NATL ACAD SCI-BIOL, V79, P4696, DOI 10.1073/pnas.79.15.4696; RAYCHOWDHURY R, 1989, SCIENCE, V244, P1163, DOI 10.1126/science.2786251; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; STRICKLAND DK, 1991, J BIOL CHEM, V266, P13364; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; STRICKLAND DK, 1988, BIOCHEMISTRY-US, V27, P1458, DOI 10.1021/bi00405a010; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; VANDRIEL IR, 1989, J BIOL CHEM, V264, P9533; WARSHAWSKY I, 1993, J BIOL CHEM, V268, P22046; WARSHAWSKY I, 1993, J CLIN INVEST, V92, P937, DOI 10.1172/JCI116669; WEISGRABER KH, 1983, J BIOL CHEM, V258, P2348; WILLIAMS SE, 1994, J BIOL CHEM, V269, P8653; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; WILLNOW TE, 1992, J BIOL CHEM, V267, P26172	48	112	114	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					536	540		10.1074/jbc.270.2.536	http://dx.doi.org/10.1074/jbc.270.2.536			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822276	hybrid			2022-12-27	WOS:A1995QB81600008
J	DONALD, R; BALLARD, DW; HAWIGER, J				DONALD, R; BALLARD, DW; HAWIGER, J			PROTEOLYTIC PROCESSING OF NF-KAPPA-B I-KAPPA-B IN HUMAN MONOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							TUMOR-NECROSIS-FACTOR; DNA-BINDING SUBUNIT; PRECURSOR P105; P50 PRECURSOR; REL ONCOGENE; C-REL; ALPHA; GENE; ACTIVATION; PROTEINS	Proteolytic processing of select constituents of the nuclear factor kappa B (NF-kappa B)/inhibitor kappa B alpha (I kappa B) transcription factor system plays an important role in regulating the biological responses of monocytes to pro-inflammatory mediators. Nuclear translocation of NF-KB is preceded by the proteolytic degradation of I kappa B alpha, an ankyrin motif-rich inhibitor that traps NF-kappa B in the cytoplasm. In addition, formation of cytoplasmic NF-kappa B/I kappa B alpha complexes in quiescent cells requires constitutive proteolytic processing of p105, another ankyrin motif-rich inhibitory protein from which the p50 subunit of NF-kappa B is generated, We have demonstrated that, following stimulation of human monocytic cells with lipopolysaccharide or tumor necrosis factor-alpha, this critical p105 processing event is up-regulated in concert with the inactivation of I kappa B alpha. Moreover, the degradative loss of both p105 and I kappa B alpha is prevented in cells depleted of intracellular ATP. In activated monocytes, however, I kappa B alpha degradation occurs more rapidly than p105 processing to p50, Together these findings provide direct biochemical evidence that p105 and I kappa B alpha are differentially sensitive targets for inducible proteolysis via ATP-dependent degradative pathways.	VANDERBILT UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,NASHVILLE,TN 37212; VANDERBILT UNIV,MED CTR,HOWARD HUGHES MED INST,NASHVILLE,TN 37232	Vanderbilt University; Howard Hughes Medical Institute; Vanderbilt University					NHLBI NIH HHS [HL 45994, HL 30647] Funding Source: Medline; NIAID NIH HHS [1 RO1 AI33839] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030647, R37HL030647, R01HL045994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033839] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; BLANK V, 1991, EMBO J, V10, P4159, DOI 10.1002/j.1460-2075.1991.tb04994.x; BOURS V, 1990, NATURE, V348, P76, DOI 10.1038/348076a0; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; COGSWELL PC, 1993, J IMMUNOL, V150, P2794; CORDLE SR, 1993, J BIOL CHEM, V268, P11803; DEMARTIN R, 1993, EMBO J, V12, P2773, DOI 10.1002/j.1460-2075.1993.tb05938.x; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GREEN PL, 1992, J VIROL, V66, P4325, DOI 10.1128/JVI.66.7.4325-4330.1992; GRILLI M, 1993, INT REV CYTOL, V143, P1; HAAS JG, 1990, P NATL ACAD SCI USA, V87, P9563, DOI 10.1073/pnas.87.24.9563; HATADA EN, 1992, P NATL ACAD SCI USA, V89, P2489, DOI 10.1073/pnas.89.6.2489; HENKEL T, 1992, CELL, V68, P1121, DOI 10.1016/0092-8674(92)90083-O; HOLMSEN H, 1974, BIOCHEM J, V144, P385, DOI 10.1042/bj1440385; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBAIL O, 1993, EMBO J, V12, P5043, DOI 10.1002/j.1460-2075.1993.tb06197.x; LIOU HC, 1992, EMBO J, V11, P3003, DOI 10.1002/j.1460-2075.1992.tb05370.x; MELLITS KH, 1993, NUCLEIC ACIDS RES, V21, P5059, DOI 10.1093/nar/21.22.5059; MERCURIO F, 1993, GENE DEV, V7, P705, DOI 10.1101/gad.7.4.705; MEYER R, 1991, P NATL ACAD SCI USA, V88, P966, DOI 10.1073/pnas.88.3.966; NAUMANN M, 1993, EMBO J, V12, P213, DOI 10.1002/j.1460-2075.1993.tb05647.x; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; RICE NR, 1992, CELL, V71, P243, DOI 10.1016/0092-8674(92)90353-E; RICE NR, 1993, EMBO J, V12, P4685, DOI 10.1002/j.1460-2075.1993.tb06157.x; TEN RM, 1992, EMBO J, V11, P195, DOI 10.1002/j.1460-2075.1992.tb05042.x; ZIEGLERHEITBROC.HW, 1994, J BIOL CHEM, V269, P17001	30	63	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					9	12		10.1074/jbc.270.1.9	http://dx.doi.org/10.1074/jbc.270.1.9			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814425	hybrid			2022-12-27	WOS:A1995QA28700003
J	ZHANG, GF; PATTON, WA; LEE, FJS; LIYANAGE, M; HAN, JS; RHEE, SG; MOSS, J; VAUGHAN, M				ZHANG, GF; PATTON, WA; LEE, FJS; LIYANAGE, M; HAN, JS; RHEE, SG; MOSS, J; VAUGHAN, M			DIFFERENT ARF DOMAINS ARE REQUIRED FOR THE ACTIVATION OF CHOLERA-TOXIN AND PHOSPHOLIPASE-D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ADP-RIBOSYLATION FACTOR; GTP-BINDING PROTEIN; GOLGI MEMBRANES; DROSOPHILA; TRANSPORT; COP	ADP-ribosylation factors (ARE's), initially described as activators of cholera toxin ADP-ribosyltransferase activity, regulate intracellular vesicular membrane trafficking and stimulate a phospholipase D (PLD) isoform, ARF-like (ARL) proteins are structurally related to ARFs but do not activate cholera toxin and have relatively little effect on PLD. A new human ARL gene termed hARL1, which shares 57% amino acid identity with hARF1, was identified using a polymerase chain reaction based cloning method. To determine whether different structural elements are responsible for the activation of the A subunit of cholera toxin and PLD, chimeric proteins were constructed by switching the amino-terminal 73 amino acids of ARF1 and ARL1. The recombinant rL73/F protein, in which the amino-terminal 73 amino acids of ARL1 replaced those of ARF1, activated the A subunit of cholera toxin, whereas the rF73/L protein, in which the NH2-terminal 73 amino acids of ARF1 replaced those of ARL1, was inactive. The two chimeric proteins had quite opposite effects on PLD activity, rF73/L activated PLD as effectively as rARF1, whereas rL73/F protein activated PLD only slightly. It appears that the amino terminal region of ARF1 is not critical for its action as a GTP-dependent activator of cholera toxin, whereas it is necessary for activation of the putative effector enzyme, PLD.	NHLBI,BIOCHEM LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	ZHANG, GF (corresponding author), NHLBI,PULM CRIT CARE MED BRANCH,RM 5N307,BLDG 10,BETHESDA,MD 20892, USA.		; Han, Joong-Soo/P-2072-2015	LEE, FANG-JEN/0000-0002-2167-2426; Han, Joong-Soo/0000-0002-0875-6158				BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; CAVENAGH MM, 1994, J BIOL CHEM, V269, P18937; CLARK J, 1993, P NATL ACAD SCI USA, V90, P8952, DOI 10.1073/pnas.90.19.8952; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; FIELD M, 1979, AM J CLIN NUTR, V32, P189, DOI 10.1093/ajcn/32.1.189; HAUN RS, 1993, J BIOL CHEM, V268, P7064; HONG JX, 1994, J BIOL CHEM, V269, P9743; KAHN RA, 1984, J BIOL CHEM, V259, P6228; KAHN RA, 1992, J BIOL CHEM, V267, P13039; KELLY MT, 1986, PEDIATR INFECT DIS J, V5, pS101; LENHARD JM, 1992, J BIOL CHEM, V267, P13047; LISCOVITCH M, 1994, J BIOL CHEM, V269, P21403; MASSENBURG D, 1994, IN PRESS P NATL ACAD; MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303; MOSS J, 1993, CELL SIGNAL, V5, P367, DOI 10.1016/0898-6568(93)90076-X; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; PRICE SR, 1990, ADP RIBOSYLATING TOX, P397; SCHURMANN A, 1994, J BIOL CHEM, V269, P15683; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; TAMKUN JW, 1991, P NATL ACAD SCI USA, V88, P3120, DOI 10.1073/pnas.88.8.3120; TSAI SC, 1987, P NATL ACAD SCI USA, V84, P5139, DOI 10.1073/pnas.84.15.5139; TSAI SC, 1988, J BIOL CHEM, V263, P1768; WELSH CF, 1994, J BIOL CHEM, V269, P15583	25	56	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					21	24		10.1074/jbc.270.1.21	http://dx.doi.org/10.1074/jbc.270.1.21			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814376	hybrid			2022-12-27	WOS:A1995QA28700006
J	KIM, KS; LEWIS, IC; SYKES, BD				KIM, KS; LEWIS, IC; SYKES, BD			SOLUTION STRUCTURE OF GRO/MELANOMA GROWTH-STIMULATORY ACTIVITY DETERMINED BY H-1-NMR SPECTROSCOPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL-ACTIVATING PEPTIDE-2; NUCLEAR-MAGNETIC-RESONANCE; 3-DIMENSIONAL SOLUTION STRUCTURE; HUMAN INTERLEUKIN-8 RECEPTOR; MOLECULAR CHARACTERIZATION; BETA-THROMBOGLOBULIN; SECONDARY STRUCTURE; PROTEIN STRUCTURES; DISTANCE GEOMETRY; ACTIVITY MGSA	The three dimensional solution structure of the growth-related protein-alpha/melanoma growth stimulatory activity (GRO/MGSA) has been solved by two-dimensional H-1 nuclear magnetic resonance spectroscopy. The GRO/MGSA monomer consists of an NH2-terminal loop, a three-stranded antiparallel beta-sheet, and a COOH-terminal alpha-helix. Dimerization, which is apparent under the experimental conditions used (2 mM, pH 5.10, 30 degrees C), results in a six stranded antiparallel beta-sheet and a pair of helices with 2-fold symmetry. While the basic fold is similar to that seen for interleukin-8 (IL-8) (Clore, G. M., Appella, E., Yamada, M., Matsushima, K., and Gronenborn, A. M. (1990) Biochemistry, 29, 1689-1696), there are differences in the ELR motif (residues 6-8), the turn involving residues 31-36, which is linked to the NH2-terminal region through the 9-35 disulfide bond. The most significant differences are in the NH2-terminal loop (residues 12-23). In IL-8, all the corresponding regions have been shown to be required for receptor binding (Clark-Lewis, I., Dewald, B., Loetscher, M., Moser, B., and Baggiolini, M. (1994) J. Biol. Chem. 269, 16075-16081). The structural differences thus have been identified between GRO/MGSA and IL-8 could contribute to their different receptor binding specificities.	UNIV ALBERTA, PROT ENGN NETWORK CTR EXCELLENCE, EDMONTON, AB T6G 2S2, CANADA; UNIV ALBERTA, DEPT BIOCHEM, EDMONTON, AB T6G 2S2, CANADA; UNIV BRITISH COLUMBIA, BIOMED RES CTR, PENCE, VANCOUVER, BC V6T 1Z3, CANADA; UNIV BRITISH COLUMBIA, DEPT BIOCHEM & MOLEC BIOL, VANCOUVER, BC V6T 1Z3, CANADA	University of Alberta; University of Alberta; University of British Columbia; University of British Columbia					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050969] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM50969-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANISOWICZ A, 1987, P NATL ACAD SCI USA, V84, P7188, DOI 10.1073/pnas.84.20.7188; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; BALDWIN ET, 1991, P NATL ACAD SCI USA, V88, P502, DOI 10.1073/pnas.88.2.502; BALENTIEN E, 1991, ONCOGENE, V6, P1115; BAX A, 1989, METHOD ENZYMOL, V176, P151; BOTHNERBY AA, 1984, J AM CHEM SOC, V106, P811, DOI 10.1021/ja00315a069; BRUNGER AT, 1992, XPLOR SYSTEM XRAY CR; CERRETTI DP, 1993, MOL IMMUNOL, V30, P359; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; CLARKLEWIS I, 1994, J BIOL CHEM, V269, P16075; CLARKLEWIS I, 1993, P NATL ACAD SCI USA, V90, P3574, DOI 10.1073/pnas.90.8.3574; CLARKLEWIS I, 1991, BIOCHEMISTRY-US, V30, P3128, DOI 10.1021/bi00226a021; CLORE GM, 1989, J BIOL CHEM, V264, P18907; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; CLORE GM, 1991, J MOL BIOL, V217, P611, DOI 10.1016/0022-2836(91)90518-B; FAIRBROTHER WJ, 1993, FEBS LETT, V330, P302, DOI 10.1016/0014-5793(93)80893-Y; HASKILL S, 1990, P NATL ACAD SCI USA, V87, P7732, DOI 10.1073/pnas.87.19.7732; HEBERT CA, 1991, J BIOL CHEM, V266, P18989; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; HORUK R, 1993, J BIOL CHEM, V268, P541; KIM KS, 1993, BIOCHEMISTRY-US, V32, P9600, DOI 10.1021/bi00088a012; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LODI PJ, 1994, SCIENCE, V263, P1762, DOI 10.1126/science.8134838; MILLER MD, 1992, CRIT REV IMMUNOL, V12, P17; MOSER B, 1990, J EXP MED, V171, P1797, DOI 10.1084/jem.171.5.1797; MOSER B, 1991, J BIOL CHEM, V266, P10666; MUELLER L, 1987, J MAGN RESON, V72, P191, DOI 10.1016/0022-2364(87)90188-0; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; NEOTE K, 1993, J BIOL CHEM, V268, P12247; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; POWERS R, 1993, BIOCHEMISTRY-US, V32, P6744, DOI 10.1021/bi00077a030; PROOST P, 1993, BIOCHEMISTRY-US, V32, P10170, DOI 10.1021/bi00089a037; RAJARATHNAM K, 1994, SCIENCE, V264, P90, DOI 10.1126/science.8140420; RAJARATHNAM K, 1994, BIOCHEMISTRY-US, V33, P6623, DOI 10.1021/bi00187a032; RICHMOND A, 1988, EMBO J, V7, P2025, DOI 10.1002/j.1460-2075.1988.tb03042.x; SCHUMACHER C, 1992, P NATL ACAD SCI USA, V89, P10542, DOI 10.1073/pnas.89.21.10542; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; TEKAMPOLSON P, 1990, J EXP MED, V172, P911, DOI 10.1084/jem.172.3.911; WAGNER G, 1987, J MOL BIOL, V196, P611, DOI 10.1016/0022-2836(87)90037-4; WALZ A, 1989, BIOCHEM BIOPH RES CO, V159, P969, DOI 10.1016/0006-291X(89)92203-1; WALZ A, 1991, J EXP MED, V174, P1355, DOI 10.1084/jem.174.6.1355; WEN DZ, 1989, EMBO J, V8, P1761, DOI 10.1002/j.1460-2075.1989.tb03569.x; WUTHRICH K, 1986, NMR PROTEIN NUCLEIC; ZUIDERWEG ERP, 1985, BIOPOLYMERS, V24, P601, DOI 10.1002/bip.360240402; [No title captured]	46	59	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					32909	32915						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806518				2022-12-27	WOS:A1994QA63800031
J	REED, VS; YANG, DCH				REED, VS; YANG, DCH			CHARACTERIZATION OF A NOVEL N-TERMINAL PEPTIDE IN HUMAN ASPARTYL-TRANSFER-RNA SYNTHETASE - ROLES IN THE TRANSFER OF AMINOACYL-TRANSFER-RNA FROM AMINOACYL-TRANSFER-RNA SYNTHETASE TO THE ELONGATION-FACTOR 1-ALPHA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; STRUCTURAL ORGANIZATION; MULTISYNTHETASE COMPLEX; AMPHIPHILIC HELIX; ESCHERICHIA-COLI; DOMAIN; MODEL; FORMS	The kinetics of the N-terminal 32 residue deleted human aspartyl-tRNA synthetase (hDRS Delta 32) was analyzed, The kinetics of aspartyl-adenylate formation and Asp-tRNA synthesis by hDRS Delta 32 were indistinguishable from those of hDRS, However, the dissociation of Asp-tRNA from hDRS Delta 32 was much faster than that of hDRS, Unlike hDRS Delta 32-catalyzed aspartylation of tRNA was not affected by the elongation factor 1 alpha. Two N-terminal peptides of hDRS, hDRS(T5-E26) and hDRS(D12-R27), were synthesized, Both peptides bind to tRNA-Sepharose, Both peptides, hDRS(T5-E26) and hDRS(D12-R27), are monomeric and oligomerize at high peptide concentration or in 50% propylene glycol, The peptide hDRS(T5-E26) showed little alpha-helical content as analyzed by CD spectroscopy, while hDRS(D12-R27) showed appreciable alpha-helical contents in nonpolar solvents. These results suggest that the N terminus in hDRS may mediate the slow release of Asp-tRNA and facilitate the interaction of the hDRS Asp-tRNA complex with the elongation factor 1 alpha. The demonstration of alpha-helix formation of the hDRS N-terminal peptide is consistent with the hypothetical amphiphilic helix of the N terminal extension in hDRS. A model for the transfer of Asp-tRNA from hDRS to elongation factor 1 alpha is presented,	GEORGETOWN UNIV, DEPT CHEM, WASHINGTON, DC 20057 USA	Georgetown University			Yang, David/A-7294-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025848] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-25848] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CERINI C, 1991, EMBO J, V10, P4267, DOI 10.1002/j.1460-2075.1991.tb05005.x; CIRAKOGLU B, 1985, FEBS LETT, V183, P185; DEUTSCHER MP, 1984, J CELL BIOL, V99, P373, DOI 10.1083/jcb.99.2.373; ESCALANTE C, 1993, J BIOL CHEM, V268, P6014; FETT R, 1991, J BIOL CHEM, V266, P1448; GHOSH HP, 1967, J MOL BIOL, V25, P275, DOI 10.1016/0022-2836(67)90142-8; GODAR DE, 1988, BIOCHEMISTRY-US, V27, P6921, DOI 10.1021/bi00418a038; JACOBOMOLINA A, 1989, J BIOL CHEM, V264, P16608; KELLERMANN O, 1982, J BIOL CHEM, V257, P1041; KINZY TG, 1992, J BIOL CHEM, V267, P1623; KJELDGAARD M, 1992, J MOL BIOL, V223, P721, DOI 10.1016/0022-2836(92)90986-T; LORBER B, 1988, EUR J BIOCHEM, V174, P155, DOI 10.1111/j.1432-1033.1988.tb14076.x; MIRANDE M, 1992, EUR J BIOCHEM, V203, P459, DOI 10.1111/j.1432-1033.1992.tb16570.x; MIRANDE M, 1991, PROG NUCLEIC ACID RE, V40, P95; MIRANDE M, 1989, J BIOL CHEM, V264, P842; PERCZEL A, 1992, ANAL BIOCHEM, V203, P83, DOI 10.1016/0003-2697(92)90046-A; REED VS, 1994, J BIOL CHEM, V269, P32932; REMY P, 1972, FEBS LETT, V27, P134, DOI 10.1016/0014-5793(72)80426-5; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; SIDDIQUI FA, 1985, BIOCHIM BIOPHYS ACTA, V828, P177, DOI 10.1016/0167-4838(85)90055-X; SIVARAM P, 1990, P NATL ACAD SCI USA, V87, P3665, DOI 10.1073/pnas.87.10.3665; Xie J., UNPUB; YANG DCH, 1985, CURR TOP CELL REGUL, V26, P325	23	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					32937	32941						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806522				2022-12-27	WOS:A1994QA63800035
J	BLACK, BL; MARTIN, JF; OLSON, EN				BLACK, BL; MARTIN, JF; OLSON, EN			THE MOUSE MRF4 PROMOTER IS TRANS-ACTIVATED DIRECTLY AND INDIRECTLY BY MUSCLE-SPECIFIC TRANSCRIPTION FACTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ENHANCER-BINDING-FACTOR; REGULATORY ELEMENTS; MYOGENIC LINEAGE; GENE-PRODUCTS; EXPRESSION; PROTEINS; MEMBER; FAMILY; DIFFERENTIATION; IDENTIFICATION	MRF4 is a member of the basic helix-loop-helix (bHLH) family of muscle-specific transcription factors, which also includes MyoD, myogenin, and myf5. The myocyte enhancer binding factor 2 (MEF2) proteins also serve as important muscle-specific transcription factors. In addition to activating the expression of many muscle specific structural genes, various members of these two classes of proteins activate their own expression and the expression of each other in a complex transcriptional network that results in the establishment and maintenance of the muscle phenotype. To begin to determine how the expression of MRF4 is regulated by other muscle-specific transcription factors, we have isolated a region of the MRF4 gene that confers muscle-specific expression and have analyzed this promoter region for cis-acting elements involved in trans-activation by the myogenic bHLH and MEF2 transcription factors. Here, we show that in 10T1/2 fibroblasts the MRF4 promoter is trans-activated by myogenin, MyoD, myf5, and by the MEF2 factors, but that MRF4 does not activate expression of its own promoter. Myogenin activated the MRF4 promoter directly by an E box-dependent mechanism, while MEF2 factors activated the prometer through an indirect pathway. The E box-dependent regulation of the MRF4 promoter is in contrast to the regulation of the myogenin and MyoD promoters and may represent a mechanism for the differential expression of these factors during myogenesis.	UNIV TEXAS,MD ANDERSON CANC CTR,DEPT BIOCHEM & MOLEC BIOL,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center				Black, Brian/0000-0002-6664-8913				BLACK BL, 1992, J VIROL, V66, P4058, DOI 10.1128/JVI.66.7.4058-4064.1992; BOBER E, 1991, J CELL BIOL, V113, P1255, DOI 10.1083/jcb.113.6.1255; BRAUN T, 1990, EMBO J, V9, P821, DOI 10.1002/j.1460-2075.1990.tb08179.x; BRAUN T, 1989, EMBO J, V8, P3617, DOI 10.1002/j.1460-2075.1989.tb08535.x; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; BREITBART RE, 1993, DEVELOPMENT, V118, P1095; CHAMBERS AE, 1992, EMBO J, V11, P4981, DOI 10.1002/j.1460-2075.1992.tb05605.x; CHENG TC, 1993, SCIENCE, V261, P215, DOI 10.1126/science.8392225; CSERJESI P, 1991, MOL CELL BIOL, V11, P4854, DOI 10.1128/MCB.11.10.4854; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DECHESNE CA, 1994, MOL CELL BIOL, V14, P5474, DOI 10.1128/MCB.14.8.5474; EDMONDSON DG, 1992, MOL CELL BIOL, V12, P3665, DOI 10.1128/MCB.12.9.3665; EDMONDSON DG, 1993, J BIOL CHEM, V268, P755; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; HINTERBERGER TJ, 1991, DEV BIOL, V147, P144, DOI 10.1016/S0012-1606(05)80014-4; HINTERBERGER TJ, 1992, GENE, V117, P201, DOI 10.1016/0378-1119(92)90730-D; Horton R.M., 1993, PCR PROTOCOLS CURREN, V15, P251; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; LEIBHAM D, 1994, MOL CELL BIOL, V14, P686, DOI 10.1128/MCB.14.1.686; LEIFER D, 1993, P NATL ACAD SCI USA, V90, P1546, DOI 10.1073/pnas.90.4.1546; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAR JH, 1988, P NATL ACAD SCI USA, V85, P6404, DOI 10.1073/pnas.85.17.6404; MARTIN JF, 1994, MOL CELL BIOL, V14, P1647, DOI 10.1128/MCB.14.3.1647; MARTIN JF, 1993, P NATL ACAD SCI USA, V90, P5282, DOI 10.1073/pnas.90.11.5282; MCDERMOTT JC, 1993, MOL CELL BIOL, V13, P2564, DOI 10.1128/MCB.13.4.2564; MINER JH, 1990, P NATL ACAD SCI USA, V87, P1089, DOI 10.1073/pnas.87.3.1089; OLSON EN, 1992, DEV BIOL, V154, P261, DOI 10.1016/0012-1606(92)90066-P; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; PATAPOUTIAN A, 1993, DEVELOPMENT, V118, P61; POLLOCK R, 1991, GENE DEV, V5, P2327, DOI 10.1101/gad.5.12a.2327; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sambrook J, 1989, MOL CLONING LABORATO; SASSOON DA, 1993, DEV BIOL, V156, P11, DOI 10.1006/dbio.1993.1055; STERNBERG EA, 1988, MOL CELL BIOL, V8, P2896, DOI 10.1128/MCB.8.7.2896; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; WOBBE CR, 1990, MOL CELL BIOL, V10, P3859, DOI 10.1128/MCB.10.8.3859; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783	42	85	85	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					2889	2892		10.1074/jbc.270.7.2889	http://dx.doi.org/10.1074/jbc.270.7.2889			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852366	hybrid			2022-12-27	WOS:A1995QG47100003
J	KOOIJMAN, M; BLOEMENDAL, M; TRAUB, P; VANGRONDELLE, R; VANAMERONGEN, H				KOOIJMAN, M; BLOEMENDAL, M; TRAUB, P; VANGRONDELLE, R; VANAMERONGEN, H			HYDRODYNAMIC AND ELECTRICAL CHARACTERIZATION OF T-VIMENTIN DIMERS AND TETRAMERS BY TRANSIENT ELECTRIC BIREFRINGENCE MEASUREMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL MOLECULES; 1/KERATIN-10 INTERMEDIATE FILAMENTS; FIBRILLARY ACIDIC PROTEIN; INTEGRAL-EQUATIONS; DESMIN; INVITRO; POLYMORPHISM; REGISTER; MYOSIN; CELLS	The structure and charge distribution of T-vimentin, which differs from the intact intermediate filament protein vimentin through the absence of the first 70 amino acids, has been studied by transient electric birefringence measurements. It is found that in 0.7 mM phosphate, pH 7.5 buffer, exclusively single dimers (with a hydrodynamic length of 40 to 43 nm) are present, which are considerably bent and/or flexible and which have a relatively large permanent dipole moment. This indicates a parallel alignment of two protein chains. In 0.2 mM phosphate, 0.5 mM MgCl2, pH 7.5, predominantly tetrameric T-vimentin is found with a rigid structure, no permanent dipole moment, and a length of 63 to 68 nm. Tetramer formation is likely to be induced by binding of Mg2+ to the protein. The observed length is in agreement with that of intact vimentin tetramers in which the 1B regions of the rod domains of the dimers overlap (A(11) configuration). A minor part of the tetramers may be in a flexible or bent A(22) form. The loss of the permanent dipole moment when tetramers are formed is, apart from charge compensation, presumably due to the antiparallel alignment of the constituting dimers in which their dipoles cancel.	ROYAL FREE HOSP,SCH MED,DEPT PROT & MOLEC BIOL,LONDON NW3 2PF,ENGLAND; MAX PLANCK INST CELL BIOL,D-68526 LADENBURG,GERMANY	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Max Planck Society	KOOIJMAN, M (corresponding author), FREE UNIV AMSTERDAM,DEPT BIOPHYS,DE BOELELAAN 1081,1081 HV AMSTERDAM,NETHERLANDS.		van Amerongen, Herbert/J-9483-2016	van Amerongen, Herbert/0000-0002-9783-2895				BROERSMA S, 1981, J CHEM PHYS, V74, P6989, DOI 10.1063/1.441071; BROERSMA S, 1960, J CHEM PHYS, V32, P1626, DOI 10.1063/1.1730994; CURRY JF, 1991, BIOPOLYMERS, V31, P1677, DOI 10.1002/bip.360311403; ENGEL A, 1985, J ULTRA MOL STRUCT R, V90, P323, DOI 10.1016/S0022-5320(85)80010-1; FISCHER S, 1986, BIOL CHEM H-S, V367, P1147, DOI 10.1515/bchm3.1986.367.2.1147; FREDERICQ E, 1973, ELECT DICHROISM ELEC, P1; GEISLER N, 1982, EMBO J, V1, P1649, DOI 10.1002/j.1460-2075.1982.tb01368.x; GEISLER N, 1985, J MOL BIOL, V182, P173, DOI 10.1016/0022-2836(85)90035-X; GEISLER N, 1992, EUR J BIOCHEM, V206, P841, DOI 10.1111/j.1432-1033.1992.tb16992.x; HIGHSMITH S, 1986, BIOCHEMISTRY-US, V25, P2237, DOI 10.1021/bi00356a058; HIGHSMITH S, 1985, BIOCHEMISTRY-US, V24, P4917, DOI 10.1021/bi00339a029; HOFMANN I, 1991, EUR J CELL BIOL, V56, P328; IP W, 1985, J MOL BIOL, V183, P365, DOI 10.1016/0022-2836(85)90007-5; KAUFMANN E, 1985, J MOL BIOL, V185, P733, DOI 10.1016/0022-2836(85)90058-0; KOOIJMAN M, 1994, J MOL BIOL, V236, P1241, DOI 10.1016/0022-2836(94)90024-8; KUIL ME, 1990, BIOCHEMISTRY-US, V29, P8184, DOI 10.1021/bi00487a028; MANDELKERN M, 1981, J MOL BIOL, V152, P153, DOI 10.1016/0022-2836(81)90099-1; NAKAMURA Y, 1991, GLIA, V4, P101, DOI 10.1002/glia.440040112; PARRY DAD, 1985, BIOCHEM BIOPH RES CO, V127, P1012, DOI 10.1016/S0006-291X(85)80045-0; POTSCHKA M, 1990, EUR J BIOCHEM, V190, P503, DOI 10.1111/j.1432-1033.1990.tb15602.x; Provencher S. W., 1976, Journal of Chemical Physics, V64, P2772, DOI 10.1063/1.432601; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6; PROVENCHER SW, 1976, BIOPHYS J, V16, P27, DOI 10.1016/S0006-3495(76)85660-3; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; QUINLAN RA, 1982, P NATL ACAD SCI-BIOL, V79, P3452, DOI 10.1073/pnas.79.11.3452; QUINLAN RA, 1984, J MOL BIOL, V178, P365, DOI 10.1016/0022-2836(84)90149-9; QUINLAN RA, 1986, J MOL BIOL, V192, P337, DOI 10.1016/0022-2836(86)90369-4; SAUK JJ, 1984, J CELL BIOL, V99, P1590, DOI 10.1083/jcb.99.5.1590; SKALLI O, 1992, Trends in Cell Biology, V2, P308, DOI 10.1016/0962-8924(92)90121-3; STEINERT PM, 1991, J STRUCT BIOL, V107, P175, DOI 10.1016/1047-8477(91)90020-W; STEINERT PM, 1993, J BIOL CHEM, V268, P24916; STEINERT PM, 1991, J STRUCT BIOL, V107, P157, DOI 10.1016/1047-8477(91)90019-S; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; STEVEN AC, 1990, CELLULAR MOL BIOL IN, P233; STEWART M, 1989, J CELL BIOL, V109, P225, DOI 10.1083/jcb.109.1.225; STROMER MH, 1987, BIOCHEM J, V246, P75, DOI 10.1042/bj2460075; TRAUB P, 1983, J CELL SCI, V63, P43; VANHAERINGEN B, 1992, J BIOMOL STRUCT DYN, V9, P991, DOI 10.1080/07391102.1992.10507972; WEAST RC, 1971, HDB CHEM PHYSICS; YANG ZW, 1988, BIOCHEMISTRY-US, V27, P7038, DOI 10.1021/bi00418a055; YANG ZW, 1988, BIOCHEMISTRY-US, V27, P7045, DOI 10.1021/bi00418a056	41	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					2931	2937		10.1074/jbc.270.7.2931	http://dx.doi.org/10.1074/jbc.270.7.2931			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852371	hybrid			2022-12-27	WOS:A1995QG47100010
J	SJOBERG, ER; CHAMMAS, R; OZAWA, H; KAWASHIMA, I; KHOO, KH; MORRIS, HR; DELL, A; TAI, T; VARKI, A				SJOBERG, ER; CHAMMAS, R; OZAWA, H; KAWASHIMA, I; KHOO, KH; MORRIS, HR; DELL, A; TAI, T; VARKI, A			EXPRESSION OF DE-N-ACETYL-GANGLIOSIDES IN HUMAN-MELANOMA CELLS IS INDUCED BY GENISTEIN OR NOCODAZOLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; RECEPTOR TYROSINE KINASE; PROTEIN-KINASE; SERIES GANGLIOSIDES; MONOCLONAL-ANTIBODIES; MASS-SPECTROMETRY; O-ACETYLATION; SIALIC ACIDS; GROWTH; DIFFERENTIATION	Neuraminic acid is the core structure of most known sialic acids. In natural systems, the amino group at the 5 position of neuraminic acid residues is usually assumed to be acylated. Previously, synthetic de-N-acetyl-gangliosides (with free amino groups at the 5 position of neuraminic acids) have been shown to modulate cellular proliferation and tyrosine phosphokinase reactions. While indirect evidence has suggested that traces of these molecules exist naturally in certain tumor cells, further exploration has been hampered by the lack of a system showing consistent expression at an easily detectable level. Using synthetic compounds as antigens, we have developed highly specific monoclonal antibodies against de-N-acetyl-G(M3) and de-N-acetyl-G(D3) that require both the free amino group and the exocyclic side chain of sialic acids for recognition. Cultured human melanoma cells showed low but variably detectable levels of reactivity with these antibodies. The ability of various biologically active molecules to stimulate this reactivity was explored. Of many compounds tested, only the tyrosine kinase inhibitor genistein induced reactivity in a dose dependent manner. Antibody reactivity with ganglioside extracts from genistein-treated cells was abolished by chemical re-N-acetylation and/or truncation of sialic acid side chains by mild periodate oxidation. High performance thin layer chromatography immune-overlay analysis confirmed the presence of the novel compound de-N-acetyl-G(D3) in these extracts. Several other tyrosine kinase inhibitors tested did not give the same increase in de-N-acetyl-ganglioside expression. However, the microtubule inhibitor nocodazole caused a similar accumulation of these molecules, particularly in non-adherent cells expected to be arrested at metaphase. Thus, genistein may induce de-N-acetyl-ganglioside expression by virtue of its known ability to arrest cells in the G(2)M phase, rather than as a general consequence of tyrosine kinase inhibition. These studies also provide a system in which to analyze the enzymatic basis of de-N-acetyl-ganglioside expression and their potential roles as growth regulating molecules.	UNIV CALIF SAN DIEGO, SCH MED, CTR CANC, GYCOBIOL PROGRAM, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, DIV CELLULAR & MOLEC MED, LA JOLLA, CA 92093 USA; TOKYO METROPOLITAN INST MED SCI, DEPT TUMOR IMMUNOL, BUNKYO KU, TOKYO 113, JAPAN; UNIV LONDON IMPERIAL COLL SCI & TECHNOL, DEPT BIOCHEM, LONDON SW7 2AY, ENGLAND	University of California System; University of California San Diego; University of California System; University of California San Diego; Tokyo Metropolitan Institute of Medical Science; Imperial College London			Chammas, Roger/A-8004-2011; Khoo, Kay-Hooi/E-1989-2019	Chammas, Roger/0000-0003-0342-8726; Khoo, Kay-Hooi/0000-0003-2906-406X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM32373] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		ABLER A, 1992, J BIOL CHEM, V267, P3946; AKIYAMA T, 1991, METHOD ENZYMOL, V201, P362; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; ANDREWS PW, 1990, DIFFERENTIATION, V43, P131, DOI 10.1111/j.1432-0436.1990.tb00439.x; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BLUM AS, 1987, P NATL ACAD SCI USA, V84, P8716, DOI 10.1073/pnas.84.23.8716; BREMER EG, 1984, J BIOL CHEM, V259, P6818; CHAOHSING KAO, 1991, ARCH DERMATOL RES, V283, P119, DOI 10.1007/BF00371620; CHERESH DA, 1986, J CELL BIOL, V102, P1887, DOI 10.1083/jcb.102.5.1887; CHERESH DA, 1984, SCIENCE, V225, P844, DOI 10.1126/science.6206564; CHERESH DA, 1986, J CELL BIOL, V102, P688, DOI 10.1083/jcb.102.3.688; CONSTANTINEPATON M, 1986, NATURE, V324, P459, DOI 10.1038/324459a0; DAWSON G, 1990, CANCER CELL-MON REV, V2, P327; DEKAN G, 1990, AM J PATHOL, V137, P913; DELL A, 1990, METHOD ENZYMOL, V193, P647, DOI 10.1016/0076-6879(90)93443-O; DYATLOVITSKAYA EV, 1991, EUR J BIOCHEM, V199, P643, DOI 10.1111/j.1432-1033.1991.tb16165.x; EGGENS I, 1989, J BIOL CHEM, V264, P9476; FENDERSON BA, 1984, J EXP MED, V160, P1591, DOI 10.1084/jem.160.5.1591; GAUTIER J, 1989, NATURE, V339, P626, DOI 10.1038/339626a0; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; HAKOMORI SI, 1993, ADV LIPID RES, V25, P147; HANAI N, 1988, J BIOL CHEM, V263, P6296; HAVERKAMP J, 1975, H-S Z PHYSIOL CHEM, V356, P1575, DOI 10.1515/bchm2.1975.356.2.1575; HSU CYJ, 1991, J BIOL CHEM, V266, P21105; HUANG JM, 1992, J BIOL CHEM, V267, P15511; ITOH K, 1991, NEUROSCI RES, V9, P279, DOI 10.1016/0168-0102(91)90029-X; KARKAS JD, 1964, J BIOL CHEM, V239, P949; KAWASHIMA I, 1992, MOL IMMUNOL, V29, P625; KOJIMA N, 1992, J BIOL CHEM, V267, P17264; KORNFELD S, 1964, P NATL ACAD SCI USA, V52, P371, DOI 10.1073/pnas.52.2.371; KOTANI M, 1992, BIOCHIM BIOPHYS ACTA, V1117, P97, DOI 10.1016/0304-4165(92)90168-T; KUSUNOKI S, 1993, BRAIN RES, V623, P83, DOI 10.1016/0006-8993(93)90013-D; LADISCH S, 1987, J CLIN INVEST, V79, P1879, DOI 10.1172/JCI113031; LEVINE JM, 1984, J NEUROSCI, V4, P820; LEVITZKI A, 1992, FASEB J, V6, P3275, DOI 10.1096/fasebj.6.14.1426765; MANZI AE, 1990, J BIOL CHEM, V265, P8094; MANZI AE, 1990, J BIOL CHEM, V265, P13091; MATSUKAWA Y, 1993, CANCER RES, V53, P1328; MORLA AO, 1989, CELL, V58, P193, DOI 10.1016/0092-8674(89)90415-7; NEUFELD EJ, 1978, ARCH BIOCHEM BIOPHYS, V188, P323, DOI 10.1016/S0003-9861(78)80016-2; NOJIRI H, 1991, J BIOL CHEM, V266, P4531; NOJIRI H, 1988, J BIOL CHEM, V263, P7443; NORES GA, 1988, CARBOHYD RES, V179, P393, DOI 10.1016/0008-6215(88)84135-1; OZAWA H, 1992, BIOCHIM BIOPHYS ACTA, V1123, P184, DOI 10.1016/0005-2760(92)90110-H; OZAWA H, 1992, BIOCH BIOPHYS ACTA L, V294, P42; POLLEY MJ, 1991, P NATL ACAD SCI USA, V88, P6224, DOI 10.1073/pnas.88.14.6224; RANDO RR, 1988, FASEB J, V2, P2348, DOI 10.1096/fasebj.2.8.3282960; ROSEMAN S, 1970, CHEM PHYS LIPIDS, V5, P270, DOI 10.1016/0009-3084(70)90024-1; SALTIEL AR, 1986, SCIENCE, V233, P967, DOI 10.1126/science.3016898; SAMUELSSON B, 1989, J BIOL CHEM, V264, P19469; SARGEANT P, 1993, J BIOL CHEM, V268, P18151; SCHAUER R, 1982, CELL BIOL MONOGRAPHS, V18; SCHNAAR RL, 1994, METHOD ENZYMOL, V230, P348; SJOBERG ER, 1993, J BIOL CHEM, V268, P10185; SJOBERG ER, 1992, J BIOL CHEM, V267, P16200; SONG WX, 1991, J BIOL CHEM, V266, P10174; SONNINO S, 1985, J LIPID RES, V26, P248; SORIO C, 1993, BIOCHEM BIOPH RES CO, V191, P1105, DOI 10.1006/bbrc.1993.1330; STRULOVICI B, 1984, SCIENCE, V225, P837, DOI 10.1126/science.6089331; STULTS CLM, 1989, METHOD ENZYMOL, V179, P167; TSUJI S, 1992, NEUROCHEM INT, V21, P549, DOI 10.1016/0197-0186(92)90087-8; UEHARA Y, 1986, MOL CELL BIOL, V6, P2198, DOI 10.1128/MCB.6.6.2198; VANLENTEN L, 1971, J BIOL CHEM, V246, P1889; VARKI A, 1991, CELL, V65, P65, DOI 10.1016/0092-8674(91)90408-Q; VARKI A, 1992, GLYCOBIOLOGY, V2, P25, DOI 10.1093/glycob/2.1.25; VONSCHAEWEN A, 1993, PLANT PHYSIOL, V102, P1109, DOI 10.1104/pp.102.4.1109; ZELLER CB, 1992, AM J PHYSIOL, V262, pC1341, DOI 10.1152/ajpcell.1992.262.6.C1341; ZHENG MZ, 1993, J BIOL CHEM, V268, P2217; ZHOU QG, 1994, J BIOL CHEM, V269, P1959; ZIEVE GW, 1980, EXP CELL RES, V126, P397, DOI 10.1016/0014-4827(80)90279-7	70	50	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					2921	2930		10.1074/jbc.270.7.2921	http://dx.doi.org/10.1074/jbc.270.7.2921			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852370	hybrid			2022-12-27	WOS:A1995QG47100009
J	TSUMAKI, N; KIMURA, T				TSUMAKI, N; KIMURA, T			DIFFERENTIAL EXPRESSION OF AN ACIDIC DOMAIN IN THE AMINO-TERMINAL PROPEPTIDE OF MOUSE PRO-ALPHA-2(XI) COLLAGEN BY COMPLEX ALTERNATIVE SPLICING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE-RICH PROTEIN; XI COLLAGEN; MESSENGER-RNA; II COLLAGEN; NH2-TERMINAL DOMAIN; V COLLAGEN; MOLECULAR-CLONING; CARTILAGE; CHAIN; GENE	We isolated and sequenced genomic and cDNA clones encoding the complete amino-terminal portion and the 5'-untranslated region of mouse pro-alpha 2(XI) collagen mRNA. Fourteen exons encoded the amino-terminal propeptide, which was divided into three consecutive domains (a long globular domain, an amino-terminal triple helical domain, and a telopeptide domain), The long globular domain was further divided into an upstream basic subdomain and a downstream highly acidic subdomain, as is the case for the amino-terminal propeptides of pro-alpha 1(V) and pro-alpha 1(XI) collagens, We also demonstrated that the primary transcript undergoes complex alternative splicing, Three consecutive exons (exons 6, 7, and 8) encoding most of the acidic subdomain showed alternative splicing which dramatically affected the structure of the amino-terminal propeptide of pro-alpha 2(XI) collagen, Using the reverse transcription-polymerase chain reaction, we analyzed the expression of these exons in various tissues and in developing limb buds of mice, The pro-alpha 2(XI) transcripts were abundant in cartilage, but most of them lacked the 3-exon sequences encoding the acidic domain, Most of other tissues also contained mRNAs that corresponded to longer splice variants, including exons 6-8. The differential expression of specific domains of pro-alpha 2(XI) collagen may be important in modulating interactions between various components of the extracellular matrix and/or may influence heterotypic collagen assembly.			TSUMAKI, N (corresponding author), OSAKA UNIV,SCH MED,DEPT ORTHOPAED SURG,2-2 YAMADAOKA,SUITA,OSAKA 565,JAPAN.			Tsumaki, Noriyuki/0000-0002-0520-3654				BALVAY L, 1993, BIOESSAYS, V15, P165, DOI 10.1002/bies.950150304; BERNARD M, 1988, J BIOL CHEM, V263, P17159; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; BIRK DE, 1990, J CELL SCI, V95, P649; BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; BROWN KE, 1991, J BIOL CHEM, V266, P23268; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHU ML, 1989, EMBO J, V8, P1939, DOI 10.1002/j.1460-2075.1989.tb03598.x; DOLIANA R, 1990, J CELL BIOL, V111, P2197, DOI 10.1083/jcb.111.5.2197; EYRE DR, 1987, FEBS LETT, V220, P337, DOI 10.1016/0014-5793(87)80842-6; FENG LL, 1994, J BIOL CHEM, V269, P2342; FESSLER JH, 1987, STRUCTURE FUNCTION C, P81; Frohman M.A., 1990, PCR PROTOCOLS GUIDE, P28; FURUTO DK, 1983, ARCH BIOCHEM BIOPHYS, V226, P604, DOI 10.1016/0003-9861(83)90329-6; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; GREENSPAN DS, 1991, J BIOL CHEM, V266, P24727; HUTTNER WB, 1987, TRENDS BIOCHEM SCI, V12, P361, DOI 10.1016/0968-0004(87)90166-6; KIMURA T, 1989, J BIOL CHEM, V264, P13910; LINSENMAYER TF, 1993, J CELL BIOL, V121, P1181, DOI 10.1083/jcb.121.5.1181; MAYNE R, 1993, J BIOL CHEM, V268, P9381; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; METSARANTA M, 1991, J BIOL CHEM, V266, P16862; MORIKAWA T, 1980, BIOCHEMISTRY-US, V19, P2646, DOI 10.1021/bi00553a017; MORRIS NP, 1987, J BIOL CHEM, V262, P11345; MORRIS NP, 1994, 40TH ANN M ORTH RES, V19, P423; NAH HD, 1992, J BIOL CHEM, V267, P22581; NAH HD, 1991, J BIOL CHEM, V266, P23446; NAKATA K, 1992, FEBS LETT, V299, P278, DOI 10.1016/0014-5793(92)80131-Y; NEAME PJ, 1990, J BIOL CHEM, V265, P20401; NIYIBIZI C, 1989, FEBS LETT, V242, P314, DOI 10.1016/0014-5793(89)80492-2; PERLMAN D, 1983, J MOL BIOL, V167, P391, DOI 10.1016/S0022-2836(83)80341-6; PETIT B, 1993, HISTOCHEMISTRY, V100, P231, DOI 10.1007/BF00269096; PIHLAJANIEMI T, 1987, P NATL ACAD SCI USA, V84, P940, DOI 10.1073/pnas.84.4.940; RYAN MC, 1990, J BIOL CHEM, V265, P10334; SABATH DE, 1990, GENE, V91, P185, DOI 10.1016/0378-1119(90)90087-8; SAITTA B, 1990, J BIOL CHEM, V265, P6473; SANDBERG MM, 1993, BIOCHEM J, V294, P595, DOI 10.1042/bj2940595; SANDELL LJ, 1991, J CELL BIOL, V114, P1307, DOI 10.1083/jcb.114.6.1307; SMBROOK J, 1989, MOL CLONING LABORATO; STUBBS L, 1993, MAMM GENOME, V4, P95, DOI 10.1007/BF00290433; TAKAHARA K, 1991, J BIOL CHEM, V266, P13124; THOM JR, 1991, J BIOL CHEM, V266, P7262; VANDERREST M, 1988, J BIOL CHEM, V263, P1615; VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991; YAMADA Y, 1980, CELL, V22, P887, DOI 10.1016/0092-8674(80)90565-6; YOSHIOKA H, 1990, J BIOL CHEM, V265, P6423; ZHIDKOVA NI, 1993, FEBS LETT, V326, P25, DOI 10.1016/0014-5793(93)81753-M	47	55	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2372	2378		10.1074/jbc.270.5.2372	http://dx.doi.org/10.1074/jbc.270.5.2372			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836472	hybrid			2022-12-27	WOS:A1995QE49300060
J	TZENG, MC; YEN, CH; HSEU, MJ; DUPUREUR, CM; TSAI, MD				TZENG, MC; YEN, CH; HSEU, MJ; DUPUREUR, CM; TSAI, MD			CONVERSION OF BOVINE PANCREATIC PHOSPHOLIPASE A(2) AT A SINGLE-SITE INTO A COMPETITOR OF NEUROTOXIC PHOSPHOLIPASES A(2) BY SITE-DIRECTED MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; GUINEA-PIG BRAIN; BINDING-PROTEIN; BETA-BUNGAROTOXIN; GEL-ELECTROPHORESIS; SYNAPTIC-MEMBRANES; ENZYMATIC-ACTIVITY; CHICK BRAIN; SNAKE-VENOM; CROTOXIN	A 45-kDa polypeptide preferentially present in neuronal membranes was previously identified as a subunit of a binding (or receptor) protein for several phospholipase A(2) variants with neurotoxicity, including crotoxin, by chemical cross-linking experiments (Yen, C.-H., and Tzeng, M. C. (1991) Biochemistry 30, 11473-11477), The binding of crotoxin to this receptor protein was completely suppressed by sufficient F22Y, a mutated bovine pancreatic phospholipase A(2) generated by site-directed mutagenesis of Phe(22) of the wild-type enzyme to Tyr, The IC50 of this inhibition was estimated to be 1 mu M. In sharp contrast, the wild-type enzyme gave no effect even at 50 mu M. This mutation resulted in only minor and localized structural perturbations with little effect on enzymatic activity. Other phospholipase A(2) molecules capable of competing with crotoxin for this binding invariably have Tyr at this position, It was concluded that this Tyr residue is an important determinant for the binding of a number of phospholipase A(2) variants to the 45-kDa receptor.	NATL TAIWAN UNIV, INST BIOCHEM SCI, TAIPEI 107, TAIWAN; OHIO STATE UNIV, DEPT CHEM, COLUMBUS, OH 43210 USA	National Taiwan University; University System of Ohio; Ohio State University	TZENG, MC (corresponding author), ACAD SINICA, INST BIOL CHEM, POB 23-106, TAIPEI 107, TAIWAN.		Tsai, Ming-Daw/G-4689-2019	Tsai, Ming-Daw/0000-0003-1374-0414	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041788] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41788] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		DAVIDSON FF, 1991, HDB NATURAL TOXINS, V5, P107; de ROBERTIS E., 1963, JOUR NEUROCHEM, V10, P225; DEGN LL, 1991, TOXICON, V29, P973, DOI 10.1016/0041-0101(91)90080-B; DENG TL, 1990, GENE, V93, P229, DOI 10.1016/0378-1119(90)90229-K; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; DUPUREUR CM, 1992, BIOCHEMISTRY-US, V31, P10576, DOI 10.1021/bi00158a021; HARRIS JB, 1991, SNAKE TOXINS, P61; Harvey A L, 1990, Int Rev Neurobiol, V32, P201; Hawgood B., 1991, HDB NATURAL TOXINS R, V5, P3; HEINRIKSON RL, 1991, METHOD ENZYMOL, V197, P201; HENDON RA, 1979, BIOCHIM BIOPHYS ACTA, V578, P243, DOI 10.1016/0005-2795(79)90132-6; HENDON RA, 1971, P NATL ACAD SCI USA, V68, P1560, DOI 10.1073/pnas.68.7.1560; HSEU MJ, 1990, J BIOENERG BIOMEMBR, V22, P39, DOI 10.1007/BF00762844; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; KINI RM, 1986, TOXICON, V24, P527, DOI 10.1016/0041-0101(86)90173-X; KRIZAJ I, 1989, BIOCHIM BIOPHYS ACTA, V999, P198, DOI 10.1016/0167-4838(89)90218-5; KUDO I, 1993, BIOCHIM BIOPHYS ACTA, V1170, P217, DOI 10.1016/0005-2760(93)90003-R; LAMBEAU G, 1990, J BIOL CHEM, V265, P9526; LAMBEAU G, 1989, J BIOL CHEM, V264, P11503; MAYER RJ, 1993, FASEB J, V7, P339, DOI 10.1096/fasebj.7.2.8440410; Mebs D., 1991, SNAKE TOXINS, P425; MOLLIER P, 1989, EUR J BIOCHEM, V185, P263, DOI 10.1111/j.1432-1033.1989.tb15111.x; NEVILLE DM, 1971, J BIOL CHEM, V246, P6328; NOEL JP, 1991, BIOCHEMISTRY-US, V30, P11801, DOI 10.1021/bi00115a010; NOEL JP, 1989, J CELL BIOCHEM, V40, P309, DOI 10.1002/jcb.240400307; ONO T, 1984, J BIOCHEM-TOKYO, V96, P785, DOI 10.1093/oxfordjournals.jbchem.a134896; OTHMAN IB, 1982, EUR J BIOCHEM, V128, P267; REHM H, 1983, EMBO J, V2, P1119, DOI 10.1002/j.1460-2075.1983.tb01555.x; REHM H, 1982, J BIOL CHEM, V257, P15; REHM H, 1988, BIOCHEM BIOPH RES CO, V153, P231, DOI 10.1016/S0006-291X(88)81213-0; RENETSEDER R, 1985, J BIOL CHEM, V260, P1627; RITONJA A, 1986, BIOL CHEM H-S, V367, P919, DOI 10.1515/bchm3.1986.367.2.919; Rosenberg P., 1990, HDB TOXINOLOGY, P67; RUBSAMEN K, 1971, N-S ARCH PHARMAKOL, V270, P274; SAYERS JR, 1992, BIOTECHNIQUES, V13, P592; SCHANBERG SM, 1967, J PHARMACOL EXP THER, V157, P311; SCHWEITZ H, 1984, TOXICON, V22, P308, DOI 10.1016/0041-0101(84)90032-1; SCOTT VES, 1990, J BIOL CHEM, V265, P20094; TAKASAKI C, 1990, TOXICON, V28, P107, DOI 10.1016/0041-0101(90)90012-V; TSAI IH, 1987, BIOCHIM BIOPHYS ACTA, V916, P94, DOI 10.1016/0167-4838(87)90215-9; TSAI IH, 1991, PEPTIDES CHEM BIOL, P460; TZENG MC, 1986, J PROTEIN CHEM, V5, P221, DOI 10.1007/BF01025490; TZENG MC, 1993, J TOXICOL-TOXIN REV, V12, P1; TZENG MC, 1983, ANAL BIOCHEM, V128, P412, DOI 10.1016/0003-2697(83)90394-9; TZENG MC, 1989, BIOCHEM BIOPH RES CO, V165, P689, DOI 10.1016/S0006-291X(89)80021-X; WHITTAKER VP, 1959, BIOCHEM J, V72, P694, DOI 10.1042/bj0720694; YANG CC, 1986, J PROTEIN CHEM, V5, P15, DOI 10.1007/BF01025581; YANG CC, 1991, BIOCHEM J, V280, P739, DOI 10.1042/bj2800739; YANG CC, 1994, J TOXICOL-TOXIN REV, V13, P125, DOI 10.3109/15569549409089958; YEN CH, 1991, BIOCHEMISTRY-US, V30, P11473, DOI 10.1021/bi00112a015	50	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2120	2123		10.1074/jbc.270.5.2120	http://dx.doi.org/10.1074/jbc.270.5.2120			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836440	Green Submitted, hybrid			2022-12-27	WOS:A1995QE49300023
J	SMITH, VM; LEE, PP; SZYCHOWSKI, S; WINOTO, A				SMITH, VM; LEE, PP; SZYCHOWSKI, S; WINOTO, A			GATA-3 DOMINANT-NEGATIVE MUTANT - FUNCTIONAL REDUNDANCY OF THE T-CELL RECEPTOR-ALPHA AND RECEPTOR-BETA ENHANCERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR PROTEINS INTERACT; DNA-BINDING PROTEIN; TRANSCRIPTIONAL ENHANCER; REGULATORY ELEMENTS; GENE-EXPRESSION; CHAIN GENE; MULTIGENE FAMILY; LOCUS; IDENTIFICATION; LINEAGE	The GATA family of transcription factors regulates a wide variety of genes, including those involved in differentiation of erythrocytes and T lymphocytes. We report here the creation of a dominant negative mutant of GATA-3, KRR, which effectively blocks wild-type GATA-1, GATA-2, and GATA-3 transactivation when coexpressed in transient assays. KRR was generated by site-directed mutagenesis while investigating a putative activation domain of GATA-3, located between its two zinc fingers. The GATA-3 KRR mutation does not affect expression, nuclear translocation, or the ability to bind to a consensus GATA sequence. KRR can suppress the activity of the minimal T cell receptor (TCR) alpha and beta enhancers by 12- and 3.4-fold, respectively. However, KRR did not have a significant effect on the activity of larger TCR-alpha and -beta enhancer fragments. Thus, functional redundancy in the TCR-alpha and -beta enhancers can compensate for the loss of GATA-3 activity.	UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,DIV IMMUNOL,BERKELEY,CA 94720; UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,CANC RES LAB,BERKELEY,CA 94720	University of California System; University of California Berkeley; University of California System; University of California Berkeley					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031558] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI31558] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; BORIES JC, 1990, J EXP MED, V171, P75, DOI 10.1084/jem.171.1.75; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; GILL LL, 1991, EUR J IMMUNOL, V21, P807, DOI 10.1002/eji.1830210339; GOTTSCHALK LR, 1990, MOL CELL BIOL, V10, P5486, DOI 10.1128/MCB.10.10.5486; HAMBOR JE, 1993, MOL CELL BIOL, V13, P7056, DOI 10.1128/MCB.13.11.7056; HENDERSON AJ, 1994, MOL CELL BIOL, V14, P4286, DOI 10.1128/MCB.14.6.4286; HO IC, 1989, P NATL ACAD SCI USA, V86, P6714, DOI 10.1073/pnas.86.17.6714; HO IC, 1991, EMBO J, V10, P1187, DOI 10.1002/j.1460-2075.1991.tb08059.x; HO IC, 1990, MOL CELL BIOL, V10, P4720, DOI 10.1128/MCB.10.9.4720; JOULIN V, 1991, EMBO J, V10, P1809, DOI 10.1002/j.1460-2075.1991.tb07706.x; KAPPES DJ, 1991, P NATL ACAD SCI USA, V88, P2204, DOI 10.1073/pnas.88.6.2204; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; KO LJ, 1991, MOL CELL BIOL, V11, P2778, DOI 10.1128/MCB.11.5.2778; KRIMPENFORT P, 1988, EMBO J, V7, P745, DOI 10.1002/j.1460-2075.1988.tb02871.x; LANDRY DB, 1993, J EXP MED, V178, P941, DOI 10.1084/jem.178.3.941; LEE ME, 1991, J BIOL CHEM, V266, P16188; LEIDEN JM, 1993, ANNU REV IMMUNOL, V11, P539, DOI 10.1146/annurev.iy.11.040193.002543; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P3155, DOI 10.1128/MCB.10.6.3155; MARINE J, 1991, P NATL ACAD SCI USA, V88, P7284, DOI 10.1073/pnas.88.16.7284; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; MCDOUGALL S, 1988, SCIENCE, V241, P205, DOI 10.1126/science.2968651; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; NELSEN B, 1990, MOL CELL BIOL, V10, P3145, DOI 10.1128/MCB.10.6.3145; OOSTERWEGEL M, 1992, DEV IMMUNOL, V3, P1, DOI 10.1155/1992/27903; ORKIN SH, 1992, BLOOD, V80, P575; PENIX L, 1993, J EXP MED, V178, P1483, DOI 10.1084/jem.178.5.1483; REDONDO JM, 1990, SCIENCE, V247, P1225, DOI 10.1126/science.2156339; SPENCER DM, 1991, P NATL ACAD SCI USA, V88, P800, DOI 10.1073/pnas.88.3.800; STAUDT LM, 1991, ANNU REV IMMUNOL, V9, P373; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; WHITELAW E, 1990, MOL CELL BIOL, V10, P6596, DOI 10.1128/MCB.10.12.6596; WHYATT DJ, 1993, EMBO J, V12, P4993, DOI 10.1002/j.1460-2075.1993.tb06193.x; WINOTO A, 1989, EMBO J, V8, P729, DOI 10.1002/j.1460-2075.1989.tb03432.x; WURSTER AL, 1994, MOL CELL BIOL, V14, P6452, DOI 10.1128/MCB.14.10.6452; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; YANG HY, 1992, MOL CELL BIOL, V12, P4562, DOI 10.1128/MCB.12.10.4562; YANG ZY, 1994, MOL CELL BIOL, V14, P2201, DOI 10.1128/MCB.14.3.2201	38	34	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1515	1520		10.1074/jbc.270.4.1515	http://dx.doi.org/10.1074/jbc.270.4.1515			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829479	hybrid			2022-12-27	WOS:A1995QD20400008
J	GESSNER, JE; GRUSSENMEYER, T; KOLANUS, W; SCHMIDT, RE				GESSNER, JE; GRUSSENMEYER, T; KOLANUS, W; SCHMIDT, RE			THE HUMAN LOW-AFFINITY IMMUNOGLOBULIN-G FC RECEPTOR III-A AND III-B GENES - MOLECULAR CHARACTERIZATION OF THE PROMOTER REGIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; GAMMA-RIII CD16; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; RESPONSE ELEMENTS; ALPHA-CHAIN; EXPRESSION; ACTIVATION; NEUTROPHILS; INTERFERON	The human Fc receptor with low affinity for IgG (Fc gamma RIII, CD16) is encoded by two nearly identical genes, Fc gamma RIII-A and Fc gamma RIII-B, resulting in tissue-specific expression of alternative membrane-anchored isoforms, The transmembrane CD16 receptor forms a heteromeric structure with the Fc epsilon RI (gamma) and/or CD3 (zeta) subunits on the surface of activated monocytes/macrophages, NK cells, and a subset of T cells, The expression of the glycosylphosphatidylinositol-anchored CD16 isoform encoded by the Fc gamma RIII-B gene is restricted to polymorphonuclear leukocytes and can be induced by Me(2)SO differentiation of HL60 cells, We have isolated and sequenced genomic clones of the human Fc gamma RIII-A and Fc gamma RIII-B genes, located their transcription initiation sites, identified a different organization of their 5' regions, and demonstrated four distinct classes of Fc gamma RIII-A transcripts (a1-a4) com pared with a single class of Fc gamma RIII-Bb1 transcripts, Both CD16 promoters (positions -198 to -10) lack the classical ''TATA'' positioning consensus sequence but confer transcriptional activity when coupled to the human lysozyme enhancer, Both promoters also display different tissue-specific transcriptional activities reflecting the expected gene expression of Fc gamma RIII-A and Fc gamma RIII-B in NH cells versus polymorphonuclear leukocytes. Within the -198/-10 fragments, the sequences of the two CD16 genes have been identified to differ in 10 positions. It is suggested that these nucleotide differences might contribute to cell type-specific transcription of Fc gamma RIII genes.	HANNOVER MED SCH, DEPT IMMUNOL, D-30625 HANNOVER, GERMANY; LUDWIG MAXIMILIANS UNIV MUNCHEN, GENZENTRUM, MOLEC BIOL LAB, D-82152 MARTINSRIED, GERMANY	Hannover Medical School; University of Munich			Grussenmeyer, Thomas/B-9859-2009	Grussenmeyer, Thomas/0000-0002-6236-9976				ANDERSON P, 1990, P NATL ACAD SCI USA, V87, P2274, DOI 10.1073/pnas.87.6.2274; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BENECH PD, 1992, J EXP MED, V176, P1115, DOI 10.1084/jem.176.4.1115; BONNEROT C, 1990, J IMMUNOL, V144, P323; BONNEROT C, 1988, J IMMUNOL, V141, P1026; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLLINS SJ, 1987, BLOOD, V70, P1233; ERNST LK, 1992, J BIOL CHEM, V267, P15692; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; FRISCHAUF AM, 1983, J MOL BIOL, V170, P827, DOI 10.1016/S0022-2836(83)80190-9; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; HARTNELL A, 1992, J IMMUNOL, V148, P1471; HUIZINGA TWJ, 1989, J IMMUNOL, V142, P2365; HUIZINGA TWJ, 1988, NATURE, V333, P667, DOI 10.1038/333667a0; HUNDT M, 1992, EUR J IMMUNOL, V22, P811, DOI 10.1002/eji.1830220327; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; KUROSAKI T, 1989, NATURE, V342, P805, DOI 10.1038/342805a0; MCKENZIE SE, 1992, MOL IMMUNOL, V29, P1165, DOI 10.1016/0161-5890(92)90052-Y; OSMAN N, 1992, J IMMUNOL, V148, P1570; PEARSE RN, 1991, P NATL ACAD SCI USA, V88, P11305, DOI 10.1073/pnas.88.24.11305; PELTZ GA, 1989, P NATL ACAD SCI USA, V86, P1013, DOI 10.1073/pnas.86.3.1013; PEREZ C, 1993, MOL CELL BIOL, V13, P2182, DOI 10.1128/MCB.13.4.2182; PERUSSIA B, 1991, EUR J IMMUNOL, V21, P425, DOI 10.1002/eji.1830210226; PETERS CWB, 1989, EUR J BIOCHEM, V182, P507, DOI 10.1111/j.1432-1033.1989.tb14857.x; PHILLIPS JH, 1991, EUR J IMMUNOL, V21, P895, DOI 10.1002/eji.1830210406; RA C, 1989, NATURE, V341, P752, DOI 10.1038/341752a0; RADEKE HH, 1994, J IMMUNOL, V153, P1281; RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325; RAVETCH JV, 1989, J EXP MED, V170, P481, DOI 10.1084/jem.170.2.481; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCALLON BJ, 1989, P NATL ACAD SCI USA, V86, P5079, DOI 10.1073/pnas.86.13.5079; SIMMONS D, 1988, NATURE, V333, P568, DOI 10.1038/333568a0; SKALNIK DG, 1991, J BIOL CHEM, V266, P16736; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; TEPLER I, 1989, J BIOL CHEM, V264, P5912; UCIECHOWSKI P, 1992, EUR J IMMUNOL, V22, P1635, DOI 10.1002/eji.1830220643; VANDEWINKEL JGJ, 1991, J LEUKOCYTE BIOL, V49, P511, DOI 10.1002/jlb.49.5.511; WASYLYK C, 1989, MOL CELL BIOL, V9, P2247, DOI 10.1128/MCB.9.5.2247; WERFEL T, 1989, J IMMUNOL, V142, P1102; WIRTHMUELLER U, 1992, J EXP MED, V175, P1381, DOI 10.1084/jem.175.5.1381; WISKOCIL R, 1985, J IMMUNOL, V134, P1599; YE ZS, 1992, J IMMUNOL, V149, P897; YODOI J, 1985, J IMMUNOL, V134, P1623	49	38	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1350	1361		10.1074/jbc.270.3.1350	http://dx.doi.org/10.1074/jbc.270.3.1350			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836402	hybrid			2022-12-27	WOS:A1995QB15600057
J	GOUX, WJ; STRONG, AAD; SCHNEIDER, BL; LEE, WNP; REITZER, LJ				GOUX, WJ; STRONG, AAD; SCHNEIDER, BL; LEE, WNP; REITZER, LJ			UTILIZATION OF ASPARTATE AS A NITROGEN-SOURCE IN ESCHERICHIA-COLI - ANALYSIS OF NITROGEN FLOW AND CHARACTERIZATION OF THE PRODUCTS OF ASPARTATE CATABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA; SACCHAROMYCES-CEREVISIAE; GLUTAMINE-SYNTHETASE; KLEBSIELLA-AEROGENES; AMINO-ACIDS; L-ARGININE; TCA CYCLE; PATHWAY; MUTANTS; ASSIMILATION	N-15 NMR, reverse phase high performance liquid chromatography and gas chromatography/mass spectrometry have been used to follow nitrogen metabolism in Escherichia coli labeled on medium containing L-[N-15]aspartate, The flow of N-15 through various nitro gen-containing metabolites was followed over the course of the labeling period. For wild-type E. coli labeled on L-[N-15]aspartate as sole source of nitrogen, significant N-15 labeling was detected only in the intracellular L-glutamate, L-alanine, L-aspartate, and putrescine pools. Intracellular concentrations of L-aspartate and L-glutamate differed significantly in extracts of an arginine auxotroph (argG(-)), which is deficient in a potential aspartate-assimilating reaction. When the L-[N-15]aspartate containing labeling medium was supplemented with unlabeled arginine, extracts of wild-type E. coli were shown to contain significant amounts of unlabeled ammonia and putrescine. There was substantial dilution of N-15 in the glutamate pool. The observation that glutamate, aspartate, and alanine are N-15-labeled, but ammonia is not, suggests that these amino acids are not the immediate source of ammonia. Our results suggest that arginine may be an intermediate for the degradation of some of the aspartate and that arginine may be an intermediate for ammonia production during nitrogen-limited growth. Our results also strongly suggest the presence of a previously uncharacterized pathway of arginine degradation.	UNIV TEXAS,DEPT MOLEC & CELL BIOL,RICHARDSON,TX 75083; UNIV CALIF LOS ANGELES,HARBOR MED CTR,TORRANCE,CA 90509	University of Texas System; University of Texas Dallas; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	GOUX, WJ (corresponding author), UNIV TEXAS,DEPT CHEM,POB 830688,RICHARDSON,TX 75083, USA.		Reitzer, Larry/A-2510-2016	Reitzer, Larry/0000-0002-4406-6090	NATIONAL CANCER INSTITUTE [P01CA042710] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR007133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM038877] Funding Source: NIH RePORTER; NCI NIH HHS [P01-CA42710] Funding Source: Medline; NCRR NIH HHS [2 S07 RR07133-23] Funding Source: Medline; NIGMS NIH HHS [R29 GM 38877] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKAMATSU N, 1978, J BACTERIOL, V133, P409, DOI 10.1128/JB.133.1.409-410.1978; ALBRECHT AM, 1964, J BIOL CHEM, V239, P1872; BACKMAN K, 1981, P NATL ACAD SCI-BIOL, V78, P3743, DOI 10.1073/pnas.78.6.3743; BAX A, 1982, 2 DIMENSIONAL NUCLEA, P50; BRENCHLEY JE, 1973, J BIOL CHEM, V248, P6122; BRENCHLEY JE, 1974, J BACTERIOL, V117, P544, DOI 10.1128/JB.117.2.544-550.1974; BROACH J, 1976, J BACTERIOL, V128, P86, DOI 10.1128/JB.128.1.86-98.1976; CSONKA LN, 1977, J BIOL CHEM, V252, P3392; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; CUNNINGHAMRUNDL.S, 1975, J BACTERIOL, V124, P791; HAAS D, 1984, MOL GEN GENET, V193, P437, DOI 10.1007/BF00382081; HAFNER EW, 1979, J BIOL CHEM, V254, P2419; HARAN N, 1983, J BIOL CHEM, V258, P2929; JANN A, 1986, P NATL ACAD SCI USA, V83, P4937, DOI 10.1073/pnas.83.13.4937; LAPIDOT A, 1977, P NATL ACAD SCI USA, V74, P1988, DOI 10.1073/pnas.74.5.1988; LEE WNP, 1992, BIOL MASS SPECTROM, V20, P451; LEGERTON TL, 1981, P NATL ACAD SCI-BIOL, V78, P1495, DOI 10.1073/pnas.78.3.1495; LEIMER KR, 1977, J CHROMATOGR, V141, P121, DOI 10.1016/S0021-9673(00)99131-3; LONDON RE, 1988, PROG NUCL MAG RES SP, V20, P337, DOI 10.1016/0079-6565(88)80010-4; MARCUS M, 1969, BIOCHIM BIOPHYS ACTA, V177, P314, DOI 10.1016/0304-4165(69)90141-X; MERCENIER A, 1980, J GEN MICROBIOL, V116, P381; MERCENIER A, 1980, J BACTERIOL, V144, P159, DOI 10.1128/JB.144.1.159-163.1980; Morris DR, 1970, J BACTERIOL, V101, P731, DOI 10.1128/JB.101.3.731-737.1970; MORRIS DR, 1969, J BIOL CHEM, V244, P6094; PAHEL G, 1978, J BACTERIOL, V133, P139, DOI 10.1128/JB.133.1.139-148.1978; Reitzer L.J., 1987, E COLI SALMONELLA CE, P302; REITZER LJ, 1982, J BACTERIOL, V151, P1299, DOI 10.1128/JB.151.3.1299-1313.1982; RICHARZ R, 1978, BIOPOLYMERS, V17, P2133, DOI 10.1002/bip.1978.360170908; ROBERTS MF, 1990, J BIOL CHEM, V265, P18207; ROBERTS RB, 1955, CARNEGIE I WASHINGTO, V607, P279; ROTHSTEIN DM, 1980, P NATL ACAD SCI-BIOL, V77, P7372, DOI 10.1073/pnas.77.12.7372; SHAIBE E, 1985, J BACTERIOL, V163, P933, DOI 10.1128/JB.163.3.933-937.1985; STALON V, 1985, EVOLUTION PROKARYOTE, P277; SUMEGI B, 1990, BIOCHEMISTRY-US, V29, P9106, DOI 10.1021/bi00491a002; SUMEGI B, 1993, BIOCHEMISTRY-US, V32, P12725, DOI 10.1021/bi00210a022; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; TYLER B, 1978, ANNU REV BIOCHEM, V47, P1127, DOI 10.1146/annurev.bi.47.070178.005403; WILKINSON JM, 1978, J CHROMATOGR SCI, V16, P547, DOI 10.1093/chromsci/16.11.547; Wohlhueter R, 1973, ENZYMES GLUTAMINE ME, P45	39	6	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					638	646						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822290				2022-12-27	WOS:A1995QB81600023
J	NADA, MA; RHEAD, WJ; SPRECHER, H; SCHULZ, H; ROE, CR				NADA, MA; RHEAD, WJ; SPRECHER, H; SCHULZ, H; ROE, CR			EVIDENCE FOR INTERMEDIATE CHANNELING IN MITOCHONDRIAL BETA-OXIDATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; COENZYME-A DEHYDROGENASE; RAT-LIVER MITOCHONDRIA; ACYL-COA DEHYDROGENASE; CULTURED FIBROBLASTS; SHORT-CHAIN; PURIFICATION; DEFICIENCY; DISORDERS; QUANTITATION	The accumulation of beta-oxidation intermediates was studied by incubating normal and beta-oxidation enzyme-deficient human fibroblasts with [H-2(4)]linoleate and L-carnitine and analyzing the resultant acylcarnitines by tandem mass spectrometry. Labeled decenoyl-, octanoyl-, hexanoyl-, and butyrylcarnitines were the only intermediates observed with normal cells. Intermediates of longer chain length, corresponding to substrates for the beta-oxidation enzymes associated with the inner mitochondrial membrane, were not observed unless a cell line was deficient in one of these enzymes, such as very-long chain acyl-CoA dehydrogenase, long-chain 3-hydroxyacyl-CoA dehydrogenase, or electron transfer flavoprotein dehydrogenase. Matrix enzyme deficiencies, such as medium- and short-chain acyl-CoA dehydrogenases, were characterized by elevated concentrations of intermediates corresponding to their respective substrates (octanoyl- and decenoylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency and butyrylcarnitine in short-chain acyl-CoA dehydrogenase deficiency). These observations agree with the notion of intermediate channeling due to the organization of beta-oxidation enzymes in complexes. The only exception is the incomplete channeling from thiolase to acyl-CoA dehydrogenase in the matrix. This situation may be a consequence of only one 3-ketoacyl-CoA thiolase being unable to interact with the several acyl-CoA dehydrogenases in the matrix.	UNIV IOWA, DEPT PEDIAT, IOWA CITY, IA 52242 USA; OHIO STATE UNIV, DEPT MED BIOCHEM, COLUMBUS, OH 43210 USA; CUNY CITY COLL, DEPT CHEM, NEW YORK, NY 10031 USA	University of Iowa; Ohio State University; City University of New York (CUNY) System; City College of New York (CUNY)	NADA, MA (corresponding author), DUKE UNIV, MED CTR, DEPT PEDIAT, DIV BIOCHEM GENET, POB 14991, RES TRIANGLE PK, NC 27709 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033289] Funding Source: NIH RePORTER; NCRR NIH HHS [M-01-RR-30] Funding Source: Medline; NICHD NIH HHS [HD24908] Funding Source: Medline; NIDDK NIH HHS [DK33289] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMENDT BA, 1987, J CLIN INVEST, V79, P1303, DOI 10.1172/JCI112953; BOHMER T, 1968, BIOCHIM BIOPHYS ACTA, V152, P559, DOI 10.1016/0005-2760(68)90096-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COATES PM, 1988, J CLIN INVEST, V81, P171, DOI 10.1172/JCI113290; DING JH, 1992, PROG CLIN BIOL RES, V375, P479; DOMMES V, 1984, J BIOL CHEM, V259, P1789; FONG JC, 1978, J BIOL CHEM, V252, P6917; HE XY, 1992, ARCH BIOCHEM BIOPHYS, V298, P527, DOI 10.1016/0003-9861(92)90445-3; IKEDA Y, 1985, J BIOL CHEM, V260, P1311; IZAI K, 1992, J BIOL CHEM, V267, P1027; KELLEY RI, 1992, BIOCHEM BIOPH RES CO, V182, P1002, DOI 10.1016/0006-291X(92)91831-A; KERNER J, 1990, BIOCHEMISTRY-US, V29, P4326, DOI 10.1021/bi00470a010; KLER RS, 1991, J BIOL CHEM, V266, P22932; KOLVRAA S, 1982, CLIN CHIM ACTA, V126, P53, DOI 10.1016/0009-8981(82)90361-8; MANNING NJ, 1990, J INHERIT METAB DIS, V13, P58, DOI 10.1007/BF01799333; MILLINGTON DS, 1991, INT J MASS SPECTROM, V111, P211, DOI 10.1016/0168-1176(91)85056-R; MILLINGTON DS, 1989, SYNTHESIS APPLICATIO, P189; MOON A, 1987, J CLIN INVEST, V79, P59, DOI 10.1172/JCI112808; MURTHY MSR, 1987, P NATL ACAD SCI USA, V84, P378, DOI 10.1073/pnas.84.2.378; OSBOND JM, 1961, J CHEM SOC, P2779, DOI 10.1039/jr9610002779; POLLTHE BT, 1988, J INHERIT METAB DIS, V11, P183, DOI 10.1007/BF01804230; RAKOFF H, 1992, LIPIDS, V27, P567, DOI 10.1007/BF02536142; RHEAD WJ, 1987, PEDIATR RES, V21, P371, DOI 10.1203/00006450-198704000-00010; SAUDUBRAY JM, 1982, PEDIATR RES, V16, P877, DOI 10.1203/00006450-198210000-00015; SCHULZ H, 1991, BIOCHIM BIOPHYS ACTA, V1081, P109, DOI 10.1016/0005-2760(91)90015-A; SCHULZ H, 1987, TRENDS BIOCHEM SCI, V12, P403, DOI 10.1016/0968-0004(87)90196-4; SPRECHER H, 1982, METHOD ENZYMOL, V86, P357; STANLEY KK, 1975, BIOCHEM J, V150, P77, DOI 10.1042/bj1500077; THORPE C, 1990, PROG CLIN BIOL RES, V321, P91; UCHIDA Y, 1992, J BIOL CHEM, V267, P1034; YAMAGUCHI S, 1993, PEDIATR RES, V34, P111, DOI 10.1203/00006450-199307000-00025	31	89	90	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					530	535		10.1074/jbc.270.2.530	http://dx.doi.org/10.1074/jbc.270.2.530			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822275	hybrid			2022-12-27	WOS:A1995QB81600007
J	NIRUNSUKSIRI, W; PRESLAND, RB; BRUMBAUGH, SG; DALE, BA; FLECKMAN, P				NIRUNSUKSIRI, W; PRESLAND, RB; BRUMBAUGH, SG; DALE, BA; FLECKMAN, P			DECREASED PROFILAGGRIN EXPRESSION IN ICHTHYOSIS-VULGARIS IS A RESULT OF SELECTIVELY IMPAIRED POSTTRANSCRIPTIONAL CONTROL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; 3' UNTRANSLATED REGION; MESSENGER-RNA DEGRADATION; CELL-CYCLE REGULATION; DNA GLYCOSYLASE GENE; NONCODING SEQUENCES; EPIDERMAL KERATINS; HUMAN SKIN; FILAGGRIN; IDENTIFICATION	Ichthyosis vulgaris is an autosomal dominant disorder of keratinization characterized by mild hyperkeratosis and reduced or absent keratohyalin granules in the epidermis, Profilaggrin, a major component of keratohyalin grannies, is reduced or absent from the skin of individuals with ichthyosis vulgaris. In this report, we have further characterized the molecular basis of low profilaggrin expression, which occurs in this disease. fn situ hybridization revealed little profilaggrin mRNA in ichthyosis vulgaris-affected epidermis, In keratinocytes cultured from the epidermis of affected individuals, the abundance of profilaggrin was reduced to less than 10% of normal controls, while the mRNA level was decreased to 30-60% of controls, Expression of K1 and loricrin, other markers of epidermal differentiation, were not affected, Nuclear run-on assays indicated that the decrease in mRNA levels was not caused by aberrant transcription. Nucleotide sequencing of 5'-upstream, 3'-noncoding and flanking regions of the profilaggrin gene from ichthyosis vulgaris-affected individuals revealed only minor changes, probably due to genetic polymorphisms. Our results indicate that defective profilaggrin expression in ichthyosis vulgaris is a result of selectively impaired posttranscriptional control.	UNIV WASHINGTON,DEPT MED,DIV DERMATOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT ORAL BIOL & PERIODONT,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle				Presland, Richard/0000-0003-1440-7402	NIADDK NIH HHS [P01 AM 21557] Funding Source: Medline; NIDCR NIH HHS [R37 DE 04660] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P01AM021557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE004660] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ANTONLAM.I, 1972, HUMANGENETIK, V15, P261, DOI 10.1007/BF00702363; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BOHJANEN PR, 1991, MOL CELL BIOL, V11, P3288, DOI 10.1128/MCB.11.6.3288; BROWN BD, 1993, GENE DEV, V7, P1620, DOI 10.1101/gad.7.8.1620; CHENG J, 1993, MOL CELL BIOL, V13, P1892, DOI 10.1128/MCB.13.3.1892; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COOPER DN, 1993, ANN MED, V25, P11, DOI 10.3109/07853899309147851; DALE BA, 1987, J INVEST DERMATOL, V88, P306, DOI 10.1111/1523-1747.ep12466185; DALE BA, 1985, J CELL BIOL, V101, P1257, DOI 10.1083/jcb.101.4.1257; DALE BA, 1993, MOL BIOL SKIN, V1, P79; DLUGOSZ AA, 1993, J CELL BIOL, V120, P217, DOI 10.1083/jcb.120.1.217; DURET L, 1993, NUCLEIC ACIDS RES, V21, P2315, DOI 10.1093/nar/21.10.2315; EICHNER R, 1984, J CELL BIOL, V98, P1388, DOI 10.1083/jcb.98.4.1388; FISHER C, 1987, J INVEST DERMATOL, V88, P661, DOI 10.1111/1523-1747.ep12470281; FISHER GJ, 1993, J INVEST DERMATOL, V101, P553, DOI 10.1111/1523-1747.ep12365967; FLECKMAN P, 1987, J INVEST DERMATOL, V88, P640, DOI 10.1111/1523-1747.ep12470251; FLECKMAN P, 1985, J INVEST DERMATOL, V85, P507, DOI 10.1111/1523-1747.ep12277306; GAN SQ, 1990, BIOCHEMISTRY-US, V29, P9432, DOI 10.1021/bi00492a018; GAY DA, 1987, CELL, V50, P671, DOI 10.1016/0092-8674(87)90325-4; GRAFI G, 1993, MOL CELL BIOL, V13, P3487, DOI 10.1128/MCB.13.6.3487; GREENBERG ME, 1990, CURRENT PROTOCOLS MO; HAYDOCK PV, 1993, J INVEST DERMATOL, V101, P118, DOI 10.1111/1523-1747.ep12363609; Hennings H, 1980, Curr Probl Dermatol, V10, P3; HOHL D, 1993, AM J DERMATOPATH, V15, P20, DOI 10.1097/00000372-199302000-00004; HOHL D, 1991, J BIOL CHEM, V266, P6626; IWAI Y, 1993, J IMMUNOL, V150, P4386; JACKSON RJ, 1993, CELL, V74, P9, DOI 10.1016/0092-8674(93)90290-7; KATZ DA, 1994, NUCLEIC ACIDS RES, V22, P238, DOI 10.1093/nar/22.2.238; KOIZUMI H, 1993, J INVEST DERMATOL, V101, P858, DOI 10.1111/1523-1747.ep12371707; KRAMER J, 1993, J CLIN INVEST, V91, P1258, DOI 10.1172/JCI116290; LIEBERMAN AP, 1992, J BIOL CHEM, V267, P2123; MANSUR NR, 1993, NUCLEIC ACIDS RES, V21, P993, DOI 10.1093/nar/21.4.993; MARKOVA NG, 1993, MOL CELL BIOL, V13, P613, DOI 10.1128/MCB.13.1.613; MEHREL T, 1990, CELL, V61, P1103, DOI 10.1016/0092-8674(90)90073-N; MERRETT JD, 1967, AM J HUM GENET, V19, P575; MEYERSIEGLER K, 1992, CARCINOGENESIS, V13, P2127, DOI 10.1093/carcin/13.11.2127; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MILSTONE LM, 1982, J INVEST DERMATOL, V79, P253, DOI 10.1111/1523-1747.ep12500073; OSTARECKLEDERER A, 1994, EMBO J, V13, P1476, DOI 10.1002/j.1460-2075.1994.tb06402.x; Peltz Stuart W., 1992, Current Opinion in Cell Biology, V4, P979, DOI 10.1016/0955-0674(92)90129-Z; PERFETTI V, 1991, LEUKEMIA, V5, P1110; PRESLAND RB, 1992, J BIOL CHEM, V267, P23772; PRESLAND RB, 1994, IN PRESS J INVEST DE; RASMUSSEN HH, 1993, J INVEST DERMATOL, V101, P560, DOI 10.1111/1523-1747.ep12365986; REPASKE DR, 1992, PROG BRAIN RES, V93, P295; RESING KA, 1993, J BIOL CHEM, V268, P25139; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; SAVANTBHONSALE S, 1992, GENE DEV, V6, P1927, DOI 10.1101/gad.6.10.1927; SCOTT IR, 1986, DEV BIOL, V115, P84, DOI 10.1016/0012-1606(86)90230-7; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; STEINERT PM, 1985, J BIOL CHEM, V260, P7142; SYBERT VP, 1985, J INVEST DERMATOL, V84, P191, DOI 10.1111/1523-1747.ep12264813; VAKALOPOULOU E, 1991, MOL CELL BIOL, V11, P3355, DOI 10.1128/MCB.11.6.3355; VINCENT S, 1993, NUCLEIC ACIDS RES, V21, P1498, DOI 10.1093/nar/21.6.1498; WELLS RS, 1966, BRIT MED J, V1, P947, DOI 10.1136/bmj.1.5493.947; WELLS RS, 1966, J INVEST DERMATOL, V46, P530, DOI 10.1038/jid.1966.80; WISDOM R, 1991, GENE DEV, V5, P232, DOI 10.1101/gad.5.2.232; WU CH, 1991, J BIOL CHEM, V266, P2983; XU HX, 1990, MOL CELL BIOL, V10, P2687, DOI 10.1128/MCB.10.6.2687	59	44	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					871	876		10.1074/jbc.270.2.871	http://dx.doi.org/10.1074/jbc.270.2.871			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822325	hybrid			2022-12-27	WOS:A1995QB81600059
J	KAHN, RA; CLARK, J; RULKA, C; STEARNS, T; ZHANG, CJ; RANDAZZO, PA; TERUI, T; CAVENAGH, M				KAHN, RA; CLARK, J; RULKA, C; STEARNS, T; ZHANG, CJ; RANDAZZO, PA; TERUI, T; CAVENAGH, M			MUTATIONAL ANALYSIS OF SACCHAROMYCES-CEREVISIAE ARF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; STIMULATORY REGULATORY COMPONENT; GTP-BINDING-PROTEIN; ADENYLATE-CYCLASE; CHOLERA-TOXIN; CATALYTIC SUBUNIT; ESCHERICHIA-COLI; ALPHA-SUBUNIT; YEAST; COFACTOR	Wild type and eight point mutants of Saccharomyces cerevisiae ARF1 were expressed in yeast and bacteria to determine the roles of specific residues in in vivo and in vitro activities. Mutations at either Gly(2) or Asp(26) resulted in recessive loss of function. It was concluded that N-myristoylation is required for Arf action in cells but not for either nucleotide exchange or cofactor activities in vitro. Asp(26) (homologous to Gly(12) of p21(ras)) was essential for the binding of the activating nucleotide, guanosine 5'-3-O-(thio)triphosphate. This is in marked contrast to results obtained after mutagenesis of the homologous residue in p21(ras) or G(s) alpha, and suggests a fundamental difference in the guanine nucleotide binding site of Arf with respect to these other GTP binding proteins. Two dominant alleles were also identified, one activating dominant ([Q71L]Arf1) and the other ([N126I]) a negative dominant. A conditional allele, [W66R]Arf1, was characterized and shown to have approximate to 300-fold lower specific activity in an in vitro Arf assay. Two high-copy suppressors of this conditional phenotype were cloned and sequenced. One of these suppressors, SFS4, was found to be identical to PBS2/HOG4, recently shown to encode a microtubule associated protein kinase kinase in yeast.	NCI, DIV CANC TREATMENT, DEV THERAPEUT PROGRAM, BIOL CHEM LAB, BETHESDA, MD 20892 USA; STANFORD UNIV, DEPT BIOL SCI, STANFORD, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University			Kahn, Richard/ABD-2666-2020	Kahn, Richard/0000-0002-0259-0601; Stearns, Tim/0000-0002-0671-6582				BALCH WE, 1992, J BIOL CHEM, V267, P13053; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOGUSLAWSKI G, 1987, P NATL ACAD SCI USA, V84, P5848, DOI 10.1073/pnas.84.16.5848; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; CREWS CM, 1993, CELL, V74, P215, DOI 10.1016/0092-8674(93)90411-I; DASCHER C, 1994, J BIOL CHEM, V269, P1437; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; GANSTER RW, 1993, MOL CELL BIOL, V13, P3650, DOI 10.1128/MCB.13.6.3650; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; GRAND RJA, 1991, BIOCHEM J, V279, P609, DOI 10.1042/bj2790609; GRAZIANO MP, 1989, J BIOL CHEM, V264, P15475; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; HANEY SA, 1994, J BIOL CHEM, V269, P16541; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JACQUET E, 1988, EMBO J, V7, P2861, DOI 10.1002/j.1460-2075.1988.tb03142.x; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; KAHN RA, 1984, J BIOL CHEM, V259, P6228; KAHN RA, 1992, J BIOL CHEM, V267, P13039; KAHN RA, 1991, J BIOL CHEM, V266, P2606; KAHN RA, 1986, J BIOL CHEM, V261, P7906; KAHN RA, 1993, HDB EXPT PHARM GTPAS, P529; KAHN RA, 1991, METHOD ENZYMOL, V195, P233; KHOSRAVIFAR R, 1994, CANCER METAST REV, V13, P67, DOI 10.1007/BF00690419; LAI CC, 1993, MOL CELL BIOL, V13, P1345, DOI 10.1128/MCB.13.3.1345; LENHARD JM, 1992, J BIOL CHEM, V267, P13047; LINDER ME, 1991, J BIOL CHEM, V266, P4654; MASTERS SB, 1989, J BIOL CHEM, V264, P15467; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; NORTHUP JK, 1983, J BIOL CHEM, V258, P1369; RANDAZZO PA, 1992, METHOD ENZYMOL, V219, P362; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; RANDAZZO PA, 1993, J BIOL CHEM, V268, P9555; RANDAZZO PA, 1994, IN PRESS METHODS ENZ; ROSENWALD AG, 1994, CHALL MOD MED, V6, P143; SCHLEIFER LS, 1982, J BIOL CHEM, V257, P20; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; STEARNS T, 1990, MOL CELL BIOL, V10, P6690, DOI 10.1128/MCB.10.12.6690; STEARNS T, 1990, P NATL ACAD SCI USA, V87, P1238, DOI 10.1073/pnas.87.3.1238; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TAYLOR TC, 1992, CELL, V70, P69, DOI 10.1016/0092-8674(92)90534-J; TEAL SB, 1994, J BIOL CHEM, V269, P3135; WALWORTH NC, 1989, EMBO J, V8, P1685, DOI 10.1002/j.1460-2075.1989.tb03560.x; WEISS O, 1989, J BIOL CHEM, V264, P21066; YONEMOTO W, 1993, J BIOL CHEM, V268, P2348; ZHANG CJ, 1994, J CELL BIOL, V124, P289, DOI 10.1083/jcb.124.3.289; ZHENG JH, 1993, PROTEIN SCI, V2, P1559, DOI 10.1002/pro.5560021003	48	71	73	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					143	150		10.1074/jbc.270.1.143	http://dx.doi.org/10.1074/jbc.270.1.143			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814365	hybrid			2022-12-27	WOS:A1995QA28700026
J	LI, J; PERRELLA, MA; TSAI, JC; YET, SF; HSIEH, CM; YOSHIZUMI, M; PATTERSON, C; ENDEGE, WO; ZHOU, F; LEE, ME				LI, J; PERRELLA, MA; TSAI, JC; YET, SF; HSIEH, CM; YOSHIZUMI, M; PATTERSON, C; ENDEGE, WO; ZHOU, F; LEE, ME			INDUCTION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR GENE-EXPRESSION BY INTERLEUKIN-1-BETA IN RAT AORTIC SMOOTH-MUSCLE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; ANGIOGENESIS; ATHEROSCLEROSIS; RECEPTOR; INVIVO; INHIBITION; ARTERIES; PROTEIN; MITOGEN	Vascular endothelial growth factor (VEGF) is a potent and specific mitogen for vascular endothelial cells and promotes neovascularization in vivo. To determine whether interleukin-1 beta (IL-1 beta), which is present in atherosclerotic lesions, induces VEGF gene expression in vascular smooth muscle cells, we performed RNA blot analysis on rat aortic smooth muscle cells (RASMC) with a rat VEGF cDNA probe. IL-1 beta increased VEGF mRNA levels in RASMC in a time- and dose-dependent manner. As little as 0.1 ng/ml IL-1 beta increased VEGF mRNA levels by S-fold and 10 ng/ml IL-1 beta increased VEGF mRNA by 4-fold. We also measured the half-life of VEGF mRNA and performed nuclear run on experiments before and after addition of IL-1 beta to see if IL-1 beta increased VEGF mRNA levels by stabilizing the mRNA or by increasing its rate of transcription. The normal, 2-h half-life of VEGF mRNA in RASMC was lengthened to 3.2 h (60%) by IL-1 beta, and IL-1 beta increased the rate of VEGF gene transcription by 2.1-fold. In immunoblot experiments with an antibody specific for VEGF, we found that IL-1 beta increased VEGF protein levels in RASMC by 3.3-fold. Together these data indicate that IL-1 beta induces VEGF gene expression in smooth muscle cells. This IL-1 beta-induced expression of VEGF may accelerate the progression of atherosclerotic lesions by promoting the development of new blood vessels.	HARVARD UNIV,SCH PUBL HLTH,CARDIOVASC BIOL LAB,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DIV CARDIOVASC,BOSTON,MA 02115	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital			Yet, Shaw-Fang/O-8583-2019; Yet, Shaw-Fang/B-1067-2010					Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BARGER AC, 1984, NEW ENGL J MED, V310, P175, DOI 10.1056/NEJM198401193100307; BENEZRA D, 1990, ARCH OPHTHALMOL-CHIC, V108, P573, DOI 10.1001/archopht.1990.01070060121061; BO WJ, 1992, ATHEROSCLEROSIS, V94, P71, DOI 10.1016/0021-9150(92)90189-N; CLAFFEY KP, 1992, J BIOL CHEM, V267, P16317; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; EISENSTEIN R, 1991, PHARMACOL THERAPEUT, V49, P1, DOI 10.1016/0163-7258(91)90019-I; FAN TPD, 1993, BRIT J PHARMACOL, V110, P43, DOI 10.1111/j.1476-5381.1993.tb13769.x; Ferrara N, 1991, Growth Factors, V5, P141, DOI 10.3109/08977199109000278; FERRARA N, 1993, TRENDS CARDIOVAS MED, V3, P244, DOI 10.1016/1050-1738(93)90046-9; FERRARA N, 1992, ENDOCR REV, V13, P18, DOI 10.1210/er.13.1.18; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; FRYER JA, 1987, J VASC SURG, V6, P341, DOI 10.1067/mva.1987.avs0060341; GARRIDO C, 1993, GROWTH FACTORS, V8, P109, DOI 10.3109/08977199309046931; GUNTHER S, 1982, J CELL BIOL, V92, P289, DOI 10.1083/jcb.92.2.289; HARADA S, 1994, J CLIN INVEST, V93, P2490, DOI 10.1172/JCI117258; KAHLON R, 1992, CAN J CARDIOL, V8, P60; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; KLAGSBRUN M, 1991, ANNU REV PHYSIOL, V53, P217, DOI 10.1146/annurev.physiol.53.1.217; LEE ME, 1991, J BIOL CHEM, V266, P16188; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; LI XM, 1994, J BIOL CHEM, V269, P19653; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; MILLAUER B, 1993, CELL, V72, P895; MOYER CF, 1991, AM J PATHOL, V138, P951; MUEGGE K, 1989, SCIENCE, V246, P249, DOI 10.1126/science.2799385; OBRIEN KD, 1993, J CLIN INVEST, V92, P945, DOI 10.1172/JCI116670; PERRELLA MA, 1994, J BIOL CHEM, V269, P14595; PERTOVAARA L, 1994, J BIOL CHEM, V269, P6271; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; SAEGUSA Y, 1990, J CELL PHYSIOL, V142, P488, DOI 10.1002/jcp.1041420307; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Sueishi K, 1993, Curr Top Pathol, V87, P47; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; TISCHER E, 1991, J BIOL CHEM, V266, P11947; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2483	37	311	328	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					308	312		10.1074/jbc.270.1.308	http://dx.doi.org/10.1074/jbc.270.1.308			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814392	hybrid			2022-12-27	WOS:A1995QA28700049
J	ZWEIER, JL; WANG, PH; KUPPUSAMY, P				ZWEIER, JL; WANG, PH; KUPPUSAMY, P			DIRECT MEASUREMENT OF NITRIC-OXIDE GENERATION IN THE ISCHEMIC HEART USING ELECTRON-PARAMAGNETIC-RESONANCE SPECTROSCOPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-RADICAL GENERATION; MYOCARDIAL REPERFUSION INJURY; RELAXING FACTOR; L-ARGININE; ENDOTHELIAL DYSFUNCTION; SUPEROXIDE-DISMUTASE; MECHANISM; RAT; ACETYLCHOLINE; REJECTION	Nitric oxide, NO., exerts numerous important regulatory functions in biological tissues and has been hypothesized to have a role in the pathogenesis of cellular injury in a number of diseases, It has been suggested that alterations in NO. generation are a critical cause of injury in the ischemic heart, However, the precise alterations in NO. generation which occur are not known, and there is considerable controversy regarding whether myocardial ischemia results in increased or decreased NO. formation, Therefore, electron paramagnetic resonance studies were performed to directly measure NO. in isolated rat hearts subjected to global ischemia, using the direct NO. trap Fe2+-N-methyl-D-glucamine dithiocarbamate, which specifically binds NO. giving rise to a characteristic triplet EPR spectrum with g = 2.04 and a(N) = 13.2 G, While only a small triplet signal was observed in normally perfused hearts, a 10-fold increase in this triplet EPR spectrum was observed after 30 min of ischemia indicating a marked increase in NO. formation and trapping, Measurements were performed as a function of the duration of ischemia, and it was determined that with increased duration of ischemia NO. formation and trapping was also increased, NO. generation was inhibited by the nitric oxide synthase blocker, N-nitro-L-arginine methyl ester (L-NAME), suggesting that NO. was generated via nitric oxide synthase, Blockade of NO. generation with L-NAME resulted in more than a 2-fold increase in the recovery of contractile function in hearts reperfused after 30 min of global ischemia, Thus, ischemia causes a marked duration-dependent increase of NO. in the heart which may in turn mediate postischemic injury.	JOHNS HOPKINS MED INST, JOHNS HOPKINS BAYVIEW MED CTR, DEPT MED, DIV CARDIOL, BALTIMORE, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine	ZWEIER, JL (corresponding author), JOHNS HOPKINS MED INST, JOHNS HOPKINS BAYVIEW MED CTR, JOHNS HOPKINS ASTHMA & ALLERGY CTR, BALTIMORE, MD USA.				NHLBI NIH HHS [HL-17655, HL-38324] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL017655, R29HL038324, R01HL038324] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BREDT DS, 1992, NEURON, V8, P3, DOI 10.1016/0896-6273(92)90104-L; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; GREENBERG SS, 1990, CIRC RES, V67, P1446, DOI 10.1161/01.RES.67.6.1446; IGNARRO LJ, 1986, J BIOL CHEM, V261, P4997; IGNARRO LJ, 1987, CIRC RES, V61, P866, DOI 10.1161/01.RES.61.6.866; JOLLY SR, 1984, CIRC RES, V54, P277, DOI 10.1161/01.RES.54.3.277; LAI CS, 1994, FEBS LETT, V345, P120, DOI 10.1016/0014-5793(94)00422-6; LANCASTER JR, 1992, J BIOL CHEM, V267, P10994; LANGREHR JM, 1993, TRANSPLANTATION, V55, P1205, DOI 10.1097/00007890-199306000-00001; LANGREHR JM, 1992, SURGERY, V112, P395; LEFER AM, 1991, FASEB J, V5, P2029, DOI 10.1096/fasebj.5.7.2010056; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; MATHEIS G, 1992, AM J PHYSIOL, V262, pH616, DOI 10.1152/ajpheart.1992.262.2.H616; MONCADA S, 1989, BIOCHEM PHARMACOL, V38, P1709, DOI 10.1016/0006-2952(89)90403-6; MONCADA S, 1991, PHARMACOL REV, V43, P109; MORDVINTCEV P, 1991, ANAL BIOCHEM, V199, P142, DOI 10.1016/0003-2697(91)90282-X; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; SHINOBU LA, 1984, ACTA PHARMACOL TOX, V54, P189; SHLAFER M, 1982, J THORAC CARDIOV SUR, V83, P830; THOMPSONGORMAN SL, 1990, J BIOL CHEM, V265, P6656; TSAO PS, 1990, AM J PHYSIOL, V259, pH1660, DOI 10.1152/ajpheart.1990.259.6.H1660; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404; ZWEIER JL, 1988, J BIOL CHEM, V263, P1353; ZWEIER JL, 1994, J BIOL CHEM, V269, P24156; ZWEIER JL, 1988, P NATL ACAD SCI USA, V85, P4046, DOI 10.1073/pnas.85.11.4046; ZWEIER JL, 1989, J BIOL CHEM, V264, P18890	30	217	222	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					304	307		10.1074/jbc.270.1.304	http://dx.doi.org/10.1074/jbc.270.1.304			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814391	hybrid			2022-12-27	WOS:A1995QA28700048
J	MORRICAL, SW; HEMPSTEAD, K; MORRICAL, MD				MORRICAL, SW; HEMPSTEAD, K; MORRICAL, MD			THE GENE 59 PROTEIN OF BACTERIOPHAGE-T4 MODULATES THE INTRINSIC AND SINGLE-STRANDED DNA-STIMULATED ATPASE ACTIVITIES OF GENE-41 PROTEIN, THE T4-REPLICATIVE DNA HELICASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; RNA PRIMERS; PURIFICATION; EXPRESSION; CLONING; INVITRO	The T4 gene 59 protein (gp59) serves as an accessory protein to the essential T4-encoded DNA helicase, the gene 41 protein (gp41). gp59 stimulates gp41-dependent DNA synthesis reactions by promoting the assembly of gp41 onto single-stranded DNA (ssDNA), where the enzyme is activated to perform its DNA helicase functions. To better understand the mechanism of helicase-ssDNA assembly, we have studied the effects of gp59 on the intrinsic and ssDNA-stimulated ATPase activities of gp41. Our results indicate that gp59 exerts a direct effect upon the conformation and ATPase activity of gp41, by increasing the affinity of gp41 for ATP. In addition, we find that gp59 is nearly essential for promoting the assembly of gp41 onto ssDNA molecules that are covered with saturating amounts of the T4 encoded helix-destabilizing protein, gene 32 protein (gp32). Results of protein affinity chromatography experiments suggest that gp59 contains distinct binding sites for gp41 and gp32 and may therefore act as a molecular adapter between the helicase and helix-destabilizing proteins. Together, the data indicate that specific gp59-gp41 and gp59-gp32 protein-protein interactions both play important roles in the assembly of the helicase onto single-stranded DNA.	UNIV VERMONT, COLL MED, DEPT MICROBIOL & MOLEC GENET, BURLINGTON, VT 05405 USA; UNIV VERMONT, COLL MED, VERMONT CANC CTR, BURLINGTON, VT 05405 USA	University of Vermont; University of Vermont	MORRICAL, SW (corresponding author), UNIV VERMONT, COLL MED, DEPT BIOCHEM, BURLINGTON, VT 05405 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048847, R56GM048847] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM48847] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTS BM, 1987, PHILOS T ROY SOC B, V317, P395, DOI 10.1098/rstb.1987.0068; ALBERTS BM, 1980, ICN UCLA S MOL CELL, V19, P449; BARRY J, 1994, J BIOL CHEM, V269, P33063; BARRY J, 1994, J BIOL CHEM, V269, P33049; BITTNER M, 1979, J BIOL CHEM, V254, P9565; CHA TA, 1988, CANCER CELL, V6, P1; DONG F, 1993, BIOPHYS J, V64, pA238; EASTERBY JS, 1973, BIOCHIM BIOPHYS ACTA, V293, P552, DOI 10.1016/0005-2744(73)90362-8; Fersht AR., 1977, ENZYME STRUCTURE MEC; FORMOSA T, 1983, P NATL ACAD SCI-BIOL, V80, P2442, DOI 10.1073/pnas.80.9.2442; HINTON DM, 1985, J BIOL CHEM, V260, P2851; HINTON DM, 1987, UCLA S MOL CELLULAR, V47, P173; Kreuzer K. N., 1994, MOL BIOL BACTERIOP T, P28; LIU CC, 1981, J BIOL CHEM, V256, P2813; LIU CC, 1979, COLD SPRING HARB SYM, V43, P469, DOI 10.1101/SQB.1979.043.01.053; MATHEWS CK, 1972, J BIOL CHEM, V247, P7430; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; MILLER H, 1987, METHOD ENZYMOL, V152, P145; MORRICAL SW, 1991, J BIOL CHEM, V266, P14031; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; MORRIS CF, 1979, J BIOL CHEM, V254, P6797; Nossal N.G., 1983, BACTERIOPHAGE T4, P71; NOSSAL NG, 1979, J BIOL CHEM, V254, P6026; NOSSAL NG, 1980, J BIOL CHEM, V255, P2176; RICHARDSON RW, 1989, J BIOL CHEM, V264, P4725; RICHARDSON RW, 1989, J BIOL CHEM, V264, P4732; SHAMOO Y, 1986, P NATL ACAD SCI USA, V83, P8844, DOI 10.1073/pnas.83.23.8844; SILVER LL, 1982, J BIOL CHEM, V257, P1696; SPACCIAPOLI P, 1994, J BIOL CHEM, V269, P447; VENKATESAN M, 1982, J BIOL CHEM, V257, P2426; YAMAMOTO KR, 1970, VIROLOGY, V40, P734, DOI 10.1016/0042-6822(70)90218-7; YONESAKI T, 1994, J BIOL CHEM, V269, P1284; YOUNG MC, 1994, J MOL BIOL, V235, P1436, DOI 10.1006/jmbi.1994.1099; YOUNG MC, 1994, J MOL BIOL, V235, P1447, DOI 10.1006/jmbi.1994.1100	34	64	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					33069	33081						13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806535				2022-12-27	WOS:A1994QA63800052
J	BUDHRAMMAHADEO, V; MORRIS, PJ; LAKIN, ND; THEIL, T; CHING, GY; LILLYCROP, KA; MOROY, T; LIEM, RKH; LATCHMAN, DS				BUDHRAMMAHADEO, V; MORRIS, PJ; LAKIN, ND; THEIL, T; CHING, GY; LILLYCROP, KA; MOROY, T; LIEM, RKH; LATCHMAN, DS			ACTIVATION OF THE ALPHA-INTERNEXIN PROMOTER BY THE BRN-3A TRANSCRIPTION FACTOR IS DEPENDENT ON THE N-TERMINAL REGION OF THE PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE FILAMENT PROTEIN; POU-DOMAIN PROTEIN; FUNCTIONAL-ANALYSIS; REPORTER GENE; I-POU; HOMEODOMAIN; NEURONS; OCT-2; CELLS; PHOSPHORYLATION	The Brn-3a, Brn-3b, and Brn-3c proteins are closely related POU (Pit-Oct-Unc) family transcription factors which are expressed predominantly in neuronal cells, We have identified the alpha-internexin gene as the first reported, neuronally expressed, target gene whose promoter activity is modulated by these factors, Both the Brn-3a and Brn-3c factors can activate the alpha-internexin promoter while Brn-3b represses it and can prevent activation by Brn-3a. Using chimeric constructs containing different regions of Brn-3a or Brn-3b, we show that activation of the alpha-internexin promoter requires the N-terminal region of Brn-3a. In contrast the activation by Brn-3a but not Brn-3b, of an artificial promoter containing a synthetic Brn-3 binding site can be shown using the same constructs to be dependent on the POU domain of Brn-3a. Moreover, the isolated POU domain of Brn-3a can activate this artificial promoter but not the alpha-internexin promoter. Hence Brn-3a contains two distinct transactivation domains, at the N terminus and within the POU domain, whose effect is dependent upon the target promoter, The relationship of gene transactivation by Brn-3a to its ability to transform primary cells which is also dependent on the N-terminal region of the protein is discussed.	UCL, SCH MED, DEPT MOLEC PATHOL, MED MOLEC BIOL UNIT, LONDON W1P 6DB, ENGLAND; UNIV MARBURG, INST MOLEK BIOL & TUMORFORSCH, D-35037 MARBURG, GERMANY; COLUMBIA UNIV, COLL PHYS & SURG, DEPT PATHOL, NEW YORK, NY 10032 USA	University of London; University College London; UCL Medical School; Philipps University Marburg; Columbia University			Moroy, Tarik/D-9923-2011	Theil, Thomas/0000-0001-6590-8309				ABKEN H, 1992, NUCLEIC ACIDS RES, V20, P3527, DOI 10.1093/nar/20.13.3527; ALVAREZ E, 1991, J BIOL CHEM, V266, P15277; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROAD PM, 1989, NUCLEIC ACIDS RES, V17, P6999, DOI 10.1093/nar/17.17.6999; BUDHRAMMAHADEO V, 1994, NUCLEIC ACIDS RES, V22, P3092, DOI 10.1093/nar/22.15.3092; CHING GY, 1991, J BIOL CHEM, V266, P19459; CLERC RG, 1988, GENE DEV, V2, P1570, DOI 10.1101/gad.2.12a.1570; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; FINNEY M, 1988, CELL, V55, P757, DOI 10.1016/0092-8674(88)90132-8; GERRERO MR, 1993, P NATL ACAD SCI USA, V90, P10841, DOI 10.1073/pnas.90.22.10841; GERSTER T, 1990, EMBO J, V9, P1635, DOI 10.1002/j.1460-2075.1990.tb08283.x; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; KAPLAN MP, 1990, J NEUROSCI, V10, P2735; LALLI E, 1994, J BIOL CHEM, V269, P17359; LI P, 1993, GENE DEV, V7, P2483, DOI 10.1101/gad.7.12b.2483; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LILLYCROP KA, 1992, NUCLEIC ACIDS RES, V20, P5093, DOI 10.1093/nar/20.19.5093; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MACPHERSON I, 1962, VIROLOGY, V16, P147, DOI 10.1016/0042-6822(62)90290-8; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; MORRIS PJ, 1994, MOL CELL BIOL, V14, P6907, DOI 10.1128/MCB.14.10.6907; MULLERIMMERGLUCK MM, 1990, EMBO J, V9, P1625, DOI 10.1002/j.1460-2075.1990.tb08282.x; NINKINA NN, 1993, NUCLEIC ACIDS RES, V21, P3175, DOI 10.1093/nar/21.14.3175; RADOVICK S, 1992, SCIENCE, V257, P1115, DOI 10.1126/science.257.5073.1115; RING CJA, 1993, NUCLEIC ACIDS RES, V21, P2946, DOI 10.1093/nar/21.12.2946; TANAKA M, 1992, CELL, V68, P755, DOI 10.1016/0092-8674(92)90150-B; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; THEIL T, 1994, CYTOGENET CELL GENET, V66, P267, DOI 10.1159/000133709; TREACY MN, 1992, CELL, V68, P491, DOI 10.1016/0092-8674(92)90186-G; TREACY MN, 1991, NATURE, V350, P577, DOI 10.1038/350577a0; TURNER EE, 1994, NEURON, V12, P205, DOI 10.1016/0896-6273(94)90164-3; VERRIJZER CP, 1993, BIOCHIM BIOPHYS ACTA, V1173, P1, DOI 10.1016/0167-4781(93)90237-8; VERRIJZER CP, 1992, MOL CELL BIOL, V12, P542, DOI 10.1128/MCB.12.2.542; VICKERS JC, 1992, BRAIN RES, V585, P205, DOI 10.1016/0006-8993(92)91208-V; Wegner M, 1993, CURR OPIN CELL BIOL, V5, P488, DOI 10.1016/0955-0674(93)90015-I; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0; YOON SO, 1992, NEURON, V9, P55, DOI 10.1016/0896-6273(92)90220-8; ZIANG M, 1993, NEURON, V11, P689	39	69	71	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2853	2858		10.1074/jbc.270.6.2853	http://dx.doi.org/10.1074/jbc.270.6.2853			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852360	hybrid			2022-12-27	WOS:A1995QF53500070
J	IZUTA, S; ROBERTS, JD; KUNKEL, TA				IZUTA, S; ROBERTS, JD; KUNKEL, TA			REPLICATION ERROR RATES FOR G-CENTER-DOT-DGTP, T-CENTER-DOT-DGTP, AND A-CENTER-DOT-DGTP MISPAIRS AND EVIDENCE FOR DIFFERENTIAL PROOFREADING BY LEADING AND LAGGING-STRAND DNA-REPLICATION COMPLEXES IN HUMAN-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UV-IRRADIATED DNA; FRAMESHIFT FIDELITY; POLYMERASE; INVITRO; ALPHA; EXONUCLEASE; EXTRACTS; DELTA	We have determined the fidelity of DNA replication by human cell extracts in reactions containing excess dGTP, Replication errors were scored using two M13 DNA substrates having the replication origin on opposite sides of the lacZ alpha-complementation gene, The data suggest that the average rates for replication errors resulting from G(template), T(.)dGTP, and A(.)dGTP mispairs are 25 x 10(-6), 12 x 10(-6), and 3 x 10(-6), respectively. The data also suggest that error rates for both the (+) and (-) strands differ by less than 2-fold when they are replicated either as the leading or lagging strand. This is in contrast to the 33- and 8-fold differences observed earlier for G(.)dTTP and C(.)dTTP mispairs on the (+) strand when replicated by the leading or lagging strand complex (Roberts, J. D., Izuta, S., Thomas, D. C., and Kunkel, T. A. (1994) J. Biol. Chem. 269, 1711-1717), Thus, the relative fidelity of the leading and lagging strand replication proteins varies with the mispair and sequence considered, Misincorporation of dGTP preferentially occurs at template positions where dGTP is the next correct nucleotide to be incorporated, This ''next nucleo tide'' effect is characteristic of reduced exonucleolytic proofreading and suggests that these replication errors are normally proofread efficiently, Fidelity measure ments performed in the absence or presence of dGMP, an inhibitor of proofreading exonuclease activity, suggest that the leading strand replication complex proofreads some mispairs more efficiently than does the lagging strand replication complex.	NIEHS,MOLEC GENET LAB,RES TRIANGLE PK,NC 27709	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)			Kunkel, Thomas A./D-5088-2019	Kunkel, Thomas A./0000-0002-9900-1788				BEBENEK K, 1992, J BIOL CHEM, V267, P3589; BEBENEK K, 1990, P NATL ACAD SCI USA, V87, P4946, DOI 10.1073/pnas.87.13.4946; BIALEK G, 1993, J BIOL CHEM, V268, P6024; CARTY MP, 1992, MUTAT RES, V274, P29, DOI 10.1016/0921-8777(92)90041-Z; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; HAUSER J, 1988, MOL CELL BIOL, V8, P3267, DOI 10.1128/MCB.8.8.3267; HAY RT, 1982, CELL, V28, P769; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; KUNKEL TA, 1988, CELL, V53, P837, DOI 10.1016/S0092-8674(88)90189-4; KUNKEL TA, 1992, J BIOL CHEM, V267, P18251; LEE SH, 1989, P NATL ACAD SCI USA, V86, P7361, DOI 10.1073/pnas.86.19.7361; LEE SH, 1993, NUCLEIC ACIDS RES, V21, P1935, DOI 10.1093/nar/21.8.1935; LI JJ, 1985, MOL CELL BIOL, V5, P1238, DOI 10.1128/MCB.5.6.1238; LINN S, 1991, CELL, V66, P185, DOI 10.1016/0092-8674(91)90608-2; MELENDY T, 1989, J BIOL CHEM, V266, P1942; PAVLOV YI, 1994, BIOCHEMISTRY-US, V33, P4695, DOI 10.1021/bi00181a029; ROBERTS JD, 1994, J BIOL CHEM, V269, P1711; ROBERTS JD, 1993, BIOCHEMISTRY-US, V32, P4083, DOI 10.1021/bi00066a033; ROBERTS JD, 1991, P NATL ACAD SCI USA, V88, P3465, DOI 10.1073/pnas.88.8.3465; ROBERTS JD, 1988, P NATL ACAD SCI USA, V85, P7064, DOI 10.1073/pnas.85.19.7064; ROBERTS JD, 1993, METHODS MOL GENET, V2, P295; STILLMAN B, 1994, CELL, V78, P725, DOI 10.1016/S0092-8674(94)90362-X; THOMAS DC, 1994, P NATL ACAD SCI USA, V91, P7752, DOI 10.1073/pnas.91.16.7752; THOMAS DC, 1993, P NATL ACAD SCI USA, V90, P7744, DOI 10.1073/pnas.90.16.7744; THOMAS DC, 1991, BIOCHEMISTRY-US, V30, P11751, DOI 10.1021/bi00115a003; THOMAS DC, 1993, BIOCHEMISTRY-US, V32, P11476, DOI 10.1021/bi00094a002; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; WEINBERG DH, 1989, P NATL ACAD SCI USA, V86, P9742, DOI 10.1073/pnas.86.24.9742; WOLD MS, 1988, CANCER CELL, V6, P133	29	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2595	2600		10.1074/jbc.270.6.2595	http://dx.doi.org/10.1074/jbc.270.6.2595			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852323	hybrid			2022-12-27	WOS:A1995QF53500031
J	TARUMI, K; YONESAKI, T				TARUMI, K; YONESAKI, T			FUNCTIONAL INTERACTIONS OF GENE-32, GENE-41, AND GENE-59 PROTEINS OF BACTERIOPHAGE-T4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; PURIFICATION; UVSX	Genes 41 and 59 of bacteriophage T4 are involved in DNA recombination as well as in DNA replication. The 41 protein has a DNA helicase activity. The 59 protein has been recently purified and found to have a specific affinity for both 32 protein (single-stranded DNA-binding protein) and 41 protein (Yonesaki 1994, J. Biol. Chem. 269, 1284-1289). We examined the effects of 59 protein on ssDNA-dependent ATPase activity and DNA helicase activity of 41 protein in the presence or absence of 32 protein. The ATPase activity of 41 protein was strongly inhibited by 32 protein over a wide range of amounts from subsaturation to oversaturation of ssDNA. The 32 protein was also inhibitory toward DNA helicase activity. Addition of 59 protein effectively eliminated these inhibitory effects of 32 protein. Moreover, 59 protein facilitated 41 protein to overcome the barrier to initiate the unwinding reaction with a duplex nanking a single-stranded DNA gap. Intriguingly, 32 protein at an amount optimal for saturation of ssDNA stimulated the overcoming of the barrier when 59 protein was present. For the best circumvention of this initiation barrier, only eight monomers of 59 protein/one DNA substrate molecule containing 2900 nucleotides of ssDNA were required. These results strongly suggest that 59 protein modulates 41 protein activities by forming a complex with 41 protein and that 41 protein can produce recombinogenic ssDNA with the aid of 32 and 59 proteins.	OSAKA UNIV,FAC SCI,DEPT BIOL,TOYONAKA,OSAKA 560,JAPAN	Osaka University								BARRY J, 1994, IN PRESS J BIOL CHEM; FORMOSA T, 1986, J BIOL CHEM, V261, P6107; HINTON DM, 1985, J BIOL CHEM, V260, P2851; LIU CC, 1981, J BIOL CHEM, V256, P2813; MORRIS CF, 1979, J BIOL CHEM, V254, P6797; NEWPORT JW, 1981, J MOL BIOL, V145, P105, DOI 10.1016/0022-2836(81)90336-3; NOSSAL NG, 1979, J BIOL CHEM, V254, P6026; NOSSAL NG, 1983, BACTERIOPHAGE T, V4, P71; PRASHAD N, 1972, J MOL BIOL, V70, P617, DOI 10.1016/0022-2836(72)90562-1; RICHARDSON RW, 1989, J BIOL CHEM, V264, P4725; SHAH DB, 1976, J VIROL, V17, P175, DOI 10.1128/JVI.17.1.175-182.1976; SHIGESADA K, 1984, GENE, V29, P199; VONHIPPEL PH, 1983, BACTERIOPHAGE T, V4, P202; WAKEM LP, 1981, VIROLOGY, V112, P472; WU R, 1974, VIROLOGY, V59, P108, DOI 10.1016/0042-6822(74)90209-8; YONESAKI T, 1994, GENETICS, V138, P247; YONESAKI T, 1989, J BIOL CHEM, V264, P7814; YONESAKI T, 1985, EMBO J, V4, P3321, DOI 10.1002/j.1460-2075.1985.tb04083.x; YONESAKI T, 1994, J BIOL CHEM, V269, P1284	19	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2614	2619		10.1074/jbc.270.6.2614	http://dx.doi.org/10.1074/jbc.270.6.2614			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852326	hybrid			2022-12-27	WOS:A1995QF53500034
J	WANG, ZQ; LIN, HN; LI, SS; HUANG, CH				WANG, ZQ; LIN, HN; LI, SS; HUANG, CH			PHASE-TRANSITION BEHAVIOR AND MOLECULAR-STRUCTURES OF MONOUNSATURATED PHOSPHATIDYLCHOLINES - CALORIMETRIC STUDIES AND MOLECULAR MECHANICS SIMULATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIXED-CHAIN PHOSPHATIDYLCHOLINES; MODEL MEMBRANES; PACKING; PHOSPHOLIPIDS; DISPERSIONS; MOIETIES; SERIES	High resolution differential scanning calorimetric studies were performed to investigate the thermotropic phase behavior of 26 molecular species of sn-l saturated/sn-2 monounsaturated phosphatidylcholines. In parallel with calorimetric studies, the energy-minimized structures and steric energies of the diglyceride moieties of these monoenoic lipids were determined using a molecular mechanics approach, The combined calorimetric and computational studies led to the following results and conclusions, (i) When a single cis-carbon-carbon double bond (Delta) is incorporated into a saturated diacylphosphatidylcholine molecule at any position within the central segment of the long sn-2 acyl chain, the resulting monoenoic lipid molecules will, in excess water, exhibit reduced phase transition temperature (T-m) and transition enthalpy (Delta H) as they undergo the gel to liquid-crystalline phase transition, The T-m and Delta H-lowering effects of the Delta bond can be attributed to a decrease in the chain length of the sn-2 acyl chain, a change in the chain length difference between the sn-l and sn-2 acyl chains, and a local perturbation of the chain chain van der Waals interaction in the vicinity of the Delta bond, (ii) For a series of positional isomers of 1-stearoyl-2-cis-octadecenoylphosphatidylcholine, C(18):C(18:1 Delta(n))PC, with a Delta bond at different positions along the sn-2 acyl chain, the T-m value depends critically on the position of the Delta bond, Specifically, the T-m value is minimal as the Delta bond is located at the geometric center of the linear segment of the sn-2 acyl chain, and the T-m value is progressively increased as the Delta bond migrates toward either end of the sn-2 acyl chain, (iii) The various monoenoic phosphatidylcholines under study can be divided into two groups, The T-m values of most lipids in each group can be correlated in an identical manner with their structural parameters, yielding a common T-m-structure relationship.	UNIV VIRGINIA,HLTH SCI CTR,DEPT BIOCHEM,CHARLOTTESVILLE,VA 22908	University of Virginia					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM017452] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-17452] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLINGER NL, 1977, J AM CHEM SOC, V99, P8127, DOI 10.1021/ja00467a001; BARTON PG, 1975, J BIOL CHEM, V250, P4470; BORKMAN M, 1993, NEW ENGL J MED, V328, P238, DOI 10.1056/NEJM199301283280404; CHAPMAN D., 1967, CHEM PHYS LIPIDS, V1, P445, DOI 10.1016/0009-3084(67)90023-0; Chapman D., 1993, BIOMEMBRANES PHYSICA, P29; COOLBEAR KP, 1983, BIOCHEMISTRY-US, V22, P1466, DOI 10.1021/bi00275a022; CURATOLO W, 1985, BIOCHIM BIOPHYS ACTA, V817, P261, DOI 10.1016/0005-2736(85)90027-6; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; GAO Q, 1986, J LIPID RES, V27, P1214; GOERKE J, 1974, BIOCHIM BIOPHYS ACTA, V344, P241, DOI 10.1016/0304-4157(74)90009-4; HUANG C, 1994, BBA-BIOMEMBRANES, V1189, P7, DOI 10.1016/0005-2736(94)90273-9; KEOUGH KMW, 1987, BIOCHIM BIOPHYS ACTA, V902, P1, DOI 10.1016/0005-2736(87)90129-5; KUNAU WH, 1976, ANGEW CHEM INT EDIT, V15, P61, DOI 10.1002/anie.197600611; LANDS WEM, 1966, J AM OIL CHEM SOC, V43, P290, DOI 10.1007/BF02609676; LEWIS RNAH, 1987, BIOCHEMISTRY-US, V26, P6118, DOI 10.1021/bi00393a026; LI SS, 1993, BIOPHYS J, V65, P1415, DOI 10.1016/S0006-3495(93)81205-0; LI SS, 1994, BIOPHYS J, V66, P2005, DOI 10.1016/S0006-3495(94)80993-2; LIN HN, 1990, BIOCHEMISTRY-US, V29, P7063, DOI 10.1021/bi00482a017; LITMAN BJ, 1991, BIOCHEMISTRY-US, V30, P313, DOI 10.1021/bi00216a001; LIU S, 1994, BIOCHEM J, V299, P831, DOI 10.1042/bj2990831; MENA PL, 1985, CHEM PHYS LIPIDS, V37, P257, DOI 10.1016/0009-3084(85)90014-3; MYHER JJ, 1982, CAN J BIOCHEM CELL B, V60, P638, DOI 10.1139/o82-079; OBRIEN JF, 1974, J LIPID RES, V15, P44; TATTRIE NH, 1968, CAN J BIOCHEM CELL B, V46, P819, DOI 10.1139/o68-124; TRONCHERE H, 1994, BBA-LIPID LIPID MET, V1212, P137, DOI 10.1016/0005-2760(94)90248-8; WANG ZQ, 1994, J BIOL CHEM, V269, P23491	26	36	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2014	2023		10.1074/jbc.270.5.2014	http://dx.doi.org/10.1074/jbc.270.5.2014			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836427	hybrid			2022-12-27	WOS:A1995QE49300008
J	CHERNIACK, AD; KLARLUND, JK; CONWAY, BR; CZECH, MP				CHERNIACK, AD; KLARLUND, JK; CONWAY, BR; CZECH, MP			DISASSEMBLY OF SON-OF-SEVENLESS PROTEINS FROM GRB2 DURING P21(RAS) DESENSITIZATION BY INSULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							EPIDERMAL-GROWTH-FACTOR; NUCLEOTIDE EXCHANGE FACTOR; GTPASE-ACTIVATING PROTEIN; RECEPTOR TYROSINE KINASES; GENE-EXPRESSION; P21RAS ACTIVATION; MAP KINASES; RAS; PHOSPHORYLATION; STIMULATION	Insulin receptor signaling acutely stimulates GTP loading of p21(ras), apparently by mobilizing complexes of Grb2 and the guanine nucleotide exchangers Son-of-sevenless (Sos) 1 and 2 to associate with tyrosine-phosphorylated proteins in the plasma membrane. Here we show that in P-32-labeled 3T3-L1 adipocytes the elevated cellular concentrations of [P-32]GTP-bound p21(ras) in response to insulin return to near basal levels after 20-30 min of hormone stimulation, while insulin receptors remain activated. Lysates of such desensitized cells were quantitatively immunoprecipitated with an antiserum recognizing both Sos1 and Sos2 proteins or a specific anti-Sos2 antiserum. Immunoblot analysis of these precipitates revealed that insulin causes a marked hyperphosphorylation of Sos1 and a 50% decrease in Grb2 associated with Sos proteins under these conditions. Similarly, anti-Grb2 immunoprecipitates of such lysates revealed the presence of decreased Sos1 protein due to insulin action. The disassembly of Grb2 from Sos proteins slightly precedes the time course of p21(ras) deactivation in response to insulin, These data are consistent with the hypothesis that the dissociation of Grb2 from Sos proteins caused by insulin in 3T3-L1 cells mediates p21(ras) deactivation and desensitization.	UNIV MASSACHUSETTS,MED CTR,DEPT BIOCHEM & MOLEC BIOL,WORCESTER,MA 01605	University of Massachusetts System; University of Massachusetts Worcester	CHERNIACK, AD (corresponding author), UNIV MASSACHUSETTS,MED CTR,PROGRAM MOLEC MED,WORCESTER,MA 01605, USA.		Cherniack, Andrew D./AAY-8132-2020	Cherniack, Andrew D./0000-0003-0470-0111	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030648] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK30648] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BALTENSPERGER K, 1993, SCIENCE, V260, P1950, DOI 10.1126/science.8391166; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; BURGERING BMT, 1991, EMBO J, V10, P1103, DOI 10.1002/j.1460-2075.1991.tb08050.x; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; CHERNIACK AD, 1994, J BIOL CHEM, V269, P4717; CLANCY BM, 1991, J BIOL CHEM, V265, P12434; DEVRIESSMITS AMM, 1992, NATURE, V357, P602, DOI 10.1038/357602a0; DOWNWARD J, 1994, FEBS LETT, V338, P113, DOI 10.1016/0014-5793(94)80346-3; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; DURONIO V, 1992, P NATL ACAD SCI USA, V89, P1587, DOI 10.1073/pnas.89.5.1587; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; FARNSWORTH CL, 1991, CELL, V64, P625, DOI 10.1016/0092-8674(91)90246-U; FEIG LA, 1994, CURR OPIN CELL BIOL, V6, P204, DOI 10.1016/0955-0674(94)90137-6; GIBBS JB, 1990, J BIOL CHEM, V265, P20437; GROSS E, 1992, NATURE, V360, P762, DOI 10.1038/360762a0; GUPTA S, 1993, P NATL ACAD SCI USA, V90, P3216, DOI 10.1073/pnas.90.8.3216; JOHNSON GL, 1994, CURR OPIN CELL BIOL, V6, P230, DOI 10.1016/0955-0674(94)90141-4; KHOSRAVIFAR R, 1994, CANCER METAST REV, V13, P67, DOI 10.1007/BF00690419; KNUTSON VP, 1992, J BIOL CHEM, V267, P931; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; LIHLING L, 1993, CELL, V72, P269; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; MCCORMICK F, 1994, CURR OPIN GENET DEV, V4, P71, DOI 10.1016/0959-437X(94)90093-0; McCormick Frank, 1994, Trends in Cell Biology, V4, P347, DOI 10.1016/0962-8924(94)90075-2; MEDEMA RH, 1991, MOL CELL BIOL, V11, P5963, DOI 10.1128/MCB.11.12.5963; MOODIE SA, 1994, TRENDS GENET, V10, P44, DOI 10.1016/0168-9525(94)90147-3; MYERS MG, 1994, TRENDS BIOCHEM SCI, V19, P289, DOI 10.1016/0968-0004(94)90007-8; NAFUKU M, 1992, J BIOL CHEM, V267, P19448; OSTEROP APRM, 1993, EUR J BIOCHEM, V212, P477, DOI 10.1111/j.1432-1033.1993.tb17684.x; PELLICI G, 1992, CELL, V70, P93; PERALDI P, 1993, EUR J BIOCHEM, V218, P815, DOI 10.1111/j.1432-1033.1993.tb18436.x; PERALDI P, 1993, ENDOCRINOLOGY, V132, P2578, DOI 10.1210/en.132.6.2578; PRIGENT SA, 1990, J BIOL CHEM, V265, P9970; PRONK GJ, 1994, MOL CELL BIOL, V14, P1575, DOI 10.1128/MCB.14.3.1575; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; SATOH T, 1990, P NATL ACAD SCI USA, V87, P7926, DOI 10.1073/pnas.87.20.7926; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P2; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; WARD Y, 1994, NATURE, V367, P651, DOI 10.1038/367651a0; WELHAM MJ, 1994, J BIOL CHEM, V269, P21165; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O	49	103	103	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1485	1488		10.1074/jbc.270.4.1485	http://dx.doi.org/10.1074/jbc.270.4.1485			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829473				2022-12-27	WOS:A1995QD20400002
J	DATTA, AK; PAULSON, JC				DATTA, AK; PAULSON, JC			THE SIALYLTRANSFERASE SIALYLMOTIF PARTICIPATES IN BINDING THE DONOR SUBSTRATE CMP-NEUAC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; GAL-BETA-1->3(4)GLCNAC ALPHA-2->3 SIALYLTRANSFERASE; NH2-TERMINAL SIGNAL ANCHOR; GAL-BETA-1,3(4)GLCNAC ALPHA-2,3-SIALYLTRANSFERASE; MOLECULAR-CLONING; BOVINE COLOSTRUM; GOLGI-APPARATUS; GENE FAMILY; RAT-LIVER; EXPRESSION	All members of the sialyltransferase gene family cloned to date contain a conserved region, the ''sialyl-motif,'' consisting of 48-49 amino acids in the center of the coding sequence. To investigate the function of this motif, mutant constructs of the Gal beta 1,4GlcNAc alpha 2,6-sialyltransferase were designed by site directed mutagenesis, replacing 11 individual conserved amino acids with alanine. Each of the mutants was expressed in COS-1 cells, and eight of these retained sialyltransferase activity, allowing comparison of their enzymatic properties with that of the wild type enzyme. Kinetic analysis showed that six of eight mutants had a 3-12-fold higher K-m for the donor substrate CMP-NeuAc relative to the wild type enzyme, while the K-m values for the acceptor substrate were within 0.5-1.2-fold of the wild type for all eight mutants evaluated. The K-i of the donor substrate analog CDP was also evaluated for the recombinant sialyltransferase with the Val to Ala mutation at residue 220, which produced a 6-fold increase in K-m of CMP-NeuAc. A corresponding increase in K-i of 3.4-fold was observed for CDP, indicating a decreased affinity for the cytidine nucleotide. Taken together, these results suggest that the conserved sialylmotif in the sialyltransferase gene family participates in the binding of the common donor substrate, CMP-NeuAc.	CYTEL CORP, SAN DIEGO, CA 92121 USA; Scripps Res Inst, DEPT CHEM & MOLEC BIOL, SAN DIEGO, CA 92121 USA	Scripps Research Institute			Paulson, James/AAG-3565-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027904] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM27904] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAST BJEG, 1992, J CELL BIOL, V116, P423, DOI 10.1083/jcb.116.2.423; COLLEY KJ, 1989, J BIOL CHEM, V264, P17619; COLLEY KJ, 1992, J BIOL CHEM, V267, P7784; Corfield A. P., 1982, CELL BIOL MONOGR, V10, P195; DATTA AK, 1993, J BIOL CHEM, V268, P12663; DRICKAMER K, 1993, GLYCOBIOLOGY, V3, P2, DOI 10.1093/glycob/3.1.2; GILLESPIE W, 1992, J BIOL CHEM, V267, P21004; GROSS HJ, 1989, BIOCHEMISTRY-US, V28, P7386, DOI 10.1021/bi00444a036; GRUNDMANN U, 1990, NUCLEIC ACIDS RES, V18, P667, DOI 10.1093/nar/18.3.667; Hamamoto T, 1993, Bioorg Med Chem, V1, P141, DOI 10.1016/S0968-0896(00)82111-2; HARAGUCHI M, 1994, P NATL ACAD SCI USA, V91, P10455, DOI 10.1073/pnas.91.22.10455; HARLOW E, 1988, ANTIBODIES; KITAGAWA H, 1994, J BIOL CHEM, V269, P1394; KITAGAWA H, 1993, BIOCHEM BIOPH RES CO, V194, P375, DOI 10.1006/bbrc.1993.1830; KUROSAWA N, 1994, J BIOL CHEM, V269, P1402; KUROSAWA N, 1994, EUR J BIOCHEM, V219, P375, DOI 10.1111/j.1432-1033.1994.tb19949.x; LEE EU, 1989, J BIOL CHEM, V264, P13848; LEE YC, 1993, EUR J BIOCHEM, V216, P377, DOI 10.1111/j.1432-1033.1993.tb18155.x; LEE YC, 1994, J BIOL CHEM, V269, P10028; LIVINGSTON BD, 1993, J BIOL CHEM, V268, P11504; NARA K, 1994, P NATL ACAD SCI USA, V91, P7952, DOI 10.1073/pnas.91.17.7952; PAULSON JC, 1977, J BIOL CHEM, V252, P2356; PAULSON JC, 1977, J BIOL CHEM, V252, P2363; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; SASAKI K, 1994, J BIOL CHEM, V269, P15950; SASAKI K, 1993, J BIOL CHEM, V268, P22782; Schmid K., 1975, PLASMA PROTEINS, P183; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13845; WEINSTEIN J, 1987, J BIOL CHEM, V262, P17735; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13835; WEN DX, 1992, J BIOL CHEM, V267, P21011; YORK JL, 1986, TDB BIOCH, P117	35	170	185	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1497	1500		10.1074/jbc.270.4.1497	http://dx.doi.org/10.1074/jbc.270.4.1497			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829476	hybrid			2022-12-27	WOS:A1995QD20400005
J	KUNJI, ERS; HAGTING, A; DEVRIES, CJ; JUILLARD, V; HAANDRIKMAN, AJ; POOLMAN, B; KONINGS, WN				KUNJI, ERS; HAGTING, A; DEVRIES, CJ; JUILLARD, V; HAANDRIKMAN, AJ; POOLMAN, B; KONINGS, WN			TRANSPORT OF BETA-CASEIN-DERIVED PEPTIDES BY THE OLIGOPEPTIDE TRANSPORT-SYSTEM IS A CRUCIAL STEP IN THE PROTEOLYTIC PATHWAY OF LACTOCOCCUS-LACTIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSP CREMORIS WG2; STREPTOCOCCUS-LACTIS; MECHANISM; GROWTH	In the proteolytic pathway of Lactococcus lactis, milk proteins (caseins) are hydrolyzed extracellularly to oligopeptides by the proteinase (PrtP). The fate of these peptides, i.e. extracellular hydrolysis followed by amino acid uptake or transport followed by intracellular hydrolysis, has been addressed. Mutants have been constructed that lack a functional di-tripeptide transport system (DtpT) and/or oligopeptide transport system (Opp) but do express the P-1-type proteinase (specific for hydrolysis of beta- and to a lesser extent kappa-casein). The wild type strain and the DtpT(-) mutant accumulate all beta-casein-derived amino acids in the presence of beta-casein as protein substrate and glucose as a source of metabolic energy. The amino acids are not accumulated significantly inside the cells by the Opp(-) and DtpT(-) Opp(-) mutants. When cells are incubated with a mixture of amino acids mimicking the composition of beta-casein, the amino acids are taken up to the same extent in all four strains. Analysis of the extracellular peptide fraction, formed by the action of PrtP on beta-casein, indicates that distinct peptides disappear only when the cells express an active Opp system. These and other experiments indicate that (i) oligopeptide transport is essential for the accumulation of all beta-casein-derived amino acids, (ii) the activity of the Opp system is sufficiently high to support high growth rates on beta-casein provided leucine and histidine are present as free amino acids, and (iii) extracellular peptidase activity is not present in L. lactis.	UNIV GRONINGEN,GRONINGEN BIOMOLEC SCI & BIOTECHNOL INST,DEPT MICROBIOL,9751 NN HAREN,NETHERLANDS; UNIV GRONINGEN,GRONINGEN BIOMOLEC SCI & BIOTECHNOL INST,DEPT GENET,9751 NN HAREN,NETHERLANDS	University of Groningen; University of Groningen			Konings, Wilhelmus N./C-7063-2013; Kunji, Edmund/AAH-2362-2020	Kunji, Edmund/0000-0002-0610-4500				ANDERSON DG, 1983, APPL ENVIRON MICROB, V46, P549, DOI 10.1128/AEM.46.3.549-552.1983; BAANKREIS R, 1992, THESIS U WAGENINGEN; EXTERKATE FA, 1990, APPL MICROBIOL BIOT, V33, P401, DOI 10.1007/BF00176654; GASSON MJ, 1980, FEMS MICROBIOL LETT, V7, P51, DOI 10.1111/j.1574-6941.1980.tb01575.x; GASSON MJ, 1983, J BACTERIOL, V154, P1; HAGTING A, 1994, J BIOL CHEM, V269, P11391; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; HUGENHOLTZ J, 1985, FEMS MICROBIOL ECOL, V31, P57, DOI 10.1111/j.1574-6968.1985.tb01131.x; KOK J, 1984, APPL ENVIRON MICROB, V48, P726, DOI 10.1128/AEM.48.4.726-731.1984; KOK J, 1993, GENETICS BIOTECHNOLO, P169; KUNJI ERS, 1993, J BACTERIOL, V175, P2052, DOI 10.1128/JB.175.7.2052-2059.1993; LAAN H, 1989, APPL ENVIRON MICROB, V55, P3101, DOI 10.1128/AEM.55.12.3101-3106.1989; LEENHOUTS KJ, 1990, APPL ENVIRON MICROB, V56, P2726, DOI 10.1128/AEM.56.9.2726-2735.1990; LEENHOUTS KJ, 1991, APPL ENVIRON MICROB, V57, P2568, DOI 10.1128/AEM.57.9.2568-2575.1991; LOWRY OH, 1951, J BIOL CHEM, V193, P265; PAYNE JW, 1994, ADV MICROB PHYSIOL, V36, P1, DOI 10.1016/S0065-2911(08)60176-9; POOLMAN B, 1987, J BACTERIOL, V169, P2755, DOI 10.1128/jb.169.6.2755-2761.1987; POOLMAN B, 1987, J BACTERIOL, V169, P5597, DOI 10.1128/jb.169.12.5597-5604.1987; POOLMAN B, 1988, J BACTERIOL, V170, P700, DOI 10.1128/jb.170.2.700-707.1988; PRITCHARD GG, 1993, FEMS MICROBIOL REV, V12, P179, DOI [10.1016/0168-6445(93)90063-F, 10.1111/j.1574-6976.1993.tb00018.x]; SMID EJ, 1989, J BACTERIOL, V171, P6135, DOI 10.1128/jb.171.11.6135-6140.1989; SMID EJ, 1989, J BACTERIOL, V171, P292, DOI 10.1128/jb.171.1.292-298.1989; SMID EJ, 1991, APPL ENVIRON MICROB, V57, P2447, DOI 10.1128/AEM.57.9.2447-2452.1991; TAN PST, 1990, APPL ENVIRON MICROB, V56, P526, DOI 10.1128/AEM.56.2.526-532.1990; TAN PST, 1992, APPL ENVIRON MICROB, V58, P285, DOI 10.1128/AEM.58.1.285-290.1992; TYNKKYNEN S, 1993, J BACTERIOL, V175, P7523, DOI 10.1128/JB.175.23.7523-7532.1993	26	91	94	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1569	1574		10.1074/jbc.270.4.1569	http://dx.doi.org/10.1074/jbc.270.4.1569			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829486	hybrid, Green Submitted			2022-12-27	WOS:A1995QD20400016
J	MISHRA, VK; PALGUNACHARI, MN; LUNDKATZ, S; PHILLIPS, MC; SEGREST, JP; ANANTHARAMAIAH, GM				MISHRA, VK; PALGUNACHARI, MN; LUNDKATZ, S; PHILLIPS, MC; SEGREST, JP; ANANTHARAMAIAH, GM			EFFECT OF THE ARRANGEMENT OF TANDEM REPEATING UNITS OF CLASS-A AMPHIPATHIC ALPHA-HELIXES ON LIPID INTERACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHETIC PEPTIDE ANALOGS; APOLIPOPROTEIN-A-I; HIGH-DENSITY-LIPOPROTEIN; PERFORMANCE LIQUID-CHROMATOGRAPHY; CHOLESTEROL ACYLTRANSFERASE; PROTEIN INTERACTIONS; PLASMA LIPOPROTEINS; TRYPTOPHAN RESIDUES; SECONDARY STRUCTURE; WATER INTERFACE	Exchangeable apolipoproteins possess tandem repeating units of class A amphipathic helical segments and many of them are linked together by proline residues. To understand the optimal arrangement of the amphipathic helixes for lipid association, we have studied the interactions of three model class A amphipathic helical peptides with lipids. The three peptides are: 37pA, a dimer of 18A (DWLKAFYDKVAEKLKEAF) linked together by a Pro (18A-Pro-18A); 37aA, a dimer of 18A linked together by an Ala (18A-Ala-18A); and 36A, a dimer of 18A without any linker residue (18A-18A). Circular dichroism (CD) spectra showed that the peptides are predominantly alpha-helical in aqueous and lipid environments. Temperature dependent CD studies indicated that in buffer helix stability decreases in the order 36A > 37aA > 37pA; however, in the presence of dimyristoyl phosphatidylcholine (DMPC), the above order is reversed. The retention times of the peptides on a C-18 reversed-phase high performance liquid chromatography column decreased in the order 36A > 37aA > 37pA, consistent with the lengths of the nonpolar faces of the alpha-helixes being in the same order; the retention time of the parent 18A was shorter than 37pA. While 37pA adsorbed to egg phosphatidylcholine monolayers most strongly, the degree and rate of association of 36A were significantly lower. Differential scanning calorimetry indicated that, while 37pA was most effective in reducing the enthalpy of the gel to liquid-crystalline phase transition of DMPC multilamellar vesicles, 36A was least effective; 36A was even less effective than 18A. Fluorescence quenching experiments with iodide and acrylamide indicated that, in the presence of DMPC, Trp residues in 36A are most exposed to the quenchers while in 37pA they are least exposed. In the presence of DMPC, shielding of Trp in 18A from the quenchers was more than that observed with Trp residues in 36A. The results of this study suggest that the arrangement of tandem repeating amphipathic helical units which results in the formation of a class A amphipathic helix with a nonpolar face longer than five or six turns reduces the ability of the helix to associate with phospholipid.	UNIV ALABAMA,MED CTR,DEPT MED,BIRMINGHAM,AL 35294; UNIV ALABAMA,MED CTR,DEPT BIOCHEM,BIRMINGHAM,AL 35294; UNIV ALABAMA,MED CTR,ATHEROSCLEROSIS RES INST,BIRMINGHAM,AL 35294; MED COLL PENN,DEPT BIOCHEM,PHILADELPHIA,PA 19129	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Drexel University			Mishra, Vinod/S-1151-2019	Mishra, Vinod/0000-0002-4527-1512; Phillips, Michael/0000-0002-7147-8007	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034343, P01HL022633] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL34343, HL22633] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGUILAR MI, 1993, J CHROMATOGR, V646, P53, DOI 10.1016/S0021-9673(99)87007-1; ANANTHARAMAIAH GM, 1986, METHOD ENZYMOL, V128, P627; ANANTHARAMAIAH GM, 1990, ARTERIOSCLEROSIS, V10, P95, DOI 10.1161/01.ATV.10.1.95; ANANTHARAMAIAH GM, 1985, J BIOL CHEM, V260, P248; Atherton E., 1987, PEPTIDES ANAL SYNTHE, V9, P1; BLONDELLE SE, 1992, BIOCHEMISTRY-US, V31, P12688, DOI 10.1021/bi00165a020; BLONDELLE SE, 1993, BIOCHIM BIOPHYS ACTA, V1202, P331, DOI 10.1016/0167-4838(93)90024-L; BRASSEUR R, 1991, J BIOL CHEM, V266, P16120; BROUILLETTE CG, 1984, BIOCHEMISTRY-US, V23, P359, DOI 10.1021/bi00297a027; CHUNG BH, 1985, J BIOL CHEM, V260, P256; CORIJN J, 1993, BIOCHIM BIOPHYS ACTA, V1170, P8, DOI 10.1016/0005-2760(93)90169-A; DEKROON AIP, 1990, BIOCHEMISTRY-US, V29, P8229, DOI 10.1021/bi00488a006; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; IBDAH JA, 1989, BIOCHIM BIOPHYS ACTA, V1004, P300, DOI 10.1016/0005-2760(89)90077-5; JORGENSEN EV, 1989, J BIOL CHEM, V264, P9215; KURZBAN GP, 1989, BIOCHEMISTRY-US, V28, P8537, DOI 10.1021/bi00447a040; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; LAU SYM, 1984, J CHROMATOGR, V317, P129, DOI 10.1016/S0021-9673(01)91653-X; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; LIU DX, 1990, BIOCHEMISTRY-US, V29, P3637, DOI 10.1021/bi00467a008; Marsh D., 2013, HDB LIPID BILAYERS; MCLEAN LR, 1991, BIOCHEMISTRY-US, V30, P31, DOI 10.1021/bi00215a005; MISHRA VK, 1994, J BIOL CHEM, V269, P7185; MORRISET.JD, 1973, BIOCHEMISTRY-US, V12, P1290, DOI 10.1021/bi00731a008; MORRISETT JD, 1977, BIOCHIM BIOPHYS ACTA, V472, P93, DOI 10.1016/0304-4157(77)90015-6; NAKAGAWA SH, 1985, J AM CHEM SOC, V107, P7087, DOI 10.1021/ja00310a055; PHILLIPS MC, 1986, METHOD ENZYMOL, V128, P387; PONSIN G, 1986, J BIOL CHEM, V261, P9202; Richardson J. S., 1989, PREDICTION PROTEIN S, P1; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; SEGREST JP, 1992, J LIPID RES, V33, P141; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; SPARKS DL, 1992, J BIOL CHEM, V267, P25830; SPARROW JT, 1992, BIOCHEMISTRY-US, V31, P1065, DOI 10.1021/bi00119a015; THIAUDIERE E, 1993, BIOCHEMISTRY-US, V32, P12186, DOI 10.1021/bi00096a031; VENKATACHALAPATHI, 1993, PROTEINS, V15, P349; WESTERLUND JA, 1993, J BIOL CHEM, V268, P15745; Woody RW, 1985, PEPTIDES ANAL SYNTHE, P15; ZHOU N E, 1990, Peptide Research, V3, P8; [No title captured]	42	33	46	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1602	1611		10.1074/jbc.270.4.1602	http://dx.doi.org/10.1074/jbc.270.4.1602			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829491	hybrid			2022-12-27	WOS:A1995QD20400021
J	ROULEAU, J; MACLEOD, AR; SZYF, M				ROULEAU, J; MACLEOD, AR; SZYF, M			REGULATION OF THE DNA METHYLTRANSFERASE BY THE RAS-AP-1 SIGNALING PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENOVO METHYLATION; C-JUN; GLUCOCORTICOID RECEPTOR; CARCINOMA-CELLS; GENE-EXPRESSION; COLON CANCER; CPG ISLANDS; HA-RAS; LEVEL; CDNA	Using deletion analysis and site-specific mutagenesis to map the 5' regulatory region of the DNA methyltransferase (MeTase) gene, we show that a 106-bp sequence (at -1744 to -1650) bearing three AP-1 sites is responsible for induction of DNA MeTase promoter activity. Using transient cotransfection chloramphenicol acetyltransferase assays in P19 cells, we show that the DNA MeTase promoter is induced by c-Jun or Ha-Ras but not by a dominant negative mutant of Jun, partial derivative 9. The activation of the DNA MeTase promoter by Jun is inhibited in a ligand dependent manner by the glucocorticoid receptor, Stable expression of Ha-Ras in P19 cells results in induction of transcription of the DNA MeTase mRNA as determined by nuclear run on assays and the steady state levels of DNA MeTase mRNA as determined by an RNase protection assay. These experiments establish a potential molecular link between nodal cellular signaling pathways and the control of expression of the DNA MeTase gene. This provides us with a possible molecular explanation for the hyperactivation of DNA MeTase in many cancer cells and suggests that DNA MeTase is one possible downstream effector of Ras.	MCGILL UNIV, DEPT PHARMACOL & THERAPEUT, MONTREAL, PQ H3G 1Y6, CANADA	McGill University								ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; AUSBEL FM, 1988, CURRENT PROTOCOLS MO; BAXTER JD, 1972, AM J MED, V53, P573, DOI 10.1016/0002-9343(72)90154-4; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; BINETRUY B, 1991, NATURE, V351, P122, DOI 10.1038/351122a0; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; DEBUSTROS A, 1988, P NATL ACAD SCI USA, V85, P5693; DEGROOT RP, 1990, NUCLEIC ACIDS RES, V18, P3195, DOI 10.1093/nar/18.11.3195; DEGROOT RP, 1990, EMBO J, V9, P1831, DOI 10.1002/j.1460-2075.1990.tb08308.x; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; ELDEIRY WS, 1991, P NATL ACAD SCI USA, V88, P3470, DOI 10.1073/pnas.88.8.3470; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Jones P A, 1990, Adv Cancer Res, V54, P1, DOI 10.1016/S0065-230X(08)60806-4; JONES PA, 1990, P NATL ACAD SCI USA, V87, P6117, DOI 10.1073/pnas.87.16.6117; JONES PA, 1992, BIOESSAYS, V14, P33, DOI 10.1002/bies.950140107; JONES PA, 1985, CELL, V40, P485, DOI 10.1016/0092-8674(85)90192-8; KAUTIAINEN TL, 1986, J BIOL CHEM, V261, P1594; LEE SW, 1992, P NATL ACAD SCI USA, V89, P2504, DOI 10.1073/pnas.89.6.2504; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LLOYD A, 1991, NATURE, V352, P632, DOI 10.1038/352635a0; MAKOS M, 1992, P NATL ACAD SCI USA, V89, P1929, DOI 10.1073/pnas.89.5.1929; MIGEON BR, 1991, SOMAT CELL MOLEC GEN, V17, P159, DOI 10.1007/BF01232973; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; RAZIN A, 1984, BIOCHIM BIOPHYS ACTA, V782, P331, DOI 10.1016/0167-4781(84)90043-5; RAZIN A, 1985, BIOCH BIOL DNA METHY, P239; ROULEAU J, 1992, J BIOL CHEM, V267, P7368; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; SZYF M, 1992, J BIOL CHEM, V267, P12831; SZYF M, 1985, J BIOL CHEM, V260, P8653; SZYF M, 1989, P NATL ACAD SCI USA, V86, P6853, DOI 10.1073/pnas.86.18.6853; SZYF M, 1991, J BIOL CHEM, V266, P10027; SZYF M, 1991, BIOCHEM CELL BIOL, V69, P764, DOI 10.1139/o91-117; SZYF M, 1994, TRENDS PHARMACOL SCI, V15, P233, DOI 10.1016/0165-6147(94)90317-4; SZYF M, 1984, P NATL ACAD SCI-BIOL, V81, P3278, DOI 10.1073/pnas.81.11.3278; SZYF M, 1990, MOL ENDOCRINOL, V4, P1144, DOI 10.1210/mend-4-8-1144; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; WELLER MD, 1987, J BIOL CHEM, V262, P15202; WU JJ, 1993, P NATL ACAD SCI USA, V90, P8891, DOI 10.1073/pnas.90.19.8891; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; YISRAELI J, 1984, DNA METHYLATION BIOC, P353	45	124	127	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1595	1601		10.1074/jbc.270.4.1595	http://dx.doi.org/10.1074/jbc.270.4.1595			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829490	hybrid			2022-12-27	WOS:A1995QD20400020
J	WANG, GL; SEMENZA, GL				WANG, GL; SEMENZA, GL			PURIFICATION AND CHARACTERIZATION OF HYPOXIA-INDUCIBLE FACTOR-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ERYTHROPOIETIN GENE; DNA-BINDING ACTIVITY; FACTOR-I; TRANSCRIPTIONAL RESPONSE; POLYACRYLAMIDE GELS; ENHANCER ELEMENT; HEPATOMA-CELLS; PHORBOL ESTER; EXPRESSION; PROTEIN	Hypoxia-inducible factor 1 (HIP-1) is a DNA-binding protein that activates erythropoietin (Epo) gene transcription in Hep3B cells subjected to hypoxia or cobalt chloride treatment. HIF-1 DNA binding activity is also induced by hypoxia or cobalt in non-Epo-producing cells, suggesting a general role for HIF-1 in hypoxia signal transduction and transcriptional regulation. Here we report the biochemical purification of HIF-1 from Epo-producing Hep3B cells and non-Epo-producing HeLa S3 cells. HIF-1 protein was purified 11,250-fold by DEAE ion-exchange and DNA affinity chromatography. Analysis of HIF-1 isolated from a preparative gel shift assay revealed four polypeptides. Peptide mapping of these HIF-1 components demonstrated that 91-, 93-, and 94-kDa polypeptides had similar tryptic maps, whereas the 120-kDa polypeptide had a distinct profile. Glycerol gradient sedimentation analysis suggested that HIF-1 exists predominantly in a heterodimeric form and to a lesser extent as a heterotetramer. Partially purified HIF-1 bound specifically to the wild-type HIF-1 binding site from the EPO enhancer but not to a mutant sequence that lacks hypoxia-inducible enhancer activity. UV cross-linking analysis with purified HIF-1 indicated that both subunits of HIF-1 contact DNA directly. We conclude that in both cobalt chloride treated HeLa cells and hypoxic Hep3B cells HIF-1 is composed of two different subunits: 120-kDa HIF-1 alpha and 91-94-kDa HIF-1 beta.	JOHNS HOPKINS UNIV, SCH MED, CTR GENET MED, DEPT PEDIAT, BALTIMORE, MD 21287 USA; JOHNS HOPKINS UNIV, SCH MED, CTR GENET MED, DEPT MED, BALTIMORE, MD 21287 USA	Johns Hopkins University; Johns Hopkins University					NIDDK NIH HHS [DK 39869] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039869] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BECK I, 1993, BLOOD, V82, P704; BECK I, 1991, J BIOL CHEM, V266, P15563; BERU N, 1986, MOL CELL BIOL, V6, P2571, DOI 10.1128/MCB.6.7.2571; BEST S, 1994, TECHNIQUES IN PROTEIN CHEMISTRY V, P205; BLANCHARD KL, 1992, MOL CELL BIOL, V12, P5373, DOI 10.1128/MCB.12.12.5373; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CZYZYKKRZESKA MF, 1994, J BIOL CHEM, V269, P760; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GOLDBERG MA, 1991, BLOOD, V77, P271; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; JACKSON SP, 1989, P NATL ACAD SCI USA, V86, P1781, DOI 10.1073/pnas.86.6.1781; JELKMANN W, 1991, BIOCHEM BIOPH RES CO, V179, P1441, DOI 10.1016/0006-291X(91)91734-T; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KOUREMBANAS S, 1991, J CLIN INVEST, V88, P1054, DOI 10.1172/JCI115367; KOUREMBANAS S, 1990, J CLIN INVEST, V86, P670, DOI 10.1172/JCI114759; KRANTZ SB, 1991, BLOOD, V77, P419; KURTZ A, 1992, AM J PHYSIOL, V262, pC1204, DOI 10.1152/ajpcell.1992.262.5.C1204; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LICHTSTEINER S, 1989, CELL, V57, P1179, DOI 10.1016/0092-8674(89)90055-X; MADAN A, 1993, P NATL ACAD SCI USA, V90, P3928, DOI 10.1073/pnas.90.9.3928; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MAXWELL PH, 1993, P NATL ACAD SCI USA, V90, P2423, DOI 10.1073/pnas.90.6.2423; PUGH CW, 1991, P NATL ACAD SCI USA, V88, P10553, DOI 10.1073/pnas.88.23.10553; ROSENFELD PJ, 1986, J BIOL CHEM, V261, P1398; SCHUSTER SJ, 1989, BLOOD, V73, P13; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; SWITZER RC, 1979, ANAL BIOCHEM, V98, P231, DOI 10.1016/0003-2697(79)90732-2; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1993, BLOOD, V82, P3610; WANG GL, 1993, J BIOL CHEM, V268, P21513; WEBSTER KA, 1990, J CELL PHYSIOL, V142, P566, DOI 10.1002/jcp.1041420316	36	1615	1717	5	139	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1230	1237		10.1074/jbc.270.3.1230	http://dx.doi.org/10.1074/jbc.270.3.1230			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836384	hybrid			2022-12-27	WOS:A1995QB15600039
J	BEGUM, N				BEGUM, N			STIMULATION OF PROTEIN PHOSPHATASE-1 ACTIVITY BY INSULIN IN RAT ADIPOCYTES - EVALUATION OF THE ROLE OF MITOGEN-ACTIVATED PROTEIN-KINASE PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; 3T3-L1 ADIPOCYTES; GLYCOGEN-SYNTHESIS; SIGNALING PATHWAY; GLUCOSE-TRANSPORT; PHOSPHORYLATION; SUBUNIT; CELLS; CAMP; IDENTIFICATION	In this study, we examined the distribution of protein serine/threonine phosphatase-1 (PP-1) and analyzed the effect of insulin on PP-1 and its mechanism of activation in freshly isolated rat adipocytes. The adipocyte particulate fraction (PF) constituted approximate to 80% of cellular PP-1 activity, while PP-2A was entirely cytosolic. Insulin rapidly stimulated PF PP-1 in a time- and dose-dependent manner (maximum stimulation at 5 min with 4 nM insulin). Immunoprecipitation of PF with an antibody against the site-1 sequence of rabbit skeletal muscle glycogen-associated PP-1 (PP-1G) subunit indicated that approximate to 40% of adipocyte PP-1 activity was due to PP-1G form of the enzyme, Insulin stimulated PP-1G (120% over basal levels) without affecting the other forms of PP-1 in the PF. Insulin activation of PP-1 was accompanied by > 2-fold increase in the phosphorylation state of the 160-kDa regulatory subunit of PP-1. Stimulation of p21(Ras)/mitogen-activated protein kinase pathway (MAP) with GTP analogues also resulted in stimulation of PP-1 similar to insulin, The insulin effect on MAP kinase and PP-1 activation was blocked by a GTP antagonist, guanyl-5'-yl thiophosphate. The inhibitors of MAP kinase activation (viz. cAMP agonists, SpcAMP and ML-9) also blocked PP-1 stimulation by insulin. The time course of MAP kinase activation preceded the phosphorylation of PP-1 regulatory subunit and PP-1 activation, We conclude that insulin rapidly activates a membrane-associated PP-1 in adipocytes, which may be similar to rabbit skeletal muscle PP-1G, and the activation is mediated by p21(Ras)/MAP kinase pathway.	SUNY STONY BROOK, SCH MED, STONY BROOK, NY 11790 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	BEGUM, N (corresponding author), WINTHROP UNIV HOSP, DIABET RES LAB, 259 1ST ST, MINEOLA, NY 11501 USA.							ALESSI DR, 1993, EUR J BIOCHEM, V213, P1055, DOI 10.1111/j.1432-1033.1993.tb17853.x; AVRUCH J, 1976, J BIOL CHEM, V251, P1511; BEGUM N, 1994, AM J PHYSIOL, V267, pE14, DOI 10.1152/ajpendo.1994.267.1.E14; BURGERING BMT, 1991, EMBO J, V10, P1103, DOI 10.1002/j.1460-2075.1991.tb08050.x; BURGERING BMT, 1993, EMBO J, V12, P4211, DOI 10.1002/j.1460-2075.1993.tb06105.x; CHAN CP, 1988, P NATL ACAD SCI USA, V85, P6257, DOI 10.1073/pnas.85.17.6257; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; CHUNG J, 1991, P NATL ACAD SCI USA, V88, P4981, DOI 10.1073/pnas.88.11.4981; COHEN P, 1988, PROC R SOC SER B-BIO, V234, P115, DOI 10.1098/rspb.1988.0040; COHEN P, 1991, METHOD ENZYMOL, V201, P389; COHEN P, 1989, FEBS LETT, V250, P596, DOI 10.1016/0014-5793(89)80803-8; COHEN P, 1983, METHOD ENZYMOL, V99, P243; COHEN P, 1989, J BIOL CHEM, V264, P21435; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; DENT P, 1990, NATURE, V348, P302, DOI 10.1038/348302a0; DRAZNIN B, 1993, J BIOL CHEM, V268, P19998; FINGAR DC, 1994, ENDOCRINOLOGY, V134, P728, DOI 10.1210/en.134.2.728; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; GRUPPUSO PA, 1987, BIOCHEM BIOPH RES CO, V148, P1174, DOI 10.1016/S0006-291X(87)80256-5; HIRAGA A, 1987, EUR J BIOCHEM, V163, P253, DOI 10.1111/j.1432-1033.1987.tb10795.x; HUBBARD MJ, 1990, EUR J BIOCHEM, V189, P243, DOI 10.1111/j.1432-1033.1990.tb15483.x; HUBBARD MJ, 1989, EUR J BIOCHEM, V186, P701, DOI 10.1111/j.1432-1033.1989.tb15263.x; INOUE G, 1993, J BIOL CHEM, V268, P5272; KLARLUND JK, 1993, J BIOL CHEM, V268, P7646; KOZMA L, 1993, P NATL ACAD SCI USA, V90, P4460, DOI 10.1073/pnas.90.10.4460; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LARNER J, 1990, ADV ENZYMOL RAMB, V63, P173; LAVOINNE A, 1991, EUR J BIOCHEM, V199, P723, DOI 10.1111/j.1432-1033.1991.tb16176.x; MACKINTOSH C, 1988, FEBS LETT, V234, P189, DOI 10.1016/0014-5793(88)81331-0; OKADA T, 1994, J BIOL CHEM, V269, P3563; ROBINSON LJ, 1993, J BIOL CHEM, V268, P26422; SATOH T, 1992, J BIOL CHEM, V267, P24149; SEALS JR, 1979, J BIOL CHEM, V254, P6991; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SRINIVASAN M, 1994, J BIOL CHEM, V269, P16662; STEVENSON BR, 1993, P NATL ACAD SCI USA, V90, P10305; TANG PM, 1991, J BIOL CHEM, V266, P15782; VANDENBERGHE N, 1994, MOL CELL BIOL, V14, P2372, DOI 10.1128/MCB.14.4.2372; VILLAMORUZZI E, 1989, FEBS LETT, V258, P208, DOI 10.1016/0014-5793(89)81654-0; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366	41	49	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					709	714		10.1074/jbc.270.2.709	http://dx.doi.org/10.1074/jbc.270.2.709			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822300	hybrid			2022-12-27	WOS:A1995QB81600034
J	CHENG, D; CHANG, CCY; QU, XM; CHANG, TY				CHENG, D; CHANG, CCY; QU, XM; CHANG, TY			ACTIVATION OF ACYL-COENZYME A-CHOLESTEROL ACYLTRANSFERASE BY CHOLESTEROL OR BY OXYSTEROL IN A CELL-FREE SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEIN; HAMSTER OVARY CELLS; INTRACELLULAR-TRANSPORT; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; METABOLISM; COA; ATHEROSCLEROSIS; RECONSTITUTION; FIBROBLASTS	Acyl-coenzyme A:cholesterol acyltransferase (ACAT) is an intracellular enzyme that catalyzes the conjugation of long chain fatty acid and cholesterol to form cholesteryl esters. It is an integral membrane protein located in the endoplasmic reticulum. Experiments performed in intact mammalian cells have shown that the rate of cholesteryl ester synthesis in intact cells, as well as the ACAT activity from cell extracts, are greatly activated by the addition of low density lipoprotein (LDL) or oxygenated sterols such as 25-hydroxycholesterol to the growth medium, However, the molecular mechanism(s) by which sterol(s) stimulate the ACAT activity remains to be elucidated. Recently, our laboratory reported the expression cloning of human ACAT cDNA (Chang, C. C. Y., Huh, H. Y., Cadigan, K. M., and Chang, T. Y. 1993) J. Biol. Chem. 268, 20747-20755). In the current study, we report the expression of human ACAT cDNA in insect Sf9 cells, Uninfected Sf9 cells do not express detectable ACAT-like activity. Infecting these cells with recombinant virus containing ACAT cDNA caused these cells to express high levels of ACAT protein and high levels of ACAT activity when assayed in vitro. The catalytic properties of ACAT expressed in these cells were found to be similar to those found in human tissue culture cells, The combination of high level of ACAT protein expression and the low level of cellular cholesterol content in the infected cells have provided us a novel opportunity to establish a simple cell-free system, whereby stimulation of ACAT by sterols can be readily demonstrated, Using this system, we have shown that cholesterol itself can serve as an ACAT activator in vitro, in addition to its role as an ACAT substrate. The current work provides the experimental basis to hypothesize that, inside mammalian cells, cholesterol itself may serve as a physiological regulator of ACAT.	DARTMOUTH COLL,SCH MED,DEPT BIOCHEM,HANOVER,NH 03755	Dartmouth College				Chang, Ta-Yuan/0000-0002-3249-0468	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036709, R01HL036709] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL36709] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BECKER A, 1994, ARTERIOSCLER THROMB, V14, P1346, DOI 10.1161/01.ATV.14.8.1346; BILLHEIMER JT, 1990, Patent No. 372445; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; BROWN MS, 1975, J BIOL CHEM, V250, P4925; CADIGAN KM, 1988, J LIPID RES, V29, P1683; CADIGAN KM, 1989, J CELL BIOL, V108, P2201, DOI 10.1083/jcb.108.6.2201; CADIGAN KM, 1988, J BIOL CHEM, V263, P274; CHANG CCY, 1986, BIOCHEMISTRY-US, V25, P1700, DOI 10.1021/bi00355a039; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; CHANG CCY, 1994, SOMAT CELL MOLEC GEN, V20, P71, DOI 10.1007/BF02257489; CHANG TY, 1981, ANAL BIOCHEM, V116, P298, DOI 10.1016/0003-2697(81)90360-2; CHANG TY, 1994, TRENDS CARDIOVAS MED, V4, P223, DOI 10.1016/1050-1738(94)90038-8; CHANG TY, 1983, ENZYMES, V16, P523; COLEMAN RA, 1983, ENZYMES, V16, P605; DAHL NK, 1992, J BIOL CHEM, V267, P4889; DAWIDOWICZ EA, 1987, ANNU REV BIOCHEM, V56, P43, DOI 10.1146/annurev.bi.56.070187.000355; DEGRELLA RF, 1982, J BIOL CHEM, V257, P4256; DOOLITTLE GM, 1982, BIOCHIM BIOPHYS ACTA, V713, P529, DOI 10.1016/0005-2760(82)90313-7; DOOLITTLE GM, 1982, BIOCHEMISTRY-US, V21, P674, DOI 10.1021/bi00533a014; ERICKSON SK, 1994, J LIPID RES, V35, P763; ERICKSON SK, 1980, J LIPID RES, V21, P930; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; GOLDSTEIN JL, 1974, P NATL ACAD SCI USA, V71, P4288, DOI 10.1073/pnas.71.11.4288; HARTE RA, 1993, BIOCHEM SOC T, V21, P3255; HEYMANN E, 1980, ENZYMATIC BASIS DETO, V2, P291; JINGAMI H, 1987, J CELL BIOL, V104, P1693, DOI 10.1083/jcb.104.6.1693; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; KOSHLAND DE, 1968, ANNU REV BIOCHEM, V37, P359, DOI 10.1146/annurev.bi.37.070168.002043; KRAUSE BR, 1989, 10TH INT S DRUGS AFF; KROETZ DL, 1993, BIOCHEMISTRY-US, V32, P11606, DOI 10.1021/bi00094a018; KRUTH HS, 1986, J BIOL CHEM, V261, P6769; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGE Y, 1983, J BIOL CHEM, V258, P5130; LANGE Y, 1993, J BIOL CHEM, V268, P13838; LAUTENSCHLAEGER H H, 1986, Drugs of the Future, V11, P26; LICHTENSTEIN AH, 1980, J BIOL CHEM, V255, P9098; LISCUM L, 1989, J CELL BIOL, V108, P1625, DOI 10.1083/jcb.108.5.1625; Liscum Laura, 1994, Current Opinion in Lipidology, V5, P221, DOI 10.1097/00041433-199405030-00010; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; MUNGER JS, 1991, J BIOL CHEM, V266, P18832; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; OZOLS J, 1989, J BIOL CHEM, V264, P12533; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; RUDEL LL, 1973, J LIPID RES, V14, P364; Sambrook J, 1989, MOL CLONING LABORATO; SINENSKY M, 1981, ARCH BIOCHEM BIOPHYS, V209, P321, DOI 10.1016/0003-9861(81)90287-3; SKALNIK DG, 1988, J BIOL CHEM, V263, P6836; SUCKLING KE, 1985, J LIPID RES, V26, P647; SUMMERS MD, 1987, B TEXAS AGR EXPT STA, V1555, P10; TABAS I, 1988, J BIOL CHEM, V263, P1266; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VENTIMIGLIA JB, 1986, ANAL BIOCHEM, V157, P323, DOI 10.1016/0003-2697(86)90633-0; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8	53	143	149	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					685	695		10.1074/jbc.270.2.685	http://dx.doi.org/10.1074/jbc.270.2.685			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822296	hybrid			2022-12-27	WOS:A1995QB81600030
J	KEREN, N; GONG, HS; OHAD, I				KEREN, N; GONG, HS; OHAD, I			OSCILLATIONS OF REACTION-CENTER-II D1-PROTEIN-DEGRADATION IN-VIVO INDUCED BY REPETITIVE LIGHT-FLASHES - CORRELATION BETWEEN THE LEVEL OF RCII-Q(B)(-), AND PROTEIN-DEGRADATION IN LOW-LIGHT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; II REACTION CENTER; PHOTOSYSTEM-II; THERMO-LUMINESCENCE; D1 PROTEIN; CHLAMYDOMONAS-REINHARDTII; PHOTOINHIBITION INVIVO; SCENEDESMUS-OBLIQUUS; THYLAKOID MEMBRANES; ELECTRON-TRANSFER	The D1 protein subunit of the photochemical reaction center II (RCII) turns over rapidly in oxygenic photosynthetic organisms exposed to the light. At high photon nux densities (PFD), photoinactivation of RCII precedes the degradation of the D1 protein. We Pound that the apparent quantum yield for the DI protein degradation in Chlamydomonas cells is severalfold higher at low PFDs (10-100 mu mol m(-2) s(-1)) as compared to that observed at PFDs which induce photoinactivation of RCII (1.53 x 10(3) mu mol m(-2) s(-1)). Relative high levels of reduced RCII secondary plastoquinone acceptor, Q(B)(-), are induced in cells exposed to low PFDs as determined by thermoluminescence measurements. The probability of generating elevated levels of Q(B)(-) which may recombine with the S-2,S-3 oxidized states of the oxygen evolving complex decreases with increase in the light intensities at which consecutive double reduction of Q(B) and exchange with the plastoquinone pool prevail. We have used light flashes to test if a correlation exists between the degradation of D1 protein and the relative level of Q(B)(-). D1 protein degradation could be induced in dark-incubated cells exposed to a series of 1.4 x 10(3) single light flashes given at intervals compatible with generation of elevated levels of Q(B)(-) and its decay by charge recombination. Oscillations of the Q(B)(-) level in cells exposed to 960-1440 series of 1 to several flashes correlated with oscillations of the D1 protein degradation in Chlamydomonas cells and in the Scenedesmus wild type but not in the LF-1 mutant lacking photosystem II donor side activity. In this mutant the ''S state cycle'' and Q(B)(-) oscillations are abolished. We propose that the process of recombination of long lived RCII-Q(B)(-) with the S-2,S-3 states may involve damaging events related to the D1 protein degradation induced by light flashes or continuous low light in vivo.	HEBREW UNIV JERUSALEM,SILBERMAN INST LIFE SCI,DEPT BIOL CHEM,IL-91904 JERUSALEM,ISRAEL; UNIV OSLO,DEPT BIOL,N-0316 OSLO 3,NORWAY	Hebrew University of Jerusalem; University of Oslo				Keren, Nir/0000-0002-7356-8831				ADIR N, 1988, J BIOL CHEM, V263, P283; ANDERSSON B, 1992, 2 PHOTOSYSTEMS OXYGE, P122; ARNTZ B, 1986, FEBS LETT, V194, P43, DOI 10.1016/0014-5793(86)80048-5; ARO EM, 1990, BIOCHIM BIOPHYS ACTA, V1019, P269, DOI 10.1016/0005-2728(90)90204-H; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; ARO EM, 1994, PLANT PHYSIOL, V104, P1033, DOI 10.1104/pp.104.3.1033; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; BURNAP RL, 1992, BIOCHEMISTRY-US, V31, P7404, DOI 10.1021/bi00147a027; DEMETER S, 1989, PHYSIOL PLANTARUM, V75, P121, DOI 10.1111/j.1399-3054.1989.tb02073.x; DINER BA, 1988, J BIOL CHEM, V263, P8972; DURRANT JR, 1990, BIOCHIM BIOPHYS ACTA, V1017, P167, DOI 10.1016/0005-2728(90)90148-W; ECKERT HJ, 1991, PHOTOSYNTH RES, V27, P97, DOI 10.1007/BF00033249; ETIENNE AL, 1993, PHOTOSYNTH RES, V38, P387, DOI 10.1007/BF00046765; GEIGER R, 1987, Z NATURFORSCH C, V42, P491; GONG H, 1991, J BIOL CHEM, V266, P21293; GREENBERG BM, 1987, EMBO J, V6, P2865, DOI 10.1002/j.1460-2075.1987.tb02588.x; GREENBERG BM, 1989, P NATL ACAD SCI USA, V86, P6617, DOI 10.1073/pnas.86.17.6617; HIDEG E, 1994, BBA-BIOENERGETICS, V1186, P143, DOI 10.1016/0005-2728(94)90173-2; HUNDAL T, 1990, FEBS LETT, V267, P203, DOI 10.1016/0014-5793(90)80925-9; JANSEN MAK, 1993, J BIOL CHEM, V268, P21246; KIRILOVSKY DL, 1990, BIOCHEMISTRY-US, V29, P8100, DOI 10.1021/bi00487a016; KOIVUNIEMI A, 1993, FEBS LETT, V327, P343, DOI 10.1016/0014-5793(93)81017-T; KRIEGER A, 1992, BIOCHIM BIOPHYS ACTA, V1102, P167, DOI 10.1016/0005-2728(92)90097-L; KRIEGER A, 1993, PHOTOSYNTH RES, V37, P117, DOI 10.1007/BF02187470; KYLE DJ, 1987, TOPICS PHOTOSYNTHESI, V9, P197; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVANON H, 1982, MOL BIOL BIOCH BIOPH, V35, P152; MAYES SR, 1991, BIOCHIM BIOPHYS ACTA, V1060, P1, DOI 10.1016/S0005-2728(05)80112-4; MEUNIER PC, 1993, PHOTOSYNTH RES, V36, P111, DOI 10.1007/BF00016276; OHAD I, 1967, J CELL BIOL, V35, P521, DOI 10.1083/jcb.35.3.521; OHAD I, 1990, J BIOL CHEM, V265, P1972; OHAD I, 1988, BIOCHIM BIOPHYS ACTA, V933, P288, DOI 10.1016/0005-2728(88)90036-9; OHAD I, 1994, PHOTOINHIBITION PHOT, P165; OHAD N, 1990, Z NATURFORSCH C, V45, P402; ONO T, 1989, BIOCHIM BIOPHYS ACTA, V973, P443, DOI 10.1016/S0005-2728(89)80386-X; PEREWOSKA I, 1994, PLANT PHYSIOL, V104, P235, DOI 10.1104/pp.104.1.235; PRASIL O, 1992, PHOTOSYSTEMS STRUCTU, P295, DOI DOI 10.1016/B978-0-444-89440-3.50017-5; RADMER RJ, 1977, ENCYCLOPEDIA PLANT P, V5, P125; RAVEN AJ, 1982, PLANT CELL ENVIRON, V5, P117; ROVA M, 1994, PHOTOSYNTH RES, V39, P75, DOI 10.1007/BF00027145; RUTHERFORD AW, 1982, BIOCHIM BIOPHYS ACTA, V682, P457, DOI 10.1016/0005-2728(82)90061-5; RUTHERFORD AW, 1989, TRENDS BIOCHEM SCI, V14, P227, DOI 10.1016/0968-0004(89)90032-7; SCHNETTGER B, 1994, PLANT CELL ENVIRON, V17, P85; SCHUSTER G, 1988, EUR J BIOCHEM, V177, P403, DOI 10.1111/j.1432-1033.1988.tb14389.x; SEIBERT M, 1989, BIOCHIM BIOPHYS ACTA, V974, P185, DOI 10.1016/S0005-2728(89)80371-8; SUNDBY C, 1993, J BIOL CHEM, V268, P25476; VANGORKOM HJ, 1985, PHOTOSYNTH RES, V6, P97, DOI 10.1007/BF00032785; VANGORKOM HJ, 1986, PHOTOSYNTH RES, V9, P55, DOI 10.1007/BF00029731; VANMIEGHEM FJE, 1989, BIOCHIM BIOPHYS ACTA, V977, P207, DOI 10.1016/S0005-2728(89)80073-8; VASS I, 1992, BIOCHIM BIOPHYS ACTA, V1102, P195, DOI 10.1016/0005-2728(92)90100-G; VASS I, 1981, BIOCHIM BIOPHYS ACTA, V634, P140, DOI 10.1016/0005-2728(81)90134-1; VASS I, 1992, P NATL ACAD SCI USA, V89, P1408, DOI 10.1073/pnas.89.4.1408; VOLK M, 1993, FEBS LETT, V336, P357, DOI 10.1016/0014-5793(93)80837-K; ZER H, 1994, J BIOL CHEM, V269, P17670	54	92	92	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					806	814		10.1074/jbc.270.2.806	http://dx.doi.org/10.1074/jbc.270.2.806			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822315	hybrid			2022-12-27	WOS:A1995QB81600049
J	MACDOUGALD, OA; CORNELIUS, P; LIU, R; LANE, MD				MACDOUGALD, OA; CORNELIUS, P; LIU, R; LANE, MD			INSULIN REGULATES TRANSCRIPTION OF THE CCAAT/ENHANCER BINDING-PROTEIN (C/EBP) ALPHA-GENE, BETA-GENE, AND DELTA-GENE IN FULLY-DIFFERENTIATE 3T3-L1 ADIPOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; ALPHA-1-ACID GLYCOPROTEIN GENE; ADIPOSE CELL LINE; GLUCOSE TRANSPORTER; MESSENGER-RNA; ACTIVATOR PROTEIN; OKADAIC ACID; DNA-BINDING; EXPRESSION; PREADIPOCYTES	The effect of insulin on expression of CCAAT/enhancer binding protein (C/EBP) alpha, beta, and delta was investigated in fully-differentiated 3T3-L1 adipocytes. Treatment of adipocytes with insulin stimulated rapid dephosphorylation of C/EBP alpha, and repressed the expression of C/EBP alpha within 2-4 h, with > 90% suppression occurring at 24 h, While insulin induced expression of C/EBP beta and C/EBP delta within 1 h and caused a > 20-fold increase by 4 h, expression returned to nearly pretreat ment levels by 24 h, The insulin concentration dependence of these effects was consistent with involvement of the insulin receptor, Gel shift analysis revealed that 6 h of insulin treatment decreased the binding of nuclear C/EBP alpha while increasing binding of nuclear C/EBP beta and C/EBP delta. The reciprocal effects of insulin on the steady-state levels of C/EBP transcription factors can be accounted for kinetically and quantitatively by changes in their mRNA levels, which can be accounted for by effects on gene transcription. The effects of insulin on adipocyte gene transcription (e.g. GLUT4) may be mediated, at least in part, by down-regulation of C/EBP alpha and/or its dephosphorylation.	JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21205	Johns Hopkins University				MacDougald, Ormond/0000-0001-6907-7960				ALAM T, 1992, J BIOL CHEM, V267, P5021; BAUMANN H, 1992, J BIOL CHEM, V267, P19744; BERNLOHR DA, 1985, J BIOL CHEM, V260, P5563; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CHAN CP, 1988, P NATL ACAD SCI USA, V85, P6257, DOI 10.1073/pnas.85.17.6257; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; COLEMAN RA, 1978, J BIOL CHEM, V253, P7256; COOK KS, 1985, J CELL BIOL, V100, P514, DOI 10.1083/jcb.100.2.514; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; CORNELIUS P, 1990, J BIOL CHEM, V265, P20506; DECAUX JF, 1991, J BIOL CHEM, V266, P3432; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOHADWALA M, 1994, P NATL ACAD SCI USA, V91, P6408, DOI 10.1073/pnas.91.14.6408; EXTON JH, 1972, J BIOL CHEM, V247, P3579; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FLORESRIVEROS JR, 1993, P NATL ACAD SCI USA, V90, P512, DOI 10.1073/pnas.90.2.512; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; HUANG JH, 1994, MOL CELL BIOL, V14, P4475, DOI 10.1128/MCB.14.7.4475; JEANRENAUD B, 1960, J BIOL CHEM, V235, P2217; JUAN TSC, 1993, P NATL ACAD SCI USA, V90, P2584, DOI 10.1073/pnas.90.7.2584; KAESTNER KH, 1990, P NATL ACAD SCI USA, V87, P251, DOI 10.1073/pnas.87.1.251; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; LIN FT, 1992, GENE DEV, V6, P533, DOI 10.1101/gad.6.4.533; MACDOUGALD OA, 1994, J BIOL CHEM, V269, P19041; MACKALL JC, 1976, J BIOL CHEM, V251, P6462; MACKALL JC, 1977, BIOCHEM BIOPH RES CO, V79, P720, DOI 10.1016/0006-291X(77)91171-8; MAHONEY CW, 1992, J BIOL CHEM, V267, P19396; MCKNIGHT SL, 1989, GENE DEV, V3, P2021, DOI 10.1101/gad.3.12b.2021; McKnight SL, 1992, TRANSCRIPTIONAL REGU, P771; NISHIO Y, 1993, MOL CELL BIOL, V13, P1854, DOI 10.1128/MCB.13.3.1854; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; POTTER JJ, 1992, ARCH BIOCHEM BIOPHYS, V295, P360, DOI 10.1016/0003-9861(92)90529-6; RATAJCZAK T, 1992, J BIOL CHEM, V267, P11111; RAY A, 1994, MOL CELL BIOL, V14, P4324, DOI 10.1128/MCB.14.6.4324; RODBELL M, 1964, J BIOL CHEM, V239, P375; RON D, 1992, J CLIN INVEST, V89, P223, DOI 10.1172/JCI115566; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; RUBIN CS, 1977, J BIOL CHEM, V252, P3554; Sambrook J, 1989, MOL CLONING LABORATO; SAMUELSSON L, 1991, EMBO J, V10, P3787, DOI 10.1002/j.1460-2075.1991.tb04948.x; SRINIVASAN M, 1994, J BIOL CHEM, V269, P16662; STEPHENS JM, 1991, J BIOL CHEM, V266, P21839; STEPHENS JM, 1992, J BIOL CHEM, V267, P13580; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; SWICK AG, 1989, NUCLEIC ACIDS RES, V17, P9291, DOI 10.1093/nar/17.22.9291; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; VILLAMORUZZI E, 1989, FEBS LETT, V258, P208, DOI 10.1016/0014-5793(89)81654-0	58	141	143	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					647	654		10.1074/jbc.270.2.647	http://dx.doi.org/10.1074/jbc.270.2.647			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822291	hybrid			2022-12-27	WOS:A1995QB81600024
J	WEI, SH; EPISKOPOU, V; PIANTEDOSI, R; MAEDA, S; SHIMADA, K; GOTTESMAN, ME; BLANER, WS				WEI, SH; EPISKOPOU, V; PIANTEDOSI, R; MAEDA, S; SHIMADA, K; GOTTESMAN, ME; BLANER, WS			STUDIES ON THE METABOLISM OF RETINOL AND RETINOL-BINDING PROTEIN IN TRANSTHYRETIN-DEFICIENT MICE PRODUCED BY HOMOLOGOUS RECOMBINATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-A; PLASMA RETINOL; ACID-BINDING; RAT-TISSUES; LIQUID-CHROMATOGRAPHY; TRANSPORT PROTEIN; NUCLEAR RECEPTOR; CHOROID-PLEXUS; MESSENGER-RNA; HUMAN-SERUM	Tissue needs for retinoids are believed to be satisfied through the delivery in the circulation of retinol by its specific plasma transport protein, retinol-binding protein (REP), which circulates as a 1-to-1 protein complex with transthyretin (TTR). The binding of REP to TTR is thought to prevent filtration of retinol-RBP in the kidney and to play a role in secretion of REP from hepatocytes. Recently a strain of mice (TTR(-)) that totally lacks immunoreactive TTR was produced by targeted mutagenesis. We have explored the effects of TTR deficiency on retinol and REP metabolism in this mutant strain. In pooled plasma from the TTR(-) mice retinol levels averaged 6% of those of wild type animals. Similarly, plasma REP in the TTR(-) mice was found to be 5% of wild type levels. Hepatic retinol and retinyl ester levels were similar for mutant and wild type mice, suggesting that the mutation affects neither the uptake nor storage of dietary retinol. Levels of retinol and retinyl esters in testis, kidney, spleen, and eye cups from TTR(-) mice were normal. Plasma all-trans-retinoic acid levels for the TTR(-) mice were 2.3-fold higher than those of wild type (425 versus 190 ng/dl). Kidney REP levels were similar for the mutant and wild type mice and we were unable to detect intact REP in urine from TTR(-) mice. Hepatic REP levels in the TTR(-) mice were 60% higher than those of wild type mice (39.8 versus 25.0 pp of RBP/g of tissue). These data may suggest that there is a partial blockage in REP secretion from TTR(-) hepatocytes that leads to lessened plasma levels of retinol-RBP.	COLUMBIA UNIV,COLL PHYS & SURG,INST HUMAN NUTR,NEW YORK,NY 10032; ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,LONDON W2 1PG,ENGLAND; YAMANASHI MED UNIV,DEPT BIOCHEM,TAMAHO,YAMANASHI 40938,JAPAN; OSAKA UNIV,MICROBIAL DIS RES INST,DEPT MED GENET,DIV MOLEC BIOMED,SUITA,OSAKA 565,JAPAN; COLUMBIA UNIV,INST CANC RES,NEW YORK,NY 10032	Columbia University; Imperial College London; University of Yamanashi; Osaka University; Columbia University			Episkopou, Vasso/E-2952-2010		MRC [MC_U120074332] Funding Source: UKRI; Medical Research Council [MC_U120074332] Funding Source: Medline; NIDDK NIH HHS [DK47389] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047389] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BENBROOK D, 1988, NATURE, V333, P669, DOI 10.1038/333669a0; BHAT PV, 1991, CAN J PHYSIOL PHARM, V69, P826, DOI 10.1139/y91-124; BHAT PV, 1988, BIOCHEM CELL BIOL, V66, P735, DOI 10.1139/o88-084; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; Blaner William S., 1994, P229; BLANER WS, 1989, ENDOCR REV, V10, P308, DOI 10.1210/edrv-10-3-308; BLANER WS, 1987, J BIOL CHEM, V262, P53; BLANER WS, 1990, METHOD ENZYMOL, V189, P270; BLANER WS, 1985, J NUTR, V115, P856, DOI 10.1093/jn/115.7.856; BLANER WS, 1986, J LIPID RES, V27, P1084; BLOMHOFF R, 1990, SCIENCE, V250, P399, DOI 10.1126/science.2218545; BRIDGES CDB, 1982, METHOD ENZYMOL, V81, P463; BROUWER A, 1988, CHEM-BIOL INTERACT, V68, P203, DOI 10.1016/0009-2797(88)90017-8; CHANOINE JP, 1992, ENDOCRINOLOGY, V130, P933, DOI 10.1210/en.130.2.933; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CULLUM ME, 1985, J BIOL CHEM, V260, P590; DE LUCA LM, 1991, FASEB J, V5, P2924; DELEENHEER AP, 1982, J LIPID RES, V23, P1362; DIXON JL, 1987, J CELL PHYSIOL, V130, P14, DOI 10.1002/jcp.1041300104; ECKHOFF C, 1990, J LIPID RES, V31, P1445; EPISKOPOU V, 1993, P NATL ACAD SCI USA, V90, P2375, DOI 10.1073/pnas.90.6.2375; FERGUSON RN, 1975, BIOCHEMISTRY-US, V14, P282, DOI 10.1021/bi00673a014; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GOODMAN DS, 1965, J LIPID RES, V6, P390; GOODMAN DS, 1984, NEW ENGL J MED, V310, P1023, DOI 10.1056/NEJM198404193101605; GOODMAN DS, 1983, BIOCHIM BIOPHYS ACTA, V750, P223, DOI 10.1016/0005-2760(83)90022-X; Goodman DS, 1984, RETINOIDS, P41, DOI DOI 10.1016/B978-0-12-658102-7.50008-7; GOODMAN DS, 1984, RETINOIDS, V2, P1; HERBERT J, 1986, NEUROLOGY, V36, P900, DOI 10.1212/WNL.36.7.900; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; KANDA Y, 1974, J BIOL CHEM, V249, P6796; KATO M, 1985, J BIOL CHEM, V260, P4832; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; LEWIS KC, 1990, J LIPID RES, V31, P1535; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; MELHUS H, 1992, J BIOL CHEM, V267, P12036; MELHUS H, 1991, EXP CELL RES, V197, P119, DOI 10.1016/0014-4827(91)90488-G; MOORE T, 1957, VITAMIN A, P295; MORALES C, 1987, ENDOCRINOLOGY, V121, P432, DOI 10.1210/endo-121-1-432; NAPOLI JL, 1985, J LIPID RES, V26, P387; NOY N, 1992, BIOCHEMISTRY-US, V31, P11118, DOI 10.1021/bi00160a023; PANGARO LN, 1990, PRINCIPLES PRACTICE, P271; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; RAJAN N, 1990, J LIPID RES, V31, P821; RAZ A, 1970, J BIOL CHEM, V245, P1903; Sambrook J, 1989, MOL CLONING LABORATO; SMITH WC, 1991, EMBO J, V10, P2223, DOI 10.1002/j.1460-2075.1991.tb07758.x; Snedecor G.W., 1980, STAT METHODS, V7; SOPRANO DR, 1985, J BIOL CHEM, V260, P1793; SOPRANO DR, 1988, J BIOL CHEM, V263, P2934; SUHARA A, 1990, J LIPID RES, V31, P1669; Underwood BA, 1984, RETINOIDS, P281; VANJAARSVELD PP, 1973, J BIOL CHEM, V248, P4698; WAKASUGI S, 1986, J BIOCHEM-TOKYO, V100, P49, DOI 10.1093/oxfordjournals.jbchem.a121705; Wolbach SB, 1925, J EXP MED, V42, P753, DOI 10.1084/jem.42.6.753	56	101	102	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					866	870		10.1074/jbc.270.2.866	http://dx.doi.org/10.1074/jbc.270.2.866			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822324	hybrid			2022-12-27	WOS:A1995QB81600058
J	HU, B; COULSON, L; MOYER, B; PRICE, PA				HU, B; COULSON, L; MOYER, B; PRICE, PA			ISOLATION AND MOLECULAR-CLONING OF A NOVEL BONE PHOSPHOPROTEIN RELATED IN SEQUENCE TO THE CYSTATIN FAMILY OF THIOL PROTEASE INHIBITORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX GLA PROTEIN; CYSTEINE PROTEINASES; PROTEOGLYCAN-II; BOVINE BONE; CDNA; RAT; SIALOPROTEIN; PEPTIDES; ACID; ALPHA-2-HS-GLYCOPROTEIN	We describe here the isolation of a novel non-collagenous protein from the acid demineralization extract of bovine cortical bone. This 24-kDa protein is multiply phosphorylated at serine residues in Ser-X-Glu/Ser(P) sequences, a recognition motif for phosphorylation by the secretory pathway protein kinase, and we have termed this protein secreted phosphoprotein 24 (spp24). The cDNA structure of spp24 was determined by sequencing cDNA fragments obtained by reverse transcription-polymerase chain reaction, 3'-rapid amplification of cDNA ends, and screening a lambda gt11 cDNA library. This cDNA sequence predicts a 200-residue initial translation product which consists of a 20-residue signal sequence and the 180-residue mature spp24. Northern blot analysis using the spp24 cDNA showed that spp24 mRNA is in liver and bone but not in heart, lung, kidney, or spleen. A search of existing protein sequences revealed that the N-terminal 107 residues of mature spp24 are related in sequence to the cystatin family of thiol protease inhibitors, which suggests that spp24 could function to modulate the thiol protease activities that are known to be involved in bone turnover. Several of the proteins in the cystatin family that are most closely related to spp24 are not only thiol protease inhibitors but are also precursors to peptides with potent biological activity, peptides such as bradykinin and the neutrophil antibiotic peptides. It is therefore possible that the intact form of spp24 found in bone could also be a precursor to a biologically active peptide, a peptide which could coordinate an aspect of bone turnover.	UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA	University of California System; University of California San Diego					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR025921] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR25921] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AKHOUNDI C, 1994, J BIOL CHEM, V269, P15925; BODE W, 1988, EMBO J, V7, P2593, DOI 10.1002/j.1460-2075.1988.tb03109.x; BOLANDER ME, 1988, P NATL ACAD SCI USA, V85, P2919, DOI 10.1073/pnas.85.9.2919; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DAY AA, 1987, BIOCHEM J, V248, P801, DOI 10.1042/bj2480801; DELAISSE JM, 1980, BIOCHEM J, V192, P365, DOI 10.1042/bj1920365; DELSAL G, 1992, BIOCHEM BIOPH RES CO, V187, P467, DOI 10.1016/S0006-291X(05)81517-7; DIECKMANN T, 1993, J MOL BIOL, V234, P1048, DOI 10.1006/jmbi.1993.1658; ELZANOWSKI A, 1988, FEBS LETT, V227, P167, DOI 10.1016/0014-5793(88)80890-1; FISHER LW, 1989, J BIOL CHEM, V264, P4571; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; GOTO T, 1993, HISTOCHEMISTRY, V99, P411, DOI 10.1007/BF00717054; HALE JE, 1991, J BIOL CHEM, V266, P21145; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KRUSIUS T, 1986, P NATL ACAD SCI USA, V83, P7683, DOI 10.1073/pnas.83.20.7683; LEE CC, 1987, P NATL ACAD SCI USA, V84, P4403, DOI 10.1073/pnas.84.13.4403; MASON IJ, 1986, EMBO J, V5, P1831, DOI 10.1002/j.1460-2075.1986.tb04434.x; MEGGIO F, 1988, EUR J BIOCHEM, V177, P281, DOI 10.1111/j.1432-1033.1988.tb14374.x; MEYER HE, 1991, METHOD ENZYMOL, V201, P169; OHNISHI T, 1993, J BONE MINER RES, V8, P367; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; OLDBERG A, 1988, J BIOL CHEM, V263, P19430; PAN LC, 1985, P NATL ACAD SCI USA, V82, P6109, DOI 10.1073/pnas.82.18.6109; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PERLMAN D, 1983, J MOL BIOL, V167, P391, DOI 10.1016/S0022-2836(83)80341-6; PRICE PA, 1987, P NATL ACAD SCI USA, V84, P8335, DOI 10.1073/pnas.84.23.8335; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P3374, DOI 10.1073/pnas.73.10.3374; PRICE PA, 1994, PROTEIN SCI, V3, P822; PRICE PA, 1985, J BIOL CHEM, V260, P4971; RITONJA A, 1989, FEBS LETT, V255, P211, DOI 10.1016/0014-5793(89)81093-2; SALVESEN G, 1986, BIOCHEM J, V234, P429, DOI 10.1042/bj2340429; SORENSEN ES, 1994, BIOCHEM BIOPH RES CO, V198, P200, DOI 10.1006/bbrc.1994.1028; STORICI P, 1992, FEBS LETT, V314, P187, DOI 10.1016/0014-5793(92)80971-I; TAKAGAKI Y, 1985, J BIOL CHEM, V260, P8601; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; YOUNG MF, 1992, CLIN ORTHOP RELAT R, P275; ZANETTI M, 1993, J BIOL CHEM, V268, P522	37	47	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					431	436		10.1074/jbc.270.1.431	http://dx.doi.org/10.1074/jbc.270.1.431			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814406	hybrid			2022-12-27	WOS:A1995QA28700068
J	SEARLES, RP; MIDSON, CN; NIPPER, VJ; MACHIDA, CA				SEARLES, RP; MIDSON, CN; NIPPER, VJ; MACHIDA, CA			TRANSCRIPTION OF THE RAT BETA(1)-ADRENERGIC RECEPTOR GENE - CHARACTERIZATION OF THE TRANSCRIPT AND IDENTIFICATION OF IMPORTANT SEQUENCES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BETA-1-ADRENERGIC RECEPTOR; BETA-ADRENERGIC RECEPTORS; BETA-2-ADRENERGIC RECEPTORS; MOLECULAR-CLONING; PROMOTER REGION; MESSENGER-RNA; REPORTER GENE; EXPRESSION; INVITRO	We have characterized the 5' and 3' ends of the rat beta(1)-adrenergic receptor transcript using RNase protection assays and have used transient transfection analysis to identify regions of the beta(1)-adrenergic gene 5'-flanking sequences which are important for expression, The transcript has multiple start sites, occurring primarily in two clusters at bases -250 and -280, relative to the first base of the initiation codon, Two potential polyadenylation signals at +2450 and +2732 are both functional, although the site at +2732 is preferred both in C6 glioma cells and in heart tissue. Characterization of the gene by transient transfection analysis has identified a region between bases -389 and -325 which is necessary for expression. The specific deletion of a potentially functional inverted CCAAT sequence within this region does not significantly alter activity, In addition to the region from -389 and -325, deletion of the bases between -1 and -159 and between -186 and -211 significantly alters expression. Both of these regions are downstream from the beta(1)-adrenergic receptor gene start sites and may function either through regulation of transcription or through alteration of the transcript structure.	OREGON HLTH SCI UNIV,DEPT BIOCHEM & MOLEC BIOL,PORTLAND,OR 97201	Oregon Health & Science University	SEARLES, RP (corresponding author), OREGON REG PRIMATE RES CTR,DIV NEUROSCI,505 NW 185TH AVE,BEAVERTON,OR 97006, USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL042358, F32HL008189, R01HL042358] Funding Source: NIH RePORTER; NCRR NIH HHS [RR0163] Funding Source: Medline; NHLBI NIH HHS [HL42358, HL08189] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRASIER AR, 1989, BIOTECHNIQUES, V7, P1116; BRODDE OE, 1991, PHARMACOL REV, V43, P203; COHEN JA, 1993, DNA CELL BIOL, V12, P537, DOI 10.1089/dna.1993.12.537; COLLINS S, 1993, BIOCHIM BIOPHYS ACTA, V1172, P171, DOI 10.1016/0167-4781(93)90287-N; DULLEY JR, 1975, ANAL BIOCHEM, V64, P136, DOI 10.1016/0003-2697(75)90415-7; EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461; FENG P, 1990, J BIOL CHEM, V265, P2022; FRIELLE T, 1988, TRENDS NEUROSCI, V11, P321, DOI 10.1016/0166-2236(88)90095-1; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; GAO B, 1994, J BIOL CHEM, V269, P15762; GILMAN M, 1993, CURRENT PROTOCOLS MO; GRANNEMAN JG, 1992, MOL PHARMACOL, V40, P895; HANDY DE, 1992, J BIOL CHEM, V267, P24017; HOUGH C, 1990, BIOCHEM BIOPH RES CO, V171, P46; JACKSON RJ, 1993, CELL, V74, P9, DOI 10.1016/0092-8674(93)90290-7; KINGSTON RE, 1990, CURRENT PROTOCOLS MO; KOBILKA BK, 1987, J BIOL CHEM, V262, P7321; LEFF SE, 1986, ANNU REV BIOCHEM, V55, P1091, DOI 10.1146/annurev.bi.55.070186.005303; LEFKOWITZ RJ, 1983, ANNU REV BIOCHEM, V52, P159, DOI 10.1146/annurev.bi.52.070183.001111; LUO XC, 1990, NUCLEIC ACIDS RES, V18, P3249, DOI 10.1093/nar/18.11.3249; MACHIDA CA, 1990, J BIOL CHEM, V265, P12960; MAHAN LC, 1987, ANNU REV PHARMACOL, V27, P215; MANN KP, 1993, MOL CELL BIOL, V9, P2411; MERMOD N, 1988, NATURE, V332, P557, DOI 10.1038/332557a0; MUZZIN P, 1991, J BIOL CHEM, V266, P24053; NICHOLAS AP, 1993, NEUROSCIENCE, V56, P1023, DOI 10.1016/0306-4522(93)90148-9; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; RAMARAO CS, 1992, J BIOL CHEM, V267, P21936; REYNOLDS GA, 1984, CELL, V38, P275, DOI 10.1016/0092-8674(84)90549-X; SEARLES RP, 1994, DNA SEQUENCE, V4, P231, DOI 10.3109/10425179409020846; STEGGLES AW, 1989, BIOTECHNIQUES, V7, P241	31	27	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					157	162		10.1074/jbc.270.1.157	http://dx.doi.org/10.1074/jbc.270.1.157			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814367	hybrid			2022-12-27	WOS:A1995QA28700028
J	STEWART, AE; ARFIN, SM; BRADSHAW, RA				STEWART, AE; ARFIN, SM; BRADSHAW, RA			THE SEQUENCE OF PORCINE PROTEIN NH2-TERMINAL ASPARAGINE AMIDOHYDROLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							POST-TRANSLATIONAL MODIFICATION; ESCHERICHIA-COLI; BINDING-SITES; GENE; PURIFICATION; SPECIFICITY; RESIDUE; LIGASE; CELLS	Co- and post translational amino-terminal processing of proteins is one mechanism by which intracellular proteins can be either protected from or targeted to degradation by the N-end Rule pathway (Bachmair, A., Finley, D., and Varshavsky, A. (1986) Science 234, 179-186). A novel enzyme, protein NH2-terminal asparagine amidohydrolase, which can function in this pathway by potentially directing critical regulatory proteins possessing an amino-terminal asparagine residue formed from the removal of N-acetylmethionine, has recently been purified and characterized (Stewart, A. E., Arfin, S. M., and Bradshaw, R. A. (1994) J. Biol. Chem. 269, 23509-23517). Here, we report the isolation and characterization of a cDNA for porcine protein NH2-terminal asparagine amidohydrolase, which indicates that it is a new type of enzyme, not homologous to any previously identified protein, This provides strong evidence for the importance of regulated protein degradation in cellular functioning.	UNIV CALIF IRVINE,SCH MED,DEPT BIOL CHEM,IRVINE,CA 92717	University of California System; University of California Irvine			Bradshaw, Ralph A/K-1515-2013		NIDDK NIH HHS [DK-32456] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARFIN SM, 1988, BIOCHEMISTRY-US, V27, P7979, DOI 10.1021/bi00421a001; AUSEBEL FM, 1987, CURRENT PROTOCOLS MO; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BONTHRON DT, 1990, GENE, V91, P101, DOI 10.1016/0378-1119(90)90168-Q; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CIECHANOVER A, 1988, J BIOL CHEM, V263, P11155; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HUANG S, 1987, BIOCHEMISTRY-US, V26, P8242, DOI 10.1021/bi00399a033; KENDALL RL, 1992, J BIOL CHEM, V267, P20667; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; PISZKIEW.D, 1970, BIOCHEM BIOPH RES CO, V40, P1173, DOI 10.1016/0006-291X(70)90918-6; REISS Y, 1988, J BIOL CHEM, V263, P2693; REISS Y, 1990, J BIOL CHEM, V265, P3685; Sambrook J, 1989, MOL CLONING LABORATO; SOFFER RL, 1973, MOL CELL BIOCHEM, V2, P3, DOI 10.1007/BF01738673; SPRING KJ, 1986, J BACTERIOL, V166, P135, DOI 10.1128/jb.166.1.135-142.1986; STEWART AE, 1994, J BIOL CHEM, V269, P23509; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; YAMADA R, 1991, BIOCHEMISTRY-US, V30, P1010, DOI 10.1021/bi00218a018	24	18	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					25	28		10.1074/jbc.270.1.25	http://dx.doi.org/10.1074/jbc.270.1.25			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814382	hybrid			2022-12-27	WOS:A1995QA28700007
J	TAO, Y; CHEN, KY				TAO, Y; CHEN, KY			PURIFICATION OF DEOXYHYPUSINE SYNTHASE FROM NEUROSPORA-CRASSA TO HOMOGENEITY BY SUBSTRATE ELUTION AFFINITY-CHROMATOGRAPHY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL FORMATION; SPERMIDINE DEHYDROGENASE; POLYACRYLAMIDE GELS; PROTEIN; POLYAMINES; HYPUSINE; BINDING	Deoxyhypusine synthase is an NAD(+)-dependent enzyme that catalyzes the formation of deoxyhypusine residue on the eIF-5A precursor by using spermidine as the substrate. Deoxyhypusine synthase bound tightly to 1,12-diaminododecane-agarose and could be eluted selectively by spermidine. This finding enabled us to develop a simple two column procedure to purify deoxyhypusine synthase from Neurospora crassa to apparent homogeneity. The purified enzyme had a specific activity of 130,000 units/mg of protein, representing a 64,000-fold purification from cell extracts. Size exclusion chromatography indicated that the native enzyme had a molecular mass of 180 kDa. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the pure enzyme showed a single band at the 40-kDa position, suggesting that Neurospora deoxyhypusine synthase is a homotetramer. Deoxyhypusine synthase appeared to be hydrophobic and required non-ionic detergent such as Tween 20 to stabilize the activity. Treatment of the enzyme with sulfhydryl reagents resulted in a complete loss of activity. Inclusion of NAD(+) reduced the inactivation rate by manyfold, indicating the presence of -SH groups at or near the active site. Partial amino acid sequences of four peptide fragments that cover about one quarter of the enzyme were obtained for cDNA and genomic cloning work.	RUTGERS STATE UNIV,DEPT CHEM,PISCATAWAY,NJ 08855; RUTGERS STATE UNIV,GRAD PROGRAM BIOCHEM,PISCATAWAY,NJ 08855	Rutgers State University New Brunswick; Rutgers State University New Brunswick				Chen, Kuang Yu/0000-0002-5629-7785	NATIONAL CANCER INSTITUTE [R01CA049695] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA49695] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN KY, 1983, BIOCHIM BIOPHYS ACTA, V756, P395, DOI 10.1016/0304-4165(83)90350-1; CHEN KY, 1988, FEBS LETT, V229, P325, DOI 10.1016/0014-5793(88)81149-9; COHEN SS, 1971, INTRO POLYAMINES, P1; COOPER HL, 1982, CELL, V29, P791, DOI 10.1016/0092-8674(82)90441-X; DOU QP, 1990, BIOCHIM BIOPHYS ACTA, V1036, P128, DOI 10.1016/0304-4165(90)90024-Q; HISANO T, 1992, BIOSCI BIOTECH BIOCH, V56, P1916, DOI 10.1271/bbb.56.1916; JAKUS J, 1993, J BIOL CHEM, V268, P13151; OKADA M, 1979, J BIOCHEM, V85, P1225; PARK MH, 1993, BIOFACTORS, V4, P95; PARK MH, 1984, J BIOL CHEM, V259, P4563; SCARBOROUGH GA, 1975, J BIOL CHEM, V250, P1106; SCHWELBERGER HG, 1993, J BIOL CHEM, V268, P14018; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TAO Y, 1994, BIOCHEM J, V302, P517, DOI 10.1042/bj3020517; TAO Y, 1994, ANAL BIOCHEM, V221, P103, DOI 10.1006/abio.1994.1385; TEMPST P, 1990, ELECTROPHORESIS, V11, P537, DOI 10.1002/elps.1150110704	18	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					383	386		10.1074/jbc.270.1.383	http://dx.doi.org/10.1074/jbc.270.1.383			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814398	hybrid			2022-12-27	WOS:A1995QA28700060
J	BARRY, J; ALBERTS, B				BARRY, J; ALBERTS, B			A ROLE FOR 2 DNA HELICASES IN THE REPLICATION OF T4-BACTERIOPHAGE DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE ACCESSORY PROTEINS; RNA-POLYMERASE; DDA PROTEIN; HOLOENZYME; APPARATUS; PURIFICATION; TEMPLATE; INVITRO; PASS; FORK	The T4 bacteriophage gene 41 protein is the highly processive DNA helicase of the T4 primosome, a central part of the protein machinery that moves the T4 DNA replication fork. The T4 gene 59 protein accelerates the loading of 41 protein onto DNA covered with 32 protein (the T4 single strand binding protein), and it makes the 41 protein DNA helicase activity rapidly available to catalyze replication fork movement through a DNA double helix (Barry, J., and Alberts, B. M. (1994) J. Biol. Chem. 269, 33049-33062). With the aid of the 59 protein, we show that the T4 primosome (the T4 gene 41 and 61 proteins) can move rapidly through a promoter-bound RNA polymerase molecule that would otherwise stop replication fork movement. A second, very different DNA helicase, the T4 dda protein, provides an alternative pathway for replication past this DNA-bound RNA polymerase (Bedinger, P., Hochstrasser, M., Jongeneel, C. V., and Alberts, B. M. (1983) Cell 34, 115-123). Combined with other data, these in vitro experiments allow us to propose a model that explains why either the 59 protein or the dda protein, but not both, are required to begin efficient DNA replication inside the T4 bacteriophage-infected cell.	UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco					NIGMS NIH HHS [GM24020] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024020, R01GM024020] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTS BM, 1985, TRENDS GENET, V1, P26, DOI 10.1016/0168-9525(85)90011-3; ALBERTS BM, 1987, PHILOS T ROY SOC B, V317, P395, DOI 10.1098/rstb.1987.0068; BARRY J, 1994, J BIOL CHEM, V269, P33049; BEDINGER P, 1983, CELL, V34, P115, DOI 10.1016/0092-8674(83)90141-1; CAPSON TL, 1991, CELL, V65, P249, DOI 10.1016/0092-8674(91)90159-V; FORMOSA T, 1986, CELL, V47, P793, DOI 10.1016/0092-8674(86)90522-2; GAUSS P, 1994, J BACTERIOL, V176, P1667, DOI 10.1128/jb.176.6.1667-1672.1994; HACKER KJ, 1994, J BIOL CHEM, V269, P24209; HACKER KJ, 1994, J BIOL CHEM, V269, P24221; HACKER KJ, 1992, J BIOL CHEM, V267, P20674; HINKLE DC, 1972, J MOL BIOL, V70, P197, DOI 10.1016/0022-2836(72)90533-5; JARVIS TC, 1991, J BIOL CHEM, V266, P1830; JONGENEEL CV, 1984, J BIOL CHEM, V259, P2933; JONGENEEL CV, 1984, J BIOL CHEM, V259, P2925; KREUZER KN, 1994, MOL BIOL BACTERIOPHA, P28; LIU B, 1993, NATURE, V366, P33, DOI 10.1038/366033a0; LIU CC, 1981, J BIOL CHEM, V256, P2813; MORRICAL SW, 1994, J BIOL CHEM, V269, P33069; MORRIS CF, 1975, P NATL ACAD SCI USA, V72, P4800, DOI 10.1073/pnas.72.12.4800; MOSIG G, 1983, BACTERIOPHAGE T4, P120; Nossal N.G., 1983, BACTERIOPHAGE T4, P71; Nossal Nancy G., 1994, P43; NOSSAL NG, 1992, FASEB J, V6, P871, DOI 10.1096/fasebj.6.3.1310946; ODONNELL M, 1992, MOL BIOL CELL, V3, P953, DOI 10.1091/mbc.3.9.953; RICHARDSON RW, 1989, J BIOL CHEM, V264, P4732; SINHA NK, 1980, J BIOL CHEM, V255, P4290; TSURIMOTO T, 1990, P NATL ACAD SCI USA, V87, P1023, DOI 10.1073/pnas.87.3.1023; YONESAKI T, 1990, J BIOL CHEM, V269, P1284; YOUNG MC, 1992, BIOCHEMISTRY-US, V31, P8675, DOI 10.1021/bi00152a001	29	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					33063	33068						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806534				2022-12-27	WOS:A1994QA63800051
J	THOMPSON, J; ZIMMERMANN, W; NOLLAU, P; NEUMAIER, M; WEBERARDEN, J; SCHREWE, H; CRAIG, I; WILLCOCKS, T				THOMPSON, J; ZIMMERMANN, W; NOLLAU, P; NEUMAIER, M; WEBERARDEN, J; SCHREWE, H; CRAIG, I; WILLCOCKS, T			CGM2, A MEMBER OF THE CARCINOEMBRYONIC ANTIGEN GENE FAMILY IS DOWN-REGULATED IN COLORECTAL CARCINOMAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-REACTING ANTIGEN; IMMUNOGLOBULIN SUPERGENE FAMILY; BILIARY GLYCOPROTEIN GENE; CELL-ADHESION MOLECULE; GLYCOSYL-PHOSPHATIDYLINOSITOL; MONOCLONAL-ANTIBODIES; GENOMIC ORGANIZATION; SEQUENCE-ANALYSIS; CEA; EXPRESSION	We have determined the precise chromosomal location, the exon structure, and the expression pattern of CGM2, a member of the carcinoembryonic antigen (CEA) gene family. CGM2 cDNA was amplified by reverse transcription-polymerase chain reaction (RT/PCR) from the colon adenocarcinoma cell line, LS174T. A defective exon is missing from this cDNA clone, leading to a novel domain organization for the human CEA family with two immunoglobulin-like domains. The derived C-terminal domain predicts that the CGM2 protein is membrane-bound through a glycosyl phosphatidylinositol anchor. RT/PCR analyses identified CGM2 transcripts in mucinous ovarian and colonic adenocarcinomas as well as in adjacent colonic tissue, but not in other tumors including leukocytes from six chronic myeloid leukemia patients. Thus, unlike several other family members, CGM2 is not expressed in granulocytes but reveals a more CEA-like expression pattern. Northern blot analyses identified a 2.5-kilobase CGM2 mRNA that is strongly downregulated in colonic adenocarcinomas compared with adjacent colonic mucosa, suggesting a possible tumor suppressor function. In addition, a 3.2-kilobase transcript was observed in a number of colon tumors that is not detectable in normal colonic tissue. This mRNA species could represent a tumor-specific CGM2 splice variant.	UNIV HAMBURG,HOSP EPPENDORF,DEPT CLIN CHEM,D-20251 HAMBURG,GERMANY; UNIV OXFORD,DEPT BIOCHEM,GENET LAB,OXFORD OX1 3QU,ENGLAND; NATL UNIV IRELAND UNIV COLL DUBLIN,CTR BIOTECHNOL,DUBLIN 4,IRELAND	University of Hamburg; University of Oxford; University College Dublin	THOMPSON, J (corresponding author), UNIV FREIBURG,INST IMMUNBIOL,STEFAN MEIER STR 8,D-79104 FREIBURG,GERMANY.		Zimmermann, Wolfgang/L-9277-2013; Craig, Ian/AAF-9167-2019	Craig, Ian/0000-0002-4063-1005				AFAR DEH, 1992, BIOCHIM BIOPHYS ACTA, V1134, P46, DOI 10.1016/0167-4889(92)90026-8; BARNETT TR, 1993, MOL CELL BIOL, V13, P1273, DOI 10.1128/MCB.13.2.1273; BENCHIMOL S, 1987, CELL, V57, P327; BERLING B, 1990, CANCER RES, V50, P6534; BOUCHER D, 1989, CANCER RES, V49, P847; BRANDRIFF BF, 1992, GENOMICS, V12, P773, DOI 10.1016/0888-7543(92)90308-F; CHI KF, 1991, TUMOR BIOL, V12, P298, DOI 10.1159/000217718; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DANIEL S, 1993, INT J CANCER, V55, P303, DOI 10.1002/ijc.2910550222; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; HASHINO J, 1994, BIOCHEM BIOPH RES CO, V200, P1748, DOI 10.1006/bbrc.1994.1655; HEFTA LJF, 1990, CANCER RES, V50, P2397; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; HIXSON DC, 1989, CANCER RES, V49, P6788; KODELJA V, 1989, J BIOL CHEM, V264, P6906; KOLBINGER F, 1989, BIOCHEM BIOPH RES CO, V161, P1126, DOI 10.1016/0006-291X(89)91359-4; KUIJPERS TW, 1992, J CELL BIOL, V118, P457, DOI 10.1083/jcb.118.2.457; KUROKI M, 1991, J BIOL CHEM, V266, P11810; LUNDJOHANSEN F, 1993, EUR J IMMUNOL, V23, P2782, DOI 10.1002/eji.1830231110; MAHRENHOLZ AM, 1993, J BIOL CHEM, V268, P13015; MARGOLIS RN, 1990, BIOCHEM BIOPH RES CO, V166, P562, DOI 10.1016/0006-291X(90)90845-E; NAGEL G, 1993, EUR J BIOCHEM, V214, P27, DOI 10.1111/j.1432-1033.1993.tb17892.x; NAP M, 1988, TUMOR BIOL, V9, P145, DOI 10.1159/000217555; NEUMAIER M, 1988, J BIOL CHEM, V263, P3202; NEUMAIER M, 1993, P NATL ACAD SCI USA, V90, P10744, DOI 10.1073/pnas.90.22.10744; OIKAWA S, 1989, BIOCHEM BIOPH RES CO, V164, P39, DOI 10.1016/0006-291X(89)91679-3; PAXTON RJ, 1987, P NATL ACAD SCI USA, V84, P920, DOI 10.1073/pnas.84.4.920; RISINGER JI, 1994, NAT GENET, V7, P98, DOI 10.1038/ng0594-98; ROJAS M, 1990, CELL GROWTH DIFFER, V1, P527; ROSENBERG M, 1993, CANCER RES, V53, P4938; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHREWE H, 1990, MOL CELL BIOL, V10, P2738, DOI 10.1128/MCB.10.6.2738; SHENOYSCARIA AM, 1993, MOL CELL BIOL, V13, P6385, DOI 10.1128/MCB.13.10.6385; SHIVELY JE, 1985, CRC CR REV ONCOL-HEM, V2, P355, DOI 10.1016/S1040-8428(85)80008-1; STOFFEL A, 1993, J IMMUNOL, V150, P4978; SVENBERG T, 1976, INT J CANCER, V17, P588, DOI 10.1002/ijc.2910170506; TEGLUND S, 1994, GENOMICS, V23, P669, DOI 10.1006/geno.1994.1556; THOMPSON J, 1992, GENOMICS, V12, P761, DOI 10.1016/0888-7543(92)90307-E; THOMPSON J, 1993, INT J CANCER, V55, P311, DOI 10.1002/ijc.2910550223; THOMPSON J, 1990, BIOCHEM BIOPH RES CO, V167, P848, DOI 10.1016/0006-291X(90)92103-7; THOMPSON J, 1989, CARCINOEMBRYONIC ANT, P65; THOMPSON JA, 1987, P NATL ACAD SCI USA, V84, P2965, DOI 10.1073/pnas.84.9.2965; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; THOMPSON JA, 1989, BIOCHEM BIOPH RES CO, V158, P996, DOI 10.1016/0006-291X(89)92821-0; TORIBARA NW, 1989, CANCER RES, V49, P3321; TYNAN K, 1992, NUCLEIC ACIDS RES, V20, P1629, DOI 10.1093/nar/20.7.1629; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WILLCOCKS TC, 1990, GENOMICS, V8, P492, DOI 10.1016/0888-7543(90)90036-T; WILLCOCKS TC, 1989, ANN HUM GENET, V53, P141, DOI 10.1111/j.1469-1809.1989.tb01778.x; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; ZIMMERMANN W, 1987, P NATL ACAD SCI USA, V84, P2960, DOI 10.1073/pnas.84.9.2960	53	34	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					32924	32931						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806520				2022-12-27	WOS:A1994QA63800033
J	THONBERG, H; ZHANG, SJ; TVRDIK, P; JACOBSSON, A; NEDERGAARD, J				THONBERG, H; ZHANG, SJ; TVRDIK, P; JACOBSSON, A; NEDERGAARD, J			NOREPINEPHRINE UTILIZES ALPHA(1)-ADRRENOCEPTORS AND BETA-ADRENOCEPTORS SYNERGISTICALLY TO MAXIMALLY INDUCE C-FOS EXPRESSION IN BROWN ADIPOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCOUPLING PROTEIN THERMOGENIN; ADIPOSE-TISSUE; GENE-EXPRESSION; FAT-CELLS; GROWTH-HORMONE; ADRENERGIC CONTROL; KINASE-C; PROTOONCOGENES FOS; 3T3-L1 FIBROBLASTS; PRIMARY CULTURE	In order to examine how norepinephrine stimulates proliferation and differentiation in brown fat cells, we have investigated the ability of brown fat cells to respond to norepinephrine stimulation with an increase in the expression of the proto-oncogene c-fos. Stimulation of brown fat precursor cells (isolated from young mice and grown for 4 days in culture) with norepinephrine led to a marked but transient (maximal approximate to 30 min) induction of c-fos expression. The magnitude of this induction was similar in pre- and postconfluent cells, The norepinephrine effect could be blocked by both alpha(1)- and beta-adrenergic antagonists. Forskolin had a small inductive ability, as had the selective alpha(1)-agonist cirazoline, but with both together a high induction was obtained, The phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) could in itself induce c-fos expression, but pretreatment with TPA did not abolish the ability of norepinephrine to induce c-fos expression, indicating that TPA sensitive protein kinase C was not a primary mediator in this pathway. Also the Ca2+ ionophore A23187 had in itself an inductive ability, but A23187 in combination with forskolin led to a large increase in c-fos expression, indicating synergistic interaction between a cAMP pathway and a [Ca2+](i) pathway. This interaction was not proximal, i.e. alpha(1) stimulation or increase in [Ca2+](i) by A23187 did not augment forskolin induced cAMP levels, and beta stimulation or forskolin did not affect [Ca2+](i) levels; and it did not require protein synthesis. It was concluded that norepinephrine, in agreement with its fundamental role in the control of brown fat cell growth and development, was able to induce c-fos expression, that this induction was not exclusively linked to promotion of either proliferation or differentiation, and that the induction was mediated via a distal synergism between beta/cAMP and alpha(1)/[Ca2+](i) pathways, thus conferring to the alpha(1)-adrenoreceptors on the cell a potentially significant role in the control of cell growth and development.			THONBERG, H (corresponding author), UNIV STOCKHOLM, WENNER GREN INST, ARRHENIUS LABS F3, S-10691 STOCKHOLM, SWEDEN.		Nedergaard, Jan/A-1706-2010; Nedergaard, Jan/Q-8286-2019; Tvrdik, Petr/AAK-4398-2021	Tvrdik, Petr/0000-0002-8750-9672; Nedergaard, Jan/0000-0003-2070-1587				ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ASHCOM G, 1992, ENDOCRINOLOGY, V131, P1915, DOI 10.1210/en.131.4.1915; BARCELLINICOUGET S, 1994, BIOCHEM BIOPH RES CO, V199, P136, DOI 10.1006/bbrc.1994.1205; BARCELLINICOUGET S, 1993, ENDOCRINOLOGY, V132, P53, DOI 10.1210/en.132.1.53; BARGE RM, 1988, AM J PHYSIOL, V254, pE323, DOI 10.1152/ajpendo.1988.254.3.E323; BORNER C, 1992, J BIOL CHEM, V267, P12892; BOUTILLIER AL, 1992, J BIOL CHEM, V267, P23520; BOUTILLIER AL, 1991, MOL ENDOCRINOL, V5, P1301, DOI 10.1210/mend-5-9-1301; BRASELMANN S, 1992, J CELL SCI, P97; BRONNIKOV G, 1992, J BIOL CHEM, V267, P2006; CHAMPIGNY O, 1992, MOL CELL ENDOCRINOL, V86, P73, DOI 10.1016/0303-7207(92)90177-8; CONNOLLY E, 1984, EUR J BIOCHEM, V141, P187, DOI 10.1111/j.1432-1033.1984.tb08173.x; CORNELIUS P, 1991, J CELL PHYSIOL, V146, P298, DOI 10.1002/jcp.1041460215; CUNNINGHAM SA, 1987, BIOCHEM J, V245, P485, DOI 10.1042/bj2450485; CURRAN T, 1993, ADV SEC MESS PHOSPH, V28, P271; DEBELLE I, 1991, MOL CELL BIOL, V11, P2752, DOI 10.1128/MCB.11.5.2752; DICKER A, 1992, AM J PHYSIOL, V263, pE654, DOI 10.1152/ajpendo.1992.263.4.E654; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; FISCH TM, 1989, GENE DEV, V3, P198, DOI 10.1101/gad.3.2.198; FOSTER DO, 1985, INT J OBESITY, V9, P25; GABELLINI N, 1991, EXP CELL RES, V194, P210, DOI 10.1016/0014-4827(91)90356-Y; GELOEN A, 1988, AM J PHYSIOL, V254, pC175, DOI 10.1152/ajpcell.1988.254.1.C175; GRANNEMAN JG, 1988, J PHARMACOL EXP THER, V245, P1075; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GURLAND G, 1990, ENDOCRINOLOGY, V127, P3187, DOI 10.1210/endo-127-6-3187; HEICK HMC, 1973, CAN J PHYSIOL PHARM, V51, P751, DOI 10.1139/y73-114; HERRON D, 1989, AM J PHYSIOL, V257, pC920, DOI 10.1152/ajpcell.1989.257.5.C920; HERRON D, 1990, FEBS LETT, V268, P296, DOI 10.1016/0014-5793(90)81031-I; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HOUSTEK J, 1990, BIOCHIM BIOPHYS ACTA, V1018, P243, DOI 10.1016/0005-2728(90)90258-6; JACOBSSON A, 1986, BIOSCIENCE REP, V6, P621, DOI 10.1007/BF01114756; KOPECKY J, 1990, J BIOL CHEM, V265, P22204; LEE SC, 1993, AM J PHYSIOL, V264, pC217, DOI 10.1152/ajpcell.1993.264.1.C217; LORENZO M, 1993, J CELL BIOL, V123, P1567, DOI 10.1083/jcb.123.6.1567; MOHELL N, 1984, MOL PHARMACOL, V25, P64; MOHELL N, 1983, EUR J PHARMACOL, V93, P183, DOI 10.1016/0014-2999(83)90136-X; MOHELL N, 1983, EUR J PHARMACOL, V92, P15, DOI 10.1016/0014-2999(83)90103-6; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MORY G, 1984, FEBS LETT, V166, P393, DOI 10.1016/0014-5793(84)80120-9; MUNOZ E, 1992, EUR J IMMUNOL, V22, P2101, DOI 10.1002/eji.1830220821; NANBERG E, 1984, BIOCHIM BIOPHYS ACTA, V804, P291, DOI 10.1016/0167-4889(84)90132-0; NANBERG E, 1986, FEBS LETT, V195, P319, DOI 10.1016/0014-5793(86)80185-5; NANBERG E, 1987, BIOCHIM BIOPHYS ACTA, V930, P438, DOI 10.1016/0167-4889(87)90017-6; NAVRE M, 1989, J CELL BIOL, V109, P1857, DOI 10.1083/jcb.109.4.1857; NECHAD M, 1983, EXP CELL RES, V149, P105, DOI 10.1016/0014-4827(83)90384-1; NEDERGAARD J, 1982, INT REV CYTOL, V74, P187, DOI 10.1016/S0074-7696(08)61173-0; NEDERGAARD J, 1994, OBESITY EUROPE 1993, P69; PAVELKA S, 1993, BIOCHEM J, V292, P303, DOI 10.1042/bj2920303; PICO C, 1994, BIOCHEM J, V302, P81, DOI 10.1042/bj3020081; PUIGSERVER P, 1992, BIOCHEM J, V284, P393, DOI 10.1042/bj2840393; RAASMAJA A, 1990, ACTA PHYSIOL SCAND, V139, P7; RAASMAJA A, 1989, ENDOCRINOLOGY, V125, P2502, DOI 10.1210/endo-125-5-2502; RAASMAJA A, 1988, BIOCHEM J, V249, P831, DOI 10.1042/bj2490831; RAASMAJA A, 1984, BIOSCIENCE REP, V4, P851, DOI 10.1007/BF01138167; RAASMAJA A, 1984, EUR J PHARMACOL, V106, P489, DOI 10.1016/0014-2999(84)90052-9; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; REHNMARK S, 1993, FEBS LETT, V318, P235, DOI 10.1016/0014-5793(93)80519-Z; REHNMARK S, 1989, EXP CELL RES, V182, P75, DOI 10.1016/0014-4827(89)90280-2; REHNMARK S, 1989, EXP CELL RES, V180, P574, DOI 10.1016/0014-4827(89)90086-4; REHNMARK S, 1990, J BIOL CHEM, V265, P16464; RUTHER U, 1985, EMBO J, V4, P1775, DOI 10.1002/j.1460-2075.1985.tb03850.x; SCHIMMEL RJ, 1983, AM J PHYSIOL, V244, pC362, DOI 10.1152/ajpcell.1983.244.5.C362; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SMEYNE RJ, 1993, ADV NEUROL, V59, P285; SPIEGELMAN BM, 1988, J CELL BIOL, V107, P829, DOI 10.1083/jcb.107.3.829; STUMPO DJ, 1986, P NATL ACAD SCI USA, V83, P9453, DOI 10.1073/pnas.83.24.9453; SUMANTRAN VN, 1992, ENDOCRINOLOGY, V130, P2016, DOI 10.1210/en.130.4.2016; UEHARA T, 1991, BIOCHIM BIOPHYS ACTA, V1088, P41, DOI 10.1016/0167-4781(91)90151-B; VALVERDE AM, 1991, EXP CELL RES, V194, P232, DOI 10.1016/0014-4827(91)90359-3; VANBEVEREN C, 1983, CELL, V32, P1241, DOI 10.1016/0092-8674(83)90306-9; WILCKE M, 1989, BIOCHEM BIOPH RES CO, V163, P292, DOI 10.1016/0006-291X(89)92134-7; YAMASHITA H, 1994, ADV PHARM SCI TEMPER, P241	74	54	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					33179	33186						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806548				2022-12-27	WOS:A1994QA63800068
J	HERMOLIN, J; FILLINGAME, RH				HERMOLIN, J; FILLINGAME, RH			ASSEMBLY OF F-0 SECTOR OF ESCHERICHIA-COLI H+ ATP SYNTHASE - INTERDEPENDENCE OF SUBUNIT INSERTION INTO THE MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-TRANSLOCATING ATPASE; OXIDATIVE-PHOSPHORYLATION; F0 SUBUNITS; GENES; F1F0; OVERPRODUCTION; F1F0-ATPASE; MUTATIONS; PROTEINS; COMPLEX	The F-0 sector of the Escherichia coli H+ transporting ATP synthase is composed of a complex of three subunits, each of which traverses the inner membrane. We have studied the interdependence of subunit insertion into the membrane in a series of chromosomal mutants in which the primary mutation prevented insertion of one of the F-0 subunits. Subunit insertion was assessed using Western blots of mutant membrane preparations. Subunit b and subunit c were found to insert into the membrane independently of the other two F-0 subunits. On the other hand, subunit a was not inserted into membranes that lacked either subunit b or subunit c. The conclusion that subunit a insertion is dependent upon the co-insertion of subunits b and c differs from the conclusion of several studies, where subunits were expressed from multicopy plasmids.	UNIV WISCONSIN,SCH MED,DEPT BIOMOLEC CHEM,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison					NIGMS NIH HHS [GM23105] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023105, R01GM023105] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		DECKERSHEBESTRE.G, 1986, EUR J BIOCHEM, V161, P225; DOWNIE JA, 1981, J BACTERIOL, V145, P200, DOI 10.1128/JB.145.1.200-210.1981; EYA S, 1989, J BACTERIOL, V171, P6853, DOI 10.1128/jb.171.12.6853-6858.1989; EYA S, 1991, ARCH BIOCHEM BIOPHYS, V284, P71, DOI 10.1016/0003-9861(91)90265-K; FELTON J, 1980, J BACTERIOL, V142, P221, DOI 10.1128/JB.142.1.221-228.1980; FILLINGAME RH, 1986, J BACTERIOL, V165, P244, DOI 10.1128/jb.165.1.244-251.1986; FILLINGAME RH, 1983, J BIOL CHEM, V258, P604; FILLINGAME RH, 1975, J BACTERIOL, V124, P870, DOI 10.1128/JB.124.2.870-883.1975; FILLINGAME RH, 1990, BACTERIA TREATISE ST, V12, P345; FOSTER DL, 1982, J BIOL CHEM, V257, P2009; FRAGA D, 1994, J BIOL CHEM, V269, P7532; FRAGA D, 1994, J BIOL CHEM, V269, P2562; FRIEDL P, 1981, P NATL ACAD SCI-BIOL, V78, P6643, DOI 10.1073/pnas.78.11.6643; FRIEDL P, 1983, EMBO J, V2, P99, DOI 10.1002/j.1460-2075.1983.tb01388.x; GIBSON F, 1977, BIOCHEM J, V162, P665, DOI 10.1042/bj1620665; GIRVIN ME, 1993, BIOCHEMISTRY-US, V32, P12167, DOI 10.1021/bi00096a029; GIRVIN ME, 1989, BIOCHEMISTRY-US, V28, P4340, DOI 10.1021/bi00436a032; GOODFRIEND TL, 1964, SCIENCE, V144, P1344, DOI 10.1126/science.144.3624.1344; GUNSALUS RP, 1982, P NATL ACAD SCI-BIOL, V79, P320, DOI 10.1073/pnas.79.2.320; Harlow E, 1988, ANTIBODIES LABORATOR, P471; JANS DA, 1985, J BACTERIOL, V160, P764; KLIONSKY DJ, 1983, J BIOL CHEM, V258, P136; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Miller J. H., 1972, EXPT MOL GENETICS, P431; MONTICELLO RA, 1992, J BACTERIOL, V174, P3370, DOI 10.1128/jb.174.10.3370-3376.1992; MOSHER ME, 1983, J BACTERIOL, V156, P1078, DOI 10.1128/JB.156.3.1078-1092.1983; PAULE CR, 1989, ARCH BIOCHEM BIOPHYS, V274, P270, DOI 10.1016/0003-9861(89)90439-6; PERLIN DS, 1985, ARCH BIOCHEM BIOPHYS, V236, P603, DOI 10.1016/0003-9861(85)90664-2; SCHNEIDER E, 1984, P NATL ACAD SCI-BIOL, V81, P7279, DOI 10.1073/pnas.81.23.7279; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VIK SB, 1987, J BIOL CHEM, V262, P8340; VONMEYENBURG K, 1985, EMBO J, V4, P2357, DOI 10.1002/j.1460-2075.1985.tb03939.x	33	45	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2815	2817		10.1074/jbc.270.6.2815	http://dx.doi.org/10.1074/jbc.270.6.2815			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852354	hybrid			2022-12-27	WOS:A1995QF53500064
J	HAIN, J; ONOUE, H; MAYRLEITNER, M; FLEISCHER, S; SCHINDLER, H				HAIN, J; ONOUE, H; MAYRLEITNER, M; FLEISCHER, S; SCHINDLER, H			PHOSPHORYLATION MODULATES THE FUNCTION OF THE CALCIUM-RELEASE CHANNEL OF SARCOPLASMIC-RETICULUM FROM CARDIAC-MUSCLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; RYANODINE RECEPTOR; SKELETAL-MUSCLE; FEET STRUCTURES; CALMODULIN; CA-2+; HEART; RECONSTITUTION; BIOCHEMISTRY; PURIFICATION	The cardiac calcium release channel (CRC) of sarcoplasmic reticulum vesicles was incorporated into planar lipid membranes to evaluate modulation of channel activity by phosphorylation and dephosphorylation. For this purpose a microsyringe application directly to the membrane was used to achieve sequential and multiple treatments of channels with highly purified kinases and phosphatases. Cyclic application of protein kinase A (PKA) or Ca2+/calmodulin-dependent protein kinase II (CalPK) and potato acid phosphatase or protein phosphatase 1 revealed a channel block by Mg2+ (similar to mM), that is referable to dephosphorylated states of the channel, and that the Mg2+ block could be removed by phosphorylation of the CRC by either PKA or CalPK, By contrast, activation of endogenous CalPK (end CalPK) led to channel closure which could be reversed by dephosphorylation using potato acid phosphatase or protein phosphatase 1, Calmodulin by itself (which activates end CalPK in the presence of MgATP) blocks the channel in the dephosphorylated state, which can be overcome by treatment with CalPK but not PKA. Our findings reveal important insights regarding channel regulation of the ryanodine receptor: 1) the calcium release channel must be phosphorylated to be in the active state at conditions approximating physiological Mg2+ concentrations (similar to mM); and 2) there are multiple sites of phosphorylation on the calcium release channel with different functional consequences, which may be relevant to the regulation of E-C coupling, Phosphorylation of the CRC may be involved in recruitment of active channels, and/or it may be directly involved in each Ca2+ contraction cycle of the heart, For example, Ca2+ release may require phosphorylation of the CRC by protein kinases at sites which overcome the block by Mg2+, Inactivation may involve CRC block by calmodulin and/or phosphorylation by endogenous CalPK at the junctional face membrane.	UNIV LINZ, INST BIOPHYS, A-4040 LINZ, AUSTRIA; VANDERBILT UNIV, DEPT MOLEC BIOL, NASHVILLE, TN 37235 USA	Johannes Kepler University Linz; Vanderbilt University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032711, P01HL046681] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 46681, HL32711] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BLACKSHEAR PJ, 1988, FASEB J, V2, P2957, DOI 10.1096/fasebj.2.14.2972578; BORGATTA L, 1991, P NATL ACAD SCI USA, V88, P2486, DOI 10.1073/pnas.88.6.2486; BRICKEY DA, 1990, BIOCHEM BIOPH RES CO, V173, P578, DOI 10.1016/S0006-291X(05)80074-9; CAMPBELL KP, 1988, TRENDS NEUROSCI, V11, P425, DOI 10.1016/0166-2236(88)90193-2; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; CHADWICK CC, 1992, J BIOL CHEM, V267, P3473; CHAMBERLAIN BK, 1983, J BIOL CHEM, V258, P6602; CHU A, 1990, BIOCHEMISTRY-US, V29, P5899, DOI 10.1021/bi00477a003; COX JA, 1984, FED PROC, V43, P3000; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.bb.18.060189.002001; GLOSSMANN H, 1988, VITAM HORM, V44, P155; HAIN J, 1994, BIOPHYS J, V67, P1823, DOI 10.1016/S0006-3495(94)80664-2; HAIN J, 1994, BIOPHYS J, V66, pA225; HERRMANNFRANK A, 1993, FEBS LETT, V332, P237, DOI 10.1016/0014-5793(93)80640-G; HYMEL L, 1988, BIOCHEM BIOPH RES CO, V152, P308, DOI 10.1016/S0006-291X(88)80715-0; INUI M, 1987, J BIOL CHEM, V262, P15637; INUI M, 1987, J BIOL CHEM, V262, P1740; INUI M, 1988, J BIOL CHEM, V263, P10843; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; MCGREW SG, 1989, BIOCHEMISTRY-US, V28, P1686, DOI 10.1021/bi00430a039; MEISSNER G, 1986, BIOCHEMISTRY-US, V25, P244, DOI 10.1021/bi00349a034; NAGASAKI K, 1989, CELL CALCIUM, V10, P63, DOI 10.1016/0143-4160(89)90045-6; NAGASAKI K, 1983, J BIOCHEM-TOKYO, V94, P1101, DOI 10.1093/oxfordjournals.jbchem.a134453; OTSU K, 1990, J BIOL CHEM, V265, P13472; RENTER H, 1983, NATURE, V325, P717; ROBERTSON S, 1984, METHOD PHARMACOL, V5, P63, DOI DOI 10.1007/978-1-4684-4778-1_6; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; SCHULMAN H, 1984, J CELL BIOL, V99, P11, DOI 10.1083/jcb.99.1.11; SMITH JS, 1986, J GEN PHYSIOL, V88, P573, DOI 10.1085/jgp.88.5.573; SUKO J, 1993, BIOCHIM BIOPHYS ACTA, V1175, P193, DOI 10.1016/0167-4889(93)90023-I; TAKASAGO T, 1991, J BIOCHEM-TOKYO, V109, P163, DOI 10.1093/oxfordjournals.jbchem.a123339; TSIEN RW, 1986, J MOL CELL CARDIOL, V18, P691, DOI 10.1016/S0022-2828(86)80941-5; WANG JX, 1992, NATURE, V359, P739, DOI 10.1038/359739a0; WITCHER DR, 1991, J BIOL CHEM, V266, P11144; WOLFE L, 1987, J BIOL CHEM, V262, P16906; YOSHIDA A, 1992, J BIOCHEM-TOKYO, V111, P186, DOI 10.1093/oxfordjournals.jbchem.a123735; ZHANG ZJ, 1992, J BIOL CHEM, V267, P1484	39	247	258	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2074	2081		10.1074/jbc.270.5.2074	http://dx.doi.org/10.1074/jbc.270.5.2074			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836435	hybrid			2022-12-27	WOS:A1995QE49300017
J	BAYLISS, CD; CONDIT, RC				BAYLISS, CD; CONDIT, RC			THE VACCINIA VIRUS A18R GENE-PRODUCT IS A DNA-DEPENDENT ATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-T7 RNA-POLYMERASE; TEMPERATURE-SENSITIVE MUTANTS; TRANSCRIPTION FACTOR; XERODERMA-PIGMENTOSUM; INDUCED BREAKDOWN; REPAIR GENE; EXPRESSION; HELICASE; INVITRO; SYSTEM	The predicted amino acid sequence of the vaccinia virus gene A18R shows significant homology to the human ERCC3 gene product, which is a member of the DEXH subfamily of the DNA and RNA helicase superfamily II and which plays a role in both RNA polymerase II transcription and nucleotide excision repair of DNA. The vaccinia virus A18R gene product is expressed throughout infection and is encapsidated in virions. Vaccinia virions containing mutant A18R gene product are defective in early viral transcription in vitro, and infection with A18R mutant virus results in aberrant viral transcription late during infection. Thus we hypothesize that the vaccinia virus A18R gene product is a helicase that plays a role in viral transcription and possibly DNA repair. As a first test of this hypothesis, we have affinity purified an amino-terminal polyhistidine-tagged A18R protein and shown that it has DNA-dependent ATPase activity. The A18R ATPase activity is stimulated by both single-stranded and double-stranded DNA and by RNA-DNA hybrids, but not by either single-stranded or double-stranded RNA.	UNIV FLORIDA, DEPT MOLEC GENET & MICROBIOL, GAINESVILLE, FL 32610 USA	State University System of Florida; University of Florida				Bayliss, Christopher/0000-0002-5564-2145	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018094] Funding Source: NIH RePORTER; NIAID NIH HHS [AI18094] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHN BY, 1994, J BIOL CHEM, V269, P7552; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BALDICK CJ, 1993, J VIROL, V67, P3515, DOI 10.1128/JVI.67.6.3515-3527.1993; BAYLISS CD, 1993, VIROLOGY, V194, P254, DOI 10.1006/viro.1993.1256; BROYLES SS, 1987, MOL CELL BIOL, V7, P7, DOI 10.1128/MCB.7.1.7; BROYLES SS, 1988, J BIOL CHEM, V263, P10761; BURATOWSKI S, 1993, SCIENCE, V260, P37, DOI 10.1126/science.8465198; COHRS RJ, 1989, J VIROL, V63, P948, DOI 10.1128/JVI.63.2.948-951.1989; CONDIT RC, 1990, CURR TOP MICROBIOL, V163, P1; CONDIT RC, 1983, VIROLOGY, V128, P429, DOI 10.1016/0042-6822(83)90268-4; CONDIT RC, 1981, VIROLOGY, V113, P224, DOI 10.1016/0042-6822(81)90150-1; CONDIT RC, 1991, VIROLOGY, V185, P857, DOI 10.1016/0042-6822(91)90559-T; DENG L, 1994, J BIOL CHEM, V269, P14323; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; HAGLER J, 1994, J BIOL CHEM, V269, P10050; JENG ST, 1992, J BIOL CHEM, V267, P19306; JOKLIK W K, 1990, P383; KOONIN EV, 1992, J GEN VIROL, V73, P989, DOI 10.1099/0022-1317-73-4-989; KOVACS GR, 1994, J VIROL, V68, P3443, DOI 10.1128/JVI.68.5.3443-3447.1994; KUNZI MS, 1989, J VIROL, V63, P3999; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LI J, 1994, J VIROL, V68, P2605, DOI 10.1128/JVI.68.4.2605-2614.1994; MA LB, 1994, NUCLEIC ACIDS RES, V22, P4095, DOI 10.1093/nar/22.20.4095; MACDONALD LE, 1993, J MOL BIOL, V232, P1030, DOI 10.1006/jmbi.1993.1458; MACDONALD LE, 1994, J MOL BIOL, V238, P145, DOI 10.1006/jmbi.1994.1277; MEIS RJ, 1991, VIROLOGY, V182, P442, DOI 10.1016/0042-6822(91)90585-Y; MEIS RJ, 1990, THESIS STATE U NEW Y; MOSS B, 1991, J BIOL CHEM, V266, P1355; MOSS B, 1990, ANNU REV BIOCHEM, V59, P661, DOI 10.1146/annurev.biochem.59.1.661; MOSS B, 1990, P2079; PACHA RF, 1990, J VIROL, V64, P3853, DOI 10.1128/JVI.64.8.3853-3863.1990; PACHA RF, 1985, J VIROL, V56, P395, DOI 10.1128/JVI.56.2.395-403.1985; PARK E, 1992, P NATL ACAD SCI USA, V89, P11416, DOI 10.1073/pnas.89.23.11416; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; QIU HF, 1993, GENE DEV, V7, P2161, DOI 10.1101/gad.7.11.2161; ROSALES R, 1994, P NATL ACAD SCI USA, V91, P3794, DOI 10.1073/pnas.91.9.3794; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHWER B, 1988, EMBO J, V7, P1183, DOI 10.1002/j.1460-2075.1988.tb02929.x; SHUMAN S, 1980, J BIOL CHEM, V255, P5396; SIMPSON DA, 1994, J VIROL, V68, P3642, DOI 10.1128/JVI.68.6.3642-3649.1994; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SWEDER KS, 1994, J BIOL CHEM, V269, P1852; VOS JC, 1991, CELL, V65, P105, DOI 10.1016/0092-8674(91)90412-R; VOS JC, 1991, EMBO J, V10, P2553, DOI 10.1002/j.1460-2075.1991.tb07795.x; WANG ZG, 1994, NATURE, V368, P74, DOI 10.1038/368074a0; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U; WRIGHT CF, 1993, J VIROL, V67, P7264, DOI 10.1128/JVI.67.12.7264-7270.1993	51	35	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1550	1556		10.1074/jbc.270.4.1550	http://dx.doi.org/10.1074/jbc.270.4.1550			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829483	hybrid			2022-12-27	WOS:A1995QD20400013
J	YE, WL; ALI, N; BEMBENEK, ME; SHEARS, SB; LAFER, EM				YE, WL; ALI, N; BEMBENEK, ME; SHEARS, SB; LAFER, EM			INHIBITION OF CLATHRIN ASSEMBLY BY HIGH-AFFINITY BINDING OF SPECIFIC INOSITOL POLYPHOSPHATES TO THE SYNAPSE-SPECIFIC CLATHRIN ASSEMBLY PROTEIN AP-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COATED VESICLES; MONOCLONAL-ANTIBODIES; F1-20 PROTEIN; BOVINE BRAIN; HEXAKISPHOSPHATE; CELLS; PHOSPHATES; NP185; PENTAKISPHOSPHATE; EXPRESSION	Bacterially expressed synapse-specific clathrin assembly protein, AP-3 (F1-20/AP180/NP185/pp155), bound with high affinity both inositol hexakisphosphate (InsP(6)) (K-d = 239 nM) and diphosphoinositol pentakisphosphate (PP-InsP(5)) (K-d = 22 nM). The specificity of this ligand binding was demonstrated by competitive displacement of bound [H-3]InsP(6). IC50 values were as follows: PP-InsP(5) = 50 nM, InsP(6) = 240 nM, inositol-1,2,4,5,6-pentakisphosphate (Ins(1,2,4,5,6)P-5) = 2.2 mu M, inositol-1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P-5) = 5 mu M, inositol-1,3,4,5-tetrakisphosphate (Ins(1,3,4,5)P-4) > 10 mu M, inositol-1,4,5-trisphosphate (Ins(1,4,5)P-3) > 10 mu M. Moreover, 10 mu M inositol hexasulfate (InsS(6)) displaced only 15% of [H-3]InsP(6). The physiological significance of this binding is the ligand-specific inhibition of clathrin assembly (PP-InsP(5) > InsP(6) > Ins(1,2,4,5,6)P-5); Ins(1,3,4,5,6)P-5 and InsS(6) did not inhibit clathrin assembly. We also observed high affinity binding of InsP(6) to purified bovine brain AP-3. We separately expressed the 33-kDa amino terminus and the 58-kDa carboxyl terminus, and it was the former that contained the high affinity inositol polyphosphate binding site, These studies suggest that specific inositol polyphosphates may play a role in the regulation of synaptic function by interacting with the synapse-specific clathrin assembly protein AP-3.	UNIV TEXAS,HLTH SCI CTR,INST BIOTECHNOL,CTR MOLEC MED,SAN ANTONIO,TX 78245; UNIV PITTSBURGH,DEPT BIOL SCI,PITTSBURGH,PA 15260; NIEHS,CELLULAR & MOLEC PHARMACOL LAB,RES TRIANGLE PK,NC 27709; DUPONT CO INC,DEPT MED PROD,NEW ENGLAND NUCL,BOSTON,MA 02118	University of Texas System; University of Texas Health San Antonio; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); DuPont			Shears, Stephen B/C-6335-2019	Shears, Stephen B/0000-0001-7309-8916; Lafer, Eileen/0000-0002-0493-6522; Ye, Weilan/0000-0002-6219-3982	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029051, R56NS029051] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS029051, NS29051] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHLE S, 1986, EMBO J, V5, P3143, DOI 10.1002/j.1460-2075.1986.tb04621.x; ALI N, 1993, J BIOL CHEM, V268, P6161; BARRACO RA, 1989, EUR J PHARMACOL, V173, P75, DOI 10.1016/0014-2999(89)90010-1; BECK KA, 1991, J BIOL CHEM, V266, P4442; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; FLEISCHER B, 1994, J BIOL CHEM, V269, P17826; FRENCH PJ, 1991, P ROY SOC B-BIOL SCI, V245, P193, DOI 10.1098/rspb.1991.0109; GLENNON MC, 1994, BIOCHEM J, V299, P583; IRVINE RF, 1988, PHILOS T ROY SOC B, V320, P281, DOI 10.1098/rstb.1988.0077; JACKSON AP, 1987, NATURE, V326, P154, DOI 10.1038/326154a0; KEEN JH, 1986, J CELL BIOL, V102, P1325, DOI 10.1083/jcb.102.4.1325; KIRCHHAUSEN T, 1987, SCIENCE, V236, P320, DOI 10.1126/science.3563513; KIRCHHAUSEN T, 1993, CURR OPIN STRUC BIOL, V3, P182, DOI 10.1016/S0959-440X(05)80150-2; KIRCHHAUSEN T, 1987, P NATL ACAD SCI USA, V84, P8805, DOI 10.1073/pnas.84.24.8805; KOHTZ DS, 1988, J BIOL CHEM, V263, P7418; LINDNER R, 1992, J BIOL CHEM, V267, P16567; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; MORRIS SA, 1990, J BIOL CHEM, V265, P3354; MORRIS SA, 1993, EMBO J, V12, P667, DOI 10.1002/j.1460-2075.1993.tb05700.x; MURPHY JE, 1994, J BIOL CHEM, V269, P21346; MURPHY JE, 1991, J BIOL CHEM, V266, P4401; PERRY DG, 1991, J HISTOCHEM CYTOCHEM, V39, P1461, DOI 10.1177/39.11.1918924; PERRY DG, 1992, J NEUROSCI RES, V33, P408, DOI 10.1002/jnr.490330307; POYNER DR, 1993, J BIOL CHEM, V268, P1032; PRASAD K, 1988, BIOCHEMISTRY-US, V27, P6098, DOI 10.1021/bi00416a040; SASAKAWA N, 1992, J NEUROCHEM, V58, P2116, DOI 10.1111/j.1471-4159.1992.tb10953.x; SASAKAWA N, 1993, BRAIN RES, V623, P155, DOI 10.1016/0006-8993(93)90023-G; Shears Stephen B., 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P63; SOUSA R, 1990, NEUROSCIENCE, V34, P403, DOI 10.1016/0306-4522(90)90149-X; SOUSA R, 1992, J NEUROSCI, V12, P2130; SZWERGOLD BS, 1987, BIOCHEM BIOPH RES CO, V149, P874, DOI 10.1016/0006-291X(87)90489-X; TIMERMAN AP, 1992, P NATL ACAD SCI USA, V89, P8976, DOI 10.1073/pnas.89.19.8976; VALLEJO M, 1987, NATURE, V330, P656, DOI 10.1038/330656a0; VOGLMAIER SM, 1992, BIOCHEM BIOPH RES CO, V187, P158, DOI 10.1016/S0006-291X(05)81473-1; YE W, 1995, IN PRESS J NEUROSCI, V40; ZHOU SB, 1992, J NEUROSCI, V12, P2144; ZHOU SB, 1993, J BIOL CHEM, V268, P12655	37	161	163	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1564	1568		10.1074/jbc.270.4.1564	http://dx.doi.org/10.1074/jbc.270.4.1564			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829485	hybrid			2022-12-27	WOS:A1995QD20400015
J	ZHANG, DW; BURTONWURSTER, N; LUST, G				ZHANG, DW; BURTONWURSTER, N; LUST, G			ALTERNATIVE SPLICING OF ED-A AND ED-B SEQUENCES OF FIBRONECTIN PRE-MESSENGER-RNA DIFFERS IN CHONDROCYTES FROM DIFFERENT CARTILAGINOUS TISSUES AND CAN BE MODULATED BY BIOLOGICAL FACTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MESSENGER-RNA; ARTICULAR-CARTILAGE; GENE; EXPRESSION; METABOLISM; CULTURES; COLLAGEN; PATTERN; PROTEIN	The alternative splicing of the ED-A and ED-B segments of fibronectin pre-mRNA was examined in epiphyseal, costal, and meniscal cartilage from 3-week-old beagles and in nasal, tracheal, articular, and meniscal cartilage from 1- and g2year-old Labrador retrievers. In contrast to the 100% expression of ED-B(+) mRNA that has been reported for embryonic chick cartilage (Bennett, V. D., Pallante, K. M., and Adams, S. K. (1991) J. Biol. Chem. 266, 5918-5924), all cartilages studied expressed both the ED-B(+) and ED-B(-) forms of fibronectin mRNA with the exception of the trachea, in which expression was 100% ED-B(-). Of all cartilages studied, only the meniscus had detectable levels of ED-A(+) mRNA. Placing articular cartilage chondrocytes in primary monolayer culture dramatically up-regulated the expression of ED-A(+) mRNA to 25% of the total, and this expression was further increased by the addition of transforming growth factor beta 1 or fucoidan to the culture medium. The expression of ED-B(+) mRNA remained at about 18% in the cultured chondrocytes and was not further affected by either transforming growth factor beta 1 or fucoidan. In contrast, dibutyryl cyclic adenosine monophosphate decreased the relative expression of both the ED-A(+) and ED-B(+) forms of fibronectin pre mRNA. We concluded that the expression of ED-B(+) fibronectin remains relatively high in chondrocytes from cartilaginous canine tissues (15-35%) with the exception of the trachea, in contrast to the less than 10% expression of ED-B(+) fibronectin reported for other non-fetal tissues.	CORNELL UNIV,COLL VET MED,JAMES A BAKER INST ANIM HLTH,ITHACA,NY 14853	Cornell University					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035664] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR35664] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADAMS ME, 1992, ANAL BIOCHEM, V202, P89, DOI 10.1016/0003-2697(92)90211-O; BENNETT VD, 1991, J BIOL CHEM, V266, P5918; BORSI L, 1990, FEBS LETT, V261, P175, DOI 10.1016/0014-5793(90)80664-5; BURTONWURSTER N, 1990, ARCH BIOCHEM BIOPHYS, V283, P27, DOI 10.1016/0003-9861(90)90607-Z; BURTONWURSTER N, 1988, BIOCHEM BIOPH RES CO, V154, P1088, DOI 10.1016/0006-291X(88)90252-5; BURTONWURSTER N, 1989, BIOCHEM BIOPH RES CO, V165, P782, DOI 10.1016/S0006-291X(89)80034-8; ELLINGSWORTH LR, 1986, J BIOL CHEM, V261, P2362; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; HUH GS, 1993, MOL CELL BIOL, V13, P5301, DOI 10.1128/MCB.13.9.5301; HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cb.01.110185.000435; Hynes RO, 1990, FIBRONECTINS; LEIPOLD HR, 1992, J ORTHOP RES, V10, P33, DOI 10.1002/jor.1100100105; MAGNUSON VL, 1991, J BIOL CHEM, V266, P14654; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MORALES TI, 1988, J BIOL CHEM, V263, P12828; NEMETH GG, 1989, ANAL BIOCHEM, V183, P301, DOI 10.1016/0003-2697(89)90483-1; ODERMATT E, 1985, P NATL ACAD SCI USA, V82, P6571, DOI 10.1073/pnas.82.19.6571; PENA SDJ, 1980, BIOCHEM J, V189, P337, DOI 10.1042/bj1890337; REDINI F, 1988, FEBS LETT, V234, P172, DOI 10.1016/0014-5793(88)81327-9; SCHWARZBAUER JE, 1987, EMBO J, V6, P2573, DOI 10.1002/j.1460-2075.1987.tb02547.x; VIBEPEDERSEN K, 1984, EMBO J, V3, P2511, DOI 10.1002/j.1460-2075.1984.tb02165.x; VISCHER P, 1991, EUR J CELL BIOL, V56, P407; WURSTER NB, 1982, BIOCHEM BIOPH RES CO, V109, P1094, DOI 10.1016/0006-291X(82)91889-7; ZHANG DW, 1993, T ORTHOP RES SOC, V18, P662	24	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1817	1822		10.1074/jbc.270.4.1817	http://dx.doi.org/10.1074/jbc.270.4.1817			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829518	hybrid			2022-12-27	WOS:A1995QD20400052
J	MILBURN, JL; HIROSE, H; LEE, YH; NAGASAWA, Y; OGAWA, A; OHNEDA, M; BELTRANDELRIO, H; NEWGARD, CB; JOHNSON, JH; UNGER, RH				MILBURN, JL; HIROSE, H; LEE, YH; NAGASAWA, Y; OGAWA, A; OHNEDA, M; BELTRANDELRIO, H; NEWGARD, CB; JOHNSON, JH; UNGER, RH			PANCREATIC BETA-CELLS IN OBESITY - EVIDENCE FOR INDUCTION OF FUNCTIONAL, MORPHOLOGIC, AND METABOLIC ABNORMALITIES BY INCREASED LONG-CHAIN FATTY-ACIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; GLUCOSE TRANSPORTERS; ISLETS; OXIDATION	To elucidate the mechanism of the basal hyperinsulinemia of obesity, we perfused pancreata from obese Zucker and lean Wistar rats with substimulatory concentrations of glucose, Insulin secretion at 4.2 and 5.6 mM glucose was similar to 10 times that of controls, whereas beta-cell volume fraction was increased only 4-fold and DNA per islet 3,5-fold. We therefore compared glucose usage at 1.4, 2.8, and 5.6 mM, Usage was 8-11.4 times greater in Zucker islets at 1.4 and 2.8 mM and 4 times greater at 5.6 mM; glucose oxidation at 2.8 and 5.6 mM glucose was >12 times lean controls, To determine if the high free fatty acid (FFA) levels of obesity induce these abnormalities, normal Wistar islets were cultured with 0, 1, or 2 mM long chain FFA for 7 days. Compared to islets cultured without EFA insulin secretion by FFA-cultured islets (2 mM) perifused with 1.4, 3, or 5.6 mM glucose was increased more than P-fold, bromodeoxyuridine incorporation was increased 3-fold, and glucose usage at 2.8 and 5.6 mM glucose was increased approximately 2-fold (1 mM FFA) and 3-fold (2 mM FFA), We conclude that hypersecretion of insulin by islets of obese Zucker fatty rats is associated with, and probably caused by, enhanced low K-m glucose metabolism and beta-cell hyperplasia, abnormalities that can be induced in normal islets by increased FFA.	UNIV TEXAS, SW MED CTR, CTR DIABET RES, GIFFORD LABS, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, DEPT INTERNAL MED, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, DEPT BIOCHEM, DALLAS, TX 75235 USA; DEPT VET AFFAIRS MED CTR, DALLAS, TX 75216 USA	Diabetes & Endocrine Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas					NIDDK NIH HHS [DK02700, 1-P01-DK42582] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK042582, R01DK002700, R37DK002700] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASHCROFT SJH, 1981, ISLETS LANGERHANS BI, P117; BECKER TC, 1994, J BIOL CHEM, V269, P21234; BERNE C, 1975, BIOCHEM J, V152, P661, DOI 10.1042/bj1520661; BERNSTEIN IA, 1957, METHOD ENZYMOL, V4, P561, DOI 10.1016/0076-6879(57)04071-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAY GA, 1979, PHYSIOL REV, V59, P719, DOI 10.1152/physrev.1979.59.3.719; CAMPBELL PJ, 1994, AM J PHYSIOL, V266, pE600, DOI 10.1152/ajpendo.1994.266.4.E600; CHAN CB, 1993, CAN J PHYSIOL PHARM, V71, P34, DOI 10.1139/y93-005; CRESPIN SR, 1969, J CLIN INVEST, V48, P1934, DOI 10.1172/JCI106160; ELKS ML, 1993, ENDOCRINOLOGY, V133, P208, DOI 10.1210/en.133.1.208; GORDON ES, 1960, AM J CLIN NUTR, V8, P740, DOI 10.1093/ajcn/8.5.740; Grodsky G M, 1975, Methods Enzymol, V39, P364; HISATOMI A, 1985, J CLIN INVEST, V75, P420, DOI 10.1172/JCI111716; HOPCROFT DW, 1985, HORM METAB RES, V17, P559, DOI 10.1055/s-2007-1013606; JOHNSON JH, 1990, NEW ENGL J MED, V322, P653, DOI 10.1056/NEJM199003083221003; JOHNSON JH, 1990, SCIENCE, V250, P546, DOI 10.1126/science.2237405; KARAM JH, 1963, DIABETES, V12, P197, DOI 10.2337/diab.12.3.197; KUWAJIMA M, 1986, J BIOL CHEM, V261, P8849; LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; MADISON LL, 1968, METABOLISM, V17, P301, DOI 10.1016/0026-0495(68)90097-8; MATCHINSKY FM, 1980, DIABETES 1979, P154; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; MEGLASSON M D, 1986, Diabetes Metabolism Reviews, V2, P163; NAHER SP, 1980, DIABETOLOGIA, V19, P439; NILSSON NO, 1980, FEBS LETT, V111, P125, DOI 10.1016/0014-5793(80)80776-9; OGAWA A, 1992, J CLIN INVEST, V90, P497, DOI 10.1172/JCI115886; ORCI L, 1990, P NATL ACAD SCI USA, V87, P9953, DOI 10.1073/pnas.87.24.9953; PORTE D, 1973, J CLIN INVEST, V52, P210, DOI 10.1172/JCI107168; RANDLE PJ, 1963, LANCET, V1, P785; RASSCHAERT J, 1990, BIOCHIM BIOPHYS ACTA, V1015, P353, DOI 10.1016/0005-2728(90)90040-B; SAKO Y, 1990, ENDOCRINOLOGY, V127, P1580, DOI 10.1210/endo-127-4-1580; SCHUTTE B, 1987, J HISTOCHEM CYTOCHEM, V35, P1343, DOI 10.1177/35.11.3116075; VOSSMCCOWAN ME, 1994, J BIOL CHEM, V269, P15814; WEIBEL ER, 1979, STEREOLOGICAL METHOD, V1, P101; YALOW RS, 1960, DIABETES, V9, P254, DOI 10.2337/diab.9.4.254; ZAWALICH WS, 1977, ENDOCRINOLOGY, V100, P1276, DOI 10.1210/endo-100-5-1276; ZAWALICH WS, 1977, ENDOCRINOLOGY, V100, P1; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	39	267	272	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1295	1299		10.1074/jbc.270.3.1295	http://dx.doi.org/10.1074/jbc.270.3.1295			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836394	hybrid			2022-12-27	WOS:A1995QB15600049
J	FUTEY, LM; MEDLEY, QG; COTE, GP; EGELHOFF, TT				FUTEY, LM; MEDLEY, QG; COTE, GP; EGELHOFF, TT			STRUCTURAL-ANALYSIS OF MYOSIN HEAVY-CHAIN KINASE-A FROM DICTYOSTELIUM - EVIDENCE FOR A HIGHLY DIVERGENT PROTEIN-KINASE DOMAIN, AN AMINO-TERMINAL COILED-COIL DOMAIN, AND A DOMAIN HOMOLOGOUS TO THE BETA-SUBUNIT OF HETEROTRIMERIC G-PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOATTRACTANT-ELICITED INCREASES; CYCLIC-GMP; CONSERVED FEATURES; PHOSPHORYLATION; FAMILY; DISCOIDEUM; GENE; IDENTIFICATION; CYTOSKELETON; PURIFICATION	We report here the cloning and characterization of the gene encoding the 130-kDa myosin heavy chain kinase (MHCK A) from the amoeba Dictyostelium. Previous studies have shown that purified MHCK A phosphorylates threonines in the carboxyl-terminal tail portion of the Dictyostelium myosin II heavy chain and that phosphorylation of these sites is critical in regulating the assembly and disassembly of myosin II filaments in vitro and in vivo. Biochemical analysis of MHCK A, together with analysis of the primary sequence, suggests that the amino-terminal similar to 500 amino acids form an alpha-helical colied-coli domain and that residues from position similar to 860 to the carboxyl terminus (residue 1146) form a domain with significant similarity to the beta-subunit of heterotrimeric G proteins, No part of the MHCK A sequence displays significant similarity to the catalytic domain of conventional eukaryotic protein kinases, However, both native and recombinant MHCK A displayed autophosphorylation activity following renaturation from SDS gels, and MHCK A expressed in Escherichia coli phosphorylated purified Dictyostelium myosin, confirming that MHCK A is a bona fide protein kinase. Cross-linking studies demonstrated that native MHCK A is a multimer, consistent with the presence of an amino-terminal colied-coli domain, Southern blot analysis indicates that MHCK A is encoded by a single gene that has no detectable introns.	CASE WESTERN RESERVE UNIV, SCH MED, DEPT PHYSIOL & BIOPHYS, CLEVELAND, OH 44106 USA; QUEENS UNIV, DEPT BIOCHEM, KINGSTON, ON K7L 3N6, CANADA	Case Western Reserve University; Queens University - Canada					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050009, R29GM050009] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM50009] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEELER JF, 1994, MOL CELL BIOL, V14, P982, DOI 10.1128/MCB.14.2.982; BERLOT CH, 1985, CELL, V43, P307, DOI 10.1016/0092-8674(85)90036-4; BERLOT CH, 1987, J BIOL CHEM, V262, P3918; CARBONI JM, 1985, J CELL BIOL, V100, P1884, DOI 10.1083/jcb.100.6.1884; CELENZA JL, 1986, SCIENCE, V233, P1175, DOI 10.1126/science.3526554; COHEN C, 1994, SCIENCE, V263, P488, DOI 10.1126/science.8290957; COTE GP, 1987, J BIOL CHEM, V262, P1065; COTE GP, 1987, J BIOL CHEM, V262, P13033; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; EGELHOFF TT, 1993, CELL, V75, P363, DOI 10.1016/0092-8674(93)80077-R; EGELHOFF TT, 1989, MOL CELL BIOL, V9, P1965, DOI 10.1128/MCB.9.5.1965; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; FUKUI Y, 1990, J CELL BIOL, V110, P367, DOI 10.1083/jcb.110.2.367; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; KLUMPP DJ, 1988, J BACTERIOL, V170, P2763, DOI 10.1128/jb.170.6.2763-2769.1988; KUCZMARSKI ER, 1980, P NATL ACAD SCI-BIOL, V77, P7292, DOI 10.1073/pnas.77.12.7292; LILLY P, 1993, GENE DEV, V7, P986, DOI 10.1101/gad.7.6.986; LIU G, 1988, J CELL SCI, V90, P123; LIU G, 1993, J CELL SCI, V106, P591; LIU G, 1991, J CELL SCI, V98, P483; LUCKVIELMETTER D, 1990, FEBS LETT, V269, P239, DOI 10.1016/0014-5793(90)81163-I; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MANSTEIN DJ, 1989, EMBO J, V8, P923, DOI 10.1002/j.1460-2075.1989.tb03453.x; MARU Y, 1991, CELL, V67, P459, DOI 10.1016/0092-8674(91)90521-Y; MARUTA H, 1983, EMBO J, V2, P535, DOI 10.1002/j.1460-2075.1983.tb01459.x; MEDLEY Q G, 1991, Journal of Cell Biology, V115, p29A; Medley Q.G., 1990, Protein Expression and Purification, V1, P155, DOI 10.1016/1046-5928(90)90010-V; MEDLEY QG, 1990, BIOCHEMISTRY-US, V29, P8992, DOI 10.1021/bi00490a016; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; OLSON NJ, 1990, P NATL ACAD SCI USA, V87, P2284, DOI 10.1073/pnas.87.6.2284; PASTERNAK C, 1989, NATURE, V341, P549, DOI 10.1038/341549a0; PEITSCH MC, 1993, TRENDS BIOCHEM SCI, V18, P292, DOI 10.1016/0968-0004(93)90038-O; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; POPOV KM, 1993, J BIOL CHEM, V268, P26602; RAVID S, 1992, P NATL ACAD SCI USA, V89, P5877, DOI 10.1073/pnas.89.13.5877; RAVID S, 1989, J BIOL CHEM, V264, P15144; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Sambrook J, 1989, MOL CLONING LABORATO; SHOEMAKER MO, 1990, J CELL BIOL, V111, P1107, DOI 10.1083/jcb.111.3.1107; TAN JL, 1991, J BIOL CHEM, V266, P16044; TAYLOR SS, 1992, ANNU REV CELL BIOL, V8, P429, DOI 10.1146/annurev.cb.08.110192.002241; VAILLANCOURT JP, 1988, J BIOL CHEM, V263, P10082; WESSELS D, 1988, DEV BIOL, V128, P164, DOI 10.1016/0012-1606(88)90279-5	47	75	76	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					523	529		10.1074/jbc.270.2.523	http://dx.doi.org/10.1074/jbc.270.2.523			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822274	hybrid			2022-12-27	WOS:A1995QB81600006
J	PETRUSKA, J; GOODMAN, MF				PETRUSKA, J; GOODMAN, MF			ENTHALPY-ENTROPY COMPENSATION IN DNA MELTING THERMODYNAMICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE FIDELITY; PROTEINS; WATER; SEQUENCE; BINDING; ACIDS	We investigate enthalpy-entropy compensation for melting of nearest-neighbor doublets in DNA. Eased on data for 10 normal doublets and for doublets containing a mispaired or analog base, the correlation of Delta S degrees with Delta H degrees follows a rectangular hyperbola. Doublet melting temperature relates linearly to Delta H degrees by T-m = T-o + Delta H degrees/a, where T-o approximate to 273 K and a approximate to 80 cal/mol-K. Thus T-m is proportional to Delta H degrees + aT(o) rather than to Delta H degrees alone as previously thought by assuming Delta S degrees to be constant. The term aT(o) approximate to 21.8 kcal/mol may reflect a constant enthalpy change in solvent accompanying the DNA enthalpy change for doublet melting and is roughly equivalent to breaking four H-bonds between water molecules for each melted doublet. The solvent entropy change (aT(o)/T-m) declines with increasing T-m, while the DNA entropy change (Delta H degrees/T-m) rises, so the combined DNA + solvent entropy change stays constant at 80 cal/K/mol of doublet. If such constancy in DNA + solvent entropy changes also holds for enzyme clefts as ''solvent,'' then free energy differences for competing correct and incorrect base pairs in polymerase clefts may be as large as enthalpy differences and possibly sufficient to account for DNA polymerase accuracy. The hyperbolic relationship between Delta S degrees and Delta H degrees observed in 1 M salt can be used to evaluate Delta H degrees and Delta S degrees from T-m at lower, physiologically relevant, salt concentrations.			PETRUSKA, J (corresponding author), UNIV SO CALIF,DEPT BIOL SCI,LOS ANGELES,CA 90089, USA.				NIA NIH HHS [AG11398] Funding Source: Medline; NIGMS NIH HHS [GM21422] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021422, R01GM021422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011398] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABOULELA F, 1985, NUCLEIC ACIDS RES, V13, P4811, DOI 10.1093/nar/13.13.4811; BLAKE RD, 1990, BIOPOLYMERS, V29, P393, DOI 10.1002/bip.360290211; BLAKE RD, 1987, BIOPOLYMERS, V26, P1063, DOI 10.1002/bip.360260706; BRESLAUER KJ, 1987, P NATL ACAD SCI USA, V84, P8922, DOI 10.1073/pnas.84.24.8922; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; DELCOURT SG, 1991, J BIOL CHEM, V266, P15160; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; GAFFNEY BL, 1989, BIOCHEMISTRY-US, V28, P5881, DOI 10.1021/bi00440a026; GALAS DJ, 1978, J MOL BIOL, V88, P653; GOODMAN MF, 1988, MUTAT RES, V200, P11, DOI 10.1016/0027-5107(88)90067-X; GOTOH O, 1981, BIOPOLYMERS, V20, P1033, DOI 10.1002/bip.1981.360200513; LUMRY R, 1970, BIOPOLYMERS, V9, P1125, DOI 10.1002/bip.1970.360091002; MANNING GS, 1978, Q REV BIOPHYS, V11, P179, DOI 10.1017/S0033583500002031; MARKY LA, 1987, BIOPOLYMERS, V26, P1621, DOI 10.1002/bip.360260912; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; MARMUR J, 1962, J MOL BIOL, V5, P109, DOI 10.1016/S0022-2836(62)80066-7; MARTIN FH, 1971, J MOL BIOL, V57, P201, DOI 10.1016/0022-2836(71)90341-X; Pauling L., 1960, NATURE CHEM BOND; PETRUSKA J, 1986, P NATL ACAD SCI USA, V83, P1559, DOI 10.1073/pnas.83.6.1559; PETRUSKA J, 1988, P NATL ACAD SCI USA, V85, P6252, DOI 10.1073/pnas.85.17.6252; PORSCHKE D, 1971, BIOPOLYMERS, V10, P1989, DOI 10.1002/bip.360101016; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; SARAI A, 1988, BIOCHEMISTRY-US, V27, P8498, DOI 10.1021/bi00422a030; Segel I.H., 1975, ENZYME KINETICS	24	82	87	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					746	750		10.1074/jbc.270.2.746	http://dx.doi.org/10.1074/jbc.270.2.746			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822305	hybrid			2022-12-27	WOS:A1995QB81600039
J	MA, YS; KOBRINSKY, E; MARKS, AR				MA, YS; KOBRINSKY, E; MARKS, AR			CLONING AND EXPRESSION OF A NOVEL TRUNCATED CALCIUM-CHANNEL FROM NONEXCITABLE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE ERYTHROLEUKEMIA-CELLS; SKELETAL-MUSCLE; FUNCTIONAL EXPRESSION; ALPHA-1 SUBUNIT; INDUCED-DIFFERENTIATION; SMOOTH-MUSCLE; CA2+ CHANNELS; ACINAR-CELLS; RECEPTOR; IDENTIFICATION	Calcium entry, via a dihydropyridine-sensitive pathway, is required for differentiation in murine erythroleukemia cells (MELC). Calcium channel currents have been identified physiologically in some non-excitable cells, but little is known regarding the structure of these channels. We show that a truncated form of the alpha(1) subunit of the cardiac voltage-gated calcium channel (dihydropyridine receptor, DHPR) is expressed in MELC. This MELC calcium channel lacks the first four transmembrane segments of the DHPR (IS1 to IS4). A MELC calcium channel/cardiac DHPR chimera, co-expressed with the alpha(2) and beta subunits of the DHPR, forms a functional calcium channel in Xenopus oocytes.	CUNY MT SINAI SCH MED,BROOKDALE CTR MOLEC BIOL,PROGRAM MOLEC MED,NEW YORK,NY 10029; CUNY MT SINAI SCH MED,DEPT MED,PROGRAM MOLEC MED,NEW YORK,NY 10029	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai					NINDS NIH HHS [R01-NS29814] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029814] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BENHAM CD, 1987, NATURE, V328, P275, DOI 10.1038/328275a0; BRIDGES K, 1981, J CELL BIOL, V90, P542, DOI 10.1083/jcb.90.2.542; DIEBOLD RJ, 1992, P NATL ACAD SCI USA, V89, P1497, DOI 10.1073/pnas.89.4.1497; FRIEND C, 1977, HARVEY LECT, P253; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GILLO B, 1993, BLOOD, V81, P783; HALLAM TJ, 1989, TRENDS PHARMACOL SCI, V10, P8, DOI 10.1016/0165-6147(89)90092-8; HARLOW E, 1988, ANTIBODIES LABORATOR; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HENSOLD JO, 1991, BLOOD, V77, P1362; Hille B., 1992, IONIC CHANNELS EXCIT; HOCKBERGER PE, 1987, CELL MOL NEUROBIOL, V7, P229, DOI 10.1007/BF00711301; JACOB R, 1990, BIOCHIM BIOPHYS ACTA, V1052, P427, DOI 10.1016/0167-4889(90)90152-4; KOCH WJ, 1990, J BIOL CHEM, V265, P17786; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; MALOUF NN, 1992, NEURON, V8, P899, DOI 10.1016/0896-6273(92)90204-Q; Maniatis T., 1982, MOL CLONING; MARKS AR, 1990, J BIOL CHEM, V265, P20719; MARUYAMA Y, 1982, NATURE, V300, P61, DOI 10.1038/300061a0; MASON WT, 1986, NEUROENDOCRINOLOGY, V43, P205, DOI 10.1159/000124529; MELDOLESI J, 1987, EXP CELL RES, V171, P271, DOI 10.1016/0014-4827(87)90161-3; MELLONI E, 1988, P NATL ACAD SCI USA, V85, P3835, DOI 10.1073/pnas.85.11.3835; MERRITT JE, 1987, J BIOL CHEM, V262, P4958; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; NAKAYAMA H, 1991, P NATL ACAD SCI USA, V88, P9203, DOI 10.1073/pnas.88.20.9203; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; PECHT I, 1987, EMBO J, V6, P1935, DOI 10.1002/j.1460-2075.1987.tb02454.x; PENNER R, 1988, J EXP BIOL, V139, P329; PETERS G, 1990, CELL GROWTH DIFFER, V1, P503; PURI TS, 1994, BIOPHYS J, V66, pA319; REED R, 1986, CELL, V46, P681, DOI 10.1016/0092-8674(86)90343-0; REUBEN RC, 1976, P NATL ACAD SCI USA, V73, P862, DOI 10.1073/pnas.73.3.862; RINK TJ, 1988, NATURE, V334, P649, DOI 10.1038/334649a0; Sambrook J, 1989, MOL CLONING LABORATO; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; STRIESSNIG J, 1990, P NATL ACAD SCI USA, V87, P9108, DOI 10.1073/pnas.87.23.9108; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L; ZSCHAUER A, 1988, NATURE, V334, P703, DOI 10.1038/334703a0	41	28	29	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					483	493		10.1074/jbc.270.1.483	http://dx.doi.org/10.1074/jbc.270.1.483			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814415	hybrid			2022-12-27	WOS:A1995QA28700076
J	SANTOS, MA; GARCIARAMIREZ, JJ; REVUELTA, JL				SANTOS, MA; GARCIARAMIREZ, JJ; REVUELTA, JL			RIBOFLAVIN BIOSYNTHESIS IN SACCHAROMYCES-CEREVISIAE - CLONING, CHARACTERIZATION, AND EXPRESSION OF THE RIB5 GENE ENCODING RIBOFLAVIN SYNTHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; ESCHERICHIA-COLI; YEAST; SEQUENCE; TRANSFORMATION; TRANSCRIPTION; PURIFICATION; MUTAGENESIS; PROTEIN; POLYMERASE	Saccharomyces cerevisiae has a monofunctional riboflavin synthase that catalyzes the formation of riboflavin from 6,7-dimethyl-8-ribityllumazine. We have isolated the gene encoding this enzyme from a yeast genomic library by functional complementation of a mutant, rib5-10, lacking riboflavin synthase activity. Deletion of the chromosomal copy of RIB5 led to riboflavin auxotrophy and loss of enzyme activity. Intragenic complementation between point and deletion mutant alleles suggested that the encoded protein (Rib5p) assembles into a multimeric complex and predicted the existence of a discrete functional domain located at the N terminus. Nucleotide sequencing revealed a 714-base pair open reading frame encoding a 25-kDa protein, Rib5p was purified to apparent homogeneity by a simple procedure. The specific activity of the enzyme was enriched 8500-fold. The N-terminal sequence of the purified enzyme was identical to the sequence predicted from the nucleotide sequence of the RIB5 gene. Initial structural characterization of riboflavin synthase by gel filtration chromatography and both nondenaturing pore limit and SDS-polyacrylamide gel electrophoresis showed that the enzyme forms a trimer of identical 25-kDa subunits. The derived amino acid sequence of RIB5 shows extensive homology to the sequences of the alpha subunits of riboflavin synthase from Bacillus subtilis and other prokaryotes. In addition, the sequence also shows internal homology between the N-terminal and the C-terminal halves of the protein. Taken together, these results suggest that the Rib5p subunit contains two structurally related (substrate binding) but catalytically different (acceptor and donator) domains.	UNIV SALAMANCA, DEPT GENET & MICROBIOL, E-37007 SALAMANCA, SPAIN	University of Salamanca			Revuelta, Jose L/C-2324-2012; Revuelta, Jose Luis/ABG-1502-2020; Santos, Maria Angeles/H-2239-2015; Garcia-Ramirez, Jose J/L-2153-2014	Revuelta, Jose L/0000-0001-7838-5308; Revuelta, Jose Luis/0000-0001-7838-5308; Santos, Maria Angeles/0000-0002-1257-7611; Garcia-Ramirez, Jose J/0000-0002-8348-3727				ANDERSSON LO, 1972, FEBS LETT, V20, P199, DOI 10.1016/0014-5793(72)80793-2; BACHER A, 1980, J BIOL CHEM, V255, P632; BACHER A, 1986, J MOL BIOL, V187, P75, DOI 10.1016/0022-2836(86)90407-9; Bacher A., 1991, CHEM BIOCH FLAVOPROT, P215; BOTSTEIN D, 1979, GENE, V8, P17, DOI 10.1016/0378-1119(79)90004-0; CHEN W, 1988, P NATL ACAD SCI USA, V85, P2691, DOI 10.1073/pnas.85.8.2691; CIGAN AM, 1987, GENE, V59, P1; DEMAIN AL, 1972, ANNU REV MICROBIOL, V26, P369, DOI 10.1146/annurev.mi.26.100172.002101; DOIGNON F, 1993, YEAST, V9, P189, DOI 10.1002/yea.320090210; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HARBURY PAB, 1989, MOL CELL BIOL, V9, P5298, DOI 10.1128/MCB.9.12.5298; HARVEY RA, 1966, J BIOL CHEM, V241, P2120; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LADENSTEIN R, 1986, J MOL BIOL, V187, P87, DOI 10.1016/0022-2836(86)90408-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGFORD CJ, 1984, CELL, V36, P645, DOI 10.1016/0092-8674(84)90344-1; LAWRENCE CW, 1991, METHOD ENZYMOL, V194, P273; LEE CY, 1992, BIOCHEM BIOPH RES CO, V186, P690, DOI 10.1016/0006-291X(92)90802-R; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARSTON FAO, 1986, BIOCHEM J, V240, P1, DOI 10.1042/bj2400001; MCNEIL JB, 1986, J MOL BIOL, V187, P363, DOI 10.1016/0022-2836(86)90439-0; OKANE DJ, 1991, P NATL ACAD SCI USA, V88, P110; OLTMANNS O, 1972, J BACTERIOL, V110, P818, DOI 10.1128/JB.110.3.818-822.1972; OLTMANNS O, 1969, MOL GEN GENET, V105, P306, DOI 10.1007/BF00277585; OTTO MK, 1981, EUR J BIOCHEM, V115, P511; PLAUT GWE, 1970, BIOCHEMISTRY-US, V9, P771, DOI 10.1021/bi00806a010; Plaut GWE, 1971, METHODS ENZYMOL B, V18, P515; PLAUT GWE, 1971, COMPREHENSIVE BIOCH, V21, P11; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTOS MD, 1988, CURR GENET, V14, P419; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SCHOTT K, 1990, J BIOL CHEM, V265, P4204; SHARP PM, 1991, YEAST, V7, P657, DOI 10.1002/yea.320070702; Sherman F., 1986, METHODS YEAST GENETI; SILVERMAN SJ, 1982, MOL CELL BIOL, V2, P1212, DOI 10.1128/MCB.2.10.1212; STRUHL K, 1989, ANNU REV BIOCHEM, V58, P1051, DOI 10.1146/annurev.bi.58.070189.005155; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; VOLK R, 1988, J AM CHEM SOC, V110, P3651, DOI 10.1021/ja00219a047; WICKERHAM LJ, 1951, TECH B US DEP AGRIC, V1029, P1; ZARET KS, 1982, CELL, V28, P563, DOI 10.1016/0092-8674(82)90211-2	50	28	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					437	444		10.1074/jbc.270.1.437	http://dx.doi.org/10.1074/jbc.270.1.437			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814407	hybrid			2022-12-27	WOS:A1995QA28700069
J	WANG, YL; MACDONALD, JIS; KENT, C				WANG, YL; MACDONALD, JIS; KENT, C			IDENTIFICATION OF THE NUCLEAR-LOCALIZATION SIGNAL OF RAT-LIVER CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHINESE-HAMSTER OVARY; CHOLINE-PHOSPHATE CYTIDYLYLTRANSFERASE; PHOSPHOLIPASE-C TREATMENT; MEMBRANE-ASSOCIATED CTP; PHOSPHATIDYLCHOLINE SYNTHESIS; ENDOPLASMIC-RETICULUM; LARGE-T; CELLS; PROTEIN; EXPRESSION	CTP:phosphocholine cytidylyltransferase (CT) is a major regulatory enzyme in phosphatidylcholine synthesis in mammalian cells, CT is found in both soluble and particulate forms, both of which are nuclear. We report here the identification of a al-residue sequence at the amino terminus of CT, (8)KVNSRKRRKEVPGPNGATEED(28), which was sufficient to direct beta-galactosidase into the cell nucleus. Further deletions from either end of this sequence greatly reduced the nuclear localization of beta-galactosidase. Deletions of amino acids within the nuclear localization signal or of the entire signal disrupted CT nuclear localization, but CT was not completely excluded from the nucleus. Clones of stable transfectants of the nuclear localization signal-deficient CT expressed in Chinese hamster ovary (CHO) 58 cells, which is temperature-sensitive for growth and CT activity, were isolated and characterized. The deletion mutants were active under the same conditions as the wildtype enzyme. Despite the difference in subcellular location from wild-type CT, the nuclear localization mutants were fully able to complement the CT-deficient cell line CHO 58 for both growth and choline incorporation into phosphatidylcholine at the nonpermissive temperature. The mobility of the mutant enzymes on SDS gels was altered relative to the mobility of wild-type CT; however, the extent of phosphorylation of the mutant enzymes was decreased only slightly. Thus, the distribution of CT in both cytoplasm and nucleus, rather than exclusively nucleus, has little effect on the ability of CT to function in growing CHO cells.	UNIV MICHIGAN,MED CTR,DEPT BIOL CHEM,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan								ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CORNELL R, 1989, J BIOL CHEM, V264, P9077; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; ESKO JD, 1982, P NATL ACAD SCI-BIOL, V79, P1698, DOI 10.1073/pnas.79.6.1698; EXTON JH, 1990, J BIOL CHEM, V265, P1; FELDMAN DA, 1993, J BIOL CHEM, V268, P3127; GARCIABUSTOS J, 1991, BIOCHIM BIOPHYS ACTA, V1071, P83, DOI 10.1016/0304-4157(91)90013-M; HIGGINS JA, 1987, J LIPID RES, V28, P268; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; JELSEMA CL, 1978, J BIOL CHEM, V253, P7960; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; KALMAR GB, 1990, P NATL ACAD SCI USA, V87, P6029, DOI 10.1073/pnas.87.16.6029; KENT C, 1990, PROG LIPID RES, V29, P87, DOI 10.1016/0163-7827(90)90010-I; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; MACDONALD JIS, 1993, PROTEIN EXPRES PURIF, V4, P1, DOI 10.1006/prep.1993.1001; MORAND JN, 1989, J BIOL CHEM, V264, P13785; PELECH SL, 1983, J BIOL CHEM, V258, P6782; RICHARDSON WD, 1986, CELL, V44, P77, DOI 10.1016/0092-8674(86)90486-1; RUTHERFORD MS, 1992, GENOMICS, V18, P698; SAYERS JR, 1988, NUCLEIC ACIDS RES, V16, P791, DOI 10.1093/nar/16.3.791; SLEIGHT R, 1983, J BIOL CHEM, V258, P831; SWEITZER TD, 1994, ARCH BIOCHEM BIOPHYS, V311, P107, DOI 10.1006/abbi.1994.1215; TAPAROWSKY EJ, 1987, CANCER RES, V47, P4125; TERCE F, 1992, BIOCHEM J, V282, P333, DOI 10.1042/bj2820333; UNDERWOOD MR, 1990, EMBO J, V9, P91, DOI 10.1002/j.1460-2075.1990.tb08084.x; VANCE JE, 1988, J BIOL CHEM, V263, P5898; WANG YL, 1993, J BIOL CHEM, V268, P5512; WANG YL, 1993, J BIOL CHEM, V268, P5899; WATKINS JD, 1991, J BIOL CHEM, V266, P21113; WATKINS JD, 1992, J BIOL CHEM, V267, P5686; WEINHOLD PA, 1992, METHOD ENZYMOL, V209, P248; WEINHOLD PA, 1989, BIOCHIM BIOPHYS ACTA, V1006, P299, DOI 10.1016/0005-2760(89)90017-9; ZACKSENHAUS E, 1993, MOL CELL BIOL, V13, P4588, DOI 10.1128/MCB.13.8.4588	37	84	84	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					354	360		10.1074/jbc.270.1.354	http://dx.doi.org/10.1074/jbc.270.1.354			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814396	hybrid			2022-12-27	WOS:A1995QA28700056
J	ZHANG, Y; FILLINGAME, RH				ZHANG, Y; FILLINGAME, RH			CHANGING THE ION-BINDING SPECIFICITY OF THE ESCHERICHIA-COLI H+-TRANSPORTING ATP SYNTHASE BY DIRECTED MUTAGENESIS OF SUBUNIT-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPIONIGENIUM-MODESTUM; ADENOSINE-TRIPHOSPHATASE; NUCLEOTIDE-SEQUENCE; NA+/H+ ANTIPORTER; F1F0 ATPASE; UNC OPERON; F0; DICYCLOHEXYLCARBODIIMIDE; TRANSLOCATION; EXPRESSION	Most F1F0 type ATP synthases, including that in Escherichia coli, use H+ as the coupling ion for ATP synthesis. However, the structurally related F1F0 ATP synthase in Propionigenium modestum uses Na+ in stead. The binding site for Na+ resides in the F-0 sector of the P. modestum enzyme. We postulated that Na+ might interact with subunit c of F-0. Subunit c of P. modestum and E. coli are reasonably homologous (19% identity) but show striking variations around the H+-translocating, dicyclohexylcarbodiimide-reactive carboxyl (Asp(61) in E. coli). Several hydrophobic residues around Asp(61) were replaced with polar residues according to the P. modestum sequence in the hope that the polar replacements might provide liganding groups for Na+. One mutant from 31 different mutation combinations did generate an active enzyme that binds Li+, the combination being V60A, D61E, A62S, and I63T. Li+ binding was detected by Li+ inhibition of ATP-driven H+ transport, Li+ inhibition of F1F0-ATPase activity, and Li+ inhibition of F-0-mediated H+ transport. The Li+ effects were observed with membrane vesicles prepared from a Delta nhaA, Delta nhaB mutant background which lacks Na+/H+ antiporters, and with purified, reconstituted preparations of F-0 prepared from this background strain. Li+ inhibition was observed at pH 8.5 but not at pH 7.0. H+ thus appears to compete with Li+ for the binding site. Li+ binding was abolished by replacement of Glu(61) by Asp or Ser(62) by Ala. The side chains at Ala(60) and Thr(63) may act in a supporting structural role by providing a more flexible conformation for the Li+ binding cavity. Thr(63) does not appear to provide a liganding group since H+ transport in two other mutants, with Gly or Ala in place of Thr(63), was also inhibited by Li+. We suggest that a X-Glu-Ser-Y or X-Glu-Thr-Y sequence may provide a general structural motif for monovalent cation binding, and that the flexibility provided by residues X and Y will prove crucial to this structure.	UNIV WISCONSIN,SCH MED,DEPT BIOMOLEC CHEM,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison			Zhang, Ying E/G-3657-2015	Zhang, Ying E/0000-0003-2753-7601	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023105, R37GM023105] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM23105] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BADGER J, 1994, BIOPHYS J, V66, P286, DOI 10.1016/S0006-3495(94)80795-7; BRUSILOW WSA, 1983, J BACTERIOL, V155, P1265, DOI 10.1128/JB.155.3.1265-1270.1983; DOWNIE JA, 1979, J BACTERIOL, V137, P711, DOI 10.1128/JB.137.2.711-718.1979; ESSER U, 1990, NUCLEIC ACIDS RES, V18, P5887, DOI 10.1093/nar/18.19.5887; FILLINGAME RH, 1975, J BACTERIOL, V124, P870, DOI 10.1128/JB.124.2.870-883.1975; FILLINGAME RH, 1990, BACTERIA TREATISE ST, V12, P345; FIMMEL AL, 1983, BIOCHEM J, V213, P481; FOSTER DL, 1982, J BIOL CHEM, V257, P2009; FRAGA D, 1991, J BACTERIOL, V173, P2639, DOI 10.1128/jb.173.8.2639-2643.1991; FRAGA D, 1994, J BIOL CHEM, V269, P7532; FRAGA D, 1990, THESIS U WISCONSIN M; GIRVIN ME, 1994, BIOCHEMISTRY-US, V33, P665, DOI 10.1021/bi00169a006; HERLITZE S, 1990, GENE, V91, P143, DOI 10.1016/0378-1119(90)90177-S; HILLE B, 1990, IONIC CHANNELS EXCIT, P261; HOPPE J, 1984, BIOCHIM BIOPHYS ACTA, V768, P1, DOI 10.1016/0304-4173(84)90005-3; KAIM G, 1993, EUR J BIOCHEM, V218, P937, DOI 10.1111/j.1432-1033.1993.tb18450.x; KAIM G, 1992, EUR J BIOCHEM, V207, P463, DOI 10.1111/j.1432-1033.1992.tb17072.x; KAKINUMA Y, 1993, BIOCHEM BIOPH RES CO, V195, P1063, DOI 10.1006/bbrc.1993.2152; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; KLUGE C, 1992, BIOCHEMISTRY-US, V31, P12665, DOI 10.1021/bi00165a017; KLUGE C, 1993, BIOCHEMISTRY-US, V32, P10378, DOI 10.1021/bi00090a013; KLUGE C, 1993, J BIOL CHEM, V268, P14557; KLUGE C, 1994, FEBS LETT, V340, P245, DOI 10.1016/0014-5793(94)80147-9; LAUBINGER W, 1987, EUR J BIOCHEM, V168, P475, DOI 10.1111/j.1432-1033.1987.tb13441.x; LAUBINGER W, 1990, BIOCHEMISTRY-US, V29, P5458, DOI 10.1021/bi00475a008; LAUBINGER W, 1988, BIOCHEMISTRY-US, V27, P7531, DOI 10.1021/bi00419a053; LAUBINGER W, 1989, BIOCHEMISTRY-US, V28, P7194, DOI 10.1021/bi00444a010; LUDWIG W, 1990, EUR J BIOCHEM, V193, P395, DOI 10.1111/j.1432-1033.1990.tb19352.x; MILLER MJ, 1989, J BIOL CHEM, V264, P305; MILLER MJ, 1990, P NATL ACAD SCI USA, V87, P4900, DOI 10.1073/pnas.87.13.4900; MOSHER ME, 1985, J BIOL CHEM, V260, P4807; PINNER E, 1993, J BIOL CHEM, V268, P1729; SCHNEIDER E, 1984, P NATL ACAD SCI USA, V51, P7279; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; SONE N, 1977, J BIOCHEM-TOKYO, V82, P1751, DOI 10.1093/oxfordjournals.jbchem.a131873; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8764; TONEY MD, 1993, SCIENCE, V261, P756, DOI 10.1126/science.8342040; WALKER JE, 1984, BIOCHIM BIOPHYS ACTA, V768, P164, DOI 10.1016/0304-4173(84)90003-X; WEBER E, 1981, TOP CURR CHEM, V98, P1; ZHANG Y, 1994, J BIOL CHEM, V269, P5473; ZHANG Y, 1994, J BIOL CHEM, V269, P10221	42	81	81	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					87	93		10.1074/jbc.270.1.87	http://dx.doi.org/10.1074/jbc.270.1.87			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814424	hybrid			2022-12-27	WOS:A1995QA28700019
J	HAYNES, PA; MEDH, JD; WEIGEL, PH				HAYNES, PA; MEDH, JD; WEIGEL, PH			INHIBITION OF TYROSINE PHOSPHORYLATION IN THE RAT HEPATIC LECTIN-1 SUBUNIT OF THE RAT ASIALOGLYCOPROTEIN RECEPTOR PREVENTS ATP-DEPENDENT RECEPTOR INACTIVATION IN PERMEABILIZED HEPATOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GALACTOSYL RECEPTORS; MEDIATED ENDOCYTOSIS; TRANSFERRIN RECEPTOR; PHORBOL ESTERS; MONENSIN; VANADATE; SUBPOPULATION; CHLOROQUINE; SURFACE; DEPLETION	We previously reconstituted the ATP dependent inactivation of asialoglycoprotein receptors (ASGPRs) in digitonin-permeabilized hepatocytes (Medh, J. D., and Weigel, P. H. (1991) J. Biol. Chem. 266, 8771-8778). Here we report that rat hepatic lectin 1 (RHL1) is the only ASGPR subunit that becomes radiolabeled when permeabilized washed hepatocytes are incubated at 4 degrees C in the presence of [gamma-P-32]ATP; RHL2 and RHL3 are not radiolabeled. Phosphorylation of RHL1 was rapid (t1/2 approximate to 4 min) and complete within 30 min. Inclusion of 20 mM EDTA inhibited phosphorylation of RHL1 completely. Phosphoamino acid analysis identified Tyr(P) as the predominant (>90%) radiolabeled phosphoamino acid. Addition of vanadate enhanced phosphorylation of Tyr in RHL1 4-fold. Phosphorylation of RHL1 occurred to the same extent in hepatocytes permeabilized with either 0.006% (w/v) or 0.055% digitonin and in the presence or the absence of ligand (50 mu g/ml asialo-orosomucoid; ASOR) and/or 10 mM CaCl2. Sequential purification of active ASGPRs (using ASOR-Sepharose) and inactive ASGPRs from the ASOR-Sepharose flow-through (using anti-ASGPR antibody-Sepharose) demonstrated that radiolabeled RHL1 was present almost exclusively in active ASGPR oligomers. When permeabilized hepatocytes radiolabeled with [gamma-P-32]ATP at 4 degrees C were warmed to 37 degrees C, a temperature at which ATP-dependent ASGPR inactivation occurs, RHL1 was dephosphorylated rapidly (t1/2 approximate to 4 min) and completely within similar to 30 min. Western blot analysis using a monoclonal anti-Tyr(P) antibody showed that the steady-state level of endogenous Tyr(P) in RHL1 doubled as a result of ATP treatment at 4 degrees C and then decreased to undetectable levels upon warming to 37 degrees C. The protein-tyrosine kinase inhibitor tyrphostin 51 inhibited phosphorylation of RHL1 at 4 degrees C and also prevented ATP-dependent ASGPR inactivation at 37 degrees C. We conclude that phosphorylation of Tyr in RHL1 of active ASGPRs is a prerequisite for ATP-dependent ASGPR inactivation.	UNIV TEXAS, MED BRANCH, DEPT HUMAN BIOL CHEM & GENET, GALVESTON, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston					NIGMS NIH HHS [GM 49695, GM 30218] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049695, R01GM030218] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERG T, 1983, EXP CELL RES, V148, P319, DOI 10.1016/0014-4827(83)90156-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREITFELD PP, 1990, J BIOL CHEM, V265, P13750; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; CLARKE BL, 1985, J BIOL CHEM, V260, P128; DRICKAMER K, 1984, J BIOL CHEM, V259, P770; EARP HS, 1983, FEBS LETT, V161, P180; FALLON RJ, 1994, J BIOL CHEM, V269, P11011; FALLON RJ, 1990, J BIOL CHEM, V265, P3401; FALLON RJ, 1988, J BIOL CHEM, V263, P13159; FALLON RJ, 1986, J BIOL CHEM, V261, P5081; FIETE D, 1983, J BIOL CHEM, V258, P817; GEFFEN I, 1991, P NATL ACAD SCI USA, V88, P8425, DOI 10.1073/pnas.88.19.8425; GEFFEN I, 1993, J BIOL CHEM, V268, P20772; GEFFEN I, 1992, INT REV CYTOL, V137B, P181; GIRONES N, 1991, J BIOL CHEM, V266, P19006; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; GRUPPUSO PA, 1991, BIOCHEM J, V274, P361, DOI 10.1042/bj2740361; HAYNES PA, 1994, J BIOL CHEM, V269, P33146; HERZIG MCS, 1990, BIOCHEMISTRY-US, V29, P6437, DOI 10.1021/bi00479a015; KINDBERG GM, 1990, J BIOL CHEM, V265, P8999; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MCABEE DD, 1989, BIOCHEM BIOPH RES CO, V161, P261, DOI 10.1016/0006-291X(89)91589-1; MCABEE DD, 1991, J CELL BIOCHEM, V45, P59, DOI 10.1002/jcb.240450113; MCABEE DD, 1988, BIOCHEMISTRY-US, V27, P2061, DOI 10.1021/bi00406a037; MCABEE DD, 1987, J BIOL CHEM, V262, P1942; MCABEE DD, 1990, J BIOL CHEM, V265, P629; MEDH JD, 1991, J BIOL CHEM, V266, P8771; OKA JA, 1991, ARCH BIOCHEM BIOPHYS, V289, P362, DOI 10.1016/0003-9861(91)90424-H; OKA JA, 1987, J CELL PHYSIOL, V133, P243, DOI 10.1002/jcp.1041330207; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; RAY DA, 1985, ANAL BIOCHEM, V145, P37, DOI 10.1016/0003-2697(85)90323-9; SCARMATO P, 1986, BIOL CELL, V56, P255, DOI 10.1111/j.1768-322X.1986.tb00457.x; Schwartz A L, 1991, Targeted Diagn Ther, V4, P3; SCHWARTZ AL, 1984, BIOCHEM J, V223, P481, DOI 10.1042/bj2230481; STEER CJ, 1986, PROG LIVER DIS, V8, P99; TAKAHASHI T, 1985, BIOCHEM BIOPH RES CO, V126, P1054, DOI 10.1016/0006-291X(85)90292-X; TAMURA S, 1984, J BIOL CHEM, V259, P6650; TOLLESHAUG H, 1979, BIOCHEM PHARMACOL, V28, P2919, DOI 10.1016/0006-2952(79)90586-0; TOLLESHAUG H, 1985, BIOCHEM PHARMACOL, V34, P1639, DOI 10.1016/0006-2952(85)90628-8; WEIGEL PH, 1982, J BIOL CHEM, V257, P1201; WEIGEL PH, 1994, MOL BIOL CELL, V5, P227, DOI 10.1091/mbc.5.2.227; WEIGEL PH, 1993, J BIOL CHEM, V268, P27186; WEIGEL PH, 1993, ENDOCYTIC COMPONENTS, P125; ZIJDERHANDBLEEKEMOLEN JE, 1987, J CELL BIOL, V104, P1647, DOI 10.1083/jcb.104.6.1647	45	16	16	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					33152	33158						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806545				2022-12-27	WOS:A1994QA63800064
J	POTGENS, AJG; LUBSEN, NH; VANALTENA, MC; VERMEULEN, R; BAKKER, A; SCHOENMAKERS, JGG; RUITER, DJ; DEWAAL, RMW				POTGENS, AJG; LUBSEN, NH; VANALTENA, MC; VERMEULEN, R; BAKKER, A; SCHOENMAKERS, JGG; RUITER, DJ; DEWAAL, RMW			COVALENT DIMERIZATION OF VASCULAR-PERMEABILITY FACTOR VASCULAR ENDOTHELIAL GROWTH-FACTOR IS ESSENTIAL FOR ITS BIOLOGICAL-ACTIVITY - EVIDENCE FROM CYS TO SER MUTATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; TUMOR-GROWTH; FACTOR VEGF; EXPRESSION; CELLS; ANGIOGENESIS; IDENTIFICATION; INHIBITION; RESOLUTION; RECEPTORS	Vascular permeability factor, or vascular endothelial growth factor (VPF/VEGF) is an important factor in the regulation of vascular growth and vascular permeability. VPF is a secreted, dimeric protein and has 8 cysteine residues conserved with platelet-derived growth factor (PDGF). To study the role of some of these cysteine residues in maintaining the structure and function of VPF, we replaced the codons for the second, third, fourth, and fifth cysteine by serine codons, and expressed the mutant proteins in a mammalian expression system. Cysteine residues 2 and 4 in VPF were found to be directly involved in anti parallel interchain disulfide bonds, as in PDGF. VPF mutants lacking one of these cysteines were severely impaired in their S-linked dimerization, while upon coexpression of both mutants the ability to form dimers was restored. The VPF mutants lacking cysteine residue 2 or 4 also competed poorly for receptor binding of labeled VPF and had low biological activity, but these defects were also complemented by coexpressing the two mutants, indicating that for efficient receptor binding and activation VPF needs to be a covalent dimer, unlike PDGP-BB. Furthermore, cysteine residue 5 was found to be essential for VPF dimerization and activity, while the mutant lacking cysteine residue 3 was only mildly affected in its ability to dimerize and had partial biological activity.	UNIV NIJMEGEN HOSP,INST PATHOL,6500 HB NIJMEGEN,NETHERLANDS; UNIV NIJMEGEN,DEPT BIOL MOLEC,NIJMEGEN,NETHERLANDS	Radboud University Nijmegen; Radboud University Nijmegen			Ruiter, D.J./L-4617-2015; Bakker, Arnold B./F-8494-2010; Waal, R.M.W./L-4739-2015; Lubsen, Nicolette H./B-8426-2011	Bakker, Arnold B./0000-0003-1489-1847; 				ADAMIS AP, 1993, BIOCHEM BIOPH RES CO, V193, P631, DOI 10.1006/bbrc.1993.1671; ANDERSSON M, 1992, J BIOL CHEM, V267, P11260; BARLEON B, 1994, J CELL BIOCHEM, V54, P56, DOI 10.1002/jcb.240540107; BERSE B, 1992, MOL BIOL CELL, V3, P211, DOI 10.1091/mbc.3.2.211; BREIER G, 1992, DEVELOPMENT, V114, P521; BROWN LF, 1992, J EXP MED, V176, P1375, DOI 10.1084/jem.176.5.1375; CLAUSS M, 1990, J EXP MED, V172, P1535, DOI 10.1084/jem.172.6.1535; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; GIESE NA, 1987, SCIENCE, V236, P1315, DOI 10.1126/science.3035718; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; KENNEY WC, 1994, J BIOL CHEM, V269, P12351; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; KIMURA H, 1993, P NATL ACAD SCI USA, V90, P2165, DOI 10.1073/pnas.90.6.2165; KONDO S, 1993, BIOCHEM BIOPH RES CO, V194, P1234, DOI 10.1006/bbrc.1993.1955; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; OEFNER C, 1992, EMBO J, V11, P3921, DOI 10.1002/j.1460-2075.1992.tb05485.x; PEPPER MS, 1991, BIOCHEM BIOPH RES CO, V181, P902, DOI 10.1016/0006-291X(91)91276-I; POTGENS AJG, 1994, THROMB HAEMOSTASIS, V71, P208; Sambrook J, 1989, MOL CLONING LABORATO; SARVER N, 1981, MOL CELL BIOL, V1, P486, DOI 10.1128/MCB.1.6.486; SAUER MK, 1988, MOL CELL BIOL, V3, P1011; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; SHEN H, 1993, BLOOD, V81, P2767; SHWEIKI D, 1993, J CLIN INVEST, V91, P2235, DOI 10.1172/JCI116450; UDAKA K, 1970, P SOC EXP BIOL MED, V133, P1384; UNEMORI EN, 1992, J CELL PHYSIOL, V153, P557, DOI 10.1002/jcp.1041530317; VASSBOTN FS, 1993, MOL CELL BIOL, V13, P4066, DOI 10.1128/MCB.13.7.4066; WIEDLOCHA A, 1994, CELL, V76, P1039, DOI 10.1016/0092-8674(94)90381-6; YEO TK, 1991, BIOCHEM BIOPH RES CO, V179, P1568, DOI 10.1016/0006-291X(91)91752-X	37	86	104	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					32879	32885						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806514				2022-12-27	WOS:A1994QA63800027
J	BELOGRUDOV, GI; TOMICH, JM; HATEFI, Y				BELOGRUDOV, GI; TOMICH, JM; HATEFI, Y			ATP SYNTHASE COMPLEX - PROXIMITIES OF SUBUNITS IN BOVINE SUBMITOCHONDRIAL PARTICLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVITY-CONFERRING PROTEIN; DICYCLOHEXYLCARBODIIMIDE-BINDING PROTEIN; OXIDATIVE-PHOSPHORYLATION SYSTEM; COUPLING FACTOR-B; ESCHERICHIA-COLI; HEART-MITOCHONDRIA; DELTA-SUBUNIT; BEEF-HEART; ALPHA-SUBUNIT; F1-ATPASE	The catalytic sector, F-1, and the membrane sector, F-0, of the mitochondrial ATP synthase complex are joined together by a 45-Angstrom-long stalk. Knowledge of the composition and structure of the stalk is crucial to investigating the mechanism of conformational energy transfer between F-0 and F-1. This paper reports on the near neighbor relationships of the stalk subunits with one another and with the subunits of F-1 and F-0, as revealed by cross-linking experiments. The preparations subjected to cross-linking were bovine heart submitochondrial particles (SMP) and F-1-deficient SMP. The cross-linkers were three reagents of different chemical specificities and different lengths of cross-linking from zero to 10 Angstrom. Cross-linked products were identified after gel electrophoresis of the particles and immunoblotting with subunit-specific antibodies to the individual subunits alpha, beta gamma, delta, OSCP, F-6, A6L, a (subunit 6), b, c, and d. The results suggested that the two b subunits form the principal stem of the stalk to which OSCP, d, and F-6 are bound independent of one another. Subunits b, OSCP, d, and F-6 cross-linked to alpha and/or beta, but not to gamma or delta. The COOH-terminal half of A6L, which is extramembranous, crosslinked to d but not to any other stalk or F-1 subunit. No cross-links of subunits a and c with any stalk or F-1 subunits were detected. In F-1-deficient SMP, cross-linked b + b and d + F-6 dimers appeared, and the extent of cross-linking between b and OSCP diminished greatly. The addition of F-1 to F-1-deficient particles appeared to reverse these changes. Treatment of F-1-deficient particles with trypsin rapidly hydrolyzed away OSCP and F-6, fragmented b to membrane bound 18-, 12-, and 8-9-kDa antigenic fragments, which cross-linked to d and/or with one another. Trypsin also removed the COOH-terminal part of A6L, but the remainder still cross-linked to subunit d. Models showing the near neighbor relationships of the stalk subunits with one another and with the alpha and beta subunits at a level near the proximal end (bottom) of F-1 and at the membrane-matrix interface are presented.	SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, DIV BIOCHEM, LA JOLLA, CA 92037 USA; KANSAS STATE UNIV AGR & APPL SCI, DEPT BIOCHEM, MANHATTAN, KS 66506 USA	Scripps Research Institute; Kansas State University					NIDDK NIH HHS [DK08126] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK008126, R37DK008126] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ABRAHAMS JP, 1993, EMBO J, V12, P1775, DOI 10.1002/j.1460-2075.1993.tb05825.x; ALSHAWI MK, 1990, J BIOL CHEM, V265, P4402; ARCHINARD P, 1986, BIOCHEMISTRY-US, V25, P3397, DOI 10.1021/bi00359a045; BELOGRUDOV G, 1994, BIOCHEMISTRY-US, V33, P4571, DOI 10.1021/bi00181a018; BELOGRUDOV GI, 1988, BIOL MEMBRANY, V5, P677; BIANCHET M, 1991, J BIOL CHEM, V266, P21197; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; CAPALDI RA, 1992, J BIOENERG BIOMEMBR, V24, P435, DOI 10.1007/BF00762359; COLLINSON IR, 1994, BIOCHEM J, V303, P639, DOI 10.1042/bj3030639; COLLINSON IR, 1994, BIOCHEMISTRY-US, V33, P7971, DOI 10.1021/bi00191a026; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; DUBACHEV GE, 1993, FEBS LETT, V336, P181, DOI 10.1016/0014-5793(93)81636-E; DUNN SD, 1980, J BIOL CHEM, V255, P6891; DUNN SD, 1981, ARCH BIOCHEM BIOPHYS, V210, P421, DOI 10.1016/0003-9861(81)90206-X; DUPUIS A, 1983, BIOCHEMISTRY-US, V22, P5951, DOI 10.1021/bi00294a039; DUPUIS A, 1985, BIOCHEMISTRY-US, V24, P728, DOI 10.1021/bi00324a029; EYTAN GD, 1990, J BIOL CHEM, V265, P12949; FESSENDENRADEN JM, 1972, J BIOL CHEM, V247, P2351; FILLINGAME RH, 1990, BACTERIA TREATISE ST, V12, P345; GALANTE YM, 1981, ARCH BIOCHEM BIOPHYS, V211, P643, DOI 10.1016/0003-9861(81)90500-2; GALANTE YM, 1979, J BIOL CHEM, V254, P2372; GIRVIN ME, 1993, BIOCHEMISTRY-US, V32, P12167, DOI 10.1021/bi00096a029; GIRVIN ME, 1994, BIOCHEMISTRY-US, V33, P665, DOI 10.1021/bi00169a006; GRAF T, 1978, FEBS LETT, V94, P218, DOI 10.1016/0014-5793(78)80941-7; HATEFI Y, 1993, EUR J BIOCHEM, V218, P759, DOI 10.1111/j.1432-1033.1993.tb18431.x; HEKMAN C, 1991, J BIOL CHEM, V266, P13564; HUNDAL T, 1983, FEBS LETT, V162, P5, DOI 10.1016/0014-5793(83)81038-2; JOSHI S, 1990, J BIOL CHEM, V265, P14518; KIEHL R, 1980, BIOCHEMISTRY-US, V19, P541, DOI 10.1021/bi00544a023; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUTTER R, 1993, BIOCHEM J, V295, P799, DOI 10.1042/bj2950799; MAGGIO MB, 1988, J BIOL CHEM, V263, P4619; MATSUNOYAGI A, 1990, J BIOL CHEM, V265, P82; MATSUNOYAGI A, 1984, BIOCHEMISTRY-US, V23, P3508, DOI 10.1021/bi00310a019; MENDELHARTVIG J, 1991, BIOCHIM BIOPHYS ACTA, V1060, P115, DOI 10.1016/S0005-2728(05)80126-4; OLMSTED JB, 1981, J BIOL CHEM, V256, P1955; OVCHINNIKOV YA, 1984, FEBS LETT, V166, P19, DOI 10.1016/0014-5793(84)80036-8; PENEFSKY HS, 1991, ADV ENZYMOL RAMB, V64, P173; RACKER E, 1967, J BIOL CHEM, V242, P2547; SANADI DR, 1982, BIOCHIM BIOPHYS ACTA, V683, P39; SEBALD W, 1979, EUR J BIOCHEM, V93, P587, DOI 10.1111/j.1432-1033.1979.tb12859.x; Senior A E, 1979, Methods Enzymol, V55, P391; SOPER JW, 1979, J BIOL CHEM, V254, P1170; STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4; STEFFENS K, 1987, J BIOL CHEM, V262, P5866; STEINMEIER RC, 1979, BIOCHEMISTRY-US, V18, P11, DOI 10.1021/bi00568a002; STIGGALL DL, 1979, ARCH BIOCHEM BIOPHYS, V196, P638, DOI 10.1016/0003-9861(79)90318-7; STIGGALL DL, 1978, J BIOL CHEM, V253, P956; WALKER JE, 1994, FEBS LETT, V346, P39, DOI 10.1016/0014-5793(94)00368-8; WALKER JE, 1991, BIOCHEMISTRY-US, V30, P5369, DOI 10.1021/bi00236a007; WALKER JE, 1982, FEBS LETT, V146, P393, DOI 10.1016/0014-5793(82)80960-5; WILKENS S, 1994, BIOL CHEM H-S, V375, P43; YAGI T, 1984, BIOCHEMISTRY-US, V23, P2449, DOI 10.1021/bi00306a020; YOU KS, 1976, BIOCHIM BIOPHYS ACTA, V423, P398, DOI 10.1016/0005-2728(76)90196-1; ZANOTTI F, 1988, FEBS LETT, V237, P9, DOI 10.1016/0014-5793(88)80161-3	57	47	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2053	2060		10.1074/jbc.270.5.2053	http://dx.doi.org/10.1074/jbc.270.5.2053			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836433	hybrid			2022-12-27	WOS:A1995QE49300014
J	IZBAN, MG; SAMKURASHVILI, I; LUSE, DS				IZBAN, MG; SAMKURASHVILI, I; LUSE, DS			RNA-POLYMERASE-II TERNARY COMPLEXES MAY BECOME ARRESTED AFTER TRANSCRIBING TO WITHIN 10 BASES OF THE END OF LINEAR TEMPLATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION FACTOR-SII; TRANSCRIPTION ELONGATION; DEPENDENT TRANSCRIPTION; ATTENUATION SITE; INVITRO; DNA; TERMINATION; CLEAVAGE; IDENTIFICATION; INITIATION	In the presence of elongation factor SII, arrested RNA polymerase II ternary complexes cleave 7-17 nucleotides from the 3'-ends of their nascent RNAs. It has been shown that transcription of linear templates generates apparent run-off RNAs, which are nevertheless truncated upon incubation with SII. By using high resolution gels, we demonstrate that transcription of blunt or 3'-overhung templates with RNA polymerase II generates two populations of ternary complexes, The first class pauses 5-10 bases prior to the end of the template strand, These complexes respond to SII by cleaving approximately 9-17 nucleotide RNAs from their 3'-ends and therefore may be termed arrested, A second class of complexes, which fail to respond to SII, transcribe to within 3 bases of the end of the template strand, These complexes appear to have run off the template since they have released their nascent RNAs. Run-off transcription occurs on all types of templates, but it is the predominant reaction on DNAs with 5'-overhung ends. Thus, RNA polymerase II ternary complexes that retain 5-10 bases of contact with the template strand downstream of the catalytic site become arrested, Further reduction of downstream template contacts can lead to termination, We also show that the addition of Sarkosyl to the elongation reactions significantly changes the pattern of transcriptional arrest near the end of linear templates.	UNIV CINCINNATI,COLL MED,DEPT MOLEC GENET BIOCHEM & MICROBIOL,CINCINNATI,OH 45267	University of Cincinnati					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029487] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 29487] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENGAL E, 1991, MOL CELL BIOL, V11, P1195, DOI 10.1128/MCB.11.3.1195; CAHMBERLIN MJ, 1994, HARVEY LECT, P1; COPPOLA JA, 1983, P NATL ACAD SCI-BIOL, V80, P1251, DOI 10.1073/pnas.80.5.1251; GU WG, 1993, J BIOL CHEM, V268, P25604; GUO HL, 1993, J BIOL CHEM, V268, P18762; HAWLEY DK, 1985, J BIOL CHEM, V260, P8163; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; IZBAN MG, 1993, J BIOL CHEM, V268, P12874; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; IZBAN MG, 1993, J BIOL CHEM, V268, P12864; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; JACOB GA, 1994, J BIOL CHEM, V269, P3655; JOHNSON TL, 1994, CELL, V77, P217, DOI 10.1016/0092-8674(94)90314-X; KEPHART DD, 1992, MOL CELL BIOL, V12, P2067, DOI 10.1128/MCB.12.5.2067; KERPPOLA TK, 1990, BIOCHEMISTRY-US, V29, P269, DOI 10.1021/bi00453a037; KESSLER M, 1989, J BIOL CHEM, V264, P9785; LINN SC, 1991, MOL CELL BIOL, V11, P1508, DOI 10.1128/MCB.11.3.1508; LONDON L, 1991, MOL CELL BIOL, V11, P4599, DOI 10.1128/MCB.11.9.4599; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; REINES D, 1987, J MOL BIOL, V196, P299, DOI 10.1016/0022-2836(87)90691-7; REINES D, 1992, J BIOL CHEM, V267, P15516; REINES D, 1992, J BIOL CHEM, V267, P3795; REINES D, 1989, J BIOL CHEM, V264, P10799; REINES D, 1993, P NATL ACAD SCI USA, V90, P1917, DOI 10.1073/pnas.90.5.1917; RESNEKOV O, 1989, J BIOL CHEM, V264, P9953; RESNEKOV O, 1989, P NATL ACAD SCI USA, V86, P12, DOI 10.1073/pnas.86.1.12; RICE GA, 1993, NUCLEIC ACIDS RES, V21, P113, DOI 10.1093/nar/21.1.113; RUDD MD, 1994, P NATL ACAD SCI USA, V91, P8057, DOI 10.1073/pnas.91.17.8057; WANG DG, 1993, P NATL ACAD SCI USA, V90, P843, DOI 10.1073/pnas.90.3.843; WIEST DK, 1992, J BIOL CHEM, V267, P7733; WIEST DK, 1990, MOL CELL BIOL, V10, P5782, DOI 10.1128/MCB.10.11.5782; YOO OJ, 1991, NUCLEIC ACIDS RES, V19, P1073, DOI 10.1093/nar/19.5.1073	33	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2290	2297		10.1074/jbc.270.5.2290	http://dx.doi.org/10.1074/jbc.270.5.2290			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836462	hybrid			2022-12-27	WOS:A1995QE49300049
J	LI, LX; MACPHERSON, JJ; ADELSTEIN, S; BUNN, CL; ATKINSON, K; PHADKE, K; KRILIS, SA				LI, LX; MACPHERSON, JJ; ADELSTEIN, S; BUNN, CL; ATKINSON, K; PHADKE, K; KRILIS, SA			CONDITIONED MEDIA FROM A CELL STRAIN DERIVED FROM A PATIENT WITH MASTOCYTOSIS INDUCES PREFERENTIAL DEVELOPMENT OF CELLS THAT POSSESS HIGH-AFFINITY IGE RECEPTORS AND THE GRANULE PROTEASE PHENOTYPE OF MATURE CUTANEOUS MAST-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; C-KIT LIGAND; MURINE BONE-MARROW; FETAL LIVER-CELLS; GROWTH-FACTOR; RECOMBINANT HUMAN; CARBOXYPEPTIDASE-A; COMPLEMENTARY-DNA; HUMAN TRYPTASE; MOUSE	We have demonstrated for the first time that a conditioned medium from a human cell strain can induce morphologically mature mast cells that express Fc epsilon RI and three mast cell-specific proteases from normal bone marrow progenitor cells. In contrast, recombinant human Kit ligand induced the differentiation of mast cells that were tryptase-positive but negative for chymase, carboxypeptidase, and Fc epsilon RI. This data indicates that factors other than Kit ligand are critical for inducing the differentiation and maturation of mast cells in the human. The HBM-M cell was originally derived from a patient with mastocytosis, As mastocytosis is thought to represent a reactive hyperplasia rather than a mast cell malignancy, the factor secreted by the HBM-M cell strain could well be responsible for the mast cell hyperplasia seen in some patients with mastocytosis.	ST GEORGE HOSP,DEPT IMMUNOL ALLERGY & INFECT DIS,KOGARAH,NSW 2217,AUSTRALIA; ST GEORGE HOSP,DEPT ONCOL,KOGARAH,NSW 2217,AUSTRALIA; UNIV NEW S WALES,SCH MED,KENSINGTON,NSW 2033,AUSTRALIA; ST VINCENTS HOSP,DEPT HAEMATOL,SYDNEY,NSW 2010,AUSTRALIA	St George Hospital; St George Hospital; University of New South Wales Sydney; St Vincents Hospital Sydney			Adelstein, Stephen/I-7936-2016; Macpherson, Janet/D-8702-2012	Adelstein, Stephen/0000-0001-7221-6298; Macpherson, Janet/0000-0003-0702-9546				BRESSLER RB, 1989, J IMMUNOL, V143, P135; CAUGHEY GH, 1991, J BIOL CHEM, V266, P12956; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COPELAND NG, 1990, CELL, V63, P175, DOI 10.1016/0092-8674(90)90298-S; DEVRIES P, 1991, J EXP MED, V173, P1205, DOI 10.1084/jem.173.5.1205; DVORAK AM, 1989, LAB INVEST, V61, P116; EKLUND KK, 1993, J IMMUNOL, V151, P4266; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; FURITSU T, 1989, P NATL ACAD SCI USA, V86, P10039, DOI 10.1073/pnas.86.24.10039; GHILDYAL N, 1992, J IMMUNOL, V149, P2123; GHILDYAL N, 1992, J BIOL CHEM, V267, P8473; GOLDSTEIN SM, 1987, J IMMUNOL, V139, P2724; GOLDSTEIN SM, 1989, J CLIN INVEST, V83, P1630, DOI 10.1172/JCI114061; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; HAMAGUCHI Y, 1987, J EXP MED, V165, P268, DOI 10.1084/jem.165.1.268; HULTNER L, 1990, EUR J IMMUNOL, V20, P1413, DOI 10.1002/eji.1830200632; IHLE JN, 1983, J IMMUNOL, V131, P282; IRANI AA, 1992, IMMUNOLOGY, V77, P136; IRANI AMA, 1992, BLOOD, V80, P3009; IRANI AMA, 1991, J IMMUNOL, V147, P247; ISHIZAKA T, 1991, INT ARCH ALLER A IMM, V94, P116, DOI 10.1159/000235341; ISHIZAKA T, 1989, MAST CELL BASOPHIL D, P39; KILGUS O, 1993, ADV EXP MED BIOL, V329, P237; KIRAHENBAUM AS, 1992, J IMMUNOL, V148, P772; KRILIS SA, 1991, BLOOD, V78, P290; KRILIS SA, 1992, BLOOD, V79, P144, DOI 10.1182/blood.V79.1.144.bloodjournal791144; KURIU A, 1991, BLOOD, V78, P2834; LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061; LEVISCHAFFER F, 1987, J IMMUNOL, V139, P3431; LEVISCHAFFER F, 1987, J IMMUNOL, V139, P494; LEVISCHAFFER F, 1985, J IMMUNOL, V135, P3454; MACPHERSON JL, 1992, INT ARCH ALLERGY IMM, V99, P346, DOI 10.1159/000236281; MATSUDA H, 1991, J EXP MED, V174, P7, DOI 10.1084/jem.174.1.7; MILLER JS, 1990, J CLIN INVEST, V86, P864, DOI 10.1172/JCI114786; MILLER JS, 1989, J CLIN INVEST, V84, P1188, DOI 10.1172/JCI114284; MITSUI H, 1993, P NATL ACAD SCI USA, V90, P735, DOI 10.1073/pnas.90.2.735; NILSSON G, 1993, IMMUNOLOGY, V79, P325; RAZIN E, 1984, J IMMUNOL, V132, P1479; REYNOLDS DS, 1989, P NATL ACAD SCI USA, V86, P9480, DOI 10.1073/pnas.86.23.9480; REYNOLDS DS, 1992, J CLIN INVEST, V89, P273, DOI 10.1172/JCI115571; SAITO H, 1988, P NATL ACAD SCI USA, V85, P2288, DOI 10.1073/pnas.85.7.2288; SCHECHTER NM, 1986, J IMMUNOL, V137, P962; SCHNEIDER E, 1987, J IMMUNOL, V139, P3710; SCHWARTZ LB, 1981, J BIOL CHEM, V256, P1939; SERAFIN WE, 1987, J IMMUNOL, V139, P3771; THOMPSONSNIPES LA, 1991, J EXP MED, V173, P507, DOI 10.1084/jem.173.2.507; TOKSOZ D, 1992, P NATL ACAD SCI USA, V89, P7350, DOI 10.1073/pnas.89.16.7350; TSAI M, 1991, P NATL ACAD SCI USA, V88, P6382, DOI 10.1073/pnas.88.14.6382; TSUJI K, 1991, J CELL PHYSIOL, V148, P362, DOI 10.1002/jcp.1041480306; URATA H, 1991, J BIOL CHEM, V266, P17173; VALENT P, 1992, BLOOD, V80, P2237; VANDERSLICE P, 1990, P NATL ACAD SCI USA, V87, P3811, DOI 10.1073/pnas.87.10.3811; ZSEBO KM, 1990, CELL, V63, P195, DOI 10.1016/0092-8674(90)90300-4; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	54	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2258	2263		10.1074/jbc.270.5.2258	http://dx.doi.org/10.1074/jbc.270.5.2258			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836459	hybrid			2022-12-27	WOS:A1995QE49300044
J	NORDSTROM, T; ROTSTEIN, OD; ROMANEK, R; ASOTRA, S; HEERSCHE, JNM; MANOLSON, MF; BRISSEAU, GF; GRINSTEIN, S				NORDSTROM, T; ROTSTEIN, OD; ROMANEK, R; ASOTRA, S; HEERSCHE, JNM; MANOLSON, MF; BRISSEAU, GF; GRINSTEIN, S			REGULATION OF CYTOPLASMIC PH IN OSTEOCLASTS - CONTRIBUTION OF PROTON PUMPS AND A PROTON-SELECTIVE CONDUCTANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-ION CURRENTS; VACUOLAR H+-ATPASE; BONE-RESORPTION; INTRACELLULAR PH; CARBONIC-ANHYDRASE; CHLORIDE-BICARBONATE; PARATHYROID HORMONE; RABBIT OSTEOCLASTS; AVIAN OSTEOCLASTS; PLASMA-MEMBRANE	Osteoclasts resorb bone by secreting protons into an extracellular resorption zone through vacuolar-type proton pumps located in the ruffled border, The present study was undertaken to evaluate whether proton pumps also contribute to intracellular pH (pH(i)) regulation. Fluorescence imaging and photometry, and electrophysiological methods were used to characterize the mechanisms of pH regulation in isolated rabbit osteoclasts. The fluorescence of single osteoclasts cultured on glass coverslips and loaded with a pH-sensitive indicator was measured in nominally HCO3--free solutions. When suspended in Na+-rich medium, the cells recovered from an acute acid load primarily by means of an amiloride sensitive Na+/H+ antiporter. However, rapid recovery was also observed in Na+-free medium when K+ was used as the substitute. Bafilomycin-sensitive, vacuolar-type pumps were found to contribute marginally to pH regulation and no evidence was found for K+/H+ exchange. In contrast, pH(i) recovery in high K+ medium was largely attributed to a Zn2+-sensitive proton conductive pathway. The properties of this conductance were analyzed by patch-clamping osteoclasts in the whole-cell configuration. Depolarizing pulses induced a slowly developing outward current and a concomitant cytosolic alkalinization. Determination of the reversal potential during ion substitution experiments indicated that the current was due to H+ (equivalent) translocation across the membrane. The H+ current was greatly stimulated by reducing pH(i), consistent with a homeostatic role of the conductive pathway during intracellular acidosis. These results suggest that vacuolar-type proton pumps contribute minimally to the recovery of cytoplasmic pH from intracellular acid loads. Instead, the data indicate the presence of a pH- and membrane potential-sensitive H+ conductance in the plasma membrane of osteoclasts. This conductance may contribute to translocation of charges and acid equivalents during bone resorption and/or generation of reactive oxygen intermediates by osteoclasts.	HOSP SICK CHILDREN,DIV CELL BIOL,TORONTO,ON M5G 1X8,CANADA; TORONTO GEN HOSP,DEPT SURG,TORONTO,ON M5G 2C4,CANADA; UNIV TORONTO,TORONTO,ON M5G 2C4,CANADA; UNIV TORONTO,FAC DENT,TORONTO,ON M5G 1G6,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto			Nordström, Tommy/H-9111-2016	Nordström, Tommy/0000-0002-2153-5819; Manolson, Morris/0000-0001-8755-5460				ALAWQATI Q, 1986, ANNU REV CELL BIOL, V2, P179, DOI 10.1146/annurev.cellbio.2.1.179; ARKETT SA, 1994, J MEMBRANE BIOL, V140, P163; ARKETT SA, 1992, J PHYSIOL-LONDON, V458, P633, DOI 10.1113/jphysiol.1992.sp019438; ASOTRA S, 1994, J BONE MINER RES, V9, P1115; BARON R, 1985, J CELL BIOL, V101, P2210, DOI 10.1083/jcb.101.6.2210; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; DECOURSEY TE, 1993, BIOPHYS J, V65, P1590, DOI 10.1016/S0006-3495(93)81198-6; DECOURSEY TE, 1994, J MEMBRANE BIOL, V141, P203; DEMAUREX N, 1993, J PHYSIOL-LONDON, V466, P329; FERRIER J, 1986, J CELL PHYSIOL, V128, P23, DOI 10.1002/jcp.1041280105; FUSHIMI H, 1993, DIABETES RES CLIN PR, V20, P191, DOI 10.1016/0168-8227(93)90077-I; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; GOLDHABER P, 1987, AM J PHYSIOL, V253, pE90, DOI 10.1152/ajpendo.1987.253.1.E90; GRINSTEIN S, 1994, AM J PHYSIOL-CELL PH, V267, pC1152, DOI 10.1152/ajpcell.1994.267.4.C1152; HALL GE, 1987, CALCIFIED TISSUE INT, V40, P212, DOI 10.1007/BF02556624; HALL TJ, 1990, J CELL PHYSIOL, V142, P420, DOI 10.1002/jcp.1041420227; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HUNTER SJ, 1991, J BONE MINER RES, V6, P61; KALLIO DM, 1971, J ULTRA MOL STRUCT R, V37, P169, DOI 10.1016/S0022-5320(71)80048-5; KANEHISA J, 1988, BONE, V9, P73, DOI 10.1016/8756-3282(88)90106-8; KAPUS A, 1993, J GEN PHYSIOL, V102, P729, DOI 10.1085/jgp.102.4.729; KEY LL, 1990, BONE, V11, P115, DOI 10.1016/8756-3282(90)90058-7; LAITALA T, 1993, J BONE MINER RES, V8, P119; LUKACS GL, 1993, AM J PHYSIOL, V265, pC3, DOI 10.1152/ajpcell.1993.265.1.C3; MAHAUTSMITH MP, 1989, J EXP BIOL, V145, P455; MEARS DC, 1971, ENDOCRINOLOGY, V88, P1021, DOI 10.1210/endo-88-4-1021; MOONGA BS, 1994, J BONE MINER RES  S1, V9, pB236; NEUMAN WF, 1958, CHEM DYNAMICS BONE M, pCH2; RAVESLOOT JH, 1989, P NATL ACAD SCI USA, V86, P6821, DOI 10.1073/pnas.86.17.6821; REDHEAD CR, 1988, CALCIFIED TISSUE INT, V42, P237, DOI 10.1007/BF02553749; ROMANEK R, 1994, IN PRESS CELL BIOL L; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; SHIBATA Y, 1993, J BONE MINER RES, V8, pS379; SHIBUTANI T, 1993, J BONE MINER RES, V8, P331; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; SIMMS SM, 1989, AM J PHYSIOL, V256, pC1277; SUNDQUIST K, 1990, BIOCHEM BIOPH RES CO, V168, P309, DOI 10.1016/0006-291X(90)91709-2; SWALLOW CJ, 1990, J BIOL CHEM, V265, P7645; TETI A, 1989, J CLIN INVEST, V83, P227, DOI 10.1172/JCI113863; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; TSIEN RY, 1989, FLUORESCENCE MICROSC, P127; VAANANEN HK, 1990, J CELL BIOL, V111, P1305, DOI 10.1083/jcb.111.3.1305; WALSH CA, 1990, J BONE MINER RES, V5, P1243; XIE XS, 1993, J BIOL CHEM, V268, P25063; YAMAGUCHI M, 1987, BIOCHEM PHARMACOL, V36, P4007, DOI 10.1016/0006-2952(87)90471-0; ZHANG K, 1992, J BIOL CHEM, V267, P14539	47	82	82	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2203	2212		10.1074/jbc.270.5.2203	http://dx.doi.org/10.1074/jbc.270.5.2203			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836451	hybrid			2022-12-27	WOS:A1995QE49300036
J	LIU, SJ; BAKER, JC; ROCHE, TE				LIU, SJ; BAKER, JC; ROCHE, TE			BINDING OF THE PYRUVATE-DEHYDROGENASE KINASE TO RECOMBINANT CONSTRUCTS CONTAINING THE INNER LIPOYL DOMAIN OF THE DIHYDROLIPOYL ACETYLTRANSFERASE COMPONENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-X; BOVINE KIDNEY; TRANSACETYLASE COMPONENT; NUCLEOTIDE-SEQUENCE; COMPLEX; PURIFICATION; CORE; CLEAVAGE; SURFACE; REGION	The dihydrolipoyl acetyltransferase (E2) component of the mammalian pyruvate dehydrogenase complex forms a 60-subunit core in which E2's inner domain forms a dodecahedron shaped structure surrounded by its globular outer domains that are connected to each other and the inner domain by 2-3-kDa mobile hinge regions. Two of the outer domains are similar to 10 kDa lipoyl domains, an NH2-terminal one, E2(L1), and, after the first hinge region a second one, E2(L2). The pyruvate dehydrogenase kinase binds tightly to the lipoyl domain region of the oligomeric E2 core and phosphorylates and inactivates the pyruvate dehydrogenase (E1) component. We wished to determine whether lipoyl domain constructs prepared by recombinant techniques from a cDNA for human E2 could bind the bovine E1 kinase and, that being the case, to pursue which lipoyl domain the kinase binds. We also wished to gain insights into how a molecule of kinase tightly bound to the E2 core can rapidly phosphorylate 20-30 molecules of the pyruvate dehydrogenase (E1) component which are also bound to an outer domain of the E2 core. We prepared recombinant constructs consisting of the entire lipoyl domain region or the individual lipoyl domains with or without the intervening hinge region. Constructs were made and used both as free lipoyl domains and fused to glutathione S-transferase (GST). Using GSH-Sepharose to selectively bind GST constructs, tightly bound kinase was shown to rapidly transfer in a highly preferential way from intact E2 core to GST constructs containing the E2(L2) domain rather than to ones containing only the E2(L1) domain. GST E2(L2)-kinase complexes could be eluted from GSH-Sepharose with glutathione. Delipoylation of E2(L2) by treatment with lipoamidase eliminated kinase binding supporting a direct role of the lipoyl prosthetic group in this association. Transfer to and selective binding of the kinase by E2(L2) but not E2(L1) was also demonstrated with free constructs using a sucrose gradient procedure to separate the large E2 core from the various lipoyl domain constructs. E2(L2) but not E2(L1) increased the activity of resolved kinase by up to 43%. We conclude that the kinase selectively binds to the inner lipoyl domain of E2 subunits and that this association involves its lipoyl prosthetic group. We further suggest that transfer of tightly bound kinase between E2(L2) domains occurs by a direct interchange mechanism without formation of free kinase (model presented), Such interdomain movement would explain how a kinase molecule can rapidly phosphorylate a large complement of pyruvate dehydrogenase tetramers which are bound throughout the surface of the E2 oligomer.	KANSAS STATE UNIV AGR & APPL SCI, DEPT BIOCHEM, MANHATTAN, KS 66506 USA	Kansas State University					NIDDK NIH HHS [DK18320] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018320, R55DK018320] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEHAL RH, 1989, P NATL ACAD SCI USA, V86, P8732, DOI 10.1073/pnas.86.22.8732; BRANDT DR, 1983, BIOCHEMISTRY-US, V22, P2958, DOI 10.1021/bi00281a027; BRANDT DR, 1983, BIOCHEMISTRY-US, V22, P2966, DOI 10.1021/bi00281a028; COPPEL RL, 1988, P NATL ACAD SCI USA, V85, P7317, DOI 10.1073/pnas.85.19.7317; JAKOBY WB, 1985, METHOD ENZYMOL, V113, P495; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI L, 1992, ARCH BIOCHEM BIOPHYS, V296, P497, DOI 10.1016/0003-9861(92)90603-T; LINN TC, 1972, ARCH BIOCHEM BIOPHYS, V148, P327, DOI 10.1016/0003-9861(72)90151-8; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; ONO K, 1993, J BIOL CHEM, V268, P26135; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; POPOV KM, 1993, J BIOL CHEM, V268, P26602; POPOV KM, 1994, J BIOL CHEM, V269, P29720; RADKE GA, 1993, BIOCHEM BIOPH RES CO, V190, P982, DOI 10.1006/bbrc.1993.1146; RAHMATULLAH M, 1990, J BIOL CHEM, V265, P14512; RAHMATULLAH M, 1989, J BIOL CHEM, V264, P1245; RAHMATULLAH M, 1985, J BIOL CHEM, V260, P146; RAHMATULLAH M, 1989, J BIOL CHEM, V264, P2221; RAHMATULLAH M, 1987, J BIOL CHEM, V262, P10265; REED LJ, 1990, J BIOL CHEM, V265, P8971; REINEMER P, 1991, EMBO J, V10, P1997, DOI 10.1002/j.1460-2075.1991.tb07729.x; ROCHE TE, 1989, ANN NY ACAD SCI, V573, P168, DOI 10.1111/j.1749-6632.1989.tb14994.x; ROCHE TE, 1977, ARCH BIOCHEM BIOPHYS, V183, P664, DOI 10.1016/0003-9861(77)90400-3; SCHUSTER SC, 1993, NATURE, V365, P343, DOI 10.1038/365343a0; STEPP LR, 1983, J BIOL CHEM, V258, P9454; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; SUZUKI K, 1963, J BIOL CHEM, V238, P4021; SWANSON RV, 1993, MOL MICROBIOL, V8, P435, DOI 10.1111/j.1365-2958.1993.tb01588.x; THEKKUMKARA TJ, 1988, FEBS LETT, V240, P45, DOI 10.1016/0014-5793(88)80337-5	30	57	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					793	800		10.1074/jbc.270.2.793	http://dx.doi.org/10.1074/jbc.270.2.793			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822313	hybrid			2022-12-27	WOS:A1995QB81600047
J	SABERS, CJ; MARTIN, MM; BRUNN, GJ; WILLIAMS, JM; DUMONT, FJ; WIEDERRECHT, G; ABRAHAM, RT				SABERS, CJ; MARTIN, MM; BRUNN, GJ; WILLIAMS, JM; DUMONT, FJ; WIEDERRECHT, G; ABRAHAM, RT			ISOLATION OF A PROTEIN TARGET OF THE FKBP12-RAPAMYCIN COMPLEX IN MAMMALIAN-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC-BINDING-PROTEIN; P70 S6 KINASE; CYCLOSPORINE-A; IMMUNOSUPPRESSANT RAPAMYCIN; SEQUENCE-ANALYSIS; LYMPHOCYTES-T; ACTIVATION; CALCINEURIN; FK-506; YEAST	The immunosuppressive drug, rapamycin, interferes with an undefined signaling pathway required for the progression of G(1)-phase T-cells into S phase. Genetic analyses in yeast indicate that binding of rapamycin to its intracellular receptor, FKBP12, generates a toxic complex that inhibits cell growth in G(1) phase. These analyses implicated two related proteins, TOR1 and TOR2, as targets of the FKBP12-rapamycin complex in yeast. In this study, we have used a glutathione S-transferase (GST)-FKBP12-rapamycin affinity matrix to isolate putative mammalian targets of rapamycin (mTOR) from tissue extracts. In the presence of rapamycin, immobilized GST-FKBP12 specifically precipitates similar high molecular mass proteins from both rat brain and murine T-lymphoma cell extracts, Binding experiments performed with rapamycin-sensitive and -resistant mutant clones derived from the YAC-1 T-lymphoma cell line demonstrate that the GST-FKBP12-rapamycin complex recovers significantly lower amounts of the candidate mTOR from rapamycin-resistant cell lines. The latter results suggest that mTOR is a relevant target of rapamycin in these cells. Finally, we report the isolation of a full-length mTOR cDNA that encodes a direct ligand for the FKBP12-rapamycin complex. The deduced amino acid sequence of mTOR displays 42 and 45% identity to those of yeast TOR1 and TOR2, respectively, These results strongly suggest that the FKBP12-rapamycin complex interacts with homologous ligands in yeast and mammalian cells and that the loss of mTOR function is directly related to the inhibitory effect of rapamycin on G(1)- to S-phase progression in T-lymphocytes and other sensitive cell types.	MAYO CLIN & MAYO FDN,DEPT IMMUNOL,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT PHARMACOL,ROCHESTER,MN 55905; MERCK & CO INC,MERCK SHARP & DOHME RES LABS,DEPT IMMUNOL RES,RAHWAY,NJ 07065	Mayo Clinic; Mayo Clinic; Merck & Company					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047286] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM47286] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTMEYER A, 1993, CYTOKINE, V5, P133, DOI 10.1016/1043-4666(93)90052-7; ALTMEYER A, 1991, CELL IMMUNOL, V138, P94, DOI 10.1016/0008-8749(91)90135-X; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; CAFFERKEY R, 1993, MOL CELL BIOL, V13, P6012, DOI 10.1128/MCB.13.10.6012; CALVO V, 1992, P NATL ACAD SCI USA, V89, P7571, DOI 10.1073/pnas.89.16.7571; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; DUMONT FJ, 1994, J IMMUNOL, V152, P992; DUMONT FJ, 1990, J IMMUNOL, V144, P1418; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105, DOI 10.1091/mbc.5.1.105; KOZAK M, 1986, NUCLEIC ACIDS RES, V15, P8125; KUNZ J, 1993, TRENDS BIOCHEM SCI, V18, P334, DOI 10.1016/0968-0004(93)90069-Y; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; KUO CJ, 1992, NATURE, V358, P70, DOI 10.1038/358070a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MORICE WG, 1993, J BIOL CHEM, V268, P3734; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; SIEKIERKA JJ, 1990, J BIOL CHEM, V265, P21011; SIGAL NH, 1992, ANNU REV IMMUNOL, V10, P519, DOI 10.1146/annurev.iy.10.040192.002511; STANDAERT RF, 1990, NATURE, V346, P671, DOI 10.1038/346671a0; TERADA N, 1993, J CELL PHYSIOL, V154, P7, DOI 10.1002/jcp.1041540103	29	662	689	3	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					815	822		10.1074/jbc.270.2.815	http://dx.doi.org/10.1074/jbc.270.2.815			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822316	hybrid			2022-12-27	WOS:A1995QB81600050
J	SINGHAL, RK; PRASAD, R; WILSON, SH				SINGHAL, RK; PRASAD, R; WILSON, SH			DNA-POLYMERASE-BETA CONDUCTS THE GAP-FILLING STEP IN URACIL-INITIATED BASE EXCISION-REPAIR IN A BOVINE TESTIS NUCLEAR EXTRACT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MONKEY CELLS; IDENTIFICATION; ALPHA; ENDONUCLEASES; GLYCOSYLASES; PURIFICATION; RESIDUES; ENZYME; DOMAIN	The GU mismatch in genomic DNA mainly arises from deamination of cytosine residues and is repaired by the base excision repair pathway, We found that a bovine testis crude nuclear extract conducts uracil-initiated base excision repair in vitro. A 51-base pair synthetic DNA substrate containing a single G:U mismatch was used, and incorporation of dCMP during repair was exclusively to replace uracil. A neutralizing polyclonal antibody against DNA polymerase beta (beta-pol) inhibited the repair reaction, ddCTP also inhibited the repair reaction, whereas aphidicolin had no significant effect, suggesting that activity of beta-pol was required, Next, the base excision repair system was reconstituted using partially purified components. Several of the enzymatic activities required were resolved, such that DNA Ligase and the uracil-DNA glycosylase/apurinic/apyrimidinic endonuclease activities were separated from the DNA polymerase requirement. We found that purified beta-pol could restore full DNA repair activity to the DNA polymerase-depleted fraction, whereas purified DNA polymerases alpha, delta, and epsilon could not, These results with purified proteins corroborated results obtained with the crude extract and indicate that beta-pol is responsible for the single-nucleotide gap filling reaction involved in this in vitro base excision repair system.	UNIV TEXAS, MED BRANCH, SEALY CTR MOLEC SCI, GALVESTON, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston			Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293				ABBOTTS J, 1988, BIOCHEMISTRY-US, V27, P901, DOI 10.1021/bi00403a010; Barnes DE, 1993, CURR OPIN CELL BIOL, V5, P424, DOI 10.1016/0955-0674(93)90007-D; DIANOV G, 1992, MOL CELL BIOL, V12, P1605, DOI 10.1128/MCB.12.4.1605; DOETSCH PW, 1990, MUTAT RES, V236, P173, DOI 10.1016/0921-8777(90)90004-O; FREIDBERG EC, 1985, DNA REPAIR; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; HANAWALT PC, 1979, ANNU REV BIOCHEM, V48, P783, DOI 10.1146/annurev.bi.48.070179.004031; HARLOW E, 1988, ANTIBODIES LABORATOR; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; KARAWYA E, 1984, P NATL ACAD SCI-BIOL, V81, P7777, DOI 10.1073/pnas.81.24.7777; KUMAR A, 1990, J BIOL CHEM, V265, P2124; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDAHL T, 1992, ANNU REV BIOCHEM, V61, P251, DOI 10.1146/annurev.bi.61.070192.001343; Lindahl T, 1979, Prog Nucleic Acid Res Mol Biol, V22, P135; MATSUMOTO Y, 1991, MOL CELL BIOL, V11, P4441, DOI 10.1128/MCB.11.9.4441; MATSUMOTO Y, 1994, MOL CELL BIOL, V14, P6187, DOI 10.1128/MCB.14.9.6187; MOSBAUGH DW, 1983, J BIOL CHEM, V258, P108; PERRINO FW, 1990, MUTAT RES, V236, P289, DOI 10.1016/0921-8777(90)90012-T; PRASAD R, 1993, J BIOL CHEM, V268, P22746; PRASAD R, 1993, NUCLEIC ACIDS RES, V21, P5301, DOI 10.1093/nar/21.23.5301; RANDAHL H, 1988, J BIOL CHEM, V263, P12228; REGAN JD, 1974, CANCER RES, V34, P3318; SADAKANE Y, 1994, BIOCHEM BIOPH RES CO, V200, P219, DOI 10.1006/bbrc.1994.1437; SAKUMI K, 1990, MUTAT RES, V236, P161, DOI 10.1016/0921-8777(90)90003-N; SANCAR A, 1988, ANNU REV BIOCHEM, V57, P29, DOI 10.1146/annurev.bi.57.070188.000333; SHIMIZU K, 1993, J BIOL CHEM, V268, P27148; SINGHAL RK, 1993, J BIOL CHEM, V268, P15906; TANABE K, 1983, NUCLEIC ACIDS RES, V11, P8253, DOI 10.1093/nar/11.23.8253; WALLACE SS, 1988, ENVIRON MOL MUTAGEN, V12, P431, DOI 10.1002/em.2860120411; WANG LM, 1992, CANCER RES, V52, P4824; WANG ZG, 1993, MOL CELL BIOL, V13, P1051, DOI 10.1128/MCB.13.2.1051; WIDEN SG, 1991, BIOCHEMISTRY-US, V30, P6296, DOI 10.1021/bi00239a031; WIEBAUER K, 1990, P NATL ACAD SCI USA, V87, P5842, DOI 10.1073/pnas.87.15.5842; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068	34	292	300	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					949	957		10.1074/jbc.270.2.949	http://dx.doi.org/10.1074/jbc.270.2.949			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822335	hybrid			2022-12-27	WOS:A1995QB81600070
J	GU, W; MORALES, C; HECHT, NB				GU, W; MORALES, C; HECHT, NB			IN MALE-MOUSE GERM-CELLS, COPPER-ZINC SUPEROXIDE-DISMUTASE UTILIZES ALTERNATIVE PROMOTERS THAT PRODUCE MULTIPLE TRANSCRIPTS WITH DIFFERENT TRANSLATION POTENTIAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; CDNA CLONE; MOLECULAR-BIOLOGY; GENE-EXPRESSION; TRANSGENIC MICE; DOWNS-SYNDROME; CYTOCHROME-C; RAT TESTIS; SPERMATOGENESIS; PROTEIN	Copper zinc superoxide dismutase (SOD-1) is an enzyme that is widely expressed in eukaryotic cells and performs a vital role in protecting cells against free radical damage. In mouse testis, three different sizes of SOD-l mRNAs of about 0.73, 0.80, and 0.93 kilobases (kb) are detected. The 0.73-kb mRNA is found in early stages of male germ cells and in all somatic tissues. The mRNAs of 0.80 and 0.93 kb are exclusively detected in post-meiotic germ cells. RNase H digestions and Northern blot analyses reveal that the three SOD-l mRNAs are derived from two transcripts, a ubiquitously expressed transcript and a post-meiotic transcript, which differ by 114-120 nucleotides. RNase protection assays demonstrate that the additional nucleotides present in the post-meiotic mRNA are solely in the 5'-untranslated region. Using a probe derived from the 5'-untranslated region of the 0.93-kb SOD-l mRNA, we have established that it originates from an alternative upstream promoter contiguous with the somatic SOD-l promoter. Polysomal gradient analysis of the three mouse testis SOD-1 mRNAs reveals that the 0.93-kb SOD-l mRNA is primarily non-polysomal, while the 0.80 and 0.73 kb SOD-l mRNAs are mostly polysome associated. A faster migrating form of the 0.93-kb SOD-l mRNA is present on polysomes as a result of partial deadenylation. In a cell-free translation system, the 0.73-kb SOD-1 mRNA translates about 2-fold more efficiently than the 0.93 kb SOD-l mRNA These data demonstrate that male germ cells transcribe two size classes of SOD-1 mRNAs with different translation potential by utilizing two different promoters, post meiotic SOD-1 mRNAs undergo adenylation changes, and one of the post-meiotic SOD-l mRNAs is transcribed during mid-spermiogenesis and translated days later in a partially deadenylated form.	TUFTS UNIV, DEPT BIOL, MEDFORD, MA 02155 USA; MCGILL UNIV, DEPT ANAT, MONTREAL, PQ H3A 2B2, CANADA	Tufts University; McGill University					NICHD NIH HHS [HD 28832] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028832] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALCIVAR AA, 1989, DEV BIOL, V135, P263, DOI 10.1016/0012-1606(89)90178-4; Ausubel FM, 1991, CURRENT PROTOCOLS MO, V1; AVRAHAM KB, 1988, CELL, V54, P823, DOI 10.1016/S0092-8674(88)91153-1; BARRA D, 1984, J BIOL CHEM, V259, P2595; BENEDETTO MT, 1991, GENE, V99, P191, DOI 10.1016/0378-1119(91)90126-V; BEWLEY GC, 1988, NUCLEIC ACIDS RES, V16, P2728, DOI 10.1093/nar/16.6.2728; CEHALLOSPICOT I, 1992, EXPER SUPPL BASEL, V62, P89; CHURCH GM, 1984, P NATL ACAD SCI USA, V74, P5463; CRAPO JD, 1992, P NATL ACAD SCI USA, V89, P10405, DOI 10.1073/pnas.89.21.10405; DELABAR JM, 1987, EUR J BIOCHEM, V166, P181, DOI 10.1111/j.1432-1033.1987.tb13500.x; DELMAS V, 1993, MOL ENDOCRINOL, V7, P1502, DOI 10.1210/me.7.11.1502; FISCHMAN K, 1990, MOL CELL BIOL, V10, P146, DOI 10.1128/MCB.10.1.146; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; GARRETT JE, 1989, MOL CELL BIOL, V9, P4381, DOI 10.1128/MCB.9.10.4381; GRISWOLD MD, 1988, OXFORD REV REPROD B, V10, P124; GU W, 1994, IN PRESS MOL REPROD; HAKE LE, 1990, DEVELOPMENT, V110, P249; HAKE LE, 1993, J BIOL CHEM, V268, P4788; Hecht N. B., 1990, Biology of mammalian germ cell mutagenesis.., P67; Hecht N. B., 1993, CELL MOL BIOL TESTIS, P400; HEIDARAN MA, 1987, GENE, V54, P281, DOI 10.1016/0378-1119(87)90498-7; HSU JL, 1992, BIOCHEM BIOPH RES CO, V186, P936, DOI 10.1016/0006-291X(92)90836-A; JOHNSON PA, 1988, BIOCHIM BIOPHYS ACTA, V950, P45, DOI 10.1016/0167-4781(88)90071-1; JOW WW, 1993, J ANDROL, V14, P439; KILPATRICK DL, 1990, MOL CELL BIOL, V10, P3717, DOI 10.1128/MCB.10.7.3717; KIM YH, 1993, GENE, V133, P267; KLEENE KC, 1987, J BIOL CHEM, V262, P17272; KLEENE KC, 1989, DEVELOPMENT, V106, P367; KLEENE KC, 1984, DEV BIOL, V105, P71, DOI 10.1016/0012-1606(84)90262-8; KLEENE KC, 1983, DEV BIOL, V98, P455, DOI 10.1016/0012-1606(83)90375-5; KWON YK, 1993, MOL CELL BIOL, V13, P6547, DOI 10.1128/MCB.13.10.6547; LANGFORD KG, 1991, J BIOL CHEM, V266, P15559; LASO MRV, 1993, J BIOL CHEM, V268, P6453; LEVANON D, 1985, EMBO J, V4, P77, DOI 10.1002/j.1460-2075.1985.tb02320.x; LIEMANHURWITZ J, 1982, P NATL ACAD SCI-BIOL, V79, P2808, DOI 10.1073/pnas.79.9.2808; Maniatis T., 1982, MOL CLONING; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MORALES CR, 1994, BIOL REPROD, V50, P309, DOI 10.1095/biolreprod50.2.309; NANBU R, 1991, BIOCHIM BIOPHYS ACTA, V1088, P71, DOI 10.1016/0167-4781(91)90154-E; NONOGAKI T, 1992, HUM REPROD, V7, P81, DOI 10.1093/oxfordjournals.humrep.a137565; RAO SM, 1993, J BIOL CHEM, V268, P22164; ROMRELL LJ, 1976, DEV BIOL, V49, P119, DOI 10.1016/0012-1606(76)90262-1; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; SHAPER NL, 1990, P NATL ACAD SCI USA, V87, P791, DOI 10.1073/pnas.87.2.791; SHERMAN L, 1984, NUCLEIC ACIDS RES, V12, P9349, DOI 10.1093/nar/12.24.9349; SINET PM, 1982, ANN NY ACAD SCI, V396, P83, DOI 10.1111/j.1749-6632.1982.tb26845.x; WOLGEMUTH DJ, 1991, MAMM GENOME, V1, P283, DOI 10.1007/BF00352340; YIU G, 1994, IN PRESS NUCLEIC ACI	49	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					236	243		10.1074/jbc.270.1.236	http://dx.doi.org/10.1074/jbc.270.1.236			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814380	hybrid			2022-12-27	WOS:A1995QA28700039
J	SHARMA, E; LOMBROSO, PJ				SHARMA, E; LOMBROSO, PJ			A NEURONAL PROTEIN-TYROSINE-PHOSPHATASE INDUCED BY NERVE GROWTH-FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PC12 CELLS; TRK PROTOONCOGENE; RECEPTOR; PHOSPHORYLATION; PURIFICATION; DIFFERENTIATION; EXPRESSION; CLONING; KINASE; PRODUCT	A new protein tyrosine phosphatase (PC12-PTP1) was identified in nerve growth factor (NGF) treated PC12 cells, The mRNA level of PC12-PTP1 is increased 9-fold over the initial 8 h of NGF treatment and then decreases dramatically after 24 h of treatment, In rat brain, three transcripts corresponding to 1.5, 2.6, and 3.0 kilobases (kb) in size are detected by Northern blot analysis. Although the 1.5- and 2.6-kb transcripts are present in brain and other tissues, the 3-kb transcript is exclusively expressed in brain and the expression of this transcript alone increases following NGF treatment, PC12-PTP1 is a non-receptor protein tyrosine phosphatase (PTP) with a 50% sequence homology in the phosphatase domain with several other non-receptor PTPs. PC12-PTP1 fusion protein exhibits tyrosine phosphatase activity, and in vitro translation of the PC12-PTP1 transcript produces a major protein of 39 kDa. The data presented suggest that NGF regulates the expression of PC12-PTP1 during periods of neuronal growth and differentiation.	YALE UNIV,SCH MED,CTR CHILD STUDY,NEW HAVEN,CT 06520	Yale University					NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH049351] Funding Source: NIH RePORTER; NIMH NIH HHS [MH00856, MH18268, MH49351] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADACHI M, 1992, BIOCHEM BIOPH RES CO, V186, P1607, DOI 10.1016/S0006-291X(05)81592-X; ALTIN JG, 1989, J NEUROCHEM, V54, P1666; APARICIO LF, 1992, CELL GROWTH DIFFER, V3, P363; BARKER PA, 1992, MOL CELL BIOCHEM, V110, P1, DOI 10.1007/BF02385000; CARBONNEAU H, 1989, P NATL ACAD SCI USA, V86, P5252; CHAO MV, 1992, CELL, V68, P995, DOI 10.1016/0092-8674(92)90068-N; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; DITCHLER MA, 1977, NATURE, V268, P501; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENE LA, 1983, J CELL BIOL, V96, P76, DOI 10.1083/jcb.96.1.76; GREENE LA, 1975, NATURE, V258, P341; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; JAISWAL RK, 1993, J BIOL CHEM, V268, P7055; JONES SW, 1989, J BIOL CHEM, V264, P7747; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; KIM UH, 1991, J BIOL CHEM, V266, P1359; LEVI A, 1991, ANNU REV PHARMACOL, V31, P205; LOMBROSO PJ, 1993, J NEUROSCI, V13, P3064; LOMBROSO PJ, 1991, P NATL ACAD SCI USA, V88, P7242, DOI 10.1073/pnas.88.16.7242; LONGO FM, 1993, J BIOL CHEM, V268, P26503; MAHER PA, 1988, P NATL ACAD SCI USA, V85, P6788, DOI 10.1073/pnas.85.18.6788; MATTHEWS RJ, 1990, P NATL ACAD SCI USA, V87, P444; MEI L, 1991, J BIOL CHEM, V266, P16063; NAEGELE JR, 1995, IN PRESS CRIT REV NE; NAKAFUKU M, 1992, J BIOL CHEM, V267, P19448; PAN MG, 1993, J BIOL CHEM, V268, P19284; PESSIN MS, 1991, CELL REGUL, V2, P383, DOI 10.1091/mbc.2.5.383; RICHTERLANDSBER.C, 1985, J NEUROSCI, V5, P468; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; TONKS NK, 1988, J BIOL CHEM, V263, P6731; TSAO H, 1990, J BIOL CHEM, V265, P15471; VETTER ML, 1991, P NATL ACAD SCI USA, V88, P5650, DOI 10.1073/pnas.88.13.5650; WALAAS SI, 1991, PHARMACOL REV, V43, P299; WU YY, 1993, J CELL BIOL, V121, P409, DOI 10.1083/jcb.121.2.409; YAN H, 1993, J BIOL CHEM, V268, P24880; ZANKE B, 1992, EUR J IMMUNOL, V22, P235, DOI 10.1002/eji.1830220134	36	58	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					49	53		10.1074/jbc.270.1.49	http://dx.doi.org/10.1074/jbc.270.1.49			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814416	hybrid			2022-12-27	WOS:A1995QA28700013
J	CREEMERS, JWM; VEY, M; SCHAFER, W; AYOUBI, TAY; ROEBROEK, AJM; KLENK, HD; GARTEN, W; VANDEVEN, WJM				CREEMERS, JWM; VEY, M; SCHAFER, W; AYOUBI, TAY; ROEBROEK, AJM; KLENK, HD; GARTEN, W; VANDEVEN, WJM			ENDOPROTEOLYTIC CLEAVAGE OF ITS PROPEPTIDE IS A PREREQUISITE FOR EFFICIENT TRANSPORT OF FURIN OUT OF THE ENDOPLASMIC-RETICULUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPROTEIN PROCESSING ENZYME; CONSTITUTIVE SECRETORY PATHWAY; SITE-DIRECTED MUTAGENESIS; SUBTILISIN-LIKE PROTEASE; HAMSTER OVARY CELLS; GLYCOSYLATION SITES; VIRUS HEMAGGLUTININ; PRECURSOR CLEAVAGE; GENE-EXPRESSION; ACTIVATION	The trans-Golgi network (TGN) proprotein convertase furin is synthesized in a zymogenic form and is activated by intramolecular, autoproteolytic cleavage of the propeptide from its precursor. To obtain insight in possible functions of the furin propeptide, we have studied biosynthesis, propeptide cleavage, biological activity, and intracellular localization of human and bovine furin. Analysis of autocatalytic cleavage site mutants of furin revealed that efficient propeptide cleavage requires the presence of the complete furin cleavage consensus sequence Arg-X-Lys Arg. In studies of a mutant in which the P1+P4+P5 residues of the autoproteolytic cleavage site were substituted, no substrate processing activity could be demonstrated, indicating a complete block of maturation. In immunofluorescence analysis, this mutant was found in the endoplasmic reticulum (ER), suggesting ER retention of profurin. This ER retention, however, appeared saturable. Furin proteins encoded by oxyanion hole mutant N188A and negative side chain mutant D248L, which possess autoprocessing activity but lack substrate processing activity, were found in the Golgi and the ER, respectively. Finally, analysis of a furin mutant, in which all three potential sites for N-linked glycosylation were altered, revealed autocatalytic cleavage, substrate processing, and transport to the Golgi. Our results indicate that cleavage of the propeptide occurs in the endoplasmic reticulum and is necessary but not sufficient for transport of furin out of this compartment.	CATHOLIC UNIV LEUVEN,CTR HUMAN GENET,MOLEC ONCOL LAB,B-3000 LOUVAIN,BELGIUM; UNIV MARBURG,INST VIROL,D-35037 MARBURG,GERMANY	KU Leuven; Philipps University Marburg								Baker D, 1993, CURR OPIN CELL BIOL, V5, P966, DOI 10.1016/0955-0674(93)90078-5; BARR PJ, 1991, DNA CELL BIOL, V10, P319, DOI 10.1089/dna.1991.10.319; BARR PJ, 1991, CELL, V66, P1, DOI 10.1016/0092-8674(91)90129-M; BRESNAHAN PA, 1990, J CELL BIOL, V111, P2851, DOI 10.1083/jcb.111.6.2851; CREEMERS JWM, 1993, J BIOL CHEM, V268, P21826; DOUGLASS J, 1984, ANNU REV BIOCHEM, V53, P665; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GETHING MJ, 1992, NATURE, V335, P33; HALBAN PA, 1994, BIOCHEM J, V299, P1; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; HATSUZAWA K, 1992, J BIOL CHEM, V267, P16094; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; JULIUS D, 1984, CELL, V37, P1075, DOI 10.1016/0092-8674(84)90442-2; KLENK HD, 1993, VIRUS STRATEGIES MOL, P195; LEDUC R, 1992, J BIOL CHEM, V267, P14304; MACHAMER CE, 1988, J BIOL CHEM, V263, P5955; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; OU WJ, 1993, NATURE, V264, P771; REHEMTULLA A, 1992, P NATL ACAD SCI USA, V89, P8235, DOI 10.1073/pnas.89.17.8235; ROBERTS PC, 1993, J VIROL, V67, P3048, DOI 10.1128/JVI.67.6.3048-3060.1993; Roebroek A. J. M., 1992, MOL BIOL LIFE SCI AD, V11, P127; ROEBROEK AJM, 1986, EMBO J, V5, P2197, DOI 10.1002/j.1460-2075.1986.tb04484.x; SCHALKEN JA, 1987, J CLIN INVEST, V80, P1545, DOI 10.1172/JCI113240; SIEZEN RJ, 1994, EUR J BIOCHEM, V222, P255, DOI 10.1111/j.1432-1033.1994.tb18864.x; SOSSIN WS, 1989, NEURON, V2, P1407, DOI 10.1016/0896-6273(89)90186-4; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; VANDENOUWELAND AMW, 1989, NUCLEIC ACIDS RES, V17, P7101, DOI 10.1093/nar/17.17.7101; VANDENOUWELAND AMW, 1990, NUCLEIC ACIDS RES, V18, P664, DOI 10.1093/nar/18.3.664; VANDEVEN WJM, 1990, MOL BIOL REP, V14, P265, DOI 10.1007/BF00429896; VANDEVEN WJM, 1992, CRIT REV ONCOGENESIS, V4, P115; VANDUIJNHOVEN HLP, 1992, HYBRIDOMA, V11, P71, DOI 10.1089/hyb.1992.11.71; VEY M, 1995, IN PRESS J CELL BIOL; WATANABE T, 1992, J BIOL CHEM, V267, P8270; WEITZ G, 1992, J BIOL CHEM, V267, P10039; WISE RJ, 1990, P NATL ACAD SCI USA, V87, P9378, DOI 10.1073/pnas.87.23.9378; YOSHIMASA Y, 1990, J BIOL CHEM, V265, P17230	36	98	101	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2695	2702		10.1074/jbc.270.6.2695	http://dx.doi.org/10.1074/jbc.270.6.2695			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852339	hybrid			2022-12-27	WOS:A1995QF53500047
J	GEREN, LM; BEASLEY, JR; FINE, BR; SAUNDERS, AJ; HIBDON, S; PIELAK, GJ; DURHAM, B; MILLETT, F				GEREN, LM; BEASLEY, JR; FINE, BR; SAUNDERS, AJ; HIBDON, S; PIELAK, GJ; DURHAM, B; MILLETT, F			DESIGN OF A RUTHENIUM CYTOCHROME-C DERIVATIVE TO MEASURE ELECTRON-TRANSFER TO THE INITIAL ACCEPTOR IN CYTOCHROME-C-OXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEADY-STATE KINETICS; YEAST ISO-1-CYTOCHROME-C; PROTON TRANSLOCATION; TUNNELING PATHWAYS; HIGH-AFFINITY; COPPER-A; SITE; HORSE; IDENTIFICATION; BINDING	A ruthenium-labeled cytochrome c derivative was prepared to meet two design criteria: the ruthenium group must transfer an electron rapidly to the heme group, but not alter the interaction with cytochrome c oxidase. Site-directed mutagenesis was used to replace His(39) on the backside of yeast C102T iso-1-cytochrome c with a cysteine residue, and the single sulfhydryl group was labeled with (4-bromomethyl-4'methylbipyridine) (bis-bipyridine)ruthenium(II) to form Ru-39-cytochrome c (cyt c), There is an efficient pathway for electron transfer from the ruthenium group to the heme group of Ru-39-cyt c comprising 13 covalent bonds and one hydrogen bond. Electron transfer from the excited state Ru(II*) to ferric heme c occurred with a rate constant of (6.0 +/- 2.0) x 10(5) s(-1), followed by electron transfer from ferrous heme c to Ru(III) with a rate constant of (1.0 +/- 0.2) x 10(6) s(-1), Laser excitation of a complex between Ru-39-cyt c and beef cytochrome c oxidase in low ionic strength buffer (5 mM phosphate, pH 7) resulted in electron transfer from photoreduced heme c to Cu-A with a rate constant of (6 +/- 2) x 10(4) s(-1), followed by electron transfer from Cu-A to heme a with a rate constant of (1.8 +/- 0.3) x 10(4) s(-1), Increasing the ionic strength to 100 mM leads to bimolecular kinetics as the complex is dissociated. The second-order rate constant is (2.5 +/- 0.4) x 10(7) M(-1) s(-1) at 230 mM ionic strength, nearly the same as that of wild-type iso-1-cytochrome c.	UNIV ARKANSAS,DEPT CHEM & BIOCHEM,FAYETTEVILLE,AR 72701; UNIV N CAROLINA,DEPT CHEM,CHAPEL HILL,NC 27599; UNIV N CAROLINA,DEPT BIOCHEM & BIOPHYS,CHAPEL HILL,NC 27599	University of Arkansas System; University of Arkansas Fayetteville; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill				Saunders, Aleister/0000-0002-7298-7823	NIGMS NIH HHS [GM42501, GM08332, GM20488] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042501, R29GM042501, T32GM008332] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMAD I, 1982, BIOCHEMISTRY-US, V21, P3122, DOI 10.1021/bi00256a014; ANTALIS TM, 1982, J BIOL CHEM, V257, P6194; ANTHOLINE WE, 1992, EUR J BIOCHEM, V209, P875, DOI 10.1111/j.1432-1033.1992.tb17360.x; AULD DS, 1993, PROTEIN SCI, V2, P2187, DOI 10.1002/pro.5560021218; BERATAN DN, 1990, J AM CHEM SOC, V112, P7915, DOI 10.1021/ja00178a011; BERGHUIS AM, 1992, J MOL BIOL, V223, P959, DOI 10.1016/0022-2836(92)90255-I; BETZ SF, 1992, BIOCHEMISTRY-US, V31, P12337, DOI 10.1021/bi00164a007; BLAIR DF, 1982, BIOCHEMISTRY-US, V21, P6928, DOI 10.1021/bi00269a048; BLAIR DF, 1983, CHEM SCRIPTA, V21, P43; CAPALDI RA, 1972, FEBS LETT, V26, P261, DOI 10.1016/0014-5793(72)80587-8; COOPER CE, 1990, BIOCHIM BIOPHYS ACTA, V1017, P187, DOI 10.1016/0005-2728(90)90184-6; CUTLER RL, 1987, PROTEIN ENG, V1, P95, DOI 10.1093/protein/1.2.95; DETHMERS JK, 1979, J BIOL CHEM, V254, P1973; DURHAM B, 1990, ADV CHEM SER, V226, P181; DURHAM B, 1989, BIOCHEMISTRY-US, V28, P8659, DOI 10.1021/bi00447a057; ELTIS LD, 1991, BIOCHEMISTRY-US, V30, P3663, DOI 10.1021/bi00229a011; ERECINSKA M, 1971, FEBS LETT, V16, P284, DOI 10.1016/0014-5793(71)80371-X; FERGUSONMILLER S, 1978, J BIOL CHEM, V253, P149; GAO Y, 1990, BIOCHEMISTRY-US, V29, P6994, DOI 10.1021/bi00482a007; GARBER EAE, 1990, BIOCHIM BIOPHYS ACTA, V1015, P279, DOI 10.1016/0005-2728(90)90032-Y; GEREN L, 1991, BIOCHEMISTRY-US, V30, P9450, DOI 10.1021/bi00103a009; GUPTE SS, 1988, J BIOL CHEM, V263, P5241; GURBIEL RJ, 1993, J AM CHEM SOC, V115, P10888, DOI 10.1021/ja00076a053; HAHM S, 1994, BIOCHEMISTRY-US, V33, P1473, DOI 10.1021/bi00172a025; HAHM S, 1992, BIOCHEMISTRY-US, V31, P3472, DOI 10.1021/bi00128a022; HALL J, 1988, J BIOL CHEM, V263, P8142; HAWKINS BK, 1994, J AM CHEM SOC, V116, P3111, DOI 10.1021/ja00086a046; HAZZARD JT, 1991, BIOCHEMISTRY-US, V30, P213, DOI 10.1021/bi00215a031; HILGEN SE, 1991, PROT ENG, V5, P575; HILL BC, 1991, J BIOL CHEM, V266, P2219; HOSLER JP, 1993, J BIOENERG BIOMEMBR, V25, P121, DOI 10.1007/BF00762854; KOBAYASHI K, 1989, J BIOL CHEM, V264, P7976; KRONECK PMH, 1990, FEBS LETT, V268, P274, DOI 10.1016/0014-5793(90)81026-K; LARSEN RW, 1992, J PHYS CHEM-US, V96, P8023, DOI 10.1021/j100199a036; LEMASTERS JJ, 1978, FEBS LETT, V88, P10, DOI 10.1016/0014-5793(78)80595-X; MARGOLIASH E, 1959, BIOCHEM J, V71, P570, DOI 10.1042/bj0710570; MARTIN CT, 1988, J BIOL CHEM, V263, P8420; MILLETT F, 1983, BIOCHEMISTRY-US, V22, P546, DOI 10.1021/bi00272a004; MINNAERT K, 1961, BIOCHIM BIOPHYS ACTA, V50, P23, DOI 10.1016/0006-3002(61)91055-1; Moore G. R., 1990, CYTOCHROMES C EVOLUT; MORGAN JE, 1989, BIOCHEMISTRY-US, V28, P6975, DOI 10.1021/bi00443a030; NILSSON T, 1992, P NATL ACAD SCI USA, V89, P6497, DOI 10.1073/pnas.89.14.6497; NORTHRUP SH, 1988, SCIENCE, V241, P67, DOI 10.1126/science.2838904; PAN LP, 1990, BIOCHEMISTRY-US, V29, P3231, DOI 10.1021/bi00465a013; PAN LP, 1988, BIOCHEMISTRY-US, V27, P7180, DOI 10.1021/bi00419a003; PAN LP, 1992, BIOCHEMISTRY-US, V32, P8492; RIEDER R, 1980, J BIOL CHEM, V255, P4732; ROUSSEAU DL, 1993, J BIOENERG BIOMEMBR, V25, P165, DOI 10.1007/BF00762858; SCHROEDL NA, 1977, BIOCHEMISTRY-US, V16, P4961, DOI 10.1021/bi00642a003; SCOTT JR, 1993, J AM CHEM SOC, V115, P6820, DOI 10.1021/ja00068a045; SHAPLEIGH JP, 1992, P NATL ACAD SCI USA, V89, P4786, DOI 10.1073/pnas.89.11.4786; SINJORGO KMC, 1984, BIOCHIM BIOPHYS ACTA, V767, P48, DOI 10.1016/0005-2728(84)90078-1; SMITH HT, 1977, BIOCHEMISTRY-US, V16, P4971, DOI 10.1021/bi00642a005; SMITH HT, 1981, J BIOL CHEM, V256, P4984; STEVENS TH, 1982, J BIOL CHEM, V257, P2106; THERIEN MJ, 1990, J AM CHEM SOC, V112, P2420, DOI 10.1021/ja00162a054; WACHENFELDT CV, 1994, FEBS LETT, V340, P109; WIKSTROM M, 1989, NATURE, V338, P776, DOI 10.1038/338776a0; WILLIE A, 1992, BIOCHEMISTRY-US, V31, P7237, DOI 10.1021/bi00147a005; WILLIE A, 1993, BIOCHEMISTRY-US, V32, P7519, DOI 10.1021/bi00080a025; WILMS J, 1981, BIOCHIM BIOPHYS ACTA, V635, P13, DOI 10.1016/0005-2728(81)90003-7; WILSON DF, 1976, ARCH BIOCHEM BIOPHYS, V175, P160, DOI 10.1016/0003-9861(76)90495-1; WILSON DF, 1972, BIOCHIM BIOPHYS ACTA, V256, P277, DOI 10.1016/0005-2728(72)90058-8; WILSON MT, 1975, BIOCHEM J, V147, P145, DOI 10.1042/bj1470145; WOODRUFF WH, 1993, J BIOENERG BIOMEMBR, V25, P177, DOI 10.1007/BF00762859; WUTTKE DS, 1992, SCIENCE, V256, P1007, DOI 10.1126/science.256.5059.1007; YONETANI T, 1965, J BIOL CHEM, V240, P3392	67	80	80	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2466	2472		10.1074/jbc.270.6.2466	http://dx.doi.org/10.1074/jbc.270.6.2466			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852307	hybrid, Green Published			2022-12-27	WOS:A1995QF53500013
J	POLLER, W; WILLNOW, TE; HILPERT, J; HERZ, J				POLLER, W; WILLNOW, TE; HILPERT, J; HERZ, J			DIFFERENTIAL RECOGNITION OF ALPHA(1)-ANTITRYPSIN-ELASTASE AND ALPHA(1)-ANTICHYMOTRYPSIN-CATHEPSIN-G COMPLEXES BY THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEYMANN NEPHRITIS ANTIGEN; ALPHA-2-MACROGLOBULIN RECEPTOR; ALPHA-1-PROTEINASE INHIBITOR; PLASMINOGEN-ACTIVATOR; HIGH-AFFINITY; LUNG-DISEASE; BINDING; ALPHA-1-ANTITRYPSIN; CELLS; ALPHA-1-ANTICHYMOTRYPSIN	Two multifunctional receptors, low density lipoprotein receptor-related protein (LRP) and gp330, have been implicated in the cellular uptake and degradation of a wide spectrum of functionally diverse ligands including plasma lipoproteins, proteases, and proteinase-inhibitor complexes, The two receptors show distinct tissue-specific expression patterns, suggesting different physiological functions, We have examined the cellular degradation of two serine proteinase inhibitor (serpin)-protease complexes, alpha(1)-antitrypsin-neutrophil elastase (alpha(1)AT-NEL) and alpha(1)-antichymotsypsin-cathepsin G (alpha(1)ACT-CathG) by normal murine fibroblasts (MEF) expressing LRP, and by a mutant fibroblast cell line (PEA13) which is genetically deficient for LRP, alpha(1)AT-NEL complexes bound to LRP on ligand blots and were degraded efficiently by the MEF cells, but not by PEA13 cells, Degradation of the complexes was also significantly reduced by antibodies directed against LRP, further suggesting that fibroblasts require LRP for the cellular uptake and degradation of alpha(1)AT-NEL complexes, In contrast to alpha(1)AT-NEL, MEF cells did not degrade alpha(1)ACT-CathG complexes, However, these complexes were rapidly degraded by the rat embryonal carcinoma cell line L2p58 which abundantly expresses gp330, raising the possibility that the alpha(1)ACT-CathG complex might be recognized by gp330, Both complexes were efficiently metabolized by the hepatoma cell line HepG2, presumably involving the serpin-enzyme complex receptor, The differential recognition of serpin-protease complexes by fibroblasts and hepatoma cells, however, indicates that LRP, gp330, and the serpin-enzyme complex receptor are distinct proteins.	UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas			Poller, Wolfgang/AAB-2185-2021	Poller, Wolfgang/0000-0002-2805-6634; Willnow, Thomas/0000-0001-9515-7921	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 20948] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BANDA MJ, 1988, J BIOL CHEM, V263, P4481; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; BILLINGSLEY GD, 1993, AM J HUM GENET, V52, P343; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BU GJ, 1992, P NATL ACAD SCI USA, V89, P7427, DOI 10.1073/pnas.89.16.7427; BURNETT D, 1984, AM REV RESPIR DIS, V129, P473; CHANDRA T, 1983, BIOCHEMISTRY-US, V22, P5055, DOI 10.1021/bi00291a001; Cox DW, 1989, METABOLIC BASIS INHE, P2409; CRYSTAL RG, 1990, J CLIN INVEST, V85, P1343, DOI 10.1172/JCI114578; FABER JP, 1993, J HEPATOL, V18, P313, DOI 10.1016/S0168-8278(05)80275-2; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; HERZ J, 1993, CELL, V73, P428, DOI 10.1016/0092-8674(93)90130-I; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; HERZ J, 1991, J BIOL CHEM, V266, P21232; JOSLIN G, 1993, J BIOL CHEM, V268, P1886; KERJASCHKI D, 1983, J EXP MED, V157, P667, DOI 10.1084/jem.157.2.667; KOTAS RV, 1991, PEDIATR PULM, V10, P260, DOI 10.1002/ppul.1950100407; KOUNNAS MZ, 1993, J BIOL CHEM, V268, P21862; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; KOWAL RC, 1990, J BIOL CHEM, V265, P10771; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; KURDOWSKA A, 1990, J BIOL CHEM, V265, P21023; MISRA UK, 1993, BIOCHEM J, V290, P885, DOI 10.1042/bj2900885; MOESTRUP SK, 1992, CELL TISSUE RES, V269, P375, DOI 10.1007/BF00353892; MOESTRUP SK, 1991, J BIOL CHEM, V266, P14011; MORNEX JF, 1986, J CLIN INVEST, V77, P1952, DOI 10.1172/JCI112524; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; ORLANDO RA, 1993, P NATL ACAD SCI USA, V90, P4082, DOI 10.1073/pnas.90.9.4082; ORTH K, 1992, P NATL ACAD SCI USA, V89, P7422, DOI 10.1073/pnas.89.16.7422; PERLMUTTER DH, 1988, J CLIN INVEST, V81, P1774, DOI 10.1172/JCI113519; PERLMUTTER DH, 1990, J BIOL CHEM, V265, P16713; PERLMUTTER DH, 1990, P NATL ACAD SCI USA, V87, P3753, DOI 10.1073/pnas.87.10.3753; POLLER W, 1993, GENOMICS, V17, P740, DOI 10.1006/geno.1993.1396; RUBIN H, 1990, J BIOL CHEM, V265, P1199; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; STOUFFER GA, 1993, J BIOL CHEM, V268, P18340; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; TRAVIS J, 1988, AM J MED, V84, P37; WARSHAWSKY I, 1994, P NATL ACAD SCI USA, V91, P6664, DOI 10.1073/pnas.91.14.6664; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; WILLNOW TE, 1994, J CELL SCI, V107, P719; WILLNOW TE, 1992, J BIOL CHEM, V267, P26172; WILLNOW TE, 1994, J BIOL CHEM, V269, P15827; WOLF BB, 1992, AM J PATHOL, V141, P37	48	52	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2841	2845		10.1074/jbc.270.6.2841	http://dx.doi.org/10.1074/jbc.270.6.2841			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852358	hybrid			2022-12-27	WOS:A1995QF53500068
J	SCHONHERR, E; WITSCHPREHM, P; HARRACH, B; ROBENEK, H; RAUTERBERG, J; KRESSE, H				SCHONHERR, E; WITSCHPREHM, P; HARRACH, B; ROBENEK, H; RAUTERBERG, J; KRESSE, H			INTERACTION OF BIGLYCAN WITH TYPE-I COLLAGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DERMATAN SULFATE PROTEOGLYCAN; BOVINE ARTICULAR-CARTILAGE; GROWTH-FACTOR-BETA; CORE PROTEIN; EXTRACELLULAR-MATRIX; KERATAN SULFATE; VI COLLAGEN; FIBRILLAR COLLAGEN; HUMAN-SKIN; DECORIN	The small proteoglycan decorin is known to interact with type I collagen fibrils, thereby influencing the kinetics of fibril formation and the distance between adjacent collagen fibrils. The structurally related proteoglycan biglycan has been proposed not to bind to fibrillar collagens. However, when osteosarcoma cells were cultured on reconstituted type I collagen fibrils, both decorin and biglycan were retained by the matrix. Immunogold labeling at the electron microscopic level showed that both proteoglycans were distributed along collagen fibrils not only in osteosarcoma cell-populated collagen lattices but also in human skin. Reconstituted type I collagen fibrils were able to bind in vitro native and N-glycan-free biglycan as well as recombinant biglycan core protein. From Scatchard plots dissociation, constants were obtained that were higher for glycanated biglycan (8.7 x 10(-8) mol/liter) than for glycanated decorin (7 x 10(-10) mol/liter and 3 x 10(-9) mol/liter, respectively). A similar number of binding sites for either proteoglycan was calculated. Recombinant biglycan and decorin were characterized by lower dissociation constants compared with the glycanated forms. Glycanated as well as recombinant decorin competed with glycanated biglycan for collagen binding, suggesting that identical or adjacent binding sites on the fibril are used by both proteoglycans. These data suggest that, because of its trivalency, biglycan could have a special organizing function on the assembly of the extracellular matrix.	UNIV MUNSTER, INST ARTERIOSCLEROSIS RES, W-4400 MUNSTER, GERMANY	University of Munster	SCHONHERR, E (corresponding author), UNIV MUNSTER, INST PHYSIOL CHEM & PATHOBIOCHEM, WALDEYERSTR 15, D-48149 MUNSTER, GERMANY.							BEAVAN LA, 1993, J BIOL CHEM, V268, P9856; BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616; BIDANSET DJ, 1992, J BIOL CHEM, V267, P5250; BLOCHBERGER TC, 1992, J BIOL CHEM, V267, P347; BREUER B, 1990, BIOCHEM J, V269, P551, DOI 10.1042/bj2690551; BROWN DC, 1990, MATRIX, V9, P468, DOI 10.1016/S0934-8832(11)80016-8; CHOI HU, 1989, J BIOL CHEM, V264, P2876; FEDARKO NS, 1992, J CELL PHYSIOL, V151, P215, DOI 10.1002/jcp.1041510202; FESSLER JH, 1987, STRUCTURE FUNCTION C, P81; FISHER LW, 1989, J BIOL CHEM, V264, P4571; FLEISCHMAJER R, 1991, J STRUCT BIOL, V106, P82, DOI 10.1016/1047-8477(91)90065-5; FUJII T, 1975, H-S Z PHYSIOL CHEM, V356, P1793, DOI 10.1515/bchm2.1975.356.2.1793; GREVE H, 1990, BIOCHEM J, V269, P149, DOI 10.1042/bj2690149; HAUSSER H, 1989, BIOCHEM J, V263, P137, DOI 10.1042/bj2630137; HAUSSER H, 1992, J BIOL CHEM, V267, P11559; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; HEDBOM E, 1993, J BIOL CHEM, V268, P27307; HENKEL W, 1982, EUR J BIOCHEM, V122, P205, DOI 10.1111/j.1432-1033.1982.tb05868.x; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; KRESSE H, 1993, EXPERIENTIA, V49, P403, DOI 10.1007/BF01923585; KRUSIUS T, 1986, P NATL ACAD SCI USA, V83, P7683, DOI 10.1073/pnas.83.20.7683; LINSENMAYER TF, 1986, DEV BIOL, V118, P425, DOI 10.1016/0012-1606(86)90013-8; MIOSGE N, 1995, IN PRESS HISTOCHEM J; NEAME PJ, 1989, J BIOL CHEM, V264, P8653; OLDBERG A, 1989, EMBO J, V8, P2601, DOI 10.1002/j.1460-2075.1989.tb08399.x; POGANY G, 1992, BIOCHEM BIOPH RES CO, V189, P165, DOI 10.1016/0006-291X(92)91539-3; PRINGLE GA, 1990, J HISTOCHEM CYTOCHEM, V38, P1405, DOI 10.1177/38.10.1698203; RIESSEN R, 1994, AM J PATHOL, V144, P962; ROSENBERG L, 1993, DERMATAN SULPHATE PR, P225; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; SAITO H, 1968, J BIOL CHEM, V243, P1536; Sambrook J, 1989, MOL CLONING LABORATO; SCHONHERR E, 1993, BIOCHEM J, V290, P893, DOI 10.1042/bj2900893; SCHWARZ K, 1990, J BIOL CHEM, V265, P22023; SCOTT JE, 1985, BIOSCIENCE REP, V5, P71, DOI 10.1007/BF01117443; SCOTT JE, 1988, BIOCHEM J, V252, P313, DOI 10.1042/bj2520313; SCOTT JE, 1988, BIOCHEM J, V253, P607, DOI 10.1042/bj2530607; SCOTT JE, 1993, DERMATAN SULPHATE PR, P165; SCOTT PG, 1986, BIOCHEM BIOPH RES CO, V138, P1348, DOI 10.1016/S0006-291X(86)80431-4; SVOBODA M, 1985, ANAL BIOCHEM, V151, P16, DOI 10.1016/0003-2697(85)90046-6; TAKAHASHI T, 1993, J HISTOCHEM CYTOCHEM, V41, P1447, DOI 10.1177/41.10.8245404; THIE M, 1991, EUR J CELL BIOL, V55, P295; VOGEL KG, 1987, BIOCHEM BIOPH RES CO, V148, P658, DOI 10.1016/0006-291X(87)90927-2; VOGEL KG, 1987, COLLAGEN REL RES, V7, P105; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; VOLKER W, 1985, J MICROSC-OXFORD, V138, P91; WRANA JL, 1988, J CELL BIOL, V106, P915, DOI 10.1083/jcb.106.3.915	48	310	315	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2776	2783		10.1074/jbc.270.6.2776	http://dx.doi.org/10.1074/jbc.270.6.2776			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852349	hybrid			2022-12-27	WOS:A1995QF53500059
J	REUSCH, JEB; BHURIPANYO, P; CAREL, K; LEITNER, JW; HSIEH, P; DEPAOLO, D; DRAZNIN, B				REUSCH, JEB; BHURIPANYO, P; CAREL, K; LEITNER, JW; HSIEH, P; DEPAOLO, D; DRAZNIN, B			DIFFERENTIAL REQUIREMENT FOR P21(RAS) ACTIVATION IN THE METABOLIC SIGNALING BY INSULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; CARBOXYL METHYLATION; GUANINE-NUCLEOTIDES; GLUCOSE-TRANSPORT; KINASE-KINASE; RAS; P21RAS; TRANSDUCTION; STIMULATION	To evaluate the role of the ''Ras pathway'' in mediating metabolic signaling by insulin, we employed lovastatin to inhibit isoprenilation of Ras proteins in Rat-1 fibroblasts transfected with human insulin receptors (HIRc cells) and in differentiated 3T3-L1 adipocytes, Lovastatin blocked an ability of insulin to activate p21(ras) and mitogen-activated protein kinase, Lovastatin also significantly (p < 0.01) reduced insulin effects on thymidine incorporation and glucose incorporation into glycogen, Nevertheless, an effect of insulin on glucose uptake remained unaffected, It appears that in contrast to its mitogenic action and to its effect on glycogenesis, an effect of insulin on glucose uptake does not require p21(ras) activation.	VET AFFAIRS MED CTR,MED RES SERV,ENDOCRINOL SECT 111H,DENVER,CO 80220; VET AFFAIRS MED CTR,DEPT MED,DENVER,CO 80220; UNIV COLORADO,HLTH SCI CTR,DENVER,CO 80220	US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver				Reusch, Jane/0000-0001-8620-1003				BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BUDAY L, 1993, MOL CELL BIOL, V13, P1903, DOI 10.1128/MCB.13.3.1903; CASEY PJ, 1994, RECENT PROG HORM RES, V49, P215; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; CHUANG LM, 1993, MOL CELL BIOL, V13, P6653, DOI 10.1128/MCB.13.11.6653; CLORE JN, 1994, DIABETES, V43, P256, DOI 10.2337/diabetes.43.2.256; COX AD, 1993, J BIOL CHEM, V268, P11548; DRAZNIN B, 1993, J BIOL CHEM, V268, P19998; DRAZNIN B, 1982, J BIOL CHEM, V257, P1988; FINGAR DC, 1994, J BIOL CHEM, V269, P10127; HAUSDORFF SF, 1994, J BIOL CHEM, V269, P21391; HEASLEY LE, 1994, IN PRESS AM J PHYSL; HEIDENREICH KA, 1989, J NEUROSCI RES, V22, P397, DOI 10.1002/jnr.490220405; JAMES GL, 1993, SCIENCE, V260, P1937, DOI 10.1126/science.8316834; KOZMA L, 1993, P NATL ACAD SCI USA, V90, P4460, DOI 10.1073/pnas.90.10.4460; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; MEDEMA RH, 1993, MOL CELL BIOL, V13, P155, DOI 10.1128/MCB.13.1.155; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; OKADA T, 1994, J BIOL CHEM, V269, P3568; PHILIPS MR, 1993, SCIENCE, V259, P977, DOI 10.1126/science.8438158; PORFIRI E, 1994, J BIOL CHEM, V269, P22672; ROBINSON LJ, 1993, J BIOL CHEM, V268, P26422; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; THIES RS, 1989, J BIOL CHEM, V264, P12820; VANDENBERGHE N, 1994, MOL CELL BIOL, V14, P2372, DOI 10.1128/MCB.14.4.2372; VOLKER C, 1991, J BIOL CHEM, V266, P21515; YAMAUCHI K, 1993, J BIOL CHEM, V268, P14597	27	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2036	2040		10.1074/jbc.270.5.2036	http://dx.doi.org/10.1074/jbc.270.5.2036			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836430	hybrid			2022-12-27	WOS:A1995QE49300011
J	ELSEA, SH; HSIUNG, YC; NITISS, JL; OSHEROFF, N				ELSEA, SH; HSIUNG, YC; NITISS, JL; OSHEROFF, N			A YEAST TYPE-II TOPOISOMERASE SELECTED FOR RESISTANCE TO QUINOLONES - MUTATION OF HISTIDINE-1012 TO TYROSINE CONFERS RESISTANCE TO NONINTERCALATIVE DRUGS BUT HYPERSENSITIVITY TO ELLIPTICINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED DNA CLEAVAGE; OVARY CELL-LINE; EUKARYOTIC TOPOISOMERASE; DROSOPHILA-MELANOGASTER; ANTINEOPLASTIC DRUGS; INTERCALATING AGENTS; POINT MUTATION; SACCHAROMYCES-CEREVISIAE; INTERACTION DOMAINS; ESCHERICHIA-COLI	A mutant yeast type II topoisomerase was generated by in vitro mutagenesis followed by selection in vivo for resistance to the quinolone CP-115,953. The resulting mutant enzyme had a single point mutation which converted His(1012) to Tyr (top2H1012Y). top2H1012Y was overexpressed in yeast, purified, and characterized in vitro, The mutant type II topoisomerase was slightly less active than the wild type enzyme, apparently due to a decreased affinity for DNA. The affinity of the mutant enzyme for ATP was similar to that of wild type topoisomerase ZI. As determined by DNA cleavage assays, top2H1012Y was resistant to CP-115,953 and etoposide both prior to and following the DNA strand-passage event. In marked contrast, the mutant enzyme displayed wild type sensitivity to amsacrine and was severalfold hypersensitive to ellipticine, A similar pattern of resistance was observed in yeast cells harboring the top2H1012Y allele. Thus, it appears that the mutant type II topoisomerase can distinguish between nonintercalative and intercalative agents, Finally, the His(1012) --> Tyr mutation defines a potential new drug resistance-conferring region on eukaryotic topoisomerase II.	VANDERBILT UNIV, SCH MED, DEPT BIOCHEM, NASHVILLE, TN 37232 USA; VANDERBILT UNIV, SCH MED, DEPT MED, NASHVILLE, TN 37232 USA; UNIV SO CALIF, DEPT BIOCHEM, LOS ANGELES, CA 90027 USA; CHILDRENS HOSP LOS ANGELES, DIV HEMATOL ONCOL, LOS ANGELES, CA 90027 USA	Vanderbilt University; Vanderbilt University; University of Southern California; Children's Hospital Los Angeles			Nitiss, John/E-9974-2010	Elsea, Sarah/0000-0002-1400-8519; Nitiss, John/0000-0002-1013-4972	NATIONAL CANCER INSTITUTE [T32CA009582, R01CA052814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033944] Funding Source: NIH RePORTER; NCI NIH HHS [5 T32 CA09582, CA52814] Funding Source: Medline; NIGMS NIH HHS [GM33944] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BUGG BY, 1991, P NATL ACAD SCI USA, V88, P7654, DOI 10.1073/pnas.88.17.7654; CARON PR, 1994, MOL CELL BIOL, V14, P3197, DOI 10.1128/MCB.14.5.3197; CHAN VTW, 1993, J BIOL CHEM, V268, P2160; CHEN AY, 1994, ANNU REV PHARMACOL, V34, P191, DOI 10.1146/annurev.pa.34.040194.001203; CHOW KC, 1988, MOL PHARMACOL, V34, P467; CORBETT AH, 1993, J BIOL CHEM, V268, P14394; CORBETT AH, 1993, ANTIMICROB AGENTS CH, V37, P2599, DOI 10.1128/AAC.37.12.2599; CORBETT AH, 1993, CHEM RES TOXICOL, V6, P585, DOI 10.1021/tx00035a001; CRENSHAW DG, 1993, J BIOL CHEM, V268, P21328; Danks M K, 1989, Cancer Commun, V1, P101; DANKS MK, 1993, CANCER RES, V53, P1373; DANKS MK, 1987, CANCER RES, V47, P1297; DARPA P, 1990, CANCER RES, V50, P6919; ELSEA SH, 1993, ANTIMICROB AGENTS CH, V37, P2179, DOI 10.1128/AAC.37.10.2179; ELSEA SH, 1992, J BIOL CHEM, V267, P13150; GIACCONE G, 1994, ANTICANCER RES, V14, P269; GUPTA RS, 1983, CANCER RES, V43, P1568; HINDS M, 1991, CANCER RES, V51, P4729; HOOPER DC, 1991, NEW ENGL J MED, V324, P384, DOI 10.1056/NEJM199102073240606; HOOPER DC, 1993, DRUGS, V3, P8; HUANG WM, 1990, DNA TOPOLOGY ITS BIO, P409; HUFF AC, 1990, MOL GEN GENET, V221, P27, DOI 10.1007/BF00280363; JANNATIPOUR M, 1993, J BIOL CHEM, V268, P18586; LEE MS, 1992, J MOL BIOL, V223, P837, DOI 10.1016/0022-2836(92)90245-F; LINDSLEY JE, 1993, J BIOL CHEM, V268, P8096; LIU YX, 1994, CANCER RES, V54, P2943; MAXWELL A, 1992, J ANTIMICROB CHEMOTH, V30, P409, DOI 10.1093/jac/30.4.409; MINFORD J, 1986, BIOCHEMISTRY-US, V25, P9, DOI 10.1021/bi00349a002; NITISS J, 1988, P NATL ACAD SCI USA, V85, P7501, DOI 10.1073/pnas.85.20.7501; NITISS JL, 1993, CANCER RES, V53, P89; NITISS JL, 1992, CANCER RES, V52, P4467; OSHEROFF N, 1989, BIOCHEMISTRY-US, V28, P6157, DOI 10.1021/bi00441a005; OSHEROFF N, 1991, BIOESSAYS, V13, P269, DOI 10.1002/bies.950130603; OSHEROFF N, 1987, BIOCHEMISTRY-US, V26, P4303, DOI 10.1021/bi00388a018; OSHEROFF N, 1989, PHARMACOL THERAPEUT, V41, P223, DOI 10.1016/0163-7258(89)90108-3; OSHEROFF N, 1986, J BIOL CHEM, V261, P9944; OSHEROFF N, 1983, J BIOL CHEM, V258, P9536; PATEL S, 1990, ANTI-CANCER DRUG DES, V5, P149; PATEL S, 1993, BRIT J CANCER, V67, P456, DOI 10.1038/bjc.1993.87; POMMIER Y, 1993, CANCER CHEMOTH PHARM, V32, P103, DOI 10.1007/BF00685611; POMMIER Y, 1984, BIOCHEMISTRY-US, V23, P3194, DOI 10.1021/bi00309a013; POMMIER Y, 1985, BIOCHEMISTRY-US, V24, P6414; REECE RJ, 1991, CRIT REV BIOCHEM MOL, V26, P335, DOI 10.3109/10409239109114072; ROBINSON MJ, 1993, BIOCHEMISTRY-US, V32, P3638, DOI 10.1021/bi00065a016; ROBINSON MJ, 1992, ANTIMICROB AGENTS CH, V36, P751, DOI 10.1128/AAC.36.4.751; ROBINSON MJ, 1991, BIOCHEMISTRY-US, V30, P1807, DOI 10.1021/bi00221a012; ROBINSON MJ, 1990, BIOCHEMISTRY-US, V29, P2511, DOI 10.1021/bi00462a012; ROBINSON MJ, 1991, J BIOL CHEM, V266, P14585; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schneider E, 1990, Adv Pharmacol, V21, P149, DOI 10.1016/S1054-3589(08)60342-7; SCHNEIDER E, 1989, BIOCHEM PHARMACOL, V38, P263, DOI 10.1016/0006-2952(89)90036-1; SHELTON ER, 1983, J BIOL CHEM, V258, P9530; SHIOZAKI K, 1992, J CELL BIOL, V119, P1023, DOI 10.1083/jcb.119.5.1023; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; SORENSEN BS, 1992, J MOL BIOL, V228, P778, DOI 10.1016/0022-2836(92)90863-F; STRATHERN JN, 1991, METHOD ENZYMOL, V194, P319; SULLIVAN DM, 1989, BIOCHEMISTRY-US, V28, P5680, DOI 10.1021/bi00439a051; TARTOF KD, 1987, FOCUS, V9, P2; THOMAS W, 1991, GENETICS, V128, P703; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665; WARING MJ, 1981, ANNU REV BIOCHEM, V50, P159, DOI 10.1146/annurev.bi.50.070181.001111; WASSERMAN RA, 1994, CANCER RES, V54, P1795; WILSON WR, 1981, MOL PHARMACOL, V20, P404; WORLAND ST, 1989, J BIOL CHEM, V264, P4412; WYCKOFF E, 1989, J MOL BIOL, V205, P1, DOI 10.1016/0022-2836(89)90361-6; YANG L, 1985, CANCER RES, V45, P5872; YANG L, 1985, CELL, V41, P127, DOI 10.1016/0092-8674(85)90067-4; YOSHIDA H, 1991, ANTIMICROB AGENTS CH, V35, P1647, DOI 10.1128/AAC.35.8.1647; ZHANG H, 1990, CANCER CELL-MON REV, V2, P23; ZWELLING LA, 1989, J BIOL CHEM, V264, P16411; ZWELLING LA, 1981, BIOCHEMISTRY-US, V20, P6553, DOI 10.1021/bi00526a006; ZWELLING LA, 1989, MOL ENDOCRINOL, V3, P603, DOI 10.1210/mend-3-3-603; ZWELLING LA, 1991, BIOCHEMISTRY-US, V30, P4048, DOI 10.1021/bi00230a032	75	71	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1913	1920		10.1074/jbc.270.4.1913	http://dx.doi.org/10.1074/jbc.270.4.1913			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829529	hybrid			2022-12-27	WOS:A1995QD20400065
J	MISENHEIMER, TM; MOSHER, DF				MISENHEIMER, TM; MOSHER, DF			CALCIUM-ION BINDING TO THROMBOSPONDIN-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PLATELET THROMBOSPONDIN; GENE FAMILY; ADHESIVE GLYCOPROTEIN; MONOCLONAL-ANTIBODIES; ACTIVATED PLATELETS; EXPRESSION; PROTEINS; MEMBER; LOCALIZATION; EVOLUTION	We have quantified the binding of Ca2+ to platelet thrombospondin 1 (TSP1) using equilibrium dialysis with (CaCl2)-Ca-45. Ca2+ binding to TSP1 was found to be cooperative with 10% occupancy at 15-20 mu M CaCl2, 90% occupancy at 100 mu M CaCl2, and a Hill coefficient of 2.4 +/- 0.2. The average apparent K-d was 52 +/- 5 mu M. Maximum binding, assuming M(r) = 450,000 and epsilon = 0.918 (A280/mg/ml), was 35 +/- 3 Ca2+/TSP1. This value is close to the 33 sites (11 per subunit) predicted based on homology of the epidermal growth factor (1 site) and aspartate rich (10 sites) regions to known Ca2+ binding sequences, Ca2+ protected the aspartate-rich region from trypsin proteolysis, but not until nearly all of the Ca2+ binding sites were filled. At lower occupancy of Ca2+ binding sites, several limited tryptic digest products were obtained, This finding and the previous demonstration of extensive thiol disulfide isomerization within the aspartate-rich regions suggest that subregions of the aspartate-rich region are stabilized in different conformers, Zn2+, Cu2+, Mn2+ Mg2+ Co2+, Cd2+, and Ba2+ were tested for their ability tb modulate Ca2+ binding and protease sensitivity of TSP1, Zn2+ inhibited 40% of the Ca2+ binding but neither protected TSP1 from trypsin proteolysis, nor labilized TSP1 toward trypsin proteolysis. These results provide direct evidence for high capacity, cooperative and specific binding of Ca2+ to conformationally labile aspartate-rich repeats of TSP1.	UNIV WISCONSIN,DEPT MED,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison					NHLBI NIH HHS [R01-HL49111, F32-HL08640] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL008640, R01HL049111] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOOTHE RL, 1969, J BIOL CHEM, V244, P399; BORNSTEIN P, 1991, J BIOL CHEM, V266, P12821; BORNSTEIN P, 1992, FASEB J, V6, P3290, DOI 10.1096/fasebj.6.14.1426766; CHEN K, 1992, BLOOD, V79, P2226; DANISHEFSKY KJ, 1984, BIOCHEMISTRY-US, V23, P4984, DOI 10.1021/bi00316a024; DIXIT VM, 1986, J BIOL CHEM, V261, P1962; FEX G, 1991, LAURELLS KLINISK KEM, P167; FRAZIER WA, 1987, J CELL BIOL, V105, P625, DOI 10.1083/jcb.105.2.625; GALVIN NJ, 1985, J CELL BIOL, V101, P1434, DOI 10.1083/jcb.101.4.1434; GORODETSKY R, 1993, AM J HEMATOL, V42, P278, DOI 10.1002/ajh.2830420307; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAIECH J, 1979, BIOCHEMISTRY-US, V18, P2752, DOI 10.1021/bi00580a010; HOGG PJ, 1993, J BIOL CHEM, V268, P21811; LABELL TL, 1992, GENOMICS, V12, P421, DOI 10.1016/0888-7543(92)90430-Z; LAWLER J, 1993, J CELL BIOL, V120, P1059, DOI 10.1083/jcb.120.4.1059; LAWLER J, 1993, J MOL EVOL, V36, P509, DOI 10.1007/BF00556355; LAWLER J, 1985, J BIOL CHEM, V260, P3762; LAWLER J, 1982, J BIOL CHEM, V257, P2257; LAWLER J, 1983, J BIOL CHEM, V258, P2098; LAWLER J, 1988, J CELL BIOL, V107, P2351, DOI 10.1083/jcb.107.6.2351; LAWLER J, 1992, BIOCHEMISTRY-US, V31, P1173, DOI 10.1021/bi00119a029; LAWLER J, 1986, J CELL BIOL, V103, P1635, DOI 10.1083/jcb.103.5.1635; LIMBIRD LE, 1986, CELL SURFACE RECEPTO, P51; MARGOSSIAN SS, 1981, J BIOL CHEM, V256, P7495; MCPHALEN CA, 1991, ADV PROTEIN CHEM, V42, P77; MONCRIEF ND, 1990, J MOL EVOL, V30, P522, DOI 10.1007/BF02101108; Mosher D.F., 1985, PLATELET MEMBRANE GL, P171; MOSHER DF, 1990, ANNU REV MED, V41, P85; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; QABAR AN, 1994, J BIOL CHEM, V269, P1262; SELANDERSUNNERH.M, 1992, J BIOL CHEM, V0267; SNYDER EE, 1990, BIOCHEMISTRY-US, V29, P3937, DOI 10.1021/bi00468a021; SPEZIALE MV, 1990, J BIOL CHEM, V265, P17859; SPEZIALE MV, 1991, ARCH BIOCHEM BIOPHYS, V286, P546, DOI 10.1016/0003-9861(91)90077-V; SUN X, 1992, J CELL BIOL, V118, P693, DOI 10.1083/jcb.118.3.693; VOS HL, 1992, J BIOL CHEM, V267, P12192	36	64	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1729	1733		10.1074/jbc.270.4.1729	http://dx.doi.org/10.1074/jbc.270.4.1729			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829507	hybrid			2022-12-27	WOS:A1995QD20400040
J	ALLEN, DH; TRACY, PB				ALLEN, DH; TRACY, PB			HUMAN COAGULATION-FACTOR-V IS ACTIVATED TO THE FUNCTIONAL COFACTOR BY ELASTASE AND CATHEPSIN-G EXPRESSED AT THE MONOCYTE SURFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED PLATELET ACTIVATION; FACTOR PATHWAY INHIBITOR; NEUTROPHIL ELASTASE; FACTOR-X; LEUKOCYTE ELASTASE; ALVEOLAR MACROPHAGES; DEGRADATION INVITRO; NEUTRAL PROTEASES; HUMAN-PROTHROMBIN; HEPARIN COFACTOR	The ability of intact peripheral blood monocytes to modulate factor V procoagulant activity was studied using electrophoretic and autoradiographic techniques coupled to functional assessment of cofactor activity. Incubation of plasma concentrations of factor V with monocytes (5 x 10(6)/ml) resulted in the time-dependent cleavage of the 330-kDa protein. Activation occurred via several high molecular mass intermediates (greater than or equal to 200 kDa) to yield peptides of 150, 140, 120, 94, 98, 82, and 80 kDa, which paralleled the expression of cofactor activity. The cleavage pattern observed differed from that obtained with either thrombin or factor Xa as an activator. The incubation time required to achieve full cofactor activity was dependent on the monocyte donor and ranged from 10 min to 1 h and was consistently slightly lower than that obtained with thrombin-activated factor Va. Cofactor activity was not diminished by additional incubation. The cofactor activity generated bound to the monocyte such that a competent prothrombinase complex was formed at the monocyte membrane surface. Furthermore, within 5 min of factor V addition to monocytes, near maximal cofactor activity (similar to 70%) was bound and expressed on the monocyte membrane. The proteolytic activity toward factor V was associated primarily with the monocyte membrane, as little proteolytic activity was released into the cell-free supernatant. Proteolytic activity was inhibited by diisopropyl fluorophosphate and phenylmethanesulfonyl fluoride. However, the inhibitor profile obtained with alpha(1)-antiproteinase inhibitor, alpha(1)-antichymotrypsin, and alpha(2)-macroglobulin suggested membrane-bound forms of elastase and cathepsin G were mediating, in large part, the proteolysis observed. These data were confirmed using purified preparations of both proteases and a specific anti-human leukocyte elastase antibody. Thus, expression of these proteases at the monocyte surface may contribute to thrombin generation at extravascular tissue sites by catalyzing the activation of the essential cofactor, factor Va, which binds to the monocyte surface and supports the factor Xa catalyzed activation of prothrombin.	UNIV VERMONT,COLL MED,DEPT BIOCHEM,BURLINGTON,VT 05405	University of Vermont					NHLBI NIH HHS [HL-34863, HL-46703] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R23HL034863, R01HL034863, P01HL046703] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTIERI DC, 1989, J BIOL CHEM, V264, P2969; ANDERSSEN T, 1993, THROMB HAEMOSTASIS, P414; BAJAJ SP, 1981, PREP BIOCHEM, V11, P397, DOI 10.1080/00327488108065531; BAKER JB, 1979, NATURE, V278, P743, DOI 10.1038/278743a0; BARSHAVIT R, 1983, J CELL BIOL, V96, P282, DOI 10.1083/jcb.96.1.282; BINI A, 1989, ARTERIOSCLEROSIS, V9, P109, DOI 10.1161/01.ATV.9.1.109; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BROWER MS, 1982, J BIOL CHEM, V257, P9849; CAMPBELL EJ, 1989, J IMMUNOL, V143, P2961; CAMPBELL EJ, 1987, CHEST, V92, P161, DOI 10.1378/chest.92.1.161; COLVIN RB, 1975, J IMMUNOL, V114, P377; ECKLE I, 1993, SCAND J CLIN LAB INV, V53, P281, DOI 10.3109/00365519309088420; ECKLE I, 1991, BIOL CHEM H-S, V372, P1007, DOI 10.1515/bchm3.1991.372.2.1007; EDWARDS RL, 1984, PROGR HEMOSTASIS THR, P183; FENTON JW, 1977, CHEM BIOL THROMBIN, P43; FOSTER WB, 1983, J BIOL CHEM, V258, P3970; FUKS A, 1983, BIOCHIM BIOPHYS ACTA, V755, P195, DOI 10.1016/0304-4165(83)90203-9; HATTLER BG, 1973, CELL IMMUNOL, V9, P289, DOI 10.1016/0008-8749(73)90080-4; HIGUCHI DA, 1992, BLOOD, V79, P1712; Jesty J, 1976, Methods Enzymol, V45, P95; JOCHUM M, 1981, H-S Z PHYSIOL CHEM, V362, P103, DOI 10.1515/bchm2.1981.362.1.103; JORDAN RE, 1987, SCIENCE, V237, P777, DOI 10.1126/science.3649921; KANE WH, 1982, J CLIN INVEST, V70, P1092, DOI 10.1172/JCI110697; KARGI HA, 1990, J HISTOCHEM CYTOCHEM, V38, P1179, DOI 10.1177/38.8.2164060; KATZMANN JA, 1981, P NATL ACAD SCI-BIOL, V78, P162, DOI 10.1073/pnas.78.1.162; KISIEL W, 1976, BIOCHEMISTRY-US, V15, P4901, DOI 10.1021/bi00667a023; KOPEC M, 1980, THROMB HAEMOSTASIS, V43, P211; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CD, 1989, BLOOD, V73, P185; MACHOVICH R, 1989, BIOCHEMISTRY-US, V28, P4517, DOI 10.1021/bi00436a059; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MCGEE MP, 1991, J BIOL CHEM, V266, P8079; MCGOWAN SE, 1983, AM REV RESPIR DIS, V128, P688; MENKOVIC DD, 1990, BIOCHEMISTRY-US, V29, P1118; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; NICOLAISEN EM, 1993, FEBS LETT, V317, P245, DOI 10.1016/0014-5793(93)81285-8; NORDENMAN B, 1977, EUR J BIOCHEM, V78, P195, DOI 10.1111/j.1432-1033.1977.tb11730.x; OATES AM, 1987, BLOOD, V70, P846; OWEN W G, 1973, Thrombosis Research, V3, P705, DOI 10.1016/0049-3848(73)90017-0; OWEN WG, 1975, BIOCHIM BIOPHYS ACTA, V405, P380, DOI 10.1016/0005-2795(75)90103-8; PELLEGRINO MA, 1976, J IMMUNOL METHODS, V11, P273, DOI 10.1016/0022-1759(76)90120-4; PEMBERTON PA, 1989, BIOCHEM J, V258, P193, DOI 10.1042/bj2580193; PETERSEN LC, 1992, THROMB HAEMOSTASIS, V67, P537; RENESTO P, 1993, BLOOD, V82, P139, DOI 10.1182/blood.V82.1.139.bloodjournal821139; RODGERS GM, 1986, J CLIN INVEST, V77, P1909, DOI 10.1172/JCI112519; SCHMIDT W, 1975, THROMB RES, V6, P315, DOI 10.1016/0049-3848(75)90081-X; SELAK MA, 1992, THROMB HAEMOSTASIS, V68, P570; SIE P, 1987, THROMB RES, V47, P657, DOI 10.1016/0049-3848(87)90104-6; SMITH EB, 1990, ARTERIOSCLEROSIS, V10, P263, DOI 10.1161/01.ATV.10.2.263; SOLYMOSS S, 1988, J BIOL CHEM, V263, P14884; TAKAKI A, 1983, J CLIN INVEST, V72, P1706, DOI 10.1172/JCI111130; TRACY PB, 1982, BLOOD, V60, P59; TRACY PB, 1985, J BIOL CHEM, V260, P2119; TRACY PB, 1983, J BIOL CHEM, V258, P7264; TRACY PB, 1983, FED PROC, V42, pA117; TURKINGTON PT, 1986, THROMB RES, V44, P339, DOI 10.1016/0049-3848(86)90008-3; TURKINGTON PT, 1991, HAEMOSTASIS, V21, P111; WEITZ JI, 1987, J EXP MED, V166, P1836, DOI 10.1084/jem.166.6.1836; WORFOLK LA, 1992, BLOOD, V80, P1989; WORFOLK LA, 1991, BLOOD S1, V78, pA58	60	80	80	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1408	1415		10.1074/jbc.270.3.1408	http://dx.doi.org/10.1074/jbc.270.3.1408			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836408	hybrid			2022-12-27	WOS:A1995QB15600065
J	SRINIVASAN, M; KALOUSEK, F; FARRELL, L; CURTHOYS, NP				SRINIVASAN, M; KALOUSEK, F; FARRELL, L; CURTHOYS, NP			ROLE OF THE N-TERMINAL-118 AMINO-ACIDS IN THE PROCESSING OF THE RAT RENAL MITOCHONDRIAL GLUTAMINASE PRECURSOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATION; CLEAVAGE; PROTEINS; KIDNEY	Rat renal mitochondrial glutaminase (GA) is synthesized as a 74-kDa cytosolic precursor that is translocated into mitochondria and processed via a 72-kDa intermediate to yield a 3:1 ratio of mature 66- and 68-kDa subunits, respectively. The 66 kDa subunit is derived by removal of a 72-amino-acid presequence, The structural determinants necessary for translocation and proteolytic processing were further delineated by characterizing the processing of different chimeric constructs formed by fusing various segments of the N-terminal sequence of the GA precursor to chloramphenicol acetyl transferase (CAT). GA(1-118)CAT is translocated and processed in isolated rat liver mitochondria or cleaved by purified mitochondrial processing peptidase (MPP) to yield an intermediate peptide and two mature subunits that are analogous to the products of processing of the GA precursor. The two reactions also occur with kinetics which are similar to those observed for processing of the GA precursor, Thus, all of the information required for the translocation and synthesis of the mature subunits of GA reside in the N-terminal 118 amino acids of the GA precursor. In contrast, GA(1-72)CAT, a construct that contains the GA presequence fused to CAT, is apparently translocated and processed less efficiently. It yields only two peptides that are analogous to the intermediate and 68 kDa forms of GA. In addition, GA(1-31)CAT associates with mitochondria but is not proteolytically processed and GA(1-31,73-118)CAT is slowly translocated and processed to a single peptide that is analogous to the 66 kDa form of GA, The latter results suggest that the MPP cleavage reactions which yield the GA intermediate and the 66 kDa subunit depend primarily on information that is present C-terminal to the respective sites of cleavage.	COLORADO STATE UNIV,DEPT BIOCHEM & MOLEC BIOL,FT COLLINS,CO 80523; YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06520	Colorado State University; Yale University					NIDDK NIH HHS [DK-37124, DK-09527] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK009527, R01DK037124] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARRETZ M, 1994, J BIOL CHEM, V269, P4959; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; COHEN NS, 1985, BIOCHEM J, V229, P205, DOI 10.1042/bj2290205; CURTHOYS NP, 1988, PH HOMEOSTASIS MECHA, P323; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; HASER WG, 1985, BIOCHEM J, V229, P399, DOI 10.1042/bj2290399; HORWICH AL, 1986, CELL, V44, P451, DOI 10.1016/0092-8674(86)90466-6; ISAYA G, 1991, J CELL BIOL, V113, P65, DOI 10.1083/jcb.113.1.65; JAGUS R, 1987, METHOD ENZYMOL, V152, P267; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maniatis T, 1989, DECONTAMINATION DILU; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; PERERA SY, 1990, J BIOL CHEM, V265, P17764; ROBBEN J, 1993, J BIOL CHEM, V268, P24555; ROISE D, 1993, AMPHIPATHIC HELIX, P257; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; SHAPIRO RA, 1991, J BIOL CHEM, V266, P18792; SRINIVASAN M, 1995, J BIOL CHEM, V270, P1185, DOI 10.1074/jbc.270.3.1185; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x	23	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1191	1197		10.1074/jbc.270.3.1191	http://dx.doi.org/10.1074/jbc.270.3.1191			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836379	hybrid			2022-12-27	WOS:A1995QB15600034
J	BOS, CR; SHANK, SL; SNIDER, MD				BOS, CR; SHANK, SL; SNIDER, MD			ROLE OF CLATHRIN-COATED VESICLES IN GLYCOPROTEIN TRANSPORT FROM THE CELL-SURFACE TO THE GOLGI-COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; MANNOSE 6-PHOSPHATE RECEPTOR; INTEGRAL MEMBRANE-PROTEIN; CULTURED HUMAN-CELLS; FAMILIAL HYPERCHOLESTEROLEMIA; MEDIATED ENDOCYTOSIS; TRANSFERRIN RECEPTOR; BREFELDIN-A; INTRACELLULAR MOVEMENT; CYTOPLASMIC DOMAIN	Plasma membrane glycoproteins recycle to the Golgi complex, but the route followed by these proteins is not known. To elucidate the pathway of transport, the involvement of clathrin-coated vesicles was tested. This was accomplished by comparing the traffic of wild type low density lipoprotein receptor (LDLR) and FEZ 683, a mutant receptor whose endocytosis from the cell surface in coated vesicles is reduced by 90-95%. Wild type LDLR traveled from the cell surface to the sialyltransferase compartment of the Golgi with a half-time of 2.5 h in K562 human leukemia cells expressing receptor from a transfected cDNA. In contrast, FH 683 LDLR recycled to the Golgi at 33% of the wild type rate, suggesting that wild type LDLR is largely transported to the Golgi by a pathway that involves clathrin-coated vesicles. Moreover, because clathrin coated vesicles that bud from the plasma membrane are transported to endosomes, surface-to-Golgi transport probably involves an endosomal intermediate. Finally, because there was substantial transport of mutant LDLR to the Golgi even though its endocytosis in coated vesicles was greatly reduced, there may be a second pathway of surface-to-Golgi traffic. Our results suggest that wild type LDLR may move from plasma membrane to Golgi by two routes. Two-thirds of the traffic proceeds via a coated vesicle-mediated pathway while the remainder may follow a clathrin-independent pathway.			BOS, CR (corresponding author), CASE WESTERN RESERVE UNIV, SCH MED, DEPT BIOCHEM, CLEVELAND, OH 44106 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038183] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38183] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEISIEGEL U, 1981, J BIOL CHEM, V256, P1923; BONIFACINO JS, 1989, J CELL SCI, V92, P701; BRETSCHER MS, 1988, EMBO J, V7, P4087, DOI 10.1002/j.1460-2075.1988.tb03302.x; CARLSON DM, 1968, J BIOL CHEM, V243, P616; CRESSWELL P, 1985, P NATL ACAD SCI USA, V82, P8188, DOI 10.1073/pnas.82.23.8188; CUMMINGS RD, 1983, J BIOL CHEM, V258, P5261; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; DAVIS CG, 1986, J BIOL CHEM, V261, P2828; DRAPER RK, 1990, SCIENCE, V248, P1539, DOI 10.1126/science.2163108; DUNCAN JR, 1988, J CELL BIOL, V106, P617, DOI 10.1083/jcb.106.3.617; DUNN WA, 1980, J BIOL CHEM, V255, P5971; FISHMAN JB, 1987, CELL, V48, P157, DOI 10.1016/0092-8674(87)90366-7; GEUZE HJ, 1984, EMBO J, V3, P2677, DOI 10.1002/j.1460-2075.1984.tb02193.x; GODA Y, 1988, CELL, V55, P309, DOI 10.1016/0092-8674(88)90054-2; GOLDSTEIN JL, 1974, J BIOL CHEM, V249, P5153; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; GREEN SA, 1990, J BIOL CHEM, V265, P21269; GREEN SA, 1992, J CELL BIOL, V117, P47, DOI 10.1083/jcb.117.1.47; HANSEN SH, 1993, J CELL BIOL, V123, P89, DOI 10.1083/jcb.123.1.89; HUANG KM, 1993, J BIOL CHEM, V268, P9302; HULL SR, 1991, J BIOL CHEM, V266, P13580; HUMPHREY JS, 1993, J CELL BIOL, V120, P1123, DOI 10.1083/jcb.120.5.1123; HUNTER A, 1989, EXP CELL RES, V182, P445, DOI 10.1016/0014-4827(89)90249-8; HUNZIKER W, 1991, CELL, V67, P617, DOI 10.1016/0092-8674(91)90535-7; HURTLEY SM, 1993, J CELL SCI, V106, P649; JIN M, 1989, J BIOL CHEM, V264, P7675; JIN MJ, 1993, J BIOL CHEM, V268, P18390; KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; KREISEL W, 1993, BIOL CHEM H-S, V374, P255, DOI 10.1515/bchm3.1993.374.1-6.255; LEHRMAN MA, 1985, CELL, V41, P735, DOI 10.1016/S0092-8674(85)80054-4; LEMANSKY P, 1990, J CELL BIOL, V110, P1525, DOI 10.1083/jcb.110.5.1525; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; LUZIO JP, 1990, BIOCHEM J, V270, P97, DOI 10.1042/bj2700097; MARSH M, 1983, CELL, V32, P931, DOI 10.1016/0092-8674(83)90078-8; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; MIQUELIS R, 1993, J CELL BIOL, V123, P1695, DOI 10.1083/jcb.123.6.1695; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; NEEFJES JJ, 1988, J CELL BIOL, V107, P79, DOI 10.1083/jcb.107.1.79; PATZAK A, 1986, J CELL BIOL, V102, P510, DOI 10.1083/jcb.102.2.510; REAVES B, 1993, MOL BIOL CELL, V4, P93, DOI 10.1091/mbc.4.1.93; REGOECZI E, 1982, P NATL ACAD SCI-BIOL, V79, P2226, DOI 10.1073/pnas.79.7.2226; REICHNER JS, 1988, J BIOL CHEM, V263, P16316; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; ROBERTSON BJ, 1992, ARCH BIOCHEM BIOPHYS, V292, P190, DOI 10.1016/0003-9861(92)90067-7; Segrest J P, 1971, Biochem Biophys Res Commun, V44, P390; SCHNEIDER WJ, 1980, J BIOL CHEM, V255, P1442; SNIDER MD, 1985, J CELL BIOL, V100, P826, DOI 10.1083/jcb.100.3.826; SNIDER MD, 1986, J CELL BIOL, V103, P265, DOI 10.1083/jcb.103.1.265; SNIDER MD, 1991, INTRACELLULAR TRAFFI, P361; TOLLESHAUG H, 1982, CELL, V30, P715, DOI 10.1016/0092-8674(82)90276-8; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5; WOODS JW, 1985, J CELL BIOL, V102, P277	53	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					665	671		10.1074/jbc.270.2.665	http://dx.doi.org/10.1074/jbc.270.2.665			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822293	hybrid			2022-12-27	WOS:A1995QB81600027
J	CAO, XJ; ZHOU, YH; LEE, AS				CAO, XJ; ZHOU, YH; LEE, AS			REQUIREMENT OF TYROSINE AND SERINE/THREONINE KINASE IN THE TRANSCRIPTIONAL ACTIVATION OF THE MAMMALIAN GRP78/BIP PROMOTER BY THAPSIGARGIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-REGULATED PROTEINS; OKADAIC ACID; GENE-EXPRESSION; HAMSTER FIBROBLASTS; TUMOR PROMOTER; CELL-LINE; TRANSMEMBRANE PROTEIN; MALFOLDED PROTEINS; CALCIUM IONOPHORE; BREFELDIN-A	Depletion of endoplasmic reticulum (ER) Ca2+ store by thapsigargin (Tg) in mammalian cells induces a set of ER protein genes known as the glucose-regulated proteins. Recently, IRE1p, a transmembrane protein postulated to have a serine/threonine kinase activity, has been identified as required for the induction of ER resident proteins genes in Saccharomyces cerevisiae. To investigate whether IRE1p can stimulate mammalian grp transcription, a stable Chinese hamster ovary cell line containing amplified copies of IRE1p has been created. The IRE1p expressing transfectants exhibited a modest (2-fold) enhancement of both the basal and Tg induced level of grp78 and grp94, two coordinately regulated grp genes. Using okadaic acid as a specific inhibitor for the endogenous serine/threonine protein phosphatase activities, a mild (2-fold) stimulative effect was observed for Tg induction of grp78 transcription. The okadaic acid potentiating ef feet requires a 50-base pair region in the vicinity of the grp78 TATA element. In contrast, the transcriptional activation of grp78 by Tg is almost totally eliminated by genistein, a tyrosine kinase inhibitor. The grp core, the C3 and C1 elements which are major Tg response elements of the rat grp78 promoter, are also major targets of the inhibitive effects of genistein.	UNIV SO CALIF, SCH MED, DEPT BIOCHEM & MOLEC BIOL, LOS ANGELES, CA 90033 USA; UNIV SO CALIF, SCH MED, NORRIS CANC CTR, LOS ANGELES, CA 90033 USA	University of Southern California; University of Southern California				Lee, Amy/0000-0002-0378-5443	NCI NIH HHS [R37 CA27607] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA027607] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; ALEXANDRE S, 1991, MOL ENDOCRINOL, V5, P1862, DOI 10.1210/mend-5-12-1862; BALDARI CT, 1994, EUR J IMMUNOL, V24, P1046, DOI 10.1002/eji.1830240506; CHANG NT, 1993, J BIOL CHEM, V268, P1436; CHANG SC, 1987, P NATL ACAD SCI USA, V84, P680, DOI 10.1073/pnas.84.3.680; CHAUHAN D, 1994, CANCER RES, V54, P2234; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; DRUMMOND IAS, 1987, J BIOL CHEM, V262, P12801; GUTCH MJ, 1992, P NATL ACAD SCI USA, V89, P11411, DOI 10.1073/pnas.89.23.11411; GUY GR, 1992, J BIOL CHEM, V267, P1846; HALL C V, 1983, Journal of Molecular and Applied Genetics, V2, P101; HYUN SW, 1994, J BIOL CHEM, V269, P364; JACKSON TR, 1988, BIOCHEM J, V253, P81, DOI 10.1042/bj2530081; KHARBANDA S, 1993, CELL GROWTH DIFFER, V4, P17; KIM YK, 1989, GENE, V77, P123, DOI 10.1016/0378-1119(89)90366-1; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; LEE A S, 1992, Current Opinion in Cell Biology, V4, P267, DOI 10.1016/0955-0674(92)90042-B; LEE AS, 1983, J BIOL CHEM, V258, P597; LEE AS, 1981, J CELL PHYSIOL, V106, P119, DOI 10.1002/jcp.1041060113; LEE AS, 1987, TRENDS BIOCHEM SCI, V12, P20, DOI 10.1016/0968-0004(87)90011-9; LI LJ, 1992, J CELL PHYSIOL, V153, P575, DOI 10.1002/jcp.1041530319; LI WW, 1994, MOL CELL BIOL, V14, P5533, DOI 10.1128/MCB.14.8.5533; LI WWF, 1993, J BIOL CHEM, V268, P12003; LI X, 1989, MOL ENDOCRINOL, V3, P1944, DOI 10.1210/mend-3-12-1944; LI X, 1991, MOL CELL BIOL, V11, P3446, DOI 10.1128/MCB.11.7.3446; LIN AY, 1984, P NATL ACAD SCI-BIOL, V81, P988, DOI 10.1073/pnas.81.4.988; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; LIU ES, 1992, J BIOL CHEM, V267, P7128; LIU ES, 1991, NUCLEIC ACIDS RES, V19, P5425, DOI 10.1093/nar/19.19.5425; LIU Z, 1994, BIOTECHNIQUES, V16, P56; MORI K, 1993, CELL, V74, P743; NOUSPIKEL T, 1992, EUR J BIOCHEM, V210, P365, DOI 10.1111/j.1432-1033.1992.tb17430.x; ONODA T, 1989, J NAT PROD, V52, P1252, DOI 10.1021/np50066a009; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; PRICE BD, 1992, J CELL PHYSIOL, V152, P545, DOI 10.1002/jcp.1041520314; RESENDEZ E, 1988, MOL CELL BIOL, V8, P4579, DOI 10.1128/MCB.8.10.4579; RESENDEZ E, 1986, J CELL BIOL, V103, P2145, DOI 10.1083/jcb.103.6.2145; SCHONTHAL A, 1991, ONCOGENE, V6, P423; SCHONTHAL A, 1992, NEW BIOL, V4, P16; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; URLAUB G, 1986, SOMAT CELL MOLEC GEN, V12, P555, DOI 10.1007/BF01671941; WATOWICH SS, 1988, MOL CELL BIOL, V8, P393, DOI 10.1128/MCB.8.1.393; WERA S, 1993, MOL ENDOCRINOL, V7, P965, DOI 10.1210/me.7.8.965; WOODEN SK, 1991, MOL CELL BIOL, V11, P5612, DOI 10.1128/MCB.11.11.5612	45	52	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					494	502		10.1074/jbc.270.1.494	http://dx.doi.org/10.1074/jbc.270.1.494			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814417	hybrid			2022-12-27	WOS:A1995QA28700077
J	KORNER, C; NURNBERG, B; UHDE, M; BRAULKE, T				KORNER, C; NURNBERG, B; UHDE, M; BRAULKE, T			MANNOSE 6-PHOSPHATE INSULIN-LIKE GROWTH-FACTOR-II RECEPTOR FAILS TO INTERACT WITH G-PROTEINS - ANALYSIS OF MUTANT CYTOPLASMIC-RECEPTOR DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING PROTEINS; BETA-ADRENERGIC-RECEPTOR; PERTUSSIS-TOXIN; BETA-2-ADRENERGIC RECEPTOR; DEPENDENT PHOSPHORYLATION; SIGNAL TRANSDUCTION; LYSOSOMAL-ENZYMES; HUMAN-FIBROBLASTS; CALCIUM INFLUX; IGF RECEPTOR	The binding of insulin-like growth factor II (IGF II) to the mannose 6-phosphate (M6P)/IGF II receptor has previously been reported to induce the activation of trimeric G(12) proteins by functional coupling to a 14-amino acid region within the cytoplasmic receptor domain (Nishimoto, I., Murayama, Y,, Hatada, T,, Ui, M,, and Ogata, E, (1989) J, Biol, Chem, 264, 14029-14038), In the present study, we examined further the potential functional coupling of G-proteins with the human M6P/IGF II receptor and mutant receptors lacking the proposed G-protein activator sequence, IGF II treatment of mouse L-cells expressing either wild type or mutant M6P/IGF II receptors failed to attenuate the pertussis toxin-catalyzed modification of a 40-kDa protein or enhance GTPase activity, In broken L-cell membranes expressing wild type or mutant M6P/IGF II receptors, 30 nM IGF II also failed to affect the pertussis toxin substrate activity, By using phospholipid vesicles reconstituted with human wild type or mutant M6P/IGF II receptors and pertussis toxin-sensitive G-proteins, no stimulation of GTP gamma S binding to or GTPase activity of G(i2), G(o1), or G(i)/G(o) mixtures were observed in response to 1 mu M IGF II, Furthermore, in vesicles containing purified wild type M6P/IGF II receptors and monomeric G alpha(o1) or G alpha(i2), and beta gamma dimers no effects of IGF II on GTP gamma S binding could be detected, However, when vesicles reconstituted with M6P/IGF II receptors and G(i2) proteins were incubated with 100 mu M mastoparan GTP gamma S binding was stimulated and GTPase activity was increased significantly, These results indicate that the human M6P/IGF II receptor neither interacts with G proteins in mouse L-cell membranes nor is coupled to G(i2) proteins in phospholipid vesicles, This study suggests strongly that the M6P/IGF II receptor does not function in transmembrane signaling in response to IGF II.	UNIV GOTTINGEN, INST BIOCHEM 2, D-37073 GOTTINGEN, GERMANY; FREE UNIV BERLIN, INST PHARMAKOL, D-14195 BERLIN, GERMANY	University of Gottingen; Free University of Berlin			Braulke, Thomas/AAV-9121-2020	Braulke, Thomas/0000-0002-2336-8532; Nurnberg, Bernd/0000-0002-5995-6555				BALDWIN JM, 1994, CURR OPIN CELL BIOL, V6, P180, DOI 10.1016/0955-0674(94)90134-1; Barr F A, 1992, Trends Cell Biol, V2, P91, DOI 10.1016/0962-8924(92)90001-4; BOMSEL M, 1992, MOL BIOL CELL, V3, P1317, DOI 10.1091/mbc.3.12.1317; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BRAULKE T, 1987, J CELL BIOL, V104, P1735, DOI 10.1083/jcb.104.6.1735; BRAULKE T, 1990, EUR J BIOCHEM, V189, P609, DOI 10.1111/j.1432-1033.1990.tb15529.x; BRAULKE T, 1989, EMBO J, V8, P681, DOI 10.1002/j.1460-2075.1989.tb03426.x; BUERGISSER DM, 1991, J BIOL CHEM, V266, P1029; CERIONE RA, 1984, BIOCHEMISTRY-US, V23, P4519, DOI 10.1021/bi00315a003; CHAO HHJ, 1990, EMBO J, V9, P3507, DOI 10.1002/j.1460-2075.1990.tb07559.x; CHURCH JG, 1988, J BIOL CHEM, V263, P4242; CLAPHAM DE, 1993, NATURE, V365, P403, DOI 10.1038/365403a0; CODINA J, 1991, METHOD ENZYMOL, V195, P177; CONOVER CA, 1986, BIOCHEM BIOPH RES CO, V139, P501, DOI 10.1016/S0006-291X(86)80019-5; DAMKE H, 1994, MOL CELL ENDOCRINOL, V99, pR25, DOI 10.1016/0303-7207(94)90026-4; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; GIERSCHIK P, 1989, EUR J BIOCHEM, V183, P97, DOI 10.1111/j.1432-1033.1989.tb14901.x; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOLLASCH M, 1993, P NATL ACAD SCI USA, V90, P6265, DOI 10.1073/pnas.90.13.6265; GUSE AH, 1992, ENDOCRINOLOGY, V130, P145, DOI 10.1210/en.130.1.145; HAGA K, 1992, J BIOL CHEM, V267, P2222; HARTMANN H, 1992, DIABETOLOGIA, V35, P216, DOI 10.1007/BF00400920; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; HINSCH KD, 1989, BIOCHIM BIOPHYS ACTA, V1013, P60, DOI 10.1016/0167-4889(89)90128-6; HUMBEL RE, 1990, EUR J BIOCHEM, V190, P445, DOI 10.1111/j.1432-1033.1990.tb15595.x; JACKSON TR, 1992, J BIOL CHEM, V267, P16627; KIESS W, 1987, J BIOL CHEM, V262, P12745; KOJIMA I, 1988, J BIOL CHEM, V263, P16561; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; KWATRA MM, 1993, J BIOL CHEM, V268, P9161; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; LOBEL P, 1989, CELL, V57, P787, DOI 10.1016/0092-8674(89)90793-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACDONALD RG, 1988, SCIENCE, V239, P1134, DOI 10.1126/science.2964083; MELLAS J, 1986, J BIOL CHEM, V261, P4437; MERESSE S, 1993, J CELL BIOL, V120, P67, DOI 10.1083/jcb.120.1.67; MERESSE S, 1990, J BIOL CHEM, V265, P18833; MORISHITA R, 1989, BIOCHEM BIOPH RES CO, V161, P1280, DOI 10.1016/0006-291X(89)91381-8; MURAYAMA Y, 1990, J BIOL CHEM, V265, P17456; NISHIMOTO I, 1989, J BIOL CHEM, V264, P14029; NISHIMOTO I, 1987, J BIOL CHEM, V262, P12120; NURNBERG B, 1994, BIOCHEM J, V300, P387; OKAMOTO T, 1991, CELL, V67, P723, DOI 10.1016/0092-8674(91)90067-9; OKAMOTO T, 1991, J BIOL CHEM, V266, P1085; OKAMOTO T, 1990, CELL, V62, P709, DOI 10.1016/0092-8674(90)90116-V; ROGERS SA, 1989, J BIOL CHEM, V264, P4273; ROSENTHAL W, 1986, EUR J BIOCHEM, V158, P255, DOI 10.1111/j.1432-1033.1986.tb09745.x; ROSORIUS O, 1993, J BIOL CHEM, V268, P21470; SAKANO KI, 1991, J BIOL CHEM, V266, P20626; SAYERS JR, 1989, PROTEIN FUNCTION PRA, P279; SCHMIDT A, 1991, J BIOL CHEM, V266, P18025; SHIMIZU M, 1986, AM J PHYSIOL, V251, pE611, DOI 10.1152/ajpendo.1986.251.5.E611; SPICHER K, 1992, FEBS LETT, V307, P215, DOI 10.1016/0014-5793(92)80770-H; SPICHER K, 1991, BIOCHEM BIOPH RES CO, V175, P473, DOI 10.1016/0006-291X(91)91588-4; STERNWEIS PC, 1994, CURR OPIN CELL BIOL, V6, P198, DOI 10.1016/0955-0674(94)90136-8; STERNWEIS PC, 1990, RECEPTOR EFFECTOR CO, P1; TAKAHASHI K, 1993, P NATL ACAD SCI USA, V90, P11772, DOI 10.1073/pnas.90.24.11772; THAKKER JK, 1989, J BIOL CHEM, V264, P7169; TONG PY, 1988, J BIOL CHEM, V263, P2585; VONFIGURA K, 1984, EMBO J, V3, P1281, DOI 10.1002/j.1460-2075.1984.tb01963.x; WAHEED A, 1988, BIOCHEM BIOPH RES CO, V152, P1248, DOI 10.1016/S0006-291X(88)80419-4; WALKER F, 1993, J BIOL CHEM, V268, P19552; WALSETH TF, 1979, BIOCHIM BIOPHYS ACTA, V562, P11, DOI 10.1016/0005-2787(79)90122-9; ZAPF J, 1981, J CLIN INVEST, V68, P1321, DOI 10.1172/JCI110379	66	89	98	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					287	295		10.1074/jbc.270.1.287	http://dx.doi.org/10.1074/jbc.270.1.287			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814388	hybrid			2022-12-27	WOS:A1995QA28700046
J	ZU, YL; AI, YX; HUANG, CK				ZU, YL; AI, YX; HUANG, CK			CHARACTERIZATION OF AN AUTOINHIBITORY DOMAIN IN HUMAN MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN-KINASE-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP-KINASE; SIGNAL-TRANSDUCTION; IDENTIFICATION; PHOSPHORYLATION; RAF; PURIFICATION; SEQUENCE; PATHWAY; INVITRO	Mitogen-activated protein (MAP) kinase-activated protein kinase 2, a Ser/Thr kinase, is phosphorylated and activated by MAP kinase. Sequence analysis of a clone isolated from the human HL-60 cell line revealed a 370-amino acid protein with a proline-rich N terminus, a highly conserved catalytic domain, and a C-terminal region containing a MAP kinase phosphorylation site. To better understand how the kinase is regulated, mutation analysis was used to map the functional domain(s). The wild type recombinant kinase had a low basal activity as detected by phosphorylation of a substrate peptide derived from the N terminus of glycogen synthase. Deletion of the proline rich N terminus showed little effect on the basal activity. Deletion of the C terminus resulted in a marked increase in catalytic activity either with or without the pretreatment of the kinase by MAP kinase. Further analysis indicated that amino acid residues 339-353 in the C-terminal region were acting as an autoinhibitory domain. A synthetic peptide (RVLKEDK-ERWEDVK-amide) derived from this autoinhibitory do main inhibited the kinase activity in a concentration-dependent manner. These results suggest a regulatory model for the kinase.	UNIV CONNECTICUT, CTR HLTH, DEPT PATHOL, FARMINGTON, CT 06030 USA	University of Connecticut					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020943] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 20943] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahn Natalie G., 1992, Current Opinion in Cell Biology, V4, P992, DOI 10.1016/0955-0674(92)90131-U; BIRGE RB, 1993, SCIENCE, V262, P1522, DOI 10.1126/science.7504323; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; CHENG HC, 1985, BIOCHEM J, V231, P655, DOI 10.1042/bj2310655; CICCHETTI P, 1992, SCIENCE, V257, P803, DOI 10.1126/science.1379745; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; Cobb MH, 1991, CURR OPIN CELL BIOL, V3, P1025, DOI 10.1016/0955-0674(91)90124-H; CRUZALEGUI FH, 1992, P NATL ACAD SCI USA, V89, P12127, DOI 10.1073/pnas.89.24.12127; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; ENGEL K, 1993, FEBS LETT, V336, P143, DOI 10.1016/0014-5793(93)81628-D; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; GUESDON F, 1993, J BIOL CHEM, V268, P4236; HACCARD O, 1993, SCIENCE, V262, P1262, DOI 10.1126/science.8235656; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HJELMQUIST G, 1974, BIOCHEM BIOPH RES CO, V61, P559, DOI 10.1016/0006-291X(74)90993-0; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LAVOINNE A, 1991, EUR J BIOCHEM, V199, P723, DOI 10.1111/j.1432-1033.1991.tb16176.x; LOMAX KJ, 1989, SCIENCE, V245, P409, DOI 10.1126/science.2547247; MATSUDA S, 1992, EMBO J, V11, P973, DOI 10.1002/j.1460-2075.1992.tb05136.x; MING Z, 1993, J BIOL CHEM, V268, P35; NEIMAN AM, 1994, P NATL ACAD SCI USA, V91, P3398, DOI 10.1073/pnas.91.8.3398; NOMURA N, 1993, J BIOL CHEM, V268, P4259; OLIVIER JP, 1993, CELL, V73, P179, DOI 10.1016/0092-8674(93)90170-U; POSADA J, 1993, MOL CELL BIOL, V13, P2546, DOI 10.1128/MCB.13.4.2546; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Ruderman JV, 1993, CURR OPIN CELL BIOL, V5, P207, DOI 10.1016/0955-0674(93)90104-X; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STOKOE D, 1993, BIOCHEM J, V296, P843, DOI 10.1042/bj2960843; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; SUTHERLAND C, 1993, EUR J BIOCHEM, V217, P715, DOI 10.1111/j.1432-1033.1993.tb18297.x; SUTHERLAND C, 1993, EUR J BIOCHEM, V212, P581, DOI 10.1111/j.1432-1033.1993.tb17696.x; VOLPP BD, 1989, P NATL ACAD SCI USA, V86, P9563; ZU YL, 1994, BIOCHEM BIOPH RES CO, V200, P1118, DOI 10.1006/bbrc.1994.1566; ZU YL, 1992, J BIOL CHEM, V267, P20181	44	35	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					202	206		10.1074/jbc.270.1.202	http://dx.doi.org/10.1074/jbc.270.1.202			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814374	hybrid			2022-12-27	WOS:A1995QA28700034
J	KJELDSEN, T; WIBERG, FC; ANDERSEN, AS				KJELDSEN, T; WIBERG, FC; ANDERSEN, AS			CHIMERIC RECEPTORS INDICATE THAT PHENYLALANINE-39 IS A MAJOR CONTRIBUTOR TO INSULIN SPECIFICITY OF THE INSULIN-RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I RECEPTOR; ALPHA-SUBUNIT; BINDING-SITE; LIGAND SPECIFICITY; GROWTH-FACTORS; AMINO-ACID; REGION; IDENTIFICATION; DETERMINANTS; DOMAIN	The exact nature of how the insulin molecule interacts with the insulin receptor is obscure although chimeric receptors have shown that the ligand specificity of the insulin receptor and the IGF-I receptor (i,e, the sequences that discriminate between insulin and insulinlike growth factor I) reside in different regions of a common binding site and that the N-terminal 68 amino acids of the insulin receptor are involved in conferring specificity for insulin on this receptor (Kjeldsen, T., Andersen, A, S,, Wiberg, F. C,, Rasmussen, J, S,, Schaffer, L,, Balschmidt, P,, Moller, K, B., and Moller, N, P, H. (1991) Proc, Natl. Acad. Sci, U,S. A, 88, 4404-4408), Using chimeric insulin/IGF-I receptors to elucidate how the insulin receptor interacts with the insulin molecule we identified phenylalanine 39 of the insulin receptor as a major contributor in determining the receptor specificity for insulin, increasing insulin affinity 15-fold when replacing the corresponding amino acid in the insulin-like growth factor I receptor. Furthermore, replacement of the insulin receptor amino acid phenylalanine 39 with the corresponding IGF-I receptor amino acid, serine 35, decreased insulin affinity 8-fold.	NOVO NORDISK AS,BIOSCI,DK-2880 BAGSVAERD,DENMARK	Novo Nordisk	KJELDSEN, T (corresponding author), NOVO NORDISK AS,DIABET RES,NOVO ALLE,DK-2880 BAGSVAERD,DENMARK.			Kjeldsen, Thomas/0000-0003-0094-9286				ANDERSEN AS, 1990, BIOCHEMISTRY-US, V29, P7363, DOI 10.1021/bi00484a002; ANDERSEN AS, 1992, J BIOL CHEM, V267, P13681; BEINBORN M, 1993, NATURE, V362, P348, DOI 10.1038/362348a0; CZECH MP, 1989, CELL, V59, P235, DOI 10.1016/0092-8674(89)90281-X; DEMEYTS P, 1990, MOL ENDOCRINOL, V4, P409, DOI 10.1210/mend-4-3-409; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; FONG TM, 1993, NATURE, V362, P350; GETHER U, 1993, NATURE, V362, P345, DOI 10.1038/362345a0; GUSTAFSON TA, 1990, J BIOL CHEM, V265, P18663; HOLLENBERG MD, 1985, INSULIN ITS RECEPTOR, P57; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; KADOWAKI T, 1990, J BIOL CHEM, V265, P19143; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; LEATHERBARROW RJ, 1992, GRAFIT VERSION 3 01; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MIRMIRA RG, 1989, J BIOL CHEM, V264, P6349; RAFAELOFF R, 1989, J BIOL CHEM, V264, P15900; SCHUMACHER R, 1991, J BIOL CHEM, V266, P19288; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; WAUGH SM, 1989, BIOCHEMISTRY-US, V28, P3448, DOI 10.1021/bi00434a045; WEDEKIND F, 1989, BIOL CHEM H-S, V370, P251, DOI 10.1515/bchm3.1989.370.1.251; YARDEN Y, 1988, BIOCHEMISTRY-US, V27, P3113, DOI 10.1021/bi00409a001; YIP CC, 1988, BIOCHEM BIOPH RES CO, V157, P321, DOI 10.1016/S0006-291X(88)80050-0; YIP CC, 1991, BIOCHEMISTRY-US, V30, P695, DOI 10.1021/bi00217a016; ZHANG B, 1991, P NATL ACAD SCI USA, V88, P9858, DOI 10.1073/pnas.88.21.9858; ZHANG B, 1991, BIOCHEMISTRY-US, V30, P5113, DOI 10.1021/bi00235a001	27	16	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					32942	32946						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806523				2022-12-27	WOS:A1994QA63800036
J	OLESEN, OF				OLESEN, OF			EXPRESSION OF LOW-MOLECULAR-WEIGHT ISOFORMS OF MICROTUBULE-ASSOCIATED PROTEIN-2 - PHOSPHORYLATION AND INDUCTION OF MICROTUBULE ASSEMBLY IN-VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN; MOUSE-BRAIN; TAU-PROTEIN; TUBULIN; KINASE; BINDING; DOMAINS; MAP2; POLYMERIZATION; HETEROGENEITY	In rat brain, the microtubule-associated protein 2 (MAPS) contains two low molecular weight isoforms, consisting of 467 and 498 amino acids and designated MAP2c and d, respectively. The present study describes the expression of these isoforms in Escherichia coli and their subsequent purification to homogeneity. On SDS-polyacrylamide gel electrophoresis, the recombinant proteins ran with apparent molecular masses of 69 and 74 kDa. A microtubule-assembling assay demonstrated that the recombinant protein was biologically active and that the tubulin polymerization rate for MAP2d was twice as fast as that for MAP2c. After dephosphorylation with alkaline phosphatase, preparations of low molecular weight MAPS from fetal rat brain aligned with recombinant MAP2c. Moreover, recombinant MAP2c could be phosphorylated with a brain extract kinase activity, resulting in a reduced electrophoretic mobility similar to that observed in fetal MAPS.	AARHUS UNIV,DIV BIOSTRUCT,DK-8000 AARHUS C,DENMARK	Aarhus University			Olesen, Ole/AGN-9447-2022	Olesen, Ole/0000-0002-3025-2466				AIZAWA H, 1988, J BIOL CHEM, V262, P3782; BINDER LI, 1984, P NATL ACAD SCI-BIOL, V81, P5613, DOI 10.1073/pnas.81.17.5613; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; CRANDALL JE, 1989, J NEUROCHEM, V53, P1910, DOI 10.1111/j.1471-4159.1989.tb09261.x; DOLL T, 1993, J CELL SCI, V106, P633; ENNULAT DJ, 1989, J BIOL CHEM, V264, P5327; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOLDENRING JR, 1983, J BIOL CHEM, V258, P2632; JOLY JC, 1989, J CELL BIOL, V109, P2289, DOI 10.1083/jcb.109.5.2289; KINDLER S, 1990, J BIOL CHEM, V265, P19679; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; LICHTENBERG B, 1988, NATURE, V334, P359, DOI 10.1038/334359a0; MANDELKOW EM, 1985, J MOL BIOL, V185, P311, DOI 10.1016/0022-2836(85)90406-1; Matus A, 1990, CURR OPIN CELL BIOL, V2, P10, DOI 10.1016/S0955-0674(05)80024-9; MCLEOD M, 1987, EMBO J, V6, P729, DOI 10.1002/j.1460-2075.1987.tb04814.x; MURPHY DB, 1975, P NATL ACAD SCI USA, V72, P2696, DOI 10.1073/pnas.72.7.2696; RAY LB, 1988, J BIOL CHEM, V263, P12721; RIEDERER B, 1988, P NATL ACAD SCI USA, V82, P6006; SILLIMAN CC, 1989, BIOCHEM BIOPH RES CO, V160, P993, DOI 10.1016/S0006-291X(89)80099-3; SLOBODA RD, 1976, BIOCHEMISTRY-US, V15, P4497, DOI 10.1021/bi00665a026; THEURKAUF WE, 1983, J BIOL CHEM, V258, P7883; TUCKER RP, 1988, J NEUROSCI, V8, P4503; VALLEE RB, 1981, J CELL BIOL, V90, P568, DOI 10.1083/jcb.90.3.568; WILLE H, 1992, J BIOL CHEM, V267, P10737	26	12	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					32904	32908						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806517				2022-12-27	WOS:A1994QA63800030
J	REED, VS; WASTNEY, ME; YANG, DCH				REED, VS; WASTNEY, ME; YANG, DCH			MECHANISMS OF THE TRANSFER OF AMINOACYL-TRANSFER-RNA FROM AMINOACYL-TRANSFER-RNA SYNTHETASE TO THE ELONGATION-FACTOR 1-ALPHA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER RNA-SYNTHETASE; FACTOR TU-GTP; PROTEIN-SYNTHESIS; ESCHERICHIA-COLI; AMPHIPHILIC HELIX; CRYSTAL-STRUCTURE; COMPLEX; YEAST; PYROPHOSPHATASE; DISCRIMINATION	Aspartylation of mammalian tRNA(Asp) by bacteria-expressed human aspartyl-tRNA synthetase (hDRS) was examined, The kinetics of the aspartylation of tRNA was consistent with the following reaction pathway, [GRAPHICS] where E, represents aspartyl-tRNA synthetase. A set of rate constants was obtained which fit single turnover time courses at varying concentrations of the enzyme, tRNA, and AMP using the SAAM program, The dissociation of Asp-tRNA (k(3)) was found to be rate limiting, The elongation factor 1 alpha (EF1 alpha) and GTP stimulated the hDRS aspartylation, The stimulation depended on the presence of both EF1 alpha and GTP, Kinetic analysis indicated that EF1 alpha formed a complex with the hDRS Asp-tRNA complex and stimulated the dissociation of Asp-tRNA In the presence of 0.5 at NH4Cl, which enhances the binding of Asp tRNA by EF1 alpha, hDRS-bound Asp-tRNA can be transferred directly to EF1 alpha. The implications of these results on the function of the multi-tRNA synthetase complex will be discussed.	GEORGETOWN UNIV, DEPT CHEM, WASHINGTON, DC 20057 USA; GEORGETOWN UNIV, DEPT PEDIAT, WASHINGTON, DC 20057 USA	Georgetown University; Georgetown University			Yang, David/A-7294-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025848] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-25848] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; BERMAN M, 1962, BIOPHYS J, V2, P275, DOI 10.1016/S0006-3495(62)86855-6; Berman M, 1983, CONSAM USERS GUIDE; CERINI C, 1991, EMBO J, V10, P4267, DOI 10.1002/j.1460-2075.1991.tb05005.x; DEUTSCHER MP, 1984, J CELL BIOL, V99, P373, DOI 10.1083/jcb.99.2.373; DIGNAM JD, 1979, BIOCHEMISTRY-US, V18, P3165, DOI 10.1021/bi00581a039; ELDRED EW, 1972, BIOCHEMISTRY-US, V11, P17, DOI 10.1021/bi00751a004; ESCALANTE C, 1993, J BIOL CHEM, V268, P6014; FETT R, 1991, J BIOL CHEM, V266, P1448; FREIST W, 1984, BIOCHEMISTRY-US, V23, P5742, DOI 10.1021/bi00319a012; GEHRKE L, 1983, P NATL ACAD SCI-BIOL, V80, P3274, DOI 10.1073/pnas.80.11.3274; GHOSH HP, 1967, J MOL BIOL, V25, P275, DOI 10.1016/0022-2836(67)90142-8; HOD Y, 1976, J BIOL CHEM, V251, P4458; JACOBOMOLINA A, 1989, J BIOL CHEM, V264, P16608; KHVOROVA AM, 1992, FEBS LETT, V311, P139, DOI 10.1016/0014-5793(92)81385-Y; KINZY TG, 1992, J BIOL CHEM, V267, P1623; KJELDGAARD M, 1992, J MOL BIOL, V223, P721, DOI 10.1016/0022-2836(92)90986-T; KNOWLTON RG, 1980, J MOL BIOL, V139, P721, DOI 10.1016/0022-2836(80)90057-1; LOUIE A, 1984, J BIOL CHEM, V259, P5010; MIRANDE M, 1991, PROG NUCLEIC ACID RE, V40, P95; MIRANDE M, 1989, J BIOL CHEM, V264, P842; MOLDAVE K, 1985, ANNU REV BIOCHEM, V54, P1109, DOI 10.1146/annurev.biochem.54.1.1109; MUENCH KH, 1966, PROCEDURES NUCLEIC A, P375; NEGRUTSKII BS, 1991, P NATL ACAD SCI USA, V88, P4991, DOI 10.1073/pnas.88.11.4991; REED VS, 1994, J BIOL CHEM, V269, P32937; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; YANG DCH, 1985, CURR TOP CELL REGUL, V26, P325; YARUS M, 1970, ANAL BIOCHEM, V35, P450, DOI 10.1016/0003-2697(70)90207-1	30	53	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	1994	269	52					32932	32936						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA638	7806521				2022-12-27	WOS:A1994QA63800034
J	HOMANICS, GE; DESILVA, HV; OSADA, J; ZHANG, SH; WONG, H; BORENSZTAJN, J; MAEDA, N				HOMANICS, GE; DESILVA, HV; OSADA, J; ZHANG, SH; WONG, H; BORENSZTAJN, J; MAEDA, N			MILD DYSLIPIDEMIA IN MICE FOLLOWING TARGETED INACTIVATION OF THE HEPATIC LIPASE GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY LIPOPROTEIN; RELEASABLE LIVER LIPASE; EMBRYONIC STEM-CELLS; PLASMA-LIPOPROTEINS; TRIGLYCERIDE LIPASE; ENDOTHELIAL LIPASE; APOLIPOPROTEIN-E; DEFICIENCY; HEPARIN; METABOLISM	In order to gain better understanding of the function of hepatic lipase (HL) in vivo, we have generated mice that lack HL using gene targeting in embryonic stem cells. No mRNA for HL was detected in the liver of homozygous mutants, and no HL activity was detected in their plasma. Total cholesterol levels in plasma of mutant mice were increased by about 30% compared with wild type animals. Plasma phospholipids and high density lipoprotein (HDL) cholesterol were also increased, but plasma levels of triglycerides were not altered. Analysis of density fractions of plasma lipoproteins revealed that HDL(1) (d = 1.02-1.04) was increased in homozygous mutants fed regular chow. In response to a diet containing high fat and high cholesterol, HDL cholesterol was doubled in the mutants, but was slightly decreased in the wild type mice. These results clearly demonstrate the importance of HL in HDL remodeling and metabolism in vivo. Various earlier studies suggested a role of HL in metabolism of triglyceride-rich particles, but the mutant mice appear to have no impairment in clearing them; the mutants clear exogenously introduced chylomicrons from plasma at a normal rate, and they tolerate acute fat loading as well as normal animals unless the loading is extreme. These differences may reflect species differences. However, it is also possible that the consequence of absence of HL as in our mutants is different from the consequence when nonfunctional HL protein is present as in the human HL-deficient patients and in rats treated with HL antibodies. We hypothesize that absence of HL in mutant mice allows other lipases to bind to the sites in the liver normally occupied by HL and facilitate the clearance of triglyceride-rich particles in these mice.	UNIV N CAROLINA, DEPT PATHOL, CHAPEL HILL, NC 27599 USA; UNIV N CAROLINA, DEPT BIOL, CHARLOTTE, NC 28223 USA; UNIV CALIF LOS ANGELES, VET ADM WADSWORTH MED CTR, LOS ANGELES, CA 90073 USA; NORTHWESTERN UNIV, SCH MED, DEPT PATHOL, CHICAGO, IL 60611 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Charlotte; University of California System; University of California Los Angeles; Northwestern University				Homanics, Gregg/0000-0003-3641-8153	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL008639, R01HL042630, R37HL042630] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL42630, HL08639] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMEIS D, 1990, J BIOL CHEM, V265, P6552; AUWERX JH, 1990, AM J HUM GENET, V46, P470; AUWERX JH, 1989, ARTERIOSCLEROSIS, V9, P319, DOI 10.1161/01.ATV.9.3.319; BAMBERGER M, 1985, BIOCHEMISTRY-US, V24, P3693, DOI 10.1021/bi00335a044; BORENSZTAJN J, 1984, P NATL ACAD SCI-BIOL, V81, P5863, DOI 10.1073/pnas.81.18.5863; BRECKENRIDGE WC, 1982, ATHEROSCLEROSIS, V45, P161, DOI 10.1016/0021-9150(82)90136-8; BRINTON EA, 1991, J CLIN INVEST, V87, P536, DOI 10.1172/JCI115028; BUSCH SJ, 1994, J BIOL CHEM, V269, P16376; CARLSON LA, 1986, ACTA MED SCAND, V219, P435; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CONNELLY PW, 1990, ARTERIOSCLEROSIS, V10, P40, DOI 10.1161/01.ATV.10.1.40; DAGGY BP, 1986, BIOCHIM BIOPHYS ACTA, V877, P252, DOI 10.1016/0005-2760(86)90302-4; DAVIS RC, 1990, J BIOL CHEM, V265, P6291; DESILVA HV, 1994, J LIPID RES, V35, P1297; DURSTENFELD A, 1994, ARTERIOSCLER THROMB, V14, P381, DOI 10.1161/01.ATV.14.3.381; Eisenberg S., 1990, CURR OPIN LIPIDOL, V1, P205; GOLDBERG IJ, 1982, J CLIN INVEST, V70, P1184, DOI 10.1172/JCI110717; GREEN MC, 1968, BIOL LABORATORY MOUS; GROSSER J, 1981, J LIPID RES, V22, P437; HAMILTON RL, 1976, J CLIN INVEST, V58, P667, DOI 10.1172/JCI108513; HEGELE RA, 1993, ARTERIOSCLER THROMB, V13, P720, DOI 10.1161/01.ATV.13.5.720; HOOPER M, 1987, NATURE, V330, P576; JANSEN H, 1980, BIOCHEM BIOPH RES CO, V92, P53, DOI 10.1016/0006-291X(80)91518-1; JI ZS, 1994, J BIOL CHEM, V269, P13429; KINGSTON RE, 1987, CURRENT PROTOCOLS MO; KNUSI T, 1979, FEBS LETT, V104, P384; KOLLER BH, 1989, P NATL ACAD SCI USA, V86, P8927, DOI 10.1073/pnas.86.22.8927; KOMAROMY MC, 1987, P NATL ACAD SCI USA, V84, P1526, DOI 10.1073/pnas.84.6.1526; KUUSI T, 1980, ATHEROSCLEROSIS, V36, P589, DOI 10.1016/0021-9150(80)90251-8; LI H, 1993, ARTERIOSCLER THROMB, V13, P1814, DOI 10.1161/01.ATV.13.12.1814; Little J A, 1986, Adv Exp Med Biol, V201, P253; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; NILSSON A, 1987, J LIPID RES, V28, P510; NISHINA PM, 1990, J LIPID RES, V31, P859; PAIGEN B, 1987, P NATL ACAD SCI USA, V84, P3763, DOI 10.1073/pnas.84.11.3763; PETERSON J, 1986, BIOCHIM BIOPHYS ACTA, V878, P65, DOI 10.1016/0005-2760(86)90344-9; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; PITAS RE, 1979, P NATL ACAD SCI USA, V76, P2311, DOI 10.1073/pnas.76.5.2311; RAO SN, 1982, FEBS LETT, V150, P255, DOI 10.1016/0014-5793(82)81345-8; SHAFI S, 1994, J LIPID RES, V35, P709; SHIRAI K, 1981, BIOCHEM BIOPH RES CO, V100, P591, DOI 10.1016/S0006-291X(81)80217-3; SULTAN F, 1990, BIOCHIM BIOPHYS ACTA, V1042, P150, DOI 10.1016/0005-2760(90)90071-5; THUREN T, 1991, J BIOL CHEM, V266, P4853; TWU JS, 1984, BIOCHIM BIOPHYS ACTA, V792, P330, DOI 10.1016/0005-2760(84)90201-7; VANTOL A, 1980, BIOCHEM BIOPH RES CO, V94, P101, DOI 10.1016/S0006-291X(80)80193-8; YOSHIDA Y, 1980, J BIOCHEM-TOKYO, V88, P463, DOI 10.1093/oxfordjournals.jbchem.a132993; YOUNG SG, 1987, J CLIN INVEST, V79, P1831, DOI 10.1172/JCI113025; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	48	168	170	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 17	1995	270	7					2974	2980		10.1074/jbc.270.7.2974	http://dx.doi.org/10.1074/jbc.270.7.2974			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QG471	7852377	Green Published, hybrid			2022-12-27	WOS:A1995QG47100016
J	DESHPANDE, RV; GOUST, JM; CHAKRABARTI, AK; BARBOSA, E; HOGAN, EL; BANIK, NL				DESHPANDE, RV; GOUST, JM; CHAKRABARTI, AK; BARBOSA, E; HOGAN, EL; BANIK, NL			CALPAIN EXPRESSION IN LYMPHOID-CELLS - INCREASED MESSENGER-RNA AND PROTEIN-LEVELS AFTER CELL ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA-2+-ACTIVATED NEUTRAL PROTEASE; CALCIUM-DEPENDENT PROTEASE; LEUCINE METHYL-ESTER; LARGE SUBUNIT; MULTIPLE-SCLEROSIS; SPINAL-CORD; CDNA; INTERLEUKIN-1-ALPHA; LYMPHOCYTES; PRECURSOR	Although calpain is ubiquitously present in human tissues and is thought to play a role in demyelination, its activity is very low in resting normal lymphocytes. To determine the nature of calpain expression at the mRNA and protein levels in human lymphoid cells, we studied human T lymphocytic, B lymphocytic, and monocytic Lines as well as peripheral blood mononuclear cells. Stimulation of cells with the phorbol ester phorbol myristate acetate and the calcium ionophore A23187 resulted in increased calpain mRNA and protein expression. Calpain mRNA expression is also increased in human T cells stimulated with anti-CD3. A dissociation between the increases of RNA and protein suggested that calpain could be released from the cells; the subsequent experiments showed its presence in the extracellular environment, 5,6-Dichloro-1b-D-ribofuranosylbenzimidazoIe, a reversible inhibitor of mRNA synthesis, reduced calpain mRNA levels by 50-67% and protein levels by 72-91%, Its removal resulted in resumption of both calpain mRNA and protein synthesis. Cycloheximide, a translational inhibitor, reduced calpain protein levels by 77-81% and calpain mRNA levels by 96% in activated THP-1 cells. Interferon-gamma induced calpain mRNA and protein in U-937 and THP-1 cells. Dexamethasone increased mRNA expression in THP-1 cells, Our results indicate that activation of lymphoid cells results in de novo synthesis and secretion of calpain.	MED UNIV S CAROLINA,DEPT NEUROL,CHARLESTON,SC 29425; MED UNIV S CAROLINA,DEPT MICROBIOL & IMMUNOL,CHARLESTON,SC 29425	Medical University of South Carolina; Medical University of South Carolina					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031622, P01NS011066, F32NS011066] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-11066, NS-31622] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AOKI K, 1986, FEBS LETT, V205, P313, DOI 10.1016/0014-5793(86)80919-X; Banik Naren L., 1992, P571; BANIK NL, 1992, CRIT REV NEUROBIOL, V16, P257; CABANAS C, 1990, EUR J BIOCHEM, V191, P599, DOI 10.1111/j.1432-1033.1990.tb19163.x; CARRUTH LM, 1991, J BIOL CHEM, V266, P12162; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COOLICAN SA, 1984, J BIOL CHEM, V259, P1627; DESHPANDE RV, 1993, NEUROCHEM RES, V18, P767, DOI 10.1007/BF00966771; DESHPANDE RV, 1992, T AM SOC NEUROCHEM, V23, P158; EFRAT S, 1984, P NATL ACAD SCI-BIOL, V81, P2601, DOI 10.1073/pnas.81.9.2601; EMORI Y, 1986, J BIOL CHEM, V261, P9465; GRAY PW, 1986, J IMMUNOL, V137, P3644; HATA A, 1989, J BIOL CHEM, V264, P6404; HAZUDA DJ, 1988, J BIOL CHEM, V263, P8473; HOGAN EL, 1987, CELLULAR HUMORAL COM, V129, P479; IMAJOH S, 1988, BIOCHEMISTRY-US, V27, P8122, DOI 10.1021/bi00421a022; MANGER B, 1988, T CELL RECEPTORS, P133; MERRILL JE, 1988, P NATL ACAD SCI USA, V89, P574; MURACHI T, 1989, BIOCHEM INT, V18, P263; NAMAJIMAIIJIMA S, 1985, P NATL ACAD SCI USA, V82, P6133; NOELLE RJ, 1991, FASEB J, V5, P2770, DOI 10.1096/fasebj.5.13.1833257; NOLFO R, 1989, PROSTAGLANDINS, V39, P157; PANITCH HS, 1987, NEUROLOGY, V37, P1097, DOI 10.1212/WNL.37.7.1097; PING L, 1992, J IMMUNOL, V148, P3354; RAINE CS, 1991, NEUROPATH APPL NEURO, V17, P265, DOI 10.1111/j.1365-2990.1991.tb00724.x; SCHMAIER AH, 1990, BLOOD, V75, P1273; SHAU H, 1985, J IMMUNOL, V134, P1136; SIMMONS RD, 1990, J NEUROL SCI, V100, P37, DOI 10.1016/0022-510X(90)90010-K; TAMM I, 1978, ADV VIRUS RES, V22, P188; THIELE DL, 1986, J IMMUNOL, V136, P1038; TSUBATA T, 1989, J BIOCHEM-TOKYO, V105, P23, DOI 10.1093/oxfordjournals.jbchem.a122611; WANG IY, 1988, HYBRIDOMA, V7, P529, DOI 10.1089/hyb.1988.7.529; WERNERFELMAYER G, 1990, CANCER RES, V50, P2863; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0	34	79	81	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2497	2505		10.1074/jbc.270.6.2497	http://dx.doi.org/10.1074/jbc.270.6.2497			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852311	hybrid			2022-12-27	WOS:A1995QF53500018
J	LAI, K; BOLOGNESE, CP; SWIFT, S; MCGRAW, P				LAI, K; BOLOGNESE, CP; SWIFT, S; MCGRAW, P			REGULATION OF INOSITOL TRANSPORT IN SACCHAROMYCES-CEREVISIAE INVOLVES INOSITOL-INDUCED CHANGES IN PERMEASE STABILITY AND ENDOCYTIC DEGRADATION IN THE VACUOLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; PHOSPHATIDYLINOSITOL SYNTHASE; TRANSCRIPTIONAL REGULATOR; GENE ENCODES; YEAST; INVIVO; PURIFICATION; BIOSYNTHESIS; PROTEOLYSIS; REPRESSOR	Uptake of inositol by Saccharomyces cerevisiae is mediated by a specific inositol permease encoded by the ITR1 gene, Removal of inositol from the growth medium results in an increase in ITR1 mRNA abundance, The increase in ITR1 mRNA is accompanied by an increase in de novo synthesis of the Itr1 permease leading to an increased capacity for uptake, When inositol is added to the growth medium inactivation of uptake activity occurs, and both transcription of ITR1 and uptake activity are repressed to a basal level of function, The transcriptional regulation of ITR1 depends on the INO2, INO4, and OPI1 genes, In addition, repression is also achieved by regulation of ITR1 expression at the post-translational level, In this study, we show that there is a change in the stability of the Itr1 permease after the addition of inositol to the growth medium, Immunoblot analysis using a monoclonal antibody against an epitope attached to the Itr1 permease showed that the addition of inositol causes a dramatic increase in the rate of degradation of the permease, After the repressed (basal) level is achieved, turnover continues to be rapid, The increased rate of degradation was also observed in strains with mutations that block conjugation to ubiquitin, Degradation was not observed in strains defective in the END3/END4 endocytic pathway or in the production of vacuolar proteases (PEP4). Thus, inactivation of the Itr1 permease is accompanied by endocytic internalization followed by degradation in the vacuole, Inactivation may be a separate process that precedes and signals endocytic degradation, Since the end3/end4 mutations did not affect uptake activity under derepressed conditions, endocytosis is not required for normal inositol uptake.	UNIV MARYLAND,DEPT BIOL SCI,BALTIMORE,MD 21228	University System of Maryland; University of Maryland Baltimore				Swift, Steven/0000-0002-3840-4401				CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; DAVIS NG, 1993, J CELL BIOL, V122, P53, DOI 10.1083/jcb.122.1.53; FISCHL AS, 1986, J BIOL CHEM, V261, P3178; FISCHL AS, 1983, J BACTERIOL, V154, P304, DOI 10.1128/JB.154.1.304-311.1983; GOLDSTEIN JL, 1979, NATURE, V279, P679, DOI 10.1038/279679a0; GREENBERG ML, 1982, GENETICS, V100, P19; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; JENTSCH S, 1992, ANNU REV GENET, V26, P177; JONES EW, 1991, J BIOL CHEM, V266, P7963; KARIN M, 1981, J BIOL CHEM, V256, P3245; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; Knop M, 1993, CURR OPIN CELL BIOL, V5, P990, DOI 10.1016/0955-0674(93)90082-2; LAI K, 1994, J BIOL CHEM, V269, P2245; LUCERO P, 1993, FEBS LETT, V333, P165, DOI 10.1016/0014-5793(93)80397-D; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; NIKAWA J, 1991, J BIOL CHEM, V266, P11184; PALTAUF F, 1992, MOL CELLULAR BIOL YE, V2, P415; POSTERNAK T, 1965, CYCLITOLS; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; REIZMAN H, 1993, TRENDS CELL BIOL, V3, P273; SCHORK SM, 1994, NATURE, V369, P283, DOI 10.1038/369283a0; SIMEON A, 1992, FEBS LETT, V301, P231, DOI 10.1016/0014-5793(92)81254-J; SPIEGEL S, 1993, AV LIPID RES, VA, P105; SPRAGUE GF, 1991, TRENDS GENET, V7, P393, DOI 10.1016/0168-9525(91)90262-O; TAN PK, 1993, J CELL BIOL, V123, P1707, DOI 10.1083/jcb.123.6.1707; TEICHERT U, 1989, J BIOL CHEM, V264, P16037; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; WOOLFORD CA, 1986, MOL CELL BIOL, V6, P2500, DOI 10.1128/MCB.6.7.2500	30	69	70	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2525	2534		10.1074/jbc.270.6.2525	http://dx.doi.org/10.1074/jbc.270.6.2525			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852314	hybrid			2022-12-27	WOS:A1995QF53500022
J	RAY, MK; MAGDALENO, SW; FINEGOLD, MJ; DEMAYO, FJ				RAY, MK; MAGDALENO, SW; FINEGOLD, MJ; DEMAYO, FJ			CIS-ACTING ELEMENTS INVOLVED IN THE REGULATION OF MOUSE CLARA CELL-SPECIFIC 10-KDA PROTEIN GENE - IN-VITRO AND IN-VIVO ANALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-SPECIFIC EXPRESSION; PULMONARY SURFACTANT PROTEINS; RABBIT UTEROGLOBIN GENE; TRANSGENIC MICE; BRONCHIOLAR EPITHELIUM; KDA PROTEIN; RAT; LUNG; TRANSCRIPTION; FRAGMENTS	Transient transfection and murine germ line gene transfer analysis was used to determine the regions of DNA necessary to confer the appropriate level and cell specificity of the expression of the gene coding for the murine Clara cell 10-kDa protein, mCC10. To identify the cis-acting elements involved in the regulation of mCC10 gene, different lengths of the B'-flanking sequence were ligated to the bacterial chloramphenicol acetyltransferase gene for transient transfection to H441 cells (human lung adenocarcinoma cell line). The corresponding sequences were also fused to the human growth hormone gene and transferred to the murine genome for an in vivo analysis of mCC10 promoter activity, The results of the transient transfection analysis identified the region from -166 to -124 of the 5'-flanking region of the mCC10 gene as necessary for the expression of this gene in H441 cells, The transgenic mouse analysis confirmed that the 166 base pairs of 5'-flanking DNA was sufficient to confer cell specific expression, However, the transgenic mouse analysis also showed that, to achieve the full quantitative level of transgene (human growth hormone) expression, regions between -803 and -166 base pairs of the B'-flanking sequences are required for maximum expression of mCC10 gene promoter activity.	BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PATHOL,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine			DeMayo, Francesco/C-6255-2019	DeMayo, Francesco/0000-0002-9480-7336	NHLBI NIH HHS [HL47620] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047620] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AUMULLER G, 1985, HISTOCHEMISTRY, V83, P413, DOI 10.1007/BF00509202; BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; CATO ACB, 1984, EMBO J, V3, P2771, DOI 10.1002/j.1460-2075.1984.tb02208.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; DEMAYO FJ, 1991, MOL ENDOCRINOL, V5, P311, DOI 10.1210/mend-5-3-311; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GAIL DB, 1983, AM REV RESPIR DIS, V127, P366; GLASSER SW, 1991, AM J PHYSIOL, V261, pL349, DOI 10.1152/ajplung.1991.261.4.L349; HACKETT BP, 1992, AM J PHYSIOL, V262, pL399, DOI 10.1152/ajplung.1992.262.4.L399; HACKETT BP, 1992, P NATL ACAD SCI USA, V89, P9079, DOI 10.1073/pnas.89.19.9079; HAGEN G, 1990, NUCLEIC ACIDS RES, V18, P2939, DOI 10.1093/nar/18.10.2939; HOGAN B, 1986, COLD SPRING HARB SYM, V98, P503; KRISHNAN RS, 1967, SCIENCE, V158, P490, DOI 10.1126/science.158.3800.490; LACAZEMASMONTEIL T, 1992, EUR J BIOCHEM, V206, P613, DOI 10.1111/j.1432-1033.1992.tb16966.x; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; LUND J, 1988, BIOCHEMISTRY-US, V27, P7895, DOI 10.1021/bi00420a047; LYNCH DC, 1994, MOL CELL BIOL, V14, P999; MANIATIS T, 1983, MOL CLONING; MARGRAF LR, 1993, AM J RESP CELL MOL, V9, P231, DOI 10.1165/ajrcmb/9.3.231; MENDEL DB, 1991, GENE DEV, V5, P1042, DOI 10.1101/gad.5.6.1042; PHELPS DS, 1991, EXP LUNG RES, V17, P985, DOI 10.3109/01902149109064330; RAY MK, 1993, BIOCHEM BIOPH RES CO, V197, P163, DOI 10.1006/bbrc.1993.2455; REID L, 1979, FED PROC, V38, P191; SAWAYA PL, 1993, MOL CELL BIOL, V13, P3860, DOI 10.1128/MCB.13.7.3860; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; SEPULVEDA AR, 1989, CANCER RES, V49, P6108; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STRIPP BR, 1994, GENOMICS, V20, P27, DOI 10.1006/geno.1994.1123; STRIPP BR, 1990, AM J PHYSIOL, V259, pL185, DOI 10.1152/ajplung.1990.259.4.L185; STRIPP BR, 1992, J BIOL CHEM, V261, P14703; Suske Guntram, 1992, Gene Expression, V2, P339; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; UMLAND TC, 1992, J MOL BIOL, V224, P441, DOI 10.1016/0022-2836(92)91006-B; WIKENHEISER KA, 1992, AM J PHYSIOL, V262, pL32, DOI 10.1152/ajplung.1992.262.1.L32; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; XANTHOPOULOS KG, 1991, P NATL ACAD SCI USA, V88, P3807, DOI 10.1073/pnas.88.9.3807	37	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2689	2694		10.1074/jbc.270.6.2689	http://dx.doi.org/10.1074/jbc.270.6.2689			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852338	hybrid			2022-12-27	WOS:A1995QF53500046
J	GRUNE, T; REINHECKEL, T; JOSHI, M; DAVIES, KJA				GRUNE, T; REINHECKEL, T; JOSHI, M; DAVIES, KJA			PROTEOLYSIS IN CULTURED LIVER EPITHELIAL-CELLS DURING OXIDATIVE STRESS - ROLE OF THE MULTICATALYTIC PROTEINASE COMPLEX, PROTEASOME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIXED-FUNCTION OXIDATION; RAT SKELETAL-MUSCLE; RED BLOOD-CELLS; GLUTAMINE-SYNTHETASE; OXYGEN RADICALS; DENATURED PROTEINS; MAMMALIAN-CELLS; HUMAN-ERYTHROCYTES; ALKALINE PROTEASE; MOLECULAR-CLONING	Exposure to various forms of mild oxidative stress significantly increased the intracellular degradation of both ''short-lived'' and ''long-lived,'' metabolically radiolabeled, cell proteins in cultures of Clone 9 liver cells (normal liver epithelia), The oxidative stresses employed were bolus H2O2 addition; continuous H2O2 flux; the redox cycling quinones, menadione and paraquat; and the aldehydic products of lipid peroxidation, 4-hydroxynonenal, malonyldialdehyde, and hexenal. In general, exposure to more severe oxidative stress produced a concentration-dependent decline in intracellular proteolysis, in some cases to below baseline levels, Oxidatively modified ''foreign'' proteins (superoxide dismutase and hemoglobin) were also selectively degraded, in comparison with untreated foreign proteins, when added to lysates of Clone 9 liver cells. As with intracellular proteolysis, the degradation of foreign proteins added to cell lysates was greatly increased by mild oxidative modification, but depressed by more severe oxidative modification, The proteinase activity was recovered in >300-kDa cell fractions, and inhibitor profiles and immunoprecipitation studies indicated that the multicatalytic proteinase complex, proteasome, was responsible for most of the selective degradation observed with mild oxidative stress; up to approximately 95% for intracellular proteolysis and 65-80% for degradation of foreign modified proteins, Seven days of daily treatment with an antisense oligodeoxynucleotide, directed against the initiation codon region of the proteasome C2 subunit gene, severely depressed the intracellular levels of several proteasome subunit polypeptides (by Western blot analysis), and also depressed the H2O2 induced increase in intracellular proteolysis by approximately 95%, without significantly affecting baseline proteolytic rates. Extensive studies revealed only small or no increases in the overall capacity of oxidatively stressed cells to degrade oxidatively modified protein substrates; a finding supported by both Western blot and Northern blot analyses which revealed no significant increase in the levels of proteasome subunit polypeptides or mRNA transcripts. We conclude that mild oxidative stress increases intracellular proteolysis by modifying cellular proteins, thus increasing their proteolytic susceptibility, In contrast, severe oxidative stress diminishes intracellular proteolysis, probably by generating severely damaged cell proteins that cannot be easily degraded (e.g, cross-linked/aggregated proteins), and by damaging proteolytic enzymes, We further conclude that the multicatalytic proteinase complex proteasome is responsible for most of the recognition and selective degradation of oxidatively modified proteins in Clone 9 Liver cells.	ALBANY MED COLL, DEPT BIOCHEM & MOLEC BIOL, ALBANY, NY 12208 USA	Albany Medical College			Reinheckel, Thomas/AAL-9761-2021	Reinheckel, Thomas/0000-0001-9866-9105; Grune, Tilman/0000-0003-4775-9973; Davies, Kelvin/0000-0001-7790-3003	NIEHS NIH HHS [ES-03598] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R23ES003598, R56ES003598, R01ES003598] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AHN JY, 1991, J BIOL CHEM, V266, P15746; ARRIGO AP, 1988, NATURE, V331, P192, DOI 10.1038/331192a0; BAUMEISTER W, 1988, FEBS LETT, V241, P239, DOI 10.1016/0014-5793(88)81069-X; CERVERA J, 1988, FASEB J, V2, P2591, DOI 10.1096/fasebj.2.10.2898411; DAHLMANN B, 1983, FEBS LETT, V160, P243, DOI 10.1016/0014-5793(83)80975-2; DAHLMANN B, 1988, BIOCHEM J, V255, P750; DAHLMANN B, 1985, BIOCHEM J, V228, P171, DOI 10.1042/bj2280171; DAVIES K J A, 1986, Journal of Free Radicals in Biology and Medicine, V2, P155, DOI 10.1016/S0748-5514(86)80066-6; DAVIES KJA, 1987, J BIOL CHEM, V262, P9895; DAVIES KJA, 1993, BIOCHEM SOC T, V21, P346, DOI 10.1042/bst0210346; DAVIES KJA, 1988, FREE RADICAL BIO MED, V5, P215, DOI 10.1016/0891-5849(88)90015-9; DAVIES KJA, 1988, FREE RADICAL BIO MED, V5, P225, DOI 10.1016/0891-5849(88)90016-0; DAVIES KJA, 1987, J BIOL CHEM, V262, P8220; DAVIES KJA, 1987, J BIOL CHEM, V262, P9908; DAVIES KJA, 1987, J BIOL CHEM, V262, P9902; DAVIES KJA, 1987, J BIOL CHEM, V262, P9914; DAVIES KJA, 1987, J BIOL CHEM, V262, P8227; DEAN RT, 1986, BIOCHEM J, V240, P489, DOI 10.1042/bj2400489; DEAN RT, 1993, TRENDS BIOCHEM SCI, V18, P437, DOI 10.1016/0968-0004(93)90145-D; DEMARTINO GN, 1979, J BIOL CHEM, V254, P3712; FALKENBURG PE, 1988, NATURE, V331, P190, DOI 10.1038/331190a0; FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521; FUJIWARA T, 1990, J BIOL CHEM, V265, P16604; FUJIWARA T, 1989, BIOCHEMISTRY-US, V28, P7332, DOI 10.1021/bi00444a028; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; GIULIVI C, 1994, ARCH BIOCHEM BIOPHYS, V311, P329, DOI 10.1006/abbi.1994.1245; GIULIVI C, 1990, J BIOL CHEM, V265, P19453; GIULIVI C, 1993, J BIOL CHEM, V268, P8752; HOUGH R, 1987, J BIOL CHEM, V262, P8303; ISHIURA S, 1985, FEBS LETT, V189, P119, DOI 10.1016/0014-5793(85)80854-1; JENTOFT N, 1979, J BIOL CHEM, V254, P4359; LEVINE RL, 1983, J BIOL CHEM, V258, P1828; LEVINE RL, 1981, P NATL ACAD SCI-BIOL, V78, P2120, DOI 10.1073/pnas.78.4.2120; LEVINE RL, 1983, J BIOL CHEM, V258, P1823; MARCILLAT O, 1988, BIOCHEM J, V254, P677, DOI 10.1042/bj2540677; MATTHEWS W, 1989, P NATL ACAD SCI USA, V86, P2597, DOI 10.1073/pnas.86.8.2597; MCGUIRE MJ, 1989, BIOCHIM BIOPHYS ACTA, V995, P181, DOI 10.1016/0167-4838(89)90078-2; MCGUIRE MJ, 1986, BIOCHIM BIOPHYS ACTA, V873, P279, DOI 10.1016/0167-4838(86)90055-5; MICHIELS C, 1991, TOXICOLOGY, V66, P225, DOI 10.1016/0300-483X(91)90221-L; MURAKAMI K, 1990, FREE RADICAL BIO MED, V8, P217, DOI 10.1016/0891-5849(90)90066-R; NAKAMURA K, 1984, P NATL ACAD SCI-BIOL, V81, P2011, DOI 10.1073/pnas.81.7.2011; ORINO E, 1991, FEBS LETT, V284, P206, DOI 10.1016/0014-5793(91)80686-W; PACIFICI RE, 1993, J BIOL CHEM, V268, P15405; PACIFICI RE, 1989, FREE RADICAL BIO MED, V7, P521, DOI 10.1016/0891-5849(89)90028-2; PACIFICI RE, 1990, METHOD ENZYMOL, V186, P485; RAY K, 1985, P NATL ACAD SCI USA, V82, P7545, DOI 10.1073/pnas.82.22.7545; RIVETT AJ, 1985, J BIOL CHEM, V260, P2600; RIVETT AJ, 1989, ARCH BIOCHEM BIOPHYS, V268, P1, DOI 10.1016/0003-9861(89)90558-4; RIVETT AJ, 1985, J BIOL CHEM, V260, P300; RIVETT AJ, 1993, BIOCHEM J, V291, P1; SALO DC, 1990, J BIOL CHEM, V265, P11919; SALO DC, 1988, FREE RADICAL BIO MED, V5, P335, DOI 10.1016/0891-5849(88)90105-0; SHIMBARA N, 1992, J BIOL CHEM, V267, P18100; TAMURA T, 1991, BIOCHIM BIOPHYS ACTA, V1089, P95, DOI 10.1016/0167-4781(91)90090-9; TAYLOR A, 1987, FREE RADICAL BIO MED, V3, P371, DOI 10.1016/0891-5849(87)90015-3; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WILK S, 1980, J NEUROCHEM, V35, P1172, DOI 10.1111/j.1471-4159.1980.tb07873.x; WOLFF SP, 1986, TRENDS BIOCHEM SCI, V11, P27, DOI 10.1016/0968-0004(86)90228-8; WOLFF SP, 1986, BIOCHEM J, V234, P399, DOI 10.1042/bj2340399	59	380	385	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2344	2351		10.1074/jbc.270.5.2344	http://dx.doi.org/10.1074/jbc.270.5.2344			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836468				2022-12-27	WOS:A1995QE49300056
J	SALZET, M; BULET, P; WATTEZ, C; VERGERBOCQUET, M; MALECHA, J				SALZET, M; BULET, P; WATTEZ, C; VERGERBOCQUET, M; MALECHA, J			STRUCTURAL CHARACTERIZATION OF A DIURETIC PEPTIDE FROM THE CENTRAL-NERVOUS-SYSTEM OF THE LEECH ERPOBDELLA-OCTOCULATA - ANGIOTENSIN-II AMIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THEROMYZON-TESSULATUM OFM; MESSENGER-RNA SEQUENCES; RAT-BRAIN; OXYTOCIN; PHARMACOLOGY; FMRFAMIDE; BALANCE; RENIN	Purification of a material immunoreactive to an antiserum against angiotensin II and present in the central nervous system of the pharyngobdellid leech Erpobdella octoculata was performed by reversed-phase high pressure liquid chromatography combined with both enzyme-linked immunosorbent assay and dot immunobinding assays for angiotensin II. Establishment of the amino acid sequence by Edman degradation, electrospray, and fast atom bombardement mass spectrometry measurements and enzymatic treatment by carboxypeptidase A indicated that this ''central'' angiotensin II-like material, the first one fully characterized in the animal kingdom, is an angiotensin II amide. This finding constitutes also the first biochemical characterization of a peptide of the angiotensin family in an invertebrate. Synthetic angiotensin II amide exerts, when injected in leeches, a diuretic effect and is, 1 and 2 h postinjection, 100-fold more potent than vertebrate angiotensin II. An identification of the proteins immunoreactive to an antiserum against angiotensin II performed at the level of both central nervous system extracts and in vitro central nervous system-translated RNA products indicated that in the two cases, two proteins were detected. Their molecular masses, which were, respectively, similar to 14 and similar to 18 kDa for the central nervous system extracts and similar to 15 and similar to 19 kDa for in vitro central nervous system-translated RNA products, differ from that of angiotensinogen (similar to 60 kDa), the precursor of vertebrate angiotensin II.	INST BIOL MOLEC & CELLULAIRE,CNRS,UPR 9022,F-67084 STRASBOURG,FRANCE	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	SALZET, M (corresponding author), UNIV SCI & TECH LILLE FLANDRES ARTOIS,PHYLOGENIE MOLEC ANNELIDES LAB,CNRS,ER 87,F-59655 VILLENEUVE DASCQ,FRANCE.		Salzet, Michel/A-7675-2011; BULET, Philippe/C-8557-2014	Salzet, Michel/0000-0003-4318-0817; BULET, Philippe/0000-0001-9016-265X				AGUILERA G, 1981, NATURE, V289, P507, DOI 10.1038/289507a0; Cochran WG, 1977, SAMPLING TECHNIQUES, Vthird, P1; DZAU VJ, 1987, AM J CARDIOL, V59, pA59, DOI 10.1016/0002-9149(87)90178-0; DZAU VJ, 1986, HYPERTENSION, V8, P544, DOI 10.1161/01.HYP.8.6.544; GOHLKE P, 1988, J KARDIOL S3, V77, P1; GRAY DA, 1989, J COMP PHYSIOL B, V158, P651, DOI 10.1007/BF00693003; HERMANN K, 1982, EXP BRAIN RES S, V4, P192; KHOSLA MC, 1985, PEPTIDES, V6, P289, DOI 10.1016/0196-9781(85)90388-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LYNCH KR, 1986, HYPERTENSION, V8, P540, DOI 10.1161/01.HYP.8.6.540; MALECHA J, 1983, GEN COMP ENDOCR, V49, P344, DOI 10.1016/0016-6480(83)90198-3; MALECHA J, 1989, CR ACAD SCI III-VIE, V309, P127; MULLER KJ, 1981, NEUROBIOLOGY LEECH, P1; PHILLIPS MI, 1993, REGUL PEPTIDES, V43, P1; PHILLIPS MI, 1985, CIRC RES, V56, P212, DOI 10.1161/01.RES.56.2.212; PHILLIPS MI, 1991, METHODS NEUROSCI, V6, P177; POHL M, 1988, J NEUROCHEM, V51, P1407, DOI 10.1111/j.1471-4159.1988.tb01105.x; SAAVEDRA JM, 1992, ENDOCR REV, V13, P329, DOI 10.1210/er.13.2.329; SALZET M, 1993, EUR J BIOCHEM, V217, P897, DOI 10.1111/j.1432-1033.1993.tb18319.x; SALZET M, 1994, EUR J BIOCHEM, V221, P269, DOI 10.1111/j.1432-1033.1994.tb18738.x; SALZET M, 1993, BRAIN RES, V601, P173, DOI 10.1016/0006-8993(93)91708-Z; SALZET M, 1992, COMP BIOCHEM PHYS C, V102, P483, DOI 10.1016/0742-8413(92)90147-Y; SALZET M, 1992, COMP BIOCHEM PHYS A, V101, P83, DOI 10.1016/0300-9629(92)90632-Z; SALZET M, 1993, BRAIN RES, V631, P247, DOI 10.1016/0006-8993(93)91542-Z; Sambrook J, 1989, MOL CLONING LABORATO; Schooley David A., 1993, Molecular Comparative Physiology, V12, P22; SKEGGS LT, 1956, J EXP MED, V103, P295, DOI 10.1084/jem.103.3.295; VANDERLANDE VM, 1983, J ZOOL, V201, P377; WENNING A, 1993, J EXP BIOL, V182, P81; ZERBSTBOROFFKA I, 1973, J COMP PHYSIOL, V84, P185, DOI 10.1007/BF00697606	30	48	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1575	1582		10.1074/jbc.270.4.1575	http://dx.doi.org/10.1074/jbc.270.4.1575			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829487	hybrid			2022-12-27	WOS:A1995QD20400017
J	JERKINS, AA; LIU, WR; LEE, S; SUL, HS				JERKINS, AA; LIU, WR; LEE, S; SUL, HS			CHARACTERIZATION OF THE MURINE MITOCHONDRIAL GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-KINASE GENE; FATTY-ACID SYNTHASE; CARBOHYDRATE RESPONSE ELEMENT; HORMONAL-REGULATION; MESSENGER-RNAS; 3T3-L1 CELLS; EXPRESSION; LIVER; IDENTIFICATION; FRAGMENTS	Glycerol-3-phosphate acyltransferase (GPAT) catalyzes the acylation of sn-glycerol 3-phosphate to form 1-acyl-sn-glycerol 3-phosphate, a committed step in triacylglycerol and phospholipid biosynthesis, We have previously reported the cDNA cloning and transcriptional regulation of the murine mitochondrial GPAT (mGPAT), We now report the cloning of the 5'-flanking region of the murine mitochondrial GPAT, The transcription start site was identified by primer extension and RNase protection assays, A TATA box-like motif (TTATTAT) was located between -34 and -29 and a reverse CCAAT box (ATTGG) was located between -78 and -74 relative to the transcription start site. To begin studying mechanisms underlying transcriptional regulation of the mGPAT gene, chimeric luciferase (LUG) plasmids containing serial deletions, from -1447 to -38, of the 5'-flanking region of the murine mGPAT gene were prepared and transfected into 3T3-L1 cells, The fusion construct -1447 GPAT.LUC showed high promoter activity and deletions to -1353, -747, -322, and -86 did not markedly change the promoter activity, With all constructs, luciferase activity was 2-fold higher when plasmids were transfected into 3T3-L1 adipocytes, However, deletion of sequences between -86 and -55 resulted in a 9-fold decrease in LUC activity in both preadipocytes and adipocytes. Deletion of sequences between -55 and -38 did not alter promoter activity, DNase I footprint analysis revealed a protected region between -95 and -65 which included the putative CTF/NF1 binding site, Electrophoretic mobility shift assays demonstrated a single protein-DNA complex formation. Oligonucleotides synthesized according to the CTF/NF1 consensus sequence or the adenovirus NF-1 site showed a different and more complex pattern of protein-DNA interaction and were not able to compete away the mGPAT promoter-protein complex, indicating that a distinct protein was bound to -86/-55, a region important for the basal promoter activity in 3T3-L1 cells, Luciferase activity was increased 2.8- and 8-fold when adipocytes stably transfected with -322 GPAT.LUC were treated with 5 and 25 mM glucose, respectively, in the presence of 10 nM insulin. These results indicate that carbohydrate-responsive sequences are located within -322 base pairs of the mGPAT promoter.	UNIV CALIF BERKELEY, DEPT NUTR SCI, BERKELEY, CA 94720 USA; HARVARD UNIV, SCH PUBL HLTH, DEPT NUTR, BOSTON, MA 02115 USA	University of California System; University of California Berkeley; Harvard University; Harvard T.H. Chan School of Public Health			Han, Zaiqi/AAI-2233-2019		NIDDK NIH HHS [DK 36264] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036264] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMY CM, 1990, BIOCHEM J, V271, P675, DOI 10.1042/bj2710675; BELL RM, 1983, ENZYMES, P87; BERGOT MO, 1992, NUCLEIC ACIDS RES, V20, P1871, DOI 10.1093/nar/20.8.1871; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRASIER AR, 1989, BIOTECHNIQUES, V7, P1116; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Brindley D. N, 1991, BIOCH LIPIDS LIPOPRO, P171; BUCHER P, 1986, NUCLEIC ACIDS RES, V14, P10009, DOI 10.1093/nar/14.24.10009; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GEKAKIS N, 1994, BIOCHEMISTRY-US, V33, P1771, DOI 10.1021/bi00173a021; GUERRA MJMD, 1993, MOL CELL BIOL, V13, P7725, DOI 10.1128/MCB.13.12.7725; HENNIGHAUSEN L, 1987, METHOD ENZYMOL, V152, P721; KINGSTON RE, 1989, CURRENT PROTOCOLS MO; LIU ZR, 1993, J BIOL CHEM, V268, P12787; LUO XC, 1989, P NATL ACAD SCI USA, V86, P4042, DOI 10.1073/pnas.86.11.4042; MONROY G, 1972, J BIOL CHEM, V247, P6884; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; PAULAUSKIS JD, 1988, J BIOL CHEM, V263, P7049; RONGNOPARUT P, 1991, J BIOL CHEM, V266, P8086; ROSENTHAL N, 1987, GUIDE MOL CLONING TE, P718; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLOSSMAN DM, 1976, J BIOL CHEM, V251, P5738; SHIH HM, 1994, J BIOL CHEM, V269, P9380; SHIH HM, 1992, J BIOL CHEM, V267, P13222; SHIN DH, 1991, J BIOL CHEM, V266, P23834; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPOEREL NA, 1987, METHOD ENZYMOL, V152, P598; THOMPSON KS, 1991, J BIOL CHEM, V266, P8679; YET SF, 1993, BIOCHEMISTRY-US, V32, P9486, DOI 10.1021/bi00087a029	31	46	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1416	1421		10.1074/jbc.270.3.1416	http://dx.doi.org/10.1074/jbc.270.3.1416			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836409	hybrid			2022-12-27	WOS:A1995QB15600066
J	PAVLOFF, N; POTEMPA, J; PIKE, RN; PROCHAZKA, V; KIEFER, MC; TRAVIS, J; BARR, PJ				PAVLOFF, N; POTEMPA, J; PIKE, RN; PROCHAZKA, V; KIEFER, MC; TRAVIS, J; BARR, PJ			MOLECULAR-CLONING AND STRUCTURAL CHARACTERIZATION OF THE ARG-GINGIPAIN PROTEINASE OF PORPHYROMONAS-GINGIVALIS - BIOSYNTHESIS AS A PROTEINASE-ADHESIN POLYPROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							BLACK-PIGMENTED BACTEROIDES; PROTEASE GENE; COLLAGENASE ACTIVITY; ESCHERICHIA-COLI; PRTC GENE; PERIODONTITIS; DEGRADATION; EXPRESSION; VIRULENT	The identification of proteinases of Porphyromonas gingivalis that act as virulence factors in periodontal disease has important implications in the study of host-pathogen interactions as well as in the discovery of potential therapeutic and immunoprophylactic agents. We have cloned and characterized a gene that encodes the 50-kDa cysteine proteinase gingipain or Arg-gingipain-1 (RGP-1) described previously (Chen, Z., Potempa, J., Polanowski, A., Wikstrom, M., and Travis, J. (1992) J. Biol. Chem,.267, 18896-18901). Analysis of the amino acid sequence of RGP-1 deduced from the cloned DNA sequence showed that the biosynthesis of this proteinase involves processing of a polyprotein that contains multiple adhesin molecules located at its carboxyl terminus, This finding corroborates previous evidence (Pike R., McGraw, W., Potempa, J., and Travis, J. (1994) J. Biol. Chem. 269, 406-411) that RGP-1 is closely associated with adhesin molecules, and that high molecular weight forms of the proteinase are involved in the binding of erythrocytes.	JAGIELLONIAN UNIV,INST MOLEC BIOL,DEPT MICROBIOL & IMMUNOL,PL-31120 KRAKOW,POLAND; UNIV GEORGIA,DEPT BIOCHEM,ATHENS,GA 30602	Jagiellonian University; University System of Georgia; University of Georgia	PAVLOFF, N (corresponding author), LXR BIOTECHNOL INC,1401 MARINA WAY S,RICHMOND,CA 94804, USA.		Prochazka, Vaclav/M-2176-2019	Pike, Robert/0000-0002-2083-0269				ARNOTT MA, 1990, ARCH ORAL BIOL, V35, pS97, DOI 10.1016/0003-9969(90)90137-Y; BEDI GS, 1994, J BIOL CHEM, V269, P599; BOURGEAU G, 1992, INFECT IMMUN, V60, P3186, DOI 10.1128/IAI.60.8.3186-3192.1992; CARLSSON J, 1984, J MED MICROBIOL, V18, P39, DOI 10.1099/00222615-18-1-39; CHEN ZX, 1992, J BIOL CHEM, V267, P18896; GRENIER D, 1987, J CLIN MICROBIOL, V25, P738, DOI 10.1128/JCM.25.4.738-740.1987; GRENIER D, 1992, INFECT IMMUN, V60, P1854, DOI 10.1128/IAI.60.5.1854-1857.1992; IMAMURA T, 1994, J CLIN INVEST, V94, P361, DOI 10.1172/JCI117330; KATO T, 1992, J BACTERIOL, V174, P3889, DOI 10.1128/jb.174.12.3889-3895.1992; KILIAN M, 1981, INFECT IMMUN, V34, P757, DOI 10.1128/IAI.34.3.757-765.1981; KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993; LALA A, 1994, BIOCHEM BIOPH RES CO, V199, P1489, DOI 10.1006/bbrc.1994.1399; Maniatis T., 1982, MOL CLONING; MARSH PD, 1989, FEMS MICROBIOL LETT, V59, P181; OTOGOTO JI, 1993, INFECT IMMUN, V61, P117, DOI 10.1128/IAI.61.1.117-123.1993; PARK Y, 1992, FEMS MICROBIOL LETT, V92, P273, DOI 10.1016/0378-1097(92)90721-Y; PIKE R, 1994, J BIOL CHEM, V269, P406; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SLOTS J, 1977, SCAND J DENT RES, V85, P114; SMALLEY JW, 1989, ORAL MICROBIOL IMMUN, V4, P178, DOI 10.1111/j.1399-302X.1989.tb00249.x; SUNDQVIST G, 1988, ORAL MICROBIOL IMMUN, V3, P103, DOI 10.1111/j.1399-302X.1988.tb00093.x; TAKAHASHI N, 1991, FEMS MICROBIOL LETT, V84, P135; UITTO VJ, 1989, INFECT IMMUN, V57, P213, DOI 10.1128/IAI.57.1.213-218.1989; VANWINKELHOFF AJ, 1988, J CLIN PERIODONTOL, V15, P145; WAXDAL MJ, 1968, BIOCHEMISTRY-US, V7, P1959, DOI 10.1021/bi00845a046; WHITE D, 1981, J PERIODONTAL RES, V16, P259, DOI 10.1111/j.1600-0765.1981.tb00974.x	27	164	181	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1007	1010		10.1074/jbc.270.3.1007	http://dx.doi.org/10.1074/jbc.270.3.1007			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836351	hybrid			2022-12-27	WOS:A1995QB15600006
J	PUCEAT, M; KORICHNEVA, I; CASSOLY, R; VASSORT, G				PUCEAT, M; KORICHNEVA, I; CASSOLY, R; VASSORT, G			IDENTIFICATION OF BAND-3-LIKE PROTEINS AND CL-/HCO3- EXCHANGE IN ISOLATED CARDIOMYOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ERYTHROCYTE MEMBRANE; ANION TRANSPORT-SYSTEM; RAT CARDIAC-CELLS; INDUCED ACIDIFICATION; CHLORIDE TRANSPORT; INTRACELLULAR PH; HEART-CELLS; MYOCYTES; CDNA; H+	The identification of the protein that exerts the function of Cl-/HCO3- exchange is still unresolved in cardiac tissue, We have addressed this issue by using a multiple technical approach, Western blotting analysis with an antibody raised against human erythroid whole band 3 protein, the so-called protein that mediates the Cl-/HCO3- exchange in erythrocytes, showed that adult cardiomyocytes expressed two proteins immunologically related to the erythroid band 3, These proteins migrated in SDS-polyacrylamide gel electrophoresis with apparent molecular masses of 80 and 120 kDa, They were specifically found in the membrane but not in the cytosolic or the myofibril fractions of adult cardiomyocytes. Confocal microscopy further indicated that the immunostained proteins were mainly located at the sarcolemma and along T-tubules, typical membrane structures of adult cardiomyocytes. Using an antibody raised against a cardiac: amino-terminal domain of rat AE3, we found that the 120-kDa protein is the translation product of the AE3 gene specifically expressed in heart and brain, Using an antiserum raised against a specific domain of mouse erythroid band 3 (AE1), which is not shared by AE3, we showed that the 80-kDa protein is likely to be a truncated translation product of the AE1 gene, Microinjection of the anti-human erythroid whole band 3 antibody into single isolated cardiac cells significantly inhibited the Cl-/HCO3-, exchange activity, Furthermore, the anti-AE1 antibody strongly decreased the efficiency of 4,4'-diisothiocyanatostiibene-2,2'-disulfonate to inhibit the ionic exchange, We thus suggest that the 80-kDa or both the 80 and the 120-kDa proteins immunologically related to the erythroid band 3 protein perform the anionic exchange in rat cardiomyocytes.	UNIV PARIS 07,INST JACQUES MONOD,CNRS,UNITE MIXTE RECH 9922,F-75251 PARIS,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	PUCEAT, M (corresponding author), CHU ARNAUD & VILLENEUVE,INSERM,U390,PHYSIOPATHOL CARDIOVASC LAB,F-34295 MONTPELLIER,FRANCE.		PUCEAT, michel/R-6140-2017	PUCEAT, michel/0000-0001-9055-7563				ALPER SL, 1991, ANNU REV PHYSIOL, V53, P549, DOI 10.1146/annurev.physiol.53.1.549; ALPER SL, 1989, P NATL ACAD SCI USA, V86, P5429, DOI 10.1073/pnas.86.14.5429; BENNETT V, 1980, J BIOL CHEM, V255, P6424; BENNETT V, 1990, PHYSIOL REV, V70, P1029, DOI 10.1152/physrev.1990.70.4.1029; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC857, DOI 10.1152/ajpcell.1988.255.6.C857; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROSIUS FC, 1989, J BIOL CHEM, V264, P7784; CABANTCHIK ZI, 1978, BIOCHIM BIOPHYS ACTA, V515, P239; CASSOLY R, 1983, J BIOL CHEM, V258, P3859; CHENG S, 1980, J BIOL CHEM, V255, P2637; DESILETS M, 1994, CIRC RES, V75, P862, DOI 10.1161/01.RES.75.5.862; DESILETS M, 1993, J PHYSIOL-LONDON, V459, pP223; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; DRENCKHAHN D, 1984, EUR J CELL BIOL, V34, P114; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; FLIEGEL L, 1991, FEBS LETT, V279, P25, DOI 10.1016/0014-5793(91)80241-T; FRANK JS, 1992, J CELL BIOL, V117, P337, DOI 10.1083/jcb.117.2.337; FRELIN C, 1984, J BIOL CHEM, V259, P8880; FUNDER J, 1976, J PHYSIOL-LONDON, V262, P679, DOI 10.1113/jphysiol.1976.sp011615; GUNN RB, 1973, J GEN PHYSIOL, V61, P185, DOI 10.1085/jgp.61.2.185; KAY MMB, 1991, P NATL ACAD SCI USA, V88, P2778, DOI 10.1073/pnas.88.7.2778; KAY MMB, 1983, P NATL ACAD SCI-BIOL, V80, P6882, DOI 10.1073/pnas.80.22.6882; KIMURA A, 1992, J BIOCHEM-TOKYO, V112, P220, DOI 10.1093/oxfordjournals.jbchem.a123880; KOPITO RR, 1985, NATURE, V316, P234, DOI 10.1038/316234a0; KOPITO RR, 1989, CELL, V59, P927, DOI 10.1016/0092-8674(89)90615-6; KUDRYCKI KE, 1990, J BIOL CHEM, V265, P462; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGADICGOSSMANN D, 1992, J PHYSIOL-LONDON, V458, P361, DOI 10.1113/jphysiol.1992.sp019422; LEE BS, 1991, J BIOL CHEM, V266, P11448; LINN SC, 1992, J BIOL CHEM, V267, P7927; LIU S, 1990, J GEN PHYSIOL, V96, P1247, DOI 10.1085/jgp.96.6.1247; ORCHARD CH, 1990, AM J PHYSIOL, V258, pC967, DOI 10.1152/ajpcell.1990.258.6.C967; PARDO JV, 1983, J CELL BIOL, V97, P1081, DOI 10.1083/jcb.97.4.1081; PIWNICAWORMS D, 1983, AM J PHYSIOL, V244, pC422, DOI 10.1152/ajpcell.1983.244.5.C422; PUCEAT M, 1991, BIOCHEM J, V274, P55, DOI 10.1042/bj2740055; PUCEAT M, 1991, J PHYSIOL-LONDON, V444, P241, DOI 10.1113/jphysiol.1991.sp018875; PUCEAT M, 1993, J PHYSIOL-LONDON, V459, pP226; PUCEAT M, 1993, AM J PHYSIOL, V264, pH310, DOI 10.1152/ajpheart.1993.264.2.H310; RALEYSUSMAN KM, 1993, BRAIN RES, V614, P308, DOI 10.1016/0006-8993(93)91049-X; SALHANY JM, 1990, ERYTHROCYTE BAND, V3; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VASSEUR C, 1988, PREP BIOCHEM, V18, P293, DOI 10.1080/00327488808062530; VAUGHANJONES RD, 1979, J PHYSIOL-LONDON, V295, P111, DOI 10.1113/jphysiol.1979.sp012957; WHITE RL, 1990, J GEN PHYSIOL, V95, P1061, DOI 10.1085/jgp.95.6.1061	44	50	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1315	1322		10.1074/jbc.270.3.1315	http://dx.doi.org/10.1074/jbc.270.3.1315			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836397	hybrid			2022-12-27	WOS:A1995QB15600052
J	SUGITA, M; BRENNER, MB				SUGITA, M; BRENNER, MB			ASSOCIATION OF THE INVARIANT CHAIN WITH MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I MOLECULES DIRECTS TRAFFICKING TO ENDOCYTIC COMPARTMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; ANTIGEN PRESENTATION; T-CELL; INTRACELLULAR-TRANSPORT; EXOGENOUS ANTIGEN; PEPTIDE; EFFICIENT; PATHWAYS; ANTIBODY; PROTEIN	Major histocompatibility complex (MHC) class I and class II molecules have been shown to present peptides of different origin to alpha beta T cells. Most peptides presented by class I molecules are derived from endogenously synthesized proteins, whereas most peptides presented by class II molecules are from exogenous sources. This functional dichotomy can largely be achieved by the preferential intracellular association of the invariant chain (Ii) with MHC class II molecules, which may inhibit binding of endogenous peptides to class II molecules and direct them to endocytic compartments where extracellularly derived peptides can be sampled. Here, we show that Ii also can associate with a subset of MHC class I molecules and direct them to endocytic compartments. Ii was coprecipitated with class I molecules after lysis of human lymphocytes in mild detergent such as 3-[ (3-cholamidopropyl)dimethylammonio]-1-propane-sulfonic acid or digitonin, and the association was more clearly visualized by the use of dithiobis[succinimidylpropionate], a homobifunctional chemical cross-linker. The class I.Ii complex was reconstituted in Ii negative cells by transfection of corresponding cDNA clones and was found to be transported through the Golgi to acidic endocytic compartments. These observations may explain how same exogenous antigens can be presented by MHC class I molecules and how MHC class II molecules can bind self peptides derived from MHC class I molecules in endocytic compartments.	HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED, DEPT RHEUMATOL & IMMUNOL,LYMPHOCYTE BIOL SECT, BOSTON, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School								AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; ANDERSON KS, 1994, EMBO J, V13, P675, DOI 10.1002/j.1460-2075.1994.tb06306.x; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; BRODSKY FM, 1982, J IMMUNOL, V128, P129; BRODSKY FM, 1979, EUR J IMMUNOL, V9, P536, DOI 10.1002/eji.1830090709; CARBONE FR, 1990, J EXP MED, V171, P377, DOI 10.1084/jem.171.2.377; CERUNDOLO V, 1992, EUR J IMMUNOL, V22, P2243, DOI 10.1002/eji.1830220910; CHEN BP, 1990, J EXP MED, V172, P779, DOI 10.1084/jem.172.3.779; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; CLAESSON L, 1983, P NATL ACAD SCI-BIOL, V80, P7395, DOI 10.1073/pnas.80.24.7395; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DAVID V, 1993, J BIOL CHEM, V268, P9585; DAVIDSON HW, 1991, CELL, V67, P105, DOI 10.1016/0092-8674(91)90575-J; DEGEN E, 1992, J EXP MED, V175, P1653, DOI 10.1084/jem.175.6.1653; ELLIS SA, 1982, HUM IMMUNOL, V5, P49, DOI 10.1016/0198-8859(82)90030-1; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; HAMMERLING GJ, 1990, IMMUNOL TODAY, V11, P337; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; LAMB CA, 1991, P NATL ACAD SCI USA, V88, P5998, DOI 10.1073/pnas.88.14.5998; LAMB CA, 1992, J IMMUNOL, V148, P3478; LAMPSON LA, 1980, J IMMUNOL, V125, P293; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MALNATI MS, 1992, NATURE, V357, P702, DOI 10.1038/357702a0; MARIC MA, 1994, P NATL ACAD SCI USA, V91, P2171, DOI 10.1073/pnas.91.6.2171; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; NEEFJES JJ, 1992, IMMUNOL TODAY, V13, P179, DOI 10.1016/0167-5699(92)90123-O; NUCHTERN JG, 1990, NATURE, V343, P74, DOI 10.1038/343074a0; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; PFEIFER JD, 1993, NATURE, V361, P359, DOI 10.1038/361359a0; QIU Y, 1994, J CELL BIOL, V125, P595, DOI 10.1083/jcb.125.3.595; RAJAGOPALAN S, 1994, J EXP MED, V180, P407, DOI 10.1084/jem.180.1.407; RIBERDY JM, 1992, J IMMUNOL, V148, P2586; ROCHE PA, 1991, P NATL ACAD SCI USA, V88, P3150, DOI 10.1073/pnas.88.8.3150; ROCK KL, 1990, SCIENCE, V249, P918, DOI 10.1126/science.2392683; ROMAGNOLI P, 1993, J EXP MED, V177, P583, DOI 10.1084/jem.177.3.583; SCHREIBER KL, 1994, INT IMMUNOL, V6, P101, DOI 10.1093/intimm/6.1.101; STAM NJ, 1986, J IMMUNOL, V137, P2299; STRUBIN M, 1984, EMBO J, V3, P869, DOI 10.1002/j.1460-2075.1984.tb01898.x; STRUBIN M, 1986, EMBO J, V5, P3483, DOI 10.1002/j.1460-2075.1986.tb04673.x; SUGITA M, 1994, J EXP MED, V180, P2163, DOI 10.1084/jem.180.6.2163; SWANSON J, 1989, METHOD CELL BIOL, V29, P137; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TEYTON L, 1990, NATURE, V348, P39, DOI 10.1038/348039a0; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; VANBLEEK GM, 1990, NATURE, V348, P213; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0; YILLA M, 1993, J BIOL CHEM, V268, P19092	55	83	85	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1443	1448		10.1074/jbc.270.3.1443	http://dx.doi.org/10.1074/jbc.270.3.1443			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836413	hybrid			2022-12-27	WOS:A1995QB15600070
J	WUEBBENS, MM; RAJAGOPALAN, KV				WUEBBENS, MM; RAJAGOPALAN, KV			INVESTIGATION OF THE EARLY STEPS OF MOLYBDOPTERIN BIOSYNTHESIS IN ESCHERICHIA-COLI THROUGH THE USE OF IN-VIVO LABELING STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLYBDENUM COFACTOR BIOSYNTHESIS; SULFITE OXIDASE; XANTHINE-OXIDASE; STRUCTURAL CHARACTERIZATION; C-13-LABELED PRECURSORS; CONVERTING FACTOR; XYLENE RING; RIBOFLAVIN; IDENTIFICATION; PURIFICATION	The early steps in the biosynthesis of the molybdopterin portion of the molybdenum cofactor have been investigated through the use of radiolabeled precursors. Labeled guanosine was added to growing cultures of the molybdopterin-deficient Escherichia coli mutant, moeB, which accumulates large amounts of precursor Z, the final intermediate in molybdopterin biosynthesis (Wuebbens, M. M., and Rajagopalan, K. V. (1993) J. Biol. Chem. 268, 13493-13498). Precursor Z is readily oxidized to the stable, fluorescent pterin, compound Z, which contains all 10 of the carbon atoms present in molybdopterin. For these experiments, compound Z was isolated from both the cells and culture media and analyzed for the presence of label. The development of a method for sequential cleavage of the compound Z side chain carbons facilitated determination of the distribution of label between the ring and the side chain of compound Z. Addition of uniformly labeled [C-14]guanosine to moeB cultures produced compound Z labeled in both the ring and the side chain. Growth on [8-C-14]guanosine resulted in transfer of label to the C-1' position of compound Z. The label present in compound Z purified from cultures grown on [8,5'-H-3]guanosine was lost by removal of the three terminal side chain carbons. These results indicate that although a guanosine compound serves as the initial precursor for molybdopterin biosynthesis, the early steps of this pathway in E. coli proceed via a pathway unlike that of any known pteridine biosynthetic pathway.	DUKE UNIV, MED CTR, DEPT BIOCHEM, DURHAM, NC 27710 USA	Duke University					NIGMS NIH HHS [GM00091] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACHER A, 1983, J BIOL CHEM, V258, P3431; BACHER A, 1985, J AM CHEM SOC, V107, P6380, DOI 10.1021/ja00308a037; Brown G. M., 1985, FOLATES PTERINS, P115; BURG AW, 1968, J BIOL CHEM, V243, P2349; Davis R.H., 1970, METHODS ENZYMOL, V17, P79, DOI [10.1016/0076-6879(71)17168-6, DOI 10.1016/0076-6879(71)17168-6]; FOOR F, 1975, J BIOL CHEM, V250, P3545; FORREST HS, 1954, J AM CHEM SOC, V76, P5658, DOI 10.1021/ja01651a017; GARDLIK S, 1991, J BIOL CHEM, V266, P16627; GARDLIK S, 1991, J BIOL CHEM, V266, P4889; GARDLIK S, 1990, J BIOL CHEM, V265, P13047; JOHNSON JL, 1991, J BIOL CHEM, V266, P12140; JOHNSON JL, 1980, J BIOL CHEM, V255, P1783; JOHNSON JL, 1989, J CLIN INVEST, V83, P897, DOI 10.1172/JCI113974; JOHNSON JL, 1982, P NATL ACAD SCI-BIOL, V79, P6856, DOI 10.1073/pnas.79.22.6856; JOHNSON JL, 1984, J BIOL CHEM, V259, P5414; JOHNSON JL, 1989, J BIOL CHEM, V264, P13440; JOHNSON ME, 1987, J BACTERIOL, V169, P110, DOI 10.1128/jb.169.1.110-116.1987; KRAMER SP, 1987, J BIOL CHEM, V262, P16357; LEVAN Q, 1985, J BACTERIOL, V162, P1280, DOI 10.1128/JB.162.3.1280-1284.1985; LEVY CC, 1964, J BIOL CHEM, V239, P560; LOWRY OH, 1949, J BIOL CHEM, V180, P389; MCNUTT WS, 1961, J AM CHEM SOC, V83, P2303, DOI 10.1021/ja01471a020; MCNUTT WS, 1956, J BIOL CHEM, V219, P365; MCNUTT WS, 1954, J BIOL CHEM, V210, P511; PFLEIDERER W, 1985, FOLATES PTERINS, V2, P43; PITTERLE DM, 1993, J BIOL CHEM, V268, P13499; PITTERLE DM, 1993, J BIOL CHEM, V268, P13506; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; RAJAGOPALAN KV, 1991, ADV ENZYMOL RAMB, V64, P215; REYNOLDS JJ, 1964, J BIOL CHEM, V239, P317; SHANMUGAM KT, 1992, MOL MICROBIOL, V6, P3452, DOI 10.1111/j.1365-2958.1992.tb02215.x; WATT WB, 1967, J BIOL CHEM, V242, P565; WUEBBENS MM, 1993, J BIOL CHEM, V268, P13493; YIM JJ, 1976, J BIOL CHEM, V251, P5087	34	130	133	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1082	1087		10.1074/jbc.270.3.1082	http://dx.doi.org/10.1074/jbc.270.3.1082			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836363	hybrid			2022-12-27	WOS:A1995QB15600018
J	ITOH, K; KASE, R; SHIMMOTO, M; SATAKE, A; SAKURABA, H; SUZUKI, Y				ITOH, K; KASE, R; SHIMMOTO, M; SATAKE, A; SAKURABA, H; SUZUKI, Y			PROTECTIVE PROTEIN AS AN ENDOGENOUS ENDOTHELIN DEGRADATION ENZYME IN HUMAN TISSUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							LYSOSOMAL BETA-GALACTOSIDASE; NEURAMINIDASE DEFICIENCY; CDNA CLONING; GALACTOSIALIDOSIS; EXPRESSION; PEPTIDE; PROTEASES; DEAMIDASE; SYSTEM; CELLS	An enzyme hydrolyzing the carboxyl terminus of endothelin-1 was detected in control human tissues but was deficient in tissues from a patient with galactosialidosis, a metabolic disease caused by the protective protein gene mutation. It was proportional to the amount of immunologically estimated mature protective protein. An antibody against the lysosomal protective protein/beta-galactosidase complex precipitated the enzyme activity almost completely. Transfection of the human cDNA for protective protein resulted in high expression of the enzyme activity in transformed fibroblasts from a galactosialidosis patient, These results indicated that the mature protective protein is a major soluble endogenous endothelin degradation enzyme in human tissues.			ITOH, K (corresponding author), TOKYO METROPOLITAN INST MED SCI,DEPT CLIN GENET,BUNKYO KU,3-18-22 HONKOMAGOME,TOKYO 113,JAPAN.							ABASSI ZA, 1992, HYPERTENSION, V20, P89, DOI 10.1161/01.HYP.20.1.89; AMANO N, 1983, ACTA NEUROPATHOL, V61, P283, DOI 10.1007/BF00691999; BLOCH KD, 1989, J BIOL CHEM, V264, P18156; CHITAYAT D, 1988, AM J MED GENET, V31, P887, DOI 10.1002/ajmg.1320310423; DAZZO A, 1982, P NATL ACAD SCI-BIOL, V79, P4535, DOI 10.1073/pnas.79.15.4535; DENG AY, 1994, J BIOCHEM-TOKYO, V115, P120, DOI 10.1093/oxfordjournals.jbchem.a124285; GALJART NJ, 1988, CELL, V54, P755, DOI 10.1016/S0092-8674(88)90999-3; GALJART NJ, 1990, J BIOL CHEM, V265, P4678; GALJART NJ, 1991, J BIOL CHEM, V266, P14574; GIAID A, 1989, P NATL ACAD SCI USA, V86, P7634, DOI 10.1073/pnas.86.19.7634; HOOGEVEEN AT, 1983, J BIOL CHEM, V258, P2143; ITOH K, 1993, J BIOL CHEM, V268, P1180; JACKMAN HL, 1992, J BIOL CHEM, V267, P2872; JACKMAN HL, 1990, J BIOL CHEM, V265, P11265; KASE R, 1990, BIOCHEM BIOPH RES CO, V172, P1175, DOI 10.1016/0006-291X(90)91572-A; KIMURA S, 1988, BIOCHEM BIOPH RES CO, V156, P1182, DOI 10.1016/S0006-291X(88)80757-5; LEE ME, 1990, J CLIN INVEST, V86, P141, DOI 10.1172/JCI114677; LIAO DI, 1990, J BIOL CHEM, V265, P6528; MACCUMBER MW, 1989, P NATL ACAD SCI USA, V86, P7285, DOI 10.1073/pnas.86.18.7285; NAKAJIMA K, 1989, BIOCHEM BIOPH RES CO, V163, P424, DOI 10.1016/0006-291X(89)92153-0; NANBA E, 1987, BIOCHEM BIOPH RES CO, V144, P138, DOI 10.1016/S0006-291X(87)80486-2; NUNEZ DJR, 1990, J CLIN INVEST, V85, P1537, DOI 10.1172/JCI114601; RANDALL MD, 1991, PHARMACOL THERAPEUT, V50, P73, DOI 10.1016/0163-7258(91)90073-U; SAKURABA H, 1982, CLIN CHIM ACTA, V125, P275; SHIBOUTA Y, 1990, LIFE SCI, V46, P1611; SHIMMOTO M, 1993, J CLIN INVEST, V91, P2393, DOI 10.1172/JCI116472; SIMONSON MS, 1992, J LAB CLIN MED, V119, P622; SIMONSON MS, 1991, HYPERTENSION, V17, P856, DOI 10.1161/01.HYP.17.6.856; SORENSEN SB, 1989, CARLSBERG RES COMMUN, V54, P193, DOI 10.1007/BF02904473; Suzuki Y, 1988, BRAIN DYSFUNCT, V1, P285; Suzuki Y., 1985, DEV BRAIN ITS DISORD, P161; TAKAHASHI Y, 1991, CLIN CHIM ACTA, V203, P199, DOI 10.1016/0009-8981(91)90292-K; TRANCHEMONTAGNE J, 1990, BIOCHEM BIOPH RES CO, V168, P22, DOI 10.1016/0006-291X(90)91669-J; VERHEIJEN FW, 1985, EUR J BIOCHEM, V149, P315, DOI 10.1111/j.1432-1033.1985.tb08928.x; WATANABE T, 1990, NATURE, V344, P114, DOI 10.1038/344114a0; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; YOSHIBAYASHI M, 1991, CIRCULATION, V84, P2280, DOI 10.1161/01.CIR.84.6.2280; YOSHIZAWA T, 1990, SCIENCE, V247, P462, DOI 10.1126/science.2405487	38	60	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					515	518		10.1074/jbc.270.2.515	http://dx.doi.org/10.1074/jbc.270.2.515			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822272	hybrid			2022-12-27	WOS:A1995QB81600004
J	SCHWARZENBACH, H; NEWELL, JW; MATTHIAS, P				SCHWARZENBACH, H; NEWELL, JW; MATTHIAS, P			INVOLVEMENT OF THE ETS FAMILY FACTOR PU.1 IN THE ACTIVATION OF IMMUNOGLOBULIN PROMOTERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN PROMOTER; CELL-TYPE-SPECIFICITY; TRANSCRIPTION FACTOR-I; DNA-SEQUENCE ELEMENTS; HISTONE H2B GENE; CONSERVED SEQUENCE; PROTEIN-BINDING; REGULATES EXPRESSION; ENHANCER ACTIVITY; NUCLEAR FACTOR	The B cell-specific expression of immunoglobulin (Ig) genes is controlled by the concerted action of variable (V) region promoters and intronic or 3' enhancers, all of which are active in a lymphoid-specific manner, A crucial highly conserved element of the V region promoters is the octamer site -ATTTGCAT-, which can be bound by ubiquitous (Oct-1) as well as B cell-specific (Oct-2) factors. Another less conserved element found in many Ig promoters is pyrimidine-rich and has been shown to be functionally important, in particular for those Ig promoters that have only an imperfect octamer site. In this study we have analyzed the factors binding specifically to the pyrimidine-rich motif of the V kappa 19 promoter, a light chain gene promoter with an imperfect octamer site. Using nuclear extracts prepared from B cells, we detected two sets of specific complexes in electrophoretic mobility shift experiments. One complex appears to be ubiquitous but enriched in lymphoid cells and represents the binding of a potentially novel factor with an apparent molecular mass of similar to 50 kDa. The other complex was found only with extracts from pre-B or B cells as well as from a macrophage cell Line and appears to be caused by the binding of PU.1, a factor of the Ets family. We show that on this Ig promoter Oct factors (Oct-1 or Oct-2) and PU.1 can bind concomitantly but without synergism. By transfection experiments in non-B cells we demonstrate that PU.1 is indeed able to activate this promoter in concert with Oct-2. Furthermore, we show that PU.1 can bind with varying affinities to the pyrimidine rich elements of several other Ig promoters. These data suggest a more general role for PU.1 or other members of the Ets family in the activation of Ig promoters.	FRIEDRICH MIESCHER INST,CH-4002 BASEL,SWITZERLAND	Friedrich Miescher Institute for Biomedical Research								ATCHISON ML, 1990, EMBO J, V9, P3109, DOI 10.1002/j.1460-2075.1990.tb07508.x; BALLARD DW, 1986, P NATL ACAD SCI USA, V83, P9626, DOI 10.1073/pnas.83.24.9626; BAUMRUKER T, 1988, GENE DEV, V2, P1400, DOI 10.1101/gad.2.11.1400; BERGMAN Y, 1984, P NATL ACAD SCI-BIOL, V81, P7041, DOI 10.1073/pnas.81.22.7041; BHAT NK, 1987, P NATL ACAD SCI USA, V84, P3161, DOI 10.1073/pnas.84.10.3161; BOHMANN D, 1987, NATURE, V325, P268, DOI 10.1038/325268a0; BOSSELUT R, 1993, NUCLEIC ACIDS RES, V21, P5184, DOI 10.1093/nar/21.22.5184; CHUVPILO S, 1993, NUCLEIC ACIDS RES, V21, P5694, DOI 10.1093/nar/21.24.5694; CORCORAN LM, 1993, GENE DEV, V7, P570, DOI 10.1101/gad.7.4.570; DAVIDSON I, 1986, NATURE, V323, P544, DOI 10.1038/323544a0; DREYFUS M, 1987, EMBO J, V6, P1685, DOI 10.1002/j.1460-2075.1987.tb02418.x; EATON S, 1987, P NATL ACAD SCI USA, V84, P7634, DOI 10.1073/pnas.84.21.7634; EISENBEIS CF, 1993, MOL CELL BIOL, V13, P6452, DOI 10.1128/MCB.13.10.6452; FALKNER FG, 1984, NATURE, V310, P71, DOI 10.1038/310071a0; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; GALSON DL, 1993, MOL CELL BIOL, V13, P2929, DOI 10.1128/MCB.13.5.2929; GERSTER T, 1987, EMBO J, V6, P1323, DOI 10.1002/j.1460-2075.1987.tb02371.x; GERSTER T, 1988, P NATL ACAD SCI USA, V85, P6347, DOI 10.1073/pnas.85.17.6347; GROSSCHEDL R, 1985, CELL, V41, P885, DOI 10.1016/S0092-8674(85)80069-6; HO IC, 1990, SCIENCE, V250, P814, DOI 10.1126/science.2237431; JENUWEIN T, 1991, GENE DEV, V5, P932, DOI 10.1101/gad.5.6.932; KARIM FD, 1990, GENE DEV, V4, P1451, DOI 10.1101/gad.4.9.1451; KATAOKA T, 1982, J BIOL CHEM, V257, P277; KEMLER I, 1989, EMBO J, V8, P2001, DOI 10.1002/j.1460-2075.1989.tb03607.x; KEMLER I, 1991, NUCLEIC ACIDS RES, V19, P237, DOI 10.1093/nar/19.2.237; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; KLEMSZ MJ, 1993, J BIOL CHEM, V268, P5769; KUWABARA MD, 1987, BIOCHEMISTRY-US, V26, P7234, DOI 10.1021/bi00397a006; LABELLA F, 1988, GENE DEV, V2, P32, DOI 10.1101/gad.2.1.32; LANDOLFI NF, 1986, NATURE, V323, P548, DOI 10.1038/323548a0; LEBOWITZ JH, 1989, GENE DEV, V3, P1625, DOI 10.1101/gad.3.10.1625; LEE KH, 1987, J MOL BIOL, V195, P761, DOI 10.1016/0022-2836(87)90482-7; LUO Y, 1992, CELL, V71, P231, DOI 10.1016/0092-8674(92)90352-D; MACLEOD K, 1992, TRENDS BIOCHEM SCI, V17, P251, DOI 10.1016/0968-0004(92)90404-W; MASON JO, 1985, CELL, V41, P479, DOI 10.1016/S0092-8674(85)80021-0; MATHER EL, 1983, P NATL ACAD SCI-BIOL, V80, P4689, DOI 10.1073/pnas.80.15.4689; MATTHIAS P, 1989, NUCLEIC ACIDS RES, V17, P6418, DOI 10.1093/nar/17.15.6418; MOREAUGACHELIN F, 1989, ONCOGENE, V4, P1449; MOULTON KS, 1994, MOL CELL BIOL, V14, P4408, DOI 10.1128/MCB.14.7.4408; MOYNET D, 1985, J IMMUNOL, V135, P727; MULLER MM, 1988, NATURE, V336, P544, DOI 10.1038/336544a0; NAHMIAS C, 1988, J IMMUNOL, V140, P1304; NELSEN B, 1993, SCIENCE, V261, P82, DOI 10.1126/science.8316859; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; OHARE P, 1988, EMBO J, V7, P4231, DOI 10.1002/j.1460-2075.1988.tb03320.x; PAHL HL, 1993, J BIOL CHEM, V268, P5014; PARRY HD, 1989, TRENDS BIOCHEM SCI, V14, P15, DOI 10.1016/0968-0004(89)90083-2; PARSLOW TG, 1984, P NATL ACAD SCI-BIOL, V81, P2650, DOI 10.1073/pnas.81.9.2650; PAUL R, 1991, J VIROL, V65, P464, DOI 10.1128/JVI.65.1.464-467.1991; PETTERSSON M, 1987, GENE DEV, V1, P962, DOI 10.1101/gad.1.9.962; PICARD D, 1985, EMBO J, V4, P2831, DOI 10.1002/j.1460-2075.1985.tb04011.x; PIERANI A, 1990, MOL CELL BIOL, V10, P6204, DOI 10.1128/MCB.10.12.6204; POELLINGER L, 1989, NATURE, V337, P573, DOI 10.1038/337573a0; POELLINGER L, 1989, MOL CELL BIOL, V9, P747, DOI 10.1128/MCB.9.2.747; POGNONEC P, 1989, ONCOGENE, V4, P691; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; PONGUBALA JMR, 1993, SCIENCE, V259, P1622, DOI 10.1126/science.8456286; RAO VN, 1989, SCIENCE, V244, P66, DOI 10.1126/science.2539641; RIVERA RR, 1993, MOL CELL BIOL, V13, P7163, DOI 10.1128/MCB.13.11.7163; SCHEIDEREIT C, 1987, CELL, V51, P783, DOI 10.1016/0092-8674(87)90101-2; SCHIBLER U, 1978, CELL, V15, P1495, DOI 10.1016/0092-8674(78)90072-7; SCHREIBER E, 1989, TISSUE SPECIFIC GENE, P83; SETH A, 1993, ONCOGENE, V8, P1783; SHIN MK, 1993, GENE DEV, V7, P2006, DOI 10.1101/gad.7.10.2006; SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0; SIVE HL, 1986, P NATL ACAD SCI USA, V83, P6382, DOI 10.1073/pnas.83.17.6382; STAUDT LM, 1986, NATURE, V323, P640, DOI 10.1038/323640a0; STERN S, 1989, NATURE, V341, P624, DOI 10.1038/341624a0; STURM R, 1987, GENE DEV, V1, P1147, DOI 10.1101/gad.1.10.1147; THOMPSON CB, 1992, MOL CELL BIOL, V12, P1043, DOI 10.1128/MCB.12.3.1043; WASYLYK B, 1990, NATURE, V346, P191, DOI 10.1038/346191a0; WASYLYK C, 1992, GENE DEV, V6, P965, DOI 10.1101/gad.6.6.965; WASYLYK C, 1991, EMBO J, V10, P1127, DOI 10.1002/j.1460-2075.1991.tb08053.x; WESTIN G, 1987, NUCLEIC ACIDS RES, V15, P6787, DOI 10.1093/nar/15.17.6787; WIRTH T, 1987, NATURE, V329, P174, DOI 10.1038/329174a0	75	55	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					898	907		10.1074/jbc.270.2.898	http://dx.doi.org/10.1074/jbc.270.2.898			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822329	hybrid			2022-12-27	WOS:A1995QB81600063
J	TONG, ZB; NELSON, LM; DEAN, J				TONG, ZB; NELSON, LM; DEAN, J			INHIBITION OF ZONA-PELLUCIDA GENE-EXPRESSION BY ANTISENSE OLIGONUCLEOTIDES INJECTED INTO MOUSE OOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATERNAL MESSENGER-RNAS; SPERM RECEPTOR; DEVELOPMENTAL REGULATION; MONOCLONAL-ANTIBODIES; POLYACRYLAMIDE GELS; OOGENESIS; PROTEINS; BIOSYNTHESIS; TRANSLATION; ZP3	During murine oogenesis, the zona pellucida proteins (ZP1, ZP2, and ZP3) are synthesized and secreted to form an extracellular matrix that surrounds the oocyte and mediates specific biological functions essential to mammalian fertilization and early development. To investigate the relationship among the zona proteins during zona matrix assembly, we have undertaken to inhibit de novo biosynthesis of specific zona proteins with antisense oligonucleotides complementary to the 5'-ends of ZP2 (nucleotide position 19-42) and ZP3 (nucleotide 21-44) mRNAs, When injected into the cytoplasm of growing mouse oocytes, the antisense oligonucleotides targeted specific zona mRNAs for degradation, as confirmed by a RNase protection assay, Individual zona pellucida protein synthesis was followed by immunoprecipitation with ZP2- and ZP3-specific monoclonal antibodies, New zona protein synthesis from the targeted mRNA was abolished, but nontargeted zona protein continued to be synthesized, Interestingly, abolishment of either ZP2 or ZP3 protein synthesis prevented the incorporation of the other protein into the extracellular zona matrix, These results suggest that ZP2 and ZP3 proteins are independent of each other in their biosynthesis but are dependent upon each other for their incorporation into the zona pellucida matrix, This study provides an experimental system in which destruction of a targeted mRNA generates a transient loss-of-expression phenotype during mouse oocyte growth.	NICHHD, DEV ENDOCRINOL BRANCH, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	TONG, ZB (corresponding author), NIDDK, CELLULAR & DEV BIOL LAB,BLDG 6,RM B1-26,6 CTR DR, MSC 2715, BETHESDA, MD 20892 USA.							AGRAWAL S, 1990, P NATL ACAD SCI USA, V87, P1401, DOI 10.1073/pnas.87.4.1401; BACHVAROVA R, 1989, DEVELOPMENT, V106, P561; BEEBE SJ, 1992, DEV BIOL, V151, P48, DOI 10.1016/0012-1606(92)90212-Y; BLEIL JD, 1980, DEV BIOL, V76, P185, DOI 10.1016/0012-1606(80)90371-1; BLEIL JD, 1980, P NATL ACAD SCI-BIOL, V77, P1029, DOI 10.1073/pnas.77.2.1029; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CURCI A, 1991, DEV BIOL, V144, P362, DOI 10.1016/0012-1606(91)90428-6; DASH P, 1987, P NATL ACAD SCI USA, V84, P7896, DOI 10.1073/pnas.84.22.7896; EAST IJ, 1985, DEV BIOL, V109, P268, DOI 10.1016/0012-1606(85)90454-3; EAST IJ, 1984, J CELL BIOL, V98, P795, DOI 10.1083/jcb.98.3.795; GRAVES RA, 1985, P NATL ACAD SCI USA, V82, P5685, DOI 10.1073/pnas.82.17.5685; GREVE JM, 1985, J MOL BIOL, V181, P253, DOI 10.1016/0022-2836(85)90089-0; GREVE JM, 1982, CELL, V31, P749, DOI 10.1016/0092-8674(82)90329-4; GWATKIN RBL, 1967, J REPROD FERTIL, V13, P577; HAINES DS, 1992, BIOTECHNIQUES, V12, P736; HUARTE J, 1987, GENE DEV, V1, P1201, DOI 10.1101/gad.1.10.1201; KINLOCH RA, 1991, J CELL BIOL, V115, P655, DOI 10.1083/jcb.115.3.655; LIANG LF, 1990, MOL CELL BIOL, V10, P1507, DOI 10.1128/MCB.10.4.1507; MANGIA F, 1976, DEV BIOL, V54, P146, DOI 10.1016/0012-1606(76)90293-1; OKEEFE SJ, 1989, P NATL ACAD SCI USA, V86, P7038, DOI 10.1073/pnas.86.18.7038; PAULES RS, 1989, P NATL ACAD SCI USA, V86, P5395, DOI 10.1073/pnas.86.14.5395; PAYNTON BV, 1988, DEV BIOL, V129, P304, DOI 10.1016/0012-1606(88)90377-6; PHILLIPS DM, 1980, J ULTRA MOL STRUCT R, V72, P1, DOI 10.1016/S0022-5320(80)90129-X; PHILPOTT CC, 1987, DEV BIOL, V121, P568, DOI 10.1016/0012-1606(87)90192-8; PROPST F, 1987, MOL CELL BIOL, V7, P1629, DOI 10.1128/MCB.7.5.1629; RINGUETTE MJ, 1988, DEV BIOL, V127, P287, DOI 10.1016/0012-1606(88)90315-6; ROSENTHAL ET, 1987, DEV BIOL, V121, P237, DOI 10.1016/0012-1606(87)90155-2; SALLES FJ, 1992, GENE DEV, V6, P1202, DOI 10.1101/gad.6.7.1202; SALZMANN GS, 1983, EMBO J, V2, P1451, DOI 10.1002/j.1460-2075.1983.tb01607.x; SHIMIZU S, 1982, BIOCHEM BIOPH RES CO, V109, P449, DOI 10.1016/0006-291X(82)91742-9; SHIMIZU S, 1983, J BIOL CHEM, V258, P5858; SHUTTLEWORTH J, 1988, EMBO J, V7, P427, DOI 10.1002/j.1460-2075.1988.tb02830.x; STRICKLAND S, 1988, SCIENCE, V241, P680, DOI 10.1126/science.2456615; WALDER RY, 1988, P NATL ACAD SCI USA, V85, P5011, DOI 10.1073/pnas.85.14.5011	35	40	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					849	853		10.1074/jbc.270.2.849	http://dx.doi.org/10.1074/jbc.270.2.849			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822321	hybrid			2022-12-27	WOS:A1995QB81600055
J	KOLOSHA, VO; MARTIN, SL				KOLOSHA, VO; MARTIN, SL			POLYMORPHIC SEQUENCES ENCODING THE FIRST OPEN READING FRAME PROTEIN FROM LINE-1 RIBONUCLEOPROTEIN-PARTICLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; TRANSPOSABLE ELEMENT; 5' END; RNA; DNA	The mouse LINE-1 (L1) retrotransposon contains two open reading frames (ORFs), Three classes of the protein encoded by the first open reading frame (ORF1) are expressed in the mouse embryonal carcinoma cell Line, F9; the apparent molecular sizes of these proteins are 41.3, 43, and 43.5 kDa. Two of these three proteins (41.3 and 43 kDa) are translated in vitro from full-length, sense strand L1 RNA isolated from ribonucleoprotein particles. A reverse transcription-polymerase chain reaction approach was used to clone the ORF1 region from RNA isolated from ribonucleoprotein particles, then the coding capacity of these clones was examined using in vitro transcription and translation. Multiple sequences that encode ORF1 were recovered by this approach, indicating that multiple loci of L1 in the mouse genome are expressed in F9 cells. In addition, L1 sequences with intact ORF1 regions appear to be selectively enriched in the ribonucleoprotein particles.	UNIV COLORADO, SCH MED, DEPT CELLULAR & STRUCT BIOL, DENVER, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver					NIGMS NIH HHS [GM40367] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040367, R29GM040367] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; DEMERS GW, 1989, J MOL EVOL, V29, P3, DOI 10.1007/BF02106177; DERAGON JM, 1990, EMBO J, V9, P3363, DOI 10.1002/j.1460-2075.1990.tb07537.x; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; HARDIES SC, 1990, UCLA SYM BI, V122, P127; HERRIN DL, 1988, BIOTECHNIQUES, V6, P196; HOLMES SE, 1992, J BIOL CHEM, V267, P19765; HOLMES SE, 1994, NAT GENET, V7, P143, DOI 10.1038/ng0694-143; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; KINGSMORE SF, 1994, NAT GENET, V7, P136, DOI 10.1038/ng0694-136; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LIEBOLD DM, 1990, P NATL ACAD SCI USA, V87, P6990; LOEB DD, 1986, MOL CELL BIOL, V6, P168, DOI 10.1128/MCB.6.1.168; Martin SL, 1991, CURR OPIN GENET DEV, V1, P505, DOI 10.1016/S0959-437X(05)80199-6; MARTIN SL, 1993, MOL CELL BIOL, V13, P5383, DOI 10.1128/MCB.13.9.5383; MARTIN SL, 1991, MOL CELL BIOL, V11, P4804, DOI 10.1128/MCB.11.9.4804; PERLER F, 1980, CELL, V20, P555, DOI 10.1016/0092-8674(80)90641-8; SCHICHMAN SA, 1992, J MOL BIOL, V224, P559, DOI 10.1016/0022-2836(92)90544-T; SHEHEE WR, 1987, J MOL BIOL, V196, P757, DOI 10.1016/0022-2836(87)90402-5; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; [No title captured]	22	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 10	1995	270	6					2868	2873		10.1074/jbc.270.6.2868	http://dx.doi.org/10.1074/jbc.270.6.2868			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QF535	7852362	hybrid			2022-12-27	WOS:A1995QF53500072
J	CREMO, CR; SELLERS, JR; FACEMYER, KC				CREMO, CR; SELLERS, JR; FACEMYER, KC			2 HEADS ARE REQUIRED FOR PHOSPHORYLATION-DEPENDENT REGULATION OF SMOOTH-MUSCLE MYOSIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT CHAIN; HEAVY-MEROMYOSIN; ACTIN-FILAMENTS; GIZZARD MYOSIN; MOVEMENT; SUBFRAGMENT-1; CONFORMATION; PROTEOLYSIS; CONTRACTION; FRAGMENTS	Recent structural evidence (Rayment, I., Holden, H. M., Whittaker, M., Yohn, C. B., Lorenz, M., Holmes, K. C., and Milligan, R. A. (1993) Science 261, 58-65) suggests that the two heads of skeletal muscle myosin interact when the protein is bound to filamentous actin, Direct chemical cross-linking experiments show that the two heads of smooth muscle myosin interact in the presence of filamentous actin and the absence of ATP (Onishi, H., Maita, T., Matsuda, G., and Fujiwara, K. (1992) Biochemistry 31, 1201-1210). Head-head interactions may be important in the mechanism of phosphorylation-dependent regulation of smooth muscle myosin. To explore the structural elements essential for phosphorylation-dependent regulation, we purified a proteolytic fragment of chicken gizzard myosin containing only one head attached to an intact tail. This molecule contained a partially digested regulatory light chain, which was replaced with exogenously added intact light chain in either the thiophosphorylated or the unphosphorylated state, Control experiments showed that this replacement was nearly quantitative and did not alter the actin-activated ATPase of this myosin. Electron micrographs confirmed that the single-headed preparation contained an intact form of single-headed myosin. The unphosphorylated single-headed myosin hydrolyzed ATP rapidly and moved actin filaments in an in vitro motility assay, Phosphorylation had minimal effects upon these properties, Therefore, we conclude that phosphorylation-dependent regulation in this myosin requires two heads. These findings may have important implications in studies of other regulated motor proteins that contain two motor domains.	NHLBI,MOLEC CARDIOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	CREMO, CR (corresponding author), WASHINGTON STATE UNIV,DEPT BIOCHEM & BIOPHYS,PULLMAN,WA 99164, USA.							COOKE R, 1978, J MOL BIOL, V120, P861; FACEMYER KC, 1992, BIOCONJUGATE CHEM, V3, P408, DOI 10.1021/bc00017a009; HARADA Y, 1987, NATURE, V326, P805, DOI 10.1038/326805a0; HARTSHORNE DJ, 1987, PHYSL GASTROINTESTIN, V1, P423; HASEGAWA Y, 1990, J BIOCHEM-TOKYO, V108, P909, DOI 10.1093/oxfordjournals.jbchem.a123313; HOMSHER E, 1992, AM J PHYSIOL, V262, pC714, DOI 10.1152/ajpcell.1992.262.3.C714; IKEBE M, 1982, J BIOCHEM-TOKYO, V91, P1809, DOI 10.1093/oxfordjournals.jbchem.a133874; IKEBE M, 1984, J BIOL CHEM, V259, P1639; IKEBE M, 1985, J BIOL CHEM, V260, P3146; IKEBE M, 1991, J BIOL CHEM, V266, P21339; IKEBE M, 1985, BIOCHEMISTRY-US, V24, P2380, DOI 10.1021/bi00330a038; JACKSON AP, 1988, BIOCHEM J, V251, P515, DOI 10.1042/bj2510515; JAKES R, 1976, FEBS LETT, V70, P229, DOI 10.1016/0014-5793(76)80763-6; KENDRICKJONES J, 1977, EXCITATION CONTRACTI, P348; Lowey S, 1974, J Mechanochem Cell Motil, V2, P241; MARGOSSIAN SS, 1973, J MOL BIOL, V74, P301, DOI 10.1016/0022-2836(73)90375-6; MARGOSSIAN SS, 1984, J BIOL CHEM, V259, P3534; MCLACHLAN AD, 1982, NATURE, V299, P226, DOI 10.1038/299226a0; MORITA JI, 1991, BIOCHEMISTRY-US, V30, P9539, DOI 10.1021/bi00103a022; NATH N, 1982, BIOPHYS J, V37, P47; ONISHI H, 1992, BIOCHEMISTRY-US, V31, P1201, DOI 10.1021/bi00119a033; PERSECHINI A, 1981, SCIENCE, V213, P1383, DOI 10.1126/science.6455737; PERSECHINI A, 1986, J BIOL CHEM, V261, P6293; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P1; SEIDEL JC, 1980, J BIOL CHEM, V255, P4355; Sellers JR, 1991, CURR OPIN CELL BIOL, V3, P98, DOI 10.1016/0955-0674(91)90171-T; SELLERS JR, 1983, J BIOL CHEM, V258, P4181; SELLERS JR, 1981, J BIOL CHEM, V256, P3137; SELLERS JR, 1987, ENZYMES, P381; SHIRINSKY VP, 1992, J BIOL CHEM, V267, P15886; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STAFFORD WF, 1979, BIOCHEMISTRY-US, V18, P5273, DOI 10.1021/bi00591a002; TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445; TRYBUS KM, 1988, J BIOL CHEM, V263, P16485; TRYBUS KM, 1989, J CELL BIOL, V109, P2887, DOI 10.1083/jcb.109.6.2887; TRYBUS KM, 1993, J BIOL CHEM, V268, P4412; TRYBUS KM, 1994, J BIOL CHEM, V269, P20819; TYLER JM, 1980, J ULTRA MOL STRUCT R, V71, P95, DOI 10.1016/S0022-5320(80)90098-2; XIE X, 1994, SCIENCE, V368, P306	40	88	89	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2171	2175		10.1074/jbc.270.5.2171	http://dx.doi.org/10.1074/jbc.270.5.2171			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836446				2022-12-27	WOS:A1995QE49300031
J	PLEY, UM; HILL, BL; ALIBERT, C; BRODSKY, FM; PARHAM, P				PLEY, UM; HILL, BL; ALIBERT, C; BRODSKY, FM; PARHAM, P			THE INTERACTION OF CALMODULIN WITH CLATHRIN-COATED VESICLES, TRISKELIONS, AND LIGHT-CHAINS - LOCALIZATION OF A BINDING-SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCOATING ATPASE; AXONAL-TRANSPORT; CELL-GROWTH; PROTEINS; KINASE; RECOGNITION; DOMAINS; PHOSPHORYLATION; PURIFICATION; SEQUENCES	The binding of clathrin-coated vesicles, clathrin triskelions, and free clathrin light chains to calmodulin-Sepharose was compared, When isolated from bovine brain, all three components bound to calmodulin-Sepharose in the presence of calcium and could be eluted by its removal, In contrast, coated vesicles and triskelions isolated from bovine adrenal gland did not bind to calmodulin-Sepharose, although the free light chains from adrenal gland bound as effectively as those from brain, As distinct isoforms of the clathrin light chains are expressed by brain and adrenal gland, these results implicate the clathrin light chains as the calmodulin-binding component of coated vesicles and triskelions. Furthermore, the insertion sequences found in the neuron-specific isoforms, although not necessary for the binding of free clathrin light chains to calmodulin, must facilitate the interaction of heavy chain-associated light chains with calmodulin, Recombinant mutants of LCa, with deletions spanning the entire sequence, were tested for binding to calmodulin-Sepharose. Those mutants retaining structural integrity, as assessed by the binding of a panel of monoclonal antibodies, exhibited varying amounts of calmodulin binding activity, However, deletion of the carboxyl-terminal 20 residues abolished calmodulin interaction, Thus, the carboxyl terminus of LCa appears to constitute a calmodulin-binding site, Peptides corresponding to the carboxyl terminus of LCa or LCb inhibited the interaction of the light chains with calmodulin, suggesting that this region forms the calmodulin-binding site of both LCa and LCb, The carboxyl-terminal peptides of LCa and LCb inhibited the interaction of light chains with calmodulin similar to 10-fold less effectively than a calmodulin-binding peptide derived from smooth muscle myosin light chain kinase, but much more effectively than a calmodulin-binding peptide derived from adenylate cyclase, This comparison places the clathrin light chain-calmodulin interaction within the physiological range seen for other calmodulin-binding proteins.	STANFORD UNIV,SCH MED,DEPT CELL BIOL,STANFORD,CA 94305; STANFORD UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,STANFORD,CA 94305; UNIV CALIF SAN FRANCISCO,SCH PHARM,DEPT PHARM & PHARMACEUT CHEM,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,SCH MED,DEPT MICROBIOL & IMMUNOL,SAN FRANCISCO,CA 94143	Stanford University; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco				Brodsky, Frances/0000-0002-1334-9258	NIGMS NIH HHS [GM38093] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038093] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARZVI D, 1986, J BIOL CHEM, V261, P9614; BRODSKY FM, 1988, SCIENCE, V242, P1396, DOI 10.1126/science.2904698; BRODSKY FM, 1991, TRENDS BIOCHEM SCI, V16, P208, DOI 10.1016/0968-0004(91)90087-C; BRODSKY FM, 1985, J CELL BIOL, V101, P2047, DOI 10.1083/jcb.101.6.2047; BRODSKY FM, 1983, J CELL BIOL, V96, P911, DOI 10.1083/jcb.96.3.911; BRODSKY FM, 1987, NATURE, V326, P203, DOI 10.1038/326203a0; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; DASGUPTA M, 1989, J BIOL CHEM, V264, P17156; DELUCAFLAHERTY C, 1990, CELL, V62, P875, DOI 10.1016/0092-8674(90)90263-E; DEWAEGH S, 1989, J NEUROSCI RES, V23, P433, DOI 10.1002/jnr.490230409; FISHER PJ, 1994, NATURE, V368, P651, DOI 10.1038/368651a0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JACKSON AP, 1988, J BIOL CHEM, V263, P16688; JACKSON AP, 1987, NATURE, V326, P154, DOI 10.1038/326154a0; KIRCHHAUSEN T, 1987, SCIENCE, V236, P320, DOI 10.1126/science.3563513; KIRCHHAUSEN T, 1983, P NATL ACAD SCI-BIOL, V80, P2481, DOI 10.1073/pnas.80.9.2481; KIRCHHAUSEN T, 1981, CELL, V23, P755, DOI 10.1016/0092-8674(81)90439-6; LADANT D, 1989, J BIOL CHEM, V264, P4015; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDEN CD, 1981, P NATL ACAD SCI USA, V78, P3008; LISANTI MP, 1982, EUR J BIOCHEM, V125, P463, DOI 10.1111/j.1432-1033.1982.tb06706.x; LISANTI MP, 1982, EUR J BIOCHEM, V121, P617, DOI 10.1111/j.1432-1033.1982.tb05830.x; LITTLE AM, 1993, HISTOCOMPATIBILITY T, P159; LUKAS TJ, 1986, BIOCHEMISTRY-US, V25, P1458, DOI 10.1021/bi00354a041; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MERISKO EM, 1988, J BIOL CHEM, V263, P15705; MERISKO EM, 1985, EUR J CELL BIOL, V39, P167; MOOIBROEK MJ, 1987, J BIOL CHEM, V262, P25; MORGAN K, 1985, J BIOL CHEM, V260, P3595; MOSKOWITZ N, 1982, J NEUROCHEM, V38, P1742, DOI 10.1111/j.1471-4159.1982.tb06657.x; NATHKE I, 1990, J BIOL CHEM, V265, P18621; NATHKE IS, 1992, CELL, V68, P899, DOI 10.1016/0092-8674(92)90033-9; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; PARHAM P, 1989, BIOCHEM J, V257, P775, DOI 10.1042/bj2570775; PAYNE GS, 1985, SCIENCE, V230, P1009, DOI 10.1126/science.2865811; PEARSON RB, 1988, SCIENCE, V241, P970, DOI 10.1126/science.3406746; PLEY U, 1993, CRIT REV BIOCHEM MOL, V28, P431, DOI 10.3109/10409239309078441; SCHMID SL, 1984, NATURE, V311, P228, DOI 10.1038/311228a0; SILVEIRA LA, 1990, J CELL BIOL, V111, P1437, DOI 10.1083/jcb.111.4.1437; TYTELL M, 1981, SCIENCE, V214, P179, DOI 10.1126/science.6169148; UNGEWICKELL E, 1985, EMBO J, V4, P3385, DOI 10.1002/j.1460-2075.1985.tb04094.x; UNGEWICKELL E, 1981, NATURE, V289, P420, DOI 10.1038/289420a0; WYLIE DC, 1988, CALMODULIN, P1	43	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 3	1995	270	5					2395	2402		10.1074/jbc.270.5.2395	http://dx.doi.org/10.1074/jbc.270.5.2395			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QE493	7836475	hybrid			2022-12-27	WOS:A1995QE49300063
J	FRICK, DN; BESSMAN, MJ				FRICK, DN; BESSMAN, MJ			CLONING, PURIFICATION, AND PROPERTIES OF A NOVEL NADH PYROPHOSPHATASE - EVIDENCE FOR A NUCLEOTIDE PYROPHOSPHATASE CATALYTIC DOMAIN IN MUTT-LIKE ENZYMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; NUCLEOSIDE TRIPHOSPHATASE; SUBSTRATE; SEQUENCE; PROTEINS; CLEAVAGE; GENE; NMR	An Escherichia coli open reading frame containing significant homology to the active site of the MutT enzyme codes for a novel dinucleotide pyrophosphatase, The motif shared by these two proteins and several others is conserved throughout nature and may designate a nucleotide-binding or pyrophosphatase domain. The E. coli NADH pyrophosphatase has been cloned, overexpressed, and purified to near homogeneity. The protein contains 257 amino acids (M(r) = 29,774) and migrates on gel filtration columns as an apparent dimer. The enzyme catalyzes the hydrolysis of a broad range of dinucleotide pyrophosphates, but uniquely prefers the reduced form of NADH. The V-max/K-m for NADH (69 mu mol min(-1) mg(-1) mM(-1)) is an order of magnitude higher than for any other dinucleotide pyrophosphate tested. In addition, the K-m for NADH (0.1 mM) is 50-fold lower than the K-m for NAD(+). The hydrolysis of dinucleotide pyrophosphates requires divalent metal ions and yields two mononucleoside 5'-phosphates. The metals that most efficiently stimulate activity are Mg2+ and Mn2+. Although these metals support similar V-max values at optimal metal concentration, the apparent K-m for Mg2+ is 3.7 mM (at 1 mM NADH), whereas the apparent K-m for Mn2+ at the same NADH concentration is 30 mu M.	JOHNS HOPKINS UNIV,DEPT BIOL,BALTIMORE,MD 21218; JOHNS HOPKINS UNIV,MCCOLLUM PRATT INST,BALTIMORE,MD 21218	Johns Hopkins University; Johns Hopkins University				Frick, David/0000-0002-2434-7223	NIGMS NIH HHS [GM18649] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMES BN, 1960, J BIOL CHEM, V235, P769; BHATNAGAR SK, 1991, J BIOL CHEM, V266, P9050; BHATNAGAR SK, 1988, J BIOL CHEM, V263, P8953; BULLIONS LC, 1994, J BIOL CHEM, V269, P12339; Cleland W W, 1979, Methods Enzymol, V63, P103; FRICK DN, 1994, J BIOL CHEM, V269, P1794; FRICK DN, 1994, FASEB J, V8, pA1278; JACOBSON KB, 1957, J BIOL CHEM, V226, P427; KALCKAR HM, 1947, J BIOL CHEM, V176, P461; KAMATH AV, 1993, GENE, V134, P99, DOI 10.1016/0378-1119(93)90180-B; KANO Y, 1987, MOL GEN GENET, V209, P408, DOI 10.1007/BF00329674; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P4847, DOI 10.1093/nar/21.20.4847; KORNBERG A, 1950, J BIOL CHEM, V182, P763; KORNBERG A, 1950, J BIOL CHEM, V182, P779; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; MALEY F, 1958, J BIOL CHEM, V233, P1538; MARKHAM R, 1952, BIOCHEM J, V52, P552, DOI 10.1042/bj0520552; MEJEAN V, 1994, MOL MICROBIOL, V11, P323, DOI 10.1111/j.1365-2958.1994.tb00312.x; NAKAJIMA Y, 1973, BIOCHIM BIOPHYS ACTA, V293, P242, DOI 10.1016/0005-2744(73)90397-5; NIKIFORUK G, 1955, METHOD ENZYMOL, V2, P469, DOI 10.1016/S0076-6879(55)02232-5; SAKUMI K, 1993, J BIOL CHEM, V268, P23524; Sambrook J, 1989, MOL CLONING LABORATO; SCHULZ GE, 1992, CURR OPIN STRUC BIOL, V2, P61; SILHAVY TJ, 1984, DNA EXTRACTIONS BACT; WEBER DJ, 1992, J BIOL CHEM, V267, P16939; WEBER DJ, 1993, BIOCHEMISTRY-US, V32, P13081, DOI 10.1021/bi00211a018; YAMASHINA I, 1983, MOL CELL BIOCHEM, V52, P107; YOSHIDA H, 1983, J BIOCHEM-TOKYO, V93, P1641, DOI 10.1093/oxfordjournals.jbchem.a134303	29	82	86	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 27	1995	270	4					1529	1534		10.1074/jbc.270.4.1529	http://dx.doi.org/10.1074/jbc.270.4.1529			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QD204	7829480	hybrid			2022-12-27	WOS:A1995QD20400010
J	GROBLEWSKI, GE; WANG, YL; ERNST, SA; KENT, C; WILLIAMS, JA				GROBLEWSKI, GE; WANG, YL; ERNST, SA; KENT, C; WILLIAMS, JA			CHOLECYSTOKININ STIMULATES THE DOWN-REGULATION OF CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE IN PANCREATIC ACINAR-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; HELA-CELLS; CALYCULIN-A; PHOSPHATIDYLCHOLINE; PHOSPHORYLATION; LOCALIZATION; HYDROLYSIS; BREAKDOWN; ACID	Stimulation of rat pancreatic acinar cells with cholecystokinin (CCK) is known to result in a significant inhibition of CTP:phosphocholine cytidylyltransferase (CT), a rate-limiting enzyme in phosphatidylcholine biosynthesis. Immunoprecipitation of CT from P-32-labeled acinar cells revealed that CCK treatment also caused a marked reduction in CT phosphate levels. The effects of CCK were maximal over 60 min and dependent on concentration, exhibiting an EC(50) of 800 pM. Other calcium mobilizing secretagogues such as carbamylcholine (100 mu M) and bombesin (10 nM) also reduced CT phosphate levels to 20 and 39% of control, respectively, Treatment of cells with thapsigargin and/or 12-O-tetradecanoylphorbol-13-acetate established that a combination of increased intracellular Ca2+ and protein kinase C activation was necessary to decrease phosphorylated CT content. Conversely, secretin (10 nM) or 8-(4-chlorophenylthio) -cAMP (100 mu M) added alone had no effects. Use of the compound JMV-180 indicated CCK was acting through the low affinity state of the CCKA receptor to reduce CT phosphate levels. Further, the decrease in phosphorylated CT caused by CCB was blocked by the phosphatase inhibitors okadaic acid (3 mu M) and calyculin A (100 nM). Finally, immunoblotting from whole cell lysates revealed CT was partially degraded in response to CCK, providing a novel mechanism by which the inhibition of CT enzyme activity occurs in response to the hormone. Moreover, this degradation was also blocked by a phosphatase inhibitor. These data suggest that the dephosphorylation of either CT itself or some other regulatory molecule(s) which mediates the CCH-induced protease activation may play a central role in reducing CT enzyme levels in acinar cells.	UNIV MICHIGAN,SCH MED,DEPT BIOL CHEM,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT ANAT & CELL BIOL,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT INTERNAL MED,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	GROBLEWSKI, GE (corresponding author), UNIV MICHIGAN,SCH MED,DEPT PHYSIOL,7737 MED SCI II,ANN ARBOR,MI 48109, USA.			Williams, John/0000-0002-6063-7615	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK041122, R01DK041122, F32DK008819] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-41122, DK-08819] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; ERNST SA, 1995, AM J PHYSIOL, V267, pC990; EXTON JH, 1990, J BIOL CHEM, V265, P1; GROBLEWSKI GE, 1994, J BIOL CHEM, V269, P15111; HOUWELING M, 1994, J BIOL CHEM, V269, P7544; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; KENT C, 1990, PROG LIPID RES, V29, P87, DOI 10.1016/0163-7827(90)90010-I; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; MATOZAKI T, 1991, J BIOL CHEM, V266, P22246; MATOZAKI T, 1989, J BIOL CHEM, V264, P14729; MATOZAKI T, 1990, J BIOL CHEM, V265, P6247; MEYERALBER A, 1994, BIOCHEM BIOPH RES CO, V201, P1470, DOI 10.1006/bbrc.1994.1869; RIVARD N, 1994, AM J PHYSIOL, V266, pG62, DOI 10.1152/ajpgi.1994.266.1.G62; RUBIN RP, 1992, BIOCHIM BIOPHYS ACTA, V1133, P127, DOI 10.1016/0167-4889(92)90059-K; SANGHERA JS, 1989, J BIOL CHEM, V264, P1215; UTAL AK, 1991, J BIOL CHEM, V266, P24084; WAGNER ACC, 1992, BIOCHEM BIOPH RES CO, V189, P1606, DOI 10.1016/0006-291X(92)90260-R; WAGNER ACC, 1992, AM J PHYSIOL, V262, pC1172; WANG YL, 1993, J BIOL CHEM, V268, P5512; WANG YL, 1993, J BIOL CHEM, V268, P5899; WATKINS JD, 1992, ARCH BIOCHEM BIOPHYS, V292, P360, DOI 10.1016/0003-9861(92)90003-F; WATKINS JD, 1991, J BIOL CHEM, V266, P21113; WATKINS JD, 1992, J BIOL CHEM, V267, P5686; WATKINS JD, 1990, J BIOL CHEM, V265, P2190; WEINHOLD PA, 1992, METHOD ENZYMOL, V209, P248; WEINHOLD PA, 1994, BBA-LIPID LIPID MET, V1210, P335, DOI 10.1016/0005-2760(94)90238-0; WILLIAMS JA, 1993, PHYSIOL REV, V73, P701, DOI 10.1152/physrev.1993.73.4.701; YULE DI, 1994, PHYSL GASTROINTESTIN, P1477	29	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1437	1442		10.1074/jbc.270.3.1437	http://dx.doi.org/10.1074/jbc.270.3.1437			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836412	hybrid			2022-12-27	WOS:A1995QB15600069
J	SHIBATA, N; IKUTA, K; IMAI, T; SATOH, Y; SATOH, R; SUZUKI, A; KOJIMA, C; KOBAYASHI, H; HISAMICHI, K; SUZUKI, S				SHIBATA, N; IKUTA, K; IMAI, T; SATOH, Y; SATOH, R; SUZUKI, A; KOJIMA, C; KOBAYASHI, H; HISAMICHI, K; SUZUKI, S			EXISTENCE OF BRANCHED SIDE-CHAINS IN THE CELL-WALL MANNAN OF PATHOGENIC YEAST, CANDIDA-ALBICANS - STRUCTURE-ANTIGENICITY RELATIONSHIP BETWEEN THE CELL-WALL MANNANS OF CANDIDA-ALBICANS AND CANDIDA-PARAPSILOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIH B-792 STRAIN; PHOSPHO-D-MANNAN; SEROTYPE-A; ENZYME-IMMUNOASSAY; OLIGOMANNOSYL RESIDUES; MONOCLONAL-ANTIBODIES; NIH-B-792 STRAIN; SACCHAROMYCES-CEREVISIAE; INVASIVE CANDIDIASIS; SUPPRESSOR CELLS	Isolation of side chain oligosaccharides from mannans of Candida albicans NIH B-792 (serotype B) and Candida parapsilosis IFO 1396 strains has been conducted by acetolysis under mild conditions. Structural study of these oligosaccharides by H-1 and C-13 NMR and methylation analyses indicated the presence of novel branched side chains with the following structures in C. albicans mannan. GRAPHICS It was observed that the H-1 proton chemical shifts of the second and the third mannose units from the reducing terminus in each oligosaccharide are shifted upfield by substitution with an alpha-linked mannose unit at position 6 of the 3-O-substituted mannose unit. An agglutination inhibition assay between factor 4 serum and cells of Candida stellatoidea IFO 1397 lacking the beta-1,2-linked mannose unit, with oligosaccharides obtained from these mannans, indicated that only the branched oligosaccharides were active. This finding suggests that the branched oligosaccharides correspond to the epitope of antigenic factor 4, The presence of the branched structure in other mannans was detected by the characteristic H-1-H-2-correlated cross-peak of the alpha-1,2-linked mannose unit connected with the 3,6-di-O-substituted one by two-dimensional homonuclear Hartmann-Hahn spectroscopy.	TOHOKU COLL PHARMACEUT SCI, DEPT HYG CHEM 2, SENDAI, MIYAGI 981, JAPAN; TOHOKU COLL PHARMACEUT SCI, DEPT MED CHEM 1, SENDAI, MIYAGI 981, JAPAN	Tohoku Medical & Pharmaceutical University; Tohoku Medical & Pharmaceutical University								AMES BN, 1960, J BIOL CHEM, V235, P769; BALLOU L, 1989, J BIOL CHEM, V264, P11857; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; CARROW EW, 1985, INFECT IMMUN, V49, P172, DOI 10.1128/IAI.49.1.172-181.1985; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; COHEN RE, 1980, BIOCHEMISTRY-US, V19, P4345, DOI 10.1021/bi00559a031; CUFF CF, 1986, CELL IMMUNOL, V100, P47, DOI 10.1016/0008-8749(86)90005-5; DOMER JE, 1986, CELL IMMUNOL, V101, P403, DOI 10.1016/0008-8749(86)90153-X; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; DURANDY A, 1987, J CLIN IMMUNOL, V7, P400, DOI 10.1007/BF00917018; FUNAYAMA M, 1984, MICROBIOL IMMUNOL, V28, P1359, DOI 10.1111/j.1348-0421.1984.tb00794.x; FUNAYAMA M, 1983, CARBOHYD RES, V117, P229, DOI 10.1016/0008-6215(83)88089-6; GARCIADELOMAS J, 1988, MYCOPATHOLOGIA, V102, P175, DOI 10.1007/BF00437401; GARNER RE, 1990, INFECT IMMUN, V58, P2613, DOI 10.1128/IAI.58.8.2613-2620.1990; HASE S, 1984, J BIOCHEM-TOKYO, V95, P197, DOI 10.1093/oxfordjournals.jbchem.a134585; HASE S, 1988, J CHROMATOGR, V434, P15; HASENCLEVER H, 1961, J BACTERIOL, V82, P570, DOI 10.1128/JB.82.4.570-573.1961; HEARN VM, 1993, STRUCTURE ANTIGENS, P211; HERNANDEZ LM, 1989, J BIOL CHEM, V264, P13648; HUNTER SW, 1990, J BIOL CHEM, V265, P9272; KAGAYA K, 1989, J IMMUNOL, V143, P3353; KANBE T, 1994, INFECT IMMUN, V62, P1662, DOI 10.1128/IAI.62.5.1662-1668.1994; KOBAYASHI H, 1992, INFECT IMMUN, V60, P2106, DOI 10.1128/IAI.60.5.2106-2109.1992; KOBAYASHI H, 1991, BIOCHEM BIOPH RES CO, V175, P1003, DOI 10.1016/0006-291X(91)91664-X; KOBAYASHI H, 1989, ARCH BIOCHEM BIOPHYS, V272, P364, DOI 10.1016/0003-9861(89)90230-0; KOBAYASHI H, 1990, ARCH BIOCHEM BIOPHYS, V278, P195, DOI 10.1016/0003-9861(90)90248-W; KOCOUREK J, 1969, J BACTERIOL, V100, P1175, DOI 10.1128/JB.100.3.1175-1181.1969; KOGAN G, 1988, CARBOHYD RES, V172, P243, DOI 10.1016/S0008-6215(00)90858-9; KOGAN G, 1990, CARBOHYD POLYM, V14, P65, DOI 10.1016/0144-8617(90)90007-F; KORTING HC, 1988, J CLIN MICROBIOL, V26, P2626, DOI 10.1128/JCM.26.12.2626-2631.1988; LEHMANN PF, 1980, MYCOPATHOLOGIA, V70, P83, DOI 10.1007/BF00443072; LEMIEUX C, 1990, J CLIN MICROBIOL, V28, P249, DOI 10.1128/JCM.28.2.249-253.1990; LEW MA, 1982, J INFECT DIS, V145, P45, DOI 10.1093/infdis/145.1.45; LI RK, 1993, J BIOL CHEM, V268, P18293; MIYAKAWA Y, 1992, INFECT IMMUN, V60, P2493, DOI 10.1128/IAI.60.6.2493-2499.1992; MIYAKAWA Y, 1986, J CLIN MICROBIOL, V23, P881, DOI 10.1128/JCM.23.5.881-886.1986; NAKAMURA A, 1991, J CLIN MICROBIOL, V29, P2363, DOI 10.1128/JCM.29.11.2363-2367.1991; NELSON RD, 1991, CLIN MICROBIOL REV, V4, P1; NELSON RD, 1984, INFECT IMMUN, V43, P1041, DOI 10.1128/IAI.43.3.1041-1046.1984; NNALUE NA, 1991, INFECT IMMUN, V59, P229, DOI 10.1128/IAI.59.1.229-233.1991; Odds FC., 1988, CANDIDA CANDIDOSIS; OKAWA Y, 1994, FEBS LETT, V345, P167, DOI 10.1016/0014-5793(94)00434-X; OXLEY D, 1991, CARBOHYD RES, V212, P213, DOI 10.1016/0008-6215(91)84058-M; PODZORSKI RP, 1990, J IMMUNOL, V144, P707; REISS E, 1981, BIOMED MASS SPECTROM, V8, P252, DOI 10.1002/bms.1200080605; REISS E, 1986, J CLIN MICROBIOL, V24, P796, DOI 10.1128/JCM.24.5.796-802.1986; REISS E, 1982, CLIN CHEM, V28, P306; SHIBATA N, 1985, ARCH BIOCHEM BIOPHYS, V243, P338, DOI 10.1016/0003-9861(85)90511-9; SHIBATA N, 1992, INFECT IMMUN, V60, P4100, DOI 10.1128/IAI.60.10.4100-4110.1992; SHIBATA N, 1993, ARCH BIOCHEM BIOPHYS, V302, P113, DOI 10.1006/abbi.1993.1188; SHIBATA N, 1992, BIOCHEMISTRY-US, V31, P5680, DOI 10.1021/bi00139a036; SHIBATA N, 1989, CARBOHYD RES, V187, P239, DOI 10.1016/0008-6215(89)80006-0; SHIBATA N, 1993, EUR J BIOCHEM, V217, P1, DOI 10.1111/j.1432-1033.1993.tb18211.x; SHIBATA N, 1991, ARCH BIOCHEM BIOPHYS, V290, P535, DOI 10.1016/0003-9861(91)90578-7; SHIBATA N, 1986, ARCH BIOCHEM BIOPHYS, V251, P697, DOI 10.1016/0003-9861(86)90379-6; SUZUKI M, 1982, MICROBIOL IMMUNOL, V26, P387, DOI 10.1111/j.1348-0421.1982.tb00189.x; SUZUKI S, 1991, FUNGAL CELL WALL IMM, P111; TOJO M, 1990, CARBOHYD RES, V199, P215, DOI 10.1016/0008-6215(90)84263-T; TSUCHIYA T, 1974, MYCOPATH MYCOL APPL, V53, P77, DOI 10.1007/BF02127199	59	122	122	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	1995	270	3					1113	1122		10.1074/jbc.270.3.1113	http://dx.doi.org/10.1074/jbc.270.3.1113			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB156	7836369	hybrid			2022-12-27	WOS:A1995QB15600024
J	MOUSTAKAS, A; TAKUMI, T; LIN, HY; LODISH, HF				MOUSTAKAS, A; TAKUMI, T; LIN, HY; LODISH, HF			GH3 PITUITARY-TUMOR CELLS CONTAIN HETEROMERIC TYPE-I AND TYPE-II RECEPTOR COMPLEXES FOR TRANSFORMING GROWTH-FACTOR-BETA AND ACTIVIN-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE SERINE KINASE; RAT GRANULOSA-CELLS; TGF-BETA; XENOPUS EMBRYOS; EXPRESSION CLONING; THREONINE KINASE; INHIBIN; MESODERM; DIFFERENTIATION; PURIFICATION	Transforming growth factors beta (TGF-beta s) and activins induce and inhibins block secretion of follicle-stimulating hormone by rat GH3 pituitary tumor cells. Cheifetz et al. (Cheifetz, S., Ling, N., Guillemin, R., and Massague, J. (1988) J. Biol. Chem. 263, 17225-17228) reported that GH3 cells express a similar to 50-kDa surface protein, termed the type IV TGF-beta receptor, that directly binds all of these peptide hormones. Here we show that GH3 cells express the previously identified type I and type II receptors for TGF-beta and activin-A. Immunoprecipitation of affinity-labeled surface binding proteins with antisera specific to known receptors demonstrated independent heteromeric complexes of TGF-beta types I and II receptors and of activin types I and II receptors. As judged by ligand-binding and cross linking analysis, TGF-beta binding to the TGF-beta receptors is not inhibited by activin-A and activin-A binding to its receptors is not inhibited by TGF-beta. Screening of a cDNA library from GH3 cells for potential receptor serine-threonine kinases yielded the known types I and II TGF-beta and activin receptors. The presumed common intracellular signaling pathway for TGF-beta and activin in GH3 cells appears to be mediated by distinct cell-surface receptors.	WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA 02142 USA; MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)					NCI NIH HHS [CA-63260] Funding Source: Medline; NHLBI NIH HHS [HL 41484] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA063260] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041484] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; BARNETT JV, 1994, DEV DYNAM, V199, P12, DOI 10.1002/aja.1001990103; BASSING CH, 1994, SCIENCE, V263, P87, DOI 10.1126/science.8272871; BASSING CH, 1994, J BIOL CHEM, V269, P14861; BRAND T, 1993, J BIOL CHEM, V268, P11500; BUSHAN A, 1994, MOL CELL BIOL, V14, P4280; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; CHEIFETZ S, 1988, J BIOL CHEM, V263, P17225; CHEN RH, 1993, SCIENCE, V260, P1335, DOI 10.1126/science.8388126; DODSON WC, 1987, ENDOCRINOLOGY, V120, P512, DOI 10.1210/endo-120-2-512; EBNER R, 1993, SCIENCE, V262, P900, DOI 10.1126/science.8235612; EBNER R, 1993, SCIENCE, V260, P1344, DOI 10.1126/science.8388127; ETO Y, 1987, BIOCHEM BIOPH RES CO, V142, P1095, DOI 10.1016/0006-291X(87)91528-2; FILVAROFF EH, 1994, DEVELOPMENT, V120, P1085; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; GONZALEZMANCHON C, 1989, ENDOCRINOLOGY, V125, P1666, DOI 10.1210/endo-125-3-1666; HARLOW E, 1988, ANTIBODIES LABORATOR, P78; HEMMATIBRIVANLOU A, 1994, CELL, V77, P273, DOI 10.1016/0092-8674(94)90319-0; HEMMATIBRIVANLOU A, 1992, NATURE, V359, P609, DOI 10.1038/359609a0; HENIS YI, 1994, J CELL BIOL, V126, P139, DOI 10.1083/jcb.126.1.139; INAGAKI M, 1993, P NATL ACAD SCI USA, V90, P5359, DOI 10.1073/pnas.90.11.5359; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; KNECHT M, 1987, ENDOCRINOLOGY, V120, P1243, DOI 10.1210/endo-120-4-1243; Lin Herbert Y., 1993, Trends in Cell Biology, V3, P14, DOI 10.1016/0962-8924(93)90195-7; LIN HY, 1994, CELL MOL BIOL, V40, P337; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; LING N, 1986, NATURE, V321, P779, DOI 10.1038/321779a0; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; MATHEWS LS, 1992, SCIENCE, V255, P1702, DOI 10.1126/science.1313188; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; MIYAZONO K, 1994, ADV IMMUNOL, V55, P181; MOUSTAKAS A, 1993, J BIOL CHEM, V268, P22215; NISHIMATSU S, 1992, FEBS LETT, V312, P169, DOI 10.1016/0014-5793(92)80928-A; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, V95, P421; RUSCETTI F W, 1991, Progress in Growth Factor Research, V3, P159, DOI 10.1016/S0955-2235(05)80006-7; SMITH JC, 1993, EMBO J, V12, P4463, DOI 10.1002/j.1460-2075.1993.tb06135.x; TAKUMI T, 1994, IN PRESS BIOTECHNIQU; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; THOMSEN G, 1990, CELL, V63, P485, DOI 10.1016/0092-8674(90)90445-K; TSUCHIDA K, 1993, BIOCHEM BIOPH RES CO, V191, P790, DOI 10.1006/bbrc.1993.1286; TSUCHIDA K, 1993, P NATL ACAD SCI USA, V90, P11242, DOI 10.1073/pnas.90.23.11242; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; Vale W., 1990, HDB EXPT PHARM, P211; WEISER R, 1993, MOL CELL BIOL, V13, P7239; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; XIE T, 1994, SCIENCE, V263, P1756, DOI 10.1126/science.8134837; YING SY, 1986, BIOCHEM BIOPH RES CO, V135, P950, DOI 10.1016/0006-291X(86)91020-X; YING SY, 1986, BIOCHEM BIOPH RES CO, V136, P969, DOI 10.1016/0006-291X(86)90427-4	51	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					765	769		10.1074/jbc.270.2.765	http://dx.doi.org/10.1074/jbc.270.2.765			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822308	hybrid			2022-12-27	WOS:A1995QB81600042
J	MUMMANENI, P; WALKER, KA; BISHOP, PL; TURKER, MS				MUMMANENI, P; WALKER, KA; BISHOP, PL; TURKER, MS			EPIGENETIC GENE INACTIVATION INDUCED BY A CIS-ACTING METHYLATION CENTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; STEM-CELLS; APRT GENE; PATTERNS; EXPRESSION; LINE	In this report we test the hypothesis that a cis-acting methylation center can induce epigenetic gene inactivation. The cis-acting element used is an 838-base pair fragment that was shown previously to provide a de novo methylation signal (Mummaneni, P., Bishop, P. L., and Turker, M. S. (1993) J. Biol. Chem. 268, 552-558). Its normal location is approximately 1.3 kilobase pairs upstream of the mouse aprt (adenine phosphoribosyltransferase) gene. To determine if the methylation center could induce inactivation of the aprt gene, a plasmid construct was created in which the methylation center was moved next to the aprt promoter. Transfection experiments demonstrated inactivation of the aprt gene on the hybrid construct. The inactivation event was shown with a Southern blot analysis to correlate with hypermethylation and to be reversible by treatment with 2-deoxy-5'-azacytidine, a demethylating agent, Interestingly, gene inactivation induced by the methylation center required truncation of the aprt promoter. The results demonstrate that epigenetic gene inactivation can be induced by a DNA methylation center.	UNIV KENTUCKY,MARKEY CANC CTR,DEPT PATHOL,LEXINGTON,KY 40536; UNIV KENTUCKY,DEPT MICROBIOL & IMMUNOL,LEXINGTON,KY 40536	University of Kentucky; University of Kentucky				Walker, Kimberly A/0000-0002-6360-2792	NATIONAL CANCER INSTITUTE [R01CA056383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG008199] Funding Source: NIH RePORTER; NCI NIH HHS [CA56383] Funding Source: Medline; NIA NIH HHS [AG08199] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAYLIN SB, 1991, CANCER CELL-MON REV, V3, P383; Bestor TH, 1993, J NIH RES, V5, P57; BOYCE J, 1992, EMBO J, V11, P327; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; COOPER GE, 1992, SOMAT CELL MOLEC GEN, V18, P215, DOI 10.1007/BF01233858; COOPER GE, 1993, SOMAT CELL MOLEC GEN, V19, P221, DOI 10.1007/BF01233070; DUSH MK, 1988, NUCLEIC ACIDS RES, V16, P8509, DOI 10.1093/nar/16.17.8509; HANSEN RS, 1992, HUM MOL GENET, V1, P571, DOI 10.1093/hmg/1.8.571; HARRINGTON MA, 1988, P NATL ACAD SCI USA, V85, P2066, DOI 10.1073/pnas.85.7.2066; HASSE A, 1994, J BIOL CHEM, V269, P1821; Jones PA, 1984, DNA METHYLATION BIOC, P165; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; LIU WM, 1993, NUCLEIC ACIDS RES, V21, P1351, DOI 10.1093/nar/21.6.1351; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; MAGEWU AN, 1994, MOL CELL BIOL, V14, P4225, DOI 10.1128/MCB.14.6.4225; MUMMANENI P, 1993, J BIOL CHEM, V268, P552; RAZIN A, 1991, MICROBIOL REV, P451; ROYERPOKORA B, 1992, GENE CHROMOSOME CANC, V5, P132, DOI 10.1002/gcc.2870050207; SAKAI T, 1991, AM J HUM GENET, V48, P880; Singer-Sam J., 1993, DNA methylation: molecular biology and biological significance., P358; SZYF M, 1990, MOL CELL BIOL, V10, P4396, DOI 10.1128/MCB.10.8.4396; SZYF M, 1991, BIOCHEM CELL BIOL, V69, P764, DOI 10.1139/o91-117; TURKER MS, 1991, SOMAT CELL MOLEC GEN, V17, P151, DOI 10.1007/BF01232972; TURKER MS, 1984, SOMAT CELL MOLEC GEN, V10, P55, DOI 10.1007/BF01534473; TURKER MS, 1989, J BIOL CHEM, V264, P11632; TURKER MS, 1995, IN PRESS ADV EXP MED	27	69	71	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					788	792		10.1074/jbc.270.2.788	http://dx.doi.org/10.1074/jbc.270.2.788			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822312	hybrid			2022-12-27	WOS:A1995QB81600046
J	OSUNA, J; VIADIU, H; FINK, AL; SOBERON, X				OSUNA, J; VIADIU, H; FINK, AL; SOBERON, X			SUBSTITUTION OF ASP FOR ASN AT POSITION-132 IN THE ACTIVE-SITE OF TEM BETA-LACTAMASE - ACTIVITY TOWARD DIFFERENT SUBSTRATES AND EFFECTS OF NEIGHBORING RESIDUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-LICHENIFORMIS 749/C; STAPHYLOCOCCUS-AUREUS PC1; ACYL-ENZYME INTERMEDIATE; DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; RESOLUTION; HYDROLYSIS; LYSINE-234; CATALYSIS; MUTATION	Using a random, combinatorial scheme of mutagenesis directed against the conserved SDN region of TEM beta-lactamase, and selective screening in ampicillin-plates, we obtained the N132D mutant enzyme. The kinetic characterization of this mutant indicated relatively small effects compared to the wild-type, Both pK(1) and pK(2) for catalysis were decreased about 1 unit relative to the pK's for the wild type. This effect was predominantly due to changes in K-m. In contrast to the wild-type, the pH-rate profiles of the mutant showed that K-m for several side chain containing penicillin substrates increases when the pH is above 5.5. 6-Aminopenicillanic acid, which lacks a side chain, did not show this effect. With benzylpenicillin, ampicillin, and carbenicillin, k(cat) for the mutant showed a similar pH dependence as the wild type. With 6-aminopenicillanic acid, k(cat) for the mutant was greater than that for the wild type, The nature of the 104 side chain may affect the environment of Asp(132); double mutants N132D/E104X (where X can be Q or N) are unable to confer antibiotic resistance to bacterial cells. The computed contact interactions from modeling substrate complexes between benzylpenicillin or 6-aminopenicillanic acid with the N132D mutant confirmed the importance of the protonation state of residue Asp(132) for the complex stability with side chain containing substrates. The data indicate that the contact between the side chain of residue 132 and the substrate is relevant for the ground state recognition, but because of close contact with several important groups in its neighborhood, residue 132 is also indirectly involved in the catalytic step of the wild-type enzyme.	UNIV NACL AUTONOMA MEXICO, INST BIOTECNOL, CUERNAVACA 62271, MORELOS, MEXICO; UNIV CALIF SANTA CRUZ, DEPT CHEM & BIOCHEM, SANTA CRUZ, CA 95064 USA	Universidad Nacional Autonoma de Mexico; University of California System; University of California Santa Cruz			Soberon, Xavier/A-8826-2008; Viadiu, Hector/E-7785-2013	Osuna, Joel/0000-0002-8904-0724				ADACHI H, 1991, J BIOL CHEM, V266, P3186; AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; BRANNIGAN J, 1991, BIOCHEM J, V278, P673, DOI 10.1042/bj2780673; CHEN CCH, 1992, J MOL BIOL, V224, P1103, DOI 10.1016/0022-2836(92)90472-V; CHEN CCH, 1993, J MOL BIOL, V234, P165, DOI 10.1006/jmbi.1993.1571; DELAIRE M, 1991, PROTEIN ENG, V4, P805, DOI 10.1093/protein/4.7.805; ELLERBY LM, 1990, BIOCHEMISTRY-US, V29, P5797, DOI 10.1021/bi00476a022; ESCOBAR WA, 1991, BIOCHEMISTRY-US, V30, P10783, DOI 10.1021/bi00108a025; HARDY LW, 1984, BIOCHEMISTRY-US, V23, P1288, DOI 10.1021/bi00301a042; HERZBERG O, 1987, SCIENCE, V236, P694, DOI 10.1126/science.3107125; HERZBERG O, 1991, J MOL BIOL, V217, P701, DOI 10.1016/0022-2836(91)90527-D; HERZBERG O, 1991, BIOCHEMISTRY-US, V30, P9503, DOI 10.1021/bi00103a017; Herzberg O, 1991, CURR OPIN STRUC BIOL, V1, P946, DOI 10.1016/0959-440X(91)90090-G; JACOB F, 1990, PROTEIN ENG, V4, P79, DOI 10.1093/protein/4.1.79; JACOB F, 1990, BIOCHEM J, V271, P399, DOI 10.1042/bj2710399; JELSCH C, 1993, PROTEINS, V16, P364, DOI 10.1002/prot.340160406; JUTEAU JM, 1992, PROTEIN ENG, V5, P693, DOI 10.1093/protein/5.7.693; KNOX JR, 1991, J MOL BIOL, V220, P435, DOI 10.1016/0022-2836(91)90023-Y; KNOX JR, 1993, PROTEIN ENG, V6, P11, DOI 10.1093/protein/6.1.11; LENFANT F, 1991, J BIOL CHEM, V266, P17187; MERINO E, 1992, BIOTECHNIQUES, V12, P508; MOEWS PC, 1990, PROTEINS, V7, P156, DOI 10.1002/prot.340070205; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; WALEY SG, 1974, BIOCHEM J, V139, P789, DOI 10.1042/bj1390789	24	26	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	1995	270	2					775	780		10.1074/jbc.270.2.775	http://dx.doi.org/10.1074/jbc.270.2.775			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QB816	7822310	hybrid			2022-12-27	WOS:A1995QB81600044
J	ALLEN, LA; ZHAO, XJ; CAUGHEY, W; POYTON, RO				ALLEN, LA; ZHAO, XJ; CAUGHEY, W; POYTON, RO			ISOFORMS OF YEAST CYTOCHROME-C-OXIDASE SUBUNIT-V AFFECT THE BINUCLEAR REACTION-CENTER AND AFTER THE KINETICS OF INTERACTION WITH THE ISOFORMS OF YEAST CYTOCHROME-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; INFRARED-SPECTRA; CATALYTIC SITE; IONIC-STRENGTH; BAKERS-YEAST; BINDING; GENES; IDENTIFICATION; OXYGEN; HEME	Subunit V, one of the nuclear coded subunits of yeast cytochrome c oxidase, has two isoforms, Va and Vb. These alter the in vivo intramolecular rates of electron transfer within the holoenzyme (Waterland, R. A., Basu, A., Chance, B., and Poyton, R. O. (1991) J. Biol. Chen. 266, 4180-4186). The isozyme with Vb has a higher turnover rate and a higher intramolecular transfer rate than the isozyme with Va. To determine how these isoforms affect catalysis, we have examined their effects on the binuclear reaction center and on the interaction between cytochrome c oxidase and the two isoforms, iso-1 and iso-2, of yeast cytochrome c. Infrared spectroscopy of carbon monoxide liganded to heme a(3) has revealed a single conformer for the binuclear reaction center in the isozyme with Vb but two discrete conformers in the isozyme with Va. The kinetics of interaction for all four pairwise combinations of isozymes with each subunit V isoform and the two cytochrome c isoforms are biphasic, with high and low affinity electron transfer reactions. In general, the isoforms of cytochrome c and subunit V do not alter the K-m but do affect the TNmax. The TNmax for isozymes carrying Vb are higher at both high and low affinity sites for each cytochrome c isoform. Iso-1-cytochrome c supports a higher TNmax than Iso-2-cytochrome c. Surprisingly, the combinatorial effect of both sets of isoforms on TNmax is minimized with the pairs of isoforms (iso-1-cytochrome c and subunit Va or iso-2 and subunit Vb) that are co-expressed in cells. Together, these findings support the conclusion that the subunit V isoforms modulate catalysis and suggest that they do so by affecting the environment or structure of the binuclear reaction center. They also suggest that the coexpression of the two cytochrome c isoforms with two subunit V isoforms serves to minimize differences in electron transfer rates brought about by the subunit V isoforms.	UNIV COLORADO, DEPT MOLEC CELLULAR & DEV BIOL, BOULDER, CO 80309 USA; COLORADO STATE UNIV, DEPT BIOCHEM & MOLEC BIOL, FT COLLINS, CO 80523 USA	University of Colorado System; University of Colorado Boulder; Colorado State University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM030306, R01GM030306, R01GM039324] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM39324, GM30306] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEYNE TA, 1992, BIOCHEM J, V287, P951, DOI 10.1042/bj2870951; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; BISSON R, 1977, FEBS LETT, V81, P147, DOI 10.1016/0014-5793(77)80948-4; BORDEN M, 1967, HDB BIOCH, V3, P268; BRUNORI M, 1987, EUR J BIOCHEM, V169, P1, DOI 10.1111/j.1432-1033.1987.tb13572.x; BRUNORI M, 1985, EMBO J, V4, P2365, DOI 10.1002/j.1460-2075.1985.tb03940.x; BRZEZINSKI P, 1986, P NATL ACAD SCI USA, V83, P4282, DOI 10.1073/pnas.83.12.4282; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; CAUGHEY WS, 1993, J BIOENERG BIOMEMBR, V25, P81, DOI 10.1007/BF00762850; CAUGHEY WS, 1970, J CHEM SOC CHEM COMM, P950, DOI 10.1039/c29700000950; CUMSKY MG, 1987, MOL CELL BIOL, V7, P3511, DOI 10.1128/MCB.7.10.3511; DETHMERS JK, 1979, J BIOL CHEM, V254, P1973; EINARSDOTTIR O, 1988, J BIOL CHEM, V263, P13641; FERGUSONMILLER S, 1978, J BIOL CHEM, V253, P149; FERGUSONMILLER S, 1976, J BIOL CHEM, V251, P1104; GARBER EAE, 1990, BIOCHIM BIOPHYS ACTA, V1015, P279, DOI 10.1016/0005-2728(90)90032-Y; GARBER EAE, 1988, OXIDASES RELATED RED, P749; GELLES J, 1986, BIOCHIM BIOPHYS ACTA, V853, P205, DOI 10.1016/0304-4173(87)90002-4; GEORGENASCIMENTO C, 1981, J BIOL CHEM, V256, P9363; HALL J, 1988, J BIOL CHEM, V263, P8142; HILL BC, 1991, J BIOL CHEM, V266, P2219; HODGE MR, 1989, MOL CELL BIOL, V9, P1958, DOI 10.1128/MCB.9.5.1958; MASON TL, 1973, J BIOL CHEM, V248, P1346; MERLE P, 1980, EUR J BIOCHEM, V105, P499, DOI 10.1111/j.1432-1033.1980.tb04525.x; MICHEL B, 1984, J BIOL CHEM, V259, P85; MILLETT F, 1983, BIOCHEMISTRY-US, V22, P546, DOI 10.1021/bi00272a004; MILLETT F, 1982, BIOCHEMISTRY-US, V21, P3857, DOI 10.1021/bi00259a021; NICHOLLS P, 1965, OXIDASES RELATED RED, P764; Osheroff N. O., 1978, FRONTIERS BIOL ENERG, V1, P439; PATTERSON TE, 1987, CYTOCHROME SYSTEMS M, P253; POTTER WT, 1990, BIOCHEMISTRY-US, V29, P6283, DOI 10.1021/bi00478a025; POWER SD, 1984, J BIOL CHEM, V259, P6564; POYTON RO, 1975, J BIOL CHEM, V250, P752; POYTON RO, 1988, ANN NY ACAD SCI, V550, P289, DOI 10.1111/j.1749-6632.1988.tb35344.x; POYTON RO, 1992, BIOCHIM BIOPHYS ACTA, V1101, P252, DOI 10.1016/S0005-2728(05)80033-7; POYTON RO, 1995, IN PRESS METHODS ENZ; SARASTE M, 1990, Q REV BIOPHYS, V23, P331, DOI 10.1017/S0033583500005588; SHAPLEIGH JP, 1992, P NATL ACAD SCI USA, V89, P4786, DOI 10.1073/pnas.89.11.4786; SINJORGO KMC, 1986, BIOCHIM BIOPHYS ACTA, V850, P108, DOI 10.1016/0005-2728(86)90014-9; SMITH L, 1963, BIOCHEMISTRY-US, V2, P1432, DOI 10.1021/bi00906a040; SPECK SH, 1984, P NATL ACAD SCI-BIOL, V81, P347, DOI 10.1073/pnas.81.2.347; TAANMAN JW, 1992, J BIOL CHEM, V267, P22481; TAYLOR JR, 1982, INTRO ERROR ANAL, P153; TRUEBLOOD CE, 1988, GENETICS, V120, P671; TRUEBLOOD CE, 1987, MOL CELL BIOL, V7, P3520, DOI 10.1128/MCB.7.10.3520; TRUEBLOOD CE, 1988, MOL CELL BIOL, V8, P4537, DOI 10.1128/MCB.8.10.4537; WATERLAND RA, 1991, J BIOL CHEM, V266, P4180; WIKSTROM M, 1989, NATURE, V338, P776, DOI 10.1038/338776a0; WILMS J, 1981, BIOCHIM BIOPHYS ACTA, V635, P13, DOI 10.1016/0005-2728(81)90003-7; WRIGHT RM, 1987, CYTOCHROME SYSTEMS M, P49; YOSHIKAWA S, 1977, J BIOL CHEM, V252, P5498; YOUNG LJ, 1984, BIOCHEM BIOPH RES CO, V123, P247, DOI 10.1016/0006-291X(84)90405-4	52	79	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					110	118		10.1074/jbc.270.1.110	http://dx.doi.org/10.1074/jbc.270.1.110			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814361	hybrid			2022-12-27	WOS:A1995QA28700022
J	BALASUBRAMANIAN, S; BEGER, RD; BENNETT, SE; MOSBAUGH, DW; BOLTON, PH				BALASUBRAMANIAN, S; BEGER, RD; BENNETT, SE; MOSBAUGH, DW; BOLTON, PH			SECONDARY STRUCTURE OF URACIL-DNA GLYCOSYLASE INHIBITOR PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDEHYDIC ABASIC SITES; UV ENDONUCLEASE-V; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; NMR-SPECTROSCOPY; CYTOSINE RESIDUES; VACCINIA VIRUS; N-GLYCOSIDASE; DUPLEX DNA; BACTERIOPHAGE-PBS2	The Bacillus subtilis bacteriophage PBS2 uracil-DNA glycosylase inhibitor (Ugi) is an acidic protein of 84 amino acids that inactivates uracil-DNA glycosylase from diverse organisms (Wang, Z., and Mosbaugh, D, W. (1989) J. Biol. Chem. 264, 1163-1171). The secondary structure of Ugi has been determined by solution state multidimensional nuclear magnetic resonance, The protein adopts a single well defined structure consisting of five anti parallel beta-strands and two alpha-helices. Six loop or turn regions were identified that contain approximately one half of the acidic amino acid residues and connect the beta-strands sequentially to one another, The secondary structure suggests which regions of Ugi may be involved in interactions with uracil-DNA glycosylase.	WESLEYAN UNIV,DEPT CHEM,MIDDLETOWN,CT 06450; OREGON STATE UNIV,DEPT AGR CHEM,CORVALLIS,OR 97331; OREGON STATE UNIV,DEPT BIOCHEM & BIOPHYS,CORVALLIS,OR 97331; OREGON STATE UNIV,CTR ENVIRONM HLTH SCI,CORVALLIS,OR 97331	Wesleyan University; Oregon State University; Oregon State University; Oregon State University				Balasubramanian, Suganthi/0000-0003-2243-5948	NIEHS NIH HHS [ES 00210] Funding Source: Medline; NIGMS NIH HHS [GM 32823] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032823] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENNETT SE, 1993, J BIOL CHEM, V268, P26879; BENNETT SE, 1992, J BIOL CHEM, V267, P22512; BENNETT SE, 1994, J BIOL CHEM, V269, P21870; CARRADONNA SJ, 1981, J BIOL CHEM, V256, P9834; CLORE GM, 1993, J MOL BIOL, V231, P82, DOI 10.1006/jmbi.1993.1259; CONE R, 1977, BIOCHEMISTRY-US, V16, P3194, DOI 10.1021/bi00633a024; DIANOV G, 1992, MOL CELL BIOL, V12, P1605, DOI 10.1128/MCB.12.4.1605; DISTEFANO DL, 1987, BIOCHEMISTRY-US, V26, P7272, DOI 10.1021/bi00397a012; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; EMERSON SD, 1994, BIOCHEMISTRY-US, V33, P7745, DOI 10.1021/bi00191a001; FOCHER F, 1993, BIOCHEM J, V292, P883, DOI 10.1042/bj2920883; FOCHER F, 1992, CHROMOSOMA, V102, pS67, DOI 10.1007/BF02451788; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; FRIEDBERG EC, 1975, J VIROL, V16, P315, DOI 10.1128/JVI.16.2.315-321.1975; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; GOLJER I, 1992, BIOCHEMISTRY-US, V31, P11614, DOI 10.1021/bi00161a047; HITZEMAN RA, 1978, J BIOL CHEM, V253, P8518; KARRAN P, 1981, BIOCHEMISTRY-US, V20, P6092, DOI 10.1021/bi00524a027; KLUPP BG, 1994, J VIROL, V68, P3868, DOI 10.1128/JVI.68.6.3868-3878.1994; LEMASTER DM, 1994, PROG NUCL MAG RES SP, V26, P371, DOI 10.1016/0079-6565(94)80010-3; LINDAHL T, 1977, J BIOL CHEM, V252, P3286; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; MANOHARAN M, 1988, J AM CHEM SOC, V110, P2690, DOI 10.1021/ja00216a074; MANOHARAN M, 1988, J AM CHEM SOC, V110, P1620, DOI 10.1021/ja00213a044; MAZUMDER A, 1991, BIOCHEMISTRY-US, V30, P1119, DOI 10.1021/bi00218a033; MAZUMDER A, 1989, J AM CHEM SOC, V111, P8029, DOI 10.1021/ja00202a062; MILLNS AK, 1994, VIROLOGY, V198, P504, DOI 10.1006/viro.1994.1061; MOSBAUGH DW, 1993, PROG NUCLEIC ACID RE, V48, P315; OLSEN LC, 1991, NUCLEIC ACIDS RES, V19, P4473, DOI 10.1093/nar/19.16.4473; OLSEN LC, 1989, EMBO J, V8, P3121, DOI 10.1002/j.1460-2075.1989.tb08464.x; PALMER AG, 1992, J MAGN RESON, V96, P416, DOI 10.1016/0022-2364(92)90097-Q; PRICE AR, 1975, J BIOL CHEM, V250, P8804; STUART DT, 1993, J VIROL, V67, P2503, DOI 10.1128/JVI.67.5.2503-2512.1993; TAKAHASHI I, 1963, NATURE, V197, P794, DOI 10.1038/197794a0; TARTAGLIA J, 1990, J GEN VIROL, V71, P1517, DOI 10.1099/0022-1317-71-7-1517; UPTON C, 1993, P NATL ACAD SCI USA, V90, P4518, DOI 10.1073/pnas.90.10.4518; WANG Z, 1989, J BIOL CHEM, V264, P1163; WANG ZG, 1988, J BACTERIOL, V170, P1082, DOI 10.1128/jb.170.3.1082-1091.1988; WANG ZG, 1991, GENE, V99, P31; WILDE JA, 1989, J AM CHEM SOC, V111, P1894, DOI 10.1021/ja00187a062; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; WITHKA JM, 1991, BIOCHEMISTRY-US, V30, P9931, DOI 10.1021/bi00105a017; WORRAD DM, 1988, J VIROL, V62, P4774, DOI 10.1128/JVI.62.12.4774-4777.1988; WUTHRICH K, 1990, J BIOL CHEM, V265, P22059; Wuthrich K., 1986, NMR PROTEINS NUCL AC	45	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 6	1995	270	1					296	303		10.1074/jbc.270.1.296	http://dx.doi.org/10.1074/jbc.270.1.296			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	QA287	7814390	hybrid			2022-12-27	WOS:A1995QA28700047
